data_1k0s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1k0s _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.793 0.33 . . . . 10.0 110.406 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 29.3 mp0 -103.88 164.31 11.78 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.426 0.631 . . . . 10.0 110.975 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.628 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 17.5 t80 -161.4 140.11 9.77 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.936 -1.029 . . . . 10.0 112.963 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 32.6 mt-10 -88.71 140.54 29.34 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.639 -0.709 . . . . 10.0 109.622 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.651 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -155.85 168.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 113.093 0.775 . . . . 10.0 113.093 -175.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 2.3 tm? -88.89 134.2 34.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.521 -1.289 . . . . 10.0 107.521 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.529 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 81.1 p -143.03 152.97 42.48 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.592 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 6.1 p90 -150.42 167.6 26.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.299 -1.319 . . . . 10.0 110.297 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -88.55 138.5 31.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.682 -0.488 . . . . 10.0 109.682 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 HG13 HD23 ' A' ' 23' ' ' LEU . 33.4 mm -136.56 93.23 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.335 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 50.1 m-20 45.59 60.08 3.28 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.593 -0.731 . . . . 10.0 112.513 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.6 mt-10 83.73 -39.99 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.29 -0.868 . . . . 10.0 112.081 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.3 pt20 -88.91 149.55 23.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.164 -0.31 . . . . 10.0 110.164 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.535 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.55 159.52 17.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.338 . . . . 10.0 110.893 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.546 ' HG ' ' CE1' ' A' ' 16' ' ' PHE . 2.1 tp -147.67 136.88 22.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.768 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -136.92 146.87 45.99 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.517 0.562 . . . . 10.0 112.517 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 2.0 m-30 -121.47 135.87 55.0 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.585 -0.894 . . . . 10.0 108.585 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.558 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 28.3 t70 -44.2 100.95 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.581 0.705 . . . . 10.0 110.499 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.518 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 6.2 p -50.37 -14.44 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.648 -1.16 . . . . 10.0 111.978 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.558 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 7.6 m-20 -64.51 -44.65 90.23 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.468 -0.493 . . . . 10.0 109.906 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -83.24 -41.51 18.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.725 -0.671 . . . . 10.0 110.733 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.404 HG23 ' HG ' ' A' ' 14' ' ' LEU . 32.9 mm -59.64 123.5 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.58 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 32' ' ' MET . 66.6 mm-40 -81.97 -61.89 1.78 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.01 0.374 . . . . 10.0 112.01 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.6 mtm -169.04 157.27 7.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 10.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -88.92 137.16 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.934 -0.576 . . . . 10.0 111.228 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.507 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 11.4 pt -123.96 135.53 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.345 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -88.99 118.74 28.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.518 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HB3' HD11 ' A' ' 81' ' ' ILE . 39.5 ttmt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.958 0.409 . . . . 10.0 110.917 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -68.86 -30.5 69.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.3 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.413 ' O ' HG13 ' A' ' 52' ' ' VAL . . . -166.82 -175.91 37.39 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.536 -0.84 . . . . 10.0 112.959 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 61' ' ' PRO . 2.9 m -160.42 170.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.123 -0.695 . . . . 10.0 109.123 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.425 HG12 HD13 ' A' ' 60' ' ' ILE . 30.1 pt . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 120.992 0.425 . . . . 10.0 111.884 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.479 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.3 pp . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.594 0.235 . . . . 10.0 110.983 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 85.0 Cg_endo -92.83 124.42 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.932 2.422 . . . . 10.0 112.735 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.432 ' O ' HG21 ' A' ' 62' ' ' VAL . 23.2 m -102.79 125.34 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.788 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 14.0 t -130.66 -175.9 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.283 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.594 ' H ' ' CG1' ' A' ' 63' ' ' VAL . 5.2 m120 -120.24 96.85 5.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.71 -0.223 . . . . 10.0 110.526 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.778 ' O ' HG22 ' A' ' 68' ' ' ILE . 3.1 tt -56.21 -32.13 64.11 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.273 0.559 . . . . 10.0 109.838 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.68 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -61.74 -24.52 66.86 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.23 -0.441 . . . . 10.0 109.884 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.446 ' HD2' ' C ' ' A' ' 67' ' ' LYS . 1.4 tmmm? -82.28 -44.04 16.77 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.295 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.778 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.7 tt -64.58 -40.85 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.447 -0.946 . . . . 10.0 108.447 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.641 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -77.88 -53.01 7.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 113.903 -1.499 . . . . 10.0 109.487 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.574 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 118.93 -80.48 0.32 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 115.454 -0.794 . . . . 10.0 112.702 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.828 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.3 pt 45.19 178.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.7 m -55.44 -37.53 67.82 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 109.054 -0.721 . . . . 10.0 109.054 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.828 ' HB3' HG13 ' A' ' 71' ' ' ILE . 16.1 t80 -31.07 143.92 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.772 -1.104 . . . . 10.0 112.995 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 9.4 t70 -169.84 39.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.351 -0.84 . . . . 10.0 109.702 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 56.13 39.04 30.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.034 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -87.24 -63.76 1.26 Allowed 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 112.327 0.492 . . . . 10.0 112.327 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -108.35 16.24 23.3 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.538 0.57 . . . . 10.0 112.538 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.508 ' HE2' ' CD1' ' A' ' 73' ' ' PHE . 17.7 mmt -52.86 138.33 29.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.907 -0.133 . . . . 10.0 110.963 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -159.46 -48.63 0.05 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.524 0.565 . . . . 10.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.401 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 65.1 m -88.94 163.75 15.44 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.803 0.298 . . . . 10.0 111.803 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 94' ' ' LEU . 72.6 mt -127.7 154.15 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.031 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 11.8 mt -128.15 146.12 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.421 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.14 149.93 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.438 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -156.86 130.61 8.23 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.497 -0.32 . . . . 10.0 111.776 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.521 ' C ' HG22 ' A' ' 86' ' ' THR . 15.0 ptm180 -88.8 133.17 34.34 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.715 -0.846 . . . . 10.0 108.715 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.521 HG22 ' C ' ' A' ' 85' ' ' ARG . 43.8 p -147.63 108.61 4.22 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.669 0.618 . . . . 10.0 112.669 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 47.78 49.25 16.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.705 -0.68 . . . . 10.0 110.82 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 70.41 33.65 2.44 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.216 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.55 HG11 HG21 ' A' ' 91' ' ' VAL . 76.8 t -133.56 111.63 16.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.24 -0.891 . . . . 10.0 109.34 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.544 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 39.8 mt-10 -88.56 92.45 9.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.114 -1.439 . . . . 10.0 107.114 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.55 HG21 HG11 ' A' ' 89' ' ' VAL . 2.7 t -88.66 158.15 3.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 112.796 -2.002 . . . . 10.0 111.719 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -138.11 144.6 15.88 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 120.165 -1.016 . . . . 10.0 113.458 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.62 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 t80 -133.36 122.02 23.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.777 0.323 . . . . 10.0 110.618 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 6.5 tt -88.85 132.56 34.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.141 0.496 . . . . 10.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.518 ' N ' HD22 ' A' ' 94' ' ' LEU . 15.9 m -130.94 -175.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.431 -0.804 . . . . 10.0 111.373 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -81.27 -75.95 0.26 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.153 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -134.27 107.17 7.51 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.282 -0.872 . . . . 10.0 108.733 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.592 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -88.97 116.99 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 122.418 1.104 . . . . 10.0 111.967 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.571 HD22 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -68.75 -27.59 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.909 -1.95 . . . . 10.0 110.715 -178.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.74 -126.58 8.34 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.635 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -52.28 133.14 14.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.976 0.388 . . . . 10.0 110.754 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.564 ' HG ' HG12 ' A' ' 104' ' ' ILE . 43.9 tp -137.7 138.33 39.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.059 0.457 . . . . 10.0 110.854 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.6 ptp180 -88.8 72.74 8.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.198 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.651 ' HB ' HG11 ' A' ' 13' ' ' VAL . 14.3 mm -88.98 131.62 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.771 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.6 p -88.76 147.24 24.56 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.356 -1.72 . . . . 10.0 106.356 175.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -134.47 81.77 1.93 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.365 -0.934 . . . . 10.0 113.08 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -76.05 -5.28 45.7 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.296 -0.865 . . . . 10.0 109.343 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.335 -179.766 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.54 ' CE2' ' CD2' ' A' ' 69' ' ' LEU . 4.3 t80 . . . . . 0 CA--C 1.515 -0.377 0 CA-C-O 121.534 0.683 . . . . 10.0 109.487 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 122' ' ' SER . . . -74.2 35.6 0.94 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.857 -1.065 . . . . 10.0 113.351 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 118' ' ' PHE . 34.4 mmtp -79.34 -32.63 43.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.346 0.593 . . . . 10.0 109.452 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 17.1 tppt? -156.9 32.99 0.3 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.195 -0.911 . . . . 10.0 110.112 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.619 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 79.6 p . . . . . 0 CA--C 1.53 0.193 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.211 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.539 HG13 ' HB ' ' A' ' 133' ' ' ILE . 2.3 p . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 121.34 0.59 . . . . 10.0 111.605 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.47 ' NZ ' ' HB3' ' A' ' 127' ' ' LYS . 7.2 ttpm? -152.14 140.31 20.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 18.7 m -159.67 144.63 15.32 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.887 0.375 . . . . 10.0 111.109 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.421 ' OD1' ' HB3' ' A' ' 131' ' ' ARG . 2.9 p30 45.95 48.36 12.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.615 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.07 42.41 81.2 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.711 -0.757 . . . . 10.0 112.383 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.7 OUTLIER -136.25 139.93 43.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.823 0.344 . . . . 10.0 110.454 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 4.1 mp -88.87 137.28 32.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.98 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.539 ' HB ' HG13 ' A' ' 126' ' ' VAL . 5.0 mt -156.03 151.36 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.551 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.508 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.7 mp -101.41 144.69 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.516 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 35.6 t80 -139.75 142.64 36.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.839 -0.744 . . . . 10.0 111.973 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.709 HD23 ' H ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -158.1 144.17 17.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.644 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 9.2 t70 -97.2 33.99 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.718 . . . . 10.0 110.004 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.82 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 18.5 tt 42.4 20.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.048 -0.978 . . . . 10.0 113.337 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.408 ' O ' HG22 ' A' ' 142' ' ' ILE . 38.6 t70 -77.14 -54.97 5.85 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -79.21 -30.66 43.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.151 0.5 . . . . 10.0 110.937 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.82 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.46 -45.33 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.657 -0.701 . . . . 10.0 110.199 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.626 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 8.3 tp -67.17 -45.5 86.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 120.622 -0.431 . . . . 10.0 110.538 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -48.05 -43.21 30.18 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.374 0.607 . . . . 10.0 109.64 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -72.44 -31.33 65.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.083 -0.962 . . . . 10.0 110.865 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.732 HG13 ' O ' ' A' ' 141' ' ' ILE . 38.6 mt -54.99 -41.59 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.942 0.401 . . . . 10.0 110.652 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.8 p -81.01 -52.26 7.62 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.926 -0.579 . . . . 10.0 112.162 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.8 p -82.14 13.1 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.697 0.284 . . . . 10.0 111.739 -178.869 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.423 ' HG3' ' HG3' ' A' ' 10' ' ' GLU . 21.0 ptmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.89 0.376 . . . . 10.0 110.964 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 39.8 mt-10 -117.7 164.26 15.25 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.319 0.58 . . . . 10.0 110.471 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.569 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 15.5 t80 -157.25 137.16 12.47 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.005 -0.998 . . . . 10.0 112.748 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -88.73 139.86 30.04 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.476 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.727 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.1 p -156.06 171.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.55 ' N ' HG21 ' A' ' 13' ' ' VAL . 3.3 tm? -88.92 137.18 32.55 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.609 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 76.7 p -149.19 153.62 37.92 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.685 0.995 . . . . 10.0 113.685 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.682 ' HZ ' ' CE1' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -147.18 156.43 42.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.154 -1.384 . . . . 10.0 110.142 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -88.77 99.91 12.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.388 0.613 . . . . 10.0 109.868 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.549 HG13 HD23 ' A' ' 23' ' ' LEU . 27.6 mm -88.91 101.36 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.034 -0.985 . . . . 10.0 111.866 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.1 m-20 46.18 60.15 3.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.566 -0.743 . . . . 10.0 112.926 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.7 mt-10 86.6 -39.63 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.385 -0.825 . . . . 10.0 112.015 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 16.5 pt20 -88.83 -175.61 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.788 -0.449 . . . . 10.0 109.788 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.556 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -115.43 158.11 22.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.171 0.51 . . . . 10.0 111.472 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.577 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -145.39 133.3 21.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.144 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -137.05 149.43 47.42 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.717 1.006 . . . . 10.0 113.717 -177.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.682 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 0.9 OUTLIER -132.18 138.11 47.87 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.634 -1.167 . . . . 10.0 108.329 178.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -49.0 122.69 6.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.066 0.46 . . . . 10.0 111.325 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 14' ' ' LEU . 23.9 m -61.05 -14.24 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.63 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.14 -39.78 91.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.068 0.461 . . . . 10.0 110.22 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -95.49 -44.77 7.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.245 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mm -57.32 129.53 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.59 -0.277 . . . . 10.0 110.471 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 32' ' ' MET . 50.4 mt-10 -88.32 -61.6 1.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.5 mtm -169.03 157.95 8.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.983 0.42 . . . . 10.0 111.563 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -88.87 151.16 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.474 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.529 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 13.5 pt -154.13 134.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.01 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.93 111.81 24.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 10.0 110.608 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.699 -179.758 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.461 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 48.7 t . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.872 0.367 . . . . 10.0 110.902 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.9 -37.82 62.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.146 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.02 -175.86 38.08 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.958 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 61' ' ' PRO . 2.5 m -154.16 170.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.839 -0.43 . . . . 10.0 109.839 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.443 HG12 HD13 ' A' ' 60' ' ' ILE . 30.9 pt . . . . . 0 C--N 1.324 -0.524 0 CA-C-O 120.867 0.365 . . . . 10.0 111.084 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.3 pp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.523 0.202 . . . . 10.0 110.935 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 79.5 Cg_endo -92.02 114.31 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.762 2.308 . . . . 10.0 113.383 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 m -91.05 136.03 25.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.461 ' CG2' ' HA ' ' A' ' 49' ' ' VAL . 62.7 t -139.09 159.01 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.719 0.771 . . . . 10.0 112.92 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.434 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 5.7 m120 -74.14 63.0 0.95 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.745 -1.116 . . . . 10.0 109.062 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.796 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.9 tt -53.69 -32.21 50.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.763 -0.653 . . . . 10.0 111.22 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.644 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -62.85 -24.09 67.61 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.259 -0.576 . . . . 10.0 109.872 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.508 ' N ' ' HE2' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -83.06 -45.41 14.05 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.137 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.796 HG22 ' O ' ' A' ' 65' ' ' LEU . 9.6 tt -57.73 -38.67 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 107.687 -1.227 . . . . 10.0 107.687 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.619 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.22 -47.15 18.61 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.801 -1.545 . . . . 10.0 108.473 177.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 117.67 -90.5 0.5 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.456 -0.793 . . . . 10.0 112.714 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.842 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.2 pt 47.66 165.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.399 0.889 . . . . 10.0 113.399 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.6 m -47.05 -37.77 9.99 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.18 -0.674 . . . . 10.0 109.18 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.842 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.6 t80 -28.08 141.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.395 -1.275 . . . . 10.0 113.283 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -166.79 37.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.241 -0.891 . . . . 10.0 110.235 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 55.94 32.67 20.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.78 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.433 ' NE2' ' OD2' ' A' ' 19' ' ' ASP . 22.3 pt20 -95.42 -44.41 7.56 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -113.2 13.94 19.32 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.23 0.456 . . . . 10.0 112.23 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.431 ' HE2' ' CD1' ' A' ' 73' ' ' PHE . 29.5 mmt -59.8 140.62 56.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.904 0.383 . . . . 10.0 111.686 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 14.4 ptmm? -179.64 39.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.817 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.3 t -169.19 164.85 11.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.795 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 43.6 mt -139.84 152.25 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.961 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.586 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 9.8 mt -131.36 130.35 62.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.727 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.6 t -98.24 156.83 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.051 0.453 . . . . 10.0 111.307 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -156.52 172.1 19.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.617 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.431 ' C ' HG22 ' A' ' 86' ' ' THR . 14.4 ptm180 -130.6 130.7 44.34 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.468 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 46.7 p -145.36 109.27 4.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 87' ' ' LYS . 8.1 ttpt 48.02 49.89 16.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.614 0.721 . . . . 10.0 110.689 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 71.0 32.13 2.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.037 -0.983 . . . . 10.0 111.484 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.543 HG11 HG21 ' A' ' 91' ' ' VAL . 71.4 t -129.01 109.52 18.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.275 -0.875 . . . . 10.0 109.192 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.644 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 25.0 mp0 -88.35 97.36 11.0 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.278 -1.749 . . . . 10.0 106.278 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.543 HG21 HG11 ' A' ' 89' ' ' VAL . 3.6 t -88.55 153.55 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 113.291 -1.777 . . . . 10.0 113.016 -174.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.97 158.03 18.47 Favored Glycine 0 C--N 1.317 -0.485 0 CA-C-N 114.495 -1.229 . . . . 10.0 113.185 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.622 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -146.95 128.11 14.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.873 0.368 . . . . 10.0 110.915 -179.168 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.488 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 52.1 tp -88.66 128.14 35.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.999 0.428 . . . . 10.0 110.751 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.505 HG13 ' CE2' ' A' ' 16' ' ' PHE . 29.8 m -137.01 -175.11 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.428 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 45.8 t0 -92.96 -73.33 0.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.354 0.597 . . . . 10.0 111.17 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.9 ttt-85 -137.63 120.81 16.8 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.196 -0.911 . . . . 10.0 108.616 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.594 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.1 p -101.69 117.12 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 122.361 1.077 . . . . 10.0 112.898 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -65.42 -28.82 69.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.083 -1.871 . . . . 10.0 111.059 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.57 -122.63 6.57 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.552 -0.833 . . . . 10.0 111.171 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.97 133.59 16.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 117.045 0.422 . . . . 10.0 110.322 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.646 ' HG ' HG12 ' A' ' 104' ' ' ILE . 57.2 tp -136.17 137.72 41.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.989 0.423 . . . . 10.0 111.048 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.9 ptp180 -88.85 71.73 8.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.315 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.727 ' HB ' HG11 ' A' ' 13' ' ' VAL . 14.2 mm -88.84 128.45 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.732 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 18.5 p -88.68 147.59 24.44 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.655 -1.609 . . . . 10.0 106.655 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -137.07 79.08 1.73 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.443 -0.903 . . . . 10.0 112.663 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -72.98 -10.6 59.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.619 -0.719 . . . . 10.0 109.533 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-N 115.443 -0.799 . . . . 10.0 110.932 -179.701 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.597 ' CE1' HD23 ' A' ' 69' ' ' LEU . 56.6 t80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.11 0.481 . . . . 10.0 110.55 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 150.53 -54.5 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.568 -0.742 . . . . 10.0 112.091 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 54.9 tptt 173.85 60.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.978 0.418 . . . . 10.0 110.063 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 118' ' ' PHE . 4.2 tppp? -154.47 -39.43 0.09 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.658 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.635 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 94.9 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.561 -0.291 . . . . 10.0 110.724 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.553 ' CG1' ' HB2' ' A' ' 135' ' ' TYR . 2.4 p . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 121.452 0.644 . . . . 10.0 112.28 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -158.95 138.45 11.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.502 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 7.0 m -165.01 146.83 7.86 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.926 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 54.79 42.71 30.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.986 0.422 . . . . 10.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.4 37.68 60.67 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.836 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -130.15 136.58 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.273 -0.269 . . . . 10.0 110.273 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 133' ' ' ILE . 4.7 tt -88.93 136.75 32.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.605 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.556 HG12 ' CB ' ' A' ' 22' ' ' ALA . 6.0 mt -154.01 143.48 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 10.0 110.789 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.515 ' O ' HD11 ' A' ' 23' ' ' LEU . 2.0 mp -96.1 134.8 32.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 109.072 -0.714 . . . . 10.0 109.072 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.553 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 41.1 t80 -129.33 140.4 51.4 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.773 -0.771 . . . . 10.0 111.385 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.635 ' CB ' ' HB2' ' A' ' 122' ' ' SER . 0.0 OUTLIER -159.97 151.2 19.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.36 0.6 . . . . 10.0 111.881 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 139' ' ' ASP . 1.4 m-20 -102.33 37.87 1.8 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.498 -0.774 . . . . 10.0 110.501 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.835 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 19.8 tt 39.63 20.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.58 -1.191 . . . . 10.0 113.653 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.494 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.9 t70 -79.53 -57.45 3.68 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -76.92 -32.5 57.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 10.0 110.356 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.835 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.78 -45.68 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.183 -0.917 . . . . 10.0 110.489 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.629 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.5 tp -64.13 -44.82 97.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 120.375 -0.53 . . . . 10.0 109.953 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -48.13 -43.16 30.92 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.404 ' OE2' ' HD3' ' A' ' 121' ' ' LYS . 44.5 mt-10 -69.99 -32.89 71.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.236 -0.893 . . . . 10.0 110.58 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 141' ' ' ILE . 34.1 mt -55.51 -40.38 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 120.953 0.406 . . . . 10.0 110.801 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.6 p -77.74 -50.63 12.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.873 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.6 p -77.89 5.06 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.088 0.403 . . . . 10.0 112.088 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.9 pttm . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.696 0.284 . . . . 10.0 111.638 -179.356 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 tptm . . . . . 0 CA--C 1.526 0.036 0 N-CA-C 111.835 0.309 . . . . 10.0 111.835 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 34.2 mt-10 -121.69 164.28 17.63 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.738 0.78 . . . . 10.0 111.513 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 12.7 t80 -158.76 136.71 10.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.268 -1.333 . . . . 10.0 112.259 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.75 140.76 29.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.655 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.802 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -157.99 171.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 113.583 0.957 . . . . 10.0 113.583 -174.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.0 tm? -88.77 132.1 34.77 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.61 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 80.9 p -143.7 156.92 44.69 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.542 0.942 . . . . 10.0 113.542 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.626 ' CZ ' ' HG ' ' A' ' 23' ' ' LEU . 4.1 p90 -153.11 158.35 41.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.902 -1.499 . . . . 10.0 109.81 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -88.58 125.4 34.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.351 0.596 . . . . 10.0 109.556 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.568 HG22 ' CD1' ' A' ' 71' ' ' ILE . 32.9 mm -115.09 81.03 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.51 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 58.8 m-20 52.29 60.26 3.94 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.957 -0.565 . . . . 10.0 112.12 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 8.2 mp0 80.96 -31.97 0.11 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.261 -0.881 . . . . 10.0 111.771 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -88.81 137.82 31.97 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.076 -0.712 . . . . 10.0 109.076 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.541 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.65 155.09 19.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.044 0.45 . . . . 10.0 111.21 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.626 ' HG ' ' CZ ' ' A' ' 16' ' ' PHE . 1.8 tp -148.14 140.85 24.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.355 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -144.99 155.93 43.67 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.893 0.701 . . . . 10.0 112.893 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.515 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.3 m-85 -136.4 141.21 43.62 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.319 -0.855 . . . . 10.0 109.187 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.07 120.54 5.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.195 0.521 . . . . 10.0 110.692 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 14' ' ' LEU . 34.2 m -60.36 -12.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.048 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -62.14 -46.86 87.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.006 0.431 . . . . 10.0 110.376 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.429 ' ND2' ' CG2' ' A' ' 138' ' ' ILE . 13.9 t30 -86.67 -45.33 11.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.924 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.4 mm -57.71 126.8 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.784 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.11 -65.78 0.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.533 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -169.13 168.77 9.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 10.0 111.683 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.86 148.4 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.366 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.404 HD12 ' HD2' ' A' ' 36' ' ' LYS . 17.6 pt -150.85 128.81 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -88.85 63.76 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.446 . . . . 10.0 111.234 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 68.6 mttm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.205 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.459 ' CG1' HG13 ' A' ' 52' ' ' VAL . 48.0 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.921 0.391 . . . . 10.0 111.57 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -61.02 -29.19 69.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.962 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.21 168.19 31.36 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.435 -0.888 . . . . 10.0 112.926 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 2.3 m -160.18 167.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.94 -0.393 . . . . 10.0 109.94 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 60' ' ' ILE . 29.7 pt . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.226 0.536 . . . . 10.0 112.068 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.526 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.1 pp . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.435 0.159 . . . . 10.0 111.202 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 50.6 Cg_endo -95.67 124.92 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.413 2.742 . . . . 10.0 113.431 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.54 135.63 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.76 -0.459 . . . . 10.0 109.76 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 64' ' ' ASN . 91.3 t -142.27 156.34 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.49 0.662 . . . . 10.0 112.379 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.444 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 74.5 m-20 -72.69 74.98 1.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.151 -0.931 . . . . 10.0 109.364 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.744 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.8 tt -54.87 -35.89 64.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.286 0.565 . . . . 10.0 110.859 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.665 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -59.87 -20.9 59.82 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.447 -0.501 . . . . 10.0 109.687 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -83.15 -49.42 9.5 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.098 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.2 tt -58.32 -39.59 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.707 -1.22 . . . . 10.0 107.707 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.563 ' CD1' HG21 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -79.89 -36.05 37.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.267 -1.788 . . . . 10.0 109.573 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.723 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 67.16 124.45 0.02 OUTLIER Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.676 -0.693 . . . . 10.0 112.89 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.723 HG21 ' O ' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -165.4 -168.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.727 0.411 . . . . 10.0 110.859 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 19' ' ' ASP . 67.0 m -48.43 -35.02 11.96 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.665 ' CD2' ' CB ' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -31.3 135.82 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.251 -1.341 . . . . 10.0 113.53 176.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' A' ' 75' ' ' GLU . 64.2 t0 -129.33 -65.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.156 -0.929 . . . . 10.0 110.038 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER 157.58 -27.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.332 -0.394 . . . . 10.0 111.468 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.476 ' N ' ' OE1' ' A' ' 75' ' ' GLU . 24.9 pt20 -60.06 -48.32 82.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 32.0 mmtp -77.87 -45.07 25.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.975 0.417 . . . . 10.0 111.592 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.466 ' CE ' ' HA ' ' A' ' 95' ' ' VAL . 18.5 mmm -35.62 141.58 0.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.633 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -169.4 -28.95 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.424 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 48.1 t -88.85 -175.96 5.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.628 0.252 . . . . 10.0 111.095 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 57.9 mt -156.61 140.48 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.954 0.407 . . . . 10.0 111.508 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.565 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 13.5 mt -113.27 150.12 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.607 . . . . 10.0 110.669 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.54 149.71 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.919 0.39 . . . . 10.0 110.852 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -151.3 -175.9 5.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.126 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.416 ' O ' ' CG2' ' A' ' 86' ' ' THR . 14.6 ptm180 -135.9 144.41 45.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.713 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.542 HG21 HG12 ' A' ' 138' ' ' ILE . 34.8 p -160.16 109.47 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 10.0 112.083 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.3 tppp? 47.19 47.16 16.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.691 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 53.0 m-20 74.18 33.54 0.91 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.144 -0.935 . . . . 10.0 111.279 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 91' ' ' VAL . 60.4 t -130.47 110.14 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-N 115.215 -0.902 . . . . 10.0 109.485 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 46.1 mt-10 -88.35 100.62 13.16 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.515 -2.032 . . . . 10.0 105.515 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.504 HG21 HG11 ' A' ' 89' ' ' VAL . 5.0 t -88.62 153.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 113.343 -1.753 . . . . 10.0 113.482 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.1 155.1 17.24 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 114.231 -1.349 . . . . 10.0 112.707 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.568 ' HD1' ' N ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -144.43 126.66 15.69 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 120.963 0.411 . . . . 10.0 110.963 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.568 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 55.6 tp -88.64 130.27 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.111 0.482 . . . . 10.0 110.833 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.466 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 27.3 m -140.61 -175.27 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.961 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 78' ' ' MET . 19.8 t70 -93.92 -73.05 0.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.196 0.522 . . . . 10.0 111.161 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -131.27 115.42 16.28 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.341 -0.845 . . . . 10.0 108.923 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.574 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 8.7 p -98.02 111.7 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-O 122.354 1.074 . . . . 10.0 111.455 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -64.22 -27.15 68.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.062 -1.881 . . . . 10.0 111.131 -178.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.99 -121.42 5.51 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.949 -0.86 . . . . 10.0 110.949 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.4 t -52.86 129.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 117.145 0.472 . . . . 10.0 109.908 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.62 ' HG ' HG12 ' A' ' 104' ' ' ILE . 60.8 tp -132.98 139.22 47.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.144 0.497 . . . . 10.0 111.226 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 15.9 ptp180 -88.89 71.27 8.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.564 -0.744 . . . . 10.0 109.641 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.802 ' HB ' HG11 ' A' ' 13' ' ' VAL . 6.4 mm -88.8 126.76 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.783 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 16.9 p -88.57 145.25 25.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.944 -1.873 . . . . 10.0 105.944 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -147.33 89.51 1.79 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.845 -1.142 . . . . 10.0 112.846 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -86.43 7.56 25.31 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.552 -0.749 . . . . 10.0 109.5 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-N 115.576 -0.738 . . . . 10.0 111.003 -179.24 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.504 ' CE2' ' CD2' ' A' ' 69' ' ' LEU . 29.8 t80 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.092 0.472 . . . . 10.0 110.305 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 156.6 -53.25 0.41 Allowed Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.647 -0.706 . . . . 10.0 112.038 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 27.4 tptp 174.81 57.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 10.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -153.02 -42.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.41 -0.359 . . . . 10.0 111.888 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.743 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 93.6 p . . . . . 0 C--N 1.328 -0.362 0 C-N-CA 121.017 -0.273 . . . . 10.0 111.692 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.517 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.2 p . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 121.419 0.628 . . . . 10.0 112.366 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.512 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -165.6 135.15 3.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.08 -0.964 . . . . 10.0 109.744 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 4.3 m -159.51 152.58 22.01 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.031 0.443 . . . . 10.0 111.304 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.4 t70 55.81 47.07 21.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.773 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.72 33.55 49.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.513 -0.851 . . . . 10.0 111.663 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.6 ptp180 -138.78 134.0 32.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.348 . . . . 10.0 110.332 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.88 148.52 23.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.172 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.541 HG12 ' CB ' ' A' ' 22' ' ' ALA . 2.9 mt -147.97 132.31 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.656 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.552 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.3 mp -88.78 141.2 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.441 ' OH ' ' CZ ' ' A' ' 11' ' ' PHE . 24.4 t80 -125.95 147.22 49.56 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.521 0.677 . . . . 10.0 111.595 -178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.743 ' HG ' ' HB2' ' A' ' 122' ' ' SER . 6.7 mp -140.3 165.73 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.042 0.925 . . . . 10.0 112.86 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.431 ' O ' HG21 ' A' ' 138' ' ' ILE . 35.6 t70 -135.21 26.16 3.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.849 -1.523 . . . . 10.0 107.833 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.816 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.4 tt 42.29 16.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.929 -1.487 . . . . 10.0 114.353 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 142' ' ' ILE . 38.8 t70 -81.29 -60.29 2.33 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.671 0.619 . . . . 10.0 112.671 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 140' ' ' LYS . 12.6 mptt -76.02 -29.76 58.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.437 0.637 . . . . 10.0 110.396 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.816 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.11 -46.96 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.137 -0.938 . . . . 10.0 110.715 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.631 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.6 tp -63.0 -43.95 99.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 120.012 -0.675 . . . . 10.0 109.624 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -48.11 -46.61 34.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.635 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -73.52 -30.51 63.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.432 -0.804 . . . . 10.0 110.574 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 141' ' ' ILE . 35.8 mt -54.69 -31.77 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 120.899 0.38 . . . . 10.0 110.788 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.3 p -96.47 -49.19 5.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.983 -0.553 . . . . 10.0 112.402 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 p -85.49 13.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.875 0.694 . . . . 10.0 112.875 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 N-CA-C 111.789 0.292 . . . . 10.0 111.789 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.659 ' HG2' ' HG3' ' A' ' 10' ' ' GLU . 56.8 tttm . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.91 0.385 . . . . 10.0 110.747 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.659 ' HG3' ' HG2' ' A' ' 9' ' ' LYS . 88.3 mt-10 -149.04 164.24 35.2 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.356 0.598 . . . . 10.0 110.33 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.628 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.8 t80 -156.6 138.8 14.64 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.014 -0.993 . . . . 10.0 112.531 -174.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.417 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 12.3 pt-20 -88.81 138.85 31.04 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.771 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -155.94 166.62 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.62 0.724 . . . . 10.0 112.937 -177.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 3.0 tm? -88.88 133.5 34.26 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 37.2 t -153.29 151.39 29.96 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.648 ' HA ' HD22 ' A' ' 99' ' ' LEU . 0.2 OUTLIER -138.49 174.98 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.288 -1.324 . . . . 10.0 110.773 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -88.58 139.77 30.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.348 -0.982 . . . . 10.0 108.348 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.611 HG13 ' HB2' ' A' ' 23' ' ' LEU . 21.0 mm -146.97 76.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.828 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.522 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 1.1 m-20 58.12 51.83 8.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.943 0.402 . . . . 10.0 111.281 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 38.4 mt-10 85.88 -25.64 0.11 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.224 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -88.82 130.64 35.34 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 110.237 -0.283 . . . . 10.0 110.237 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.562 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.66 114.32 25.15 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -88.85 136.6 32.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.096 -177.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -143.18 142.29 31.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.255 0.55 . . . . 10.0 112.344 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -131.4 138.35 49.07 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.235 -1.024 . . . . 10.0 108.235 178.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' OD1' ' CB ' ' A' ' 28' ' ' ASP . 9.6 t0 -49.15 120.76 4.21 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.628 -0.429 . . . . 10.0 110.817 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 14' ' ' LEU . 19.1 m -57.98 -14.94 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.235 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' CB ' ' OD1' ' A' ' 26' ' ' ASP . 7.2 t70 -63.02 -36.2 82.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.162 0.505 . . . . 10.0 109.898 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -95.19 -45.89 7.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.506 -0.77 . . . . 10.0 111.362 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 25' ' ' PHE . 23.3 mm -61.35 132.31 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 120.823 0.344 . . . . 10.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' O ' ' CE ' ' A' ' 32' ' ' MET . 50.5 mt-10 -87.95 -64.46 1.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.962 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.417 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.07 173.03 7.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.39 . . . . 10.0 110.855 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.0 m -100.31 126.76 53.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.781 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.67 HG13 ' HB ' ' A' ' 81' ' ' ILE . 11.9 pt -103.88 155.45 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.124 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -88.79 -175.78 5.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.991 -0.549 . . . . 10.0 111.171 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.411 ' CE ' ' HB3' ' A' ' 79' ' ' LYS . 19.3 ptpt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.025 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.7 t . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.846 0.355 . . . . 10.0 111.12 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -69.64 -40.73 76.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.611 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 52' ' ' VAL . . . -165.91 -175.95 36.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.551 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.443 HG13 ' HA ' ' A' ' 61' ' ' PRO . 2.0 m -155.31 168.88 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.248 -0.278 . . . . 10.0 110.248 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.2 pt . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 120.766 0.317 . . . . 10.0 111.463 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.5 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 29.1 pt . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.621 0.248 . . . . 10.0 111.345 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.782 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 85.0 Cg_endo -82.54 115.91 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.507 2.138 . . . . 10.0 112.808 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 63' ' ' VAL . 23.1 m -88.98 133.39 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.168 -0.679 . . . . 10.0 109.168 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 49' ' ' VAL . 59.5 t -145.17 157.79 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.799 0.809 . . . . 10.0 113.153 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 67' ' ' LYS . 5.2 m120 -78.15 66.71 3.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.391 -1.277 . . . . 10.0 108.698 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.623 ' HB3' ' CG ' ' A' ' 93' ' ' PHE . 6.4 tt -53.88 -29.35 41.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.837 -0.62 . . . . 10.0 111.531 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.575 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -64.89 -25.84 68.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.54 -0.541 . . . . 10.0 109.54 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.483 ' N ' ' CE2' ' A' ' 73' ' ' PHE . 24.1 ttpt -77.91 -52.13 9.32 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.236 -0.893 . . . . 10.0 111.0 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.616 HG22 ' HA ' ' A' ' 65' ' ' LEU . 10.3 tt -53.82 -40.17 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.596 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 1.1 tm? -75.72 -44.99 39.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.545 -1.661 . . . . 10.0 109.534 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.502 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 113.06 -95.65 0.78 Allowed Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.049 -0.523 . . . . 10.0 113.133 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.868 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.6 pt 48.66 164.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.097 0.777 . . . . 10.0 113.097 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.2 m -47.03 -36.81 8.39 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.158 -0.682 . . . . 10.0 109.158 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.868 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.0 t80 -26.09 140.09 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.791 -1.095 . . . . 10.0 112.808 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -160.31 34.66 0.17 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.248 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.498 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 50.4 mt-10 52.53 46.93 25.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.247 0.462 . . . . 10.0 112.247 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.424 ' HG3' ' HG2' ' A' ' 77' ' ' LYS . 23.9 pt20 -97.87 -47.2 5.65 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 14.3 mmmm -108.96 -25.15 10.88 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.362 0.505 . . . . 10.0 112.362 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.547 ' CE ' ' HA ' ' A' ' 95' ' ' VAL . 3.2 mmm -35.94 144.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.724 0.409 . . . . 10.0 111.972 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 51.5 mtmt -160.7 -45.06 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.201 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.5 m -88.86 142.86 27.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.994 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.67 ' HB ' HG13 ' A' ' 34' ' ' ILE . 73.6 mt -100.66 160.52 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.314 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.575 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 31.8 mt -123.63 158.74 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.591 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.68 150.77 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.032 0.444 . . . . 10.0 111.222 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -156.15 171.78 19.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.896 -178.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -128.24 129.05 45.82 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.582 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 67.1 p -145.51 108.27 4.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.879 0.325 . . . . 10.0 111.879 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 88' ' ' ASP . 14.9 tppt? 47.4 59.95 3.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.211 0.529 . . . . 10.0 110.269 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.492 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 2.4 p30 59.16 32.54 22.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.828 -1.078 . . . . 10.0 111.59 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.582 ' HB ' ' O ' ' A' ' 86' ' ' THR . 66.1 t -128.58 109.34 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 115.3 -0.864 . . . . 10.0 109.156 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.782 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 34.1 mt-10 -88.28 97.78 11.22 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.281 -1.748 . . . . 10.0 106.281 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.522 HG21 HG11 ' A' ' 89' ' ' VAL . 3.4 t -88.46 152.23 3.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 113.478 -1.692 . . . . 10.0 113.059 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.56 148.4 17.19 Favored Glycine 0 C--N 1.316 -0.547 0 CA-C-N 114.66 -1.155 . . . . 10.0 113.494 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.623 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -138.76 124.78 20.02 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.75 0.309 . . . . 10.0 110.45 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.492 ' O ' HG11 ' A' ' 95' ' ' VAL . 54.7 tp -88.62 130.07 35.36 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.603 0.594 . . . . 10.0 112.603 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.547 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 34.2 m -143.55 -175.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 115.33 -0.85 . . . . 10.0 110.504 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 78' ' ' MET . 28.5 t70 -108.7 -62.96 1.39 Allowed 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 112.599 0.592 . . . . 10.0 112.599 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 16' ' ' PHE . 13.6 tpt180 -119.34 117.9 29.78 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.41 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.638 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.0 p -112.52 115.42 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 122.432 1.11 . . . . 10.0 111.502 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.648 HD22 ' HA ' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -65.84 -31.21 72.03 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 112.962 -1.926 . . . . 10.0 110.809 -178.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.55 -124.53 6.99 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.258 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.1 t -53.05 129.65 13.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.909 0.354 . . . . 10.0 110.129 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.641 ' HG ' HG12 ' A' ' 104' ' ' ILE . 59.7 tp -132.68 138.9 47.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.994 0.426 . . . . 10.0 111.177 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -88.82 70.16 8.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.984 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.771 ' HB ' HG11 ' A' ' 13' ' ' VAL . 8.8 mm -88.94 130.87 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 32.0 p -88.75 -175.89 5.05 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.605 -1.257 . . . . 10.0 107.605 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -147.9 73.03 1.25 Allowed 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 118.929 -1.108 . . . . 10.0 112.79 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -102.57 20.79 16.45 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.701 -1.136 . . . . 10.0 109.1 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 115.474 -0.784 . . . . 10.0 111.382 -179.284 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.562 ' CE2' HD23 ' A' ' 69' ' ' LEU . 32.3 t80 . . . . . 0 N--CA 1.462 0.131 0 CA-C-O 121.011 0.434 . . . . 10.0 110.772 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.76 -137.73 7.15 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.564 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 120' ' ' LYS . 63.9 tttp -80.54 58.25 3.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.875 0.369 . . . . 10.0 110.934 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.561 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 16.2 tppt? -161.26 -40.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 10.0 110.804 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 C--N 1.326 -0.424 0 N-CA-C 108.68 -0.859 . . . . 10.0 108.68 179.737 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.539 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.934 0.397 . . . . 10.0 111.589 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.491 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 8.5 ptpp? -164.26 142.28 7.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.587 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.495 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 3.2 m -164.83 148.67 8.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.378 -0.374 . . . . 10.0 110.761 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.33 47.71 20.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.934 0.397 . . . . 10.0 111.019 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.81 33.56 43.03 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.997 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 128' ' ' THR . 6.5 ptt-85 -137.84 130.24 29.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.761 0.315 . . . . 10.0 110.251 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 4.1 mp -88.93 139.74 30.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.989 0.424 . . . . 10.0 111.183 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.562 HG12 ' CB ' ' A' ' 22' ' ' ALA . 3.7 mt -133.25 129.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.15 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.407 ' HB ' HD11 ' A' ' 23' ' ' LEU . 24.4 mm -88.92 120.74 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 108.606 -0.887 . . . . 10.0 108.606 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 52.9 t80 -121.38 148.51 44.28 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.239 -0.584 . . . . 10.0 110.363 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -161.01 148.12 15.25 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.505 0.669 . . . . 10.0 111.399 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.8 p-10 -95.87 32.43 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.4 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.834 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 19.7 tt 40.07 18.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.603 -1.18 . . . . 10.0 114.041 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.459 ' O ' HG22 ' A' ' 142' ' ' ILE . 38.4 t70 -79.73 -53.82 6.45 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.966 0.728 . . . . 10.0 112.966 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 121' ' ' LYS . 17.3 tppt? -77.77 -34.17 52.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.447 0.642 . . . . 10.0 110.438 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.834 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.52 -45.95 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.422 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.621 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.7 tp -64.48 -43.41 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.403 -0.519 . . . . 10.0 109.733 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -47.95 -41.16 24.24 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.117 -0.697 . . . . 10.0 109.117 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 50.7 mm-40 -70.73 -35.77 72.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.008 -0.996 . . . . 10.0 110.829 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 141' ' ' ILE . 60.3 mt -55.18 -50.98 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.822 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.9 p -73.5 -53.34 10.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.975 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.437 ' CG1' ' HA ' ' A' ' 144' ' ' GLU . 14.4 p -63.0 -17.81 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 10.0 111.791 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.518 ' HA ' ' HE2' ' A' ' 148' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 120.779 0.323 . . . . 10.0 111.392 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.928 0.394 . . . . 10.0 111.213 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 41.4 mt-10 -140.49 164.17 30.85 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.331 0.586 . . . . 10.0 110.531 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.0 t80 -156.52 139.36 15.24 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.894 -1.048 . . . . 10.0 112.453 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.42 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 16.7 pt-20 -88.76 138.77 31.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.567 -0.901 . . . . 10.0 108.567 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.756 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -154.97 170.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 113.317 0.858 . . . . 10.0 113.317 -176.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.516 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 3.1 tm? -88.62 132.79 34.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.988 -1.116 . . . . 10.0 107.988 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.544 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 83.5 p -143.16 152.55 41.92 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.376 0.88 . . . . 10.0 113.376 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.61 ' CZ ' ' HG ' ' A' ' 23' ' ' LEU . 15.1 p90 -150.83 162.8 40.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.47 -1.241 . . . . 10.0 109.908 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -88.45 139.81 30.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 73' ' ' PHE . 35.5 mm -134.47 90.03 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.421 -0.809 . . . . 10.0 111.697 -177.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 47.5 m-20 44.62 60.17 3.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.373 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.2 mt-10 87.36 -42.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.196 -0.911 . . . . 10.0 112.093 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.0 pt20 -88.96 146.18 25.05 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.603 -0.439 . . . . 10.0 109.879 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.506 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.61 166.97 13.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 10.0 110.882 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.61 ' HG ' ' CZ ' ' A' ' 16' ' ' PHE . 1.3 tp -152.17 140.2 20.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.325 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -145.89 151.12 37.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 -177.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -133.12 141.3 48.09 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.15 -0.932 . . . . 10.0 108.714 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -49.73 122.76 6.83 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.551 -0.46 . . . . 10.0 111.046 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 14' ' ' LEU . 24.8 m -61.27 -13.85 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.015 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -64.61 -40.48 95.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.406 0.622 . . . . 10.0 109.531 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.489 ' CG ' ' O ' ' A' ' 85' ' ' ARG . 16.5 t-20 -87.81 -46.09 9.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.972 -1.013 . . . . 10.0 110.54 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.508 HG13 ' HB2' ' A' ' 25' ' ' PHE . 22.5 mm -65.85 132.3 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.541 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.411 ' O ' ' CE ' ' A' ' 32' ' ' MET . 53.5 mm-40 -82.64 -64.03 1.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.656 -0.247 . . . . 10.0 111.368 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.411 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.03 172.54 7.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 10.0 111.026 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -89.0 147.09 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.749 -0.659 . . . . 10.0 111.613 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 29.0 pt -145.83 129.86 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.558 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 50.1 mt-10 -98.43 124.7 43.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.489 -0.323 . . . . 10.0 111.118 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.481 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 62.7 mttp . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.215 -0.448 . . . . 10.0 110.937 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.559 ' HA ' HG23 ' A' ' 63' ' ' VAL . 40.1 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.83 0.347 . . . . 10.0 111.917 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.41 ' OE1' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -93.46 -24.29 18.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.583 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' O ' ' CG1' ' A' ' 49' ' ' VAL . . . -152.86 165.04 30.99 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.804 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 1.9 m -151.11 163.64 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.287 0.543 . . . . 10.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 27.6 pt . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.137 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.425 HG12 HG13 ' A' ' 53' ' ' ILE . 26.1 pt . . . . . 0 C--O 1.234 0.246 0 N-CA-C 111.432 0.16 . . . . 10.0 111.432 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 77.6 Cg_endo -95.46 114.76 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.352 2.701 . . . . 10.0 112.712 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.508 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 33.7 m -88.98 141.04 14.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.648 -0.251 . . . . 10.0 110.512 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 49' ' ' VAL . 84.1 t -142.93 156.29 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.258 0.551 . . . . 10.0 111.694 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.58 ' O ' ' HD3' ' A' ' 67' ' ' LYS . 4.0 m120 -77.26 61.39 2.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.951 0.882 . . . . 10.0 109.584 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.651 ' O ' HG22 ' A' ' 68' ' ' ILE . 7.5 tt -48.86 -26.34 2.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.776 . . . . 10.0 112.379 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.696 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -69.44 -26.34 64.55 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.993 -0.683 . . . . 10.0 111.301 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.642 ' HD3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -87.42 -35.01 18.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.723 -0.391 . . . . 10.0 110.775 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.5 tt -57.84 -41.18 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.606 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -79.36 -46.99 16.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.249 -1.796 . . . . 10.0 108.505 176.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 116.15 -85.17 0.39 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.173 -0.921 . . . . 10.0 112.656 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.831 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.0 pt 46.86 166.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 42.9 t -47.69 -34.72 8.56 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.831 ' HB3' HG13 ' A' ' 71' ' ' ILE . 14.6 t80 -31.37 143.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.877 -1.056 . . . . 10.0 112.932 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.95 41.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.722 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 57.37 38.05 28.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.108 -0.496 . . . . 10.0 111.228 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -90.28 -72.47 0.57 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.398 0.518 . . . . 10.0 112.398 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 78' ' ' MET . 0.1 OUTLIER -90.87 -20.73 21.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 10.0 112.204 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.452 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 20.9 mmt -21.13 138.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.087 0.773 . . . . 10.0 113.087 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -172.15 -38.96 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.492 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.415 ' O ' HD11 ' A' ' 94' ' ' LEU . 70.9 m -88.85 166.9 13.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.702 0.287 . . . . 10.0 110.997 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 85.5 mt -138.65 156.3 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.218 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.513 HD13 ' CD2' ' A' ' 16' ' ' PHE . 48.6 mt -132.78 158.23 43.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 121.081 0.467 . . . . 10.0 111.84 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.422 ' CG2' ' CD1' ' A' ' 34' ' ' ILE . 50.5 t -130.96 143.1 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.635 -0.712 . . . . 10.0 110.155 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -140.22 178.19 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.511 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.489 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 54.7 ttp180 -132.95 130.15 39.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.594 ' OG1' ' HB ' ' A' ' 89' ' ' VAL . 62.8 p -137.64 103.07 4.92 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.438 0.637 . . . . 10.0 111.832 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.6 tppp? 47.59 47.26 17.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.902 -1.045 . . . . 10.0 110.78 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 45.2 m-20 81.55 28.5 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.932 -1.031 . . . . 10.0 111.985 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.594 ' HB ' ' OG1' ' A' ' 86' ' ' THR . 50.8 t -125.76 108.93 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.39 -0.823 . . . . 10.0 109.146 176.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 87.9 tt0 -88.24 99.49 12.26 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.521 HG21 ' CG1' ' A' ' 89' ' ' VAL . 2.7 t -88.66 157.71 3.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 113.338 -1.755 . . . . 10.0 112.653 -174.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -125.24 158.23 19.62 Favored Glycine 0 C--N 1.317 -0.487 0 CA-C-N 114.719 -1.128 . . . . 10.0 112.211 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.619 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.2 t80 -158.42 128.55 5.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.096 0.474 . . . . 10.0 112.082 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 63.2 tp -88.84 127.38 35.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.683 -0.69 . . . . 10.0 111.439 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.441 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 32.5 m -135.34 -175.14 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.12 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -88.36 -79.64 0.3 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.167 0.508 . . . . 10.0 111.317 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -130.96 108.19 9.64 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.031 -0.729 . . . . 10.0 109.031 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.1 p -88.97 114.58 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.302 1.049 . . . . 10.0 111.58 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.71 -28.43 69.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.235 -1.802 . . . . 10.0 110.944 -178.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.1 -125.78 7.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.677 -0.773 . . . . 10.0 111.533 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -51.76 131.1 12.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.974 0.387 . . . . 10.0 110.499 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.609 ' HG ' HG12 ' A' ' 104' ' ' ILE . 50.0 tp -134.92 138.51 44.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.952 0.406 . . . . 10.0 111.118 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.3 ptp85 -88.83 72.27 8.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.756 ' HB ' HG11 ' A' ' 13' ' ' VAL . 10.3 mm -88.95 130.17 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.598 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 16.3 p -88.64 149.66 23.42 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.454 -1.684 . . . . 10.0 106.454 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.424 ' OE1' ' CE2' ' A' ' 135' ' ' TYR . 8.3 tp10 -134.57 80.73 1.87 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 114.088 1.144 . . . . 10.0 114.088 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -88.66 -6.81 57.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 . . . . . 0 C--O 1.232 0.15 0 CA-C-N 114.784 -1.098 . . . . 10.0 111.025 -179.666 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 69' ' ' LEU . 6.1 t80 . . . . . 0 CA--C 1.518 -0.286 0 CA-C-O 121.442 0.639 . . . . 10.0 109.441 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.23 28.29 1.18 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 114.949 -1.023 . . . . 10.0 113.592 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 118' ' ' PHE . 62.5 tttp -70.63 -34.45 72.1 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 121' ' ' LYS . 16.6 tppt? -159.47 37.17 0.2 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.998 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.643 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 88.9 p . . . . . 0 CA--C 1.537 0.461 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.736 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 133' ' ' ILE . 1.4 p . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 121.373 0.606 . . . . 10.0 111.842 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.499 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -158.91 132.62 7.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.43 -0.805 . . . . 10.0 110.724 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.749 ' O ' ' HB2' ' A' ' 131' ' ' ARG . 8.9 m -164.27 140.74 6.38 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.062 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 62.42 45.74 6.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.03 0.443 . . . . 10.0 110.201 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 56.03 25.12 45.33 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.433 -0.889 . . . . 10.0 110.961 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 128' ' ' THR . 99.5 mtt180 -107.89 120.86 43.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.435 -0.383 . . . . 10.0 111.471 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 21' ' ' GLN . 86.1 mt -89.07 82.92 6.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.517 ' O ' HG11 ' A' ' 126' ' ' VAL . 2.4 mt -88.77 131.37 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.43 HG22 ' CD2' ' A' ' 118' ' ' PHE . 1.4 mp -88.98 148.35 4.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 107.917 -1.142 . . . . 10.0 107.917 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 35.7 t80 -141.16 151.89 44.23 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.028 -0.669 . . . . 10.0 111.457 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.643 ' CB ' ' HB2' ' A' ' 122' ' ' SER . 0.0 OUTLIER -169.07 150.79 4.56 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 113.638 0.977 . . . . 10.0 113.638 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.402 ' O ' HG21 ' A' ' 138' ' ' ILE . 55.0 p30 -99.33 32.92 2.59 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.604 -1.18 . . . . 10.0 109.716 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.866 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 16.2 tt 40.15 24.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.44 -1.255 . . . . 10.0 113.636 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 142' ' ' ILE . 7.3 t70 -77.56 -60.41 2.38 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.017 0.747 . . . . 10.0 113.017 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -74.28 -29.19 61.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.162 0.506 . . . . 10.0 111.08 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.866 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.35 -46.78 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.737 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.565 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.2 tp -63.34 -47.11 93.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 120.29 -0.564 . . . . 10.0 110.482 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -50.97 -39.47 55.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.408 ' HG3' ' CD ' ' A' ' 121' ' ' LYS . 5.7 mm-40 -77.86 -27.08 49.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.358 -0.837 . . . . 10.0 111.061 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 141' ' ' ILE . 37.5 mt -53.85 -49.28 59.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 121.064 0.459 . . . . 10.0 110.211 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 77.9 p -82.65 -45.84 14.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.767 -0.652 . . . . 10.0 111.364 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 51.5 t -58.15 -30.55 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.239 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.7 tptp . . . . . 0 C--N 1.328 -0.36 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -178.184 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.74 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER . . . . . 0 CA--C 1.526 0.044 0 CA-C-O 120.723 0.297 . . . . 10.0 110.585 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 33.5 mt-10 -139.4 164.14 30.64 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.337 -0.392 . . . . 10.0 109.988 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.547 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.5 t80 -164.78 139.67 5.37 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 113.265 0.839 . . . . 10.0 113.265 -174.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.423 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 3.0 mt-10 -88.67 135.03 33.71 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.294 -0.866 . . . . 10.0 109.16 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.735 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.2 p -152.36 169.35 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.823 0.675 . . . . 10.0 112.823 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.496 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 3.4 tm? -88.84 138.1 31.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.551 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 97.6 p -145.61 153.91 41.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 113.613 0.968 . . . . 10.0 113.613 -177.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.638 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -152.88 159.04 42.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.17 -1.377 . . . . 10.0 110.403 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HG2' HD21 ' A' ' 99' ' ' LEU . 53.1 mm-40 -88.63 124.11 33.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.341 0.591 . . . . 10.0 109.968 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.57 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 22.9 mm -118.52 94.45 3.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.177 -0.92 . . . . 10.0 110.865 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 30.8 m-20 44.05 60.13 2.88 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.827 0.677 . . . . 10.0 112.827 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 48.2 mt-10 88.54 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.49 -0.777 . . . . 10.0 112.607 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -88.84 152.96 21.44 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.438 -0.505 . . . . 10.0 110.278 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.536 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -89.03 155.52 19.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.807 0.336 . . . . 10.0 110.875 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.638 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -141.35 133.96 28.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.469 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -140.18 153.29 46.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.91 0.707 . . . . 10.0 112.91 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 2.8 m-85 -138.08 144.89 41.13 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -43.53 100.49 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.425 0.631 . . . . 10.0 110.447 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 3.5 p -46.84 -19.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.021 -0.991 . . . . 10.0 111.137 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.62 -43.68 88.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.121 0.486 . . . . 10.0 109.75 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.541 ' OD1' ' O ' ' A' ' 85' ' ' ARG . 18.0 t-20 -78.46 -43.27 27.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.485 -0.78 . . . . 10.0 110.607 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.472 HG23 ' HG ' ' A' ' 14' ' ' LEU . 13.0 mm -63.83 125.41 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.32 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.6 ' O ' ' HG3' ' A' ' 32' ' ' MET . 4.6 mm-40 -84.24 -76.6 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.764 0.283 . . . . 10.0 111.764 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.6 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 5.0 mtm -157.34 150.69 23.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.193 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -88.9 128.03 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.391 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.9 pt -100.38 179.48 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 10.0 111.29 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -88.91 150.87 22.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.119 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.4 tttm . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.16 -179.695 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 63' ' ' VAL . 55.2 t . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.86 0.362 . . . . 10.0 111.14 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 17.0 pt-20 -71.86 -40.04 69.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.583 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -169.06 -175.92 38.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.753 -0.737 . . . . 10.0 112.63 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.453 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 3.5 m -158.93 172.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.691 0.282 . . . . 10.0 110.283 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.453 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 30.7 pt . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.813 0.34 . . . . 10.0 111.344 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.457 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.2 pp . . . . . 0 C--O 1.235 0.339 0 CA-C-O 120.516 0.198 . . . . 10.0 110.788 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 60' ' ' ILE . 66.0 Cg_endo -98.15 117.72 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.203 2.602 . . . . 10.0 113.634 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.423 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 18.5 m -97.12 133.64 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 109.084 -0.71 . . . . 10.0 109.084 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 68.0 t -141.3 159.9 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.783 0.801 . . . . 10.0 113.079 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.773 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.4 m120 -76.61 66.9 2.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.819 -1.082 . . . . 10.0 109.052 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.788 ' O ' HG22 ' A' ' 68' ' ' ILE . 6.3 tt -50.05 -26.46 4.4 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.705 -0.68 . . . . 10.0 111.404 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.656 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -64.91 -27.71 69.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.671 -0.412 . . . . 10.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.773 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -88.4 -36.92 16.27 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.015 -0.365 . . . . 10.0 110.015 178.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.5 tt -61.18 -37.7 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.645 HD12 ' CG2' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -77.88 -40.51 39.75 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 113.278 -1.783 . . . . 10.0 109.598 177.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.541 ' C ' HG12 ' A' ' 71' ' ' ILE . . . 112.3 -102.54 1.36 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 116.07 -0.514 . . . . 10.0 112.961 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.645 ' CG2' HD12 ' A' ' 69' ' ' LEU . 6.5 pt 45.98 -179.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 113.088 0.773 . . . . 10.0 113.088 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.653 ' O ' ' O ' ' A' ' 73' ' ' PHE . 72.1 m -57.52 -98.6 0.0 OUTLIER 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.62 -1.622 . . . . 10.0 106.62 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.67 ' HE2' ' N ' ' A' ' 67' ' ' LYS . 1.4 t80 50.65 138.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 119.22 -0.992 . . . . 10.0 113.357 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -159.55 27.39 0.19 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.71 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 66.89 -48.63 0.47 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.13 0.789 . . . . 10.0 113.13 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -38.89 -42.49 0.85 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 77' ' ' LYS . 32.1 mmtp -79.5 -39.7 31.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.947 0.404 . . . . 10.0 111.395 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.53 ' HG3' ' HA ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -47.33 135.21 10.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.902 0.705 . . . . 10.0 112.902 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 78' ' ' MET . 36.7 mtmm -164.43 32.57 0.07 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.91 -1.041 . . . . 10.0 109.624 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.7 t -169.12 151.25 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.274 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.5 mt -120.16 143.08 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.998 0.427 . . . . 10.0 111.985 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.563 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 4.2 mt -111.67 123.48 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.971 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.9 t -92.86 148.13 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.973 0.416 . . . . 10.0 111.008 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -143.91 -175.87 4.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.69 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.57 ' O ' ' CG2' ' A' ' 86' ' ' THR . 15.3 tpp85 -133.3 160.84 36.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.381 -0.6 . . . . 10.0 109.381 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.684 ' OG1' ' HB ' ' A' ' 89' ' ' VAL . 18.9 p -169.06 100.0 0.37 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.293 0.568 . . . . 10.0 112.018 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HA ' ' CE ' ' A' ' 87' ' ' LYS . 2.2 tpmt? 43.99 46.41 6.92 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.002 -0.999 . . . . 10.0 110.55 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 11.6 m-20 82.8 31.96 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.69 -1.141 . . . . 10.0 111.713 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.684 ' HB ' ' OG1' ' A' ' 86' ' ' THR . 44.4 t -130.03 112.12 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.26 -0.882 . . . . 10.0 109.261 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 12.2 mt-10 -88.36 99.91 12.61 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.176 -1.787 . . . . 10.0 106.176 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.506 HG21 HG11 ' A' ' 89' ' ' VAL . 2.6 t -88.77 159.54 2.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 113.91 -1.495 . . . . 10.0 112.106 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -127.89 154.22 19.67 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.546 -0.835 . . . . 10.0 113.415 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -144.62 128.64 17.54 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 120.722 0.296 . . . . 10.0 110.71 -179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.465 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 65.1 tp -88.67 134.39 33.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.228 0.537 . . . . 10.0 111.698 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.53 ' HA ' ' HG3' ' A' ' 78' ' ' MET . 35.6 m -147.93 -175.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.936 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -105.11 -65.2 1.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.317 0.488 . . . . 10.0 112.317 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -130.65 120.36 23.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.754 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.57 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.5 p -108.1 115.06 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-O 122.245 1.022 . . . . 10.0 111.621 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -64.95 -29.94 70.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.272 -1.786 . . . . 10.0 111.114 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 91.89 -124.43 7.65 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.646 -0.787 . . . . 10.0 111.321 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.43 134.1 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 117.01 0.405 . . . . 10.0 110.549 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.583 ' HG ' HG12 ' A' ' 104' ' ' ILE . 59.8 tp -135.7 139.92 44.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.199 0.523 . . . . 10.0 111.178 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 27.1 ptt180 -88.91 71.63 8.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.67 -0.696 . . . . 10.0 110.407 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.735 ' HB ' HG11 ' A' ' 13' ' ' VAL . 17.8 mm -88.75 133.14 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 18.2 p -88.84 -175.94 5.04 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.395 -0.965 . . . . 10.0 108.395 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -147.31 77.4 1.44 Allowed 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.128 -1.029 . . . . 10.0 112.808 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -102.02 17.59 22.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.665 -1.152 . . . . 10.0 109.23 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 . . . . . 0 C--N 1.333 -0.113 0 CA-C-N 115.574 -0.739 . . . . 10.0 111.133 -179.525 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.511 ' CE1' HD23 ' A' ' 69' ' ' LEU . 39.7 t80 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.193 0.521 . . . . 10.0 110.315 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 143.92 45.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.821 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 62.31 52.34 3.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.055 0.455 . . . . 10.0 110.314 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -141.56 -35.75 0.45 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 10.0 111.369 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.718 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 97.2 p . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 116.764 -0.198 . . . . 10.0 110.514 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.596 ' O ' ' O ' ' A' ' 133' ' ' ILE . 2.4 p . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 121.707 0.765 . . . . 10.0 112.111 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -141.41 135.53 30.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.651 ' O ' ' HB2' ' A' ' 131' ' ' ARG . 8.5 m -164.11 137.79 5.41 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.167 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 65.6 t0 60.78 41.99 14.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.89 0.376 . . . . 10.0 110.459 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.24 30.87 55.9 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.754 -0.938 . . . . 10.0 110.754 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.651 ' HB2' ' O ' ' A' ' 128' ' ' THR . 37.5 mmt180 -117.17 133.46 55.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.263 -0.469 . . . . 10.0 111.024 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 57.1 tp -88.91 79.55 7.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.11 -0.496 . . . . 10.0 110.143 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.596 ' O ' ' O ' ' A' ' 126' ' ' VAL . 4.0 mt -88.99 148.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 10.0 111.828 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.586 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.4 mp -103.32 129.27 55.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 N-CA-C 108.69 -0.856 . . . . 10.0 108.69 177.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.441 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 40.5 t80 -117.09 144.51 44.59 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.02 -0.672 . . . . 10.0 111.615 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.718 ' HG ' ' HB2' ' A' ' 122' ' ' SER . 8.5 mp -137.61 169.06 18.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.18 -0.918 . . . . 10.0 111.852 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -136.58 21.76 3.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.705 -1.134 . . . . 10.0 108.34 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.807 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 13.0 tt 43.76 17.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.173 -1.376 . . . . 10.0 113.824 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.574 ' O ' HG22 ' A' ' 142' ' ' ILE . 8.6 t0 -81.48 -59.11 2.74 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.627 0.603 . . . . 10.0 112.627 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 140' ' ' LYS . 12.2 mptt -76.55 -34.18 58.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.613 0.721 . . . . 10.0 109.895 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.807 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.27 -46.0 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.835 -1.075 . . . . 10.0 110.63 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.69 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.5 tp -62.89 -43.2 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 120.254 -0.578 . . . . 10.0 109.725 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -47.11 -46.47 23.0 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.03 -36.89 85.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.25 -0.887 . . . . 10.0 110.298 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 141' ' ' ILE . 23.3 mt -54.71 -41.12 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 120.896 0.379 . . . . 10.0 110.948 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.7 p -80.44 -50.3 10.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.636 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.78 9.24 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.596 0.236 . . . . 10.0 111.613 -179.234 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.492 ' HD2' ' HG3' ' A' ' 10' ' ' GLU . 6.3 tmtm? . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 45.5 mt-10 -140.71 164.25 30.69 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.004 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.642 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 9.9 t80 -160.11 139.49 11.0 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.567 -0.742 . . . . 10.0 112.789 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.445 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 23.5 tp10 -88.68 133.99 34.04 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.778 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.6 p -152.93 166.94 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 113.967 1.099 . . . . 10.0 113.967 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.579 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.2 tm? -88.94 134.54 33.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.158 -0.928 . . . . 10.0 108.657 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.552 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 40.5 t -148.56 158.04 43.86 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.772 0.796 . . . . 10.0 112.687 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.595 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -148.35 165.61 30.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.182 -1.372 . . . . 10.0 110.411 -178.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG3' HD21 ' A' ' 99' ' ' LEU . 56.6 mt-10 -88.65 133.22 34.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 73' ' ' PHE . 35.0 mm -132.06 95.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.437 -177.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 26.8 m-20 42.45 60.18 2.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.676 -0.693 . . . . 10.0 112.525 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.1 mt-10 85.72 -44.77 0.06 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.39 -0.823 . . . . 10.0 111.621 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -89.03 145.36 25.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.572 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.58 168.14 12.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.986 0.422 . . . . 10.0 111.089 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.541 ' HG ' ' CZ ' ' A' ' 16' ' ' PHE . 0.9 OUTLIER -147.11 135.04 21.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.586 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -137.56 152.91 49.94 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.999 0.741 . . . . 10.0 112.999 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.519 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.2 m-85 -135.16 142.76 46.2 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.146 -0.934 . . . . 10.0 108.814 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' HZ ' ' A' ' 11' ' ' PHE . 12.7 p-10 -52.43 122.05 8.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.271 0.558 . . . . 10.0 111.328 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 14' ' ' LEU . 27.2 m -61.27 -14.7 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.44 -0.8 . . . . 10.0 110.653 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.43 -44.51 94.35 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.184 0.516 . . . . 10.0 109.829 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.429 ' ND2' HG23 ' A' ' 138' ' ' ILE . 21.7 t-20 -89.57 -42.52 11.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 10.0 110.566 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.405 HG21 ' O ' ' A' ' 83' ' ' VAL . 26.8 mm -62.45 130.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.865 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 32' ' ' MET . 52.0 mm-40 -85.79 -68.97 0.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.33 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.6 mtm -169.21 156.02 6.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.148 0.499 . . . . 10.0 111.609 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.407 ' HB ' HG11 ' A' ' 98' ' ' VAL . 34.6 m -88.88 159.1 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.567 -0.742 . . . . 10.0 111.304 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.403 HG13 ' HB ' ' A' ' 81' ' ' ILE . 23.1 pt -151.55 162.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.963 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -88.83 146.58 24.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.174 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.8 tptp . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.297 -179.606 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 51' ' ' GLY . 38.4 t . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.944 0.402 . . . . 10.0 111.19 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 9.8 pt-20 -75.77 -38.54 58.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.571 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.433 ' O ' ' CG1' ' A' ' 49' ' ' VAL . . . -144.22 -177.04 18.78 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 120.183 -1.008 . . . . 10.0 113.095 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.492 HG13 ' HA ' ' A' ' 61' ' ' PRO . 3.4 m -160.08 175.32 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.519 HG13 HG13 ' A' ' 60' ' ' ILE . 2.2 pp . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 10.0 111.251 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.523 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.4 pp . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.546 0.213 . . . . 10.0 110.839 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 89.0 Cg_endo -82.95 119.61 2.89 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.678 2.252 . . . . 10.0 113.483 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.402 ' O ' HG21 ' A' ' 62' ' ' VAL . 35.9 m -95.75 138.51 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.427 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 94.5 t -139.88 151.44 22.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.715 0.769 . . . . 10.0 112.581 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -78.57 67.44 4.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.688 -1.142 . . . . 10.0 109.668 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.9 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.3 tt -52.78 -38.56 61.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.305 -0.861 . . . . 10.0 111.2 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.575 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -53.34 -24.29 11.62 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.314 -0.554 . . . . 10.0 109.711 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.562 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -85.51 -48.37 9.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.784 -0.643 . . . . 10.0 110.307 178.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.9 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.2 tt -54.42 -38.85 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 107.867 -1.16 . . . . 10.0 107.867 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.62 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -79.65 -51.05 9.74 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 113.52 -1.673 . . . . 10.0 109.684 177.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.535 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 118.64 -86.38 0.4 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.879 -0.601 . . . . 10.0 112.508 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.897 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.5 pt 46.55 165.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 113.115 0.783 . . . . 10.0 113.115 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.5 m -47.8 -35.26 9.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.897 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.7 t80 -27.63 140.56 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.757 -1.11 . . . . 10.0 112.578 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 8.8 t70 -143.99 30.45 1.3 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.154 0.502 . . . . 10.0 110.815 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.42 ' HA ' ' CE1' ' A' ' 73' ' ' PHE . 49.0 mt-10 66.69 -51.57 0.45 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.15 0.796 . . . . 10.0 113.15 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -44.84 -42.78 8.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.274 0.842 . . . . 10.0 113.274 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.52 ' NZ ' ' HB3' ' A' ' 77' ' ' LYS . 6.3 mtpm? -81.53 10.63 5.57 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.441 0.904 . . . . 10.0 113.441 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.438 ' CE ' ' CE1' ' A' ' 73' ' ' PHE . 33.8 mmt -68.11 145.4 54.43 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.205 -0.309 . . . . 10.0 111.005 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 54.9 mtpt -158.84 -50.43 0.06 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.654 0.264 . . . . 10.0 111.634 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.5 t -88.88 -176.03 5.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 10.0 111.615 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.448 HG12 HD11 ' A' ' 94' ' ' LEU . 47.0 mt -145.38 159.24 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.87 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 13.2 mt -136.62 141.33 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.405 ' O ' HG21 ' A' ' 30' ' ' ILE . 61.5 t -117.79 153.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.583 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -158.51 176.86 11.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.309 -0.405 . . . . 10.0 111.267 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.507 ' HD3' ' O ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -134.64 135.3 42.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.841 178.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.47 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 72.9 p -148.99 110.83 4.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 21.9 ttmm 47.31 48.52 16.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.346 0.593 . . . . 10.0 110.949 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 72.39 33.21 1.5 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.094 -0.957 . . . . 10.0 111.461 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 91' ' ' VAL . 57.5 t -130.19 111.04 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.199 -0.91 . . . . 10.0 109.097 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 66.4 mt-10 -88.38 97.75 11.23 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 106.177 -1.786 . . . . 10.0 106.177 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 89' ' ' VAL . 3.9 t -88.75 153.87 3.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 113.334 -1.757 . . . . 10.0 113.234 -174.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -128.74 143.5 14.51 Favored Glycine 0 C--N 1.316 -0.577 0 CA-C-N 114.586 -1.188 . . . . 10.0 113.044 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.537 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.6 OUTLIER -131.61 125.55 32.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.811 0.338 . . . . 10.0 110.24 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.476 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 40.1 tp -88.6 130.88 35.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.023 0.44 . . . . 10.0 110.835 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.475 HG13 ' CE2' ' A' ' 16' ' ' PHE . 28.1 m -137.01 -175.09 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.964 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 59.7 t0 -89.01 -76.6 0.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.29 0.567 . . . . 10.0 110.998 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -131.75 113.22 13.28 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.115 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.595 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.9 p -95.88 115.85 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 122.408 1.099 . . . . 10.0 111.772 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -68.1 -28.24 67.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.044 -1.889 . . . . 10.0 111.043 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.92 -123.24 6.88 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.633 -0.794 . . . . 10.0 111.824 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.9 m -51.07 133.05 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.799 0.3 . . . . 10.0 111.03 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.588 ' HG ' HG12 ' A' ' 104' ' ' ILE . 57.4 tp -137.77 139.79 40.24 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.08 0.467 . . . . 10.0 111.211 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 16.2 ptm180 -88.84 73.6 8.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.592 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.778 ' HB ' HG11 ' A' ' 13' ' ' VAL . 16.4 mm -88.79 165.28 2.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 25.4 p -124.61 -176.0 3.42 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.764 -1.199 . . . . 10.0 107.764 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 87.7 tt0 -137.04 67.05 1.45 Allowed 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.258 -0.977 . . . . 10.0 112.045 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -104.8 26.11 9.56 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.462 -1.245 . . . . 10.0 109.035 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 106' ' ' GLU . 3.0 pm0 . . . . . 0 C--N 1.328 -0.334 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.515 ' CE2' HD23 ' A' ' 69' ' ' LEU . 51.6 t80 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.053 0.454 . . . . 10.0 110.159 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 120' ' ' LYS . . . 166.45 -49.36 0.26 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.604 -0.725 . . . . 10.0 112.012 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER 171.97 -33.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.044 0.45 . . . . 10.0 110.405 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -54.89 -46.45 74.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.754 -0.657 . . . . 10.0 111.257 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.502 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 80.9 p . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.864 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.544 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.051 0.453 . . . . 10.0 111.667 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 22.2 pttp -163.65 133.92 4.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.546 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.579 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 14.0 m -167.09 156.43 10.55 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.369 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.4 ' N ' ' CG2' ' A' ' 128' ' ' THR . 62.7 m-20 59.94 45.76 11.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.967 0.413 . . . . 10.0 110.84 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.0 28.23 11.97 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.615 -0.802 . . . . 10.0 111.914 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 128' ' ' THR . 14.8 ptt180 -139.33 132.82 30.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 3.9 mp -88.82 136.68 32.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.937 0.399 . . . . 10.0 111.546 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.572 HG12 ' CB ' ' A' ' 22' ' ' ALA . 3.6 mt -126.52 129.56 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.936 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.536 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.4 mp -88.82 141.36 14.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 N-CA-C 108.934 -0.765 . . . . 10.0 108.934 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.436 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 42.3 t80 -124.8 146.2 49.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.28 0.562 . . . . 10.0 111.325 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.514 ' CD2' HG21 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -144.39 141.08 29.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.761 0.652 . . . . 10.0 112.761 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.412 ' O ' HG21 ' A' ' 138' ' ' ILE . 55.6 p30 -105.8 25.37 10.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.228 -0.896 . . . . 10.0 108.896 177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.87 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 15.3 tt 41.19 16.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 114.346 1.239 . . . . 10.0 114.346 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 142' ' ' ILE . 38.2 t70 -79.69 -61.21 2.07 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.085 0.772 . . . . 10.0 113.085 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -74.91 -30.54 61.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.535 0.684 . . . . 10.0 110.567 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.87 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.25 -48.4 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.972 -1.013 . . . . 10.0 110.606 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.616 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.4 tp -62.19 -45.75 98.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 120.213 -0.595 . . . . 10.0 110.209 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -47.74 -43.68 27.29 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 51.9 mm-40 -71.85 -39.27 69.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.045 -0.979 . . . . 10.0 110.429 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.593 HG13 ' O ' ' A' ' 141' ' ' ILE . 46.8 mt -45.17 -38.48 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-O 120.803 0.335 . . . . 10.0 111.24 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.1 p -97.77 -53.79 3.31 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.21 0.818 . . . . 10.0 113.21 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.6 p -84.2 13.16 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 113.466 0.913 . . . . 10.0 113.466 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.623 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 84.9 tttt . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 120.271 -0.572 . . . . 10.0 110.788 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.472 ' HD2' ' C ' ' A' ' 9' ' ' LYS . 2.6 tmmm? . . . . . 0 C--O 1.23 0.075 0 N-CA-C 109.928 -0.397 . . . . 10.0 109.928 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 88.3 tt0 -138.96 161.14 38.06 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.272 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.592 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 11.0 t80 -165.85 139.48 4.39 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.45 -0.796 . . . . 10.0 112.917 -173.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 16.7 mt-10 -88.82 134.41 33.94 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.711 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -149.05 170.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 113.307 0.854 . . . . 10.0 113.307 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.521 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 3.1 tm? -88.91 132.88 34.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.533 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 86.6 p -143.09 153.64 43.12 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.687 0.756 . . . . 10.0 112.746 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.599 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 0.5 OUTLIER -149.93 160.4 43.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.252 -1.34 . . . . 10.0 110.012 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -88.67 135.98 33.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.353 -0.61 . . . . 10.0 109.353 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.502 HG22 ' CD1' ' A' ' 71' ' ' ILE . 34.8 mm -130.79 81.99 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.361 -0.836 . . . . 10.0 111.34 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.684 ' OD2' ' HA ' ' A' ' 73' ' ' PHE . 19.9 m-20 50.82 60.23 4.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.462 0.542 . . . . 10.0 112.462 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 81.3 mt-10 81.98 -35.89 0.1 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.171 -0.922 . . . . 10.0 111.107 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.455 ' NE2' HD11 ' A' ' 134' ' ' ILE . 37.5 tt0 -88.87 136.71 32.86 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.252 -0.647 . . . . 10.0 109.252 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.537 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.72 162.12 16.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.054 0.454 . . . . 10.0 111.222 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.589 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 1.5 tp -148.63 139.33 22.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.165 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 135' ' ' TYR . . . -143.55 153.56 42.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.927 0.714 . . . . 10.0 112.927 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 13' ' ' VAL . 6.0 m-85 -135.37 140.56 45.1 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.222 -0.899 . . . . 10.0 109.169 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . 47.0 p-10 -49.17 123.3 7.09 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.106 0.479 . . . . 10.0 111.25 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.422 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 31.1 m -62.26 -13.25 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.573 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -61.16 -46.05 92.09 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.031 0.443 . . . . 10.0 110.047 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.41 ' ND2' HG23 ' A' ' 138' ' ' ILE . 16.0 t-20 -89.28 -45.04 9.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.562 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -60.97 120.67 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.234 -0.439 . . . . 10.0 109.906 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 32' ' ' MET . 8.8 pt-20 -81.19 -58.85 2.88 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.198 0.444 . . . . 10.0 112.198 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.458 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -169.12 157.94 8.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.038 0.446 . . . . 10.0 111.725 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.4 m -88.94 152.16 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.697 -0.683 . . . . 10.0 111.508 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 pt -148.35 129.81 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -88.82 128.63 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 10.0 110.241 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.725 ' HA ' ' HE3' ' A' ' 36' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.883 0.373 . . . . 10.0 110.959 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.457 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 44.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.975 0.417 . . . . 10.0 111.632 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -90.31 -46.84 8.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.579 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.491 ' O ' HG13 ' A' ' 52' ' ' VAL . . . -133.04 -179.08 15.98 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.764 -0.731 . . . . 10.0 112.774 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 51' ' ' GLY . 2.4 m -160.81 168.81 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 CA-C-O 120.848 0.356 . . . . 10.0 110.53 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.411 HG12 HD13 ' A' ' 60' ' ' ILE . 28.5 pt . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.319 -0.4 . . . . 10.0 110.719 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 90' ' ' GLU . 2.1 pp . . . . . 0 C--O 1.232 0.153 0 N-CA-C 111.663 0.245 . . . . 10.0 111.663 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 70.2 Cg_endo -86.09 117.75 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.747 2.298 . . . . 10.0 112.958 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.43 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 35.1 m -96.0 134.84 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.639 -0.504 . . . . 10.0 109.639 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 57.4 t -140.31 156.0 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.561 0.696 . . . . 10.0 112.406 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 67' ' ' LYS . 5.6 m120 -77.16 72.27 3.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.949 -1.023 . . . . 10.0 109.805 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.791 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.1 tt -53.86 -37.55 63.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.308 0.575 . . . . 10.0 110.587 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.649 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -56.75 -25.88 55.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.132 0.492 . . . . 10.0 109.69 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.528 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -82.01 -42.71 18.95 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.243 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.791 HG22 ' O ' ' A' ' 65' ' ' LEU . 7.9 tt -61.84 -37.61 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.613 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 1.1 tm? -78.35 -52.02 9.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 113.738 -1.574 . . . . 10.0 108.92 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.492 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 117.68 -82.87 0.33 Allowed Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.66 -0.7 . . . . 10.0 112.744 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.763 HG13 ' HB3' ' A' ' 73' ' ' PHE . 2.7 pt 45.36 173.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -50.16 -39.25 43.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.433 0.635 . . . . 10.0 109.32 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.763 ' HB3' HG13 ' A' ' 71' ' ' ILE . 4.3 t80 -28.21 145.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.672 -1.149 . . . . 10.0 113.904 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 65.4 t0 -137.63 -52.8 0.65 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.785 -1.098 . . . . 10.0 109.906 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' A' ' 74' ' ' ASP . 16.4 pt-20 163.57 -44.0 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.983 0.421 . . . . 10.0 111.624 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -51.31 -37.63 48.62 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.2 mmpt? -74.72 -29.68 61.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.11 0.411 . . . . 10.0 112.11 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.407 ' O ' ' CG ' ' A' ' 79' ' ' LYS . 29.3 mmt -43.84 130.55 5.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.888 0.375 . . . . 10.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 78' ' ' MET . 53.2 mtmt -162.1 -44.89 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.547 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.5 t -88.95 164.29 15.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.495 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.444 HD11 ' HB3' ' A' ' 36' ' ' LYS . 45.4 mt -140.98 125.97 18.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.694 0.283 . . . . 10.0 111.351 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.549 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 6.2 mt -100.42 155.27 4.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.459 -0.337 . . . . 10.0 111.203 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.75 145.66 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.645 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -143.46 -177.06 5.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.474 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 6.5 ptm180 -139.05 128.89 24.88 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.877 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.458 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 69.0 p -142.85 109.69 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.026 0.441 . . . . 10.0 111.914 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 47.8 49.99 16.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.388 0.614 . . . . 10.0 110.753 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 72.91 31.24 1.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.009 -0.996 . . . . 10.0 111.555 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.531 HG11 HG21 ' A' ' 91' ' ' VAL . 66.1 t -126.95 109.74 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.262 -0.881 . . . . 10.0 109.397 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 36.9 tt0 -88.36 99.12 12.01 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.799 -1.926 . . . . 10.0 105.799 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.531 HG21 HG11 ' A' ' 89' ' ' VAL . 5.3 t -88.67 152.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 113.181 -1.827 . . . . 10.0 113.196 -173.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -119.18 153.25 16.95 Favored Glycine 0 C--N 1.315 -0.606 0 CA-C-N 114.381 -1.281 . . . . 10.0 113.156 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -143.95 125.09 14.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.861 0.362 . . . . 10.0 110.559 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.522 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 42.3 tp -88.66 124.74 34.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.124 0.488 . . . . 10.0 110.516 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.465 HG13 ' CD2' ' A' ' 16' ' ' PHE . 17.1 m -132.87 -175.07 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.672 -0.694 . . . . 10.0 110.944 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 17.2 t70 -87.67 -71.79 0.55 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.536 0.684 . . . . 10.0 110.993 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -146.59 112.41 5.69 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.904 -1.044 . . . . 10.0 108.324 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.599 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -89.01 118.26 33.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 122.31 1.053 . . . . 10.0 112.939 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -66.12 -29.29 69.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.031 -1.895 . . . . 10.0 110.923 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.74 -123.43 7.31 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.556 -0.747 . . . . 10.0 111.498 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 m -52.89 136.85 13.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.977 0.389 . . . . 10.0 110.84 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.545 ' HG ' HG12 ' A' ' 104' ' ' ILE . 45.5 tp -139.21 141.89 37.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.17 0.509 . . . . 10.0 111.237 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.3 ptp85 -88.9 71.8 8.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.753 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.711 ' HB ' HG11 ' A' ' 13' ' ' VAL . 15.7 mm -88.75 136.75 22.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 N-CA-C 109.554 -0.536 . . . . 10.0 109.554 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 14.7 p -88.82 -175.76 4.99 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -144.34 77.37 1.54 Allowed 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.721 -1.192 . . . . 10.0 113.262 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.41 22.17 16.3 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.414 -1.267 . . . . 10.0 108.173 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 . . . . . 0 C--N 1.333 -0.149 0 CA-C-N 114.81 -1.086 . . . . 10.0 111.921 -178.631 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.507 ' CE2' HD23 ' A' ' 69' ' ' LEU . 33.4 t80 . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 120.949 0.404 . . . . 10.0 110.808 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.67 -144.02 9.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.951 -0.643 . . . . 10.0 112.405 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -85.22 58.03 4.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.695 0.283 . . . . 10.0 110.639 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -154.31 -40.05 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.919 0.341 . . . . 10.0 111.919 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 90.2 p . . . . . 0 C--N 1.329 -0.314 0 C-N-CA 121.187 -0.205 . . . . 10.0 110.824 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 133' ' ' ILE . 1.6 p . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 121.416 0.627 . . . . 10.0 112.389 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.516 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 92.7 mttt -152.27 132.35 13.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.145 -0.934 . . . . 10.0 109.742 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 2.6 m -169.07 152.12 5.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.825 0.345 . . . . 10.0 111.164 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.83 47.95 16.98 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.916 0.389 . . . . 10.0 111.244 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 49.12 30.92 10.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.116 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 128' ' ' THR . 3.5 ptm180 -137.94 136.4 36.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.171 -0.307 . . . . 10.0 110.171 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 132' ' ' LEU . 2.0 mm? -88.88 135.59 33.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.907 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.555 ' O ' HG11 ' A' ' 126' ' ' VAL . 3.9 mt -128.78 131.51 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.864 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.556 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.6 mp -88.87 140.12 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.238 -0.653 . . . . 10.0 109.238 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.472 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 49.0 t80 -128.72 141.45 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.33 0.586 . . . . 10.0 111.282 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 122' ' ' SER . 7.6 mp -136.47 172.51 12.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.823 0.82 . . . . 10.0 112.666 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 9.8 t70 -136.36 25.09 3.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.099 -1.41 . . . . 10.0 107.667 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.817 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 10.5 tt 42.6 17.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 114.164 -1.38 . . . . 10.0 114.086 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.566 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.5 t70 -82.33 -62.99 1.47 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.604 0.594 . . . . 10.0 112.604 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -73.93 -30.89 62.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.612 0.72 . . . . 10.0 109.981 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.817 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -69.29 -47.48 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.817 -1.083 . . . . 10.0 110.839 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.653 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.3 tp -60.74 -47.35 93.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 120.313 -0.555 . . . . 10.0 110.206 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -49.14 -43.55 41.83 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.289 0.566 . . . . 10.0 109.62 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 5.7 mm-40 -72.6 -34.81 67.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.192 -0.913 . . . . 10.0 110.898 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 141' ' ' ILE . 33.9 mt -47.93 -46.38 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-O 120.941 0.401 . . . . 10.0 111.093 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 80.6 p -86.25 -50.59 6.85 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.135 0.791 . . . . 10.0 113.135 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.6 p -82.36 13.03 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.537 0.94 . . . . 10.0 113.537 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 62.4 tttm . . . . . 0 C--N 1.328 -0.35 0 C-N-CA 120.124 -0.63 . . . . 10.0 111.019 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.0 pttt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.007 0.432 . . . . 10.0 110.464 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 41.8 mt-10 -145.48 164.25 32.16 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.449 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.501 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 16.1 t80 -153.38 141.9 20.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.863 -1.062 . . . . 10.0 112.606 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -88.75 139.27 30.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.538 -0.756 . . . . 10.0 109.174 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.85 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -154.09 169.05 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.395 0.887 . . . . 10.0 113.395 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.53 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 2.9 tm? -88.79 132.26 34.71 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.544 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 94.7 p -140.8 150.35 43.21 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.695 ' HZ ' ' CE1' ' A' ' 25' ' ' PHE . 4.6 p90 -150.71 162.57 40.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.523 -1.217 . . . . 10.0 110.308 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.64 137.73 32.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.123 0.487 . . . . 10.0 109.802 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.615 HG13 HD23 ' A' ' 23' ' ' LEU . 17.8 mm -136.11 99.36 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.642 -0.708 . . . . 10.0 111.289 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.545 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 48.7 m-20 42.0 60.14 2.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.479 -0.782 . . . . 10.0 112.84 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.1 mt-10 86.6 -42.68 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.304 -0.862 . . . . 10.0 112.581 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.464 ' OE1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -89.03 155.7 19.31 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.393 -0.523 . . . . 10.0 110.261 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.586 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.64 165.84 14.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.846 0.355 . . . . 10.0 110.677 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.617 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -152.27 133.05 14.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.329 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -142.83 141.25 31.57 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.356 0.598 . . . . 10.0 112.372 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.695 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -118.0 141.08 48.84 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.248 -1.39 . . . . 10.0 107.248 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.44 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . 12.5 p-10 -45.29 105.85 0.07 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.365 0.602 . . . . 10.0 110.612 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.57 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 6.3 p -51.15 -18.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.212 -0.903 . . . . 10.0 110.685 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.69 -39.29 93.51 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 85' ' ' ARG . 11.7 t30 -84.46 -45.78 12.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.091 -0.959 . . . . 10.0 110.506 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.444 HG23 ' HG ' ' A' ' 14' ' ' LEU . 27.0 mm -63.68 131.92 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.021 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -93.82 -61.19 1.59 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.028 0.381 . . . . 10.0 112.028 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.404 ' HE2' ' HB3' ' A' ' 32' ' ' MET . 9.1 ptp -169.03 161.79 10.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 10.0 111.489 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 33.9 m -88.94 143.1 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.973 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.6 HG13 ' HB ' ' A' ' 81' ' ' ILE . 20.1 pt -126.47 157.36 37.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.572 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -88.82 139.93 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.945 0.402 . . . . 10.0 111.28 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.01 -179.88 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.407 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 60.7 t . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.896 0.379 . . . . 10.0 111.368 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -73.88 -39.78 63.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.668 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.31 -175.8 23.5 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.253 -0.975 . . . . 10.0 113.009 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 m -156.01 171.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.847 0.356 . . . . 10.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.455 HG12 HD13 ' A' ' 60' ' ' ILE . 31.2 pt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.781 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.3 pp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.512 0.196 . . . . 10.0 111.296 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.612 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 95.3 Cg_endo -80.0 121.4 4.47 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.484 2.122 . . . . 10.0 112.815 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.409 ' O ' HG21 ' A' ' 62' ' ' VAL . 35.0 m -93.38 132.08 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.759 -0.655 . . . . 10.0 109.945 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.5 t -141.31 162.34 21.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.278 0.561 . . . . 10.0 111.208 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.446 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 4.6 m120 -102.78 85.42 2.56 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.693 -0.685 . . . . 10.0 110.593 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.88 ' O ' HG22 ' A' ' 68' ' ' ILE . 3.2 tt -53.25 -41.34 65.35 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.542 -0.463 . . . . 10.0 110.521 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.669 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -55.6 -24.41 32.81 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.472 -0.491 . . . . 10.0 109.955 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.501 ' HD2' ' C ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -86.36 -38.54 17.33 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.01 178.303 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.88 HG22 ' O ' ' A' ' 65' ' ' LEU . 5.7 tt -64.83 -36.16 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 107.481 -1.303 . . . . 10.0 107.481 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.63 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -81.89 -53.74 5.91 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.292 -1.777 . . . . 10.0 108.643 178.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . 116.07 -76.28 0.27 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.801 -1.09 . . . . 10.0 112.182 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.782 HG13 ' HB3' ' A' ' 73' ' ' PHE . 6.5 pt 43.05 -175.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 112.341 0.497 . . . . 10.0 112.341 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 52.5 m -60.33 -39.3 86.58 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.782 ' HB3' HG13 ' A' ' 71' ' ' ILE . 11.4 t80 -26.01 137.14 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.035 -0.984 . . . . 10.0 112.88 177.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.435 ' O ' ' OE2' ' A' ' 75' ' ' GLU . 9.8 t70 -158.72 43.76 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.267 -0.879 . . . . 10.0 109.395 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 1.4 pp20? 37.53 38.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.176 -0.92 . . . . 10.0 112.091 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -87.67 -49.47 7.12 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.786 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.441 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -106.87 -1.85 21.98 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.666 0.617 . . . . 10.0 112.666 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 12.1 mmt -42.07 139.28 1.38 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.71 0.291 . . . . 10.0 111.74 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -177.23 36.19 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.632 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.9 m -169.02 143.73 3.12 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.499 -0.319 . . . . 10.0 110.624 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.6 ' HB ' HG13 ' A' ' 34' ' ' ILE . 67.1 mt -114.26 152.51 15.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 10.0 111.333 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.559 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 14.1 mt -123.98 133.45 69.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.7 t -103.33 150.45 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 10.0 110.83 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -158.08 174.0 15.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.242 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.497 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 6.8 ptm180 -129.28 147.58 51.12 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.206 -0.665 . . . . 10.0 109.206 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.484 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 67.5 p -161.82 109.02 1.38 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.011 0.434 . . . . 10.0 112.081 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 14.9 tppt? 46.8 48.86 14.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.416 0.627 . . . . 10.0 110.809 178.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 20.7 m-20 72.17 33.76 1.51 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 10.0 111.433 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 91' ' ' VAL . 59.0 t -132.18 112.27 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 115.293 -0.867 . . . . 10.0 109.255 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.612 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 73.9 mt-10 -88.22 95.12 10.05 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 89' ' ' VAL . 3.5 t -88.69 152.25 3.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 113.374 -1.739 . . . . 10.0 113.067 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -132.46 143.12 14.69 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.959 -1.019 . . . . 10.0 113.367 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.727 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.3 t80 -131.19 128.64 40.41 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.827 0.346 . . . . 10.0 111.061 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.49 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 58.2 tp -88.8 126.86 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.876 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.526 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 21.6 m -132.01 -175.22 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.693 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.441 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 44.1 t0 -87.98 -74.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.362 0.601 . . . . 10.0 111.273 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -130.7 117.42 19.43 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.166 -0.925 . . . . 10.0 108.521 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.591 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -101.05 116.6 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 122.484 1.135 . . . . 10.0 112.073 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -65.09 -29.27 70.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.002 -1.908 . . . . 10.0 110.801 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.3 -127.33 8.64 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.825 -0.702 . . . . 10.0 111.718 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.3 t -51.25 132.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 117.011 0.406 . . . . 10.0 110.472 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.589 ' HG ' HG12 ' A' ' 104' ' ' ILE . 59.0 tp -137.09 138.86 40.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.027 0.441 . . . . 10.0 111.358 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.84 72.57 8.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.678 -0.692 . . . . 10.0 110.823 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.85 ' HB ' HG11 ' A' ' 13' ' ' VAL . 16.3 mm -88.78 133.3 31.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 N-CA-C 109.654 -0.498 . . . . 10.0 109.654 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 19.2 p -88.81 149.72 23.27 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -128.41 80.03 1.94 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 113.697 0.999 . . . . 10.0 113.697 -175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -97.69 2.75 50.06 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.59 -1.186 . . . . 10.0 107.896 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 . . . . . 0 C--N 1.339 0.151 0 CA-C-N 114.885 -1.052 . . . . 10.0 110.946 -179.546 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.552 ' CE2' ' CD2' ' A' ' 69' ' ' LEU . 26.0 t80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.167 0.508 . . . . 10.0 109.969 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.77 36.07 38.22 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.527 -0.761 . . . . 10.0 111.9 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.423 ' HB3' ' CD1' ' A' ' 118' ' ' PHE . 87.7 tttt 178.86 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.629 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 10.5 tppt? -130.47 -68.43 0.69 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.441 -0.504 . . . . 10.0 112.066 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.485 ' HB3' HD13 ' A' ' 136' ' ' LEU . 38.1 t . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 120.88 0.372 . . . . 10.0 110.588 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.516 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.962 0.41 . . . . 10.0 110.81 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.482 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 1.0 OUTLIER -160.5 133.42 6.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.361 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.505 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 10.2 m -161.61 148.33 14.28 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.634 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.12 42.73 27.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.036 0.446 . . . . 10.0 110.761 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.16 36.16 51.49 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.736 -0.745 . . . . 10.0 112.059 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 128' ' ' THR . 5.0 ptp180 -132.86 139.71 47.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.639 0.257 . . . . 10.0 110.442 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 132' ' ' LEU . 2.3 mm? -88.78 139.33 30.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.875 0.369 . . . . 10.0 110.848 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.586 HG12 ' CB ' ' A' ' 22' ' ' ALA . 3.8 mt -150.85 143.44 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.413 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 23' ' ' LEU . 11.8 mt -111.82 122.62 66.49 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.745 0 N-CA-C 109.11 -0.7 . . . . 10.0 109.11 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.44 ' OH ' ' HB3' ' A' ' 26' ' ' ASP . 16.4 t80 -100.99 172.53 6.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.529 HD12 HD11 ' A' ' 65' ' ' LEU . 4.1 tt -169.01 128.07 1.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.437 -0.505 . . . . 10.0 111.12 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.3 p-10 -91.12 16.2 10.21 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.191 0.441 . . . . 10.0 112.191 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.896 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 20.5 tt 42.33 18.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 113.908 1.077 . . . . 10.0 113.908 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.9 t0 -76.33 -56.19 4.86 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.94 0.719 . . . . 10.0 112.94 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 34.4 mmtp -80.1 -28.6 39.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.936 0.398 . . . . 10.0 110.997 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.896 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.5 -46.45 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.095 -0.502 . . . . 10.0 109.973 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.589 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 8.0 tp -65.04 -46.6 90.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 120.322 -0.551 . . . . 10.0 110.315 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -48.56 -40.02 25.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 54.8 mm-40 -76.47 -34.86 58.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.838 -1.074 . . . . 10.0 110.729 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.639 HG13 ' O ' ' A' ' 141' ' ' ILE . 43.4 mt -48.97 -38.91 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 120.971 0.415 . . . . 10.0 110.824 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 79.5 p -88.66 -51.75 5.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.968 0.729 . . . . 10.0 112.968 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.83 13.15 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.232 0.827 . . . . 10.0 113.232 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 28.0 tptp . . . . . 0 C--N 1.326 -0.437 0 C-N-CA 120.668 -0.413 . . . . 10.0 111.248 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 121.02 0.438 . . . . 10.0 110.19 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 95.1 mt-10 -140.8 164.28 30.64 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.509 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.545 ' CE2' ' OH ' ' A' ' 135' ' ' TYR . 18.5 t80 -140.49 125.28 18.17 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 114.363 1.246 . . . . 10.0 114.363 -174.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -88.98 125.75 35.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.688 -1.967 . . . . 10.0 105.688 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.7 HG11 ' HB ' ' A' ' 104' ' ' ILE . 5.8 p -150.79 167.74 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 114.439 1.274 . . . . 10.0 114.439 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.544 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.3 tm? -88.77 133.58 34.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.051 -1.092 . . . . 10.0 108.051 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.574 ' O ' HG21 ' A' ' 98' ' ' VAL . 57.1 p -144.89 158.11 43.91 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.749 0.785 . . . . 10.0 112.99 -177.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.602 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 2.1 p90 -152.97 156.8 39.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.147 -1.388 . . . . 10.0 109.996 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -88.67 106.39 18.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.363 0.602 . . . . 10.0 110.203 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.534 HG13 HD23 ' A' ' 23' ' ' LEU . 36.5 mm -88.89 102.51 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.173 -0.921 . . . . 10.0 110.973 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.583 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 12.2 p-10 32.92 60.33 0.41 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.094 1.146 . . . . 10.0 114.094 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 103.03 -51.3 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.07 0.948 . . . . 10.0 112.712 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.443 ' NE2' ' HB3' ' A' ' 72' ' ' SER . 1.6 pm0 -88.8 -175.73 4.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.695 -0.402 . . . . 10.0 110.363 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.531 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -112.83 159.83 18.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.104 0.478 . . . . 10.0 111.815 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.573 ' HB3' ' CE2' ' A' ' 16' ' ' PHE . 3.4 tp -150.4 136.72 18.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.951 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -138.77 152.5 47.98 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.335 0.865 . . . . 10.0 113.335 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.7 m-85 -131.95 142.32 49.59 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.128 -0.942 . . . . 10.0 109.322 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' OD2' ' HB3' ' A' ' 28' ' ' ASP . 21.4 t0 -52.48 123.28 10.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.152 0.501 . . . . 10.0 110.415 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 14' ' ' LEU . 33.2 m -63.69 -8.61 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 10.0 112.141 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.527 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 38.9 t70 -66.64 -47.4 72.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.533 -0.467 . . . . 10.0 109.833 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.427 ' ND2' HG23 ' A' ' 138' ' ' ILE . 19.2 t-20 -84.42 -44.43 13.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.637 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.3 mm -60.46 125.79 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.275 -0.421 . . . . 10.0 110.315 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.405 ' HB3' ' CE ' ' A' ' 32' ' ' MET . 44.5 mt-10 -85.28 -62.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.58 -0.282 . . . . 10.0 111.435 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.405 ' CE ' ' HB3' ' A' ' 31' ' ' GLU . 1.2 pmm? -169.11 156.95 7.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.036 0.446 . . . . 10.0 111.322 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.93 161.66 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.761 -0.654 . . . . 10.0 111.547 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 34' ' ' ILE . 22.3 pt -158.06 133.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.502 -0.772 . . . . 10.0 110.742 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.8 63.82 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.326 0.584 . . . . 10.0 110.845 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.487 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 14.5 mmmm . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.341 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.507 ' CG1' ' CG1' ' A' ' 52' ' ' VAL . 41.0 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.947 0.403 . . . . 10.0 111.393 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.5 -38.19 77.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.715 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.401 ' O ' HG13 ' A' ' 52' ' ' VAL . . . -148.49 165.57 29.1 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.382 -0.913 . . . . 10.0 113.324 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.507 ' CG1' ' CG1' ' A' ' 49' ' ' VAL . 2.9 m -161.91 169.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.438 HG12 HD13 ' A' ' 60' ' ' ILE . 30.3 pt . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 121.067 0.461 . . . . 10.0 111.73 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.2 pp . . . . . 0 C--O 1.236 0.391 0 CA-C-O 120.594 0.235 . . . . 10.0 111.504 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 98.0 Cg_endo -102.64 122.28 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.86 3.04 . . . . 10.0 112.589 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.418 ' O ' HG21 ' A' ' 62' ' ' VAL . 29.2 m -99.84 133.22 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 69.2 t -140.87 155.66 22.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.375 0.607 . . . . 10.0 111.75 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.75 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 4.2 m120 -70.27 66.59 0.3 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.39 -0.823 . . . . 10.0 109.777 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.771 ' O ' HG22 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -52.08 -18.2 1.35 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.732 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.655 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -74.86 -27.68 60.35 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.465 -0.494 . . . . 10.0 110.169 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.75 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.94 -39.26 21.65 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.638 -0.504 . . . . 10.0 109.638 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.771 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.6 tt -57.78 -40.08 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 106.909 -1.515 . . . . 10.0 106.909 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.614 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.37 -45.13 23.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.399 -1.728 . . . . 10.0 107.939 176.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . 113.08 -86.09 0.41 Allowed Glycine 0 C--N 1.335 0.488 0 CA-C-N 114.905 -1.043 . . . . 10.0 112.599 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.753 HG13 ' HB3' ' A' ' 73' ' ' PHE . 2.3 pt 46.89 167.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 113.41 0.893 . . . . 10.0 113.41 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.443 ' HB3' ' NE2' ' A' ' 21' ' ' GLN . 47.1 t -49.07 -37.93 22.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.364 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.753 ' HB3' HG13 ' A' ' 71' ' ' ILE . 3.1 t80 -22.5 141.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.274 1.213 . . . . 10.0 114.274 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 75' ' ' GLU . 9.7 t70 -132.03 -58.64 0.95 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.803 -1.089 . . . . 10.0 109.306 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 11.7 pt-20 153.2 -42.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.027 0.531 . . . . 10.0 111.294 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -47.38 -40.95 18.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 10.0 112.239 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.494 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.7 mmpt? -77.09 -41.91 40.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.351 . . . . 10.0 111.054 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.643 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 21.4 mmt -45.39 144.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.422 0.527 . . . . 10.0 112.422 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -178.36 48.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.158 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 79.1 p -169.05 -177.05 2.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.171 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 47.8 mt -154.41 140.27 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.074 0.398 . . . . 10.0 112.074 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 7.5 mt -108.84 162.45 6.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.171 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.48 147.94 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.946 0.403 . . . . 10.0 110.958 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -155.15 175.33 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.838 -0.619 . . . . 10.0 111.172 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.414 ' O ' HG22 ' A' ' 86' ' ' THR . 11.6 ptp180 -131.69 131.27 42.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.479 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 59.1 p -145.75 109.38 4.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.954 0.407 . . . . 10.0 112.096 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 87' ' ' LYS . 37.4 ttmt 47.54 50.62 14.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.477 0.656 . . . . 10.0 110.765 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.01 32.21 2.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.1 -0.955 . . . . 10.0 111.524 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.528 HG11 HG21 ' A' ' 91' ' ' VAL . 66.0 t -129.62 109.85 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.207 177.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 32.2 mt-10 -88.38 97.79 11.25 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.078 -1.823 . . . . 10.0 106.078 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.528 HG21 HG11 ' A' ' 89' ' ' VAL . 4.2 t -88.59 153.94 3.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 113.285 -1.779 . . . . 10.0 113.56 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.71 158.73 22.33 Favored Glycine 0 C--N 1.318 -0.445 0 CA-C-N 114.509 -1.223 . . . . 10.0 112.802 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.61 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 t80 -144.45 134.5 24.04 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.851 0.358 . . . . 10.0 111.287 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 45.6 tp -88.56 123.02 32.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.935 0.398 . . . . 10.0 111.038 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.643 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 5.2 m -132.91 -175.04 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.803 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 12.5 t70 -99.53 -56.02 2.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.356 0.598 . . . . 10.0 111.902 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.0 tpp85 -150.08 123.8 9.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.217 -0.902 . . . . 10.0 108.706 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.602 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.9 p -108.25 113.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 122.389 1.09 . . . . 10.0 112.325 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.33 -28.22 69.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 112.945 -1.934 . . . . 10.0 111.104 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.19 -118.94 5.09 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.825 -0.91 . . . . 10.0 110.825 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.9 130.1 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 117.066 0.433 . . . . 10.0 110.21 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.571 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 15.3 tp -135.18 143.47 46.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.416 . . . . 10.0 110.755 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 2.4 ptp180 -88.86 78.11 7.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.772 -0.649 . . . . 10.0 111.742 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.7 ' HB ' HG11 ' A' ' 13' ' ' VAL . 14.5 mm -88.81 178.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 106.856 -1.535 . . . . 10.0 106.856 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 17.3 p -141.43 -175.91 4.53 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 88.2 tt0 -127.73 72.3 1.39 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.949 0.88 . . . . 10.0 112.738 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -108.82 19.49 19.57 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.197 -1.365 . . . . 10.0 107.767 176.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 . . . . . 0 C--N 1.335 -0.059 0 CA-C-N 115.068 -0.969 . . . . 10.0 111.363 -178.823 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.549 ' CE1' HD23 ' A' ' 69' ' ' LEU . 45.2 t80 . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 121.272 0.558 . . . . 10.0 109.864 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 144.61 -53.19 0.58 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.365 -0.834 . . . . 10.0 111.961 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 62.6 tttm 171.72 55.24 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.42 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 4.1 tppp? -154.41 -30.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.604 0.594 . . . . 10.0 112.604 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.766 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 87.8 p . . . . . 0 N--CA 1.455 -0.21 0 C-N-CA 120.694 -0.402 . . . . 10.0 111.833 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.519 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 121.405 0.621 . . . . 10.0 111.847 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.505 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -163.07 137.4 6.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.592 -0.731 . . . . 10.0 110.617 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.554 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 8.7 m -165.14 150.09 9.22 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.623 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 56.83 44.17 23.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.943 0.402 . . . . 10.0 110.801 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.21 33.91 39.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.696 -0.764 . . . . 10.0 112.04 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 128' ' ' THR . 14.2 ptt180 -133.49 136.19 44.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.1 mt -88.89 139.95 29.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.046 0.451 . . . . 10.0 111.585 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.531 HG12 ' CB ' ' A' ' 22' ' ' ALA . 4.1 mt -145.37 132.8 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.543 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.524 ' O ' HD11 ' A' ' 23' ' ' LEU . 2.0 mp -88.89 149.56 3.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.617 -0.882 . . . . 10.0 108.617 177.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.545 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 38.6 t80 -135.38 145.11 47.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.036 -0.665 . . . . 10.0 111.707 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.766 ' HG ' ' HB2' ' A' ' 122' ' ' SER . 6.2 mp -138.85 164.23 30.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.758 0.79 . . . . 10.0 112.416 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.459 ' O ' HG21 ' A' ' 138' ' ' ILE . 37.0 t70 -134.53 26.71 3.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.439 -1.255 . . . . 10.0 108.402 178.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.788 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 8.4 tt 41.21 17.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 114.375 -1.284 . . . . 10.0 114.211 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 142' ' ' ILE . 7.9 t70 -81.36 -62.42 1.66 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.691 0.626 . . . . 10.0 112.691 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -75.82 -31.85 59.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.611 0.719 . . . . 10.0 109.903 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.788 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.59 -45.82 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 114.759 -1.11 . . . . 10.0 110.785 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.683 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.9 tp -64.48 -43.18 96.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 C-N-CA 119.987 -0.685 . . . . 10.0 109.902 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -47.71 -46.47 29.63 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.293 0.568 . . . . 10.0 110.072 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.423 ' HA ' ' CG1' ' A' ' 147' ' ' VAL . 53.2 mm-40 -67.4 -36.45 81.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.409 -0.814 . . . . 10.0 110.597 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 141' ' ' ILE . 54.1 mt -53.77 -38.72 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.92 0.391 . . . . 10.0 110.843 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.6 p -74.81 -48.8 23.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.368 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.423 ' CG1' ' HA ' ' A' ' 144' ' ' GLU . 14.8 p -79.23 6.26 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 111.952 0.353 . . . . 10.0 111.952 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.6 pttp . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.687 0.28 . . . . 10.0 111.462 -179.501 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 tptt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.746 0.307 . . . . 10.0 111.274 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 40.3 tt0 -117.02 163.9 15.53 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.435 0.636 . . . . 10.0 111.021 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.616 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.6 t80 -163.19 137.95 6.36 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.834 -1.075 . . . . 10.0 112.855 -174.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 68.1 mt-10 -88.8 138.93 30.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.632 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.692 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.1 p -155.58 174.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 -175.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' N ' HG21 ' A' ' 13' ' ' VAL . 3.2 tm? -88.74 136.98 32.72 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.004 -1.109 . . . . 10.0 108.004 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.537 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 81.8 p -149.37 157.67 43.52 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 113.993 1.108 . . . . 10.0 113.993 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.724 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -149.98 158.08 43.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 113.948 -1.478 . . . . 10.0 109.837 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HG2' HD21 ' A' ' 99' ' ' LEU . 5.1 mm-40 -88.59 88.95 7.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 10.0 111.048 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.512 HD12 HG12 ' A' ' 95' ' ' VAL . 16.8 mm -88.91 124.21 41.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.852 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.552 ' CG ' ' HB3' ' A' ' 72' ' ' SER . 1.9 p30 36.62 60.07 0.95 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.601 -0.727 . . . . 10.0 112.571 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 76.97 -43.46 0.44 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.037 -0.983 . . . . 10.0 112.688 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 22' ' ' ALA . 3.0 pp0? -89.02 166.0 14.18 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 120.915 -0.314 . . . . 10.0 110.38 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.524 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.77 150.17 23.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 10.0 112.27 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.724 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -133.56 130.69 38.77 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 178.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -138.33 153.88 48.98 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.615 0.968 . . . . 10.0 113.615 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.513 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.3 m-85 -135.73 142.31 45.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.527 -1.215 . . . . 10.0 107.97 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -50.81 123.46 9.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 10.0 110.374 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 14' ' ' LEU . 34.7 m -60.03 -12.29 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.508 -0.769 . . . . 10.0 111.863 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -63.42 -42.77 98.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.98 0.419 . . . . 10.0 110.127 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.447 ' ND2' HG23 ' A' ' 138' ' ' ILE . 12.1 t-20 -87.34 -45.68 10.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.561 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.401 HG23 ' HG ' ' A' ' 14' ' ' LEU . 11.8 mm -65.55 138.55 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.045 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 32' ' ' MET . 24.9 pt-20 -113.31 -50.07 2.88 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 3.5 mtm -163.95 -175.96 4.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.966 0.412 . . . . 10.0 111.552 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.84 126.59 67.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.934 -0.576 . . . . 10.0 111.465 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.2 pt -96.15 171.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.038 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -88.83 147.63 24.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 10.0 110.947 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.4 tttp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.166 -179.726 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 63' ' ' VAL . 62.0 t . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.857 0.361 . . . . 10.0 111.146 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -75.82 -39.04 57.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.027 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -167.91 -175.91 38.05 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.54 -0.838 . . . . 10.0 113.085 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.454 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 3.2 m -159.13 171.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.756 -0.461 . . . . 10.0 109.756 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.454 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 31.5 pt . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 121.147 0.498 . . . . 10.0 112.332 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 90' ' ' GLU . 2.2 pp . . . . . 0 C--O 1.235 0.301 0 CA-C-O 120.479 0.181 . . . . 10.0 110.735 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 60' ' ' ILE . 92.1 Cg_endo -100.55 114.05 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.301 2.668 . . . . 10.0 113.19 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 m -89.14 133.12 32.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.956 -0.757 . . . . 10.0 108.956 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 63.1 t -143.31 156.21 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.657 0.741 . . . . 10.0 112.953 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.429 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 74.6 m-20 -74.49 68.36 1.58 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.756 -1.111 . . . . 10.0 109.214 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.805 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.3 tt -53.41 -30.59 41.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.239 0.542 . . . . 10.0 110.814 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.626 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -63.01 -26.5 68.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.524 ' N ' ' HE2' ' A' ' 73' ' ' PHE . 0.8 OUTLIER -83.5 -42.0 17.36 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.966 179.19 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 65' ' ' LEU . 12.8 tt -58.79 -42.1 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 107.175 -1.416 . . . . 10.0 107.175 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.602 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -73.82 -45.28 52.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 113.76 -1.564 . . . . 10.0 108.435 176.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 113.52 -91.24 0.57 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.539 -0.755 . . . . 10.0 113.15 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.838 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.1 pt 48.28 164.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 112.812 0.671 . . . . 10.0 112.812 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.552 ' HB3' ' CG ' ' A' ' 19' ' ' ASP . 29.4 t -47.23 -32.99 4.98 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.328 -0.619 . . . . 10.0 109.328 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.838 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.2 t80 -33.18 141.55 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.191 -0.913 . . . . 10.0 112.533 176.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -171.87 43.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.49 -0.777 . . . . 10.0 110.196 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 78' ' ' MET . 50.0 mt-10 62.79 43.45 7.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.51 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 19.4 pt20 -74.54 -52.66 11.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.51 ' HD2' ' C ' ' A' ' 76' ' ' GLN . 2.6 mptt -146.4 18.97 1.36 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 112.275 0.472 . . . . 10.0 112.275 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.546 ' CE ' ' HA ' ' A' ' 95' ' ' VAL . 9.4 mmm -47.45 145.85 2.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.582 0.229 . . . . 10.0 110.525 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -174.38 38.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 10.0 111.14 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.1 m -169.14 162.47 10.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 10.0 109.875 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 70.3 mt -139.61 123.49 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.606 -0.438 . . . . 10.0 111.969 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 10.7 mt -89.01 130.96 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.494 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.32 146.64 9.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.071 0.462 . . . . 10.0 111.125 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -145.19 -178.72 6.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.566 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 41.8 mtm-85 -138.95 131.07 28.09 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.46 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 82.4 p -144.2 110.99 5.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.927 0.394 . . . . 10.0 112.035 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.8 tppp? 47.8 48.2 17.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.349 0.595 . . . . 10.0 110.735 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.51 32.35 1.21 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.085 -0.961 . . . . 10.0 111.564 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 91' ' ' VAL . 53.7 t -128.4 110.88 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.311 -0.859 . . . . 10.0 109.451 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 88.5 tt0 -88.27 98.34 11.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 106.14 -1.8 . . . . 10.0 106.14 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.513 HG21 HG11 ' A' ' 89' ' ' VAL . 3.6 t -88.62 153.93 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 112.983 -1.917 . . . . 10.0 113.353 -173.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -124.13 152.66 17.35 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-N 114.506 -1.225 . . . . 10.0 113.148 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.623 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -141.66 130.0 22.39 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.52 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 66.1 tp -88.56 133.68 34.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.205 0.526 . . . . 10.0 111.445 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.546 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 27.1 m -150.27 -175.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.357 -0.838 . . . . 10.0 110.776 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -111.51 -56.85 2.33 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.338 0.496 . . . . 10.0 112.338 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -133.87 124.72 26.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.986 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.585 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 5.9 p -115.94 113.12 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-O 122.336 1.065 . . . . 10.0 112.004 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.82 -30.19 71.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.292 -1.776 . . . . 10.0 111.343 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.58 -120.14 5.47 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.707 -0.957 . . . . 10.0 110.707 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.8 p -54.57 131.23 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 117.099 0.449 . . . . 10.0 110.064 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.579 ' CD2' HG12 ' A' ' 104' ' ' ILE . 54.6 tp -135.02 139.42 44.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.142 0.496 . . . . 10.0 111.469 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.1 ptp85 -88.9 72.35 8.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.1 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.692 ' HB ' HG11 ' A' ' 13' ' ' VAL . 9.6 mm -88.73 132.79 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.188 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.8 p -88.51 148.28 24.21 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 106.989 -1.486 . . . . 10.0 106.989 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -140.25 90.08 2.34 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.506 -0.878 . . . . 10.0 111.849 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -91.15 16.43 9.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.741 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-N 115.524 -0.762 . . . . 10.0 110.685 -179.616 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 69' ' ' LEU . 25.3 t80 . . . . . 0 N--CA 1.46 0.073 0 CA-C-O 121.031 0.443 . . . . 10.0 110.495 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.34 -146.58 18.24 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.712 -0.676 . . . . 10.0 112.341 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -88.23 54.05 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 10.0 110.678 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 68' ' ' ILE . 17.9 tppt? -139.55 -39.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.033 0.383 . . . . 10.0 112.033 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.569 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 99.6 p . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.664 0.269 . . . . 10.0 110.697 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.523 HG13 ' HB ' ' A' ' 133' ' ' ILE . 2.4 p . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 121.295 0.569 . . . . 10.0 111.686 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.42 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 96.5 mttt -147.02 140.65 25.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 131' ' ' ARG . 6.3 m -163.24 142.08 8.31 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.803 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 56.02 44.1 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.958 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.56 35.23 29.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.105 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.529 ' HD2' ' CG1' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -133.84 148.86 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.464 ' O ' ' HD3' ' A' ' 131' ' ' ARG . 4.2 mp -88.75 139.33 30.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.399 0.619 . . . . 10.0 112.471 -177.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.529 ' CG1' ' HD2' ' A' ' 131' ' ' ARG . 6.2 mt -151.5 150.35 13.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.241 -0.891 . . . . 10.0 110.571 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.541 ' O ' HD11 ' A' ' 23' ' ' LEU . 6.1 mm -103.6 130.9 53.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.481 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 10.3 t80 -117.42 139.26 51.13 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 119.915 -0.714 . . . . 10.0 111.364 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' ' 122' ' ' SER . 7.2 mp -135.67 165.98 24.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.497 -0.774 . . . . 10.0 112.145 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -135.45 24.28 3.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.657 -1.156 . . . . 10.0 108.293 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.799 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 11.1 tt 41.7 17.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.286 -1.325 . . . . 10.0 113.961 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.576 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.7 t70 -82.72 -60.19 2.26 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.729 0.64 . . . . 10.0 112.729 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 140' ' ' LYS . 3.4 mptp? -75.3 -34.26 61.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.699 0.761 . . . . 10.0 109.631 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.799 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.45 -46.15 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.664 -1.153 . . . . 10.0 110.732 179.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.706 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.6 tp -62.73 -45.84 97.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 C-N-CA 120.193 -0.603 . . . . 10.0 110.436 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -47.92 -44.61 30.01 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.351 0.596 . . . . 10.0 109.756 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.449 ' HA ' ' CG1' ' A' ' 147' ' ' VAL . 49.3 mt-10 -69.6 -30.94 68.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.246 -0.888 . . . . 10.0 110.898 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.613 HG13 ' O ' ' A' ' 141' ' ' ILE . 48.4 mt -57.61 -54.01 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 120.843 0.354 . . . . 10.0 111.418 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.4 p -69.05 -52.28 30.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.868 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 144' ' ' GLU . 14.0 p -67.25 -12.46 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.811 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.609 ' HA ' ' HE2' ' A' ' 148' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.842 0.354 . . . . 10.0 111.092 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.2 tttm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.005 0.431 . . . . 10.0 110.557 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 35.1 mt-10 -124.95 164.23 20.56 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.53 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.606 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 12.1 t80 -153.6 137.51 16.27 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.718 -1.128 . . . . 10.0 113.037 -174.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 70.8 mt-10 -88.78 137.36 32.38 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.791 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.743 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -152.07 171.05 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.333 -0.849 . . . . 10.0 112.504 -175.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.545 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.9 tm? -88.85 134.94 33.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.53 ' O ' HG21 ' A' ' 98' ' ' VAL . 80.6 p -148.16 153.03 38.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.096 0.776 . . . . 10.0 113.096 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.689 ' HZ ' ' CE1' ' A' ' 25' ' ' PHE . 1.8 p90 -149.79 168.1 24.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.269 -1.332 . . . . 10.0 110.143 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.55 129.67 35.42 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.512 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 4.5 mm -136.65 117.77 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.759 -0.655 . . . . 10.0 111.519 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.9 p30 38.44 60.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.17 -0.923 . . . . 10.0 112.621 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER 78.4 -43.06 0.35 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.916 -1.038 . . . . 10.0 112.742 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.512 ' NE2' ' HB ' ' A' ' 18' ' ' ILE . 3.5 pp0? -89.25 163.07 15.54 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.871 -0.332 . . . . 10.0 110.88 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.539 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.73 151.63 22.29 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.804 0.335 . . . . 10.0 110.84 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.585 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -133.58 134.75 43.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.077 -179.221 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -137.23 141.02 42.07 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.214 0.82 . . . . 10.0 113.214 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.689 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 1.4 m-85 -119.23 135.86 54.49 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.826 -1.175 . . . . 10.0 107.826 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -51.06 123.59 9.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.467 -0.493 . . . . 10.0 110.802 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 14' ' ' LEU . 15.7 m -64.4 -8.68 5.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.608 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.6 -31.43 68.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.01 0.433 . . . . 10.0 110.524 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.472 ' CB ' HG22 ' A' ' 138' ' ' ILE . 14.5 t30 -106.88 -50.22 3.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.918 -0.583 . . . . 10.0 112.401 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 mm -49.61 135.88 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.779 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 32' ' ' MET . 16.3 pt-20 -111.45 -51.65 2.84 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.889 0.7 . . . . 10.0 112.889 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.4 mtm -169.07 157.93 8.16 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.058 0.456 . . . . 10.0 111.88 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 34.8 m -89.68 177.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.033 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.598 HG13 ' HB ' ' A' ' 81' ' ' ILE . 20.6 pt -160.66 157.47 2.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.383 -0.826 . . . . 10.0 110.192 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -88.75 136.62 32.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 10.0 111.398 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.531 ' HB2' HG13 ' A' ' 81' ' ' ILE . 1.2 tmtp? . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.009 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.639 0.257 . . . . 10.0 110.776 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 1.7 pp20? -72.8 -35.91 67.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.445 -0.343 . . . . 10.0 111.725 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -158.66 -176.01 30.23 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 119.659 -1.258 . . . . 10.0 113.755 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.411 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 2.0 m -156.95 169.76 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.486 HG12 HD13 ' A' ' 60' ' ' ILE . 26.9 pt . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.946 0.403 . . . . 10.0 111.583 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.541 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.4 pp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.717 0.294 . . . . 10.0 111.326 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 95.2 Cg_endo -84.6 116.43 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.384 2.056 . . . . 10.0 112.593 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 7.6 m -89.0 99.54 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.346 -0.612 . . . . 10.0 109.346 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.721 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 3.1 t -99.52 -175.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.019 -0.991 . . . . 10.0 110.144 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.809 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 38.1 m-20 -132.55 87.82 2.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.08 -0.509 . . . . 10.0 109.986 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.682 ' O ' HG22 ' A' ' 68' ' ' ILE . 3.6 tt -51.14 -24.75 4.38 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.122 -0.631 . . . . 10.0 111.137 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.615 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -66.67 -29.51 69.54 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.827 -0.349 . . . . 10.0 111.058 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.809 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -86.08 -37.88 18.39 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.812 0.339 . . . . 10.0 110.15 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.3 tt -65.35 -38.24 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 107.508 -1.293 . . . . 10.0 107.508 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.59 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 1.5 tm? -78.29 -46.94 18.94 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.553 -1.658 . . . . 10.0 108.724 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 115.02 -89.64 0.51 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.305 -0.861 . . . . 10.0 112.633 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.819 HG13 ' HB3' ' A' ' 73' ' ' PHE . 4.4 pt 47.12 164.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 16.3 t -48.1 -33.05 7.62 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.819 ' HB3' HG13 ' A' ' 71' ' ' ILE . 16.5 t80 -30.6 145.42 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.219 -0.9 . . . . 10.0 112.634 176.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -166.44 33.62 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.31 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.475 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 56.2 mt-10 55.0 46.03 25.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.683 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.409 ' HB2' ' HE2' ' A' ' 77' ' ' LYS . 98.6 mm-40 -95.64 -53.48 3.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.434 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -102.09 -32.75 9.98 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.298 0.481 . . . . 10.0 112.298 -178.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.544 ' CE ' ' HA ' ' A' ' 95' ' ' VAL . 2.9 mmm -28.85 142.65 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.87 0.468 . . . . 10.0 112.248 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.76 39.33 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.079 -0.509 . . . . 10.0 111.283 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.4 t -169.06 127.69 1.02 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.736 -0.665 . . . . 10.0 109.644 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.598 ' HB ' HG13 ' A' ' 34' ' ' ILE . 47.8 mt -98.2 151.31 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.522 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 11.0 mt -115.65 123.8 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.879 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.3 t -91.31 147.6 5.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.503 0.668 . . . . 10.0 111.928 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -150.67 171.31 17.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.017 -0.992 . . . . 10.0 110.384 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.459 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 12.1 ptp180 -127.29 143.79 51.17 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.541 -0.54 . . . . 10.0 109.541 178.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.491 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 34.5 p -159.0 108.56 1.94 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.269 0.47 . . . . 10.0 112.269 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.2 tppp? 46.79 48.49 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.355 0.598 . . . . 10.0 110.816 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 72.47 33.88 1.37 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.081 -0.963 . . . . 10.0 111.244 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.53 HG11 HG21 ' A' ' 91' ' ' VAL . 75.0 t -132.45 110.62 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-N 115.122 -0.945 . . . . 10.0 109.193 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 1.7 mp0 -88.36 96.25 10.51 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 89' ' ' VAL . 3.4 t -88.64 153.26 3.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 113.273 -1.785 . . . . 10.0 112.792 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -131.84 153.87 20.69 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 114.997 -1.001 . . . . 10.0 113.701 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.721 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 t80 -139.86 128.54 23.12 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.441 ' O ' ' CE1' ' A' ' 93' ' ' PHE . 51.1 tp -88.72 136.19 33.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.562 0.696 . . . . 10.0 112.209 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.544 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 23.8 m -148.86 -175.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.805 -1.089 . . . . 10.0 110.098 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.434 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 6.6 t70 -106.31 -57.96 1.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -133.96 116.34 15.45 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.369 0.604 . . . . 10.0 109.825 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.585 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.3 p -105.08 116.09 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 122.49 1.138 . . . . 10.0 111.852 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -65.73 -29.69 70.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.908 -1.951 . . . . 10.0 110.774 -178.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.8 -122.14 5.91 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.174 -0.77 . . . . 10.0 111.174 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -53.22 129.91 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 117.148 0.474 . . . . 10.0 110.292 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.586 ' HG ' HG12 ' A' ' 104' ' ' ILE . 60.7 tp -132.02 141.66 49.32 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.104 0.478 . . . . 10.0 111.236 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 103' ' ' ARG . 14.4 ptp180 -88.87 68.79 8.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.743 ' HB ' HG11 ' A' ' 13' ' ' VAL . 22.3 mm -88.75 132.04 34.63 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 30.3 p -88.73 -175.77 5.02 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.223 -1.028 . . . . 10.0 108.223 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -147.3 75.71 1.38 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.322 -0.951 . . . . 10.0 112.423 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -103.1 20.63 17.27 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.763 -1.108 . . . . 10.0 109.272 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.453 -179.396 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.546 ' CE1' HD23 ' A' ' 69' ' ' LEU . 19.8 t80 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.005 0.431 . . . . 10.0 110.949 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 146.57 53.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.901 -0.666 . . . . 10.0 112.16 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 68.62 55.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.087 0.47 . . . . 10.0 110.844 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.44 ' HD2' ' CE2' ' A' ' 118' ' ' PHE . 24.2 ttmm -148.08 -37.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.609 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 92.1 p . . . . . 0 C--N 1.328 -0.334 0 N-CA-C 109.746 -0.465 . . . . 10.0 109.746 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.522 HG13 ' HB ' ' A' ' 133' ' ' ILE . 2.2 p . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 121.096 0.474 . . . . 10.0 111.015 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -152.89 140.99 20.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.162 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 6.2 m -167.46 147.49 5.24 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.849 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 57.28 42.86 24.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.431 . . . . 10.0 110.809 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.0 34.44 30.94 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.108 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -132.99 148.44 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.693 0.282 . . . . 10.0 110.274 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.8 139.47 30.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 10.0 111.11 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.539 HG12 ' CB ' ' A' ' 22' ' ' ALA . 5.2 mt -152.28 156.56 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.954 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.488 ' O ' HD11 ' A' ' 23' ' ' LEU . 63.4 mt -117.79 126.91 75.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.448 ' HB2' HG12 ' A' ' 126' ' ' VAL . 15.1 t80 -116.03 146.47 42.14 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.924 -0.31 . . . . 10.0 110.535 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 122' ' ' SER . 0.0 OUTLIER -161.29 154.05 20.68 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.752 0.787 . . . . 10.0 112.717 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.489 ' O ' HG21 ' A' ' 141' ' ' ILE . 2.9 p30 -105.59 133.99 49.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.754 -1.112 . . . . 10.0 108.52 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.847 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 15.2 tt -67.11 6.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.494 ' O ' HG22 ' A' ' 142' ' ' ILE . 7.5 t70 -74.89 -47.79 28.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.902 0.382 . . . . 10.0 111.652 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' A' ' 140' ' ' LYS . 12.4 mptt -83.66 -34.76 24.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.163 0.506 . . . . 10.0 110.585 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.847 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -69.05 -35.83 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.593 179.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.701 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.8 tp -71.14 -44.15 74.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -47.3 -42.7 21.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.09 -35.34 71.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.471 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.693 HG13 ' O ' ' A' ' 141' ' ' ILE . 26.7 mt -53.43 -38.84 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-O 120.8 0.333 . . . . 10.0 111.096 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.6 p -80.65 -50.46 9.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.903 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.2 p -76.71 4.91 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 112.05 0.389 . . . . 10.0 112.05 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.0 pttp . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.527 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 N--CA 1.46 0.071 0 CA-C-O 120.747 0.308 . . . . 10.0 111.801 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 77.2 mt-10 -129.84 164.26 24.51 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.364 0.602 . . . . 10.0 111.038 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 15.7 t80 -161.67 138.62 8.48 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.937 -1.029 . . . . 10.0 112.881 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.76 140.62 29.26 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.724 -0.671 . . . . 10.0 109.632 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.783 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -156.39 169.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 113.287 0.847 . . . . 10.0 113.287 -174.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.498 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 2.9 tm? -88.95 133.92 34.14 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.742 -1.207 . . . . 10.0 107.742 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.532 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 74.6 p -145.34 153.8 41.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 113.083 0.772 . . . . 10.0 113.083 -177.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.611 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 3.1 p90 -151.81 165.3 34.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.375 -1.284 . . . . 10.0 110.371 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -88.58 134.07 33.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.504 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 21.3 mm -131.56 93.49 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.479 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.0 OUTLIER 42.65 60.19 2.5 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 113.073 0.768 . . . . 10.0 113.073 178.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 88.71 -43.34 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.115 -0.948 . . . . 10.0 112.632 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.509 ' C ' ' OE1' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -88.98 151.52 22.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.377 -0.529 . . . . 10.0 110.412 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.84 156.93 18.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.844 0.354 . . . . 10.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.595 HD11 ' O ' ' A' ' 134' ' ' ILE . 1.2 tp -144.74 135.52 24.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.885 0.374 . . . . 10.0 110.858 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 135' ' ' TYR . . . -142.27 151.69 42.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.943 -0.572 . . . . 10.0 112.364 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.62 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.8 m-85 -129.36 141.64 51.02 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -48.55 101.34 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.644 0.735 . . . . 10.0 109.369 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.438 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 3.8 p -47.15 -13.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.523 -1.217 . . . . 10.0 112.862 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -62.9 -41.95 99.61 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.226 -0.589 . . . . 10.0 109.712 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' ND2' HD12 ' A' ' 138' ' ' ILE . 13.4 t30 -81.85 -48.4 11.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.126 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.407 HG23 ' HG ' ' A' ' 14' ' ' LEU . 18.0 mm -58.52 123.58 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.133 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 32' ' ' MET . 15.7 pt-20 -87.19 -54.81 4.11 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.477 0.547 . . . . 10.0 112.477 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.3 mtm -169.23 157.87 7.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.161 0.505 . . . . 10.0 112.352 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -88.88 148.05 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.057 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 34' ' ' ILE . 32.0 pt -139.52 155.34 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -88.8 152.79 21.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.066 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.433 ' HD3' ' C ' ' A' ' 36' ' ' LYS . 12.3 tmtt? . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.721 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.516 ' HA ' HG22 ' A' ' 63' ' ' VAL . 58.6 t . . . . . 0 C--O 1.231 0.107 0 N-CA-C 111.912 0.338 . . . . 10.0 111.912 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -66.25 -30.94 71.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.972 0.415 . . . . 10.0 110.169 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.28 169.04 31.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.712 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.469 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 3.6 m -158.62 171.96 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.661 0.267 . . . . 10.0 110.499 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.508 HD13 HG13 ' A' ' 60' ' ' ILE . 2.2 pp . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.008 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.508 HG13 HD13 ' A' ' 53' ' ' ILE . 2.0 pp . . . . . 0 C--O 1.236 0.38 0 CA-C-O 120.303 0.097 . . . . 10.0 110.87 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 61.7 Cg_endo -97.31 123.97 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.365 2.71 . . . . 10.0 113.546 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.408 ' O ' HG21 ' A' ' 62' ' ' VAL . 34.4 m -102.62 135.5 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 49' ' ' VAL . 99.5 t -143.68 158.16 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.569 0.7 . . . . 10.0 112.543 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.8 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 4.1 m120 -70.38 67.69 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.945 -1.025 . . . . 10.0 109.702 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.772 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.9 tt -50.99 -31.07 16.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.336 0.589 . . . . 10.0 110.61 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.742 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -62.7 -22.96 66.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.81 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.8 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -88.4 -41.85 12.54 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 178.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.772 HG22 ' O ' ' A' ' 65' ' ' LEU . 7.6 tt -59.15 -40.38 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.566 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.88 -40.19 33.07 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.31 -1.768 . . . . 10.0 108.267 176.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.725 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 71.32 121.62 0.05 OUTLIER Glycine 0 C--N 1.333 0.386 0 CA-C-N 114.791 -1.095 . . . . 10.0 113.05 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.725 HG21 ' O ' ' A' ' 70' ' ' GLY . 0.3 OUTLIER -162.86 -167.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.152 0.581 . . . . 10.0 109.972 -179.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 71.9 m -50.4 -32.34 17.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.616 0.722 . . . . 10.0 109.14 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.742 ' CD2' ' CB ' ' A' ' 66' ' ' ALA . 7.3 t80 -35.81 143.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.418 -1.265 . . . . 10.0 112.682 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -169.98 36.11 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.649 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 56.2 mt-10 55.54 37.7 29.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.439 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -82.85 -70.81 0.53 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.816 0.341 . . . . 10.0 111.718 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.599 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.4 mptt -94.93 -31.14 13.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.683 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.477 ' CE ' ' HA ' ' A' ' 95' ' ' VAL . 12.3 mmm -23.22 140.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.542 0.737 . . . . 10.0 112.221 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -164.11 -37.04 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.972 0.36 . . . . 10.0 111.972 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 80.2 p -88.75 163.87 15.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.584 0.231 . . . . 10.0 111.002 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.423 HG12 HD11 ' A' ' 94' ' ' LEU . 67.7 mt -132.64 129.15 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.722 0.296 . . . . 10.0 111.643 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.586 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 7.5 mt -93.5 150.79 3.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.741 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 84' ' ' ALA . 46.6 t -121.45 142.04 39.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.458 . . . . 10.0 110.778 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -145.0 175.97 9.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.782 -0.644 . . . . 10.0 111.015 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.455 ' O ' ' CG2' ' A' ' 86' ' ' THR . 6.6 ptm180 -128.25 146.38 50.76 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.54 HG21 HG12 ' A' ' 138' ' ' ILE . 73.3 p -160.93 108.67 1.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.466 0.543 . . . . 10.0 112.466 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 47.08 48.41 15.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.371 0.605 . . . . 10.0 110.779 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 72.26 33.54 1.51 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.117 -0.947 . . . . 10.0 111.235 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 91' ' ' VAL . 54.2 t -131.46 111.81 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-N 115.166 -0.924 . . . . 10.0 109.211 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 27.1 mt-10 -88.34 97.93 11.32 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.053 -1.832 . . . . 10.0 106.053 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.537 HG21 HG11 ' A' ' 89' ' ' VAL . 4.8 t -88.55 154.48 3.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.256 -1.793 . . . . 10.0 112.658 -174.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.1 156.3 21.91 Favored Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.702 -1.136 . . . . 10.0 113.065 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.564 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 t80 -146.3 131.94 18.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 10.0 110.935 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 58.8 tp -88.7 126.83 35.5 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.266 0.555 . . . . 10.0 112.066 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.477 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 30.4 m -137.25 -175.08 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.261 -0.882 . . . . 10.0 109.89 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.78 -62.56 1.32 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.061 0.458 . . . . 10.0 112.191 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -133.93 117.86 17.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.756 -0.656 . . . . 10.0 109.66 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.611 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.3 p -104.95 116.07 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 122.451 1.12 . . . . 10.0 111.805 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -64.61 -30.33 71.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.02 -1.9 . . . . 10.0 110.747 -178.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.99 -124.4 6.98 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.487 -0.779 . . . . 10.0 111.259 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.3 p -52.17 128.15 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 117.035 0.418 . . . . 10.0 110.422 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.573 ' HG ' HG12 ' A' ' 104' ' ' ILE . 51.8 tp -132.06 139.06 48.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.039 0.447 . . . . 10.0 110.927 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.0 ptp85 -88.86 73.25 8.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.828 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.783 ' HB ' HG11 ' A' ' 13' ' ' VAL . 11.8 mm -88.78 126.21 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.737 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 17.7 p -88.74 146.21 25.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 176.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -131.31 70.7 1.46 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.069 -1.053 . . . . 10.0 113.398 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.99 -9.5 59.83 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.654 -1.157 . . . . 10.0 108.564 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-N 114.98 -1.009 . . . . 10.0 110.875 -179.93 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.488 ' CE1' HD23 ' A' ' 69' ' ' LEU . 23.7 t80 . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.188 0.518 . . . . 10.0 110.054 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' A' ' 120' ' ' LYS . . . 141.75 -58.75 0.56 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.478 -0.783 . . . . 10.0 112.052 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.441 ' CG ' ' O ' ' A' ' 119' ' ' GLY . 51.7 mtmt -163.78 56.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.55 0.214 . . . . 10.0 110.529 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 121' ' ' LYS . 2.4 tpmt? -150.88 -40.54 0.12 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.504 ' CB ' ' HG ' ' A' ' 136' ' ' LEU . 91.8 p . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 121.0 -0.28 . . . . 10.0 111.386 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.62 HG11 ' O ' ' A' ' 133' ' ' ILE . 2.3 p . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 121.603 0.716 . . . . 10.0 112.844 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.49 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 62.3 pttt -164.48 132.08 3.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.901 -1.045 . . . . 10.0 109.529 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 5.4 m -159.53 148.88 18.22 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.965 0.412 . . . . 10.0 111.476 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.442 ' HB3' ' NH2' ' A' ' 131' ' ' ARG . 38.6 t70 56.16 46.1 22.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.731 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.23 32.87 57.52 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.597 -0.811 . . . . 10.0 111.743 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.5 ptp85 -130.63 132.33 45.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.808 0.337 . . . . 10.0 110.221 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.5 tp -88.8 139.13 30.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.159 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.62 ' O ' HG11 ' A' ' 126' ' ' VAL . 2.6 mt -141.57 126.69 17.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.039 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.595 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.2 mp -89.03 136.59 23.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 46.5 t80 -128.8 140.96 51.47 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.537 0.684 . . . . 10.0 111.376 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.504 ' HG ' ' CB ' ' A' ' 122' ' ' SER . 6.9 mp -130.89 178.26 6.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.486 -0.779 . . . . 10.0 112.078 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.8 p-10 -141.37 23.28 2.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.336 -1.302 . . . . 10.0 108.063 177.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.829 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.3 tt 40.75 16.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 114.112 -1.404 . . . . 10.0 114.059 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.529 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.7 t0 -80.0 -61.36 2.01 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.61 0.596 . . . . 10.0 112.61 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -78.34 -29.68 47.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.383 0.611 . . . . 10.0 110.412 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.829 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.21 -45.64 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 115.367 -0.833 . . . . 10.0 110.118 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.659 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 8.0 tp -64.42 -43.32 96.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 120.013 -0.675 . . . . 10.0 109.512 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -48.16 -42.59 30.01 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.814 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.445 ' HA ' ' CG1' ' A' ' 147' ' ' VAL . 55.1 mm-40 -70.26 -33.73 71.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.24 -0.891 . . . . 10.0 110.421 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 141' ' ' ILE . 41.9 mt -57.22 -35.42 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.806 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.5 p -81.73 -50.45 9.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.655 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 144' ' ' GLU . 14.7 p -72.24 -5.21 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.948 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.42 ' CD ' ' O ' ' A' ' 145' ' ' ILE . 57.0 pttt . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.878 0.37 . . . . 10.0 111.469 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 10' ' ' GLU . 24.8 tptt . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 112.077 0.399 . . . . 10.0 112.077 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 42.4 tt0 -155.88 164.14 38.88 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.524 0.678 . . . . 10.0 111.477 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.652 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 11.4 t80 -159.49 140.41 12.53 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.616 -1.175 . . . . 10.0 112.483 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.66 130.64 35.25 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.168 -1.049 . . . . 10.0 108.168 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.777 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.6 p -149.0 166.23 3.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 -175.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.494 ' N ' HG21 ' A' ' 13' ' ' VAL . 3.0 tm? -89.01 140.02 29.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.551 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 53.4 p -154.92 158.03 38.65 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 119.806 -0.757 . . . . 10.0 112.851 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.68 ' CZ ' ' HG ' ' A' ' 23' ' ' LEU . 17.4 p90 -150.42 166.16 30.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.589 -1.187 . . . . 10.0 110.109 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.46 ' HG2' HD21 ' A' ' 99' ' ' LEU . 53.2 mm-40 -88.54 142.38 27.75 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.699 -0.482 . . . . 10.0 109.699 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.596 HG13 HD23 ' A' ' 23' ' ' LEU . 33.4 mm -140.52 93.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.78 -0.645 . . . . 10.0 111.45 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 62.3 m-20 43.24 60.06 2.71 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.89 -0.595 . . . . 10.0 112.39 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.8 mt-10 85.53 -42.71 0.05 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.145 -0.934 . . . . 10.0 112.307 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.481 ' NE2' HD11 ' A' ' 134' ' ' ILE . 19.1 pt20 -88.96 147.08 24.51 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.612 -0.435 . . . . 10.0 109.988 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.545 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.92 166.53 13.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.127 0.489 . . . . 10.0 111.927 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.68 ' HG ' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -140.39 143.57 35.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.549 -179.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -144.45 149.25 35.7 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.738 0.644 . . . . 10.0 112.738 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -138.39 137.88 37.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.689 -0.856 . . . . 10.0 108.689 179.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -56.17 123.93 16.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.224 -0.591 . . . . 10.0 110.144 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.8 m -59.77 -10.54 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.381 -0.827 . . . . 10.0 112.098 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 1.4 p30 -60.03 -40.67 90.14 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.087 0.47 . . . . 10.0 110.089 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.435 ' CG ' HG23 ' A' ' 138' ' ' ILE . 14.7 t-20 -93.3 -47.35 6.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 10.0 111.192 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 mm -57.93 121.91 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 32' ' ' MET . 12.4 pt-20 -84.34 -51.14 7.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.16 0.43 . . . . 10.0 112.16 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.9 mtm -169.1 154.69 6.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.248 0.547 . . . . 10.0 111.885 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.95 149.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.399 -0.819 . . . . 10.0 111.395 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.478 HG13 ' HB ' ' A' ' 81' ' ' ILE . 10.7 pt -143.57 -178.14 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.723 -0.672 . . . . 10.0 110.622 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -155.75 104.14 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.179 0.514 . . . . 10.0 110.701 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.788 -0.642 . . . . 10.0 111.083 -179.659 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.476 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 61.5 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.949 0.404 . . . . 10.0 111.476 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.85 -45.28 12.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.335 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 52' ' ' VAL . . . -139.13 -176.38 14.65 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.578 -0.737 . . . . 10.0 112.498 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 51' ' ' GLY . 2.5 m -160.51 169.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 10.0 110.232 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 53' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 120.991 0.424 . . . . 10.0 111.211 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.508 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 20.3 pt . . . . . 0 C--O 1.234 0.287 0 N-CA-C 111.563 0.208 . . . . 10.0 111.563 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 94.2 Cg_endo -77.82 117.84 4.33 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.593 2.195 . . . . 10.0 112.201 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.416 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 28.7 m -94.92 137.68 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.715 0.293 . . . . 10.0 110.423 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 88.3 t -140.47 154.91 22.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.479 0.657 . . . . 10.0 111.924 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.811 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.3 m120 -77.65 65.92 3.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.157 -0.929 . . . . 10.0 109.15 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.731 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.7 tt -49.64 -26.73 3.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.575 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.66 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -66.78 -29.15 69.02 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.347 -0.541 . . . . 10.0 110.596 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.811 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -87.92 -33.9 18.32 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 121.088 -0.245 . . . . 10.0 110.988 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.8 tt -57.37 -41.41 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 106.336 -1.727 . . . . 10.0 106.336 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.606 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -77.7 -49.74 13.86 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.231 -1.804 . . . . 10.0 108.392 176.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 115.48 -79.17 0.28 Allowed Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.229 -0.896 . . . . 10.0 112.746 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.817 HG13 ' HB3' ' A' ' 73' ' ' PHE . 2.3 pt 46.05 173.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.619 0.6 . . . . 10.0 112.619 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.505 ' CB ' ' HB2' ' A' ' 19' ' ' ASP . 71.4 m -51.62 -36.21 44.97 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.817 ' HB3' HG13 ' A' ' 71' ' ' ILE . 3.7 t80 -30.14 145.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.996 -1.002 . . . . 10.0 113.536 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 35.9 t70 -134.62 -54.37 0.83 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.051 -0.977 . . . . 10.0 110.117 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 74' ' ' ASP . 10.5 pt-20 164.52 -45.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.865 0.364 . . . . 10.0 111.644 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -55.52 -37.91 68.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.487 ' HE3' ' N ' ' A' ' 77' ' ' LYS . 0.8 OUTLIER -68.27 -26.9 65.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.771 0.319 . . . . 10.0 111.331 -179.385 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.418 ' SD ' ' CE1' ' A' ' 73' ' ' PHE . 27.5 mmt -47.6 134.7 12.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.495 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 54.8 mtmt -160.75 -51.57 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.726 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.3 m -90.14 -175.99 4.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.318 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.478 ' HB ' HG13 ' A' ' 34' ' ' ILE . 75.5 mt -152.28 160.59 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.549 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.541 HD13 ' CD2' ' A' ' 16' ' ' PHE . 15.2 mt -142.23 140.69 29.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.903 0.382 . . . . 10.0 111.263 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.62 149.74 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.139 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -147.9 175.6 10.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.8 -0.636 . . . . 10.0 110.573 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.43 ' C ' HG22 ' A' ' 86' ' ' THR . 12.1 ptp180 -133.21 129.99 38.48 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.482 ' OG1' HG12 ' A' ' 142' ' ' ILE . 44.8 p -144.42 108.78 4.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.319 0.489 . . . . 10.0 112.319 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.485 ' CE ' ' O ' ' A' ' 87' ' ' LYS . 8.1 ttpt 47.67 51.23 14.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.704 0.764 . . . . 10.0 110.806 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.0 31.1 2.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.964 -1.016 . . . . 10.0 111.611 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.535 HG11 HG21 ' A' ' 91' ' ' VAL . 55.7 t -128.33 108.37 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 115.178 -0.919 . . . . 10.0 109.028 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.645 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 1.4 mp0 -88.26 99.83 12.53 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.628 -1.99 . . . . 10.0 105.628 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.535 HG21 HG11 ' A' ' 89' ' ' VAL . 4.8 t -88.57 149.62 3.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 113.378 -1.737 . . . . 10.0 112.908 -173.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -119.07 157.78 15.16 Favored Glycine 0 C--N 1.31 -0.898 0 CA-C-N 113.862 -1.517 . . . . 10.0 112.423 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.65 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 0.6 OUTLIER -149.75 123.66 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.292 0.568 . . . . 10.0 111.866 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.578 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 46.6 tp -88.78 120.18 29.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.954 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.08 -175.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.48 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 5.2 t0 -84.61 -79.94 0.21 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.32 0.581 . . . . 10.0 110.704 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.81 110.59 8.71 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.675 -0.861 . . . . 10.0 108.675 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.571 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 10.5 p -88.93 114.52 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-O 122.319 1.057 . . . . 10.0 111.833 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.537 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -62.47 -28.65 69.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.23 -1.805 . . . . 10.0 110.827 -178.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.22 -121.07 5.93 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.006 -0.837 . . . . 10.0 111.006 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.68 127.33 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 117.076 0.438 . . . . 10.0 110.453 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.551 ' CD2' ' HB3' ' A' ' 15' ' ' SER . 46.9 tp -126.57 139.26 53.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.171 0.51 . . . . 10.0 110.743 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.0 ptp85 -88.87 76.95 7.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.381 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.777 ' HB ' HG11 ' A' ' 13' ' ' VAL . 10.1 mm -88.64 161.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 24.0 p -122.32 147.28 46.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 11.4 tt0 -104.96 66.81 0.77 Allowed 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.953 0.882 . . . . 10.0 112.256 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -96.31 17.74 15.28 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.456 -1.247 . . . . 10.0 108.677 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 C--O 1.231 0.128 0 CA-C-N 115.617 -0.72 . . . . 10.0 112.208 -179.486 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.534 ' CZ ' HD13 ' A' ' 69' ' ' LEU . 45.8 t80 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 121.304 0.574 . . . . 10.0 109.791 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 175.04 -55.91 0.12 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.096 -0.956 . . . . 10.0 111.336 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 5.8 tmtt? 173.34 44.76 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 110.196 -0.298 . . . . 10.0 110.196 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 121' ' ' LYS . 26.3 ttpp -163.89 48.78 0.13 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.408 0.522 . . . . 10.0 112.408 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.635 ' HB2' ' HB3' ' A' ' 136' ' ' LEU . 8.2 p . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 120.958 0.409 . . . . 10.0 112.056 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 133' ' ' ILE . 1.7 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.543 0.687 . . . . 10.0 112.138 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 27.9 mtpp -154.62 134.02 12.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.944 -1.025 . . . . 10.0 109.839 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.431 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 16.3 m -163.04 149.9 12.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.895 0.379 . . . . 10.0 111.23 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.459 ' OD1' ' HB3' ' A' ' 131' ' ' ARG . 2.8 p30 46.15 48.49 12.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 10.0 111.5 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.66 43.24 68.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.82 -0.705 . . . . 10.0 112.212 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.459 ' HB3' ' OD1' ' A' ' 129' ' ' ASP . 3.5 ptm180 -138.97 134.17 32.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 10.0 110.625 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.93 137.37 32.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.939 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.61 ' O ' HG13 ' A' ' 126' ' ' VAL . 3.9 mt -144.8 130.14 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.003 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.507 ' N ' HD13 ' A' ' 134' ' ' ILE . 1.4 mp -88.99 137.31 21.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.5 ' HB2' HG11 ' A' ' 126' ' ' VAL . 70.9 t80 -130.89 142.61 50.38 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.221 -0.592 . . . . 10.0 111.037 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 122' ' ' SER . 0.0 OUTLIER -164.67 147.01 8.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.367 0.603 . . . . 10.0 112.35 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.409 ' OD1' ' CB ' ' A' ' 139' ' ' ASP . 3.0 p30 -96.46 35.02 1.53 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.806 0.812 . . . . 10.0 110.194 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.878 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 20.9 tt 39.95 20.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.328 -1.306 . . . . 10.0 114.14 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.59 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.5 t0 -79.3 -57.06 3.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.04 0.756 . . . . 10.0 113.04 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 121' ' ' LYS . 22.5 ttmm -77.96 -33.55 51.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 10.0 110.265 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.878 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -64.98 -45.26 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.946 178.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.625 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 5.8 tp -61.36 -44.57 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 C-N-CA 120.1 -0.64 . . . . 10.0 109.531 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 139' ' ' ASP . 43.6 mm-40 -47.16 -41.67 18.21 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.433 ' HG3' ' CD ' ' A' ' 121' ' ' LYS . 59.1 mm-40 -73.48 -31.39 63.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.36 -0.836 . . . . 10.0 111.177 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 141' ' ' ILE . 44.5 mt -54.27 -48.16 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.973 0.416 . . . . 10.0 110.595 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.3 p -85.48 -45.98 11.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.978 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 143' ' ' GLU . 44.5 t -56.71 -31.49 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.585 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.4 tptt . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.066 0.46 . . . . 10.0 111.007 -179.196 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.533 ' HE3' ' CB ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 121.148 0.499 . . . . 10.0 110.189 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 43.3 tt0 -148.52 163.96 35.65 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.661 -0.7 . . . . 10.0 110.648 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.651 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.4 t80 -158.79 139.14 12.38 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.052 -0.976 . . . . 10.0 112.54 -174.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -88.59 130.37 35.28 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.433 -0.951 . . . . 10.0 108.433 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.741 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.6 p -148.87 169.13 2.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 -175.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.555 ' N ' HG21 ' A' ' 13' ' ' VAL . 3.3 tm? -88.8 139.18 30.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.595 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 83.3 p -149.15 154.17 38.79 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 119.806 -0.758 . . . . 10.0 112.881 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.702 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -149.24 167.18 26.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.409 -1.269 . . . . 10.0 110.775 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -88.63 123.81 33.46 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.03 -0.73 . . . . 10.0 109.03 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.475 HG23 ' CD1' ' A' ' 71' ' ' ILE . 9.7 mm -134.39 115.84 21.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.709 -0.678 . . . . 10.0 111.784 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.52 ' CG ' ' HB2' ' A' ' 72' ' ' SER . 2.0 p30 39.08 60.12 1.53 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.717 . . . . 10.0 112.484 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 52.6 mt-10 78.08 -42.87 0.36 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.923 -1.035 . . . . 10.0 112.469 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.455 ' OE1' HG12 ' A' ' 134' ' ' ILE . 3.7 pp0? -91.83 158.74 16.16 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.295 -0.253 . . . . 10.0 110.717 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.76 ' O ' ' HA ' ' A' ' 133' ' ' ILE . . . -88.74 148.37 24.0 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 121.078 0.466 . . . . 10.0 111.662 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.702 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -124.35 133.19 53.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.409 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -134.06 152.15 51.72 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.443 0.905 . . . . 10.0 113.443 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' CZ ' HD22 ' A' ' 65' ' ' LEU . 5.6 m-85 -135.98 139.08 42.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.941 -1.027 . . . . 10.0 109.024 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -49.54 122.49 6.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.143 0.497 . . . . 10.0 111.175 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 19.9 m -61.06 -13.51 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.789 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -59.98 -41.81 92.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.13 0.49 . . . . 10.0 109.708 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 85' ' ' ARG . 12.1 t30 -92.16 -48.52 6.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.641 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 25' ' ' PHE . 22.3 mm -60.89 129.23 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.445 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 32' ' ' MET . 16.4 pt-20 -100.37 -53.01 3.22 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.452 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.7 mtm -169.22 156.11 6.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 10.0 111.732 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 33.1 m -100.1 129.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.76 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.417 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 27.5 pt -105.78 137.68 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 10.0 111.015 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -90.48 119.51 30.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.829 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 68.7 mttm . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.818 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 50.0 t . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.086 0.469 . . . . 10.0 111.669 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HG3' ' ND2' ' A' ' 64' ' ' ASN . 35.7 mm-40 -63.71 -47.79 79.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.994 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.426 ' O ' ' CG1' ' A' ' 49' ' ' VAL . . . -155.47 -176.01 27.15 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.415 -0.811 . . . . 10.0 112.576 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 m -148.16 169.97 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.878 0.37 . . . . 10.0 110.98 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.6 pt . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 10.0 111.311 179.627 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.45 HG21 ' CG ' ' A' ' 90' ' ' GLU . 22.3 pt . . . . . 0 C--O 1.234 0.275 0 CA-C-O 120.675 0.274 . . . . 10.0 111.669 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 83.0 Cg_endo -80.16 116.54 3.38 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.816 2.344 . . . . 10.0 113.362 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' HG21 ' A' ' 62' ' ' VAL . 22.4 m -95.45 133.97 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.525 ' CG2' ' HA ' ' A' ' 49' ' ' VAL . 59.3 t -142.59 156.74 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.665 0.745 . . . . 10.0 112.832 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.865 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 80.1 m-20 -75.87 62.17 1.54 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.874 -1.057 . . . . 10.0 108.724 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.738 ' O ' HG22 ' A' ' 68' ' ' ILE . 0.8 OUTLIER -51.85 -20.48 2.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.74 -0.664 . . . . 10.0 111.621 -179.034 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.596 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -71.51 -30.66 66.21 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.287 -0.565 . . . . 10.0 110.133 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.865 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.58 -36.38 26.27 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.557 -0.164 . . . . 10.0 110.557 178.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 65' ' ' LEU . 9.1 tt -56.14 -40.86 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 106.402 -1.703 . . . . 10.0 106.402 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -76.81 -38.58 53.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 113.407 -1.724 . . . . 10.0 108.961 176.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.51 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 106.09 -92.12 0.78 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.607 -0.724 . . . . 10.0 113.598 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.882 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.4 pt 48.32 164.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 112.712 0.634 . . . . 10.0 112.712 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.52 ' HB2' ' CG ' ' A' ' 19' ' ' ASP . 29.2 m -49.16 -30.5 6.87 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.266 -0.642 . . . . 10.0 109.266 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.882 ' HB3' HG13 ' A' ' 71' ' ' ILE . 12.0 t80 -30.09 141.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.265 -0.88 . . . . 10.0 112.74 176.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -174.32 42.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.573 -0.739 . . . . 10.0 110.348 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 58.52 38.57 25.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -71.63 -42.77 67.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.846 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 96' ' ' ASP . 32.2 mmmt -146.11 23.92 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.85 0.315 . . . . 10.0 111.85 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.495 ' CE ' ' CE1' ' A' ' 73' ' ' PHE . 16.7 mmt -47.63 133.04 13.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.554 -0.294 . . . . 10.0 111.062 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -172.82 36.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.834 0.349 . . . . 10.0 111.137 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.3 p -169.11 154.07 5.83 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.637 -0.505 . . . . 10.0 109.637 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 51.8 mt -133.2 145.12 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.621 -0.432 . . . . 10.0 111.682 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.593 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 6.4 mt -110.21 144.6 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.483 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.99 140.09 46.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.147 0.499 . . . . 10.0 110.654 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.609 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -141.91 -175.97 4.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.992 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.48 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 6.4 ptm180 -135.55 143.1 45.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.498 ' OG1' ' HB ' ' A' ' 89' ' ' VAL . 41.6 p -158.83 109.39 2.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.876 0.37 . . . . 10.0 111.836 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 36.4 ttmt 46.72 47.25 15.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.649 . . . . 10.0 110.687 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 52.8 m-20 74.49 34.07 0.8 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.939 -1.028 . . . . 10.0 111.342 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.51 HG11 HG21 ' A' ' 91' ' ' VAL . 60.1 t -130.36 110.76 19.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.419 -0.809 . . . . 10.0 109.858 177.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 35.6 tt0 -88.34 99.74 12.48 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 105.68 -1.97 . . . . 10.0 105.68 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.51 HG21 HG11 ' A' ' 89' ' ' VAL . 4.6 t -88.6 149.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 113.329 -1.76 . . . . 10.0 113.36 -173.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -121.56 149.56 17.22 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 113.912 -1.494 . . . . 10.0 113.071 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.608 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -141.83 128.49 20.33 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 120.783 0.325 . . . . 10.0 110.891 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.456 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 36.3 tp -88.64 131.38 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.108 0.48 . . . . 10.0 110.986 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.52 HG13 ' CD2' ' A' ' 16' ' ' PHE . 18.8 m -143.02 -175.02 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.386 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 7.9 t70 -90.94 -70.49 0.68 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.316 0.579 . . . . 10.0 111.902 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -142.14 112.91 7.34 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.175 -0.921 . . . . 10.0 108.678 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.599 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -91.35 114.42 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 122.463 1.125 . . . . 10.0 112.017 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.532 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -63.03 -29.13 70.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 112.817 -1.992 . . . . 10.0 110.969 -178.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.58 -123.59 6.99 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.595 -0.812 . . . . 10.0 111.279 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.69 133.36 16.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.061 0.431 . . . . 10.0 110.5 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.595 ' CD2' ' HB3' ' A' ' 15' ' ' SER . 53.6 tp -135.15 138.96 44.23 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.232 0.539 . . . . 10.0 111.234 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.628 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.1 OUTLIER -88.82 73.75 8.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.32 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.741 ' HB ' HG11 ' A' ' 13' ' ' VAL . 11.5 mm -88.8 133.06 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.691 -0.485 . . . . 10.0 109.691 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.6 p -88.57 146.54 25.07 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -129.26 75.2 1.63 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 114.164 1.172 . . . . 10.0 114.164 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -97.16 2.7 51.41 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.56 -1.274 . . . . 10.0 107.56 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 . . . . . 0 N--CA 1.452 -0.359 0 CA-C-N 114.621 -1.172 . . . . 10.0 110.7 -179.565 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.507 ' CZ ' HD22 ' A' ' 69' ' ' LEU . 25.2 t80 . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 121.172 0.51 . . . . 10.0 110.035 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.7 -144.28 10.39 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.079 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -91.49 55.73 2.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.599 0.238 . . . . 10.0 110.667 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.496 ' NZ ' ' HB ' ' A' ' 141' ' ' ILE . 1.1 tmpt? -144.7 -44.79 0.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.915 -0.314 . . . . 10.0 111.314 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.513 ' OG ' HD21 ' A' ' 136' ' ' LEU . 47.4 t . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 119.643 -0.218 . . . . 10.0 110.428 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.607 HG11 ' O ' ' A' ' 133' ' ' ILE . 1.7 p . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.211 0.529 . . . . 10.0 112.017 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 94.6 mttt -160.24 135.91 8.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.306 -0.861 . . . . 10.0 109.876 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 5.7 m -163.9 149.28 10.78 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.973 0.416 . . . . 10.0 111.254 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 55.24 46.64 23.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.838 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.52 34.53 49.5 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.581 -0.819 . . . . 10.0 111.797 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' THR . 2.5 ptp180 -136.21 135.42 39.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.824 0.345 . . . . 10.0 110.21 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.9 152.42 21.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.158 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.76 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 6.3 mt -151.22 129.86 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.05 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.455 HG12 ' OE1' ' A' ' 21' ' ' GLN . 6.7 mm -90.29 145.0 7.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.507 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 38.1 t80 -133.5 136.32 45.0 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.197 0.522 . . . . 10.0 111.525 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.513 HD21 ' OG ' ' A' ' 122' ' ' SER . 16.0 mt -138.17 147.5 43.92 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.66 0.743 . . . . 10.0 112.003 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.473 ' O ' HG21 ' A' ' 138' ' ' ILE . 12.2 p-10 -105.51 26.43 9.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.703 -1.135 . . . . 10.0 108.86 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.851 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.6 tt 38.91 16.86 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 114.477 1.288 . . . . 10.0 114.477 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 142' ' ' ILE . 7.9 t0 -80.05 -62.35 1.71 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 144' ' ' GLU . 14.5 mmmm -73.7 -31.54 63.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.416 0.626 . . . . 10.0 110.451 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.851 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.96 -46.61 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.302 -0.863 . . . . 10.0 110.771 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.622 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 6.6 tp -60.92 -46.71 95.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 119.8 -0.76 . . . . 10.0 109.826 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 139' ' ' ASP . 96.7 mt-10 -48.87 -40.41 29.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 148' ' ' LYS . 44.8 mt-10 -71.21 -39.03 72.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.182 -0.917 . . . . 10.0 110.528 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 141' ' ' ILE . 34.4 mt -48.16 -43.79 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 120.797 0.332 . . . . 10.0 111.443 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.6 p -84.71 -53.47 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 144' ' ' GLU . 14.5 p -63.35 -21.45 28.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 111.718 0.266 . . . . 10.0 111.718 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HD2' ' CB ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.728 0.299 . . . . 10.0 110.832 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 37.8 tt0 -164.01 164.01 23.2 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.838 0.828 . . . . 10.0 111.295 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.602 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.3 t80 -150.85 138.62 19.83 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.964 -1.471 . . . . 10.0 112.862 -174.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 2.1 mt-10 -88.7 132.43 34.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.377 -0.828 . . . . 10.0 108.893 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.755 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.3 p -150.31 167.2 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 112.906 0.706 . . . . 10.0 112.906 -176.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.56 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.8 tm? -88.95 130.5 35.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.681 -0.859 . . . . 10.0 108.681 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.565 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 41.9 t -143.82 155.35 44.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.864 0.84 . . . . 10.0 112.565 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.617 ' HZ ' ' CE1' ' A' ' 25' ' ' PHE . 2.2 p90 -150.09 163.74 37.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.181 -1.372 . . . . 10.0 110.241 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -88.53 129.09 35.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.468 HG13 HD23 ' A' ' 23' ' ' LEU . 32.3 mm -122.85 87.89 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.319 -0.855 . . . . 10.0 111.259 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 41.5 m-20 51.48 60.04 4.15 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.838 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 61.7 mm-40 77.46 -32.48 0.18 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.45 -0.795 . . . . 10.0 111.708 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.515 ' NE2' HD11 ' A' ' 134' ' ' ILE . 38.6 tt0 -88.75 142.27 27.81 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.569 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.67 158.34 18.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.061 0.458 . . . . 10.0 112.086 -178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.572 HD11 ' O ' ' A' ' 134' ' ' ILE . 2.0 tp -152.28 139.62 19.47 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.123 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -141.99 144.68 33.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.426 0.528 . . . . 10.0 112.426 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 1.8 m-85 -119.54 138.84 52.93 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.969 -1.122 . . . . 10.0 107.969 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.659 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 26.4 t70 -51.57 123.52 10.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.01 0.433 . . . . 10.0 111.26 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 14' ' ' LEU . 12.7 m -64.29 -10.53 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.705 -0.679 . . . . 10.0 112.106 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.659 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 53.6 m-20 -69.37 -38.94 78.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.007 -0.677 . . . . 10.0 109.454 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.472 ' OD1' HG22 ' A' ' 86' ' ' THR . 12.6 t-20 -89.86 -44.83 9.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.234 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -65.41 129.24 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.091 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 32' ' ' MET . 14.8 pt-20 -95.55 -50.99 4.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.054 0.39 . . . . 10.0 112.054 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.7 mtm -168.99 155.07 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.185 0.516 . . . . 10.0 112.017 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.03 155.89 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.498 -0.774 . . . . 10.0 111.28 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.528 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 22.8 pt -150.44 138.58 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.046 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 22.7 pt-20 -104.65 110.96 23.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.693 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.182 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 121.007 0.432 . . . . 10.0 111.069 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -79.49 -34.94 40.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.857 -0.611 . . . . 10.0 111.31 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.6 -175.74 23.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.933 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.2 169.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.442 HG13 HG12 ' A' ' 60' ' ' ILE . 27.6 pt . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 10.0 111.052 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.477 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 18.7 pt . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.602 0.239 . . . . 10.0 111.494 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 80.7 Cg_endo -77.19 121.98 5.97 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.631 2.22 . . . . 10.0 112.601 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.2 m -88.92 129.67 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.687 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.566 ' CG1' ' H ' ' A' ' 64' ' ' ASN . 3.2 t -113.5 -175.81 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.595 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.566 ' H ' ' CG1' ' A' ' 63' ' ' VAL . 11.7 p-10 -133.7 70.18 1.46 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.358 0.599 . . . . 10.0 110.709 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.903 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.6 tt -53.76 -37.59 63.56 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.821 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.642 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -50.57 -29.16 10.09 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.338 -0.545 . . . . 10.0 109.876 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.594 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -82.64 -43.59 16.77 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.617 -0.719 . . . . 10.0 110.631 178.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.903 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.0 tt -61.03 -37.58 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 122.096 0.951 . . . . 10.0 108.646 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.631 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -81.83 -53.95 5.76 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.713 -1.585 . . . . 10.0 109.219 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.519 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 119.09 -77.81 0.3 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.383 -0.826 . . . . 10.0 112.136 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.776 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.8 pt 44.69 177.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 113.122 0.786 . . . . 10.0 113.122 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 41.1 t -54.87 -38.37 67.42 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.776 ' HB3' HG13 ' A' ' 71' ' ' ILE . 5.9 t80 -24.6 140.66 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.635 -1.166 . . . . 10.0 113.571 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -172.71 37.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.321 -0.854 . . . . 10.0 110.095 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 54.33 35.11 22.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.884 -0.598 . . . . 10.0 111.304 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.03 -61.36 1.98 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.398 -0.364 . . . . 10.0 111.652 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 78' ' ' MET . 2.3 mppt? -103.14 -25.37 13.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.429 -0.35 . . . . 10.0 111.847 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.553 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 20.0 mmt -17.9 136.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -170.19 -34.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.771 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -88.85 -176.02 5.07 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.832 0.349 . . . . 10.0 111.444 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 45.7 mt -152.37 158.34 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.897 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.515 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 12.3 mt -133.05 139.98 48.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.774 0.321 . . . . 10.0 111.052 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.439 HG11 ' N ' ' A' ' 84' ' ' ALA . 44.4 t -109.17 152.68 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.066 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.439 ' N ' HG11 ' A' ' 83' ' ' VAL . . . -155.37 169.71 23.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.364 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.457 ' O ' HG22 ' A' ' 86' ' ' THR . 14.3 ptm180 -128.04 132.72 49.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.589 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 57.6 p -148.3 109.19 4.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.817 0.303 . . . . 10.0 111.817 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.456 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 22.3 ttmm 49.49 60.21 3.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.147 0.499 . . . . 10.0 110.282 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 87' ' ' LYS . 7.4 p-10 55.1 32.68 18.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.036 -0.984 . . . . 10.0 111.551 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.589 ' HB ' ' O ' ' A' ' 86' ' ' THR . 70.7 t -125.62 109.34 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 115.16 -0.927 . . . . 10.0 108.732 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.602 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 28.5 mt-10 -88.46 94.59 9.91 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.871 -1.529 . . . . 10.0 106.871 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.532 HG21 HG11 ' A' ' 89' ' ' VAL . 3.1 t -88.57 155.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 113.035 -1.893 . . . . 10.0 112.856 -174.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.32 165.93 21.81 Favored Glycine 0 C--N 1.314 -0.693 0 CA-C-N 114.679 -1.146 . . . . 10.0 112.468 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.541 ' HE2' ' CZ ' ' A' ' 16' ' ' PHE . 2.6 t80 -151.62 133.61 15.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 10.0 110.839 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.49 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 67.3 tp -88.72 126.27 35.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.238 0.542 . . . . 10.0 111.898 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.553 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 15.4 m -135.61 -175.27 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.02 178.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -100.37 -60.04 1.6 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.203 0.525 . . . . 10.0 111.656 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.1 ttt-85 -144.46 117.08 8.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.382 -0.826 . . . . 10.0 108.891 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.591 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -101.08 118.22 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 122.336 1.065 . . . . 10.0 112.482 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -66.03 -29.22 69.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.219 -1.81 . . . . 10.0 110.674 -179.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.16 -125.05 7.61 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.485 -0.78 . . . . 10.0 111.425 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 m -52.33 131.13 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.944 0.372 . . . . 10.0 110.513 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 104' ' ' ILE . 56.6 tp -135.2 141.46 45.85 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.151 0.5 . . . . 10.0 111.258 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 103' ' ' ARG . 16.2 ptm180 -88.81 70.55 8.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.049 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.755 ' HB ' HG11 ' A' ' 13' ' ' VAL . 17.2 mm -88.65 136.76 22.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 107.922 -1.14 . . . . 10.0 107.922 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 37.9 p -88.65 -175.88 5.07 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -149.6 77.06 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.06 -1.056 . . . . 10.0 113.393 -178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -111.69 22.17 15.28 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.255 -1.339 . . . . 10.0 107.519 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-N 114.902 -1.044 . . . . 10.0 111.628 -178.712 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.587 ' CZ ' HD22 ' A' ' 69' ' ' LEU . 26.6 t80 . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.833 0.349 . . . . 10.0 110.91 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.61 -36.64 0.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.56 -0.828 . . . . 10.0 112.941 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.475 ' HB2' ' NZ ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER 176.33 124.98 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 2.7 tppp? 73.28 117.87 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.495 -0.775 . . . . 10.0 110.541 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.444 ' OG ' ' CD2' ' A' ' 69' ' ' LEU . 1.8 p . . . . . 0 CA--C 1.516 -0.345 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 133' ' ' ILE . 1.1 p . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 121.35 0.595 . . . . 10.0 111.593 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.505 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 87.0 tttt -164.77 135.81 4.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 10.0 110.284 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 8.5 m -161.76 150.52 15.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 120.976 0.417 . . . . 10.0 111.013 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 9.8 t70 55.18 48.02 20.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.442 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.3 35.03 34.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.664 -0.779 . . . . 10.0 111.977 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.5 OUTLIER -137.33 133.14 34.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.703 0.287 . . . . 10.0 110.273 -179.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 3.7 mp -88.93 139.08 30.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.892 0.377 . . . . 10.0 111.316 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.569 HG12 ' CB ' ' A' ' 22' ' ' ALA . 3.1 mt -145.36 136.7 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 10.0 110.621 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.572 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.4 mp -95.87 132.92 38.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.467 ' HB2' HG12 ' A' ' 126' ' ' VAL . 12.7 t80 -120.43 144.69 47.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.229 0.538 . . . . 10.0 110.421 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 138' ' ' ILE . 0.1 OUTLIER -151.88 131.81 13.37 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.52 -0.764 . . . . 10.0 111.234 -177.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.459 ' N ' HD21 ' A' ' 136' ' ' LEU . 12.2 p-10 -95.05 34.74 1.34 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.218 0.532 . . . . 10.0 111.296 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.813 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.6 tt 38.4 19.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.375 1.25 . . . . 10.0 114.375 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 137' ' ' ASP . 64.3 t0 -77.29 -57.11 4.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.274 0.842 . . . . 10.0 113.274 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -76.08 -28.93 57.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.318 0.58 . . . . 10.0 111.248 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.813 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.76 -45.99 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.438 -0.801 . . . . 10.0 110.878 -179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.559 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 8.9 tp -67.34 -47.65 80.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 120.252 -0.579 . . . . 10.0 111.212 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -50.33 -42.54 53.06 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.392 -0.595 . . . . 10.0 109.392 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 57.4 mm-40 -75.17 -27.24 59.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.123 -0.944 . . . . 10.0 111.04 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.648 HG13 ' O ' ' A' ' 141' ' ' ILE . 23.5 mt -55.41 -43.1 70.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.907 0.384 . . . . 10.0 110.72 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.4 p -86.33 -52.51 5.58 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.571 0.582 . . . . 10.0 112.571 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -84.78 13.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.85 0.685 . . . . 10.0 112.85 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.582 ' HA ' ' HE2' ' A' ' 148' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 120.712 0.292 . . . . 10.0 111.769 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.777 0.322 . . . . 10.0 111.075 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -152.26 164.3 37.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.969 0.89 . . . . 10.0 111.842 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.532 ' CE2' ' OH ' ' A' ' 135' ' ' TYR . 35.0 t80 -117.0 127.94 54.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.794 -1.548 . . . . 10.0 113.802 -175.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -89.02 126.2 35.32 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.649 -1.611 . . . . 10.0 106.649 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.725 HG11 ' HB ' ' A' ' 104' ' ' ILE . 4.2 p -151.83 167.74 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 114.476 1.287 . . . . 10.0 114.476 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.577 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.4 tm? -88.9 137.93 31.87 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 107.91 -1.144 . . . . 10.0 107.91 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.558 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 57.0 p -149.29 158.99 44.64 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.203 0.816 . . . . 10.0 113.203 -177.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.596 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 6.9 p90 -152.3 165.92 33.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.217 -1.356 . . . . 10.0 110.42 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.6 137.25 32.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 10.0 109.715 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.493 HD12 ' CE1' ' A' ' 16' ' ' PHE . 28.4 mm -134.37 92.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.164 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 41.6 m-20 44.74 60.25 3.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.64 . . . . 10.0 112.701 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 45.9 mt-10 85.17 -42.59 0.06 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.282 -0.872 . . . . 10.0 111.879 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -88.95 145.72 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.576 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.49 166.81 13.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.908 0.385 . . . . 10.0 110.785 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.588 ' HG ' ' CZ ' ' A' ' 16' ' ' PHE . 1.5 tp -149.43 139.33 21.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.505 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 135' ' ' TYR . . . -142.58 146.66 34.8 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.489 0.922 . . . . 10.0 113.489 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CE2' HD22 ' A' ' 136' ' ' LEU . 1.6 m-85 -124.24 143.51 50.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.224 -0.898 . . . . 10.0 108.615 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -53.69 123.23 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.05 -0.352 . . . . 10.0 110.05 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 14' ' ' LEU . 27.4 m -58.04 -14.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.567 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -62.64 -43.59 98.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.061 0.458 . . . . 10.0 110.204 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.463 ' ND2' HD12 ' A' ' 138' ' ' ILE . 14.9 t30 -84.7 -47.02 10.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.675 -0.693 . . . . 10.0 111.164 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.8 mm -61.03 132.28 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.217 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HB3' ' CE ' ' A' ' 32' ' ' MET . 43.9 mt-10 -94.91 -60.4 1.7 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.376 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.423 ' CE ' ' HB3' ' A' ' 31' ' ' GLU . 1.2 pmm? -169.01 156.55 7.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.367 -0.379 . . . . 10.0 111.003 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.84 144.58 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 10.0 111.791 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.6 pt -137.89 136.81 45.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.593 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -88.95 120.82 30.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 10.0 110.68 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.451 ' HB2' HD11 ' A' ' 81' ' ' ILE . 62.0 mttp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.804 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.531 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 44.6 t . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.03 0.443 . . . . 10.0 111.58 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.407 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 24.2 mm-40 -88.34 -40.9 13.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.772 -0.649 . . . . 10.0 110.601 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -135.22 160.9 24.54 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.345 -0.931 . . . . 10.0 113.747 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.476 HG13 HG11 ' A' ' 49' ' ' VAL . 2.6 m -159.81 169.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.437 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 31.6 pt . . . . . 0 C--N 1.324 -0.534 0 CA-C-O 120.862 0.363 . . . . 10.0 111.073 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.529 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.1 pp . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.55 -0.167 . . . . 10.0 110.55 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.454 ' HA ' HG13 ' A' ' 52' ' ' VAL . 92.8 Cg_endo -99.57 121.82 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.068 2.512 . . . . 10.0 113.864 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.443 ' O ' HG21 ' A' ' 62' ' ' VAL . 19.5 m -103.52 127.57 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.844 -0.798 . . . . 10.0 108.844 177.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 47.3 t -139.59 160.36 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.851 0.834 . . . . 10.0 113.204 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.444 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 4.3 m120 -75.96 73.39 2.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.591 -1.186 . . . . 10.0 108.667 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.817 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.3 tt -52.87 -38.53 61.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.293 0.568 . . . . 10.0 111.397 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.686 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -59.9 -18.5 45.29 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.193 -0.603 . . . . 10.0 110.03 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.1 tmmm? -85.41 -46.9 10.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.017 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.4 tt -53.86 -35.21 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 107.611 -1.255 . . . . 10.0 107.611 178.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.63 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -86.1 -56.08 3.63 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.08 -1.873 . . . . 10.0 109.82 178.263 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.596 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 121.92 -81.47 0.34 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.307 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.759 HG13 ' HB3' ' A' ' 73' ' ' PHE . 2.9 pt 45.11 179.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.698 0.629 . . . . 10.0 112.698 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 45.7 t -54.75 -39.08 67.94 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.151 -0.685 . . . . 10.0 109.151 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.759 ' HB3' HG13 ' A' ' 71' ' ' ILE . 14.8 t80 -32.4 143.69 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.784 -1.098 . . . . 10.0 112.896 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -166.77 37.4 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.532 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 55.28 38.76 30.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.776 -0.647 . . . . 10.0 111.22 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.422 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 17.7 pt20 -94.01 -50.51 5.28 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.262 0.467 . . . . 10.0 112.262 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 12.4 mptt -111.16 -25.01 9.95 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.55 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 16.9 mmt -36.72 143.77 0.07 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.758 0.651 . . . . 10.0 112.758 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 53.6 mtmt -159.53 -41.38 0.05 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.91 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.427 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 46.8 t -88.78 -175.99 5.08 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.913 0.387 . . . . 10.0 111.551 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.467 HG12 HD11 ' A' ' 94' ' ' LEU . 77.4 mt -146.55 154.22 12.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.328 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 16' ' ' PHE . 10.8 mt -120.63 143.9 31.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.739 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.1 t -111.41 149.85 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.974 0.416 . . . . 10.0 110.892 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -153.57 174.33 14.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 10.0 111.001 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 6.3 ptm180 -135.71 132.11 36.47 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.471 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 59.0 p -145.51 109.54 4.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.962 0.41 . . . . 10.0 111.922 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 14.7 tppt? 47.53 49.74 15.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.328 0.585 . . . . 10.0 110.851 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.05 31.57 1.45 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.066 -0.97 . . . . 10.0 111.519 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.53 HG11 HG21 ' A' ' 91' ' ' VAL . 67.6 t -128.33 108.56 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.23 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 6.4 mp0 -88.4 98.47 11.64 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.198 -1.779 . . . . 10.0 106.198 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 89' ' ' VAL . 3.0 t -88.7 157.2 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 113.089 -1.869 . . . . 10.0 112.711 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -140.25 151.21 22.08 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 114.895 -1.048 . . . . 10.0 113.258 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.578 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.1 t80 -140.77 134.39 30.16 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.93 0.395 . . . . 10.0 111.003 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 31.7 tp -88.61 115.5 26.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 10.0 111.46 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.55 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 12.8 m -122.43 -175.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.933 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -100.15 -59.98 1.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.174 0.512 . . . . 10.0 111.825 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -141.26 113.37 7.94 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.547 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.596 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.5 p -99.79 111.28 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 122.461 1.124 . . . . 10.0 111.168 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -62.72 -28.51 70.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.909 -1.95 . . . . 10.0 111.161 -178.526 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.92 -122.73 6.52 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.964 -0.854 . . . . 10.0 110.964 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -53.94 131.82 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 117.06 0.43 . . . . 10.0 110.229 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.575 HD21 HD11 ' A' ' 104' ' ' ILE . 19.4 tp -137.07 142.94 42.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 10.0 111.257 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.1 ptp85 -88.85 79.82 7.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.529 -0.76 . . . . 10.0 111.295 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.725 ' HB ' HG11 ' A' ' 13' ' ' VAL . 11.6 mm -88.76 178.78 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.517 ' N ' ' CG2' ' A' ' 104' ' ' ILE . 22.1 p -134.96 -175.85 4.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.774 -0.824 . . . . 10.0 108.774 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 35.5 tt0 -136.71 79.04 1.74 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.934 0.873 . . . . 10.0 112.516 -178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -119.89 22.29 11.58 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.23 -1.35 . . . . 10.0 107.522 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.466 0.36 0 CA-C-N 114.997 -1.001 . . . . 10.0 113.606 -178.258 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.51 ' CE1' HD23 ' A' ' 69' ' ' LEU . 20.2 t80 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.584 0.23 . . . . 10.0 111.494 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.0 -43.69 1.48 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.488 -0.863 . . . . 10.0 112.202 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -156.66 38.22 0.32 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.667 0.27 . . . . 10.0 111.013 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . 39.9 ttmt -157.06 -112.94 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.446 -0.343 . . . . 10.0 110.594 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 74.4 m . . . . . 0 CA--C 1.506 -0.714 0 N-CA-C 112.765 0.654 . . . . 10.0 112.765 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.52 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.1 p . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.41 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 8.1 ptpp? -154.77 143.9 21.07 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.132 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.461 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 23.8 m -152.61 140.02 19.6 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.578 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 p30 45.28 48.39 10.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.045 0.45 . . . . 10.0 111.219 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.42 97.15 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.647 -0.787 . . . . 10.0 111.773 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.7 ptp180 -130.08 136.94 49.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.653 0.263 . . . . 10.0 110.581 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 3.7 mp -88.9 138.56 31.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.661 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.576 HG12 ' CB ' ' A' ' 22' ' ' ALA . 5.5 mt -156.92 144.64 10.84 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-N 116.465 -0.334 . . . . 10.0 111.741 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.44 ' HB ' HD11 ' A' ' 23' ' ' LEU . 2.2 mp -99.69 146.82 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.532 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 56.5 t80 -141.36 151.22 43.36 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.494 -0.482 . . . . 10.0 110.98 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.615 ' N ' ' CD1' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -169.09 150.64 4.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.146 0.795 . . . . 10.0 113.146 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.413 ' O ' HG21 ' A' ' 138' ' ' ILE . 38.5 t70 -95.26 32.74 1.67 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.885 -1.052 . . . . 10.0 110.127 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.803 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 10.1 tt 38.69 23.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 114.836 -1.075 . . . . 10.0 113.683 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.6 t0 -75.79 -58.28 3.38 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.545 0.943 . . . . 10.0 113.545 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' A' ' 140' ' ' LYS . 7.2 mmpt? -78.23 -31.94 49.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.042 0.448 . . . . 10.0 110.698 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.803 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -65.17 -45.25 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.04 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.611 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.7 tp -65.49 -46.61 89.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.506 -0.478 . . . . 10.0 110.861 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -48.46 -40.82 27.63 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.993 0.425 . . . . 10.0 110.159 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.436 ' HA ' ' CG1' ' A' ' 147' ' ' VAL . 49.1 mt-10 -68.67 -36.85 79.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.69 -0.686 . . . . 10.0 110.11 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 141' ' ' ILE . 35.4 mt -53.62 -41.43 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.151 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.8 p -76.56 -49.93 15.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.785 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.436 ' CG1' ' HA ' ' A' ' 144' ' ' GLU . 14.7 p -75.33 1.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 112.082 0.401 . . . . 10.0 112.082 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.873 0.368 . . . . 10.0 111.274 -179.645 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 10' ' ' GLU . 18.1 ttpt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.795 0.331 . . . . 10.0 111.419 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 42.6 tt0 -160.21 164.1 33.05 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.691 0.758 . . . . 10.0 111.464 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.57 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 14.6 t80 -158.55 138.91 12.47 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 114.26 -1.336 . . . . 10.0 112.527 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 29.2 mt-10 -88.62 139.47 30.44 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.938 -0.574 . . . . 10.0 109.527 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.713 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -155.47 167.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.752 1.019 . . . . 10.0 113.752 -175.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.498 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 1.7 tm? -89.19 127.83 35.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.231 -0.895 . . . . 10.0 108.677 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.539 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 39.1 t -143.8 156.13 44.38 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.839 0.828 . . . . 10.0 113.131 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.643 ' CE1' ' HG ' ' A' ' 23' ' ' LEU . 1.3 p90 -146.53 160.05 42.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.851 -1.522 . . . . 10.0 109.917 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -88.74 107.2 18.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.469 0.652 . . . . 10.0 110.066 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' A' ' 71' ' ' ILE . 30.6 mm -88.96 90.65 3.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.843 -1.071 . . . . 10.0 111.714 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 9.5 p-10 36.46 60.38 0.9 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.857 -1.065 . . . . 10.0 113.498 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 47.2 mt-10 100.07 -52.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.668 -1.151 . . . . 10.0 111.685 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -89.04 150.17 22.9 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.569 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.76 170.44 10.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.643 ' HG ' ' CE1' ' A' ' 16' ' ' PHE . 1.2 tp -159.06 136.84 10.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.597 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -141.42 152.76 44.56 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.481 0.549 . . . . 10.0 112.481 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 4.9 m-85 -130.04 138.94 51.03 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.293 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -47.49 122.33 4.66 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.899 0.381 . . . . 10.0 110.982 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 14' ' ' LEU . 27.4 m -61.91 -12.79 8.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.073 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.87 -42.51 97.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.96 0.41 . . . . 10.0 110.161 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 85' ' ' ARG . 11.7 t30 -90.06 -47.24 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.895 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.414 HG13 ' HB2' ' A' ' 25' ' ' PHE . 19.7 mm -58.87 128.81 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.004 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' O ' ' CE ' ' A' ' 32' ' ' MET . 54.4 mt-10 -82.66 -65.4 1.02 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.077 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.414 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.7 tpp -169.08 173.71 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 10.0 111.322 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -89.01 150.99 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.488 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.522 HG13 ' HB ' ' A' ' 81' ' ' ILE . 12.7 pt -142.35 121.64 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.647 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.03 118.74 28.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 10.0 109.51 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 81' ' ' ILE . 23.3 tptm . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.027 0.442 . . . . 10.0 111.026 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.462 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 46.8 t . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.016 0.436 . . . . 10.0 111.869 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 16.9 pt-20 -79.79 -37.39 35.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.418 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.413 ' O ' HG13 ' A' ' 52' ' ' VAL . . . -161.02 -175.93 32.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.053 -0.594 . . . . 10.0 112.234 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' A' ' 61' ' ' PRO . 3.5 m -158.46 175.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 110.163 -0.31 . . . . 10.0 110.163 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.428 HG13 HG12 ' A' ' 60' ' ' ILE . 24.3 pt . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.64 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.482 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 28.5 pt . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.507 0.194 . . . . 10.0 110.974 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 86.3 Cg_endo -81.89 119.65 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.402 2.068 . . . . 10.0 113.252 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' HG21 ' A' ' 62' ' ' VAL . 27.7 m -98.49 137.25 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.312 -0.625 . . . . 10.0 109.312 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 96.6 t -143.0 156.09 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.717 0.77 . . . . 10.0 112.744 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.782 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 76.1 m-20 -73.74 66.09 1.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.704 -1.135 . . . . 10.0 108.33 177.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.769 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.6 tt -49.32 -28.33 4.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.921 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.683 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -61.89 -29.81 70.45 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.821 -0.351 . . . . 10.0 110.953 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.782 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -87.31 -36.94 17.58 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 110.423 -0.214 . . . . 10.0 110.423 178.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.1 tt -61.16 -41.04 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 106.623 -1.621 . . . . 10.0 106.623 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.564 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -76.05 -38.66 56.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 113.407 -1.724 . . . . 10.0 107.972 176.465 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.64 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 70.06 120.82 0.04 OUTLIER Glycine 0 C--N 1.335 0.492 0 CA-C-N 114.827 -1.079 . . . . 10.0 113.154 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.64 HG21 ' O ' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -160.57 -167.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.332 0.653 . . . . 10.0 109.546 -179.146 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.419 ' CB ' ' OD2' ' A' ' 19' ' ' ASP . 29.2 t -53.16 -34.41 56.71 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.683 ' CD2' ' CB ' ' A' ' 66' ' ' ALA . 6.0 t80 -28.57 138.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.608 -1.178 . . . . 10.0 112.95 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 9.2 t70 -160.58 35.66 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.581 -0.736 . . . . 10.0 109.986 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.95 40.01 3.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.502 -0.772 . . . . 10.0 112.194 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.416 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 21.0 mt-30 -95.98 -49.55 5.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.606 0.241 . . . . 10.0 111.29 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 78' ' ' MET . 2.3 mppt? -98.09 -31.76 11.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.506 -0.316 . . . . 10.0 111.629 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.604 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 21.7 mmt -27.01 141.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt 178.62 50.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.79 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.419 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 80.0 p -169.03 155.34 6.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.795 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.522 ' HB ' HG13 ' A' ' 34' ' ' ILE . 61.0 mt -126.88 142.22 43.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.781 -0.367 . . . . 10.0 111.595 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 4.5 mt -119.42 143.72 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.642 -0.253 . . . . 10.0 110.556 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.451 ' CG2' ' CD1' ' A' ' 34' ' ' ILE . 79.9 t -113.62 152.46 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.231 0.539 . . . . 10.0 111.328 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -155.93 173.73 16.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.449 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 6.7 ptm180 -130.4 146.7 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.566 -0.531 . . . . 10.0 109.566 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.501 HG21 HG12 ' A' ' 138' ' ' ILE . 41.1 p -160.47 108.55 1.62 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 36.7 ttmt 46.27 48.76 13.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.386 0.613 . . . . 10.0 110.892 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 72.84 33.67 1.24 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.56 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.497 HG11 HG21 ' A' ' 91' ' ' VAL . 53.8 t -131.75 110.84 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 115.268 -0.878 . . . . 10.0 109.122 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' A' ' 90' ' ' GLU . 1.5 mp0 -88.38 97.81 11.26 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.341 -1.726 . . . . 10.0 106.341 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.497 HG21 HG11 ' A' ' 89' ' ' VAL . 3.4 t -88.55 153.18 3.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 113.367 -1.742 . . . . 10.0 112.474 -174.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -130.47 152.95 19.97 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 114.861 -1.063 . . . . 10.0 113.499 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.611 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -139.94 128.03 22.31 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.906 0.384 . . . . 10.0 110.898 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.455 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 50.8 tp -88.57 128.17 35.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.943 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.604 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 19.7 m -136.74 -175.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.971 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -96.88 -65.35 0.97 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.131 0.491 . . . . 10.0 112.188 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.1 tpt85 -135.81 119.25 16.87 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.529 -0.76 . . . . 10.0 109.144 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.603 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 8.6 p -106.29 112.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 122.5 1.143 . . . . 10.0 112.045 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -66.2 -27.93 68.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.825 -1.989 . . . . 10.0 111.305 -178.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.62 -122.15 6.13 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.526 -0.845 . . . . 10.0 111.327 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.0 t -52.49 134.4 14.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.868 0.334 . . . . 10.0 110.569 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.597 HD21 ' CD1' ' A' ' 104' ' ' ILE . 57.7 tp -140.27 141.07 35.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.076 0.465 . . . . 10.0 111.219 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.7 ptp180 -88.92 73.08 8.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.521 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.713 ' HB ' HG11 ' A' ' 13' ' ' VAL . 17.6 mm -88.59 131.8 35.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 109.892 -0.41 . . . . 10.0 109.892 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 22.8 p -88.83 151.1 22.58 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 20.4 tt0 -124.49 73.89 1.29 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.123 0.964 . . . . 10.0 112.99 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.425 ' N ' ' OE1' ' A' ' 108' ' ' GLN . 5.7 m120 -113.65 15.67 18.8 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.844 -1.525 . . . . 10.0 107.403 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.45 ' N ' ' OE1' ' A' ' 108' ' ' GLN . 6.6 pm0 . . . . . 0 CA--C 1.519 -0.237 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.205 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.425 ' CE2' HD13 ' A' ' 69' ' ' LEU . 21.7 t80 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 121.072 0.463 . . . . 10.0 110.241 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 120' ' ' LYS . . . 148.91 -64.66 0.4 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.753 -0.658 . . . . 10.0 112.374 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 119' ' ' GLY . 67.7 mttm -163.61 53.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.673 0.273 . . . . 10.0 110.508 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -151.23 -43.34 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.879 0.326 . . . . 10.0 111.879 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.572 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 89.2 p . . . . . 0 CA--C 1.534 0.363 0 C-N-CA 121.245 -0.182 . . . . 10.0 111.312 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 133' ' ' ILE . 1.5 p . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 121.389 0.614 . . . . 10.0 112.29 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 87.1 tttt -164.49 134.25 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.08 -0.964 . . . . 10.0 109.786 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 4.6 m -162.7 151.54 14.85 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 120.924 0.392 . . . . 10.0 111.12 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.42 45.8 21.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.979 0.419 . . . . 10.0 110.746 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.41 33.59 47.18 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.665 -0.778 . . . . 10.0 111.83 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 128' ' ' THR . 12.7 ptt180 -134.93 130.53 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.184 -0.302 . . . . 10.0 110.184 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -88.87 135.23 33.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.852 0.358 . . . . 10.0 110.736 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.569 HG12 ' CB ' ' A' ' 22' ' ' ALA . 3.2 mt -130.8 130.75 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.345 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.536 ' HB ' ' CD1' ' A' ' 23' ' ' LEU . 5.1 mm -88.87 147.45 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.975 -1.12 . . . . 10.0 107.975 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.461 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 32.9 t80 -137.02 141.39 42.5 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.71 -0.796 . . . . 10.0 111.671 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.572 ' HG ' ' HB2' ' A' ' 122' ' ' SER . 6.7 mp -133.32 172.99 11.94 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.067 0.936 . . . . 10.0 112.679 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.432 ' O ' HG21 ' A' ' 138' ' ' ILE . 1.5 m-20 -140.37 24.94 2.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.935 -1.484 . . . . 10.0 108.336 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.79 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 10.3 tt 40.38 19.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.267 -1.333 . . . . 10.0 114.259 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.556 ' O ' HG22 ' A' ' 142' ' ' ILE . 9.1 t0 -82.64 -62.7 1.54 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -75.03 -29.81 60.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.447 0.642 . . . . 10.0 110.073 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.79 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.78 -46.36 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 115.097 -0.956 . . . . 10.0 110.723 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.651 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.6 tp -61.22 -44.56 98.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 119.911 -0.716 . . . . 10.0 109.595 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -49.42 -47.52 47.98 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.829 -0.623 . . . . 10.0 109.985 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 49.5 mm-40 -66.13 -37.36 85.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.477 -0.783 . . . . 10.0 110.948 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 141' ' ' ILE . 60.0 mt -51.4 -43.24 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 120.886 0.374 . . . . 10.0 111.208 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.9 p -87.61 -49.43 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.684 0.624 . . . . 10.0 112.684 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.85 13.03 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.935 0.717 . . . . 10.0 112.935 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.54 ' HE3' ' HA ' ' A' ' 148' ' ' LYS . 2.0 tpmt? . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 120.708 -0.397 . . . . 10.0 111.131 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HD2' ' C ' ' A' ' 9' ' ' LYS . 3.4 tmmm? . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.028 0.442 . . . . 10.0 110.23 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 44.1 tt0 -141.37 163.46 32.89 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.392 0.615 . . . . 10.0 110.8 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.57 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.9 t80 -162.36 138.9 7.79 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.804 -1.089 . . . . 10.0 111.959 -174.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.422 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -88.68 141.22 28.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.722 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -157.43 171.32 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 113.817 1.043 . . . . 10.0 113.817 -176.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.54 ' N ' HG21 ' A' ' 13' ' ' VAL . 3.1 tm? -88.72 136.03 33.21 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.626 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 55.5 p -151.42 156.49 40.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.8 0.81 . . . . 10.0 113.119 -177.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.696 ' CZ ' ' HG ' ' A' ' 23' ' ' LEU . 7.7 p90 -149.67 166.54 29.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.198 -1.365 . . . . 10.0 110.06 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -88.59 140.33 29.56 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.215 -0.661 . . . . 10.0 109.215 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.454 HG23 HD13 ' A' ' 18' ' ' ILE . 35.8 mm -138.8 86.03 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.63 -0.714 . . . . 10.0 111.889 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.8 OUTLIER 51.48 60.03 4.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.808 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 48.4 mt-10 78.56 -35.15 0.18 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.465 -0.788 . . . . 10.0 111.09 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.46 ' NE2' HD11 ' A' ' 134' ' ' ILE . 25.5 tt0 -88.82 139.31 30.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.525 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.75 163.87 15.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 10.0 111.118 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.696 ' HG ' ' CZ ' ' A' ' 16' ' ' PHE . 1.0 OUTLIER -147.01 138.23 24.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.559 . . . . 10.0 111.133 -178.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -138.94 155.28 48.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.8 m-85 -138.44 138.67 38.38 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.995 -1.002 . . . . 10.0 108.926 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -51.35 121.57 6.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.948 0.404 . . . . 10.0 110.379 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 14' ' ' LEU . 32.2 m -61.37 -11.9 5.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 10.0 111.175 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.99 -41.33 96.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 10.0 110.41 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.438 ' ND2' ' CG2' ' A' ' 138' ' ' ILE . 12.1 t30 -92.51 -46.68 7.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.35 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.413 HG23 ' HG ' ' A' ' 14' ' ' LEU . 27.7 mm -57.67 127.11 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.896 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' CE ' ' A' ' 32' ' ' MET . 54.2 mt-10 -82.93 -63.6 1.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.948 0.351 . . . . 10.0 111.948 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.418 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.8 tpp -169.08 173.91 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.979 0.418 . . . . 10.0 111.381 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -95.61 156.36 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.725 -0.67 . . . . 10.0 111.996 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.421 HG13 ' HB ' ' A' ' 81' ' ' ILE . 17.3 pt -160.05 123.62 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.557 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.458 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 48.6 mp0 -89.13 116.92 27.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 10.0 111.214 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.472 ' NZ ' ' HB2' ' A' ' 36' ' ' LYS . 5.0 ttmp? . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.801 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.456 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 96.8 t . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 121.14 0.495 . . . . 10.0 111.261 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.79 -40.18 79.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.463 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -163.02 -175.79 34.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.331 -0.938 . . . . 10.0 113.219 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.436 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 1.9 m -147.33 167.83 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.664 -0.495 . . . . 10.0 109.664 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.464 HG22 ' HD2' ' A' ' 36' ' ' LYS . 30.1 pt . . . . . 0 C--N 1.326 -0.437 0 CA-C-O 120.942 0.401 . . . . 10.0 111.551 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.504 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.4 pp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.666 0.269 . . . . 10.0 111.126 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 83.4 Cg_endo -81.04 115.38 2.99 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.469 2.113 . . . . 10.0 112.889 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.02 135.63 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.456 ' CG2' ' HA ' ' A' ' 49' ' ' VAL . 82.6 t -137.36 154.38 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.791 0.805 . . . . 10.0 113.074 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.407 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 74.6 m-20 -76.7 65.73 2.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.521 -1.218 . . . . 10.0 109.263 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.791 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.6 tt -53.48 -36.35 61.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.158 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.597 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -57.75 -23.47 52.29 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.207 -0.597 . . . . 10.0 109.426 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.629 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -82.86 -48.77 10.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.69 -0.686 . . . . 10.0 110.744 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.791 HG22 ' O ' ' A' ' 65' ' ' LEU . 11.0 tt -58.5 -39.87 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.863 -1.162 . . . . 10.0 107.863 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.614 HD11 HG12 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -76.42 -48.98 17.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 113.711 -1.586 . . . . 10.0 109.795 177.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.521 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 118.56 -93.26 0.56 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.169 -0.539 . . . . 10.0 113.125 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.852 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.0 pt 48.57 163.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 113.112 0.782 . . . . 10.0 113.112 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 74.8 m -45.29 -36.54 4.12 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.852 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.7 t80 -27.03 141.52 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.546 -1.206 . . . . 10.0 113.005 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 9.0 t70 -161.81 32.15 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.242 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.479 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 94.4 mt-10 54.55 45.54 26.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.938 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -98.2 -36.12 10.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.492 0.553 . . . . 10.0 112.492 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 70.6 mmtt -136.88 17.9 3.04 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.357 0.873 . . . . 10.0 113.357 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.479 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 14.0 mmm -53.93 142.5 24.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.44 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -172.55 42.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.892 0.377 . . . . 10.0 111.267 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.2 p -169.09 158.02 8.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 10.0 110.155 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.421 ' HB ' HG13 ' A' ' 34' ' ' ILE . 45.1 mt -137.35 132.24 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.876 0.369 . . . . 10.0 111.404 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.508 HD13 ' CE2' ' A' ' 16' ' ' PHE . 26.5 mt -105.34 129.96 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.953 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.406 ' CG2' ' CD1' ' A' ' 34' ' ' ILE . 91.7 t -98.81 150.62 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.047 0.451 . . . . 10.0 110.93 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -153.73 174.84 14.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.962 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' CG2' ' A' ' 86' ' ' THR . 23.5 ptt180 -127.39 143.8 51.15 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.538 HG21 HG12 ' A' ' 138' ' ' ILE . 45.5 p -160.02 108.19 1.7 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.532 0.568 . . . . 10.0 112.532 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.4 tppp? 46.44 47.72 13.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.777 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.35 34.32 1.02 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.167 -0.924 . . . . 10.0 111.285 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.51 HG11 HG21 ' A' ' 91' ' ' VAL . 59.0 t -134.0 110.42 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 115.141 -0.936 . . . . 10.0 109.25 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.673 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 83.4 mt-10 -88.23 97.92 11.28 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.51 HG21 HG11 ' A' ' 89' ' ' VAL . 4.5 t -88.55 152.24 3.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.4 -1.727 . . . . 10.0 113.33 -173.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -124.5 157.26 18.79 Favored Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.443 -1.253 . . . . 10.0 113.164 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.592 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -143.84 123.83 13.58 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 120.964 0.412 . . . . 10.0 110.613 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.59 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 64.9 tp -88.74 126.75 35.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.146 0.498 . . . . 10.0 111.179 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.447 HG13 ' CE1' ' A' ' 16' ' ' PHE . 26.8 m -136.88 -175.26 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.697 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 3.0 t0 -88.12 -77.94 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.501 . . . . 10.0 111.253 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 -128.63 107.97 10.13 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.574 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.0 p -88.99 113.79 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 122.434 1.111 . . . . 10.0 111.396 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -62.7 -28.67 70.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.036 -1.893 . . . . 10.0 111.106 -178.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.81 -121.2 5.51 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.777 -0.929 . . . . 10.0 110.777 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.99 126.77 9.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 117.203 0.501 . . . . 10.0 109.769 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.626 ' CD2' ' HB3' ' A' ' 15' ' ' SER . 54.8 tp -128.05 136.16 50.85 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.028 0.442 . . . . 10.0 111.139 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -88.82 78.64 7.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.584 179.2 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.722 ' HB ' HG11 ' A' ' 13' ' ' VAL . 6.8 mm -88.57 157.39 3.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.832 -0.622 . . . . 10.0 109.454 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 24.0 p -116.65 148.47 40.97 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.056 -1.09 . . . . 10.0 108.056 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 37.1 tt0 -111.77 68.31 0.66 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.996 0.903 . . . . 10.0 112.016 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -99.55 8.31 44.58 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.02 -1.445 . . . . 10.0 108.014 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-N 114.691 -1.14 . . . . 10.0 110.398 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.499 ' CZ ' HD13 ' A' ' 69' ' ' LEU . 55.9 t80 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.013 0.435 . . . . 10.0 110.309 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.88 -42.67 0.45 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.708 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER 179.85 40.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.622 ' O ' ' HB3' ' A' ' 122' ' ' SER . 2.9 tppp? -177.92 116.74 0.09 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.157 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.622 ' HB3' ' O ' ' A' ' 121' ' ' LYS . 13.2 t . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.903 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 133' ' ' ILE . 1.8 p . . . . . 0 C--O 1.227 -0.13 0 CA-C-O 120.962 0.41 . . . . 10.0 111.593 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.488 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -165.91 132.24 2.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.203 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.499 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 15.6 m -163.91 157.47 18.68 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.354 -0.384 . . . . 10.0 110.662 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.42 ' N ' ' CG2' ' A' ' 128' ' ' THR . 63.1 m-20 58.16 44.57 18.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.958 0.409 . . . . 10.0 110.735 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.59 32.16 38.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.65 -0.786 . . . . 10.0 111.764 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 128' ' ' THR . 3.2 ptp180 -138.89 136.14 35.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 10.0 110.417 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.92 143.46 26.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.733 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.6 ' O ' HG13 ' A' ' 126' ' ' VAL . 4.3 mt -137.43 129.19 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 10.0 111.567 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.517 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.4 mp -88.97 134.54 28.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.447 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 31.1 t80 -118.31 136.09 53.91 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.514 0.673 . . . . 10.0 111.467 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.561 ' HG ' ' OG ' ' A' ' 122' ' ' SER . 6.1 mp -126.81 172.39 10.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.127 0.965 . . . . 10.0 112.603 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.449 ' O ' HG21 ' A' ' 138' ' ' ILE . 9.8 t70 -144.2 26.59 1.48 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.635 -1.62 . . . . 10.0 107.211 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.808 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 11.9 tt 40.4 17.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 113.846 -1.525 . . . . 10.0 114.349 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 142' ' ' ILE . 7.8 t0 -79.53 -61.73 1.91 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.794 0.665 . . . . 10.0 112.794 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -77.05 -30.88 55.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.457 0.646 . . . . 10.0 110.341 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.808 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.89 -45.69 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 114.97 -1.014 . . . . 10.0 110.63 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.676 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.9 tp -65.91 -43.04 93.06 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 C-N-CA 119.898 -0.721 . . . . 10.0 110.034 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -46.47 -46.7 19.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.312 0.577 . . . . 10.0 109.788 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 148' ' ' LYS . 61.0 mm-40 -68.89 -39.58 79.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.205 -0.907 . . . . 10.0 110.761 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 141' ' ' ILE . 56.4 mt -48.52 -44.02 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.83 0.347 . . . . 10.0 111.505 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.9 p -75.57 -51.35 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 10.0 112.152 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 144' ' ' GLU . 12.9 p -70.79 -6.22 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.461 0.541 . . . . 10.0 112.461 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.814 0.34 . . . . 10.0 110.754 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.843 0.354 . . . . 10.0 111.22 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 83.4 mt-10 -138.77 164.3 29.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.522 0.677 . . . . 10.0 111.301 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.613 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.3 t80 -161.83 139.62 8.89 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.573 -1.194 . . . . 10.0 112.501 -174.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 24.5 pt-20 -88.68 140.01 29.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.52 -0.919 . . . . 10.0 108.52 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.76 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -155.47 171.28 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 N-CA-C 114.084 1.142 . . . . 10.0 114.084 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 2.8 tm? -88.81 134.73 33.84 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.505 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 82.6 p -146.17 152.12 38.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 113.242 0.831 . . . . 10.0 113.242 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.627 ' CE1' ' HG ' ' A' ' 23' ' ' LEU . 2.4 p90 -149.43 166.81 27.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.181 -1.372 . . . . 10.0 109.991 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.447 ' HG3' HD21 ' A' ' 99' ' ' LEU . 94.8 mt-10 -88.56 139.36 30.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.253 0.549 . . . . 10.0 109.745 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.439 HG22 ' CD1' ' A' ' 71' ' ' ILE . 28.5 mm -138.96 103.27 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.364 -0.834 . . . . 10.0 110.957 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.9 OUTLIER 42.69 60.15 2.53 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.533 0.568 . . . . 10.0 112.533 179.331 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 86.7 mt-10 80.82 -42.89 0.2 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.385 -0.825 . . . . 10.0 111.912 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.503 ' HB2' HD21 ' A' ' 132' ' ' LEU . 17.3 pt20 -88.97 154.41 20.24 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.526 ' O ' HG12 ' A' ' 134' ' ' ILE . . . -88.91 168.52 12.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HG ' ' CE1' ' A' ' 16' ' ' PHE . 1.0 OUTLIER -152.31 135.6 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.617 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -140.34 153.81 46.53 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.846 0.684 . . . . 10.0 112.846 -177.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.597 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.8 m-85 -135.54 143.07 45.52 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.071 -0.714 . . . . 10.0 109.071 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 36.6 t70 -49.39 124.24 8.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.18 0.514 . . . . 10.0 110.806 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 14' ' ' LEU . 30.1 m -64.76 -9.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.37 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.57 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 1.3 m-20 -72.0 -43.26 65.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.663 ' OD1' ' O ' ' A' ' 85' ' ' ARG . 10.1 t30 -80.78 -49.77 10.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.776 -1.102 . . . . 10.0 110.071 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.474 HG13 ' HB2' ' A' ' 25' ' ' PHE . 21.9 mm -62.32 134.2 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.013 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.409 ' O ' ' CE ' ' A' ' 32' ' ' MET . 4.5 mm-40 -94.09 -68.77 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.745 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.409 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.1 172.46 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.097 0.475 . . . . 10.0 111.087 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.54 145.8 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.571 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.446 HD11 HG21 ' A' ' 34' ' ' ILE . 11.1 pt -142.46 122.74 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.868 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 48.7 mt-10 -88.98 104.31 16.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.834 -0.432 . . . . 10.0 109.834 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 35' ' ' GLU . 67.9 mttm . . . . . 0 C--N 1.329 -0.305 0 N-CA-C 112.218 0.451 . . . . 10.0 112.218 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.437 ' CG2' ' HE2' ' A' ' 148' ' ' LYS . 61.6 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.978 0.418 . . . . 10.0 111.39 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 16.7 pt-20 -78.06 -39.12 42.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.983 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 52' ' ' VAL . . . -158.06 179.36 33.82 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.314 -0.946 . . . . 10.0 113.275 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.462 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 3.2 m -162.54 171.72 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 31.7 pt . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 10.0 112.069 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.0 pp . . . . . 0 C--O 1.234 0.252 0 CA-C-O 120.626 0.251 . . . . 10.0 110.919 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 72.1 Cg_endo -99.7 114.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.178 2.585 . . . . 10.0 113.169 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.424 ' O ' HG21 ' A' ' 62' ' ' VAL . 29.1 m -89.0 134.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.457 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 92.0 t -143.21 154.2 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.736 0.779 . . . . 10.0 112.957 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.402 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 74.5 m-20 -73.29 67.17 0.96 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.662 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.77 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.9 tt -53.58 -34.17 57.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.121 -178.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.645 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -61.27 -22.13 64.56 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.325 -0.55 . . . . 10.0 109.642 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.478 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.6 tmmm? -83.85 -50.14 8.37 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.835 -0.62 . . . . 10.0 109.945 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.0 tt -54.25 -40.12 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 107.602 -1.258 . . . . 10.0 107.602 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD11 HG12 ' A' ' 71' ' ' ILE . 0.6 OUTLIER -77.67 -47.3 19.56 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.526 -1.67 . . . . 10.0 109.383 177.49 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.491 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 116.63 -92.78 0.57 Allowed Glycine 0 C--N 1.337 0.63 0 CA-C-N 115.975 -0.557 . . . . 10.0 113.193 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.899 HG13 ' HB3' ' A' ' 73' ' ' PHE . 2.9 pt 48.25 164.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 45.2 t -45.83 -34.9 4.04 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.899 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.7 t80 -31.48 143.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.582 -1.19 . . . . 10.0 113.09 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -173.53 41.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.071 -0.968 . . . . 10.0 109.888 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 62.92 41.6 8.4 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.782 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -72.44 -49.05 36.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.05 -0.523 . . . . 10.0 112.388 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.03 18.92 0.68 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.371 -0.532 . . . . 10.0 112.346 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.47 ' HE3' ' CD1' ' A' ' 73' ' ' PHE . 3.4 mmm -53.14 146.61 11.22 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.149 -0.315 . . . . 10.0 110.149 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HE2' ' OD1' ' A' ' 96' ' ' ASP . 48.2 mtmt -159.39 -45.85 0.05 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.779 0.323 . . . . 10.0 111.533 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.8 m -88.87 133.38 34.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.211 0.529 . . . . 10.0 111.332 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.43 ' HB ' HG13 ' A' ' 34' ' ' ILE . 25.9 mt -89.65 151.09 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.526 -0.761 . . . . 10.0 111.527 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.512 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 23.1 mt -115.04 156.6 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 10.0 110.291 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 41.3 t -133.61 148.73 30.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.931 0.396 . . . . 10.0 110.995 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.677 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -152.89 175.86 12.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.798 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.663 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 52.6 ttm-85 -133.08 132.6 41.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.873 -0.417 . . . . 10.0 109.873 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.556 ' OG1' ' HB ' ' A' ' 89' ' ' VAL . 65.4 p -141.53 102.14 4.13 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.378 0.609 . . . . 10.0 111.602 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 15.1 tppt? 48.56 48.26 19.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.005 -0.998 . . . . 10.0 110.771 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 13.5 m-20 80.17 27.32 0.3 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.917 -1.038 . . . . 10.0 111.999 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.556 ' HB ' ' OG1' ' A' ' 86' ' ' THR . 51.6 t -124.59 108.98 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.057 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 33.9 tt0 -88.37 97.88 11.3 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.373 -1.714 . . . . 10.0 106.373 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.499 HG21 HG11 ' A' ' 89' ' ' VAL . 3.2 t -88.57 158.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 113.123 -1.853 . . . . 10.0 112.14 -174.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.13 143.03 14.6 Favored Glycine 0 C--N 1.317 -0.486 0 C-N-CA 120.234 -0.984 . . . . 10.0 113.833 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.599 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -131.38 128.77 40.29 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.453 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 65.5 tp -88.52 133.52 34.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.437 0.636 . . . . 10.0 111.904 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.532 HG13 ' CE1' ' A' ' 16' ' ' PHE . 27.6 m -147.28 -175.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.014 -0.994 . . . . 10.0 110.209 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.444 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 16.0 t70 -109.94 -58.44 2.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.551 0.574 . . . . 10.0 112.551 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -127.83 122.72 33.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.383 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.592 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.3 p -116.35 117.78 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 122.3 1.048 . . . . 10.0 111.643 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -69.71 -29.33 66.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.183 -1.826 . . . . 10.0 110.852 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.33 -125.59 7.73 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.778 -0.725 . . . . 10.0 111.701 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.8 t -50.84 132.27 11.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 117.079 0.44 . . . . 10.0 110.367 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.582 ' HG ' HG12 ' A' ' 104' ' ' ILE . 51.8 tp -135.69 139.9 44.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.019 0.437 . . . . 10.0 111.519 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.3 ptp180 -88.85 76.26 7.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.453 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.76 ' HB ' HG11 ' A' ' 13' ' ' VAL . 14.3 mm -88.73 168.37 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 22.4 p -131.67 148.08 52.56 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.426 -0.953 . . . . 10.0 108.426 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 81.0 tt0 -106.4 72.07 0.9 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.894 0.854 . . . . 10.0 112.466 -177.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -108.48 21.09 17.77 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-N 114.61 -1.177 . . . . 10.0 111.699 -178.747 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.459 ' CZ ' HD13 ' A' ' 69' ' ' LEU . 2.9 t80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.927 0.394 . . . . 10.0 110.428 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.22 -145.26 10.53 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.529 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -87.43 -38.1 16.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.941 0.401 . . . . 10.0 110.93 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.472 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -55.25 -33.23 62.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.696 -179.195 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.419 ' OG ' ' HG ' ' A' ' 136' ' ' LEU . 37.3 t . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 121.108 -0.237 . . . . 10.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 133' ' ' ILE . 1.8 p . . . . . 0 C--O 1.226 -0.184 0 CA-C-O 120.979 0.419 . . . . 10.0 112.021 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 39.7 ttmt -163.66 132.76 3.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.663 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 129' ' ' ASP . 16.1 m -161.92 158.81 25.85 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 120.925 0.393 . . . . 10.0 111.435 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.451 ' N ' ' CG2' ' A' ' 128' ' ' THR . 9.4 p-10 44.6 52.89 7.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.69 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.6 37.13 41.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.541 -0.838 . . . . 10.0 111.98 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -146.06 126.46 14.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -88.95 144.74 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.458 . . . . 10.0 110.607 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.524 HG12 ' CB ' ' A' ' 22' ' ' ALA . 5.9 mt -133.91 139.77 47.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.548 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 22' ' ' ALA . 4.3 mm -88.81 143.71 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.413 -0.958 . . . . 10.0 108.413 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.451 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 38.1 t80 -138.77 136.46 35.74 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.609 0.719 . . . . 10.0 111.824 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.465 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 4.3 mp -129.43 149.8 51.06 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.719 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.509 ' O ' HG21 ' A' ' 138' ' ' ILE . 9.9 t70 -113.65 19.61 16.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.253 -1.339 . . . . 10.0 107.623 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.801 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.4 tt 39.19 20.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 114.283 -1.326 . . . . 10.0 113.67 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.7 t0 -81.89 -60.83 2.1 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.72 0.637 . . . . 10.0 112.72 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -75.48 -32.72 60.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.534 0.683 . . . . 10.0 109.915 -179.645 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.801 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.28 -45.25 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 114.911 -1.04 . . . . 10.0 110.558 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.668 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 8.0 tp -61.99 -46.02 97.41 Favored 'Isoleucine or valine' 0 C--N 1.337 0.054 0 C-N-CA 120.339 -0.545 . . . . 10.0 110.14 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 139' ' ' ASP . 51.9 mt-10 -49.24 -43.76 43.04 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.192 0.52 . . . . 10.0 109.72 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -66.25 -32.13 73.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.323 -0.853 . . . . 10.0 110.555 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 141' ' ' ILE . 31.1 mt -58.98 -42.15 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 120.926 0.393 . . . . 10.0 110.85 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.3 p -79.8 -50.26 10.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.771 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.9 p -75.78 0.96 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.437 ' HE2' ' CG2' ' A' ' 49' ' ' VAL . 23.0 pttp . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.837 0.351 . . . . 10.0 111.229 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.773 0.321 . . . . 10.0 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.518 ' O ' ' OG1' ' A' ' 3' ' ' THR . 18.5 ptpt -64.0 -43.47 95.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.828 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 34.4 p 65.73 -55.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.969 -0.56 . . . . 10.0 112.139 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 5' ' ' ALA . 4.1 pp -55.98 -36.71 68.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.705 0.288 . . . . 10.0 111.23 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.473 ' N ' ' CD1' ' A' ' 4' ' ' LEU . . . 62.39 134.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.083 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -178.6 140.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 64.01 143.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.226 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 109' ' ' LEU . 85.7 mt -147.5 44.75 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.828 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -81.83 -57.75 3.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.406 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 29.3 mp0 -103.88 164.31 11.78 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.426 0.631 . . . . 10.0 110.975 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.628 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 17.5 t80 -161.4 140.11 9.77 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.936 -1.029 . . . . 10.0 112.963 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.403 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 32.6 mt-10 -88.71 140.54 29.34 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.639 -0.709 . . . . 10.0 109.622 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.651 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -155.85 168.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 113.093 0.775 . . . . 10.0 113.093 -175.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 2.3 tm? -88.89 134.2 34.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.521 -1.289 . . . . 10.0 107.521 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.529 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 81.1 p -143.03 152.97 42.48 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.592 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 6.1 p90 -150.42 167.6 26.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.299 -1.319 . . . . 10.0 110.297 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -88.55 138.5 31.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.682 -0.488 . . . . 10.0 109.682 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 HG13 HD23 ' A' ' 23' ' ' LEU . 33.4 mm -136.56 93.23 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.335 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 50.1 m-20 45.59 60.08 3.28 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.593 -0.731 . . . . 10.0 112.513 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.6 mt-10 83.73 -39.99 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.29 -0.868 . . . . 10.0 112.081 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.3 pt20 -88.91 149.55 23.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.164 -0.31 . . . . 10.0 110.164 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.535 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.55 159.52 17.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.338 . . . . 10.0 110.893 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.546 ' HG ' ' CE1' ' A' ' 16' ' ' PHE . 2.1 tp -147.67 136.88 22.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.768 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -136.92 146.87 45.99 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.517 0.562 . . . . 10.0 112.517 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 2.0 m-30 -121.47 135.87 55.0 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.585 -0.894 . . . . 10.0 108.585 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.558 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 28.3 t70 -44.2 100.95 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.581 0.705 . . . . 10.0 110.499 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.518 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 6.2 p -50.37 -14.44 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.648 -1.16 . . . . 10.0 111.978 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.558 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 7.6 m-20 -64.51 -44.65 90.23 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.468 -0.493 . . . . 10.0 109.906 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -83.24 -41.51 18.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.725 -0.671 . . . . 10.0 110.733 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.404 HG23 ' HG ' ' A' ' 14' ' ' LEU . 32.9 mm -59.64 123.5 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.58 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 32' ' ' MET . 66.6 mm-40 -81.97 -61.89 1.78 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.01 0.374 . . . . 10.0 112.01 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.6 mtm -169.04 157.27 7.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 10.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -88.92 137.16 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.934 -0.576 . . . . 10.0 111.228 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.507 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 11.4 pt -123.96 135.53 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.345 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -88.99 118.74 28.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.518 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HB3' HD11 ' A' ' 81' ' ' ILE . 39.5 ttmt -169.14 165.23 11.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.6 t -155.32 154.65 32.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 10.0 111.199 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.5 t70 54.15 46.29 25.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.466 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 40' ' ' THR . 17.1 mt -70.15 137.4 24.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.827 -0.624 . . . . 10.0 111.515 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.604 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 4.8 m 38.49 78.83 0.34 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.108 -0.496 . . . . 10.0 112.076 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -86.17 -50.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.929 2.419 . . . . 10.0 113.997 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 19.1 m -73.45 -33.88 2.05 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.761 0.652 . . . . 10.0 112.761 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 42' ' ' VAL . 12.6 Cg_exo -70.74 10.55 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.381 2.054 . . . . 10.0 113.532 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -46.46 159.48 0.09 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 120.662 0.268 . . . . 10.0 110.522 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.8 p -174.75 -53.26 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.389 -0.524 . . . . 10.0 110.945 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -76.06 -118.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.625 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -169.33 -49.95 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.834 0.35 . . . . 10.0 110.583 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.491 ' CG ' ' HD2' ' A' ' 148' ' ' LYS . 3.1 m-85 -65.29 -52.54 53.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.913 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.94 107.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.917 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -68.86 -30.5 69.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.3 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' O ' HG13 ' A' ' 52' ' ' VAL . . . -166.82 -175.91 37.39 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.536 -0.84 . . . . 10.0 112.959 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.604 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.9 m -160.42 170.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.123 -0.695 . . . . 10.0 109.123 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.44 ' CG2' HG22 ' A' ' 39' ' ' ILE . 30.1 pt -157.77 137.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.992 0.425 . . . . 10.0 111.884 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -88.84 136.4 33.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.693 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.0 tp -169.1 140.79 2.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 52.1 ttm-85 48.66 46.16 21.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.176 0.512 . . . . 10.0 110.859 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.27 41.79 80.45 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.034 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -167.09 125.15 1.3 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 10.0 111.078 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -91.82 134.98 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.923 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.479 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.3 pp -109.22 135.88 20.19 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.518 -0.31 . . . . 10.0 110.983 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 85.0 Cg_endo -92.83 124.42 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.932 2.422 . . . . 10.0 112.735 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 62' ' ' VAL . 23.2 m -102.79 125.34 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.788 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 14.0 t -130.66 -175.9 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.283 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.594 ' H ' ' CG1' ' A' ' 63' ' ' VAL . 5.2 m120 -120.24 96.85 5.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.71 -0.223 . . . . 10.0 110.526 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.778 ' O ' HG22 ' A' ' 68' ' ' ILE . 3.1 tt -56.21 -32.13 64.11 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.273 0.559 . . . . 10.0 109.838 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.68 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -61.74 -24.52 66.86 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.23 -0.441 . . . . 10.0 109.884 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HE3' ' CE2' ' A' ' 48' ' ' PHE . 1.4 tmmm? -82.28 -44.04 16.77 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.295 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.778 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.7 tt -64.58 -40.85 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.447 -0.946 . . . . 10.0 108.447 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.641 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -77.88 -53.01 7.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 113.903 -1.499 . . . . 10.0 109.487 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.574 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 118.93 -80.48 0.32 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 115.454 -0.794 . . . . 10.0 112.702 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.828 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.3 pt 45.19 178.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.7 m -55.44 -37.53 67.82 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 109.054 -0.721 . . . . 10.0 109.054 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.828 ' HB3' HG13 ' A' ' 71' ' ' ILE . 16.1 t80 -31.07 143.92 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.772 -1.104 . . . . 10.0 112.995 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 9.4 t70 -169.84 39.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.351 -0.84 . . . . 10.0 109.702 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 56.13 39.04 30.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.034 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -87.24 -63.76 1.26 Allowed 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 112.327 0.492 . . . . 10.0 112.327 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -108.35 16.24 23.3 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.538 0.57 . . . . 10.0 112.538 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.508 ' HE2' ' CD1' ' A' ' 73' ' ' PHE . 17.7 mmt -52.86 138.33 29.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.907 -0.133 . . . . 10.0 110.963 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -159.46 -48.63 0.05 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.524 0.565 . . . . 10.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.401 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 65.1 m -88.94 163.75 15.44 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.803 0.298 . . . . 10.0 111.803 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 94' ' ' LEU . 72.6 mt -127.7 154.15 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.031 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 11.8 mt -128.15 146.12 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.421 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.14 149.93 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.438 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -156.86 130.61 8.23 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.497 -0.32 . . . . 10.0 111.776 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.521 ' C ' HG22 ' A' ' 86' ' ' THR . 15.0 ptm180 -88.8 133.17 34.34 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.715 -0.846 . . . . 10.0 108.715 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.521 HG22 ' C ' ' A' ' 85' ' ' ARG . 43.8 p -147.63 108.61 4.22 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.669 0.618 . . . . 10.0 112.669 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 47.78 49.25 16.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.705 -0.68 . . . . 10.0 110.82 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 70.41 33.65 2.44 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.216 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.55 HG11 HG21 ' A' ' 91' ' ' VAL . 76.8 t -133.56 111.63 16.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.24 -0.891 . . . . 10.0 109.34 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.544 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 39.8 mt-10 -88.56 92.45 9.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.114 -1.439 . . . . 10.0 107.114 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.55 HG21 HG11 ' A' ' 89' ' ' VAL . 2.7 t -88.66 158.15 3.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 112.796 -2.002 . . . . 10.0 111.719 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -138.11 144.6 15.88 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 120.165 -1.016 . . . . 10.0 113.458 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.62 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 t80 -133.36 122.02 23.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.777 0.323 . . . . 10.0 110.618 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 81' ' ' ILE . 6.5 tt -88.85 132.56 34.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.141 0.496 . . . . 10.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.518 ' N ' HD22 ' A' ' 94' ' ' LEU . 15.9 m -130.94 -175.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.431 -0.804 . . . . 10.0 111.373 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -81.27 -75.95 0.26 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.153 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -134.27 107.17 7.51 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.282 -0.872 . . . . 10.0 108.733 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.592 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -88.97 116.99 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 122.418 1.104 . . . . 10.0 111.967 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.571 HD22 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -68.75 -27.59 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.909 -1.95 . . . . 10.0 110.715 -178.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.74 -126.58 8.34 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.635 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -52.28 133.14 14.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.976 0.388 . . . . 10.0 110.754 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.564 ' HG ' HG12 ' A' ' 104' ' ' ILE . 43.9 tp -137.7 138.33 39.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.059 0.457 . . . . 10.0 110.854 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.6 ptp180 -88.8 72.74 8.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.198 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.651 ' HB ' HG11 ' A' ' 13' ' ' VAL . 14.3 mm -88.98 131.62 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.771 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.6 p -88.76 147.24 24.56 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.356 -1.72 . . . . 10.0 106.356 175.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HG2' ' HG ' ' A' ' 109' ' ' LEU . 84.3 tt0 -134.47 81.77 1.93 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.365 -0.934 . . . . 10.0 113.08 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -76.05 -5.28 45.7 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.296 -0.865 . . . . 10.0 109.343 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -64.8 -54.84 24.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.335 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.425 ' CD1' ' HB3' ' A' ' 8' ' ' LEU . 2.2 pp -81.28 145.19 31.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.668 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -172.9 -52.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.715 -0.675 . . . . 10.0 109.81 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 111' ' ' LEU . 3.7 mp -94.88 -40.54 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.633 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.2 t 176.52 44.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.292 -0.867 . . . . 10.0 110.339 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.437 ' O ' ' CG1' ' A' ' 114' ' ' VAL . 24.3 t-20 62.87 125.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.73 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -174.01 113.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.409 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.0 t -172.85 130.96 0.52 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.215 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -105.92 25.82 10.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.405 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -51.72 -35.32 42.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.539 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.54 ' CE2' ' CD2' ' A' ' 69' ' ' LEU . 4.3 t80 -165.19 38.94 0.07 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.534 0.683 . . . . 10.0 109.487 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 122' ' ' SER . . . -74.2 35.6 0.94 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.857 -1.065 . . . . 10.0 113.351 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 118' ' ' PHE . 34.4 mmtp -79.34 -32.63 43.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.346 0.593 . . . . 10.0 109.452 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 121' ' ' LYS . 17.1 tppt? -156.9 32.99 0.3 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.195 -0.911 . . . . 10.0 110.112 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.619 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 79.6 p 178.25 -160.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.211 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 136' ' ' LEU . 42.2 mmtm -72.62 -52.36 15.73 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 111.422 0.156 . . . . 10.0 111.422 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 118' ' ' PHE . . . 157.24 172.54 24.56 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.285 -1.436 . . . . 10.0 115.05 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.554 HD11 ' O ' ' A' ' 126' ' ' VAL . 2.6 tm? -72.29 144.4 48.37 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.818 -0.691 . . . . 10.0 110.762 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.554 ' O ' HD11 ' A' ' 125' ' ' LEU . 2.3 p -121.08 153.27 24.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.34 0.59 . . . . 10.0 111.605 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.47 ' NZ ' ' HB3' ' A' ' 127' ' ' LYS . 7.2 ttpm? -152.14 140.31 20.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 18.7 m -159.67 144.63 15.32 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.887 0.375 . . . . 10.0 111.109 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.421 ' OD1' ' HB3' ' A' ' 131' ' ' ARG . 2.9 p30 45.95 48.36 12.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.615 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.07 42.41 81.2 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.711 -0.757 . . . . 10.0 112.383 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.7 OUTLIER -136.25 139.93 43.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.823 0.344 . . . . 10.0 110.454 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 4.1 mp -88.87 137.28 32.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.98 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.539 ' HB ' HG13 ' A' ' 126' ' ' VAL . 5.0 mt -156.03 151.36 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.551 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.508 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.7 mp -101.41 144.69 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.516 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 35.6 t80 -139.75 142.64 36.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.839 -0.744 . . . . 10.0 111.973 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.709 HD23 ' H ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -158.1 144.17 17.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.644 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 137' ' ' ASP . 9.2 t70 -97.2 33.99 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.718 . . . . 10.0 110.004 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.82 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 18.5 tt 42.4 20.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.048 -0.978 . . . . 10.0 113.337 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.421 ' CB ' ' NZ ' ' A' ' 123' ' ' LYS . 38.6 t70 -77.14 -54.97 5.85 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -79.21 -30.66 43.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.151 0.5 . . . . 10.0 110.937 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.82 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.46 -45.33 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.657 -0.701 . . . . 10.0 110.199 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.626 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 8.3 tp -67.17 -45.5 86.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 120.622 -0.431 . . . . 10.0 110.538 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -48.05 -43.21 30.18 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.374 0.607 . . . . 10.0 109.64 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -72.44 -31.33 65.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.083 -0.962 . . . . 10.0 110.865 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.732 HG13 ' O ' ' A' ' 141' ' ' ILE . 38.6 mt -54.99 -41.59 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.942 0.401 . . . . 10.0 110.652 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.8 p -81.01 -52.26 7.62 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.926 -0.579 . . . . 10.0 112.162 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.8 p -82.14 13.1 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.491 ' HD2' ' CG ' ' A' ' 48' ' ' PHE . 24.3 ttpp -44.79 -43.77 8.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.697 0.284 . . . . 10.0 111.739 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -56.84 127.13 30.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 10.0 111.023 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 168.91 -47.84 0.22 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.819 -0.705 . . . . 10.0 112.535 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.327 . . . . 10.0 111.054 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' HG2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.546 0.212 . . . . 10.0 111.488 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' N ' ' HG2' ' A' ' 1' ' ' MET . 13.1 mmmm 62.16 60.8 1.41 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.958 0.409 . . . . 10.0 111.246 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 t -50.66 -24.44 3.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 10.0 111.173 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.9 mt -56.84 -39.28 73.95 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.009 0.433 . . . . 10.0 110.2 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.65 132.32 53.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.587 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' A' ' 9' ' ' LYS . 35.7 t70 -178.8 163.32 1.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.979 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.32 139.01 3.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.94 0.4 . . . . 10.0 111.539 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.526 ' HB3' HD13 ' A' ' 109' ' ' LEU . 86.0 mt 66.19 44.05 2.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.448 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.471 ' HB3' ' OD2' ' A' ' 6' ' ' ASP . 21.0 ptmt -86.04 -48.28 8.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.964 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 39.8 mt-10 -117.7 164.26 15.25 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.319 0.58 . . . . 10.0 110.471 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.569 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 15.5 t80 -157.25 137.16 12.47 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.005 -0.998 . . . . 10.0 112.748 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -88.73 139.86 30.04 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.476 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.727 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.1 p -156.06 171.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.55 ' N ' HG21 ' A' ' 13' ' ' VAL . 3.3 tm? -88.92 137.18 32.55 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.609 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 76.7 p -149.19 153.62 37.92 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.685 0.995 . . . . 10.0 113.685 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.682 ' HZ ' ' CE1' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -147.18 156.43 42.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.154 -1.384 . . . . 10.0 110.142 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -88.77 99.91 12.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.388 0.613 . . . . 10.0 109.868 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.549 HG13 HD23 ' A' ' 23' ' ' LEU . 27.6 mm -88.91 101.36 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.034 -0.985 . . . . 10.0 111.866 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.1 m-20 46.18 60.15 3.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.566 -0.743 . . . . 10.0 112.926 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.7 mt-10 86.6 -39.63 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.385 -0.825 . . . . 10.0 112.015 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 16.5 pt20 -88.83 -175.61 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.788 -0.449 . . . . 10.0 109.788 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.556 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -115.43 158.11 22.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.171 0.51 . . . . 10.0 111.472 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.577 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -145.39 133.3 21.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.144 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -137.05 149.43 47.42 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.717 1.006 . . . . 10.0 113.717 -177.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.682 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 0.9 OUTLIER -132.18 138.11 47.87 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.634 -1.167 . . . . 10.0 108.329 178.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -49.0 122.69 6.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.066 0.46 . . . . 10.0 111.325 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 14' ' ' LEU . 23.9 m -61.05 -14.24 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.63 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.14 -39.78 91.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.068 0.461 . . . . 10.0 110.22 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -95.49 -44.77 7.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.245 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mm -57.32 129.53 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.59 -0.277 . . . . 10.0 110.471 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 32' ' ' MET . 50.4 mt-10 -88.32 -61.6 1.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.5 mtm -169.03 157.95 8.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.983 0.42 . . . . 10.0 111.563 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -88.87 151.16 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.474 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.529 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 13.5 pt -154.13 134.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.01 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.93 111.81 24.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 10.0 110.608 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.446 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 2.0 tmtp? -169.18 66.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.699 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.3 p -55.74 -168.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.37 . . . . 10.0 111.272 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 38.74 46.54 1.04 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.243 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.49 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 19.6 mt -77.56 138.38 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.665 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.64 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 4.0 m 34.57 91.57 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.963 -0.562 . . . . 10.0 112.499 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -89.24 -57.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.684 2.256 . . . . 10.0 113.506 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.578 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 14.2 p -81.54 -31.97 0.6 Allowed Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.198 0.814 . . . . 10.0 113.198 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 42' ' ' VAL . 14.8 Cg_exo -67.97 5.16 1.18 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.124 1.882 . . . . 10.0 113.703 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -50.92 148.87 3.84 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.157 0.503 . . . . 10.0 112.04 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 41.7 t 174.92 60.28 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.725 . . . . 10.0 110.92 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 20.8 tpp180 -170.46 -31.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.422 -0.353 . . . . 10.0 111.88 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 92.9 m-70 73.73 146.98 0.09 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.749 0.309 . . . . 10.0 110.676 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.463 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 1.8 t80 83.52 -46.74 0.12 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.737 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.461 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 48.7 t -72.65 128.56 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.902 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.9 -37.82 62.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.146 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.02 -175.86 38.08 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.958 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.64 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.5 m -154.16 170.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.839 -0.43 . . . . 10.0 109.839 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.443 HG12 HD13 ' A' ' 60' ' ' ILE . 30.9 pt -157.47 145.21 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.867 0.365 . . . . 10.0 111.084 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -88.71 142.11 27.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 10.0 111.167 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 tp -168.29 138.71 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.823 -0.626 . . . . 10.0 110.586 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.518 ' HG3' ' HG2' ' A' ' 58' ' ' ARG . 16.4 ptm180 44.79 45.75 8.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.38 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.49 40.89 99.31 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.85 -0.614 . . . . 10.0 113.704 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.518 ' HG2' ' HG3' ' A' ' 56' ' ' ARG . 16.0 ptp180 -169.15 130.06 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.877 0.338 . . . . 10.0 110.979 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -89.03 133.53 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.23 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.3 pp -104.86 135.74 19.26 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.935 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 79.5 Cg_endo -92.02 114.31 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.762 2.308 . . . . 10.0 113.383 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 m -91.05 136.03 25.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.461 ' CG2' ' HA ' ' A' ' 49' ' ' VAL . 62.7 t -139.09 159.01 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.719 0.771 . . . . 10.0 112.92 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.434 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 5.7 m120 -74.14 63.0 0.95 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.745 -1.116 . . . . 10.0 109.062 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.796 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.9 tt -53.69 -32.21 50.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.763 -0.653 . . . . 10.0 111.22 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.644 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -62.85 -24.09 67.61 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.259 -0.576 . . . . 10.0 109.872 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.508 ' N ' ' HE2' ' A' ' 73' ' ' PHE . 1.0 OUTLIER -83.06 -45.41 14.05 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.137 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.796 HG22 ' O ' ' A' ' 65' ' ' LEU . 9.6 tt -57.73 -38.67 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 107.687 -1.227 . . . . 10.0 107.687 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.619 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.22 -47.15 18.61 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.801 -1.545 . . . . 10.0 108.473 177.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 117.67 -90.5 0.5 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.456 -0.793 . . . . 10.0 112.714 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.842 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.2 pt 47.66 165.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.399 0.889 . . . . 10.0 113.399 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.6 m -47.05 -37.77 9.99 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.18 -0.674 . . . . 10.0 109.18 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.842 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.6 t80 -28.08 141.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.395 -1.275 . . . . 10.0 113.283 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -166.79 37.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.241 -0.891 . . . . 10.0 110.235 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 55.94 32.67 20.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.78 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.433 ' NE2' ' OD2' ' A' ' 19' ' ' ASP . 22.3 pt20 -95.42 -44.41 7.56 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -113.2 13.94 19.32 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.23 0.456 . . . . 10.0 112.23 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.431 ' HE2' ' CD1' ' A' ' 73' ' ' PHE . 29.5 mmt -59.8 140.62 56.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.904 0.383 . . . . 10.0 111.686 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 14.4 ptmm? -179.64 39.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.817 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.3 t -169.19 164.85 11.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.795 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 43.6 mt -139.84 152.25 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.961 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.586 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 9.8 mt -131.36 130.35 62.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.727 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.6 t -98.24 156.83 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.051 0.453 . . . . 10.0 111.307 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -156.52 172.1 19.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.617 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.431 ' C ' HG22 ' A' ' 86' ' ' THR . 14.4 ptm180 -130.6 130.7 44.34 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.468 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 46.7 p -145.36 109.27 4.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 87' ' ' LYS . 8.1 ttpt 48.02 49.89 16.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.614 0.721 . . . . 10.0 110.689 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 71.0 32.13 2.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.037 -0.983 . . . . 10.0 111.484 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.543 HG11 HG21 ' A' ' 91' ' ' VAL . 71.4 t -129.01 109.52 18.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.275 -0.875 . . . . 10.0 109.192 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.644 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 25.0 mp0 -88.35 97.36 11.0 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.278 -1.749 . . . . 10.0 106.278 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.543 HG21 HG11 ' A' ' 89' ' ' VAL . 3.6 t -88.55 153.55 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 113.291 -1.777 . . . . 10.0 113.016 -174.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.97 158.03 18.47 Favored Glycine 0 C--N 1.317 -0.485 0 CA-C-N 114.495 -1.229 . . . . 10.0 113.185 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.622 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -146.95 128.11 14.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.873 0.368 . . . . 10.0 110.915 -179.168 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.488 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 52.1 tp -88.66 128.14 35.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.999 0.428 . . . . 10.0 110.751 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.505 HG13 ' CE2' ' A' ' 16' ' ' PHE . 29.8 m -137.01 -175.11 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.428 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 45.8 t0 -92.96 -73.33 0.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.354 0.597 . . . . 10.0 111.17 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.9 ttt-85 -137.63 120.81 16.8 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.196 -0.911 . . . . 10.0 108.616 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.594 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.1 p -101.69 117.12 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 122.361 1.077 . . . . 10.0 112.898 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -65.42 -28.82 69.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.083 -1.871 . . . . 10.0 111.059 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.57 -122.63 6.57 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.552 -0.833 . . . . 10.0 111.171 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.97 133.59 16.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 117.045 0.422 . . . . 10.0 110.322 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.646 ' HG ' HG12 ' A' ' 104' ' ' ILE . 57.2 tp -136.17 137.72 41.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.989 0.423 . . . . 10.0 111.048 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.9 ptp180 -88.85 71.73 8.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.315 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.727 ' HB ' HG11 ' A' ' 13' ' ' VAL . 14.2 mm -88.84 128.45 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.732 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 18.5 p -88.68 147.59 24.44 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.655 -1.609 . . . . 10.0 106.655 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.463 ' O ' ' CD1' ' A' ' 109' ' ' LEU . 35.0 tt0 -137.07 79.08 1.73 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.443 -0.903 . . . . 10.0 112.663 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -72.98 -10.6 59.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.619 -0.719 . . . . 10.0 109.533 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -63.09 -48.39 78.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.443 -0.799 . . . . 10.0 110.932 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.526 HD13 ' HB3' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -61.57 165.47 4.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.921 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -175.74 -46.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.607 -0.724 . . . . 10.0 110.002 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.8 tp -124.65 -32.75 3.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.987 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.1 t 177.28 43.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.432 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 m120 61.65 120.54 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.999 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 115' ' ' SER . 10.9 t -156.79 97.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.142 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 46.1 t 175.34 133.83 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.797 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.424 ' O ' ' HA2' ' A' ' 124' ' ' GLY . 34.3 t70 -71.29 -70.1 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.761 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.591 ' HB2' ' CA ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER 66.57 -55.09 0.42 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 179.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.597 ' CE1' HD23 ' A' ' 69' ' ' LEU . 56.6 t80 -69.85 -58.04 4.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.11 0.481 . . . . 10.0 110.55 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 150.53 -54.5 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.568 -0.742 . . . . 10.0 112.091 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 54.9 tptt 173.85 60.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.978 0.418 . . . . 10.0 110.063 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 118' ' ' PHE . 4.2 tppp? -154.47 -39.43 0.09 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.658 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.635 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 94.9 p -140.88 -163.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.561 -0.291 . . . . 10.0 110.724 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.539 ' HA ' ' HE2' ' A' ' 123' ' ' LYS . 5.4 mmpt? -70.6 -49.66 45.44 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.766 -0.374 . . . . 10.0 111.707 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.591 ' CA ' ' HB2' ' A' ' 117' ' ' LYS . . . 170.29 151.93 7.75 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 118.428 -1.844 . . . . 10.0 116.109 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 126' ' ' VAL . 2.8 tm? -73.61 124.41 25.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.563 -0.818 . . . . 10.0 109.653 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.553 ' CG1' ' HB2' ' A' ' 135' ' ' TYR . 2.4 p -97.63 154.19 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.452 0.644 . . . . 10.0 112.28 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -158.95 138.45 11.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.502 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 7.0 m -165.01 146.83 7.86 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.926 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 54.79 42.71 30.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.986 0.422 . . . . 10.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.4 37.68 60.67 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.836 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -130.15 136.58 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.273 -0.269 . . . . 10.0 110.273 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 133' ' ' ILE . 4.7 tt -88.93 136.75 32.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.605 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.556 HG12 ' CB ' ' A' ' 22' ' ' ALA . 6.0 mt -154.01 143.48 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 10.0 110.789 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.515 ' O ' HD11 ' A' ' 23' ' ' LEU . 2.0 mp -96.1 134.8 32.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 109.072 -0.714 . . . . 10.0 109.072 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.553 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 41.1 t80 -129.33 140.4 51.4 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.773 -0.771 . . . . 10.0 111.385 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.635 ' CB ' ' HB2' ' A' ' 122' ' ' SER . 0.0 OUTLIER -159.97 151.2 19.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.36 0.6 . . . . 10.0 111.881 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 139' ' ' ASP . 1.4 m-20 -102.33 37.87 1.8 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.498 -0.774 . . . . 10.0 110.501 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.835 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 19.8 tt 39.63 20.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.58 -1.191 . . . . 10.0 113.653 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.494 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.9 t70 -79.53 -57.45 3.68 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -76.92 -32.5 57.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 10.0 110.356 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.835 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.78 -45.68 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.183 -0.917 . . . . 10.0 110.489 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.629 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.5 tp -64.13 -44.82 97.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 120.375 -0.53 . . . . 10.0 109.953 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -48.13 -43.16 30.92 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.404 ' OE2' ' HD3' ' A' ' 121' ' ' LYS . 44.5 mt-10 -69.99 -32.89 71.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.236 -0.893 . . . . 10.0 110.58 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 141' ' ' ILE . 34.1 mt -55.51 -40.38 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 120.953 0.406 . . . . 10.0 110.801 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.6 p -77.74 -50.63 12.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.873 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.6 p -77.89 5.06 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.088 0.403 . . . . 10.0 112.088 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 48' ' ' PHE . 23.9 pttm -46.42 -41.44 13.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.696 0.284 . . . . 10.0 111.638 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 63.8 132.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.664 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -103.22 -47.13 1.36 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.71 -0.757 . . . . 10.0 112.424 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.817 0.342 . . . . 10.0 110.956 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' HG2' ' A' ' 1' ' ' MET . 27.8 ttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.001 0.429 . . . . 10.0 110.818 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' O ' ' HB ' ' A' ' 3' ' ' THR . 75.0 mmtt -64.09 -42.83 96.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 51.0 m 72.65 -48.87 0.69 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.319 -0.401 . . . . 10.0 111.744 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.2 pp -56.14 -28.7 58.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.873 0.368 . . . . 10.0 110.945 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.415 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -54.0 131.89 41.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.222 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 62.16 123.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.986 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.31 135.95 55.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.426 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.428 ' CD1' HD21 ' A' ' 109' ' ' LEU . 84.3 mt -82.26 47.76 1.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.858 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -82.67 -53.41 5.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.477 -0.329 . . . . 10.0 111.835 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 34.2 mt-10 -121.69 164.28 17.63 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.738 0.78 . . . . 10.0 111.513 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 12.7 t80 -158.76 136.71 10.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.268 -1.333 . . . . 10.0 112.259 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.75 140.76 29.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.655 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.802 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -157.99 171.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 113.583 0.957 . . . . 10.0 113.583 -174.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.0 tm? -88.77 132.1 34.77 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.61 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 80.9 p -143.7 156.92 44.69 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.542 0.942 . . . . 10.0 113.542 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.626 ' CZ ' ' HG ' ' A' ' 23' ' ' LEU . 4.1 p90 -153.11 158.35 41.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.902 -1.499 . . . . 10.0 109.81 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -88.58 125.4 34.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.351 0.596 . . . . 10.0 109.556 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.568 HG22 ' CD1' ' A' ' 71' ' ' ILE . 32.9 mm -115.09 81.03 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.51 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 58.8 m-20 52.29 60.26 3.94 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.957 -0.565 . . . . 10.0 112.12 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 8.2 mp0 80.96 -31.97 0.11 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.261 -0.881 . . . . 10.0 111.771 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -88.81 137.82 31.97 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.076 -0.712 . . . . 10.0 109.076 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.541 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.65 155.09 19.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.044 0.45 . . . . 10.0 111.21 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.626 ' HG ' ' CZ ' ' A' ' 16' ' ' PHE . 1.8 tp -148.14 140.85 24.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.355 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -144.99 155.93 43.67 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.893 0.701 . . . . 10.0 112.893 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.515 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.3 m-85 -136.4 141.21 43.62 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.319 -0.855 . . . . 10.0 109.187 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.07 120.54 5.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.195 0.521 . . . . 10.0 110.692 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 14' ' ' LEU . 34.2 m -60.36 -12.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.048 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -62.14 -46.86 87.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.006 0.431 . . . . 10.0 110.376 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.429 ' ND2' ' CG2' ' A' ' 138' ' ' ILE . 13.9 t30 -86.67 -45.33 11.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.924 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.4 mm -57.71 126.8 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.784 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.11 -65.78 0.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.533 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -169.13 168.77 9.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 10.0 111.683 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.86 148.4 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.366 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.404 HD12 ' HD2' ' A' ' 36' ' ' LYS . 17.6 pt -150.85 128.81 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -88.85 63.76 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.446 . . . . 10.0 111.234 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 68.6 mttm -89.06 154.23 20.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.205 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.1 p -152.61 144.39 23.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.364 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.5 t70 50.1 45.12 25.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.259 0.552 . . . . 10.0 110.787 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 45.4 mt -61.04 -69.77 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.12 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.463 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 96.7 m -149.71 66.7 8.33 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.231 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.42 -49.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.875 2.384 . . . . 10.0 113.205 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.505 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 45.6 t -72.46 -44.47 9.83 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.469 -0.332 . . . . 10.0 111.757 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 42' ' ' VAL . 12.1 Cg_exo -70.07 8.63 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.651 2.234 . . . . 10.0 113.538 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -48.82 156.59 0.47 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.043 0.449 . . . . 10.0 111.829 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.2 t 177.76 48.72 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.589 -0.732 . . . . 10.0 111.438 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 6.9 tpm_? -166.24 16.55 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.558 -0.292 . . . . 10.0 111.671 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.481 ' O ' ' O ' ' A' ' 46' ' ' ARG . 17.6 m80 56.49 137.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.766 0.317 . . . . 10.0 111.185 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' GLU . 3.2 m-85 68.8 -47.66 0.57 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.92 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.459 ' CG1' HG13 ' A' ' 52' ' ' VAL . 48.0 t -54.4 80.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.921 0.391 . . . . 10.0 111.57 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 48' ' ' PHE . 24.6 pt-20 -61.02 -29.19 69.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.962 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.433 ' HA2' ' HB ' ' A' ' 40' ' ' THR . . . -152.21 168.19 31.36 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.435 -0.888 . . . . 10.0 112.926 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.484 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 2.3 m -160.18 167.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.94 -0.393 . . . . 10.0 109.94 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 60' ' ' ILE . 29.7 pt -156.55 132.53 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.226 0.536 . . . . 10.0 112.068 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -88.91 140.94 28.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.44 -0.8 . . . . 10.0 110.812 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.2 tp -169.01 137.16 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.892 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 45.65 46.98 11.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.56 44.82 90.69 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.694 -0.765 . . . . 10.0 112.212 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 58' ' ' ARG . 4.5 tmm_? -161.14 125.04 3.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 10.0 111.034 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.453 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.6 mp -100.83 145.96 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.758 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.526 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.1 pp -126.86 137.13 29.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.61 -0.268 . . . . 10.0 111.202 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 50.6 Cg_endo -95.67 124.92 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.413 2.742 . . . . 10.0 113.431 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.54 135.63 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.76 -0.459 . . . . 10.0 109.76 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 64' ' ' ASN . 91.3 t -142.27 156.34 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.49 0.662 . . . . 10.0 112.379 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.444 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 74.5 m-20 -72.69 74.98 1.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.151 -0.931 . . . . 10.0 109.364 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.744 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.8 tt -54.87 -35.89 64.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.286 0.565 . . . . 10.0 110.859 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.665 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -59.87 -20.9 59.82 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.447 -0.501 . . . . 10.0 109.687 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -83.15 -49.42 9.5 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.098 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.2 tt -58.32 -39.59 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.707 -1.22 . . . . 10.0 107.707 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.563 ' CD1' HG21 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -79.89 -36.05 37.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.267 -1.788 . . . . 10.0 109.573 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.723 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 67.16 124.45 0.02 OUTLIER Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.676 -0.693 . . . . 10.0 112.89 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.723 HG21 ' O ' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -165.4 -168.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.727 0.411 . . . . 10.0 110.859 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 19' ' ' ASP . 67.0 m -48.43 -35.02 11.96 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.665 ' CD2' ' CB ' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -31.3 135.82 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.251 -1.341 . . . . 10.0 113.53 176.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' A' ' 75' ' ' GLU . 64.2 t0 -129.33 -65.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.156 -0.929 . . . . 10.0 110.038 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER 157.58 -27.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.332 -0.394 . . . . 10.0 111.468 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.476 ' N ' ' OE1' ' A' ' 75' ' ' GLU . 24.9 pt20 -60.06 -48.32 82.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 32.0 mmtp -77.87 -45.07 25.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.975 0.417 . . . . 10.0 111.592 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.466 ' CE ' ' HA ' ' A' ' 95' ' ' VAL . 18.5 mmm -35.62 141.58 0.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.633 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -169.4 -28.95 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.424 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 48.1 t -88.85 -175.96 5.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.628 0.252 . . . . 10.0 111.095 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 57.9 mt -156.61 140.48 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.954 0.407 . . . . 10.0 111.508 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.565 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 13.5 mt -113.27 150.12 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.607 . . . . 10.0 110.669 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.54 149.71 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.919 0.39 . . . . 10.0 110.852 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -151.3 -175.9 5.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.126 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.416 ' O ' ' CG2' ' A' ' 86' ' ' THR . 14.6 ptm180 -135.9 144.41 45.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.713 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.542 HG21 HG12 ' A' ' 138' ' ' ILE . 34.8 p -160.16 109.47 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 10.0 112.083 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.3 tppp? 47.19 47.16 16.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.691 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 53.0 m-20 74.18 33.54 0.91 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.144 -0.935 . . . . 10.0 111.279 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 91' ' ' VAL . 60.4 t -130.47 110.14 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-N 115.215 -0.902 . . . . 10.0 109.485 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 46.1 mt-10 -88.35 100.62 13.16 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.515 -2.032 . . . . 10.0 105.515 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.504 HG21 HG11 ' A' ' 89' ' ' VAL . 5.0 t -88.62 153.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 113.343 -1.753 . . . . 10.0 113.482 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.1 155.1 17.24 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 114.231 -1.349 . . . . 10.0 112.707 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.568 ' HD1' ' N ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -144.43 126.66 15.69 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 120.963 0.411 . . . . 10.0 110.963 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.568 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 55.6 tp -88.64 130.27 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.111 0.482 . . . . 10.0 110.833 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.466 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 27.3 m -140.61 -175.27 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.961 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 78' ' ' MET . 19.8 t70 -93.92 -73.05 0.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.196 0.522 . . . . 10.0 111.161 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -131.27 115.42 16.28 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.341 -0.845 . . . . 10.0 108.923 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.574 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 8.7 p -98.02 111.7 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-O 122.354 1.074 . . . . 10.0 111.455 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -64.22 -27.15 68.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.062 -1.881 . . . . 10.0 111.131 -178.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.99 -121.42 5.51 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.949 -0.86 . . . . 10.0 110.949 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.4 t -52.86 129.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 117.145 0.472 . . . . 10.0 109.908 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.62 ' HG ' HG12 ' A' ' 104' ' ' ILE . 60.8 tp -132.98 139.22 47.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.144 0.497 . . . . 10.0 111.226 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 15.9 ptp180 -88.89 71.27 8.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.564 -0.744 . . . . 10.0 109.641 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.802 ' HB ' HG11 ' A' ' 13' ' ' VAL . 6.4 mm -88.8 126.76 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.783 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 16.9 p -88.57 145.25 25.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.944 -1.873 . . . . 10.0 105.944 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.496 ' CG ' ' CD1' ' A' ' 109' ' ' LEU . 2.4 tp10 -147.33 89.51 1.79 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.845 -1.142 . . . . 10.0 112.846 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -86.43 7.56 25.31 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.552 -0.749 . . . . 10.0 109.5 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.43 ' OE1' ' CB ' ' A' ' 115' ' ' SER . 55.8 mm-40 -69.11 -52.49 27.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.576 -0.738 . . . . 10.0 111.003 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.512 ' H ' ' CD1' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -76.6 45.1 0.39 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.17 -0.468 . . . . 10.0 112.209 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.415 ' OD2' HD11 ' A' ' 111' ' ' LEU . 37.7 t70 -74.66 -53.07 9.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.977 0.418 . . . . 10.0 110.311 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 111' ' ' LEU . 4.0 mp -102.75 -39.52 6.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.962 -0.563 . . . . 10.0 109.951 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t 176.04 39.63 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.437 -0.802 . . . . 10.0 110.742 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.412 ' H ' ' HA ' ' A' ' 109' ' ' LEU . 5.3 m120 60.6 111.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.909 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.458 ' O ' ' OG ' ' A' ' 115' ' ' SER . 6.6 t -159.49 100.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.13 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 114' ' ' VAL . 66.1 m -173.02 -175.76 1.28 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.967 0.413 . . . . 10.0 111.438 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -73.49 63.83 0.82 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.474 0.654 . . . . 10.0 110.989 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.514 ' HD2' ' HD2' ' A' ' 123' ' ' LYS . 47.3 mtmt -47.96 -41.87 26.11 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.055 -0.975 . . . . 10.0 111.545 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.504 ' CE2' ' CD2' ' A' ' 69' ' ' LEU . 29.8 t80 -178.4 -52.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.305 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 156.6 -53.25 0.41 Allowed Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.647 -0.706 . . . . 10.0 112.038 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 27.4 tptp 174.81 57.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 10.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -153.02 -42.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.41 -0.359 . . . . 10.0 111.888 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.743 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 93.6 p -116.79 -139.14 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.017 -0.273 . . . . 10.0 111.692 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 23.2 tptm -159.96 16.79 0.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.629 0.603 . . . . 10.0 112.629 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -153.02 152.27 23.95 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 119.416 -1.373 . . . . 10.0 113.785 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 2.5 tm? -153.19 141.37 20.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.106 -0.701 . . . . 10.0 109.106 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.517 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.2 p -157.78 162.28 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.419 0.628 . . . . 10.0 112.366 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.512 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -165.6 135.15 3.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.08 -0.964 . . . . 10.0 109.744 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 4.3 m -159.51 152.58 22.01 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.031 0.443 . . . . 10.0 111.304 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.4 t70 55.81 47.07 21.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.773 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.72 33.55 49.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.513 -0.851 . . . . 10.0 111.663 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.6 ptp180 -138.78 134.0 32.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.348 . . . . 10.0 110.332 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.88 148.52 23.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.172 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.541 HG12 ' CB ' ' A' ' 22' ' ' ALA . 2.9 mt -147.97 132.31 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.656 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.552 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.3 mp -88.78 141.2 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.458 ' O ' ' CA ' ' A' ' 124' ' ' GLY . 24.4 t80 -125.95 147.22 49.56 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.521 0.677 . . . . 10.0 111.595 -178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.743 ' HG ' ' HB2' ' A' ' 122' ' ' SER . 6.7 mp -140.3 165.73 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.042 0.925 . . . . 10.0 112.86 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.431 ' O ' HG21 ' A' ' 138' ' ' ILE . 35.6 t70 -135.21 26.16 3.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.849 -1.523 . . . . 10.0 107.833 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.816 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.4 tt 42.29 16.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.929 -1.487 . . . . 10.0 114.353 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 142' ' ' ILE . 38.8 t70 -81.29 -60.29 2.33 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.671 0.619 . . . . 10.0 112.671 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.435 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.6 mptt -76.02 -29.76 58.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.437 0.637 . . . . 10.0 110.396 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.816 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.11 -46.96 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.137 -0.938 . . . . 10.0 110.715 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.631 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.6 tp -63.0 -43.95 99.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 120.012 -0.675 . . . . 10.0 109.624 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -48.11 -46.61 34.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.635 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -73.52 -30.51 63.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.432 -0.804 . . . . 10.0 110.574 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 141' ' ' ILE . 35.8 mt -54.69 -31.77 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 120.899 0.38 . . . . 10.0 110.788 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.3 p -96.47 -49.19 5.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.983 -0.553 . . . . 10.0 112.402 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 p -85.49 13.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.875 0.694 . . . . 10.0 112.875 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -47.04 -40.89 15.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.789 0.292 . . . . 10.0 111.789 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.81 130.38 45.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.92 0.39 . . . . 10.0 111.088 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 173.39 42.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.826 -0.702 . . . . 10.0 112.489 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 10.0 111.023 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.779 0.323 . . . . 10.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 39.5 ttmt -85.92 44.9 1.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.279 -0.418 . . . . 10.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.7 m 67.68 -60.35 0.39 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.364 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 5' ' ' ALA . 3.9 pp -63.37 -33.17 74.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.077 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.45 ' N ' ' CD1' ' A' ' 4' ' ' LEU . . . -57.8 135.17 56.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.391 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -159.62 133.64 7.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.724 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.08 130.03 42.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.315 -0.402 . . . . 10.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 110' ' ' ASP . 68.6 mt -92.57 44.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 10.0 111.402 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.659 ' HG2' ' HG3' ' A' ' 10' ' ' GLU . 56.8 tttm -97.1 -60.69 1.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.747 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.659 ' HG3' ' HG2' ' A' ' 9' ' ' LYS . 88.3 mt-10 -149.04 164.24 35.2 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.356 0.598 . . . . 10.0 110.33 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.628 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.8 t80 -156.6 138.8 14.64 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.014 -0.993 . . . . 10.0 112.531 -174.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.417 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 12.3 pt-20 -88.81 138.85 31.04 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.771 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -155.94 166.62 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.62 0.724 . . . . 10.0 112.937 -177.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 3.0 tm? -88.88 133.5 34.26 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 37.2 t -153.29 151.39 29.96 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.648 ' HA ' HD22 ' A' ' 99' ' ' LEU . 0.2 OUTLIER -138.49 174.98 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.288 -1.324 . . . . 10.0 110.773 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -88.58 139.77 30.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.348 -0.982 . . . . 10.0 108.348 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.611 HG13 ' HB2' ' A' ' 23' ' ' LEU . 21.0 mm -146.97 76.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.828 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.522 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 1.1 m-20 58.12 51.83 8.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.943 0.402 . . . . 10.0 111.281 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 38.4 mt-10 85.88 -25.64 0.11 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.224 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -88.82 130.64 35.34 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 110.237 -0.283 . . . . 10.0 110.237 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.562 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.66 114.32 25.15 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -88.85 136.6 32.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.096 -177.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -143.18 142.29 31.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.255 0.55 . . . . 10.0 112.344 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -131.4 138.35 49.07 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.235 -1.024 . . . . 10.0 108.235 178.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' OD1' ' CB ' ' A' ' 28' ' ' ASP . 9.6 t0 -49.15 120.76 4.21 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.628 -0.429 . . . . 10.0 110.817 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 14' ' ' LEU . 19.1 m -57.98 -14.94 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.235 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' CB ' ' OD1' ' A' ' 26' ' ' ASP . 7.2 t70 -63.02 -36.2 82.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.162 0.505 . . . . 10.0 109.898 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -95.19 -45.89 7.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.506 -0.77 . . . . 10.0 111.362 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 25' ' ' PHE . 23.3 mm -61.35 132.31 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 120.823 0.344 . . . . 10.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' O ' ' CE ' ' A' ' 32' ' ' MET . 50.5 mt-10 -87.95 -64.46 1.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.962 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.417 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.07 173.03 7.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.39 . . . . 10.0 110.855 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.0 m -100.31 126.76 53.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.781 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.67 HG13 ' HB ' ' A' ' 81' ' ' ILE . 11.9 pt -103.88 155.45 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.124 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -88.79 -175.78 5.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.991 -0.549 . . . . 10.0 111.171 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' CE ' ' HB3' ' A' ' 79' ' ' LYS . 19.3 ptpt -88.68 141.15 28.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.025 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.4 p -175.41 168.81 3.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 10.0 110.661 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -46.51 141.13 3.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.757 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 52' ' ' VAL . 6.5 mt -155.25 155.81 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.391 0.615 . . . . 10.0 112.303 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.495 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 15.2 m -45.61 98.52 0.19 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 114.774 -1.103 . . . . 10.0 111.523 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 39' ' ' ILE . 87.2 Cg_endo -96.51 -54.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.28 2.653 . . . . 10.0 114.524 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.587 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 47.3 t -63.6 -50.43 72.4 Favored Pre-proline 0 N--CA 1.463 0.178 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 78.0 Cg_exo -49.45 -59.0 1.4 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.084 1.856 . . . . 10.0 112.54 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 45' ' ' SER . 4.0 tmmm? 57.92 -78.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.025 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.592 ' O ' ' HB2' ' A' ' 46' ' ' ARG . 30.2 t 55.34 154.67 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.861 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.592 ' HB2' ' O ' ' A' ' 45' ' ' SER . 1.3 mpp_? 82.12 -29.78 0.1 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.942 -0.572 . . . . 10.0 112.095 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 90.6 m-70 68.74 50.4 0.65 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.008 0.432 . . . . 10.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CE1' ' HE3' ' A' ' 67' ' ' LYS . 8.5 t80 -172.36 -43.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.846 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.7 t -70.2 128.83 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.518 -0.765 . . . . 10.0 111.12 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -69.64 -40.73 76.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.611 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 52' ' ' VAL . . . -165.91 -175.95 36.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.551 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.561 ' O ' HG22 ' A' ' 39' ' ' ILE . 2.0 m -155.31 168.88 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.248 -0.278 . . . . 10.0 110.248 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 26.2 pt -154.48 144.14 13.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.766 0.317 . . . . 10.0 111.463 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -88.78 137.68 32.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.044 -0.525 . . . . 10.0 111.295 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.43 ' HG ' ' HG2' ' A' ' 56' ' ' ARG . 54.4 tp -169.12 136.7 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.557 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.472 ' NE ' ' HA ' ' A' ' 56' ' ' ARG . 5.1 mmp_? 52.47 46.06 27.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.809 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.77 35.34 62.65 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.874 -0.603 . . . . 10.0 112.889 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -160.85 127.99 4.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 10.0 110.569 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 1.6 mp -89.05 124.37 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.109 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.5 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 29.1 pt -95.86 124.96 50.55 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.633 -0.258 . . . . 10.0 111.345 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.782 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 85.0 Cg_endo -82.54 115.91 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.507 2.138 . . . . 10.0 112.808 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 63' ' ' VAL . 23.1 m -88.98 133.39 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.168 -0.679 . . . . 10.0 109.168 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 49' ' ' VAL . 59.5 t -145.17 157.79 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.799 0.809 . . . . 10.0 113.153 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 67' ' ' LYS . 5.2 m120 -78.15 66.71 3.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.391 -1.277 . . . . 10.0 108.698 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.623 ' HB3' ' CG ' ' A' ' 93' ' ' PHE . 6.4 tt -53.88 -29.35 41.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.837 -0.62 . . . . 10.0 111.531 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.575 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -64.89 -25.84 68.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.54 -0.541 . . . . 10.0 109.54 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.485 ' HE3' ' CE1' ' A' ' 48' ' ' PHE . 24.1 ttpt -77.91 -52.13 9.32 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.236 -0.893 . . . . 10.0 111.0 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.616 HG22 ' HA ' ' A' ' 65' ' ' LEU . 10.3 tt -53.82 -40.17 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.596 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 1.1 tm? -75.72 -44.99 39.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.545 -1.661 . . . . 10.0 109.534 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.502 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 113.06 -95.65 0.78 Allowed Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.049 -0.523 . . . . 10.0 113.133 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.868 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.6 pt 48.66 164.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.097 0.777 . . . . 10.0 113.097 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.2 m -47.03 -36.81 8.39 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.158 -0.682 . . . . 10.0 109.158 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.868 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.0 t80 -26.09 140.09 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.791 -1.095 . . . . 10.0 112.808 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -160.31 34.66 0.17 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.248 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.498 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 50.4 mt-10 52.53 46.93 25.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.247 0.462 . . . . 10.0 112.247 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.424 ' NE2' ' OD2' ' A' ' 19' ' ' ASP . 23.9 pt20 -97.87 -47.2 5.65 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 14.3 mmmm -108.96 -25.15 10.88 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.362 0.505 . . . . 10.0 112.362 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.547 ' CE ' ' HA ' ' A' ' 95' ' ' VAL . 3.2 mmm -35.94 144.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.724 0.409 . . . . 10.0 111.972 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 51.5 mtmt -160.7 -45.06 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.201 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.5 m -88.86 142.86 27.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.994 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.67 ' HB ' HG13 ' A' ' 34' ' ' ILE . 73.6 mt -100.66 160.52 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.314 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.575 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 31.8 mt -123.63 158.74 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.591 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.68 150.77 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.032 0.444 . . . . 10.0 111.222 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -156.15 171.78 19.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.896 -178.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -128.24 129.05 45.82 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.582 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 67.1 p -145.51 108.27 4.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.879 0.325 . . . . 10.0 111.879 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 88' ' ' ASP . 14.9 tppt? 47.4 59.95 3.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.211 0.529 . . . . 10.0 110.269 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.492 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 2.4 p30 59.16 32.54 22.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.828 -1.078 . . . . 10.0 111.59 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.582 ' HB ' ' O ' ' A' ' 86' ' ' THR . 66.1 t -128.58 109.34 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 115.3 -0.864 . . . . 10.0 109.156 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.782 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 34.1 mt-10 -88.28 97.78 11.22 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.281 -1.748 . . . . 10.0 106.281 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.522 HG21 HG11 ' A' ' 89' ' ' VAL . 3.4 t -88.46 152.23 3.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 113.478 -1.692 . . . . 10.0 113.059 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.56 148.4 17.19 Favored Glycine 0 C--N 1.316 -0.547 0 CA-C-N 114.66 -1.155 . . . . 10.0 113.494 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.623 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -138.76 124.78 20.02 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.75 0.309 . . . . 10.0 110.45 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.492 ' O ' HG11 ' A' ' 95' ' ' VAL . 54.7 tp -88.62 130.07 35.36 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.603 0.594 . . . . 10.0 112.603 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.547 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 34.2 m -143.55 -175.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 115.33 -0.85 . . . . 10.0 110.504 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 78' ' ' MET . 28.5 t70 -108.7 -62.96 1.39 Allowed 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 112.599 0.592 . . . . 10.0 112.599 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 16' ' ' PHE . 13.6 tpt180 -119.34 117.9 29.78 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.41 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.638 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.0 p -112.52 115.42 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 122.432 1.11 . . . . 10.0 111.502 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.648 HD22 ' HA ' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -65.84 -31.21 72.03 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 112.962 -1.926 . . . . 10.0 110.809 -178.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.55 -124.53 6.99 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.258 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.1 t -53.05 129.65 13.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.909 0.354 . . . . 10.0 110.129 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.641 ' HG ' HG12 ' A' ' 104' ' ' ILE . 59.7 tp -132.68 138.9 47.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.994 0.426 . . . . 10.0 111.177 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.613 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -88.82 70.16 8.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.984 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.771 ' HB ' HG11 ' A' ' 13' ' ' VAL . 8.8 mm -88.94 130.87 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 32.0 p -88.75 -175.89 5.05 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.605 -1.257 . . . . 10.0 107.605 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 38.7 tt0 -147.9 73.03 1.25 Allowed 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 118.929 -1.108 . . . . 10.0 112.79 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -102.57 20.79 16.45 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.701 -1.136 . . . . 10.0 109.1 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -125.05 -46.26 1.83 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.474 -0.784 . . . . 10.0 111.382 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.8 mt -69.66 -146.08 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.966 -0.383 . . . . 10.0 109.966 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.434 ' HB2' HD22 ' A' ' 8' ' ' LEU . 15.9 t70 70.9 -145.52 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.447 0.165 . . . . 10.0 111.447 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.419 ' H ' ' CG ' ' A' ' 110' ' ' ASP . 86.7 mt -68.77 -44.06 74.47 Favored 'General case' 0 CA--C 1.523 -0.078 0 N-CA-C 111.635 0.235 . . . . 10.0 111.635 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 113' ' ' ASN . 6.7 t -48.28 -32.22 7.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.069 0.461 . . . . 10.0 110.768 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.411 ' N ' HG22 ' A' ' 112' ' ' THR . 23.9 p30 44.75 54.85 6.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 10.0 112.167 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.497 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 40.8 t -68.89 63.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.264 0.554 . . . . 10.0 110.078 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.551 ' HA ' ' HB2' ' A' ' 123' ' ' LYS . 45.6 t -66.96 -12.38 59.53 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.621 -0.718 . . . . 10.0 111.739 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.97 17.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.062 0.764 . . . . 10.0 113.062 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.637 ' HD2' ' HB3' ' A' ' 125' ' ' LEU . 73.0 mmtt -64.24 -86.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.824 0.305 . . . . 10.0 111.824 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.562 ' CE2' HD23 ' A' ' 69' ' ' LEU . 32.3 t80 -70.61 -59.04 3.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.011 0.434 . . . . 10.0 110.772 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.76 -137.73 7.15 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.564 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 120' ' ' LYS . 63.9 tttp -80.54 58.25 3.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.875 0.369 . . . . 10.0 110.934 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.561 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 16.2 tppt? -161.26 -40.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 10.0 110.804 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.0 p -163.52 -154.49 0.28 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.68 -0.859 . . . . 10.0 108.68 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -176.65 40.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.852 0.686 . . . . 10.0 112.852 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.874 ' O ' ' HB3' ' A' ' 135' ' ' TYR . . . -121.04 44.16 1.41 Allowed Glycine 0 C--O 1.223 -0.538 0 C-N-CA 119.899 -1.143 . . . . 10.0 112.571 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.637 ' HB3' ' HD2' ' A' ' 117' ' ' LYS . 2.1 tm? -62.98 130.17 43.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.539 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.0 OUTLIER -144.1 163.14 14.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.589 -178.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.491 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 8.5 ptpp? -164.26 142.28 7.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.587 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.495 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 3.2 m -164.83 148.67 8.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.378 -0.374 . . . . 10.0 110.761 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.33 47.71 20.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.934 0.397 . . . . 10.0 111.019 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.81 33.56 43.03 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.997 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 128' ' ' THR . 6.5 ptt-85 -137.84 130.24 29.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.761 0.315 . . . . 10.0 110.251 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 4.1 mp -88.93 139.74 30.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.989 0.424 . . . . 10.0 111.183 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.562 HG12 ' CB ' ' A' ' 22' ' ' ALA . 3.7 mt -133.25 129.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.15 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.407 ' HB ' HD11 ' A' ' 23' ' ' LEU . 24.4 mm -88.92 120.74 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 108.606 -0.887 . . . . 10.0 108.606 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.874 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 52.9 t80 -121.38 148.51 44.28 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.239 -0.584 . . . . 10.0 110.363 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -161.01 148.12 15.25 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.505 0.669 . . . . 10.0 111.399 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.8 p-10 -95.87 32.43 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.4 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.834 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 19.7 tt 40.07 18.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.603 -1.18 . . . . 10.0 114.041 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.459 ' O ' HG22 ' A' ' 142' ' ' ILE . 38.4 t70 -79.73 -53.82 6.45 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.966 0.728 . . . . 10.0 112.966 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 121' ' ' LYS . 17.3 tppt? -77.77 -34.17 52.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.447 0.642 . . . . 10.0 110.438 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.834 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.52 -45.95 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.422 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.621 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.7 tp -64.48 -43.41 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.403 -0.519 . . . . 10.0 109.733 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -47.95 -41.16 24.24 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.117 -0.697 . . . . 10.0 109.117 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 50.7 mm-40 -70.73 -35.77 72.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.008 -0.996 . . . . 10.0 110.829 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 141' ' ' ILE . 60.3 mt -55.18 -50.98 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.822 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.9 p -73.5 -53.34 10.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.975 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.437 ' CG1' ' HA ' ' A' ' 144' ' ' GLU . 14.4 p -63.0 -17.81 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 10.0 111.791 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.1 OUTLIER -44.29 -48.73 9.56 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.779 0.323 . . . . 10.0 111.392 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -64.61 147.44 52.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.979 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -160.39 47.98 0.39 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 10.0 112.492 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.341 . . . . 10.0 110.961 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.776 0.322 . . . . 10.0 111.324 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -158.18 -114.17 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.367 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.6 p -157.37 -50.69 0.07 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.737 0.303 . . . . 10.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 5' ' ' ALA . 2.9 pp -59.13 -33.85 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.345 -0.389 . . . . 10.0 111.026 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 4' ' ' LEU . . . 54.38 62.65 2.47 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.247 0.462 . . . . 10.0 112.247 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.409 ' H ' ' CD1' ' A' ' 4' ' ' LEU . 56.4 m-20 58.79 135.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.132 0.491 . . . . 10.0 111.667 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 173.67 -69.56 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.965 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.7 mt 45.38 43.5 8.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.542 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -82.21 -52.57 6.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.035 -0.53 . . . . 10.0 111.213 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 41.4 mt-10 -140.49 164.17 30.85 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.331 0.586 . . . . 10.0 110.531 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.0 t80 -156.52 139.36 15.24 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.894 -1.048 . . . . 10.0 112.453 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 16.7 pt-20 -88.76 138.77 31.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.567 -0.901 . . . . 10.0 108.567 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.756 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -154.97 170.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 113.317 0.858 . . . . 10.0 113.317 -176.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.516 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 3.1 tm? -88.62 132.79 34.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.988 -1.116 . . . . 10.0 107.988 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.544 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 83.5 p -143.16 152.55 41.92 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.376 0.88 . . . . 10.0 113.376 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.61 ' CZ ' ' HG ' ' A' ' 23' ' ' LEU . 15.1 p90 -150.83 162.8 40.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.47 -1.241 . . . . 10.0 109.908 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -88.45 139.81 30.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 73' ' ' PHE . 35.5 mm -134.47 90.03 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.421 -0.809 . . . . 10.0 111.697 -177.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 47.5 m-20 44.62 60.17 3.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.373 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.2 mt-10 87.36 -42.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.196 -0.911 . . . . 10.0 112.093 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.0 pt20 -88.96 146.18 25.05 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.603 -0.439 . . . . 10.0 109.879 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.506 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.61 166.97 13.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 10.0 110.882 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.61 ' HG ' ' CZ ' ' A' ' 16' ' ' PHE . 1.3 tp -152.17 140.2 20.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.325 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -145.89 151.12 37.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 -177.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -133.12 141.3 48.09 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.15 -0.932 . . . . 10.0 108.714 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -49.73 122.76 6.83 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.551 -0.46 . . . . 10.0 111.046 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 14' ' ' LEU . 24.8 m -61.27 -13.85 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.015 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -64.61 -40.48 95.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.406 0.622 . . . . 10.0 109.531 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.489 ' CG ' ' O ' ' A' ' 85' ' ' ARG . 16.5 t-20 -87.81 -46.09 9.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.972 -1.013 . . . . 10.0 110.54 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.508 HG13 ' HB2' ' A' ' 25' ' ' PHE . 22.5 mm -65.85 132.3 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.541 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.411 ' O ' ' CE ' ' A' ' 32' ' ' MET . 53.5 mm-40 -82.64 -64.03 1.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.656 -0.247 . . . . 10.0 111.368 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.411 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.03 172.54 7.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 10.0 111.026 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -89.0 147.09 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.749 -0.659 . . . . 10.0 111.613 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 29.0 pt -145.83 129.86 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.558 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 50.1 mt-10 -98.43 124.7 43.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.489 -0.323 . . . . 10.0 111.118 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.481 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 62.7 mttp -160.42 -176.02 5.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.215 -0.448 . . . . 10.0 110.937 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.3 p -167.22 145.14 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.091 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 t70 48.82 45.01 22.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.304 0.573 . . . . 10.0 109.984 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.576 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 26.0 mt -49.81 -69.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.105 -0.952 . . . . 10.0 112.771 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.486 ' CG2' ' HG3' ' A' ' 43' ' ' PRO . 95.5 m -143.15 130.13 10.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.301 -0.409 . . . . 10.0 111.36 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -91.89 130.07 1.13 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.371 2.714 . . . . 10.0 113.366 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.796 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 40.1 t 58.53 43.19 0.87 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.346 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.796 ' HD3' ' N ' ' A' ' 42' ' ' VAL . 4.0 Cg_exo -79.83 3.28 7.71 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.648 2.232 . . . . 10.0 112.46 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -49.13 151.01 1.45 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.022 0.439 . . . . 10.0 112.06 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.3 t -174.2 68.25 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.853 -0.612 . . . . 10.0 111.773 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.5 ' O ' ' CG ' ' A' ' 47' ' ' HIS . 31.7 tpt85 66.97 46.53 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.049 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.5 ' CG ' ' O ' ' A' ' 46' ' ' ARG . 90.7 m-70 -163.07 -113.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.894 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.496 ' O ' ' CG ' ' A' ' 48' ' ' PHE . 16.2 t80 -173.8 36.79 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.157 0.503 . . . . 10.0 110.104 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.559 ' HA ' HG23 ' A' ' 63' ' ' VAL . 40.1 t -84.3 127.78 39.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.725 -0.67 . . . . 10.0 111.917 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.41 ' OE1' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -93.46 -24.29 18.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.583 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.501 ' HA2' ' HG2' ' A' ' 43' ' ' PRO . . . -152.86 165.04 30.99 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.804 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.576 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 1.9 m -151.11 163.64 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.287 0.543 . . . . 10.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 27.6 pt -160.22 146.26 5.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.137 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -88.8 134.24 33.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.732 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.6 tp -169.05 143.05 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.662 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.442 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 78.0 ttt180 52.77 45.81 27.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.255 0.55 . . . . 10.0 110.493 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.4 38.09 61.68 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.755 -0.657 . . . . 10.0 112.746 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -169.06 139.06 2.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.824 0.345 . . . . 10.0 111.007 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.99 128.24 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.156 -0.474 . . . . 10.0 111.054 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.425 HG12 HG13 ' A' ' 53' ' ' ILE . 26.1 pt -98.69 139.92 21.43 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.432 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 77.6 Cg_endo -95.46 114.76 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.352 2.701 . . . . 10.0 112.712 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.508 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 33.7 m -88.98 141.04 14.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.648 -0.251 . . . . 10.0 110.512 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 49' ' ' VAL . 84.1 t -142.93 156.29 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.258 0.551 . . . . 10.0 111.694 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.58 ' O ' ' HD3' ' A' ' 67' ' ' LYS . 4.0 m120 -77.26 61.39 2.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.951 0.882 . . . . 10.0 109.584 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.651 ' O ' HG22 ' A' ' 68' ' ' ILE . 7.5 tt -48.86 -26.34 2.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.776 . . . . 10.0 112.379 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.696 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -69.44 -26.34 64.55 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.993 -0.683 . . . . 10.0 111.301 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.642 ' HD3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -87.42 -35.01 18.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.723 -0.391 . . . . 10.0 110.775 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.5 tt -57.84 -41.18 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.606 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -79.36 -46.99 16.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.249 -1.796 . . . . 10.0 108.505 176.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 116.15 -85.17 0.39 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.173 -0.921 . . . . 10.0 112.656 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.831 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.0 pt 46.86 166.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 42.9 t -47.69 -34.72 8.56 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.831 ' HB3' HG13 ' A' ' 71' ' ' ILE . 14.6 t80 -31.37 143.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.877 -1.056 . . . . 10.0 112.932 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.95 41.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.722 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 57.37 38.05 28.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.108 -0.496 . . . . 10.0 111.228 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -90.28 -72.47 0.57 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.398 0.518 . . . . 10.0 112.398 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 78' ' ' MET . 0.1 OUTLIER -90.87 -20.73 21.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 10.0 112.204 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.452 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 20.9 mmt -21.13 138.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.087 0.773 . . . . 10.0 113.087 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -172.15 -38.96 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.492 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.415 ' O ' HD11 ' A' ' 94' ' ' LEU . 70.9 m -88.85 166.9 13.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.702 0.287 . . . . 10.0 110.997 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 85.5 mt -138.65 156.3 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.218 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.513 HD13 ' CD2' ' A' ' 16' ' ' PHE . 48.6 mt -132.78 158.23 43.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 121.081 0.467 . . . . 10.0 111.84 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.422 ' CG2' ' CD1' ' A' ' 34' ' ' ILE . 50.5 t -130.96 143.1 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.635 -0.712 . . . . 10.0 110.155 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -140.22 178.19 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.511 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.489 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 54.7 ttp180 -132.95 130.15 39.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.594 ' OG1' ' HB ' ' A' ' 89' ' ' VAL . 62.8 p -137.64 103.07 4.92 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.438 0.637 . . . . 10.0 111.832 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.6 tppp? 47.59 47.26 17.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.902 -1.045 . . . . 10.0 110.78 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 45.2 m-20 81.55 28.5 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.932 -1.031 . . . . 10.0 111.985 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.594 ' HB ' ' OG1' ' A' ' 86' ' ' THR . 50.8 t -125.76 108.93 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.39 -0.823 . . . . 10.0 109.146 176.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 87.9 tt0 -88.24 99.49 12.26 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.521 HG21 ' CG1' ' A' ' 89' ' ' VAL . 2.7 t -88.66 157.71 3.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 113.338 -1.755 . . . . 10.0 112.653 -174.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -125.24 158.23 19.62 Favored Glycine 0 C--N 1.317 -0.487 0 CA-C-N 114.719 -1.128 . . . . 10.0 112.211 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.619 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.2 t80 -158.42 128.55 5.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.096 0.474 . . . . 10.0 112.082 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 63.2 tp -88.84 127.38 35.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.683 -0.69 . . . . 10.0 111.439 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.441 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 32.5 m -135.34 -175.14 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.12 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -88.36 -79.64 0.3 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.167 0.508 . . . . 10.0 111.317 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -130.96 108.19 9.64 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.031 -0.729 . . . . 10.0 109.031 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.1 p -88.97 114.58 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.302 1.049 . . . . 10.0 111.58 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.71 -28.43 69.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.235 -1.802 . . . . 10.0 110.944 -178.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.1 -125.78 7.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.677 -0.773 . . . . 10.0 111.533 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -51.76 131.1 12.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.974 0.387 . . . . 10.0 110.499 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.609 ' HG ' HG12 ' A' ' 104' ' ' ILE . 50.0 tp -134.92 138.51 44.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.952 0.406 . . . . 10.0 111.118 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.3 ptp85 -88.83 72.27 8.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.756 ' HB ' HG11 ' A' ' 13' ' ' VAL . 10.3 mm -88.95 130.17 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.598 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 16.3 p -88.64 149.66 23.42 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.454 -1.684 . . . . 10.0 106.454 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.437 ' CG ' ' HG ' ' A' ' 109' ' ' LEU . 8.3 tp10 -134.57 80.73 1.87 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 114.088 1.144 . . . . 10.0 114.088 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -88.66 -6.81 57.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -76.28 -53.2 8.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.784 -1.098 . . . . 10.0 111.025 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 54.4 mt -68.8 45.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 10.0 112.324 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 64.5 t0 -76.63 113.11 13.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 110' ' ' ASP . 84.2 mt 69.28 -47.13 0.58 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.58 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.6 t -176.74 67.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.716 0.293 . . . . 10.0 111.393 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 p-10 44.89 71.25 0.27 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.26 -0.427 . . . . 10.0 111.462 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 115' ' ' SER . 34.6 m -78.17 41.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 112.419 0.526 . . . . 10.0 112.419 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 42.1 t 172.56 129.57 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.757 0.313 . . . . 10.0 110.703 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -73.0 -54.07 9.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.746 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 125' ' ' LEU . 74.1 mmtt 66.74 -55.91 0.42 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.088 -0.505 . . . . 10.0 111.949 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 69' ' ' LEU . 6.1 t80 -137.77 36.91 2.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.442 0.639 . . . . 10.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.23 28.29 1.18 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 114.949 -1.023 . . . . 10.0 113.592 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 118' ' ' PHE . 62.5 tttp -70.63 -34.45 72.1 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 121' ' ' LYS . 16.6 tppt? -159.47 37.17 0.2 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.998 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.643 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 88.9 p -176.57 -144.12 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.736 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.474 ' HE3' ' HG2' ' A' ' 140' ' ' LYS . 95.5 mttt -160.94 26.2 0.14 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -149.62 154.37 25.69 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 119.242 -1.456 . . . . 10.0 113.75 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 117' ' ' LYS . 2.2 tm? -159.63 139.58 11.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 133' ' ' ILE . 1.4 p -150.46 161.03 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.373 0.606 . . . . 10.0 111.842 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.499 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -158.91 132.62 7.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.43 -0.805 . . . . 10.0 110.724 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.749 ' O ' ' HB2' ' A' ' 131' ' ' ARG . 8.9 m -164.27 140.74 6.38 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.062 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 62.42 45.74 6.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.03 0.443 . . . . 10.0 110.201 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 56.03 25.12 45.33 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.433 -0.889 . . . . 10.0 110.961 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 128' ' ' THR . 99.5 mtt180 -107.89 120.86 43.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.435 -0.383 . . . . 10.0 111.471 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 21' ' ' GLN . 86.1 mt -89.07 82.92 6.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.517 ' O ' HG11 ' A' ' 126' ' ' VAL . 2.4 mt -88.77 131.37 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.43 HG22 ' CD2' ' A' ' 118' ' ' PHE . 1.4 mp -88.98 148.35 4.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 107.917 -1.142 . . . . 10.0 107.917 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.527 ' O ' ' CA ' ' A' ' 124' ' ' GLY . 35.7 t80 -141.16 151.89 44.23 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.028 -0.669 . . . . 10.0 111.457 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.643 ' CB ' ' HB2' ' A' ' 122' ' ' SER . 0.0 OUTLIER -169.07 150.79 4.56 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 113.638 0.977 . . . . 10.0 113.638 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.402 ' O ' HG21 ' A' ' 138' ' ' ILE . 55.0 p30 -99.33 32.92 2.59 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.604 -1.18 . . . . 10.0 109.716 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.866 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 16.2 tt 40.15 24.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.44 -1.255 . . . . 10.0 113.636 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 142' ' ' ILE . 7.3 t70 -77.56 -60.41 2.38 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.017 0.747 . . . . 10.0 113.017 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.474 ' HG2' ' HE3' ' A' ' 123' ' ' LYS . 42.9 mmtm -74.28 -29.19 61.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.162 0.506 . . . . 10.0 111.08 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.866 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.35 -46.78 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.737 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.565 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.2 tp -63.34 -47.11 93.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 120.29 -0.564 . . . . 10.0 110.482 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -50.97 -39.47 55.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.408 ' HG3' ' CD ' ' A' ' 121' ' ' LYS . 5.7 mm-40 -77.86 -27.08 49.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.358 -0.837 . . . . 10.0 111.061 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 141' ' ' ILE . 37.5 mt -53.85 -49.28 59.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 121.064 0.459 . . . . 10.0 110.211 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 77.9 p -82.65 -45.84 14.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.767 -0.652 . . . . 10.0 111.364 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 51.5 t -58.15 -30.55 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.239 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.443 ' HG2' ' CD2' ' A' ' 48' ' ' PHE . 27.7 tptp -38.86 -48.84 1.6 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 61.38 151.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 10.0 110.89 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -161.45 -42.72 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.741 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.893 0.378 . . . . 10.0 111.049 179.929 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.731 0.301 . . . . 10.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' O ' ' HB ' ' A' ' 3' ' ' THR . 36.9 mtmm -59.58 -45.36 92.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.998 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 54.8 m 71.69 -49.38 0.69 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.67 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' A' ' 5' ' ' ALA . 4.3 pp -65.41 -40.81 93.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 10.0 110.555 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.479 ' N ' ' CD1' ' A' ' 4' ' ' LEU . . . -94.77 130.1 41.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.224 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.473 ' O ' HD21 ' A' ' 8' ' ' LEU . 1.5 m-20 -68.4 133.4 48.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.454 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.23 132.6 54.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.786 0.327 . . . . 10.0 111.533 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.473 HD21 ' O ' ' A' ' 6' ' ' ASP . 3.0 mm? -87.33 47.94 1.58 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.288 -0.414 . . . . 10.0 111.208 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.74 ' HE3' ' HA ' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -153.84 -54.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.723 0.297 . . . . 10.0 110.585 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 33.5 mt-10 -139.4 164.14 30.64 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.337 -0.392 . . . . 10.0 109.988 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.547 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.5 t80 -164.78 139.67 5.37 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 113.265 0.839 . . . . 10.0 113.265 -174.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.423 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 3.0 mt-10 -88.67 135.03 33.71 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.294 -0.866 . . . . 10.0 109.16 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.735 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.2 p -152.36 169.35 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.823 0.675 . . . . 10.0 112.823 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.496 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 3.4 tm? -88.84 138.1 31.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.551 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 97.6 p -145.61 153.91 41.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 113.613 0.968 . . . . 10.0 113.613 -177.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.638 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -152.88 159.04 42.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.17 -1.377 . . . . 10.0 110.403 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HG2' HD21 ' A' ' 99' ' ' LEU . 53.1 mm-40 -88.63 124.11 33.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.341 0.591 . . . . 10.0 109.968 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.57 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 22.9 mm -118.52 94.45 3.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.177 -0.92 . . . . 10.0 110.865 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 30.8 m-20 44.05 60.13 2.88 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.827 0.677 . . . . 10.0 112.827 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 48.2 mt-10 88.54 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.49 -0.777 . . . . 10.0 112.607 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -88.84 152.96 21.44 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.438 -0.505 . . . . 10.0 110.278 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.536 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -89.03 155.52 19.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.807 0.336 . . . . 10.0 110.875 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.638 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -141.35 133.96 28.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.469 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -140.18 153.29 46.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.91 0.707 . . . . 10.0 112.91 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 2.8 m-85 -138.08 144.89 41.13 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -43.53 100.49 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.425 0.631 . . . . 10.0 110.447 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 3.5 p -46.84 -19.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.021 -0.991 . . . . 10.0 111.137 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.62 -43.68 88.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.121 0.486 . . . . 10.0 109.75 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.541 ' OD1' ' O ' ' A' ' 85' ' ' ARG . 18.0 t-20 -78.46 -43.27 27.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.485 -0.78 . . . . 10.0 110.607 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.472 HG23 ' HG ' ' A' ' 14' ' ' LEU . 13.0 mm -63.83 125.41 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.32 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.6 ' O ' ' HG3' ' A' ' 32' ' ' MET . 4.6 mm-40 -84.24 -76.6 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.764 0.283 . . . . 10.0 111.764 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.6 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 5.0 mtm -157.34 150.69 23.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.193 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -88.9 128.03 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.391 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.9 pt -100.38 179.48 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 10.0 111.29 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -88.91 150.87 22.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.119 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -88.83 134.98 33.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.16 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t 178.29 -174.22 0.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.903 -0.589 . . . . 10.0 110.58 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.32 144.18 25.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 10.0 110.547 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.494 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 21.4 mt -155.61 -70.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.584 0.586 . . . . 10.0 112.584 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.436 ' CG2' ' HG2' ' A' ' 43' ' ' PRO . 99.2 m -145.86 66.43 11.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.474 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.75 -50.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.946 2.43 . . . . 10.0 112.985 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 60.0 t -78.29 -53.93 1.28 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.804 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 42' ' ' VAL . 19.1 Cg_endo -60.82 -12.48 22.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.176 1.918 . . . . 10.0 112.941 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -41.62 158.36 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.886 0.374 . . . . 10.0 110.951 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.6 t -178.98 66.53 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.809 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 39.3 mmt180 -152.24 -33.29 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.925 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 19.8 m80 69.45 46.47 0.74 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.274 0.559 . . . . 10.0 110.653 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE2' ' HE3' ' A' ' 67' ' ' LYS . 2.0 t80 -179.94 -41.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.389 -0.823 . . . . 10.0 108.915 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 63' ' ' VAL . 55.2 t -73.78 129.26 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.14 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 17.0 pt-20 -71.86 -40.04 69.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.583 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -169.06 -175.92 38.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.753 -0.737 . . . . 10.0 112.63 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.494 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 3.5 m -158.93 172.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.691 0.282 . . . . 10.0 110.283 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.453 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 30.7 pt -161.33 144.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.813 0.34 . . . . 10.0 111.344 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -88.71 137.64 32.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.894 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.4 tp -169.07 140.09 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 49.07 46.92 22.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.264 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.37 40.32 76.14 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.912 -0.661 . . . . 10.0 112.729 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.8 tpt85 -168.92 128.06 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.686 0.279 . . . . 10.0 110.366 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -88.99 123.68 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.236 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.457 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.2 pp -89.18 134.34 33.31 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 116.563 -0.29 . . . . 10.0 110.788 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 60' ' ' ILE . 66.0 Cg_endo -98.15 117.72 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.203 2.602 . . . . 10.0 113.634 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.423 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 18.5 m -97.12 133.64 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 109.084 -0.71 . . . . 10.0 109.084 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 68.0 t -141.3 159.9 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.783 0.801 . . . . 10.0 113.079 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.773 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.4 m120 -76.61 66.9 2.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.819 -1.082 . . . . 10.0 109.052 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.788 ' O ' HG22 ' A' ' 68' ' ' ILE . 6.3 tt -50.05 -26.46 4.4 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.705 -0.68 . . . . 10.0 111.404 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.656 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -64.91 -27.71 69.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.671 -0.412 . . . . 10.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.773 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -88.4 -36.92 16.27 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.015 -0.365 . . . . 10.0 110.015 178.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.5 tt -61.18 -37.7 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.645 HD12 ' CG2' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -77.88 -40.51 39.75 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 113.278 -1.783 . . . . 10.0 109.598 177.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.541 ' C ' HG12 ' A' ' 71' ' ' ILE . . . 112.3 -102.54 1.36 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 116.07 -0.514 . . . . 10.0 112.961 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.645 ' CG2' HD12 ' A' ' 69' ' ' LEU . 6.5 pt 45.98 -179.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 113.088 0.773 . . . . 10.0 113.088 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.653 ' O ' ' O ' ' A' ' 73' ' ' PHE . 72.1 m -57.52 -98.6 0.0 OUTLIER 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.62 -1.622 . . . . 10.0 106.62 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.67 ' HE2' ' N ' ' A' ' 67' ' ' LYS . 1.4 t80 50.65 138.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 119.22 -0.992 . . . . 10.0 113.357 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -159.55 27.39 0.19 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.71 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 66.89 -48.63 0.47 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.13 0.789 . . . . 10.0 113.13 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -38.89 -42.49 0.85 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 77' ' ' LYS . 32.1 mmtp -79.5 -39.7 31.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.947 0.404 . . . . 10.0 111.395 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.53 ' HG3' ' HA ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -47.33 135.21 10.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.902 0.705 . . . . 10.0 112.902 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 78' ' ' MET . 36.7 mtmm -164.43 32.57 0.07 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.91 -1.041 . . . . 10.0 109.624 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.7 t -169.12 151.25 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.274 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.5 mt -120.16 143.08 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.998 0.427 . . . . 10.0 111.985 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.563 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 4.2 mt -111.67 123.48 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.971 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.9 t -92.86 148.13 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.973 0.416 . . . . 10.0 111.008 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -143.91 -175.87 4.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.69 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.57 ' O ' ' CG2' ' A' ' 86' ' ' THR . 15.3 tpp85 -133.3 160.84 36.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.381 -0.6 . . . . 10.0 109.381 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.684 ' OG1' ' HB ' ' A' ' 89' ' ' VAL . 18.9 p -169.06 100.0 0.37 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.293 0.568 . . . . 10.0 112.018 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HA ' ' CE ' ' A' ' 87' ' ' LYS . 2.2 tpmt? 43.99 46.41 6.92 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.002 -0.999 . . . . 10.0 110.55 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 11.6 m-20 82.8 31.96 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.69 -1.141 . . . . 10.0 111.713 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.684 ' HB ' ' OG1' ' A' ' 86' ' ' THR . 44.4 t -130.03 112.12 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.26 -0.882 . . . . 10.0 109.261 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 12.2 mt-10 -88.36 99.91 12.61 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.176 -1.787 . . . . 10.0 106.176 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.506 HG21 HG11 ' A' ' 89' ' ' VAL . 2.6 t -88.77 159.54 2.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 113.91 -1.495 . . . . 10.0 112.106 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -127.89 154.22 19.67 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.546 -0.835 . . . . 10.0 113.415 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -144.62 128.64 17.54 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 120.722 0.296 . . . . 10.0 110.71 -179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.465 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 65.1 tp -88.67 134.39 33.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.228 0.537 . . . . 10.0 111.698 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.53 ' HA ' ' HG3' ' A' ' 78' ' ' MET . 35.6 m -147.93 -175.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.936 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -105.11 -65.2 1.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.317 0.488 . . . . 10.0 112.317 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -130.65 120.36 23.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.754 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.57 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.5 p -108.1 115.06 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-O 122.245 1.022 . . . . 10.0 111.621 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -64.95 -29.94 70.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.272 -1.786 . . . . 10.0 111.114 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 91.89 -124.43 7.65 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.646 -0.787 . . . . 10.0 111.321 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.43 134.1 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 117.01 0.405 . . . . 10.0 110.549 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.583 ' HG ' HG12 ' A' ' 104' ' ' ILE . 59.8 tp -135.7 139.92 44.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.199 0.523 . . . . 10.0 111.178 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 27.1 ptt180 -88.91 71.63 8.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.67 -0.696 . . . . 10.0 110.407 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.735 ' HB ' HG11 ' A' ' 13' ' ' VAL . 17.8 mm -88.75 133.14 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 18.2 p -88.84 -175.94 5.04 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.395 -0.965 . . . . 10.0 108.395 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.459 ' CD ' ' HB2' ' A' ' 109' ' ' LEU . 37.9 tt0 -147.31 77.4 1.44 Allowed 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.128 -1.029 . . . . 10.0 112.808 -177.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -102.02 17.59 22.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.665 -1.152 . . . . 10.0 109.23 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -118.48 -49.26 2.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.574 -0.739 . . . . 10.0 111.133 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.459 ' HB2' ' CD ' ' A' ' 106' ' ' GLU . 27.9 mt -63.16 141.12 58.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.616 -0.266 . . . . 10.0 110.335 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 65.0 t0 -165.52 134.21 3.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.625 -0.261 . . . . 10.0 110.658 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 110' ' ' ASP . 79.9 mt 70.63 -49.16 0.66 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.3 -0.409 . . . . 10.0 111.001 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.1 t -176.11 46.35 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.164 0.507 . . . . 10.0 110.126 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 66.4 124.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.633 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 115' ' ' SER . 46.5 t -72.75 -50.38 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.885 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 66.3 m 71.89 40.7 0.73 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.152 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 1.8 m-20 -146.59 92.88 2.21 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.721 -0.672 . . . . 10.0 111.395 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.56 ' HB2' ' CA ' ' A' ' 124' ' ' GLY . 32.8 mmtp -159.96 -46.12 0.05 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.687 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.511 ' CE1' HD23 ' A' ' 69' ' ' LEU . 39.7 t80 -67.22 -53.42 30.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.193 0.521 . . . . 10.0 110.315 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 143.92 45.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.821 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 62.31 52.34 3.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.055 0.455 . . . . 10.0 110.314 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -141.56 -35.75 0.45 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 10.0 111.369 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.718 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 97.2 p -147.63 -159.95 1.1 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.764 -0.198 . . . . 10.0 110.514 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.522 ' HD2' ' HB2' ' A' ' 137' ' ' ASP . 2.0 tpmt? -64.64 -52.76 55.69 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.719 -0.392 . . . . 10.0 110.723 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.56 ' CA ' ' HB2' ' A' ' 117' ' ' LYS . . . 155.91 153.93 6.77 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.111 -1.519 . . . . 10.0 114.927 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 126' ' ' VAL . 2.8 tm? -68.95 140.35 55.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.051 -0.575 . . . . 10.0 109.912 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.596 ' O ' ' O ' ' A' ' 133' ' ' ILE . 2.4 p -123.48 152.77 28.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.707 0.765 . . . . 10.0 112.111 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -141.41 135.53 30.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.651 ' O ' ' HB2' ' A' ' 131' ' ' ARG . 8.5 m -164.11 137.79 5.41 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.167 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 65.6 t0 60.78 41.99 14.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.89 0.376 . . . . 10.0 110.459 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.24 30.87 55.9 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.754 -0.938 . . . . 10.0 110.754 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.651 ' HB2' ' O ' ' A' ' 128' ' ' THR . 37.5 mmt180 -117.17 133.46 55.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.263 -0.469 . . . . 10.0 111.024 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 57.1 tp -88.91 79.55 7.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.11 -0.496 . . . . 10.0 110.143 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.596 ' O ' ' O ' ' A' ' 126' ' ' VAL . 4.0 mt -88.99 148.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 10.0 111.828 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.586 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.4 mp -103.32 129.27 55.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 N-CA-C 108.69 -0.856 . . . . 10.0 108.69 177.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.441 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 40.5 t80 -117.09 144.51 44.59 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.02 -0.672 . . . . 10.0 111.615 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.718 ' HG ' ' HB2' ' A' ' 122' ' ' SER . 8.5 mp -137.61 169.06 18.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.18 -0.918 . . . . 10.0 111.852 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.522 ' HB2' ' HD2' ' A' ' 123' ' ' LYS . 34.0 t70 -136.58 21.76 3.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.705 -1.134 . . . . 10.0 108.34 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.807 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 13.0 tt 43.76 17.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.173 -1.376 . . . . 10.0 113.824 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.574 ' O ' HG22 ' A' ' 142' ' ' ILE . 8.6 t0 -81.48 -59.11 2.74 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.627 0.603 . . . . 10.0 112.627 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.2 mptt -76.55 -34.18 58.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.613 0.721 . . . . 10.0 109.895 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.807 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.27 -46.0 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.835 -1.075 . . . . 10.0 110.63 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.69 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.5 tp -62.89 -43.2 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 120.254 -0.578 . . . . 10.0 109.725 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -47.11 -46.47 23.0 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.03 -36.89 85.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.25 -0.887 . . . . 10.0 110.298 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 141' ' ' ILE . 23.3 mt -54.71 -41.12 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 120.896 0.379 . . . . 10.0 110.948 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.7 p -80.44 -50.3 10.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.636 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.78 9.24 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 46' ' ' ARG . 22.8 ttpp -46.92 -47.6 21.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.596 0.236 . . . . 10.0 111.613 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 62.61 141.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.874 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -170.33 48.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.656 -0.783 . . . . 10.0 112.526 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.792 0.33 . . . . 10.0 111.042 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ttt . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 110.333 -0.247 . . . . 10.0 110.333 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.581 ' O ' ' CG2' ' A' ' 3' ' ' THR . 31.6 mmmt -68.38 -47.39 67.5 Favored 'General case' 0 C--N 1.334 -0.087 0 O-C-N 122.184 -0.322 . . . . 10.0 111.166 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.581 ' CG2' ' O ' ' A' ' 2' ' ' LYS . 14.3 t 60.83 -39.92 0.1 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.636 0.774 . . . . 10.0 113.014 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.462 ' N ' HG23 ' A' ' 3' ' ' THR . 3.5 pp -58.52 -32.1 68.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.38 . . . . 10.0 110.767 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.455 ' N ' ' CD1' ' A' ' 4' ' ' LEU . . . -64.61 138.91 58.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.084 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -169.78 128.66 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 10.0 111.03 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 169.41 140.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.748 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.481 HD13 ' CD1' ' A' ' 111' ' ' LEU . 30.7 mt 62.79 54.48 2.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.102 0.477 . . . . 10.0 111.329 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.492 ' HD2' ' HG3' ' A' ' 10' ' ' GLU . 6.3 tmtm? -136.71 -47.02 0.6 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.508 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 45.5 mt-10 -140.71 164.25 30.69 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.004 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.642 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 9.9 t80 -160.11 139.49 11.0 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.567 -0.742 . . . . 10.0 112.789 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 23.5 tp10 -88.68 133.99 34.04 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.778 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.6 p -152.93 166.94 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 113.967 1.099 . . . . 10.0 113.967 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.579 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.2 tm? -88.94 134.54 33.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.158 -0.928 . . . . 10.0 108.657 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.552 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 40.5 t -148.56 158.04 43.86 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.772 0.796 . . . . 10.0 112.687 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.595 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -148.35 165.61 30.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.182 -1.372 . . . . 10.0 110.411 -178.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG3' HD21 ' A' ' 99' ' ' LEU . 56.6 mt-10 -88.65 133.22 34.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 73' ' ' PHE . 35.0 mm -132.06 95.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.437 -177.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 26.8 m-20 42.45 60.18 2.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.676 -0.693 . . . . 10.0 112.525 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.1 mt-10 85.72 -44.77 0.06 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.39 -0.823 . . . . 10.0 111.621 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -89.03 145.36 25.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.572 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.58 168.14 12.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.986 0.422 . . . . 10.0 111.089 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.541 ' HG ' ' CZ ' ' A' ' 16' ' ' PHE . 0.9 OUTLIER -147.11 135.04 21.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.586 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -137.56 152.91 49.94 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.999 0.741 . . . . 10.0 112.999 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.2 m-85 -135.16 142.76 46.2 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.146 -0.934 . . . . 10.0 108.814 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' HZ ' ' A' ' 11' ' ' PHE . 12.7 p-10 -52.43 122.05 8.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.271 0.558 . . . . 10.0 111.328 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 14' ' ' LEU . 27.2 m -61.27 -14.7 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.44 -0.8 . . . . 10.0 110.653 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.43 -44.51 94.35 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.184 0.516 . . . . 10.0 109.829 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.429 ' ND2' HG23 ' A' ' 138' ' ' ILE . 21.7 t-20 -89.57 -42.52 11.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 10.0 110.566 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.405 HG21 ' O ' ' A' ' 83' ' ' VAL . 26.8 mm -62.45 130.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.865 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 32' ' ' MET . 52.0 mm-40 -85.79 -68.97 0.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.33 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.6 mtm -169.21 156.02 6.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.148 0.499 . . . . 10.0 111.609 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.407 ' HB ' HG11 ' A' ' 98' ' ' VAL . 34.6 m -88.88 159.1 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.567 -0.742 . . . . 10.0 111.304 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.403 HG13 ' HB ' ' A' ' 81' ' ' ILE . 23.1 pt -151.55 162.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.963 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -88.83 146.58 24.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.174 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -88.9 130.32 35.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.297 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.7 t 177.29 136.15 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.64 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t0 45.8 70.49 0.36 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 10.0 110.99 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.522 ' CG2' ' N ' ' A' ' 40' ' ' THR . 14.0 mt -141.51 158.1 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.475 0.655 . . . . 10.0 112.528 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.531 ' CG2' ' CD ' ' A' ' 43' ' ' PRO . 82.2 m -38.69 117.85 1.03 Allowed Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 114.624 -1.171 . . . . 10.0 111.55 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.47 -65.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.625 2.217 . . . . 10.0 112.865 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.562 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 10.4 p -176.19 56.22 0.13 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.411 -0.359 . . . . 10.0 111.621 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 42' ' ' VAL . 8.6 Cg_exo -71.76 -34.07 9.41 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.93 2.42 . . . . 10.0 111.861 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.3 -136.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.241 -0.652 . . . . 10.0 109.241 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.7 t 65.83 48.0 1.95 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.856 0.36 . . . . 10.0 110.969 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' ND1' ' A' ' 47' ' ' HIS . 16.1 tpp85 -170.93 -70.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.842 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.46 ' ND1' ' O ' ' A' ' 46' ' ' ARG . 41.7 m80 -155.95 -172.14 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 10.0 110.797 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 48' ' ' PHE . 45.8 t80 -68.83 60.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.751 -0.659 . . . . 10.0 111.065 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 51' ' ' GLY . 38.4 t -128.43 128.56 68.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 10.0 111.19 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 9.8 pt-20 -75.77 -38.54 58.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.571 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.433 ' O ' ' CG1' ' A' ' 49' ' ' VAL . . . -144.22 -177.04 18.78 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 120.183 -1.008 . . . . 10.0 113.095 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.53 ' H ' ' HB ' ' A' ' 40' ' ' THR . 3.4 m -160.08 175.32 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.519 HG13 HG13 ' A' ' 60' ' ' ILE . 2.2 pp -155.94 137.72 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 10.0 111.251 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.424 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 25.7 t-20 -88.97 135.1 33.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.663 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 54' ' ' ASN . 83.1 mt -161.68 135.74 6.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.294 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 55' ' ' LEU . 16.3 ptm180 45.84 46.87 12.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.196 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.33 41.4 87.32 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.96 -0.638 . . . . 10.0 112.886 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -158.88 124.0 4.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.838 0.351 . . . . 10.0 110.552 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.484 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -93.94 132.91 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.148 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.523 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.4 pp -111.12 136.95 20.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.407 -0.361 . . . . 10.0 110.839 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 89.0 Cg_endo -82.95 119.61 2.89 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.678 2.252 . . . . 10.0 113.483 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.402 ' O ' HG21 ' A' ' 62' ' ' VAL . 35.9 m -95.75 138.51 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.427 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 94.5 t -139.88 151.44 22.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.715 0.769 . . . . 10.0 112.581 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -78.57 67.44 4.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.688 -1.142 . . . . 10.0 109.668 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.9 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.3 tt -52.78 -38.56 61.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.305 -0.861 . . . . 10.0 111.2 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.575 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -53.34 -24.29 11.62 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.314 -0.554 . . . . 10.0 109.711 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.562 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -85.51 -48.37 9.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.784 -0.643 . . . . 10.0 110.307 178.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.9 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.2 tt -54.42 -38.85 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 107.867 -1.16 . . . . 10.0 107.867 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.62 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -79.65 -51.05 9.74 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 113.52 -1.673 . . . . 10.0 109.684 177.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.535 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 118.64 -86.38 0.4 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.879 -0.601 . . . . 10.0 112.508 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.897 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.5 pt 46.55 165.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 113.115 0.783 . . . . 10.0 113.115 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.5 m -47.8 -35.26 9.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.897 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.7 t80 -27.63 140.56 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.757 -1.11 . . . . 10.0 112.578 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 8.8 t70 -143.99 30.45 1.3 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.154 0.502 . . . . 10.0 110.815 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.42 ' HA ' ' CE1' ' A' ' 73' ' ' PHE . 49.0 mt-10 66.69 -51.57 0.45 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.15 0.796 . . . . 10.0 113.15 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -44.84 -42.78 8.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.274 0.842 . . . . 10.0 113.274 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.52 ' NZ ' ' HB3' ' A' ' 77' ' ' LYS . 6.3 mtpm? -81.53 10.63 5.57 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.441 0.904 . . . . 10.0 113.441 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.438 ' CE ' ' CE1' ' A' ' 73' ' ' PHE . 33.8 mmt -68.11 145.4 54.43 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.205 -0.309 . . . . 10.0 111.005 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 54.9 mtpt -158.84 -50.43 0.06 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.654 0.264 . . . . 10.0 111.634 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.5 t -88.88 -176.03 5.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 10.0 111.615 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.448 HG12 HD11 ' A' ' 94' ' ' LEU . 47.0 mt -145.38 159.24 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.87 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 13.2 mt -136.62 141.33 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.405 ' O ' HG21 ' A' ' 30' ' ' ILE . 61.5 t -117.79 153.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.583 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -158.51 176.86 11.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.309 -0.405 . . . . 10.0 111.267 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.507 ' O ' ' HD3' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -134.64 135.3 42.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.841 178.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.47 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 72.9 p -148.99 110.83 4.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 87' ' ' LYS . 21.9 ttmm 47.31 48.52 16.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.346 0.593 . . . . 10.0 110.949 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 72.39 33.21 1.5 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.094 -0.957 . . . . 10.0 111.461 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 91' ' ' VAL . 57.5 t -130.19 111.04 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.199 -0.91 . . . . 10.0 109.097 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 66.4 mt-10 -88.38 97.75 11.23 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 106.177 -1.786 . . . . 10.0 106.177 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 89' ' ' VAL . 3.9 t -88.75 153.87 3.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 113.334 -1.757 . . . . 10.0 113.234 -174.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -128.74 143.5 14.51 Favored Glycine 0 C--N 1.316 -0.577 0 CA-C-N 114.586 -1.188 . . . . 10.0 113.044 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.537 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.6 OUTLIER -131.61 125.55 32.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.811 0.338 . . . . 10.0 110.24 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.476 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 40.1 tp -88.6 130.88 35.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.023 0.44 . . . . 10.0 110.835 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.475 HG13 ' CE2' ' A' ' 16' ' ' PHE . 28.1 m -137.01 -175.09 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.964 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 59.7 t0 -89.01 -76.6 0.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.29 0.567 . . . . 10.0 110.998 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -131.75 113.22 13.28 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.115 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.595 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.9 p -95.88 115.85 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 122.408 1.099 . . . . 10.0 111.772 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -68.1 -28.24 67.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.044 -1.889 . . . . 10.0 111.043 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.92 -123.24 6.88 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.633 -0.794 . . . . 10.0 111.824 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.9 m -51.07 133.05 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.799 0.3 . . . . 10.0 111.03 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.588 ' HG ' HG12 ' A' ' 104' ' ' ILE . 57.4 tp -137.77 139.79 40.24 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.08 0.467 . . . . 10.0 111.211 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 16.2 ptm180 -88.84 73.6 8.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.592 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.778 ' HB ' HG11 ' A' ' 13' ' ' VAL . 16.4 mm -88.79 165.28 2.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 25.4 p -124.61 -176.0 3.42 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.764 -1.199 . . . . 10.0 107.764 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.51 ' HG3' ' HB2' ' A' ' 109' ' ' LEU . 87.7 tt0 -137.04 67.05 1.45 Allowed 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.258 -0.977 . . . . 10.0 112.045 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -104.8 26.11 9.56 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.462 -1.245 . . . . 10.0 109.035 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 106' ' ' GLU . 3.0 pm0 -154.99 -30.82 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.51 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 43.7 mt -63.2 -47.49 82.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.003 0.372 . . . . 10.0 112.003 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 111' ' ' LEU . 23.0 t70 -158.48 -131.38 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.946 -0.301 . . . . 10.0 111.122 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 110' ' ' ASP . 24.9 tp 70.41 -46.44 0.62 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.96 0.345 . . . . 10.0 111.609 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.2 t 178.99 -33.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.253 0.549 . . . . 10.0 110.327 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -57.06 -76.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.446 -0.797 . . . . 10.0 111.18 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.8 t 60.35 111.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.148 0.499 . . . . 10.0 110.777 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.7 t -176.61 140.1 0.34 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.059 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 11.0 p-10 -53.95 -39.33 65.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.97 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER 69.99 -59.29 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.217 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.515 ' CE2' HD23 ' A' ' 69' ' ' LEU . 51.6 t80 -71.8 -51.56 21.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.053 0.454 . . . . 10.0 110.159 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 120' ' ' LYS . . . 166.45 -49.36 0.26 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.604 -0.725 . . . . 10.0 112.012 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER 171.97 -33.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.044 0.45 . . . . 10.0 110.405 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -54.89 -46.45 74.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.754 -0.657 . . . . 10.0 111.257 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.502 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 80.9 p -116.13 -128.63 0.29 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.864 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 116' ' ' ASP . 59.5 tptt -173.08 -35.72 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.728 0.64 . . . . 10.0 112.728 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -85.94 148.84 22.74 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.132 -1.033 . . . . 10.0 113.895 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.513 ' CB ' ' HB3' ' A' ' 117' ' ' LYS . 2.4 tm? -161.23 142.38 11.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.004 -0.739 . . . . 10.0 109.004 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.544 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.0 OUTLIER -160.37 164.46 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.051 0.453 . . . . 10.0 111.667 -177.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 22.2 pttp -163.65 133.92 4.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.546 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.579 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 14.0 m -167.09 156.43 10.55 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.369 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.4 ' N ' ' CG2' ' A' ' 128' ' ' THR . 62.7 m-20 59.94 45.76 11.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.967 0.413 . . . . 10.0 110.84 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.0 28.23 11.97 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.615 -0.802 . . . . 10.0 111.914 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 128' ' ' THR . 14.8 ptt180 -139.33 132.82 30.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 3.9 mp -88.82 136.68 32.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.937 0.399 . . . . 10.0 111.546 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.572 HG12 ' CB ' ' A' ' 22' ' ' ALA . 3.6 mt -126.52 129.56 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.936 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.536 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.4 mp -88.82 141.36 14.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 N-CA-C 108.934 -0.765 . . . . 10.0 108.934 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.479 ' O ' ' CA ' ' A' ' 124' ' ' GLY . 42.3 t80 -124.8 146.2 49.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.28 0.562 . . . . 10.0 111.325 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.514 ' CD2' HG21 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -144.39 141.08 29.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.761 0.652 . . . . 10.0 112.761 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.412 ' O ' HG21 ' A' ' 138' ' ' ILE . 55.6 p30 -105.8 25.37 10.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.228 -0.896 . . . . 10.0 108.896 177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.87 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 15.3 tt 41.19 16.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 114.346 1.239 . . . . 10.0 114.346 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.503 ' O ' HG22 ' A' ' 142' ' ' ILE . 38.2 t70 -79.69 -61.21 2.07 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.085 0.772 . . . . 10.0 113.085 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -74.91 -30.54 61.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.535 0.684 . . . . 10.0 110.567 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.87 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.25 -48.4 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.972 -1.013 . . . . 10.0 110.606 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.616 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.4 tp -62.19 -45.75 98.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 120.213 -0.595 . . . . 10.0 110.209 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -47.74 -43.68 27.29 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 51.9 mm-40 -71.85 -39.27 69.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.045 -0.979 . . . . 10.0 110.429 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.593 HG13 ' O ' ' A' ' 141' ' ' ILE . 46.8 mt -45.17 -38.48 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-O 120.803 0.335 . . . . 10.0 111.24 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.1 p -97.77 -53.79 3.31 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.21 0.818 . . . . 10.0 113.21 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.6 p -84.2 13.16 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 113.466 0.913 . . . . 10.0 113.466 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.623 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 84.9 tttt -60.97 -42.12 97.71 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.271 -0.572 . . . . 10.0 110.788 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -170.27 135.51 1.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.908 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -178.93 -41.3 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.134 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 10.0 111.096 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.877 0.37 . . . . 10.0 111.209 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -59.99 -44.57 94.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.054 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.3 m 71.5 -49.08 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.833 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' A' ' 5' ' ' ALA . 4.0 pp -62.35 -37.12 84.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.917 0.389 . . . . 10.0 110.448 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.479 ' N ' ' CD1' ' A' ' 4' ' ' LEU . . . -86.5 47.98 1.56 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.283 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -134.39 145.24 48.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 70.5 53.68 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.335 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.5 mt -145.73 53.19 1.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.806 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.472 ' HD2' ' C ' ' A' ' 9' ' ' LYS . 2.6 tmmm? -145.88 -51.81 0.24 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.993 -0.549 . . . . 10.0 109.928 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 88.3 tt0 -138.96 161.14 38.06 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.272 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.592 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 11.0 t80 -165.85 139.48 4.39 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.45 -0.796 . . . . 10.0 112.917 -173.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 16.7 mt-10 -88.82 134.41 33.94 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.711 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -149.05 170.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 113.307 0.854 . . . . 10.0 113.307 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.521 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 3.1 tm? -88.91 132.88 34.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.533 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 86.6 p -143.09 153.64 43.12 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.687 0.756 . . . . 10.0 112.746 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.599 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 0.5 OUTLIER -149.93 160.4 43.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.252 -1.34 . . . . 10.0 110.012 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -88.67 135.98 33.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.353 -0.61 . . . . 10.0 109.353 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.502 HG22 ' CD1' ' A' ' 71' ' ' ILE . 34.8 mm -130.79 81.99 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.361 -0.836 . . . . 10.0 111.34 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.684 ' OD2' ' HA ' ' A' ' 73' ' ' PHE . 19.9 m-20 50.82 60.23 4.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.462 0.542 . . . . 10.0 112.462 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 81.3 mt-10 81.98 -35.89 0.1 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.171 -0.922 . . . . 10.0 111.107 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.455 ' NE2' HD11 ' A' ' 134' ' ' ILE . 37.5 tt0 -88.87 136.71 32.86 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.252 -0.647 . . . . 10.0 109.252 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.537 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.72 162.12 16.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.054 0.454 . . . . 10.0 111.222 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.589 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 1.5 tp -148.63 139.33 22.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.165 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 135' ' ' TYR . . . -143.55 153.56 42.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.927 0.714 . . . . 10.0 112.927 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 13' ' ' VAL . 6.0 m-85 -135.37 140.56 45.1 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.222 -0.899 . . . . 10.0 109.169 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . 47.0 p-10 -49.17 123.3 7.09 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.106 0.479 . . . . 10.0 111.25 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.422 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 31.1 m -62.26 -13.25 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.573 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -61.16 -46.05 92.09 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.031 0.443 . . . . 10.0 110.047 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.41 ' ND2' HG23 ' A' ' 138' ' ' ILE . 16.0 t-20 -89.28 -45.04 9.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.562 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 mm -60.97 120.67 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.234 -0.439 . . . . 10.0 109.906 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 32' ' ' MET . 8.8 pt-20 -81.19 -58.85 2.88 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.198 0.444 . . . . 10.0 112.198 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.458 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -169.12 157.94 8.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.038 0.446 . . . . 10.0 111.725 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.4 m -88.94 152.16 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.697 -0.683 . . . . 10.0 111.508 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 pt -148.35 129.81 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -88.82 128.63 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 10.0 110.241 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.725 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -169.0 165.96 11.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.883 0.373 . . . . 10.0 110.959 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.4 t -154.27 148.61 26.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.176 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 9.8 t70 52.93 47.08 25.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.448 0.642 . . . . 10.0 110.021 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 19.9 mt -59.25 -69.43 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.221 -0.9 . . . . 10.0 112.513 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.599 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 75.4 m -153.84 67.07 5.81 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.99 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -83.51 -49.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.947 2.431 . . . . 10.0 113.942 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.574 ' CG2' ' HD3' ' A' ' 43' ' ' PRO . 18.9 m -74.99 -34.51 1.72 Allowed Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.984 0.735 . . . . 10.0 112.984 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.574 ' HD3' ' CG2' ' A' ' 42' ' ' VAL . 12.9 Cg_exo -69.11 -79.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.98 1.786 . . . . 10.0 112.491 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 45' ' ' SER . 1.3 mmmm -70.83 130.54 41.95 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.879 -0.786 . . . . 10.0 108.879 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 29.1 t -175.87 118.09 0.15 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.237 -0.985 . . . . 10.0 111.571 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 16.5 ptm180 175.82 -47.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.793 -0.64 . . . . 10.0 110.695 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.417 ' CD2' ' HG3' ' A' ' 46' ' ' ARG . 84.3 m-70 -99.35 -152.97 0.42 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.431 . . . . 10.0 111.058 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.508 ' CE2' HG11 ' A' ' 63' ' ' VAL . 3.9 t80 -72.57 -35.02 67.87 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.457 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 44.9 t -54.45 127.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.975 0.417 . . . . 10.0 111.632 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -90.31 -46.84 8.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.579 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.491 ' O ' HG13 ' A' ' 52' ' ' VAL . . . -133.04 -179.08 15.98 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.764 -0.731 . . . . 10.0 112.774 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.599 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.4 m -160.81 168.81 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 CA-C-O 120.848 0.356 . . . . 10.0 110.53 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.466 HG23 HG21 ' A' ' 39' ' ' ILE . 28.5 pt -157.8 147.37 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.319 -0.4 . . . . 10.0 110.719 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -88.66 137.47 32.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.066 0.46 . . . . 10.0 111.305 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -169.07 141.55 2.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.595 -0.73 . . . . 10.0 110.216 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 51.8 ttm-85 51.36 45.75 27.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.174 0.511 . . . . 10.0 110.444 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.68 40.19 69.91 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.789 -0.642 . . . . 10.0 112.725 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -168.71 137.91 2.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 10.0 110.917 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.89 132.62 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.93 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 90' ' ' GLU . 2.1 pp -103.38 139.28 19.97 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 10.0 111.663 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 70.2 Cg_endo -86.09 117.75 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.747 2.298 . . . . 10.0 112.958 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.43 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 35.1 m -96.0 134.84 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.639 -0.504 . . . . 10.0 109.639 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 57.4 t -140.31 156.0 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.561 0.696 . . . . 10.0 112.406 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 67' ' ' LYS . 5.6 m120 -77.16 72.27 3.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.949 -1.023 . . . . 10.0 109.805 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.791 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.1 tt -53.86 -37.55 63.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.308 0.575 . . . . 10.0 110.587 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.649 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -56.75 -25.88 55.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.132 0.492 . . . . 10.0 109.69 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.528 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -82.01 -42.71 18.95 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.243 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.791 HG22 ' O ' ' A' ' 65' ' ' LEU . 7.9 tt -61.84 -37.61 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.613 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 1.1 tm? -78.35 -52.02 9.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 113.738 -1.574 . . . . 10.0 108.92 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.492 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 117.68 -82.87 0.33 Allowed Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.66 -0.7 . . . . 10.0 112.744 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.763 HG13 ' HB3' ' A' ' 73' ' ' PHE . 2.7 pt 45.36 173.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -50.16 -39.25 43.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.433 0.635 . . . . 10.0 109.32 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.763 ' HB3' HG13 ' A' ' 71' ' ' ILE . 4.3 t80 -28.21 145.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.672 -1.149 . . . . 10.0 113.904 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 65.4 t0 -137.63 -52.8 0.65 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.785 -1.098 . . . . 10.0 109.906 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' A' ' 74' ' ' ASP . 16.4 pt-20 163.57 -44.0 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.983 0.421 . . . . 10.0 111.624 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -51.31 -37.63 48.62 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 10.2 mmpt? -74.72 -29.68 61.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.11 0.411 . . . . 10.0 112.11 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.407 ' O ' ' CG ' ' A' ' 79' ' ' LYS . 29.3 mmt -43.84 130.55 5.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.888 0.375 . . . . 10.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 78' ' ' MET . 53.2 mtmt -162.1 -44.89 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.547 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.5 t -88.95 164.29 15.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.495 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.444 HD11 ' HB3' ' A' ' 36' ' ' LYS . 45.4 mt -140.98 125.97 18.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.694 0.283 . . . . 10.0 111.351 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.549 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 6.2 mt -100.42 155.27 4.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.459 -0.337 . . . . 10.0 111.203 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.75 145.66 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.645 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -143.46 -177.06 5.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.474 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 6.5 ptm180 -139.05 128.89 24.88 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.877 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.458 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 69.0 p -142.85 109.69 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.026 0.441 . . . . 10.0 111.914 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 47.8 49.99 16.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.388 0.614 . . . . 10.0 110.753 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 72.91 31.24 1.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.009 -0.996 . . . . 10.0 111.555 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.531 HG11 HG21 ' A' ' 91' ' ' VAL . 66.1 t -126.95 109.74 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.262 -0.881 . . . . 10.0 109.397 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 36.9 tt0 -88.36 99.12 12.01 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.799 -1.926 . . . . 10.0 105.799 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.531 HG21 HG11 ' A' ' 89' ' ' VAL . 5.3 t -88.67 152.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 113.181 -1.827 . . . . 10.0 113.196 -173.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -119.18 153.25 16.95 Favored Glycine 0 C--N 1.315 -0.606 0 CA-C-N 114.381 -1.281 . . . . 10.0 113.156 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -143.95 125.09 14.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.861 0.362 . . . . 10.0 110.559 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.522 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 42.3 tp -88.66 124.74 34.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.124 0.488 . . . . 10.0 110.516 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.465 HG13 ' CD2' ' A' ' 16' ' ' PHE . 17.1 m -132.87 -175.07 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.672 -0.694 . . . . 10.0 110.944 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 17.2 t70 -87.67 -71.79 0.55 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.536 0.684 . . . . 10.0 110.993 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -146.59 112.41 5.69 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.904 -1.044 . . . . 10.0 108.324 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.599 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -89.01 118.26 33.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 122.31 1.053 . . . . 10.0 112.939 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -66.12 -29.29 69.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.031 -1.895 . . . . 10.0 110.923 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.74 -123.43 7.31 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.556 -0.747 . . . . 10.0 111.498 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 m -52.89 136.85 13.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.977 0.389 . . . . 10.0 110.84 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.545 ' HG ' HG12 ' A' ' 104' ' ' ILE . 45.5 tp -139.21 141.89 37.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.17 0.509 . . . . 10.0 111.237 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.3 ptp85 -88.9 71.8 8.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.753 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.711 ' HB ' HG11 ' A' ' 13' ' ' VAL . 15.7 mm -88.75 136.75 22.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 N-CA-C 109.554 -0.536 . . . . 10.0 109.554 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 14.7 p -88.82 -175.76 4.99 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.52 ' HG3' ' HB2' ' A' ' 109' ' ' LEU . 87.0 tt0 -144.34 77.37 1.54 Allowed 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.721 -1.192 . . . . 10.0 113.262 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.41 22.17 16.3 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.414 -1.267 . . . . 10.0 108.173 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.485 ' O ' ' CD2' ' A' ' 109' ' ' LEU . 14.0 pt20 -163.24 59.58 0.18 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.81 -1.086 . . . . 10.0 111.921 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.52 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 89.1 mt -168.69 32.33 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.776 -1.102 . . . . 10.0 110.003 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -55.78 155.35 6.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.32 . . . . 10.0 110.633 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.1 tp -43.24 -49.06 6.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.921 0.391 . . . . 10.0 110.408 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -74.23 -31.63 62.68 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.516 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 61.09 122.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.694 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 115' ' ' SER . 11.5 t -155.46 90.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.781 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 114' ' ' VAL . 72.0 p 174.47 125.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.872 0.368 . . . . 10.0 111.297 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 119' ' ' GLY . 5.4 t70 -68.75 -52.15 33.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.509 . . . . 10.0 109.82 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 117' ' ' LYS . 7.4 mmpt? 66.08 -59.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.354 -0.839 . . . . 10.0 112.275 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.507 ' CE2' HD23 ' A' ' 69' ' ' LEU . 33.4 t80 -103.09 -68.96 0.81 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.949 0.404 . . . . 10.0 110.808 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 162.67 -144.02 9.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.951 -0.643 . . . . 10.0 112.405 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -85.22 58.03 4.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.695 0.283 . . . . 10.0 110.639 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -154.31 -40.05 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.919 0.341 . . . . 10.0 111.919 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 90.2 p -146.09 -142.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.187 -0.205 . . . . 10.0 110.824 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 32.9 mmmt -157.35 -33.48 0.08 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.415 0.524 . . . . 10.0 112.415 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -81.94 144.38 23.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.396 -0.907 . . . . 10.0 113.644 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.522 ' CB ' ' HB3' ' A' ' 117' ' ' LYS . 1.6 tm? -162.38 84.64 0.56 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.195 -0.668 . . . . 10.0 109.195 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 133' ' ' ILE . 1.6 p -88.75 160.93 2.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.179 -0.919 . . . . 10.0 112.389 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.516 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 92.7 mttt -152.27 132.35 13.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.145 -0.934 . . . . 10.0 109.742 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 2.6 m -169.07 152.12 5.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.825 0.345 . . . . 10.0 111.164 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.83 47.95 16.98 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.916 0.389 . . . . 10.0 111.244 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 49.12 30.92 10.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.116 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 128' ' ' THR . 3.5 ptm180 -137.94 136.4 36.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.171 -0.307 . . . . 10.0 110.171 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 132' ' ' LEU . 2.0 mm? -88.88 135.59 33.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.907 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.555 ' O ' HG11 ' A' ' 126' ' ' VAL . 3.9 mt -128.78 131.51 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.864 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.556 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.6 mp -88.87 140.12 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.238 -0.653 . . . . 10.0 109.238 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.481 ' O ' ' CA ' ' A' ' 124' ' ' GLY . 49.0 t80 -128.72 141.45 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.33 0.586 . . . . 10.0 111.282 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 122' ' ' SER . 7.6 mp -136.47 172.51 12.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.823 0.82 . . . . 10.0 112.666 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 137' ' ' ASP . 9.8 t70 -136.36 25.09 3.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.099 -1.41 . . . . 10.0 107.667 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.817 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 10.5 tt 42.6 17.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 114.164 -1.38 . . . . 10.0 114.086 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.566 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.5 t70 -82.33 -62.99 1.47 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.604 0.594 . . . . 10.0 112.604 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -73.93 -30.89 62.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.612 0.72 . . . . 10.0 109.981 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.817 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -69.29 -47.48 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.817 -1.083 . . . . 10.0 110.839 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.653 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.3 tp -60.74 -47.35 93.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 120.313 -0.555 . . . . 10.0 110.206 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -49.14 -43.55 41.83 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.289 0.566 . . . . 10.0 109.62 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 5.7 mm-40 -72.6 -34.81 67.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.192 -0.913 . . . . 10.0 110.898 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 141' ' ' ILE . 33.9 mt -47.93 -46.38 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-O 120.941 0.401 . . . . 10.0 111.093 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 80.6 p -86.25 -50.59 6.85 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.135 0.791 . . . . 10.0 113.135 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.6 p -82.36 13.03 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.537 0.94 . . . . 10.0 113.537 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.487 ' HD3' ' CG ' ' A' ' 48' ' ' PHE . 62.4 tttm -58.87 -59.92 4.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.124 -0.63 . . . . 10.0 111.019 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -89.77 49.19 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 10.0 111.143 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -175.37 44.19 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.688 -0.768 . . . . 10.0 112.375 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 10.0 111.032 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.751 0.31 . . . . 10.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' O ' ' OG1' ' A' ' 3' ' ' THR . 97.1 mttt -60.38 -45.61 92.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.951 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 31.9 p 66.91 -50.87 0.47 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.089 -0.505 . . . . 10.0 112.307 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 5' ' ' ALA . 3.6 pp -47.72 -36.65 11.68 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.678 0.275 . . . . 10.0 111.671 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.47 ' N ' ' CD1' ' A' ' 4' ' ' LEU . . . 48.65 -168.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.404 . . . . 10.0 111.754 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.23 135.42 50.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.939 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.54 137.56 58.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.659 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.5 mt 58.68 47.58 12.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 10.0 111.489 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -64.02 -45.68 87.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.007 0.432 . . . . 10.0 110.464 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 41.8 mt-10 -145.48 164.25 32.16 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.449 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.501 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 16.1 t80 -153.38 141.9 20.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.863 -1.062 . . . . 10.0 112.606 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -88.75 139.27 30.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.538 -0.756 . . . . 10.0 109.174 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.85 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -154.09 169.05 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.395 0.887 . . . . 10.0 113.395 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.53 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 2.9 tm? -88.79 132.26 34.71 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.544 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 94.7 p -140.8 150.35 43.21 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.695 ' HZ ' ' CE1' ' A' ' 25' ' ' PHE . 4.6 p90 -150.71 162.57 40.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.523 -1.217 . . . . 10.0 110.308 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.64 137.73 32.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.123 0.487 . . . . 10.0 109.802 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.615 HG13 HD23 ' A' ' 23' ' ' LEU . 17.8 mm -136.11 99.36 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.642 -0.708 . . . . 10.0 111.289 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.545 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 48.7 m-20 42.0 60.14 2.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.479 -0.782 . . . . 10.0 112.84 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.1 mt-10 86.6 -42.68 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.304 -0.862 . . . . 10.0 112.581 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.464 ' OE1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -89.03 155.7 19.31 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.393 -0.523 . . . . 10.0 110.261 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.586 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.64 165.84 14.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.846 0.355 . . . . 10.0 110.677 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.617 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -152.27 133.05 14.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.329 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -142.83 141.25 31.57 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.356 0.598 . . . . 10.0 112.372 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.695 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -118.0 141.08 48.84 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.248 -1.39 . . . . 10.0 107.248 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.44 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . 12.5 p-10 -45.29 105.85 0.07 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.365 0.602 . . . . 10.0 110.612 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.57 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 6.3 p -51.15 -18.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.212 -0.903 . . . . 10.0 110.685 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.69 -39.29 93.51 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 85' ' ' ARG . 11.7 t30 -84.46 -45.78 12.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.091 -0.959 . . . . 10.0 110.506 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.444 HG23 ' HG ' ' A' ' 14' ' ' LEU . 27.0 mm -63.68 131.92 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.021 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -93.82 -61.19 1.59 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.028 0.381 . . . . 10.0 112.028 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.404 ' HE2' ' HB3' ' A' ' 32' ' ' MET . 9.1 ptp -169.03 161.79 10.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 10.0 111.489 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 33.9 m -88.94 143.1 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.973 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.6 HG13 ' HB ' ' A' ' 81' ' ' ILE . 20.1 pt -126.47 157.36 37.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.572 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -88.82 139.93 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.945 0.402 . . . . 10.0 111.28 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -88.77 134.54 33.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.01 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.443 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 68.6 m -168.91 127.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.472 . . . . 10.0 110.806 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 37' ' ' SER . 57.2 p30 24.73 47.13 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.687 0.617 . . . . 10.0 112.326 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.5 ' CG2' ' N ' ' A' ' 40' ' ' THR . 7.9 mt -64.53 156.72 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.353 0.597 . . . . 10.0 112.086 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.5 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 51.9 m -37.82 94.05 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 114.771 -1.104 . . . . 10.0 112.004 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -93.4 -62.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.032 2.488 . . . . 10.0 113.582 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.581 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 13.6 p -76.46 -33.36 1.19 Allowed Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 42' ' ' VAL . 11.9 Cg_exo -71.06 11.05 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.265 1.977 . . . . 10.0 113.45 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -45.1 159.27 0.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.086 0.469 . . . . 10.0 111.655 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.8 t 179.15 -30.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.554 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 38.6 mmt180 -68.12 50.27 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 45.98 -129.78 1.24 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.484 0.549 . . . . 10.0 112.484 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.579 ' CE2' ' HE3' ' A' ' 67' ' ' LYS . 7.2 t80 -48.31 -34.99 11.44 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.443 ' HB ' ' HB2' ' A' ' 46' ' ' ARG . 60.7 t -45.68 128.22 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 10.0 111.368 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -73.88 -39.78 63.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.668 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.31 -175.8 23.5 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.253 -0.975 . . . . 10.0 113.009 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.418 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.4 m -156.01 171.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.847 0.356 . . . . 10.0 110.605 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.455 HG12 HD13 ' A' ' 60' ' ' ILE . 31.2 pt -157.65 144.24 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.781 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -88.78 132.87 34.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 10.0 111.403 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.4 mt -160.78 140.65 10.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.297 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 49.76 45.89 24.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.962 0.41 . . . . 10.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.15 40.67 84.29 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.866 -0.683 . . . . 10.0 112.607 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -167.77 134.99 2.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 10.0 110.784 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.469 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.92 134.15 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.144 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.3 pp -109.23 132.98 20.93 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.296 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.612 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 95.3 Cg_endo -80.0 121.4 4.47 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.484 2.122 . . . . 10.0 112.815 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.409 ' O ' HG21 ' A' ' 62' ' ' VAL . 35.0 m -93.38 132.08 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.759 -0.655 . . . . 10.0 109.945 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 86.5 t -141.31 162.34 21.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.278 0.561 . . . . 10.0 111.208 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.446 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 4.6 m120 -102.78 85.42 2.56 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.693 -0.685 . . . . 10.0 110.593 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.88 ' O ' HG22 ' A' ' 68' ' ' ILE . 3.2 tt -53.25 -41.34 65.35 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.542 -0.463 . . . . 10.0 110.521 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.669 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -55.6 -24.41 32.81 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.472 -0.491 . . . . 10.0 109.955 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.579 ' HE3' ' CE2' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -86.36 -38.54 17.33 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.01 178.303 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.88 HG22 ' O ' ' A' ' 65' ' ' LEU . 5.7 tt -64.83 -36.16 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 107.481 -1.303 . . . . 10.0 107.481 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.63 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -81.89 -53.74 5.91 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.292 -1.777 . . . . 10.0 108.643 178.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . 116.07 -76.28 0.27 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.801 -1.09 . . . . 10.0 112.182 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.782 HG13 ' HB3' ' A' ' 73' ' ' PHE . 6.5 pt 43.05 -175.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 112.341 0.497 . . . . 10.0 112.341 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 52.5 m -60.33 -39.3 86.58 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.782 ' HB3' HG13 ' A' ' 71' ' ' ILE . 11.4 t80 -26.01 137.14 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.035 -0.984 . . . . 10.0 112.88 177.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.435 ' O ' ' OE2' ' A' ' 75' ' ' GLU . 9.8 t70 -158.72 43.76 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.267 -0.879 . . . . 10.0 109.395 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 1.4 pp20? 37.53 38.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.176 -0.92 . . . . 10.0 112.091 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -87.67 -49.47 7.12 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.786 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.441 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -106.87 -1.85 21.98 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.666 0.617 . . . . 10.0 112.666 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 12.1 mmt -42.07 139.28 1.38 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.71 0.291 . . . . 10.0 111.74 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -177.23 36.19 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.632 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.9 m -169.02 143.73 3.12 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.499 -0.319 . . . . 10.0 110.624 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.6 ' HB ' HG13 ' A' ' 34' ' ' ILE . 67.1 mt -114.26 152.51 15.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 10.0 111.333 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.559 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 14.1 mt -123.98 133.45 69.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.7 t -103.33 150.45 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 10.0 110.83 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -158.08 174.0 15.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.242 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.497 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 6.8 ptm180 -129.28 147.58 51.12 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.206 -0.665 . . . . 10.0 109.206 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.484 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 67.5 p -161.82 109.02 1.38 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.011 0.434 . . . . 10.0 112.081 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 14.9 tppt? 46.8 48.86 14.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.416 0.627 . . . . 10.0 110.809 178.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 20.7 m-20 72.17 33.76 1.51 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 10.0 111.433 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 91' ' ' VAL . 59.0 t -132.18 112.27 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 115.293 -0.867 . . . . 10.0 109.255 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.612 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 73.9 mt-10 -88.22 95.12 10.05 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 89' ' ' VAL . 3.5 t -88.69 152.25 3.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 113.374 -1.739 . . . . 10.0 113.067 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -132.46 143.12 14.69 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.959 -1.019 . . . . 10.0 113.367 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.727 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.3 t80 -131.19 128.64 40.41 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.827 0.346 . . . . 10.0 111.061 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.49 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 58.2 tp -88.8 126.86 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.876 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.526 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 21.6 m -132.01 -175.22 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.693 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.441 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 44.1 t0 -87.98 -74.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.362 0.601 . . . . 10.0 111.273 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -130.7 117.42 19.43 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.166 -0.925 . . . . 10.0 108.521 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.591 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -101.05 116.6 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 122.484 1.135 . . . . 10.0 112.073 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -65.09 -29.27 70.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.002 -1.908 . . . . 10.0 110.801 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.3 -127.33 8.64 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.825 -0.702 . . . . 10.0 111.718 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.3 t -51.25 132.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 117.011 0.406 . . . . 10.0 110.472 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.589 ' HG ' HG12 ' A' ' 104' ' ' ILE . 59.0 tp -137.09 138.86 40.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.027 0.441 . . . . 10.0 111.358 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.647 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.84 72.57 8.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.678 -0.692 . . . . 10.0 110.823 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.85 ' HB ' HG11 ' A' ' 13' ' ' VAL . 16.3 mm -88.78 133.3 31.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 N-CA-C 109.654 -0.498 . . . . 10.0 109.654 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 19.2 p -88.81 149.72 23.27 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -128.41 80.03 1.94 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 113.697 0.999 . . . . 10.0 113.697 -175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -97.69 2.75 50.06 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.59 -1.186 . . . . 10.0 107.896 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -84.23 -58.84 2.59 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 114.885 -1.052 . . . . 10.0 110.946 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 110' ' ' ASP . 12.1 mt -57.73 -61.22 2.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.773 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.424 ' HB3' ' ND2' ' A' ' 113' ' ' ASN . 38.5 t70 45.13 101.42 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.25 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 112' ' ' THR . 3.1 mm? 68.64 -61.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.923 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 111' ' ' LEU . 8.4 t 167.59 43.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.76 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 110' ' ' ASP . 80.2 m-20 -69.95 -52.14 26.92 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.881 -0.328 . . . . 10.0 111.192 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.7 t 67.56 113.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.152 0.501 . . . . 10.0 110.464 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.0 m -123.53 136.49 54.58 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.644 -0.707 . . . . 10.0 111.1 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 122' ' ' SER . 56.6 m-20 -60.23 -51.85 67.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.169 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.491 ' HA ' ' NZ ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER 60.84 33.5 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 10.0 111.135 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.552 ' CE2' ' CD2' ' A' ' 69' ' ' LEU . 26.0 t80 -175.6 -41.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.167 0.508 . . . . 10.0 109.969 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.77 36.07 38.22 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.527 -0.761 . . . . 10.0 111.9 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.423 ' HB3' ' CD1' ' A' ' 118' ' ' PHE . 87.7 tttt 178.86 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.629 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 10.5 tppt? -130.47 -68.43 0.69 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.441 -0.504 . . . . 10.0 112.066 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.485 ' HB3' HD13 ' A' ' 136' ' ' LEU . 38.1 t 174.78 -79.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.88 0.372 . . . . 10.0 110.588 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.637 ' O ' ' N ' ' A' ' 125' ' ' LEU . 85.9 tttt 43.08 48.65 5.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 10.0 112.063 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.485 ' HA2' ' CB ' ' A' ' 117' ' ' LYS . . . -56.77 72.72 0.01 OUTLIER Glycine 0 C--N 1.329 0.162 0 N-CA-C 111.021 -0.832 . . . . 10.0 111.021 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.637 ' N ' ' O ' ' A' ' 123' ' ' LYS . 1.3 tm? -42.58 138.28 1.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.417 0.627 . . . . 10.0 111.776 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.516 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.0 OUTLIER -146.65 160.22 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.954 -1.021 . . . . 10.0 110.81 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.482 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 1.0 OUTLIER -160.5 133.42 6.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.361 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.505 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 10.2 m -161.61 148.33 14.28 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.634 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.12 42.73 27.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.036 0.446 . . . . 10.0 110.761 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.16 36.16 51.49 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.736 -0.745 . . . . 10.0 112.059 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 128' ' ' THR . 5.0 ptp180 -132.86 139.71 47.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.639 0.257 . . . . 10.0 110.442 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 132' ' ' LEU . 2.3 mm? -88.78 139.33 30.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.875 0.369 . . . . 10.0 110.848 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.586 HG12 ' CB ' ' A' ' 22' ' ' ALA . 3.8 mt -150.85 143.44 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.413 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 23' ' ' LEU . 11.8 mt -111.82 122.62 66.49 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.745 0 N-CA-C 109.11 -0.7 . . . . 10.0 109.11 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.44 ' OH ' ' HB3' ' A' ' 26' ' ' ASP . 16.4 t80 -100.99 172.53 6.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.529 HD12 HD11 ' A' ' 65' ' ' LEU . 4.1 tt -169.01 128.07 1.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.437 -0.505 . . . . 10.0 111.12 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.3 p-10 -91.12 16.2 10.21 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.191 0.441 . . . . 10.0 112.191 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.896 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 20.5 tt 42.33 18.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 113.908 1.077 . . . . 10.0 113.908 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.9 t0 -76.33 -56.19 4.86 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.94 0.719 . . . . 10.0 112.94 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 34.4 mmtp -80.1 -28.6 39.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.936 0.398 . . . . 10.0 110.997 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.896 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.5 -46.45 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.095 -0.502 . . . . 10.0 109.973 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.589 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 8.0 tp -65.04 -46.6 90.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 120.322 -0.551 . . . . 10.0 110.315 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -48.56 -40.02 25.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 54.8 mm-40 -76.47 -34.86 58.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.838 -1.074 . . . . 10.0 110.729 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.639 HG13 ' O ' ' A' ' 141' ' ' ILE . 43.4 mt -48.97 -38.91 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 120.971 0.415 . . . . 10.0 110.824 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 79.5 p -88.66 -51.75 5.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.968 0.729 . . . . 10.0 112.968 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.83 13.15 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.232 0.827 . . . . 10.0 113.232 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.573 ' HG2' ' CD2' ' A' ' 48' ' ' PHE . 28.0 tptp -57.45 -41.96 81.55 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.668 -0.413 . . . . 10.0 111.248 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -166.2 139.62 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.401 . . . . 10.0 111.014 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -176.39 41.94 0.11 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.78 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 10.0 110.943 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.82 0.343 . . . . 10.0 111.159 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.54 -47.9 81.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.087 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.4 m 68.18 -60.67 0.41 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.297 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' A' ' 5' ' ' ALA . 4.2 pp -61.49 -42.14 98.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.553 -0.294 . . . . 10.0 111.076 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.475 ' N ' ' CD1' ' A' ' 4' ' ' LEU . . . 44.14 64.63 1.24 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.135 0.42 . . . . 10.0 112.135 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -73.15 124.7 26.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.739 0.304 . . . . 10.0 110.851 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.66 -52.78 41.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.48 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt 51.34 44.2 29.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.162 0.506 . . . . 10.0 110.988 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -158.09 -47.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.624 -0.716 . . . . 10.0 110.19 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 95.1 mt-10 -140.8 164.28 30.64 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.509 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.545 ' CE2' ' OH ' ' A' ' 135' ' ' TYR . 18.5 t80 -140.49 125.28 18.17 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 114.363 1.246 . . . . 10.0 114.363 -174.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -88.98 125.75 35.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.688 -1.967 . . . . 10.0 105.688 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.7 HG11 ' HB ' ' A' ' 104' ' ' ILE . 5.8 p -150.79 167.74 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 114.439 1.274 . . . . 10.0 114.439 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.544 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.3 tm? -88.77 133.58 34.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.051 -1.092 . . . . 10.0 108.051 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.574 ' O ' HG21 ' A' ' 98' ' ' VAL . 57.1 p -144.89 158.11 43.91 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.749 0.785 . . . . 10.0 112.99 -177.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.602 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 2.1 p90 -152.97 156.8 39.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.147 -1.388 . . . . 10.0 109.996 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -88.67 106.39 18.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.363 0.602 . . . . 10.0 110.203 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.534 HG13 HD23 ' A' ' 23' ' ' LEU . 36.5 mm -88.89 102.51 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.173 -0.921 . . . . 10.0 110.973 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.583 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 12.2 p-10 32.92 60.33 0.41 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.094 1.146 . . . . 10.0 114.094 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 103.03 -51.3 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.07 0.948 . . . . 10.0 112.712 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.443 ' NE2' ' HB3' ' A' ' 72' ' ' SER . 1.6 pm0 -88.8 -175.73 4.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.695 -0.402 . . . . 10.0 110.363 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.531 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -112.83 159.83 18.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.104 0.478 . . . . 10.0 111.815 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.573 ' HB3' ' CE2' ' A' ' 16' ' ' PHE . 3.4 tp -150.4 136.72 18.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.951 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -138.77 152.5 47.98 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.335 0.865 . . . . 10.0 113.335 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.7 m-85 -131.95 142.32 49.59 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.128 -0.942 . . . . 10.0 109.322 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' OD2' ' HB3' ' A' ' 28' ' ' ASP . 21.4 t0 -52.48 123.28 10.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.152 0.501 . . . . 10.0 110.415 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 14' ' ' LEU . 33.2 m -63.69 -8.61 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 10.0 112.141 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.527 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 38.9 t70 -66.64 -47.4 72.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.533 -0.467 . . . . 10.0 109.833 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.427 ' ND2' HG23 ' A' ' 138' ' ' ILE . 19.2 t-20 -84.42 -44.43 13.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.637 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.3 mm -60.46 125.79 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.275 -0.421 . . . . 10.0 110.315 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.405 ' HB3' ' CE ' ' A' ' 32' ' ' MET . 44.5 mt-10 -85.28 -62.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.58 -0.282 . . . . 10.0 111.435 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.405 ' CE ' ' HB3' ' A' ' 31' ' ' GLU . 1.2 pmm? -169.11 156.95 7.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.036 0.446 . . . . 10.0 111.322 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.93 161.66 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.761 -0.654 . . . . 10.0 111.547 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 34' ' ' ILE . 22.3 pt -158.06 133.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.502 -0.772 . . . . 10.0 110.742 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.8 63.82 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.326 0.584 . . . . 10.0 110.845 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.487 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 14.5 mmmm -88.98 153.13 21.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.341 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.9 m -156.73 150.25 24.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.422 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.1 t0 51.11 43.36 29.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.349 0.595 . . . . 10.0 110.542 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.503 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 24.8 mt -71.89 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.167 -0.924 . . . . 10.0 112.376 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.506 ' HB ' ' HA2' ' A' ' 51' ' ' GLY . 58.5 m -146.04 78.69 11.33 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.747 -177.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -80.34 -56.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.348 2.699 . . . . 10.0 114.265 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.585 ' CG2' ' HD3' ' A' ' 43' ' ' PRO . 17.0 m -74.31 -35.9 2.44 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 112.821 0.675 . . . . 10.0 112.821 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.585 ' HD3' ' CG2' ' A' ' 42' ' ' VAL . 6.0 Cg_exo -76.66 13.75 1.36 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.328 2.019 . . . . 10.0 113.205 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.519 ' NZ ' ' HB3' ' A' ' 44' ' ' LYS . 5.6 ttpm? -45.78 -74.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.158 0.504 . . . . 10.0 111.659 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.9 t 44.4 42.42 5.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.482 -0.781 . . . . 10.0 111.532 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.541 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 38.7 mmt180 -158.32 -8.17 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.136 -0.484 . . . . 10.0 112.022 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 18.3 m80 69.52 -62.42 0.41 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.509 0.195 . . . . 10.0 111.29 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.454 ' HB2' ' HD2' ' A' ' 148' ' ' LYS . 3.7 m-85 -74.97 -47.98 26.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.719 0.295 . . . . 10.0 111.361 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 46' ' ' ARG . 41.0 t -61.18 80.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.393 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.5 -38.19 77.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.715 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.506 ' HA2' ' HB ' ' A' ' 40' ' ' THR . . . -148.49 165.57 29.1 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.382 -0.913 . . . . 10.0 113.324 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.507 ' CG1' ' CG1' ' A' ' 49' ' ' VAL . 2.9 m -161.91 169.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.438 HG12 HD13 ' A' ' 60' ' ' ILE . 30.3 pt -156.12 137.74 5.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.067 0.461 . . . . 10.0 111.73 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.44 ' ND2' ' CD1' ' A' ' 59' ' ' ILE . 23.3 t-20 -125.95 119.8 28.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.239 -0.891 . . . . 10.0 110.108 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 54' ' ' ASN . 92.9 mt -161.36 141.07 10.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.945 0.402 . . . . 10.0 111.134 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 46.48 46.65 14.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.224 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.54 41.81 97.4 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.537 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -139.42 118.15 12.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 10.0 110.354 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -119.87 135.01 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.003 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.2 pp -143.74 135.86 13.19 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 121.0 -0.28 . . . . 10.0 111.504 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 98.0 Cg_endo -102.64 122.28 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.86 3.04 . . . . 10.0 112.589 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 62' ' ' VAL . 29.2 m -99.84 133.22 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 69.2 t -140.87 155.66 22.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.375 0.607 . . . . 10.0 111.75 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.75 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 4.2 m120 -70.27 66.59 0.3 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.39 -0.823 . . . . 10.0 109.777 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.771 ' O ' HG22 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -52.08 -18.2 1.35 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.732 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.655 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -74.86 -27.68 60.35 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.465 -0.494 . . . . 10.0 110.169 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.75 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.94 -39.26 21.65 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.638 -0.504 . . . . 10.0 109.638 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.771 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.6 tt -57.78 -40.08 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 106.909 -1.515 . . . . 10.0 106.909 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.614 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.37 -45.13 23.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.399 -1.728 . . . . 10.0 107.939 176.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . 113.08 -86.09 0.41 Allowed Glycine 0 C--N 1.335 0.488 0 CA-C-N 114.905 -1.043 . . . . 10.0 112.599 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.753 HG13 ' HB3' ' A' ' 73' ' ' PHE . 2.3 pt 46.89 167.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 113.41 0.893 . . . . 10.0 113.41 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.443 ' HB3' ' NE2' ' A' ' 21' ' ' GLN . 47.1 t -49.07 -37.93 22.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.364 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.753 ' HB3' HG13 ' A' ' 71' ' ' ILE . 3.1 t80 -22.5 141.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.274 1.213 . . . . 10.0 114.274 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 75' ' ' GLU . 9.7 t70 -132.03 -58.64 0.95 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.803 -1.089 . . . . 10.0 109.306 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 11.7 pt-20 153.2 -42.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.027 0.531 . . . . 10.0 111.294 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -47.38 -40.95 18.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 10.0 112.239 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 10.7 mmpt? -77.09 -41.91 40.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.351 . . . . 10.0 111.054 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.643 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 21.4 mmt -45.39 144.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.422 0.527 . . . . 10.0 112.422 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -178.36 48.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.158 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 79.1 p -169.05 -177.05 2.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.171 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 47.8 mt -154.41 140.27 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.074 0.398 . . . . 10.0 112.074 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 7.5 mt -108.84 162.45 6.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.171 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.48 147.94 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.946 0.403 . . . . 10.0 110.958 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -155.15 175.33 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.838 -0.619 . . . . 10.0 111.172 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.414 ' O ' HG22 ' A' ' 86' ' ' THR . 11.6 ptp180 -131.69 131.27 42.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.479 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 59.1 p -145.75 109.38 4.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.954 0.407 . . . . 10.0 112.096 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 87' ' ' LYS . 37.4 ttmt 47.54 50.62 14.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.477 0.656 . . . . 10.0 110.765 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.01 32.21 2.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.1 -0.955 . . . . 10.0 111.524 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.528 HG11 HG21 ' A' ' 91' ' ' VAL . 66.0 t -129.62 109.85 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.207 177.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 32.2 mt-10 -88.38 97.79 11.25 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.078 -1.823 . . . . 10.0 106.078 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.528 HG21 HG11 ' A' ' 89' ' ' VAL . 4.2 t -88.59 153.94 3.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 113.285 -1.779 . . . . 10.0 113.56 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.71 158.73 22.33 Favored Glycine 0 C--N 1.318 -0.445 0 CA-C-N 114.509 -1.223 . . . . 10.0 112.802 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.61 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 t80 -144.45 134.5 24.04 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.851 0.358 . . . . 10.0 111.287 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 45.6 tp -88.56 123.02 32.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.935 0.398 . . . . 10.0 111.038 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.643 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 5.2 m -132.91 -175.04 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.803 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 12.5 t70 -99.53 -56.02 2.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.356 0.598 . . . . 10.0 111.902 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.0 tpp85 -150.08 123.8 9.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.217 -0.902 . . . . 10.0 108.706 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.602 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.9 p -108.25 113.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 122.389 1.09 . . . . 10.0 112.325 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.33 -28.22 69.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 112.945 -1.934 . . . . 10.0 111.104 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.19 -118.94 5.09 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.825 -0.91 . . . . 10.0 110.825 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.9 130.1 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 117.066 0.433 . . . . 10.0 110.21 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.571 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 15.3 tp -135.18 143.47 46.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.416 . . . . 10.0 110.755 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 2.4 ptp180 -88.86 78.11 7.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.772 -0.649 . . . . 10.0 111.742 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.7 ' HB ' HG11 ' A' ' 13' ' ' VAL . 14.5 mm -88.81 178.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 106.856 -1.535 . . . . 10.0 106.856 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 17.3 p -141.43 -175.91 4.53 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.436 ' HG3' HD22 ' A' ' 109' ' ' LEU . 88.2 tt0 -127.73 72.3 1.39 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.949 0.88 . . . . 10.0 112.738 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -108.82 19.49 19.57 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.197 -1.365 . . . . 10.0 107.767 176.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -125.64 -65.75 0.98 Allowed 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.068 -0.969 . . . . 10.0 111.363 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 1.5 pt? -82.57 48.59 1.33 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.013 -0.54 . . . . 10.0 112.066 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.26 133.93 52.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 10.0 110.86 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.4 mt 68.94 -54.8 0.56 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.123 -0.49 . . . . 10.0 111.987 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.4 t -179.02 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.99 0.424 . . . . 10.0 111.229 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 24.6 t-20 67.31 114.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.972 -0.558 . . . . 10.0 111.007 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -84.93 -42.66 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.342 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.4 m -168.4 153.05 6.2 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.092 -0.504 . . . . 10.0 111.01 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 26.8 m-20 -51.67 -34.44 38.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.501 . . . . 10.0 111.388 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 47.0 mmtm 69.24 -56.77 0.54 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.367 -0.378 . . . . 10.0 111.719 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.549 ' CE1' HD23 ' A' ' 69' ' ' LEU . 45.2 t80 -58.23 -46.37 86.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.272 0.558 . . . . 10.0 109.864 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 144.61 -53.19 0.58 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.365 -0.834 . . . . 10.0 111.961 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 62.6 tttm 171.72 55.24 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.42 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 4.1 tppp? -154.41 -30.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.604 0.594 . . . . 10.0 112.604 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.766 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 87.8 p -145.6 -163.9 1.83 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.694 -0.402 . . . . 10.0 111.833 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.11 -50.84 24.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.692 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 170.02 -160.21 33.06 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 119.816 -1.183 . . . . 10.0 113.956 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.526 HD11 ' O ' ' A' ' 126' ' ' VAL . 2.4 tm? -129.94 135.91 48.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.121 -0.54 . . . . 10.0 110.855 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.526 ' O ' HD11 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -117.47 159.98 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.405 0.621 . . . . 10.0 111.847 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.505 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -163.07 137.4 6.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.592 -0.731 . . . . 10.0 110.617 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.554 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 8.7 m -165.14 150.09 9.22 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.623 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 56.83 44.17 23.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.943 0.402 . . . . 10.0 110.801 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.21 33.91 39.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.696 -0.764 . . . . 10.0 112.04 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 128' ' ' THR . 14.2 ptt180 -133.49 136.19 44.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.1 mt -88.89 139.95 29.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.046 0.451 . . . . 10.0 111.585 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.531 HG12 ' CB ' ' A' ' 22' ' ' ALA . 4.1 mt -145.37 132.8 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.543 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.524 ' O ' HD11 ' A' ' 23' ' ' LEU . 2.0 mp -88.89 149.56 3.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.617 -0.882 . . . . 10.0 108.617 177.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.545 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 38.6 t80 -135.38 145.11 47.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.036 -0.665 . . . . 10.0 111.707 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.766 ' HG ' ' HB2' ' A' ' 122' ' ' SER . 6.2 mp -138.85 164.23 30.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.758 0.79 . . . . 10.0 112.416 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.459 ' O ' HG21 ' A' ' 138' ' ' ILE . 37.0 t70 -134.53 26.71 3.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.439 -1.255 . . . . 10.0 108.402 178.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.788 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 8.4 tt 41.21 17.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 114.375 -1.284 . . . . 10.0 114.211 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 142' ' ' ILE . 7.9 t70 -81.36 -62.42 1.66 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.691 0.626 . . . . 10.0 112.691 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -75.82 -31.85 59.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.611 0.719 . . . . 10.0 109.903 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.788 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.59 -45.82 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 114.759 -1.11 . . . . 10.0 110.785 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.683 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.9 tp -64.48 -43.18 96.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 C-N-CA 119.987 -0.685 . . . . 10.0 109.902 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -47.71 -46.47 29.63 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.293 0.568 . . . . 10.0 110.072 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.423 ' HA ' ' CG1' ' A' ' 147' ' ' VAL . 53.2 mm-40 -67.4 -36.45 81.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.409 -0.814 . . . . 10.0 110.597 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 141' ' ' ILE . 54.1 mt -53.77 -38.72 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.92 0.391 . . . . 10.0 110.843 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.6 p -74.81 -48.8 23.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.368 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.423 ' CG1' ' HA ' ' A' ' 144' ' ' GLU . 14.8 p -79.23 6.26 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 111.952 0.353 . . . . 10.0 111.952 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.454 ' HD2' ' HB2' ' A' ' 48' ' ' PHE . 22.6 pttp -51.0 -34.09 27.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.687 0.28 . . . . 10.0 111.462 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 52.8 mm-40 65.2 136.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.878 0.371 . . . . 10.0 111.038 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -176.54 45.35 0.11 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.898 -0.668 . . . . 10.0 112.33 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 43.8 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.352 . . . . 10.0 111.035 -179.884 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.845 0.355 . . . . 10.0 111.153 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.508 ' HG3' ' HG ' ' A' ' 4' ' ' LEU . 19.9 tptm -164.23 -43.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.266 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 38.6 m 76.29 -46.42 0.53 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.508 ' HG ' ' HG3' ' A' ' 2' ' ' LYS . 3.9 pp -53.32 -43.69 67.82 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.178 -0.209 . . . . 10.0 111.32 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.476 ' N ' ' CD1' ' A' ' 4' ' ' LEU . . . -179.38 134.96 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 10.0 111.521 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -67.03 148.65 51.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.634 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 8' ' ' LEU . . . -171.25 140.44 1.47 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.214 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 7' ' ' ALA . 80.4 mt 70.46 115.28 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.535 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 tptt -155.52 -57.85 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.526 -0.761 . . . . 10.0 111.274 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 40.3 tt0 -117.02 163.9 15.53 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.435 0.636 . . . . 10.0 111.021 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.616 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.6 t80 -163.19 137.95 6.36 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.834 -1.075 . . . . 10.0 112.855 -174.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 68.1 mt-10 -88.8 138.93 30.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.632 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.692 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.1 p -155.58 174.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 -175.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' N ' HG21 ' A' ' 13' ' ' VAL . 3.2 tm? -88.74 136.98 32.72 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.004 -1.109 . . . . 10.0 108.004 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.537 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 81.8 p -149.37 157.67 43.52 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 113.993 1.108 . . . . 10.0 113.993 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.724 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -149.98 158.08 43.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 113.948 -1.478 . . . . 10.0 109.837 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HG2' HD21 ' A' ' 99' ' ' LEU . 5.1 mm-40 -88.59 88.95 7.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 10.0 111.048 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.512 HD12 HG12 ' A' ' 95' ' ' VAL . 16.8 mm -88.91 124.21 41.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.852 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.552 ' CG ' ' HB3' ' A' ' 72' ' ' SER . 1.9 p30 36.62 60.07 0.95 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.601 -0.727 . . . . 10.0 112.571 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 76.97 -43.46 0.44 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.037 -0.983 . . . . 10.0 112.688 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 22' ' ' ALA . 3.0 pp0? -89.02 166.0 14.18 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 120.915 -0.314 . . . . 10.0 110.38 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.524 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.77 150.17 23.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 10.0 112.27 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.724 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -133.56 130.69 38.77 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 178.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -138.33 153.88 48.98 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.615 0.968 . . . . 10.0 113.615 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.513 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.3 m-85 -135.73 142.31 45.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.527 -1.215 . . . . 10.0 107.97 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -50.81 123.46 9.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 10.0 110.374 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 14' ' ' LEU . 34.7 m -60.03 -12.29 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.508 -0.769 . . . . 10.0 111.863 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -63.42 -42.77 98.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.98 0.419 . . . . 10.0 110.127 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.447 ' ND2' HG23 ' A' ' 138' ' ' ILE . 12.1 t-20 -87.34 -45.68 10.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.561 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.401 HG23 ' HG ' ' A' ' 14' ' ' LEU . 11.8 mm -65.55 138.55 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.045 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 32' ' ' MET . 24.9 pt-20 -113.31 -50.07 2.88 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 3.5 mtm -163.95 -175.96 4.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.966 0.412 . . . . 10.0 111.552 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.84 126.59 67.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.934 -0.576 . . . . 10.0 111.465 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.2 pt -96.15 171.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.038 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -88.83 147.63 24.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 10.0 110.947 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -88.87 136.49 32.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.166 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 87.1 p 179.13 -167.67 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.81 -0.632 . . . . 10.0 110.353 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -52.31 140.0 22.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.543 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 52' ' ' VAL . 24.7 mt -155.25 -83.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.414 ' CG2' ' HB2' ' A' ' 43' ' ' PRO . 96.3 m -139.68 70.78 37.44 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.861 0.362 . . . . 10.0 111.253 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -86.14 -50.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.092 2.528 . . . . 10.0 113.448 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.585 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 13.2 p -74.43 -33.9 1.75 Allowed Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 112.682 0.623 . . . . 10.0 112.682 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 42' ' ' VAL . 10.5 Cg_exo -72.42 12.16 0.7 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.432 2.088 . . . . 10.0 113.141 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' HB2' ' NZ ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -45.56 160.03 0.06 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.174 0.511 . . . . 10.0 111.765 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 47.3 t 176.92 45.52 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.225 -0.898 . . . . 10.0 110.773 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -177.75 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 10.0 110.731 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.482 ' HB3' ' O ' ' A' ' 46' ' ' ARG . 77.4 t60 82.23 -45.97 0.17 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.727 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.503 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -57.2 -50.65 72.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 10.0 110.496 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 63' ' ' VAL . 62.0 t -73.4 130.55 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -75.82 -39.04 57.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.027 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -167.91 -175.91 38.05 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.54 -0.838 . . . . 10.0 113.085 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.454 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 3.2 m -159.13 171.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.756 -0.461 . . . . 10.0 109.756 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.454 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 31.5 pt -159.51 132.31 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.147 0.498 . . . . 10.0 112.332 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.418 ' ND2' HD12 ' A' ' 59' ' ' ILE . 20.7 t-20 -93.8 134.24 36.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.536 -0.757 . . . . 10.0 110.348 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.1 tp -169.09 138.77 2.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.988 0.423 . . . . 10.0 111.275 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 48.72 46.89 21.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.228 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.64 40.74 71.76 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.697 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -158.19 121.64 3.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 10.0 110.737 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -101.09 132.74 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.858 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 90' ' ' GLU . 2.2 pp -114.01 134.24 22.19 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.638 -0.256 . . . . 10.0 110.735 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 60' ' ' ILE . 92.1 Cg_endo -100.55 114.05 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.301 2.668 . . . . 10.0 113.19 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 m -89.14 133.12 32.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.956 -0.757 . . . . 10.0 108.956 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 63.1 t -143.31 156.21 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.657 0.741 . . . . 10.0 112.953 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.429 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 74.6 m-20 -74.49 68.36 1.58 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.756 -1.111 . . . . 10.0 109.214 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.805 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.3 tt -53.41 -30.59 41.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.239 0.542 . . . . 10.0 110.814 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.626 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -63.01 -26.5 68.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.524 ' N ' ' HE2' ' A' ' 73' ' ' PHE . 0.8 OUTLIER -83.5 -42.0 17.36 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.966 179.19 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 65' ' ' LEU . 12.8 tt -58.79 -42.1 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 107.175 -1.416 . . . . 10.0 107.175 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.602 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -73.82 -45.28 52.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 113.76 -1.564 . . . . 10.0 108.435 176.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 113.52 -91.24 0.57 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.539 -0.755 . . . . 10.0 113.15 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.838 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.1 pt 48.28 164.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 112.812 0.671 . . . . 10.0 112.812 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.552 ' HB3' ' CG ' ' A' ' 19' ' ' ASP . 29.4 t -47.23 -32.99 4.98 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.328 -0.619 . . . . 10.0 109.328 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.838 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.2 t80 -33.18 141.55 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.191 -0.913 . . . . 10.0 112.533 176.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -171.87 43.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.49 -0.777 . . . . 10.0 110.196 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 78' ' ' MET . 50.0 mt-10 62.79 43.45 7.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.51 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 19.4 pt20 -74.54 -52.66 11.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.51 ' HD2' ' C ' ' A' ' 76' ' ' GLN . 2.6 mptt -146.4 18.97 1.36 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 112.275 0.472 . . . . 10.0 112.275 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.546 ' CE ' ' HA ' ' A' ' 95' ' ' VAL . 9.4 mmm -47.45 145.85 2.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.582 0.229 . . . . 10.0 110.525 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -174.38 38.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 10.0 111.14 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.1 m -169.14 162.47 10.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 10.0 109.875 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 70.3 mt -139.61 123.49 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.606 -0.438 . . . . 10.0 111.969 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 10.7 mt -89.01 130.96 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.494 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.32 146.64 9.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.071 0.462 . . . . 10.0 111.125 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -145.19 -178.72 6.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.566 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 41.8 mtm-85 -138.95 131.07 28.09 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.46 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 82.4 p -144.2 110.99 5.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.927 0.394 . . . . 10.0 112.035 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.8 tppp? 47.8 48.2 17.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.349 0.595 . . . . 10.0 110.735 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.51 32.35 1.21 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.085 -0.961 . . . . 10.0 111.564 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 91' ' ' VAL . 53.7 t -128.4 110.88 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.311 -0.859 . . . . 10.0 109.451 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 88.5 tt0 -88.27 98.34 11.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 106.14 -1.8 . . . . 10.0 106.14 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.513 HG21 HG11 ' A' ' 89' ' ' VAL . 3.6 t -88.62 153.93 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 112.983 -1.917 . . . . 10.0 113.353 -173.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -124.13 152.66 17.35 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-N 114.506 -1.225 . . . . 10.0 113.148 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.623 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -141.66 130.0 22.39 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.52 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 66.1 tp -88.56 133.68 34.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.205 0.526 . . . . 10.0 111.445 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.546 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 27.1 m -150.27 -175.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.357 -0.838 . . . . 10.0 110.776 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -111.51 -56.85 2.33 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.338 0.496 . . . . 10.0 112.338 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -133.87 124.72 26.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.986 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.585 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 5.9 p -115.94 113.12 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-O 122.336 1.065 . . . . 10.0 112.004 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.82 -30.19 71.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.292 -1.776 . . . . 10.0 111.343 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.58 -120.14 5.47 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.707 -0.957 . . . . 10.0 110.707 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.8 p -54.57 131.23 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 117.099 0.449 . . . . 10.0 110.064 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.579 ' CD2' HG12 ' A' ' 104' ' ' ILE . 54.6 tp -135.02 139.42 44.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.142 0.496 . . . . 10.0 111.469 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.1 ptp85 -88.9 72.35 8.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.1 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.692 ' HB ' HG11 ' A' ' 13' ' ' VAL . 9.6 mm -88.73 132.79 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.188 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.8 p -88.51 148.28 24.21 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 106.989 -1.486 . . . . 10.0 106.989 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.461 ' HG2' ' CD2' ' A' ' 109' ' ' LEU . 18.6 tp10 -140.25 90.08 2.34 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.506 -0.878 . . . . 10.0 111.849 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -91.15 16.43 9.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.741 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.567 ' HA ' ' HB2' ' A' ' 113' ' ' ASN . 1.5 pt20 -118.97 -80.17 0.61 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.524 -0.762 . . . . 10.0 110.685 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.461 ' CD2' ' HG2' ' A' ' 106' ' ' GLU . 79.3 mt 63.5 -121.72 0.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.02 -0.537 . . . . 10.0 111.528 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.573 ' HA ' HG22 ' A' ' 114' ' ' VAL . 7.6 t70 -151.53 -45.49 0.11 Allowed 'General case' 0 C--O 1.23 0.047 0 CA-C-O 120.857 0.361 . . . . 10.0 110.79 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' CD2' ' C ' ' A' ' 111' ' ' LEU . 5.6 tt -63.94 -40.66 96.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.748 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.41 HG21 ' N ' ' A' ' 113' ' ' ASN . 9.4 t -95.01 -46.02 7.0 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.151 0.501 . . . . 10.0 111.288 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.567 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 75.5 m-80 -159.34 -158.31 0.66 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.309 -0.86 . . . . 10.0 109.904 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 110' ' ' ASP . 5.1 t -162.21 -58.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.841 0.353 . . . . 10.0 110.467 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 114' ' ' VAL . 99.4 p 58.55 117.92 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.22 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.421 ' O ' ' HA3' ' A' ' 124' ' ' GLY . 12.1 p-10 -60.24 -48.31 82.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.45 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HB2' ' HA3' ' A' ' 124' ' ' GLY . 74.2 mmtt 64.82 -57.46 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.177 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 69' ' ' LEU . 25.3 t80 -89.48 -56.39 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.031 0.443 . . . . 10.0 110.495 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.34 -146.58 18.24 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.712 -0.676 . . . . 10.0 112.341 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -88.23 54.05 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 10.0 110.678 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 68' ' ' ILE . 17.9 tppt? -139.55 -39.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.033 0.383 . . . . 10.0 112.033 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.569 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 99.6 p -152.98 -163.1 1.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.664 0.269 . . . . 10.0 110.697 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.552 ' HE2' ' CD2' ' A' ' 135' ' ' TYR . 0.1 OUTLIER -63.13 -55.21 27.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.875 -0.33 . . . . 10.0 110.351 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.541 ' N ' ' HE3' ' A' ' 123' ' ' LYS . . . 149.56 155.89 6.98 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.355 -1.403 . . . . 10.0 114.692 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.492 HD11 ' O ' ' A' ' 126' ' ' VAL . 3.1 tm? -60.25 144.7 49.66 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.87 -0.665 . . . . 10.0 110.632 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.523 HG13 ' HB ' ' A' ' 133' ' ' ILE . 2.4 p -127.38 156.51 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.295 0.569 . . . . 10.0 111.686 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.42 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 96.5 mttt -147.02 140.65 25.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 131' ' ' ARG . 6.3 m -163.24 142.08 8.31 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.803 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 56.02 44.1 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.958 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.56 35.23 29.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.105 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.529 ' HD2' ' CG1' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -133.84 148.86 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.464 ' O ' ' HD3' ' A' ' 131' ' ' ARG . 4.2 mp -88.75 139.33 30.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.399 0.619 . . . . 10.0 112.471 -177.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.529 ' CG1' ' HD2' ' A' ' 131' ' ' ARG . 6.2 mt -151.5 150.35 13.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.241 -0.891 . . . . 10.0 110.571 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.541 ' O ' HD11 ' A' ' 23' ' ' LEU . 6.1 mm -103.6 130.9 53.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.552 ' CD2' ' HE2' ' A' ' 123' ' ' LYS . 10.3 t80 -117.42 139.26 51.13 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 119.915 -0.714 . . . . 10.0 111.364 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' A' ' 122' ' ' SER . 7.2 mp -135.67 165.98 24.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.497 -0.774 . . . . 10.0 112.145 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.44 ' OD1' ' HB2' ' A' ' 123' ' ' LYS . 10.6 p-10 -135.45 24.28 3.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.657 -1.156 . . . . 10.0 108.293 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.799 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 11.1 tt 41.7 17.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.286 -1.325 . . . . 10.0 113.961 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.576 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.7 t70 -82.72 -60.19 2.26 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.729 0.64 . . . . 10.0 112.729 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.49 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 3.4 mptp? -75.3 -34.26 61.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.699 0.761 . . . . 10.0 109.631 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.799 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.45 -46.15 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.664 -1.153 . . . . 10.0 110.732 179.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.706 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.6 tp -62.73 -45.84 97.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 C-N-CA 120.193 -0.603 . . . . 10.0 110.436 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -47.92 -44.61 30.01 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.351 0.596 . . . . 10.0 109.756 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.449 ' HA ' ' CG1' ' A' ' 147' ' ' VAL . 49.3 mt-10 -69.6 -30.94 68.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.246 -0.888 . . . . 10.0 110.898 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.613 HG13 ' O ' ' A' ' 141' ' ' ILE . 48.4 mt -57.61 -54.01 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 120.843 0.354 . . . . 10.0 111.418 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.4 p -69.05 -52.28 30.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.868 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 144' ' ' GLU . 14.0 p -67.25 -12.46 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.811 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -46.53 -52.77 12.67 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.842 0.354 . . . . 10.0 111.092 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 38.3 tt0 -178.61 46.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.059 0.457 . . . . 10.0 110.829 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 80.26 42.61 10.38 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.897 -0.668 . . . . 10.0 112.21 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 120.909 0.385 . . . . 10.0 111.027 179.823 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.799 0.333 . . . . 10.0 110.973 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' HB2' ' NZ ' ' A' ' 2' ' ' LYS . 4.9 ttmp? -63.2 -52.43 62.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.9 m 67.63 -54.64 0.49 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.495 0.554 . . . . 10.0 112.495 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.408 HD11 ' N ' ' A' ' 5' ' ' ALA . 3.1 pp -55.14 -23.93 23.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.74 0.305 . . . . 10.0 111.386 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.408 ' N ' HD11 ' A' ' 4' ' ' LEU . . . -51.51 130.09 26.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 10.0 111.431 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -67.93 142.09 56.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.779 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 8' ' ' LEU . . . -53.46 -66.54 0.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.57 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.418 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 96.9 mt -159.96 44.01 0.22 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.855 0.36 . . . . 10.0 111.166 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -74.05 -51.99 14.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.557 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 35.1 mt-10 -124.95 164.23 20.56 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.53 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.606 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 12.1 t80 -153.6 137.51 16.27 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.718 -1.128 . . . . 10.0 113.037 -174.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 70.8 mt-10 -88.78 137.36 32.38 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.791 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.743 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -152.07 171.05 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.333 -0.849 . . . . 10.0 112.504 -175.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.9 tm? -88.85 134.94 33.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.53 ' O ' HG21 ' A' ' 98' ' ' VAL . 80.6 p -148.16 153.03 38.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.096 0.776 . . . . 10.0 113.096 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.689 ' HZ ' ' CE1' ' A' ' 25' ' ' PHE . 1.8 p90 -149.79 168.1 24.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.269 -1.332 . . . . 10.0 110.143 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.55 129.67 35.42 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.512 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 4.5 mm -136.65 117.77 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.759 -0.655 . . . . 10.0 111.519 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.9 p30 38.44 60.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.17 -0.923 . . . . 10.0 112.621 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER 78.4 -43.06 0.35 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.916 -1.038 . . . . 10.0 112.742 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.512 ' NE2' ' HB ' ' A' ' 18' ' ' ILE . 3.5 pp0? -89.25 163.07 15.54 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.871 -0.332 . . . . 10.0 110.88 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.539 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.73 151.63 22.29 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.804 0.335 . . . . 10.0 110.84 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.585 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -133.58 134.75 43.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.077 -179.221 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -137.23 141.02 42.07 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.214 0.82 . . . . 10.0 113.214 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.689 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 1.4 m-85 -119.23 135.86 54.49 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.826 -1.175 . . . . 10.0 107.826 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -51.06 123.59 9.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.467 -0.493 . . . . 10.0 110.802 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 14' ' ' LEU . 15.7 m -64.4 -8.68 5.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.608 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.6 -31.43 68.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.01 0.433 . . . . 10.0 110.524 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.472 ' CB ' HG22 ' A' ' 138' ' ' ILE . 14.5 t30 -106.88 -50.22 3.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.918 -0.583 . . . . 10.0 112.401 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 mm -49.61 135.88 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.779 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 32' ' ' MET . 16.3 pt-20 -111.45 -51.65 2.84 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.889 0.7 . . . . 10.0 112.889 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.4 mtm -169.07 157.93 8.16 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.058 0.456 . . . . 10.0 111.88 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 34.8 m -89.68 177.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.033 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.598 HG13 ' HB ' ' A' ' 81' ' ' ILE . 20.6 pt -160.66 157.47 2.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.383 -0.826 . . . . 10.0 110.192 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -88.75 136.62 32.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 10.0 111.398 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' HB2' HG13 ' A' ' 81' ' ' ILE . 1.2 tmtp? -88.91 130.03 35.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.009 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.512 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 80.1 p -175.73 129.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.974 0.416 . . . . 10.0 111.846 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.1 t0 40.19 44.53 1.57 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.68 -0.691 . . . . 10.0 111.954 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 40' ' ' THR . 7.9 mt -78.3 156.31 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.108 0.48 . . . . 10.0 111.565 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.499 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 22.3 m -36.64 93.57 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.048 -0.978 . . . . 10.0 112.09 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -95.18 -52.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.293 2.662 . . . . 10.0 114.204 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 45.3 t -67.69 -47.31 45.18 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 112.659 0.615 . . . . 10.0 112.659 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 52.9 Cg_exo -53.79 -57.93 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.896 1.731 . . . . 10.0 112.22 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 58.33 -79.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.208 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' PRO . 68.3 m 42.23 44.64 3.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.65 -0.704 . . . . 10.0 112.164 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 79.5 mtt-85 -160.92 -36.88 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.48 -0.327 . . . . 10.0 111.377 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 20.8 m80 73.04 -57.3 0.64 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.188 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.459 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 2.2 t80 -68.09 -53.22 27.02 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.846 -0.427 . . . . 10.0 109.846 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.8 t -67.68 133.37 31.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.776 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 1.7 pp20? -72.8 -35.91 67.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.445 -0.343 . . . . 10.0 111.725 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -158.66 -176.01 30.23 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 119.659 -1.258 . . . . 10.0 113.755 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.471 HG22 ' CB ' ' A' ' 40' ' ' THR . 2.0 m -156.95 169.76 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.486 HG12 HD13 ' A' ' 60' ' ' ILE . 26.9 pt -158.78 138.15 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.946 0.403 . . . . 10.0 111.583 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.91 116.88 27.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.607 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -144.23 140.63 29.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.732 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.421 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 10.4 mpt_? 53.39 45.84 27.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.061 0.458 . . . . 10.0 110.731 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.81 35.66 63.79 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.719 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.1 mtm-85 -160.24 131.22 5.67 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.765 0.317 . . . . 10.0 110.815 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.467 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.92 133.85 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.746 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.541 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.4 pp -115.69 132.72 23.02 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.422 -0.354 . . . . 10.0 111.326 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 95.2 Cg_endo -84.6 116.43 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.384 2.056 . . . . 10.0 112.593 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 7.6 m -89.0 99.54 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.346 -0.612 . . . . 10.0 109.346 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.721 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 3.1 t -99.52 -175.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.019 -0.991 . . . . 10.0 110.144 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.809 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 38.1 m-20 -132.55 87.82 2.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.08 -0.509 . . . . 10.0 109.986 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.682 ' O ' HG22 ' A' ' 68' ' ' ILE . 3.6 tt -51.14 -24.75 4.38 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.122 -0.631 . . . . 10.0 111.137 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.615 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -66.67 -29.51 69.54 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.827 -0.349 . . . . 10.0 111.058 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.809 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -86.08 -37.88 18.39 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.812 0.339 . . . . 10.0 110.15 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.3 tt -65.35 -38.24 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 107.508 -1.293 . . . . 10.0 107.508 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.59 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 1.5 tm? -78.29 -46.94 18.94 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.553 -1.658 . . . . 10.0 108.724 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 115.02 -89.64 0.51 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.305 -0.861 . . . . 10.0 112.633 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.819 HG13 ' HB3' ' A' ' 73' ' ' PHE . 4.4 pt 47.12 164.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 16.3 t -48.1 -33.05 7.62 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.819 ' HB3' HG13 ' A' ' 71' ' ' ILE . 16.5 t80 -30.6 145.42 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.219 -0.9 . . . . 10.0 112.634 176.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -166.44 33.62 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.31 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.475 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 56.2 mt-10 55.0 46.03 25.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.683 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.409 ' HB2' ' HE2' ' A' ' 77' ' ' LYS . 98.6 mm-40 -95.64 -53.48 3.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.434 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -102.09 -32.75 9.98 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.298 0.481 . . . . 10.0 112.298 -178.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.544 ' CE ' ' HA ' ' A' ' 95' ' ' VAL . 2.9 mmm -28.85 142.65 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.87 0.468 . . . . 10.0 112.248 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.76 39.33 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.079 -0.509 . . . . 10.0 111.283 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.4 t -169.06 127.69 1.02 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.736 -0.665 . . . . 10.0 109.644 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.598 ' HB ' HG13 ' A' ' 34' ' ' ILE . 47.8 mt -98.2 151.31 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.522 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 11.0 mt -115.65 123.8 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.879 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.3 t -91.31 147.6 5.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.503 0.668 . . . . 10.0 111.928 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -150.67 171.31 17.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.017 -0.992 . . . . 10.0 110.384 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.459 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 12.1 ptp180 -127.29 143.79 51.17 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.541 -0.54 . . . . 10.0 109.541 178.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.491 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 34.5 p -159.0 108.56 1.94 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.269 0.47 . . . . 10.0 112.269 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.2 tppp? 46.79 48.49 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.355 0.598 . . . . 10.0 110.816 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 72.47 33.88 1.37 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.081 -0.963 . . . . 10.0 111.244 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.53 HG11 HG21 ' A' ' 91' ' ' VAL . 75.0 t -132.45 110.62 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-N 115.122 -0.945 . . . . 10.0 109.193 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 1.7 mp0 -88.36 96.25 10.51 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 89' ' ' VAL . 3.4 t -88.64 153.26 3.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 113.273 -1.785 . . . . 10.0 112.792 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -131.84 153.87 20.69 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 114.997 -1.001 . . . . 10.0 113.701 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.721 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 t80 -139.86 128.54 23.12 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.441 ' O ' ' CE1' ' A' ' 93' ' ' PHE . 51.1 tp -88.72 136.19 33.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.562 0.696 . . . . 10.0 112.209 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.544 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 23.8 m -148.86 -175.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.805 -1.089 . . . . 10.0 110.098 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.434 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 6.6 t70 -106.31 -57.96 1.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -133.96 116.34 15.45 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.369 0.604 . . . . 10.0 109.825 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.585 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.3 p -105.08 116.09 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 122.49 1.138 . . . . 10.0 111.852 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -65.73 -29.69 70.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.908 -1.951 . . . . 10.0 110.774 -178.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.8 -122.14 5.91 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.174 -0.77 . . . . 10.0 111.174 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -53.22 129.91 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 117.148 0.474 . . . . 10.0 110.292 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.586 ' HG ' HG12 ' A' ' 104' ' ' ILE . 60.7 tp -132.02 141.66 49.32 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.104 0.478 . . . . 10.0 111.236 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 103' ' ' ARG . 14.4 ptp180 -88.87 68.79 8.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.743 ' HB ' HG11 ' A' ' 13' ' ' VAL . 22.3 mm -88.75 132.04 34.63 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 30.3 p -88.73 -175.77 5.02 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.223 -1.028 . . . . 10.0 108.223 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.406 ' HG3' ' HG ' ' A' ' 109' ' ' LEU . 37.1 tt0 -147.3 75.71 1.38 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.322 -0.951 . . . . 10.0 112.423 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -103.1 20.63 17.27 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.763 -1.108 . . . . 10.0 109.272 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -126.73 -49.45 1.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.453 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.466 ' CD2' ' HD2' ' A' ' 123' ' ' LYS . 17.5 mt -62.34 -31.12 71.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.841 0.353 . . . . 10.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 109' ' ' LEU . 66.7 t0 72.8 -57.7 0.62 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.036 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' A' ' 112' ' ' THR . 3.6 pp 171.63 -35.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.566 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.475 ' N ' ' CD1' ' A' ' 111' ' ' LEU . 8.7 t -90.59 2.84 55.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.366 -0.834 . . . . 10.0 111.764 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 58.25 76.01 0.36 Allowed 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.768 0.318 . . . . 10.0 110.393 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.9 t -156.47 104.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.094 0.473 . . . . 10.0 110.721 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.9 t -174.4 -40.12 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.544 -0.753 . . . . 10.0 111.041 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 38.18 92.62 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.311 0.577 . . . . 10.0 112.005 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.607 ' HB2' ' HA3' ' A' ' 124' ' ' GLY . 73.0 mmtt -77.23 -20.47 55.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.367 -0.833 . . . . 10.0 112.124 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.703 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . 19.8 t80 -73.82 -59.81 2.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.005 0.431 . . . . 10.0 110.949 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 146.57 53.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.901 -0.666 . . . . 10.0 112.16 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 68.62 55.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.087 0.47 . . . . 10.0 110.844 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.44 ' HD2' ' CE2' ' A' ' 118' ' ' PHE . 24.2 ttmm -148.08 -37.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.609 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 92.1 p -162.84 -161.36 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.746 -0.465 . . . . 10.0 109.746 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.621 ' HB2' ' HA ' ' A' ' 136' ' ' LEU . 73.6 mmtt -58.93 -44.26 91.31 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.775 0.321 . . . . 10.0 110.399 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.703 ' HA2' ' HB2' ' A' ' 118' ' ' PHE . . . 111.96 -168.5 12.76 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.523 -0.846 . . . . 10.0 114.26 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 126' ' ' VAL . 1.8 tm? -69.18 142.21 54.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.155 0.503 . . . . 10.0 111.244 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.522 HG13 ' HB ' ' A' ' 133' ' ' ILE . 2.2 p -131.54 157.09 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.643 -0.708 . . . . 10.0 111.015 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -152.89 140.99 20.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.162 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 6.2 m -167.46 147.49 5.24 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.849 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 57.28 42.86 24.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.431 . . . . 10.0 110.809 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.0 34.44 30.94 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.108 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -132.99 148.44 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.693 0.282 . . . . 10.0 110.274 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.8 139.47 30.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 10.0 111.11 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.539 HG12 ' CB ' ' A' ' 22' ' ' ALA . 5.2 mt -152.28 156.56 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.954 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.488 ' O ' HD11 ' A' ' 23' ' ' LEU . 63.4 mt -117.79 126.91 75.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.448 ' HB2' HG12 ' A' ' 126' ' ' VAL . 15.1 t80 -116.03 146.47 42.14 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.924 -0.31 . . . . 10.0 110.535 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.621 ' HA ' ' HB2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -161.29 154.05 20.68 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.752 0.787 . . . . 10.0 112.717 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.53 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . 2.9 p30 -105.59 133.99 49.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.754 -1.112 . . . . 10.0 108.52 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.847 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 15.2 tt -67.11 6.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.494 ' O ' HG22 ' A' ' 142' ' ' ILE . 7.5 t70 -74.89 -47.79 28.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.902 0.382 . . . . 10.0 111.652 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.465 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.4 mptt -83.66 -34.76 24.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.163 0.506 . . . . 10.0 110.585 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.847 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -69.05 -35.83 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.593 179.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.701 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.8 tp -71.14 -44.15 74.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -47.3 -42.7 21.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.09 -35.34 71.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.471 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.693 HG13 ' O ' ' A' ' 141' ' ' ILE . 26.7 mt -53.43 -38.84 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-O 120.8 0.333 . . . . 10.0 111.096 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.6 p -80.65 -50.46 9.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.903 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.2 p -76.71 4.91 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 112.05 0.389 . . . . 10.0 112.05 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.433 ' HD2' ' CB ' ' A' ' 48' ' ' PHE . 22.0 pttp -46.05 -33.22 3.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.44 134.52 22.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.855 0.36 . . . . 10.0 111.156 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.4 43.27 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.985 -0.626 . . . . 10.0 112.343 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.338 . . . . 10.0 110.946 -179.939 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 62.8 mtt . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.706 0.289 . . . . 10.0 111.111 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' O ' ' OG1' ' A' ' 3' ' ' THR . 67.1 mttm 69.63 -46.64 0.59 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.222 -0.445 . . . . 10.0 112.061 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 72.8 p 56.54 30.31 17.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.119 0.485 . . . . 10.0 110.502 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.9 mt -108.3 -51.74 2.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.649 -0.705 . . . . 10.0 110.33 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.18 134.43 38.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.784 -0.643 . . . . 10.0 111.184 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 43.34 -169.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.5 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 63.65 131.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.903 0.382 . . . . 10.0 111.136 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' CD2' HD12 ' A' ' 109' ' ' LEU . 53.2 mt -88.03 46.17 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.979 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -84.93 -55.7 3.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 10.0 111.801 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 77.2 mt-10 -129.84 164.26 24.51 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.364 0.602 . . . . 10.0 111.038 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 15.7 t80 -161.67 138.62 8.48 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.937 -1.029 . . . . 10.0 112.881 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.76 140.62 29.26 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.724 -0.671 . . . . 10.0 109.632 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.783 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -156.39 169.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 113.287 0.847 . . . . 10.0 113.287 -174.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.498 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 2.9 tm? -88.95 133.92 34.14 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.742 -1.207 . . . . 10.0 107.742 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.532 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 74.6 p -145.34 153.8 41.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 113.083 0.772 . . . . 10.0 113.083 -177.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.611 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 3.1 p90 -151.81 165.3 34.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.375 -1.284 . . . . 10.0 110.371 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -88.58 134.07 33.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.504 ' O ' ' HG3' ' A' ' 21' ' ' GLN . 21.3 mm -131.56 93.49 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.479 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.0 OUTLIER 42.65 60.19 2.5 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 113.073 0.768 . . . . 10.0 113.073 178.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 88.71 -43.34 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.115 -0.948 . . . . 10.0 112.632 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.509 ' C ' ' OE1' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -88.98 151.52 22.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.377 -0.529 . . . . 10.0 110.412 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.84 156.93 18.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.844 0.354 . . . . 10.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.595 HD11 ' O ' ' A' ' 134' ' ' ILE . 1.2 tp -144.74 135.52 24.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.885 0.374 . . . . 10.0 110.858 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 135' ' ' TYR . . . -142.27 151.69 42.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.943 -0.572 . . . . 10.0 112.364 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.62 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.8 m-85 -129.36 141.64 51.02 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -48.55 101.34 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.644 0.735 . . . . 10.0 109.369 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.438 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 3.8 p -47.15 -13.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.523 -1.217 . . . . 10.0 112.862 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -62.9 -41.95 99.61 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.226 -0.589 . . . . 10.0 109.712 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' ND2' HD12 ' A' ' 138' ' ' ILE . 13.4 t30 -81.85 -48.4 11.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.126 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.407 HG23 ' HG ' ' A' ' 14' ' ' LEU . 18.0 mm -58.52 123.58 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.133 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 32' ' ' MET . 15.7 pt-20 -87.19 -54.81 4.11 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.477 0.547 . . . . 10.0 112.477 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.3 mtm -169.23 157.87 7.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.161 0.505 . . . . 10.0 112.352 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -88.88 148.05 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.057 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 34' ' ' ILE . 32.0 pt -139.52 155.34 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -88.8 152.79 21.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.066 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' HD3' ' C ' ' A' ' 36' ' ' LYS . 12.3 tmtt? -88.79 125.78 35.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.721 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.432 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 48.4 t 178.38 137.36 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.841 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.2 t0 42.28 44.57 3.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.178 0.513 . . . . 10.0 111.14 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 40' ' ' THR . 26.7 mt -93.61 -76.19 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.548 -0.751 . . . . 10.0 112.443 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.627 ' OG1' HG22 ' A' ' 52' ' ' VAL . 2.0 m -170.3 117.78 0.5 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.42 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.38 -85.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.831 2.354 . . . . 10.0 113.513 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.613 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 35.1 m -149.08 47.24 0.48 Allowed Pre-proline 0 CA--C 1.531 0.231 0 N-CA-C 112.426 0.528 . . . . 10.0 112.426 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.616 ' CD ' HG22 ' A' ' 40' ' ' THR . 53.1 Cg_exo -55.35 -19.87 23.61 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.552 2.168 . . . . 10.0 111.672 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt 60.31 -131.36 0.88 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.467 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 10.7 m 55.52 25.22 7.63 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.838 0.352 . . . . 10.0 110.792 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 36.3 mmt180 -163.33 -37.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.653 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 83.6 m-70 80.35 -56.93 0.34 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.998 -0.547 . . . . 10.0 111.174 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.448 ' HB2' ' HD2' ' A' ' 148' ' ' LYS . 2.0 m-85 -77.64 -49.02 15.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 10.0 110.585 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.516 ' HA ' HG22 ' A' ' 63' ' ' VAL . 58.6 t -56.94 85.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.743 -0.662 . . . . 10.0 111.912 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -66.25 -30.94 71.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.972 0.415 . . . . 10.0 110.169 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' HA2' ' HB ' ' A' ' 40' ' ' THR . . . -152.28 169.04 31.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.712 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.627 HG22 ' OG1' ' A' ' 40' ' ' THR . 3.6 m -158.62 171.96 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.661 0.267 . . . . 10.0 110.499 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.508 HD13 HG13 ' A' ' 60' ' ' ILE . 2.2 pp -160.94 143.08 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.008 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -88.84 142.28 27.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.479 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -168.87 134.0 1.6 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.527 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 15.1 ttp-105 48.71 47.2 21.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.777 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 58' ' ' ARG . . . 56.1 39.15 79.47 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.959 -0.564 . . . . 10.0 113.02 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 57' ' ' GLY . 37.8 mmt180 -159.59 124.8 4.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.764 0.316 . . . . 10.0 110.646 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.494 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -90.43 129.26 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.085 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.508 HG13 HD13 ' A' ' 53' ' ' ILE . 2.0 pp -99.09 139.65 21.14 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.87 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 61.7 Cg_endo -97.31 123.97 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.365 2.71 . . . . 10.0 113.546 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.408 ' O ' HG21 ' A' ' 62' ' ' VAL . 34.4 m -102.62 135.5 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 49' ' ' VAL . 99.5 t -143.68 158.16 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.569 0.7 . . . . 10.0 112.543 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.8 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 4.1 m120 -70.38 67.69 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.945 -1.025 . . . . 10.0 109.702 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.772 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.9 tt -50.99 -31.07 16.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.336 0.589 . . . . 10.0 110.61 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.742 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -62.7 -22.96 66.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.81 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.8 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -88.4 -41.85 12.54 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 178.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.772 HG22 ' O ' ' A' ' 65' ' ' LEU . 7.6 tt -59.15 -40.38 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.566 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.88 -40.19 33.07 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.31 -1.768 . . . . 10.0 108.267 176.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.725 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 71.32 121.62 0.05 OUTLIER Glycine 0 C--N 1.333 0.386 0 CA-C-N 114.791 -1.095 . . . . 10.0 113.05 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.725 HG21 ' O ' ' A' ' 70' ' ' GLY . 0.3 OUTLIER -162.86 -167.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.152 0.581 . . . . 10.0 109.972 -179.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 71.9 m -50.4 -32.34 17.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.616 0.722 . . . . 10.0 109.14 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.742 ' CD2' ' CB ' ' A' ' 66' ' ' ALA . 7.3 t80 -35.81 143.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.418 -1.265 . . . . 10.0 112.682 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -169.98 36.11 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.649 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 56.2 mt-10 55.54 37.7 29.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.439 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -82.85 -70.81 0.53 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.816 0.341 . . . . 10.0 111.718 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.599 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.4 mptt -94.93 -31.14 13.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.683 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.477 ' CE ' ' HA ' ' A' ' 95' ' ' VAL . 12.3 mmm -23.22 140.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.542 0.737 . . . . 10.0 112.221 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -164.11 -37.04 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.972 0.36 . . . . 10.0 111.972 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 80.2 p -88.75 163.87 15.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.584 0.231 . . . . 10.0 111.002 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.423 HG12 HD11 ' A' ' 94' ' ' LEU . 67.7 mt -132.64 129.15 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.722 0.296 . . . . 10.0 111.643 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.586 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 7.5 mt -93.5 150.79 3.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.741 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 84' ' ' ALA . 46.6 t -121.45 142.04 39.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.458 . . . . 10.0 110.778 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -145.0 175.97 9.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.782 -0.644 . . . . 10.0 111.015 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.455 ' O ' ' CG2' ' A' ' 86' ' ' THR . 6.6 ptm180 -128.25 146.38 50.76 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.54 HG21 HG12 ' A' ' 138' ' ' ILE . 73.3 p -160.93 108.67 1.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.466 0.543 . . . . 10.0 112.466 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 47.08 48.41 15.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.371 0.605 . . . . 10.0 110.779 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 72.26 33.54 1.51 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.117 -0.947 . . . . 10.0 111.235 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 91' ' ' VAL . 54.2 t -131.46 111.81 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-N 115.166 -0.924 . . . . 10.0 109.211 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 27.1 mt-10 -88.34 97.93 11.32 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.053 -1.832 . . . . 10.0 106.053 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.537 HG21 HG11 ' A' ' 89' ' ' VAL . 4.8 t -88.55 154.48 3.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.256 -1.793 . . . . 10.0 112.658 -174.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.1 156.3 21.91 Favored Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.702 -1.136 . . . . 10.0 113.065 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.564 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 t80 -146.3 131.94 18.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 10.0 110.935 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 58.8 tp -88.7 126.83 35.5 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.266 0.555 . . . . 10.0 112.066 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.477 ' HA ' ' CE ' ' A' ' 78' ' ' MET . 30.4 m -137.25 -175.08 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.261 -0.882 . . . . 10.0 109.89 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.78 -62.56 1.32 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.061 0.458 . . . . 10.0 112.191 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -133.93 117.86 17.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.756 -0.656 . . . . 10.0 109.66 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.611 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.3 p -104.95 116.07 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 122.451 1.12 . . . . 10.0 111.805 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -64.61 -30.33 71.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.02 -1.9 . . . . 10.0 110.747 -178.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.99 -124.4 6.98 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.487 -0.779 . . . . 10.0 111.259 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.3 p -52.17 128.15 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 117.035 0.418 . . . . 10.0 110.422 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.573 ' HG ' HG12 ' A' ' 104' ' ' ILE . 51.8 tp -132.06 139.06 48.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.039 0.447 . . . . 10.0 110.927 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.0 ptp85 -88.86 73.25 8.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.828 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.783 ' HB ' HG11 ' A' ' 13' ' ' VAL . 11.8 mm -88.78 126.21 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.737 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 17.7 p -88.74 146.21 25.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 176.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -131.31 70.7 1.46 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.069 -1.053 . . . . 10.0 113.398 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.99 -9.5 59.83 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.654 -1.157 . . . . 10.0 108.564 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -93.14 -51.34 5.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.98 -1.009 . . . . 10.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.432 HD12 ' CD2' ' A' ' 8' ' ' LEU . 0.4 OUTLIER 38.98 -144.88 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.424 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -130.64 41.28 3.4 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.098 0.475 . . . . 10.0 110.397 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.442 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 1.5 pt? -178.98 -39.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.85 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.481 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 6.0 t -57.47 -41.88 81.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.948 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 112' ' ' THR . 9.7 m120 -163.49 -38.8 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.522 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 113' ' ' ASN . 59.8 t 73.66 -58.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.681 0.276 . . . . 10.0 111.083 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.6 m 69.62 -61.44 0.44 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.113 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 33.9 t70 -164.38 -46.08 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.049 -0.26 . . . . 10.0 111.437 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 10.1 mtmp? 72.21 -51.83 0.7 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.72 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.488 ' CE1' HD23 ' A' ' 69' ' ' LEU . 23.7 t80 179.49 -53.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.188 0.518 . . . . 10.0 110.054 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' A' ' 120' ' ' LYS . . . 141.75 -58.75 0.56 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.478 -0.783 . . . . 10.0 112.052 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.441 ' CG ' ' O ' ' A' ' 119' ' ' GLY . 51.7 mtmt -163.78 56.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.55 0.214 . . . . 10.0 110.529 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.458 ' HA ' ' HE3' ' A' ' 121' ' ' LYS . 2.4 tpmt? -150.88 -40.54 0.12 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.504 ' CB ' ' HG ' ' A' ' 136' ' ' LEU . 91.8 p -149.95 -135.06 0.07 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 121.0 -0.28 . . . . 10.0 111.386 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 117' ' ' LYS . 47.3 mmtm -152.84 25.26 0.57 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.566 0.58 . . . . 10.0 112.566 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' A' ' 135' ' ' TYR . . . -146.6 139.93 8.37 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 119.297 -1.43 . . . . 10.0 114.116 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 2.3 tm? -155.44 78.93 1.02 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.538 -0.912 . . . . 10.0 108.538 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.62 HG11 ' O ' ' A' ' 133' ' ' ILE . 2.3 p -88.81 159.57 2.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.351 -0.84 . . . . 10.0 112.844 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.49 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 62.3 pttt -164.48 132.08 3.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.901 -1.045 . . . . 10.0 109.529 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 5.4 m -159.53 148.88 18.22 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.965 0.412 . . . . 10.0 111.476 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.442 ' HB3' ' NH2' ' A' ' 131' ' ' ARG . 38.6 t70 56.16 46.1 22.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.731 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.23 32.87 57.52 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.597 -0.811 . . . . 10.0 111.743 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.5 ptp85 -130.63 132.33 45.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.808 0.337 . . . . 10.0 110.221 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.5 tp -88.8 139.13 30.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.159 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.62 ' O ' HG11 ' A' ' 126' ' ' VAL . 2.6 mt -141.57 126.69 17.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.039 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.595 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.2 mp -89.03 136.59 23.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 46.5 t80 -128.8 140.96 51.47 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.537 0.684 . . . . 10.0 111.376 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.504 ' HG ' ' CB ' ' A' ' 122' ' ' SER . 6.9 mp -130.89 178.26 6.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.486 -0.779 . . . . 10.0 112.078 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.8 p-10 -141.37 23.28 2.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.336 -1.302 . . . . 10.0 108.063 177.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.829 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.3 tt 40.75 16.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 114.112 -1.404 . . . . 10.0 114.059 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.529 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.7 t0 -80.0 -61.36 2.01 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.61 0.596 . . . . 10.0 112.61 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -78.34 -29.68 47.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.383 0.611 . . . . 10.0 110.412 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.829 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.21 -45.64 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 115.367 -0.833 . . . . 10.0 110.118 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.659 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 8.0 tp -64.42 -43.32 96.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 120.013 -0.675 . . . . 10.0 109.512 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -48.16 -42.59 30.01 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.814 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.445 ' HA ' ' CG1' ' A' ' 147' ' ' VAL . 55.1 mm-40 -70.26 -33.73 71.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.24 -0.891 . . . . 10.0 110.421 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 141' ' ' ILE . 41.9 mt -57.22 -35.42 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.806 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.5 p -81.73 -50.45 9.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.655 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 144' ' ' GLU . 14.7 p -72.24 -5.21 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.948 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 48' ' ' PHE . 57.0 pttt -41.96 -44.12 3.35 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.878 0.37 . . . . 10.0 111.469 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -60.13 135.05 57.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.015 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.88 -45.47 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.414 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 10.0 110.979 -179.996 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.844 0.354 . . . . 10.0 111.119 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' O ' ' HB ' ' A' ' 3' ' ' THR . 87.9 tttt -174.56 -63.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.729 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 5.3 t 171.43 -49.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.031 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.6 mt -81.25 -54.28 5.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.974 0.416 . . . . 10.0 110.915 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.85 135.89 41.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.125 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 61.26 154.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 10.0 110.864 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.3 167.43 10.17 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.074 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 106' ' ' GLU . 43.1 mt -68.78 58.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.097 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 10' ' ' GLU . 24.8 tptt -127.39 -60.6 1.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.077 0.399 . . . . 10.0 112.077 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 42.4 tt0 -155.88 164.14 38.88 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.524 0.678 . . . . 10.0 111.477 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.652 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 11.4 t80 -159.49 140.41 12.53 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.616 -1.175 . . . . 10.0 112.483 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.66 130.64 35.25 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.168 -1.049 . . . . 10.0 108.168 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.777 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.6 p -149.0 166.23 3.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 -175.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.494 ' N ' HG21 ' A' ' 13' ' ' VAL . 3.0 tm? -89.01 140.02 29.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.551 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 53.4 p -154.92 158.03 38.65 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 119.806 -0.757 . . . . 10.0 112.851 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.68 ' CZ ' ' HG ' ' A' ' 23' ' ' LEU . 17.4 p90 -150.42 166.16 30.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.589 -1.187 . . . . 10.0 110.109 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.46 ' HG2' HD21 ' A' ' 99' ' ' LEU . 53.2 mm-40 -88.54 142.38 27.75 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.699 -0.482 . . . . 10.0 109.699 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.596 HG13 HD23 ' A' ' 23' ' ' LEU . 33.4 mm -140.52 93.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.78 -0.645 . . . . 10.0 111.45 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 62.3 m-20 43.24 60.06 2.71 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.89 -0.595 . . . . 10.0 112.39 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.8 mt-10 85.53 -42.71 0.05 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.145 -0.934 . . . . 10.0 112.307 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.481 ' NE2' HD11 ' A' ' 134' ' ' ILE . 19.1 pt20 -88.96 147.08 24.51 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.612 -0.435 . . . . 10.0 109.988 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.545 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.92 166.53 13.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.127 0.489 . . . . 10.0 111.927 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.68 ' HG ' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -140.39 143.57 35.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.549 -179.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -144.45 149.25 35.7 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.738 0.644 . . . . 10.0 112.738 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -138.39 137.88 37.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.689 -0.856 . . . . 10.0 108.689 179.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -56.17 123.93 16.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.224 -0.591 . . . . 10.0 110.144 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.8 m -59.77 -10.54 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.381 -0.827 . . . . 10.0 112.098 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 1.4 p30 -60.03 -40.67 90.14 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.087 0.47 . . . . 10.0 110.089 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.435 ' CG ' HG23 ' A' ' 138' ' ' ILE . 14.7 t-20 -93.3 -47.35 6.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 10.0 111.192 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 mm -57.93 121.91 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 32' ' ' MET . 12.4 pt-20 -84.34 -51.14 7.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.16 0.43 . . . . 10.0 112.16 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.9 mtm -169.1 154.69 6.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.248 0.547 . . . . 10.0 111.885 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.95 149.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.399 -0.819 . . . . 10.0 111.395 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.478 HG13 ' HB ' ' A' ' 81' ' ' ILE . 10.7 pt -143.57 -178.14 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.723 -0.672 . . . . 10.0 110.622 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -155.75 104.14 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.179 0.514 . . . . 10.0 110.701 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.44 ' HG3' HD11 ' A' ' 39' ' ' ILE . 18.3 ptpt -169.25 66.34 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.788 -0.642 . . . . 10.0 111.083 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -53.06 -170.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.989 0.423 . . . . 10.0 111.497 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p30 42.42 43.6 3.14 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.902 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.474 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 25.6 mt -73.65 144.29 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.846 -0.615 . . . . 10.0 111.802 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.628 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 20.1 m 25.97 71.32 0.39 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.722 -0.672 . . . . 10.0 112.337 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -86.35 -47.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.194 2.596 . . . . 10.0 113.127 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.498 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 47.1 t -67.61 -44.06 42.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.905 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 42' ' ' VAL . 35.6 Cg_exo -59.94 -55.55 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.127 1.885 . . . . 10.0 112.227 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' HD3' ' C ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 39.53 -158.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.378 -0.374 . . . . 10.0 111.329 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 43.9 t 69.04 54.82 0.44 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.871 0.367 . . . . 10.0 111.451 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 11.5 tpt180 -140.15 40.19 1.94 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.133 0.492 . . . . 10.0 110.502 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.435 ' CD2' ' HA2' ' A' ' 150' ' ' GLY . 11.5 m80 54.98 -134.79 1.49 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.891 -0.595 . . . . 10.0 111.276 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.601 ' CD1' ' HG2' ' A' ' 148' ' ' LYS . 8.6 t80 -52.84 -36.79 59.32 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.796 0.331 . . . . 10.0 111.133 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.476 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 61.5 t -57.75 126.73 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 10.0 111.476 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.85 -45.28 12.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.335 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 52' ' ' VAL . . . -139.13 -176.38 14.65 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.578 -0.737 . . . . 10.0 112.498 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.628 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.5 m -160.51 169.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 10.0 110.232 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -159.9 143.22 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.991 0.424 . . . . 10.0 111.211 178.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -88.75 134.69 33.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.166 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.8 mt -160.04 136.54 8.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.668 -0.696 . . . . 10.0 110.207 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.492 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 52.17 46.42 26.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.109 0.481 . . . . 10.0 110.413 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.34 37.42 65.51 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.801 -0.636 . . . . 10.0 112.822 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -159.36 130.5 6.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.773 0.32 . . . . 10.0 110.731 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.84 129.74 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.319 -0.4 . . . . 10.0 110.755 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.508 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 20.3 pt -107.6 129.81 23.7 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.305 -0.407 . . . . 10.0 111.563 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 94.2 Cg_endo -77.82 117.84 4.33 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.593 2.195 . . . . 10.0 112.201 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.416 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 28.7 m -94.92 137.68 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.715 0.293 . . . . 10.0 110.423 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 88.3 t -140.47 154.91 22.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.479 0.657 . . . . 10.0 111.924 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.811 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.3 m120 -77.65 65.92 3.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.157 -0.929 . . . . 10.0 109.15 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.731 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.7 tt -49.64 -26.73 3.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.575 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.66 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -66.78 -29.15 69.02 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.347 -0.541 . . . . 10.0 110.596 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.811 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -87.92 -33.9 18.32 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 121.088 -0.245 . . . . 10.0 110.988 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.8 tt -57.37 -41.41 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 106.336 -1.727 . . . . 10.0 106.336 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.606 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -77.7 -49.74 13.86 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.231 -1.804 . . . . 10.0 108.392 176.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 115.48 -79.17 0.28 Allowed Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.229 -0.896 . . . . 10.0 112.746 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.817 HG13 ' HB3' ' A' ' 73' ' ' PHE . 2.3 pt 46.05 173.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.619 0.6 . . . . 10.0 112.619 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.505 ' CB ' ' HB2' ' A' ' 19' ' ' ASP . 71.4 m -51.62 -36.21 44.97 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.817 ' HB3' HG13 ' A' ' 71' ' ' ILE . 3.7 t80 -30.14 145.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.996 -1.002 . . . . 10.0 113.536 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 35.9 t70 -134.62 -54.37 0.83 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.051 -0.977 . . . . 10.0 110.117 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 74' ' ' ASP . 10.5 pt-20 164.52 -45.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.865 0.364 . . . . 10.0 111.644 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -55.52 -37.91 68.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.487 ' HE3' ' N ' ' A' ' 77' ' ' LYS . 0.8 OUTLIER -68.27 -26.9 65.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.771 0.319 . . . . 10.0 111.331 -179.385 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.418 ' SD ' ' CE1' ' A' ' 73' ' ' PHE . 27.5 mmt -47.6 134.7 12.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.495 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 54.8 mtmt -160.75 -51.57 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.726 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 52.3 m -90.14 -175.99 4.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.318 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.478 ' HB ' HG13 ' A' ' 34' ' ' ILE . 75.5 mt -152.28 160.59 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.549 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.541 HD13 ' CD2' ' A' ' 16' ' ' PHE . 15.2 mt -142.23 140.69 29.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.903 0.382 . . . . 10.0 111.263 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.62 149.74 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.139 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -147.9 175.6 10.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.8 -0.636 . . . . 10.0 110.573 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.43 ' C ' HG22 ' A' ' 86' ' ' THR . 12.1 ptp180 -133.21 129.99 38.48 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.482 ' OG1' HG12 ' A' ' 142' ' ' ILE . 44.8 p -144.42 108.78 4.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.319 0.489 . . . . 10.0 112.319 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.485 ' CE ' ' O ' ' A' ' 87' ' ' LYS . 8.1 ttpt 47.67 51.23 14.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.704 0.764 . . . . 10.0 110.806 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.0 31.1 2.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.964 -1.016 . . . . 10.0 111.611 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.535 HG11 HG21 ' A' ' 91' ' ' VAL . 55.7 t -128.33 108.37 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 115.178 -0.919 . . . . 10.0 109.028 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.645 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 1.4 mp0 -88.26 99.83 12.53 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.628 -1.99 . . . . 10.0 105.628 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.535 HG21 HG11 ' A' ' 89' ' ' VAL . 4.8 t -88.57 149.62 3.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 113.378 -1.737 . . . . 10.0 112.908 -173.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -119.07 157.78 15.16 Favored Glycine 0 C--N 1.31 -0.898 0 CA-C-N 113.862 -1.517 . . . . 10.0 112.423 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.65 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 0.6 OUTLIER -149.75 123.66 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.292 0.568 . . . . 10.0 111.866 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.578 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 46.6 tp -88.78 120.18 29.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.954 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.08 -175.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.48 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 5.2 t0 -84.61 -79.94 0.21 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.32 0.581 . . . . 10.0 110.704 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.81 110.59 8.71 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.675 -0.861 . . . . 10.0 108.675 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.571 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 10.5 p -88.93 114.52 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-O 122.319 1.057 . . . . 10.0 111.833 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.537 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -62.47 -28.65 69.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.23 -1.805 . . . . 10.0 110.827 -178.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.22 -121.07 5.93 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.006 -0.837 . . . . 10.0 111.006 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.68 127.33 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 117.076 0.438 . . . . 10.0 110.453 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.551 ' CD2' ' HB3' ' A' ' 15' ' ' SER . 46.9 tp -126.57 139.26 53.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.171 0.51 . . . . 10.0 110.743 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.0 ptp85 -88.87 76.95 7.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.381 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.777 ' HB ' HG11 ' A' ' 13' ' ' VAL . 10.1 mm -88.64 161.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 24.0 p -122.32 147.28 46.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 109' ' ' LEU . 11.4 tt0 -104.96 66.81 0.77 Allowed 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.953 0.882 . . . . 10.0 112.256 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -96.31 17.74 15.28 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.456 -1.247 . . . . 10.0 108.677 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.625 ' HA ' ' HB2' ' A' ' 113' ' ' ASN . 2.2 pm0 -153.76 -46.42 0.09 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.617 -0.72 . . . . 10.0 112.208 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.59 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 7.6 mp -48.31 126.0 10.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.761 0.315 . . . . 10.0 111.603 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' A' ' 109' ' ' LEU . 38.8 t70 82.48 -51.06 0.2 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.771 -0.649 . . . . 10.0 111.693 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.532 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . 49.3 tp -73.42 5.3 3.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.799 0.333 . . . . 10.0 111.01 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 111' ' ' LEU . 9.5 t 47.41 43.16 15.21 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 112.804 0.668 . . . . 10.0 112.804 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.625 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.1 m120 -80.79 -31.7 35.62 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.48 -0.488 . . . . 10.0 110.13 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 115' ' ' SER . 35.5 m -29.84 -45.71 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.822 -0.627 . . . . 10.0 112.373 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 114' ' ' VAL . 29.1 t 78.09 -43.72 0.38 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.378 -0.373 . . . . 10.0 111.229 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 36.4 t70 -134.41 -38.61 0.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.753 -0.203 . . . . 10.0 111.262 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 50.8 mttp 79.87 -45.97 0.32 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.355 -0.384 . . . . 10.0 111.516 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.534 ' CZ ' HD13 ' A' ' 69' ' ' LEU . 45.8 t80 179.45 -45.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.304 0.574 . . . . 10.0 109.791 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 175.04 -55.91 0.12 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.096 -0.956 . . . . 10.0 111.336 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 5.8 tmtt? 173.34 44.76 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 110.196 -0.298 . . . . 10.0 110.196 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 121' ' ' LYS . 26.3 ttpp -163.89 48.78 0.13 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.408 0.522 . . . . 10.0 112.408 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.635 ' HB2' ' HB3' ' A' ' 136' ' ' LEU . 8.2 p 172.45 171.69 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.958 0.409 . . . . 10.0 112.056 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 22.2 tptm -72.62 -52.69 14.36 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 117' ' ' LYS . . . -167.55 -164.02 22.47 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 119.23 -1.462 . . . . 10.0 114.837 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 1.7 tm? -139.02 125.42 20.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.155 -0.523 . . . . 10.0 109.901 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 133' ' ' ILE . 1.7 p -103.71 154.53 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.543 0.687 . . . . 10.0 112.138 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 27.9 mtpp -154.62 134.02 12.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.944 -1.025 . . . . 10.0 109.839 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.431 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 16.3 m -163.04 149.9 12.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.895 0.379 . . . . 10.0 111.23 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.459 ' OD1' ' HB3' ' A' ' 131' ' ' ARG . 2.8 p30 46.15 48.49 12.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 10.0 111.5 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.66 43.24 68.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.82 -0.705 . . . . 10.0 112.212 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.459 ' HB3' ' OD1' ' A' ' 129' ' ' ASP . 3.5 ptm180 -138.97 134.17 32.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 10.0 110.625 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.93 137.37 32.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.939 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.61 ' O ' HG13 ' A' ' 126' ' ' VAL . 3.9 mt -144.8 130.14 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.003 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.507 ' N ' HD13 ' A' ' 134' ' ' ILE . 1.4 mp -88.99 137.31 21.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.5 ' HB2' HG11 ' A' ' 126' ' ' VAL . 70.9 t80 -130.89 142.61 50.38 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.221 -0.592 . . . . 10.0 111.037 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 122' ' ' SER . 0.0 OUTLIER -164.67 147.01 8.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.367 0.603 . . . . 10.0 112.35 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.409 ' OD1' ' CB ' ' A' ' 139' ' ' ASP . 3.0 p30 -96.46 35.02 1.53 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.806 0.812 . . . . 10.0 110.194 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.878 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 20.9 tt 39.95 20.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.328 -1.306 . . . . 10.0 114.14 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.59 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.5 t0 -79.3 -57.06 3.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.04 0.756 . . . . 10.0 113.04 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 121' ' ' LYS . 22.5 ttmm -77.96 -33.55 51.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 10.0 110.265 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.878 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -64.98 -45.26 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.946 178.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.625 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 5.8 tp -61.36 -44.57 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 C-N-CA 120.1 -0.64 . . . . 10.0 109.531 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 139' ' ' ASP . 43.6 mm-40 -47.16 -41.67 18.21 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.433 ' HG3' ' CD ' ' A' ' 121' ' ' LYS . 59.1 mm-40 -73.48 -31.39 63.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.36 -0.836 . . . . 10.0 111.177 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 141' ' ' ILE . 44.5 mt -54.27 -48.16 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.973 0.416 . . . . 10.0 110.595 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.3 p -85.48 -45.98 11.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.978 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 143' ' ' GLU . 44.5 t -56.71 -31.49 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.585 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.601 ' HG2' ' CD1' ' A' ' 48' ' ' PHE . 48.4 tptt -42.38 -48.04 5.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.066 0.46 . . . . 10.0 111.007 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -179.31 126.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.431 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.435 ' HA2' ' CD2' ' A' ' 47' ' ' HIS . . . 172.97 44.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.615 -0.802 . . . . 10.0 112.563 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 10.0 111.092 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttp . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.893 0.378 . . . . 10.0 111.171 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' O ' ' HB ' ' A' ' 3' ' ' THR . 97.6 mttt -64.59 -43.11 94.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.013 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 54.8 m 72.43 -51.8 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.435 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 5' ' ' ALA . 4.2 pp -65.94 -39.07 90.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.872 0.368 . . . . 10.0 110.689 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.47 ' N ' ' CD1' ' A' ' 4' ' ' LEU . . . -74.8 128.91 36.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.227 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.06 135.86 44.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.808 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.28 131.22 47.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.141 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.4 mt 62.52 109.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.66 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.533 ' HE3' ' CB ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -157.4 -50.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.189 -179.5 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 43.3 tt0 -148.52 163.96 35.65 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.661 -0.7 . . . . 10.0 110.648 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.651 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.4 t80 -158.79 139.14 12.38 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.052 -0.976 . . . . 10.0 112.54 -174.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -88.59 130.37 35.28 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.433 -0.951 . . . . 10.0 108.433 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.741 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.6 p -148.87 169.13 2.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 -175.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.555 ' N ' HG21 ' A' ' 13' ' ' VAL . 3.3 tm? -88.8 139.18 30.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.595 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 83.3 p -149.15 154.17 38.79 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 119.806 -0.758 . . . . 10.0 112.881 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.702 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -149.24 167.18 26.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.409 -1.269 . . . . 10.0 110.775 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -88.63 123.81 33.46 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.03 -0.73 . . . . 10.0 109.03 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.475 HG23 ' CD1' ' A' ' 71' ' ' ILE . 9.7 mm -134.39 115.84 21.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.709 -0.678 . . . . 10.0 111.784 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.52 ' CG ' ' HB2' ' A' ' 72' ' ' SER . 2.0 p30 39.08 60.12 1.53 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.717 . . . . 10.0 112.484 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 52.6 mt-10 78.08 -42.87 0.36 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.923 -1.035 . . . . 10.0 112.469 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.455 ' OE1' HG12 ' A' ' 134' ' ' ILE . 3.7 pp0? -91.83 158.74 16.16 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.295 -0.253 . . . . 10.0 110.717 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.76 ' O ' ' HA ' ' A' ' 133' ' ' ILE . . . -88.74 148.37 24.0 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 121.078 0.466 . . . . 10.0 111.662 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.702 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -124.35 133.19 53.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.409 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -134.06 152.15 51.72 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.443 0.905 . . . . 10.0 113.443 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' CZ ' HD22 ' A' ' 65' ' ' LEU . 5.6 m-85 -135.98 139.08 42.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.941 -1.027 . . . . 10.0 109.024 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -49.54 122.49 6.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.143 0.497 . . . . 10.0 111.175 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 19.9 m -61.06 -13.51 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.789 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -59.98 -41.81 92.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.13 0.49 . . . . 10.0 109.708 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 85' ' ' ARG . 12.1 t30 -92.16 -48.52 6.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.641 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 25' ' ' PHE . 22.3 mm -60.89 129.23 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.445 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 32' ' ' MET . 16.4 pt-20 -100.37 -53.01 3.22 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.452 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.7 mtm -169.22 156.11 6.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 10.0 111.732 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 33.1 m -100.1 129.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.76 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.417 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 27.5 pt -105.78 137.68 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 10.0 111.015 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -90.48 119.51 30.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.829 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 68.7 mttm -159.67 -178.65 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.818 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.6 t -168.12 148.94 5.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.87 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 t70 49.54 44.45 24.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.141 0.496 . . . . 10.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 41' ' ' PRO . 19.4 mt -63.42 155.83 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.499 -0.773 . . . . 10.0 111.917 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.526 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 16.0 m -20.48 81.77 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.958 -1.019 . . . . 10.0 112.826 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' N ' ' O ' ' A' ' 39' ' ' ILE . 88.8 Cg_endo -91.41 -50.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.966 2.444 . . . . 10.0 113.891 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.476 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 45.3 t -64.86 -45.1 74.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 112.288 0.477 . . . . 10.0 112.288 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 42' ' ' VAL . 50.6 Cg_exo -54.75 -49.67 15.93 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.293 1.995 . . . . 10.0 112.773 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' OG ' ' A' ' 45' ' ' SER . 36.4 pttt 43.61 -129.02 0.83 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.61 -0.268 . . . . 10.0 111.198 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 44' ' ' LYS . 80.3 p 63.02 67.77 0.66 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.078 0.551 . . . . 10.0 111.681 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.457 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 2.8 tpm_? -161.26 -57.84 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.918 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.432 ' O ' ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER 169.77 -154.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.408 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.463 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 60.9 t80 -66.9 62.5 0.05 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.801 0.334 . . . . 10.0 110.298 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 50.0 t -132.0 133.52 60.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.086 0.469 . . . . 10.0 111.669 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HG3' ' ND2' ' A' ' 64' ' ' ASN . 35.7 mm-40 -63.71 -47.79 79.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.994 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 40' ' ' THR . . . -155.47 -176.01 27.15 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.415 -0.811 . . . . 10.0 112.576 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 2.0 m -148.16 169.97 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.878 0.37 . . . . 10.0 110.98 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.402 HG23 HG21 ' A' ' 39' ' ' ILE . 29.6 pt -153.26 139.89 12.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 10.0 111.311 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -88.82 133.88 34.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.995 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 97.1 mt -159.73 138.09 10.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.369 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.519 ' NE ' ' HA ' ' A' ' 56' ' ' ARG . 1.8 tpm_? 48.13 46.34 19.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.176 0.513 . . . . 10.0 110.559 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.36 42.66 89.39 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.954 -0.641 . . . . 10.0 112.661 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -165.37 129.17 2.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 10.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.49 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -88.96 132.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.101 -0.499 . . . . 10.0 111.076 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.45 HG21 ' CG ' ' A' ' 90' ' ' GLU . 22.3 pt -111.47 135.07 21.05 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.669 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 83.0 Cg_endo -80.16 116.54 3.38 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.816 2.344 . . . . 10.0 113.362 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' HG21 ' A' ' 62' ' ' VAL . 22.4 m -95.45 133.97 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.525 ' CG2' ' HA ' ' A' ' 49' ' ' VAL . 59.3 t -142.59 156.74 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.665 0.745 . . . . 10.0 112.832 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.865 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 80.1 m-20 -75.87 62.17 1.54 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.874 -1.057 . . . . 10.0 108.724 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.738 ' O ' HG22 ' A' ' 68' ' ' ILE . 0.8 OUTLIER -51.85 -20.48 2.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.74 -0.664 . . . . 10.0 111.621 -179.034 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.596 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -71.51 -30.66 66.21 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.287 -0.565 . . . . 10.0 110.133 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.865 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.58 -36.38 26.27 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.557 -0.164 . . . . 10.0 110.557 178.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 65' ' ' LEU . 9.1 tt -56.14 -40.86 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 106.402 -1.703 . . . . 10.0 106.402 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -76.81 -38.58 53.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 113.407 -1.724 . . . . 10.0 108.961 176.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.51 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 106.09 -92.12 0.78 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.607 -0.724 . . . . 10.0 113.598 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.882 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.4 pt 48.32 164.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 112.712 0.634 . . . . 10.0 112.712 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.52 ' HB2' ' CG ' ' A' ' 19' ' ' ASP . 29.2 m -49.16 -30.5 6.87 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.266 -0.642 . . . . 10.0 109.266 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.882 ' HB3' HG13 ' A' ' 71' ' ' ILE . 12.0 t80 -30.09 141.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.265 -0.88 . . . . 10.0 112.74 176.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -174.32 42.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.573 -0.739 . . . . 10.0 110.348 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 58.52 38.57 25.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -71.63 -42.77 67.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.846 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 96' ' ' ASP . 32.2 mmmt -146.11 23.92 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.85 0.315 . . . . 10.0 111.85 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.495 ' CE ' ' CE1' ' A' ' 73' ' ' PHE . 16.7 mmt -47.63 133.04 13.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.554 -0.294 . . . . 10.0 111.062 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -172.82 36.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.834 0.349 . . . . 10.0 111.137 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.3 p -169.11 154.07 5.83 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.637 -0.505 . . . . 10.0 109.637 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 51.8 mt -133.2 145.12 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.621 -0.432 . . . . 10.0 111.682 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.593 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 6.4 mt -110.21 144.6 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.483 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.99 140.09 46.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.147 0.499 . . . . 10.0 110.654 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.609 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -141.91 -175.97 4.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.992 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.48 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 6.4 ptm180 -135.55 143.1 45.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.498 ' OG1' ' HB ' ' A' ' 89' ' ' VAL . 41.6 p -158.83 109.39 2.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.876 0.37 . . . . 10.0 111.836 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 36.4 ttmt 46.72 47.25 15.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.649 . . . . 10.0 110.687 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 52.8 m-20 74.49 34.07 0.8 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.939 -1.028 . . . . 10.0 111.342 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.51 HG11 HG21 ' A' ' 91' ' ' VAL . 60.1 t -130.36 110.76 19.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.419 -0.809 . . . . 10.0 109.858 177.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 35.6 tt0 -88.34 99.74 12.48 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 105.68 -1.97 . . . . 10.0 105.68 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.51 HG21 HG11 ' A' ' 89' ' ' VAL . 4.6 t -88.6 149.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 113.329 -1.76 . . . . 10.0 113.36 -173.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -121.56 149.56 17.22 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 113.912 -1.494 . . . . 10.0 113.071 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.608 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -141.83 128.49 20.33 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 120.783 0.325 . . . . 10.0 110.891 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.456 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 36.3 tp -88.64 131.38 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.108 0.48 . . . . 10.0 110.986 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.52 HG13 ' CD2' ' A' ' 16' ' ' PHE . 18.8 m -143.02 -175.02 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.386 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 7.9 t70 -90.94 -70.49 0.68 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.316 0.579 . . . . 10.0 111.902 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -142.14 112.91 7.34 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.175 -0.921 . . . . 10.0 108.678 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.599 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -91.35 114.42 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 122.463 1.125 . . . . 10.0 112.017 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.532 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -63.03 -29.13 70.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 112.817 -1.992 . . . . 10.0 110.969 -178.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.58 -123.59 6.99 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.595 -0.812 . . . . 10.0 111.279 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.69 133.36 16.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.061 0.431 . . . . 10.0 110.5 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.595 ' CD2' ' HB3' ' A' ' 15' ' ' SER . 53.6 tp -135.15 138.96 44.23 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.232 0.539 . . . . 10.0 111.234 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.628 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.1 OUTLIER -88.82 73.75 8.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.32 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.741 ' HB ' HG11 ' A' ' 13' ' ' VAL . 11.5 mm -88.8 133.06 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.691 -0.485 . . . . 10.0 109.691 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.6 p -88.57 146.54 25.07 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -129.26 75.2 1.63 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 114.164 1.172 . . . . 10.0 114.164 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -97.16 2.7 51.41 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.56 -1.274 . . . . 10.0 107.56 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.458 ' HB3' ' CE ' ' A' ' 117' ' ' LYS . 64.2 mm-40 -77.13 -61.71 1.89 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.621 -1.172 . . . . 10.0 110.7 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.0 mt -50.68 147.41 4.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.164 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 111' ' ' LEU . 66.5 t0 -153.05 67.9 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.258 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.508 ' CB ' ' O ' ' A' ' 110' ' ' ASP . 0.5 OUTLIER 97.45 -30.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.468 -0.787 . . . . 10.0 110.244 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.423 ' CG2' ' CD1' ' A' ' 111' ' ' LEU . 10.4 t -179.49 45.98 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.553 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.69 124.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.584 -0.28 . . . . 10.0 110.297 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.22 57.12 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 112.477 0.547 . . . . 10.0 112.477 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.406 ' HB3' ' NZ ' ' A' ' 117' ' ' LYS . 41.2 t 178.61 132.26 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 10.0 111.682 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.504 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 1.5 m-20 -73.78 -51.46 16.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.519 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.503 ' HB3' ' CB ' ' A' ' 125' ' ' LEU . 48.5 mttm 70.66 -59.94 0.52 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.649 -0.705 . . . . 10.0 111.348 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.507 ' CZ ' HD22 ' A' ' 69' ' ' LEU . 25.2 t80 -78.18 -52.68 8.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.172 0.51 . . . . 10.0 110.035 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.7 -144.28 10.39 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.079 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -91.49 55.73 2.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.599 0.238 . . . . 10.0 110.667 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.496 ' NZ ' ' HB ' ' A' ' 141' ' ' ILE . 1.1 tmpt? -144.7 -44.79 0.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.915 -0.314 . . . . 10.0 111.314 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.513 ' OG ' HD21 ' A' ' 136' ' ' LEU . 47.4 t -137.54 -137.88 0.14 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.643 -0.218 . . . . 10.0 110.428 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.504 ' HD3' ' HA ' ' A' ' 116' ' ' ASP . 48.5 mmtm -158.53 -29.66 0.07 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.685 0.994 . . . . 10.0 113.685 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.562 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -81.43 147.68 27.22 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.035 -1.079 . . . . 10.0 114.753 -177.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.503 ' CB ' ' HB3' ' A' ' 117' ' ' LYS . 2.8 tm? -162.36 138.54 7.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.607 HG11 ' O ' ' A' ' 133' ' ' ILE . 1.7 p -149.79 159.57 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.211 0.529 . . . . 10.0 112.017 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 94.6 mttt -160.24 135.91 8.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.306 -0.861 . . . . 10.0 109.876 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 5.7 m -163.9 149.28 10.78 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.973 0.416 . . . . 10.0 111.254 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 55.24 46.64 23.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.838 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.52 34.53 49.5 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.581 -0.819 . . . . 10.0 111.797 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' THR . 2.5 ptp180 -136.21 135.42 39.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.824 0.345 . . . . 10.0 110.21 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.9 152.42 21.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.158 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.76 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 6.3 mt -151.22 129.86 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.05 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.455 HG12 ' OE1' ' A' ' 21' ' ' GLN . 6.7 mm -90.29 145.0 7.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.562 ' O ' ' CA ' ' A' ' 124' ' ' GLY . 38.1 t80 -133.5 136.32 45.0 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.197 0.522 . . . . 10.0 111.525 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.513 HD21 ' OG ' ' A' ' 122' ' ' SER . 16.0 mt -138.17 147.5 43.92 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.66 0.743 . . . . 10.0 112.003 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.473 ' O ' HG21 ' A' ' 138' ' ' ILE . 12.2 p-10 -105.51 26.43 9.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.703 -1.135 . . . . 10.0 108.86 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.851 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.6 tt 38.91 16.86 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 114.477 1.288 . . . . 10.0 114.477 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 142' ' ' ILE . 7.9 t0 -80.05 -62.35 1.71 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 144' ' ' GLU . 14.5 mmmm -73.7 -31.54 63.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.416 0.626 . . . . 10.0 110.451 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.851 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.96 -46.61 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.302 -0.863 . . . . 10.0 110.771 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.622 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 6.6 tp -60.92 -46.71 95.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 119.8 -0.76 . . . . 10.0 109.826 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 139' ' ' ASP . 96.7 mt-10 -48.87 -40.41 29.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 148' ' ' LYS . 44.8 mt-10 -71.21 -39.03 72.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.182 -0.917 . . . . 10.0 110.528 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 141' ' ' ILE . 34.4 mt -48.16 -43.79 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 120.797 0.332 . . . . 10.0 111.443 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.6 p -84.71 -53.47 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 144' ' ' GLU . 14.5 p -63.35 -21.45 28.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 0.5 OUTLIER -39.83 -41.68 1.17 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 111.718 0.266 . . . . 10.0 111.718 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -65.41 133.4 51.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.82 0.343 . . . . 10.0 110.796 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 175.43 41.51 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.779 -0.724 . . . . 10.0 111.982 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 10.0 110.982 -179.93 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtm . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.846 0.355 . . . . 10.0 111.232 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.57 -55.68 30.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.722 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t 174.7 -50.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.615 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 5' ' ' ALA . 3.9 pp -78.66 -37.41 42.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.546 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.447 ' N ' ' CD1' ' A' ' 4' ' ' LEU . . . 61.03 122.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.991 -0.55 . . . . 10.0 111.219 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.2 t70 60.45 136.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.177 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 171.93 130.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.063 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt -92.02 42.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 10.0 111.088 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HD2' ' CB ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -98.61 -42.02 7.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.832 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 37.8 tt0 -164.01 164.01 23.2 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.838 0.828 . . . . 10.0 111.295 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.3 t80 -150.85 138.62 19.83 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.964 -1.471 . . . . 10.0 112.862 -174.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 2.1 mt-10 -88.7 132.43 34.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.377 -0.828 . . . . 10.0 108.893 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.755 HG11 ' HB ' ' A' ' 104' ' ' ILE . 1.3 p -150.31 167.2 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 112.906 0.706 . . . . 10.0 112.906 -176.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.56 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.8 tm? -88.95 130.5 35.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.681 -0.859 . . . . 10.0 108.681 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.565 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 41.9 t -143.82 155.35 44.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.864 0.84 . . . . 10.0 112.565 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.617 ' HZ ' ' CE1' ' A' ' 25' ' ' PHE . 2.2 p90 -150.09 163.74 37.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.181 -1.372 . . . . 10.0 110.241 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -88.53 129.09 35.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.468 HG13 HD23 ' A' ' 23' ' ' LEU . 32.3 mm -122.85 87.89 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.319 -0.855 . . . . 10.0 111.259 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 41.5 m-20 51.48 60.04 4.15 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.838 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 61.7 mm-40 77.46 -32.48 0.18 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.45 -0.795 . . . . 10.0 111.708 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.515 ' NE2' HD11 ' A' ' 134' ' ' ILE . 38.6 tt0 -88.75 142.27 27.81 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.569 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.67 158.34 18.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.061 0.458 . . . . 10.0 112.086 -178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.572 HD11 ' O ' ' A' ' 134' ' ' ILE . 2.0 tp -152.28 139.62 19.47 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.123 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -141.99 144.68 33.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.426 0.528 . . . . 10.0 112.426 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 1.8 m-85 -119.54 138.84 52.93 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.969 -1.122 . . . . 10.0 107.969 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.659 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 26.4 t70 -51.57 123.52 10.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.01 0.433 . . . . 10.0 111.26 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 14' ' ' LEU . 12.7 m -64.29 -10.53 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.705 -0.679 . . . . 10.0 112.106 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.659 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 53.6 m-20 -69.37 -38.94 78.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.007 -0.677 . . . . 10.0 109.454 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.472 ' OD1' HG22 ' A' ' 86' ' ' THR . 12.6 t-20 -89.86 -44.83 9.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.234 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mm -65.41 129.24 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.091 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 32' ' ' MET . 14.8 pt-20 -95.55 -50.99 4.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.054 0.39 . . . . 10.0 112.054 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.7 mtm -168.99 155.07 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.185 0.516 . . . . 10.0 112.017 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.03 155.89 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.498 -0.774 . . . . 10.0 111.28 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.528 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 22.8 pt -150.44 138.58 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.046 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 22.7 pt-20 -104.65 110.96 23.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.693 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -169.12 63.94 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.182 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.8 p -54.66 -173.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 10.0 111.16 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 t70 46.42 45.26 13.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.568 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 41' ' ' PRO . 15.4 mt -77.72 156.27 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.737 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.534 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 27.8 m -17.17 80.55 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.047 -0.979 . . . . 10.0 112.895 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.477 ' N ' ' O ' ' A' ' 39' ' ' ILE . 84.3 Cg_endo -90.69 -50.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.032 2.488 . . . . 10.0 113.824 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.486 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 42.4 t -64.78 -45.62 75.28 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 112.058 0.392 . . . . 10.0 112.058 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 42' ' ' VAL . 44.2 Cg_exo -57.19 -54.3 3.76 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.212 1.942 . . . . 10.0 112.553 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? 43.66 -129.64 0.81 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.459 -0.337 . . . . 10.0 111.611 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t 67.24 54.48 0.72 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 122.794 0.438 . . . . 10.0 111.813 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -160.28 44.07 0.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.4 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 56.95 -133.39 1.35 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.197 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CE2' ' CG1' ' A' ' 63' ' ' VAL . 4.1 t80 -55.44 -34.05 64.13 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.604 0.24 . . . . 10.0 111.624 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -47.76 116.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.007 0.432 . . . . 10.0 111.069 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -79.49 -34.94 40.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.857 -0.611 . . . . 10.0 111.31 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.6 -175.74 23.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.933 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.534 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.3 m -154.2 169.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.442 HG13 HG12 ' A' ' 60' ' ' ILE . 27.6 pt -157.88 141.07 6.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 10.0 111.052 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -88.81 138.94 30.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.02 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.451 ' CD1' ' HB2' ' A' ' 56' ' ' ARG . 2.4 tm? -169.1 138.43 2.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.581 . . . . 10.0 110.459 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.463 ' O ' ' CD ' ' A' ' 56' ' ' ARG . 0.7 OUTLIER 48.67 48.98 19.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.119 0.485 . . . . 10.0 110.373 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 53.34 41.67 62.94 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.886 -0.673 . . . . 10.0 112.808 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -165.94 128.23 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 10.0 110.859 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -88.99 132.74 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.865 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.477 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 18.7 pt -112.72 126.98 27.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.494 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 80.7 Cg_endo -77.19 121.98 5.97 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.631 2.22 . . . . 10.0 112.601 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.2 m -88.92 129.67 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.687 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.566 ' CG1' ' H ' ' A' ' 64' ' ' ASN . 3.2 t -113.5 -175.81 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.595 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.566 ' H ' ' CG1' ' A' ' 63' ' ' VAL . 11.7 p-10 -133.7 70.18 1.46 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.358 0.599 . . . . 10.0 110.709 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.903 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.6 tt -53.76 -37.59 63.56 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.821 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.642 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -50.57 -29.16 10.09 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.338 -0.545 . . . . 10.0 109.876 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.594 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -82.64 -43.59 16.77 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.617 -0.719 . . . . 10.0 110.631 178.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.903 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.0 tt -61.03 -37.58 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 122.096 0.951 . . . . 10.0 108.646 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.631 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -81.83 -53.95 5.76 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.713 -1.585 . . . . 10.0 109.219 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.519 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 119.09 -77.81 0.3 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.383 -0.826 . . . . 10.0 112.136 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.776 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.8 pt 44.69 177.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 113.122 0.786 . . . . 10.0 113.122 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 41.1 t -54.87 -38.37 67.42 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.776 ' HB3' HG13 ' A' ' 71' ' ' ILE . 5.9 t80 -24.6 140.66 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.635 -1.166 . . . . 10.0 113.571 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -172.71 37.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.321 -0.854 . . . . 10.0 110.095 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 54.33 35.11 22.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.884 -0.598 . . . . 10.0 111.304 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -81.03 -61.36 1.98 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.398 -0.364 . . . . 10.0 111.652 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 78' ' ' MET . 2.3 mppt? -103.14 -25.37 13.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.429 -0.35 . . . . 10.0 111.847 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.553 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 20.0 mmt -17.9 136.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -170.19 -34.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.771 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -88.85 -176.02 5.07 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.832 0.349 . . . . 10.0 111.444 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 45.7 mt -152.37 158.34 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.897 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.515 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 12.3 mt -133.05 139.98 48.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.774 0.321 . . . . 10.0 111.052 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.439 HG11 ' N ' ' A' ' 84' ' ' ALA . 44.4 t -109.17 152.68 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.066 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.439 ' N ' HG11 ' A' ' 83' ' ' VAL . . . -155.37 169.71 23.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.364 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.457 ' O ' HG22 ' A' ' 86' ' ' THR . 14.3 ptm180 -128.04 132.72 49.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.589 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 57.6 p -148.3 109.19 4.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.817 0.303 . . . . 10.0 111.817 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.456 ' HE2' ' HB2' ' A' ' 87' ' ' LYS . 22.3 ttmm 49.49 60.21 3.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.147 0.499 . . . . 10.0 110.282 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 87' ' ' LYS . 7.4 p-10 55.1 32.68 18.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.036 -0.984 . . . . 10.0 111.551 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.589 ' HB ' ' O ' ' A' ' 86' ' ' THR . 70.7 t -125.62 109.34 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 115.16 -0.927 . . . . 10.0 108.732 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.602 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 28.5 mt-10 -88.46 94.59 9.91 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.871 -1.529 . . . . 10.0 106.871 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.532 HG21 HG11 ' A' ' 89' ' ' VAL . 3.1 t -88.57 155.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 113.035 -1.893 . . . . 10.0 112.856 -174.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.32 165.93 21.81 Favored Glycine 0 C--N 1.314 -0.693 0 CA-C-N 114.679 -1.146 . . . . 10.0 112.468 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.541 ' HE2' ' CZ ' ' A' ' 16' ' ' PHE . 2.6 t80 -151.62 133.61 15.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 10.0 110.839 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.49 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 67.3 tp -88.72 126.27 35.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.238 0.542 . . . . 10.0 111.898 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.553 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 15.4 m -135.61 -175.27 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.02 178.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -100.37 -60.04 1.6 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.203 0.525 . . . . 10.0 111.656 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.1 ttt-85 -144.46 117.08 8.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.382 -0.826 . . . . 10.0 108.891 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.591 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -101.08 118.22 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 122.336 1.065 . . . . 10.0 112.482 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -66.03 -29.22 69.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.219 -1.81 . . . . 10.0 110.674 -179.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.16 -125.05 7.61 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.485 -0.78 . . . . 10.0 111.425 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 m -52.33 131.13 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.944 0.372 . . . . 10.0 110.513 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 104' ' ' ILE . 56.6 tp -135.2 141.46 45.85 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.151 0.5 . . . . 10.0 111.258 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 103' ' ' ARG . 16.2 ptm180 -88.81 70.55 8.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.049 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.755 ' HB ' HG11 ' A' ' 13' ' ' VAL . 17.2 mm -88.65 136.76 22.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 107.922 -1.14 . . . . 10.0 107.922 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 37.9 p -88.65 -175.88 5.07 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 109' ' ' LEU . 38.2 tt0 -149.6 77.06 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.06 -1.056 . . . . 10.0 113.393 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -111.69 22.17 15.28 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.255 -1.339 . . . . 10.0 107.519 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.581 ' HA ' ' HB3' ' A' ' 113' ' ' ASN . 3.3 pm0 -158.77 59.71 0.43 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.902 -1.044 . . . . 10.0 111.628 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.438 ' HB2' ' CG ' ' A' ' 106' ' ' GLU . 76.5 mt -154.08 -43.12 0.09 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.914 -1.039 . . . . 10.0 111.409 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -168.69 157.34 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.069 0.461 . . . . 10.0 111.241 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.499 ' O ' ' CG2' ' A' ' 112' ' ' THR . 84.9 mt 65.72 97.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.184 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.499 ' CG2' ' O ' ' A' ' 111' ' ' LEU . 9.1 t 48.89 48.02 20.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.63 -0.713 . . . . 10.0 111.232 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.581 ' HB3' ' HA ' ' A' ' 108' ' ' GLN . 78.5 m-20 -158.14 135.15 9.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.635 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -179.97 116.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.266 -179.462 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 t -168.12 147.69 4.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.065 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.616 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 1.5 m-20 -52.12 -48.4 64.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.172 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.527 ' HE3' ' O ' ' A' ' 123' ' ' LYS . 35.0 mtmt 73.43 -59.62 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.676 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.587 ' CZ ' HD22 ' A' ' 69' ' ' LEU . 26.6 t80 -96.81 -66.56 0.9 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.833 0.349 . . . . 10.0 110.91 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.61 -36.64 0.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.56 -0.828 . . . . 10.0 112.941 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.475 ' NZ ' ' HB2' ' A' ' 120' ' ' LYS . 0.1 OUTLIER 176.33 124.98 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 2.7 tppp? 73.28 117.87 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.495 -0.775 . . . . 10.0 110.541 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.444 ' OG ' ' CD2' ' A' ' 69' ' ' LEU . 1.8 p 53.81 47.05 24.49 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.616 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 22.5 pttp -75.79 47.76 0.44 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.532 -1.213 . . . . 10.0 113.883 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.738 ' O ' ' HB3' ' A' ' 135' ' ' TYR . . . -107.89 46.78 1.12 Allowed Glycine 0 C--O 1.221 -0.659 0 C-N-CA 119.713 -1.232 . . . . 10.0 112.455 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 117' ' ' LYS . 2.5 tm? -52.72 140.82 22.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.193 -0.593 . . . . 10.0 111.006 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 133' ' ' ILE . 1.1 p -148.15 160.69 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-O 121.35 0.595 . . . . 10.0 111.593 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.505 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 87.0 tttt -164.77 135.81 4.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 10.0 110.284 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 8.5 m -161.76 150.52 15.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 120.976 0.417 . . . . 10.0 111.013 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 9.8 t70 55.18 48.02 20.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.442 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.3 35.03 34.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.664 -0.779 . . . . 10.0 111.977 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.5 OUTLIER -137.33 133.14 34.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.703 0.287 . . . . 10.0 110.273 -179.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 3.7 mp -88.93 139.08 30.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.892 0.377 . . . . 10.0 111.316 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.569 HG12 ' CB ' ' A' ' 22' ' ' ALA . 3.1 mt -145.36 136.7 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 10.0 110.621 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.572 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.4 mp -95.87 132.92 38.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.738 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 12.7 t80 -120.43 144.69 47.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.229 0.538 . . . . 10.0 110.421 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 138' ' ' ILE . 0.1 OUTLIER -151.88 131.81 13.37 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.52 -0.764 . . . . 10.0 111.234 -177.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.459 ' N ' HD21 ' A' ' 136' ' ' LEU . 12.2 p-10 -95.05 34.74 1.34 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.218 0.532 . . . . 10.0 111.296 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.813 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.6 tt 38.4 19.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.375 1.25 . . . . 10.0 114.375 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 137' ' ' ASP . 64.3 t0 -77.29 -57.11 4.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.274 0.842 . . . . 10.0 113.274 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -76.08 -28.93 57.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.318 0.58 . . . . 10.0 111.248 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.813 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.76 -45.99 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.438 -0.801 . . . . 10.0 110.878 -179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.559 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 8.9 tp -67.34 -47.65 80.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 120.252 -0.579 . . . . 10.0 111.212 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -50.33 -42.54 53.06 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.392 -0.595 . . . . 10.0 109.392 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 57.4 mm-40 -75.17 -27.24 59.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.123 -0.944 . . . . 10.0 111.04 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.648 HG13 ' O ' ' A' ' 141' ' ' ILE . 23.5 mt -55.41 -43.1 70.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.907 0.384 . . . . 10.0 110.72 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.4 p -86.33 -52.51 5.58 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.571 0.582 . . . . 10.0 112.571 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -84.78 13.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.85 0.685 . . . . 10.0 112.85 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.582 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.2 OUTLIER -40.02 -56.76 1.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.712 0.292 . . . . 10.0 111.769 -178.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 178.66 133.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.827 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.423 ' O ' ' CG1' ' A' ' 151' ' ' VAL . . . -67.97 -46.9 63.25 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.469 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 150' ' ' GLY . 12.3 p . . . . . 0 N--CA 1.464 0.237 0 CA-C-O 120.878 0.371 . . . . 10.0 111.539 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.812 0.339 . . . . 10.0 111.133 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -58.95 -44.66 91.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 10.0 111.092 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.1 m 69.65 -56.2 0.57 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.495 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 5' ' ' ALA . 3.5 pp -56.81 -30.26 63.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 10.0 110.936 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.42 ' N ' ' CD1' ' A' ' 4' ' ' LEU . . . 67.78 133.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.34 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.06 139.05 57.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 178.87 140.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.165 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.5 mt -147.88 42.81 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.656 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -88.95 -64.66 1.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 10.0 111.075 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -152.26 164.3 37.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.969 0.89 . . . . 10.0 111.842 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.532 ' CE2' ' OH ' ' A' ' 135' ' ' TYR . 35.0 t80 -117.0 127.94 54.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.794 -1.548 . . . . 10.0 113.802 -175.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -89.02 126.2 35.32 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.649 -1.611 . . . . 10.0 106.649 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.725 HG11 ' HB ' ' A' ' 104' ' ' ILE . 4.2 p -151.83 167.74 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 114.476 1.287 . . . . 10.0 114.476 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.577 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.4 tm? -88.9 137.93 31.87 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 107.91 -1.144 . . . . 10.0 107.91 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.558 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 57.0 p -149.29 158.99 44.64 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.203 0.816 . . . . 10.0 113.203 -177.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.596 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 6.9 p90 -152.3 165.92 33.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.217 -1.356 . . . . 10.0 110.42 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.6 137.25 32.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 10.0 109.715 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.493 HD12 ' CE1' ' A' ' 16' ' ' PHE . 28.4 mm -134.37 92.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.164 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 41.6 m-20 44.74 60.25 3.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.64 . . . . 10.0 112.701 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 45.9 mt-10 85.17 -42.59 0.06 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.282 -0.872 . . . . 10.0 111.879 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -88.95 145.72 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.576 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.49 166.81 13.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.908 0.385 . . . . 10.0 110.785 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.588 ' HG ' ' CZ ' ' A' ' 16' ' ' PHE . 1.5 tp -149.43 139.33 21.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.505 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 135' ' ' TYR . . . -142.58 146.66 34.8 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.489 0.922 . . . . 10.0 113.489 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CE2' HD22 ' A' ' 136' ' ' LEU . 1.6 m-85 -124.24 143.51 50.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.224 -0.898 . . . . 10.0 108.615 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -53.69 123.23 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.05 -0.352 . . . . 10.0 110.05 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 14' ' ' LEU . 27.4 m -58.04 -14.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.567 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -62.64 -43.59 98.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.061 0.458 . . . . 10.0 110.204 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.463 ' ND2' HD12 ' A' ' 138' ' ' ILE . 14.9 t30 -84.7 -47.02 10.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.675 -0.693 . . . . 10.0 111.164 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.8 mm -61.03 132.28 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.217 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HB3' ' CE ' ' A' ' 32' ' ' MET . 43.9 mt-10 -94.91 -60.4 1.7 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.376 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.423 ' CE ' ' HB3' ' A' ' 31' ' ' GLU . 1.2 pmm? -169.01 156.55 7.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.367 -0.379 . . . . 10.0 111.003 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.84 144.58 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 10.0 111.791 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.6 pt -137.89 136.81 45.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.593 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -88.95 120.82 30.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 10.0 110.68 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.451 ' HB2' HD11 ' A' ' 81' ' ' ILE . 62.0 mttp -162.56 156.58 21.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.804 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.5 m -167.65 37.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.356 0.598 . . . . 10.0 111.059 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -167.86 44.03 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.151 -0.931 . . . . 10.0 110.567 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.445 HG23 ' N ' ' A' ' 40' ' ' THR . 15.9 mt -93.66 138.31 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.883 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.592 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 6.0 m 37.51 77.66 0.39 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.903 -0.59 . . . . 10.0 112.545 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -86.93 -47.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.801 2.334 . . . . 10.0 113.433 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.586 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 14.8 p -84.57 -31.2 0.46 Allowed Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 113.595 0.961 . . . . 10.0 113.595 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 42' ' ' VAL . 47.4 Cg_exo -55.57 -56.31 2.35 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.655 1.57 . . . . 10.0 112.913 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.486 ' NZ ' ' HB3' ' A' ' 44' ' ' LYS . 3.3 ttpm? 56.18 -131.85 1.66 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.603 -0.271 . . . . 10.0 110.3 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 23.3 t 78.64 -45.69 0.4 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.882 0.473 . . . . 10.0 112.188 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' CB ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -64.34 -31.4 72.6 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.895 0.331 . . . . 10.0 111.895 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 38.2 m80 69.87 -62.71 0.41 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.203 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' CE1' ' HE3' ' A' ' 67' ' ' LYS . 2.4 t80 -69.89 -43.49 71.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.133 0.492 . . . . 10.0 109.784 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.531 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 44.6 t -78.51 135.5 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.598 -0.728 . . . . 10.0 111.58 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.407 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 24.2 mm-40 -88.34 -40.9 13.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.772 -0.649 . . . . 10.0 110.601 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -135.22 160.9 24.54 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.345 -0.931 . . . . 10.0 113.747 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.592 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.6 m -159.81 169.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.437 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 31.6 pt -159.08 142.46 5.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.862 0.363 . . . . 10.0 111.073 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -88.75 141.38 28.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.989 -0.551 . . . . 10.0 111.064 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' CD1' ' HG2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -168.71 133.04 1.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.84 -0.618 . . . . 10.0 109.981 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.541 ' HG2' ' CD1' ' A' ' 55' ' ' LEU . 35.3 mmt180 50.46 45.76 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 10.0 110.925 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.7 38.17 80.92 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.8 -0.636 . . . . 10.0 112.977 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -158.41 124.42 4.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.744 0.306 . . . . 10.0 110.596 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.466 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.6 mp -91.0 127.4 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.25 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.529 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.1 pp -94.92 134.94 24.09 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.55 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.454 ' HA ' HG13 ' A' ' 52' ' ' VAL . 92.8 Cg_endo -99.57 121.82 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.068 2.512 . . . . 10.0 113.864 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 62' ' ' VAL . 19.5 m -103.52 127.57 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.844 -0.798 . . . . 10.0 108.844 177.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 47.3 t -139.59 160.36 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.851 0.834 . . . . 10.0 113.204 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.444 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 4.3 m120 -75.96 73.39 2.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.591 -1.186 . . . . 10.0 108.667 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.817 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.3 tt -52.87 -38.53 61.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.293 0.568 . . . . 10.0 111.397 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.686 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -59.9 -18.5 45.29 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.193 -0.603 . . . . 10.0 110.03 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.1 tmmm? -85.41 -46.9 10.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.017 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.4 tt -53.86 -35.21 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 107.611 -1.255 . . . . 10.0 107.611 178.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.63 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -86.1 -56.08 3.63 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.08 -1.873 . . . . 10.0 109.82 178.263 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.596 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 121.92 -81.47 0.34 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.307 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.759 HG13 ' HB3' ' A' ' 73' ' ' PHE . 2.9 pt 45.11 179.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.698 0.629 . . . . 10.0 112.698 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 45.7 t -54.75 -39.08 67.94 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.151 -0.685 . . . . 10.0 109.151 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.759 ' HB3' HG13 ' A' ' 71' ' ' ILE . 14.8 t80 -32.4 143.69 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.784 -1.098 . . . . 10.0 112.896 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -166.77 37.4 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.532 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 55.28 38.76 30.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.776 -0.647 . . . . 10.0 111.22 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.422 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 17.7 pt20 -94.01 -50.51 5.28 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.262 0.467 . . . . 10.0 112.262 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 12.4 mptt -111.16 -25.01 9.95 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.55 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 16.9 mmt -36.72 143.77 0.07 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.758 0.651 . . . . 10.0 112.758 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 53.6 mtmt -159.53 -41.38 0.05 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.91 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.427 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 46.8 t -88.78 -175.99 5.08 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.913 0.387 . . . . 10.0 111.551 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.467 HG12 HD11 ' A' ' 94' ' ' LEU . 77.4 mt -146.55 154.22 12.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.328 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 16' ' ' PHE . 10.8 mt -120.63 143.9 31.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.739 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.1 t -111.41 149.85 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.974 0.416 . . . . 10.0 110.892 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -153.57 174.33 14.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 10.0 111.001 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 6.3 ptm180 -135.71 132.11 36.47 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.471 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 59.0 p -145.51 109.54 4.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.962 0.41 . . . . 10.0 111.922 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 14.7 tppt? 47.53 49.74 15.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.328 0.585 . . . . 10.0 110.851 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.05 31.57 1.45 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.066 -0.97 . . . . 10.0 111.519 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.53 HG11 HG21 ' A' ' 91' ' ' VAL . 67.6 t -128.33 108.56 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.23 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 6.4 mp0 -88.4 98.47 11.64 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.198 -1.779 . . . . 10.0 106.198 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 89' ' ' VAL . 3.0 t -88.7 157.2 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 113.089 -1.869 . . . . 10.0 112.711 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -140.25 151.21 22.08 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 114.895 -1.048 . . . . 10.0 113.258 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.578 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.1 t80 -140.77 134.39 30.16 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.93 0.395 . . . . 10.0 111.003 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 31.7 tp -88.61 115.5 26.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 10.0 111.46 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.55 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 12.8 m -122.43 -175.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.933 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -100.15 -59.98 1.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.174 0.512 . . . . 10.0 111.825 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -141.26 113.37 7.94 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.547 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.596 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.5 p -99.79 111.28 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 122.461 1.124 . . . . 10.0 111.168 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -62.72 -28.51 70.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.909 -1.95 . . . . 10.0 111.161 -178.526 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.92 -122.73 6.52 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.964 -0.854 . . . . 10.0 110.964 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -53.94 131.82 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 117.06 0.43 . . . . 10.0 110.229 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.575 HD21 HD11 ' A' ' 104' ' ' ILE . 19.4 tp -137.07 142.94 42.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 10.0 111.257 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.1 ptp85 -88.85 79.82 7.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.529 -0.76 . . . . 10.0 111.295 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.725 ' HB ' HG11 ' A' ' 13' ' ' VAL . 11.6 mm -88.76 178.78 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.517 ' N ' ' CG2' ' A' ' 104' ' ' ILE . 22.1 p -134.96 -175.85 4.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.774 -0.824 . . . . 10.0 108.774 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.645 ' HG3' ' HB2' ' A' ' 109' ' ' LEU . 35.5 tt0 -136.71 79.04 1.74 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.934 0.873 . . . . 10.0 112.516 -178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -119.89 22.29 11.58 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.23 -1.35 . . . . 10.0 107.522 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.413 ' HG3' HD12 ' A' ' 109' ' ' LEU . 3.0 pt20 -150.11 -23.6 0.25 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.997 -1.001 . . . . 10.0 113.606 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.645 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 6.8 mp -57.43 -164.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.816 0.341 . . . . 10.0 111.341 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.99 -44.32 73.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.442 -0.344 . . . . 10.0 111.864 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.3 mt -54.06 -52.96 59.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.602 -0.272 . . . . 10.0 111.545 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 113' ' ' ASN . 9.0 t -60.66 -22.02 63.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 10.0 110.692 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 112' ' ' THR . 68.7 m-80 76.91 46.72 0.07 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.609 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 t -152.01 45.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.055 0.455 . . . . 10.0 110.335 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 53.5 m -77.89 45.41 0.52 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.108 0.781 . . . . 10.0 113.108 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.69 -53.65 43.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 122' ' ' SER . 90.5 mttt 61.6 112.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.999 -1.0 . . . . 10.0 113.612 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.732 ' H ' ' HA2' ' A' ' 124' ' ' GLY . 20.2 t80 58.33 19.99 6.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.639 -1.164 . . . . 10.0 111.494 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.0 -43.69 1.48 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.488 -0.863 . . . . 10.0 112.202 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -156.66 38.22 0.32 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.667 0.27 . . . . 10.0 111.013 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . 39.9 ttmt -157.06 -112.94 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.446 -0.343 . . . . 10.0 110.594 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.75 ' O ' ' N ' ' A' ' 124' ' ' GLY . 74.4 m -143.76 -45.35 0.27 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 112.765 0.654 . . . . 10.0 112.765 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.64 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . 0.2 OUTLIER -53.85 55.92 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.487 -0.779 . . . . 10.0 112.132 -177.196 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.75 ' N ' ' O ' ' A' ' 122' ' ' SER . . . -51.63 130.19 34.58 Favored Glycine 0 CA--C 1.509 -0.341 0 CA-C-N 115.135 -0.939 . . . . 10.0 111.802 178.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -70.74 127.41 32.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.549 0.69 . . . . 10.0 111.524 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.52 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.1 p -123.02 155.77 28.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.783 -1.099 . . . . 10.0 109.944 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.41 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 8.1 ptpp? -154.77 143.9 21.07 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.132 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.461 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 23.8 m -152.61 140.02 19.6 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.578 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 p30 45.28 48.39 10.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.045 0.45 . . . . 10.0 111.219 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.42 97.15 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.647 -0.787 . . . . 10.0 111.773 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.7 ptp180 -130.08 136.94 49.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.653 0.263 . . . . 10.0 110.581 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 3.7 mp -88.9 138.56 31.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.661 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.576 HG12 ' CB ' ' A' ' 22' ' ' ALA . 5.5 mt -156.92 144.64 10.84 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-N 116.465 -0.334 . . . . 10.0 111.741 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.489 ' CG2' ' HB3' ' A' ' 123' ' ' LYS . 2.2 mp -99.69 146.82 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.532 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 56.5 t80 -141.36 151.22 43.36 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.494 -0.482 . . . . 10.0 110.98 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.615 ' N ' ' CD1' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -169.09 150.64 4.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.146 0.795 . . . . 10.0 113.146 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.413 ' O ' HG21 ' A' ' 138' ' ' ILE . 38.5 t70 -95.26 32.74 1.67 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.885 -1.052 . . . . 10.0 110.127 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.803 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 10.1 tt 38.69 23.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 114.836 -1.075 . . . . 10.0 113.683 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.6 t0 -75.79 -58.28 3.38 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.545 0.943 . . . . 10.0 113.545 -178.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' A' ' 140' ' ' LYS . 7.2 mmpt? -78.23 -31.94 49.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.042 0.448 . . . . 10.0 110.698 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.803 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -65.17 -45.25 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.04 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.611 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.7 tp -65.49 -46.61 89.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.506 -0.478 . . . . 10.0 110.861 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -48.46 -40.82 27.63 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.993 0.425 . . . . 10.0 110.159 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.436 ' HA ' ' CG1' ' A' ' 147' ' ' VAL . 49.1 mt-10 -68.67 -36.85 79.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.69 -0.686 . . . . 10.0 110.11 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 141' ' ' ILE . 35.4 mt -53.62 -41.43 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.151 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.8 p -76.56 -49.93 15.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.785 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.436 ' CG1' ' HA ' ' A' ' 144' ' ' GLU . 14.7 p -75.33 1.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 112.082 0.401 . . . . 10.0 112.082 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.465 ' HD2' ' HB3' ' A' ' 48' ' ' PHE . 23.7 pttm -46.17 -44.63 16.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.873 0.368 . . . . 10.0 111.274 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -61.35 138.06 58.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.939 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.425 ' O ' ' CG1' ' A' ' 151' ' ' VAL . . . -176.74 -44.51 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.79 -0.719 . . . . 10.0 112.499 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 150' ' ' GLY . 11.8 p . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 120.832 0.349 . . . . 10.0 111.522 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.803 0.335 . . . . 10.0 111.203 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.409 ' O ' ' HB ' ' A' ' 3' ' ' THR . 61.0 tttm -171.12 -63.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 7.7 t 171.44 -45.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.492 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.5 mt -69.5 -41.43 76.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.736 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.51 48.33 4.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.936 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -158.43 147.32 18.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.72 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -170.8 133.63 0.96 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.951 0.405 . . . . 10.0 111.442 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.0 mt -74.31 59.25 0.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.172 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 10' ' ' GLU . 18.1 ttpt -138.48 -53.29 0.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.795 0.331 . . . . 10.0 111.419 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 42.6 tt0 -160.21 164.1 33.05 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.691 0.758 . . . . 10.0 111.464 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.57 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 14.6 t80 -158.55 138.91 12.47 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 114.26 -1.336 . . . . 10.0 112.527 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 29.2 mt-10 -88.62 139.47 30.44 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.938 -0.574 . . . . 10.0 109.527 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.713 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -155.47 167.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.752 1.019 . . . . 10.0 113.752 -175.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.498 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 1.7 tm? -89.19 127.83 35.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.231 -0.895 . . . . 10.0 108.677 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.539 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 39.1 t -143.8 156.13 44.38 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.839 0.828 . . . . 10.0 113.131 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.643 ' CE1' ' HG ' ' A' ' 23' ' ' LEU . 1.3 p90 -146.53 160.05 42.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.851 -1.522 . . . . 10.0 109.917 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -88.74 107.2 18.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.469 0.652 . . . . 10.0 110.066 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' A' ' 71' ' ' ILE . 30.6 mm -88.96 90.65 3.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.843 -1.071 . . . . 10.0 111.714 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 9.5 p-10 36.46 60.38 0.9 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.857 -1.065 . . . . 10.0 113.498 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 47.2 mt-10 100.07 -52.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.668 -1.151 . . . . 10.0 111.685 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -89.04 150.17 22.9 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.569 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.76 170.44 10.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.643 ' HG ' ' CE1' ' A' ' 16' ' ' PHE . 1.2 tp -159.06 136.84 10.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.597 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -141.42 152.76 44.56 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.481 0.549 . . . . 10.0 112.481 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE1' ' HZ ' ' A' ' 16' ' ' PHE . 4.9 m-85 -130.04 138.94 51.03 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.293 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -47.49 122.33 4.66 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.899 0.381 . . . . 10.0 110.982 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 14' ' ' LEU . 27.4 m -61.91 -12.79 8.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.073 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.87 -42.51 97.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.96 0.41 . . . . 10.0 110.161 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 85' ' ' ARG . 11.7 t30 -90.06 -47.24 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.895 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.414 HG13 ' HB2' ' A' ' 25' ' ' PHE . 19.7 mm -58.87 128.81 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.004 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' O ' ' CE ' ' A' ' 32' ' ' MET . 54.4 mt-10 -82.66 -65.4 1.02 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.077 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.414 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.7 tpp -169.08 173.71 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 10.0 111.322 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -89.01 150.99 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.488 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.522 HG13 ' HB ' ' A' ' 81' ' ' ILE . 12.7 pt -142.35 121.64 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.647 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.03 118.74 28.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 10.0 109.51 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.506 ' HB3' HD11 ' A' ' 81' ' ' ILE . 23.3 tptm -169.04 163.3 11.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.027 0.442 . . . . 10.0 111.026 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.411 ' N ' ' HG3' ' A' ' 36' ' ' LYS . 38.8 t -152.08 -166.6 2.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.461 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 p30 40.94 37.46 0.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.291 0.567 . . . . 10.0 111.576 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 40' ' ' THR . 9.5 mt -80.31 158.26 4.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.337 -0.847 . . . . 10.0 110.959 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.56 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 84.1 m -18.96 110.05 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.094 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.26 44.97 1.71 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.176 2.584 . . . . 10.0 113.836 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.443 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 39.6 t 51.85 51.41 9.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.843 0.354 . . . . 10.0 111.507 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.474 ' CD ' ' CG2' ' A' ' 40' ' ' THR . 85.4 Cg_endo -77.83 -100.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.612 2.208 . . . . 10.0 111.941 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -51.28 -41.13 60.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.602 0.715 . . . . 10.0 110.092 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.409 ' O ' ' CD2' ' A' ' 47' ' ' HIS . 43.7 t -48.0 -62.0 1.69 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.585 -1.189 . . . . 10.0 111.715 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.497 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 77.9 ttt180 49.79 27.09 2.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.586 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.409 ' CD2' ' O ' ' A' ' 45' ' ' SER . 42.9 m170 -117.01 -157.94 0.68 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 10.0 111.45 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.513 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 7.0 t80 -62.8 -39.15 93.36 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.816 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.462 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 46.8 t -57.04 129.76 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.869 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 16.9 pt-20 -79.79 -37.39 35.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.418 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' O ' HG13 ' A' ' 52' ' ' VAL . . . -161.02 -175.93 32.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.053 -0.594 . . . . 10.0 112.234 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.56 ' H ' ' HB ' ' A' ' 40' ' ' THR . 3.5 m -158.46 175.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 110.163 -0.31 . . . . 10.0 110.163 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 24.3 pt -157.41 144.27 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.64 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -88.74 133.87 34.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 10.0 111.567 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.2 mt -161.04 138.33 9.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.47 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 20.8 tpp180 48.94 48.64 20.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.016 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 53.83 40.4 64.45 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.869 -0.681 . . . . 10.0 112.719 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.491 ' HD3' ' N ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -166.9 130.28 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.873 -0.418 . . . . 10.0 109.873 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.491 ' N ' ' HD3' ' A' ' 58' ' ' ARG . 1.4 mp -88.83 124.79 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.378 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.482 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 28.5 pt -92.75 130.2 37.54 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.974 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 86.3 Cg_endo -81.89 119.65 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.402 2.068 . . . . 10.0 113.252 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 62' ' ' VAL . 27.7 m -98.49 137.25 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.312 -0.625 . . . . 10.0 109.312 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 93' ' ' PHE . 96.6 t -143.0 156.09 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.717 0.77 . . . . 10.0 112.744 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.782 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 76.1 m-20 -73.74 66.09 1.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.704 -1.135 . . . . 10.0 108.33 177.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.769 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.6 tt -49.32 -28.33 4.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.921 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.683 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -61.89 -29.81 70.45 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.821 -0.351 . . . . 10.0 110.953 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.782 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -87.31 -36.94 17.58 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 110.423 -0.214 . . . . 10.0 110.423 178.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.1 tt -61.16 -41.04 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 106.623 -1.621 . . . . 10.0 106.623 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.564 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -76.05 -38.66 56.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 113.407 -1.724 . . . . 10.0 107.972 176.465 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.64 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 70.06 120.82 0.04 OUTLIER Glycine 0 C--N 1.335 0.492 0 CA-C-N 114.827 -1.079 . . . . 10.0 113.154 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.64 HG21 ' O ' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -160.57 -167.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.332 0.653 . . . . 10.0 109.546 -179.146 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.419 ' CB ' ' OD2' ' A' ' 19' ' ' ASP . 29.2 t -53.16 -34.41 56.71 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.683 ' CD2' ' CB ' ' A' ' 66' ' ' ALA . 6.0 t80 -28.57 138.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.608 -1.178 . . . . 10.0 112.95 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 9.2 t70 -160.58 35.66 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.581 -0.736 . . . . 10.0 109.986 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.95 40.01 3.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.502 -0.772 . . . . 10.0 112.194 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.416 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 21.0 mt-30 -95.98 -49.55 5.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.606 0.241 . . . . 10.0 111.29 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 78' ' ' MET . 2.3 mppt? -98.09 -31.76 11.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.506 -0.316 . . . . 10.0 111.629 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.604 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 21.7 mmt -27.01 141.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt 178.62 50.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.79 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.419 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 80.0 p -169.03 155.34 6.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.795 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.522 ' HB ' HG13 ' A' ' 34' ' ' ILE . 61.0 mt -126.88 142.22 43.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.781 -0.367 . . . . 10.0 111.595 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 4.5 mt -119.42 143.72 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.642 -0.253 . . . . 10.0 110.556 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.451 ' CG2' ' CD1' ' A' ' 34' ' ' ILE . 79.9 t -113.62 152.46 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.231 0.539 . . . . 10.0 111.328 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -155.93 173.73 16.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.449 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 6.7 ptm180 -130.4 146.7 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.566 -0.531 . . . . 10.0 109.566 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.501 HG21 HG12 ' A' ' 138' ' ' ILE . 41.1 p -160.47 108.55 1.62 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 36.7 ttmt 46.27 48.76 13.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.386 0.613 . . . . 10.0 110.892 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 72.84 33.67 1.24 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.56 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.497 HG11 HG21 ' A' ' 91' ' ' VAL . 53.8 t -131.75 110.84 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 115.268 -0.878 . . . . 10.0 109.122 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 1.5 mp0 -88.38 97.81 11.26 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.341 -1.726 . . . . 10.0 106.341 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.497 HG21 HG11 ' A' ' 89' ' ' VAL . 3.4 t -88.55 153.18 3.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 113.367 -1.742 . . . . 10.0 112.474 -174.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -130.47 152.95 19.97 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 114.861 -1.063 . . . . 10.0 113.499 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.611 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -139.94 128.03 22.31 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.906 0.384 . . . . 10.0 110.898 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.455 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 50.8 tp -88.57 128.17 35.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.943 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.604 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 19.7 m -136.74 -175.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.971 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -96.88 -65.35 0.97 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.131 0.491 . . . . 10.0 112.188 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.1 tpt85 -135.81 119.25 16.87 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.529 -0.76 . . . . 10.0 109.144 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.603 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 8.6 p -106.29 112.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 122.5 1.143 . . . . 10.0 112.045 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -66.2 -27.93 68.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.825 -1.989 . . . . 10.0 111.305 -178.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.62 -122.15 6.13 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.526 -0.845 . . . . 10.0 111.327 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.0 t -52.49 134.4 14.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.868 0.334 . . . . 10.0 110.569 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.597 HD21 ' CD1' ' A' ' 104' ' ' ILE . 57.7 tp -140.27 141.07 35.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.076 0.465 . . . . 10.0 111.219 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.7 ptp180 -88.92 73.08 8.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.521 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.713 ' HB ' HG11 ' A' ' 13' ' ' VAL . 17.6 mm -88.59 131.8 35.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 109.892 -0.41 . . . . 10.0 109.892 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 22.8 p -88.83 151.1 22.58 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.492 ' HG3' ' HG ' ' A' ' 109' ' ' LEU . 20.4 tt0 -124.49 73.89 1.29 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.123 0.964 . . . . 10.0 112.99 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.425 ' N ' ' OE1' ' A' ' 108' ' ' GLN . 5.7 m120 -113.65 15.67 18.8 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.844 -1.525 . . . . 10.0 107.403 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.5 ' HG2' HD23 ' A' ' 109' ' ' LEU . 6.6 pm0 -142.42 41.08 1.61 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.205 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.5 HD23 ' HG2' ' A' ' 108' ' ' GLN . 1.6 pt? 173.55 51.14 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.68 -1.145 . . . . 10.0 110.661 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -172.72 -49.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.503 -0.771 . . . . 10.0 110.276 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.556 ' O ' ' CG2' ' A' ' 112' ' ' THR . 13.9 tp -94.29 -12.55 27.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.634 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.556 ' CG2' ' O ' ' A' ' 111' ' ' LEU . 15.1 t 56.42 42.31 27.73 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.327 0.651 . . . . 10.0 112.527 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.421 ' OD1' ' CG ' ' A' ' 111' ' ' LEU . 4.6 m120 -95.44 -29.86 14.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.101 0.476 . . . . 10.0 110.221 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 8.5 m -141.71 73.1 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.199 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.3 m -70.92 52.4 0.15 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.56 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.09 28.46 1.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.202 0.525 . . . . 10.0 110.561 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.412 ' HD3' ' CG ' ' A' ' 123' ' ' LYS . 91.9 mttt -46.56 -51.51 15.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.38 -0.827 . . . . 10.0 112.131 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.425 ' CE2' HD13 ' A' ' 69' ' ' LEU . 21.7 t80 -175.8 -53.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.072 0.463 . . . . 10.0 110.241 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 120' ' ' LYS . . . 148.91 -64.66 0.4 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.753 -0.658 . . . . 10.0 112.374 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 119' ' ' GLY . 67.7 mttm -163.61 53.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.673 0.273 . . . . 10.0 110.508 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -151.23 -43.34 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.879 0.326 . . . . 10.0 111.879 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.572 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 89.2 p -126.77 -140.2 0.27 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 121.245 -0.182 . . . . 10.0 111.312 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 123' ' ' LYS . 56.9 tttm -164.88 28.04 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.935 -0.306 . . . . 10.0 111.82 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.487 ' C ' ' HB3' ' A' ' 135' ' ' TYR . . . -151.43 145.66 13.7 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.736 -1.221 . . . . 10.0 113.422 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 126' ' ' VAL . 2.9 tm? -155.54 141.13 17.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 133' ' ' ILE . 1.5 p -160.87 160.94 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.389 0.614 . . . . 10.0 112.29 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 87.1 tttt -164.49 134.25 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.08 -0.964 . . . . 10.0 109.786 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 4.6 m -162.7 151.54 14.85 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 120.924 0.392 . . . . 10.0 111.12 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.42 45.8 21.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.979 0.419 . . . . 10.0 110.746 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.41 33.59 47.18 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.665 -0.778 . . . . 10.0 111.83 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 128' ' ' THR . 12.7 ptt180 -134.93 130.53 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.184 -0.302 . . . . 10.0 110.184 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -88.87 135.23 33.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.852 0.358 . . . . 10.0 110.736 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.569 HG12 ' CB ' ' A' ' 22' ' ' ALA . 3.2 mt -130.8 130.75 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.345 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.536 ' HB ' ' CD1' ' A' ' 23' ' ' LEU . 5.1 mm -88.87 147.45 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.975 -1.12 . . . . 10.0 107.975 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.487 ' HB3' ' C ' ' A' ' 124' ' ' GLY . 32.9 t80 -137.02 141.39 42.5 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.71 -0.796 . . . . 10.0 111.671 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.572 ' HG ' ' HB2' ' A' ' 122' ' ' SER . 6.7 mp -133.32 172.99 11.94 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.067 0.936 . . . . 10.0 112.679 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.432 ' O ' HG21 ' A' ' 138' ' ' ILE . 1.5 m-20 -140.37 24.94 2.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.935 -1.484 . . . . 10.0 108.336 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.79 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 10.3 tt 40.38 19.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.267 -1.333 . . . . 10.0 114.259 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.556 ' O ' HG22 ' A' ' 142' ' ' ILE . 9.1 t0 -82.64 -62.7 1.54 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -75.03 -29.81 60.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.447 0.642 . . . . 10.0 110.073 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.79 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.78 -46.36 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 115.097 -0.956 . . . . 10.0 110.723 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.651 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.6 tp -61.22 -44.56 98.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 119.911 -0.716 . . . . 10.0 109.595 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -49.42 -47.52 47.98 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.829 -0.623 . . . . 10.0 109.985 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 49.5 mm-40 -66.13 -37.36 85.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.477 -0.783 . . . . 10.0 110.948 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 141' ' ' ILE . 60.0 mt -51.4 -43.24 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 120.886 0.374 . . . . 10.0 111.208 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.9 p -87.61 -49.43 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.684 0.624 . . . . 10.0 112.684 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.85 13.03 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.935 0.717 . . . . 10.0 112.935 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.54 ' HA ' ' HE3' ' A' ' 148' ' ' LYS . 2.0 tpmt? -53.99 -45.79 71.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.708 -0.397 . . . . 10.0 111.131 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -57.34 130.88 48.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.084 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 174.28 -46.65 0.14 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.843 -0.694 . . . . 10.0 112.377 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.6 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.828 0.347 . . . . 10.0 111.018 -179.968 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.803 0.335 . . . . 10.0 111.088 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.46 ' O ' ' HB ' ' A' ' 3' ' ' THR . 61.5 tttm -66.47 -74.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.634 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 9.2 t 169.07 -46.9 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.018 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.8 mt -73.57 -42.31 61.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.259 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.97 57.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.824 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.36 135.98 55.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.743 0.306 . . . . 10.0 110.776 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 63.19 144.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.165 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -155.27 55.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.918 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HD2' ' C ' ' A' ' 9' ' ' LYS . 3.4 tmmm? -156.52 -47.74 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.834 -0.621 . . . . 10.0 110.23 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 44.1 tt0 -141.37 163.46 32.89 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.392 0.615 . . . . 10.0 110.8 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.57 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.9 t80 -162.36 138.9 7.79 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.804 -1.089 . . . . 10.0 111.959 -174.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.422 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -88.68 141.22 28.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.722 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -157.43 171.32 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 113.817 1.043 . . . . 10.0 113.817 -176.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.54 ' N ' HG21 ' A' ' 13' ' ' VAL . 3.1 tm? -88.72 136.03 33.21 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.626 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 55.5 p -151.42 156.49 40.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.8 0.81 . . . . 10.0 113.119 -177.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.696 ' CZ ' ' HG ' ' A' ' 23' ' ' LEU . 7.7 p90 -149.67 166.54 29.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.198 -1.365 . . . . 10.0 110.06 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -88.59 140.33 29.56 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.215 -0.661 . . . . 10.0 109.215 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.454 HG23 HD13 ' A' ' 18' ' ' ILE . 35.8 mm -138.8 86.03 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.63 -0.714 . . . . 10.0 111.889 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.8 OUTLIER 51.48 60.03 4.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.808 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 48.4 mt-10 78.56 -35.15 0.18 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.465 -0.788 . . . . 10.0 111.09 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.46 ' NE2' HD11 ' A' ' 134' ' ' ILE . 25.5 tt0 -88.82 139.31 30.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.525 ' CB ' HG12 ' A' ' 133' ' ' ILE . . . -88.75 163.87 15.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 10.0 111.118 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.696 ' HG ' ' CZ ' ' A' ' 16' ' ' PHE . 1.0 OUTLIER -147.01 138.23 24.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.559 . . . . 10.0 111.133 -178.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -138.94 155.28 48.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.523 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.8 m-85 -138.44 138.67 38.38 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.995 -1.002 . . . . 10.0 108.926 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -51.35 121.57 6.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.948 0.404 . . . . 10.0 110.379 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 14' ' ' LEU . 32.2 m -61.37 -11.9 5.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 10.0 111.175 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.99 -41.33 96.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 10.0 110.41 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.438 ' ND2' ' CG2' ' A' ' 138' ' ' ILE . 12.1 t30 -92.51 -46.68 7.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.35 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.413 HG23 ' HG ' ' A' ' 14' ' ' LEU . 27.7 mm -57.67 127.11 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.896 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' CE ' ' A' ' 32' ' ' MET . 54.2 mt-10 -82.93 -63.6 1.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.948 0.351 . . . . 10.0 111.948 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.418 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.8 tpp -169.08 173.91 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.979 0.418 . . . . 10.0 111.381 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -95.61 156.36 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.725 -0.67 . . . . 10.0 111.996 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.421 HG13 ' HB ' ' A' ' 81' ' ' ILE . 17.3 pt -160.05 123.62 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.557 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 48.6 mp0 -89.13 116.92 27.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 10.0 111.214 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.472 ' HB2' ' NZ ' ' A' ' 36' ' ' LYS . 5.0 ttmp? -169.21 63.82 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.801 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 51.9 m -57.12 163.16 2.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.702 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 t70 55.96 50.65 13.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.704 -0.68 . . . . 10.0 112.158 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.514 ' O ' ' C ' ' A' ' 40' ' ' THR . 17.5 mt -77.17 147.54 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.44 -0.345 . . . . 10.0 111.666 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.717 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 55.1 m 3.95 70.57 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.246 -0.888 . . . . 10.0 112.956 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -87.81 -52.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.76 2.307 . . . . 10.0 113.738 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 27.4 m -79.88 -30.38 0.61 Allowed Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 113.341 0.867 . . . . 10.0 113.341 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 42' ' ' VAL . 77.8 Cg_exo -51.51 -71.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.777 1.651 . . . . 10.0 112.95 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' NZ ' ' HB ' ' A' ' 49' ' ' VAL . 32.2 ttpt -67.91 -69.35 0.32 Allowed 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.664 0.745 . . . . 10.0 109.636 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.1 t 50.15 59.51 4.5 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.541 -1.209 . . . . 10.0 111.948 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.8 mmt-85 -148.1 -62.93 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.848 0.314 . . . . 10.0 111.848 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 44' ' ' LYS . 91.1 m-70 -76.42 -170.79 1.59 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 10.0 111.889 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.462 ' CG ' ' HD3' ' A' ' 148' ' ' LYS . 21.3 t80 -71.24 -43.69 66.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.331 -0.85 . . . . 10.0 111.094 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.456 ' HA ' ' CG2' ' A' ' 63' ' ' VAL . 96.8 t -49.23 127.33 4.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.14 0.495 . . . . 10.0 111.261 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.79 -40.18 79.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.463 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -163.02 -175.79 34.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.331 -0.938 . . . . 10.0 113.219 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.717 ' H ' ' HB ' ' A' ' 40' ' ' THR . 1.9 m -147.33 167.83 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.664 -0.495 . . . . 10.0 109.664 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.464 HG22 ' HD2' ' A' ' 36' ' ' LYS . 30.1 pt -158.87 145.48 7.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.942 0.401 . . . . 10.0 111.551 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -88.79 135.57 33.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.001 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 97.3 mt -159.32 138.89 11.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.376 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.2 mmt-85 48.38 45.69 20.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.449 . . . . 10.0 110.786 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.24 41.58 94.96 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.929 -0.653 . . . . 10.0 112.617 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -167.87 133.0 1.86 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.838 0.351 . . . . 10.0 110.97 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.464 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.94 141.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.099 -0.501 . . . . 10.0 111.123 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.504 ' CG2' ' HB2' ' A' ' 90' ' ' GLU . 2.4 pp -126.22 132.51 24.34 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.385 -0.371 . . . . 10.0 111.126 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 83.4 Cg_endo -81.04 115.38 2.99 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.469 2.113 . . . . 10.0 112.889 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.02 135.63 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.456 ' CG2' ' HA ' ' A' ' 49' ' ' VAL . 82.6 t -137.36 154.38 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.791 0.805 . . . . 10.0 113.074 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.407 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 74.6 m-20 -76.7 65.73 2.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.521 -1.218 . . . . 10.0 109.263 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.791 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.6 tt -53.48 -36.35 61.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.158 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.597 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -57.75 -23.47 52.29 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.207 -0.597 . . . . 10.0 109.426 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.629 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -82.86 -48.77 10.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.69 -0.686 . . . . 10.0 110.744 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.791 HG22 ' O ' ' A' ' 65' ' ' LEU . 11.0 tt -58.5 -39.87 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.863 -1.162 . . . . 10.0 107.863 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.614 HD11 HG12 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -76.42 -48.98 17.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 113.711 -1.586 . . . . 10.0 109.795 177.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.521 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 118.56 -93.26 0.56 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.169 -0.539 . . . . 10.0 113.125 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.852 HG13 ' HB3' ' A' ' 73' ' ' PHE . 3.0 pt 48.57 163.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 113.112 0.782 . . . . 10.0 113.112 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 74.8 m -45.29 -36.54 4.12 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.852 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.7 t80 -27.03 141.52 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.546 -1.206 . . . . 10.0 113.005 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 9.0 t70 -161.81 32.15 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.242 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.479 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 94.4 mt-10 54.55 45.54 26.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.938 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -98.2 -36.12 10.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.492 0.553 . . . . 10.0 112.492 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 70.6 mmtt -136.88 17.9 3.04 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.357 0.873 . . . . 10.0 113.357 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.479 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 14.0 mmm -53.93 142.5 24.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.44 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -172.55 42.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.892 0.377 . . . . 10.0 111.267 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.2 p -169.09 158.02 8.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 10.0 110.155 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.421 ' HB ' HG13 ' A' ' 34' ' ' ILE . 45.1 mt -137.35 132.24 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.876 0.369 . . . . 10.0 111.404 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.508 HD13 ' CE2' ' A' ' 16' ' ' PHE . 26.5 mt -105.34 129.96 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.953 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.406 ' CG2' ' CD1' ' A' ' 34' ' ' ILE . 91.7 t -98.81 150.62 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.047 0.451 . . . . 10.0 110.93 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -153.73 174.84 14.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.962 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' CG2' ' A' ' 86' ' ' THR . 23.5 ptt180 -127.39 143.8 51.15 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.538 HG21 HG12 ' A' ' 138' ' ' ILE . 45.5 p -160.02 108.19 1.7 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.532 0.568 . . . . 10.0 112.532 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.4 tppp? 46.44 47.72 13.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.777 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.35 34.32 1.02 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.167 -0.924 . . . . 10.0 111.285 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.51 HG11 HG21 ' A' ' 91' ' ' VAL . 59.0 t -134.0 110.42 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 115.141 -0.936 . . . . 10.0 109.25 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.673 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 83.4 mt-10 -88.23 97.92 11.28 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.51 HG21 HG11 ' A' ' 89' ' ' VAL . 4.5 t -88.55 152.24 3.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.4 -1.727 . . . . 10.0 113.33 -173.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -124.5 157.26 18.79 Favored Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.443 -1.253 . . . . 10.0 113.164 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.592 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -143.84 123.83 13.58 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 120.964 0.412 . . . . 10.0 110.613 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.59 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 64.9 tp -88.74 126.75 35.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.146 0.498 . . . . 10.0 111.179 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.447 HG13 ' CE1' ' A' ' 16' ' ' PHE . 26.8 m -136.88 -175.26 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.697 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 3.0 t0 -88.12 -77.94 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.501 . . . . 10.0 111.253 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 -128.63 107.97 10.13 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.574 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.0 p -88.99 113.79 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 122.434 1.111 . . . . 10.0 111.396 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -62.7 -28.67 70.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.036 -1.893 . . . . 10.0 111.106 -178.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.81 -121.2 5.51 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.777 -0.929 . . . . 10.0 110.777 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.99 126.77 9.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 117.203 0.501 . . . . 10.0 109.769 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.626 ' CD2' ' HB3' ' A' ' 15' ' ' SER . 54.8 tp -128.05 136.16 50.85 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.028 0.442 . . . . 10.0 111.139 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.615 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -88.82 78.64 7.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.584 179.2 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.722 ' HB ' HG11 ' A' ' 13' ' ' VAL . 6.8 mm -88.57 157.39 3.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.832 -0.622 . . . . 10.0 109.454 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 24.0 p -116.65 148.47 40.97 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.056 -1.09 . . . . 10.0 108.056 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 37.1 tt0 -111.77 68.31 0.66 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.996 0.903 . . . . 10.0 112.016 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -99.55 8.31 44.58 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.02 -1.445 . . . . 10.0 108.014 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 113' ' ' ASN . 22.5 pt20 -106.68 -45.7 4.16 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.691 -1.14 . . . . 10.0 110.398 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 mt -85.38 33.79 0.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.115 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.429 ' OD1' ' HG ' ' A' ' 111' ' ' LEU . 6.7 t70 -75.04 120.85 21.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.634 0.254 . . . . 10.0 111.236 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.429 ' HG ' ' OD1' ' A' ' 110' ' ' ASP . 81.9 mt 65.76 -54.57 0.36 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.183 -0.462 . . . . 10.0 112.095 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 113' ' ' ASN . 9.1 t -176.58 56.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.97 0.414 . . . . 10.0 110.557 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 108' ' ' GLN . 5.1 m120 69.47 131.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.693 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 115' ' ' SER . 37.5 t -131.23 42.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.076 0.465 . . . . 10.0 111.146 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 44.7 t 176.03 -151.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.731 -0.668 . . . . 10.0 109.83 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.476 ' O ' ' CG ' ' A' ' 117' ' ' LYS . 2.3 p30 -91.04 -125.74 0.08 Allowed 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.61 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 37.8 mttp -166.53 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.161 0.505 . . . . 10.0 110.086 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.499 ' CZ ' HD13 ' A' ' 69' ' ' LEU . 55.9 t80 -176.34 -51.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.309 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.88 -42.67 0.45 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.708 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.435 ' O ' ' HD3' ' A' ' 120' ' ' LYS . 0.1 OUTLIER 179.85 40.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.622 ' O ' ' HB3' ' A' ' 122' ' ' SER . 2.9 tppp? -177.92 116.74 0.09 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.157 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.622 ' HB3' ' O ' ' A' ' 121' ' ' LYS . 13.2 t 81.26 143.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.903 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.61 ' HA ' ' HB3' ' A' ' 117' ' ' LYS . 22.0 pttp -105.13 30.9 5.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.962 0.727 . . . . 10.0 112.962 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -134.38 143.53 15.23 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 119.792 -1.194 . . . . 10.0 112.9 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 2.2 tm? -153.5 134.31 13.82 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.812 -0.44 . . . . 10.0 109.812 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 133' ' ' ILE . 1.8 p -149.58 162.31 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.962 0.41 . . . . 10.0 111.593 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.488 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -165.91 132.24 2.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.203 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.499 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 15.6 m -163.91 157.47 18.68 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.354 -0.384 . . . . 10.0 110.662 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' N ' ' CG2' ' A' ' 128' ' ' THR . 63.1 m-20 58.16 44.57 18.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.958 0.409 . . . . 10.0 110.735 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.59 32.16 38.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.65 -0.786 . . . . 10.0 111.764 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 128' ' ' THR . 3.2 ptp180 -138.89 136.14 35.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 10.0 110.417 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.92 143.46 26.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.733 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.6 ' O ' HG13 ' A' ' 126' ' ' VAL . 4.3 mt -137.43 129.19 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 10.0 111.567 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.517 ' O ' HD11 ' A' ' 23' ' ' LEU . 1.4 mp -88.97 134.54 28.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.475 ' O ' ' CA ' ' A' ' 124' ' ' GLY . 31.1 t80 -118.31 136.09 53.91 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.514 0.673 . . . . 10.0 111.467 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.561 ' HG ' ' OG ' ' A' ' 122' ' ' SER . 6.1 mp -126.81 172.39 10.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.127 0.965 . . . . 10.0 112.603 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.449 ' O ' HG21 ' A' ' 138' ' ' ILE . 9.8 t70 -144.2 26.59 1.48 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.635 -1.62 . . . . 10.0 107.211 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.808 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 11.9 tt 40.4 17.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 113.846 -1.525 . . . . 10.0 114.349 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 142' ' ' ILE . 7.8 t0 -79.53 -61.73 1.91 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.794 0.665 . . . . 10.0 112.794 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -77.05 -30.88 55.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.457 0.646 . . . . 10.0 110.341 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.808 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.89 -45.69 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 114.97 -1.014 . . . . 10.0 110.63 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.676 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 7.9 tp -65.91 -43.04 93.06 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 C-N-CA 119.898 -0.721 . . . . 10.0 110.034 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -46.47 -46.7 19.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.312 0.577 . . . . 10.0 109.788 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 148' ' ' LYS . 61.0 mm-40 -68.89 -39.58 79.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.205 -0.907 . . . . 10.0 110.761 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 141' ' ' ILE . 56.4 mt -48.52 -44.02 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.83 0.347 . . . . 10.0 111.505 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.9 p -75.57 -51.35 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 10.0 112.152 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' A' ' 144' ' ' GLU . 12.9 p -70.79 -6.22 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.461 0.541 . . . . 10.0 112.461 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -50.55 -44.23 56.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.814 0.34 . . . . 10.0 110.754 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 56.73 -168.22 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.497 . . . . 10.0 111.204 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.9 -40.62 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.048 -0.596 . . . . 10.0 112.08 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 10.0 111.072 179.922 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.872 0.367 . . . . 10.0 111.092 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.404 ' O ' ' CG2' ' A' ' 3' ' ' THR . 5.8 ptpp? -94.29 -119.91 0.1 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.593 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 2' ' ' LYS . 72.5 p -160.67 -46.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 69.4 mt -67.63 -34.33 76.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.613 -0.721 . . . . 10.0 109.995 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -139.65 -160.37 1.06 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.012 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -151.27 129.95 12.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.109 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.4 142.61 47.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.445 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.7 mt -148.12 43.29 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.502 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -92.32 -49.98 5.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.22 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 83.4 mt-10 -138.77 164.3 29.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.522 0.677 . . . . 10.0 111.301 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.613 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.3 t80 -161.83 139.62 8.89 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.573 -1.194 . . . . 10.0 112.501 -174.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 24.5 pt-20 -88.68 140.01 29.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.52 -0.919 . . . . 10.0 108.52 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.76 HG11 ' HB ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -155.47 171.28 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 N-CA-C 114.084 1.142 . . . . 10.0 114.084 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' N ' ' CG2' ' A' ' 13' ' ' VAL . 2.8 tm? -88.81 134.73 33.84 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.505 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 82.6 p -146.17 152.12 38.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 113.242 0.831 . . . . 10.0 113.242 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.627 ' CE1' ' HG ' ' A' ' 23' ' ' LEU . 2.4 p90 -149.43 166.81 27.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.181 -1.372 . . . . 10.0 109.991 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.447 ' HG3' HD21 ' A' ' 99' ' ' LEU . 94.8 mt-10 -88.56 139.36 30.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.253 0.549 . . . . 10.0 109.745 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.439 HG22 ' CD1' ' A' ' 71' ' ' ILE . 28.5 mm -138.96 103.27 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.364 -0.834 . . . . 10.0 110.957 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.9 OUTLIER 42.69 60.15 2.53 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.533 0.568 . . . . 10.0 112.533 179.331 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 86.7 mt-10 80.82 -42.89 0.2 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.385 -0.825 . . . . 10.0 111.912 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.503 ' HB2' HD21 ' A' ' 132' ' ' LEU . 17.3 pt20 -88.97 154.41 20.24 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.526 ' O ' HG12 ' A' ' 134' ' ' ILE . . . -88.91 168.52 12.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HG ' ' CE1' ' A' ' 16' ' ' PHE . 1.0 OUTLIER -152.31 135.6 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.617 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -140.34 153.81 46.53 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.846 0.684 . . . . 10.0 112.846 -177.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.597 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.8 m-85 -135.54 143.07 45.52 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.071 -0.714 . . . . 10.0 109.071 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 36.6 t70 -49.39 124.24 8.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.18 0.514 . . . . 10.0 110.806 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 14' ' ' LEU . 30.1 m -64.76 -9.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.37 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.57 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 1.3 m-20 -72.0 -43.26 65.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.663 ' OD1' ' O ' ' A' ' 85' ' ' ARG . 10.1 t30 -80.78 -49.77 10.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.776 -1.102 . . . . 10.0 110.071 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.474 HG13 ' HB2' ' A' ' 25' ' ' PHE . 21.9 mm -62.32 134.2 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.013 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' O ' ' CE ' ' A' ' 32' ' ' MET . 4.5 mm-40 -94.09 -68.77 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.745 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.409 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.1 172.46 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.097 0.475 . . . . 10.0 111.087 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.54 145.8 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.571 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.446 HG21 HD11 ' A' ' 34' ' ' ILE . 11.1 pt -142.46 122.74 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.868 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 48.7 mt-10 -88.98 104.31 16.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.834 -0.432 . . . . 10.0 109.834 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 35' ' ' GLU . 67.9 mttm -161.34 69.79 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.218 0.451 . . . . 10.0 112.218 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.4 t -63.63 -169.46 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.797 0.332 . . . . 10.0 110.51 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 9.5 t70 45.32 47.67 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.018 0.437 . . . . 10.0 111.556 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.495 HG21 HG23 ' A' ' 53' ' ' ILE . 28.4 mt -82.32 -100.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.11 -0.495 . . . . 10.0 111.319 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.571 ' CG2' ' CD ' ' A' ' 43' ' ' PRO . 20.0 m -102.83 122.78 44.6 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 122.905 0.482 . . . . 10.0 109.888 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.94 36.3 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.81 2.34 . . . . 10.0 114.66 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.736 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 41.1 t 57.78 48.26 2.73 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.859 0.361 . . . . 10.0 111.2 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.736 ' HD3' ' N ' ' A' ' 42' ' ' VAL . 6.1 Cg_exo -76.19 -74.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.808 2.338 . . . . 10.0 111.059 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -77.95 -33.75 51.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.446 0.641 . . . . 10.0 110.111 178.17 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.444 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 26.6 t -40.41 150.58 0.06 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.665 -1.152 . . . . 10.0 112.92 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.401 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 27.0 mmm180 -84.57 40.93 0.82 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.418 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.401 ' HB3' ' O ' ' A' ' 46' ' ' ARG . 30.9 t-80 70.97 -49.6 0.68 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CE1' ' HE3' ' A' ' 67' ' ' LYS . 2.0 t80 -54.84 -52.25 63.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.604 0.24 . . . . 10.0 111.637 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.437 ' CG2' ' HE2' ' A' ' 148' ' ' LYS . 61.6 t -68.56 131.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 10.0 111.39 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 16.7 pt-20 -78.06 -39.12 42.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.983 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.515 ' HA2' ' HB ' ' A' ' 40' ' ' THR . . . -158.06 179.36 33.82 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.314 -0.946 . . . . 10.0 113.275 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.505 ' H ' ' HB ' ' A' ' 40' ' ' THR . 3.2 m -162.54 171.72 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.495 HG23 HG21 ' A' ' 39' ' ' ILE . 31.7 pt -159.8 138.92 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 10.0 112.069 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.435 ' ND2' ' CD1' ' A' ' 59' ' ' ILE . 21.3 t-20 -114.18 118.87 35.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.078 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 54' ' ' ASN . 3.5 mm? -144.48 135.22 24.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.765 0.317 . . . . 10.0 111.487 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 42.66 51.09 5.01 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.669 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.24 42.56 97.32 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.711 -0.757 . . . . 10.0 112.454 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -145.49 119.31 9.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 10.0 110.396 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.507 ' CD1' ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -110.05 140.86 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.988 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.0 pp -142.61 134.62 13.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.919 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 72.1 Cg_endo -99.7 114.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.178 2.585 . . . . 10.0 113.169 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 62' ' ' VAL . 29.1 m -89.0 134.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.457 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 92.0 t -143.21 154.2 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.736 0.779 . . . . 10.0 112.957 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.402 ' N ' ' CG1' ' A' ' 63' ' ' VAL . 74.5 m-20 -73.29 67.17 0.96 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.662 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.77 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.9 tt -53.58 -34.17 57.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.121 -178.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.645 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -61.27 -22.13 64.56 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.325 -0.55 . . . . 10.0 109.642 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.478 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.6 tmmm? -83.85 -50.14 8.37 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.835 -0.62 . . . . 10.0 109.945 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.0 tt -54.25 -40.12 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 107.602 -1.258 . . . . 10.0 107.602 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD11 HG12 ' A' ' 71' ' ' ILE . 0.6 OUTLIER -77.67 -47.3 19.56 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.526 -1.67 . . . . 10.0 109.383 177.49 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.491 ' N ' HD11 ' A' ' 69' ' ' LEU . . . 116.63 -92.78 0.57 Allowed Glycine 0 C--N 1.337 0.63 0 CA-C-N 115.975 -0.557 . . . . 10.0 113.193 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.899 HG13 ' HB3' ' A' ' 73' ' ' PHE . 2.9 pt 48.25 164.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 45.2 t -45.83 -34.9 4.04 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.899 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.7 t80 -31.48 143.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.582 -1.19 . . . . 10.0 113.09 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -173.53 41.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.071 -0.968 . . . . 10.0 109.888 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 62.92 41.6 8.4 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.782 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -72.44 -49.05 36.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.05 -0.523 . . . . 10.0 112.388 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.03 18.92 0.68 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.371 -0.532 . . . . 10.0 112.346 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.47 ' HE3' ' CD1' ' A' ' 73' ' ' PHE . 3.4 mmm -53.14 146.61 11.22 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.149 -0.315 . . . . 10.0 110.149 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HE2' ' OD1' ' A' ' 96' ' ' ASP . 48.2 mtmt -159.39 -45.85 0.05 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.779 0.323 . . . . 10.0 111.533 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.8 m -88.87 133.38 34.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.211 0.529 . . . . 10.0 111.332 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.43 ' HB ' HG13 ' A' ' 34' ' ' ILE . 25.9 mt -89.65 151.09 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.526 -0.761 . . . . 10.0 111.527 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.512 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 23.1 mt -115.04 156.6 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 10.0 110.291 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 41.3 t -133.61 148.73 30.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.931 0.396 . . . . 10.0 110.995 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.677 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -152.89 175.86 12.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.798 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.663 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 52.6 ttm-85 -133.08 132.6 41.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.873 -0.417 . . . . 10.0 109.873 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.556 ' OG1' ' HB ' ' A' ' 89' ' ' VAL . 65.4 p -141.53 102.14 4.13 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.378 0.609 . . . . 10.0 111.602 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 15.1 tppt? 48.56 48.26 19.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.005 -0.998 . . . . 10.0 110.771 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 13.5 m-20 80.17 27.32 0.3 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.917 -1.038 . . . . 10.0 111.999 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.556 ' HB ' ' OG1' ' A' ' 86' ' ' THR . 51.6 t -124.59 108.98 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.057 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 33.9 tt0 -88.37 97.88 11.3 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.373 -1.714 . . . . 10.0 106.373 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.499 HG21 HG11 ' A' ' 89' ' ' VAL . 3.2 t -88.57 158.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 113.123 -1.853 . . . . 10.0 112.14 -174.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.13 143.03 14.6 Favored Glycine 0 C--N 1.317 -0.486 0 C-N-CA 120.234 -0.984 . . . . 10.0 113.833 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.599 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -131.38 128.77 40.29 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.453 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 65.5 tp -88.52 133.52 34.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.437 0.636 . . . . 10.0 111.904 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.532 HG13 ' CE1' ' A' ' 16' ' ' PHE . 27.6 m -147.28 -175.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.014 -0.994 . . . . 10.0 110.209 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.444 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 16.0 t70 -109.94 -58.44 2.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.551 0.574 . . . . 10.0 112.551 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -127.83 122.72 33.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.383 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.592 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.3 p -116.35 117.78 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 122.3 1.048 . . . . 10.0 111.643 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -69.71 -29.33 66.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.183 -1.826 . . . . 10.0 110.852 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.33 -125.59 7.73 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.778 -0.725 . . . . 10.0 111.701 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.8 t -50.84 132.27 11.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 117.079 0.44 . . . . 10.0 110.367 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.582 ' HG ' HG12 ' A' ' 104' ' ' ILE . 51.8 tp -135.69 139.9 44.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.019 0.437 . . . . 10.0 111.519 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.3 ptp180 -88.85 76.26 7.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.453 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.76 ' HB ' HG11 ' A' ' 13' ' ' VAL . 14.3 mm -88.73 168.37 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 22.4 p -131.67 148.08 52.56 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.426 -0.953 . . . . 10.0 108.426 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 109' ' ' LEU . 81.0 tt0 -106.4 72.07 0.9 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.894 0.854 . . . . 10.0 112.466 -177.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -108.48 21.09 17.77 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.408 ' O ' ' CD2' ' A' ' 109' ' ' LEU . 19.6 pt20 -176.26 68.57 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.61 -1.177 . . . . 10.0 111.699 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.607 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 78.4 mt -154.02 -42.02 0.09 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.098 -0.955 . . . . 10.0 111.485 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 111' ' ' LEU . 36.5 t70 -155.32 154.22 31.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 10.0 111.216 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 110' ' ' ASP . 56.4 tp 72.29 -57.46 0.62 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.179 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.7 t -62.1 -46.68 87.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.04 0.447 . . . . 10.0 110.892 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 m120 44.27 46.74 7.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.571 -0.741 . . . . 10.0 111.568 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.411 ' HB ' ' NZ ' ' A' ' 117' ' ' LYS . 68.3 t -62.95 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.528 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.8 t 179.63 167.47 1.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.838 0.351 . . . . 10.0 111.549 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 1.5 m-20 -52.32 -33.62 43.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.947 -0.569 . . . . 10.0 111.23 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.51 ' HB3' ' CB ' ' A' ' 125' ' ' LEU . 46.2 mmtm 71.82 -56.61 0.64 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.12 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.459 ' CZ ' HD13 ' A' ' 69' ' ' LEU . 2.9 t80 -108.59 -51.99 2.82 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.686 -0.406 . . . . 10.0 110.428 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.22 -145.26 10.53 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.529 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -87.43 -38.1 16.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.941 0.401 . . . . 10.0 110.93 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.472 ' NZ ' ' HB2' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -55.25 -33.23 62.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.696 -179.195 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.419 ' OG ' ' HG ' ' A' ' 136' ' ' LEU . 37.3 t -150.17 -149.94 0.32 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.108 -0.237 . . . . 10.0 111.18 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.478 ' NZ ' ' HB3' ' A' ' 123' ' ' LYS . 4.2 mmmp? -158.46 -25.41 0.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.632 0.605 . . . . 10.0 112.632 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.526 ' HA3' ' HB3' ' A' ' 135' ' ' TYR . . . -74.35 137.81 23.32 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.182 -1.008 . . . . 10.0 113.914 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.51 ' CB ' ' HB3' ' A' ' 117' ' ' LYS . 1.7 tm? -158.1 79.92 0.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.504 ' CG1' ' HB ' ' A' ' 133' ' ' ILE . 1.8 p -88.82 163.6 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.177 -0.919 . . . . 10.0 112.021 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 39.7 ttmt -163.66 132.76 3.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.663 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 129' ' ' ASP . 16.1 m -161.92 158.81 25.85 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 120.925 0.393 . . . . 10.0 111.435 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.451 ' N ' ' CG2' ' A' ' 128' ' ' THR . 9.4 p-10 44.6 52.89 7.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.69 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.6 37.13 41.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.541 -0.838 . . . . 10.0 111.98 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -146.06 126.46 14.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -88.95 144.74 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.458 . . . . 10.0 110.607 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.524 HG12 ' CB ' ' A' ' 22' ' ' ALA . 5.9 mt -133.91 139.77 47.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.548 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 22' ' ' ALA . 4.3 mm -88.81 143.71 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.413 -0.958 . . . . 10.0 108.413 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.526 ' HB3' ' HA3' ' A' ' 124' ' ' GLY . 38.1 t80 -138.77 136.46 35.74 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.609 0.719 . . . . 10.0 111.824 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.465 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 4.3 mp -129.43 149.8 51.06 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.719 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.509 ' O ' HG21 ' A' ' 138' ' ' ILE . 9.9 t70 -113.65 19.61 16.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.253 -1.339 . . . . 10.0 107.623 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.801 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.4 tt 39.19 20.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 114.283 -1.326 . . . . 10.0 113.67 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.7 t0 -81.89 -60.83 2.1 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.72 0.637 . . . . 10.0 112.72 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -75.48 -32.72 60.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.534 0.683 . . . . 10.0 109.915 -179.645 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.801 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.28 -45.25 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 114.911 -1.04 . . . . 10.0 110.558 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.668 ' CG2' ' O ' ' A' ' 138' ' ' ILE . 8.0 tp -61.99 -46.02 97.41 Favored 'Isoleucine or valine' 0 C--N 1.337 0.054 0 C-N-CA 120.339 -0.545 . . . . 10.0 110.14 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 139' ' ' ASP . 51.9 mt-10 -49.24 -43.76 43.04 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.192 0.52 . . . . 10.0 109.72 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -66.25 -32.13 73.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.323 -0.853 . . . . 10.0 110.555 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 141' ' ' ILE . 31.1 mt -58.98 -42.15 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 120.926 0.393 . . . . 10.0 110.85 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.3 p -79.8 -50.26 10.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.771 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.9 p -75.78 0.96 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.437 ' HE2' ' CG2' ' A' ' 49' ' ' VAL . 23.0 pttp -45.22 -46.48 12.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.837 0.351 . . . . 10.0 111.229 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.96 134.24 49.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.841 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 178.31 43.71 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.636 -0.793 . . . . 10.0 112.513 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 10.0 111.009 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.793 0.33 . . . . 10.0 110.406 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.624 ' HG3' HG22 ' A' ' 105' ' ' THR . 29.3 mp0 -103.88 164.31 11.78 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.426 0.631 . . . . 10.0 110.975 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.641 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 17.5 t80 -161.4 140.11 9.77 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.936 -1.029 . . . . 10.0 112.963 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 27' ' ' VAL . 32.6 mt-10 -88.71 140.54 29.34 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.639 -0.709 . . . . 10.0 109.622 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.788 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -155.85 168.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 113.093 0.775 . . . . 10.0 113.093 -175.131 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.938 HD11 HD13 ' A' ' 82' ' ' ILE . 2.3 tm? -88.89 134.2 34.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.521 -1.289 . . . . 10.0 107.521 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.792 ' HB3' HD22 ' A' ' 102' ' ' LEU . 81.1 p -143.03 152.97 42.48 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.717 ' CE1' HG11 ' A' ' 95' ' ' VAL . 6.1 p90 -150.42 167.6 26.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.299 -1.319 . . . . 10.0 110.297 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -88.55 138.5 31.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.682 -0.488 . . . . 10.0 109.682 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.989 HG21 HD12 ' A' ' 71' ' ' ILE . 33.4 mm -136.56 93.23 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.335 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 50.1 m-20 45.59 60.08 3.28 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.593 -0.731 . . . . 10.0 112.513 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.6 mt-10 83.73 -39.99 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.29 -0.868 . . . . 10.0 112.081 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.3 pt20 -88.91 149.55 23.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.164 -0.31 . . . . 10.0 110.164 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.027 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.55 159.52 17.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.338 . . . . 10.0 110.893 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.857 HD13 ' HB ' ' A' ' 134' ' ' ILE . 2.1 tp -147.67 136.88 22.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.768 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.801 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -136.92 146.87 45.99 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.517 0.562 . . . . 10.0 112.517 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.003 ' CE2' HD13 ' A' ' 65' ' ' LEU . 2.0 m-30 -121.47 135.87 55.0 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.585 -0.894 . . . . 10.0 108.585 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.562 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 28.3 t70 -44.2 100.95 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.581 0.705 . . . . 10.0 110.499 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 6.2 p -50.37 -14.44 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.648 -1.16 . . . . 10.0 111.978 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.562 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 7.6 m-20 -64.51 -44.65 90.23 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.468 -0.493 . . . . 10.0 109.906 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.657 HD21 HG22 ' A' ' 86' ' ' THR . 22.6 t-20 -83.24 -41.51 18.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.725 -0.671 . . . . 10.0 110.733 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.758 HG21 ' HG ' ' A' ' 14' ' ' LEU . 32.9 mm -59.64 123.5 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.58 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 32' ' ' MET . 66.6 mm-40 -81.97 -61.89 1.78 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.01 0.374 . . . . 10.0 112.01 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.6 mtm -169.04 157.27 7.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 10.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.507 HG11 HG11 ' A' ' 98' ' ' VAL . 33.7 m -88.92 137.16 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.934 -0.576 . . . . 10.0 111.228 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.519 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 11.4 pt -123.96 135.53 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.345 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -88.99 118.74 28.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.518 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.834 ' HB3' HD12 ' A' ' 81' ' ' ILE . 39.5 ttmt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.759 ' HA ' HG22 ' A' ' 63' ' ' VAL . 49.0 t . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.958 0.409 . . . . 10.0 110.917 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -68.86 -30.5 69.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.3 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.636 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -166.82 -175.91 37.39 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.536 -0.84 . . . . 10.0 112.959 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 61' ' ' PRO . 2.9 m -160.42 170.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.123 -0.695 . . . . 10.0 109.123 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 60' ' ' ILE . 30.1 pt . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 120.992 0.425 . . . . 10.0 111.884 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.814 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.594 0.235 . . . . 10.0 110.983 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 85.0 Cg_endo -92.83 124.42 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.932 2.422 . . . . 10.0 112.735 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.636 HG22 ' C ' ' A' ' 51' ' ' GLY . 23.2 m -102.79 125.34 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.788 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.878 HG12 ' H ' ' A' ' 64' ' ' ASN . 14.0 t -130.66 -175.9 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.283 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.878 ' H ' HG12 ' A' ' 63' ' ' VAL . 5.2 m120 -120.24 96.85 5.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.71 -0.223 . . . . 10.0 110.526 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.003 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.1 tt -56.21 -32.13 64.11 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.273 0.559 . . . . 10.0 109.838 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.998 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -61.74 -24.52 66.86 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.23 -0.441 . . . . 10.0 109.884 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.442 ' C ' ' HD2' ' A' ' 67' ' ' LYS . 1.4 tmmm? -82.28 -44.04 16.77 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.295 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.7 tt -64.58 -40.85 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.447 -0.946 . . . . 10.0 108.447 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.039 HD21 ' CE2' ' A' ' 118' ' ' PHE . 0.7 OUTLIER -77.88 -53.01 7.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 113.903 -1.499 . . . . 10.0 109.487 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 118.93 -80.48 0.32 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 115.454 -0.794 . . . . 10.0 112.702 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.998 HD11 ' CB ' ' A' ' 66' ' ' ALA . 3.3 pt 45.19 178.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.7 m -55.44 -37.53 67.82 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 109.054 -0.721 . . . . 10.0 109.054 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.841 ' HB3' HG13 ' A' ' 71' ' ' ILE . 16.1 t80 -31.07 143.92 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.772 -1.104 . . . . 10.0 112.995 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 9.4 t70 -169.84 39.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.351 -0.84 . . . . 10.0 109.702 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 78' ' ' MET . 94.9 mt-10 56.13 39.04 30.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.034 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -87.24 -63.76 1.26 Allowed 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 112.327 0.492 . . . . 10.0 112.327 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -108.35 16.24 23.3 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.538 0.57 . . . . 10.0 112.538 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.482 ' HE2' ' HD1' ' A' ' 73' ' ' PHE . 17.7 mmt -52.86 138.33 29.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.907 -0.133 . . . . 10.0 110.963 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -159.46 -48.63 0.05 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.524 0.565 . . . . 10.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.414 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 65.1 m -88.94 163.75 15.44 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.803 0.298 . . . . 10.0 111.803 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.834 HD12 ' HB3' ' A' ' 36' ' ' LYS . 72.6 mt -127.7 154.15 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.031 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.938 HD13 HD11 ' A' ' 14' ' ' LEU . 11.8 mt -128.15 146.12 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.421 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.14 149.93 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.438 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -156.86 130.61 8.23 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.497 -0.32 . . . . 10.0 111.776 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -88.8 133.17 34.34 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.715 -0.846 . . . . 10.0 108.715 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.657 HG22 HD21 ' A' ' 29' ' ' ASN . 43.8 p -147.63 108.61 4.22 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.669 0.618 . . . . 10.0 112.669 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 47.78 49.25 16.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.705 -0.68 . . . . 10.0 110.82 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 70.41 33.65 2.44 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.216 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.953 HG12 HG22 ' A' ' 91' ' ' VAL . 76.8 t -133.56 111.63 16.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.24 -0.891 . . . . 10.0 109.34 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.755 ' HB2' HG22 ' A' ' 60' ' ' ILE . 39.8 mt-10 -88.56 92.45 9.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.114 -1.439 . . . . 10.0 107.114 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.065 HG21 HD13 ' A' ' 142' ' ' ILE . 2.7 t -88.66 158.15 3.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 112.796 -2.002 . . . . 10.0 111.719 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -138.11 144.6 15.88 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 120.165 -1.016 . . . . 10.0 113.458 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 t80 -133.36 122.02 23.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.777 0.323 . . . . 10.0 110.618 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 95' ' ' VAL . 6.5 tt -88.85 132.56 34.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.141 0.496 . . . . 10.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.717 HG11 ' CE1' ' A' ' 16' ' ' PHE . 15.9 m -130.94 -175.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.431 -0.804 . . . . 10.0 111.373 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -81.27 -75.95 0.26 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.153 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -134.27 107.17 7.51 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.282 -0.872 . . . . 10.0 108.733 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.617 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -88.97 116.99 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 122.418 1.104 . . . . 10.0 111.967 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.607 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -68.75 -27.59 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.909 -1.95 . . . . 10.0 110.715 -178.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.74 -126.58 8.34 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.635 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -52.28 133.14 14.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.976 0.388 . . . . 10.0 110.754 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.792 HD22 ' HB3' ' A' ' 15' ' ' SER . 43.9 tp -137.7 138.33 39.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.059 0.457 . . . . 10.0 110.854 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.6 ptp180 -88.8 72.74 8.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.198 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.034 HD12 HG21 ' A' ' 126' ' ' VAL . 14.3 mm -88.98 131.62 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.771 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.624 HG22 ' HG3' ' A' ' 10' ' ' GLU . 20.6 p -88.76 147.24 24.56 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.356 -1.72 . . . . 10.0 106.356 175.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -134.47 81.77 1.93 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.365 -0.934 . . . . 10.0 113.08 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -76.05 -5.28 45.7 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.296 -0.865 . . . . 10.0 109.343 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.335 -179.766 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 1.039 ' CE2' HD21 ' A' ' 69' ' ' LEU . 4.3 t80 . . . . . 0 CA--C 1.515 -0.377 0 CA-C-O 121.534 0.683 . . . . 10.0 109.487 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 122' ' ' SER . . . -74.2 35.6 0.94 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.857 -1.065 . . . . 10.0 113.351 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -79.34 -32.63 43.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.346 0.593 . . . . 10.0 109.452 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 17.1 tppt? -156.9 32.99 0.3 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.195 -0.911 . . . . 10.0 110.112 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.643 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 79.6 p . . . . . 0 CA--C 1.53 0.193 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.211 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 1.034 HG21 HD12 ' A' ' 104' ' ' ILE . 2.3 p . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 121.34 0.59 . . . . 10.0 111.605 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.483 ' HB3' ' NZ ' ' A' ' 127' ' ' LYS . 7.2 ttpm? -152.14 140.31 20.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 18.7 m -159.67 144.63 15.32 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.887 0.375 . . . . 10.0 111.109 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 131' ' ' ARG . 2.9 p30 45.95 48.36 12.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.615 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.07 42.41 81.2 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.711 -0.757 . . . . 10.0 112.383 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.494 ' HD2' HD11 ' A' ' 133' ' ' ILE . 0.7 OUTLIER -136.25 139.93 43.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.823 0.344 . . . . 10.0 110.454 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.1 mp -88.87 137.28 32.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.98 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.027 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.0 mt -156.03 151.36 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.551 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.857 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.7 mp -101.41 144.69 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.467 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 35.6 t80 -139.75 142.64 36.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.839 -0.744 . . . . 10.0 111.973 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.855 HD22 ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -158.1 144.17 17.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.644 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 9.2 t70 -97.2 33.99 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.718 . . . . 10.0 110.004 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.855 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 18.5 tt 42.4 20.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.048 -0.978 . . . . 10.0 113.337 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -77.14 -54.97 5.85 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -79.21 -30.66 43.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.151 0.5 . . . . 10.0 110.937 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.855 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.46 -45.33 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.657 -0.701 . . . . 10.0 110.199 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.065 HD13 HG21 ' A' ' 91' ' ' VAL . 8.3 tp -67.17 -45.5 86.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 120.622 -0.431 . . . . 10.0 110.538 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.662 ' O ' HG12 ' A' ' 147' ' ' VAL . 15.0 tp10 -48.05 -43.21 30.18 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.374 0.607 . . . . 10.0 109.64 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.663 ' HB2' HD11 ' A' ' 68' ' ' ILE . 55.5 mm-40 -72.44 -31.33 65.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.083 -0.962 . . . . 10.0 110.865 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.751 HG13 ' O ' ' A' ' 141' ' ' ILE . 38.6 mt -54.99 -41.59 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.942 0.401 . . . . 10.0 110.652 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.8 p -81.01 -52.26 7.62 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.926 -0.579 . . . . 10.0 112.162 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 143' ' ' GLU . 10.8 p -82.14 13.1 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.697 0.284 . . . . 10.0 111.739 -178.869 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HG3' ' HG3' ' A' ' 10' ' ' GLU . 21.0 ptmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.89 0.376 . . . . 10.0 110.964 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 105' ' ' THR . 39.8 mt-10 -117.7 164.26 15.25 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.319 0.58 . . . . 10.0 110.471 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.576 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 15.5 t80 -157.25 137.16 12.47 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.005 -0.998 . . . . 10.0 112.748 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -88.73 139.86 30.04 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.476 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.98 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.1 p -156.06 171.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.948 HD11 HD13 ' A' ' 82' ' ' ILE . 3.3 tm? -88.92 137.18 32.55 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.871 ' HB3' HD22 ' A' ' 102' ' ' LEU . 76.7 p -149.19 153.62 37.92 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.685 0.995 . . . . 10.0 113.685 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.781 ' CE2' HG11 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -147.18 156.43 42.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.154 -1.384 . . . . 10.0 110.142 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -88.77 99.91 12.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.388 0.613 . . . . 10.0 109.868 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.992 HG21 HD12 ' A' ' 71' ' ' ILE . 27.6 mm -88.91 101.36 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.034 -0.985 . . . . 10.0 111.866 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.1 m-20 46.18 60.15 3.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.566 -0.743 . . . . 10.0 112.926 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.7 mt-10 86.6 -39.63 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.385 -0.825 . . . . 10.0 112.015 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.754 ' OE1' HD22 ' A' ' 132' ' ' LEU . 16.5 pt20 -88.83 -175.61 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.788 -0.449 . . . . 10.0 109.788 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.016 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -115.43 158.11 22.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.171 0.51 . . . . 10.0 111.472 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.909 HD12 ' N ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -145.39 133.3 21.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.144 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.909 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -137.05 149.43 47.42 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.717 1.006 . . . . 10.0 113.717 -177.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.923 ' CE2' HD21 ' A' ' 136' ' ' LEU . 0.9 OUTLIER -132.18 138.11 47.87 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.634 -1.167 . . . . 10.0 108.329 178.725 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -49.0 122.69 6.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.066 0.46 . . . . 10.0 111.325 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.98 HG13 ' HA ' ' A' ' 13' ' ' VAL . 23.9 m -61.05 -14.24 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.63 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.14 -39.78 91.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.068 0.461 . . . . 10.0 110.22 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.753 HD21 HG22 ' A' ' 86' ' ' THR . 20.6 t-20 -95.49 -44.77 7.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.245 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.728 HG21 ' HG ' ' A' ' 14' ' ' LEU . 28.1 mm -57.32 129.53 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.59 -0.277 . . . . 10.0 110.471 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 32' ' ' MET . 50.4 mt-10 -88.32 -61.6 1.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.5 mtm -169.03 157.95 8.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.983 0.42 . . . . 10.0 111.563 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 98' ' ' VAL . 33.8 m -88.87 151.16 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.474 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.543 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 13.5 pt -154.13 134.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.01 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.93 111.81 24.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 10.0 110.608 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.699 -179.758 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.948 ' HA ' HG22 ' A' ' 63' ' ' VAL . 48.7 t . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.872 0.367 . . . . 10.0 110.902 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.545 ' HG3' HG23 ' A' ' 62' ' ' VAL . 12.3 pt-20 -74.9 -37.82 62.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.146 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 62' ' ' VAL . . . -168.02 -175.86 38.08 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.958 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 61' ' ' PRO . 2.5 m -154.16 170.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.839 -0.43 . . . . 10.0 109.839 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.468 HG12 HD11 ' A' ' 60' ' ' ILE . 30.9 pt . . . . . 0 C--N 1.324 -0.524 0 CA-C-O 120.867 0.365 . . . . 10.0 111.084 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.804 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.523 0.202 . . . . 10.0 110.935 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 79.5 Cg_endo -92.02 114.31 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.762 2.308 . . . . 10.0 113.383 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 49' ' ' VAL . 23.0 m -91.05 136.03 25.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.948 HG22 ' HA ' ' A' ' 49' ' ' VAL . 62.7 t -139.09 159.01 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.719 0.771 . . . . 10.0 112.92 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.529 ' N ' HG12 ' A' ' 63' ' ' VAL . 5.7 m120 -74.14 63.0 0.95 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.745 -1.116 . . . . 10.0 109.062 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.863 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.9 tt -53.69 -32.21 50.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.763 -0.653 . . . . 10.0 111.22 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.853 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -62.85 -24.09 67.61 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.259 -0.576 . . . . 10.0 109.872 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -83.06 -45.41 14.05 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.137 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.813 HG22 ' O ' ' A' ' 65' ' ' LEU . 9.6 tt -57.73 -38.67 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 107.687 -1.227 . . . . 10.0 107.687 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.879 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.22 -47.15 18.61 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.801 -1.545 . . . . 10.0 108.473 177.127 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 117.67 -90.5 0.5 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.456 -0.793 . . . . 10.0 112.714 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.992 HD12 HG21 ' A' ' 18' ' ' ILE . 3.2 pt 47.66 165.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.399 0.889 . . . . 10.0 113.399 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.6 m -47.05 -37.77 9.99 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.18 -0.674 . . . . 10.0 109.18 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.863 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.6 t80 -28.08 141.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.395 -1.275 . . . . 10.0 113.283 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -166.79 37.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.241 -0.891 . . . . 10.0 110.235 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 55.94 32.67 20.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.78 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.433 ' NE2' ' OD2' ' A' ' 19' ' ' ASP . 22.3 pt20 -95.42 -44.41 7.56 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -113.2 13.94 19.32 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.23 0.456 . . . . 10.0 112.23 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.42 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 29.5 mmt -59.8 140.62 56.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.904 0.383 . . . . 10.0 111.686 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 14.4 ptmm? -179.64 39.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.817 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.895 ' O ' HD12 ' A' ' 94' ' ' LEU . 47.3 t -169.19 164.85 11.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.543 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 43.6 mt -139.84 152.25 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.961 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.948 HD13 HD11 ' A' ' 14' ' ' LEU . 9.8 mt -131.36 130.35 62.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.727 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 84' ' ' ALA . 74.6 t -98.24 156.83 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.051 0.453 . . . . 10.0 111.307 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.654 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -156.52 172.1 19.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.617 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -130.6 130.7 44.34 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.753 HG22 HD21 ' A' ' 29' ' ' ASN . 46.7 p -145.36 109.27 4.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 87' ' ' LYS . 8.1 ttpt 48.02 49.89 16.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.614 0.721 . . . . 10.0 110.689 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 71.0 32.13 2.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.037 -0.983 . . . . 10.0 111.484 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.926 HG12 HG22 ' A' ' 91' ' ' VAL . 71.4 t -129.01 109.52 18.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.275 -0.875 . . . . 10.0 109.192 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.776 ' HB2' HG22 ' A' ' 60' ' ' ILE . 25.0 mp0 -88.35 97.36 11.0 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.278 -1.749 . . . . 10.0 106.278 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.017 HG21 HD13 ' A' ' 142' ' ' ILE . 3.6 t -88.55 153.55 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 113.291 -1.777 . . . . 10.0 113.016 -174.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.97 158.03 18.47 Favored Glycine 0 C--N 1.317 -0.485 0 CA-C-N 114.495 -1.229 . . . . 10.0 113.185 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.644 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -146.95 128.11 14.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.873 0.368 . . . . 10.0 110.915 -179.168 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.895 HD12 ' O ' ' A' ' 80' ' ' SER . 52.1 tp -88.66 128.14 35.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.999 0.428 . . . . 10.0 110.751 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.781 HG11 ' CE2' ' A' ' 16' ' ' PHE . 29.8 m -137.01 -175.11 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.428 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 45.8 t0 -92.96 -73.33 0.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.354 0.597 . . . . 10.0 111.17 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.494 ' NH1' HD22 ' A' ' 99' ' ' LEU . 57.9 ttt-85 -137.63 120.81 16.8 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.196 -0.911 . . . . 10.0 108.616 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.649 HG23 ' HD1' ' A' ' 16' ' ' PHE . 7.1 p -101.69 117.12 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 122.361 1.077 . . . . 10.0 112.898 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -65.42 -28.82 69.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.083 -1.871 . . . . 10.0 111.059 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.57 -122.63 6.57 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.552 -0.833 . . . . 10.0 111.171 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.97 133.59 16.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 117.045 0.422 . . . . 10.0 110.322 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.871 HD22 ' HB3' ' A' ' 15' ' ' SER . 57.2 tp -136.17 137.72 41.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.989 0.423 . . . . 10.0 111.048 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.9 ptp180 -88.85 71.73 8.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.315 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.04 HD12 HG21 ' A' ' 126' ' ' VAL . 14.2 mm -88.84 128.45 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.732 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.613 HG22 ' HG2' ' A' ' 10' ' ' GLU . 18.5 p -88.68 147.59 24.44 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.655 -1.609 . . . . 10.0 106.655 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -137.07 79.08 1.73 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.443 -0.903 . . . . 10.0 112.663 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -72.98 -10.6 59.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.619 -0.719 . . . . 10.0 109.533 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-N 115.443 -0.799 . . . . 10.0 110.932 -179.701 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.684 ' CE1' HD21 ' A' ' 69' ' ' LEU . 56.6 t80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.11 0.481 . . . . 10.0 110.55 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 150.53 -54.5 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.568 -0.742 . . . . 10.0 112.091 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 54.9 tptt 173.85 60.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.978 0.418 . . . . 10.0 110.063 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.463 ' HB3' ' CE2' ' A' ' 118' ' ' PHE . 4.2 tppp? -154.47 -39.43 0.09 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.658 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.654 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 94.9 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.561 -0.291 . . . . 10.0 110.724 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 1.04 HG21 HD12 ' A' ' 104' ' ' ILE . 2.4 p . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 121.452 0.644 . . . . 10.0 112.28 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -158.95 138.45 11.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.497 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 7.0 m -165.01 146.83 7.86 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.926 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 54.79 42.71 30.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.986 0.422 . . . . 10.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.4 37.68 60.67 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.836 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -130.15 136.58 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.273 -0.269 . . . . 10.0 110.273 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.882 HD23 ' N ' ' A' ' 133' ' ' ILE . 4.7 tt -88.93 136.75 32.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.605 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.016 HG12 ' HB3' ' A' ' 22' ' ' ALA . 6.0 mt -154.01 143.48 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 10.0 110.789 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.909 ' HB ' HD13 ' A' ' 23' ' ' LEU . 2.0 mp -96.1 134.8 32.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 109.072 -0.714 . . . . 10.0 109.072 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.582 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 41.1 t80 -129.33 140.4 51.4 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.773 -0.771 . . . . 10.0 111.385 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.923 HD21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -159.97 151.2 19.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.36 0.6 . . . . 10.0 111.881 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 139' ' ' ASP . 1.4 m-20 -102.33 37.87 1.8 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.498 -0.774 . . . . 10.0 110.501 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.874 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 19.8 tt 39.63 20.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.58 -1.191 . . . . 10.0 113.653 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 137' ' ' ASP . 37.9 t70 -79.53 -57.45 3.68 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 122' ' ' SER . 31.2 mmmt -76.92 -32.5 57.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 10.0 110.356 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.874 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.78 -45.68 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.183 -0.917 . . . . 10.0 110.489 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.017 HD13 HG21 ' A' ' 91' ' ' VAL . 7.5 tp -64.13 -44.82 97.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 120.375 -0.53 . . . . 10.0 109.953 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 142' ' ' ILE . 44.7 tt0 -48.13 -43.16 30.92 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 68' ' ' ILE . 44.5 mt-10 -69.99 -32.89 71.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.236 -0.893 . . . . 10.0 110.58 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.698 ' CD1' HG11 ' A' ' 91' ' ' VAL . 34.1 mt -55.51 -40.38 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 120.953 0.406 . . . . 10.0 110.801 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.6 p -77.74 -50.63 12.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.873 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.6 p -77.89 5.06 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.088 0.403 . . . . 10.0 112.088 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.9 pttm . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.696 0.284 . . . . 10.0 111.638 -179.356 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 105' ' ' THR . 22.8 tptm . . . . . 0 CA--C 1.526 0.036 0 N-CA-C 111.835 0.309 . . . . 10.0 111.835 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.592 ' HG2' HG22 ' A' ' 105' ' ' THR . 34.2 mt-10 -121.69 164.28 17.63 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.738 0.78 . . . . 10.0 111.513 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.569 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 12.7 t80 -158.76 136.71 10.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.268 -1.333 . . . . 10.0 112.259 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.75 140.76 29.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.655 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.859 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -157.99 171.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 113.583 0.957 . . . . 10.0 113.583 -174.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.998 HD11 HD13 ' A' ' 82' ' ' ILE . 2.0 tm? -88.77 132.1 34.77 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.855 ' CB ' HD22 ' A' ' 102' ' ' LEU . 80.9 p -143.7 156.92 44.69 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.542 0.942 . . . . 10.0 113.542 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.767 ' CD1' HD11 ' A' ' 82' ' ' ILE . 4.1 p90 -153.11 158.35 41.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.902 -1.499 . . . . 10.0 109.81 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -88.58 125.4 34.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.351 0.596 . . . . 10.0 109.556 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.83 HG21 HD12 ' A' ' 71' ' ' ILE . 32.9 mm -115.09 81.03 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.51 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 58.8 m-20 52.29 60.26 3.94 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.957 -0.565 . . . . 10.0 112.12 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 8.2 mp0 80.96 -31.97 0.11 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.261 -0.881 . . . . 10.0 111.771 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -88.81 137.82 31.97 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.076 -0.712 . . . . 10.0 109.076 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.008 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.65 155.09 19.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.044 0.45 . . . . 10.0 111.21 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.882 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.8 tp -148.14 140.85 24.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.355 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.766 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -144.99 155.93 43.67 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.893 0.701 . . . . 10.0 112.893 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.863 ' CE2' HD22 ' A' ' 136' ' ' LEU . 3.3 m-85 -136.4 141.21 43.62 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.319 -0.855 . . . . 10.0 109.187 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.07 120.54 5.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.195 0.521 . . . . 10.0 110.692 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.859 HG13 ' HA ' ' A' ' 13' ' ' VAL . 34.2 m -60.36 -12.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.048 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -62.14 -46.86 87.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.006 0.431 . . . . 10.0 110.376 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.828 ' OD1' HG21 ' A' ' 138' ' ' ILE . 7.2 t-20 -86.67 -45.33 11.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.924 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.718 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.4 mm -57.71 126.8 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.784 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.11 -65.78 0.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.533 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -169.13 168.77 9.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 10.0 111.683 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.404 ' HB ' HG11 ' A' ' 98' ' ' VAL . 35.2 m -88.86 148.4 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.366 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.43 HD12 ' HD2' ' A' ' 36' ' ' LYS . 17.6 pt -150.85 128.81 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -88.85 63.76 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.446 . . . . 10.0 111.234 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.948 ' HB2' HD12 ' A' ' 81' ' ' ILE . 68.6 mttm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.205 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.585 ' HA ' HG22 ' A' ' 63' ' ' VAL . 48.0 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.921 0.391 . . . . 10.0 111.57 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -61.02 -29.19 69.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.962 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.741 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -152.21 168.19 31.36 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.435 -0.888 . . . . 10.0 112.926 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 2.3 m -160.18 167.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.94 -0.393 . . . . 10.0 109.94 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.504 HG12 HD11 ' A' ' 60' ' ' ILE . 29.7 pt . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.226 0.536 . . . . 10.0 112.068 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.806 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.435 0.159 . . . . 10.0 111.202 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 50.6 Cg_endo -95.67 124.92 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.413 2.742 . . . . 10.0 113.431 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.741 HG22 ' C ' ' A' ' 51' ' ' GLY . 27.0 m -103.54 135.63 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.76 -0.459 . . . . 10.0 109.76 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 49' ' ' VAL . 91.3 t -142.27 156.34 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.49 0.662 . . . . 10.0 112.379 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.79 ' OD1' HD23 ' A' ' 94' ' ' LEU . 74.5 m-20 -72.69 74.98 1.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.151 -0.931 . . . . 10.0 109.364 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.872 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.8 tt -54.87 -35.89 64.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.286 0.565 . . . . 10.0 110.859 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.819 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -59.87 -20.9 59.82 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.447 -0.501 . . . . 10.0 109.687 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -83.15 -49.42 9.5 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.098 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.709 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.2 tt -58.32 -39.59 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.707 -1.22 . . . . 10.0 107.707 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.972 HD12 HD13 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -79.89 -36.05 37.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.267 -1.788 . . . . 10.0 109.573 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.612 ' O ' HD13 ' A' ' 69' ' ' LEU . . . 67.16 124.45 0.02 OUTLIER Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.676 -0.693 . . . . 10.0 112.89 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.972 HD13 HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -165.4 -168.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.727 0.411 . . . . 10.0 110.859 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 67.0 m -48.43 -35.02 11.96 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -31.3 135.82 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.251 -1.341 . . . . 10.0 113.53 176.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' A' ' 75' ' ' GLU . 64.2 t0 -129.33 -65.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.156 -0.929 . . . . 10.0 110.038 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER 157.58 -27.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.332 -0.394 . . . . 10.0 111.468 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.476 ' N ' ' OE1' ' A' ' 75' ' ' GLU . 24.9 pt20 -60.06 -48.32 82.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -77.87 -45.07 25.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.975 0.417 . . . . 10.0 111.592 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 96' ' ' ASP . 18.5 mmm -35.62 141.58 0.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.633 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -169.4 -28.95 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.829 ' O ' HD12 ' A' ' 94' ' ' LEU . 48.1 t -88.85 -175.96 5.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.628 0.252 . . . . 10.0 111.095 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.948 HD12 ' HB2' ' A' ' 36' ' ' LYS . 57.9 mt -156.61 140.48 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.954 0.407 . . . . 10.0 111.508 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.998 HD13 HD11 ' A' ' 14' ' ' LEU . 13.5 mt -113.27 150.12 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.607 . . . . 10.0 110.669 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.54 149.71 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.919 0.39 . . . . 10.0 110.852 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -151.3 -175.9 5.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.126 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.529 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 14.6 ptm180 -135.9 144.41 45.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.713 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.527 HG21 HG12 ' A' ' 138' ' ' ILE . 34.8 p -160.16 109.47 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 10.0 112.083 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.3 tppp? 47.19 47.16 16.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.691 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 53.0 m-20 74.18 33.54 0.91 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.144 -0.935 . . . . 10.0 111.279 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.878 HG12 HG22 ' A' ' 91' ' ' VAL . 60.4 t -130.47 110.14 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-N 115.215 -0.902 . . . . 10.0 109.485 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 46.1 mt-10 -88.35 100.62 13.16 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.515 -2.032 . . . . 10.0 105.515 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.983 HG21 HD13 ' A' ' 142' ' ' ILE . 5.0 t -88.62 153.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 113.343 -1.753 . . . . 10.0 113.482 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.491 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -123.1 155.1 17.24 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 114.231 -1.349 . . . . 10.0 112.707 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.579 ' HD1' ' N ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -144.43 126.66 15.69 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 120.963 0.411 . . . . 10.0 110.963 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.829 HD12 ' O ' ' A' ' 80' ' ' SER . 55.6 tp -88.64 130.27 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.111 0.482 . . . . 10.0 110.833 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.515 HG11 ' CD2' ' A' ' 16' ' ' PHE . 27.3 m -140.61 -175.27 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.961 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' MET . 19.8 t70 -93.92 -73.05 0.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.196 0.522 . . . . 10.0 111.161 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -131.27 115.42 16.28 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.341 -0.845 . . . . 10.0 108.923 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 8.7 p -98.02 111.7 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-O 122.354 1.074 . . . . 10.0 111.455 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -64.22 -27.15 68.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.062 -1.881 . . . . 10.0 111.131 -178.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.99 -121.42 5.51 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.949 -0.86 . . . . 10.0 110.949 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.4 t -52.86 129.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 117.145 0.472 . . . . 10.0 109.908 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.855 HD22 ' CB ' ' A' ' 15' ' ' SER . 60.8 tp -132.98 139.22 47.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.144 0.497 . . . . 10.0 111.226 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 15.9 ptp180 -88.89 71.27 8.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.564 -0.744 . . . . 10.0 109.641 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.828 HD12 HG11 ' A' ' 126' ' ' VAL . 6.4 mm -88.8 126.76 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.783 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.592 HG22 ' HG2' ' A' ' 10' ' ' GLU . 16.9 p -88.57 145.25 25.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.944 -1.873 . . . . 10.0 105.944 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.406 ' OE1' ' HG2' ' A' ' 108' ' ' GLN . 2.4 tp10 -147.33 89.51 1.79 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.845 -1.142 . . . . 10.0 112.846 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -86.43 7.56 25.31 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.552 -0.749 . . . . 10.0 109.5 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.406 ' HG2' ' OE1' ' A' ' 106' ' ' GLU . 55.8 mm-40 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-N 115.576 -0.738 . . . . 10.0 111.003 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.686 ' CE2' HD21 ' A' ' 69' ' ' LEU . 29.8 t80 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.092 0.472 . . . . 10.0 110.305 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 156.6 -53.25 0.41 Allowed Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.647 -0.706 . . . . 10.0 112.038 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 27.4 tptp 174.81 57.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 10.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -153.02 -42.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.41 -0.359 . . . . 10.0 111.888 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.767 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 93.6 p . . . . . 0 C--N 1.328 -0.362 0 C-N-CA 121.017 -0.273 . . . . 10.0 111.692 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.828 HG11 HD12 ' A' ' 104' ' ' ILE . 1.2 p . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 121.419 0.628 . . . . 10.0 112.366 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.512 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -165.6 135.15 3.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.08 -0.964 . . . . 10.0 109.744 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 4.3 m -159.51 152.58 22.01 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.031 0.443 . . . . 10.0 111.304 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.4 t70 55.81 47.07 21.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.773 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.72 33.55 49.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.513 -0.851 . . . . 10.0 111.663 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.6 ptp180 -138.78 134.0 32.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.348 . . . . 10.0 110.332 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' A' ' 127' ' ' LYS . 85.6 mt -88.88 148.52 23.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.172 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.008 HG12 ' HB3' ' A' ' 22' ' ' ALA . 2.9 mt -147.97 132.31 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.656 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.882 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.3 mp -88.78 141.2 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.593 ' C ' HD12 ' A' ' 136' ' ' LEU . 24.4 t80 -125.95 147.22 49.56 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.521 0.677 . . . . 10.0 111.595 -178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.863 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.7 mp -140.3 165.73 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.042 0.925 . . . . 10.0 112.86 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -135.21 26.16 3.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.849 -1.523 . . . . 10.0 107.833 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.871 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.4 tt 42.29 16.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.929 -1.487 . . . . 10.0 114.353 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.29 -60.29 2.33 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.671 0.619 . . . . 10.0 112.671 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.453 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.6 mptt -76.02 -29.76 58.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.437 0.637 . . . . 10.0 110.396 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.871 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.11 -46.96 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.137 -0.938 . . . . 10.0 110.715 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.983 HD13 HG21 ' A' ' 91' ' ' VAL . 7.6 tp -63.0 -43.95 99.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 120.012 -0.675 . . . . 10.0 109.624 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.695 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.4 tt0 -48.11 -46.61 34.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.635 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.65 ' HB2' HD11 ' A' ' 68' ' ' ILE . 56.0 mm-40 -73.52 -30.51 63.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.432 -0.804 . . . . 10.0 110.574 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.709 HD13 HG11 ' A' ' 91' ' ' VAL . 35.8 mt -54.69 -31.77 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 120.899 0.38 . . . . 10.0 110.788 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.3 p -96.47 -49.19 5.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.983 -0.553 . . . . 10.0 112.402 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 143' ' ' GLU . 10.3 p -85.49 13.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.875 0.694 . . . . 10.0 112.875 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 N-CA-C 111.789 0.292 . . . . 10.0 111.789 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.685 ' HG2' ' HG3' ' A' ' 10' ' ' GLU . 56.8 tttm . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.91 0.385 . . . . 10.0 110.747 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.685 ' HG3' ' HG2' ' A' ' 9' ' ' LYS . 88.3 mt-10 -149.04 164.24 35.2 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.356 0.598 . . . . 10.0 110.33 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.64 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.8 t80 -156.6 138.8 14.64 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.014 -0.993 . . . . 10.0 112.531 -174.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.417 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 12.3 pt-20 -88.81 138.85 31.04 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.915 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -155.94 166.62 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.62 0.724 . . . . 10.0 112.937 -177.367 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.648 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 3.0 tm? -88.88 133.5 34.26 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.843 ' CB ' HD22 ' A' ' 102' ' ' LEU . 37.2 t -153.29 151.39 29.96 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 1.041 ' CE2' HG11 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -138.49 174.98 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.288 -1.324 . . . . 10.0 110.773 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -88.58 139.77 30.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.348 -0.982 . . . . 10.0 108.348 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.008 HG21 HD12 ' A' ' 71' ' ' ILE . 21.0 mm -146.97 76.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.828 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.587 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 1.1 m-20 58.12 51.83 8.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.943 0.402 . . . . 10.0 111.281 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 38.4 mt-10 85.88 -25.64 0.11 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.224 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -88.82 130.64 35.34 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 110.237 -0.283 . . . . 10.0 110.237 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.004 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.66 114.32 25.15 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.651 ' HB2' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -88.85 136.6 32.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.096 -177.216 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -143.18 142.29 31.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.255 0.55 . . . . 10.0 112.344 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.844 ' CD2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -131.4 138.35 49.07 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.235 -1.024 . . . . 10.0 108.235 178.396 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' OD1' ' CB ' ' A' ' 28' ' ' ASP . 9.6 t0 -49.15 120.76 4.21 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.628 -0.429 . . . . 10.0 110.817 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.915 HG13 ' HA ' ' A' ' 13' ' ' VAL . 19.1 m -57.98 -14.94 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.235 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' CB ' ' OD1' ' A' ' 26' ' ' ASP . 7.2 t70 -63.02 -36.2 82.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.162 0.505 . . . . 10.0 109.898 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.803 HD21 HG22 ' A' ' 86' ' ' THR . 15.8 t-20 -95.19 -45.89 7.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.506 -0.77 . . . . 10.0 111.362 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.645 HG21 ' HG ' ' A' ' 14' ' ' LEU . 23.3 mm -61.35 132.31 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 120.823 0.344 . . . . 10.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' O ' ' CE ' ' A' ' 32' ' ' MET . 50.5 mt-10 -87.95 -64.46 1.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.962 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.424 ' HB2' ' HE2' ' A' ' 32' ' ' MET . 6.4 tpp -169.07 173.03 7.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.39 . . . . 10.0 110.855 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.728 HG11 HG11 ' A' ' 98' ' ' VAL . 34.0 m -100.31 126.76 53.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.781 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.68 HG13 ' HB ' ' A' ' 81' ' ' ILE . 11.9 pt -103.88 155.45 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.124 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -88.79 -175.78 5.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.991 -0.549 . . . . 10.0 111.171 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.416 ' CE ' ' HB3' ' A' ' 79' ' ' LYS . 19.3 ptpt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.025 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.926 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.7 t . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.846 0.355 . . . . 10.0 111.12 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.508 ' HG3' HG23 ' A' ' 62' ' ' VAL . 15.7 pt-20 -69.64 -40.73 76.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.611 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.584 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -165.91 -175.95 36.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.551 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 61' ' ' PRO . 2.0 m -155.31 168.88 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.248 -0.278 . . . . 10.0 110.248 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.827 HD11 HD11 ' A' ' 60' ' ' ILE . 26.2 pt . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 120.766 0.317 . . . . 10.0 111.463 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.016 HG22 ' HB2' ' A' ' 90' ' ' GLU . 29.1 pt . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.621 0.248 . . . . 10.0 111.345 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.803 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 85.0 Cg_endo -82.54 115.91 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.507 2.138 . . . . 10.0 112.808 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.584 HG22 ' C ' ' A' ' 51' ' ' GLY . 23.1 m -88.98 133.39 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.168 -0.679 . . . . 10.0 109.168 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.926 HG22 ' HA ' ' A' ' 49' ' ' VAL . 59.5 t -145.17 157.79 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.799 0.809 . . . . 10.0 113.153 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.527 ' N ' HG12 ' A' ' 63' ' ' VAL . 5.2 m120 -78.15 66.71 3.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.391 -1.277 . . . . 10.0 108.698 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.791 ' O ' HD23 ' A' ' 65' ' ' LEU . 6.4 tt -53.88 -29.35 41.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.837 -0.62 . . . . 10.0 111.531 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.635 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -64.89 -25.84 68.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.54 -0.541 . . . . 10.0 109.54 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 64' ' ' ASN . 24.1 ttpt -77.91 -52.13 9.32 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.236 -0.893 . . . . 10.0 111.0 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.691 HG22 ' HA ' ' A' ' 65' ' ' LEU . 10.3 tt -53.82 -40.17 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.884 ' C ' HD13 ' A' ' 69' ' ' LEU . 1.1 tm? -75.72 -44.99 39.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.545 -1.661 . . . . 10.0 109.534 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.529 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 113.06 -95.65 0.78 Allowed Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.049 -0.523 . . . . 10.0 113.133 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.008 HD12 HG21 ' A' ' 18' ' ' ILE . 3.6 pt 48.66 164.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.097 0.777 . . . . 10.0 113.097 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.2 m -47.03 -36.81 8.39 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.158 -0.682 . . . . 10.0 109.158 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.885 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.0 t80 -26.09 140.09 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.791 -1.095 . . . . 10.0 112.808 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -160.31 34.66 0.17 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.248 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.521 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 50.4 mt-10 52.53 46.93 25.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.247 0.462 . . . . 10.0 112.247 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 77' ' ' LYS . 23.9 pt20 -97.87 -47.2 5.65 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.55 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 14.3 mmmm -108.96 -25.15 10.88 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.362 0.505 . . . . 10.0 112.362 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.64 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 3.2 mmm -35.94 144.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.724 0.409 . . . . 10.0 111.972 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 51.5 mtmt -160.7 -45.06 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.201 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.437 ' O ' HD12 ' A' ' 94' ' ' LEU . 74.5 m -88.86 142.86 27.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.994 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.68 ' HB ' HG13 ' A' ' 34' ' ' ILE . 73.6 mt -100.66 160.52 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.314 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.575 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 31.8 mt -123.63 158.74 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.591 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.512 ' N ' HG22 ' A' ' 82' ' ' ILE . 42.7 t -131.68 150.77 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.032 0.444 . . . . 10.0 111.222 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -156.15 171.78 19.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.896 -178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -128.24 129.05 45.82 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.803 HG22 HD21 ' A' ' 29' ' ' ASN . 67.1 p -145.51 108.27 4.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.879 0.325 . . . . 10.0 111.879 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 88' ' ' ASP . 14.9 tppt? 47.4 59.95 3.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.211 0.529 . . . . 10.0 110.269 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.492 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 2.4 p30 59.16 32.54 22.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.828 -1.078 . . . . 10.0 111.59 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.908 HG12 HG22 ' A' ' 91' ' ' VAL . 66.1 t -128.58 109.34 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 115.3 -0.864 . . . . 10.0 109.156 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 1.016 ' HB2' HG22 ' A' ' 60' ' ' ILE . 34.1 mt-10 -88.28 97.78 11.22 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.281 -1.748 . . . . 10.0 106.281 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.018 HG21 HD13 ' A' ' 142' ' ' ILE . 3.4 t -88.46 152.23 3.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 113.478 -1.692 . . . . 10.0 113.059 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.56 148.4 17.19 Favored Glycine 0 C--N 1.316 -0.547 0 CA-C-N 114.66 -1.155 . . . . 10.0 113.494 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.646 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -138.76 124.78 20.02 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.75 0.309 . . . . 10.0 110.45 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.566 HD13 HG12 ' A' ' 81' ' ' ILE . 54.7 tp -88.62 130.07 35.36 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.603 0.594 . . . . 10.0 112.603 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.041 HG11 ' CE2' ' A' ' 16' ' ' PHE . 34.2 m -143.55 -175.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 115.33 -0.85 . . . . 10.0 110.504 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 78' ' ' MET . 28.5 t70 -108.7 -62.96 1.39 Allowed 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 112.599 0.592 . . . . 10.0 112.599 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 16' ' ' PHE . 13.6 tpt180 -119.34 117.9 29.78 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.41 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.765 HG23 ' HD1' ' A' ' 16' ' ' PHE . 7.0 p -112.52 115.42 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 122.432 1.11 . . . . 10.0 111.502 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -65.84 -31.21 72.03 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 112.962 -1.926 . . . . 10.0 110.809 -178.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.55 -124.53 6.99 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.258 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.1 t -53.05 129.65 13.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.909 0.354 . . . . 10.0 110.129 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.843 HD22 ' CB ' ' A' ' 15' ' ' SER . 59.7 tp -132.68 138.9 47.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.994 0.426 . . . . 10.0 111.177 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.618 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -88.82 70.16 8.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.984 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.664 HG12 ' HG ' ' A' ' 102' ' ' LEU . 8.8 mm -88.94 130.87 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.656 HG22 ' HG2' ' A' ' 10' ' ' GLU . 32.0 p -88.75 -175.89 5.05 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.605 -1.257 . . . . 10.0 107.605 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -147.9 73.03 1.25 Allowed 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 118.929 -1.108 . . . . 10.0 112.79 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -102.57 20.79 16.45 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.701 -1.136 . . . . 10.0 109.1 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 115.474 -0.784 . . . . 10.0 111.382 -179.284 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.678 ' CE2' HD21 ' A' ' 69' ' ' LEU . 32.3 t80 . . . . . 0 N--CA 1.462 0.131 0 CA-C-O 121.011 0.434 . . . . 10.0 110.772 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.76 -137.73 7.15 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.564 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 120' ' ' LYS . 63.9 tttp -80.54 58.25 3.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.875 0.369 . . . . 10.0 110.934 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.597 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 16.2 tppt? -161.26 -40.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 10.0 110.804 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.408 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 88.0 p . . . . . 0 C--N 1.326 -0.424 0 N-CA-C 108.68 -0.859 . . . . 10.0 108.68 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.535 HG11 HD12 ' A' ' 104' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.934 0.397 . . . . 10.0 111.589 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.491 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 8.5 ptpp? -164.26 142.28 7.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.587 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 3.2 m -164.83 148.67 8.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.378 -0.374 . . . . 10.0 110.761 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' OD1' HG22 ' A' ' 128' ' ' THR . 1.0 OUTLIER 55.33 47.71 20.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.934 0.397 . . . . 10.0 111.019 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.81 33.56 43.03 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.997 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 128' ' ' THR . 6.5 ptt-85 -137.84 130.24 29.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.761 0.315 . . . . 10.0 110.251 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.1 mp -88.93 139.74 30.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.989 0.424 . . . . 10.0 111.183 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.004 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.7 mt -133.25 129.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.15 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.458 ' HB ' HD13 ' A' ' 23' ' ' LEU . 24.4 mm -88.92 120.74 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 108.606 -0.887 . . . . 10.0 108.606 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.527 ' CE1' HG21 ' A' ' 13' ' ' VAL . 52.9 t80 -121.38 148.51 44.28 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.239 -0.584 . . . . 10.0 110.363 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.846 HD23 HG21 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -161.01 148.12 15.25 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.505 0.669 . . . . 10.0 111.399 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.8 p-10 -95.87 32.43 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.4 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.865 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 19.7 tt 40.07 18.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.603 -1.18 . . . . 10.0 114.041 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 137' ' ' ASP . 38.4 t70 -79.73 -53.82 6.45 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.966 0.728 . . . . 10.0 112.966 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 121' ' ' LYS . 17.3 tppt? -77.77 -34.17 52.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.447 0.642 . . . . 10.0 110.438 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.865 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.52 -45.95 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.422 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.018 HD13 HG21 ' A' ' 91' ' ' VAL . 7.7 tp -64.48 -43.41 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.403 -0.519 . . . . 10.0 109.733 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.797 ' O ' HG12 ' A' ' 147' ' ' VAL . 44.4 tt0 -47.95 -41.16 24.24 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.117 -0.697 . . . . 10.0 109.117 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.458 ' HA ' HG12 ' A' ' 147' ' ' VAL . 50.7 mm-40 -70.73 -35.77 72.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.008 -0.996 . . . . 10.0 110.829 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.638 ' CD1' HG11 ' A' ' 91' ' ' VAL . 60.3 mt -55.18 -50.98 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.822 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.9 p -73.5 -53.34 10.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.975 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 143' ' ' GLU . 14.4 p -63.0 -17.81 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 10.0 111.791 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.506 ' HA ' ' HE2' ' A' ' 148' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 120.779 0.323 . . . . 10.0 111.392 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 105' ' ' THR . 13.2 mmmm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.928 0.394 . . . . 10.0 111.213 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.595 ' HG2' HG22 ' A' ' 105' ' ' THR . 41.4 mt-10 -140.49 164.17 30.85 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.331 0.586 . . . . 10.0 110.531 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.577 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.0 t80 -156.52 139.36 15.24 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.894 -1.048 . . . . 10.0 112.453 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.42 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 16.7 pt-20 -88.76 138.77 31.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.567 -0.901 . . . . 10.0 108.567 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.947 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -154.97 170.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 113.317 0.858 . . . . 10.0 113.317 -176.7 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.95 HD11 HD13 ' A' ' 82' ' ' ILE . 3.1 tm? -88.62 132.79 34.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.988 -1.116 . . . . 10.0 107.988 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.831 ' HB3' HD22 ' A' ' 102' ' ' LEU . 83.5 p -143.16 152.55 41.92 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.376 0.88 . . . . 10.0 113.376 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.728 ' CE1' HD11 ' A' ' 18' ' ' ILE . 15.1 p90 -150.83 162.8 40.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.47 -1.241 . . . . 10.0 109.908 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.52 ' HG3' HD21 ' A' ' 99' ' ' LEU . 95.7 mt-10 -88.45 139.81 30.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.037 HG21 HD12 ' A' ' 71' ' ' ILE . 35.5 mm -134.47 90.03 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.421 -0.809 . . . . 10.0 111.697 -177.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 47.5 m-20 44.62 60.17 3.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.373 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.2 mt-10 87.36 -42.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.196 -0.911 . . . . 10.0 112.093 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.0 pt20 -88.96 146.18 25.05 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.603 -0.439 . . . . 10.0 109.879 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.969 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.61 166.97 13.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 10.0 110.882 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.9 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.3 tp -152.17 140.2 20.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.325 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.763 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -145.89 151.12 37.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 -177.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.917 ' CD2' HD21 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -133.12 141.3 48.09 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.15 -0.932 . . . . 10.0 108.714 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 137' ' ' ASP . 12.6 p-10 -49.73 122.76 6.83 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.551 -0.46 . . . . 10.0 111.046 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.947 HG13 ' HA ' ' A' ' 13' ' ' VAL . 24.8 m -61.27 -13.85 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.015 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -64.61 -40.48 95.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.406 0.622 . . . . 10.0 109.531 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.748 HD21 HG22 ' A' ' 86' ' ' THR . 16.5 t-20 -87.81 -46.09 9.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.972 -1.013 . . . . 10.0 110.54 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.762 HG21 ' HG ' ' A' ' 14' ' ' LEU . 22.5 mm -65.85 132.3 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.541 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.411 ' O ' ' CE ' ' A' ' 32' ' ' MET . 53.5 mm-40 -82.64 -64.03 1.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.656 -0.247 . . . . 10.0 111.368 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.411 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.03 172.54 7.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 10.0 111.026 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.474 ' CG1' HG11 ' A' ' 98' ' ' VAL . 34.9 m -89.0 147.09 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.749 -0.659 . . . . 10.0 111.613 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.528 HD13 ' CG2' ' A' ' 83' ' ' VAL . 29.0 pt -145.83 129.86 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.558 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 50.1 mt-10 -98.43 124.7 43.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.489 -0.323 . . . . 10.0 111.118 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.865 ' HB2' HD12 ' A' ' 81' ' ' ILE . 62.7 mttp . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.215 -0.448 . . . . 10.0 110.937 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.63 ' HA ' HG22 ' A' ' 63' ' ' VAL . 40.1 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.83 0.347 . . . . 10.0 111.917 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.41 ' OE1' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -93.46 -24.29 18.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.583 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.795 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -152.86 165.04 30.99 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.804 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.604 HG12 HG11 ' A' ' 49' ' ' VAL . 1.9 m -151.11 163.64 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.287 0.543 . . . . 10.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.092 HD11 HD11 ' A' ' 60' ' ' ILE . 27.6 pt . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.137 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.092 HD11 HD11 ' A' ' 53' ' ' ILE . 26.1 pt . . . . . 0 C--O 1.234 0.246 0 N-CA-C 111.432 0.16 . . . . 10.0 111.432 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 77.6 Cg_endo -95.46 114.76 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.352 2.701 . . . . 10.0 112.712 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.795 HG22 ' C ' ' A' ' 51' ' ' GLY . 33.7 m -88.98 141.04 14.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.648 -0.251 . . . . 10.0 110.512 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.63 HG22 ' HA ' ' A' ' 49' ' ' VAL . 84.1 t -142.93 156.29 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.258 0.551 . . . . 10.0 111.694 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.589 ' O ' ' HD3' ' A' ' 67' ' ' LYS . 42.5 m-20 -77.26 61.39 2.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.951 0.882 . . . . 10.0 109.584 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.837 ' O ' HD23 ' A' ' 65' ' ' LEU . 7.5 tt -48.86 -26.34 2.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.776 . . . . 10.0 112.379 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.89 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -69.44 -26.34 64.55 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.993 -0.683 . . . . 10.0 111.301 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.658 ' HD3' ' H ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -87.42 -35.01 18.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.723 -0.391 . . . . 10.0 110.775 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.658 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 8.5 tt -57.84 -41.18 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.0 HD21 ' CE2' ' A' ' 118' ' ' PHE . 0.8 OUTLIER -79.36 -46.99 16.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.249 -1.796 . . . . 10.0 108.505 176.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 116.15 -85.17 0.39 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.173 -0.921 . . . . 10.0 112.656 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.037 HD12 HG21 ' A' ' 18' ' ' ILE . 3.0 pt 46.86 166.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 42.9 t -47.69 -34.72 8.56 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.857 ' HB3' HG13 ' A' ' 71' ' ' ILE . 14.6 t80 -31.37 143.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.877 -1.056 . . . . 10.0 112.932 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.95 41.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.722 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 57.37 38.05 28.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.108 -0.496 . . . . 10.0 111.228 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -90.28 -72.47 0.57 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.398 0.518 . . . . 10.0 112.398 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 78' ' ' MET . 0.1 OUTLIER -90.87 -20.73 21.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 10.0 112.204 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.452 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 20.9 mmt -21.13 138.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.087 0.773 . . . . 10.0 113.087 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -172.15 -38.96 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.492 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.718 ' O ' HD12 ' A' ' 94' ' ' LEU . 70.9 m -88.85 166.9 13.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.702 0.287 . . . . 10.0 110.997 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.865 HD12 ' HB2' ' A' ' 36' ' ' LYS . 85.5 mt -138.65 156.3 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.218 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.95 HD13 HD11 ' A' ' 14' ' ' LEU . 48.6 mt -132.78 158.23 43.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 121.081 0.467 . . . . 10.0 111.84 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.528 ' CG2' HD13 ' A' ' 34' ' ' ILE . 50.5 t -130.96 143.1 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.635 -0.712 . . . . 10.0 110.155 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.65 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -140.22 178.19 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.511 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.489 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 54.7 ttp180 -132.95 130.15 39.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.748 HG22 HD21 ' A' ' 29' ' ' ASN . 62.8 p -137.64 103.07 4.92 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.438 0.637 . . . . 10.0 111.832 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.6 tppp? 47.59 47.26 17.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.902 -1.045 . . . . 10.0 110.78 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 45.2 m-20 81.55 28.5 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.932 -1.031 . . . . 10.0 111.985 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.837 HG12 HG22 ' A' ' 91' ' ' VAL . 50.8 t -125.76 108.93 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.39 -0.823 . . . . 10.0 109.146 176.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.631 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 87.9 tt0 -88.24 99.49 12.26 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.869 HG21 HD13 ' A' ' 142' ' ' ILE . 2.7 t -88.66 157.71 3.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 113.338 -1.755 . . . . 10.0 112.653 -174.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -125.24 158.23 19.62 Favored Glycine 0 C--N 1.317 -0.487 0 CA-C-N 114.719 -1.128 . . . . 10.0 112.211 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.65 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.2 t80 -158.42 128.55 5.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.096 0.474 . . . . 10.0 112.082 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 80' ' ' SER . 63.2 tp -88.84 127.38 35.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.683 -0.69 . . . . 10.0 111.439 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.513 HG11 ' CZ ' ' A' ' 16' ' ' PHE . 32.5 m -135.34 -175.14 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.12 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.403 ' OD1' ' HG3' ' A' ' 77' ' ' LYS . 19.8 t70 -88.36 -79.64 0.3 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.167 0.508 . . . . 10.0 111.317 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -130.96 108.19 9.64 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.031 -0.729 . . . . 10.0 109.031 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.607 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.1 p -88.97 114.58 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.302 1.049 . . . . 10.0 111.58 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.547 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.71 -28.43 69.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.235 -1.802 . . . . 10.0 110.944 -178.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.1 -125.78 7.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.677 -0.773 . . . . 10.0 111.533 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -51.76 131.1 12.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.974 0.387 . . . . 10.0 110.499 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.831 HD22 ' HB3' ' A' ' 15' ' ' SER . 50.0 tp -134.92 138.51 44.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.952 0.406 . . . . 10.0 111.118 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.3 ptp85 -88.83 72.27 8.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.98 HD12 HG11 ' A' ' 126' ' ' VAL . 10.3 mm -88.95 130.17 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.598 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.595 HG22 ' HG2' ' A' ' 10' ' ' GLU . 16.3 p -88.64 149.66 23.42 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.454 -1.684 . . . . 10.0 106.454 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.424 ' OE1' ' CE2' ' A' ' 135' ' ' TYR . 8.3 tp10 -134.57 80.73 1.87 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 114.088 1.144 . . . . 10.0 114.088 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -88.66 -6.81 57.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 . . . . . 0 C--O 1.232 0.15 0 CA-C-N 114.784 -1.098 . . . . 10.0 111.025 -179.666 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 1.0 ' CE2' HD21 ' A' ' 69' ' ' LEU . 6.1 t80 . . . . . 0 CA--C 1.518 -0.286 0 CA-C-O 121.442 0.639 . . . . 10.0 109.441 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.23 28.29 1.18 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 114.949 -1.023 . . . . 10.0 113.592 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -70.63 -34.45 72.1 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.517 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 16.6 tppt? -159.47 37.17 0.2 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.998 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.666 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 88.9 p . . . . . 0 CA--C 1.537 0.461 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.736 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.98 HG11 HD12 ' A' ' 104' ' ' ILE . 1.4 p . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 121.373 0.606 . . . . 10.0 111.842 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -158.91 132.62 7.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.43 -0.805 . . . . 10.0 110.724 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.734 ' O ' ' HB2' ' A' ' 131' ' ' ARG . 8.9 m -164.27 140.74 6.38 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.062 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 131' ' ' ARG . 25.3 m-20 62.42 45.74 6.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.03 0.443 . . . . 10.0 110.201 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 56.03 25.12 45.33 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.433 -0.889 . . . . 10.0 110.961 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.734 ' HB2' ' O ' ' A' ' 128' ' ' THR . 99.5 mtt180 -107.89 120.86 43.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.435 -0.383 . . . . 10.0 111.471 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 21' ' ' GLN . 86.1 mt -89.07 82.92 6.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.969 HG12 ' HB3' ' A' ' 22' ' ' ALA . 2.4 mt -88.77 131.37 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.9 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.98 148.35 4.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 107.917 -1.142 . . . . 10.0 107.917 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 35.7 t80 -141.16 151.89 44.23 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.028 -0.669 . . . . 10.0 111.457 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.917 HD21 ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -169.07 150.79 4.56 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 113.638 0.977 . . . . 10.0 113.638 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.404 ' HA ' ' OD1' ' A' ' 26' ' ' ASP . 55.0 p30 -99.33 32.92 2.59 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.604 -1.18 . . . . 10.0 109.716 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.904 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 16.2 tt 40.15 24.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.44 -1.255 . . . . 10.0 113.636 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -77.56 -60.41 2.38 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.017 0.747 . . . . 10.0 113.017 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -74.28 -29.19 61.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.162 0.506 . . . . 10.0 111.08 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.904 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.35 -46.78 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.737 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.869 HD13 HG21 ' A' ' 91' ' ' VAL . 7.2 tp -63.34 -47.11 93.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 120.29 -0.564 . . . . 10.0 110.482 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 147' ' ' VAL . 50.4 mt-10 -50.97 -39.47 55.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.558 ' HB2' HD11 ' A' ' 68' ' ' ILE . 5.7 mm-40 -77.86 -27.08 49.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.358 -0.837 . . . . 10.0 111.061 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.695 ' CD1' HG11 ' A' ' 91' ' ' VAL . 37.5 mt -53.85 -49.28 59.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 121.064 0.459 . . . . 10.0 110.211 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 77.9 p -82.65 -45.84 14.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.767 -0.652 . . . . 10.0 111.364 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 143' ' ' GLU . 51.5 t -58.15 -30.55 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.239 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.7 tptp . . . . . 0 C--N 1.328 -0.36 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -178.184 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.78 ' HE3' ' HA ' ' A' ' 9' ' ' LYS . 0.4 OUTLIER . . . . . 0 CA--C 1.526 0.044 0 CA-C-O 120.723 0.297 . . . . 10.0 110.585 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 33.5 mt-10 -139.4 164.14 30.64 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.337 -0.392 . . . . 10.0 109.988 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.56 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.5 t80 -164.78 139.67 5.37 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 113.265 0.839 . . . . 10.0 113.265 -174.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.423 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 3.0 mt-10 -88.67 135.03 33.71 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.294 -0.866 . . . . 10.0 109.16 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' A' ' 102' ' ' LEU . 1.2 p -152.36 169.35 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.823 0.675 . . . . 10.0 112.823 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.724 ' HG ' HG21 ' A' ' 30' ' ' ILE . 3.4 tm? -88.84 138.1 31.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.832 ' HB3' HD22 ' A' ' 102' ' ' LEU . 97.6 p -145.61 153.91 41.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 113.613 0.968 . . . . 10.0 113.613 -177.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -152.88 159.04 42.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.17 -1.377 . . . . 10.0 110.403 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.566 ' HG2' HD21 ' A' ' 99' ' ' LEU . 53.1 mm-40 -88.63 124.11 33.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.341 0.591 . . . . 10.0 109.968 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.109 HG21 HD12 ' A' ' 71' ' ' ILE . 22.9 mm -118.52 94.45 3.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.177 -0.92 . . . . 10.0 110.865 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 30.8 m-20 44.05 60.13 2.88 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.827 0.677 . . . . 10.0 112.827 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 48.2 mt-10 88.54 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.49 -0.777 . . . . 10.0 112.607 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.682 ' NE2' HD13 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -88.84 152.96 21.44 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.438 -0.505 . . . . 10.0 110.278 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.997 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -89.03 155.52 19.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.807 0.336 . . . . 10.0 110.875 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.831 HD12 ' N ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -141.35 133.96 28.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.469 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.831 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -140.18 153.29 46.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.91 0.707 . . . . 10.0 112.91 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.942 ' CE2' HD22 ' A' ' 136' ' ' LEU . 2.8 m-85 -138.08 144.89 41.13 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -43.53 100.49 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.425 0.631 . . . . 10.0 110.447 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.615 HG12 ' HA ' ' A' ' 13' ' ' VAL . 3.5 p -46.84 -19.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.021 -0.991 . . . . 10.0 111.137 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.62 -43.68 88.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.121 0.486 . . . . 10.0 109.75 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.678 ' CG ' HG21 ' A' ' 138' ' ' ILE . 18.0 t-20 -78.46 -43.27 27.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.485 -0.78 . . . . 10.0 110.607 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.724 HG21 ' HG ' ' A' ' 14' ' ' LEU . 13.0 mm -63.83 125.41 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.32 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.607 ' O ' ' HG3' ' A' ' 32' ' ' MET . 4.6 mm-40 -84.24 -76.6 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.764 0.283 . . . . 10.0 111.764 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.607 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 5.0 mtm -157.34 150.69 23.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.193 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.858 HG11 HG11 ' A' ' 98' ' ' VAL . 34.5 m -88.9 128.03 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.391 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.404 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 29.9 pt -100.38 179.48 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 10.0 111.29 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -88.91 150.87 22.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.119 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.4 tttm . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.16 -179.695 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.886 ' HA ' HG22 ' A' ' 63' ' ' VAL . 55.2 t . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.86 0.362 . . . . 10.0 111.14 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' A' ' 62' ' ' VAL . 17.0 pt-20 -71.86 -40.04 69.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.583 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 62' ' ' VAL . . . -169.06 -175.92 38.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.753 -0.737 . . . . 10.0 112.63 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 53' ' ' ILE . 3.5 m -158.93 172.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.691 0.282 . . . . 10.0 110.283 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 52' ' ' VAL . 30.7 pt . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.813 0.34 . . . . 10.0 111.344 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.782 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.2 pp . . . . . 0 C--O 1.235 0.339 0 CA-C-O 120.516 0.198 . . . . 10.0 110.788 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 60' ' ' ILE . 66.0 Cg_endo -98.15 117.72 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.203 2.602 . . . . 10.0 113.634 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 49' ' ' VAL . 18.5 m -97.12 133.64 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 109.084 -0.71 . . . . 10.0 109.084 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.886 HG22 ' HA ' ' A' ' 49' ' ' VAL . 68.0 t -141.3 159.9 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.783 0.801 . . . . 10.0 113.079 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.779 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.4 m120 -76.61 66.9 2.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.819 -1.082 . . . . 10.0 109.052 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.932 ' O ' HD23 ' A' ' 65' ' ' LEU . 6.3 tt -50.05 -26.46 4.4 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.705 -0.68 . . . . 10.0 111.404 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.656 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -64.91 -27.71 69.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.671 -0.412 . . . . 10.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.779 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -88.4 -36.92 16.27 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.015 -0.365 . . . . 10.0 110.015 178.698 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.741 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 8.5 tt -61.18 -37.7 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.942 HD11 HG23 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -77.88 -40.51 39.75 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 113.278 -1.783 . . . . 10.0 109.598 177.453 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.577 ' C ' HG12 ' A' ' 71' ' ' ILE . . . 112.3 -102.54 1.36 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 116.07 -0.514 . . . . 10.0 112.961 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.109 HD12 HG21 ' A' ' 18' ' ' ILE . 6.5 pt 45.98 -179.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 113.088 0.773 . . . . 10.0 113.088 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.653 ' O ' ' O ' ' A' ' 73' ' ' PHE . 72.1 m -57.52 -98.6 0.0 OUTLIER 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.62 -1.622 . . . . 10.0 106.62 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.663 ' HE2' ' N ' ' A' ' 67' ' ' LYS . 1.4 t80 50.65 138.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 119.22 -0.992 . . . . 10.0 113.357 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -159.55 27.39 0.19 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.71 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 66.89 -48.63 0.47 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.13 0.789 . . . . 10.0 113.13 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -38.89 -42.49 0.85 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -79.5 -39.7 31.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.947 0.404 . . . . 10.0 111.395 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.529 ' HG3' ' HA ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -47.33 135.21 10.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.902 0.705 . . . . 10.0 112.902 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 78' ' ' MET . 36.7 mtmm -164.43 32.57 0.07 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.91 -1.041 . . . . 10.0 109.624 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.584 ' O ' HD12 ' A' ' 94' ' ' LEU . 38.7 t -169.12 151.25 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.274 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.404 ' HB ' ' CG1' ' A' ' 34' ' ' ILE . 65.5 mt -120.16 143.08 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.998 0.427 . . . . 10.0 111.985 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.6 HD13 HD11 ' A' ' 14' ' ' LEU . 4.2 mt -111.67 123.48 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.971 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.9 t -92.86 148.13 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.973 0.416 . . . . 10.0 111.008 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -143.91 -175.87 4.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.69 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.803 ' O ' HG23 ' A' ' 86' ' ' THR . 15.3 tpp85 -133.3 160.84 36.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.381 -0.6 . . . . 10.0 109.381 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 85' ' ' ARG . 18.9 p -169.06 100.0 0.37 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.293 0.568 . . . . 10.0 112.018 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.482 ' CE ' ' HA ' ' A' ' 87' ' ' LYS . 2.2 tpmt? 43.99 46.41 6.92 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.002 -0.999 . . . . 10.0 110.55 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 11.6 m-20 82.8 31.96 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.69 -1.141 . . . . 10.0 111.713 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.88 HG12 HG22 ' A' ' 91' ' ' VAL . 44.4 t -130.03 112.12 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.26 -0.882 . . . . 10.0 109.261 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 12.2 mt-10 -88.36 99.91 12.61 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.176 -1.787 . . . . 10.0 106.176 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.976 HG21 HD13 ' A' ' 142' ' ' ILE . 2.6 t -88.77 159.54 2.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 113.91 -1.495 . . . . 10.0 112.106 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.47 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -127.89 154.22 19.67 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.546 -0.835 . . . . 10.0 113.415 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -144.62 128.64 17.54 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 120.722 0.296 . . . . 10.0 110.71 -179.293 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 80' ' ' SER . 65.1 tp -88.67 134.39 33.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.228 0.537 . . . . 10.0 111.698 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' A' ' 16' ' ' PHE . 35.6 m -147.93 -175.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.936 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -105.11 -65.2 1.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.317 0.488 . . . . 10.0 112.317 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -130.65 120.36 23.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.754 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.858 HG11 HG11 ' A' ' 33' ' ' VAL . 9.5 p -108.1 115.06 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-O 122.245 1.022 . . . . 10.0 111.621 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.566 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -64.95 -29.94 70.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.272 -1.786 . . . . 10.0 111.114 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 91.89 -124.43 7.65 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.646 -0.787 . . . . 10.0 111.321 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.43 134.1 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 117.01 0.405 . . . . 10.0 110.549 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.832 HD22 ' HB3' ' A' ' 15' ' ' SER . 59.8 tp -135.7 139.92 44.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.199 0.523 . . . . 10.0 111.178 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 27.1 ptt180 -88.91 71.63 8.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.67 -0.696 . . . . 10.0 110.407 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.004 HD12 HG21 ' A' ' 126' ' ' VAL . 17.8 mm -88.75 133.14 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 18.2 p -88.84 -175.94 5.04 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.395 -0.965 . . . . 10.0 108.395 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -147.31 77.4 1.44 Allowed 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.128 -1.029 . . . . 10.0 112.808 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -102.02 17.59 22.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.665 -1.152 . . . . 10.0 109.23 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 . . . . . 0 C--N 1.333 -0.113 0 CA-C-N 115.574 -0.739 . . . . 10.0 111.133 -179.525 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.669 ' CE1' HD21 ' A' ' 69' ' ' LEU . 39.7 t80 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.193 0.521 . . . . 10.0 110.315 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 143.92 45.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.821 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 62.31 52.34 3.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.055 0.455 . . . . 10.0 110.314 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.406 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 4.1 tppp? -141.56 -35.75 0.45 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 10.0 111.369 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.727 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 97.2 p . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 116.764 -0.198 . . . . 10.0 110.514 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 1.004 HG21 HD12 ' A' ' 104' ' ' ILE . 2.4 p . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 121.707 0.765 . . . . 10.0 112.111 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -141.41 135.53 30.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.638 ' O ' ' HB2' ' A' ' 131' ' ' ARG . 8.5 m -164.11 137.79 5.41 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.167 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 65.6 t0 60.78 41.99 14.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.89 0.376 . . . . 10.0 110.459 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.24 30.87 55.9 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.754 -0.938 . . . . 10.0 110.754 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.638 ' HB2' ' O ' ' A' ' 128' ' ' THR . 37.5 mmt180 -117.17 133.46 55.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.263 -0.469 . . . . 10.0 111.024 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 57.1 tp -88.91 79.55 7.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.11 -0.496 . . . . 10.0 110.143 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.997 HG12 ' HB3' ' A' ' 22' ' ' ALA . 4.0 mt -88.99 148.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 10.0 111.828 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.804 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -103.32 129.27 55.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 N-CA-C 108.69 -0.856 . . . . 10.0 108.69 177.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.663 ' C ' HD12 ' A' ' 136' ' ' LEU . 40.5 t80 -117.09 144.51 44.59 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.02 -0.672 . . . . 10.0 111.615 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.942 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.5 mp -137.61 169.06 18.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.18 -0.918 . . . . 10.0 111.852 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.453 ' O ' HG22 ' A' ' 138' ' ' ILE . 34.0 t70 -136.58 21.76 3.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.705 -1.134 . . . . 10.0 108.34 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.9 ' HA ' HG23 ' A' ' 141' ' ' ILE . 13.0 tt 43.76 17.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.173 -1.376 . . . . 10.0 113.824 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 142' ' ' ILE . 8.6 t0 -81.48 -59.11 2.74 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.627 0.603 . . . . 10.0 112.627 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.2 mptt -76.55 -34.18 58.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.613 0.721 . . . . 10.0 109.895 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.9 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.27 -46.0 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.835 -1.075 . . . . 10.0 110.63 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.976 HD13 HG21 ' A' ' 91' ' ' VAL . 7.5 tp -62.89 -43.2 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 120.254 -0.578 . . . . 10.0 109.725 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.642 ' O ' HG12 ' A' ' 147' ' ' VAL . 4.5 tp10 -47.11 -46.47 23.0 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.658 ' HB2' HD11 ' A' ' 68' ' ' ILE . 48.5 mt-10 -65.03 -36.89 85.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.25 -0.887 . . . . 10.0 110.298 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.659 ' CD1' HG11 ' A' ' 91' ' ' VAL . 23.3 mt -54.71 -41.12 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 120.896 0.379 . . . . 10.0 110.948 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.7 p -80.44 -50.3 10.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.636 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 143' ' ' GLU . 12.6 p -78.78 9.24 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.596 0.236 . . . . 10.0 111.613 -179.234 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.535 ' HD2' ' HG3' ' A' ' 10' ' ' GLU . 6.3 tmtm? . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.624 ' HG2' HG22 ' A' ' 105' ' ' THR . 45.5 mt-10 -140.71 164.25 30.69 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.004 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 9.9 t80 -160.11 139.49 11.0 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.567 -0.742 . . . . 10.0 112.789 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.526 ' OE2' HG12 ' A' ' 101' ' ' VAL . 23.5 tp10 -88.68 133.99 34.04 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.917 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.6 p -152.93 166.94 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 113.967 1.099 . . . . 10.0 113.967 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.636 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.2 tm? -88.94 134.54 33.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.158 -0.928 . . . . 10.0 108.657 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.784 ' CB ' HD22 ' A' ' 102' ' ' LEU . 40.5 t -148.56 158.04 43.86 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.772 0.796 . . . . 10.0 112.687 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.785 ' CE2' HG11 ' A' ' 95' ' ' VAL . 0.4 OUTLIER -148.35 165.61 30.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.182 -1.372 . . . . 10.0 110.411 -178.648 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.588 ' HG3' HD21 ' A' ' 99' ' ' LEU . 56.6 mt-10 -88.65 133.22 34.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.07 HG21 HD12 ' A' ' 71' ' ' ILE . 35.0 mm -132.06 95.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.437 -177.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 26.8 m-20 42.45 60.18 2.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.676 -0.693 . . . . 10.0 112.525 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.1 mt-10 85.72 -44.77 0.06 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.39 -0.823 . . . . 10.0 111.621 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -89.03 145.36 25.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.993 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.58 168.14 12.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.986 0.422 . . . . 10.0 111.089 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.751 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.9 OUTLIER -147.11 135.04 21.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.586 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.695 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -137.56 152.91 49.94 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.999 0.741 . . . . 10.0 112.999 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.61 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.2 m-85 -135.16 142.76 46.2 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.146 -0.934 . . . . 10.0 108.814 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' HZ ' ' A' ' 11' ' ' PHE . 12.7 p-10 -52.43 122.05 8.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.271 0.558 . . . . 10.0 111.328 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.917 HG13 ' HA ' ' A' ' 13' ' ' VAL . 27.2 m -61.27 -14.7 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.44 -0.8 . . . . 10.0 110.653 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.43 -44.51 94.35 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.184 0.516 . . . . 10.0 109.829 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.697 HD21 HG22 ' A' ' 86' ' ' THR . 21.7 t-20 -89.57 -42.52 11.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 10.0 110.566 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.636 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.8 mm -62.45 130.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.865 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 32' ' ' MET . 52.0 mm-40 -85.79 -68.97 0.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.33 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.6 mtm -169.21 156.02 6.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.148 0.499 . . . . 10.0 111.609 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.773 HG11 HG11 ' A' ' 98' ' ' VAL . 34.6 m -88.88 159.1 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.567 -0.742 . . . . 10.0 111.304 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.442 HG13 ' HB ' ' A' ' 81' ' ' ILE . 23.1 pt -151.55 162.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.963 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -88.83 146.58 24.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.174 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HA ' HD11 ' A' ' 81' ' ' ILE . 27.8 tptp . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.297 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.767 ' HA ' HG22 ' A' ' 63' ' ' VAL . 38.4 t . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.944 0.402 . . . . 10.0 111.19 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 9.8 pt-20 -75.77 -38.54 58.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.571 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.744 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -144.22 -177.04 18.78 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 120.183 -1.008 . . . . 10.0 113.095 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 61' ' ' PRO . 3.4 m -160.08 175.32 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 53' ' ' ILE . 2.2 pp . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 10.0 111.251 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.786 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.546 0.213 . . . . 10.0 110.839 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.583 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 89.0 Cg_endo -82.95 119.61 2.89 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.678 2.252 . . . . 10.0 113.483 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.744 HG22 ' C ' ' A' ' 51' ' ' GLY . 35.9 m -95.75 138.51 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.767 HG22 ' HA ' ' A' ' 49' ' ' VAL . 94.5 t -139.88 151.44 22.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.715 0.769 . . . . 10.0 112.581 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -78.57 67.44 4.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.688 -1.142 . . . . 10.0 109.668 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.824 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.3 tt -52.78 -38.56 61.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.305 -0.861 . . . . 10.0 111.2 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.76 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -53.34 -24.29 11.62 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.314 -0.554 . . . . 10.0 109.711 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.573 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -85.51 -48.37 9.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.784 -0.643 . . . . 10.0 110.307 178.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.781 HG22 ' HA ' ' A' ' 65' ' ' LEU . 8.2 tt -54.42 -38.85 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 107.867 -1.16 . . . . 10.0 107.867 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.904 ' C ' HD13 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -79.65 -51.05 9.74 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 113.52 -1.673 . . . . 10.0 109.684 177.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 118.64 -86.38 0.4 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.879 -0.601 . . . . 10.0 112.508 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.07 HD12 HG21 ' A' ' 18' ' ' ILE . 3.5 pt 46.55 165.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 113.115 0.783 . . . . 10.0 113.115 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.5 m -47.8 -35.26 9.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.919 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.7 t80 -27.63 140.56 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.757 -1.11 . . . . 10.0 112.578 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 8.8 t70 -143.99 30.45 1.3 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.154 0.502 . . . . 10.0 110.815 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HA ' ' CE1' ' A' ' 73' ' ' PHE . 49.0 mt-10 66.69 -51.57 0.45 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.15 0.796 . . . . 10.0 113.15 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -44.84 -42.78 8.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.274 0.842 . . . . 10.0 113.274 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.536 ' HB3' ' NZ ' ' A' ' 77' ' ' LYS . 6.3 mtpm? -81.53 10.63 5.57 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.441 0.904 . . . . 10.0 113.441 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.438 ' CE ' ' CE1' ' A' ' 73' ' ' PHE . 33.8 mmt -68.11 145.4 54.43 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.205 -0.309 . . . . 10.0 111.005 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 54.9 mtpt -158.84 -50.43 0.06 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.654 0.264 . . . . 10.0 111.634 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.631 ' O ' HD12 ' A' ' 94' ' ' LEU . 47.5 t -88.88 -176.03 5.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 10.0 111.615 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.519 HG22 ' N ' ' A' ' 82' ' ' ILE . 47.0 mt -145.38 159.24 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.87 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 13.2 mt -136.62 141.33 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 84' ' ' ALA . 61.5 t -117.79 153.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.583 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -158.51 176.86 11.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.309 -0.405 . . . . 10.0 111.267 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -134.64 135.3 42.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.841 178.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.697 HG22 HD21 ' A' ' 29' ' ' ASN . 72.9 p -148.99 110.83 4.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 21.9 ttmm 47.31 48.52 16.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.346 0.593 . . . . 10.0 110.949 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 72.39 33.21 1.5 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.094 -0.957 . . . . 10.0 111.461 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.912 HG12 HG22 ' A' ' 91' ' ' VAL . 57.5 t -130.19 111.04 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.199 -0.91 . . . . 10.0 109.097 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.686 ' HB2' HG22 ' A' ' 60' ' ' ILE . 66.4 mt-10 -88.38 97.75 11.23 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 106.177 -1.786 . . . . 10.0 106.177 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.005 HG21 HD13 ' A' ' 142' ' ' ILE . 3.9 t -88.75 153.87 3.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 113.334 -1.757 . . . . 10.0 113.234 -174.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -128.74 143.5 14.51 Favored Glycine 0 C--N 1.316 -0.577 0 CA-C-N 114.586 -1.188 . . . . 10.0 113.044 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.6 OUTLIER -131.61 125.55 32.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.811 0.338 . . . . 10.0 110.24 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 80' ' ' SER . 40.1 tp -88.6 130.88 35.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.023 0.44 . . . . 10.0 110.835 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.785 HG11 ' CE2' ' A' ' 16' ' ' PHE . 28.1 m -137.01 -175.09 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.964 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 59.7 t0 -89.01 -76.6 0.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.29 0.567 . . . . 10.0 110.998 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -131.75 113.22 13.28 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.115 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.773 HG11 HG11 ' A' ' 33' ' ' VAL . 9.9 p -95.88 115.85 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 122.408 1.099 . . . . 10.0 111.772 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.588 HD21 ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -68.1 -28.24 67.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.044 -1.889 . . . . 10.0 111.043 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.92 -123.24 6.88 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.633 -0.794 . . . . 10.0 111.824 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.526 HG12 ' OE2' ' A' ' 12' ' ' GLU . 34.9 m -51.07 133.05 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.799 0.3 . . . . 10.0 111.03 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.784 HD22 ' CB ' ' A' ' 15' ' ' SER . 57.4 tp -137.77 139.79 40.24 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.08 0.467 . . . . 10.0 111.211 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 16.2 ptm180 -88.84 73.6 8.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.592 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.784 ' CG1' HG11 ' A' ' 13' ' ' VAL . 16.4 mm -88.79 165.28 2.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.624 HG22 ' HG2' ' A' ' 10' ' ' GLU . 25.4 p -124.61 -176.0 3.42 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.764 -1.199 . . . . 10.0 107.764 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -137.04 67.05 1.45 Allowed 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.258 -0.977 . . . . 10.0 112.045 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -104.8 26.11 9.56 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.462 -1.245 . . . . 10.0 109.035 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.665 ' CE2' HD21 ' A' ' 69' ' ' LEU . 51.6 t80 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.053 0.454 . . . . 10.0 110.159 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 120' ' ' LYS . . . 166.45 -49.36 0.26 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.604 -0.725 . . . . 10.0 112.012 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER 171.97 -33.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.044 0.45 . . . . 10.0 110.405 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -54.89 -46.45 74.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.754 -0.657 . . . . 10.0 111.257 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.523 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 80.9 p . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.864 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.661 HG11 HD12 ' A' ' 104' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.051 0.453 . . . . 10.0 111.667 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 22.2 pttp -163.65 133.92 4.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.546 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.591 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 14.0 m -167.09 156.43 10.55 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.369 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.4 ' N ' ' CG2' ' A' ' 128' ' ' THR . 62.7 m-20 59.94 45.76 11.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.967 0.413 . . . . 10.0 110.84 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.0 28.23 11.97 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.615 -0.802 . . . . 10.0 111.914 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 128' ' ' THR . 14.8 ptt180 -139.33 132.82 30.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 132' ' ' LEU . 3.9 mp -88.82 136.68 32.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.937 0.399 . . . . 10.0 111.546 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.993 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.6 mt -126.52 129.56 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.936 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.751 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.82 141.36 14.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 N-CA-C 108.934 -0.765 . . . . 10.0 108.934 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.423 ' HE1' HG21 ' A' ' 13' ' ' VAL . 42.3 t80 -124.8 146.2 49.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.28 0.562 . . . . 10.0 111.325 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.644 HD13 HG21 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -144.39 141.08 29.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.761 0.652 . . . . 10.0 112.761 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 139' ' ' ASP . 55.6 p30 -105.8 25.37 10.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.228 -0.896 . . . . 10.0 108.896 177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.919 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 15.3 tt 41.19 16.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 114.346 1.239 . . . . 10.0 114.346 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 38.2 t70 -79.69 -61.21 2.07 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.085 0.772 . . . . 10.0 113.085 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -74.91 -30.54 61.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.535 0.684 . . . . 10.0 110.567 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.919 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.25 -48.4 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.972 -1.013 . . . . 10.0 110.606 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.005 HD13 HG21 ' A' ' 91' ' ' VAL . 7.4 tp -62.19 -45.75 98.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 120.213 -0.595 . . . . 10.0 110.209 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.92 ' O ' HG12 ' A' ' 147' ' ' VAL . 63.1 mm-40 -47.74 -43.68 27.29 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 51.9 mm-40 -71.85 -39.27 69.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.045 -0.979 . . . . 10.0 110.429 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.674 ' CD1' HG11 ' A' ' 91' ' ' VAL . 46.8 mt -45.17 -38.48 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-O 120.803 0.335 . . . . 10.0 111.24 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.1 p -97.77 -53.79 3.31 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.21 0.818 . . . . 10.0 113.21 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 143' ' ' GLU . 8.6 p -84.2 13.16 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 113.466 0.913 . . . . 10.0 113.466 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 84.9 tttt . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 120.271 -0.572 . . . . 10.0 110.788 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.494 ' O ' HG22 ' A' ' 105' ' ' THR . 2.6 tmmm? . . . . . 0 C--O 1.23 0.075 0 N-CA-C 109.928 -0.397 . . . . 10.0 109.928 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 88.3 tt0 -138.96 161.14 38.06 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.272 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.602 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 11.0 t80 -165.85 139.48 4.39 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.45 -0.796 . . . . 10.0 112.917 -173.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 16.7 mt-10 -88.82 134.41 33.94 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.927 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -149.05 170.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 113.307 0.854 . . . . 10.0 113.307 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.88 HD11 HD13 ' A' ' 82' ' ' ILE . 3.1 tm? -88.91 132.88 34.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.815 ' HB3' HD22 ' A' ' 102' ' ' LEU . 86.6 p -143.09 153.64 43.12 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.687 0.756 . . . . 10.0 112.746 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.673 ' CD2' HG11 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -149.93 160.4 43.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.252 -1.34 . . . . 10.0 110.012 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -88.67 135.98 33.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.353 -0.61 . . . . 10.0 109.353 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.044 HG21 HD12 ' A' ' 71' ' ' ILE . 34.8 mm -130.79 81.99 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.361 -0.836 . . . . 10.0 111.34 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.723 ' OD2' ' HA ' ' A' ' 73' ' ' PHE . 19.9 m-20 50.82 60.23 4.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.462 0.542 . . . . 10.0 112.462 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 81.3 mt-10 81.98 -35.89 0.1 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.171 -0.922 . . . . 10.0 111.107 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.457 ' NE2' HD11 ' A' ' 134' ' ' ILE . 37.5 tt0 -88.87 136.71 32.86 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.252 -0.647 . . . . 10.0 109.252 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.019 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.72 162.12 16.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.054 0.454 . . . . 10.0 111.222 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.949 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.5 tp -148.63 139.33 22.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.165 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.756 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -143.55 153.56 42.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.927 0.714 . . . . 10.0 112.927 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.768 ' CE2' HD22 ' A' ' 136' ' ' LEU . 6.0 m-85 -135.37 140.56 45.1 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.222 -0.899 . . . . 10.0 109.169 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.452 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . 47.0 p-10 -49.17 123.3 7.09 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.106 0.479 . . . . 10.0 111.25 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.927 HG13 ' HA ' ' A' ' 13' ' ' VAL . 31.1 m -62.26 -13.25 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.573 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -61.16 -46.05 92.09 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.031 0.443 . . . . 10.0 110.047 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.715 ' CG ' HG21 ' A' ' 138' ' ' ILE . 16.0 t-20 -89.28 -45.04 9.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.562 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.69 HG21 ' HG ' ' A' ' 14' ' ' LEU . 17.5 mm -60.97 120.67 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.234 -0.439 . . . . 10.0 109.906 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 32' ' ' MET . 8.8 pt-20 -81.19 -58.85 2.88 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.198 0.444 . . . . 10.0 112.198 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.475 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -169.12 157.94 8.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.038 0.446 . . . . 10.0 111.725 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.623 ' CG1' HG11 ' A' ' 98' ' ' VAL . 30.4 m -88.94 152.16 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.697 -0.683 . . . . 10.0 111.508 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 pt -148.35 129.81 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -88.82 128.63 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 10.0 110.241 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.832 ' HB3' HD12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.883 0.373 . . . . 10.0 110.959 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.854 ' HA ' HG22 ' A' ' 63' ' ' VAL . 44.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.975 0.417 . . . . 10.0 111.632 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -90.31 -46.84 8.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.579 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.774 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -133.04 -179.08 15.98 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.764 -0.731 . . . . 10.0 112.774 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 53' ' ' ILE . 2.4 m -160.81 168.81 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 CA-C-O 120.848 0.356 . . . . 10.0 110.53 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.547 HG12 HD11 ' A' ' 60' ' ' ILE . 28.5 pt . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.319 -0.4 . . . . 10.0 110.719 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.76 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.232 0.153 0 N-CA-C 111.663 0.245 . . . . 10.0 111.663 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 70.2 Cg_endo -86.09 117.75 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.747 2.298 . . . . 10.0 112.958 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.774 HG22 ' C ' ' A' ' 51' ' ' GLY . 35.1 m -96.0 134.84 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.639 -0.504 . . . . 10.0 109.639 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.854 HG22 ' HA ' ' A' ' 49' ' ' VAL . 57.4 t -140.31 156.0 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.561 0.696 . . . . 10.0 112.406 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.493 ' N ' HG12 ' A' ' 63' ' ' VAL . 5.6 m120 -77.16 72.27 3.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.949 -1.023 . . . . 10.0 109.805 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.864 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.1 tt -53.86 -37.55 63.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.308 0.575 . . . . 10.0 110.587 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.793 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -56.75 -25.88 55.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.132 0.492 . . . . 10.0 109.69 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.526 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -82.01 -42.71 18.95 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.243 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 65' ' ' LEU . 7.9 tt -61.84 -37.61 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.883 ' C ' HD13 ' A' ' 69' ' ' LEU . 1.1 tm? -78.35 -52.02 9.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 113.738 -1.574 . . . . 10.0 108.92 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 117.68 -82.87 0.33 Allowed Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.66 -0.7 . . . . 10.0 112.744 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.044 HD12 HG21 ' A' ' 18' ' ' ILE . 2.7 pt 45.36 173.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -50.16 -39.25 43.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.433 0.635 . . . . 10.0 109.32 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.792 ' HB3' HG13 ' A' ' 71' ' ' ILE . 4.3 t80 -28.21 145.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.672 -1.149 . . . . 10.0 113.904 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 65.4 t0 -137.63 -52.8 0.65 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.785 -1.098 . . . . 10.0 109.906 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' A' ' 74' ' ' ASP . 16.4 pt-20 163.57 -44.0 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.983 0.421 . . . . 10.0 111.624 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -51.31 -37.63 48.62 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.545 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.2 mmpt? -74.72 -29.68 61.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.11 0.411 . . . . 10.0 112.11 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.407 ' O ' ' CG ' ' A' ' 79' ' ' LYS . 29.3 mmt -43.84 130.55 5.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.888 0.375 . . . . 10.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 78' ' ' MET . 53.2 mtmt -162.1 -44.89 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.547 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.601 ' HB3' HG23 ' A' ' 95' ' ' VAL . 45.5 t -88.95 164.29 15.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.495 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.832 HD12 ' HB3' ' A' ' 36' ' ' LYS . 45.4 mt -140.98 125.97 18.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.694 0.283 . . . . 10.0 111.351 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.88 HD13 HD11 ' A' ' 14' ' ' LEU . 6.2 mt -100.42 155.27 4.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.459 -0.337 . . . . 10.0 111.203 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.75 145.66 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.645 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -143.46 -177.06 5.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.474 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.05 128.89 24.88 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.877 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.722 HG21 HG12 ' A' ' 138' ' ' ILE . 69.0 p -142.85 109.69 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.026 0.441 . . . . 10.0 111.914 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 47.8 49.99 16.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.388 0.614 . . . . 10.0 110.753 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 72.91 31.24 1.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.009 -0.996 . . . . 10.0 111.555 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.89 HG12 HG22 ' A' ' 91' ' ' VAL . 66.1 t -126.95 109.74 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.262 -0.881 . . . . 10.0 109.397 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 36.9 tt0 -88.36 99.12 12.01 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.799 -1.926 . . . . 10.0 105.799 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.023 HG21 HD13 ' A' ' 142' ' ' ILE . 5.3 t -88.67 152.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 113.181 -1.827 . . . . 10.0 113.196 -173.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -119.18 153.25 16.95 Favored Glycine 0 C--N 1.315 -0.606 0 CA-C-N 114.381 -1.281 . . . . 10.0 113.156 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -143.95 125.09 14.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.861 0.362 . . . . 10.0 110.559 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.534 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 42.3 tp -88.66 124.74 34.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.124 0.488 . . . . 10.0 110.516 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.673 HG11 ' CD2' ' A' ' 16' ' ' PHE . 17.1 m -132.87 -175.07 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.672 -0.694 . . . . 10.0 110.944 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 17.2 t70 -87.67 -71.79 0.55 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.536 0.684 . . . . 10.0 110.993 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -146.59 112.41 5.69 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.904 -1.044 . . . . 10.0 108.324 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.623 HG11 ' CG1' ' A' ' 33' ' ' VAL . 7.5 p -89.01 118.26 33.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 122.31 1.053 . . . . 10.0 112.939 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -66.12 -29.29 69.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.031 -1.895 . . . . 10.0 110.923 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.74 -123.43 7.31 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.556 -0.747 . . . . 10.0 111.498 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 m -52.89 136.85 13.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.977 0.389 . . . . 10.0 110.84 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' A' ' 15' ' ' SER . 45.5 tp -139.21 141.89 37.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.17 0.509 . . . . 10.0 111.237 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.433 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.3 ptp85 -88.9 71.8 8.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.753 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.834 HD12 HG11 ' A' ' 126' ' ' VAL . 15.7 mm -88.75 136.75 22.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 N-CA-C 109.554 -0.536 . . . . 10.0 109.554 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 14.7 p -88.82 -175.76 4.99 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -144.34 77.37 1.54 Allowed 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.721 -1.192 . . . . 10.0 113.262 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.41 22.17 16.3 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.414 -1.267 . . . . 10.0 108.173 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 . . . . . 0 C--N 1.333 -0.149 0 CA-C-N 114.81 -1.086 . . . . 10.0 111.921 -178.631 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.608 ' CE2' HD21 ' A' ' 69' ' ' LEU . 33.4 t80 . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 120.949 0.404 . . . . 10.0 110.808 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.67 -144.02 9.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.951 -0.643 . . . . 10.0 112.405 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -85.22 58.03 4.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.695 0.283 . . . . 10.0 110.639 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 17.3 tppt? -154.31 -40.05 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.919 0.341 . . . . 10.0 111.919 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.519 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 90.2 p . . . . . 0 C--N 1.329 -0.314 0 C-N-CA 121.187 -0.205 . . . . 10.0 110.824 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.949 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.6 p . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 121.416 0.627 . . . . 10.0 112.389 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.516 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 92.7 mttt -152.27 132.35 13.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.145 -0.934 . . . . 10.0 109.742 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 2.6 m -169.07 152.12 5.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.825 0.345 . . . . 10.0 111.164 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' OD1' HG22 ' A' ' 128' ' ' THR . 0.9 OUTLIER 56.83 47.95 16.98 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.916 0.389 . . . . 10.0 111.244 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 49.12 30.92 10.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.116 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 128' ' ' THR . 3.5 ptm180 -137.94 136.4 36.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.171 -0.307 . . . . 10.0 110.171 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.659 ' N ' HD22 ' A' ' 132' ' ' LEU . 2.0 mm? -88.88 135.59 33.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.907 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.019 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.9 mt -128.78 131.51 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.864 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.949 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.6 mp -88.87 140.12 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.238 -0.653 . . . . 10.0 109.238 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.719 ' C ' HD12 ' A' ' 136' ' ' LEU . 49.0 t80 -128.72 141.45 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.33 0.586 . . . . 10.0 111.282 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.768 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.6 mp -136.47 172.51 12.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.823 0.82 . . . . 10.0 112.666 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 9.8 t70 -136.36 25.09 3.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.099 -1.41 . . . . 10.0 107.667 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.887 ' HA ' HG23 ' A' ' 141' ' ' ILE . 10.5 tt 42.6 17.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 114.164 -1.38 . . . . 10.0 114.086 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.408 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.5 t70 -82.33 -62.99 1.47 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.604 0.594 . . . . 10.0 112.604 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -73.93 -30.89 62.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.612 0.72 . . . . 10.0 109.981 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -69.29 -47.48 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.817 -1.083 . . . . 10.0 110.839 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.023 HD13 HG21 ' A' ' 91' ' ' VAL . 7.3 tp -60.74 -47.35 93.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 120.313 -0.555 . . . . 10.0 110.206 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.871 ' O ' HG12 ' A' ' 147' ' ' VAL . 5.5 mm-40 -49.14 -43.55 41.83 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.289 0.566 . . . . 10.0 109.62 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' A' ' 68' ' ' ILE . 5.7 mm-40 -72.6 -34.81 67.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.192 -0.913 . . . . 10.0 110.898 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.693 ' CD1' HG11 ' A' ' 91' ' ' VAL . 33.9 mt -47.93 -46.38 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-O 120.941 0.401 . . . . 10.0 111.093 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 80.6 p -86.25 -50.59 6.85 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.135 0.791 . . . . 10.0 113.135 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 143' ' ' GLU . 8.6 p -82.36 13.03 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.537 0.94 . . . . 10.0 113.537 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 62.4 tttm . . . . . 0 C--N 1.328 -0.35 0 C-N-CA 120.124 -0.63 . . . . 10.0 111.019 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.468 ' O ' HG22 ' A' ' 105' ' ' THR . 63.0 pttt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.007 0.432 . . . . 10.0 110.464 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.586 ' HG2' HG22 ' A' ' 105' ' ' THR . 41.8 mt-10 -145.48 164.25 32.16 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.449 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.5 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 16.1 t80 -153.38 141.9 20.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.863 -1.062 . . . . 10.0 112.606 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 27' ' ' VAL . 12.2 pt-20 -88.75 139.27 30.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.538 -0.756 . . . . 10.0 109.174 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.769 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -154.09 169.05 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.395 0.887 . . . . 10.0 113.395 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.879 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.9 tm? -88.79 132.26 34.71 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.819 ' HB3' HD22 ' A' ' 102' ' ' LEU . 94.7 p -140.8 150.35 43.21 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.8 ' CE1' HG11 ' A' ' 95' ' ' VAL . 4.6 p90 -150.71 162.57 40.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.523 -1.217 . . . . 10.0 110.308 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HG3' HD21 ' A' ' 99' ' ' LEU . 51.0 mt-10 -88.64 137.73 32.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.123 0.487 . . . . 10.0 109.802 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.975 HG21 HD12 ' A' ' 71' ' ' ILE . 17.8 mm -136.11 99.36 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.642 -0.708 . . . . 10.0 111.289 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.601 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 48.7 m-20 42.0 60.14 2.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.479 -0.782 . . . . 10.0 112.84 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.1 mt-10 86.6 -42.68 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.304 -0.862 . . . . 10.0 112.581 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.453 ' OE1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -89.03 155.7 19.31 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.393 -0.523 . . . . 10.0 110.261 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.799 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.64 165.84 14.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.846 0.355 . . . . 10.0 110.677 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -152.27 133.05 14.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.329 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.769 ' HB1' ' CG2' ' A' ' 13' ' ' VAL . . . -142.83 141.25 31.57 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.356 0.598 . . . . 10.0 112.372 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.092 ' CE2' HD13 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -118.0 141.08 48.84 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.248 -1.39 . . . . 10.0 107.248 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.456 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . 12.5 p-10 -45.29 105.85 0.07 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.365 0.602 . . . . 10.0 110.612 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.597 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 6.3 p -51.15 -18.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.212 -0.903 . . . . 10.0 110.685 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.69 -39.29 93.51 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.723 HD22 HG22 ' A' ' 86' ' ' THR . 15.8 t-20 -84.46 -45.78 12.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.091 -0.959 . . . . 10.0 110.506 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.879 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.0 mm -63.68 131.92 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.021 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -93.82 -61.19 1.59 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.028 0.381 . . . . 10.0 112.028 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -169.03 161.79 10.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 10.0 111.489 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.077 HG11 HG11 ' A' ' 98' ' ' VAL . 33.9 m -88.94 143.1 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.973 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.635 HG13 ' HB ' ' A' ' 81' ' ' ILE . 20.1 pt -126.47 157.36 37.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.572 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -88.82 139.93 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.945 0.402 . . . . 10.0 111.28 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.409 ' HB2' HD11 ' A' ' 81' ' ' ILE . 61.1 tttm . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.01 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.789 ' HA ' HG22 ' A' ' 63' ' ' VAL . 60.7 t . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.896 0.379 . . . . 10.0 111.368 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -73.88 -39.78 63.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.668 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.767 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -151.31 -175.8 23.5 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.253 -0.975 . . . . 10.0 113.009 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 m -156.01 171.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.847 0.356 . . . . 10.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.478 ' CD1' HD12 ' A' ' 34' ' ' ILE . 31.2 pt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.781 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.848 HG22 ' HB2' ' A' ' 90' ' ' GLU . 2.3 pp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.512 0.196 . . . . 10.0 111.296 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 95.3 Cg_endo -80.0 121.4 4.47 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.484 2.122 . . . . 10.0 112.815 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.767 HG22 ' C ' ' A' ' 51' ' ' GLY . 35.0 m -93.38 132.08 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.759 -0.655 . . . . 10.0 109.945 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 49' ' ' VAL . 86.5 t -141.31 162.34 21.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.278 0.561 . . . . 10.0 111.208 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.541 ' N ' HG12 ' A' ' 63' ' ' VAL . 57.4 m-20 -102.78 85.42 2.56 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.693 -0.685 . . . . 10.0 110.593 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.092 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.2 tt -53.25 -41.34 65.35 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.542 -0.463 . . . . 10.0 110.521 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.025 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -55.6 -24.41 32.81 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.472 -0.491 . . . . 10.0 109.955 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.496 ' C ' ' HD2' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -86.36 -38.54 17.33 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.01 178.303 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.835 HG22 ' O ' ' A' ' 65' ' ' LEU . 5.7 tt -64.83 -36.16 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 107.481 -1.303 . . . . 10.0 107.481 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.814 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -81.89 -53.74 5.91 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.292 -1.777 . . . . 10.0 108.643 178.361 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 116.07 -76.28 0.27 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.801 -1.09 . . . . 10.0 112.182 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.025 HD11 ' HB1' ' A' ' 66' ' ' ALA . 6.5 pt 43.05 -175.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 112.341 0.497 . . . . 10.0 112.341 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 52.5 m -60.33 -39.3 86.58 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.798 ' HB3' HG13 ' A' ' 71' ' ' ILE . 11.4 t80 -26.01 137.14 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.035 -0.984 . . . . 10.0 112.88 177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.435 ' O ' ' OE2' ' A' ' 75' ' ' GLU . 9.8 t70 -158.72 43.76 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.267 -0.879 . . . . 10.0 109.395 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.456 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 1.4 pp20? 37.53 38.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.176 -0.92 . . . . 10.0 112.091 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.408 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 4.0 pt20 -87.67 -49.47 7.12 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.786 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.462 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -106.87 -1.85 21.98 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.666 0.617 . . . . 10.0 112.666 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.51 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 12.1 mmt -42.07 139.28 1.38 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.71 0.291 . . . . 10.0 111.74 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -177.23 36.19 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.632 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.837 ' O ' HD12 ' A' ' 94' ' ' LEU . 69.9 m -169.02 143.73 3.12 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.499 -0.319 . . . . 10.0 110.624 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.635 ' HB ' HG13 ' A' ' 34' ' ' ILE . 67.1 mt -114.26 152.51 15.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 10.0 111.333 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.856 HD13 HD11 ' A' ' 14' ' ' LEU . 14.1 mt -123.98 133.45 69.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' A' ' 34' ' ' ILE . 83.7 t -103.33 150.45 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 10.0 110.83 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -158.08 174.0 15.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.242 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.643 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 6.8 ptm180 -129.28 147.58 51.12 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.206 -0.665 . . . . 10.0 109.206 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.723 HG22 HD22 ' A' ' 29' ' ' ASN . 67.5 p -161.82 109.02 1.38 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.011 0.434 . . . . 10.0 112.081 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? 46.8 48.86 14.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.416 0.627 . . . . 10.0 110.809 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 72.17 33.76 1.51 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 10.0 111.433 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.938 HG12 HG22 ' A' ' 91' ' ' VAL . 59.0 t -132.18 112.27 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 115.293 -0.867 . . . . 10.0 109.255 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.848 ' HB2' HG22 ' A' ' 60' ' ' ILE . 73.9 mt-10 -88.22 95.12 10.05 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.006 HG21 HD13 ' A' ' 142' ' ' ILE . 3.5 t -88.69 152.25 3.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 113.374 -1.739 . . . . 10.0 113.067 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -132.46 143.12 14.69 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.959 -1.019 . . . . 10.0 113.367 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.742 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.3 t80 -131.19 128.64 40.41 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.827 0.346 . . . . 10.0 111.061 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 80' ' ' SER . 58.2 tp -88.8 126.86 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.876 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.8 HG11 ' CE1' ' A' ' 16' ' ' PHE . 21.6 m -132.01 -175.22 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.693 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 44.1 t0 -87.98 -74.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.362 0.601 . . . . 10.0 111.273 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -130.7 117.42 19.43 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.166 -0.925 . . . . 10.0 108.521 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.077 HG11 HG11 ' A' ' 33' ' ' VAL . 7.5 p -101.05 116.6 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 122.484 1.135 . . . . 10.0 112.073 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -65.09 -29.27 70.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.002 -1.908 . . . . 10.0 110.801 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.3 -127.33 8.64 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.825 -0.702 . . . . 10.0 111.718 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.3 t -51.25 132.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 117.011 0.406 . . . . 10.0 110.472 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.819 HD22 ' HB3' ' A' ' 15' ' ' SER . 59.0 tp -137.09 138.86 40.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.027 0.441 . . . . 10.0 111.358 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.84 72.57 8.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.678 -0.692 . . . . 10.0 110.823 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.73 ' CG1' HG11 ' A' ' 13' ' ' VAL . 16.3 mm -88.78 133.3 31.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 N-CA-C 109.654 -0.498 . . . . 10.0 109.654 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.586 HG22 ' HG2' ' A' ' 10' ' ' GLU . 19.2 p -88.81 149.72 23.27 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -128.41 80.03 1.94 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 113.697 0.999 . . . . 10.0 113.697 -175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -97.69 2.75 50.06 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.59 -1.186 . . . . 10.0 107.896 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 . . . . . 0 C--N 1.339 0.151 0 CA-C-N 114.885 -1.052 . . . . 10.0 110.946 -179.546 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.552 ' CE2' ' CD2' ' A' ' 69' ' ' LEU . 26.0 t80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.167 0.508 . . . . 10.0 109.969 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 76.77 36.07 38.22 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.527 -0.761 . . . . 10.0 111.9 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 118' ' ' PHE . 87.7 tttt 178.86 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 10.5 tppt? -130.47 -68.43 0.69 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.441 -0.504 . . . . 10.0 112.066 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.611 ' HB3' HD12 ' A' ' 136' ' ' LEU . 38.1 t . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 120.88 0.372 . . . . 10.0 110.588 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 133' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.962 0.41 . . . . 10.0 110.81 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.482 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 1.0 OUTLIER -160.5 133.42 6.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.361 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.503 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 10.2 m -161.61 148.33 14.28 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.634 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.12 42.73 27.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.036 0.446 . . . . 10.0 110.761 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.16 36.16 51.49 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.736 -0.745 . . . . 10.0 112.059 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 128' ' ' THR . 5.0 ptp180 -132.86 139.71 47.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.639 0.257 . . . . 10.0 110.442 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.636 ' N ' HD22 ' A' ' 132' ' ' LEU . 2.3 mm? -88.78 139.33 30.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.875 0.369 . . . . 10.0 110.848 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.799 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.8 mt -150.85 143.44 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.413 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 23' ' ' LEU . 11.8 mt -111.82 122.62 66.49 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.745 0 N-CA-C 109.11 -0.7 . . . . 10.0 109.11 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 26' ' ' ASP . 16.4 t80 -100.99 172.53 6.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.875 ' CD1' HD11 ' A' ' 65' ' ' LEU . 4.1 tt -169.01 128.07 1.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.437 -0.505 . . . . 10.0 111.12 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 138' ' ' ILE . 12.3 p-10 -91.12 16.2 10.21 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.191 0.441 . . . . 10.0 112.191 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.931 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 20.5 tt 42.33 18.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 113.908 1.077 . . . . 10.0 113.908 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 137' ' ' ASP . 66.9 t0 -76.33 -56.19 4.86 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.94 0.719 . . . . 10.0 112.94 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 34.4 mmtp -80.1 -28.6 39.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.936 0.398 . . . . 10.0 110.997 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.931 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.5 -46.45 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.095 -0.502 . . . . 10.0 109.973 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.006 HD13 HG21 ' A' ' 91' ' ' VAL . 8.0 tp -65.04 -46.6 90.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 120.322 -0.551 . . . . 10.0 110.315 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.679 ' O ' HG12 ' A' ' 147' ' ' VAL . 3.3 tm-20 -48.56 -40.02 25.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 54.8 mm-40 -76.47 -34.86 58.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.838 -1.074 . . . . 10.0 110.729 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 141' ' ' ILE . 43.4 mt -48.97 -38.91 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 120.971 0.415 . . . . 10.0 110.824 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 79.5 p -88.66 -51.75 5.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.968 0.729 . . . . 10.0 112.968 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 143' ' ' GLU . 7.2 p -83.83 13.15 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.232 0.827 . . . . 10.0 113.232 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 28.0 tptp . . . . . 0 C--N 1.326 -0.437 0 C-N-CA 120.668 -0.413 . . . . 10.0 111.248 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 121.02 0.438 . . . . 10.0 110.19 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 95.1 mt-10 -140.8 164.28 30.64 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.509 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CE2' ' OH ' ' A' ' 135' ' ' TYR . 18.5 t80 -140.49 125.28 18.17 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 114.363 1.246 . . . . 10.0 114.363 -174.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -88.98 125.75 35.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.688 -1.967 . . . . 10.0 105.688 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.954 HG11 ' CG1' ' A' ' 104' ' ' ILE . 5.8 p -150.79 167.74 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 114.439 1.274 . . . . 10.0 114.439 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.688 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.3 tm? -88.77 133.58 34.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.051 -1.092 . . . . 10.0 108.051 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.754 ' HB3' HD22 ' A' ' 102' ' ' LEU . 57.1 p -144.89 158.11 43.91 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.749 0.785 . . . . 10.0 112.99 -177.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.61 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 2.1 p90 -152.97 156.8 39.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.147 -1.388 . . . . 10.0 109.996 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -88.67 106.39 18.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.363 0.602 . . . . 10.0 110.203 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.926 HG21 HD12 ' A' ' 71' ' ' ILE . 36.5 mm -88.89 102.51 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.173 -0.921 . . . . 10.0 110.973 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.748 ' OD1' HG22 ' A' ' 18' ' ' ILE . 12.2 p-10 32.92 60.33 0.41 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.094 1.146 . . . . 10.0 114.094 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.579 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 103.03 -51.3 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.07 0.948 . . . . 10.0 112.712 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.8 -175.73 4.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.695 -0.402 . . . . 10.0 110.363 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.017 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -112.83 159.83 18.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.104 0.478 . . . . 10.0 111.815 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.848 HD13 ' HB ' ' A' ' 134' ' ' ILE . 3.4 tp -150.4 136.72 18.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.951 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.673 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -138.77 152.5 47.98 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.335 0.865 . . . . 10.0 113.335 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.872 ' CZ ' HD22 ' A' ' 136' ' ' LEU . 4.7 m-85 -131.95 142.32 49.59 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.128 -0.942 . . . . 10.0 109.322 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.559 ' OD2' ' HB3' ' A' ' 28' ' ' ASP . 21.4 t0 -52.48 123.28 10.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.152 0.501 . . . . 10.0 110.415 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.932 HG13 ' HA ' ' A' ' 13' ' ' VAL . 33.2 m -63.69 -8.61 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 10.0 112.141 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.559 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 38.9 t70 -66.64 -47.4 72.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.533 -0.467 . . . . 10.0 109.833 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.721 ' CG ' HG21 ' A' ' 138' ' ' ILE . 19.2 t-20 -84.42 -44.43 13.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.637 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.688 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.3 mm -60.46 125.79 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.275 -0.421 . . . . 10.0 110.315 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HB3' ' CE ' ' A' ' 32' ' ' MET . 44.5 mt-10 -85.28 -62.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.58 -0.282 . . . . 10.0 111.435 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.424 ' CE ' ' HB3' ' A' ' 31' ' ' GLU . 1.2 pmm? -169.11 156.95 7.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.036 0.446 . . . . 10.0 111.322 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.592 HG11 HG11 ' A' ' 98' ' ' VAL . 35.6 m -88.93 161.66 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.761 -0.654 . . . . 10.0 111.547 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 33' ' ' VAL . 22.3 pt -158.06 133.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.502 -0.772 . . . . 10.0 110.742 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.8 63.82 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.326 0.584 . . . . 10.0 110.845 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 1.023 ' HB2' HD12 ' A' ' 81' ' ' ILE . 14.5 mmmm . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.341 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.732 ' HA ' HG22 ' A' ' 63' ' ' VAL . 41.0 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.947 0.403 . . . . 10.0 111.393 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.5 -38.19 77.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.715 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.678 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -148.49 165.57 29.1 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.382 -0.913 . . . . 10.0 113.324 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.507 ' CG1' ' CG1' ' A' ' 49' ' ' VAL . 2.9 m -161.91 169.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.426 ' CG1' HG13 ' A' ' 60' ' ' ILE . 30.3 pt . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 121.067 0.461 . . . . 10.0 111.73 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.963 HG22 ' HB2' ' A' ' 90' ' ' GLU . 2.2 pp . . . . . 0 C--O 1.236 0.391 0 CA-C-O 120.594 0.235 . . . . 10.0 111.504 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 98.0 Cg_endo -102.64 122.28 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.86 3.04 . . . . 10.0 112.589 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.678 HG22 ' C ' ' A' ' 51' ' ' GLY . 29.2 m -99.84 133.22 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.732 HG22 ' HA ' ' A' ' 49' ' ' VAL . 69.2 t -140.87 155.66 22.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.375 0.607 . . . . 10.0 111.75 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.771 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 60.4 m-20 -70.27 66.59 0.3 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.39 -0.823 . . . . 10.0 109.777 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.882 HD22 ' CD2' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -52.08 -18.2 1.35 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.732 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.854 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -74.86 -27.68 60.35 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.465 -0.494 . . . . 10.0 110.169 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.771 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.94 -39.26 21.65 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.638 -0.504 . . . . 10.0 109.638 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.6 tt -57.78 -40.08 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 106.909 -1.515 . . . . 10.0 106.909 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.879 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.37 -45.13 23.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.399 -1.728 . . . . 10.0 107.939 176.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 113.08 -86.09 0.41 Allowed Glycine 0 C--N 1.335 0.488 0 CA-C-N 114.905 -1.043 . . . . 10.0 112.599 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.926 HD12 HG21 ' A' ' 18' ' ' ILE . 2.3 pt 46.89 167.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 113.41 0.893 . . . . 10.0 113.41 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.416 ' CB ' ' OD2' ' A' ' 19' ' ' ASP . 47.1 t -49.07 -37.93 22.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.364 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.786 ' HB3' HG13 ' A' ' 71' ' ' ILE . 3.1 t80 -22.5 141.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.274 1.213 . . . . 10.0 114.274 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' OD1' ' HG2' ' A' ' 75' ' ' GLU . 9.7 t70 -132.03 -58.64 0.95 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.803 -1.089 . . . . 10.0 109.306 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.479 ' HG2' ' OD1' ' A' ' 74' ' ' ASP . 11.7 pt-20 153.2 -42.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.027 0.531 . . . . 10.0 111.294 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -47.38 -40.95 18.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 10.0 112.239 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.504 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.7 mmpt? -77.09 -41.91 40.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.351 . . . . 10.0 111.054 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.642 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 21.4 mmt -45.39 144.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.422 0.527 . . . . 10.0 112.422 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.465 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -178.36 48.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.158 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.967 ' O ' HD12 ' A' ' 94' ' ' LEU . 79.1 p -169.05 -177.05 2.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.171 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.023 HD12 ' HB2' ' A' ' 36' ' ' LYS . 47.8 mt -154.41 140.27 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.074 0.398 . . . . 10.0 112.074 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 7.5 mt -108.84 162.45 6.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.171 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.486 ' N ' HG22 ' A' ' 82' ' ' ILE . 44.3 t -132.48 147.94 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.946 0.403 . . . . 10.0 110.958 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -155.15 175.33 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.838 -0.619 . . . . 10.0 111.172 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -131.69 131.27 42.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.72 HG21 HG12 ' A' ' 138' ' ' ILE . 59.1 p -145.75 109.38 4.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.954 0.407 . . . . 10.0 112.096 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 87' ' ' LYS . 37.4 ttmt 47.54 50.62 14.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.477 0.656 . . . . 10.0 110.765 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.01 32.21 2.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.1 -0.955 . . . . 10.0 111.524 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.91 HG12 HG22 ' A' ' 91' ' ' VAL . 66.0 t -129.62 109.85 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.207 177.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.963 ' HB2' HG22 ' A' ' 60' ' ' ILE . 32.2 mt-10 -88.38 97.79 11.25 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.078 -1.823 . . . . 10.0 106.078 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.012 HG21 HD13 ' A' ' 142' ' ' ILE . 4.2 t -88.59 153.94 3.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 113.285 -1.779 . . . . 10.0 113.56 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.71 158.73 22.33 Favored Glycine 0 C--N 1.318 -0.445 0 CA-C-N 114.509 -1.223 . . . . 10.0 112.802 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.882 ' CD2' HD22 ' A' ' 65' ' ' LEU . 1.4 t80 -144.45 134.5 24.04 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.851 0.358 . . . . 10.0 111.287 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 80' ' ' SER . 45.6 tp -88.56 123.02 32.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.935 0.398 . . . . 10.0 111.038 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.683 HG23 ' OG ' ' A' ' 80' ' ' SER . 5.2 m -132.91 -175.04 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.803 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 12.5 t70 -99.53 -56.02 2.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.356 0.598 . . . . 10.0 111.902 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.0 tpp85 -150.08 123.8 9.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.217 -0.902 . . . . 10.0 108.706 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.61 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.9 p -108.25 113.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 122.389 1.09 . . . . 10.0 112.325 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.33 -28.22 69.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 112.945 -1.934 . . . . 10.0 111.104 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.19 -118.94 5.09 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.825 -0.91 . . . . 10.0 110.825 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.9 130.1 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 117.066 0.433 . . . . 10.0 110.21 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.754 HD22 ' HB3' ' A' ' 15' ' ' SER . 15.3 tp -135.18 143.47 46.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.416 . . . . 10.0 110.755 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 2.4 ptp180 -88.86 78.11 7.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.772 -0.649 . . . . 10.0 111.742 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.954 ' CG1' HG11 ' A' ' 13' ' ' VAL . 14.5 mm -88.81 178.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 106.856 -1.535 . . . . 10.0 106.856 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 17.3 p -141.43 -175.91 4.53 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 88.2 tt0 -127.73 72.3 1.39 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.949 0.88 . . . . 10.0 112.738 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -108.82 19.49 19.57 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.197 -1.365 . . . . 10.0 107.767 176.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 . . . . . 0 C--N 1.335 -0.059 0 CA-C-N 115.068 -0.969 . . . . 10.0 111.363 -178.823 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.691 ' CE1' HD21 ' A' ' 69' ' ' LEU . 45.2 t80 . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 121.272 0.558 . . . . 10.0 109.864 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 144.61 -53.19 0.58 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.365 -0.834 . . . . 10.0 111.961 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 62.6 tttm 171.72 55.24 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 4.1 tppp? -154.41 -30.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.604 0.594 . . . . 10.0 112.604 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.784 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 87.8 p . . . . . 0 N--CA 1.455 -0.21 0 C-N-CA 120.694 -0.402 . . . . 10.0 111.833 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 133' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 121.405 0.621 . . . . 10.0 111.847 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.505 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -163.07 137.4 6.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.592 -0.731 . . . . 10.0 110.617 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.553 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 8.7 m -165.14 150.09 9.22 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.623 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 56.83 44.17 23.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.943 0.402 . . . . 10.0 110.801 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.21 33.91 39.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.696 -0.764 . . . . 10.0 112.04 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 128' ' ' THR . 14.2 ptt180 -133.49 136.19 44.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.1 mt -88.89 139.95 29.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.046 0.451 . . . . 10.0 111.585 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.017 HG12 ' HB3' ' A' ' 22' ' ' ALA . 4.1 mt -145.37 132.8 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.543 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.848 ' HB ' HD13 ' A' ' 23' ' ' LEU . 2.0 mp -88.89 149.56 3.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.617 -0.882 . . . . 10.0 108.617 177.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.489 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 38.6 t80 -135.38 145.11 47.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.036 -0.665 . . . . 10.0 111.707 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.872 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 6.2 mp -138.85 164.23 30.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.758 0.79 . . . . 10.0 112.416 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -134.53 26.71 3.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.439 -1.255 . . . . 10.0 108.402 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.926 ' HA ' HG23 ' A' ' 141' ' ' ILE . 8.4 tt 41.21 17.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 114.375 -1.284 . . . . 10.0 114.211 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.36 -62.42 1.66 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.691 0.626 . . . . 10.0 112.691 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -75.82 -31.85 59.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.611 0.719 . . . . 10.0 109.903 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.59 -45.82 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 114.759 -1.11 . . . . 10.0 110.785 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.012 HD13 HG21 ' A' ' 91' ' ' VAL . 7.9 tp -64.48 -43.18 96.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 C-N-CA 119.987 -0.685 . . . . 10.0 109.902 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.535 ' N ' HG23 ' A' ' 142' ' ' ILE . 35.1 tp10 -47.71 -46.47 29.63 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.293 0.568 . . . . 10.0 110.072 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.719 ' HB2' HD11 ' A' ' 68' ' ' ILE . 53.2 mm-40 -67.4 -36.45 81.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.409 -0.814 . . . . 10.0 110.597 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.639 ' CD1' HG11 ' A' ' 91' ' ' VAL . 54.1 mt -53.77 -38.72 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.92 0.391 . . . . 10.0 110.843 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.6 p -74.81 -48.8 23.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.368 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.8 p -79.23 6.26 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 111.952 0.353 . . . . 10.0 111.952 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.6 pttp . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.687 0.28 . . . . 10.0 111.462 -179.501 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.548 ' NZ ' HG21 ' A' ' 105' ' ' THR . 19.6 tptt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.746 0.307 . . . . 10.0 111.274 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 40.3 tt0 -117.02 163.9 15.53 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.435 0.636 . . . . 10.0 111.021 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.619 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.6 t80 -163.19 137.95 6.36 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.834 -1.075 . . . . 10.0 112.855 -174.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 68.1 mt-10 -88.8 138.93 30.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.632 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.859 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.1 p -155.58 174.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 -175.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.798 HD11 HD13 ' A' ' 82' ' ' ILE . 3.2 tm? -88.74 136.98 32.72 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.004 -1.109 . . . . 10.0 108.004 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.764 ' CB ' HD22 ' A' ' 102' ' ' LEU . 81.8 p -149.37 157.67 43.52 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 113.993 1.108 . . . . 10.0 113.993 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.739 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -149.98 158.08 43.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 113.948 -1.478 . . . . 10.0 109.837 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.719 ' HG2' HD21 ' A' ' 99' ' ' LEU . 5.1 mm-40 -88.59 88.95 7.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 10.0 111.048 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.053 HG21 HD12 ' A' ' 71' ' ' ILE . 16.8 mm -88.91 124.21 41.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.852 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.754 ' OD2' HG22 ' A' ' 18' ' ' ILE . 1.9 p30 36.62 60.07 0.95 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.601 -0.727 . . . . 10.0 112.571 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 76.97 -43.46 0.44 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.037 -0.983 . . . . 10.0 112.688 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 22' ' ' ALA . 3.0 pp0? -89.02 166.0 14.18 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 120.915 -0.314 . . . . 10.0 110.38 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.015 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.77 150.17 23.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 10.0 112.27 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.941 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -133.56 130.69 38.77 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 178.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.904 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -138.33 153.88 48.98 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.615 0.968 . . . . 10.0 113.615 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.86 ' CE2' HD22 ' A' ' 136' ' ' LEU . 2.3 m-85 -135.73 142.31 45.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.527 -1.215 . . . . 10.0 107.97 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -50.81 123.46 9.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 10.0 110.374 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.859 HG13 ' HA ' ' A' ' 13' ' ' VAL . 34.7 m -60.03 -12.29 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.508 -0.769 . . . . 10.0 111.863 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -63.42 -42.77 98.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.98 0.419 . . . . 10.0 110.127 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.692 ' CG ' HG21 ' A' ' 138' ' ' ILE . 12.1 t-20 -87.34 -45.68 10.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.561 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.784 HG21 ' HG ' ' A' ' 14' ' ' LEU . 11.8 mm -65.55 138.55 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.045 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 32' ' ' MET . 24.9 pt-20 -113.31 -50.07 2.88 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 3.5 mtm -163.95 -175.96 4.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.966 0.412 . . . . 10.0 111.552 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 98' ' ' VAL . 33.9 m -127.84 126.59 67.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.934 -0.576 . . . . 10.0 111.465 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.413 HG13 ' HB ' ' A' ' 81' ' ' ILE . 27.2 pt -96.15 171.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.038 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -88.83 147.63 24.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 10.0 110.947 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.66 ' HD2' HD11 ' A' ' 94' ' ' LEU . 63.4 tttp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.166 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.816 ' HA ' HG22 ' A' ' 63' ' ' VAL . 62.0 t . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.857 0.361 . . . . 10.0 111.146 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.769 ' HG3' HG23 ' A' ' 62' ' ' VAL . 22.7 pt-20 -75.82 -39.04 57.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.445 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -167.91 -175.91 38.05 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.54 -0.838 . . . . 10.0 113.085 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 53' ' ' ILE . 3.2 m -159.13 171.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.756 -0.461 . . . . 10.0 109.756 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 52' ' ' VAL . 31.5 pt . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 121.147 0.498 . . . . 10.0 112.332 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.799 HG22 ' HB3' ' A' ' 90' ' ' GLU . 2.2 pp . . . . . 0 C--O 1.235 0.301 0 CA-C-O 120.479 0.181 . . . . 10.0 110.735 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 92.1 Cg_endo -100.55 114.05 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.301 2.668 . . . . 10.0 113.19 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.769 HG23 ' HG3' ' A' ' 50' ' ' GLU . 19.7 m -89.14 133.12 32.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.956 -0.757 . . . . 10.0 108.956 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.816 HG22 ' HA ' ' A' ' 49' ' ' VAL . 63.1 t -143.31 156.21 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.657 0.741 . . . . 10.0 112.953 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.506 ' N ' HG12 ' A' ' 63' ' ' VAL . 74.6 m-20 -74.49 68.36 1.58 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.756 -1.111 . . . . 10.0 109.214 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.911 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.3 tt -53.41 -30.59 41.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.239 0.542 . . . . 10.0 110.814 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.638 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . . . -63.01 -26.5 68.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' HE2' ' A' ' 73' ' ' PHE . 0.8 OUTLIER -83.5 -42.0 17.36 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.966 179.19 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 65' ' ' LEU . 12.8 tt -58.79 -42.1 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 107.175 -1.416 . . . . 10.0 107.175 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.88 ' C ' HD13 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -73.82 -45.28 52.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 113.76 -1.564 . . . . 10.0 108.435 176.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.498 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 113.52 -91.24 0.57 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.539 -0.755 . . . . 10.0 113.15 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.053 HD12 HG21 ' A' ' 18' ' ' ILE . 3.1 pt 48.28 164.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 112.812 0.671 . . . . 10.0 112.812 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.562 ' HB3' ' CG ' ' A' ' 19' ' ' ASP . 29.4 t -47.23 -32.99 4.98 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.328 -0.619 . . . . 10.0 109.328 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.856 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.2 t80 -33.18 141.55 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.191 -0.913 . . . . 10.0 112.533 176.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -171.87 43.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.49 -0.777 . . . . 10.0 110.196 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 78' ' ' MET . 50.0 mt-10 62.79 43.45 7.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.508 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 19.4 pt20 -74.54 -52.66 11.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HD2' ' C ' ' A' ' 76' ' ' GLN . 2.6 mptt -146.4 18.97 1.36 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 112.275 0.472 . . . . 10.0 112.275 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.628 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 9.4 mmm -47.45 145.85 2.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.582 0.229 . . . . 10.0 110.525 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -174.38 38.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 10.0 111.14 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.746 ' O ' HD12 ' A' ' 94' ' ' LEU . 71.1 m -169.14 162.47 10.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 10.0 109.875 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 70.3 mt -139.61 123.49 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.606 -0.438 . . . . 10.0 111.969 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.798 HD13 HD11 ' A' ' 14' ' ' LEU . 10.7 mt -89.01 130.96 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.494 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.32 146.64 9.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.071 0.462 . . . . 10.0 111.125 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -145.19 -178.72 6.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.566 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 41.8 mtm-85 -138.95 131.07 28.09 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.756 HG21 HG12 ' A' ' 138' ' ' ILE . 82.4 p -144.2 110.99 5.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.927 0.394 . . . . 10.0 112.035 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? 47.8 48.2 17.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.349 0.595 . . . . 10.0 110.735 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 73.51 32.35 1.21 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.085 -0.961 . . . . 10.0 111.564 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 91' ' ' VAL . 53.7 t -128.4 110.88 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.311 -0.859 . . . . 10.0 109.451 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.799 ' HB3' HG22 ' A' ' 60' ' ' ILE . 88.5 tt0 -88.27 98.34 11.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 106.14 -1.8 . . . . 10.0 106.14 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.01 HG21 HD13 ' A' ' 142' ' ' ILE . 3.6 t -88.62 153.93 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 112.983 -1.917 . . . . 10.0 113.353 -173.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -124.13 152.66 17.35 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-N 114.506 -1.225 . . . . 10.0 113.148 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.645 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -141.66 130.0 22.39 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.746 HD12 ' O ' ' A' ' 80' ' ' SER . 66.1 tp -88.56 133.68 34.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.205 0.526 . . . . 10.0 111.445 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.734 HG12 HD11 ' A' ' 18' ' ' ILE . 27.1 m -150.27 -175.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.357 -0.838 . . . . 10.0 110.776 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 78' ' ' MET . 60.3 t0 -111.51 -56.85 2.33 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.338 0.496 . . . . 10.0 112.338 -176.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -133.87 124.72 26.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.986 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 33' ' ' VAL . 5.9 p -115.94 113.12 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-O 122.336 1.065 . . . . 10.0 112.004 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.719 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -63.82 -30.19 71.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.292 -1.776 . . . . 10.0 111.343 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.58 -120.14 5.47 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.707 -0.957 . . . . 10.0 110.707 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.8 p -54.57 131.23 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 117.099 0.449 . . . . 10.0 110.064 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.764 HD22 ' CB ' ' A' ' 15' ' ' SER . 54.6 tp -135.02 139.42 44.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.142 0.496 . . . . 10.0 111.469 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.1 ptp85 -88.9 72.35 8.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.1 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.973 HD12 HG21 ' A' ' 126' ' ' VAL . 9.6 mm -88.73 132.79 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.188 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.8 p -88.51 148.28 24.21 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 106.989 -1.486 . . . . 10.0 106.989 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -140.25 90.08 2.34 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.506 -0.878 . . . . 10.0 111.849 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -91.15 16.43 9.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.741 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-N 115.524 -0.762 . . . . 10.0 110.685 -179.616 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.633 ' CE2' HD21 ' A' ' 69' ' ' LEU . 25.3 t80 . . . . . 0 N--CA 1.46 0.073 0 CA-C-O 121.031 0.443 . . . . 10.0 110.495 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.34 -146.58 18.24 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.712 -0.676 . . . . 10.0 112.341 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -88.23 54.05 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 10.0 110.678 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 68' ' ' ILE . 17.9 tppt? -139.55 -39.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.033 0.383 . . . . 10.0 112.033 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.583 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 99.6 p . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.664 0.269 . . . . 10.0 110.697 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.973 HG21 HD12 ' A' ' 104' ' ' ILE . 2.4 p . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 121.295 0.569 . . . . 10.0 111.686 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.42 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 96.5 mttt -147.02 140.65 25.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 131' ' ' ARG . 6.3 m -163.24 142.08 8.31 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.803 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 56.02 44.1 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.958 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.56 35.23 29.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.105 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.561 ' HD2' ' CG1' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -133.84 148.86 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.2 mp -88.75 139.33 30.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.399 0.619 . . . . 10.0 112.471 -177.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.015 HG12 ' HB3' ' A' ' 22' ' ' ALA . 6.2 mt -151.5 150.35 13.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.241 -0.891 . . . . 10.0 110.571 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.941 ' HB ' HD13 ' A' ' 23' ' ' LEU . 6.1 mm -103.6 130.9 53.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.552 ' C ' HD12 ' A' ' 136' ' ' LEU . 10.3 t80 -117.42 139.26 51.13 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 119.915 -0.714 . . . . 10.0 111.364 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.86 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.2 mp -135.67 165.98 24.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.497 -0.774 . . . . 10.0 112.145 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -135.45 24.28 3.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.657 -1.156 . . . . 10.0 108.293 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.901 ' HA ' HG23 ' A' ' 141' ' ' ILE . 11.1 tt 41.7 17.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.286 -1.325 . . . . 10.0 113.961 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.7 t70 -82.72 -60.19 2.26 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.729 0.64 . . . . 10.0 112.729 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 3.4 mptp? -75.3 -34.26 61.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.699 0.761 . . . . 10.0 109.631 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.901 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.45 -46.15 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.664 -1.153 . . . . 10.0 110.732 179.229 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.01 HD13 HG21 ' A' ' 91' ' ' VAL . 7.6 tp -62.73 -45.84 97.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 C-N-CA 120.193 -0.603 . . . . 10.0 110.436 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.738 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.3 tt0 -47.92 -44.61 30.01 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.351 0.596 . . . . 10.0 109.756 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.601 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.3 mt-10 -69.6 -30.94 68.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.246 -0.888 . . . . 10.0 110.898 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.653 ' CD1' HG11 ' A' ' 91' ' ' VAL . 48.4 mt -57.61 -54.01 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 120.843 0.354 . . . . 10.0 111.418 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.4 p -69.05 -52.28 30.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.868 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 143' ' ' GLU . 14.0 p -67.25 -12.46 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.811 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.625 ' HA ' ' HE2' ' A' ' 148' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.842 0.354 . . . . 10.0 111.092 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.2 tttm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.005 0.431 . . . . 10.0 110.557 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.589 ' HG2' HG22 ' A' ' 105' ' ' THR . 35.1 mt-10 -124.95 164.23 20.56 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.53 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.617 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 12.1 t80 -153.6 137.51 16.27 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.718 -1.128 . . . . 10.0 113.037 -174.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 70.8 mt-10 -88.78 137.36 32.38 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.791 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -152.07 171.05 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.333 -0.849 . . . . 10.0 112.504 -175.696 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.681 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.9 tm? -88.85 134.94 33.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.795 ' HB3' HD22 ' A' ' 102' ' ' LEU . 80.6 p -148.16 153.03 38.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.096 0.776 . . . . 10.0 113.096 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.697 ' HZ ' ' CE1' ' A' ' 25' ' ' PHE . 1.8 p90 -149.79 168.1 24.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.269 -1.332 . . . . 10.0 110.143 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.55 129.67 35.42 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.829 HD11 HG12 ' A' ' 95' ' ' VAL . 4.5 mm -136.65 117.77 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.759 -0.655 . . . . 10.0 111.519 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.573 ' OD2' HG22 ' A' ' 18' ' ' ILE . 1.9 p30 38.44 60.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.17 -0.923 . . . . 10.0 112.621 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER 78.4 -43.06 0.35 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.916 -1.038 . . . . 10.0 112.742 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.534 ' NE2' ' HB ' ' A' ' 18' ' ' ILE . 3.5 pp0? -89.25 163.07 15.54 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.871 -0.332 . . . . 10.0 110.88 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.977 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.73 151.63 22.29 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.804 0.335 . . . . 10.0 110.84 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -133.58 134.75 43.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.077 -179.221 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.66 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -137.23 141.02 42.07 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.214 0.82 . . . . 10.0 113.214 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.04 ' CE2' HD13 ' A' ' 65' ' ' LEU . 1.4 m-85 -119.23 135.86 54.49 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.826 -1.175 . . . . 10.0 107.826 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -51.06 123.59 9.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.467 -0.493 . . . . 10.0 110.802 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.717 HG13 ' HA ' ' A' ' 13' ' ' VAL . 15.7 m -64.4 -8.68 5.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.608 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.6 -31.43 68.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.01 0.433 . . . . 10.0 110.524 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.808 ' OD1' HG21 ' A' ' 138' ' ' ILE . 7.3 t-20 -106.88 -50.22 3.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.918 -0.583 . . . . 10.0 112.401 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.681 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.1 mm -49.61 135.88 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.779 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 32' ' ' MET . 16.3 pt-20 -111.45 -51.65 2.84 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.889 0.7 . . . . 10.0 112.889 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.4 mtm -169.07 157.93 8.16 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.058 0.456 . . . . 10.0 111.88 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.719 HG11 HG11 ' A' ' 98' ' ' VAL . 34.8 m -89.68 177.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.033 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.628 HG13 ' HB ' ' A' ' 81' ' ' ILE . 20.6 pt -160.66 157.47 2.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.383 -0.826 . . . . 10.0 110.192 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -88.75 136.62 32.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 10.0 111.398 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.546 ' HB2' HG13 ' A' ' 81' ' ' ILE . 1.2 tmtp? . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.009 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 63' ' ' VAL . 60.8 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.639 0.257 . . . . 10.0 110.776 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' OE2' HG23 ' A' ' 62' ' ' VAL . 1.7 pp20? -72.8 -35.91 67.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.445 -0.343 . . . . 10.0 111.725 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.539 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -158.66 -176.01 30.23 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 119.659 -1.258 . . . . 10.0 113.755 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 53' ' ' ILE . 2.0 m -156.95 169.76 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 52' ' ' VAL . 26.9 pt . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.946 0.403 . . . . 10.0 111.583 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.797 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.717 0.294 . . . . 10.0 111.326 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 95.2 Cg_endo -84.6 116.43 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.384 2.056 . . . . 10.0 112.593 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.539 HG22 ' C ' ' A' ' 51' ' ' GLY . 7.6 m -89.0 99.54 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.346 -0.612 . . . . 10.0 109.346 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 49' ' ' VAL . 3.1 t -99.52 -175.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.019 -0.991 . . . . 10.0 110.144 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.879 ' H ' HG12 ' A' ' 63' ' ' VAL . 38.1 m-20 -132.55 87.82 2.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.08 -0.509 . . . . 10.0 109.986 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.04 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.6 tt -51.14 -24.75 4.38 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.122 -0.631 . . . . 10.0 111.137 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.758 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -66.67 -29.51 69.54 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.827 -0.349 . . . . 10.0 111.058 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.828 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -86.08 -37.88 18.39 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.812 0.339 . . . . 10.0 110.15 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.728 HG22 ' HA ' ' A' ' 65' ' ' LEU . 10.3 tt -65.35 -38.24 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 107.508 -1.293 . . . . 10.0 107.508 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.827 ' C ' HD13 ' A' ' 69' ' ' LEU . 1.5 tm? -78.29 -46.94 18.94 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.553 -1.658 . . . . 10.0 108.724 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.556 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 115.02 -89.64 0.51 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.305 -0.861 . . . . 10.0 112.633 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.842 HG13 ' HB3' ' A' ' 73' ' ' PHE . 4.4 pt 47.12 164.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 16.3 t -48.1 -33.05 7.62 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.842 ' HB3' HG13 ' A' ' 71' ' ' ILE . 16.5 t80 -30.6 145.42 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.219 -0.9 . . . . 10.0 112.634 176.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -166.44 33.62 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.31 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.495 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 56.2 mt-10 55.0 46.03 25.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.683 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.45 ' HB2' ' HE2' ' A' ' 77' ' ' LYS . 98.6 mm-40 -95.64 -53.48 3.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -102.09 -32.75 9.98 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.298 0.481 . . . . 10.0 112.298 -178.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.624 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 2.9 mmm -28.85 142.65 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.87 0.468 . . . . 10.0 112.248 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.76 39.33 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.079 -0.509 . . . . 10.0 111.283 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.4 t -169.06 127.69 1.02 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.736 -0.665 . . . . 10.0 109.644 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.628 ' HB ' HG13 ' A' ' 34' ' ' ILE . 47.8 mt -98.2 151.31 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.631 HD13 HD11 ' A' ' 14' ' ' LEU . 11.0 mt -115.65 123.8 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.879 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.526 ' CG2' HD13 ' A' ' 34' ' ' ILE . 65.3 t -91.31 147.6 5.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.503 0.668 . . . . 10.0 111.928 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -150.67 171.31 17.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.017 -0.992 . . . . 10.0 110.384 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.597 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 12.1 ptp180 -127.29 143.79 51.17 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.541 -0.54 . . . . 10.0 109.541 178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.5 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 34.5 p -159.0 108.56 1.94 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.269 0.47 . . . . 10.0 112.269 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.2 tppp? 46.79 48.49 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.355 0.598 . . . . 10.0 110.816 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 72.47 33.88 1.37 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.081 -0.963 . . . . 10.0 111.244 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.935 HG12 HG22 ' A' ' 91' ' ' VAL . 75.0 t -132.45 110.62 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-N 115.122 -0.945 . . . . 10.0 109.193 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.679 ' HB2' HG22 ' A' ' 60' ' ' ILE . 1.7 mp0 -88.36 96.25 10.51 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.043 HG21 HD13 ' A' ' 142' ' ' ILE . 3.4 t -88.64 153.26 3.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 113.273 -1.785 . . . . 10.0 112.792 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -131.84 153.87 20.69 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 114.997 -1.001 . . . . 10.0 113.701 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.726 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 t80 -139.86 128.54 23.12 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.453 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 51.1 tp -88.72 136.19 33.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.562 0.696 . . . . 10.0 112.209 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.829 HG12 HD11 ' A' ' 18' ' ' ILE . 23.8 m -148.86 -175.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.805 -1.089 . . . . 10.0 110.098 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.448 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 6.6 t70 -106.31 -57.96 1.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.496 HH12 HD11 ' A' ' 99' ' ' LEU . 55.4 ttp85 -133.96 116.34 15.45 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.369 0.604 . . . . 10.0 109.825 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.719 HG11 HG11 ' A' ' 33' ' ' VAL . 9.3 p -105.08 116.09 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 122.49 1.138 . . . . 10.0 111.852 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.641 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -65.73 -29.69 70.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.908 -1.951 . . . . 10.0 110.774 -178.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.8 -122.14 5.91 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.174 -0.77 . . . . 10.0 111.174 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -53.22 129.91 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 117.148 0.474 . . . . 10.0 110.292 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.804 ' HB3' HG13 ' A' ' 13' ' ' VAL . 60.7 tp -132.02 141.66 49.32 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.104 0.478 . . . . 10.0 111.236 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 103' ' ' ARG . 14.4 ptp180 -88.87 68.79 8.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.011 HD12 HG21 ' A' ' 126' ' ' VAL . 22.3 mm -88.75 132.04 34.63 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.589 HG22 ' HG2' ' A' ' 10' ' ' GLU . 30.3 p -88.73 -175.77 5.02 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.223 -1.028 . . . . 10.0 108.223 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -147.3 75.71 1.38 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.322 -0.951 . . . . 10.0 112.423 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -103.1 20.63 17.27 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.763 -1.108 . . . . 10.0 109.272 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.453 -179.396 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.716 ' CE1' HD21 ' A' ' 69' ' ' LEU . 19.8 t80 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.005 0.431 . . . . 10.0 110.949 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 146.57 53.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.901 -0.666 . . . . 10.0 112.16 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 68.62 55.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.087 0.47 . . . . 10.0 110.844 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.439 ' HD2' ' CE2' ' A' ' 118' ' ' PHE . 24.2 ttmm -148.08 -37.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.639 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 92.1 p . . . . . 0 C--N 1.328 -0.334 0 N-CA-C 109.746 -0.465 . . . . 10.0 109.746 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 1.011 HG21 HD12 ' A' ' 104' ' ' ILE . 2.2 p . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 121.096 0.474 . . . . 10.0 111.015 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -152.89 140.99 20.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.162 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.571 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 6.2 m -167.46 147.49 5.24 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.849 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 57.28 42.86 24.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.431 . . . . 10.0 110.809 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.0 34.44 30.94 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.108 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -132.99 148.44 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.693 0.282 . . . . 10.0 110.274 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.8 139.47 30.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 10.0 111.11 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.977 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.2 mt -152.28 156.56 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.954 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.646 ' HB ' HD13 ' A' ' 23' ' ' LEU . 63.4 mt -117.79 126.91 75.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.561 ' CE1' HG21 ' A' ' 13' ' ' VAL . 15.1 t80 -116.03 146.47 42.14 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.924 -0.31 . . . . 10.0 110.535 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.787 HD21 ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -161.29 154.05 20.68 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.752 0.787 . . . . 10.0 112.717 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 141' ' ' ILE . 2.9 p30 -105.59 133.99 49.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.754 -1.112 . . . . 10.0 108.52 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.926 ' HA ' HG23 ' A' ' 141' ' ' ILE . 15.2 tt -67.11 6.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -74.89 -47.79 28.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.902 0.382 . . . . 10.0 111.652 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.4 mptt -83.66 -34.76 24.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.163 0.506 . . . . 10.0 110.585 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -69.05 -35.83 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.593 179.127 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.043 HD13 HG21 ' A' ' 91' ' ' VAL . 7.8 tp -71.14 -44.15 74.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.527 ' N ' HG23 ' A' ' 142' ' ' ILE . 39.4 tt0 -47.3 -42.7 21.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.558 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.6 mt-10 -71.09 -35.34 71.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.471 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.71 HG13 ' O ' ' A' ' 141' ' ' ILE . 26.7 mt -53.43 -38.84 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-O 120.8 0.333 . . . . 10.0 111.096 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.6 p -80.65 -50.46 9.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.903 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.2 p -76.71 4.91 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 112.05 0.389 . . . . 10.0 112.05 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.0 pttp . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.527 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.511 ' O ' HG22 ' A' ' 105' ' ' THR . 31.3 mmmt . . . . . 0 N--CA 1.46 0.071 0 CA-C-O 120.747 0.308 . . . . 10.0 111.801 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.639 ' HG2' HG22 ' A' ' 105' ' ' THR . 77.2 mt-10 -129.84 164.26 24.51 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.364 0.602 . . . . 10.0 111.038 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.563 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 15.7 t80 -161.67 138.62 8.48 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.937 -1.029 . . . . 10.0 112.881 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.76 140.62 29.26 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.724 -0.671 . . . . 10.0 109.632 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.805 HG13 ' HB3' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -156.39 169.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 113.287 0.847 . . . . 10.0 113.287 -174.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.751 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.9 tm? -88.95 133.92 34.14 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.742 -1.207 . . . . 10.0 107.742 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.812 ' HB3' HD22 ' A' ' 102' ' ' LEU . 74.6 p -145.34 153.8 41.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 113.083 0.772 . . . . 10.0 113.083 -177.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.634 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 3.1 p90 -151.81 165.3 34.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.375 -1.284 . . . . 10.0 110.371 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -88.58 134.07 33.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.916 HG21 HD12 ' A' ' 71' ' ' ILE . 21.3 mm -131.56 93.49 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.479 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.0 OUTLIER 42.65 60.19 2.5 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 113.073 0.768 . . . . 10.0 113.073 178.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.586 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 88.71 -43.34 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.115 -0.948 . . . . 10.0 112.632 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.716 ' NE2' HD13 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -88.98 151.52 22.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.377 -0.529 . . . . 10.0 110.412 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.008 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.84 156.93 18.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.844 0.354 . . . . 10.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.791 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.2 tp -144.74 135.52 24.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.885 0.374 . . . . 10.0 110.858 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.749 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -142.27 151.69 42.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.943 -0.572 . . . . 10.0 112.364 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.859 ' CE2' HD22 ' A' ' 136' ' ' LEU . 2.8 m-85 -129.36 141.64 51.02 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -48.55 101.34 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.644 0.735 . . . . 10.0 109.369 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 13' ' ' VAL . 3.8 p -47.15 -13.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.523 -1.217 . . . . 10.0 112.862 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -62.9 -41.95 99.61 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.226 -0.589 . . . . 10.0 109.712 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.717 ' OD1' HG21 ' A' ' 138' ' ' ILE . 7.3 t-20 -81.85 -48.4 11.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.126 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.751 HG21 ' HG ' ' A' ' 14' ' ' LEU . 18.0 mm -58.52 123.58 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.133 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.676 ' OE2' HG12 ' A' ' 83' ' ' VAL . 15.7 pt-20 -87.19 -54.81 4.11 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.477 0.547 . . . . 10.0 112.477 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.3 mtm -169.23 157.87 7.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.161 0.505 . . . . 10.0 112.352 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.844 HG11 HG11 ' A' ' 98' ' ' VAL . 34.3 m -88.88 148.05 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.057 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.516 HD13 HG21 ' A' ' 83' ' ' VAL . 32.0 pt -139.52 155.34 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -88.8 152.79 21.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.066 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.452 ' HD3' ' C ' ' A' ' 36' ' ' LYS . 12.3 tmtt? . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.721 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.624 ' HA ' HG22 ' A' ' 63' ' ' VAL . 58.6 t . . . . . 0 C--O 1.231 0.107 0 N-CA-C 111.912 0.338 . . . . 10.0 111.912 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -66.25 -30.94 71.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.972 0.415 . . . . 10.0 110.169 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.768 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -152.28 169.04 31.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.712 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.469 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 3.6 m -158.62 171.96 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.661 0.267 . . . . 10.0 110.499 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 53' ' ' ILE . 2.2 pp . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.008 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.783 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.0 pp . . . . . 0 C--O 1.236 0.38 0 CA-C-O 120.303 0.097 . . . . 10.0 110.87 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 61.7 Cg_endo -97.31 123.97 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.365 2.71 . . . . 10.0 113.546 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.768 HG22 ' C ' ' A' ' 51' ' ' GLY . 34.4 m -102.62 135.5 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 49' ' ' VAL . 99.5 t -143.68 158.16 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.569 0.7 . . . . 10.0 112.543 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.821 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 66.8 m-20 -70.38 67.69 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.945 -1.025 . . . . 10.0 109.702 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.927 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.9 tt -50.99 -31.07 16.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.336 0.589 . . . . 10.0 110.61 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.814 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -62.7 -22.96 66.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.81 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -88.4 -41.85 12.54 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 178.566 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 65' ' ' LEU . 7.6 tt -59.15 -40.38 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.844 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.88 -40.19 33.07 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.31 -1.768 . . . . 10.0 108.267 176.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 71' ' ' ILE . . . 71.32 121.62 0.05 OUTLIER Glycine 0 C--N 1.333 0.386 0 CA-C-N 114.791 -1.095 . . . . 10.0 113.05 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.916 HD12 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -162.86 -167.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.152 0.581 . . . . 10.0 109.972 -179.206 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 71.9 m -50.4 -32.34 17.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.616 0.722 . . . . 10.0 109.14 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.814 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 7.3 t80 -35.81 143.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.418 -1.265 . . . . 10.0 112.682 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -169.98 36.11 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.649 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 56.2 mt-10 55.54 37.7 29.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.439 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -82.85 -70.81 0.53 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.816 0.341 . . . . 10.0 111.718 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.62 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.4 mptt -94.93 -31.14 13.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.683 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.583 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 12.3 mmm -23.22 140.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.542 0.737 . . . . 10.0 112.221 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -164.11 -37.04 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.972 0.36 . . . . 10.0 111.972 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.851 ' O ' HD12 ' A' ' 94' ' ' LEU . 80.2 p -88.75 163.87 15.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.584 0.231 . . . . 10.0 111.002 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.451 HG21 HG11 ' A' ' 62' ' ' VAL . 67.7 mt -132.64 129.15 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.722 0.296 . . . . 10.0 111.643 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 14' ' ' LEU . 7.5 mt -93.5 150.79 3.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.741 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.676 HG12 ' OE2' ' A' ' 31' ' ' GLU . 46.6 t -121.45 142.04 39.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.458 . . . . 10.0 110.778 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -145.0 175.97 9.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.782 -0.644 . . . . 10.0 111.015 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.541 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 6.6 ptm180 -128.25 146.38 50.76 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.516 HG21 HG12 ' A' ' 138' ' ' ILE . 73.3 p -160.93 108.67 1.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.466 0.543 . . . . 10.0 112.466 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 47.08 48.41 15.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.371 0.605 . . . . 10.0 110.779 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 72.26 33.54 1.51 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.117 -0.947 . . . . 10.0 111.235 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.894 HG12 HG22 ' A' ' 91' ' ' VAL . 54.2 t -131.46 111.81 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-N 115.166 -0.924 . . . . 10.0 109.211 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.758 ' HB2' HG22 ' A' ' 60' ' ' ILE . 27.1 mt-10 -88.34 97.93 11.32 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.053 -1.832 . . . . 10.0 106.053 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.018 HG21 HD13 ' A' ' 142' ' ' ILE . 4.8 t -88.55 154.48 3.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.256 -1.793 . . . . 10.0 112.658 -174.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.1 156.3 21.91 Favored Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.702 -1.136 . . . . 10.0 113.065 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.59 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 t80 -146.3 131.94 18.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 10.0 110.935 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.851 HD12 ' O ' ' A' ' 80' ' ' SER . 58.8 tp -88.7 126.83 35.5 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.266 0.555 . . . . 10.0 112.066 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.583 ' HA ' ' HE3' ' A' ' 78' ' ' MET . 30.4 m -137.25 -175.08 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.261 -0.882 . . . . 10.0 109.89 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.78 -62.56 1.32 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.061 0.458 . . . . 10.0 112.191 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -133.93 117.86 17.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.756 -0.656 . . . . 10.0 109.66 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.844 HG11 HG11 ' A' ' 33' ' ' VAL . 9.3 p -104.95 116.07 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 122.451 1.12 . . . . 10.0 111.805 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -64.61 -30.33 71.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.02 -1.9 . . . . 10.0 110.747 -178.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.99 -124.4 6.98 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.487 -0.779 . . . . 10.0 111.259 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.3 p -52.17 128.15 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 117.035 0.418 . . . . 10.0 110.422 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 15' ' ' SER . 51.8 tp -132.06 139.06 48.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.039 0.447 . . . . 10.0 110.927 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.0 ptp85 -88.86 73.25 8.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.828 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.95 HD12 HG11 ' A' ' 126' ' ' VAL . 11.8 mm -88.78 126.21 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.737 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.639 HG22 ' HG2' ' A' ' 10' ' ' GLU . 17.7 p -88.74 146.21 25.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 176.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -131.31 70.7 1.46 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.069 -1.053 . . . . 10.0 113.398 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -80.99 -9.5 59.83 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.654 -1.157 . . . . 10.0 108.564 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-N 114.98 -1.009 . . . . 10.0 110.875 -179.93 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.634 ' CE1' HD21 ' A' ' 69' ' ' LEU . 23.7 t80 . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.188 0.518 . . . . 10.0 110.054 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' A' ' 120' ' ' LYS . . . 141.75 -58.75 0.56 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.478 -0.783 . . . . 10.0 112.052 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.441 ' CG ' ' O ' ' A' ' 119' ' ' GLY . 51.7 mtmt -163.78 56.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.55 0.214 . . . . 10.0 110.529 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.493 ' HG2' HD22 ' A' ' 69' ' ' LEU . 2.4 tpmt? -150.88 -40.54 0.12 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.509 ' CB ' ' HG ' ' A' ' 136' ' ' LEU . 91.8 p . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 121.0 -0.28 . . . . 10.0 111.386 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.985 HG13 ' HB ' ' A' ' 133' ' ' ILE . 2.3 p . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 121.603 0.716 . . . . 10.0 112.844 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.49 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 62.3 pttt -164.48 132.08 3.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.901 -1.045 . . . . 10.0 109.529 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 5.4 m -159.53 148.88 18.22 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.965 0.412 . . . . 10.0 111.476 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.461 ' HB3' ' NH2' ' A' ' 131' ' ' ARG . 38.6 t70 56.16 46.1 22.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.731 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.23 32.87 57.52 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.597 -0.811 . . . . 10.0 111.743 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.461 ' NH2' ' HB3' ' A' ' 129' ' ' ASP . 1.5 ptp85 -130.63 132.33 45.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.808 0.337 . . . . 10.0 110.221 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.5 tp -88.8 139.13 30.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.159 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.008 HG12 ' HB3' ' A' ' 22' ' ' ALA . 2.6 mt -141.57 126.69 17.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.039 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.791 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.2 mp -89.03 136.59 23.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.684 ' C ' HD12 ' A' ' 136' ' ' LEU . 46.5 t80 -128.8 140.96 51.47 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.537 0.684 . . . . 10.0 111.376 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.859 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.9 mp -130.89 178.26 6.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.486 -0.779 . . . . 10.0 112.078 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.8 p-10 -141.37 23.28 2.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.336 -1.302 . . . . 10.0 108.063 177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.871 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.3 tt 40.75 16.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 114.112 -1.404 . . . . 10.0 114.059 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 137' ' ' ASP . 66.7 t0 -80.0 -61.36 2.01 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.61 0.596 . . . . 10.0 112.61 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -78.34 -29.68 47.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.383 0.611 . . . . 10.0 110.412 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.871 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.21 -45.64 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 115.367 -0.833 . . . . 10.0 110.118 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.018 HD13 HG21 ' A' ' 91' ' ' VAL . 8.0 tp -64.42 -43.32 96.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 120.013 -0.675 . . . . 10.0 109.512 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.535 ' N ' HG23 ' A' ' 142' ' ' ILE . 39.5 tt0 -48.16 -42.59 30.01 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.814 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.635 ' HA ' HG12 ' A' ' 147' ' ' VAL . 55.1 mm-40 -70.26 -33.73 71.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.24 -0.891 . . . . 10.0 110.421 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.651 ' CD1' HG11 ' A' ' 91' ' ' VAL . 41.9 mt -57.22 -35.42 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.806 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.5 p -81.73 -50.45 9.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.655 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 144' ' ' GLU . 14.7 p -72.24 -5.21 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.948 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.42 ' CD ' ' O ' ' A' ' 145' ' ' ILE . 57.0 pttt . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.878 0.37 . . . . 10.0 111.469 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HE3' ' HB2' ' A' ' 10' ' ' GLU . 24.8 tptt . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 112.077 0.399 . . . . 10.0 112.077 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 42.4 tt0 -155.88 164.14 38.88 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.524 0.678 . . . . 10.0 111.477 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.676 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 11.4 t80 -159.49 140.41 12.53 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.616 -1.175 . . . . 10.0 112.483 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.66 130.64 35.25 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.168 -1.049 . . . . 10.0 108.168 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.892 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.6 p -149.0 166.23 3.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 -175.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 1.04 HD11 HD13 ' A' ' 82' ' ' ILE . 3.0 tm? -89.01 140.02 29.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.835 ' HB3' HD22 ' A' ' 102' ' ' LEU . 53.4 p -154.92 158.03 38.65 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 119.806 -0.757 . . . . 10.0 112.851 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.698 ' CZ ' ' HG ' ' A' ' 23' ' ' LEU . 17.4 p90 -150.42 166.16 30.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.589 -1.187 . . . . 10.0 110.109 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.622 ' HG2' HD21 ' A' ' 99' ' ' LEU . 53.2 mm-40 -88.54 142.38 27.75 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.699 -0.482 . . . . 10.0 109.699 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.031 HG21 HD12 ' A' ' 71' ' ' ILE . 33.4 mm -140.52 93.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.78 -0.645 . . . . 10.0 111.45 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.538 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 62.3 m-20 43.24 60.06 2.71 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.89 -0.595 . . . . 10.0 112.39 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.8 mt-10 85.53 -42.71 0.05 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.145 -0.934 . . . . 10.0 112.307 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.627 ' NE2' HG22 ' A' ' 71' ' ' ILE . 19.1 pt20 -88.96 147.08 24.51 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.612 -0.435 . . . . 10.0 109.988 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.009 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.92 166.53 13.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.127 0.489 . . . . 10.0 111.927 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.854 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.1 OUTLIER -140.39 143.57 35.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.549 -179.211 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.757 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -144.45 149.25 35.7 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.738 0.644 . . . . 10.0 112.738 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.798 ' CE2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -138.39 137.88 37.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.689 -0.856 . . . . 10.0 108.689 179.092 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -56.17 123.93 16.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.224 -0.591 . . . . 10.0 110.144 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.892 HG13 ' HA ' ' A' ' 13' ' ' VAL . 35.8 m -59.77 -10.54 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.381 -0.827 . . . . 10.0 112.098 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 1.4 p30 -60.03 -40.67 90.14 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.087 0.47 . . . . 10.0 110.089 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.745 HD21 HG22 ' A' ' 86' ' ' THR . 14.7 t-20 -93.3 -47.35 6.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 10.0 111.192 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.78 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.1 mm -57.93 121.91 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.507 ' O ' ' HG3' ' A' ' 32' ' ' MET . 12.4 pt-20 -84.34 -51.14 7.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.16 0.43 . . . . 10.0 112.16 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.9 mtm -169.1 154.69 6.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.248 0.547 . . . . 10.0 111.885 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.656 ' CG1' HD21 ' A' ' 14' ' ' LEU . 34.8 m -88.95 149.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.399 -0.819 . . . . 10.0 111.395 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.486 HG13 ' HB ' ' A' ' 81' ' ' ILE . 10.7 pt -143.57 -178.14 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.723 -0.672 . . . . 10.0 110.622 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -155.75 104.14 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.179 0.514 . . . . 10.0 110.701 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.788 -0.642 . . . . 10.0 111.083 -179.659 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.879 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.5 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.949 0.404 . . . . 10.0 111.476 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.85 -45.28 12.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.335 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.703 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -139.13 -176.38 14.65 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.578 -0.737 . . . . 10.0 112.498 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' ' 53' ' ' ILE . 2.5 m -160.51 169.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 10.0 110.232 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.68 HD13 ' N ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 120.991 0.424 . . . . 10.0 111.211 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.902 HG22 ' HB2' ' A' ' 90' ' ' GLU . 20.3 pt . . . . . 0 C--O 1.234 0.287 0 N-CA-C 111.563 0.208 . . . . 10.0 111.563 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 94.2 Cg_endo -77.82 117.84 4.33 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.593 2.195 . . . . 10.0 112.201 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.703 HG22 ' C ' ' A' ' 51' ' ' GLY . 28.7 m -94.92 137.68 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.715 0.293 . . . . 10.0 110.423 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.879 HG22 ' HA ' ' A' ' 49' ' ' VAL . 88.3 t -140.47 154.91 22.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.479 0.657 . . . . 10.0 111.924 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.821 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.3 m120 -77.65 65.92 3.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.157 -0.929 . . . . 10.0 109.15 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.901 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.7 tt -49.64 -26.73 3.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.575 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.835 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -66.78 -29.15 69.02 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.347 -0.541 . . . . 10.0 110.596 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -87.92 -33.9 18.32 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 121.088 -0.245 . . . . 10.0 110.988 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.696 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.8 tt -57.37 -41.41 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 106.336 -1.727 . . . . 10.0 106.336 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.893 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -77.7 -49.74 13.86 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.231 -1.804 . . . . 10.0 108.392 176.564 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 115.48 -79.17 0.28 Allowed Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.229 -0.896 . . . . 10.0 112.746 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.031 HD12 HG21 ' A' ' 18' ' ' ILE . 2.3 pt 46.05 173.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.619 0.6 . . . . 10.0 112.619 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 19' ' ' ASP . 71.4 m -51.62 -36.21 44.97 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.849 ' HB3' HG13 ' A' ' 71' ' ' ILE . 3.7 t80 -30.14 145.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.996 -1.002 . . . . 10.0 113.536 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 35.9 t70 -134.62 -54.37 0.83 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.051 -0.977 . . . . 10.0 110.117 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.463 ' HA ' ' HE1' ' A' ' 73' ' ' PHE . 10.5 pt-20 164.52 -45.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.865 0.364 . . . . 10.0 111.644 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -55.52 -37.91 68.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.484 ' N ' ' HE3' ' A' ' 77' ' ' LYS . 0.8 OUTLIER -68.27 -26.9 65.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.771 0.319 . . . . 10.0 111.331 -179.385 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.418 ' SD ' ' CE1' ' A' ' 73' ' ' PHE . 27.5 mmt -47.6 134.7 12.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.495 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 54.8 mtmt -160.75 -51.57 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.726 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.463 ' O ' HD12 ' A' ' 94' ' ' LEU . 52.3 m -90.14 -175.99 4.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.318 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 82' ' ' ILE . 75.5 mt -152.28 160.59 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.549 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.04 HD13 HD11 ' A' ' 14' ' ' LEU . 15.2 mt -142.23 140.69 29.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.903 0.382 . . . . 10.0 111.263 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 34' ' ' ILE . 44.8 t -110.62 149.74 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.139 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -147.9 175.6 10.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.8 -0.636 . . . . 10.0 110.573 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -133.21 129.99 38.48 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.745 HG22 HD21 ' A' ' 29' ' ' ASN . 44.8 p -144.42 108.78 4.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.319 0.489 . . . . 10.0 112.319 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.485 ' CE ' ' O ' ' A' ' 87' ' ' LYS . 8.1 ttpt 47.67 51.23 14.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.704 0.764 . . . . 10.0 110.806 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.0 31.1 2.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.964 -1.016 . . . . 10.0 111.611 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.873 HG12 HG22 ' A' ' 91' ' ' VAL . 55.7 t -128.33 108.37 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 115.178 -0.919 . . . . 10.0 109.028 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.902 ' HB2' HG22 ' A' ' 60' ' ' ILE . 1.4 mp0 -88.26 99.83 12.53 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.628 -1.99 . . . . 10.0 105.628 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.063 HG21 HD13 ' A' ' 142' ' ' ILE . 4.8 t -88.57 149.62 3.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 113.378 -1.737 . . . . 10.0 112.908 -173.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -119.07 157.78 15.16 Favored Glycine 0 C--N 1.31 -0.898 0 CA-C-N 113.862 -1.517 . . . . 10.0 112.423 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.683 ' CE2' HD22 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -149.75 123.66 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.292 0.568 . . . . 10.0 111.866 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.59 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 46.6 tp -88.78 120.18 29.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.954 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.474 HG11 ' CZ ' ' A' ' 16' ' ' PHE . 27.6 m -131.08 -175.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.48 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 5.2 t0 -84.61 -79.94 0.21 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.32 0.581 . . . . 10.0 110.704 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.81 110.59 8.71 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.675 -0.861 . . . . 10.0 108.675 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.607 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 10.5 p -88.93 114.52 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-O 122.319 1.057 . . . . 10.0 111.833 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.622 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -62.47 -28.65 69.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.23 -1.805 . . . . 10.0 110.827 -178.818 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.22 -121.07 5.93 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.006 -0.837 . . . . 10.0 111.006 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.68 127.33 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 117.076 0.438 . . . . 10.0 110.453 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.835 HD22 ' HB3' ' A' ' 15' ' ' SER . 46.9 tp -126.57 139.26 53.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.171 0.51 . . . . 10.0 110.743 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.0 ptp85 -88.87 76.95 7.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.381 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.795 ' CG1' HG11 ' A' ' 13' ' ' VAL . 10.1 mm -88.64 161.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 24.0 p -122.32 147.28 46.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 11.4 tt0 -104.96 66.81 0.77 Allowed 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.953 0.882 . . . . 10.0 112.256 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -96.31 17.74 15.28 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.456 -1.247 . . . . 10.0 108.677 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 C--O 1.231 0.128 0 CA-C-N 115.617 -0.72 . . . . 10.0 112.208 -179.486 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.637 ' CE2' HD21 ' A' ' 69' ' ' LEU . 45.8 t80 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 121.304 0.574 . . . . 10.0 109.791 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 175.04 -55.91 0.12 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.096 -0.956 . . . . 10.0 111.336 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 5.8 tmtt? 173.34 44.76 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 110.196 -0.298 . . . . 10.0 110.196 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 26.3 ttpp -163.89 48.78 0.13 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.408 0.522 . . . . 10.0 112.408 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.687 ' HB2' ' HB3' ' A' ' 136' ' ' LEU . 8.2 p . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 120.958 0.409 . . . . 10.0 112.056 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.892 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.7 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.543 0.687 . . . . 10.0 112.138 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 27.9 mtpp -154.62 134.02 12.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.944 -1.025 . . . . 10.0 109.839 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 16.3 m -163.04 149.9 12.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.895 0.379 . . . . 10.0 111.23 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.46 ' OD1' ' HB3' ' A' ' 131' ' ' ARG . 2.8 p30 46.15 48.49 12.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 10.0 111.5 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.66 43.24 68.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.82 -0.705 . . . . 10.0 112.212 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.46 ' HB3' ' OD1' ' A' ' 129' ' ' ASP . 3.5 ptm180 -138.97 134.17 32.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 10.0 110.625 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.93 137.37 32.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.939 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.009 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.9 mt -144.8 130.14 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.003 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.854 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.99 137.31 21.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 70.9 t80 -130.89 142.61 50.38 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.221 -0.592 . . . . 10.0 111.037 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.901 HD23 HG21 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -164.67 147.01 8.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.367 0.603 . . . . 10.0 112.35 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.409 ' OD1' ' CB ' ' A' ' 139' ' ' ASP . 3.0 p30 -96.46 35.02 1.53 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.806 0.812 . . . . 10.0 110.194 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.92 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 20.9 tt 39.95 20.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.328 -1.306 . . . . 10.0 114.14 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 66.5 t0 -79.3 -57.06 3.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.04 0.756 . . . . 10.0 113.04 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 121' ' ' LYS . 22.5 ttmm -77.96 -33.55 51.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 10.0 110.265 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.92 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -64.98 -45.26 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.946 178.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.063 HD13 HG21 ' A' ' 91' ' ' VAL . 5.8 tp -61.36 -44.57 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 C-N-CA 120.1 -0.64 . . . . 10.0 109.531 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 147' ' ' VAL . 43.6 mm-40 -47.16 -41.67 18.21 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.443 ' HG3' ' CD ' ' A' ' 121' ' ' LYS . 59.1 mm-40 -73.48 -31.39 63.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.36 -0.836 . . . . 10.0 111.177 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.66 ' CD1' HG11 ' A' ' 91' ' ' VAL . 44.5 mt -54.27 -48.16 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.973 0.416 . . . . 10.0 110.595 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.3 p -85.48 -45.98 11.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.978 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 143' ' ' GLU . 44.5 t -56.71 -31.49 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.585 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 48.4 tptt . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.066 0.46 . . . . 10.0 111.007 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.517 ' HE3' ' CB ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 121.148 0.499 . . . . 10.0 110.189 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 43.3 tt0 -148.52 163.96 35.65 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.661 -0.7 . . . . 10.0 110.648 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.667 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.4 t80 -158.79 139.14 12.38 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.052 -0.976 . . . . 10.0 112.54 -174.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -88.59 130.37 35.28 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.433 -0.951 . . . . 10.0 108.433 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.957 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.6 p -148.87 169.13 2.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 -175.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.818 ' HG ' HG21 ' A' ' 30' ' ' ILE . 3.3 tm? -88.8 139.18 30.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.857 ' HB3' HD22 ' A' ' 102' ' ' LEU . 83.3 p -149.15 154.17 38.79 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 119.806 -0.758 . . . . 10.0 112.881 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.77 ' CD2' HG11 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -149.24 167.18 26.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.409 -1.269 . . . . 10.0 110.775 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -88.63 123.81 33.46 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.03 -0.73 . . . . 10.0 109.03 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.908 HG21 HD12 ' A' ' 71' ' ' ILE . 9.7 mm -134.39 115.84 21.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.709 -0.678 . . . . 10.0 111.784 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.681 ' OD2' HG22 ' A' ' 18' ' ' ILE . 2.0 p30 39.08 60.12 1.53 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.717 . . . . 10.0 112.484 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 52.6 mt-10 78.08 -42.87 0.36 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.923 -1.035 . . . . 10.0 112.469 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.452 ' OE1' HG12 ' A' ' 134' ' ' ILE . 3.7 pp0? -91.83 158.74 16.16 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.295 -0.253 . . . . 10.0 110.717 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.874 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.74 148.37 24.0 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 121.078 0.466 . . . . 10.0 111.662 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.3 OUTLIER -124.35 133.19 53.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.409 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.889 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -134.06 152.15 51.72 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.443 0.905 . . . . 10.0 113.443 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.956 ' CZ ' HD12 ' A' ' 136' ' ' LEU . 5.6 m-85 -135.98 139.08 42.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.941 -1.027 . . . . 10.0 109.024 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -49.54 122.49 6.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.143 0.497 . . . . 10.0 111.175 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.957 HG13 ' HA ' ' A' ' 13' ' ' VAL . 19.9 m -61.06 -13.51 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.789 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -59.98 -41.81 92.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.13 0.49 . . . . 10.0 109.708 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.811 ' OD1' HG21 ' A' ' 138' ' ' ILE . 8.1 t-20 -92.16 -48.52 6.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.641 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.818 HG21 ' HG ' ' A' ' 14' ' ' LEU . 22.3 mm -60.89 129.23 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.445 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 32' ' ' MET . 16.4 pt-20 -100.37 -53.01 3.22 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.7 mtm -169.22 156.11 6.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 10.0 111.732 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.945 HG12 HG23 ' A' ' 82' ' ' ILE . 33.1 m -100.1 129.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.76 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.417 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 27.5 pt -105.78 137.68 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 10.0 111.015 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -90.48 119.51 30.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.829 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.859 ' HB2' HD12 ' A' ' 81' ' ' ILE . 68.7 mttm . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.818 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.866 ' HA ' HG22 ' A' ' 63' ' ' VAL . 50.0 t . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.086 0.469 . . . . 10.0 111.669 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -63.71 -47.79 79.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.994 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.579 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -155.47 -176.01 27.15 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.415 -0.811 . . . . 10.0 112.576 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 m -148.16 169.97 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.878 0.37 . . . . 10.0 110.98 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 60' ' ' ILE . 29.6 pt . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 10.0 111.311 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 53' ' ' ILE . 22.3 pt . . . . . 0 C--O 1.234 0.275 0 CA-C-O 120.675 0.274 . . . . 10.0 111.669 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 83.0 Cg_endo -80.16 116.54 3.38 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.816 2.344 . . . . 10.0 113.362 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.579 HG22 ' C ' ' A' ' 51' ' ' GLY . 22.4 m -95.45 133.97 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.866 HG22 ' HA ' ' A' ' 49' ' ' VAL . 59.3 t -142.59 156.74 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.665 0.745 . . . . 10.0 112.832 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.874 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 31.8 m120 -75.87 62.17 1.54 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.874 -1.057 . . . . 10.0 108.724 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.934 HD22 ' CD2' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -51.85 -20.48 2.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.74 -0.664 . . . . 10.0 111.621 -179.034 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.692 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -71.51 -30.66 66.21 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.287 -0.565 . . . . 10.0 110.133 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.874 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.58 -36.38 26.27 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.557 -0.164 . . . . 10.0 110.557 178.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 65' ' ' LEU . 9.1 tt -56.14 -40.86 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 106.402 -1.703 . . . . 10.0 106.402 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.009 HD11 HG23 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -76.81 -38.58 53.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 113.407 -1.724 . . . . 10.0 108.961 176.39 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.539 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 106.09 -92.12 0.78 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.607 -0.724 . . . . 10.0 113.598 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.009 HG23 HD11 ' A' ' 69' ' ' LEU . 3.4 pt 48.32 164.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 112.712 0.634 . . . . 10.0 112.712 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.543 ' HB2' ' CG ' ' A' ' 19' ' ' ASP . 29.2 m -49.16 -30.5 6.87 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.266 -0.642 . . . . 10.0 109.266 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.908 ' HB3' HG13 ' A' ' 71' ' ' ILE . 12.0 t80 -30.09 141.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.265 -0.88 . . . . 10.0 112.74 176.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -174.32 42.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.573 -0.739 . . . . 10.0 110.348 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 58.52 38.57 25.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -71.63 -42.77 67.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.846 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 96' ' ' ASP . 32.2 mmmt -146.11 23.92 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.85 0.315 . . . . 10.0 111.85 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.495 ' CE ' ' CE1' ' A' ' 73' ' ' PHE . 16.7 mmt -47.63 133.04 13.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.554 -0.294 . . . . 10.0 111.062 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -172.82 36.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.834 0.349 . . . . 10.0 111.137 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.62 ' OG ' HG23 ' A' ' 95' ' ' VAL . 92.3 p -169.11 154.07 5.83 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.637 -0.505 . . . . 10.0 109.637 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.859 HD12 ' HB2' ' A' ' 36' ' ' LYS . 51.8 mt -133.2 145.12 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.621 -0.432 . . . . 10.0 111.682 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.945 HG23 HG12 ' A' ' 33' ' ' VAL . 6.4 mt -110.21 144.6 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.483 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.99 140.09 46.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.147 0.499 . . . . 10.0 110.654 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -141.91 -175.97 4.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.992 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.629 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 6.4 ptm180 -135.55 143.1 45.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.513 ' OG1' ' HB ' ' A' ' 89' ' ' VAL . 41.6 p -158.83 109.39 2.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.876 0.37 . . . . 10.0 111.836 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 87' ' ' LYS . 36.4 ttmt 46.72 47.25 15.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.649 . . . . 10.0 110.687 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 52.8 m-20 74.49 34.07 0.8 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.939 -1.028 . . . . 10.0 111.342 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.895 HG12 HG22 ' A' ' 91' ' ' VAL . 60.1 t -130.36 110.76 19.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.419 -0.809 . . . . 10.0 109.858 177.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.692 ' HB3' HG22 ' A' ' 60' ' ' ILE . 35.6 tt0 -88.34 99.74 12.48 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 105.68 -1.97 . . . . 10.0 105.68 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.987 HG21 HD13 ' A' ' 142' ' ' ILE . 4.6 t -88.6 149.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 113.329 -1.76 . . . . 10.0 113.36 -173.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -121.56 149.56 17.22 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 113.912 -1.494 . . . . 10.0 113.071 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.934 ' CD2' HD22 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -141.83 128.49 20.33 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 120.783 0.325 . . . . 10.0 110.891 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.465 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 36.3 tp -88.64 131.38 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.108 0.48 . . . . 10.0 110.986 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.804 HG12 HD11 ' A' ' 18' ' ' ILE . 18.8 m -143.02 -175.02 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.386 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 7.9 t70 -90.94 -70.49 0.68 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.316 0.579 . . . . 10.0 111.902 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -142.14 112.91 7.34 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.175 -0.921 . . . . 10.0 108.678 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.668 ' CG1' HG21 ' A' ' 33' ' ' VAL . 7.5 p -91.35 114.42 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 122.463 1.125 . . . . 10.0 112.017 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.588 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -63.03 -29.13 70.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 112.817 -1.992 . . . . 10.0 110.969 -178.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.58 -123.59 6.99 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.595 -0.812 . . . . 10.0 111.279 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.69 133.36 16.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.061 0.431 . . . . 10.0 110.5 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.857 HD22 ' HB3' ' A' ' 15' ' ' SER . 53.6 tp -135.15 138.96 44.23 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.232 0.539 . . . . 10.0 111.234 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.699 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.1 OUTLIER -88.82 73.75 8.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.32 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.777 HD12 HG11 ' A' ' 126' ' ' VAL . 11.5 mm -88.8 133.06 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.691 -0.485 . . . . 10.0 109.691 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.6 p -88.57 146.54 25.07 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -129.26 75.2 1.63 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 114.164 1.172 . . . . 10.0 114.164 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -97.16 2.7 51.41 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.56 -1.274 . . . . 10.0 107.56 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 . . . . . 0 N--CA 1.452 -0.359 0 CA-C-N 114.621 -1.172 . . . . 10.0 110.7 -179.565 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.74 ' CE2' HD21 ' A' ' 69' ' ' LEU . 25.2 t80 . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 121.172 0.51 . . . . 10.0 110.035 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.7 -144.28 10.39 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.079 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -91.49 55.73 2.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.599 0.238 . . . . 10.0 110.667 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.516 ' NZ ' ' HB ' ' A' ' 141' ' ' ILE . 1.1 tmpt? -144.7 -44.79 0.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.915 -0.314 . . . . 10.0 111.314 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.825 ' CB ' HD22 ' A' ' 136' ' ' LEU . 47.4 t . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 119.643 -0.218 . . . . 10.0 110.428 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.91 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.7 p . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.211 0.529 . . . . 10.0 112.017 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 94.6 mttt -160.24 135.91 8.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.306 -0.861 . . . . 10.0 109.876 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 5.7 m -163.9 149.28 10.78 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.973 0.416 . . . . 10.0 111.254 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 55.24 46.64 23.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.838 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.52 34.53 49.5 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.581 -0.819 . . . . 10.0 111.797 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 128' ' ' THR . 2.5 ptp180 -136.21 135.42 39.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.824 0.345 . . . . 10.0 110.21 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.9 152.42 21.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.158 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.91 ' HB ' HG13 ' A' ' 126' ' ' VAL . 6.3 mt -151.22 129.86 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.05 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.921 ' HB ' HD13 ' A' ' 23' ' ' LEU . 6.7 mm -90.29 145.0 7.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.928 ' O ' HD23 ' A' ' 136' ' ' LEU . 38.1 t80 -133.5 136.32 45.0 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.197 0.522 . . . . 10.0 111.525 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.956 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 16.0 mt -138.17 147.5 43.92 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.66 0.743 . . . . 10.0 112.003 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.2 p-10 -105.51 26.43 9.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.703 -1.135 . . . . 10.0 108.86 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.902 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.6 tt 38.91 16.86 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 114.477 1.288 . . . . 10.0 114.477 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 137' ' ' ASP . 7.9 t0 -80.05 -62.35 1.71 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 144' ' ' GLU . 14.5 mmmm -73.7 -31.54 63.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.416 0.626 . . . . 10.0 110.451 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.902 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.96 -46.61 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.302 -0.863 . . . . 10.0 110.771 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.987 HD13 HG21 ' A' ' 91' ' ' VAL . 6.6 tp -60.92 -46.71 95.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 119.8 -0.76 . . . . 10.0 109.826 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.717 ' O ' HG12 ' A' ' 147' ' ' VAL . 96.7 mt-10 -48.87 -40.41 29.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.531 ' HA ' HG12 ' A' ' 147' ' ' VAL . 44.8 mt-10 -71.21 -39.03 72.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.182 -0.917 . . . . 10.0 110.528 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.657 ' CD1' HG11 ' A' ' 91' ' ' VAL . 34.4 mt -48.16 -43.79 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 120.797 0.332 . . . . 10.0 111.443 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.6 p -84.71 -53.47 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 143' ' ' GLU . 14.5 p -63.35 -21.45 28.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 111.718 0.266 . . . . 10.0 111.718 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HD2' ' CB ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.728 0.299 . . . . 10.0 110.832 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 37.8 tt0 -164.01 164.01 23.2 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.838 0.828 . . . . 10.0 111.295 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.611 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.3 t80 -150.85 138.62 19.83 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.964 -1.471 . . . . 10.0 112.862 -174.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 2.1 mt-10 -88.7 132.43 34.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.377 -0.828 . . . . 10.0 108.893 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.788 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.3 p -150.31 167.2 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 112.906 0.706 . . . . 10.0 112.906 -176.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 1.042 HD11 HD13 ' A' ' 82' ' ' ILE . 2.8 tm? -88.95 130.5 35.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.681 -0.859 . . . . 10.0 108.681 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.788 ' CB ' HD22 ' A' ' 102' ' ' LEU . 41.9 t -143.82 155.35 44.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.864 0.84 . . . . 10.0 112.565 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.663 ' CD2' HD11 ' A' ' 82' ' ' ILE . 2.2 p90 -150.09 163.74 37.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.181 -1.372 . . . . 10.0 110.241 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HG2' HD21 ' A' ' 99' ' ' LEU . 67.6 mm-40 -88.53 129.09 35.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.983 HG21 HD12 ' A' ' 71' ' ' ILE . 32.3 mm -122.85 87.89 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.319 -0.855 . . . . 10.0 111.259 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 41.5 m-20 51.48 60.04 4.15 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.838 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 61.7 mm-40 77.46 -32.48 0.18 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.45 -0.795 . . . . 10.0 111.708 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.495 ' NE2' HD11 ' A' ' 134' ' ' ILE . 38.6 tt0 -88.75 142.27 27.81 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.865 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.67 158.34 18.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.061 0.458 . . . . 10.0 112.086 -178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.76 HD12 ' H ' ' A' ' 24' ' ' ALA . 2.0 tp -152.28 139.62 19.47 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.123 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.76 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -141.99 144.68 33.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.426 0.528 . . . . 10.0 112.426 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.983 ' CE2' HD13 ' A' ' 65' ' ' LEU . 1.8 m-85 -119.54 138.84 52.93 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.969 -1.122 . . . . 10.0 107.969 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.66 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 26.4 t70 -51.57 123.52 10.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.01 0.433 . . . . 10.0 111.26 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.788 HG13 ' HA ' ' A' ' 13' ' ' VAL . 12.7 m -64.29 -10.53 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.705 -0.679 . . . . 10.0 112.106 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.66 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 53.6 m-20 -69.37 -38.94 78.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.007 -0.677 . . . . 10.0 109.454 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.901 HD21 HG22 ' A' ' 86' ' ' THR . 12.6 t-20 -89.86 -44.83 9.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.234 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.694 HG21 ' HG ' ' A' ' 14' ' ' LEU . 25.4 mm -65.41 129.24 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.091 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' OE2' HG12 ' A' ' 83' ' ' VAL . 14.8 pt-20 -95.55 -50.99 4.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.054 0.39 . . . . 10.0 112.054 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.7 mtm -168.99 155.07 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.185 0.516 . . . . 10.0 112.017 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.772 HG11 HG11 ' A' ' 98' ' ' VAL . 35.2 m -89.03 155.89 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.498 -0.774 . . . . 10.0 111.28 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 22.8 pt -150.44 138.58 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.046 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 22.7 pt-20 -104.65 110.96 23.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.693 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.182 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.464 HG11 ' CB ' ' A' ' 61' ' ' PRO . 57.4 t . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 121.007 0.432 . . . . 10.0 111.069 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -79.49 -34.94 40.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.857 -0.611 . . . . 10.0 111.31 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.669 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -151.6 -175.74 23.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.933 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.2 169.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.82 HD11 HD11 ' A' ' 60' ' ' ILE . 27.6 pt . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 10.0 111.052 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.883 HG22 ' HB2' ' A' ' 90' ' ' GLU . 18.7 pt . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.602 0.239 . . . . 10.0 111.494 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 80.7 Cg_endo -77.19 121.98 5.97 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.631 2.22 . . . . 10.0 112.601 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.669 HG22 ' C ' ' A' ' 51' ' ' GLY . 34.2 m -88.92 129.67 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.687 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.915 HG12 ' H ' ' A' ' 64' ' ' ASN . 3.2 t -113.5 -175.81 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.595 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.915 ' H ' HG12 ' A' ' 63' ' ' VAL . 11.7 p-10 -133.7 70.18 1.46 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.358 0.599 . . . . 10.0 110.709 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.983 HD13 ' CE2' ' A' ' 25' ' ' PHE . 5.6 tt -53.76 -37.59 63.56 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.821 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.824 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -50.57 -29.16 10.09 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.338 -0.545 . . . . 10.0 109.876 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.585 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -82.64 -43.59 16.77 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.617 -0.719 . . . . 10.0 110.631 178.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.0 tt -61.03 -37.58 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 122.096 0.951 . . . . 10.0 108.646 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.877 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -81.83 -53.95 5.76 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.713 -1.585 . . . . 10.0 109.219 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.488 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 119.09 -77.81 0.3 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.383 -0.826 . . . . 10.0 112.136 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.983 HD12 HG21 ' A' ' 18' ' ' ILE . 3.8 pt 44.69 177.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 113.122 0.786 . . . . 10.0 113.122 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.416 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 41.1 t -54.87 -38.37 67.42 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.806 ' HB3' HG13 ' A' ' 71' ' ' ILE . 5.9 t80 -24.6 140.66 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.635 -1.166 . . . . 10.0 113.571 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -172.71 37.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.321 -0.854 . . . . 10.0 110.095 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 54.33 35.11 22.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.884 -0.598 . . . . 10.0 111.304 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HB2' ' HZ3' ' A' ' 77' ' ' LYS . 98.3 mm-40 -81.03 -61.36 1.98 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.398 -0.364 . . . . 10.0 111.652 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 78' ' ' MET . 2.3 mppt? -103.14 -25.37 13.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.429 -0.35 . . . . 10.0 111.847 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 20.0 mmt -17.9 136.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -170.19 -34.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.771 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.81 ' O ' HD12 ' A' ' 94' ' ' LEU . 47.7 t -88.85 -176.02 5.07 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.832 0.349 . . . . 10.0 111.444 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 45.7 mt -152.37 158.34 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.897 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.042 HD13 HD11 ' A' ' 14' ' ' LEU . 12.3 mt -133.05 139.98 48.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.774 0.321 . . . . 10.0 111.052 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.465 HG12 ' OE2' ' A' ' 31' ' ' GLU . 44.4 t -109.17 152.68 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.066 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.47 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -155.37 169.71 23.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.364 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -128.04 132.72 49.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.901 HG22 HD21 ' A' ' 29' ' ' ASN . 57.6 p -148.3 109.19 4.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.817 0.303 . . . . 10.0 111.817 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 22.3 ttmm 49.49 60.21 3.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.147 0.499 . . . . 10.0 110.282 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 87' ' ' LYS . 7.4 p-10 55.1 32.68 18.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.036 -0.984 . . . . 10.0 111.551 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 91' ' ' VAL . 70.7 t -125.62 109.34 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 115.16 -0.927 . . . . 10.0 108.732 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.883 ' HB2' HG22 ' A' ' 60' ' ' ILE . 28.5 mt-10 -88.46 94.59 9.91 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.871 -1.529 . . . . 10.0 106.871 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.03 HG21 HD13 ' A' ' 142' ' ' ILE . 3.1 t -88.57 155.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 113.035 -1.893 . . . . 10.0 112.856 -174.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.32 165.93 21.81 Favored Glycine 0 C--N 1.314 -0.693 0 CA-C-N 114.679 -1.146 . . . . 10.0 112.468 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.551 ' HE2' ' CZ ' ' A' ' 16' ' ' PHE . 2.6 t80 -151.62 133.61 15.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 10.0 110.839 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.81 HD12 ' O ' ' A' ' 80' ' ' SER . 67.3 tp -88.72 126.27 35.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.238 0.542 . . . . 10.0 111.898 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.529 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 15.4 m -135.61 -175.27 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.02 178.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -100.37 -60.04 1.6 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.203 0.525 . . . . 10.0 111.656 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.598 HH12 HD13 ' A' ' 99' ' ' LEU . 57.1 ttt-85 -144.46 117.08 8.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.382 -0.826 . . . . 10.0 108.891 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.772 HG11 HG11 ' A' ' 33' ' ' VAL . 7.5 p -101.08 118.22 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 122.336 1.065 . . . . 10.0 112.482 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.598 HD13 HH12 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -66.03 -29.22 69.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.219 -1.81 . . . . 10.0 110.674 -179.335 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.16 -125.05 7.61 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.485 -0.78 . . . . 10.0 111.425 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 m -52.33 131.13 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.944 0.372 . . . . 10.0 110.513 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.788 HD22 ' CB ' ' A' ' 15' ' ' SER . 56.6 tp -135.2 141.46 45.85 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.151 0.5 . . . . 10.0 111.258 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 103' ' ' ARG . 16.2 ptm180 -88.81 70.55 8.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.049 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.757 ' CG1' HG11 ' A' ' 13' ' ' VAL . 17.2 mm -88.65 136.76 22.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 107.922 -1.14 . . . . 10.0 107.922 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 37.9 p -88.65 -175.88 5.07 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -149.6 77.06 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.06 -1.056 . . . . 10.0 113.393 -178.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -111.69 22.17 15.28 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.255 -1.339 . . . . 10.0 107.519 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.252 0 CA-C-N 114.902 -1.044 . . . . 10.0 111.628 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.594 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 26.6 t80 . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.833 0.349 . . . . 10.0 110.91 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.61 -36.64 0.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.56 -0.828 . . . . 10.0 112.941 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.47 ' NZ ' ' HB2' ' A' ' 120' ' ' LYS . 0.1 OUTLIER 176.33 124.98 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 2.7 tppp? 73.28 117.87 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.495 -0.775 . . . . 10.0 110.541 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.867 ' OG ' HD23 ' A' ' 69' ' ' LEU . 1.8 p . . . . . 0 CA--C 1.516 -0.345 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 133' ' ' ILE . 1.1 p . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 121.35 0.595 . . . . 10.0 111.593 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.505 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 87.0 tttt -164.77 135.81 4.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 10.0 110.284 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 8.5 m -161.76 150.52 15.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 120.976 0.417 . . . . 10.0 111.013 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 9.8 t70 55.18 48.02 20.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.442 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.3 35.03 34.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.664 -0.779 . . . . 10.0 111.977 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.618 HH12 ' HB2' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -137.33 133.14 34.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.703 0.287 . . . . 10.0 110.273 -179.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.654 HD12 ' N ' ' A' ' 132' ' ' LEU . 3.7 mp -88.93 139.08 30.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.892 0.377 . . . . 10.0 111.316 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.865 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.1 mt -145.36 136.7 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 10.0 110.621 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.717 ' CG2' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -95.87 132.92 38.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.597 ' CE1' HG21 ' A' ' 13' ' ' VAL . 12.7 t80 -120.43 144.69 47.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.229 0.538 . . . . 10.0 110.421 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.885 ' HG ' HD11 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -151.88 131.81 13.37 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.52 -0.764 . . . . 10.0 111.234 -177.516 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.708 ' N ' HD22 ' A' ' 136' ' ' LEU . 12.2 p-10 -95.05 34.74 1.34 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.218 0.532 . . . . 10.0 111.296 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.849 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.6 tt 38.4 19.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.375 1.25 . . . . 10.0 114.375 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 137' ' ' ASP . 64.3 t0 -77.29 -57.11 4.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.274 0.842 . . . . 10.0 113.274 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 121' ' ' LYS . 34.5 mmtp -76.08 -28.93 57.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.318 0.58 . . . . 10.0 111.248 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.849 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.76 -45.99 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.438 -0.801 . . . . 10.0 110.878 -179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.03 HD13 HG21 ' A' ' 91' ' ' VAL . 8.9 tp -67.34 -47.65 80.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 120.252 -0.579 . . . . 10.0 111.212 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.892 ' O ' HG12 ' A' ' 147' ' ' VAL . 48.5 mt-10 -50.33 -42.54 53.06 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.392 -0.595 . . . . 10.0 109.392 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' A' ' 68' ' ' ILE . 57.4 mm-40 -75.17 -27.24 59.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.123 -0.944 . . . . 10.0 111.04 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 142' ' ' ILE . 23.5 mt -55.41 -43.1 70.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.907 0.384 . . . . 10.0 110.72 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.4 p -86.33 -52.51 5.58 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.571 0.582 . . . . 10.0 112.571 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 143' ' ' GLU . 7.2 p -84.78 13.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.85 0.685 . . . . 10.0 112.85 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.573 ' HA ' ' HE2' ' A' ' 148' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 120.712 0.292 . . . . 10.0 111.769 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.777 0.322 . . . . 10.0 111.075 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.41 ' HG2' HG22 ' A' ' 105' ' ' THR . 93.9 mt-10 -152.26 164.3 37.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.969 0.89 . . . . 10.0 111.842 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CE2' ' OH ' ' A' ' 135' ' ' TYR . 35.0 t80 -117.0 127.94 54.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.794 -1.548 . . . . 10.0 113.802 -175.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -89.02 126.2 35.32 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.649 -1.611 . . . . 10.0 106.649 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.973 HG11 ' CG1' ' A' ' 104' ' ' ILE . 4.2 p -151.83 167.74 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 114.476 1.287 . . . . 10.0 114.476 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.76 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.4 tm? -88.9 137.93 31.87 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 107.91 -1.144 . . . . 10.0 107.91 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.779 ' CB ' HD22 ' A' ' 102' ' ' LEU . 57.0 p -149.29 158.99 44.64 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.203 0.816 . . . . 10.0 113.203 -177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.696 ' CD2' HD11 ' A' ' 82' ' ' ILE . 6.9 p90 -152.3 165.92 33.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.217 -1.356 . . . . 10.0 110.42 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.6 137.25 32.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 10.0 109.715 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.975 HG21 HD12 ' A' ' 71' ' ' ILE . 28.4 mm -134.37 92.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.164 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.494 ' OD2' ' HA ' ' A' ' 73' ' ' PHE . 41.6 m-20 44.74 60.25 3.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.64 . . . . 10.0 112.701 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 45.9 mt-10 85.17 -42.59 0.06 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.282 -0.872 . . . . 10.0 111.879 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.1 pt20 -88.95 145.72 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.021 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.49 166.81 13.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.908 0.385 . . . . 10.0 110.785 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.8 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.5 tp -149.43 139.33 21.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.505 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.775 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -142.58 146.66 34.8 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.489 0.922 . . . . 10.0 113.489 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.874 ' CE2' HD21 ' A' ' 136' ' ' LEU . 1.6 m-85 -124.24 143.51 50.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.224 -0.898 . . . . 10.0 108.615 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -53.69 123.23 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.05 -0.352 . . . . 10.0 110.05 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.905 HG13 ' HA ' ' A' ' 13' ' ' VAL . 27.4 m -58.04 -14.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.567 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -62.64 -43.59 98.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.061 0.458 . . . . 10.0 110.204 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.842 ' ND2' HG21 ' A' ' 138' ' ' ILE . 14.9 t30 -84.7 -47.02 10.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.675 -0.693 . . . . 10.0 111.164 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.76 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.8 mm -61.03 132.28 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.217 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.442 ' HB3' ' CE ' ' A' ' 32' ' ' MET . 43.9 mt-10 -94.91 -60.4 1.7 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.376 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.442 ' CE ' ' HB3' ' A' ' 31' ' ' GLU . 1.2 pmm? -169.01 156.55 7.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.367 -0.379 . . . . 10.0 111.003 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.818 HG11 HG11 ' A' ' 98' ' ' VAL . 35.3 m -88.84 144.58 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 10.0 111.791 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.492 HG12 HG23 ' A' ' 83' ' ' VAL . 31.6 pt -137.89 136.81 45.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.593 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -88.95 120.82 30.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 10.0 110.68 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.979 ' HB2' HD12 ' A' ' 81' ' ' ILE . 62.0 mttp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.804 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.941 ' HA ' HG22 ' A' ' 63' ' ' VAL . 44.6 t . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.03 0.443 . . . . 10.0 111.58 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.43 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 24.2 mm-40 -88.34 -40.9 13.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.772 -0.649 . . . . 10.0 110.601 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 62' ' ' VAL . . . -135.22 160.9 24.54 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.345 -0.931 . . . . 10.0 113.747 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 61' ' ' PRO . 2.6 m -159.81 169.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.501 HG12 HD11 ' A' ' 60' ' ' ILE . 31.6 pt . . . . . 0 C--N 1.324 -0.534 0 CA-C-O 120.862 0.363 . . . . 10.0 111.073 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.813 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.55 -0.167 . . . . 10.0 110.55 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 92.8 Cg_endo -99.57 121.82 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.068 2.512 . . . . 10.0 113.864 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 51' ' ' GLY . 19.5 m -103.52 127.57 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.844 -0.798 . . . . 10.0 108.844 177.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.941 HG22 ' HA ' ' A' ' 49' ' ' VAL . 47.3 t -139.59 160.36 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.851 0.834 . . . . 10.0 113.204 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.567 ' N ' HG12 ' A' ' 63' ' ' VAL . 4.3 m120 -75.96 73.39 2.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.591 -1.186 . . . . 10.0 108.667 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.911 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.3 tt -52.87 -38.53 61.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.293 0.568 . . . . 10.0 111.397 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.028 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -59.9 -18.5 45.29 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.193 -0.603 . . . . 10.0 110.03 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.534 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.1 tmmm? -85.41 -46.9 10.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.017 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.911 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.4 tt -53.86 -35.21 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 107.611 -1.255 . . . . 10.0 107.611 178.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.868 ' C ' HD13 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -86.1 -56.08 3.63 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.08 -1.873 . . . . 10.0 109.82 178.263 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . 121.92 -81.47 0.34 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.307 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.028 HD11 ' CB ' ' A' ' 66' ' ' ALA . 2.9 pt 45.11 179.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.698 0.629 . . . . 10.0 112.698 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 45.7 t -54.75 -39.08 67.94 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.151 -0.685 . . . . 10.0 109.151 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.78 ' HB3' HG13 ' A' ' 71' ' ' ILE . 14.8 t80 -32.4 143.69 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.784 -1.098 . . . . 10.0 112.896 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -166.77 37.4 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.532 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 55.28 38.76 30.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.776 -0.647 . . . . 10.0 111.22 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.442 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 4.2 pt20 -94.01 -50.51 5.28 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.262 0.467 . . . . 10.0 112.262 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 12.4 mptt -111.16 -25.01 9.95 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.559 ' HE2' ' HD1' ' A' ' 73' ' ' PHE . 16.9 mmt -36.72 143.77 0.07 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.758 0.651 . . . . 10.0 112.758 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 53.6 mtmt -159.53 -41.38 0.05 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.91 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.963 ' O ' HD12 ' A' ' 94' ' ' LEU . 46.8 t -88.78 -175.99 5.08 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.913 0.387 . . . . 10.0 111.551 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.979 HD12 ' HB2' ' A' ' 36' ' ' LYS . 77.4 mt -146.55 154.22 12.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.328 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.696 HD11 ' CD2' ' A' ' 16' ' ' PHE . 10.8 mt -120.63 143.9 31.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.739 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 34' ' ' ILE . 72.1 t -111.41 149.85 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.974 0.416 . . . . 10.0 110.892 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -153.57 174.33 14.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 10.0 111.001 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 6.3 ptm180 -135.71 132.11 36.47 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.737 HG22 ' OD1' ' A' ' 29' ' ' ASN . 59.0 p -145.51 109.54 4.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.962 0.41 . . . . 10.0 111.922 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 14.7 tppt? 47.53 49.74 15.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.328 0.585 . . . . 10.0 110.851 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.05 31.57 1.45 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.066 -0.97 . . . . 10.0 111.519 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.93 HG12 HG22 ' A' ' 91' ' ' VAL . 67.6 t -128.33 108.56 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.23 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.7 ' HB2' HG22 ' A' ' 60' ' ' ILE . 6.4 mp0 -88.4 98.47 11.64 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.198 -1.779 . . . . 10.0 106.198 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.005 HG21 HD13 ' A' ' 142' ' ' ILE . 3.0 t -88.7 157.2 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 113.089 -1.869 . . . . 10.0 112.711 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -140.25 151.21 22.08 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 114.895 -1.048 . . . . 10.0 113.258 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.602 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.1 t80 -140.77 134.39 30.16 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.93 0.395 . . . . 10.0 111.003 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.963 HD12 ' O ' ' A' ' 80' ' ' SER . 31.7 tp -88.61 115.5 26.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 10.0 111.46 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.528 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 12.8 m -122.43 -175.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.933 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -100.15 -59.98 1.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.174 0.512 . . . . 10.0 111.825 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -141.26 113.37 7.94 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.547 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.818 HG11 HG11 ' A' ' 33' ' ' VAL . 9.5 p -99.79 111.28 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 122.461 1.124 . . . . 10.0 111.168 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.538 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -62.72 -28.51 70.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.909 -1.95 . . . . 10.0 111.161 -178.526 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.92 -122.73 6.52 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.964 -0.854 . . . . 10.0 110.964 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -53.94 131.82 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 117.06 0.43 . . . . 10.0 110.229 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.779 HD22 ' CB ' ' A' ' 15' ' ' SER . 19.4 tp -137.07 142.94 42.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 10.0 111.257 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.1 ptp85 -88.85 79.82 7.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.529 -0.76 . . . . 10.0 111.295 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.973 ' CG1' HG11 ' A' ' 13' ' ' VAL . 11.6 mm -88.76 178.78 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 104' ' ' ILE . 22.1 p -134.96 -175.85 4.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.774 -0.824 . . . . 10.0 108.774 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 35.5 tt0 -136.71 79.04 1.74 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.934 0.873 . . . . 10.0 112.516 -178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -119.89 22.29 11.58 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.23 -1.35 . . . . 10.0 107.522 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 . . . . . 0 N--CA 1.466 0.36 0 CA-C-N 114.997 -1.001 . . . . 10.0 113.606 -178.258 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.855 ' CE1' HD21 ' A' ' 69' ' ' LEU . 20.2 t80 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.584 0.23 . . . . 10.0 111.494 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.0 -43.69 1.48 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.488 -0.863 . . . . 10.0 112.202 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -156.66 38.22 0.32 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.667 0.27 . . . . 10.0 111.013 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . 39.9 ttmt -157.06 -112.94 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.446 -0.343 . . . . 10.0 110.594 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 74.4 m . . . . . 0 CA--C 1.506 -0.714 0 N-CA-C 112.765 0.654 . . . . 10.0 112.765 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 104' ' ' ILE . 1.1 p . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 131' ' ' ARG . 8.1 ptpp? -154.77 143.9 21.07 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.132 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 23.8 m -152.61 140.02 19.6 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.578 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 p30 45.28 48.39 10.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.045 0.45 . . . . 10.0 111.219 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.42 97.15 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.647 -0.787 . . . . 10.0 111.773 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.7 ptp180 -130.08 136.94 49.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.653 0.263 . . . . 10.0 110.581 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 132' ' ' LEU . 3.7 mp -88.9 138.56 31.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.661 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.021 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.5 mt -156.92 144.64 10.84 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-N 116.465 -0.334 . . . . 10.0 111.741 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.8 ' HB ' HD13 ' A' ' 23' ' ' LEU . 2.2 mp -99.69 146.82 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.542 ' CE1' HG21 ' A' ' 13' ' ' VAL . 56.5 t80 -141.36 151.22 43.36 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.494 -0.482 . . . . 10.0 110.98 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.874 HD21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -169.09 150.64 4.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.146 0.795 . . . . 10.0 113.146 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -95.26 32.74 1.67 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.885 -1.052 . . . . 10.0 110.127 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.842 HG21 ' ND2' ' A' ' 29' ' ' ASN . 10.1 tt 38.69 23.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 114.836 -1.075 . . . . 10.0 113.683 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -75.79 -58.28 3.38 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.545 0.943 . . . . 10.0 113.545 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.589 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 7.2 mmpt? -78.23 -31.94 49.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.042 0.448 . . . . 10.0 110.698 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.832 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -65.17 -45.25 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.04 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.005 HD13 HG21 ' A' ' 91' ' ' VAL . 7.7 tp -65.49 -46.61 89.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.506 -0.478 . . . . 10.0 110.861 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 142' ' ' ILE . 47.3 mt-10 -48.46 -40.82 27.63 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.993 0.425 . . . . 10.0 110.159 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.572 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.1 mt-10 -68.67 -36.85 79.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.69 -0.686 . . . . 10.0 110.11 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.668 HD12 HD12 ' A' ' 142' ' ' ILE . 35.4 mt -53.62 -41.43 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.151 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.8 p -76.56 -49.93 15.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.785 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.7 p -75.33 1.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 112.082 0.401 . . . . 10.0 112.082 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.873 0.368 . . . . 10.0 111.274 -179.645 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.55 ' O ' HG22 ' A' ' 105' ' ' THR . 18.1 ttpt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.795 0.331 . . . . 10.0 111.419 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 42.6 tt0 -160.21 164.1 33.05 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.691 0.758 . . . . 10.0 111.464 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.569 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 14.6 t80 -158.55 138.91 12.47 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 114.26 -1.336 . . . . 10.0 112.527 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 29.2 mt-10 -88.62 139.47 30.44 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.938 -0.574 . . . . 10.0 109.527 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.921 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -155.47 167.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.752 1.019 . . . . 10.0 113.752 -175.159 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.592 HD13 ' C ' ' A' ' 14' ' ' LEU . 1.7 tm? -89.19 127.83 35.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.231 -0.895 . . . . 10.0 108.677 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.817 ' CB ' HD22 ' A' ' 102' ' ' LEU . 39.1 t -143.8 156.13 44.38 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.839 0.828 . . . . 10.0 113.131 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.696 ' HD2' HG23 ' A' ' 98' ' ' VAL . 1.3 p90 -146.53 160.05 42.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.851 -1.522 . . . . 10.0 109.917 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HG3' HD21 ' A' ' 99' ' ' LEU . 56.7 mt-10 -88.74 107.2 18.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.469 0.652 . . . . 10.0 110.066 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.75 HG21 HD12 ' A' ' 71' ' ' ILE . 30.6 mm -88.96 90.65 3.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.843 -1.071 . . . . 10.0 111.714 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 20' ' ' GLU . 9.5 p-10 36.46 60.38 0.9 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.857 -1.065 . . . . 10.0 113.498 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 19' ' ' ASP . 47.2 mt-10 100.07 -52.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.668 -1.151 . . . . 10.0 111.685 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.523 ' NE2' ' HB2' ' A' ' 72' ' ' SER . 3.3 pt20 -89.04 150.17 22.9 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.024 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.76 170.44 10.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.016 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.2 tp -159.06 136.84 10.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.597 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.757 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -141.42 152.76 44.56 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.481 0.549 . . . . 10.0 112.481 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.951 ' CE2' HD22 ' A' ' 136' ' ' LEU . 4.9 m-85 -130.04 138.94 51.03 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.293 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -47.49 122.33 4.66 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.899 0.381 . . . . 10.0 110.982 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.921 HG13 ' HA ' ' A' ' 13' ' ' VAL . 27.4 m -61.91 -12.79 8.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.073 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.87 -42.51 97.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.96 0.41 . . . . 10.0 110.161 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.81 ' OD1' HG21 ' A' ' 138' ' ' ILE . 9.6 t-20 -90.06 -47.24 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.895 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.582 HG21 ' HG ' ' A' ' 14' ' ' LEU . 19.7 mm -58.87 128.81 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.004 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' O ' ' CE ' ' A' ' 32' ' ' MET . 54.4 mt-10 -82.66 -65.4 1.02 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.077 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.414 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.7 tpp -169.08 173.71 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 10.0 111.322 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.573 ' CG1' HG11 ' A' ' 98' ' ' VAL . 35.3 m -89.01 150.99 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.488 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.574 HD13 ' CG2' ' A' ' 83' ' ' VAL . 12.7 pt -142.35 121.64 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.647 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.03 118.74 28.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 10.0 109.51 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.814 ' HB3' HD12 ' A' ' 81' ' ' ILE . 23.3 tptm . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.027 0.442 . . . . 10.0 111.026 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.9 ' HA ' HG22 ' A' ' 63' ' ' VAL . 46.8 t . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.016 0.436 . . . . 10.0 111.869 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 16.9 pt-20 -79.79 -37.39 35.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.418 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.616 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -161.02 -175.93 32.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.053 -0.594 . . . . 10.0 112.234 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 61' ' ' PRO . 3.5 m -158.46 175.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 110.163 -0.31 . . . . 10.0 110.163 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.027 HD11 HD11 ' A' ' 60' ' ' ILE . 24.3 pt . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.64 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.027 HD11 HD11 ' A' ' 53' ' ' ILE . 28.5 pt . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.507 0.194 . . . . 10.0 110.974 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 86.3 Cg_endo -81.89 119.65 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.402 2.068 . . . . 10.0 113.252 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.616 HG22 ' C ' ' A' ' 51' ' ' GLY . 27.7 m -98.49 137.25 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.312 -0.625 . . . . 10.0 109.312 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.9 HG22 ' HA ' ' A' ' 49' ' ' VAL . 96.6 t -143.0 156.09 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.717 0.77 . . . . 10.0 112.744 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.788 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 76.1 m-20 -73.74 66.09 1.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.704 -1.135 . . . . 10.0 108.33 177.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.94 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.6 tt -49.32 -28.33 4.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.921 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.694 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -61.89 -29.81 70.45 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.821 -0.351 . . . . 10.0 110.953 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.788 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -87.31 -36.94 17.58 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 110.423 -0.214 . . . . 10.0 110.423 178.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.758 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 8.1 tt -61.16 -41.04 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 106.623 -1.621 . . . . 10.0 106.623 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.843 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -76.05 -38.66 56.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 113.407 -1.724 . . . . 10.0 107.972 176.465 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 69' ' ' LEU . . . 70.06 120.82 0.04 OUTLIER Glycine 0 C--N 1.335 0.492 0 CA-C-N 114.827 -1.079 . . . . 10.0 113.154 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.791 HG23 ' CD1' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -160.57 -167.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.332 0.653 . . . . 10.0 109.546 -179.146 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.523 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 29.2 t -53.16 -34.41 56.71 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.694 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 6.0 t80 -28.57 138.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.608 -1.178 . . . . 10.0 112.95 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 9.2 t70 -160.58 35.66 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.581 -0.736 . . . . 10.0 109.986 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.95 40.01 3.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.502 -0.772 . . . . 10.0 112.194 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 74.0 mt-30 -95.98 -49.55 5.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.606 0.241 . . . . 10.0 111.29 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 76' ' ' GLN . 2.3 mppt? -98.09 -31.76 11.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.506 -0.316 . . . . 10.0 111.629 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.598 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 21.7 mmt -27.01 141.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt 178.62 50.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.79 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.923 ' O ' HD12 ' A' ' 94' ' ' LEU . 80.0 p -169.03 155.34 6.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.795 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.814 HD12 ' HB3' ' A' ' 36' ' ' LYS . 61.0 mt -126.88 142.22 43.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.781 -0.367 . . . . 10.0 111.595 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 4.5 mt -119.42 143.72 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.642 -0.253 . . . . 10.0 110.556 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.574 ' CG2' HD13 ' A' ' 34' ' ' ILE . 79.9 t -113.62 152.46 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.231 0.539 . . . . 10.0 111.328 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -155.93 173.73 16.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.449 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.587 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 6.7 ptm180 -130.4 146.7 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.566 -0.531 . . . . 10.0 109.566 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.486 HG21 HG12 ' A' ' 138' ' ' ILE . 41.1 p -160.47 108.55 1.62 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 87' ' ' LYS . 36.7 ttmt 46.27 48.76 13.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.386 0.613 . . . . 10.0 110.892 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 72.84 33.67 1.24 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.56 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.887 HG12 HG22 ' A' ' 91' ' ' VAL . 53.8 t -131.75 110.84 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 115.268 -0.878 . . . . 10.0 109.122 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.788 ' HB2' HG22 ' A' ' 60' ' ' ILE . 1.5 mp0 -88.38 97.81 11.26 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.341 -1.726 . . . . 10.0 106.341 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.014 HG21 HD13 ' A' ' 142' ' ' ILE . 3.4 t -88.55 153.18 3.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 113.367 -1.742 . . . . 10.0 112.474 -174.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -130.47 152.95 19.97 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 114.861 -1.063 . . . . 10.0 113.499 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.639 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -139.94 128.03 22.31 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.906 0.384 . . . . 10.0 110.898 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.923 HD12 ' O ' ' A' ' 80' ' ' SER . 50.8 tp -88.57 128.17 35.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.943 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.658 HG11 ' CE1' ' A' ' 16' ' ' PHE . 19.7 m -136.74 -175.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.971 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -96.88 -65.35 0.97 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.131 0.491 . . . . 10.0 112.188 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.1 tpt85 -135.81 119.25 16.87 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.529 -0.76 . . . . 10.0 109.144 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.696 HG23 ' HD2' ' A' ' 16' ' ' PHE . 8.6 p -106.29 112.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 122.5 1.143 . . . . 10.0 112.045 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -66.2 -27.93 68.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.825 -1.989 . . . . 10.0 111.305 -178.763 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.62 -122.15 6.13 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.526 -0.845 . . . . 10.0 111.327 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.0 t -52.49 134.4 14.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.868 0.334 . . . . 10.0 110.569 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.817 HD22 ' CB ' ' A' ' 15' ' ' SER . 57.7 tp -140.27 141.07 35.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.076 0.465 . . . . 10.0 111.219 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.7 ptp180 -88.92 73.08 8.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.521 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.099 HD12 HG11 ' A' ' 126' ' ' VAL . 17.6 mm -88.59 131.8 35.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 109.892 -0.41 . . . . 10.0 109.892 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 22.8 p -88.83 151.1 22.58 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 20.4 tt0 -124.49 73.89 1.29 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.123 0.964 . . . . 10.0 112.99 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.425 ' N ' ' OE1' ' A' ' 108' ' ' GLN . 73.6 m-20 -113.65 15.67 18.8 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.844 -1.525 . . . . 10.0 107.403 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.45 ' N ' ' OE1' ' A' ' 108' ' ' GLN . 6.6 pm0 . . . . . 0 CA--C 1.519 -0.237 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.205 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.439 ' CE2' HD21 ' A' ' 69' ' ' LEU . 21.7 t80 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 121.072 0.463 . . . . 10.0 110.241 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 120' ' ' LYS . . . 148.91 -64.66 0.4 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.753 -0.658 . . . . 10.0 112.374 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 119' ' ' GLY . 67.7 mttm -163.61 53.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.673 0.273 . . . . 10.0 110.508 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -151.23 -43.34 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.879 0.326 . . . . 10.0 111.879 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.608 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 89.2 p . . . . . 0 CA--C 1.534 0.363 0 C-N-CA 121.245 -0.182 . . . . 10.0 111.312 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 1.099 HG11 HD12 ' A' ' 104' ' ' ILE . 1.5 p . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 121.389 0.614 . . . . 10.0 112.29 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 87.1 tttt -164.49 134.25 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.08 -0.964 . . . . 10.0 109.786 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 4.6 m -162.7 151.54 14.85 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 120.924 0.392 . . . . 10.0 111.12 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.42 45.8 21.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.979 0.419 . . . . 10.0 110.746 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.41 33.59 47.18 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.665 -0.778 . . . . 10.0 111.83 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 128' ' ' THR . 12.7 ptt180 -134.93 130.53 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.184 -0.302 . . . . 10.0 110.184 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 133' ' ' ILE . 2.8 tm? -88.87 135.23 33.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.852 0.358 . . . . 10.0 110.736 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.024 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.2 mt -130.8 130.75 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.345 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 1.016 ' HB ' HD13 ' A' ' 23' ' ' LEU . 5.1 mm -88.87 147.45 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.975 -1.12 . . . . 10.0 107.975 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.606 ' C ' HD12 ' A' ' 136' ' ' LEU . 32.9 t80 -137.02 141.39 42.5 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.71 -0.796 . . . . 10.0 111.671 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.951 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.7 mp -133.32 172.99 11.94 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.067 0.936 . . . . 10.0 112.679 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.37 24.94 2.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.935 -1.484 . . . . 10.0 108.336 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.916 ' HA ' HG23 ' A' ' 141' ' ' ILE . 10.3 tt 40.38 19.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.267 -1.333 . . . . 10.0 114.259 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 142' ' ' ILE . 9.1 t0 -82.64 -62.7 1.54 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -75.03 -29.81 60.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.447 0.642 . . . . 10.0 110.073 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.916 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.78 -46.36 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 115.097 -0.956 . . . . 10.0 110.723 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.014 HD13 HG21 ' A' ' 91' ' ' VAL . 7.6 tp -61.22 -44.56 98.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 119.911 -0.716 . . . . 10.0 109.595 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.87 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.4 tt0 -49.42 -47.52 47.98 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.829 -0.623 . . . . 10.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.593 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.5 mm-40 -66.13 -37.36 85.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.477 -0.783 . . . . 10.0 110.948 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.661 ' CD1' HG11 ' A' ' 91' ' ' VAL . 60.0 mt -51.4 -43.24 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 120.886 0.374 . . . . 10.0 111.208 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.9 p -87.61 -49.43 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.684 0.624 . . . . 10.0 112.684 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.87 HG12 ' O ' ' A' ' 143' ' ' GLU . 7.2 p -82.85 13.03 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.935 0.717 . . . . 10.0 112.935 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.575 ' HE3' ' HA ' ' A' ' 148' ' ' LYS . 2.0 tpmt? . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 120.708 -0.397 . . . . 10.0 111.131 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.482 ' C ' ' HD2' ' A' ' 9' ' ' LYS . 3.4 tmmm? . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.028 0.442 . . . . 10.0 110.23 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 44.1 tt0 -141.37 163.46 32.89 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.392 0.615 . . . . 10.0 110.8 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.553 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.9 t80 -162.36 138.9 7.79 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.804 -1.089 . . . . 10.0 111.959 -174.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.422 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -88.68 141.22 28.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.891 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -157.43 171.32 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 113.817 1.043 . . . . 10.0 113.817 -176.134 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 1.08 HD11 HD13 ' A' ' 82' ' ' ILE . 3.1 tm? -88.72 136.03 33.21 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.942 ' HB3' HD22 ' A' ' 102' ' ' LEU . 55.5 p -151.42 156.49 40.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.8 0.81 . . . . 10.0 113.119 -177.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.729 ' CD2' HD11 ' A' ' 82' ' ' ILE . 7.7 p90 -149.67 166.54 29.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.198 -1.365 . . . . 10.0 110.06 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -88.59 140.33 29.56 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.215 -0.661 . . . . 10.0 109.215 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.015 HG21 HD12 ' A' ' 71' ' ' ILE . 35.8 mm -138.8 86.03 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.63 -0.714 . . . . 10.0 111.889 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 0.8 OUTLIER 51.48 60.03 4.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.808 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 48.4 mt-10 78.56 -35.15 0.18 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.465 -0.788 . . . . 10.0 111.09 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -88.82 139.31 30.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.078 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.75 163.87 15.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 10.0 111.118 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.894 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.0 OUTLIER -147.01 138.23 24.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.559 . . . . 10.0 111.133 -178.449 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -138.94 155.28 48.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.993 ' CE2' HD22 ' A' ' 136' ' ' LEU . 3.8 m-85 -138.44 138.67 38.38 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.995 -1.002 . . . . 10.0 108.926 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -51.35 121.57 6.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.948 0.404 . . . . 10.0 110.379 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.891 HG13 ' HA ' ' A' ' 13' ' ' VAL . 32.2 m -61.37 -11.9 5.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 10.0 111.175 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.99 -41.33 96.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 10.0 110.41 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.839 ' OD1' HG21 ' A' ' 138' ' ' ILE . 6.4 t-20 -92.51 -46.68 7.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.35 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.838 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.7 mm -57.67 127.11 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.896 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' CE ' ' A' ' 32' ' ' MET . 54.2 mt-10 -82.93 -63.6 1.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.948 0.351 . . . . 10.0 111.948 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.418 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.8 tpp -169.08 173.91 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.979 0.418 . . . . 10.0 111.381 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.527 ' CG1' HG11 ' A' ' 98' ' ' VAL . 34.8 m -95.61 156.36 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.725 -0.67 . . . . 10.0 111.996 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 33' ' ' VAL . 17.3 pt -160.05 123.62 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.557 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.458 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 48.6 mp0 -89.13 116.92 27.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 10.0 111.214 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.487 ' NZ ' ' HB2' ' A' ' 36' ' ' LYS . 5.0 ttmp? . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.801 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.954 ' HA ' HG22 ' A' ' 63' ' ' VAL . 96.8 t . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 121.14 0.495 . . . . 10.0 111.261 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.79 -40.18 79.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.463 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.443 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -163.02 -175.79 34.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.331 -0.938 . . . . 10.0 113.219 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 53' ' ' ILE . 1.9 m -147.33 167.83 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.664 -0.495 . . . . 10.0 109.664 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.474 HG21 ' HD2' ' A' ' 36' ' ' LYS . 30.1 pt . . . . . 0 C--N 1.326 -0.437 0 CA-C-O 120.942 0.401 . . . . 10.0 111.551 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.827 HG22 ' HB2' ' A' ' 90' ' ' GLU . 2.4 pp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.666 0.269 . . . . 10.0 111.126 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 83.4 Cg_endo -81.04 115.38 2.99 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.469 2.113 . . . . 10.0 112.889 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 49' ' ' VAL . 26.9 m -89.02 135.63 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.954 HG22 ' HA ' ' A' ' 49' ' ' VAL . 82.6 t -137.36 154.38 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.791 0.805 . . . . 10.0 113.074 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.473 ' N ' HG12 ' A' ' 63' ' ' VAL . 74.6 m-20 -76.7 65.73 2.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.521 -1.218 . . . . 10.0 109.263 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.86 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.6 tt -53.48 -36.35 61.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.158 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.749 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -57.75 -23.47 52.29 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.207 -0.597 . . . . 10.0 109.426 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.633 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -82.86 -48.77 10.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.69 -0.686 . . . . 10.0 110.744 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 65' ' ' LEU . 11.0 tt -58.5 -39.87 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.863 -1.162 . . . . 10.0 107.863 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.879 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -76.42 -48.98 17.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 113.711 -1.586 . . . . 10.0 109.795 177.791 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.575 ' N ' HD13 ' A' ' 69' ' ' LEU . . . 118.56 -93.26 0.56 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.169 -0.539 . . . . 10.0 113.125 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.015 HD12 HG21 ' A' ' 18' ' ' ILE . 3.0 pt 48.57 163.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 113.112 0.782 . . . . 10.0 113.112 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 74.8 m -45.29 -36.54 4.12 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.884 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.7 t80 -27.03 141.52 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.546 -1.206 . . . . 10.0 113.005 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 9.0 t70 -161.81 32.15 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.242 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 94.4 mt-10 54.55 45.54 26.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.938 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -98.2 -36.12 10.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.492 0.553 . . . . 10.0 112.492 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.463 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 70.6 mmtt -136.88 17.9 3.04 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.357 0.873 . . . . 10.0 113.357 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.496 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 14.0 mmm -53.93 142.5 24.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -172.55 42.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.892 0.377 . . . . 10.0 111.267 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.9 ' O ' HD12 ' A' ' 94' ' ' LEU . 79.2 p -169.09 158.02 8.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 10.0 110.155 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.481 HD11 ' O ' ' A' ' 36' ' ' LYS . 45.1 mt -137.35 132.24 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.876 0.369 . . . . 10.0 111.404 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.08 HD13 HD11 ' A' ' 14' ' ' LEU . 26.5 mt -105.34 129.96 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.953 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.41 HG12 ' OE1' ' A' ' 31' ' ' GLU . 91.7 t -98.81 150.62 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.047 0.451 . . . . 10.0 110.93 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -153.73 174.84 14.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.962 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.548 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 23.5 ptt180 -127.39 143.8 51.15 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.525 HG21 HG12 ' A' ' 138' ' ' ILE . 45.5 p -160.02 108.19 1.7 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.532 0.568 . . . . 10.0 112.532 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.4 tppp? 46.44 47.72 13.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.777 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.35 34.32 1.02 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.167 -0.924 . . . . 10.0 111.285 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.893 HG12 HG22 ' A' ' 91' ' ' VAL . 59.0 t -134.0 110.42 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 115.141 -0.936 . . . . 10.0 109.25 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.827 ' HB2' HG22 ' A' ' 60' ' ' ILE . 83.4 mt-10 -88.23 97.92 11.28 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.047 HG21 HD13 ' A' ' 142' ' ' ILE . 4.5 t -88.55 152.24 3.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.4 -1.727 . . . . 10.0 113.33 -173.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -124.5 157.26 18.79 Favored Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.443 -1.253 . . . . 10.0 113.164 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.618 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -143.84 123.83 13.58 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 120.964 0.412 . . . . 10.0 110.613 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 80' ' ' SER . 64.9 tp -88.74 126.75 35.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.146 0.498 . . . . 10.0 111.179 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.738 HG23 ' OG ' ' A' ' 80' ' ' SER . 26.8 m -136.88 -175.26 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.697 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 3.0 t0 -88.12 -77.94 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.501 . . . . 10.0 111.253 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 -128.63 107.97 10.13 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.611 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.0 p -88.99 113.79 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 122.434 1.111 . . . . 10.0 111.396 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -62.7 -28.67 70.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.036 -1.893 . . . . 10.0 111.106 -178.669 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.81 -121.2 5.51 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.777 -0.929 . . . . 10.0 110.777 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.99 126.77 9.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 117.203 0.501 . . . . 10.0 109.769 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 15' ' ' SER . 54.8 tp -128.05 136.16 50.85 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.028 0.442 . . . . 10.0 111.139 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -88.82 78.64 7.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.584 179.2 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.673 HG13 HG11 ' A' ' 13' ' ' VAL . 6.8 mm -88.57 157.39 3.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.832 -0.622 . . . . 10.0 109.454 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 24.0 p -116.65 148.47 40.97 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.056 -1.09 . . . . 10.0 108.056 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 37.1 tt0 -111.77 68.31 0.66 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.996 0.903 . . . . 10.0 112.016 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -99.55 8.31 44.58 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.02 -1.445 . . . . 10.0 108.014 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-N 114.691 -1.14 . . . . 10.0 110.398 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.697 ' CE2' HD21 ' A' ' 69' ' ' LEU . 55.9 t80 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.013 0.435 . . . . 10.0 110.309 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.88 -42.67 0.45 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.708 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.434 ' C ' ' HE3' ' A' ' 120' ' ' LYS . 0.1 OUTLIER 179.85 40.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 122' ' ' SER . 2.9 tppp? -177.92 116.74 0.09 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.157 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.642 ' HB3' ' O ' ' A' ' 121' ' ' LYS . 13.2 t . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.903 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.871 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.8 p . . . . . 0 C--O 1.227 -0.13 0 CA-C-O 120.962 0.41 . . . . 10.0 111.593 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.495 ' N ' ' HD3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -165.91 132.24 2.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.203 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.498 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 15.6 m -163.91 157.47 18.68 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.354 -0.384 . . . . 10.0 110.662 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.42 ' N ' ' CG2' ' A' ' 128' ' ' THR . 63.1 m-20 58.16 44.57 18.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.958 0.409 . . . . 10.0 110.735 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.59 32.16 38.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.65 -0.786 . . . . 10.0 111.764 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 128' ' ' THR . 3.2 ptp180 -138.89 136.14 35.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 10.0 110.417 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.92 143.46 26.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.733 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.078 HG12 ' HB3' ' A' ' 22' ' ' ALA . 4.3 mt -137.43 129.19 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 10.0 111.567 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.894 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.97 134.54 28.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.41 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 31.1 t80 -118.31 136.09 53.91 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.514 0.673 . . . . 10.0 111.467 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.993 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.1 mp -126.81 172.39 10.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.127 0.965 . . . . 10.0 112.603 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 9.8 t70 -144.2 26.59 1.48 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.635 -1.62 . . . . 10.0 107.211 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.863 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 11.9 tt 40.4 17.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 113.846 -1.525 . . . . 10.0 114.349 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 137' ' ' ASP . 7.8 t0 -79.53 -61.73 1.91 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.794 0.665 . . . . 10.0 112.794 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -77.05 -30.88 55.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.457 0.646 . . . . 10.0 110.341 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.863 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.89 -45.69 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 114.97 -1.014 . . . . 10.0 110.63 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.047 HD13 HG21 ' A' ' 91' ' ' VAL . 7.9 tp -65.91 -43.04 93.06 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 C-N-CA 119.898 -0.721 . . . . 10.0 110.034 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.54 ' N ' HG23 ' A' ' 142' ' ' ILE . 89.3 tt0 -46.47 -46.7 19.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.312 0.577 . . . . 10.0 109.788 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 148' ' ' LYS . 61.0 mm-40 -68.89 -39.58 79.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.205 -0.907 . . . . 10.0 110.761 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.638 ' CD1' HG11 ' A' ' 91' ' ' VAL . 56.4 mt -48.52 -44.02 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.83 0.347 . . . . 10.0 111.505 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.9 p -75.57 -51.35 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 10.0 112.152 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 144' ' ' GLU . 12.9 p -70.79 -6.22 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.461 0.541 . . . . 10.0 112.461 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.814 0.34 . . . . 10.0 110.754 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.843 0.354 . . . . 10.0 111.22 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.657 ' HG2' HG22 ' A' ' 105' ' ' THR . 83.4 mt-10 -138.77 164.3 29.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.522 0.677 . . . . 10.0 111.301 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.602 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.3 t80 -161.83 139.62 8.89 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.573 -1.194 . . . . 10.0 112.501 -174.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 24.5 pt-20 -88.68 140.01 29.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.52 -0.919 . . . . 10.0 108.52 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.911 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -155.47 171.28 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 N-CA-C 114.084 1.142 . . . . 10.0 114.084 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.713 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.8 tm? -88.81 134.73 33.84 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.779 ' HB3' HD22 ' A' ' 102' ' ' LEU . 82.6 p -146.17 152.12 38.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 113.242 0.831 . . . . 10.0 113.242 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.656 ' HD2' HG23 ' A' ' 98' ' ' VAL . 2.4 p90 -149.43 166.81 27.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.181 -1.372 . . . . 10.0 109.991 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.528 ' HG3' HD21 ' A' ' 99' ' ' LEU . 94.8 mt-10 -88.56 139.36 30.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.253 0.549 . . . . 10.0 109.745 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.016 HG21 HD12 ' A' ' 71' ' ' ILE . 28.5 mm -138.96 103.27 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.364 -0.834 . . . . 10.0 110.957 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.9 OUTLIER 42.69 60.15 2.53 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.533 0.568 . . . . 10.0 112.533 179.331 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 86.7 mt-10 80.82 -42.89 0.2 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.385 -0.825 . . . . 10.0 111.912 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.674 ' OE1' HD11 ' A' ' 134' ' ' ILE . 4.1 pt20 -88.97 154.41 20.24 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.034 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.91 168.52 12.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.906 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.0 OUTLIER -152.31 135.6 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.617 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.823 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -140.34 153.81 46.53 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.846 0.684 . . . . 10.0 112.846 -177.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CZ ' HD13 ' A' ' 136' ' ' LEU . 3.8 m-85 -135.54 143.07 45.52 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.071 -0.714 . . . . 10.0 109.071 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 36.6 t70 -49.39 124.24 8.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.18 0.514 . . . . 10.0 110.806 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.911 HG13 ' HA ' ' A' ' 13' ' ' VAL . 30.1 m -64.76 -9.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.37 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.57 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 1.3 m-20 -72.0 -43.26 65.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.922 ' ND2' HG21 ' A' ' 138' ' ' ILE . 10.1 t30 -80.78 -49.77 10.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.776 -1.102 . . . . 10.0 110.071 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.713 HG21 ' HG ' ' A' ' 14' ' ' LEU . 21.9 mm -62.32 134.2 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.013 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.409 ' O ' ' CE ' ' A' ' 32' ' ' MET . 4.5 mm-40 -94.09 -68.77 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.745 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.409 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.1 172.46 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.097 0.475 . . . . 10.0 111.087 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.025 HG11 HG11 ' A' ' 98' ' ' VAL . 33.9 m -97.54 145.8 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.571 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.458 HG13 ' HB ' ' A' ' 81' ' ' ILE . 11.1 pt -142.46 122.74 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.868 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 48.7 mt-10 -88.98 104.31 16.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.834 -0.432 . . . . 10.0 109.834 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 35' ' ' GLU . 67.9 mttm . . . . . 0 C--N 1.329 -0.305 0 N-CA-C 112.218 0.451 . . . . 10.0 112.218 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.87 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.6 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.978 0.418 . . . . 10.0 111.39 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.628 ' OE1' HD22 ' A' ' 94' ' ' LEU . 16.7 pt-20 -78.06 -39.12 42.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.983 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.634 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -158.06 179.36 33.82 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.314 -0.946 . . . . 10.0 113.275 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.462 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 3.2 m -162.54 171.72 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 31.7 pt . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 10.0 112.069 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.82 HG22 ' HB3' ' A' ' 90' ' ' GLU . 2.0 pp . . . . . 0 C--O 1.234 0.252 0 CA-C-O 120.626 0.251 . . . . 10.0 110.919 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 72.1 Cg_endo -99.7 114.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.178 2.585 . . . . 10.0 113.169 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' C ' ' A' ' 51' ' ' GLY . 29.1 m -89.0 134.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.87 HG22 ' HA ' ' A' ' 49' ' ' VAL . 92.0 t -143.21 154.2 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.736 0.779 . . . . 10.0 112.957 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.465 ' N ' HG12 ' A' ' 63' ' ' VAL . 74.5 m-20 -73.29 67.17 0.96 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.662 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.838 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.9 tt -53.58 -34.17 57.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.121 -178.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.801 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -61.27 -22.13 64.56 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.325 -0.55 . . . . 10.0 109.642 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.488 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.6 tmmm? -83.85 -50.14 8.37 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.835 -0.62 . . . . 10.0 109.945 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.0 tt -54.25 -40.12 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 107.602 -1.258 . . . . 10.0 107.602 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.897 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -77.67 -47.3 19.56 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.526 -1.67 . . . . 10.0 109.383 177.49 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.514 ' N ' HD13 ' A' ' 69' ' ' LEU . . . 116.63 -92.78 0.57 Allowed Glycine 0 C--N 1.337 0.63 0 CA-C-N 115.975 -0.557 . . . . 10.0 113.193 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.016 HD12 HG21 ' A' ' 18' ' ' ILE . 2.9 pt 48.25 164.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 45.2 t -45.83 -34.9 4.04 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.925 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.7 t80 -31.48 143.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.582 -1.19 . . . . 10.0 113.09 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -173.53 41.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.071 -0.968 . . . . 10.0 109.888 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HA ' ' HG2' ' A' ' 78' ' ' MET . 55.8 mt-10 62.92 41.6 8.4 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.782 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -72.44 -49.05 36.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.05 -0.523 . . . . 10.0 112.388 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.03 18.92 0.68 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.371 -0.532 . . . . 10.0 112.346 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.564 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 3.4 mmm -53.14 146.61 11.22 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.149 -0.315 . . . . 10.0 110.149 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HE2' ' OD1' ' A' ' 96' ' ' ASP . 48.2 mtmt -159.39 -45.85 0.05 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.779 0.323 . . . . 10.0 111.533 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.8 m -88.87 133.38 34.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.211 0.529 . . . . 10.0 111.332 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.458 ' HB ' HG13 ' A' ' 34' ' ' ILE . 25.9 mt -89.65 151.09 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.526 -0.761 . . . . 10.0 111.527 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.512 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 23.1 mt -115.04 156.6 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 10.0 110.291 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.511 ' N ' HG22 ' A' ' 82' ' ' ILE . 41.3 t -133.61 148.73 30.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.931 0.396 . . . . 10.0 110.995 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.713 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -152.89 175.86 12.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.798 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.663 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 52.6 ttm-85 -133.08 132.6 41.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.873 -0.417 . . . . 10.0 109.873 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.801 HG22 ' OD1' ' A' ' 29' ' ' ASN . 65.4 p -141.53 102.14 4.13 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.378 0.609 . . . . 10.0 111.602 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 15.1 tppt? 48.56 48.26 19.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.005 -0.998 . . . . 10.0 110.771 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 13.5 m-20 80.17 27.32 0.3 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.917 -1.038 . . . . 10.0 111.999 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.916 HG12 HG22 ' A' ' 91' ' ' VAL . 51.6 t -124.59 108.98 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.057 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.82 ' HB3' HG22 ' A' ' 60' ' ' ILE . 33.9 tt0 -88.37 97.88 11.3 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.373 -1.714 . . . . 10.0 106.373 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.992 HG21 HD13 ' A' ' 142' ' ' ILE . 3.2 t -88.57 158.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 113.123 -1.853 . . . . 10.0 112.14 -174.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.13 143.03 14.6 Favored Glycine 0 C--N 1.317 -0.486 0 C-N-CA 120.234 -0.984 . . . . 10.0 113.833 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.624 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -131.38 128.77 40.29 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.628 HD22 ' OE1' ' A' ' 50' ' ' GLU . 65.5 tp -88.52 133.52 34.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.437 0.636 . . . . 10.0 111.904 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.6 HG11 ' CE1' ' A' ' 16' ' ' PHE . 27.6 m -147.28 -175.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.014 -0.994 . . . . 10.0 110.209 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.465 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 16.0 t70 -109.94 -58.44 2.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.551 0.574 . . . . 10.0 112.551 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -127.83 122.72 33.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.383 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.025 HG11 HG11 ' A' ' 33' ' ' VAL . 7.3 p -116.35 117.78 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 122.3 1.048 . . . . 10.0 111.643 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.597 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -69.71 -29.33 66.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.183 -1.826 . . . . 10.0 110.852 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.33 -125.59 7.73 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.778 -0.725 . . . . 10.0 111.701 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.8 t -50.84 132.27 11.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 117.079 0.44 . . . . 10.0 110.367 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 15' ' ' SER . 51.8 tp -135.69 139.9 44.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.019 0.437 . . . . 10.0 111.519 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.3 ptp180 -88.85 76.26 7.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.453 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.82 ' CD1' HG11 ' A' ' 126' ' ' VAL . 14.3 mm -88.73 168.37 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.657 HG22 ' HG2' ' A' ' 10' ' ' GLU . 22.4 p -131.67 148.08 52.56 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.426 -0.953 . . . . 10.0 108.426 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 81.0 tt0 -106.4 72.07 0.9 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.894 0.854 . . . . 10.0 112.466 -177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -108.48 21.09 17.77 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-N 114.61 -1.177 . . . . 10.0 111.699 -178.747 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.73 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 2.9 t80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.927 0.394 . . . . 10.0 110.428 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.22 -145.26 10.53 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.529 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -87.43 -38.1 16.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.941 0.401 . . . . 10.0 110.93 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.47 ' NZ ' ' HB2' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -55.25 -33.23 62.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.696 -179.195 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.425 ' OG ' ' HG ' ' A' ' 136' ' ' LEU . 37.3 t . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 121.108 -0.237 . . . . 10.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 1.005 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.8 p . . . . . 0 C--O 1.226 -0.184 0 CA-C-O 120.979 0.419 . . . . 10.0 112.021 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 39.7 ttmt -163.66 132.76 3.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.663 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 129' ' ' ASP . 16.1 m -161.92 158.81 25.85 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 120.925 0.393 . . . . 10.0 111.435 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.451 ' N ' ' CG2' ' A' ' 128' ' ' THR . 9.4 p-10 44.6 52.89 7.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.69 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.6 37.13 41.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.541 -0.838 . . . . 10.0 111.98 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -146.06 126.46 14.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.61 ' C ' HD22 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -88.95 144.74 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.458 . . . . 10.0 110.607 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 1.034 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.9 mt -133.91 139.77 47.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.548 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.906 ' HB ' HD13 ' A' ' 23' ' ' LEU . 4.3 mm -88.81 143.71 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.413 -0.958 . . . . 10.0 108.413 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 38.1 t80 -138.77 136.46 35.74 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.609 0.719 . . . . 10.0 111.824 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.645 HD13 ' CZ ' ' A' ' 25' ' ' PHE . 4.3 mp -129.43 149.8 51.06 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.719 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 9.9 t70 -113.65 19.61 16.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.253 -1.339 . . . . 10.0 107.623 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.922 HG21 ' ND2' ' A' ' 29' ' ' ASN . 12.4 tt 39.19 20.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 114.283 -1.326 . . . . 10.0 113.67 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.7 t0 -81.89 -60.83 2.1 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.72 0.637 . . . . 10.0 112.72 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -75.48 -32.72 60.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.534 0.683 . . . . 10.0 109.915 -179.645 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.849 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.28 -45.25 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 114.911 -1.04 . . . . 10.0 110.558 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.992 HD13 HG21 ' A' ' 91' ' ' VAL . 8.0 tp -61.99 -46.02 97.41 Favored 'Isoleucine or valine' 0 C--N 1.337 0.054 0 C-N-CA 120.339 -0.545 . . . . 10.0 110.14 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.669 ' O ' HG12 ' A' ' 147' ' ' VAL . 51.9 mt-10 -49.24 -43.76 43.04 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.192 0.52 . . . . 10.0 109.72 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.617 ' HB2' HD11 ' A' ' 68' ' ' ILE . 54.9 mm-40 -66.25 -32.13 73.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.323 -0.853 . . . . 10.0 110.555 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.651 HD12 HD12 ' A' ' 142' ' ' ILE . 31.1 mt -58.98 -42.15 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 120.926 0.393 . . . . 10.0 110.85 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.3 p -79.8 -50.26 10.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.771 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 143' ' ' GLU . 12.9 p -75.78 0.96 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.437 ' HE2' ' CG2' ' A' ' 49' ' ' VAL . 23.0 pttp . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.837 0.351 . . . . 10.0 111.229 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.773 0.321 . . . . 10.0 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.518 ' O ' ' OG1' ' A' ' 3' ' ' THR . 18.5 ptpt -64.0 -43.47 95.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.828 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 34.4 p 65.73 -55.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.969 -0.56 . . . . 10.0 112.139 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.936 HD12 ' N ' ' A' ' 5' ' ' ALA . 4.1 pp -55.98 -36.71 68.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.705 0.288 . . . . 10.0 111.23 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.936 ' N ' HD12 ' A' ' 4' ' ' LEU . . . 62.39 134.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.083 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -178.6 140.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.708 ' O ' HD23 ' A' ' 8' ' ' LEU . . . 64.01 143.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.226 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.08 HD13 HD13 ' A' ' 109' ' ' LEU . 85.7 mt -147.5 44.75 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.828 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -81.83 -57.75 3.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.406 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.624 ' HG3' HG22 ' A' ' 105' ' ' THR . 29.3 mp0 -103.88 164.31 11.78 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.426 0.631 . . . . 10.0 110.975 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.641 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 17.5 t80 -161.4 140.11 9.77 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.936 -1.029 . . . . 10.0 112.963 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 27' ' ' VAL . 32.6 mt-10 -88.71 140.54 29.34 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.639 -0.709 . . . . 10.0 109.622 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.788 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -155.85 168.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 113.093 0.775 . . . . 10.0 113.093 -175.131 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.938 HD11 HD13 ' A' ' 82' ' ' ILE . 2.3 tm? -88.89 134.2 34.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.521 -1.289 . . . . 10.0 107.521 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.792 ' HB3' HD22 ' A' ' 102' ' ' LEU . 81.1 p -143.03 152.97 42.48 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.717 ' CE1' HG11 ' A' ' 95' ' ' VAL . 6.1 p90 -150.42 167.6 26.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.299 -1.319 . . . . 10.0 110.297 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -88.55 138.5 31.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.682 -0.488 . . . . 10.0 109.682 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.989 HG21 HD12 ' A' ' 71' ' ' ILE . 33.4 mm -136.56 93.23 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.335 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 50.1 m-20 45.59 60.08 3.28 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.593 -0.731 . . . . 10.0 112.513 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.6 mt-10 83.73 -39.99 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.29 -0.868 . . . . 10.0 112.081 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.3 pt20 -88.91 149.55 23.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.164 -0.31 . . . . 10.0 110.164 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.027 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.55 159.52 17.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.338 . . . . 10.0 110.893 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.857 HD13 ' HB ' ' A' ' 134' ' ' ILE . 2.1 tp -147.67 136.88 22.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.768 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.801 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -136.92 146.87 45.99 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.517 0.562 . . . . 10.0 112.517 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.003 ' CE2' HD13 ' A' ' 65' ' ' LEU . 2.0 m-30 -121.47 135.87 55.0 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.585 -0.894 . . . . 10.0 108.585 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.562 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 28.3 t70 -44.2 100.95 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.581 0.705 . . . . 10.0 110.499 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 6.2 p -50.37 -14.44 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.648 -1.16 . . . . 10.0 111.978 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.562 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 7.6 m-20 -64.51 -44.65 90.23 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.468 -0.493 . . . . 10.0 109.906 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.657 HD21 HG22 ' A' ' 86' ' ' THR . 22.6 t-20 -83.24 -41.51 18.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.725 -0.671 . . . . 10.0 110.733 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.758 HG21 ' HG ' ' A' ' 14' ' ' LEU . 32.9 mm -59.64 123.5 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.58 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 32' ' ' MET . 66.6 mm-40 -81.97 -61.89 1.78 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.01 0.374 . . . . 10.0 112.01 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.6 mtm -169.04 157.27 7.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 10.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.507 HG11 HG11 ' A' ' 98' ' ' VAL . 33.7 m -88.92 137.16 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.934 -0.576 . . . . 10.0 111.228 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.519 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 11.4 pt -123.96 135.53 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.345 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -88.99 118.74 28.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.518 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.834 ' HB3' HD12 ' A' ' 81' ' ' ILE . 39.5 ttmt -169.14 165.23 11.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.6 t -155.32 154.65 32.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 10.0 111.199 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.5 t70 54.15 46.29 25.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.466 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.647 HG22 ' H ' ' A' ' 52' ' ' VAL . 17.1 mt -70.15 137.4 24.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.827 -0.624 . . . . 10.0 111.515 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.82 HG23 ' HG2' ' A' ' 43' ' ' PRO . 4.8 m 38.49 78.83 0.34 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.108 -0.496 . . . . 10.0 112.076 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -86.17 -50.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.929 2.419 . . . . 10.0 113.997 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.67 HG22 ' HD3' ' A' ' 43' ' ' PRO . 19.1 m -73.45 -33.88 2.05 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.761 0.652 . . . . 10.0 112.761 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.82 ' HG2' HG23 ' A' ' 40' ' ' THR . 12.6 Cg_exo -70.74 10.55 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.381 2.054 . . . . 10.0 113.532 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -46.46 159.48 0.09 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 120.662 0.268 . . . . 10.0 110.522 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.8 p -174.75 -53.26 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.389 -0.524 . . . . 10.0 110.945 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -76.06 -118.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.625 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -169.33 -49.95 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.834 0.35 . . . . 10.0 110.583 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.522 ' CG ' ' HD2' ' A' ' 148' ' ' LYS . 3.1 m-85 -65.29 -52.54 53.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.913 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.759 ' HA ' HG22 ' A' ' 63' ' ' VAL . 49.0 t -62.94 107.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.917 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -68.86 -30.5 69.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.3 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.636 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -166.82 -175.91 37.39 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.536 -0.84 . . . . 10.0 112.959 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.647 ' H ' HG22 ' A' ' 39' ' ' ILE . 2.9 m -160.42 170.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.123 -0.695 . . . . 10.0 109.123 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 60' ' ' ILE . 30.1 pt -157.77 137.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.992 0.425 . . . . 10.0 111.884 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -88.84 136.4 33.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.693 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.0 tp -169.1 140.79 2.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 52.1 ttm-85 48.66 46.16 21.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.176 0.512 . . . . 10.0 110.859 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.27 41.79 80.45 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.034 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 58' ' ' ARG . 2.5 ptp180 -167.09 125.15 1.3 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 10.0 111.078 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.626 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -91.82 134.98 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.923 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.814 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.3 pp -109.22 135.88 20.19 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.518 -0.31 . . . . 10.0 110.983 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 85.0 Cg_endo -92.83 124.42 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.932 2.422 . . . . 10.0 112.735 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.636 HG22 ' C ' ' A' ' 51' ' ' GLY . 23.2 m -102.79 125.34 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.788 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.878 HG12 ' H ' ' A' ' 64' ' ' ASN . 14.0 t -130.66 -175.9 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.283 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.878 ' H ' HG12 ' A' ' 63' ' ' VAL . 5.2 m120 -120.24 96.85 5.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.71 -0.223 . . . . 10.0 110.526 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.003 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.1 tt -56.21 -32.13 64.11 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.273 0.559 . . . . 10.0 109.838 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.998 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -61.74 -24.52 66.86 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.23 -0.441 . . . . 10.0 109.884 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.464 ' HE3' ' CE2' ' A' ' 48' ' ' PHE . 1.4 tmmm? -82.28 -44.04 16.77 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.295 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.7 tt -64.58 -40.85 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.447 -0.946 . . . . 10.0 108.447 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.039 HD21 ' CE2' ' A' ' 118' ' ' PHE . 0.7 OUTLIER -77.88 -53.01 7.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 113.903 -1.499 . . . . 10.0 109.487 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 118.93 -80.48 0.32 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 115.454 -0.794 . . . . 10.0 112.702 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.998 HD11 ' CB ' ' A' ' 66' ' ' ALA . 3.3 pt 45.19 178.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.7 m -55.44 -37.53 67.82 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 109.054 -0.721 . . . . 10.0 109.054 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.841 ' HB3' HG13 ' A' ' 71' ' ' ILE . 16.1 t80 -31.07 143.92 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.772 -1.104 . . . . 10.0 112.995 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 9.4 t70 -169.84 39.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.351 -0.84 . . . . 10.0 109.702 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 78' ' ' MET . 94.9 mt-10 56.13 39.04 30.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.034 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -87.24 -63.76 1.26 Allowed 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 112.327 0.492 . . . . 10.0 112.327 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -108.35 16.24 23.3 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.538 0.57 . . . . 10.0 112.538 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.482 ' HE2' ' HD1' ' A' ' 73' ' ' PHE . 17.7 mmt -52.86 138.33 29.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.907 -0.133 . . . . 10.0 110.963 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -159.46 -48.63 0.05 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.524 0.565 . . . . 10.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.414 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 65.1 m -88.94 163.75 15.44 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.803 0.298 . . . . 10.0 111.803 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.834 HD12 ' HB3' ' A' ' 36' ' ' LYS . 72.6 mt -127.7 154.15 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.031 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.938 HD13 HD11 ' A' ' 14' ' ' LEU . 11.8 mt -128.15 146.12 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.421 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.14 149.93 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.438 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -156.86 130.61 8.23 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.497 -0.32 . . . . 10.0 111.776 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -88.8 133.17 34.34 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.715 -0.846 . . . . 10.0 108.715 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.657 HG22 HD21 ' A' ' 29' ' ' ASN . 43.8 p -147.63 108.61 4.22 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.669 0.618 . . . . 10.0 112.669 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 47.78 49.25 16.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.705 -0.68 . . . . 10.0 110.82 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 70.41 33.65 2.44 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.216 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.953 HG12 HG22 ' A' ' 91' ' ' VAL . 76.8 t -133.56 111.63 16.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.24 -0.891 . . . . 10.0 109.34 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.755 ' HB2' HG22 ' A' ' 60' ' ' ILE . 39.8 mt-10 -88.56 92.45 9.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.114 -1.439 . . . . 10.0 107.114 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.065 HG21 HD13 ' A' ' 142' ' ' ILE . 2.7 t -88.66 158.15 3.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 112.796 -2.002 . . . . 10.0 111.719 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -138.11 144.6 15.88 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 120.165 -1.016 . . . . 10.0 113.458 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 t80 -133.36 122.02 23.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.777 0.323 . . . . 10.0 110.618 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 95' ' ' VAL . 6.5 tt -88.85 132.56 34.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.141 0.496 . . . . 10.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.717 HG11 ' CE1' ' A' ' 16' ' ' PHE . 15.9 m -130.94 -175.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.431 -0.804 . . . . 10.0 111.373 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -81.27 -75.95 0.26 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.153 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -134.27 107.17 7.51 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.282 -0.872 . . . . 10.0 108.733 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.617 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -88.97 116.99 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 122.418 1.104 . . . . 10.0 111.967 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.607 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -68.75 -27.59 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.909 -1.95 . . . . 10.0 110.715 -178.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.74 -126.58 8.34 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.635 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -52.28 133.14 14.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.976 0.388 . . . . 10.0 110.754 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.792 HD22 ' HB3' ' A' ' 15' ' ' SER . 43.9 tp -137.7 138.33 39.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.059 0.457 . . . . 10.0 110.854 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.6 ptp180 -88.8 72.74 8.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.198 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.034 HD12 HG21 ' A' ' 126' ' ' VAL . 14.3 mm -88.98 131.62 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.771 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.624 HG22 ' HG3' ' A' ' 10' ' ' GLU . 20.6 p -88.76 147.24 24.56 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.356 -1.72 . . . . 10.0 106.356 175.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.411 ' HG2' ' HG ' ' A' ' 109' ' ' LEU . 84.3 tt0 -134.47 81.77 1.93 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.365 -0.934 . . . . 10.0 113.08 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -76.05 -5.28 45.7 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.296 -0.865 . . . . 10.0 109.343 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -64.8 -54.84 24.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.335 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 1.08 HD13 HD13 ' A' ' 8' ' ' LEU . 2.2 pp -81.28 145.19 31.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.668 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.424 ' HB3' HD12 ' A' ' 111' ' ' LEU . 38.4 t70 -172.9 -52.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.715 -0.675 . . . . 10.0 109.81 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.642 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.7 mp -94.88 -40.54 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.633 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.2 t 176.52 44.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.292 -0.867 . . . . 10.0 110.339 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.827 ' O ' HG13 ' A' ' 114' ' ' VAL . 24.3 t-20 62.87 125.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.73 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -174.01 113.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.409 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.416 ' OG ' ' HG2' ' A' ' 117' ' ' LYS . 47.0 t -172.85 130.96 0.52 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.215 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -105.92 25.82 10.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.405 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.416 ' HG2' ' OG ' ' A' ' 115' ' ' SER . 30.2 mmmt -51.72 -35.32 42.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.539 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 1.039 ' CE2' HD21 ' A' ' 69' ' ' LEU . 4.3 t80 -165.19 38.94 0.07 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.534 0.683 . . . . 10.0 109.487 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 122' ' ' SER . . . -74.2 35.6 0.94 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.857 -1.065 . . . . 10.0 113.351 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -79.34 -32.63 43.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.346 0.593 . . . . 10.0 109.452 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 17.1 tppt? -156.9 32.99 0.3 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.195 -0.911 . . . . 10.0 110.112 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.643 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 79.6 p 178.25 -160.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.211 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.558 ' HB2' ' HA ' ' A' ' 136' ' ' LEU . 42.2 mmtm -72.62 -52.36 15.73 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 111.422 0.156 . . . . 10.0 111.422 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 118' ' ' PHE . . . 157.24 172.54 24.56 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.285 -1.436 . . . . 10.0 115.05 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.931 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.6 tm? -72.29 144.4 48.37 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.818 -0.691 . . . . 10.0 110.762 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 1.034 HG21 HD12 ' A' ' 104' ' ' ILE . 2.3 p -121.08 153.27 24.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.34 0.59 . . . . 10.0 111.605 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.483 ' HB3' ' NZ ' ' A' ' 127' ' ' LYS . 7.2 ttpm? -152.14 140.31 20.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 18.7 m -159.67 144.63 15.32 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.887 0.375 . . . . 10.0 111.109 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 131' ' ' ARG . 2.9 p30 45.95 48.36 12.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.615 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.07 42.41 81.2 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.711 -0.757 . . . . 10.0 112.383 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.494 ' HD2' HD11 ' A' ' 133' ' ' ILE . 0.7 OUTLIER -136.25 139.93 43.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.823 0.344 . . . . 10.0 110.454 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.1 mp -88.87 137.28 32.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.98 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.027 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.0 mt -156.03 151.36 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.551 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.857 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.7 mp -101.41 144.69 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.467 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 35.6 t80 -139.75 142.64 36.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.839 -0.744 . . . . 10.0 111.973 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.855 HD22 ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -158.1 144.17 17.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.644 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 9.2 t70 -97.2 33.99 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.718 . . . . 10.0 110.004 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.855 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 18.5 tt 42.4 20.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.048 -0.978 . . . . 10.0 113.337 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 123' ' ' LYS . 38.6 t70 -77.14 -54.97 5.85 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -79.21 -30.66 43.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.151 0.5 . . . . 10.0 110.937 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.855 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.46 -45.33 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.657 -0.701 . . . . 10.0 110.199 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.065 HD13 HG21 ' A' ' 91' ' ' VAL . 8.3 tp -67.17 -45.5 86.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 120.622 -0.431 . . . . 10.0 110.538 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.662 ' O ' HG12 ' A' ' 147' ' ' VAL . 15.0 tp10 -48.05 -43.21 30.18 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.374 0.607 . . . . 10.0 109.64 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.663 ' HB2' HD11 ' A' ' 68' ' ' ILE . 55.5 mm-40 -72.44 -31.33 65.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.083 -0.962 . . . . 10.0 110.865 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.751 HG13 ' O ' ' A' ' 141' ' ' ILE . 38.6 mt -54.99 -41.59 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.942 0.401 . . . . 10.0 110.652 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.8 p -81.01 -52.26 7.62 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.926 -0.579 . . . . 10.0 112.162 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 143' ' ' GLU . 10.8 p -82.14 13.1 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.522 ' HD2' ' CG ' ' A' ' 48' ' ' PHE . 24.3 ttpp -44.79 -43.77 8.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.697 0.284 . . . . 10.0 111.739 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -56.84 127.13 30.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 10.0 111.023 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 168.91 -47.84 0.22 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.819 -0.705 . . . . 10.0 112.535 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.327 . . . . 10.0 111.054 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.437 ' HG2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.546 0.212 . . . . 10.0 111.488 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 1' ' ' MET . 13.1 mmmm 62.16 60.8 1.41 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.958 0.409 . . . . 10.0 111.246 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 t -50.66 -24.44 3.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 10.0 111.173 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.9 mt -56.84 -39.28 73.95 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.009 0.433 . . . . 10.0 110.2 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.65 132.32 53.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.587 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.476 ' OD2' ' HB3' ' A' ' 9' ' ' LYS . 35.7 t70 -178.8 163.32 1.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.979 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.32 139.01 3.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.94 0.4 . . . . 10.0 111.539 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.491 ' HB3' HD11 ' A' ' 109' ' ' LEU . 86.0 mt 66.19 44.05 2.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.448 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB3' ' OD2' ' A' ' 6' ' ' ASP . 21.0 ptmt -86.04 -48.28 8.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.964 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 105' ' ' THR . 39.8 mt-10 -117.7 164.26 15.25 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.319 0.58 . . . . 10.0 110.471 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.576 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 15.5 t80 -157.25 137.16 12.47 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.005 -0.998 . . . . 10.0 112.748 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -88.73 139.86 30.04 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.476 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.98 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.1 p -156.06 171.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.948 HD11 HD13 ' A' ' 82' ' ' ILE . 3.3 tm? -88.92 137.18 32.55 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.871 ' HB3' HD22 ' A' ' 102' ' ' LEU . 76.7 p -149.19 153.62 37.92 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.685 0.995 . . . . 10.0 113.685 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.781 ' CE2' HG11 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -147.18 156.43 42.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.154 -1.384 . . . . 10.0 110.142 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -88.77 99.91 12.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.388 0.613 . . . . 10.0 109.868 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.992 HG21 HD12 ' A' ' 71' ' ' ILE . 27.6 mm -88.91 101.36 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.034 -0.985 . . . . 10.0 111.866 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.1 m-20 46.18 60.15 3.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.566 -0.743 . . . . 10.0 112.926 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.7 mt-10 86.6 -39.63 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.385 -0.825 . . . . 10.0 112.015 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.754 ' OE1' HD22 ' A' ' 132' ' ' LEU . 16.5 pt20 -88.83 -175.61 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.788 -0.449 . . . . 10.0 109.788 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.016 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -115.43 158.11 22.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.171 0.51 . . . . 10.0 111.472 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.909 HD12 ' N ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -145.39 133.3 21.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.144 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.909 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -137.05 149.43 47.42 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.717 1.006 . . . . 10.0 113.717 -177.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.923 ' CE2' HD21 ' A' ' 136' ' ' LEU . 0.9 OUTLIER -132.18 138.11 47.87 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.634 -1.167 . . . . 10.0 108.329 178.725 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -49.0 122.69 6.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.066 0.46 . . . . 10.0 111.325 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.98 HG13 ' HA ' ' A' ' 13' ' ' VAL . 23.9 m -61.05 -14.24 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.63 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.14 -39.78 91.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.068 0.461 . . . . 10.0 110.22 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.753 HD21 HG22 ' A' ' 86' ' ' THR . 20.6 t-20 -95.49 -44.77 7.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.245 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.728 HG21 ' HG ' ' A' ' 14' ' ' LEU . 28.1 mm -57.32 129.53 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.59 -0.277 . . . . 10.0 110.471 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 32' ' ' MET . 50.4 mt-10 -88.32 -61.6 1.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.5 mtm -169.03 157.95 8.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.983 0.42 . . . . 10.0 111.563 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 98' ' ' VAL . 33.8 m -88.87 151.16 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.474 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.543 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 13.5 pt -154.13 134.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.01 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.93 111.81 24.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 10.0 110.608 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.446 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 2.0 tmtp? -169.18 66.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.699 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.3 p -55.74 -168.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.37 . . . . 10.0 111.272 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 38.74 46.54 1.04 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.243 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.803 HD12 HG21 ' A' ' 62' ' ' VAL . 19.6 mt -77.56 138.38 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.665 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.626 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 4.0 m 34.57 91.57 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.963 -0.562 . . . . 10.0 112.499 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -89.24 -57.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.684 2.256 . . . . 10.0 113.506 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.58 HG12 ' HD3' ' A' ' 43' ' ' PRO . 14.2 p -81.54 -31.97 0.6 Allowed Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.198 0.814 . . . . 10.0 113.198 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HB2' HG23 ' A' ' 40' ' ' THR . 14.8 Cg_exo -67.97 5.16 1.18 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.124 1.882 . . . . 10.0 113.703 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.511 ' HD3' ' O ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -50.92 148.87 3.84 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.157 0.503 . . . . 10.0 112.04 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 41.7 t 174.92 60.28 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.725 . . . . 10.0 110.92 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 20.8 tpp180 -170.46 -31.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.422 -0.353 . . . . 10.0 111.88 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 40.8 m80 73.73 146.98 0.09 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.749 0.309 . . . . 10.0 110.676 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.489 ' HB3' ' HD2' ' A' ' 148' ' ' LYS . 1.8 t80 83.52 -46.74 0.12 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.737 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.948 ' HA ' HG22 ' A' ' 63' ' ' VAL . 48.7 t -72.65 128.56 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.902 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.545 ' HG3' HG23 ' A' ' 62' ' ' VAL . 12.3 pt-20 -74.9 -37.82 62.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.146 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 62' ' ' VAL . . . -168.02 -175.86 38.08 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.958 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.626 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.5 m -154.16 170.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.839 -0.43 . . . . 10.0 109.839 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.468 HG12 HD11 ' A' ' 60' ' ' ILE . 30.9 pt -157.47 145.21 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.867 0.365 . . . . 10.0 111.084 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.557 HD22 HD11 ' A' ' 59' ' ' ILE . 24.6 t-20 -88.71 142.11 27.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 10.0 111.167 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 tp -168.29 138.71 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.823 -0.626 . . . . 10.0 110.586 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.554 ' HG3' ' HG2' ' A' ' 58' ' ' ARG . 16.4 ptm180 44.79 45.75 8.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.38 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.49 40.89 99.31 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.85 -0.614 . . . . 10.0 113.704 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.554 ' HG2' ' HG3' ' A' ' 56' ' ' ARG . 16.0 ptp180 -169.15 130.06 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.877 0.338 . . . . 10.0 110.979 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -89.03 133.53 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.23 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.804 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.3 pp -104.86 135.74 19.26 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.935 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 79.5 Cg_endo -92.02 114.31 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.762 2.308 . . . . 10.0 113.383 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.803 HG21 HD12 ' A' ' 39' ' ' ILE . 23.0 m -91.05 136.03 25.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.948 HG22 ' HA ' ' A' ' 49' ' ' VAL . 62.7 t -139.09 159.01 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.719 0.771 . . . . 10.0 112.92 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.529 ' N ' HG12 ' A' ' 63' ' ' VAL . 5.7 m120 -74.14 63.0 0.95 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.745 -1.116 . . . . 10.0 109.062 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.863 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.9 tt -53.69 -32.21 50.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.763 -0.653 . . . . 10.0 111.22 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.853 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -62.85 -24.09 67.61 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.259 -0.576 . . . . 10.0 109.872 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -83.06 -45.41 14.05 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.137 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.813 HG22 ' O ' ' A' ' 65' ' ' LEU . 9.6 tt -57.73 -38.67 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 107.687 -1.227 . . . . 10.0 107.687 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.879 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.22 -47.15 18.61 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.801 -1.545 . . . . 10.0 108.473 177.127 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 117.67 -90.5 0.5 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.456 -0.793 . . . . 10.0 112.714 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.992 HD12 HG21 ' A' ' 18' ' ' ILE . 3.2 pt 47.66 165.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.399 0.889 . . . . 10.0 113.399 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.6 m -47.05 -37.77 9.99 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.18 -0.674 . . . . 10.0 109.18 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.863 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.6 t80 -28.08 141.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.395 -1.275 . . . . 10.0 113.283 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -166.79 37.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.241 -0.891 . . . . 10.0 110.235 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 55.94 32.67 20.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.78 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.433 ' NE2' ' OD2' ' A' ' 19' ' ' ASP . 22.3 pt20 -95.42 -44.41 7.56 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -113.2 13.94 19.32 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.23 0.456 . . . . 10.0 112.23 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.42 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 29.5 mmt -59.8 140.62 56.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.904 0.383 . . . . 10.0 111.686 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 14.4 ptmm? -179.64 39.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.817 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.895 ' O ' HD12 ' A' ' 94' ' ' LEU . 47.3 t -169.19 164.85 11.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.701 HD13 HD11 ' A' ' 39' ' ' ILE . 43.6 mt -139.84 152.25 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.961 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.948 HD13 HD11 ' A' ' 14' ' ' LEU . 9.8 mt -131.36 130.35 62.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.727 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 84' ' ' ALA . 74.6 t -98.24 156.83 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.051 0.453 . . . . 10.0 111.307 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.654 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -156.52 172.1 19.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.617 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -130.6 130.7 44.34 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.753 HG22 HD21 ' A' ' 29' ' ' ASN . 46.7 p -145.36 109.27 4.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 87' ' ' LYS . 8.1 ttpt 48.02 49.89 16.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.614 0.721 . . . . 10.0 110.689 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 71.0 32.13 2.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.037 -0.983 . . . . 10.0 111.484 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.926 HG12 HG22 ' A' ' 91' ' ' VAL . 71.4 t -129.01 109.52 18.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.275 -0.875 . . . . 10.0 109.192 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.776 ' HB2' HG22 ' A' ' 60' ' ' ILE . 25.0 mp0 -88.35 97.36 11.0 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.278 -1.749 . . . . 10.0 106.278 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.017 HG21 HD13 ' A' ' 142' ' ' ILE . 3.6 t -88.55 153.55 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 113.291 -1.777 . . . . 10.0 113.016 -174.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.97 158.03 18.47 Favored Glycine 0 C--N 1.317 -0.485 0 CA-C-N 114.495 -1.229 . . . . 10.0 113.185 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.644 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -146.95 128.11 14.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.873 0.368 . . . . 10.0 110.915 -179.168 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.895 HD12 ' O ' ' A' ' 80' ' ' SER . 52.1 tp -88.66 128.14 35.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.999 0.428 . . . . 10.0 110.751 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.781 HG11 ' CE2' ' A' ' 16' ' ' PHE . 29.8 m -137.01 -175.11 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.428 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 45.8 t0 -92.96 -73.33 0.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.354 0.597 . . . . 10.0 111.17 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.494 ' NH1' HD22 ' A' ' 99' ' ' LEU . 57.9 ttt-85 -137.63 120.81 16.8 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.196 -0.911 . . . . 10.0 108.616 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.649 HG23 ' HD1' ' A' ' 16' ' ' PHE . 7.1 p -101.69 117.12 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 122.361 1.077 . . . . 10.0 112.898 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -65.42 -28.82 69.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.083 -1.871 . . . . 10.0 111.059 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.57 -122.63 6.57 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.552 -0.833 . . . . 10.0 111.171 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.97 133.59 16.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 117.045 0.422 . . . . 10.0 110.322 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.871 HD22 ' HB3' ' A' ' 15' ' ' SER . 57.2 tp -136.17 137.72 41.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.989 0.423 . . . . 10.0 111.048 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.9 ptp180 -88.85 71.73 8.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.315 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.04 HD12 HG21 ' A' ' 126' ' ' VAL . 14.2 mm -88.84 128.45 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.732 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.613 HG22 ' HG2' ' A' ' 10' ' ' GLU . 18.5 p -88.68 147.59 24.44 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.655 -1.609 . . . . 10.0 106.655 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.609 ' OE1' HD23 ' A' ' 109' ' ' LEU . 35.0 tt0 -137.07 79.08 1.73 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.443 -0.903 . . . . 10.0 112.663 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -72.98 -10.6 59.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.619 -0.719 . . . . 10.0 109.533 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -63.09 -48.39 78.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.443 -0.799 . . . . 10.0 110.932 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.609 HD23 ' OE1' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -61.57 165.47 4.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.921 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -175.74 -46.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.607 -0.724 . . . . 10.0 110.002 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.8 tp -124.65 -32.75 3.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.987 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.1 t 177.28 43.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.432 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 m120 61.65 120.54 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.999 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 115' ' ' SER . 10.9 t -156.79 97.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.142 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 46.1 t 175.34 133.83 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.797 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.445 ' O ' ' HA2' ' A' ' 124' ' ' GLY . 34.3 t70 -71.29 -70.1 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.761 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.611 ' HB2' ' CA ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER 66.57 -55.09 0.42 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 179.466 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.684 ' CE1' HD21 ' A' ' 69' ' ' LEU . 56.6 t80 -69.85 -58.04 4.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.11 0.481 . . . . 10.0 110.55 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 150.53 -54.5 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.568 -0.742 . . . . 10.0 112.091 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 54.9 tptt 173.85 60.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.978 0.418 . . . . 10.0 110.063 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.463 ' HB3' ' CE2' ' A' ' 118' ' ' PHE . 4.2 tppp? -154.47 -39.43 0.09 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.658 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.654 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 94.9 p -140.88 -163.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.561 -0.291 . . . . 10.0 110.724 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 5.4 mmpt? -70.6 -49.66 45.44 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.766 -0.374 . . . . 10.0 111.707 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.611 ' CA ' ' HB2' ' A' ' 117' ' ' LYS . . . 170.29 151.93 7.75 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 118.428 -1.844 . . . . 10.0 116.109 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.587 ' C ' HD13 ' A' ' 125' ' ' LEU . 2.8 tm? -73.61 124.41 25.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.563 -0.818 . . . . 10.0 109.653 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 1.04 HG21 HD12 ' A' ' 104' ' ' ILE . 2.4 p -97.63 154.19 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.452 0.644 . . . . 10.0 112.28 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -158.95 138.45 11.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.497 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 7.0 m -165.01 146.83 7.86 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.926 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 54.79 42.71 30.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.986 0.422 . . . . 10.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.4 37.68 60.67 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.836 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -130.15 136.58 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.273 -0.269 . . . . 10.0 110.273 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.882 HD23 ' N ' ' A' ' 133' ' ' ILE . 4.7 tt -88.93 136.75 32.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.605 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.016 HG12 ' HB3' ' A' ' 22' ' ' ALA . 6.0 mt -154.01 143.48 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 10.0 110.789 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.909 ' HB ' HD13 ' A' ' 23' ' ' LEU . 2.0 mp -96.1 134.8 32.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 109.072 -0.714 . . . . 10.0 109.072 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.582 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 41.1 t80 -129.33 140.4 51.4 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.773 -0.771 . . . . 10.0 111.385 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.923 HD21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -159.97 151.2 19.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.36 0.6 . . . . 10.0 111.881 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 139' ' ' ASP . 1.4 m-20 -102.33 37.87 1.8 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.498 -0.774 . . . . 10.0 110.501 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.874 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 19.8 tt 39.63 20.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.58 -1.191 . . . . 10.0 113.653 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 137' ' ' ASP . 37.9 t70 -79.53 -57.45 3.68 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 122' ' ' SER . 31.2 mmmt -76.92 -32.5 57.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 10.0 110.356 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.874 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.78 -45.68 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.183 -0.917 . . . . 10.0 110.489 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.017 HD13 HG21 ' A' ' 91' ' ' VAL . 7.5 tp -64.13 -44.82 97.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 120.375 -0.53 . . . . 10.0 109.953 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 142' ' ' ILE . 44.7 tt0 -48.13 -43.16 30.92 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 68' ' ' ILE . 44.5 mt-10 -69.99 -32.89 71.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.236 -0.893 . . . . 10.0 110.58 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.698 ' CD1' HG11 ' A' ' 91' ' ' VAL . 34.1 mt -55.51 -40.38 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 120.953 0.406 . . . . 10.0 110.801 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.6 p -77.74 -50.63 12.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.873 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.6 p -77.89 5.06 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.088 0.403 . . . . 10.0 112.088 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.489 ' HD2' ' HB3' ' A' ' 48' ' ' PHE . 23.9 pttm -46.42 -41.44 13.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.696 0.284 . . . . 10.0 111.638 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.824 ' HG2' HG23 ' A' ' 151' ' ' VAL . 89.0 tt0 63.8 132.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.664 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -103.22 -47.13 1.36 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.71 -0.757 . . . . 10.0 112.424 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.824 HG23 ' HG2' ' A' ' 149' ' ' GLU . 65.5 t . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.817 0.342 . . . . 10.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 1' ' ' MET . 27.8 ttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.001 0.429 . . . . 10.0 110.818 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 3' ' ' THR . 75.0 mmtt -64.09 -42.83 96.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 51.0 m 72.65 -48.87 0.69 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.319 -0.401 . . . . 10.0 111.744 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.913 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.2 pp -56.14 -28.7 58.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.873 0.368 . . . . 10.0 110.945 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.913 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -54.0 131.89 41.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.222 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 62.16 123.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.986 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.31 135.95 55.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.426 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.829 HD13 ' CD2' ' A' ' 109' ' ' LEU . 84.3 mt -82.26 47.76 1.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.858 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 105' ' ' THR . 22.8 tptm -82.67 -53.41 5.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.477 -0.329 . . . . 10.0 111.835 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.592 ' HG2' HG22 ' A' ' 105' ' ' THR . 34.2 mt-10 -121.69 164.28 17.63 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.738 0.78 . . . . 10.0 111.513 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.569 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 12.7 t80 -158.76 136.71 10.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.268 -1.333 . . . . 10.0 112.259 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.75 140.76 29.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.655 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.859 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -157.99 171.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 113.583 0.957 . . . . 10.0 113.583 -174.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.998 HD11 HD13 ' A' ' 82' ' ' ILE . 2.0 tm? -88.77 132.1 34.77 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.855 ' CB ' HD22 ' A' ' 102' ' ' LEU . 80.9 p -143.7 156.92 44.69 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.542 0.942 . . . . 10.0 113.542 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.767 ' CD1' HD11 ' A' ' 82' ' ' ILE . 4.1 p90 -153.11 158.35 41.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.902 -1.499 . . . . 10.0 109.81 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -88.58 125.4 34.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.351 0.596 . . . . 10.0 109.556 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.83 HG21 HD12 ' A' ' 71' ' ' ILE . 32.9 mm -115.09 81.03 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.51 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 58.8 m-20 52.29 60.26 3.94 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.957 -0.565 . . . . 10.0 112.12 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 8.2 mp0 80.96 -31.97 0.11 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.261 -0.881 . . . . 10.0 111.771 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -88.81 137.82 31.97 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.076 -0.712 . . . . 10.0 109.076 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.008 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.65 155.09 19.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.044 0.45 . . . . 10.0 111.21 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.882 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.8 tp -148.14 140.85 24.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.355 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.766 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -144.99 155.93 43.67 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.893 0.701 . . . . 10.0 112.893 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.863 ' CE2' HD22 ' A' ' 136' ' ' LEU . 3.3 m-85 -136.4 141.21 43.62 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.319 -0.855 . . . . 10.0 109.187 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.07 120.54 5.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.195 0.521 . . . . 10.0 110.692 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.859 HG13 ' HA ' ' A' ' 13' ' ' VAL . 34.2 m -60.36 -12.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.048 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -62.14 -46.86 87.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.006 0.431 . . . . 10.0 110.376 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.828 ' OD1' HG21 ' A' ' 138' ' ' ILE . 7.2 t-20 -86.67 -45.33 11.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.924 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.718 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.4 mm -57.71 126.8 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.784 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.11 -65.78 0.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.533 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -169.13 168.77 9.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 10.0 111.683 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.404 ' HB ' HG11 ' A' ' 98' ' ' VAL . 35.2 m -88.86 148.4 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.366 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.43 HD12 ' HD2' ' A' ' 36' ' ' LYS . 17.6 pt -150.85 128.81 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -88.85 63.76 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.446 . . . . 10.0 111.234 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.948 ' HB2' HD12 ' A' ' 81' ' ' ILE . 68.6 mttm -89.06 154.23 20.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.205 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.1 p -152.61 144.39 23.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.364 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.5 t70 50.1 45.12 25.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.259 0.552 . . . . 10.0 110.787 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 45.4 mt -61.04 -69.77 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.12 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.588 HG23 ' HB2' ' A' ' 43' ' ' PRO . 96.7 m -149.71 66.7 8.33 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.231 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.42 -49.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.875 2.384 . . . . 10.0 113.205 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.505 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 45.6 t -72.46 -44.47 9.83 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.469 -0.332 . . . . 10.0 111.757 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.588 ' HB2' HG23 ' A' ' 40' ' ' THR . 12.1 Cg_exo -70.07 8.63 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.651 2.234 . . . . 10.0 113.538 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 45' ' ' SER . 17.6 ptmt -48.82 156.59 0.47 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.043 0.449 . . . . 10.0 111.829 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 44.2 t 177.76 48.72 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.589 -0.732 . . . . 10.0 111.438 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.536 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 6.9 tpm_? -166.24 16.55 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.558 -0.292 . . . . 10.0 111.671 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.481 ' O ' ' O ' ' A' ' 46' ' ' ARG . 17.6 m80 56.49 137.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.766 0.317 . . . . 10.0 111.185 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' GLU . 3.2 m-85 68.8 -47.66 0.57 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.92 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.585 ' HA ' HG22 ' A' ' 63' ' ' VAL . 48.0 t -54.4 80.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.921 0.391 . . . . 10.0 111.57 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 48' ' ' PHE . 24.6 pt-20 -61.02 -29.19 69.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.962 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.741 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -152.21 168.19 31.36 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.435 -0.888 . . . . 10.0 112.926 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.484 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 2.3 m -160.18 167.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.94 -0.393 . . . . 10.0 109.94 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.504 HG12 HD11 ' A' ' 60' ' ' ILE . 29.7 pt -156.55 132.53 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.226 0.536 . . . . 10.0 112.068 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -88.91 140.94 28.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.44 -0.8 . . . . 10.0 110.812 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.2 tp -169.01 137.16 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.892 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 45.65 46.98 11.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.56 44.82 90.69 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.694 -0.765 . . . . 10.0 112.212 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.438 ' C ' HD12 ' A' ' 59' ' ' ILE . 4.5 tmm_? -161.14 125.04 3.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 10.0 111.034 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.6 mp -100.83 145.96 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.758 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.806 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.1 pp -126.86 137.13 29.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.61 -0.268 . . . . 10.0 111.202 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 50.6 Cg_endo -95.67 124.92 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.413 2.742 . . . . 10.0 113.431 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.741 HG22 ' C ' ' A' ' 51' ' ' GLY . 27.0 m -103.54 135.63 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.76 -0.459 . . . . 10.0 109.76 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 49' ' ' VAL . 91.3 t -142.27 156.34 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.49 0.662 . . . . 10.0 112.379 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.79 ' OD1' HD23 ' A' ' 94' ' ' LEU . 74.5 m-20 -72.69 74.98 1.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.151 -0.931 . . . . 10.0 109.364 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.872 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.8 tt -54.87 -35.89 64.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.286 0.565 . . . . 10.0 110.859 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.819 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -59.87 -20.9 59.82 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.447 -0.501 . . . . 10.0 109.687 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -83.15 -49.42 9.5 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.098 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.709 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.2 tt -58.32 -39.59 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.707 -1.22 . . . . 10.0 107.707 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.972 HD12 HD13 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -79.89 -36.05 37.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.267 -1.788 . . . . 10.0 109.573 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.612 ' O ' HD13 ' A' ' 69' ' ' LEU . . . 67.16 124.45 0.02 OUTLIER Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.676 -0.693 . . . . 10.0 112.89 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.972 HD13 HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -165.4 -168.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.727 0.411 . . . . 10.0 110.859 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 67.0 m -48.43 -35.02 11.96 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -31.3 135.82 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.251 -1.341 . . . . 10.0 113.53 176.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' A' ' 75' ' ' GLU . 64.2 t0 -129.33 -65.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.156 -0.929 . . . . 10.0 110.038 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER 157.58 -27.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.332 -0.394 . . . . 10.0 111.468 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.476 ' N ' ' OE1' ' A' ' 75' ' ' GLU . 24.9 pt20 -60.06 -48.32 82.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -77.87 -45.07 25.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.975 0.417 . . . . 10.0 111.592 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 96' ' ' ASP . 18.5 mmm -35.62 141.58 0.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.633 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -169.4 -28.95 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.829 ' O ' HD12 ' A' ' 94' ' ' LEU . 48.1 t -88.85 -175.96 5.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.628 0.252 . . . . 10.0 111.095 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.948 HD12 ' HB2' ' A' ' 36' ' ' LYS . 57.9 mt -156.61 140.48 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.954 0.407 . . . . 10.0 111.508 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.998 HD13 HD11 ' A' ' 14' ' ' LEU . 13.5 mt -113.27 150.12 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.607 . . . . 10.0 110.669 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.54 149.71 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.919 0.39 . . . . 10.0 110.852 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -151.3 -175.9 5.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.126 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.529 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 14.6 ptm180 -135.9 144.41 45.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.713 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.527 HG21 HG12 ' A' ' 138' ' ' ILE . 34.8 p -160.16 109.47 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 10.0 112.083 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.3 tppp? 47.19 47.16 16.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.691 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 53.0 m-20 74.18 33.54 0.91 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.144 -0.935 . . . . 10.0 111.279 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.878 HG12 HG22 ' A' ' 91' ' ' VAL . 60.4 t -130.47 110.14 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-N 115.215 -0.902 . . . . 10.0 109.485 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 46.1 mt-10 -88.35 100.62 13.16 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.515 -2.032 . . . . 10.0 105.515 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.983 HG21 HD13 ' A' ' 142' ' ' ILE . 5.0 t -88.62 153.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 113.343 -1.753 . . . . 10.0 113.482 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.491 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -123.1 155.1 17.24 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 114.231 -1.349 . . . . 10.0 112.707 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.579 ' HD1' ' N ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -144.43 126.66 15.69 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 120.963 0.411 . . . . 10.0 110.963 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.829 HD12 ' O ' ' A' ' 80' ' ' SER . 55.6 tp -88.64 130.27 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.111 0.482 . . . . 10.0 110.833 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.515 HG11 ' CD2' ' A' ' 16' ' ' PHE . 27.3 m -140.61 -175.27 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.961 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' MET . 19.8 t70 -93.92 -73.05 0.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.196 0.522 . . . . 10.0 111.161 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -131.27 115.42 16.28 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.341 -0.845 . . . . 10.0 108.923 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 8.7 p -98.02 111.7 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-O 122.354 1.074 . . . . 10.0 111.455 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -64.22 -27.15 68.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.062 -1.881 . . . . 10.0 111.131 -178.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.99 -121.42 5.51 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.949 -0.86 . . . . 10.0 110.949 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.4 t -52.86 129.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 117.145 0.472 . . . . 10.0 109.908 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.855 HD22 ' CB ' ' A' ' 15' ' ' SER . 60.8 tp -132.98 139.22 47.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.144 0.497 . . . . 10.0 111.226 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 15.9 ptp180 -88.89 71.27 8.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.564 -0.744 . . . . 10.0 109.641 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.828 HD12 HG11 ' A' ' 126' ' ' VAL . 6.4 mm -88.8 126.76 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.783 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.592 HG22 ' HG2' ' A' ' 10' ' ' GLU . 16.9 p -88.57 145.25 25.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.944 -1.873 . . . . 10.0 105.944 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.496 ' CG ' ' CD1' ' A' ' 109' ' ' LEU . 2.4 tp10 -147.33 89.51 1.79 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.845 -1.142 . . . . 10.0 112.846 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -86.43 7.56 25.31 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.552 -0.749 . . . . 10.0 109.5 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.43 ' OE1' ' CB ' ' A' ' 115' ' ' SER . 55.8 mm-40 -69.11 -52.49 27.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.576 -0.738 . . . . 10.0 111.003 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.955 ' H ' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -76.6 45.1 0.39 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.17 -0.468 . . . . 10.0 112.209 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.556 ' HA ' HD12 ' A' ' 8' ' ' LEU . 37.7 t70 -74.66 -53.07 9.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.977 0.418 . . . . 10.0 110.311 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.632 ' N ' HD12 ' A' ' 111' ' ' LEU . 4.0 mp -102.75 -39.52 6.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.962 -0.563 . . . . 10.0 109.951 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t 176.04 39.63 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.437 -0.802 . . . . 10.0 110.742 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.497 ' H ' ' HA ' ' A' ' 109' ' ' LEU . 5.3 m120 60.6 111.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.909 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.458 ' O ' ' OG ' ' A' ' 115' ' ' SER . 6.6 t -159.49 100.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.13 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 114' ' ' VAL . 66.1 m -173.02 -175.76 1.28 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.967 0.413 . . . . 10.0 111.438 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -73.49 63.83 0.82 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.474 0.654 . . . . 10.0 110.989 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.532 ' HD2' ' HD2' ' A' ' 123' ' ' LYS . 47.3 mtmt -47.96 -41.87 26.11 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.055 -0.975 . . . . 10.0 111.545 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.686 ' CE2' HD21 ' A' ' 69' ' ' LEU . 29.8 t80 -178.4 -52.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.305 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 156.6 -53.25 0.41 Allowed Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.647 -0.706 . . . . 10.0 112.038 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 27.4 tptp 174.81 57.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 10.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -153.02 -42.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.41 -0.359 . . . . 10.0 111.888 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.767 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 93.6 p -116.79 -139.14 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.017 -0.273 . . . . 10.0 111.692 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HD2' ' HD2' ' A' ' 117' ' ' LYS . 23.2 tptm -159.96 16.79 0.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.629 0.603 . . . . 10.0 112.629 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -153.02 152.27 23.95 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 119.416 -1.373 . . . . 10.0 113.785 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.918 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.5 tm? -153.19 141.37 20.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.106 -0.701 . . . . 10.0 109.106 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.918 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.2 p -157.78 162.28 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.419 0.628 . . . . 10.0 112.366 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.512 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -165.6 135.15 3.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.08 -0.964 . . . . 10.0 109.744 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 4.3 m -159.51 152.58 22.01 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.031 0.443 . . . . 10.0 111.304 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.4 t70 55.81 47.07 21.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.773 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.72 33.55 49.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.513 -0.851 . . . . 10.0 111.663 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.6 ptp180 -138.78 134.0 32.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.348 . . . . 10.0 110.332 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' A' ' 127' ' ' LYS . 85.6 mt -88.88 148.52 23.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.172 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.008 HG12 ' HB3' ' A' ' 22' ' ' ALA . 2.9 mt -147.97 132.31 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.656 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.882 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.3 mp -88.78 141.2 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.593 ' C ' HD12 ' A' ' 136' ' ' LEU . 24.4 t80 -125.95 147.22 49.56 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.521 0.677 . . . . 10.0 111.595 -178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.863 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.7 mp -140.3 165.73 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.042 0.925 . . . . 10.0 112.86 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -135.21 26.16 3.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.849 -1.523 . . . . 10.0 107.833 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.871 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.4 tt 42.29 16.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.929 -1.487 . . . . 10.0 114.353 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.29 -60.29 2.33 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.671 0.619 . . . . 10.0 112.671 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.453 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.6 mptt -76.02 -29.76 58.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.437 0.637 . . . . 10.0 110.396 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.871 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.11 -46.96 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.137 -0.938 . . . . 10.0 110.715 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.983 HD13 HG21 ' A' ' 91' ' ' VAL . 7.6 tp -63.0 -43.95 99.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 120.012 -0.675 . . . . 10.0 109.624 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.695 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.4 tt0 -48.11 -46.61 34.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.635 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.65 ' HB2' HD11 ' A' ' 68' ' ' ILE . 56.0 mm-40 -73.52 -30.51 63.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.432 -0.804 . . . . 10.0 110.574 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.709 HD13 HG11 ' A' ' 91' ' ' VAL . 35.8 mt -54.69 -31.77 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 120.899 0.38 . . . . 10.0 110.788 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.3 p -96.47 -49.19 5.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.983 -0.553 . . . . 10.0 112.402 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 143' ' ' GLU . 10.3 p -85.49 13.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.875 0.694 . . . . 10.0 112.875 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -47.04 -40.89 15.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.789 0.292 . . . . 10.0 111.789 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.81 130.38 45.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.92 0.39 . . . . 10.0 111.088 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 173.39 42.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.826 -0.702 . . . . 10.0 112.489 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 10.0 111.023 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.779 0.323 . . . . 10.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 39.5 ttmt -85.92 44.9 1.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.279 -0.418 . . . . 10.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.7 m 67.68 -60.35 0.39 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.364 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.925 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.9 pp -63.37 -33.17 74.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.077 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.925 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -57.8 135.17 56.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.391 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -159.62 133.64 7.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.724 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.08 130.03 42.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.315 -0.402 . . . . 10.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.696 HD11 ' CB ' ' A' ' 110' ' ' ASP . 68.6 mt -92.57 44.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 10.0 111.402 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.685 ' HG2' ' HG3' ' A' ' 10' ' ' GLU . 56.8 tttm -97.1 -60.69 1.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.747 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.685 ' HG3' ' HG2' ' A' ' 9' ' ' LYS . 88.3 mt-10 -149.04 164.24 35.2 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.356 0.598 . . . . 10.0 110.33 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.64 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.8 t80 -156.6 138.8 14.64 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.014 -0.993 . . . . 10.0 112.531 -174.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.417 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 12.3 pt-20 -88.81 138.85 31.04 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.915 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -155.94 166.62 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.62 0.724 . . . . 10.0 112.937 -177.367 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.648 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 3.0 tm? -88.88 133.5 34.26 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.843 ' CB ' HD22 ' A' ' 102' ' ' LEU . 37.2 t -153.29 151.39 29.96 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 1.041 ' CE2' HG11 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -138.49 174.98 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.288 -1.324 . . . . 10.0 110.773 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -88.58 139.77 30.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.348 -0.982 . . . . 10.0 108.348 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.008 HG21 HD12 ' A' ' 71' ' ' ILE . 21.0 mm -146.97 76.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.828 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.587 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 1.1 m-20 58.12 51.83 8.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.943 0.402 . . . . 10.0 111.281 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 38.4 mt-10 85.88 -25.64 0.11 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.224 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -88.82 130.64 35.34 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 110.237 -0.283 . . . . 10.0 110.237 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.004 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.66 114.32 25.15 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.651 ' HB2' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -88.85 136.6 32.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.096 -177.216 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -143.18 142.29 31.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.255 0.55 . . . . 10.0 112.344 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.844 ' CD2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -131.4 138.35 49.07 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.235 -1.024 . . . . 10.0 108.235 178.396 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' OD1' ' CB ' ' A' ' 28' ' ' ASP . 9.6 t0 -49.15 120.76 4.21 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.628 -0.429 . . . . 10.0 110.817 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.915 HG13 ' HA ' ' A' ' 13' ' ' VAL . 19.1 m -57.98 -14.94 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.235 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' CB ' ' OD1' ' A' ' 26' ' ' ASP . 7.2 t70 -63.02 -36.2 82.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.162 0.505 . . . . 10.0 109.898 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.803 HD21 HG22 ' A' ' 86' ' ' THR . 15.8 t-20 -95.19 -45.89 7.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.506 -0.77 . . . . 10.0 111.362 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.645 HG21 ' HG ' ' A' ' 14' ' ' LEU . 23.3 mm -61.35 132.31 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 120.823 0.344 . . . . 10.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' O ' ' CE ' ' A' ' 32' ' ' MET . 50.5 mt-10 -87.95 -64.46 1.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.962 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.424 ' HB2' ' HE2' ' A' ' 32' ' ' MET . 6.4 tpp -169.07 173.03 7.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.39 . . . . 10.0 110.855 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.728 HG11 HG11 ' A' ' 98' ' ' VAL . 34.0 m -100.31 126.76 53.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.781 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.68 HG13 ' HB ' ' A' ' 81' ' ' ILE . 11.9 pt -103.88 155.45 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.124 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -88.79 -175.78 5.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.991 -0.549 . . . . 10.0 111.171 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.416 ' CE ' ' HB3' ' A' ' 79' ' ' LYS . 19.3 ptpt -88.68 141.15 28.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.025 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.4 p -175.41 168.81 3.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 10.0 110.661 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -46.51 141.13 3.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.757 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 52' ' ' VAL . 6.5 mt -155.25 155.81 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.391 0.615 . . . . 10.0 112.303 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.877 HG23 ' HG2' ' A' ' 43' ' ' PRO . 15.2 m -45.61 98.52 0.19 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 114.774 -1.103 . . . . 10.0 111.523 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -96.51 -54.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.28 2.653 . . . . 10.0 114.524 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.605 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 47.3 t -63.6 -50.43 72.4 Favored Pre-proline 0 N--CA 1.463 0.178 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.877 ' HG2' HG23 ' A' ' 40' ' ' THR . 78.0 Cg_exo -49.45 -59.0 1.4 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.084 1.856 . . . . 10.0 112.54 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 45' ' ' SER . 4.0 tmmm? 57.92 -78.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.025 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 46' ' ' ARG . 30.2 t 55.34 154.67 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.861 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.596 ' HB2' ' O ' ' A' ' 45' ' ' SER . 1.3 mpp_? 82.12 -29.78 0.1 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.942 -0.572 . . . . 10.0 112.095 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 90.6 m-70 68.74 50.4 0.65 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.008 0.432 . . . . 10.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.496 ' CE2' ' HB ' ' A' ' 68' ' ' ILE . 8.5 t80 -172.36 -43.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.846 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.926 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.7 t -70.2 128.83 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.518 -0.765 . . . . 10.0 111.12 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.508 ' HG3' HG23 ' A' ' 62' ' ' VAL . 15.7 pt-20 -69.64 -40.73 76.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.611 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.584 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -165.91 -175.95 36.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.551 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 39' ' ' ILE . 2.0 m -155.31 168.88 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.248 -0.278 . . . . 10.0 110.248 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.827 HD11 HD11 ' A' ' 60' ' ' ILE . 26.2 pt -154.48 144.14 13.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.766 0.317 . . . . 10.0 111.463 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -88.78 137.68 32.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.044 -0.525 . . . . 10.0 111.295 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.445 ' HG ' ' HG2' ' A' ' 56' ' ' ARG . 54.4 tp -169.12 136.7 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.557 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 56' ' ' ARG . 5.1 mmp_? 52.47 46.06 27.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.809 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.77 35.34 62.65 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.874 -0.603 . . . . 10.0 112.889 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -160.85 127.99 4.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 10.0 110.569 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.613 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.6 mp -89.05 124.37 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.109 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.016 HG22 ' HB2' ' A' ' 90' ' ' GLU . 29.1 pt -95.86 124.96 50.55 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.633 -0.258 . . . . 10.0 111.345 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.803 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 85.0 Cg_endo -82.54 115.91 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.507 2.138 . . . . 10.0 112.808 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.584 HG22 ' C ' ' A' ' 51' ' ' GLY . 23.1 m -88.98 133.39 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.168 -0.679 . . . . 10.0 109.168 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.926 HG22 ' HA ' ' A' ' 49' ' ' VAL . 59.5 t -145.17 157.79 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.799 0.809 . . . . 10.0 113.153 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.527 ' N ' HG12 ' A' ' 63' ' ' VAL . 5.2 m120 -78.15 66.71 3.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.391 -1.277 . . . . 10.0 108.698 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.791 ' O ' HD23 ' A' ' 65' ' ' LEU . 6.4 tt -53.88 -29.35 41.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.837 -0.62 . . . . 10.0 111.531 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.635 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -64.89 -25.84 68.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.54 -0.541 . . . . 10.0 109.54 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HE3' ' CE1' ' A' ' 48' ' ' PHE . 24.1 ttpt -77.91 -52.13 9.32 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.236 -0.893 . . . . 10.0 111.0 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.691 HG22 ' HA ' ' A' ' 65' ' ' LEU . 10.3 tt -53.82 -40.17 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.884 ' C ' HD13 ' A' ' 69' ' ' LEU . 1.1 tm? -75.72 -44.99 39.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.545 -1.661 . . . . 10.0 109.534 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.529 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 113.06 -95.65 0.78 Allowed Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.049 -0.523 . . . . 10.0 113.133 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.008 HD12 HG21 ' A' ' 18' ' ' ILE . 3.6 pt 48.66 164.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.097 0.777 . . . . 10.0 113.097 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.2 m -47.03 -36.81 8.39 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.158 -0.682 . . . . 10.0 109.158 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.885 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.0 t80 -26.09 140.09 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.791 -1.095 . . . . 10.0 112.808 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -160.31 34.66 0.17 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.248 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.521 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 50.4 mt-10 52.53 46.93 25.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.247 0.462 . . . . 10.0 112.247 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 77' ' ' LYS . 23.9 pt20 -97.87 -47.2 5.65 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.55 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 14.3 mmmm -108.96 -25.15 10.88 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.362 0.505 . . . . 10.0 112.362 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.64 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 3.2 mmm -35.94 144.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.724 0.409 . . . . 10.0 111.972 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 51.5 mtmt -160.7 -45.06 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.201 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.437 ' O ' HD12 ' A' ' 94' ' ' LEU . 74.5 m -88.86 142.86 27.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.994 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.68 ' HB ' HG13 ' A' ' 34' ' ' ILE . 73.6 mt -100.66 160.52 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.314 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.575 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 31.8 mt -123.63 158.74 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.591 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.512 ' N ' HG22 ' A' ' 82' ' ' ILE . 42.7 t -131.68 150.77 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.032 0.444 . . . . 10.0 111.222 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -156.15 171.78 19.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.896 -178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -128.24 129.05 45.82 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.803 HG22 HD21 ' A' ' 29' ' ' ASN . 67.1 p -145.51 108.27 4.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.879 0.325 . . . . 10.0 111.879 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 88' ' ' ASP . 14.9 tppt? 47.4 59.95 3.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.211 0.529 . . . . 10.0 110.269 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.492 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 2.4 p30 59.16 32.54 22.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.828 -1.078 . . . . 10.0 111.59 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.908 HG12 HG22 ' A' ' 91' ' ' VAL . 66.1 t -128.58 109.34 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 115.3 -0.864 . . . . 10.0 109.156 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 1.016 ' HB2' HG22 ' A' ' 60' ' ' ILE . 34.1 mt-10 -88.28 97.78 11.22 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.281 -1.748 . . . . 10.0 106.281 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.018 HG21 HD13 ' A' ' 142' ' ' ILE . 3.4 t -88.46 152.23 3.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 113.478 -1.692 . . . . 10.0 113.059 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.56 148.4 17.19 Favored Glycine 0 C--N 1.316 -0.547 0 CA-C-N 114.66 -1.155 . . . . 10.0 113.494 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.646 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -138.76 124.78 20.02 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.75 0.309 . . . . 10.0 110.45 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.566 HD13 HG12 ' A' ' 81' ' ' ILE . 54.7 tp -88.62 130.07 35.36 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.603 0.594 . . . . 10.0 112.603 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.041 HG11 ' CE2' ' A' ' 16' ' ' PHE . 34.2 m -143.55 -175.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 115.33 -0.85 . . . . 10.0 110.504 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 78' ' ' MET . 28.5 t70 -108.7 -62.96 1.39 Allowed 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 112.599 0.592 . . . . 10.0 112.599 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 16' ' ' PHE . 13.6 tpt180 -119.34 117.9 29.78 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.41 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.765 HG23 ' HD1' ' A' ' 16' ' ' PHE . 7.0 p -112.52 115.42 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 122.432 1.11 . . . . 10.0 111.502 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -65.84 -31.21 72.03 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 112.962 -1.926 . . . . 10.0 110.809 -178.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.55 -124.53 6.99 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.258 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.1 t -53.05 129.65 13.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.909 0.354 . . . . 10.0 110.129 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.843 HD22 ' CB ' ' A' ' 15' ' ' SER . 59.7 tp -132.68 138.9 47.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.994 0.426 . . . . 10.0 111.177 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.618 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -88.82 70.16 8.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.984 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.664 HG12 ' HG ' ' A' ' 102' ' ' LEU . 8.8 mm -88.94 130.87 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.656 HG22 ' HG2' ' A' ' 10' ' ' GLU . 32.0 p -88.75 -175.89 5.05 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.605 -1.257 . . . . 10.0 107.605 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.799 ' OE2' HD12 ' A' ' 109' ' ' LEU . 38.7 tt0 -147.9 73.03 1.25 Allowed 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 118.929 -1.108 . . . . 10.0 112.79 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -102.57 20.79 16.45 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.701 -1.136 . . . . 10.0 109.1 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.61 ' O ' HG23 ' A' ' 112' ' ' THR . 16.4 pt20 -125.05 -46.26 1.83 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.474 -0.784 . . . . 10.0 111.382 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.799 HD12 ' OE2' ' A' ' 106' ' ' GLU . 15.8 mt -69.66 -146.08 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.966 -0.383 . . . . 10.0 109.966 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.696 ' CB ' HD11 ' A' ' 8' ' ' LEU . 15.9 t70 70.9 -145.52 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.447 0.165 . . . . 10.0 111.447 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' H ' ' CG ' ' A' ' 110' ' ' ASP . 86.7 mt -68.77 -44.06 74.47 Favored 'General case' 0 CA--C 1.523 -0.078 0 N-CA-C 111.635 0.235 . . . . 10.0 111.635 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 108' ' ' GLN . 6.7 t -48.28 -32.22 7.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.069 0.461 . . . . 10.0 110.768 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 0.4 OUTLIER 44.75 54.85 6.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 10.0 112.167 179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.522 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 40.8 t -68.89 63.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.264 0.554 . . . . 10.0 110.078 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.592 ' HA ' ' HB2' ' A' ' 123' ' ' LYS . 45.6 t -66.96 -12.38 59.53 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.621 -0.718 . . . . 10.0 111.739 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.97 17.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.062 0.764 . . . . 10.0 113.062 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.674 ' HD2' ' HB3' ' A' ' 125' ' ' LEU . 73.0 mmtt -64.24 -86.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.824 0.305 . . . . 10.0 111.824 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.678 ' CE2' HD21 ' A' ' 69' ' ' LEU . 32.3 t80 -70.61 -59.04 3.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.011 0.434 . . . . 10.0 110.772 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.76 -137.73 7.15 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.564 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 120' ' ' LYS . 63.9 tttp -80.54 58.25 3.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.875 0.369 . . . . 10.0 110.934 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.597 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 16.2 tppt? -161.26 -40.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 10.0 110.804 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.408 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 88.0 p -163.52 -154.49 0.28 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.68 -0.859 . . . . 10.0 108.68 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -176.65 40.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.852 0.686 . . . . 10.0 112.852 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 135' ' ' TYR . . . -121.04 44.16 1.41 Allowed Glycine 0 C--O 1.223 -0.538 0 C-N-CA 119.899 -1.143 . . . . 10.0 112.571 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.781 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.1 tm? -62.98 130.17 43.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.781 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -144.1 163.14 14.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.589 -178.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.491 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 8.5 ptpp? -164.26 142.28 7.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.587 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 3.2 m -164.83 148.67 8.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.378 -0.374 . . . . 10.0 110.761 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' OD1' HG22 ' A' ' 128' ' ' THR . 1.0 OUTLIER 55.33 47.71 20.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.934 0.397 . . . . 10.0 111.019 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.81 33.56 43.03 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.997 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 128' ' ' THR . 6.5 ptt-85 -137.84 130.24 29.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.761 0.315 . . . . 10.0 110.251 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.1 mp -88.93 139.74 30.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.989 0.424 . . . . 10.0 111.183 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.004 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.7 mt -133.25 129.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.15 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.458 ' HB ' HD13 ' A' ' 23' ' ' LEU . 24.4 mm -88.92 120.74 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 108.606 -0.887 . . . . 10.0 108.606 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.9 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 52.9 t80 -121.38 148.51 44.28 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.239 -0.584 . . . . 10.0 110.363 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.846 HD23 HG21 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -161.01 148.12 15.25 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.505 0.669 . . . . 10.0 111.399 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.8 p-10 -95.87 32.43 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.4 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.865 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 19.7 tt 40.07 18.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.603 -1.18 . . . . 10.0 114.041 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 137' ' ' ASP . 38.4 t70 -79.73 -53.82 6.45 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.966 0.728 . . . . 10.0 112.966 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 121' ' ' LYS . 17.3 tppt? -77.77 -34.17 52.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.447 0.642 . . . . 10.0 110.438 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.865 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.52 -45.95 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.422 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.018 HD13 HG21 ' A' ' 91' ' ' VAL . 7.7 tp -64.48 -43.41 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.403 -0.519 . . . . 10.0 109.733 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.797 ' O ' HG12 ' A' ' 147' ' ' VAL . 44.4 tt0 -47.95 -41.16 24.24 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.117 -0.697 . . . . 10.0 109.117 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.458 ' HA ' HG12 ' A' ' 147' ' ' VAL . 50.7 mm-40 -70.73 -35.77 72.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.008 -0.996 . . . . 10.0 110.829 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.638 ' CD1' HG11 ' A' ' 91' ' ' VAL . 60.3 mt -55.18 -50.98 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.822 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.9 p -73.5 -53.34 10.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.975 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 143' ' ' GLU . 14.4 p -63.0 -17.81 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 10.0 111.791 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.506 ' HA ' ' HE2' ' A' ' 148' ' ' LYS . 0.1 OUTLIER -44.29 -48.73 9.56 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.779 0.323 . . . . 10.0 111.392 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -64.61 147.44 52.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.979 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -160.39 47.98 0.39 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 10.0 112.492 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.341 . . . . 10.0 110.961 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.776 0.322 . . . . 10.0 111.324 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -158.18 -114.17 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.367 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.6 p -157.37 -50.69 0.07 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.737 0.303 . . . . 10.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.944 HD12 ' N ' ' A' ' 5' ' ' ALA . 2.9 pp -59.13 -33.85 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.345 -0.389 . . . . 10.0 111.026 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.944 ' N ' HD12 ' A' ' 4' ' ' LEU . . . 54.38 62.65 2.47 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.247 0.462 . . . . 10.0 112.247 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 56.4 m-20 58.79 135.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.132 0.491 . . . . 10.0 111.667 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 6' ' ' ASP . . . 173.67 -69.56 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.965 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.7 mt 45.38 43.5 8.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.542 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 105' ' ' THR . 13.2 mmmm -82.21 -52.57 6.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.035 -0.53 . . . . 10.0 111.213 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.595 ' HG2' HG22 ' A' ' 105' ' ' THR . 41.4 mt-10 -140.49 164.17 30.85 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.331 0.586 . . . . 10.0 110.531 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.577 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.0 t80 -156.52 139.36 15.24 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.894 -1.048 . . . . 10.0 112.453 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 16.7 pt-20 -88.76 138.77 31.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.567 -0.901 . . . . 10.0 108.567 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.947 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -154.97 170.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 113.317 0.858 . . . . 10.0 113.317 -176.7 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.95 HD11 HD13 ' A' ' 82' ' ' ILE . 3.1 tm? -88.62 132.79 34.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.988 -1.116 . . . . 10.0 107.988 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.831 ' HB3' HD22 ' A' ' 102' ' ' LEU . 83.5 p -143.16 152.55 41.92 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.376 0.88 . . . . 10.0 113.376 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.728 ' CE1' HD11 ' A' ' 18' ' ' ILE . 15.1 p90 -150.83 162.8 40.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.47 -1.241 . . . . 10.0 109.908 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.52 ' HG3' HD21 ' A' ' 99' ' ' LEU . 95.7 mt-10 -88.45 139.81 30.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.037 HG21 HD12 ' A' ' 71' ' ' ILE . 35.5 mm -134.47 90.03 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.421 -0.809 . . . . 10.0 111.697 -177.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 47.5 m-20 44.62 60.17 3.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.373 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.2 mt-10 87.36 -42.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.196 -0.911 . . . . 10.0 112.093 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.0 pt20 -88.96 146.18 25.05 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.603 -0.439 . . . . 10.0 109.879 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.969 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.61 166.97 13.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 10.0 110.882 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.9 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.3 tp -152.17 140.2 20.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.325 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.763 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -145.89 151.12 37.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 -177.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.917 ' CD2' HD21 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -133.12 141.3 48.09 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.15 -0.932 . . . . 10.0 108.714 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 137' ' ' ASP . 12.6 p-10 -49.73 122.76 6.83 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.551 -0.46 . . . . 10.0 111.046 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.947 HG13 ' HA ' ' A' ' 13' ' ' VAL . 24.8 m -61.27 -13.85 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.015 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -64.61 -40.48 95.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.406 0.622 . . . . 10.0 109.531 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.748 HD21 HG22 ' A' ' 86' ' ' THR . 16.5 t-20 -87.81 -46.09 9.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.972 -1.013 . . . . 10.0 110.54 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.762 HG21 ' HG ' ' A' ' 14' ' ' LEU . 22.5 mm -65.85 132.3 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.541 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.411 ' O ' ' CE ' ' A' ' 32' ' ' MET . 53.5 mm-40 -82.64 -64.03 1.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.656 -0.247 . . . . 10.0 111.368 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.411 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.03 172.54 7.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 10.0 111.026 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.474 ' CG1' HG11 ' A' ' 98' ' ' VAL . 34.9 m -89.0 147.09 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.749 -0.659 . . . . 10.0 111.613 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.528 HD13 ' CG2' ' A' ' 83' ' ' VAL . 29.0 pt -145.83 129.86 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.558 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 50.1 mt-10 -98.43 124.7 43.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.489 -0.323 . . . . 10.0 111.118 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.865 ' HB2' HD12 ' A' ' 81' ' ' ILE . 62.7 mttp -160.42 -176.02 5.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.215 -0.448 . . . . 10.0 110.937 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.3 p -167.22 145.14 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.091 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 t70 48.82 45.01 22.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.304 0.573 . . . . 10.0 109.984 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.79 HD11 HD13 ' A' ' 81' ' ' ILE . 26.0 mt -49.81 -69.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.105 -0.952 . . . . 10.0 112.771 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.749 HG22 ' HG3' ' A' ' 43' ' ' PRO . 95.5 m -143.15 130.13 10.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.301 -0.409 . . . . 10.0 111.36 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -91.89 130.07 1.13 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.371 2.714 . . . . 10.0 113.366 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.807 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 40.1 t 58.53 43.19 0.87 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.346 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.807 ' HD3' ' N ' ' A' ' 42' ' ' VAL . 4.0 Cg_exo -79.83 3.28 7.71 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.648 2.232 . . . . 10.0 112.46 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 44' ' ' LYS . 2.7 mmmm -49.13 151.01 1.45 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.022 0.439 . . . . 10.0 112.06 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.3 t -174.2 68.25 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.853 -0.612 . . . . 10.0 111.773 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.5 ' O ' ' CG ' ' A' ' 47' ' ' HIS . 31.7 tpt85 66.97 46.53 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.049 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.5 ' CG ' ' O ' ' A' ' 46' ' ' ARG . 90.7 m-70 -163.07 -113.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.894 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.496 ' O ' ' CG ' ' A' ' 48' ' ' PHE . 16.2 t80 -173.8 36.79 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.157 0.503 . . . . 10.0 110.104 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.63 ' HA ' HG22 ' A' ' 63' ' ' VAL . 40.1 t -84.3 127.78 39.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.725 -0.67 . . . . 10.0 111.917 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.41 ' OE1' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -93.46 -24.29 18.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.583 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.795 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -152.86 165.04 30.99 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.804 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.604 HG12 HG11 ' A' ' 49' ' ' VAL . 1.9 m -151.11 163.64 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.287 0.543 . . . . 10.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.092 HD11 HD11 ' A' ' 60' ' ' ILE . 27.6 pt -160.22 146.26 5.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.137 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.446 HD22 HD11 ' A' ' 59' ' ' ILE . 23.4 t-20 -88.8 134.24 33.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.732 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.6 tp -169.05 143.05 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.662 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 78.0 ttt180 52.77 45.81 27.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.255 0.55 . . . . 10.0 110.493 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.4 38.09 61.68 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.755 -0.657 . . . . 10.0 112.746 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -169.06 139.06 2.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.824 0.345 . . . . 10.0 111.007 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.627 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.99 128.24 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.156 -0.474 . . . . 10.0 111.054 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.092 HD11 HD11 ' A' ' 53' ' ' ILE . 26.1 pt -98.69 139.92 21.43 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.432 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 77.6 Cg_endo -95.46 114.76 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.352 2.701 . . . . 10.0 112.712 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.795 HG22 ' C ' ' A' ' 51' ' ' GLY . 33.7 m -88.98 141.04 14.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.648 -0.251 . . . . 10.0 110.512 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.63 HG22 ' HA ' ' A' ' 49' ' ' VAL . 84.1 t -142.93 156.29 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.258 0.551 . . . . 10.0 111.694 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.589 ' O ' ' HD3' ' A' ' 67' ' ' LYS . 42.5 m-20 -77.26 61.39 2.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.951 0.882 . . . . 10.0 109.584 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.837 ' O ' HD23 ' A' ' 65' ' ' LEU . 7.5 tt -48.86 -26.34 2.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.776 . . . . 10.0 112.379 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.89 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -69.44 -26.34 64.55 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.993 -0.683 . . . . 10.0 111.301 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.658 ' HD3' ' H ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -87.42 -35.01 18.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.723 -0.391 . . . . 10.0 110.775 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.658 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 8.5 tt -57.84 -41.18 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.0 HD21 ' CE2' ' A' ' 118' ' ' PHE . 0.8 OUTLIER -79.36 -46.99 16.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.249 -1.796 . . . . 10.0 108.505 176.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 116.15 -85.17 0.39 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.173 -0.921 . . . . 10.0 112.656 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.037 HD12 HG21 ' A' ' 18' ' ' ILE . 3.0 pt 46.86 166.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 42.9 t -47.69 -34.72 8.56 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.857 ' HB3' HG13 ' A' ' 71' ' ' ILE . 14.6 t80 -31.37 143.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.877 -1.056 . . . . 10.0 112.932 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.95 41.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.722 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 57.37 38.05 28.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.108 -0.496 . . . . 10.0 111.228 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -90.28 -72.47 0.57 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.398 0.518 . . . . 10.0 112.398 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 78' ' ' MET . 0.1 OUTLIER -90.87 -20.73 21.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 10.0 112.204 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.452 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 20.9 mmt -21.13 138.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.087 0.773 . . . . 10.0 113.087 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -172.15 -38.96 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.492 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.718 ' O ' HD12 ' A' ' 94' ' ' LEU . 70.9 m -88.85 166.9 13.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.702 0.287 . . . . 10.0 110.997 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.865 HD12 ' HB2' ' A' ' 36' ' ' LYS . 85.5 mt -138.65 156.3 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.218 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.95 HD13 HD11 ' A' ' 14' ' ' LEU . 48.6 mt -132.78 158.23 43.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 121.081 0.467 . . . . 10.0 111.84 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.528 ' CG2' HD13 ' A' ' 34' ' ' ILE . 50.5 t -130.96 143.1 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.635 -0.712 . . . . 10.0 110.155 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.65 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -140.22 178.19 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.511 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.489 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 54.7 ttp180 -132.95 130.15 39.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.748 HG22 HD21 ' A' ' 29' ' ' ASN . 62.8 p -137.64 103.07 4.92 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.438 0.637 . . . . 10.0 111.832 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.6 tppp? 47.59 47.26 17.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.902 -1.045 . . . . 10.0 110.78 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 45.2 m-20 81.55 28.5 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.932 -1.031 . . . . 10.0 111.985 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.837 HG12 HG22 ' A' ' 91' ' ' VAL . 50.8 t -125.76 108.93 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.39 -0.823 . . . . 10.0 109.146 176.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.631 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 87.9 tt0 -88.24 99.49 12.26 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.869 HG21 HD13 ' A' ' 142' ' ' ILE . 2.7 t -88.66 157.71 3.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 113.338 -1.755 . . . . 10.0 112.653 -174.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -125.24 158.23 19.62 Favored Glycine 0 C--N 1.317 -0.487 0 CA-C-N 114.719 -1.128 . . . . 10.0 112.211 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.65 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.2 t80 -158.42 128.55 5.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.096 0.474 . . . . 10.0 112.082 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 80' ' ' SER . 63.2 tp -88.84 127.38 35.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.683 -0.69 . . . . 10.0 111.439 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.513 HG11 ' CZ ' ' A' ' 16' ' ' PHE . 32.5 m -135.34 -175.14 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.12 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.403 ' OD1' ' HG3' ' A' ' 77' ' ' LYS . 19.8 t70 -88.36 -79.64 0.3 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.167 0.508 . . . . 10.0 111.317 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -130.96 108.19 9.64 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.031 -0.729 . . . . 10.0 109.031 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.607 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.1 p -88.97 114.58 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.302 1.049 . . . . 10.0 111.58 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.71 -28.43 69.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.235 -1.802 . . . . 10.0 110.944 -178.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.1 -125.78 7.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.677 -0.773 . . . . 10.0 111.533 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -51.76 131.1 12.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.974 0.387 . . . . 10.0 110.499 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.831 HD22 ' HB3' ' A' ' 15' ' ' SER . 50.0 tp -134.92 138.51 44.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.952 0.406 . . . . 10.0 111.118 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.3 ptp85 -88.83 72.27 8.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.98 HD12 HG11 ' A' ' 126' ' ' VAL . 10.3 mm -88.95 130.17 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.598 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.595 HG22 ' HG2' ' A' ' 10' ' ' GLU . 16.3 p -88.64 149.66 23.42 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.454 -1.684 . . . . 10.0 106.454 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 109' ' ' LEU . 8.3 tp10 -134.57 80.73 1.87 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 114.088 1.144 . . . . 10.0 114.088 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -88.66 -6.81 57.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -76.28 -53.2 8.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.784 -1.098 . . . . 10.0 111.025 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 54.4 mt -68.8 45.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 10.0 112.324 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.753 ' O ' HG13 ' A' ' 114' ' ' VAL . 64.5 t0 -76.63 113.11 13.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 110' ' ' ASP . 84.2 mt 69.28 -47.13 0.58 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.58 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 112' ' ' THR . 8.6 t -176.74 67.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.716 0.293 . . . . 10.0 111.393 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 p-10 44.89 71.25 0.27 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.26 -0.427 . . . . 10.0 111.462 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 110' ' ' ASP . 34.6 m -78.17 41.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 112.419 0.526 . . . . 10.0 112.419 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 42.1 t 172.56 129.57 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.757 0.313 . . . . 10.0 110.703 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 118' ' ' PHE . 29.6 m-20 -73.0 -54.07 9.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.746 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 125' ' ' LEU . 74.1 mmtt 66.74 -55.91 0.42 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.088 -0.505 . . . . 10.0 111.949 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 1.0 ' CE2' HD21 ' A' ' 69' ' ' LEU . 6.1 t80 -137.77 36.91 2.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.442 0.639 . . . . 10.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.23 28.29 1.18 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 114.949 -1.023 . . . . 10.0 113.592 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -70.63 -34.45 72.1 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.517 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 16.6 tppt? -159.47 37.17 0.2 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.998 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.666 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 88.9 p -176.57 -144.12 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.736 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.513 ' HE3' ' HG2' ' A' ' 140' ' ' LYS . 95.5 mttt -160.94 26.2 0.14 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -149.62 154.37 25.69 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 119.242 -1.456 . . . . 10.0 113.75 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.905 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.2 tm? -159.63 139.58 11.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.98 HG11 HD12 ' A' ' 104' ' ' ILE . 1.4 p -150.46 161.03 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.373 0.606 . . . . 10.0 111.842 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -158.91 132.62 7.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.43 -0.805 . . . . 10.0 110.724 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.734 ' O ' ' HB2' ' A' ' 131' ' ' ARG . 8.9 m -164.27 140.74 6.38 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.062 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 131' ' ' ARG . 25.3 m-20 62.42 45.74 6.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.03 0.443 . . . . 10.0 110.201 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 56.03 25.12 45.33 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.433 -0.889 . . . . 10.0 110.961 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.734 ' HB2' ' O ' ' A' ' 128' ' ' THR . 99.5 mtt180 -107.89 120.86 43.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.435 -0.383 . . . . 10.0 111.471 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 21' ' ' GLN . 86.1 mt -89.07 82.92 6.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.969 HG12 ' HB3' ' A' ' 22' ' ' ALA . 2.4 mt -88.77 131.37 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.9 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.98 148.35 4.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 107.917 -1.142 . . . . 10.0 107.917 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.527 ' O ' ' CA ' ' A' ' 124' ' ' GLY . 35.7 t80 -141.16 151.89 44.23 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.028 -0.669 . . . . 10.0 111.457 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.917 HD21 ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -169.07 150.79 4.56 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 113.638 0.977 . . . . 10.0 113.638 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.404 ' HA ' ' OD1' ' A' ' 26' ' ' ASP . 55.0 p30 -99.33 32.92 2.59 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.604 -1.18 . . . . 10.0 109.716 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.904 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 16.2 tt 40.15 24.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.44 -1.255 . . . . 10.0 113.636 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -77.56 -60.41 2.38 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.017 0.747 . . . . 10.0 113.017 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.513 ' HG2' ' HE3' ' A' ' 123' ' ' LYS . 42.9 mmtm -74.28 -29.19 61.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.162 0.506 . . . . 10.0 111.08 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.904 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.35 -46.78 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.737 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.869 HD13 HG21 ' A' ' 91' ' ' VAL . 7.2 tp -63.34 -47.11 93.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 120.29 -0.564 . . . . 10.0 110.482 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 147' ' ' VAL . 50.4 mt-10 -50.97 -39.47 55.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.558 ' HB2' HD11 ' A' ' 68' ' ' ILE . 5.7 mm-40 -77.86 -27.08 49.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.358 -0.837 . . . . 10.0 111.061 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.695 ' CD1' HG11 ' A' ' 91' ' ' VAL . 37.5 mt -53.85 -49.28 59.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 121.064 0.459 . . . . 10.0 110.211 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 77.9 p -82.65 -45.84 14.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.767 -0.652 . . . . 10.0 111.364 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 143' ' ' GLU . 51.5 t -58.15 -30.55 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.239 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.449 ' HG2' ' CG ' ' A' ' 48' ' ' PHE . 27.7 tptp -38.86 -48.84 1.6 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 61.38 151.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 10.0 110.89 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -161.45 -42.72 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.741 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.893 0.378 . . . . 10.0 111.049 179.929 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.731 0.301 . . . . 10.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HE2' ' HB3' ' A' ' 5' ' ' ALA . 36.9 mtmm -59.58 -45.36 92.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.998 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 54.8 m 71.69 -49.38 0.69 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.67 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 5' ' ' ALA . 4.3 pp -65.41 -40.81 93.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 10.0 110.555 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.882 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -94.77 130.1 41.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.224 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' O ' HD22 ' A' ' 8' ' ' LEU . 1.5 m-20 -68.4 133.4 48.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.454 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.23 132.6 54.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.786 0.327 . . . . 10.0 111.533 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.545 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.0 mm? -87.33 47.94 1.58 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.288 -0.414 . . . . 10.0 111.208 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.78 ' HE3' ' HA ' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -153.84 -54.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.723 0.297 . . . . 10.0 110.585 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 33.5 mt-10 -139.4 164.14 30.64 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.337 -0.392 . . . . 10.0 109.988 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.56 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.5 t80 -164.78 139.67 5.37 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 113.265 0.839 . . . . 10.0 113.265 -174.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.423 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 3.0 mt-10 -88.67 135.03 33.71 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.294 -0.866 . . . . 10.0 109.16 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' A' ' 102' ' ' LEU . 1.2 p -152.36 169.35 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.823 0.675 . . . . 10.0 112.823 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.724 ' HG ' HG21 ' A' ' 30' ' ' ILE . 3.4 tm? -88.84 138.1 31.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.832 ' HB3' HD22 ' A' ' 102' ' ' LEU . 97.6 p -145.61 153.91 41.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 113.613 0.968 . . . . 10.0 113.613 -177.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -152.88 159.04 42.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.17 -1.377 . . . . 10.0 110.403 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.566 ' HG2' HD21 ' A' ' 99' ' ' LEU . 53.1 mm-40 -88.63 124.11 33.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.341 0.591 . . . . 10.0 109.968 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.109 HG21 HD12 ' A' ' 71' ' ' ILE . 22.9 mm -118.52 94.45 3.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.177 -0.92 . . . . 10.0 110.865 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 30.8 m-20 44.05 60.13 2.88 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.827 0.677 . . . . 10.0 112.827 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 48.2 mt-10 88.54 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.49 -0.777 . . . . 10.0 112.607 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.682 ' NE2' HD13 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -88.84 152.96 21.44 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.438 -0.505 . . . . 10.0 110.278 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.997 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -89.03 155.52 19.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.807 0.336 . . . . 10.0 110.875 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.831 HD12 ' N ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -141.35 133.96 28.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.469 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.831 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -140.18 153.29 46.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.91 0.707 . . . . 10.0 112.91 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.942 ' CE2' HD22 ' A' ' 136' ' ' LEU . 2.8 m-85 -138.08 144.89 41.13 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -43.53 100.49 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.425 0.631 . . . . 10.0 110.447 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.615 HG12 ' HA ' ' A' ' 13' ' ' VAL . 3.5 p -46.84 -19.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.021 -0.991 . . . . 10.0 111.137 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.62 -43.68 88.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.121 0.486 . . . . 10.0 109.75 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.678 ' CG ' HG21 ' A' ' 138' ' ' ILE . 18.0 t-20 -78.46 -43.27 27.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.485 -0.78 . . . . 10.0 110.607 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.724 HG21 ' HG ' ' A' ' 14' ' ' LEU . 13.0 mm -63.83 125.41 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.32 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.607 ' O ' ' HG3' ' A' ' 32' ' ' MET . 4.6 mm-40 -84.24 -76.6 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.764 0.283 . . . . 10.0 111.764 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.607 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 5.0 mtm -157.34 150.69 23.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.193 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.858 HG11 HG11 ' A' ' 98' ' ' VAL . 34.5 m -88.9 128.03 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.391 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.404 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 29.9 pt -100.38 179.48 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 10.0 111.29 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -88.91 150.87 22.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.119 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -88.83 134.98 33.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.16 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t 178.29 -174.22 0.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.903 -0.589 . . . . 10.0 110.58 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.32 144.18 25.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 10.0 110.547 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.494 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 21.4 mt -155.61 -70.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.584 0.586 . . . . 10.0 112.584 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.858 HG23 ' HG2' ' A' ' 43' ' ' PRO . 99.2 m -145.86 66.43 11.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.474 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.75 -50.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.946 2.43 . . . . 10.0 112.985 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 60.0 t -78.29 -53.93 1.28 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.804 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.858 ' HG2' HG23 ' A' ' 40' ' ' THR . 19.1 Cg_endo -60.82 -12.48 22.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.176 1.918 . . . . 10.0 112.941 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -41.62 158.36 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.886 0.374 . . . . 10.0 110.951 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.6 t -178.98 66.53 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.809 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 39.3 mmt180 -152.24 -33.29 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.925 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 19.8 m80 69.45 46.47 0.74 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.274 0.559 . . . . 10.0 110.653 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.539 ' CE2' ' HE3' ' A' ' 67' ' ' LYS . 2.0 t80 -179.94 -41.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.389 -0.823 . . . . 10.0 108.915 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.886 ' HA ' HG22 ' A' ' 63' ' ' VAL . 55.2 t -73.78 129.26 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.14 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' A' ' 62' ' ' VAL . 17.0 pt-20 -71.86 -40.04 69.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.583 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 62' ' ' VAL . . . -169.06 -175.92 38.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.753 -0.737 . . . . 10.0 112.63 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 53' ' ' ILE . 3.5 m -158.93 172.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.691 0.282 . . . . 10.0 110.283 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 52' ' ' VAL . 30.7 pt -161.33 144.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.813 0.34 . . . . 10.0 111.344 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.572 ' ND2' HD11 ' A' ' 59' ' ' ILE . 25.6 t-20 -88.71 137.64 32.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.894 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.4 tp -169.07 140.09 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 49.07 46.92 22.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.264 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.37 40.32 76.14 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.912 -0.661 . . . . 10.0 112.729 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.8 tpt85 -168.92 128.06 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.686 0.279 . . . . 10.0 110.366 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.654 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -88.99 123.68 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.236 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.782 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.2 pp -89.18 134.34 33.31 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 116.563 -0.29 . . . . 10.0 110.788 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 60' ' ' ILE . 66.0 Cg_endo -98.15 117.72 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.203 2.602 . . . . 10.0 113.634 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 49' ' ' VAL . 18.5 m -97.12 133.64 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 109.084 -0.71 . . . . 10.0 109.084 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.886 HG22 ' HA ' ' A' ' 49' ' ' VAL . 68.0 t -141.3 159.9 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.783 0.801 . . . . 10.0 113.079 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.779 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.4 m120 -76.61 66.9 2.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.819 -1.082 . . . . 10.0 109.052 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.932 ' O ' HD23 ' A' ' 65' ' ' LEU . 6.3 tt -50.05 -26.46 4.4 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.705 -0.68 . . . . 10.0 111.404 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.656 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -64.91 -27.71 69.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.671 -0.412 . . . . 10.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.779 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -88.4 -36.92 16.27 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.015 -0.365 . . . . 10.0 110.015 178.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.741 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 8.5 tt -61.18 -37.7 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.942 HD11 HG23 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -77.88 -40.51 39.75 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 113.278 -1.783 . . . . 10.0 109.598 177.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.577 ' C ' HG12 ' A' ' 71' ' ' ILE . . . 112.3 -102.54 1.36 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 116.07 -0.514 . . . . 10.0 112.961 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.109 HD12 HG21 ' A' ' 18' ' ' ILE . 6.5 pt 45.98 -179.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 113.088 0.773 . . . . 10.0 113.088 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.653 ' O ' ' O ' ' A' ' 73' ' ' PHE . 72.1 m -57.52 -98.6 0.0 OUTLIER 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.62 -1.622 . . . . 10.0 106.62 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.663 ' HE2' ' N ' ' A' ' 67' ' ' LYS . 1.4 t80 50.65 138.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 119.22 -0.992 . . . . 10.0 113.357 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -159.55 27.39 0.19 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.71 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 66.89 -48.63 0.47 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.13 0.789 . . . . 10.0 113.13 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -38.89 -42.49 0.85 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -79.5 -39.7 31.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.947 0.404 . . . . 10.0 111.395 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.529 ' HG3' ' HA ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -47.33 135.21 10.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.902 0.705 . . . . 10.0 112.902 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 78' ' ' MET . 36.7 mtmm -164.43 32.57 0.07 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.91 -1.041 . . . . 10.0 109.624 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.584 ' O ' HD12 ' A' ' 94' ' ' LEU . 38.7 t -169.12 151.25 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.274 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.404 ' HB ' ' CG1' ' A' ' 34' ' ' ILE . 65.5 mt -120.16 143.08 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.998 0.427 . . . . 10.0 111.985 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.6 HD13 HD11 ' A' ' 14' ' ' LEU . 4.2 mt -111.67 123.48 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.971 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.9 t -92.86 148.13 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.973 0.416 . . . . 10.0 111.008 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -143.91 -175.87 4.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.69 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.803 ' O ' HG23 ' A' ' 86' ' ' THR . 15.3 tpp85 -133.3 160.84 36.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.381 -0.6 . . . . 10.0 109.381 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 85' ' ' ARG . 18.9 p -169.06 100.0 0.37 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.293 0.568 . . . . 10.0 112.018 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.482 ' CE ' ' HA ' ' A' ' 87' ' ' LYS . 2.2 tpmt? 43.99 46.41 6.92 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.002 -0.999 . . . . 10.0 110.55 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 11.6 m-20 82.8 31.96 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.69 -1.141 . . . . 10.0 111.713 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.88 HG12 HG22 ' A' ' 91' ' ' VAL . 44.4 t -130.03 112.12 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.26 -0.882 . . . . 10.0 109.261 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 12.2 mt-10 -88.36 99.91 12.61 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.176 -1.787 . . . . 10.0 106.176 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.976 HG21 HD13 ' A' ' 142' ' ' ILE . 2.6 t -88.77 159.54 2.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 113.91 -1.495 . . . . 10.0 112.106 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.47 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -127.89 154.22 19.67 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.546 -0.835 . . . . 10.0 113.415 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -144.62 128.64 17.54 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 120.722 0.296 . . . . 10.0 110.71 -179.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 80' ' ' SER . 65.1 tp -88.67 134.39 33.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.228 0.537 . . . . 10.0 111.698 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' A' ' 16' ' ' PHE . 35.6 m -147.93 -175.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.936 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -105.11 -65.2 1.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.317 0.488 . . . . 10.0 112.317 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -130.65 120.36 23.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.754 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.858 HG11 HG11 ' A' ' 33' ' ' VAL . 9.5 p -108.1 115.06 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-O 122.245 1.022 . . . . 10.0 111.621 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.566 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -64.95 -29.94 70.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.272 -1.786 . . . . 10.0 111.114 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 91.89 -124.43 7.65 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.646 -0.787 . . . . 10.0 111.321 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.43 134.1 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 117.01 0.405 . . . . 10.0 110.549 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.832 HD22 ' HB3' ' A' ' 15' ' ' SER . 59.8 tp -135.7 139.92 44.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.199 0.523 . . . . 10.0 111.178 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 27.1 ptt180 -88.91 71.63 8.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.67 -0.696 . . . . 10.0 110.407 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.004 HD12 HG21 ' A' ' 126' ' ' VAL . 17.8 mm -88.75 133.14 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 18.2 p -88.84 -175.94 5.04 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.395 -0.965 . . . . 10.0 108.395 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.737 ' OE1' HD12 ' A' ' 109' ' ' LEU . 37.9 tt0 -147.31 77.4 1.44 Allowed 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.128 -1.029 . . . . 10.0 112.808 -177.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -102.02 17.59 22.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.665 -1.152 . . . . 10.0 109.23 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 114' ' ' VAL . 17.9 pt20 -118.48 -49.26 2.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.574 -0.739 . . . . 10.0 111.133 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.81 HD13 ' OD1' ' A' ' 113' ' ' ASN . 27.9 mt -63.16 141.12 58.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.616 -0.266 . . . . 10.0 110.335 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 65.0 t0 -165.52 134.21 3.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.625 -0.261 . . . . 10.0 110.658 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 110' ' ' ASP . 79.9 mt 70.63 -49.16 0.66 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.3 -0.409 . . . . 10.0 111.001 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.1 t -176.11 46.35 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.164 0.507 . . . . 10.0 110.126 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.81 ' OD1' HD13 ' A' ' 109' ' ' LEU . 65.9 m-20 66.4 124.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.633 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 115' ' ' SER . 46.5 t -72.75 -50.38 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.885 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 66.3 m 71.89 40.7 0.73 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.152 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 1.8 m-20 -146.59 92.88 2.21 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.721 -0.672 . . . . 10.0 111.395 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.578 ' HB2' ' CA ' ' A' ' 124' ' ' GLY . 32.8 mmtp -159.96 -46.12 0.05 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.687 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.669 ' CE1' HD21 ' A' ' 69' ' ' LEU . 39.7 t80 -67.22 -53.42 30.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.193 0.521 . . . . 10.0 110.315 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 143.92 45.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.821 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 62.31 52.34 3.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.055 0.455 . . . . 10.0 110.314 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.406 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 4.1 tppp? -141.56 -35.75 0.45 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 10.0 111.369 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.727 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 97.2 p -147.63 -159.95 1.1 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.764 -0.198 . . . . 10.0 110.514 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.568 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 2.0 tpmt? -64.64 -52.76 55.69 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.719 -0.392 . . . . 10.0 110.723 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' CA ' ' HB2' ' A' ' 117' ' ' LYS . . . 155.91 153.93 6.77 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.111 -1.519 . . . . 10.0 114.927 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.87 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.8 tm? -68.95 140.35 55.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.051 -0.575 . . . . 10.0 109.912 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 1.004 HG21 HD12 ' A' ' 104' ' ' ILE . 2.4 p -123.48 152.77 28.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.707 0.765 . . . . 10.0 112.111 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -141.41 135.53 30.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.638 ' O ' ' HB2' ' A' ' 131' ' ' ARG . 8.5 m -164.11 137.79 5.41 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.167 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 65.6 t0 60.78 41.99 14.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.89 0.376 . . . . 10.0 110.459 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.24 30.87 55.9 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.754 -0.938 . . . . 10.0 110.754 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.638 ' HB2' ' O ' ' A' ' 128' ' ' THR . 37.5 mmt180 -117.17 133.46 55.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.263 -0.469 . . . . 10.0 111.024 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.662 HD12 HD11 ' A' ' 125' ' ' LEU . 57.1 tp -88.91 79.55 7.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.11 -0.496 . . . . 10.0 110.143 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.997 HG12 ' HB3' ' A' ' 22' ' ' ALA . 4.0 mt -88.99 148.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 10.0 111.828 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.804 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -103.32 129.27 55.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 N-CA-C 108.69 -0.856 . . . . 10.0 108.69 177.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.663 ' C ' HD12 ' A' ' 136' ' ' LEU . 40.5 t80 -117.09 144.51 44.59 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.02 -0.672 . . . . 10.0 111.615 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.942 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.5 mp -137.61 169.06 18.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.18 -0.918 . . . . 10.0 111.852 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.565 ' HB2' ' HD2' ' A' ' 123' ' ' LYS . 34.0 t70 -136.58 21.76 3.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.705 -1.134 . . . . 10.0 108.34 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.9 ' HA ' HG23 ' A' ' 141' ' ' ILE . 13.0 tt 43.76 17.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.173 -1.376 . . . . 10.0 113.824 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 142' ' ' ILE . 8.6 t0 -81.48 -59.11 2.74 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.627 0.603 . . . . 10.0 112.627 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.2 mptt -76.55 -34.18 58.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.613 0.721 . . . . 10.0 109.895 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.9 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.27 -46.0 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.835 -1.075 . . . . 10.0 110.63 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.976 HD13 HG21 ' A' ' 91' ' ' VAL . 7.5 tp -62.89 -43.2 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 120.254 -0.578 . . . . 10.0 109.725 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.642 ' O ' HG12 ' A' ' 147' ' ' VAL . 4.5 tp10 -47.11 -46.47 23.0 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.658 ' HB2' HD11 ' A' ' 68' ' ' ILE . 48.5 mt-10 -65.03 -36.89 85.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.25 -0.887 . . . . 10.0 110.298 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.659 ' CD1' HG11 ' A' ' 91' ' ' VAL . 23.3 mt -54.71 -41.12 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 120.896 0.379 . . . . 10.0 110.948 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.7 p -80.44 -50.3 10.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.636 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 143' ' ' GLU . 12.6 p -78.78 9.24 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.458 ' HD2' ' CB ' ' A' ' 48' ' ' PHE . 22.8 ttpp -46.92 -47.6 21.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.596 0.236 . . . . 10.0 111.613 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 62.61 141.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.874 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -170.33 48.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.656 -0.783 . . . . 10.0 112.526 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.792 0.33 . . . . 10.0 111.042 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ttt . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 110.333 -0.247 . . . . 10.0 110.333 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 3' ' ' THR . 31.6 mmmt -68.38 -47.39 67.5 Favored 'General case' 0 C--N 1.334 -0.087 0 O-C-N 122.184 -0.322 . . . . 10.0 111.166 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.826 HG22 ' O ' ' A' ' 2' ' ' LYS . 14.3 t 60.83 -39.92 0.1 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.636 0.774 . . . . 10.0 113.014 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.5 pp -58.52 -32.1 68.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.38 . . . . 10.0 110.767 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.945 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -64.61 138.91 58.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.084 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 12.2 p-10 -169.78 128.66 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 10.0 111.03 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 6' ' ' ASP . . . 169.41 140.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.748 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.711 HD13 ' HB2' ' A' ' 111' ' ' LEU . 30.7 mt 62.79 54.48 2.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.102 0.477 . . . . 10.0 111.329 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.535 ' HD2' ' HG3' ' A' ' 10' ' ' GLU . 6.3 tmtm? -136.71 -47.02 0.6 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.508 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.624 ' HG2' HG22 ' A' ' 105' ' ' THR . 45.5 mt-10 -140.71 164.25 30.69 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.004 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 9.9 t80 -160.11 139.49 11.0 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.567 -0.742 . . . . 10.0 112.789 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.526 ' OE2' HG12 ' A' ' 101' ' ' VAL . 23.5 tp10 -88.68 133.99 34.04 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.917 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.6 p -152.93 166.94 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 113.967 1.099 . . . . 10.0 113.967 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.636 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.2 tm? -88.94 134.54 33.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.158 -0.928 . . . . 10.0 108.657 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.784 ' CB ' HD22 ' A' ' 102' ' ' LEU . 40.5 t -148.56 158.04 43.86 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.772 0.796 . . . . 10.0 112.687 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.785 ' CE2' HG11 ' A' ' 95' ' ' VAL . 0.4 OUTLIER -148.35 165.61 30.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.182 -1.372 . . . . 10.0 110.411 -178.648 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.588 ' HG3' HD21 ' A' ' 99' ' ' LEU . 56.6 mt-10 -88.65 133.22 34.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.07 HG21 HD12 ' A' ' 71' ' ' ILE . 35.0 mm -132.06 95.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.437 -177.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 26.8 m-20 42.45 60.18 2.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.676 -0.693 . . . . 10.0 112.525 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.1 mt-10 85.72 -44.77 0.06 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.39 -0.823 . . . . 10.0 111.621 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -89.03 145.36 25.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.993 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.58 168.14 12.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.986 0.422 . . . . 10.0 111.089 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.751 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.9 OUTLIER -147.11 135.04 21.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.586 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.695 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -137.56 152.91 49.94 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.999 0.741 . . . . 10.0 112.999 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.61 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.2 m-85 -135.16 142.76 46.2 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.146 -0.934 . . . . 10.0 108.814 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' HZ ' ' A' ' 11' ' ' PHE . 12.7 p-10 -52.43 122.05 8.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.271 0.558 . . . . 10.0 111.328 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.917 HG13 ' HA ' ' A' ' 13' ' ' VAL . 27.2 m -61.27 -14.7 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.44 -0.8 . . . . 10.0 110.653 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.43 -44.51 94.35 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.184 0.516 . . . . 10.0 109.829 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.697 HD21 HG22 ' A' ' 86' ' ' THR . 21.7 t-20 -89.57 -42.52 11.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 10.0 110.566 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.636 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.8 mm -62.45 130.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.865 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 32' ' ' MET . 52.0 mm-40 -85.79 -68.97 0.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.33 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.6 mtm -169.21 156.02 6.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.148 0.499 . . . . 10.0 111.609 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.773 HG11 HG11 ' A' ' 98' ' ' VAL . 34.6 m -88.88 159.1 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.567 -0.742 . . . . 10.0 111.304 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.442 HG13 ' HB ' ' A' ' 81' ' ' ILE . 23.1 pt -151.55 162.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.963 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -88.83 146.58 24.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.174 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HA ' HD11 ' A' ' 81' ' ' ILE . 27.8 tptp -88.9 130.32 35.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.297 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.7 t 177.29 136.15 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.64 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t0 45.8 70.49 0.36 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 10.0 110.99 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.559 HD13 ' CG2' ' A' ' 53' ' ' ILE . 14.0 mt -141.51 158.1 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.475 0.655 . . . . 10.0 112.528 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.534 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 82.2 m -38.69 117.85 1.03 Allowed Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 114.624 -1.171 . . . . 10.0 111.55 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 40' ' ' THR . 16.0 Cg_exo -68.47 -65.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.625 2.217 . . . . 10.0 112.865 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.575 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 10.4 p -176.19 56.22 0.13 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.411 -0.359 . . . . 10.0 111.621 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 42' ' ' VAL . 8.6 Cg_exo -71.76 -34.07 9.41 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.93 2.42 . . . . 10.0 111.861 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 45' ' ' SER . 0.0 OUTLIER 62.3 -136.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.241 -0.652 . . . . 10.0 109.241 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 42.7 t 65.83 48.0 1.95 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.856 0.36 . . . . 10.0 110.969 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' ND1' ' A' ' 47' ' ' HIS . 16.1 tpp85 -170.93 -70.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.842 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.46 ' ND1' ' O ' ' A' ' 46' ' ' ARG . 41.7 m80 -155.95 -172.14 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 10.0 110.797 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 48' ' ' PHE . 45.8 t80 -68.83 60.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.751 -0.659 . . . . 10.0 111.065 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.767 ' HA ' HG22 ' A' ' 63' ' ' VAL . 38.4 t -128.43 128.56 68.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 10.0 111.19 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 9.8 pt-20 -75.77 -38.54 58.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.571 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.744 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -144.22 -177.04 18.78 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 120.183 -1.008 . . . . 10.0 113.095 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.534 ' H ' ' HB ' ' A' ' 40' ' ' THR . 3.4 m -160.08 175.32 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 53' ' ' ILE . 2.2 pp -155.94 137.72 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 10.0 111.251 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.459 ' ND2' HD11 ' A' ' 59' ' ' ILE . 25.7 t-20 -88.97 135.1 33.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.663 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 54' ' ' ASN . 83.1 mt -161.68 135.74 6.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.294 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 55' ' ' LEU . 16.3 ptm180 45.84 46.87 12.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.196 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.33 41.4 87.32 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.96 -0.638 . . . . 10.0 112.886 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -158.88 124.0 4.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.838 0.351 . . . . 10.0 110.552 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.631 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -93.94 132.91 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.148 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.786 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.4 pp -111.12 136.95 20.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.407 -0.361 . . . . 10.0 110.839 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.583 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 89.0 Cg_endo -82.95 119.61 2.89 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.678 2.252 . . . . 10.0 113.483 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.744 HG22 ' C ' ' A' ' 51' ' ' GLY . 35.9 m -95.75 138.51 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.767 HG22 ' HA ' ' A' ' 49' ' ' VAL . 94.5 t -139.88 151.44 22.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.715 0.769 . . . . 10.0 112.581 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -78.57 67.44 4.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.688 -1.142 . . . . 10.0 109.668 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.824 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.3 tt -52.78 -38.56 61.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.305 -0.861 . . . . 10.0 111.2 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.76 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -53.34 -24.29 11.62 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.314 -0.554 . . . . 10.0 109.711 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.573 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -85.51 -48.37 9.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.784 -0.643 . . . . 10.0 110.307 178.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.781 HG22 ' HA ' ' A' ' 65' ' ' LEU . 8.2 tt -54.42 -38.85 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 107.867 -1.16 . . . . 10.0 107.867 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.904 ' C ' HD13 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -79.65 -51.05 9.74 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 113.52 -1.673 . . . . 10.0 109.684 177.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 118.64 -86.38 0.4 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.879 -0.601 . . . . 10.0 112.508 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.07 HD12 HG21 ' A' ' 18' ' ' ILE . 3.5 pt 46.55 165.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 113.115 0.783 . . . . 10.0 113.115 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.5 m -47.8 -35.26 9.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.919 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.7 t80 -27.63 140.56 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.757 -1.11 . . . . 10.0 112.578 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 8.8 t70 -143.99 30.45 1.3 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.154 0.502 . . . . 10.0 110.815 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HA ' ' CE1' ' A' ' 73' ' ' PHE . 49.0 mt-10 66.69 -51.57 0.45 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.15 0.796 . . . . 10.0 113.15 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -44.84 -42.78 8.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.274 0.842 . . . . 10.0 113.274 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.536 ' HB3' ' NZ ' ' A' ' 77' ' ' LYS . 6.3 mtpm? -81.53 10.63 5.57 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.441 0.904 . . . . 10.0 113.441 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.438 ' CE ' ' CE1' ' A' ' 73' ' ' PHE . 33.8 mmt -68.11 145.4 54.43 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.205 -0.309 . . . . 10.0 111.005 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 54.9 mtpt -158.84 -50.43 0.06 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.654 0.264 . . . . 10.0 111.634 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.631 ' O ' HD12 ' A' ' 94' ' ' LEU . 47.5 t -88.88 -176.03 5.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 10.0 111.615 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.519 HG22 ' N ' ' A' ' 82' ' ' ILE . 47.0 mt -145.38 159.24 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.87 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 13.2 mt -136.62 141.33 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 84' ' ' ALA . 61.5 t -117.79 153.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.583 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -158.51 176.86 11.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.309 -0.405 . . . . 10.0 111.267 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -134.64 135.3 42.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.841 178.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.697 HG22 HD21 ' A' ' 29' ' ' ASN . 72.9 p -148.99 110.83 4.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 21.9 ttmm 47.31 48.52 16.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.346 0.593 . . . . 10.0 110.949 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 72.39 33.21 1.5 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.094 -0.957 . . . . 10.0 111.461 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.912 HG12 HG22 ' A' ' 91' ' ' VAL . 57.5 t -130.19 111.04 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.199 -0.91 . . . . 10.0 109.097 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.686 ' HB2' HG22 ' A' ' 60' ' ' ILE . 66.4 mt-10 -88.38 97.75 11.23 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 106.177 -1.786 . . . . 10.0 106.177 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.005 HG21 HD13 ' A' ' 142' ' ' ILE . 3.9 t -88.75 153.87 3.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 113.334 -1.757 . . . . 10.0 113.234 -174.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -128.74 143.5 14.51 Favored Glycine 0 C--N 1.316 -0.577 0 CA-C-N 114.586 -1.188 . . . . 10.0 113.044 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.6 OUTLIER -131.61 125.55 32.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.811 0.338 . . . . 10.0 110.24 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 80' ' ' SER . 40.1 tp -88.6 130.88 35.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.023 0.44 . . . . 10.0 110.835 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.785 HG11 ' CE2' ' A' ' 16' ' ' PHE . 28.1 m -137.01 -175.09 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.964 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 59.7 t0 -89.01 -76.6 0.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.29 0.567 . . . . 10.0 110.998 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -131.75 113.22 13.28 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.115 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.773 HG11 HG11 ' A' ' 33' ' ' VAL . 9.9 p -95.88 115.85 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 122.408 1.099 . . . . 10.0 111.772 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.588 HD21 ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -68.1 -28.24 67.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.044 -1.889 . . . . 10.0 111.043 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.92 -123.24 6.88 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.633 -0.794 . . . . 10.0 111.824 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.526 HG12 ' OE2' ' A' ' 12' ' ' GLU . 34.9 m -51.07 133.05 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.799 0.3 . . . . 10.0 111.03 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.784 HD22 ' CB ' ' A' ' 15' ' ' SER . 57.4 tp -137.77 139.79 40.24 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.08 0.467 . . . . 10.0 111.211 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 16.2 ptm180 -88.84 73.6 8.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.592 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.784 ' CG1' HG11 ' A' ' 13' ' ' VAL . 16.4 mm -88.79 165.28 2.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.624 HG22 ' HG2' ' A' ' 10' ' ' GLU . 25.4 p -124.61 -176.0 3.42 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.764 -1.199 . . . . 10.0 107.764 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.538 ' HG3' ' HB2' ' A' ' 109' ' ' LEU . 87.7 tt0 -137.04 67.05 1.45 Allowed 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.258 -0.977 . . . . 10.0 112.045 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -104.8 26.11 9.56 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.462 -1.245 . . . . 10.0 109.035 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.416 ' HB2' ' HD2' ' A' ' 117' ' ' LYS . 0.1 OUTLIER -154.99 -30.82 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 -178.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.593 HD21 ' HD2' ' A' ' 135' ' ' TYR . 43.7 mt -63.2 -47.49 82.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.003 0.372 . . . . 10.0 112.003 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 111' ' ' LEU . 23.0 t70 -158.48 -131.38 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.946 -0.301 . . . . 10.0 111.122 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.711 ' HB2' HD13 ' A' ' 8' ' ' LEU . 24.9 tp 70.41 -46.44 0.62 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.96 0.345 . . . . 10.0 111.609 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.544 HG22 ' HG ' ' A' ' 111' ' ' LEU . 8.2 t 178.99 -33.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.253 0.549 . . . . 10.0 110.327 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -57.06 -76.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.446 -0.797 . . . . 10.0 111.18 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.8 t 60.35 111.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.148 0.499 . . . . 10.0 110.777 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.7 t -176.61 140.1 0.34 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.059 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.446 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 11.0 p-10 -53.95 -39.33 65.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.97 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER 69.99 -59.29 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.217 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.665 ' CE2' HD21 ' A' ' 69' ' ' LEU . 51.6 t80 -71.8 -51.56 21.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.053 0.454 . . . . 10.0 110.159 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 120' ' ' LYS . . . 166.45 -49.36 0.26 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.604 -0.725 . . . . 10.0 112.012 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER 171.97 -33.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.044 0.45 . . . . 10.0 110.405 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -54.89 -46.45 74.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.754 -0.657 . . . . 10.0 111.257 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.523 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 80.9 p -116.13 -128.63 0.29 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.864 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.446 ' HD2' ' HA ' ' A' ' 116' ' ' ASP . 59.5 tptt -173.08 -35.72 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.728 0.64 . . . . 10.0 112.728 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -85.94 148.84 22.74 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.132 -1.033 . . . . 10.0 113.895 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.928 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.4 tm? -161.23 142.38 11.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.004 -0.739 . . . . 10.0 109.004 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.928 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -160.37 164.46 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.051 0.453 . . . . 10.0 111.667 -177.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 22.2 pttp -163.65 133.92 4.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.546 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.591 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 14.0 m -167.09 156.43 10.55 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.369 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.4 ' N ' ' CG2' ' A' ' 128' ' ' THR . 62.7 m-20 59.94 45.76 11.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.967 0.413 . . . . 10.0 110.84 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.0 28.23 11.97 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.615 -0.802 . . . . 10.0 111.914 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 128' ' ' THR . 14.8 ptt180 -139.33 132.82 30.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 132' ' ' LEU . 3.9 mp -88.82 136.68 32.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.937 0.399 . . . . 10.0 111.546 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.993 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.6 mt -126.52 129.56 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.936 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.751 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.82 141.36 14.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 N-CA-C 108.934 -0.765 . . . . 10.0 108.934 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.593 ' HD2' HD21 ' A' ' 109' ' ' LEU . 42.3 t80 -124.8 146.2 49.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.28 0.562 . . . . 10.0 111.325 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.644 HD13 HG21 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -144.39 141.08 29.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.761 0.652 . . . . 10.0 112.761 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 139' ' ' ASP . 55.6 p30 -105.8 25.37 10.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.228 -0.896 . . . . 10.0 108.896 177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.919 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 15.3 tt 41.19 16.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 114.346 1.239 . . . . 10.0 114.346 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 38.2 t70 -79.69 -61.21 2.07 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.085 0.772 . . . . 10.0 113.085 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -74.91 -30.54 61.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.535 0.684 . . . . 10.0 110.567 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.919 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.25 -48.4 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.972 -1.013 . . . . 10.0 110.606 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.005 HD13 HG21 ' A' ' 91' ' ' VAL . 7.4 tp -62.19 -45.75 98.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 120.213 -0.595 . . . . 10.0 110.209 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.92 ' O ' HG12 ' A' ' 147' ' ' VAL . 63.1 mm-40 -47.74 -43.68 27.29 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 51.9 mm-40 -71.85 -39.27 69.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.045 -0.979 . . . . 10.0 110.429 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.674 ' CD1' HG11 ' A' ' 91' ' ' VAL . 46.8 mt -45.17 -38.48 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-O 120.803 0.335 . . . . 10.0 111.24 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.1 p -97.77 -53.79 3.31 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.21 0.818 . . . . 10.0 113.21 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 143' ' ' GLU . 8.6 p -84.2 13.16 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 113.466 0.913 . . . . 10.0 113.466 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 84.9 tttt -60.97 -42.12 97.71 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.271 -0.572 . . . . 10.0 110.788 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -170.27 135.51 1.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.908 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -178.93 -41.3 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.134 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 10.0 111.096 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.877 0.37 . . . . 10.0 111.209 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.624 ' HE2' ' HB3' ' A' ' 5' ' ' ALA . 37.0 mtmm -59.99 -44.57 94.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.054 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 51.3 m 71.5 -49.08 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.833 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.944 HD12 ' N ' ' A' ' 5' ' ' ALA . 4.0 pp -62.35 -37.12 84.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.917 0.389 . . . . 10.0 110.448 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.944 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -86.5 47.98 1.56 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.283 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 51.0 m-20 -134.39 145.24 48.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.87 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.655 ' O ' HD23 ' A' ' 8' ' ' LEU . . . 70.5 53.68 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.335 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 7' ' ' ALA . 88.5 mt -145.73 53.19 1.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.806 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.494 ' O ' HG22 ' A' ' 105' ' ' THR . 2.6 tmmm? -145.88 -51.81 0.24 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.993 -0.549 . . . . 10.0 109.928 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 88.3 tt0 -138.96 161.14 38.06 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.272 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 11.0 t80 -165.85 139.48 4.39 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.45 -0.796 . . . . 10.0 112.917 -173.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 16.7 mt-10 -88.82 134.41 33.94 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.927 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -149.05 170.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 113.307 0.854 . . . . 10.0 113.307 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.88 HD11 HD13 ' A' ' 82' ' ' ILE . 3.1 tm? -88.91 132.88 34.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.815 ' HB3' HD22 ' A' ' 102' ' ' LEU . 86.6 p -143.09 153.64 43.12 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.687 0.756 . . . . 10.0 112.746 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.673 ' CD2' HG11 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -149.93 160.4 43.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.252 -1.34 . . . . 10.0 110.012 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -88.67 135.98 33.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.353 -0.61 . . . . 10.0 109.353 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.044 HG21 HD12 ' A' ' 71' ' ' ILE . 34.8 mm -130.79 81.99 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.361 -0.836 . . . . 10.0 111.34 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.723 ' OD2' ' HA ' ' A' ' 73' ' ' PHE . 19.9 m-20 50.82 60.23 4.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.462 0.542 . . . . 10.0 112.462 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 81.3 mt-10 81.98 -35.89 0.1 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.171 -0.922 . . . . 10.0 111.107 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.457 ' NE2' HD11 ' A' ' 134' ' ' ILE . 37.5 tt0 -88.87 136.71 32.86 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.252 -0.647 . . . . 10.0 109.252 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.019 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.72 162.12 16.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.054 0.454 . . . . 10.0 111.222 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.949 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.5 tp -148.63 139.33 22.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.165 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.756 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -143.55 153.56 42.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.927 0.714 . . . . 10.0 112.927 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.768 ' CE2' HD22 ' A' ' 136' ' ' LEU . 6.0 m-85 -135.37 140.56 45.1 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.222 -0.899 . . . . 10.0 109.169 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.452 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . 47.0 p-10 -49.17 123.3 7.09 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.106 0.479 . . . . 10.0 111.25 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.927 HG13 ' HA ' ' A' ' 13' ' ' VAL . 31.1 m -62.26 -13.25 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.573 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -61.16 -46.05 92.09 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.031 0.443 . . . . 10.0 110.047 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.715 ' CG ' HG21 ' A' ' 138' ' ' ILE . 16.0 t-20 -89.28 -45.04 9.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.562 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.69 HG21 ' HG ' ' A' ' 14' ' ' LEU . 17.5 mm -60.97 120.67 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.234 -0.439 . . . . 10.0 109.906 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 32' ' ' MET . 8.8 pt-20 -81.19 -58.85 2.88 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.198 0.444 . . . . 10.0 112.198 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.475 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -169.12 157.94 8.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.038 0.446 . . . . 10.0 111.725 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.623 ' CG1' HG11 ' A' ' 98' ' ' VAL . 30.4 m -88.94 152.16 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.697 -0.683 . . . . 10.0 111.508 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 pt -148.35 129.81 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -88.82 128.63 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 10.0 110.241 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.832 ' HB3' HD12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -169.0 165.96 11.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.883 0.373 . . . . 10.0 110.959 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.4 t -154.27 148.61 26.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.176 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 9.8 t70 52.93 47.08 25.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.448 0.642 . . . . 10.0 110.021 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.534 HG21 HG23 ' A' ' 53' ' ' ILE . 19.9 mt -59.25 -69.43 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.221 -0.9 . . . . 10.0 112.513 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.784 HG23 ' HG2' ' A' ' 43' ' ' PRO . 75.4 m -153.84 67.07 5.81 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.99 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -83.51 -49.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.947 2.431 . . . . 10.0 113.942 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.672 HG22 ' HD3' ' A' ' 43' ' ' PRO . 18.9 m -74.99 -34.51 1.72 Allowed Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.984 0.735 . . . . 10.0 112.984 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.784 ' HG2' HG23 ' A' ' 40' ' ' THR . 12.9 Cg_exo -69.11 -79.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.98 1.786 . . . . 10.0 112.491 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.553 ' HG3' HG11 ' A' ' 52' ' ' VAL . 1.3 mmmm -70.83 130.54 41.95 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.879 -0.786 . . . . 10.0 108.879 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 29.1 t -175.87 118.09 0.15 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.237 -0.985 . . . . 10.0 111.571 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 16.5 ptm180 175.82 -47.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.793 -0.64 . . . . 10.0 110.695 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.424 ' CD2' ' HG3' ' A' ' 46' ' ' ARG . 84.3 m-70 -99.35 -152.97 0.42 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.431 . . . . 10.0 111.058 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.593 ' CE2' HG11 ' A' ' 63' ' ' VAL . 3.9 t80 -72.57 -35.02 67.87 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.854 ' HA ' HG22 ' A' ' 63' ' ' VAL . 44.9 t -54.45 127.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.975 0.417 . . . . 10.0 111.632 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -90.31 -46.84 8.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.579 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.774 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -133.04 -179.08 15.98 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.764 -0.731 . . . . 10.0 112.774 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.617 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.4 m -160.81 168.81 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 CA-C-O 120.848 0.356 . . . . 10.0 110.53 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.547 HG12 HD11 ' A' ' 60' ' ' ILE . 28.5 pt -157.8 147.37 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.319 -0.4 . . . . 10.0 110.719 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.457 HD22 HD11 ' A' ' 59' ' ' ILE . 23.7 t-20 -88.66 137.47 32.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.066 0.46 . . . . 10.0 111.305 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.893 HD13 ' N ' ' A' ' 56' ' ' ARG . 3.1 tm? -169.07 141.55 2.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.595 -0.73 . . . . 10.0 110.216 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.893 ' N ' HD13 ' A' ' 55' ' ' LEU . 51.8 ttm-85 51.36 45.75 27.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.174 0.511 . . . . 10.0 110.444 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.68 40.19 69.91 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.789 -0.642 . . . . 10.0 112.725 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -168.71 137.91 2.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 10.0 110.917 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.89 132.62 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.93 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.76 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.1 pp -103.38 139.28 19.97 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 10.0 111.663 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 70.2 Cg_endo -86.09 117.75 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.747 2.298 . . . . 10.0 112.958 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.774 HG22 ' C ' ' A' ' 51' ' ' GLY . 35.1 m -96.0 134.84 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.639 -0.504 . . . . 10.0 109.639 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.854 HG22 ' HA ' ' A' ' 49' ' ' VAL . 57.4 t -140.31 156.0 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.561 0.696 . . . . 10.0 112.406 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.493 ' N ' HG12 ' A' ' 63' ' ' VAL . 5.6 m120 -77.16 72.27 3.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.949 -1.023 . . . . 10.0 109.805 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.864 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.1 tt -53.86 -37.55 63.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.308 0.575 . . . . 10.0 110.587 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.793 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -56.75 -25.88 55.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.132 0.492 . . . . 10.0 109.69 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.526 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -82.01 -42.71 18.95 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.243 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 65' ' ' LEU . 7.9 tt -61.84 -37.61 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.883 ' C ' HD13 ' A' ' 69' ' ' LEU . 1.1 tm? -78.35 -52.02 9.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 113.738 -1.574 . . . . 10.0 108.92 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 117.68 -82.87 0.33 Allowed Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.66 -0.7 . . . . 10.0 112.744 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.044 HD12 HG21 ' A' ' 18' ' ' ILE . 2.7 pt 45.36 173.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -50.16 -39.25 43.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.433 0.635 . . . . 10.0 109.32 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.792 ' HB3' HG13 ' A' ' 71' ' ' ILE . 4.3 t80 -28.21 145.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.672 -1.149 . . . . 10.0 113.904 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 65.4 t0 -137.63 -52.8 0.65 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.785 -1.098 . . . . 10.0 109.906 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' A' ' 74' ' ' ASP . 16.4 pt-20 163.57 -44.0 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.983 0.421 . . . . 10.0 111.624 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -51.31 -37.63 48.62 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.545 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.2 mmpt? -74.72 -29.68 61.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.11 0.411 . . . . 10.0 112.11 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.407 ' O ' ' CG ' ' A' ' 79' ' ' LYS . 29.3 mmt -43.84 130.55 5.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.888 0.375 . . . . 10.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 78' ' ' MET . 53.2 mtmt -162.1 -44.89 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.547 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.601 ' HB3' HG23 ' A' ' 95' ' ' VAL . 45.5 t -88.95 164.29 15.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.495 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.832 HD12 ' HB3' ' A' ' 36' ' ' LYS . 45.4 mt -140.98 125.97 18.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.694 0.283 . . . . 10.0 111.351 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.88 HD13 HD11 ' A' ' 14' ' ' LEU . 6.2 mt -100.42 155.27 4.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.459 -0.337 . . . . 10.0 111.203 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.75 145.66 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.645 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -143.46 -177.06 5.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.474 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.05 128.89 24.88 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.877 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.722 HG21 HG12 ' A' ' 138' ' ' ILE . 69.0 p -142.85 109.69 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.026 0.441 . . . . 10.0 111.914 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 47.8 49.99 16.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.388 0.614 . . . . 10.0 110.753 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 72.91 31.24 1.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.009 -0.996 . . . . 10.0 111.555 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.89 HG12 HG22 ' A' ' 91' ' ' VAL . 66.1 t -126.95 109.74 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.262 -0.881 . . . . 10.0 109.397 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 36.9 tt0 -88.36 99.12 12.01 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.799 -1.926 . . . . 10.0 105.799 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.023 HG21 HD13 ' A' ' 142' ' ' ILE . 5.3 t -88.67 152.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 113.181 -1.827 . . . . 10.0 113.196 -173.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -119.18 153.25 16.95 Favored Glycine 0 C--N 1.315 -0.606 0 CA-C-N 114.381 -1.281 . . . . 10.0 113.156 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -143.95 125.09 14.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.861 0.362 . . . . 10.0 110.559 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.534 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 42.3 tp -88.66 124.74 34.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.124 0.488 . . . . 10.0 110.516 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.673 HG11 ' CD2' ' A' ' 16' ' ' PHE . 17.1 m -132.87 -175.07 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.672 -0.694 . . . . 10.0 110.944 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 17.2 t70 -87.67 -71.79 0.55 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.536 0.684 . . . . 10.0 110.993 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -146.59 112.41 5.69 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.904 -1.044 . . . . 10.0 108.324 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.623 HG11 ' CG1' ' A' ' 33' ' ' VAL . 7.5 p -89.01 118.26 33.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 122.31 1.053 . . . . 10.0 112.939 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -66.12 -29.29 69.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.031 -1.895 . . . . 10.0 110.923 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.74 -123.43 7.31 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.556 -0.747 . . . . 10.0 111.498 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 m -52.89 136.85 13.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.977 0.389 . . . . 10.0 110.84 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' A' ' 15' ' ' SER . 45.5 tp -139.21 141.89 37.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.17 0.509 . . . . 10.0 111.237 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.433 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.3 ptp85 -88.9 71.8 8.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.753 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.834 HD12 HG11 ' A' ' 126' ' ' VAL . 15.7 mm -88.75 136.75 22.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 N-CA-C 109.554 -0.536 . . . . 10.0 109.554 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 14.7 p -88.82 -175.76 4.99 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 109' ' ' LEU . 87.0 tt0 -144.34 77.37 1.54 Allowed 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.721 -1.192 . . . . 10.0 113.262 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.41 22.17 16.3 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.414 -1.267 . . . . 10.0 108.173 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.584 ' O ' HD23 ' A' ' 109' ' ' LEU . 14.0 pt20 -163.24 59.58 0.18 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.81 -1.086 . . . . 10.0 111.921 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.584 HD23 ' O ' ' A' ' 108' ' ' GLN . 89.1 mt -168.69 32.33 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.776 -1.102 . . . . 10.0 110.003 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.835 ' OD2' HG22 ' A' ' 112' ' ' THR . 38.4 t70 -55.78 155.35 6.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.32 . . . . 10.0 110.633 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.1 tp -43.24 -49.06 6.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.921 0.391 . . . . 10.0 110.408 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.835 HG22 ' OD2' ' A' ' 110' ' ' ASP . 9.8 t -74.23 -31.63 62.68 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.516 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 61.09 122.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.694 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 115' ' ' SER . 11.5 t -155.46 90.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.781 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 114' ' ' VAL . 72.0 p 174.47 125.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.872 0.368 . . . . 10.0 111.297 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 119' ' ' GLY . 5.4 t70 -68.75 -52.15 33.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.509 . . . . 10.0 109.82 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.611 ' HE2' ' HA ' ' A' ' 117' ' ' LYS . 7.4 mmpt? 66.08 -59.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.354 -0.839 . . . . 10.0 112.275 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.608 ' CE2' HD21 ' A' ' 69' ' ' LEU . 33.4 t80 -103.09 -68.96 0.81 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.949 0.404 . . . . 10.0 110.808 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 162.67 -144.02 9.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.951 -0.643 . . . . 10.0 112.405 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -85.22 58.03 4.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.695 0.283 . . . . 10.0 110.639 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 17.3 tppt? -154.31 -40.05 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.919 0.341 . . . . 10.0 111.919 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.519 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 90.2 p -146.09 -142.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.187 -0.205 . . . . 10.0 110.824 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 32.9 mmmt -157.35 -33.48 0.08 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.415 0.524 . . . . 10.0 112.415 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -81.94 144.38 23.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.396 -0.907 . . . . 10.0 113.644 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.538 ' CB ' ' HB3' ' A' ' 117' ' ' LYS . 1.6 tm? -162.38 84.64 0.56 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.195 -0.668 . . . . 10.0 109.195 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.949 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.6 p -88.75 160.93 2.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.179 -0.919 . . . . 10.0 112.389 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.516 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 92.7 mttt -152.27 132.35 13.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.145 -0.934 . . . . 10.0 109.742 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 2.6 m -169.07 152.12 5.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.825 0.345 . . . . 10.0 111.164 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.465 ' OD1' HG22 ' A' ' 128' ' ' THR . 0.9 OUTLIER 56.83 47.95 16.98 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.916 0.389 . . . . 10.0 111.244 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 49.12 30.92 10.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.116 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 128' ' ' THR . 3.5 ptm180 -137.94 136.4 36.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.171 -0.307 . . . . 10.0 110.171 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.659 ' N ' HD22 ' A' ' 132' ' ' LEU . 2.0 mm? -88.88 135.59 33.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.907 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.019 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.9 mt -128.78 131.51 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.864 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.949 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.6 mp -88.87 140.12 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.238 -0.653 . . . . 10.0 109.238 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.719 ' C ' HD12 ' A' ' 136' ' ' LEU . 49.0 t80 -128.72 141.45 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.33 0.586 . . . . 10.0 111.282 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.768 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.6 mp -136.47 172.51 12.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.823 0.82 . . . . 10.0 112.666 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 9.8 t70 -136.36 25.09 3.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.099 -1.41 . . . . 10.0 107.667 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.887 ' HA ' HG23 ' A' ' 141' ' ' ILE . 10.5 tt 42.6 17.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 114.164 -1.38 . . . . 10.0 114.086 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.408 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.5 t70 -82.33 -62.99 1.47 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.604 0.594 . . . . 10.0 112.604 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -73.93 -30.89 62.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.612 0.72 . . . . 10.0 109.981 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -69.29 -47.48 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.817 -1.083 . . . . 10.0 110.839 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.023 HD13 HG21 ' A' ' 91' ' ' VAL . 7.3 tp -60.74 -47.35 93.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 120.313 -0.555 . . . . 10.0 110.206 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.871 ' O ' HG12 ' A' ' 147' ' ' VAL . 5.5 mm-40 -49.14 -43.55 41.83 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.289 0.566 . . . . 10.0 109.62 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' A' ' 68' ' ' ILE . 5.7 mm-40 -72.6 -34.81 67.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.192 -0.913 . . . . 10.0 110.898 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.693 ' CD1' HG11 ' A' ' 91' ' ' VAL . 33.9 mt -47.93 -46.38 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-O 120.941 0.401 . . . . 10.0 111.093 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 80.6 p -86.25 -50.59 6.85 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.135 0.791 . . . . 10.0 113.135 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 143' ' ' GLU . 8.6 p -82.36 13.03 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.537 0.94 . . . . 10.0 113.537 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.514 ' HD3' ' CG ' ' A' ' 48' ' ' PHE . 62.4 tttm -58.87 -59.92 4.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.124 -0.63 . . . . 10.0 111.019 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -89.77 49.19 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 10.0 111.143 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -175.37 44.19 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.688 -0.768 . . . . 10.0 112.375 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 10.0 111.032 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.751 0.31 . . . . 10.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' O ' ' OG1' ' A' ' 3' ' ' THR . 97.1 mttt -60.38 -45.61 92.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.951 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 31.9 p 66.91 -50.87 0.47 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.089 -0.505 . . . . 10.0 112.307 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.966 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.6 pp -47.72 -36.65 11.68 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.678 0.275 . . . . 10.0 111.671 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.966 ' N ' HD12 ' A' ' 4' ' ' LEU . . . 48.65 -168.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.404 . . . . 10.0 111.754 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.23 135.42 50.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.939 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.54 137.56 58.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.659 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 110' ' ' ASP . 84.5 mt 58.68 47.58 12.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 10.0 111.489 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' O ' HG22 ' A' ' 105' ' ' THR . 63.0 pttt -64.02 -45.68 87.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.007 0.432 . . . . 10.0 110.464 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.586 ' HG2' HG22 ' A' ' 105' ' ' THR . 41.8 mt-10 -145.48 164.25 32.16 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.449 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.5 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 16.1 t80 -153.38 141.9 20.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.863 -1.062 . . . . 10.0 112.606 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 27' ' ' VAL . 12.2 pt-20 -88.75 139.27 30.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.538 -0.756 . . . . 10.0 109.174 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.769 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -154.09 169.05 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.395 0.887 . . . . 10.0 113.395 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.879 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.9 tm? -88.79 132.26 34.71 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.819 ' HB3' HD22 ' A' ' 102' ' ' LEU . 94.7 p -140.8 150.35 43.21 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.8 ' CE1' HG11 ' A' ' 95' ' ' VAL . 4.6 p90 -150.71 162.57 40.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.523 -1.217 . . . . 10.0 110.308 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HG3' HD21 ' A' ' 99' ' ' LEU . 51.0 mt-10 -88.64 137.73 32.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.123 0.487 . . . . 10.0 109.802 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.975 HG21 HD12 ' A' ' 71' ' ' ILE . 17.8 mm -136.11 99.36 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.642 -0.708 . . . . 10.0 111.289 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.601 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 48.7 m-20 42.0 60.14 2.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.479 -0.782 . . . . 10.0 112.84 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.1 mt-10 86.6 -42.68 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.304 -0.862 . . . . 10.0 112.581 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.453 ' OE1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -89.03 155.7 19.31 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.393 -0.523 . . . . 10.0 110.261 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.799 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.64 165.84 14.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.846 0.355 . . . . 10.0 110.677 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -152.27 133.05 14.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.329 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.769 ' HB1' ' CG2' ' A' ' 13' ' ' VAL . . . -142.83 141.25 31.57 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.356 0.598 . . . . 10.0 112.372 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.092 ' CE2' HD13 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -118.0 141.08 48.84 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.248 -1.39 . . . . 10.0 107.248 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.456 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . 12.5 p-10 -45.29 105.85 0.07 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.365 0.602 . . . . 10.0 110.612 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.597 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 6.3 p -51.15 -18.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.212 -0.903 . . . . 10.0 110.685 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.69 -39.29 93.51 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.723 HD22 HG22 ' A' ' 86' ' ' THR . 15.8 t-20 -84.46 -45.78 12.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.091 -0.959 . . . . 10.0 110.506 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.879 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.0 mm -63.68 131.92 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.021 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -93.82 -61.19 1.59 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.028 0.381 . . . . 10.0 112.028 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -169.03 161.79 10.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 10.0 111.489 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.077 HG11 HG11 ' A' ' 98' ' ' VAL . 33.9 m -88.94 143.1 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.973 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.635 HG13 ' HB ' ' A' ' 81' ' ' ILE . 20.1 pt -126.47 157.36 37.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.572 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -88.82 139.93 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.945 0.402 . . . . 10.0 111.28 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.409 ' HB2' HD11 ' A' ' 81' ' ' ILE . 61.1 tttm -88.77 134.54 33.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.01 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.443 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 68.6 m -168.91 127.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.472 . . . . 10.0 110.806 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 37' ' ' SER . 57.2 p30 24.73 47.13 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.687 0.617 . . . . 10.0 112.326 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.5 ' CG2' ' N ' ' A' ' 40' ' ' THR . 7.9 mt -64.53 156.72 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.353 0.597 . . . . 10.0 112.086 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.616 HG21 HG22 ' A' ' 52' ' ' VAL . 51.9 m -37.82 94.05 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 114.771 -1.104 . . . . 10.0 112.004 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -93.4 -62.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.032 2.488 . . . . 10.0 113.582 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.629 HG12 ' HD3' ' A' ' 43' ' ' PRO . 13.6 p -76.46 -33.36 1.19 Allowed Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.629 ' HD3' HG12 ' A' ' 42' ' ' VAL . 11.9 Cg_exo -71.06 11.05 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.265 1.977 . . . . 10.0 113.45 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -45.1 159.27 0.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.086 0.469 . . . . 10.0 111.655 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 47.8 t 179.15 -30.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.554 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.474 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 38.6 mmt180 -68.12 50.27 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 45.98 -129.78 1.24 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.484 0.549 . . . . 10.0 112.484 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.589 ' CE2' ' HE3' ' A' ' 67' ' ' LYS . 7.2 t80 -48.31 -34.99 11.44 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.789 ' HA ' HG22 ' A' ' 63' ' ' VAL . 60.7 t -45.68 128.22 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 10.0 111.368 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -73.88 -39.78 63.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.668 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.767 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -151.31 -175.8 23.5 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.253 -0.975 . . . . 10.0 113.009 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.616 HG22 HG21 ' A' ' 40' ' ' THR . 2.4 m -156.01 171.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.847 0.356 . . . . 10.0 110.605 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.478 ' CD1' HD12 ' A' ' 34' ' ' ILE . 31.2 pt -157.65 144.24 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.781 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' O ' HD23 ' A' ' 55' ' ' LEU . 45.1 t30 -88.78 132.87 34.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 10.0 111.403 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 54' ' ' ASN . 96.4 mt -160.78 140.65 10.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.297 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 49.76 45.89 24.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.962 0.41 . . . . 10.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.15 40.67 84.29 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.866 -0.683 . . . . 10.0 112.607 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -167.77 134.99 2.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 10.0 110.784 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.92 134.15 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.144 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.848 HG22 ' HB2' ' A' ' 90' ' ' GLU . 2.3 pp -109.23 132.98 20.93 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.296 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 95.3 Cg_endo -80.0 121.4 4.47 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.484 2.122 . . . . 10.0 112.815 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.767 HG22 ' C ' ' A' ' 51' ' ' GLY . 35.0 m -93.38 132.08 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.759 -0.655 . . . . 10.0 109.945 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 49' ' ' VAL . 86.5 t -141.31 162.34 21.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.278 0.561 . . . . 10.0 111.208 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.541 ' N ' HG12 ' A' ' 63' ' ' VAL . 57.4 m-20 -102.78 85.42 2.56 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.693 -0.685 . . . . 10.0 110.593 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.092 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.2 tt -53.25 -41.34 65.35 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.542 -0.463 . . . . 10.0 110.521 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.025 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -55.6 -24.41 32.81 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.472 -0.491 . . . . 10.0 109.955 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HE3' ' CE2' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -86.36 -38.54 17.33 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.01 178.303 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.835 HG22 ' O ' ' A' ' 65' ' ' LEU . 5.7 tt -64.83 -36.16 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 107.481 -1.303 . . . . 10.0 107.481 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.814 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -81.89 -53.74 5.91 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.292 -1.777 . . . . 10.0 108.643 178.361 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 116.07 -76.28 0.27 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.801 -1.09 . . . . 10.0 112.182 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.025 HD11 ' HB1' ' A' ' 66' ' ' ALA . 6.5 pt 43.05 -175.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 112.341 0.497 . . . . 10.0 112.341 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 52.5 m -60.33 -39.3 86.58 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.798 ' HB3' HG13 ' A' ' 71' ' ' ILE . 11.4 t80 -26.01 137.14 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.035 -0.984 . . . . 10.0 112.88 177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.435 ' O ' ' OE2' ' A' ' 75' ' ' GLU . 9.8 t70 -158.72 43.76 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.267 -0.879 . . . . 10.0 109.395 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.456 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 1.4 pp20? 37.53 38.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.176 -0.92 . . . . 10.0 112.091 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.408 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 4.0 pt20 -87.67 -49.47 7.12 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.786 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.462 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -106.87 -1.85 21.98 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.666 0.617 . . . . 10.0 112.666 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.51 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 12.1 mmt -42.07 139.28 1.38 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.71 0.291 . . . . 10.0 111.74 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -177.23 36.19 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.632 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.837 ' O ' HD12 ' A' ' 94' ' ' LEU . 69.9 m -169.02 143.73 3.12 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.499 -0.319 . . . . 10.0 110.624 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.635 ' HB ' HG13 ' A' ' 34' ' ' ILE . 67.1 mt -114.26 152.51 15.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 10.0 111.333 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.856 HD13 HD11 ' A' ' 14' ' ' LEU . 14.1 mt -123.98 133.45 69.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' A' ' 34' ' ' ILE . 83.7 t -103.33 150.45 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 10.0 110.83 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -158.08 174.0 15.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.242 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.643 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 6.8 ptm180 -129.28 147.58 51.12 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.206 -0.665 . . . . 10.0 109.206 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.723 HG22 HD22 ' A' ' 29' ' ' ASN . 67.5 p -161.82 109.02 1.38 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.011 0.434 . . . . 10.0 112.081 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? 46.8 48.86 14.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.416 0.627 . . . . 10.0 110.809 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 72.17 33.76 1.51 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 10.0 111.433 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.938 HG12 HG22 ' A' ' 91' ' ' VAL . 59.0 t -132.18 112.27 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 115.293 -0.867 . . . . 10.0 109.255 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.848 ' HB2' HG22 ' A' ' 60' ' ' ILE . 73.9 mt-10 -88.22 95.12 10.05 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.006 HG21 HD13 ' A' ' 142' ' ' ILE . 3.5 t -88.69 152.25 3.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 113.374 -1.739 . . . . 10.0 113.067 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -132.46 143.12 14.69 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.959 -1.019 . . . . 10.0 113.367 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.742 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.3 t80 -131.19 128.64 40.41 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.827 0.346 . . . . 10.0 111.061 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 80' ' ' SER . 58.2 tp -88.8 126.86 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.876 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.8 HG11 ' CE1' ' A' ' 16' ' ' PHE . 21.6 m -132.01 -175.22 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.693 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 44.1 t0 -87.98 -74.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.362 0.601 . . . . 10.0 111.273 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -130.7 117.42 19.43 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.166 -0.925 . . . . 10.0 108.521 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.077 HG11 HG11 ' A' ' 33' ' ' VAL . 7.5 p -101.05 116.6 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 122.484 1.135 . . . . 10.0 112.073 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -65.09 -29.27 70.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.002 -1.908 . . . . 10.0 110.801 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.3 -127.33 8.64 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.825 -0.702 . . . . 10.0 111.718 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.3 t -51.25 132.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 117.011 0.406 . . . . 10.0 110.472 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.819 HD22 ' HB3' ' A' ' 15' ' ' SER . 59.0 tp -137.09 138.86 40.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.027 0.441 . . . . 10.0 111.358 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.84 72.57 8.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.678 -0.692 . . . . 10.0 110.823 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.73 ' CG1' HG11 ' A' ' 13' ' ' VAL . 16.3 mm -88.78 133.3 31.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 N-CA-C 109.654 -0.498 . . . . 10.0 109.654 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.586 HG22 ' HG2' ' A' ' 10' ' ' GLU . 19.2 p -88.81 149.72 23.27 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.616 ' OE2' HD12 ' A' ' 109' ' ' LEU . 37.1 tt0 -128.41 80.03 1.94 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 113.697 0.999 . . . . 10.0 113.697 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -97.69 2.75 50.06 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.59 -1.186 . . . . 10.0 107.896 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -84.23 -58.84 2.59 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 114.885 -1.052 . . . . 10.0 110.946 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.616 HD12 ' OE2' ' A' ' 106' ' ' GLU . 12.1 mt -57.73 -61.22 2.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.773 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.62 ' HA ' HD12 ' A' ' 8' ' ' LEU . 38.5 t70 45.13 101.42 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.25 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.528 ' O ' ' HB ' ' A' ' 112' ' ' THR . 3.1 mm? 68.64 -61.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.923 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.528 ' HB ' ' O ' ' A' ' 111' ' ' LEU . 8.4 t 167.59 43.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.76 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -69.95 -52.14 26.92 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.881 -0.328 . . . . 10.0 111.192 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.7 t 67.56 113.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.152 0.501 . . . . 10.0 110.464 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.0 m -123.53 136.49 54.58 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.644 -0.707 . . . . 10.0 111.1 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 122' ' ' SER . 56.6 m-20 -60.23 -51.85 67.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.169 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.501 ' HA ' ' NZ ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER 60.84 33.5 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 10.0 111.135 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.552 ' CE2' ' CD2' ' A' ' 69' ' ' LEU . 26.0 t80 -175.6 -41.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.167 0.508 . . . . 10.0 109.969 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 76.77 36.07 38.22 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.527 -0.761 . . . . 10.0 111.9 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 118' ' ' PHE . 87.7 tttt 178.86 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 10.5 tppt? -130.47 -68.43 0.69 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.441 -0.504 . . . . 10.0 112.066 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.611 ' HB3' HD12 ' A' ' 136' ' ' LEU . 38.1 t 174.78 -79.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.88 0.372 . . . . 10.0 110.588 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.637 ' O ' ' N ' ' A' ' 125' ' ' LEU . 85.9 tttt 43.08 48.65 5.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 10.0 112.063 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 117' ' ' LYS . . . -56.77 72.72 0.01 OUTLIER Glycine 0 C--N 1.329 0.162 0 N-CA-C 111.021 -0.832 . . . . 10.0 111.021 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.904 HD13 ' N ' ' A' ' 126' ' ' VAL . 1.3 tm? -42.58 138.28 1.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.417 0.627 . . . . 10.0 111.776 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.904 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -146.65 160.22 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.954 -1.021 . . . . 10.0 110.81 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.482 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 1.0 OUTLIER -160.5 133.42 6.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.361 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.503 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 10.2 m -161.61 148.33 14.28 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.634 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.12 42.73 27.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.036 0.446 . . . . 10.0 110.761 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.16 36.16 51.49 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.736 -0.745 . . . . 10.0 112.059 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 128' ' ' THR . 5.0 ptp180 -132.86 139.71 47.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.639 0.257 . . . . 10.0 110.442 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.636 ' N ' HD22 ' A' ' 132' ' ' LEU . 2.3 mm? -88.78 139.33 30.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.875 0.369 . . . . 10.0 110.848 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.799 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.8 mt -150.85 143.44 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.413 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 23' ' ' LEU . 11.8 mt -111.82 122.62 66.49 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.745 0 N-CA-C 109.11 -0.7 . . . . 10.0 109.11 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 26' ' ' ASP . 16.4 t80 -100.99 172.53 6.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.875 ' CD1' HD11 ' A' ' 65' ' ' LEU . 4.1 tt -169.01 128.07 1.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.437 -0.505 . . . . 10.0 111.12 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 138' ' ' ILE . 12.3 p-10 -91.12 16.2 10.21 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.191 0.441 . . . . 10.0 112.191 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.931 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 20.5 tt 42.33 18.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 113.908 1.077 . . . . 10.0 113.908 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 137' ' ' ASP . 66.9 t0 -76.33 -56.19 4.86 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.94 0.719 . . . . 10.0 112.94 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 34.4 mmtp -80.1 -28.6 39.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.936 0.398 . . . . 10.0 110.997 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.931 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.5 -46.45 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.095 -0.502 . . . . 10.0 109.973 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.006 HD13 HG21 ' A' ' 91' ' ' VAL . 8.0 tp -65.04 -46.6 90.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 120.322 -0.551 . . . . 10.0 110.315 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.679 ' O ' HG12 ' A' ' 147' ' ' VAL . 3.3 tm-20 -48.56 -40.02 25.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 54.8 mm-40 -76.47 -34.86 58.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.838 -1.074 . . . . 10.0 110.729 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 141' ' ' ILE . 43.4 mt -48.97 -38.91 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 120.971 0.415 . . . . 10.0 110.824 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 79.5 p -88.66 -51.75 5.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.968 0.729 . . . . 10.0 112.968 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 143' ' ' GLU . 7.2 p -83.83 13.15 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.232 0.827 . . . . 10.0 113.232 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.586 ' HG2' ' CD2' ' A' ' 48' ' ' PHE . 28.0 tptp -57.45 -41.96 81.55 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.668 -0.413 . . . . 10.0 111.248 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -166.2 139.62 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.401 . . . . 10.0 111.014 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -176.39 41.94 0.11 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.78 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 10.0 110.943 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.82 0.343 . . . . 10.0 111.159 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.54 -47.9 81.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.087 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.4 m 68.18 -60.67 0.41 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.297 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.928 HD12 ' N ' ' A' ' 5' ' ' ALA . 4.2 pp -61.49 -42.14 98.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.553 -0.294 . . . . 10.0 111.076 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.928 ' N ' HD12 ' A' ' 4' ' ' LEU . . . 44.14 64.63 1.24 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.135 0.42 . . . . 10.0 112.135 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.868 ' OD2' HD13 ' A' ' 4' ' ' LEU . 59.9 m-20 -73.15 124.7 26.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.739 0.304 . . . . 10.0 110.851 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.66 -52.78 41.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.48 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.709 HD23 ' CD ' ' A' ' 106' ' ' GLU . 87.6 mt 51.34 44.2 29.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.162 0.506 . . . . 10.0 110.988 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -158.09 -47.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.624 -0.716 . . . . 10.0 110.19 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 95.1 mt-10 -140.8 164.28 30.64 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.509 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CE2' ' OH ' ' A' ' 135' ' ' TYR . 18.5 t80 -140.49 125.28 18.17 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 114.363 1.246 . . . . 10.0 114.363 -174.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -88.98 125.75 35.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.688 -1.967 . . . . 10.0 105.688 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.954 HG11 ' CG1' ' A' ' 104' ' ' ILE . 5.8 p -150.79 167.74 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 114.439 1.274 . . . . 10.0 114.439 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.688 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.3 tm? -88.77 133.58 34.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.051 -1.092 . . . . 10.0 108.051 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.754 ' HB3' HD22 ' A' ' 102' ' ' LEU . 57.1 p -144.89 158.11 43.91 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.749 0.785 . . . . 10.0 112.99 -177.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.61 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 2.1 p90 -152.97 156.8 39.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.147 -1.388 . . . . 10.0 109.996 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -88.67 106.39 18.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.363 0.602 . . . . 10.0 110.203 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.926 HG21 HD12 ' A' ' 71' ' ' ILE . 36.5 mm -88.89 102.51 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.173 -0.921 . . . . 10.0 110.973 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.748 ' OD1' HG22 ' A' ' 18' ' ' ILE . 12.2 p-10 32.92 60.33 0.41 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.094 1.146 . . . . 10.0 114.094 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.579 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 103.03 -51.3 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.07 0.948 . . . . 10.0 112.712 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.8 -175.73 4.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.695 -0.402 . . . . 10.0 110.363 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.017 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -112.83 159.83 18.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.104 0.478 . . . . 10.0 111.815 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.848 HD13 ' HB ' ' A' ' 134' ' ' ILE . 3.4 tp -150.4 136.72 18.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.951 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.673 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -138.77 152.5 47.98 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.335 0.865 . . . . 10.0 113.335 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.872 ' CZ ' HD22 ' A' ' 136' ' ' LEU . 4.7 m-85 -131.95 142.32 49.59 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.128 -0.942 . . . . 10.0 109.322 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.559 ' OD2' ' HB3' ' A' ' 28' ' ' ASP . 21.4 t0 -52.48 123.28 10.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.152 0.501 . . . . 10.0 110.415 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.932 HG13 ' HA ' ' A' ' 13' ' ' VAL . 33.2 m -63.69 -8.61 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 10.0 112.141 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.559 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 38.9 t70 -66.64 -47.4 72.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.533 -0.467 . . . . 10.0 109.833 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.721 ' CG ' HG21 ' A' ' 138' ' ' ILE . 19.2 t-20 -84.42 -44.43 13.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.637 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.688 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.3 mm -60.46 125.79 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.275 -0.421 . . . . 10.0 110.315 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HB3' ' CE ' ' A' ' 32' ' ' MET . 44.5 mt-10 -85.28 -62.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.58 -0.282 . . . . 10.0 111.435 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.424 ' CE ' ' HB3' ' A' ' 31' ' ' GLU . 1.2 pmm? -169.11 156.95 7.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.036 0.446 . . . . 10.0 111.322 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.592 HG11 HG11 ' A' ' 98' ' ' VAL . 35.6 m -88.93 161.66 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.761 -0.654 . . . . 10.0 111.547 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 33' ' ' VAL . 22.3 pt -158.06 133.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.502 -0.772 . . . . 10.0 110.742 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.8 63.82 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.326 0.584 . . . . 10.0 110.845 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 1.023 ' HB2' HD12 ' A' ' 81' ' ' ILE . 14.5 mmmm -88.98 153.13 21.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.341 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.9 m -156.73 150.25 24.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.422 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.1 t0 51.11 43.36 29.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.349 0.595 . . . . 10.0 110.542 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 36' ' ' LYS . 24.8 mt -71.89 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.167 -0.924 . . . . 10.0 112.376 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.643 HG23 ' HG2' ' A' ' 43' ' ' PRO . 58.5 m -146.04 78.69 11.33 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.747 -177.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -80.34 -56.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.348 2.699 . . . . 10.0 114.265 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.67 HG22 ' HD3' ' A' ' 43' ' ' PRO . 17.0 m -74.31 -35.9 2.44 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 112.821 0.675 . . . . 10.0 112.821 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.67 ' HD3' HG22 ' A' ' 42' ' ' VAL . 6.0 Cg_exo -76.66 13.75 1.36 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.328 2.019 . . . . 10.0 113.205 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.535 ' NZ ' ' HB3' ' A' ' 44' ' ' LYS . 5.6 ttpm? -45.78 -74.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.158 0.504 . . . . 10.0 111.659 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.9 t 44.4 42.42 5.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.482 -0.781 . . . . 10.0 111.532 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.564 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 38.7 mmt180 -158.32 -8.17 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.136 -0.484 . . . . 10.0 112.022 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 18.3 m80 69.52 -62.42 0.41 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.509 0.195 . . . . 10.0 111.29 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.483 ' HB2' ' HD2' ' A' ' 148' ' ' LYS . 3.7 m-85 -74.97 -47.98 26.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.719 0.295 . . . . 10.0 111.361 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.732 ' HA ' HG22 ' A' ' 63' ' ' VAL . 41.0 t -61.18 80.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.393 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.5 -38.19 77.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.715 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.678 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -148.49 165.57 29.1 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.382 -0.913 . . . . 10.0 113.324 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.57 HG22 HG21 ' A' ' 40' ' ' THR . 2.9 m -161.91 169.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.46 ' CG2' HG23 ' A' ' 39' ' ' ILE . 30.3 pt -156.12 137.74 5.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.067 0.461 . . . . 10.0 111.73 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.743 ' ND2' HD11 ' A' ' 59' ' ' ILE . 23.3 t-20 -125.95 119.8 28.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.239 -0.891 . . . . 10.0 110.108 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 54' ' ' ASN . 92.9 mt -161.36 141.07 10.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.945 0.402 . . . . 10.0 111.134 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 46.48 46.65 14.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.224 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.54 41.81 97.4 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.537 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.791 ' C ' HD12 ' A' ' 59' ' ' ILE . 76.0 mtt-85 -139.42 118.15 12.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 10.0 110.354 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.791 HD12 ' C ' ' A' ' 58' ' ' ARG . 1.5 mp -119.87 135.01 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.003 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.963 HG22 ' HB2' ' A' ' 90' ' ' GLU . 2.2 pp -143.74 135.86 13.19 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 121.0 -0.28 . . . . 10.0 111.504 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 98.0 Cg_endo -102.64 122.28 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.86 3.04 . . . . 10.0 112.589 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.678 HG22 ' C ' ' A' ' 51' ' ' GLY . 29.2 m -99.84 133.22 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.732 HG22 ' HA ' ' A' ' 49' ' ' VAL . 69.2 t -140.87 155.66 22.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.375 0.607 . . . . 10.0 111.75 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.771 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 60.4 m-20 -70.27 66.59 0.3 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.39 -0.823 . . . . 10.0 109.777 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.882 HD22 ' CD2' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -52.08 -18.2 1.35 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.732 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.854 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -74.86 -27.68 60.35 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.465 -0.494 . . . . 10.0 110.169 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.771 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.94 -39.26 21.65 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.638 -0.504 . . . . 10.0 109.638 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.6 tt -57.78 -40.08 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 106.909 -1.515 . . . . 10.0 106.909 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.879 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.37 -45.13 23.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.399 -1.728 . . . . 10.0 107.939 176.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 113.08 -86.09 0.41 Allowed Glycine 0 C--N 1.335 0.488 0 CA-C-N 114.905 -1.043 . . . . 10.0 112.599 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.926 HD12 HG21 ' A' ' 18' ' ' ILE . 2.3 pt 46.89 167.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 113.41 0.893 . . . . 10.0 113.41 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.416 ' CB ' ' OD2' ' A' ' 19' ' ' ASP . 47.1 t -49.07 -37.93 22.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.364 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.786 ' HB3' HG13 ' A' ' 71' ' ' ILE . 3.1 t80 -22.5 141.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.274 1.213 . . . . 10.0 114.274 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' OD1' ' HG2' ' A' ' 75' ' ' GLU . 9.7 t70 -132.03 -58.64 0.95 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.803 -1.089 . . . . 10.0 109.306 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.479 ' HG2' ' OD1' ' A' ' 74' ' ' ASP . 11.7 pt-20 153.2 -42.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.027 0.531 . . . . 10.0 111.294 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -47.38 -40.95 18.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 10.0 112.239 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.504 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.7 mmpt? -77.09 -41.91 40.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.351 . . . . 10.0 111.054 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.642 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 21.4 mmt -45.39 144.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.422 0.527 . . . . 10.0 112.422 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.465 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -178.36 48.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.158 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.967 ' O ' HD12 ' A' ' 94' ' ' LEU . 79.1 p -169.05 -177.05 2.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.171 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.023 HD12 ' HB2' ' A' ' 36' ' ' LYS . 47.8 mt -154.41 140.27 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.074 0.398 . . . . 10.0 112.074 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 7.5 mt -108.84 162.45 6.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.171 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.486 ' N ' HG22 ' A' ' 82' ' ' ILE . 44.3 t -132.48 147.94 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.946 0.403 . . . . 10.0 110.958 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -155.15 175.33 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.838 -0.619 . . . . 10.0 111.172 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -131.69 131.27 42.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.72 HG21 HG12 ' A' ' 138' ' ' ILE . 59.1 p -145.75 109.38 4.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.954 0.407 . . . . 10.0 112.096 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 87' ' ' LYS . 37.4 ttmt 47.54 50.62 14.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.477 0.656 . . . . 10.0 110.765 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.01 32.21 2.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.1 -0.955 . . . . 10.0 111.524 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.91 HG12 HG22 ' A' ' 91' ' ' VAL . 66.0 t -129.62 109.85 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.207 177.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.963 ' HB2' HG22 ' A' ' 60' ' ' ILE . 32.2 mt-10 -88.38 97.79 11.25 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.078 -1.823 . . . . 10.0 106.078 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.012 HG21 HD13 ' A' ' 142' ' ' ILE . 4.2 t -88.59 153.94 3.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 113.285 -1.779 . . . . 10.0 113.56 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.71 158.73 22.33 Favored Glycine 0 C--N 1.318 -0.445 0 CA-C-N 114.509 -1.223 . . . . 10.0 112.802 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.882 ' CD2' HD22 ' A' ' 65' ' ' LEU . 1.4 t80 -144.45 134.5 24.04 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.851 0.358 . . . . 10.0 111.287 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 80' ' ' SER . 45.6 tp -88.56 123.02 32.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.935 0.398 . . . . 10.0 111.038 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.683 HG23 ' OG ' ' A' ' 80' ' ' SER . 5.2 m -132.91 -175.04 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.803 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 12.5 t70 -99.53 -56.02 2.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.356 0.598 . . . . 10.0 111.902 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.0 tpp85 -150.08 123.8 9.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.217 -0.902 . . . . 10.0 108.706 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.61 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.9 p -108.25 113.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 122.389 1.09 . . . . 10.0 112.325 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.33 -28.22 69.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 112.945 -1.934 . . . . 10.0 111.104 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.19 -118.94 5.09 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.825 -0.91 . . . . 10.0 110.825 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.9 130.1 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 117.066 0.433 . . . . 10.0 110.21 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.754 HD22 ' HB3' ' A' ' 15' ' ' SER . 15.3 tp -135.18 143.47 46.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.416 . . . . 10.0 110.755 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 2.4 ptp180 -88.86 78.11 7.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.772 -0.649 . . . . 10.0 111.742 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.954 ' CG1' HG11 ' A' ' 13' ' ' VAL . 14.5 mm -88.81 178.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 106.856 -1.535 . . . . 10.0 106.856 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 17.3 p -141.43 -175.91 4.53 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.709 ' CD ' HD23 ' A' ' 8' ' ' LEU . 88.2 tt0 -127.73 72.3 1.39 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.949 0.88 . . . . 10.0 112.738 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -108.82 19.49 19.57 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.197 -1.365 . . . . 10.0 107.767 176.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 114' ' ' VAL . 75.0 mm-40 -125.64 -65.75 0.98 Allowed 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.068 -0.969 . . . . 10.0 111.363 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.825 HD23 ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -82.57 48.59 1.33 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.013 -0.54 . . . . 10.0 112.066 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.26 133.93 52.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 10.0 110.86 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.4 mt 68.94 -54.8 0.56 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.123 -0.49 . . . . 10.0 111.987 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 112' ' ' THR . 9.4 t -179.02 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.99 0.424 . . . . 10.0 111.229 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.613 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 24.6 t-20 67.31 114.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.972 -0.558 . . . . 10.0 111.007 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 108' ' ' GLN . 54.6 t -84.93 -42.66 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.342 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.4 m -168.4 153.05 6.2 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.092 -0.504 . . . . 10.0 111.01 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 26.8 m-20 -51.67 -34.44 38.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.501 . . . . 10.0 111.388 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 47.0 mmtm 69.24 -56.77 0.54 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.367 -0.378 . . . . 10.0 111.719 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.691 ' CE1' HD21 ' A' ' 69' ' ' LEU . 45.2 t80 -58.23 -46.37 86.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.272 0.558 . . . . 10.0 109.864 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 144.61 -53.19 0.58 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.365 -0.834 . . . . 10.0 111.961 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 62.6 tttm 171.72 55.24 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 4.1 tppp? -154.41 -30.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.604 0.594 . . . . 10.0 112.604 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.784 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 87.8 p -145.6 -163.9 1.83 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.694 -0.402 . . . . 10.0 111.833 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 23.6 tptm -72.11 -50.84 24.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.692 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 117' ' ' LYS . . . 170.02 -160.21 33.06 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 119.816 -1.183 . . . . 10.0 113.956 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.818 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.4 tm? -129.94 135.91 48.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.121 -0.54 . . . . 10.0 110.855 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.818 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -117.47 159.98 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.405 0.621 . . . . 10.0 111.847 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.505 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -163.07 137.4 6.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.592 -0.731 . . . . 10.0 110.617 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.553 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 8.7 m -165.14 150.09 9.22 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.623 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 56.83 44.17 23.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.943 0.402 . . . . 10.0 110.801 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.21 33.91 39.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.696 -0.764 . . . . 10.0 112.04 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 128' ' ' THR . 14.2 ptt180 -133.49 136.19 44.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.1 mt -88.89 139.95 29.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.046 0.451 . . . . 10.0 111.585 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.017 HG12 ' HB3' ' A' ' 22' ' ' ALA . 4.1 mt -145.37 132.8 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.543 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.848 ' HB ' HD13 ' A' ' 23' ' ' LEU . 2.0 mp -88.89 149.56 3.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.617 -0.882 . . . . 10.0 108.617 177.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.489 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 38.6 t80 -135.38 145.11 47.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.036 -0.665 . . . . 10.0 111.707 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.872 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 6.2 mp -138.85 164.23 30.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.758 0.79 . . . . 10.0 112.416 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -134.53 26.71 3.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.439 -1.255 . . . . 10.0 108.402 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.926 ' HA ' HG23 ' A' ' 141' ' ' ILE . 8.4 tt 41.21 17.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 114.375 -1.284 . . . . 10.0 114.211 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.36 -62.42 1.66 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.691 0.626 . . . . 10.0 112.691 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -75.82 -31.85 59.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.611 0.719 . . . . 10.0 109.903 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.59 -45.82 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 114.759 -1.11 . . . . 10.0 110.785 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.012 HD13 HG21 ' A' ' 91' ' ' VAL . 7.9 tp -64.48 -43.18 96.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 C-N-CA 119.987 -0.685 . . . . 10.0 109.902 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.535 ' N ' HG23 ' A' ' 142' ' ' ILE . 35.1 tp10 -47.71 -46.47 29.63 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.293 0.568 . . . . 10.0 110.072 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.719 ' HB2' HD11 ' A' ' 68' ' ' ILE . 53.2 mm-40 -67.4 -36.45 81.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.409 -0.814 . . . . 10.0 110.597 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.639 ' CD1' HG11 ' A' ' 91' ' ' VAL . 54.1 mt -53.77 -38.72 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.92 0.391 . . . . 10.0 110.843 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.6 p -74.81 -48.8 23.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.368 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.8 p -79.23 6.26 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 111.952 0.353 . . . . 10.0 111.952 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.483 ' HD2' ' HB2' ' A' ' 48' ' ' PHE . 22.6 pttp -51.0 -34.09 27.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.687 0.28 . . . . 10.0 111.462 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 52.8 mm-40 65.2 136.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.878 0.371 . . . . 10.0 111.038 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -176.54 45.35 0.11 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.898 -0.668 . . . . 10.0 112.33 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 43.8 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.352 . . . . 10.0 111.035 -179.884 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.845 0.355 . . . . 10.0 111.153 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' HG3' ' HG ' ' A' ' 4' ' ' LEU . 19.9 tptm -164.23 -43.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.266 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 38.6 m 76.29 -46.42 0.53 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.9 pp -53.32 -43.69 67.82 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.178 -0.209 . . . . 10.0 111.32 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.852 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -179.38 134.96 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 10.0 111.521 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -67.03 148.65 51.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.634 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 8' ' ' LEU . . . -171.25 140.44 1.47 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.214 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.885 HD13 HD12 ' A' ' 109' ' ' LEU . 80.4 mt 70.46 115.28 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.535 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.548 ' NZ ' HG21 ' A' ' 105' ' ' THR . 19.6 tptt -155.52 -57.85 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.526 -0.761 . . . . 10.0 111.274 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 40.3 tt0 -117.02 163.9 15.53 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.435 0.636 . . . . 10.0 111.021 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.619 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.6 t80 -163.19 137.95 6.36 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.834 -1.075 . . . . 10.0 112.855 -174.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 68.1 mt-10 -88.8 138.93 30.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.632 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.859 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.1 p -155.58 174.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 -175.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.798 HD11 HD13 ' A' ' 82' ' ' ILE . 3.2 tm? -88.74 136.98 32.72 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.004 -1.109 . . . . 10.0 108.004 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.764 ' CB ' HD22 ' A' ' 102' ' ' LEU . 81.8 p -149.37 157.67 43.52 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 113.993 1.108 . . . . 10.0 113.993 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.739 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -149.98 158.08 43.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 113.948 -1.478 . . . . 10.0 109.837 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.719 ' HG2' HD21 ' A' ' 99' ' ' LEU . 5.1 mm-40 -88.59 88.95 7.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 10.0 111.048 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.053 HG21 HD12 ' A' ' 71' ' ' ILE . 16.8 mm -88.91 124.21 41.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.852 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.754 ' OD2' HG22 ' A' ' 18' ' ' ILE . 1.9 p30 36.62 60.07 0.95 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.601 -0.727 . . . . 10.0 112.571 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 76.97 -43.46 0.44 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.037 -0.983 . . . . 10.0 112.688 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 22' ' ' ALA . 3.0 pp0? -89.02 166.0 14.18 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 120.915 -0.314 . . . . 10.0 110.38 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.015 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.77 150.17 23.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 10.0 112.27 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.941 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -133.56 130.69 38.77 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 178.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.904 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -138.33 153.88 48.98 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.615 0.968 . . . . 10.0 113.615 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.86 ' CE2' HD22 ' A' ' 136' ' ' LEU . 2.3 m-85 -135.73 142.31 45.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.527 -1.215 . . . . 10.0 107.97 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -50.81 123.46 9.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 10.0 110.374 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.859 HG13 ' HA ' ' A' ' 13' ' ' VAL . 34.7 m -60.03 -12.29 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.508 -0.769 . . . . 10.0 111.863 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -63.42 -42.77 98.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.98 0.419 . . . . 10.0 110.127 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.692 ' CG ' HG21 ' A' ' 138' ' ' ILE . 12.1 t-20 -87.34 -45.68 10.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.561 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.784 HG21 ' HG ' ' A' ' 14' ' ' LEU . 11.8 mm -65.55 138.55 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.045 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 32' ' ' MET . 24.9 pt-20 -113.31 -50.07 2.88 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 3.5 mtm -163.95 -175.96 4.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.966 0.412 . . . . 10.0 111.552 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 98' ' ' VAL . 33.9 m -127.84 126.59 67.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.934 -0.576 . . . . 10.0 111.465 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.413 HG13 ' HB ' ' A' ' 81' ' ' ILE . 27.2 pt -96.15 171.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.038 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -88.83 147.63 24.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 10.0 110.947 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.66 ' HD2' HD11 ' A' ' 94' ' ' LEU . 63.4 tttp -88.87 136.49 32.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.166 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 87.1 p 179.13 -167.67 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.81 -0.632 . . . . 10.0 110.353 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -52.31 140.0 22.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.543 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 40' ' ' THR . 24.7 mt -155.25 -83.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.77 HG23 ' HG2' ' A' ' 43' ' ' PRO . 96.3 m -139.68 70.78 37.44 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.861 0.362 . . . . 10.0 111.253 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -86.14 -50.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.092 2.528 . . . . 10.0 113.448 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.643 HG12 ' HD3' ' A' ' 43' ' ' PRO . 13.2 p -74.43 -33.9 1.75 Allowed Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 112.682 0.623 . . . . 10.0 112.682 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.77 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.5 Cg_exo -72.42 12.16 0.7 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.432 2.088 . . . . 10.0 113.141 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.536 ' NZ ' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -45.56 160.03 0.06 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.174 0.511 . . . . 10.0 111.765 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.475 ' H ' ' HD2' ' A' ' 46' ' ' ARG . 47.3 t 176.92 45.52 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.225 -0.898 . . . . 10.0 110.773 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -177.75 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 10.0 110.731 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.508 ' HB3' ' O ' ' A' ' 46' ' ' ARG . 77.4 t60 82.23 -45.97 0.17 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.727 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.509 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -57.2 -50.65 72.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 10.0 110.496 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.816 ' HA ' HG22 ' A' ' 63' ' ' VAL . 62.0 t -73.4 130.55 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.769 ' HG3' HG23 ' A' ' 62' ' ' VAL . 22.7 pt-20 -75.82 -39.04 57.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -167.91 -175.91 38.05 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.54 -0.838 . . . . 10.0 113.085 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 53' ' ' ILE . 3.2 m -159.13 171.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.756 -0.461 . . . . 10.0 109.756 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.487 ' CG2' HG23 ' A' ' 39' ' ' ILE . 31.5 pt -159.51 132.31 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.147 0.498 . . . . 10.0 112.332 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.853 ' ND2' HD11 ' A' ' 59' ' ' ILE . 20.7 t-20 -93.8 134.24 36.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.536 -0.757 . . . . 10.0 110.348 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.1 tp -169.09 138.77 2.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.988 0.423 . . . . 10.0 111.275 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 48.72 46.89 21.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.228 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.64 40.74 71.76 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.697 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.491 ' C ' HD12 ' A' ' 59' ' ' ILE . 64.0 mtt85 -158.19 121.64 3.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 10.0 110.737 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.853 HD11 ' ND2' ' A' ' 54' ' ' ASN . 1.4 mp -101.09 132.74 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.858 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.799 HG22 ' HB3' ' A' ' 90' ' ' GLU . 2.2 pp -114.01 134.24 22.19 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.638 -0.256 . . . . 10.0 110.735 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 92.1 Cg_endo -100.55 114.05 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.301 2.668 . . . . 10.0 113.19 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.769 HG23 ' HG3' ' A' ' 50' ' ' GLU . 19.7 m -89.14 133.12 32.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.956 -0.757 . . . . 10.0 108.956 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.816 HG22 ' HA ' ' A' ' 49' ' ' VAL . 63.1 t -143.31 156.21 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.657 0.741 . . . . 10.0 112.953 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.506 ' N ' HG12 ' A' ' 63' ' ' VAL . 74.6 m-20 -74.49 68.36 1.58 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.756 -1.111 . . . . 10.0 109.214 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.911 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.3 tt -53.41 -30.59 41.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.239 0.542 . . . . 10.0 110.814 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.638 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . . . -63.01 -26.5 68.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' HE2' ' A' ' 73' ' ' PHE . 0.8 OUTLIER -83.5 -42.0 17.36 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.966 179.19 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 65' ' ' LEU . 12.8 tt -58.79 -42.1 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 107.175 -1.416 . . . . 10.0 107.175 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.88 ' C ' HD13 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -73.82 -45.28 52.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 113.76 -1.564 . . . . 10.0 108.435 176.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.498 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 113.52 -91.24 0.57 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.539 -0.755 . . . . 10.0 113.15 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.053 HD12 HG21 ' A' ' 18' ' ' ILE . 3.1 pt 48.28 164.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 112.812 0.671 . . . . 10.0 112.812 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.562 ' HB3' ' CG ' ' A' ' 19' ' ' ASP . 29.4 t -47.23 -32.99 4.98 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.328 -0.619 . . . . 10.0 109.328 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.856 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.2 t80 -33.18 141.55 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.191 -0.913 . . . . 10.0 112.533 176.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -171.87 43.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.49 -0.777 . . . . 10.0 110.196 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 78' ' ' MET . 50.0 mt-10 62.79 43.45 7.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.508 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 19.4 pt20 -74.54 -52.66 11.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HD2' ' C ' ' A' ' 76' ' ' GLN . 2.6 mptt -146.4 18.97 1.36 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 112.275 0.472 . . . . 10.0 112.275 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.628 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 9.4 mmm -47.45 145.85 2.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.582 0.229 . . . . 10.0 110.525 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -174.38 38.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 10.0 111.14 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.746 ' O ' HD12 ' A' ' 94' ' ' LEU . 71.1 m -169.14 162.47 10.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 10.0 109.875 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 70.3 mt -139.61 123.49 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.606 -0.438 . . . . 10.0 111.969 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.798 HD13 HD11 ' A' ' 14' ' ' LEU . 10.7 mt -89.01 130.96 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.494 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.32 146.64 9.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.071 0.462 . . . . 10.0 111.125 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -145.19 -178.72 6.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.566 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 41.8 mtm-85 -138.95 131.07 28.09 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.756 HG21 HG12 ' A' ' 138' ' ' ILE . 82.4 p -144.2 110.99 5.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.927 0.394 . . . . 10.0 112.035 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? 47.8 48.2 17.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.349 0.595 . . . . 10.0 110.735 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 73.51 32.35 1.21 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.085 -0.961 . . . . 10.0 111.564 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 91' ' ' VAL . 53.7 t -128.4 110.88 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.311 -0.859 . . . . 10.0 109.451 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.799 ' HB3' HG22 ' A' ' 60' ' ' ILE . 88.5 tt0 -88.27 98.34 11.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 106.14 -1.8 . . . . 10.0 106.14 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.01 HG21 HD13 ' A' ' 142' ' ' ILE . 3.6 t -88.62 153.93 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 112.983 -1.917 . . . . 10.0 113.353 -173.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -124.13 152.66 17.35 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-N 114.506 -1.225 . . . . 10.0 113.148 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.645 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -141.66 130.0 22.39 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.746 HD12 ' O ' ' A' ' 80' ' ' SER . 66.1 tp -88.56 133.68 34.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.205 0.526 . . . . 10.0 111.445 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.734 HG12 HD11 ' A' ' 18' ' ' ILE . 27.1 m -150.27 -175.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.357 -0.838 . . . . 10.0 110.776 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 78' ' ' MET . 60.3 t0 -111.51 -56.85 2.33 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.338 0.496 . . . . 10.0 112.338 -176.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -133.87 124.72 26.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.986 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 33' ' ' VAL . 5.9 p -115.94 113.12 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-O 122.336 1.065 . . . . 10.0 112.004 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.719 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -63.82 -30.19 71.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.292 -1.776 . . . . 10.0 111.343 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.58 -120.14 5.47 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.707 -0.957 . . . . 10.0 110.707 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.8 p -54.57 131.23 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 117.099 0.449 . . . . 10.0 110.064 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.764 HD22 ' CB ' ' A' ' 15' ' ' SER . 54.6 tp -135.02 139.42 44.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.142 0.496 . . . . 10.0 111.469 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.1 ptp85 -88.9 72.35 8.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.1 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.973 HD12 HG21 ' A' ' 126' ' ' VAL . 9.6 mm -88.73 132.79 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.188 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.8 p -88.51 148.28 24.21 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 106.989 -1.486 . . . . 10.0 106.989 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.479 ' HG2' ' CD2' ' A' ' 109' ' ' LEU . 18.6 tp10 -140.25 90.08 2.34 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.506 -0.878 . . . . 10.0 111.849 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -91.15 16.43 9.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.741 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.611 ' HA ' ' HB2' ' A' ' 113' ' ' ASN . 1.5 pt20 -118.97 -80.17 0.61 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.524 -0.762 . . . . 10.0 110.685 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.885 HD12 HD13 ' A' ' 8' ' ' LEU . 79.3 mt 63.5 -121.72 0.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.02 -0.537 . . . . 10.0 111.528 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.602 ' HA ' HG22 ' A' ' 114' ' ' VAL . 7.6 t70 -151.53 -45.49 0.11 Allowed 'General case' 0 C--O 1.23 0.047 0 CA-C-O 120.857 0.361 . . . . 10.0 110.79 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.752 ' O ' HD23 ' A' ' 111' ' ' LEU . 5.6 tt -63.94 -40.66 96.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.748 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.46 HG23 ' N ' ' A' ' 113' ' ' ASN . 9.4 t -95.01 -46.02 7.0 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.151 0.501 . . . . 10.0 111.288 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.611 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 75.5 m-80 -159.34 -158.31 0.66 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.309 -0.86 . . . . 10.0 109.904 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 110' ' ' ASP . 5.1 t -162.21 -58.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.841 0.353 . . . . 10.0 110.467 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 114' ' ' VAL . 99.4 p 58.55 117.92 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.22 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.438 ' O ' ' HA3' ' A' ' 124' ' ' GLY . 12.1 p-10 -60.24 -48.31 82.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.45 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.469 ' HB2' ' HA3' ' A' ' 124' ' ' GLY . 74.2 mmtt 64.82 -57.46 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.177 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.633 ' CE2' HD21 ' A' ' 69' ' ' LEU . 25.3 t80 -89.48 -56.39 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.031 0.443 . . . . 10.0 110.495 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.34 -146.58 18.24 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.712 -0.676 . . . . 10.0 112.341 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -88.23 54.05 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 10.0 110.678 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 68' ' ' ILE . 17.9 tppt? -139.55 -39.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.033 0.383 . . . . 10.0 112.033 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.583 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 99.6 p -152.98 -163.1 1.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.664 0.269 . . . . 10.0 110.697 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.565 ' HE2' ' CD2' ' A' ' 135' ' ' TYR . 0.1 OUTLIER -63.13 -55.21 27.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.875 -0.33 . . . . 10.0 110.351 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.536 ' N ' ' HE3' ' A' ' 123' ' ' LYS . . . 149.56 155.89 6.98 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.355 -1.403 . . . . 10.0 114.692 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.886 HD13 ' N ' ' A' ' 126' ' ' VAL . 3.1 tm? -60.25 144.7 49.66 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.87 -0.665 . . . . 10.0 110.632 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.973 HG21 HD12 ' A' ' 104' ' ' ILE . 2.4 p -127.38 156.51 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.295 0.569 . . . . 10.0 111.686 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.42 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 96.5 mttt -147.02 140.65 25.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 131' ' ' ARG . 6.3 m -163.24 142.08 8.31 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.803 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 56.02 44.1 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.958 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.56 35.23 29.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.105 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.561 ' HD2' ' CG1' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -133.84 148.86 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.2 mp -88.75 139.33 30.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.399 0.619 . . . . 10.0 112.471 -177.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.015 HG12 ' HB3' ' A' ' 22' ' ' ALA . 6.2 mt -151.5 150.35 13.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.241 -0.891 . . . . 10.0 110.571 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.941 ' HB ' HD13 ' A' ' 23' ' ' LEU . 6.1 mm -103.6 130.9 53.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.565 ' CD2' ' HE2' ' A' ' 123' ' ' LYS . 10.3 t80 -117.42 139.26 51.13 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 119.915 -0.714 . . . . 10.0 111.364 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.86 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.2 mp -135.67 165.98 24.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.497 -0.774 . . . . 10.0 112.145 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 123' ' ' LYS . 10.6 p-10 -135.45 24.28 3.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.657 -1.156 . . . . 10.0 108.293 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.901 ' HA ' HG23 ' A' ' 141' ' ' ILE . 11.1 tt 41.7 17.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.286 -1.325 . . . . 10.0 113.961 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.7 t70 -82.72 -60.19 2.26 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.729 0.64 . . . . 10.0 112.729 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 3.4 mptp? -75.3 -34.26 61.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.699 0.761 . . . . 10.0 109.631 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.901 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.45 -46.15 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.664 -1.153 . . . . 10.0 110.732 179.229 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.01 HD13 HG21 ' A' ' 91' ' ' VAL . 7.6 tp -62.73 -45.84 97.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 C-N-CA 120.193 -0.603 . . . . 10.0 110.436 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.738 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.3 tt0 -47.92 -44.61 30.01 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.351 0.596 . . . . 10.0 109.756 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.601 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.3 mt-10 -69.6 -30.94 68.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.246 -0.888 . . . . 10.0 110.898 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.653 ' CD1' HG11 ' A' ' 91' ' ' VAL . 48.4 mt -57.61 -54.01 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 120.843 0.354 . . . . 10.0 111.418 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.4 p -69.05 -52.28 30.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.868 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 143' ' ' GLU . 14.0 p -67.25 -12.46 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.811 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.625 ' HA ' ' HE2' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -46.53 -52.77 12.67 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.842 0.354 . . . . 10.0 111.092 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 149' ' ' GLU . 38.3 tt0 -178.61 46.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.059 0.457 . . . . 10.0 110.829 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 80.26 42.61 10.38 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.897 -0.668 . . . . 10.0 112.21 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.724 HG11 ' CG2' ' A' ' 49' ' ' VAL . 47.4 t . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 120.909 0.385 . . . . 10.0 111.027 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.799 0.333 . . . . 10.0 110.973 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.935 ' HD2' ' HB2' ' A' ' 5' ' ' ALA . 4.9 ttmp? -63.2 -52.43 62.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.9 m 67.63 -54.64 0.49 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.495 0.554 . . . . 10.0 112.495 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.823 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.1 pp -55.14 -23.93 23.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.74 0.305 . . . . 10.0 111.386 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.935 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . . . -51.51 130.09 26.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 10.0 111.431 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -67.93 142.09 56.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.779 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.54 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -53.46 -66.54 0.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.57 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 7' ' ' ALA . 96.9 mt -159.96 44.01 0.22 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.855 0.36 . . . . 10.0 111.166 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -74.05 -51.99 14.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.557 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.589 ' HG2' HG22 ' A' ' 105' ' ' THR . 35.1 mt-10 -124.95 164.23 20.56 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.53 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.617 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 12.1 t80 -153.6 137.51 16.27 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.718 -1.128 . . . . 10.0 113.037 -174.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 70.8 mt-10 -88.78 137.36 32.38 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.791 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -152.07 171.05 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.333 -0.849 . . . . 10.0 112.504 -175.696 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.681 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.9 tm? -88.85 134.94 33.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.795 ' HB3' HD22 ' A' ' 102' ' ' LEU . 80.6 p -148.16 153.03 38.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.096 0.776 . . . . 10.0 113.096 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.697 ' HZ ' ' CE1' ' A' ' 25' ' ' PHE . 1.8 p90 -149.79 168.1 24.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.269 -1.332 . . . . 10.0 110.143 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.55 129.67 35.42 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.829 HD11 HG12 ' A' ' 95' ' ' VAL . 4.5 mm -136.65 117.77 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.759 -0.655 . . . . 10.0 111.519 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.573 ' OD2' HG22 ' A' ' 18' ' ' ILE . 1.9 p30 38.44 60.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.17 -0.923 . . . . 10.0 112.621 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER 78.4 -43.06 0.35 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.916 -1.038 . . . . 10.0 112.742 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.534 ' NE2' ' HB ' ' A' ' 18' ' ' ILE . 3.5 pp0? -89.25 163.07 15.54 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.871 -0.332 . . . . 10.0 110.88 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.977 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.73 151.63 22.29 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.804 0.335 . . . . 10.0 110.84 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -133.58 134.75 43.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.077 -179.221 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.66 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -137.23 141.02 42.07 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.214 0.82 . . . . 10.0 113.214 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.04 ' CE2' HD13 ' A' ' 65' ' ' LEU . 1.4 m-85 -119.23 135.86 54.49 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.826 -1.175 . . . . 10.0 107.826 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -51.06 123.59 9.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.467 -0.493 . . . . 10.0 110.802 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.717 HG13 ' HA ' ' A' ' 13' ' ' VAL . 15.7 m -64.4 -8.68 5.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.608 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.6 -31.43 68.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.01 0.433 . . . . 10.0 110.524 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.808 ' OD1' HG21 ' A' ' 138' ' ' ILE . 7.3 t-20 -106.88 -50.22 3.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.918 -0.583 . . . . 10.0 112.401 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.681 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.1 mm -49.61 135.88 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.779 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 32' ' ' MET . 16.3 pt-20 -111.45 -51.65 2.84 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.889 0.7 . . . . 10.0 112.889 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.4 mtm -169.07 157.93 8.16 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.058 0.456 . . . . 10.0 111.88 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.719 HG11 HG11 ' A' ' 98' ' ' VAL . 34.8 m -89.68 177.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.033 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.628 HG13 ' HB ' ' A' ' 81' ' ' ILE . 20.6 pt -160.66 157.47 2.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.383 -0.826 . . . . 10.0 110.192 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -88.75 136.62 32.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 10.0 111.398 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.546 ' HB2' HG13 ' A' ' 81' ' ' ILE . 1.2 tmtp? -88.91 130.03 35.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.009 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.527 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 80.1 p -175.73 129.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.974 0.416 . . . . 10.0 111.846 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.1 t0 40.19 44.53 1.57 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.68 -0.691 . . . . 10.0 111.954 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 40' ' ' THR . 7.9 mt -78.3 156.31 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.108 0.48 . . . . 10.0 111.565 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.885 HG23 ' HG2' ' A' ' 43' ' ' PRO . 22.3 m -36.64 93.57 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.048 -0.978 . . . . 10.0 112.09 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -95.18 -52.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.293 2.662 . . . . 10.0 114.204 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.515 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 45.3 t -67.69 -47.31 45.18 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 112.659 0.615 . . . . 10.0 112.659 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.885 ' HG2' HG23 ' A' ' 40' ' ' THR . 52.9 Cg_exo -53.79 -57.93 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.896 1.731 . . . . 10.0 112.22 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.446 ' HG2' ' H ' ' A' ' 47' ' ' HIS . 37.4 ttpt 58.33 -79.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.208 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' PRO . 68.3 m 42.23 44.64 3.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.65 -0.704 . . . . 10.0 112.164 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HD3' HG21 ' A' ' 49' ' ' VAL . 79.5 mtt-85 -160.92 -36.88 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.48 -0.327 . . . . 10.0 111.377 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 20.8 m80 73.04 -57.3 0.64 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.188 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 2.2 t80 -68.09 -53.22 27.02 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.846 -0.427 . . . . 10.0 109.846 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 63' ' ' VAL . 60.8 t -67.68 133.37 31.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.776 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' OE2' HG23 ' A' ' 62' ' ' VAL . 1.7 pp20? -72.8 -35.91 67.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.445 -0.343 . . . . 10.0 111.725 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.539 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -158.66 -176.01 30.23 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 119.659 -1.258 . . . . 10.0 113.755 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.603 HG22 HG21 ' A' ' 40' ' ' THR . 2.0 m -156.95 169.76 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.595 HG13 HD23 ' A' ' 55' ' ' LEU . 26.9 pt -158.78 138.15 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.946 0.403 . . . . 10.0 111.583 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.87 ' C ' HD22 ' A' ' 55' ' ' LEU . 46.3 t30 -88.91 116.88 27.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.607 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.87 HD22 ' C ' ' A' ' 54' ' ' ASN . 3.5 mm? -144.23 140.63 29.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.732 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 56' ' ' ARG . 10.4 mpt_? 53.39 45.84 27.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.061 0.458 . . . . 10.0 110.731 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.81 35.66 63.79 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.719 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.1 mtm-85 -160.24 131.22 5.67 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.765 0.317 . . . . 10.0 110.815 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.621 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.92 133.85 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.746 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.797 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.4 pp -115.69 132.72 23.02 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.422 -0.354 . . . . 10.0 111.326 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 95.2 Cg_endo -84.6 116.43 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.384 2.056 . . . . 10.0 112.593 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.539 HG22 ' C ' ' A' ' 51' ' ' GLY . 7.6 m -89.0 99.54 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.346 -0.612 . . . . 10.0 109.346 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 49' ' ' VAL . 3.1 t -99.52 -175.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.019 -0.991 . . . . 10.0 110.144 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.879 ' H ' HG12 ' A' ' 63' ' ' VAL . 38.1 m-20 -132.55 87.82 2.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.08 -0.509 . . . . 10.0 109.986 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.04 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.6 tt -51.14 -24.75 4.38 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.122 -0.631 . . . . 10.0 111.137 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.758 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -66.67 -29.51 69.54 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.827 -0.349 . . . . 10.0 111.058 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.828 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -86.08 -37.88 18.39 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.812 0.339 . . . . 10.0 110.15 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.728 HG22 ' HA ' ' A' ' 65' ' ' LEU . 10.3 tt -65.35 -38.24 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 107.508 -1.293 . . . . 10.0 107.508 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.827 ' C ' HD13 ' A' ' 69' ' ' LEU . 1.5 tm? -78.29 -46.94 18.94 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.553 -1.658 . . . . 10.0 108.724 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.556 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 115.02 -89.64 0.51 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.305 -0.861 . . . . 10.0 112.633 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.842 HG13 ' HB3' ' A' ' 73' ' ' PHE . 4.4 pt 47.12 164.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 16.3 t -48.1 -33.05 7.62 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.842 ' HB3' HG13 ' A' ' 71' ' ' ILE . 16.5 t80 -30.6 145.42 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.219 -0.9 . . . . 10.0 112.634 176.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -166.44 33.62 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.31 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.495 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 56.2 mt-10 55.0 46.03 25.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.683 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.45 ' HB2' ' HE2' ' A' ' 77' ' ' LYS . 98.6 mm-40 -95.64 -53.48 3.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -102.09 -32.75 9.98 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.298 0.481 . . . . 10.0 112.298 -178.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.624 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 2.9 mmm -28.85 142.65 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.87 0.468 . . . . 10.0 112.248 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.76 39.33 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.079 -0.509 . . . . 10.0 111.283 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.4 t -169.06 127.69 1.02 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.736 -0.665 . . . . 10.0 109.644 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.628 ' HB ' HG13 ' A' ' 34' ' ' ILE . 47.8 mt -98.2 151.31 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.631 HD13 HD11 ' A' ' 14' ' ' LEU . 11.0 mt -115.65 123.8 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.879 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.526 ' CG2' HD13 ' A' ' 34' ' ' ILE . 65.3 t -91.31 147.6 5.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.503 0.668 . . . . 10.0 111.928 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -150.67 171.31 17.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.017 -0.992 . . . . 10.0 110.384 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.597 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 12.1 ptp180 -127.29 143.79 51.17 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.541 -0.54 . . . . 10.0 109.541 178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.5 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 34.5 p -159.0 108.56 1.94 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.269 0.47 . . . . 10.0 112.269 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.2 tppp? 46.79 48.49 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.355 0.598 . . . . 10.0 110.816 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 72.47 33.88 1.37 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.081 -0.963 . . . . 10.0 111.244 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.935 HG12 HG22 ' A' ' 91' ' ' VAL . 75.0 t -132.45 110.62 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-N 115.122 -0.945 . . . . 10.0 109.193 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.679 ' HB2' HG22 ' A' ' 60' ' ' ILE . 1.7 mp0 -88.36 96.25 10.51 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.043 HG21 HD13 ' A' ' 142' ' ' ILE . 3.4 t -88.64 153.26 3.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 113.273 -1.785 . . . . 10.0 112.792 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -131.84 153.87 20.69 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 114.997 -1.001 . . . . 10.0 113.701 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.726 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 t80 -139.86 128.54 23.12 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.453 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 51.1 tp -88.72 136.19 33.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.562 0.696 . . . . 10.0 112.209 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.829 HG12 HD11 ' A' ' 18' ' ' ILE . 23.8 m -148.86 -175.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.805 -1.089 . . . . 10.0 110.098 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.448 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 6.6 t70 -106.31 -57.96 1.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.496 HH12 HD11 ' A' ' 99' ' ' LEU . 55.4 ttp85 -133.96 116.34 15.45 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.369 0.604 . . . . 10.0 109.825 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.719 HG11 HG11 ' A' ' 33' ' ' VAL . 9.3 p -105.08 116.09 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 122.49 1.138 . . . . 10.0 111.852 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.641 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -65.73 -29.69 70.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.908 -1.951 . . . . 10.0 110.774 -178.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.8 -122.14 5.91 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.174 -0.77 . . . . 10.0 111.174 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -53.22 129.91 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 117.148 0.474 . . . . 10.0 110.292 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.804 ' HB3' HG13 ' A' ' 13' ' ' VAL . 60.7 tp -132.02 141.66 49.32 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.104 0.478 . . . . 10.0 111.236 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 103' ' ' ARG . 14.4 ptp180 -88.87 68.79 8.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.011 HD12 HG21 ' A' ' 126' ' ' VAL . 22.3 mm -88.75 132.04 34.63 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.589 HG22 ' HG2' ' A' ' 10' ' ' GLU . 30.3 p -88.73 -175.77 5.02 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.223 -1.028 . . . . 10.0 108.223 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.768 ' OE2' HD12 ' A' ' 109' ' ' LEU . 37.1 tt0 -147.3 75.71 1.38 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.322 -0.951 . . . . 10.0 112.423 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -103.1 20.63 17.27 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.763 -1.108 . . . . 10.0 109.272 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -126.73 -49.45 1.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.453 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.768 HD12 ' OE2' ' A' ' 106' ' ' GLU . 17.5 mt -62.34 -31.12 71.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.841 0.353 . . . . 10.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 109' ' ' LEU . 66.7 t0 72.8 -57.7 0.62 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.036 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.968 HD12 ' N ' ' A' ' 112' ' ' THR . 3.6 pp 171.63 -35.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.566 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.968 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.7 t -90.59 2.84 55.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.366 -0.834 . . . . 10.0 111.764 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 58.25 76.01 0.36 Allowed 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.768 0.318 . . . . 10.0 110.393 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.726 HG23 HG23 ' A' ' 112' ' ' THR . 10.9 t -156.47 104.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.094 0.473 . . . . 10.0 110.721 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.9 t -174.4 -40.12 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.544 -0.753 . . . . 10.0 111.041 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 38.18 92.62 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.311 0.577 . . . . 10.0 112.005 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.616 ' HB2' ' HA3' ' A' ' 124' ' ' GLY . 73.0 mmtt -77.23 -20.47 55.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.367 -0.833 . . . . 10.0 112.124 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.735 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . 19.8 t80 -73.82 -59.81 2.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.005 0.431 . . . . 10.0 110.949 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 146.57 53.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.901 -0.666 . . . . 10.0 112.16 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 68.62 55.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.087 0.47 . . . . 10.0 110.844 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.439 ' HD2' ' CE2' ' A' ' 118' ' ' PHE . 24.2 ttmm -148.08 -37.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.639 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 92.1 p -162.84 -161.36 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.746 -0.465 . . . . 10.0 109.746 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.739 ' HD2' HD21 ' A' ' 109' ' ' LEU . 73.6 mmtt -58.93 -44.26 91.31 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.775 0.321 . . . . 10.0 110.399 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.735 ' HA2' ' HB2' ' A' ' 118' ' ' PHE . . . 111.96 -168.5 12.76 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.523 -0.846 . . . . 10.0 114.26 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.931 HD13 ' N ' ' A' ' 126' ' ' VAL . 1.8 tm? -69.18 142.21 54.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.155 0.503 . . . . 10.0 111.244 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 1.011 HG21 HD12 ' A' ' 104' ' ' ILE . 2.2 p -131.54 157.09 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.643 -0.708 . . . . 10.0 111.015 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -152.89 140.99 20.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.162 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.571 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 6.2 m -167.46 147.49 5.24 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.849 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 57.28 42.86 24.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.431 . . . . 10.0 110.809 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.0 34.44 30.94 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.108 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -132.99 148.44 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.693 0.282 . . . . 10.0 110.274 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.8 139.47 30.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 10.0 111.11 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.977 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.2 mt -152.28 156.56 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.954 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.646 ' HB ' HD13 ' A' ' 23' ' ' LEU . 63.4 mt -117.79 126.91 75.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.561 ' CE1' HG21 ' A' ' 13' ' ' VAL . 15.1 t80 -116.03 146.47 42.14 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.924 -0.31 . . . . 10.0 110.535 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.787 HD21 ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -161.29 154.05 20.68 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.752 0.787 . . . . 10.0 112.717 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 141' ' ' ILE . 2.9 p30 -105.59 133.99 49.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.754 -1.112 . . . . 10.0 108.52 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.926 ' HA ' HG23 ' A' ' 141' ' ' ILE . 15.2 tt -67.11 6.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -74.89 -47.79 28.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.902 0.382 . . . . 10.0 111.652 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.4 mptt -83.66 -34.76 24.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.163 0.506 . . . . 10.0 110.585 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -69.05 -35.83 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.593 179.127 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.043 HD13 HG21 ' A' ' 91' ' ' VAL . 7.8 tp -71.14 -44.15 74.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.527 ' N ' HG23 ' A' ' 142' ' ' ILE . 39.4 tt0 -47.3 -42.7 21.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.558 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.6 mt-10 -71.09 -35.34 71.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.471 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.71 HG13 ' O ' ' A' ' 141' ' ' ILE . 26.7 mt -53.43 -38.84 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-O 120.8 0.333 . . . . 10.0 111.096 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.6 p -80.65 -50.46 9.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.903 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.2 p -76.71 4.91 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 112.05 0.389 . . . . 10.0 112.05 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.461 ' HD2' ' CB ' ' A' ' 48' ' ' PHE . 22.0 pttp -46.05 -33.22 3.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.44 134.52 22.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.855 0.36 . . . . 10.0 111.156 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.4 43.27 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.985 -0.626 . . . . 10.0 112.343 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.338 . . . . 10.0 110.946 -179.939 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 62.8 mtt . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.706 0.289 . . . . 10.0 111.111 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 1' ' ' MET . 67.1 mttm 69.63 -46.64 0.59 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.222 -0.445 . . . . 10.0 112.061 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.8 p 56.54 30.31 17.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.119 0.485 . . . . 10.0 110.502 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.9 mt -108.3 -51.74 2.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.649 -0.705 . . . . 10.0 110.33 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.18 134.43 38.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.784 -0.643 . . . . 10.0 111.184 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 43.34 -169.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.5 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 63.65 131.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.903 0.382 . . . . 10.0 111.136 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.962 HD13 HD12 ' A' ' 109' ' ' LEU . 53.2 mt -88.03 46.17 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.979 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.511 ' O ' HG22 ' A' ' 105' ' ' THR . 31.3 mmmt -84.93 -55.7 3.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 10.0 111.801 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.639 ' HG2' HG22 ' A' ' 105' ' ' THR . 77.2 mt-10 -129.84 164.26 24.51 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.364 0.602 . . . . 10.0 111.038 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.563 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 15.7 t80 -161.67 138.62 8.48 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.937 -1.029 . . . . 10.0 112.881 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.76 140.62 29.26 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.724 -0.671 . . . . 10.0 109.632 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.805 HG13 ' HB3' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -156.39 169.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 113.287 0.847 . . . . 10.0 113.287 -174.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.751 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.9 tm? -88.95 133.92 34.14 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.742 -1.207 . . . . 10.0 107.742 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.812 ' HB3' HD22 ' A' ' 102' ' ' LEU . 74.6 p -145.34 153.8 41.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 113.083 0.772 . . . . 10.0 113.083 -177.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.634 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 3.1 p90 -151.81 165.3 34.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.375 -1.284 . . . . 10.0 110.371 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -88.58 134.07 33.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.916 HG21 HD12 ' A' ' 71' ' ' ILE . 21.3 mm -131.56 93.49 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.479 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.0 OUTLIER 42.65 60.19 2.5 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 113.073 0.768 . . . . 10.0 113.073 178.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.586 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 88.71 -43.34 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.115 -0.948 . . . . 10.0 112.632 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.716 ' NE2' HD13 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -88.98 151.52 22.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.377 -0.529 . . . . 10.0 110.412 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.008 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.84 156.93 18.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.844 0.354 . . . . 10.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.791 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.2 tp -144.74 135.52 24.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.885 0.374 . . . . 10.0 110.858 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.749 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -142.27 151.69 42.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.943 -0.572 . . . . 10.0 112.364 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.859 ' CE2' HD22 ' A' ' 136' ' ' LEU . 2.8 m-85 -129.36 141.64 51.02 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -48.55 101.34 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.644 0.735 . . . . 10.0 109.369 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 13' ' ' VAL . 3.8 p -47.15 -13.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.523 -1.217 . . . . 10.0 112.862 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -62.9 -41.95 99.61 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.226 -0.589 . . . . 10.0 109.712 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.717 ' OD1' HG21 ' A' ' 138' ' ' ILE . 7.3 t-20 -81.85 -48.4 11.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.126 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.751 HG21 ' HG ' ' A' ' 14' ' ' LEU . 18.0 mm -58.52 123.58 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.133 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.676 ' OE2' HG12 ' A' ' 83' ' ' VAL . 15.7 pt-20 -87.19 -54.81 4.11 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.477 0.547 . . . . 10.0 112.477 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.3 mtm -169.23 157.87 7.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.161 0.505 . . . . 10.0 112.352 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.844 HG11 HG11 ' A' ' 98' ' ' VAL . 34.3 m -88.88 148.05 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.057 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.516 HD13 HG21 ' A' ' 83' ' ' VAL . 32.0 pt -139.52 155.34 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -88.8 152.79 21.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.066 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.479 ' HG2' HD12 ' A' ' 39' ' ' ILE . 12.3 tmtt? -88.79 125.78 35.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.721 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.447 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 48.4 t 178.38 137.36 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.841 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.2 t0 42.28 44.57 3.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.178 0.513 . . . . 10.0 111.14 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 52' ' ' VAL . 26.7 mt -93.61 -76.19 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.548 -0.751 . . . . 10.0 112.443 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.718 HG23 ' HG2' ' A' ' 43' ' ' PRO . 2.0 m -170.3 117.78 0.5 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.42 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.38 -85.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.831 2.354 . . . . 10.0 113.513 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.631 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 35.1 m -149.08 47.24 0.48 Allowed Pre-proline 0 CA--C 1.531 0.231 0 N-CA-C 112.426 0.528 . . . . 10.0 112.426 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.718 ' HG2' HG23 ' A' ' 40' ' ' THR . 53.1 Cg_exo -55.35 -19.87 23.61 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.552 2.168 . . . . 10.0 111.672 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt 60.31 -131.36 0.88 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.457 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 10.7 m 55.52 25.22 7.63 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.838 0.352 . . . . 10.0 110.792 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 36.3 mmt180 -163.33 -37.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.653 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 83.6 m-70 80.35 -56.93 0.34 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.998 -0.547 . . . . 10.0 111.174 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' HB2' ' HD2' ' A' ' 148' ' ' LYS . 2.0 m-85 -77.64 -49.02 15.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 10.0 110.585 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.624 ' HA ' HG22 ' A' ' 63' ' ' VAL . 58.6 t -56.94 85.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.743 -0.662 . . . . 10.0 111.912 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -66.25 -30.94 71.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.972 0.415 . . . . 10.0 110.169 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.768 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -152.28 169.04 31.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.712 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.673 ' O ' HG23 ' A' ' 39' ' ' ILE . 3.6 m -158.62 171.96 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.661 0.267 . . . . 10.0 110.499 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 53' ' ' ILE . 2.2 pp -160.94 143.08 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.008 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.478 HD22 HD11 ' A' ' 59' ' ' ILE . 24.8 t-20 -88.84 142.28 27.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.479 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.8 HD13 ' N ' ' A' ' 56' ' ' ARG . 2.8 tm? -168.87 134.0 1.6 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.527 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.8 ' N ' HD13 ' A' ' 55' ' ' LEU . 15.1 ttp-105 48.71 47.2 21.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.777 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.1 39.15 79.47 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.959 -0.564 . . . . 10.0 113.02 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -159.59 124.8 4.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.764 0.316 . . . . 10.0 110.646 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.632 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -90.43 129.26 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.085 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.783 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.0 pp -99.09 139.65 21.14 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.87 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 61.7 Cg_endo -97.31 123.97 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.365 2.71 . . . . 10.0 113.546 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.768 HG22 ' C ' ' A' ' 51' ' ' GLY . 34.4 m -102.62 135.5 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 49' ' ' VAL . 99.5 t -143.68 158.16 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.569 0.7 . . . . 10.0 112.543 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.821 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 66.8 m-20 -70.38 67.69 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.945 -1.025 . . . . 10.0 109.702 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.927 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.9 tt -50.99 -31.07 16.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.336 0.589 . . . . 10.0 110.61 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.814 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -62.7 -22.96 66.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.81 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -88.4 -41.85 12.54 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 178.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 65' ' ' LEU . 7.6 tt -59.15 -40.38 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.844 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.88 -40.19 33.07 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.31 -1.768 . . . . 10.0 108.267 176.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 71' ' ' ILE . . . 71.32 121.62 0.05 OUTLIER Glycine 0 C--N 1.333 0.386 0 CA-C-N 114.791 -1.095 . . . . 10.0 113.05 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.916 HD12 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -162.86 -167.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.152 0.581 . . . . 10.0 109.972 -179.206 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 71.9 m -50.4 -32.34 17.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.616 0.722 . . . . 10.0 109.14 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.814 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 7.3 t80 -35.81 143.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.418 -1.265 . . . . 10.0 112.682 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -169.98 36.11 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.649 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 56.2 mt-10 55.54 37.7 29.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.439 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -82.85 -70.81 0.53 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.816 0.341 . . . . 10.0 111.718 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.62 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.4 mptt -94.93 -31.14 13.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.683 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.583 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 12.3 mmm -23.22 140.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.542 0.737 . . . . 10.0 112.221 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -164.11 -37.04 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.972 0.36 . . . . 10.0 111.972 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.851 ' O ' HD12 ' A' ' 94' ' ' LEU . 80.2 p -88.75 163.87 15.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.584 0.231 . . . . 10.0 111.002 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' A' ' 39' ' ' ILE . 67.7 mt -132.64 129.15 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.722 0.296 . . . . 10.0 111.643 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 14' ' ' LEU . 7.5 mt -93.5 150.79 3.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.741 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.676 HG12 ' OE2' ' A' ' 31' ' ' GLU . 46.6 t -121.45 142.04 39.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.458 . . . . 10.0 110.778 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -145.0 175.97 9.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.782 -0.644 . . . . 10.0 111.015 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.541 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 6.6 ptm180 -128.25 146.38 50.76 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.516 HG21 HG12 ' A' ' 138' ' ' ILE . 73.3 p -160.93 108.67 1.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.466 0.543 . . . . 10.0 112.466 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 47.08 48.41 15.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.371 0.605 . . . . 10.0 110.779 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 72.26 33.54 1.51 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.117 -0.947 . . . . 10.0 111.235 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.894 HG12 HG22 ' A' ' 91' ' ' VAL . 54.2 t -131.46 111.81 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-N 115.166 -0.924 . . . . 10.0 109.211 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.758 ' HB2' HG22 ' A' ' 60' ' ' ILE . 27.1 mt-10 -88.34 97.93 11.32 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.053 -1.832 . . . . 10.0 106.053 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.018 HG21 HD13 ' A' ' 142' ' ' ILE . 4.8 t -88.55 154.48 3.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.256 -1.793 . . . . 10.0 112.658 -174.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.1 156.3 21.91 Favored Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.702 -1.136 . . . . 10.0 113.065 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.59 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 t80 -146.3 131.94 18.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 10.0 110.935 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.851 HD12 ' O ' ' A' ' 80' ' ' SER . 58.8 tp -88.7 126.83 35.5 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.266 0.555 . . . . 10.0 112.066 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.583 ' HA ' ' HE3' ' A' ' 78' ' ' MET . 30.4 m -137.25 -175.08 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.261 -0.882 . . . . 10.0 109.89 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.78 -62.56 1.32 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.061 0.458 . . . . 10.0 112.191 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -133.93 117.86 17.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.756 -0.656 . . . . 10.0 109.66 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.844 HG11 HG11 ' A' ' 33' ' ' VAL . 9.3 p -104.95 116.07 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 122.451 1.12 . . . . 10.0 111.805 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -64.61 -30.33 71.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.02 -1.9 . . . . 10.0 110.747 -178.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.99 -124.4 6.98 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.487 -0.779 . . . . 10.0 111.259 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.3 p -52.17 128.15 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 117.035 0.418 . . . . 10.0 110.422 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 15' ' ' SER . 51.8 tp -132.06 139.06 48.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.039 0.447 . . . . 10.0 110.927 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.0 ptp85 -88.86 73.25 8.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.828 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.95 HD12 HG11 ' A' ' 126' ' ' VAL . 11.8 mm -88.78 126.21 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.737 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.639 HG22 ' HG2' ' A' ' 10' ' ' GLU . 17.7 p -88.74 146.21 25.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 176.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' OE1' ' HG ' ' A' ' 109' ' ' LEU . 22.1 tt0 -131.31 70.7 1.46 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.069 -1.053 . . . . 10.0 113.398 -176.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -80.99 -9.5 59.83 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.654 -1.157 . . . . 10.0 108.564 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -93.14 -51.34 5.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.98 -1.009 . . . . 10.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.962 HD12 HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER 38.98 -144.88 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.424 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -130.64 41.28 3.4 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.098 0.475 . . . . 10.0 110.397 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.644 HD21 HD13 ' A' ' 109' ' ' LEU . 1.5 pt? -178.98 -39.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.85 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.598 ' HB ' HD12 ' A' ' 8' ' ' LEU . 6.0 t -57.47 -41.88 81.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.948 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.457 ' O ' ' HB ' ' A' ' 114' ' ' VAL . 79.1 m-20 -163.49 -38.8 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.522 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.518 HG13 ' CD ' ' A' ' 117' ' ' LYS . 59.8 t 73.66 -58.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.681 0.276 . . . . 10.0 111.083 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.6 m 69.62 -61.44 0.44 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.113 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 33.9 t70 -164.38 -46.08 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.049 -0.26 . . . . 10.0 111.437 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 10.1 mtmp? 72.21 -51.83 0.7 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.72 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.634 ' CE1' HD21 ' A' ' 69' ' ' LEU . 23.7 t80 179.49 -53.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.188 0.518 . . . . 10.0 110.054 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' A' ' 120' ' ' LYS . . . 141.75 -58.75 0.56 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.478 -0.783 . . . . 10.0 112.052 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.441 ' CG ' ' O ' ' A' ' 119' ' ' GLY . 51.7 mtmt -163.78 56.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.55 0.214 . . . . 10.0 110.529 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.493 ' HG2' HD22 ' A' ' 69' ' ' LEU . 2.4 tpmt? -150.88 -40.54 0.12 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.509 ' CB ' ' HG ' ' A' ' 136' ' ' LEU . 91.8 p -149.95 -135.06 0.07 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 121.0 -0.28 . . . . 10.0 111.386 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 117' ' ' LYS . 47.3 mmtm -152.84 25.26 0.57 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.566 0.58 . . . . 10.0 112.566 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 135' ' ' TYR . . . -146.6 139.93 8.37 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 119.297 -1.43 . . . . 10.0 114.116 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 2.3 tm? -155.44 78.93 1.02 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.538 -0.912 . . . . 10.0 108.538 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.985 HG13 ' HB ' ' A' ' 133' ' ' ILE . 2.3 p -88.81 159.57 2.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.351 -0.84 . . . . 10.0 112.844 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.49 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 62.3 pttt -164.48 132.08 3.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.901 -1.045 . . . . 10.0 109.529 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 5.4 m -159.53 148.88 18.22 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.965 0.412 . . . . 10.0 111.476 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' HB3' ' NH2' ' A' ' 131' ' ' ARG . 38.6 t70 56.16 46.1 22.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.731 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.23 32.87 57.52 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.597 -0.811 . . . . 10.0 111.743 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.461 ' NH2' ' HB3' ' A' ' 129' ' ' ASP . 1.5 ptp85 -130.63 132.33 45.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.808 0.337 . . . . 10.0 110.221 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.5 tp -88.8 139.13 30.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.159 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.008 HG12 ' HB3' ' A' ' 22' ' ' ALA . 2.6 mt -141.57 126.69 17.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.039 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.791 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.2 mp -89.03 136.59 23.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.684 ' C ' HD12 ' A' ' 136' ' ' LEU . 46.5 t80 -128.8 140.96 51.47 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.537 0.684 . . . . 10.0 111.376 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.859 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.9 mp -130.89 178.26 6.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.486 -0.779 . . . . 10.0 112.078 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.8 p-10 -141.37 23.28 2.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.336 -1.302 . . . . 10.0 108.063 177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.871 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.3 tt 40.75 16.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 114.112 -1.404 . . . . 10.0 114.059 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 137' ' ' ASP . 66.7 t0 -80.0 -61.36 2.01 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.61 0.596 . . . . 10.0 112.61 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -78.34 -29.68 47.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.383 0.611 . . . . 10.0 110.412 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.871 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.21 -45.64 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 115.367 -0.833 . . . . 10.0 110.118 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.018 HD13 HG21 ' A' ' 91' ' ' VAL . 8.0 tp -64.42 -43.32 96.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 120.013 -0.675 . . . . 10.0 109.512 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.535 ' N ' HG23 ' A' ' 142' ' ' ILE . 39.5 tt0 -48.16 -42.59 30.01 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.814 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.635 ' HA ' HG12 ' A' ' 147' ' ' VAL . 55.1 mm-40 -70.26 -33.73 71.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.24 -0.891 . . . . 10.0 110.421 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.651 ' CD1' HG11 ' A' ' 91' ' ' VAL . 41.9 mt -57.22 -35.42 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.806 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.5 p -81.73 -50.45 9.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.655 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 144' ' ' GLU . 14.7 p -72.24 -5.21 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.948 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.479 ' HD2' ' HB2' ' A' ' 48' ' ' PHE . 57.0 pttt -41.96 -44.12 3.35 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.878 0.37 . . . . 10.0 111.469 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -60.13 135.05 57.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.015 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.88 -45.47 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.414 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 10.0 110.979 -179.996 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.844 0.354 . . . . 10.0 111.119 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.63 ' HG2' HG22 ' A' ' 3' ' ' THR . 87.9 tttt -174.56 -63.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.729 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.63 HG22 ' HG2' ' A' ' 2' ' ' LYS . 5.3 t 171.43 -49.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.031 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.496 ' HG ' HG23 ' A' ' 3' ' ' THR . 79.6 mt -81.25 -54.28 5.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.974 0.416 . . . . 10.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.85 135.89 41.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.125 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 61.26 154.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 10.0 110.864 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.3 167.43 10.17 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.074 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.472 HD23 ' HG2' ' A' ' 106' ' ' GLU . 43.1 mt -68.78 58.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.097 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HE3' ' HB2' ' A' ' 10' ' ' GLU . 24.8 tptt -127.39 -60.6 1.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.077 0.399 . . . . 10.0 112.077 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 42.4 tt0 -155.88 164.14 38.88 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.524 0.678 . . . . 10.0 111.477 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.676 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 11.4 t80 -159.49 140.41 12.53 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.616 -1.175 . . . . 10.0 112.483 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.66 130.64 35.25 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.168 -1.049 . . . . 10.0 108.168 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.892 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.6 p -149.0 166.23 3.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 -175.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 1.04 HD11 HD13 ' A' ' 82' ' ' ILE . 3.0 tm? -89.01 140.02 29.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.835 ' HB3' HD22 ' A' ' 102' ' ' LEU . 53.4 p -154.92 158.03 38.65 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 119.806 -0.757 . . . . 10.0 112.851 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.698 ' CZ ' ' HG ' ' A' ' 23' ' ' LEU . 17.4 p90 -150.42 166.16 30.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.589 -1.187 . . . . 10.0 110.109 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.622 ' HG2' HD21 ' A' ' 99' ' ' LEU . 53.2 mm-40 -88.54 142.38 27.75 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.699 -0.482 . . . . 10.0 109.699 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.031 HG21 HD12 ' A' ' 71' ' ' ILE . 33.4 mm -140.52 93.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.78 -0.645 . . . . 10.0 111.45 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.538 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 62.3 m-20 43.24 60.06 2.71 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.89 -0.595 . . . . 10.0 112.39 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.8 mt-10 85.53 -42.71 0.05 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.145 -0.934 . . . . 10.0 112.307 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.627 ' NE2' HG22 ' A' ' 71' ' ' ILE . 19.1 pt20 -88.96 147.08 24.51 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.612 -0.435 . . . . 10.0 109.988 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.009 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.92 166.53 13.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.127 0.489 . . . . 10.0 111.927 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.854 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.1 OUTLIER -140.39 143.57 35.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.549 -179.211 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.757 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -144.45 149.25 35.7 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.738 0.644 . . . . 10.0 112.738 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.798 ' CE2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -138.39 137.88 37.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.689 -0.856 . . . . 10.0 108.689 179.092 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -56.17 123.93 16.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.224 -0.591 . . . . 10.0 110.144 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.892 HG13 ' HA ' ' A' ' 13' ' ' VAL . 35.8 m -59.77 -10.54 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.381 -0.827 . . . . 10.0 112.098 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 1.4 p30 -60.03 -40.67 90.14 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.087 0.47 . . . . 10.0 110.089 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.745 HD21 HG22 ' A' ' 86' ' ' THR . 14.7 t-20 -93.3 -47.35 6.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 10.0 111.192 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.78 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.1 mm -57.93 121.91 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.507 ' O ' ' HG3' ' A' ' 32' ' ' MET . 12.4 pt-20 -84.34 -51.14 7.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.16 0.43 . . . . 10.0 112.16 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.9 mtm -169.1 154.69 6.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.248 0.547 . . . . 10.0 111.885 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.656 ' CG1' HD21 ' A' ' 14' ' ' LEU . 34.8 m -88.95 149.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.399 -0.819 . . . . 10.0 111.395 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.486 HG13 ' HB ' ' A' ' 81' ' ' ILE . 10.7 pt -143.57 -178.14 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.723 -0.672 . . . . 10.0 110.622 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -155.75 104.14 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.179 0.514 . . . . 10.0 110.701 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -169.25 66.34 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.788 -0.642 . . . . 10.0 111.083 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -53.06 -170.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.989 0.423 . . . . 10.0 111.497 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p30 42.42 43.6 3.14 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.902 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.541 ' CG2' HG23 ' A' ' 53' ' ' ILE . 25.6 mt -73.65 144.29 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.846 -0.615 . . . . 10.0 111.802 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.871 HG23 ' HG2' ' A' ' 43' ' ' PRO . 20.1 m 25.97 71.32 0.39 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.722 -0.672 . . . . 10.0 112.337 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -86.35 -47.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.194 2.596 . . . . 10.0 113.127 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.498 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 47.1 t -67.61 -44.06 42.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.905 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.871 ' HG2' HG23 ' A' ' 40' ' ' THR . 35.6 Cg_exo -59.94 -55.55 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.127 1.885 . . . . 10.0 112.227 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD3' ' C ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 39.53 -158.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.378 -0.374 . . . . 10.0 111.329 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 43.9 t 69.04 54.82 0.44 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.871 0.367 . . . . 10.0 111.451 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 11.5 tpt180 -140.15 40.19 1.94 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.133 0.492 . . . . 10.0 110.502 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.443 ' CD2' ' HA2' ' A' ' 150' ' ' GLY . 11.5 m80 54.98 -134.79 1.49 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.891 -0.595 . . . . 10.0 111.276 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.615 ' CD1' ' HG2' ' A' ' 148' ' ' LYS . 8.6 t80 -52.84 -36.79 59.32 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.796 0.331 . . . . 10.0 111.133 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.879 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.5 t -57.75 126.73 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 10.0 111.476 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.85 -45.28 12.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.335 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.703 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -139.13 -176.38 14.65 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.578 -0.737 . . . . 10.0 112.498 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.59 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.5 m -160.51 169.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 10.0 110.232 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.68 HD13 ' N ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -159.9 143.22 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.991 0.424 . . . . 10.0 111.211 178.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.498 ' O ' HD23 ' A' ' 55' ' ' LEU . 41.3 t30 -88.75 134.69 33.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.166 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 54' ' ' ASN . 96.8 mt -160.04 136.54 8.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.668 -0.696 . . . . 10.0 110.207 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.489 ' NH1' ' HB2' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 52.17 46.42 26.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.109 0.481 . . . . 10.0 110.413 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.34 37.42 65.51 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.801 -0.636 . . . . 10.0 112.822 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -159.36 130.5 6.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.773 0.32 . . . . 10.0 110.731 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.84 129.74 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.319 -0.4 . . . . 10.0 110.755 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.902 HG22 ' HB2' ' A' ' 90' ' ' GLU . 20.3 pt -107.6 129.81 23.7 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.305 -0.407 . . . . 10.0 111.563 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 94.2 Cg_endo -77.82 117.84 4.33 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.593 2.195 . . . . 10.0 112.201 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.703 HG22 ' C ' ' A' ' 51' ' ' GLY . 28.7 m -94.92 137.68 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.715 0.293 . . . . 10.0 110.423 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.879 HG22 ' HA ' ' A' ' 49' ' ' VAL . 88.3 t -140.47 154.91 22.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.479 0.657 . . . . 10.0 111.924 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.821 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.3 m120 -77.65 65.92 3.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.157 -0.929 . . . . 10.0 109.15 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.901 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.7 tt -49.64 -26.73 3.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.575 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.835 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -66.78 -29.15 69.02 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.347 -0.541 . . . . 10.0 110.596 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -87.92 -33.9 18.32 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 121.088 -0.245 . . . . 10.0 110.988 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.696 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.8 tt -57.37 -41.41 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 106.336 -1.727 . . . . 10.0 106.336 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.893 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -77.7 -49.74 13.86 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.231 -1.804 . . . . 10.0 108.392 176.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 115.48 -79.17 0.28 Allowed Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.229 -0.896 . . . . 10.0 112.746 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.031 HD12 HG21 ' A' ' 18' ' ' ILE . 2.3 pt 46.05 173.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.619 0.6 . . . . 10.0 112.619 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 19' ' ' ASP . 71.4 m -51.62 -36.21 44.97 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.849 ' HB3' HG13 ' A' ' 71' ' ' ILE . 3.7 t80 -30.14 145.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.996 -1.002 . . . . 10.0 113.536 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 35.9 t70 -134.62 -54.37 0.83 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.051 -0.977 . . . . 10.0 110.117 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.463 ' HA ' ' HE1' ' A' ' 73' ' ' PHE . 10.5 pt-20 164.52 -45.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.865 0.364 . . . . 10.0 111.644 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -55.52 -37.91 68.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.484 ' N ' ' HE3' ' A' ' 77' ' ' LYS . 0.8 OUTLIER -68.27 -26.9 65.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.771 0.319 . . . . 10.0 111.331 -179.385 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.418 ' SD ' ' CE1' ' A' ' 73' ' ' PHE . 27.5 mmt -47.6 134.7 12.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.495 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 54.8 mtmt -160.75 -51.57 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.726 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.463 ' O ' HD12 ' A' ' 94' ' ' LEU . 52.3 m -90.14 -175.99 4.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.318 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 39' ' ' ILE . 75.5 mt -152.28 160.59 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.549 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.04 HD13 HD11 ' A' ' 14' ' ' LEU . 15.2 mt -142.23 140.69 29.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.903 0.382 . . . . 10.0 111.263 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 34' ' ' ILE . 44.8 t -110.62 149.74 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.139 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -147.9 175.6 10.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.8 -0.636 . . . . 10.0 110.573 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -133.21 129.99 38.48 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.745 HG22 HD21 ' A' ' 29' ' ' ASN . 44.8 p -144.42 108.78 4.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.319 0.489 . . . . 10.0 112.319 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.485 ' CE ' ' O ' ' A' ' 87' ' ' LYS . 8.1 ttpt 47.67 51.23 14.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.704 0.764 . . . . 10.0 110.806 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.0 31.1 2.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.964 -1.016 . . . . 10.0 111.611 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.873 HG12 HG22 ' A' ' 91' ' ' VAL . 55.7 t -128.33 108.37 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 115.178 -0.919 . . . . 10.0 109.028 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.902 ' HB2' HG22 ' A' ' 60' ' ' ILE . 1.4 mp0 -88.26 99.83 12.53 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.628 -1.99 . . . . 10.0 105.628 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.063 HG21 HD13 ' A' ' 142' ' ' ILE . 4.8 t -88.57 149.62 3.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 113.378 -1.737 . . . . 10.0 112.908 -173.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -119.07 157.78 15.16 Favored Glycine 0 C--N 1.31 -0.898 0 CA-C-N 113.862 -1.517 . . . . 10.0 112.423 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.683 ' CE2' HD22 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -149.75 123.66 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.292 0.568 . . . . 10.0 111.866 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.59 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 46.6 tp -88.78 120.18 29.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.954 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.474 HG11 ' CZ ' ' A' ' 16' ' ' PHE . 27.6 m -131.08 -175.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.48 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 5.2 t0 -84.61 -79.94 0.21 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.32 0.581 . . . . 10.0 110.704 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.81 110.59 8.71 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.675 -0.861 . . . . 10.0 108.675 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.607 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 10.5 p -88.93 114.52 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-O 122.319 1.057 . . . . 10.0 111.833 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.622 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -62.47 -28.65 69.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.23 -1.805 . . . . 10.0 110.827 -178.818 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.22 -121.07 5.93 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.006 -0.837 . . . . 10.0 111.006 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.68 127.33 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 117.076 0.438 . . . . 10.0 110.453 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.835 HD22 ' HB3' ' A' ' 15' ' ' SER . 46.9 tp -126.57 139.26 53.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.171 0.51 . . . . 10.0 110.743 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.0 ptp85 -88.87 76.95 7.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.381 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.795 ' CG1' HG11 ' A' ' 13' ' ' VAL . 10.1 mm -88.64 161.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 24.0 p -122.32 147.28 46.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 109' ' ' LEU . 11.4 tt0 -104.96 66.81 0.77 Allowed 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.953 0.882 . . . . 10.0 112.256 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -96.31 17.74 15.28 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.456 -1.247 . . . . 10.0 108.677 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.632 ' HG2' HD12 ' A' ' 109' ' ' LEU . 2.2 pm0 -153.76 -46.42 0.09 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.617 -0.72 . . . . 10.0 112.208 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.914 HD21 ' CE2' ' A' ' 135' ' ' TYR . 7.6 mp -48.31 126.0 10.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.761 0.315 . . . . 10.0 111.603 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 109' ' ' LEU . 38.8 t70 82.48 -51.06 0.2 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.771 -0.649 . . . . 10.0 111.693 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.53 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . 49.3 tp -73.42 5.3 3.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.799 0.333 . . . . 10.0 111.01 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 111' ' ' LEU . 9.5 t 47.41 43.16 15.21 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 112.804 0.668 . . . . 10.0 112.804 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.621 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.1 m120 -80.79 -31.7 35.62 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.48 -0.488 . . . . 10.0 110.13 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.667 HG21 ' HG2' ' A' ' 117' ' ' LYS . 35.5 m -29.84 -45.71 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.822 -0.627 . . . . 10.0 112.373 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 114' ' ' VAL . 29.1 t 78.09 -43.72 0.38 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.378 -0.373 . . . . 10.0 111.229 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 36.4 t70 -134.41 -38.61 0.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.753 -0.203 . . . . 10.0 111.262 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.667 ' HG2' HG21 ' A' ' 114' ' ' VAL . 50.8 mttp 79.87 -45.97 0.32 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.355 -0.384 . . . . 10.0 111.516 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.637 ' CE2' HD21 ' A' ' 69' ' ' LEU . 45.8 t80 179.45 -45.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.304 0.574 . . . . 10.0 109.791 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 175.04 -55.91 0.12 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.096 -0.956 . . . . 10.0 111.336 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 5.8 tmtt? 173.34 44.76 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 110.196 -0.298 . . . . 10.0 110.196 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 26.3 ttpp -163.89 48.78 0.13 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.408 0.522 . . . . 10.0 112.408 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.687 ' HB2' ' HB3' ' A' ' 136' ' ' LEU . 8.2 p 172.45 171.69 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.958 0.409 . . . . 10.0 112.056 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 22.2 tptm -72.62 -52.69 14.36 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 117' ' ' LYS . . . -167.55 -164.02 22.47 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 119.23 -1.462 . . . . 10.0 114.837 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.786 HD22 ' HA ' ' A' ' 134' ' ' ILE . 1.7 tm? -139.02 125.42 20.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.155 -0.523 . . . . 10.0 109.901 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.892 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.7 p -103.71 154.53 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.543 0.687 . . . . 10.0 112.138 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 27.9 mtpp -154.62 134.02 12.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.944 -1.025 . . . . 10.0 109.839 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 16.3 m -163.04 149.9 12.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.895 0.379 . . . . 10.0 111.23 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.46 ' OD1' ' HB3' ' A' ' 131' ' ' ARG . 2.8 p30 46.15 48.49 12.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 10.0 111.5 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.66 43.24 68.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.82 -0.705 . . . . 10.0 112.212 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.46 ' HB3' ' OD1' ' A' ' 129' ' ' ASP . 3.5 ptm180 -138.97 134.17 32.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 10.0 110.625 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.93 137.37 32.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.939 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.009 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.9 mt -144.8 130.14 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.003 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.854 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.99 137.31 21.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.914 ' CE2' HD21 ' A' ' 109' ' ' LEU . 70.9 t80 -130.89 142.61 50.38 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.221 -0.592 . . . . 10.0 111.037 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.901 HD23 HG21 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -164.67 147.01 8.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.367 0.603 . . . . 10.0 112.35 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.409 ' OD1' ' CB ' ' A' ' 139' ' ' ASP . 3.0 p30 -96.46 35.02 1.53 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.806 0.812 . . . . 10.0 110.194 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.92 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 20.9 tt 39.95 20.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.328 -1.306 . . . . 10.0 114.14 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 66.5 t0 -79.3 -57.06 3.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.04 0.756 . . . . 10.0 113.04 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 121' ' ' LYS . 22.5 ttmm -77.96 -33.55 51.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 10.0 110.265 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.92 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -64.98 -45.26 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.946 178.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.063 HD13 HG21 ' A' ' 91' ' ' VAL . 5.8 tp -61.36 -44.57 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 C-N-CA 120.1 -0.64 . . . . 10.0 109.531 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 147' ' ' VAL . 43.6 mm-40 -47.16 -41.67 18.21 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.443 ' HG3' ' CD ' ' A' ' 121' ' ' LYS . 59.1 mm-40 -73.48 -31.39 63.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.36 -0.836 . . . . 10.0 111.177 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.66 ' CD1' HG11 ' A' ' 91' ' ' VAL . 44.5 mt -54.27 -48.16 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.973 0.416 . . . . 10.0 110.595 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.3 p -85.48 -45.98 11.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.978 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 143' ' ' GLU . 44.5 t -56.71 -31.49 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.585 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.615 ' HG2' ' CD1' ' A' ' 48' ' ' PHE . 48.4 tptt -42.38 -48.04 5.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.066 0.46 . . . . 10.0 111.007 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -179.31 126.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.431 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 47' ' ' HIS . . . 172.97 44.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.615 -0.802 . . . . 10.0 112.563 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 10.0 111.092 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttp . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.893 0.378 . . . . 10.0 111.171 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 3' ' ' THR . 97.6 mttt -64.59 -43.11 94.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.013 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 54.8 m 72.43 -51.8 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.435 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.894 HD12 ' N ' ' A' ' 5' ' ' ALA . 4.2 pp -65.94 -39.07 90.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.872 0.368 . . . . 10.0 110.689 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.894 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -74.8 128.91 36.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.227 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.06 135.86 44.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.808 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.28 131.22 47.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.141 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.4 mt 62.52 109.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.66 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.517 ' HE3' ' CB ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -157.4 -50.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.189 -179.5 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 43.3 tt0 -148.52 163.96 35.65 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.661 -0.7 . . . . 10.0 110.648 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.667 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.4 t80 -158.79 139.14 12.38 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.052 -0.976 . . . . 10.0 112.54 -174.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -88.59 130.37 35.28 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.433 -0.951 . . . . 10.0 108.433 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.957 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.6 p -148.87 169.13 2.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 -175.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.818 ' HG ' HG21 ' A' ' 30' ' ' ILE . 3.3 tm? -88.8 139.18 30.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.857 ' HB3' HD22 ' A' ' 102' ' ' LEU . 83.3 p -149.15 154.17 38.79 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 119.806 -0.758 . . . . 10.0 112.881 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.77 ' CD2' HG11 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -149.24 167.18 26.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.409 -1.269 . . . . 10.0 110.775 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -88.63 123.81 33.46 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.03 -0.73 . . . . 10.0 109.03 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.908 HG21 HD12 ' A' ' 71' ' ' ILE . 9.7 mm -134.39 115.84 21.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.709 -0.678 . . . . 10.0 111.784 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.681 ' OD2' HG22 ' A' ' 18' ' ' ILE . 2.0 p30 39.08 60.12 1.53 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.717 . . . . 10.0 112.484 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 52.6 mt-10 78.08 -42.87 0.36 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.923 -1.035 . . . . 10.0 112.469 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.452 ' OE1' HG12 ' A' ' 134' ' ' ILE . 3.7 pp0? -91.83 158.74 16.16 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.295 -0.253 . . . . 10.0 110.717 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.874 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.74 148.37 24.0 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 121.078 0.466 . . . . 10.0 111.662 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.3 OUTLIER -124.35 133.19 53.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.409 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.889 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -134.06 152.15 51.72 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.443 0.905 . . . . 10.0 113.443 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.956 ' CZ ' HD12 ' A' ' 136' ' ' LEU . 5.6 m-85 -135.98 139.08 42.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.941 -1.027 . . . . 10.0 109.024 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -49.54 122.49 6.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.143 0.497 . . . . 10.0 111.175 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.957 HG13 ' HA ' ' A' ' 13' ' ' VAL . 19.9 m -61.06 -13.51 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.789 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -59.98 -41.81 92.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.13 0.49 . . . . 10.0 109.708 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.811 ' OD1' HG21 ' A' ' 138' ' ' ILE . 8.1 t-20 -92.16 -48.52 6.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.641 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.818 HG21 ' HG ' ' A' ' 14' ' ' LEU . 22.3 mm -60.89 129.23 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.445 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 32' ' ' MET . 16.4 pt-20 -100.37 -53.01 3.22 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.7 mtm -169.22 156.11 6.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 10.0 111.732 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.945 HG12 HG23 ' A' ' 82' ' ' ILE . 33.1 m -100.1 129.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.76 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.417 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 27.5 pt -105.78 137.68 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 10.0 111.015 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -90.48 119.51 30.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.829 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.859 ' HB2' HD12 ' A' ' 81' ' ' ILE . 68.7 mttm -159.67 -178.65 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.818 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.6 t -168.12 148.94 5.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.87 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 t70 49.54 44.45 24.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.141 0.496 . . . . 10.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 41' ' ' PRO . 19.4 mt -63.42 155.83 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.499 -0.773 . . . . 10.0 111.917 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.869 HG23 ' HG2' ' A' ' 43' ' ' PRO . 16.0 m -20.48 81.77 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.958 -1.019 . . . . 10.0 112.826 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' N ' ' O ' ' A' ' 39' ' ' ILE . 88.8 Cg_endo -91.41 -50.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.966 2.444 . . . . 10.0 113.891 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.48 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 45.3 t -64.86 -45.1 74.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 112.288 0.477 . . . . 10.0 112.288 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.869 ' HG2' HG23 ' A' ' 40' ' ' THR . 50.6 Cg_exo -54.75 -49.67 15.93 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.293 1.995 . . . . 10.0 112.773 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' O ' ' OG ' ' A' ' 45' ' ' SER . 36.4 pttt 43.61 -129.02 0.83 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.61 -0.268 . . . . 10.0 111.198 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 44' ' ' LYS . 80.3 p 63.02 67.77 0.66 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.078 0.551 . . . . 10.0 111.681 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 2.8 tpm_? -161.26 -57.84 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.918 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.432 ' O ' ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER 169.77 -154.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.408 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.471 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 60.9 t80 -66.9 62.5 0.05 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.801 0.334 . . . . 10.0 110.298 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.866 ' HA ' HG22 ' A' ' 63' ' ' VAL . 50.0 t -132.0 133.52 60.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.086 0.469 . . . . 10.0 111.669 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -63.71 -47.79 79.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.994 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.579 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -155.47 -176.01 27.15 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.415 -0.811 . . . . 10.0 112.576 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.548 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.0 m -148.16 169.97 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.878 0.37 . . . . 10.0 110.98 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 60' ' ' ILE . 29.6 pt -153.26 139.89 12.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 10.0 111.311 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.51 HD22 HD11 ' A' ' 59' ' ' ILE . 24.5 t-20 -88.82 133.88 34.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.995 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 54' ' ' ASN . 97.1 mt -159.73 138.09 10.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.369 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.541 ' HA ' ' NE ' ' A' ' 56' ' ' ARG . 1.8 tpm_? 48.13 46.34 19.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.176 0.513 . . . . 10.0 110.559 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.36 42.66 89.39 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.954 -0.641 . . . . 10.0 112.661 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -165.37 129.17 2.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 10.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -88.96 132.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.101 -0.499 . . . . 10.0 111.076 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 53' ' ' ILE . 22.3 pt -111.47 135.07 21.05 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.669 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 83.0 Cg_endo -80.16 116.54 3.38 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.816 2.344 . . . . 10.0 113.362 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.579 HG22 ' C ' ' A' ' 51' ' ' GLY . 22.4 m -95.45 133.97 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.866 HG22 ' HA ' ' A' ' 49' ' ' VAL . 59.3 t -142.59 156.74 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.665 0.745 . . . . 10.0 112.832 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.874 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 31.8 m120 -75.87 62.17 1.54 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.874 -1.057 . . . . 10.0 108.724 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.934 HD22 ' CD2' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -51.85 -20.48 2.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.74 -0.664 . . . . 10.0 111.621 -179.034 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.692 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -71.51 -30.66 66.21 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.287 -0.565 . . . . 10.0 110.133 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.874 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.58 -36.38 26.27 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.557 -0.164 . . . . 10.0 110.557 178.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 65' ' ' LEU . 9.1 tt -56.14 -40.86 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 106.402 -1.703 . . . . 10.0 106.402 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.009 HD11 HG23 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -76.81 -38.58 53.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 113.407 -1.724 . . . . 10.0 108.961 176.39 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.539 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 106.09 -92.12 0.78 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.607 -0.724 . . . . 10.0 113.598 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.009 HG23 HD11 ' A' ' 69' ' ' LEU . 3.4 pt 48.32 164.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 112.712 0.634 . . . . 10.0 112.712 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.543 ' HB2' ' CG ' ' A' ' 19' ' ' ASP . 29.2 m -49.16 -30.5 6.87 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.266 -0.642 . . . . 10.0 109.266 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.908 ' HB3' HG13 ' A' ' 71' ' ' ILE . 12.0 t80 -30.09 141.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.265 -0.88 . . . . 10.0 112.74 176.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -174.32 42.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.573 -0.739 . . . . 10.0 110.348 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 58.52 38.57 25.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -71.63 -42.77 67.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.846 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 96' ' ' ASP . 32.2 mmmt -146.11 23.92 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.85 0.315 . . . . 10.0 111.85 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.495 ' CE ' ' CE1' ' A' ' 73' ' ' PHE . 16.7 mmt -47.63 133.04 13.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.554 -0.294 . . . . 10.0 111.062 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -172.82 36.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.834 0.349 . . . . 10.0 111.137 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.62 ' OG ' HG23 ' A' ' 95' ' ' VAL . 92.3 p -169.11 154.07 5.83 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.637 -0.505 . . . . 10.0 109.637 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.859 HD12 ' HB2' ' A' ' 36' ' ' LYS . 51.8 mt -133.2 145.12 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.621 -0.432 . . . . 10.0 111.682 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.945 HG23 HG12 ' A' ' 33' ' ' VAL . 6.4 mt -110.21 144.6 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.483 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.99 140.09 46.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.147 0.499 . . . . 10.0 110.654 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -141.91 -175.97 4.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.992 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.629 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 6.4 ptm180 -135.55 143.1 45.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.513 ' OG1' ' HB ' ' A' ' 89' ' ' VAL . 41.6 p -158.83 109.39 2.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.876 0.37 . . . . 10.0 111.836 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 87' ' ' LYS . 36.4 ttmt 46.72 47.25 15.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.649 . . . . 10.0 110.687 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 52.8 m-20 74.49 34.07 0.8 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.939 -1.028 . . . . 10.0 111.342 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.895 HG12 HG22 ' A' ' 91' ' ' VAL . 60.1 t -130.36 110.76 19.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.419 -0.809 . . . . 10.0 109.858 177.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.692 ' HB3' HG22 ' A' ' 60' ' ' ILE . 35.6 tt0 -88.34 99.74 12.48 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 105.68 -1.97 . . . . 10.0 105.68 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.987 HG21 HD13 ' A' ' 142' ' ' ILE . 4.6 t -88.6 149.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 113.329 -1.76 . . . . 10.0 113.36 -173.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -121.56 149.56 17.22 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 113.912 -1.494 . . . . 10.0 113.071 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.934 ' CD2' HD22 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -141.83 128.49 20.33 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 120.783 0.325 . . . . 10.0 110.891 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.465 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 36.3 tp -88.64 131.38 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.108 0.48 . . . . 10.0 110.986 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.804 HG12 HD11 ' A' ' 18' ' ' ILE . 18.8 m -143.02 -175.02 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.386 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 7.9 t70 -90.94 -70.49 0.68 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.316 0.579 . . . . 10.0 111.902 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -142.14 112.91 7.34 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.175 -0.921 . . . . 10.0 108.678 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.668 ' CG1' HG21 ' A' ' 33' ' ' VAL . 7.5 p -91.35 114.42 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 122.463 1.125 . . . . 10.0 112.017 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.588 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -63.03 -29.13 70.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 112.817 -1.992 . . . . 10.0 110.969 -178.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.58 -123.59 6.99 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.595 -0.812 . . . . 10.0 111.279 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.69 133.36 16.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.061 0.431 . . . . 10.0 110.5 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.857 HD22 ' HB3' ' A' ' 15' ' ' SER . 53.6 tp -135.15 138.96 44.23 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.232 0.539 . . . . 10.0 111.234 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.699 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.1 OUTLIER -88.82 73.75 8.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.32 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.777 HD12 HG11 ' A' ' 126' ' ' VAL . 11.5 mm -88.8 133.06 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.691 -0.485 . . . . 10.0 109.691 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.6 p -88.57 146.54 25.07 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -129.26 75.2 1.63 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 114.164 1.172 . . . . 10.0 114.164 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -97.16 2.7 51.41 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.56 -1.274 . . . . 10.0 107.56 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.468 ' HB3' ' CE ' ' A' ' 117' ' ' LYS . 64.2 mm-40 -77.13 -61.71 1.89 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.621 -1.172 . . . . 10.0 110.7 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 16.0 mt -50.68 147.41 4.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.164 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 111' ' ' LEU . 66.5 t0 -153.05 67.9 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.258 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.737 ' CD1' HG22 ' A' ' 112' ' ' THR . 0.5 OUTLIER 97.45 -30.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.468 -0.787 . . . . 10.0 110.244 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.737 HG22 ' CD1' ' A' ' 111' ' ' LEU . 10.4 t -179.49 45.98 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.553 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER 62.69 124.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.584 -0.28 . . . . 10.0 110.297 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 110' ' ' ASP . 17.6 m -140.22 57.12 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 112.477 0.547 . . . . 10.0 112.477 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 117' ' ' LYS . 41.2 t 178.61 132.26 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 10.0 111.682 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 1.5 m-20 -73.78 -51.46 16.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.519 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.529 ' HB3' ' CB ' ' A' ' 125' ' ' LEU . 48.5 mttm 70.66 -59.94 0.52 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.649 -0.705 . . . . 10.0 111.348 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.74 ' CE2' HD21 ' A' ' 69' ' ' LEU . 25.2 t80 -78.18 -52.68 8.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.172 0.51 . . . . 10.0 110.035 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.7 -144.28 10.39 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.079 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -91.49 55.73 2.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.599 0.238 . . . . 10.0 110.667 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.516 ' NZ ' ' HB ' ' A' ' 141' ' ' ILE . 1.1 tmpt? -144.7 -44.79 0.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.915 -0.314 . . . . 10.0 111.314 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.825 ' CB ' HD22 ' A' ' 136' ' ' LEU . 47.4 t -137.54 -137.88 0.14 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.643 -0.218 . . . . 10.0 110.428 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.54 ' HD3' ' HA ' ' A' ' 116' ' ' ASP . 48.5 mmtm -158.53 -29.66 0.07 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.685 0.994 . . . . 10.0 113.685 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.562 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -81.43 147.68 27.22 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.035 -1.079 . . . . 10.0 114.753 -177.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.868 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.8 tm? -162.36 138.54 7.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.91 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.7 p -149.79 159.57 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.211 0.529 . . . . 10.0 112.017 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.531 ' HE3' HD11 ' A' ' 125' ' ' LEU . 94.6 mttt -160.24 135.91 8.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.306 -0.861 . . . . 10.0 109.876 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 5.7 m -163.9 149.28 10.78 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.973 0.416 . . . . 10.0 111.254 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 55.24 46.64 23.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.838 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.52 34.53 49.5 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.581 -0.819 . . . . 10.0 111.797 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 128' ' ' THR . 2.5 ptp180 -136.21 135.42 39.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.824 0.345 . . . . 10.0 110.21 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.9 152.42 21.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.158 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.91 ' HB ' HG13 ' A' ' 126' ' ' VAL . 6.3 mt -151.22 129.86 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.05 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.921 ' HB ' HD13 ' A' ' 23' ' ' LEU . 6.7 mm -90.29 145.0 7.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.928 ' O ' HD23 ' A' ' 136' ' ' LEU . 38.1 t80 -133.5 136.32 45.0 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.197 0.522 . . . . 10.0 111.525 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.956 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 16.0 mt -138.17 147.5 43.92 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.66 0.743 . . . . 10.0 112.003 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.2 p-10 -105.51 26.43 9.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.703 -1.135 . . . . 10.0 108.86 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.902 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.6 tt 38.91 16.86 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 114.477 1.288 . . . . 10.0 114.477 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 137' ' ' ASP . 7.9 t0 -80.05 -62.35 1.71 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 144' ' ' GLU . 14.5 mmmm -73.7 -31.54 63.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.416 0.626 . . . . 10.0 110.451 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.902 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.96 -46.61 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.302 -0.863 . . . . 10.0 110.771 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.987 HD13 HG21 ' A' ' 91' ' ' VAL . 6.6 tp -60.92 -46.71 95.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 119.8 -0.76 . . . . 10.0 109.826 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.717 ' O ' HG12 ' A' ' 147' ' ' VAL . 96.7 mt-10 -48.87 -40.41 29.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.531 ' HA ' HG12 ' A' ' 147' ' ' VAL . 44.8 mt-10 -71.21 -39.03 72.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.182 -0.917 . . . . 10.0 110.528 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.657 ' CD1' HG11 ' A' ' 91' ' ' VAL . 34.4 mt -48.16 -43.79 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 120.797 0.332 . . . . 10.0 111.443 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.6 p -84.71 -53.47 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 143' ' ' GLU . 14.5 p -63.35 -21.45 28.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 0.5 OUTLIER -39.83 -41.68 1.17 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 111.718 0.266 . . . . 10.0 111.718 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -65.41 133.4 51.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.82 0.343 . . . . 10.0 110.796 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 175.43 41.51 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.779 -0.724 . . . . 10.0 111.982 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 10.0 110.982 -179.93 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtm . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.846 0.355 . . . . 10.0 111.232 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.57 ' HG2' HG22 ' A' ' 3' ' ' THR . 39.9 ttmt -60.57 -55.68 30.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.722 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.57 HG22 ' HG2' ' A' ' 2' ' ' LYS . 5.3 t 174.7 -50.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.615 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.879 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.9 pp -78.66 -37.41 42.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.546 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.879 ' N ' HD12 ' A' ' 4' ' ' LEU . . . 61.03 122.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.991 -0.55 . . . . 10.0 111.219 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 37.2 t70 60.45 136.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.177 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 6' ' ' ASP . . . 171.93 130.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.063 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.94 HD11 ' HB2' ' A' ' 111' ' ' LEU . 87.6 mt -92.02 42.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 10.0 111.088 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HD2' ' CB ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -98.61 -42.02 7.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.832 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 37.8 tt0 -164.01 164.01 23.2 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.838 0.828 . . . . 10.0 111.295 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.611 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.3 t80 -150.85 138.62 19.83 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.964 -1.471 . . . . 10.0 112.862 -174.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 2.1 mt-10 -88.7 132.43 34.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.377 -0.828 . . . . 10.0 108.893 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.788 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.3 p -150.31 167.2 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 112.906 0.706 . . . . 10.0 112.906 -176.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 1.042 HD11 HD13 ' A' ' 82' ' ' ILE . 2.8 tm? -88.95 130.5 35.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.681 -0.859 . . . . 10.0 108.681 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.788 ' CB ' HD22 ' A' ' 102' ' ' LEU . 41.9 t -143.82 155.35 44.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.864 0.84 . . . . 10.0 112.565 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.663 ' CD2' HD11 ' A' ' 82' ' ' ILE . 2.2 p90 -150.09 163.74 37.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.181 -1.372 . . . . 10.0 110.241 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HG2' HD21 ' A' ' 99' ' ' LEU . 67.6 mm-40 -88.53 129.09 35.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.983 HG21 HD12 ' A' ' 71' ' ' ILE . 32.3 mm -122.85 87.89 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.319 -0.855 . . . . 10.0 111.259 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 41.5 m-20 51.48 60.04 4.15 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.838 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 61.7 mm-40 77.46 -32.48 0.18 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.45 -0.795 . . . . 10.0 111.708 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.495 ' NE2' HD11 ' A' ' 134' ' ' ILE . 38.6 tt0 -88.75 142.27 27.81 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.865 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.67 158.34 18.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.061 0.458 . . . . 10.0 112.086 -178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.76 HD12 ' H ' ' A' ' 24' ' ' ALA . 2.0 tp -152.28 139.62 19.47 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.123 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.76 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -141.99 144.68 33.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.426 0.528 . . . . 10.0 112.426 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.983 ' CE2' HD13 ' A' ' 65' ' ' LEU . 1.8 m-85 -119.54 138.84 52.93 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.969 -1.122 . . . . 10.0 107.969 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.66 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 26.4 t70 -51.57 123.52 10.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.01 0.433 . . . . 10.0 111.26 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.788 HG13 ' HA ' ' A' ' 13' ' ' VAL . 12.7 m -64.29 -10.53 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.705 -0.679 . . . . 10.0 112.106 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.66 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 53.6 m-20 -69.37 -38.94 78.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.007 -0.677 . . . . 10.0 109.454 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.901 HD21 HG22 ' A' ' 86' ' ' THR . 12.6 t-20 -89.86 -44.83 9.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.234 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.694 HG21 ' HG ' ' A' ' 14' ' ' LEU . 25.4 mm -65.41 129.24 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.091 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' OE2' HG12 ' A' ' 83' ' ' VAL . 14.8 pt-20 -95.55 -50.99 4.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.054 0.39 . . . . 10.0 112.054 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.7 mtm -168.99 155.07 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.185 0.516 . . . . 10.0 112.017 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.772 HG11 HG11 ' A' ' 98' ' ' VAL . 35.2 m -89.03 155.89 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.498 -0.774 . . . . 10.0 111.28 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 22.8 pt -150.44 138.58 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.046 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 22.7 pt-20 -104.65 110.96 23.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.693 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' O ' HG13 ' A' ' 39' ' ' ILE . 24.5 ttmm -169.12 63.94 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.182 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.8 p -54.66 -173.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 10.0 111.16 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 t70 46.42 45.26 13.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.568 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.608 ' CD1' HD13 ' A' ' 81' ' ' ILE . 15.4 mt -77.72 156.27 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.737 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.916 HG23 ' HG2' ' A' ' 43' ' ' PRO . 27.8 m -17.17 80.55 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.047 -0.979 . . . . 10.0 112.895 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.477 ' N ' ' O ' ' A' ' 39' ' ' ILE . 84.3 Cg_endo -90.69 -50.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.032 2.488 . . . . 10.0 113.824 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.486 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 42.4 t -64.78 -45.62 75.28 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 112.058 0.392 . . . . 10.0 112.058 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.916 ' HG2' HG23 ' A' ' 40' ' ' THR . 44.2 Cg_exo -57.19 -54.3 3.76 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.212 1.942 . . . . 10.0 112.553 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? 43.66 -129.64 0.81 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.459 -0.337 . . . . 10.0 111.611 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t 67.24 54.48 0.72 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 122.794 0.438 . . . . 10.0 111.813 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 96.0 mtt180 -160.28 44.07 0.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.4 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 56.95 -133.39 1.35 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.197 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' CE1' ' HE2' ' A' ' 67' ' ' LYS . 4.1 t80 -55.44 -34.05 64.13 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.604 0.24 . . . . 10.0 111.624 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.464 HG11 ' CB ' ' A' ' 61' ' ' PRO . 57.4 t -47.76 116.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.007 0.432 . . . . 10.0 111.069 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -79.49 -34.94 40.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.857 -0.611 . . . . 10.0 111.31 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.669 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -151.6 -175.74 23.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.933 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.569 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.3 m -154.2 169.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.82 HD11 HD11 ' A' ' 60' ' ' ILE . 27.6 pt -157.88 141.07 6.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 10.0 111.052 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -88.81 138.94 30.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.02 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.848 HD13 ' N ' ' A' ' 56' ' ' ARG . 2.4 tm? -169.1 138.43 2.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.581 . . . . 10.0 110.459 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.848 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.7 OUTLIER 48.67 48.98 19.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.119 0.485 . . . . 10.0 110.373 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 53.34 41.67 62.94 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.886 -0.673 . . . . 10.0 112.808 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -165.94 128.23 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 10.0 110.859 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.649 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -88.99 132.74 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.865 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.883 HG22 ' HB2' ' A' ' 90' ' ' GLU . 18.7 pt -112.72 126.98 27.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.494 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 80.7 Cg_endo -77.19 121.98 5.97 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.631 2.22 . . . . 10.0 112.601 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.669 HG22 ' C ' ' A' ' 51' ' ' GLY . 34.2 m -88.92 129.67 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.687 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.915 HG12 ' H ' ' A' ' 64' ' ' ASN . 3.2 t -113.5 -175.81 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.595 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.915 ' H ' HG12 ' A' ' 63' ' ' VAL . 11.7 p-10 -133.7 70.18 1.46 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.358 0.599 . . . . 10.0 110.709 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.983 HD13 ' CE2' ' A' ' 25' ' ' PHE . 5.6 tt -53.76 -37.59 63.56 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.821 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.824 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -50.57 -29.16 10.09 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.338 -0.545 . . . . 10.0 109.876 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.585 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -82.64 -43.59 16.77 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.617 -0.719 . . . . 10.0 110.631 178.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.0 tt -61.03 -37.58 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 122.096 0.951 . . . . 10.0 108.646 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.877 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -81.83 -53.95 5.76 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.713 -1.585 . . . . 10.0 109.219 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.488 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 119.09 -77.81 0.3 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.383 -0.826 . . . . 10.0 112.136 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.983 HD12 HG21 ' A' ' 18' ' ' ILE . 3.8 pt 44.69 177.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 113.122 0.786 . . . . 10.0 113.122 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.416 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 41.1 t -54.87 -38.37 67.42 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.806 ' HB3' HG13 ' A' ' 71' ' ' ILE . 5.9 t80 -24.6 140.66 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.635 -1.166 . . . . 10.0 113.571 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -172.71 37.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.321 -0.854 . . . . 10.0 110.095 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 54.33 35.11 22.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.884 -0.598 . . . . 10.0 111.304 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HB2' ' HZ3' ' A' ' 77' ' ' LYS . 98.3 mm-40 -81.03 -61.36 1.98 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.398 -0.364 . . . . 10.0 111.652 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 78' ' ' MET . 2.3 mppt? -103.14 -25.37 13.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.429 -0.35 . . . . 10.0 111.847 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 20.0 mmt -17.9 136.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -170.19 -34.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.771 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.81 ' O ' HD12 ' A' ' 94' ' ' LEU . 47.7 t -88.85 -176.02 5.07 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.832 0.349 . . . . 10.0 111.444 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.608 HD13 ' CD1' ' A' ' 39' ' ' ILE . 45.7 mt -152.37 158.34 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.897 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.042 HD13 HD11 ' A' ' 14' ' ' LEU . 12.3 mt -133.05 139.98 48.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.774 0.321 . . . . 10.0 111.052 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.465 HG12 ' OE2' ' A' ' 31' ' ' GLU . 44.4 t -109.17 152.68 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.066 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.47 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -155.37 169.71 23.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.364 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -128.04 132.72 49.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.901 HG22 HD21 ' A' ' 29' ' ' ASN . 57.6 p -148.3 109.19 4.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.817 0.303 . . . . 10.0 111.817 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 22.3 ttmm 49.49 60.21 3.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.147 0.499 . . . . 10.0 110.282 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 87' ' ' LYS . 7.4 p-10 55.1 32.68 18.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.036 -0.984 . . . . 10.0 111.551 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 91' ' ' VAL . 70.7 t -125.62 109.34 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 115.16 -0.927 . . . . 10.0 108.732 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.883 ' HB2' HG22 ' A' ' 60' ' ' ILE . 28.5 mt-10 -88.46 94.59 9.91 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.871 -1.529 . . . . 10.0 106.871 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.03 HG21 HD13 ' A' ' 142' ' ' ILE . 3.1 t -88.57 155.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 113.035 -1.893 . . . . 10.0 112.856 -174.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.32 165.93 21.81 Favored Glycine 0 C--N 1.314 -0.693 0 CA-C-N 114.679 -1.146 . . . . 10.0 112.468 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.551 ' HE2' ' CZ ' ' A' ' 16' ' ' PHE . 2.6 t80 -151.62 133.61 15.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 10.0 110.839 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.81 HD12 ' O ' ' A' ' 80' ' ' SER . 67.3 tp -88.72 126.27 35.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.238 0.542 . . . . 10.0 111.898 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.529 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 15.4 m -135.61 -175.27 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.02 178.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -100.37 -60.04 1.6 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.203 0.525 . . . . 10.0 111.656 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.598 HH12 HD13 ' A' ' 99' ' ' LEU . 57.1 ttt-85 -144.46 117.08 8.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.382 -0.826 . . . . 10.0 108.891 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.772 HG11 HG11 ' A' ' 33' ' ' VAL . 7.5 p -101.08 118.22 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 122.336 1.065 . . . . 10.0 112.482 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.598 HD13 HH12 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -66.03 -29.22 69.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.219 -1.81 . . . . 10.0 110.674 -179.335 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.16 -125.05 7.61 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.485 -0.78 . . . . 10.0 111.425 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 m -52.33 131.13 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.944 0.372 . . . . 10.0 110.513 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.788 HD22 ' CB ' ' A' ' 15' ' ' SER . 56.6 tp -135.2 141.46 45.85 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.151 0.5 . . . . 10.0 111.258 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 103' ' ' ARG . 16.2 ptm180 -88.81 70.55 8.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.049 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.757 ' CG1' HG11 ' A' ' 13' ' ' VAL . 17.2 mm -88.65 136.76 22.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 107.922 -1.14 . . . . 10.0 107.922 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 37.9 p -88.65 -175.88 5.07 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.615 ' HG3' HD12 ' A' ' 109' ' ' LEU . 38.2 tt0 -149.6 77.06 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.06 -1.056 . . . . 10.0 113.393 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -111.69 22.17 15.28 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.255 -1.339 . . . . 10.0 107.519 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.628 ' O ' HD23 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -158.77 59.71 0.43 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.902 -1.044 . . . . 10.0 111.628 -178.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.628 HD23 ' O ' ' A' ' 108' ' ' GLN . 76.5 mt -154.08 -43.12 0.09 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.914 -1.039 . . . . 10.0 111.409 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -168.69 157.34 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.069 0.461 . . . . 10.0 111.241 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.94 ' HB2' HD11 ' A' ' 8' ' ' LEU . 84.9 mt 65.72 97.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.184 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 111' ' ' LEU . 9.1 t 48.89 48.02 20.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.63 -0.713 . . . . 10.0 111.232 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.789 ' O ' HG13 ' A' ' 114' ' ' VAL . 78.5 m-20 -158.14 135.15 9.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.635 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -179.97 116.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.266 -179.462 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 t -168.12 147.69 4.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.065 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.623 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 1.5 m-20 -52.12 -48.4 64.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.172 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.53 ' HD3' ' CG ' ' A' ' 108' ' ' GLN . 35.0 mtmt 73.43 -59.62 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.676 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.605 ' CB ' ' HA ' ' A' ' 123' ' ' LYS . 26.6 t80 -96.81 -66.56 0.9 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.833 0.349 . . . . 10.0 110.91 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.61 -36.64 0.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.56 -0.828 . . . . 10.0 112.941 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.47 ' NZ ' ' HB2' ' A' ' 120' ' ' LYS . 0.1 OUTLIER 176.33 124.98 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 2.7 tppp? 73.28 117.87 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.495 -0.775 . . . . 10.0 110.541 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.867 ' OG ' HD23 ' A' ' 69' ' ' LEU . 1.8 p 53.81 47.05 24.49 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.623 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 22.5 pttp -75.79 47.76 0.44 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.532 -1.213 . . . . 10.0 113.883 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.766 ' O ' ' HB3' ' A' ' 135' ' ' TYR . . . -107.89 46.78 1.12 Allowed Glycine 0 C--O 1.221 -0.659 0 C-N-CA 119.713 -1.232 . . . . 10.0 112.455 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.907 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.5 tm? -52.72 140.82 22.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.193 -0.593 . . . . 10.0 111.006 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.907 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.1 p -148.15 160.69 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-O 121.35 0.595 . . . . 10.0 111.593 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.505 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 87.0 tttt -164.77 135.81 4.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 10.0 110.284 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 8.5 m -161.76 150.52 15.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 120.976 0.417 . . . . 10.0 111.013 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 9.8 t70 55.18 48.02 20.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.442 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.3 35.03 34.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.664 -0.779 . . . . 10.0 111.977 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.618 HH12 ' HB2' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -137.33 133.14 34.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.703 0.287 . . . . 10.0 110.273 -179.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.654 HD12 ' N ' ' A' ' 132' ' ' LEU . 3.7 mp -88.93 139.08 30.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.892 0.377 . . . . 10.0 111.316 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.865 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.1 mt -145.36 136.7 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 10.0 110.621 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.717 ' CG2' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -95.87 132.92 38.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.766 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 12.7 t80 -120.43 144.69 47.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.229 0.538 . . . . 10.0 110.421 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.885 ' HG ' HD11 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -151.88 131.81 13.37 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.52 -0.764 . . . . 10.0 111.234 -177.516 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.708 ' N ' HD22 ' A' ' 136' ' ' LEU . 12.2 p-10 -95.05 34.74 1.34 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.218 0.532 . . . . 10.0 111.296 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.849 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.6 tt 38.4 19.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.375 1.25 . . . . 10.0 114.375 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 137' ' ' ASP . 64.3 t0 -77.29 -57.11 4.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.274 0.842 . . . . 10.0 113.274 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 121' ' ' LYS . 34.5 mmtp -76.08 -28.93 57.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.318 0.58 . . . . 10.0 111.248 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.849 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.76 -45.99 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.438 -0.801 . . . . 10.0 110.878 -179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.03 HD13 HG21 ' A' ' 91' ' ' VAL . 8.9 tp -67.34 -47.65 80.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 120.252 -0.579 . . . . 10.0 111.212 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.892 ' O ' HG12 ' A' ' 147' ' ' VAL . 48.5 mt-10 -50.33 -42.54 53.06 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.392 -0.595 . . . . 10.0 109.392 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' A' ' 68' ' ' ILE . 57.4 mm-40 -75.17 -27.24 59.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.123 -0.944 . . . . 10.0 111.04 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 142' ' ' ILE . 23.5 mt -55.41 -43.1 70.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.907 0.384 . . . . 10.0 110.72 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.4 p -86.33 -52.51 5.58 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.571 0.582 . . . . 10.0 112.571 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 143' ' ' GLU . 7.2 p -84.78 13.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.85 0.685 . . . . 10.0 112.85 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.573 ' HA ' ' HE2' ' A' ' 148' ' ' LYS . 0.2 OUTLIER -40.02 -56.76 1.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.712 0.292 . . . . 10.0 111.769 -178.199 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 178.66 133.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.827 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.451 ' O ' HG12 ' A' ' 151' ' ' VAL . . . -67.97 -46.9 63.25 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.469 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 150' ' ' GLY . 12.3 p . . . . . 0 N--CA 1.464 0.237 0 CA-C-O 120.878 0.371 . . . . 10.0 111.539 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.812 0.339 . . . . 10.0 111.133 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -58.95 -44.66 91.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 10.0 111.092 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.1 m 69.65 -56.2 0.57 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.495 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.5 pp -56.81 -30.26 63.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 10.0 110.936 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.915 ' N ' HD12 ' A' ' 4' ' ' LEU . . . 67.78 133.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.34 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.06 139.05 57.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.68 ' O ' HD23 ' A' ' 8' ' ' LEU . . . 178.87 140.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.165 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 7' ' ' ALA . 87.5 mt -147.88 42.81 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.656 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -88.95 -64.66 1.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 10.0 111.075 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.41 ' HG2' HG22 ' A' ' 105' ' ' THR . 93.9 mt-10 -152.26 164.3 37.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.969 0.89 . . . . 10.0 111.842 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CE2' ' OH ' ' A' ' 135' ' ' TYR . 35.0 t80 -117.0 127.94 54.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.794 -1.548 . . . . 10.0 113.802 -175.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -89.02 126.2 35.32 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.649 -1.611 . . . . 10.0 106.649 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.973 HG11 ' CG1' ' A' ' 104' ' ' ILE . 4.2 p -151.83 167.74 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 114.476 1.287 . . . . 10.0 114.476 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.76 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.4 tm? -88.9 137.93 31.87 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 107.91 -1.144 . . . . 10.0 107.91 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.779 ' CB ' HD22 ' A' ' 102' ' ' LEU . 57.0 p -149.29 158.99 44.64 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.203 0.816 . . . . 10.0 113.203 -177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.696 ' CD2' HD11 ' A' ' 82' ' ' ILE . 6.9 p90 -152.3 165.92 33.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.217 -1.356 . . . . 10.0 110.42 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.6 137.25 32.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 10.0 109.715 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.975 HG21 HD12 ' A' ' 71' ' ' ILE . 28.4 mm -134.37 92.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.164 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.494 ' OD2' ' HA ' ' A' ' 73' ' ' PHE . 41.6 m-20 44.74 60.25 3.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.64 . . . . 10.0 112.701 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 45.9 mt-10 85.17 -42.59 0.06 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.282 -0.872 . . . . 10.0 111.879 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.1 pt20 -88.95 145.72 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.021 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.49 166.81 13.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.908 0.385 . . . . 10.0 110.785 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.8 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.5 tp -149.43 139.33 21.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.505 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.775 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -142.58 146.66 34.8 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.489 0.922 . . . . 10.0 113.489 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.874 ' CE2' HD21 ' A' ' 136' ' ' LEU . 1.6 m-85 -124.24 143.51 50.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.224 -0.898 . . . . 10.0 108.615 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -53.69 123.23 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.05 -0.352 . . . . 10.0 110.05 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.905 HG13 ' HA ' ' A' ' 13' ' ' VAL . 27.4 m -58.04 -14.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.567 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -62.64 -43.59 98.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.061 0.458 . . . . 10.0 110.204 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.842 ' ND2' HG21 ' A' ' 138' ' ' ILE . 14.9 t30 -84.7 -47.02 10.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.675 -0.693 . . . . 10.0 111.164 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.76 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.8 mm -61.03 132.28 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.217 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.442 ' HB3' ' CE ' ' A' ' 32' ' ' MET . 43.9 mt-10 -94.91 -60.4 1.7 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.376 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.442 ' CE ' ' HB3' ' A' ' 31' ' ' GLU . 1.2 pmm? -169.01 156.55 7.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.367 -0.379 . . . . 10.0 111.003 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.818 HG11 HG11 ' A' ' 98' ' ' VAL . 35.3 m -88.84 144.58 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 10.0 111.791 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.492 HG12 HG23 ' A' ' 83' ' ' VAL . 31.6 pt -137.89 136.81 45.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.593 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -88.95 120.82 30.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 10.0 110.68 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.979 ' HB2' HD12 ' A' ' 81' ' ' ILE . 62.0 mttp -162.56 156.58 21.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.804 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.5 m -167.65 37.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.356 0.598 . . . . 10.0 111.059 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -167.86 44.03 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.151 -0.931 . . . . 10.0 110.567 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.809 HD11 ' CD ' ' A' ' 36' ' ' LYS . 15.9 mt -93.66 138.31 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.883 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.778 HG23 ' CG ' ' A' ' 43' ' ' PRO . 6.0 m 37.51 77.66 0.39 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.903 -0.59 . . . . 10.0 112.545 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -86.93 -47.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.801 2.334 . . . . 10.0 113.433 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.586 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 14.8 p -84.57 -31.2 0.46 Allowed Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 113.595 0.961 . . . . 10.0 113.595 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.778 ' CG ' HG23 ' A' ' 40' ' ' THR . 47.4 Cg_exo -55.57 -56.31 2.35 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.655 1.57 . . . . 10.0 112.913 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' NZ ' ' HB3' ' A' ' 44' ' ' LYS . 3.3 ttpm? 56.18 -131.85 1.66 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.603 -0.271 . . . . 10.0 110.3 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 23.3 t 78.64 -45.69 0.4 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.882 0.473 . . . . 10.0 112.188 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.451 ' CB ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -64.34 -31.4 72.6 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.895 0.331 . . . . 10.0 111.895 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 38.2 m80 69.87 -62.71 0.41 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.203 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.515 ' HB3' ' HD2' ' A' ' 148' ' ' LYS . 2.4 t80 -69.89 -43.49 71.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.133 0.492 . . . . 10.0 109.784 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.941 ' HA ' HG22 ' A' ' 63' ' ' VAL . 44.6 t -78.51 135.5 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.598 -0.728 . . . . 10.0 111.58 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.43 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 24.2 mm-40 -88.34 -40.9 13.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.772 -0.649 . . . . 10.0 110.601 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 62' ' ' VAL . . . -135.22 160.9 24.54 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.345 -0.931 . . . . 10.0 113.747 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.624 ' H ' HG22 ' A' ' 39' ' ' ILE . 2.6 m -159.81 169.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.501 HG12 HD11 ' A' ' 60' ' ' ILE . 31.6 pt -159.08 142.46 5.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.862 0.363 . . . . 10.0 111.073 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -88.75 141.38 28.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.989 -0.551 . . . . 10.0 111.064 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.667 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -168.71 133.04 1.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.84 -0.618 . . . . 10.0 109.981 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.667 ' N ' HD13 ' A' ' 55' ' ' LEU . 35.3 mmt180 50.46 45.76 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 10.0 110.925 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.7 38.17 80.92 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.8 -0.636 . . . . 10.0 112.977 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -158.41 124.42 4.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.744 0.306 . . . . 10.0 110.596 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.613 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.6 mp -91.0 127.4 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.25 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.813 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.1 pp -94.92 134.94 24.09 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.55 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 92.8 Cg_endo -99.57 121.82 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.068 2.512 . . . . 10.0 113.864 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 51' ' ' GLY . 19.5 m -103.52 127.57 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.844 -0.798 . . . . 10.0 108.844 177.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.941 HG22 ' HA ' ' A' ' 49' ' ' VAL . 47.3 t -139.59 160.36 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.851 0.834 . . . . 10.0 113.204 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.567 ' N ' HG12 ' A' ' 63' ' ' VAL . 4.3 m120 -75.96 73.39 2.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.591 -1.186 . . . . 10.0 108.667 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.911 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.3 tt -52.87 -38.53 61.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.293 0.568 . . . . 10.0 111.397 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.028 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -59.9 -18.5 45.29 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.193 -0.603 . . . . 10.0 110.03 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.534 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.1 tmmm? -85.41 -46.9 10.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.017 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.911 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.4 tt -53.86 -35.21 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 107.611 -1.255 . . . . 10.0 107.611 178.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.868 ' C ' HD13 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -86.1 -56.08 3.63 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.08 -1.873 . . . . 10.0 109.82 178.263 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . 121.92 -81.47 0.34 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.307 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.028 HD11 ' CB ' ' A' ' 66' ' ' ALA . 2.9 pt 45.11 179.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.698 0.629 . . . . 10.0 112.698 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 45.7 t -54.75 -39.08 67.94 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.151 -0.685 . . . . 10.0 109.151 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.78 ' HB3' HG13 ' A' ' 71' ' ' ILE . 14.8 t80 -32.4 143.69 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.784 -1.098 . . . . 10.0 112.896 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -166.77 37.4 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.532 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 55.28 38.76 30.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.776 -0.647 . . . . 10.0 111.22 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.442 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 4.2 pt20 -94.01 -50.51 5.28 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.262 0.467 . . . . 10.0 112.262 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 12.4 mptt -111.16 -25.01 9.95 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.559 ' HE2' ' HD1' ' A' ' 73' ' ' PHE . 16.9 mmt -36.72 143.77 0.07 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.758 0.651 . . . . 10.0 112.758 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 53.6 mtmt -159.53 -41.38 0.05 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.91 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.963 ' O ' HD12 ' A' ' 94' ' ' LEU . 46.8 t -88.78 -175.99 5.08 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.913 0.387 . . . . 10.0 111.551 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.979 HD12 ' HB2' ' A' ' 36' ' ' LYS . 77.4 mt -146.55 154.22 12.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.328 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.696 HD11 ' CD2' ' A' ' 16' ' ' PHE . 10.8 mt -120.63 143.9 31.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.739 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 34' ' ' ILE . 72.1 t -111.41 149.85 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.974 0.416 . . . . 10.0 110.892 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -153.57 174.33 14.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 10.0 111.001 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 6.3 ptm180 -135.71 132.11 36.47 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.737 HG22 ' OD1' ' A' ' 29' ' ' ASN . 59.0 p -145.51 109.54 4.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.962 0.41 . . . . 10.0 111.922 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 14.7 tppt? 47.53 49.74 15.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.328 0.585 . . . . 10.0 110.851 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.05 31.57 1.45 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.066 -0.97 . . . . 10.0 111.519 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.93 HG12 HG22 ' A' ' 91' ' ' VAL . 67.6 t -128.33 108.56 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.23 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.7 ' HB2' HG22 ' A' ' 60' ' ' ILE . 6.4 mp0 -88.4 98.47 11.64 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.198 -1.779 . . . . 10.0 106.198 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.005 HG21 HD13 ' A' ' 142' ' ' ILE . 3.0 t -88.7 157.2 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 113.089 -1.869 . . . . 10.0 112.711 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -140.25 151.21 22.08 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 114.895 -1.048 . . . . 10.0 113.258 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.602 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.1 t80 -140.77 134.39 30.16 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.93 0.395 . . . . 10.0 111.003 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.963 HD12 ' O ' ' A' ' 80' ' ' SER . 31.7 tp -88.61 115.5 26.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 10.0 111.46 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.528 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 12.8 m -122.43 -175.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.933 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -100.15 -59.98 1.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.174 0.512 . . . . 10.0 111.825 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -141.26 113.37 7.94 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.547 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.818 HG11 HG11 ' A' ' 33' ' ' VAL . 9.5 p -99.79 111.28 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 122.461 1.124 . . . . 10.0 111.168 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.538 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -62.72 -28.51 70.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.909 -1.95 . . . . 10.0 111.161 -178.526 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.92 -122.73 6.52 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.964 -0.854 . . . . 10.0 110.964 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -53.94 131.82 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 117.06 0.43 . . . . 10.0 110.229 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.779 HD22 ' CB ' ' A' ' 15' ' ' SER . 19.4 tp -137.07 142.94 42.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 10.0 111.257 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.1 ptp85 -88.85 79.82 7.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.529 -0.76 . . . . 10.0 111.295 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.973 ' CG1' HG11 ' A' ' 13' ' ' VAL . 11.6 mm -88.76 178.78 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 104' ' ' ILE . 22.1 p -134.96 -175.85 4.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.774 -0.824 . . . . 10.0 108.774 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.655 ' HG3' ' HB2' ' A' ' 109' ' ' LEU . 35.5 tt0 -136.71 79.04 1.74 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.934 0.873 . . . . 10.0 112.516 -178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.552 ' C ' HG21 ' A' ' 112' ' ' THR . 80.0 m-20 -119.89 22.29 11.58 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.23 -1.35 . . . . 10.0 107.522 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.91 ' N ' HG21 ' A' ' 112' ' ' THR . 20.6 pt20 -150.11 -23.6 0.25 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.997 -1.001 . . . . 10.0 113.606 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.655 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 6.8 mp -57.43 -164.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.816 0.341 . . . . 10.0 111.341 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.99 -44.32 73.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.442 -0.344 . . . . 10.0 111.864 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.421 HD12 ' OE1' ' A' ' 106' ' ' GLU . 76.3 mt -54.06 -52.96 59.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.602 -0.272 . . . . 10.0 111.545 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.91 HG21 ' N ' ' A' ' 108' ' ' GLN . 9.0 t -60.66 -22.02 63.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 10.0 110.692 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 112' ' ' THR . 68.7 m-80 76.91 46.72 0.07 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.609 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 108' ' ' GLN . 10.6 t -152.01 45.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.055 0.455 . . . . 10.0 110.335 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 53.5 m -77.89 45.41 0.52 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.108 0.781 . . . . 10.0 113.108 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.69 -53.65 43.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 122' ' ' SER . 90.5 mttt 61.6 112.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.999 -1.0 . . . . 10.0 113.612 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.855 ' CE1' HD21 ' A' ' 69' ' ' LEU . 20.2 t80 58.33 19.99 6.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.639 -1.164 . . . . 10.0 111.494 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.0 -43.69 1.48 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.488 -0.863 . . . . 10.0 112.202 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -156.66 38.22 0.32 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.667 0.27 . . . . 10.0 111.013 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . 39.9 ttmt -157.06 -112.94 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.446 -0.343 . . . . 10.0 110.594 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.75 ' O ' ' N ' ' A' ' 124' ' ' GLY . 74.4 m -143.76 -45.35 0.27 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 112.765 0.654 . . . . 10.0 112.765 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.723 ' NZ ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -53.85 55.92 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.487 -0.779 . . . . 10.0 112.132 -177.196 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.769 ' HA2' ' H ' ' A' ' 118' ' ' PHE . . . -51.63 130.19 34.58 Favored Glycine 0 CA--C 1.509 -0.341 0 CA-C-N 115.135 -0.939 . . . . 10.0 111.802 178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.697 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.3 tm? -70.74 127.41 32.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.549 0.69 . . . . 10.0 111.524 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.697 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.1 p -123.02 155.77 28.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.783 -1.099 . . . . 10.0 109.944 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 131' ' ' ARG . 8.1 ptpp? -154.77 143.9 21.07 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.132 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 23.8 m -152.61 140.02 19.6 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.578 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 p30 45.28 48.39 10.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.045 0.45 . . . . 10.0 111.219 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.42 97.15 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.647 -0.787 . . . . 10.0 111.773 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.7 ptp180 -130.08 136.94 49.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.653 0.263 . . . . 10.0 110.581 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 132' ' ' LEU . 3.7 mp -88.9 138.56 31.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.661 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.021 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.5 mt -156.92 144.64 10.84 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-N 116.465 -0.334 . . . . 10.0 111.741 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.8 ' HB ' HD13 ' A' ' 23' ' ' LEU . 2.2 mp -99.69 146.82 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.542 ' CE1' HG21 ' A' ' 13' ' ' VAL . 56.5 t80 -141.36 151.22 43.36 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.494 -0.482 . . . . 10.0 110.98 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.874 HD21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -169.09 150.64 4.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.146 0.795 . . . . 10.0 113.146 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -95.26 32.74 1.67 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.885 -1.052 . . . . 10.0 110.127 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.842 HG21 ' ND2' ' A' ' 29' ' ' ASN . 10.1 tt 38.69 23.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 114.836 -1.075 . . . . 10.0 113.683 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -75.79 -58.28 3.38 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.545 0.943 . . . . 10.0 113.545 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.589 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 7.2 mmpt? -78.23 -31.94 49.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.042 0.448 . . . . 10.0 110.698 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.832 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -65.17 -45.25 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.04 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.005 HD13 HG21 ' A' ' 91' ' ' VAL . 7.7 tp -65.49 -46.61 89.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.506 -0.478 . . . . 10.0 110.861 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 142' ' ' ILE . 47.3 mt-10 -48.46 -40.82 27.63 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.993 0.425 . . . . 10.0 110.159 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.572 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.1 mt-10 -68.67 -36.85 79.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.69 -0.686 . . . . 10.0 110.11 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.668 HD12 HD12 ' A' ' 142' ' ' ILE . 35.4 mt -53.62 -41.43 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.151 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.8 p -76.56 -49.93 15.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.785 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.7 p -75.33 1.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 112.082 0.401 . . . . 10.0 112.082 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.515 ' HD2' ' HB3' ' A' ' 48' ' ' PHE . 23.7 pttm -46.17 -44.63 16.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.873 0.368 . . . . 10.0 111.274 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -61.35 138.06 58.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.939 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.439 ' O ' HG12 ' A' ' 151' ' ' VAL . . . -176.74 -44.51 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.79 -0.719 . . . . 10.0 112.499 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 150' ' ' GLY . 11.8 p . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 120.832 0.349 . . . . 10.0 111.522 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.803 0.335 . . . . 10.0 111.203 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.609 ' HG2' HG22 ' A' ' 3' ' ' THR . 61.0 tttm -171.12 -63.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.609 HG22 ' HG2' ' A' ' 2' ' ' LYS . 7.7 t 171.44 -45.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.492 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.479 ' N ' HG23 ' A' ' 3' ' ' THR . 84.5 mt -69.5 -41.43 76.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.736 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.51 48.33 4.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.936 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -158.43 147.32 18.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.72 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -170.8 133.63 0.96 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.951 0.405 . . . . 10.0 111.442 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.835 HD11 HD13 ' A' ' 111' ' ' LEU . 93.0 mt -74.31 59.25 0.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.172 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.55 ' O ' HG22 ' A' ' 105' ' ' THR . 18.1 ttpt -138.48 -53.29 0.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.795 0.331 . . . . 10.0 111.419 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 42.6 tt0 -160.21 164.1 33.05 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.691 0.758 . . . . 10.0 111.464 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.569 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 14.6 t80 -158.55 138.91 12.47 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 114.26 -1.336 . . . . 10.0 112.527 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 29.2 mt-10 -88.62 139.47 30.44 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.938 -0.574 . . . . 10.0 109.527 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.921 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -155.47 167.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.752 1.019 . . . . 10.0 113.752 -175.159 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.592 HD13 ' C ' ' A' ' 14' ' ' LEU . 1.7 tm? -89.19 127.83 35.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.231 -0.895 . . . . 10.0 108.677 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.817 ' CB ' HD22 ' A' ' 102' ' ' LEU . 39.1 t -143.8 156.13 44.38 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.839 0.828 . . . . 10.0 113.131 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.696 ' HD2' HG23 ' A' ' 98' ' ' VAL . 1.3 p90 -146.53 160.05 42.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.851 -1.522 . . . . 10.0 109.917 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HG3' HD21 ' A' ' 99' ' ' LEU . 56.7 mt-10 -88.74 107.2 18.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.469 0.652 . . . . 10.0 110.066 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.75 HG21 HD12 ' A' ' 71' ' ' ILE . 30.6 mm -88.96 90.65 3.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.843 -1.071 . . . . 10.0 111.714 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 20' ' ' GLU . 9.5 p-10 36.46 60.38 0.9 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.857 -1.065 . . . . 10.0 113.498 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 19' ' ' ASP . 47.2 mt-10 100.07 -52.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.668 -1.151 . . . . 10.0 111.685 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.523 ' NE2' ' HB2' ' A' ' 72' ' ' SER . 3.3 pt20 -89.04 150.17 22.9 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.024 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.76 170.44 10.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.016 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.2 tp -159.06 136.84 10.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.597 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.757 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -141.42 152.76 44.56 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.481 0.549 . . . . 10.0 112.481 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.951 ' CE2' HD22 ' A' ' 136' ' ' LEU . 4.9 m-85 -130.04 138.94 51.03 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.293 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -47.49 122.33 4.66 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.899 0.381 . . . . 10.0 110.982 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.921 HG13 ' HA ' ' A' ' 13' ' ' VAL . 27.4 m -61.91 -12.79 8.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.073 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.87 -42.51 97.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.96 0.41 . . . . 10.0 110.161 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.81 ' OD1' HG21 ' A' ' 138' ' ' ILE . 9.6 t-20 -90.06 -47.24 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.895 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.582 HG21 ' HG ' ' A' ' 14' ' ' LEU . 19.7 mm -58.87 128.81 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.004 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' O ' ' CE ' ' A' ' 32' ' ' MET . 54.4 mt-10 -82.66 -65.4 1.02 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.077 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.414 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.7 tpp -169.08 173.71 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 10.0 111.322 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.573 ' CG1' HG11 ' A' ' 98' ' ' VAL . 35.3 m -89.01 150.99 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.488 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.574 HD13 ' CG2' ' A' ' 83' ' ' VAL . 12.7 pt -142.35 121.64 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.647 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.03 118.74 28.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 10.0 109.51 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.814 ' HB3' HD12 ' A' ' 81' ' ' ILE . 23.3 tptm -169.04 163.3 11.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.027 0.442 . . . . 10.0 111.026 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.8 t -152.08 -166.6 2.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.461 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 p30 40.94 37.46 0.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.291 0.567 . . . . 10.0 111.576 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 40' ' ' THR . 9.5 mt -80.31 158.26 4.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.337 -0.847 . . . . 10.0 110.959 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.519 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 84.1 m -18.96 110.05 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.094 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 40' ' ' THR . 5.4 Cg_exo -78.26 44.97 1.71 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.176 2.584 . . . . 10.0 113.836 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 42' ' ' VAL . 39.6 t 51.85 51.41 9.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.843 0.354 . . . . 10.0 111.507 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD2' ' CG2' ' A' ' 40' ' ' THR . 85.4 Cg_endo -77.83 -100.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.612 2.208 . . . . 10.0 111.941 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -51.28 -41.13 60.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.602 0.715 . . . . 10.0 110.092 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.7 t -48.0 -62.0 1.69 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.585 -1.189 . . . . 10.0 111.715 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 46' ' ' ARG . 77.9 ttt180 49.79 27.09 2.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.586 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.422 ' HB3' ' H ' ' A' ' 48' ' ' PHE . 2.1 m-70 -117.01 -157.94 0.68 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 10.0 111.45 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.514 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 7.0 t80 -62.8 -39.15 93.36 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.816 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.9 ' HA ' HG22 ' A' ' 63' ' ' VAL . 46.8 t -57.04 129.76 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.869 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 16.9 pt-20 -79.79 -37.39 35.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.418 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.616 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -161.02 -175.93 32.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.053 -0.594 . . . . 10.0 112.234 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.519 ' H ' ' HB ' ' A' ' 40' ' ' THR . 3.5 m -158.46 175.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 110.163 -0.31 . . . . 10.0 110.163 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.027 HD11 HD11 ' A' ' 60' ' ' ILE . 24.3 pt -157.41 144.27 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.64 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.505 ' O ' HD23 ' A' ' 55' ' ' LEU . 24.8 t-20 -88.74 133.87 34.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 10.0 111.567 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 54' ' ' ASN . 96.2 mt -161.04 138.33 9.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.47 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 20.8 tpp180 48.94 48.64 20.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.016 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 53.83 40.4 64.45 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.869 -0.681 . . . . 10.0 112.719 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.503 ' HD3' ' N ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -166.9 130.28 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.873 -0.418 . . . . 10.0 109.873 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -88.83 124.79 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.378 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.027 HD11 HD11 ' A' ' 53' ' ' ILE . 28.5 pt -92.75 130.2 37.54 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.974 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 86.3 Cg_endo -81.89 119.65 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.402 2.068 . . . . 10.0 113.252 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.616 HG22 ' C ' ' A' ' 51' ' ' GLY . 27.7 m -98.49 137.25 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.312 -0.625 . . . . 10.0 109.312 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.9 HG22 ' HA ' ' A' ' 49' ' ' VAL . 96.6 t -143.0 156.09 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.717 0.77 . . . . 10.0 112.744 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.788 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 76.1 m-20 -73.74 66.09 1.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.704 -1.135 . . . . 10.0 108.33 177.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.94 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.6 tt -49.32 -28.33 4.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.921 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.694 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -61.89 -29.81 70.45 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.821 -0.351 . . . . 10.0 110.953 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.788 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -87.31 -36.94 17.58 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 110.423 -0.214 . . . . 10.0 110.423 178.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.758 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 8.1 tt -61.16 -41.04 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 106.623 -1.621 . . . . 10.0 106.623 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.843 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -76.05 -38.66 56.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 113.407 -1.724 . . . . 10.0 107.972 176.465 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 69' ' ' LEU . . . 70.06 120.82 0.04 OUTLIER Glycine 0 C--N 1.335 0.492 0 CA-C-N 114.827 -1.079 . . . . 10.0 113.154 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.791 HG23 ' CD1' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -160.57 -167.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.332 0.653 . . . . 10.0 109.546 -179.146 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.523 ' HB2' ' NE2' ' A' ' 21' ' ' GLN . 29.2 t -53.16 -34.41 56.71 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.694 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 6.0 t80 -28.57 138.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.608 -1.178 . . . . 10.0 112.95 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 9.2 t70 -160.58 35.66 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.581 -0.736 . . . . 10.0 109.986 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.95 40.01 3.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.502 -0.772 . . . . 10.0 112.194 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 74.0 mt-30 -95.98 -49.55 5.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.606 0.241 . . . . 10.0 111.29 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 76' ' ' GLN . 2.3 mppt? -98.09 -31.76 11.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.506 -0.316 . . . . 10.0 111.629 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.598 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 21.7 mmt -27.01 141.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt 178.62 50.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.79 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.923 ' O ' HD12 ' A' ' 94' ' ' LEU . 80.0 p -169.03 155.34 6.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.795 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.814 HD12 ' HB3' ' A' ' 36' ' ' LYS . 61.0 mt -126.88 142.22 43.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.781 -0.367 . . . . 10.0 111.595 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 4.5 mt -119.42 143.72 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.642 -0.253 . . . . 10.0 110.556 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.574 ' CG2' HD13 ' A' ' 34' ' ' ILE . 79.9 t -113.62 152.46 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.231 0.539 . . . . 10.0 111.328 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -155.93 173.73 16.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.449 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.587 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 6.7 ptm180 -130.4 146.7 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.566 -0.531 . . . . 10.0 109.566 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.486 HG21 HG12 ' A' ' 138' ' ' ILE . 41.1 p -160.47 108.55 1.62 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 87' ' ' LYS . 36.7 ttmt 46.27 48.76 13.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.386 0.613 . . . . 10.0 110.892 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 72.84 33.67 1.24 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.56 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.887 HG12 HG22 ' A' ' 91' ' ' VAL . 53.8 t -131.75 110.84 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 115.268 -0.878 . . . . 10.0 109.122 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.788 ' HB2' HG22 ' A' ' 60' ' ' ILE . 1.5 mp0 -88.38 97.81 11.26 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.341 -1.726 . . . . 10.0 106.341 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.014 HG21 HD13 ' A' ' 142' ' ' ILE . 3.4 t -88.55 153.18 3.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 113.367 -1.742 . . . . 10.0 112.474 -174.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -130.47 152.95 19.97 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 114.861 -1.063 . . . . 10.0 113.499 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.639 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -139.94 128.03 22.31 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.906 0.384 . . . . 10.0 110.898 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.923 HD12 ' O ' ' A' ' 80' ' ' SER . 50.8 tp -88.57 128.17 35.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.943 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.658 HG11 ' CE1' ' A' ' 16' ' ' PHE . 19.7 m -136.74 -175.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.971 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -96.88 -65.35 0.97 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.131 0.491 . . . . 10.0 112.188 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.1 tpt85 -135.81 119.25 16.87 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.529 -0.76 . . . . 10.0 109.144 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.696 HG23 ' HD2' ' A' ' 16' ' ' PHE . 8.6 p -106.29 112.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 122.5 1.143 . . . . 10.0 112.045 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -66.2 -27.93 68.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.825 -1.989 . . . . 10.0 111.305 -178.763 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.62 -122.15 6.13 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.526 -0.845 . . . . 10.0 111.327 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.0 t -52.49 134.4 14.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.868 0.334 . . . . 10.0 110.569 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.817 HD22 ' CB ' ' A' ' 15' ' ' SER . 57.7 tp -140.27 141.07 35.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.076 0.465 . . . . 10.0 111.219 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.7 ptp180 -88.92 73.08 8.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.521 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.099 HD12 HG11 ' A' ' 126' ' ' VAL . 17.6 mm -88.59 131.8 35.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 109.892 -0.41 . . . . 10.0 109.892 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 22.8 p -88.83 151.1 22.58 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.507 ' HG3' ' HG ' ' A' ' 109' ' ' LEU . 20.4 tt0 -124.49 73.89 1.29 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.123 0.964 . . . . 10.0 112.99 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 114' ' ' VAL . 73.6 m-20 -113.65 15.67 18.8 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.844 -1.525 . . . . 10.0 107.403 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.656 ' HB3' HG23 ' A' ' 114' ' ' VAL . 6.6 pm0 -142.42 41.08 1.61 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.205 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.546 ' N ' HD23 ' A' ' 109' ' ' LEU . 1.6 pt? 173.55 51.14 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.68 -1.145 . . . . 10.0 110.661 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.55 ' OD1' HD21 ' A' ' 8' ' ' LEU . 7.3 t0 -172.72 -49.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.503 -0.771 . . . . 10.0 110.276 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.835 HD13 HD11 ' A' ' 8' ' ' LEU . 13.9 tp -94.29 -12.55 27.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.634 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 111' ' ' LEU . 15.1 t 56.42 42.31 27.73 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.327 0.651 . . . . 10.0 112.527 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.426 ' OD1' ' HG ' ' A' ' 111' ' ' LEU . 4.6 m120 -95.44 -29.86 14.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.101 0.476 . . . . 10.0 110.221 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.656 HG23 ' HB3' ' A' ' 108' ' ' GLN . 8.5 m -141.71 73.1 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.199 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.3 m -70.92 52.4 0.15 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.56 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.09 28.46 1.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.202 0.525 . . . . 10.0 110.561 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.42 ' HD3' ' HG3' ' A' ' 123' ' ' LYS . 91.9 mttt -46.56 -51.51 15.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.38 -0.827 . . . . 10.0 112.131 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.439 ' CE2' HD21 ' A' ' 69' ' ' LEU . 21.7 t80 -175.8 -53.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.072 0.463 . . . . 10.0 110.241 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 120' ' ' LYS . . . 148.91 -64.66 0.4 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.753 -0.658 . . . . 10.0 112.374 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 119' ' ' GLY . 67.7 mttm -163.61 53.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.673 0.273 . . . . 10.0 110.508 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -151.23 -43.34 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.879 0.326 . . . . 10.0 111.879 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.608 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 89.2 p -126.77 -140.2 0.27 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 121.245 -0.182 . . . . 10.0 111.312 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 123' ' ' LYS . 56.9 tttm -164.88 28.04 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.935 -0.306 . . . . 10.0 111.82 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.502 ' C ' ' HB3' ' A' ' 135' ' ' TYR . . . -151.43 145.66 13.7 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.736 -1.221 . . . . 10.0 113.422 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.9 tm? -155.54 141.13 17.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 1.099 HG11 HD12 ' A' ' 104' ' ' ILE . 1.5 p -160.87 160.94 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.389 0.614 . . . . 10.0 112.29 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 87.1 tttt -164.49 134.25 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.08 -0.964 . . . . 10.0 109.786 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 4.6 m -162.7 151.54 14.85 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 120.924 0.392 . . . . 10.0 111.12 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.42 45.8 21.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.979 0.419 . . . . 10.0 110.746 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.41 33.59 47.18 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.665 -0.778 . . . . 10.0 111.83 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 128' ' ' THR . 12.7 ptt180 -134.93 130.53 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.184 -0.302 . . . . 10.0 110.184 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 133' ' ' ILE . 2.8 tm? -88.87 135.23 33.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.852 0.358 . . . . 10.0 110.736 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.024 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.2 mt -130.8 130.75 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.345 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 1.016 ' HB ' HD13 ' A' ' 23' ' ' LEU . 5.1 mm -88.87 147.45 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.975 -1.12 . . . . 10.0 107.975 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.606 ' C ' HD12 ' A' ' 136' ' ' LEU . 32.9 t80 -137.02 141.39 42.5 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.71 -0.796 . . . . 10.0 111.671 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.951 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.7 mp -133.32 172.99 11.94 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.067 0.936 . . . . 10.0 112.679 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.37 24.94 2.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.935 -1.484 . . . . 10.0 108.336 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.916 ' HA ' HG23 ' A' ' 141' ' ' ILE . 10.3 tt 40.38 19.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.267 -1.333 . . . . 10.0 114.259 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 142' ' ' ILE . 9.1 t0 -82.64 -62.7 1.54 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -75.03 -29.81 60.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.447 0.642 . . . . 10.0 110.073 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.916 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.78 -46.36 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 115.097 -0.956 . . . . 10.0 110.723 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.014 HD13 HG21 ' A' ' 91' ' ' VAL . 7.6 tp -61.22 -44.56 98.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 119.911 -0.716 . . . . 10.0 109.595 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.87 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.4 tt0 -49.42 -47.52 47.98 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.829 -0.623 . . . . 10.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.593 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.5 mm-40 -66.13 -37.36 85.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.477 -0.783 . . . . 10.0 110.948 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.661 ' CD1' HG11 ' A' ' 91' ' ' VAL . 60.0 mt -51.4 -43.24 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 120.886 0.374 . . . . 10.0 111.208 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.9 p -87.61 -49.43 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.684 0.624 . . . . 10.0 112.684 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.87 HG12 ' O ' ' A' ' 143' ' ' GLU . 7.2 p -82.85 13.03 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.935 0.717 . . . . 10.0 112.935 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.575 ' HE3' ' HA ' ' A' ' 148' ' ' LYS . 2.0 tpmt? -53.99 -45.79 71.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.708 -0.397 . . . . 10.0 111.131 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -57.34 130.88 48.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.084 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 174.28 -46.65 0.14 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.843 -0.694 . . . . 10.0 112.377 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.6 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.828 0.347 . . . . 10.0 111.018 -179.968 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.803 0.335 . . . . 10.0 111.088 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.6 ' HG2' HG22 ' A' ' 3' ' ' THR . 61.5 tttm -66.47 -74.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.634 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.6 HG22 ' HG2' ' A' ' 2' ' ' LYS . 9.2 t 169.07 -46.9 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.018 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.495 ' N ' HG23 ' A' ' 3' ' ' THR . 85.8 mt -73.57 -42.31 61.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.259 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.97 57.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.824 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.36 135.98 55.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.743 0.306 . . . . 10.0 110.776 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 63.19 144.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.165 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.783 HD21 ' HA ' ' A' ' 110' ' ' ASP . 0.5 OUTLIER -155.27 55.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.918 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' C ' ' HD2' ' A' ' 9' ' ' LYS . 3.4 tmmm? -156.52 -47.74 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.834 -0.621 . . . . 10.0 110.23 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 44.1 tt0 -141.37 163.46 32.89 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.392 0.615 . . . . 10.0 110.8 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.553 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.9 t80 -162.36 138.9 7.79 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.804 -1.089 . . . . 10.0 111.959 -174.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.422 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -88.68 141.22 28.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.891 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -157.43 171.32 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 113.817 1.043 . . . . 10.0 113.817 -176.134 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 1.08 HD11 HD13 ' A' ' 82' ' ' ILE . 3.1 tm? -88.72 136.03 33.21 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.942 ' HB3' HD22 ' A' ' 102' ' ' LEU . 55.5 p -151.42 156.49 40.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.8 0.81 . . . . 10.0 113.119 -177.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.729 ' CD2' HD11 ' A' ' 82' ' ' ILE . 7.7 p90 -149.67 166.54 29.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.198 -1.365 . . . . 10.0 110.06 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -88.59 140.33 29.56 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.215 -0.661 . . . . 10.0 109.215 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.015 HG21 HD12 ' A' ' 71' ' ' ILE . 35.8 mm -138.8 86.03 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.63 -0.714 . . . . 10.0 111.889 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 0.8 OUTLIER 51.48 60.03 4.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.808 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 48.4 mt-10 78.56 -35.15 0.18 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.465 -0.788 . . . . 10.0 111.09 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -88.82 139.31 30.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.078 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.75 163.87 15.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 10.0 111.118 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.894 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.0 OUTLIER -147.01 138.23 24.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.559 . . . . 10.0 111.133 -178.449 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -138.94 155.28 48.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.993 ' CE2' HD22 ' A' ' 136' ' ' LEU . 3.8 m-85 -138.44 138.67 38.38 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.995 -1.002 . . . . 10.0 108.926 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -51.35 121.57 6.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.948 0.404 . . . . 10.0 110.379 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.891 HG13 ' HA ' ' A' ' 13' ' ' VAL . 32.2 m -61.37 -11.9 5.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 10.0 111.175 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.99 -41.33 96.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 10.0 110.41 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.839 ' OD1' HG21 ' A' ' 138' ' ' ILE . 6.4 t-20 -92.51 -46.68 7.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.35 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.838 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.7 mm -57.67 127.11 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.896 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' CE ' ' A' ' 32' ' ' MET . 54.2 mt-10 -82.93 -63.6 1.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.948 0.351 . . . . 10.0 111.948 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.418 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.8 tpp -169.08 173.91 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.979 0.418 . . . . 10.0 111.381 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.527 ' CG1' HG11 ' A' ' 98' ' ' VAL . 34.8 m -95.61 156.36 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.725 -0.67 . . . . 10.0 111.996 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 33' ' ' VAL . 17.3 pt -160.05 123.62 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.557 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.458 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 48.6 mp0 -89.13 116.92 27.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 10.0 111.214 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.487 ' NZ ' ' HB2' ' A' ' 36' ' ' LYS . 5.0 ttmp? -169.21 63.82 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.801 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 51.9 m -57.12 163.16 2.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.702 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 t70 55.96 50.65 13.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.704 -0.68 . . . . 10.0 112.158 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.746 HD12 HG21 ' A' ' 62' ' ' VAL . 17.5 mt -77.17 147.54 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.44 -0.345 . . . . 10.0 111.666 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.8 HG23 ' HG2' ' A' ' 43' ' ' PRO . 55.1 m 3.95 70.57 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.246 -0.888 . . . . 10.0 112.956 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -87.81 -52.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.76 2.307 . . . . 10.0 113.738 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 27.4 m -79.88 -30.38 0.61 Allowed Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 113.341 0.867 . . . . 10.0 113.341 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.8 ' HG2' HG23 ' A' ' 40' ' ' THR . 77.8 Cg_exo -51.51 -71.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.777 1.651 . . . . 10.0 112.95 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' NZ ' ' HB ' ' A' ' 49' ' ' VAL . 32.2 ttpt -67.91 -69.35 0.32 Allowed 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.664 0.745 . . . . 10.0 109.636 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.1 t 50.15 59.51 4.5 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.541 -1.209 . . . . 10.0 111.948 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.8 mmt-85 -148.1 -62.93 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.848 0.314 . . . . 10.0 111.848 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.431 ' HB2' ' HZ1' ' A' ' 44' ' ' LYS . 91.1 m-70 -76.42 -170.79 1.59 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 10.0 111.889 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' CG ' ' HD3' ' A' ' 148' ' ' LYS . 21.3 t80 -71.24 -43.69 66.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.331 -0.85 . . . . 10.0 111.094 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.954 ' HA ' HG22 ' A' ' 63' ' ' VAL . 96.8 t -49.23 127.33 4.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.14 0.495 . . . . 10.0 111.261 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.79 -40.18 79.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.463 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.443 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -163.02 -175.79 34.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.331 -0.938 . . . . 10.0 113.219 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.703 ' H ' ' HB ' ' A' ' 40' ' ' THR . 1.9 m -147.33 167.83 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.664 -0.495 . . . . 10.0 109.664 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.474 HG21 ' HD2' ' A' ' 36' ' ' LYS . 30.1 pt -158.87 145.48 7.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.942 0.401 . . . . 10.0 111.551 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' O ' HD23 ' A' ' 55' ' ' LEU . 41.3 t30 -88.79 135.57 33.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.001 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 54' ' ' ASN . 97.3 mt -159.32 138.89 11.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.376 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.2 mmt-85 48.38 45.69 20.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.449 . . . . 10.0 110.786 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.24 41.58 94.96 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.929 -0.653 . . . . 10.0 112.617 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -167.87 133.0 1.86 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.838 0.351 . . . . 10.0 110.97 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.614 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.94 141.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.099 -0.501 . . . . 10.0 111.123 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.827 HG22 ' HB2' ' A' ' 90' ' ' GLU . 2.4 pp -126.22 132.51 24.34 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.385 -0.371 . . . . 10.0 111.126 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 83.4 Cg_endo -81.04 115.38 2.99 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.469 2.113 . . . . 10.0 112.889 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.746 HG21 HD12 ' A' ' 39' ' ' ILE . 26.9 m -89.02 135.63 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.954 HG22 ' HA ' ' A' ' 49' ' ' VAL . 82.6 t -137.36 154.38 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.791 0.805 . . . . 10.0 113.074 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.473 ' N ' HG12 ' A' ' 63' ' ' VAL . 74.6 m-20 -76.7 65.73 2.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.521 -1.218 . . . . 10.0 109.263 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.86 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.6 tt -53.48 -36.35 61.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.158 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.749 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -57.75 -23.47 52.29 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.207 -0.597 . . . . 10.0 109.426 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.633 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -82.86 -48.77 10.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.69 -0.686 . . . . 10.0 110.744 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 65' ' ' LEU . 11.0 tt -58.5 -39.87 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.863 -1.162 . . . . 10.0 107.863 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.879 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -76.42 -48.98 17.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 113.711 -1.586 . . . . 10.0 109.795 177.791 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.575 ' N ' HD13 ' A' ' 69' ' ' LEU . . . 118.56 -93.26 0.56 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.169 -0.539 . . . . 10.0 113.125 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.015 HD12 HG21 ' A' ' 18' ' ' ILE . 3.0 pt 48.57 163.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 113.112 0.782 . . . . 10.0 113.112 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 74.8 m -45.29 -36.54 4.12 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.884 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.7 t80 -27.03 141.52 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.546 -1.206 . . . . 10.0 113.005 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 9.0 t70 -161.81 32.15 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.242 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 94.4 mt-10 54.55 45.54 26.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.938 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -98.2 -36.12 10.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.492 0.553 . . . . 10.0 112.492 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.463 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 70.6 mmtt -136.88 17.9 3.04 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.357 0.873 . . . . 10.0 113.357 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.496 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 14.0 mmm -53.93 142.5 24.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -172.55 42.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.892 0.377 . . . . 10.0 111.267 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.9 ' O ' HD12 ' A' ' 94' ' ' LEU . 79.2 p -169.09 158.02 8.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 10.0 110.155 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.58 ' CD1' HD11 ' A' ' 39' ' ' ILE . 45.1 mt -137.35 132.24 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.876 0.369 . . . . 10.0 111.404 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.08 HD13 HD11 ' A' ' 14' ' ' LEU . 26.5 mt -105.34 129.96 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.953 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.41 HG12 ' OE1' ' A' ' 31' ' ' GLU . 91.7 t -98.81 150.62 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.047 0.451 . . . . 10.0 110.93 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -153.73 174.84 14.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.962 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.548 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 23.5 ptt180 -127.39 143.8 51.15 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.525 HG21 HG12 ' A' ' 138' ' ' ILE . 45.5 p -160.02 108.19 1.7 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.532 0.568 . . . . 10.0 112.532 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.4 tppp? 46.44 47.72 13.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.777 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.35 34.32 1.02 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.167 -0.924 . . . . 10.0 111.285 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.893 HG12 HG22 ' A' ' 91' ' ' VAL . 59.0 t -134.0 110.42 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 115.141 -0.936 . . . . 10.0 109.25 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.827 ' HB2' HG22 ' A' ' 60' ' ' ILE . 83.4 mt-10 -88.23 97.92 11.28 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.047 HG21 HD13 ' A' ' 142' ' ' ILE . 4.5 t -88.55 152.24 3.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.4 -1.727 . . . . 10.0 113.33 -173.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -124.5 157.26 18.79 Favored Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.443 -1.253 . . . . 10.0 113.164 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.618 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -143.84 123.83 13.58 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 120.964 0.412 . . . . 10.0 110.613 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 80' ' ' SER . 64.9 tp -88.74 126.75 35.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.146 0.498 . . . . 10.0 111.179 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.738 HG23 ' OG ' ' A' ' 80' ' ' SER . 26.8 m -136.88 -175.26 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.697 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 3.0 t0 -88.12 -77.94 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.501 . . . . 10.0 111.253 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 -128.63 107.97 10.13 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.611 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.0 p -88.99 113.79 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 122.434 1.111 . . . . 10.0 111.396 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -62.7 -28.67 70.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.036 -1.893 . . . . 10.0 111.106 -178.669 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.81 -121.2 5.51 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.777 -0.929 . . . . 10.0 110.777 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.99 126.77 9.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 117.203 0.501 . . . . 10.0 109.769 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 15' ' ' SER . 54.8 tp -128.05 136.16 50.85 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.028 0.442 . . . . 10.0 111.139 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -88.82 78.64 7.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.584 179.2 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.673 HG13 HG11 ' A' ' 13' ' ' VAL . 6.8 mm -88.57 157.39 3.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.832 -0.622 . . . . 10.0 109.454 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 24.0 p -116.65 148.47 40.97 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.056 -1.09 . . . . 10.0 108.056 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.503 ' OE2' HD22 ' A' ' 8' ' ' LEU . 37.1 tt0 -111.77 68.31 0.66 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.996 0.903 . . . . 10.0 112.016 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -99.55 8.31 44.58 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.02 -1.445 . . . . 10.0 108.014 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 113' ' ' ASN . 22.5 pt20 -106.68 -45.7 4.16 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.691 -1.14 . . . . 10.0 110.398 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 mt -85.38 33.79 0.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.115 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.783 ' HA ' HD21 ' A' ' 8' ' ' LEU . 6.7 t70 -75.04 120.85 21.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.634 0.254 . . . . 10.0 111.236 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.441 ' HG ' ' OD1' ' A' ' 110' ' ' ASP . 81.9 mt 65.76 -54.57 0.36 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.183 -0.462 . . . . 10.0 112.095 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 112' ' ' THR . 9.1 t -176.58 56.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.97 0.414 . . . . 10.0 110.557 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 108' ' ' GLN . 5.1 m120 69.47 131.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.693 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.616 ' O ' HG12 ' A' ' 114' ' ' VAL . 37.5 t -131.23 42.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.076 0.465 . . . . 10.0 111.146 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 44.7 t 176.03 -151.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.731 -0.668 . . . . 10.0 109.83 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.476 ' O ' ' CG ' ' A' ' 117' ' ' LYS . 2.3 p30 -91.04 -125.74 0.08 Allowed 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.662 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 37.8 mttp -166.53 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.161 0.505 . . . . 10.0 110.086 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.697 ' CE2' HD21 ' A' ' 69' ' ' LEU . 55.9 t80 -176.34 -51.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.309 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.88 -42.67 0.45 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.708 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.434 ' C ' ' HE3' ' A' ' 120' ' ' LYS . 0.1 OUTLIER 179.85 40.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 122' ' ' SER . 2.9 tppp? -177.92 116.74 0.09 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.157 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.642 ' HB3' ' O ' ' A' ' 121' ' ' LYS . 13.2 t 81.26 143.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.903 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' A' ' 117' ' ' LYS . 22.0 pttp -105.13 30.9 5.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.962 0.727 . . . . 10.0 112.962 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -134.38 143.53 15.23 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 119.792 -1.194 . . . . 10.0 112.9 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.835 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.2 tm? -153.5 134.31 13.82 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.812 -0.44 . . . . 10.0 109.812 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.871 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.8 p -149.58 162.31 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.962 0.41 . . . . 10.0 111.593 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.495 ' N ' ' HD3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -165.91 132.24 2.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.203 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.498 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 15.6 m -163.91 157.47 18.68 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.354 -0.384 . . . . 10.0 110.662 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' N ' ' CG2' ' A' ' 128' ' ' THR . 63.1 m-20 58.16 44.57 18.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.958 0.409 . . . . 10.0 110.735 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.59 32.16 38.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.65 -0.786 . . . . 10.0 111.764 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 128' ' ' THR . 3.2 ptp180 -138.89 136.14 35.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 10.0 110.417 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.92 143.46 26.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.733 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.078 HG12 ' HB3' ' A' ' 22' ' ' ALA . 4.3 mt -137.43 129.19 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 10.0 111.567 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.894 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.97 134.54 28.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.475 ' O ' ' CA ' ' A' ' 124' ' ' GLY . 31.1 t80 -118.31 136.09 53.91 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.514 0.673 . . . . 10.0 111.467 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.993 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.1 mp -126.81 172.39 10.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.127 0.965 . . . . 10.0 112.603 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 9.8 t70 -144.2 26.59 1.48 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.635 -1.62 . . . . 10.0 107.211 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.863 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 11.9 tt 40.4 17.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 113.846 -1.525 . . . . 10.0 114.349 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 137' ' ' ASP . 7.8 t0 -79.53 -61.73 1.91 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.794 0.665 . . . . 10.0 112.794 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -77.05 -30.88 55.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.457 0.646 . . . . 10.0 110.341 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.863 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.89 -45.69 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 114.97 -1.014 . . . . 10.0 110.63 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.047 HD13 HG21 ' A' ' 91' ' ' VAL . 7.9 tp -65.91 -43.04 93.06 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 C-N-CA 119.898 -0.721 . . . . 10.0 110.034 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.54 ' N ' HG23 ' A' ' 142' ' ' ILE . 89.3 tt0 -46.47 -46.7 19.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.312 0.577 . . . . 10.0 109.788 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 148' ' ' LYS . 61.0 mm-40 -68.89 -39.58 79.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.205 -0.907 . . . . 10.0 110.761 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.638 ' CD1' HG11 ' A' ' 91' ' ' VAL . 56.4 mt -48.52 -44.02 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.83 0.347 . . . . 10.0 111.505 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.9 p -75.57 -51.35 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 10.0 112.152 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 144' ' ' GLU . 12.9 p -70.79 -6.22 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.461 0.541 . . . . 10.0 112.461 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -50.55 -44.23 56.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.814 0.34 . . . . 10.0 110.754 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 56.73 -168.22 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.497 . . . . 10.0 111.204 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.9 -40.62 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.048 -0.596 . . . . 10.0 112.08 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 151' ' ' VAL . 12.5 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 10.0 111.072 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.872 0.367 . . . . 10.0 111.092 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.804 ' HD2' ' HB3' ' A' ' 5' ' ' ALA . 5.8 ptpp? -94.29 -119.91 0.1 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.593 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 2' ' ' LYS . 72.5 p -160.67 -46.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 69.4 mt -67.63 -34.33 76.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.613 -0.721 . . . . 10.0 109.995 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.804 ' HB3' ' HD2' ' A' ' 2' ' ' LYS . . . -139.65 -160.37 1.06 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.012 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -151.27 129.95 12.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.109 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.694 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -58.4 142.61 47.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.445 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.801 HD22 ' CD ' ' A' ' 106' ' ' GLU . 85.7 mt -148.12 43.29 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.502 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -92.32 -49.98 5.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.22 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.657 ' HG2' HG22 ' A' ' 105' ' ' THR . 83.4 mt-10 -138.77 164.3 29.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.522 0.677 . . . . 10.0 111.301 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.3 t80 -161.83 139.62 8.89 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.573 -1.194 . . . . 10.0 112.501 -174.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 24.5 pt-20 -88.68 140.01 29.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.52 -0.919 . . . . 10.0 108.52 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.911 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -155.47 171.28 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 N-CA-C 114.084 1.142 . . . . 10.0 114.084 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.713 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.8 tm? -88.81 134.73 33.84 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.779 ' HB3' HD22 ' A' ' 102' ' ' LEU . 82.6 p -146.17 152.12 38.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 113.242 0.831 . . . . 10.0 113.242 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.656 ' HD2' HG23 ' A' ' 98' ' ' VAL . 2.4 p90 -149.43 166.81 27.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.181 -1.372 . . . . 10.0 109.991 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.528 ' HG3' HD21 ' A' ' 99' ' ' LEU . 94.8 mt-10 -88.56 139.36 30.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.253 0.549 . . . . 10.0 109.745 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.016 HG21 HD12 ' A' ' 71' ' ' ILE . 28.5 mm -138.96 103.27 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.364 -0.834 . . . . 10.0 110.957 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.9 OUTLIER 42.69 60.15 2.53 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.533 0.568 . . . . 10.0 112.533 179.331 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 86.7 mt-10 80.82 -42.89 0.2 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.385 -0.825 . . . . 10.0 111.912 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.674 ' OE1' HD11 ' A' ' 134' ' ' ILE . 4.1 pt20 -88.97 154.41 20.24 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.034 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.91 168.52 12.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.906 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.0 OUTLIER -152.31 135.6 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.617 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.823 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -140.34 153.81 46.53 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.846 0.684 . . . . 10.0 112.846 -177.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CZ ' HD13 ' A' ' 136' ' ' LEU . 3.8 m-85 -135.54 143.07 45.52 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.071 -0.714 . . . . 10.0 109.071 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 36.6 t70 -49.39 124.24 8.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.18 0.514 . . . . 10.0 110.806 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.911 HG13 ' HA ' ' A' ' 13' ' ' VAL . 30.1 m -64.76 -9.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.37 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.57 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 1.3 m-20 -72.0 -43.26 65.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.922 ' ND2' HG21 ' A' ' 138' ' ' ILE . 10.1 t30 -80.78 -49.77 10.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.776 -1.102 . . . . 10.0 110.071 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.713 HG21 ' HG ' ' A' ' 14' ' ' LEU . 21.9 mm -62.32 134.2 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.013 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' O ' ' CE ' ' A' ' 32' ' ' MET . 4.5 mm-40 -94.09 -68.77 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.745 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.409 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.1 172.46 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.097 0.475 . . . . 10.0 111.087 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.025 HG11 HG11 ' A' ' 98' ' ' VAL . 33.9 m -97.54 145.8 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.571 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.458 HG13 ' HB ' ' A' ' 81' ' ' ILE . 11.1 pt -142.46 122.74 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.868 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 48.7 mt-10 -88.98 104.31 16.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.834 -0.432 . . . . 10.0 109.834 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 35' ' ' GLU . 67.9 mttm -161.34 69.79 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.218 0.451 . . . . 10.0 112.218 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.4 t -63.63 -169.46 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.797 0.332 . . . . 10.0 110.51 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 9.5 t70 45.32 47.67 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.018 0.437 . . . . 10.0 111.556 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.663 HD11 ' CD1' ' A' ' 81' ' ' ILE . 28.4 mt -82.32 -100.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.11 -0.495 . . . . 10.0 111.319 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.571 ' CG2' ' CD ' ' A' ' 43' ' ' PRO . 20.0 m -102.83 122.78 44.6 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 122.905 0.482 . . . . 10.0 109.888 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.94 36.3 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.81 2.34 . . . . 10.0 114.66 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.748 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 41.1 t 57.78 48.26 2.73 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.859 0.361 . . . . 10.0 111.2 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.748 ' HD3' ' N ' ' A' ' 42' ' ' VAL . 6.1 Cg_exo -76.19 -74.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.808 2.338 . . . . 10.0 111.059 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.482 ' NZ ' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -77.95 -33.75 51.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.446 0.641 . . . . 10.0 110.111 178.17 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.44 ' OG ' ' HB ' ' A' ' 49' ' ' VAL . 26.6 t -40.41 150.58 0.06 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.665 -1.152 . . . . 10.0 112.92 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 27.0 mmm180 -84.57 40.93 0.82 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.418 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.417 ' HB3' ' O ' ' A' ' 46' ' ' ARG . 30.9 t-80 70.97 -49.6 0.68 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CE1' ' HE3' ' A' ' 67' ' ' LYS . 2.0 t80 -54.84 -52.25 63.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.604 0.24 . . . . 10.0 111.637 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.87 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.6 t -68.56 131.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 10.0 111.39 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.628 ' OE1' HD22 ' A' ' 94' ' ' LEU . 16.7 pt-20 -78.06 -39.12 42.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.983 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.634 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -158.06 179.36 33.82 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.314 -0.946 . . . . 10.0 113.275 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.482 HG11 ' NZ ' ' A' ' 44' ' ' LYS . 3.2 m -162.54 171.72 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 31.7 pt -159.8 138.92 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 10.0 112.069 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.887 ' C ' HD22 ' A' ' 55' ' ' LEU . 21.3 t-20 -114.18 118.87 35.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.078 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.887 HD22 ' C ' ' A' ' 54' ' ' ASN . 3.5 mm? -144.48 135.22 24.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.765 0.317 . . . . 10.0 111.487 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 42.66 51.09 5.01 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.669 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.24 42.56 97.32 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.711 -0.757 . . . . 10.0 112.454 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.657 ' C ' HD12 ' A' ' 59' ' ' ILE . 56.3 ttp180 -145.49 119.31 9.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 10.0 110.396 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.804 HD11 ' ND2' ' A' ' 54' ' ' ASN . 1.4 mp -110.05 140.86 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.988 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.82 HG22 ' HB3' ' A' ' 90' ' ' GLU . 2.0 pp -142.61 134.62 13.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.919 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 72.1 Cg_endo -99.7 114.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.178 2.585 . . . . 10.0 113.169 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' C ' ' A' ' 51' ' ' GLY . 29.1 m -89.0 134.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.87 HG22 ' HA ' ' A' ' 49' ' ' VAL . 92.0 t -143.21 154.2 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.736 0.779 . . . . 10.0 112.957 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.465 ' N ' HG12 ' A' ' 63' ' ' VAL . 74.5 m-20 -73.29 67.17 0.96 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.662 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.838 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.9 tt -53.58 -34.17 57.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.121 -178.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.801 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -61.27 -22.13 64.56 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.325 -0.55 . . . . 10.0 109.642 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.488 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.6 tmmm? -83.85 -50.14 8.37 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.835 -0.62 . . . . 10.0 109.945 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.0 tt -54.25 -40.12 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 107.602 -1.258 . . . . 10.0 107.602 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.897 ' C ' HD13 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -77.67 -47.3 19.56 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.526 -1.67 . . . . 10.0 109.383 177.49 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.514 ' N ' HD13 ' A' ' 69' ' ' LEU . . . 116.63 -92.78 0.57 Allowed Glycine 0 C--N 1.337 0.63 0 CA-C-N 115.975 -0.557 . . . . 10.0 113.193 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.016 HD12 HG21 ' A' ' 18' ' ' ILE . 2.9 pt 48.25 164.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 45.2 t -45.83 -34.9 4.04 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.925 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.7 t80 -31.48 143.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.582 -1.19 . . . . 10.0 113.09 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -173.53 41.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.071 -0.968 . . . . 10.0 109.888 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HA ' ' HG2' ' A' ' 78' ' ' MET . 55.8 mt-10 62.92 41.6 8.4 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.782 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -72.44 -49.05 36.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.05 -0.523 . . . . 10.0 112.388 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.03 18.92 0.68 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.371 -0.532 . . . . 10.0 112.346 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.564 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 3.4 mmm -53.14 146.61 11.22 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.149 -0.315 . . . . 10.0 110.149 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HE2' ' OD1' ' A' ' 96' ' ' ASP . 48.2 mtmt -159.39 -45.85 0.05 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.779 0.323 . . . . 10.0 111.533 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.8 m -88.87 133.38 34.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.211 0.529 . . . . 10.0 111.332 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.663 ' CD1' HD11 ' A' ' 39' ' ' ILE . 25.9 mt -89.65 151.09 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.526 -0.761 . . . . 10.0 111.527 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.512 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 23.1 mt -115.04 156.6 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 10.0 110.291 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.511 ' N ' HG22 ' A' ' 82' ' ' ILE . 41.3 t -133.61 148.73 30.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.931 0.396 . . . . 10.0 110.995 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.713 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -152.89 175.86 12.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.798 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.663 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 52.6 ttm-85 -133.08 132.6 41.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.873 -0.417 . . . . 10.0 109.873 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.801 HG22 ' OD1' ' A' ' 29' ' ' ASN . 65.4 p -141.53 102.14 4.13 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.378 0.609 . . . . 10.0 111.602 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 15.1 tppt? 48.56 48.26 19.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.005 -0.998 . . . . 10.0 110.771 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 13.5 m-20 80.17 27.32 0.3 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.917 -1.038 . . . . 10.0 111.999 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.916 HG12 HG22 ' A' ' 91' ' ' VAL . 51.6 t -124.59 108.98 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.057 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.82 ' HB3' HG22 ' A' ' 60' ' ' ILE . 33.9 tt0 -88.37 97.88 11.3 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.373 -1.714 . . . . 10.0 106.373 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.992 HG21 HD13 ' A' ' 142' ' ' ILE . 3.2 t -88.57 158.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 113.123 -1.853 . . . . 10.0 112.14 -174.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.13 143.03 14.6 Favored Glycine 0 C--N 1.317 -0.486 0 C-N-CA 120.234 -0.984 . . . . 10.0 113.833 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.624 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -131.38 128.77 40.29 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.628 HD22 ' OE1' ' A' ' 50' ' ' GLU . 65.5 tp -88.52 133.52 34.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.437 0.636 . . . . 10.0 111.904 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.6 HG11 ' CE1' ' A' ' 16' ' ' PHE . 27.6 m -147.28 -175.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.014 -0.994 . . . . 10.0 110.209 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.465 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 16.0 t70 -109.94 -58.44 2.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.551 0.574 . . . . 10.0 112.551 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -127.83 122.72 33.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.383 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.025 HG11 HG11 ' A' ' 33' ' ' VAL . 7.3 p -116.35 117.78 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 122.3 1.048 . . . . 10.0 111.643 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.597 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -69.71 -29.33 66.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.183 -1.826 . . . . 10.0 110.852 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.33 -125.59 7.73 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.778 -0.725 . . . . 10.0 111.701 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.8 t -50.84 132.27 11.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 117.079 0.44 . . . . 10.0 110.367 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 15' ' ' SER . 51.8 tp -135.69 139.9 44.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.019 0.437 . . . . 10.0 111.519 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.3 ptp180 -88.85 76.26 7.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.453 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.82 ' CD1' HG11 ' A' ' 126' ' ' VAL . 14.3 mm -88.73 168.37 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.657 HG22 ' HG2' ' A' ' 10' ' ' GLU . 22.4 p -131.67 148.08 52.56 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.426 -0.953 . . . . 10.0 108.426 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.801 ' CD ' HD22 ' A' ' 8' ' ' LEU . 81.0 tt0 -106.4 72.07 0.9 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.894 0.854 . . . . 10.0 112.466 -177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -108.48 21.09 17.77 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.656 ' O ' HD23 ' A' ' 109' ' ' LEU . 19.6 pt20 -176.26 68.57 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.61 -1.177 . . . . 10.0 111.699 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 108' ' ' GLN . 78.4 mt -154.02 -42.02 0.09 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.098 -0.955 . . . . 10.0 111.485 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 111' ' ' LEU . 36.5 t70 -155.32 154.22 31.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 10.0 111.216 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 110' ' ' ASP . 56.4 tp 72.29 -57.46 0.62 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.179 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.631 ' OG1' HG23 ' A' ' 114' ' ' VAL . 9.7 t -62.1 -46.68 87.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.04 0.447 . . . . 10.0 110.892 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.5 ' N ' HG23 ' A' ' 112' ' ' THR . 5.3 m120 44.27 46.74 7.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.571 -0.741 . . . . 10.0 111.568 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.631 HG23 ' OG1' ' A' ' 112' ' ' THR . 68.3 t -62.95 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.528 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.8 t 179.63 167.47 1.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.838 0.351 . . . . 10.0 111.549 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 1.5 m-20 -52.32 -33.62 43.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.947 -0.569 . . . . 10.0 111.23 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.525 ' HB3' ' CB ' ' A' ' 125' ' ' LEU . 46.2 mmtm 71.82 -56.61 0.64 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.12 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.73 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 2.9 t80 -108.59 -51.99 2.82 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.686 -0.406 . . . . 10.0 110.428 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.22 -145.26 10.53 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.529 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -87.43 -38.1 16.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.941 0.401 . . . . 10.0 110.93 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.47 ' NZ ' ' HB2' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -55.25 -33.23 62.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.696 -179.195 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.425 ' OG ' ' HG ' ' A' ' 136' ' ' LEU . 37.3 t -150.17 -149.94 0.32 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.108 -0.237 . . . . 10.0 111.18 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.478 ' NZ ' ' HB3' ' A' ' 123' ' ' LYS . 4.2 mmmp? -158.46 -25.41 0.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.632 0.605 . . . . 10.0 112.632 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 135' ' ' TYR . . . -74.35 137.81 23.32 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.182 -1.008 . . . . 10.0 113.914 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.525 ' CB ' ' HB3' ' A' ' 117' ' ' LYS . 1.7 tm? -158.1 79.92 0.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 1.005 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.8 p -88.82 163.6 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.177 -0.919 . . . . 10.0 112.021 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 39.7 ttmt -163.66 132.76 3.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.663 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 129' ' ' ASP . 16.1 m -161.92 158.81 25.85 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 120.925 0.393 . . . . 10.0 111.435 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.451 ' N ' ' CG2' ' A' ' 128' ' ' THR . 9.4 p-10 44.6 52.89 7.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.69 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.6 37.13 41.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.541 -0.838 . . . . 10.0 111.98 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -146.06 126.46 14.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.61 ' C ' HD22 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -88.95 144.74 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.458 . . . . 10.0 110.607 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 1.034 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.9 mt -133.91 139.77 47.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.548 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.906 ' HB ' HD13 ' A' ' 23' ' ' LEU . 4.3 mm -88.81 143.71 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.413 -0.958 . . . . 10.0 108.413 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.527 ' HB3' ' HA3' ' A' ' 124' ' ' GLY . 38.1 t80 -138.77 136.46 35.74 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.609 0.719 . . . . 10.0 111.824 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.645 HD13 ' CZ ' ' A' ' 25' ' ' PHE . 4.3 mp -129.43 149.8 51.06 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.719 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 9.9 t70 -113.65 19.61 16.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.253 -1.339 . . . . 10.0 107.623 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.922 HG21 ' ND2' ' A' ' 29' ' ' ASN . 12.4 tt 39.19 20.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 114.283 -1.326 . . . . 10.0 113.67 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.7 t0 -81.89 -60.83 2.1 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.72 0.637 . . . . 10.0 112.72 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -75.48 -32.72 60.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.534 0.683 . . . . 10.0 109.915 -179.645 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.849 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.28 -45.25 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 114.911 -1.04 . . . . 10.0 110.558 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.992 HD13 HG21 ' A' ' 91' ' ' VAL . 8.0 tp -61.99 -46.02 97.41 Favored 'Isoleucine or valine' 0 C--N 1.337 0.054 0 C-N-CA 120.339 -0.545 . . . . 10.0 110.14 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.669 ' O ' HG12 ' A' ' 147' ' ' VAL . 51.9 mt-10 -49.24 -43.76 43.04 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.192 0.52 . . . . 10.0 109.72 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.617 ' HB2' HD11 ' A' ' 68' ' ' ILE . 54.9 mm-40 -66.25 -32.13 73.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.323 -0.853 . . . . 10.0 110.555 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.651 HD12 HD12 ' A' ' 142' ' ' ILE . 31.1 mt -58.98 -42.15 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 120.926 0.393 . . . . 10.0 110.85 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.3 p -79.8 -50.26 10.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.771 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 143' ' ' GLU . 12.9 p -75.78 0.96 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.437 ' HE2' ' CG2' ' A' ' 49' ' ' VAL . 23.0 pttp -45.22 -46.48 12.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.837 0.351 . . . . 10.0 111.229 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.96 134.24 49.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.841 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 178.31 43.71 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.636 -0.793 . . . . 10.0 112.513 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 10.0 111.009 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.793 0.33 . . . . 10.0 110.406 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.624 ' HG3' HG22 ' A' ' 105' ' ' THR . 29.3 mp0 -103.88 164.31 11.78 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.426 0.631 . . . . 10.0 110.975 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.641 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 17.5 t80 -161.4 140.11 9.77 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.936 -1.029 . . . . 10.0 112.963 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 27' ' ' VAL . 32.6 mt-10 -88.71 140.54 29.34 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.639 -0.709 . . . . 10.0 109.622 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.788 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -155.85 168.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 113.093 0.775 . . . . 10.0 113.093 -175.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.938 HD11 HD13 ' A' ' 82' ' ' ILE . 2.3 tm? -88.89 134.2 34.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.521 -1.289 . . . . 10.0 107.521 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.792 ' HB3' HD22 ' A' ' 102' ' ' LEU . 81.1 p -143.03 152.97 42.48 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.717 ' CE1' HG11 ' A' ' 95' ' ' VAL . 6.1 p90 -150.42 167.6 26.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.299 -1.319 . . . . 10.0 110.297 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -88.55 138.5 31.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.682 -0.488 . . . . 10.0 109.682 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.989 HG21 HD12 ' A' ' 71' ' ' ILE . 33.4 mm -136.56 93.23 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.335 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 50.1 m-20 45.59 60.08 3.28 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.593 -0.731 . . . . 10.0 112.513 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.6 mt-10 83.73 -39.99 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.29 -0.868 . . . . 10.0 112.081 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.3 pt20 -88.91 149.55 23.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.164 -0.31 . . . . 10.0 110.164 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.027 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.55 159.52 17.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.338 . . . . 10.0 110.893 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.857 HD13 ' HB ' ' A' ' 134' ' ' ILE . 2.1 tp -147.67 136.88 22.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.768 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.801 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -136.92 146.87 45.99 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.517 0.562 . . . . 10.0 112.517 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.003 ' CE2' HD13 ' A' ' 65' ' ' LEU . 2.0 m-30 -121.47 135.87 55.0 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.585 -0.894 . . . . 10.0 108.585 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.562 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 28.3 t70 -44.2 100.95 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.581 0.705 . . . . 10.0 110.499 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 6.2 p -50.37 -14.44 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.648 -1.16 . . . . 10.0 111.978 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.562 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 7.6 m-20 -64.51 -44.65 90.23 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.468 -0.493 . . . . 10.0 109.906 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.657 HD21 HG22 ' A' ' 86' ' ' THR . 22.6 t-20 -83.24 -41.51 18.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.725 -0.671 . . . . 10.0 110.733 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.758 HG21 ' HG ' ' A' ' 14' ' ' LEU . 32.9 mm -59.64 123.5 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.58 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 32' ' ' MET . 66.6 mm-40 -81.97 -61.89 1.78 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.01 0.374 . . . . 10.0 112.01 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.6 mtm -169.04 157.27 7.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 10.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.507 HG11 HG11 ' A' ' 98' ' ' VAL . 33.7 m -88.92 137.16 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.934 -0.576 . . . . 10.0 111.228 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.519 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 11.4 pt -123.96 135.53 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.345 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -88.99 118.74 28.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.518 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.834 ' HB3' HD12 ' A' ' 81' ' ' ILE . 39.5 ttmt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.759 ' HA ' HG22 ' A' ' 63' ' ' VAL . 49.0 t . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.958 0.409 . . . . 10.0 110.917 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -68.86 -30.5 69.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.3 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.636 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -166.82 -175.91 37.39 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.536 -0.84 . . . . 10.0 112.959 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 61' ' ' PRO . 2.9 m -160.42 170.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.123 -0.695 . . . . 10.0 109.123 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 60' ' ' ILE . 30.1 pt . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 120.992 0.425 . . . . 10.0 111.884 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.814 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.594 0.235 . . . . 10.0 110.983 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 85.0 Cg_endo -92.83 124.42 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.932 2.422 . . . . 10.0 112.735 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.636 HG22 ' C ' ' A' ' 51' ' ' GLY . 23.2 m -102.79 125.34 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.788 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.878 HG12 ' H ' ' A' ' 64' ' ' ASN . 14.0 t -130.66 -175.9 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.283 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.878 ' H ' HG12 ' A' ' 63' ' ' VAL . 5.2 m120 -120.24 96.85 5.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.71 -0.223 . . . . 10.0 110.526 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.003 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.1 tt -56.21 -32.13 64.11 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.273 0.559 . . . . 10.0 109.838 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.998 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -61.74 -24.52 66.86 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.23 -0.441 . . . . 10.0 109.884 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.442 ' HD2' ' C ' ' A' ' 67' ' ' LYS . 1.4 tmmm? -82.28 -44.04 16.77 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.295 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.7 tt -64.58 -40.85 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.447 -0.946 . . . . 10.0 108.447 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.039 HD21 ' CE2' ' A' ' 118' ' ' PHE . 0.7 OUTLIER -77.88 -53.01 7.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 113.903 -1.499 . . . . 10.0 109.487 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 118.93 -80.48 0.32 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 115.454 -0.794 . . . . 10.0 112.702 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.998 HD11 ' CB ' ' A' ' 66' ' ' ALA . 3.3 pt 45.19 178.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.7 m -55.44 -37.53 67.82 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 109.054 -0.721 . . . . 10.0 109.054 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.841 ' HB3' HG13 ' A' ' 71' ' ' ILE . 16.1 t80 -31.07 143.92 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.772 -1.104 . . . . 10.0 112.995 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 9.4 t70 -169.84 39.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.351 -0.84 . . . . 10.0 109.702 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 78' ' ' MET . 94.9 mt-10 56.13 39.04 30.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.034 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -87.24 -63.76 1.26 Allowed 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 112.327 0.492 . . . . 10.0 112.327 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -108.35 16.24 23.3 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.538 0.57 . . . . 10.0 112.538 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.482 ' HE2' ' HD1' ' A' ' 73' ' ' PHE . 17.7 mmt -52.86 138.33 29.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.907 -0.133 . . . . 10.0 110.963 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -159.46 -48.63 0.05 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.524 0.565 . . . . 10.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.414 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 65.1 m -88.94 163.75 15.44 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.803 0.298 . . . . 10.0 111.803 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.834 HD12 ' HB3' ' A' ' 36' ' ' LYS . 72.6 mt -127.7 154.15 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.031 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.938 HD13 HD11 ' A' ' 14' ' ' LEU . 11.8 mt -128.15 146.12 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.421 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.14 149.93 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.438 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -156.86 130.61 8.23 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.497 -0.32 . . . . 10.0 111.776 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -88.8 133.17 34.34 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.715 -0.846 . . . . 10.0 108.715 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.657 HG22 HD21 ' A' ' 29' ' ' ASN . 43.8 p -147.63 108.61 4.22 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.669 0.618 . . . . 10.0 112.669 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 47.78 49.25 16.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.705 -0.68 . . . . 10.0 110.82 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 70.41 33.65 2.44 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.216 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.953 HG12 HG22 ' A' ' 91' ' ' VAL . 76.8 t -133.56 111.63 16.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.24 -0.891 . . . . 10.0 109.34 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.755 ' HB2' HG22 ' A' ' 60' ' ' ILE . 39.8 mt-10 -88.56 92.45 9.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.114 -1.439 . . . . 10.0 107.114 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.065 HG21 HD13 ' A' ' 142' ' ' ILE . 2.7 t -88.66 158.15 3.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 112.796 -2.002 . . . . 10.0 111.719 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -138.11 144.6 15.88 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 120.165 -1.016 . . . . 10.0 113.458 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 t80 -133.36 122.02 23.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.777 0.323 . . . . 10.0 110.618 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 95' ' ' VAL . 6.5 tt -88.85 132.56 34.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.141 0.496 . . . . 10.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.717 HG11 ' CE1' ' A' ' 16' ' ' PHE . 15.9 m -130.94 -175.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.431 -0.804 . . . . 10.0 111.373 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -81.27 -75.95 0.26 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.153 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -134.27 107.17 7.51 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.282 -0.872 . . . . 10.0 108.733 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.617 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -88.97 116.99 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 122.418 1.104 . . . . 10.0 111.967 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.607 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -68.75 -27.59 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.909 -1.95 . . . . 10.0 110.715 -178.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.74 -126.58 8.34 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.635 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -52.28 133.14 14.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.976 0.388 . . . . 10.0 110.754 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.792 HD22 ' HB3' ' A' ' 15' ' ' SER . 43.9 tp -137.7 138.33 39.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.059 0.457 . . . . 10.0 110.854 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.6 ptp180 -88.8 72.74 8.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.198 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.034 HD12 HG21 ' A' ' 126' ' ' VAL . 14.3 mm -88.98 131.62 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.771 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.624 HG22 ' HG3' ' A' ' 10' ' ' GLU . 20.6 p -88.76 147.24 24.56 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.356 -1.72 . . . . 10.0 106.356 175.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -134.47 81.77 1.93 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.365 -0.934 . . . . 10.0 113.08 -176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -76.05 -5.28 45.7 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.296 -0.865 . . . . 10.0 109.343 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.335 -179.766 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 1.039 ' CE2' HD21 ' A' ' 69' ' ' LEU . 4.3 t80 . . . . . 0 CA--C 1.515 -0.377 0 CA-C-O 121.534 0.683 . . . . 10.0 109.487 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 122' ' ' SER . . . -74.2 35.6 0.94 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.857 -1.065 . . . . 10.0 113.351 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -79.34 -32.63 43.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.346 0.593 . . . . 10.0 109.452 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 121' ' ' LYS . 17.1 tppt? -156.9 32.99 0.3 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.195 -0.911 . . . . 10.0 110.112 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.643 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 79.6 p . . . . . 0 CA--C 1.53 0.193 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.211 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 1.034 HG21 HD12 ' A' ' 104' ' ' ILE . 2.3 p . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 121.34 0.59 . . . . 10.0 111.605 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.483 ' NZ ' ' HB3' ' A' ' 127' ' ' LYS . 7.2 ttpm? -152.14 140.31 20.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 18.7 m -159.67 144.63 15.32 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.887 0.375 . . . . 10.0 111.109 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 131' ' ' ARG . 2.9 p30 45.95 48.36 12.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.615 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.07 42.41 81.2 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.711 -0.757 . . . . 10.0 112.383 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.494 ' HD2' HD11 ' A' ' 133' ' ' ILE . 0.7 OUTLIER -136.25 139.93 43.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.823 0.344 . . . . 10.0 110.454 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.1 mp -88.87 137.28 32.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.98 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.027 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.0 mt -156.03 151.36 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.551 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.857 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.7 mp -101.41 144.69 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.467 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 35.6 t80 -139.75 142.64 36.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.839 -0.744 . . . . 10.0 111.973 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.855 HD22 ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -158.1 144.17 17.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.644 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 137' ' ' ASP . 9.2 t70 -97.2 33.99 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.718 . . . . 10.0 110.004 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.855 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 18.5 tt 42.4 20.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.048 -0.978 . . . . 10.0 113.337 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -77.14 -54.97 5.85 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -79.21 -30.66 43.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.151 0.5 . . . . 10.0 110.937 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.855 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.46 -45.33 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.657 -0.701 . . . . 10.0 110.199 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.065 HD13 HG21 ' A' ' 91' ' ' VAL . 8.3 tp -67.17 -45.5 86.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 120.622 -0.431 . . . . 10.0 110.538 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.662 ' O ' HG12 ' A' ' 147' ' ' VAL . 15.0 tp10 -48.05 -43.21 30.18 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.374 0.607 . . . . 10.0 109.64 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.663 ' HB2' HD11 ' A' ' 68' ' ' ILE . 55.5 mm-40 -72.44 -31.33 65.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.083 -0.962 . . . . 10.0 110.865 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.751 HG13 ' O ' ' A' ' 141' ' ' ILE . 38.6 mt -54.99 -41.59 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.942 0.401 . . . . 10.0 110.652 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.8 p -81.01 -52.26 7.62 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.926 -0.579 . . . . 10.0 112.162 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 143' ' ' GLU . 10.8 p -82.14 13.1 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.697 0.284 . . . . 10.0 111.739 -178.869 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HG3' ' HG3' ' A' ' 10' ' ' GLU . 21.0 ptmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.89 0.376 . . . . 10.0 110.964 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 105' ' ' THR . 39.8 mt-10 -117.7 164.26 15.25 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.319 0.58 . . . . 10.0 110.471 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.576 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 15.5 t80 -157.25 137.16 12.47 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.005 -0.998 . . . . 10.0 112.748 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -88.73 139.86 30.04 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.476 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.98 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.1 p -156.06 171.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.948 HD11 HD13 ' A' ' 82' ' ' ILE . 3.3 tm? -88.92 137.18 32.55 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.871 ' HB3' HD22 ' A' ' 102' ' ' LEU . 76.7 p -149.19 153.62 37.92 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.685 0.995 . . . . 10.0 113.685 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.781 ' CE2' HG11 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -147.18 156.43 42.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.154 -1.384 . . . . 10.0 110.142 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -88.77 99.91 12.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.388 0.613 . . . . 10.0 109.868 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.992 HG21 HD12 ' A' ' 71' ' ' ILE . 27.6 mm -88.91 101.36 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.034 -0.985 . . . . 10.0 111.866 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.1 m-20 46.18 60.15 3.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.566 -0.743 . . . . 10.0 112.926 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.7 mt-10 86.6 -39.63 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.385 -0.825 . . . . 10.0 112.015 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.754 ' OE1' HD22 ' A' ' 132' ' ' LEU . 16.5 pt20 -88.83 -175.61 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.788 -0.449 . . . . 10.0 109.788 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.016 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -115.43 158.11 22.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.171 0.51 . . . . 10.0 111.472 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.909 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.3 OUTLIER -145.39 133.3 21.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.144 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.909 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -137.05 149.43 47.42 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.717 1.006 . . . . 10.0 113.717 -177.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.923 ' CE2' HD21 ' A' ' 136' ' ' LEU . 0.9 OUTLIER -132.18 138.11 47.87 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.634 -1.167 . . . . 10.0 108.329 178.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -49.0 122.69 6.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.066 0.46 . . . . 10.0 111.325 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.98 HG13 ' HA ' ' A' ' 13' ' ' VAL . 23.9 m -61.05 -14.24 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.63 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.14 -39.78 91.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.068 0.461 . . . . 10.0 110.22 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.753 HD21 HG22 ' A' ' 86' ' ' THR . 20.6 t-20 -95.49 -44.77 7.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.245 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.728 HG21 ' HG ' ' A' ' 14' ' ' LEU . 28.1 mm -57.32 129.53 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.59 -0.277 . . . . 10.0 110.471 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 32' ' ' MET . 50.4 mt-10 -88.32 -61.6 1.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.5 mtm -169.03 157.95 8.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.983 0.42 . . . . 10.0 111.563 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 98' ' ' VAL . 33.8 m -88.87 151.16 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.474 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.543 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 13.5 pt -154.13 134.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.01 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.93 111.81 24.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 10.0 110.608 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.699 -179.758 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.948 ' HA ' HG22 ' A' ' 63' ' ' VAL . 48.7 t . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.872 0.367 . . . . 10.0 110.902 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.545 ' HG3' HG23 ' A' ' 62' ' ' VAL . 12.3 pt-20 -74.9 -37.82 62.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.146 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 62' ' ' VAL . . . -168.02 -175.86 38.08 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.958 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 61' ' ' PRO . 2.5 m -154.16 170.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.839 -0.43 . . . . 10.0 109.839 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.468 HG12 HD11 ' A' ' 60' ' ' ILE . 30.9 pt . . . . . 0 C--N 1.324 -0.524 0 CA-C-O 120.867 0.365 . . . . 10.0 111.084 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.804 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.523 0.202 . . . . 10.0 110.935 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 79.5 Cg_endo -92.02 114.31 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.762 2.308 . . . . 10.0 113.383 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 49' ' ' VAL . 23.0 m -91.05 136.03 25.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.948 HG22 ' HA ' ' A' ' 49' ' ' VAL . 62.7 t -139.09 159.01 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.719 0.771 . . . . 10.0 112.92 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.529 ' N ' HG12 ' A' ' 63' ' ' VAL . 5.7 m120 -74.14 63.0 0.95 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.745 -1.116 . . . . 10.0 109.062 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.863 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.9 tt -53.69 -32.21 50.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.763 -0.653 . . . . 10.0 111.22 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.853 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -62.85 -24.09 67.61 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.259 -0.576 . . . . 10.0 109.872 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -83.06 -45.41 14.05 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.137 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.813 HG22 ' O ' ' A' ' 65' ' ' LEU . 9.6 tt -57.73 -38.67 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 107.687 -1.227 . . . . 10.0 107.687 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.879 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.22 -47.15 18.61 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.801 -1.545 . . . . 10.0 108.473 177.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 117.67 -90.5 0.5 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.456 -0.793 . . . . 10.0 112.714 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.992 HD12 HG21 ' A' ' 18' ' ' ILE . 3.2 pt 47.66 165.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.399 0.889 . . . . 10.0 113.399 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.6 m -47.05 -37.77 9.99 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.18 -0.674 . . . . 10.0 109.18 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.863 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.6 t80 -28.08 141.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.395 -1.275 . . . . 10.0 113.283 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -166.79 37.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.241 -0.891 . . . . 10.0 110.235 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 55.94 32.67 20.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.78 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.433 ' NE2' ' OD2' ' A' ' 19' ' ' ASP . 22.3 pt20 -95.42 -44.41 7.56 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -113.2 13.94 19.32 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.23 0.456 . . . . 10.0 112.23 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.42 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 29.5 mmt -59.8 140.62 56.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.904 0.383 . . . . 10.0 111.686 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 14.4 ptmm? -179.64 39.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.817 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.895 ' O ' HD12 ' A' ' 94' ' ' LEU . 47.3 t -169.19 164.85 11.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.543 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 43.6 mt -139.84 152.25 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.961 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.948 HD13 HD11 ' A' ' 14' ' ' LEU . 9.8 mt -131.36 130.35 62.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.727 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 84' ' ' ALA . 74.6 t -98.24 156.83 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.051 0.453 . . . . 10.0 111.307 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.654 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -156.52 172.1 19.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.617 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -130.6 130.7 44.34 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.753 HG22 HD21 ' A' ' 29' ' ' ASN . 46.7 p -145.36 109.27 4.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 87' ' ' LYS . 8.1 ttpt 48.02 49.89 16.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.614 0.721 . . . . 10.0 110.689 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 71.0 32.13 2.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.037 -0.983 . . . . 10.0 111.484 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.926 HG12 HG22 ' A' ' 91' ' ' VAL . 71.4 t -129.01 109.52 18.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.275 -0.875 . . . . 10.0 109.192 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.776 ' HB2' HG22 ' A' ' 60' ' ' ILE . 25.0 mp0 -88.35 97.36 11.0 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.278 -1.749 . . . . 10.0 106.278 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.017 HG21 HD13 ' A' ' 142' ' ' ILE . 3.6 t -88.55 153.55 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 113.291 -1.777 . . . . 10.0 113.016 -174.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.97 158.03 18.47 Favored Glycine 0 C--N 1.317 -0.485 0 CA-C-N 114.495 -1.229 . . . . 10.0 113.185 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.644 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -146.95 128.11 14.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.873 0.368 . . . . 10.0 110.915 -179.168 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.895 HD12 ' O ' ' A' ' 80' ' ' SER . 52.1 tp -88.66 128.14 35.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.999 0.428 . . . . 10.0 110.751 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.781 HG11 ' CE2' ' A' ' 16' ' ' PHE . 29.8 m -137.01 -175.11 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.428 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 45.8 t0 -92.96 -73.33 0.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.354 0.597 . . . . 10.0 111.17 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.494 ' NH1' HD22 ' A' ' 99' ' ' LEU . 57.9 ttt-85 -137.63 120.81 16.8 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.196 -0.911 . . . . 10.0 108.616 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.649 HG23 ' HD1' ' A' ' 16' ' ' PHE . 7.1 p -101.69 117.12 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 122.361 1.077 . . . . 10.0 112.898 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -65.42 -28.82 69.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.083 -1.871 . . . . 10.0 111.059 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.57 -122.63 6.57 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.552 -0.833 . . . . 10.0 111.171 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.97 133.59 16.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 117.045 0.422 . . . . 10.0 110.322 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.871 HD22 ' HB3' ' A' ' 15' ' ' SER . 57.2 tp -136.17 137.72 41.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.989 0.423 . . . . 10.0 111.048 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.9 ptp180 -88.85 71.73 8.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.315 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.04 HD12 HG21 ' A' ' 126' ' ' VAL . 14.2 mm -88.84 128.45 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.732 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.613 HG22 ' HG2' ' A' ' 10' ' ' GLU . 18.5 p -88.68 147.59 24.44 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.655 -1.609 . . . . 10.0 106.655 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -137.07 79.08 1.73 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.443 -0.903 . . . . 10.0 112.663 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -72.98 -10.6 59.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.619 -0.719 . . . . 10.0 109.533 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-N 115.443 -0.799 . . . . 10.0 110.932 -179.701 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.684 ' CE1' HD21 ' A' ' 69' ' ' LEU . 56.6 t80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.11 0.481 . . . . 10.0 110.55 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 150.53 -54.5 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.568 -0.742 . . . . 10.0 112.091 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 54.9 tptt 173.85 60.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.978 0.418 . . . . 10.0 110.063 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.463 ' HB3' ' CE2' ' A' ' 118' ' ' PHE . 4.2 tppp? -154.47 -39.43 0.09 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.658 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.654 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 94.9 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.561 -0.291 . . . . 10.0 110.724 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 1.04 HG21 HD12 ' A' ' 104' ' ' ILE . 2.4 p . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 121.452 0.644 . . . . 10.0 112.28 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -158.95 138.45 11.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.497 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 7.0 m -165.01 146.83 7.86 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.926 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 54.79 42.71 30.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.986 0.422 . . . . 10.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.4 37.68 60.67 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.836 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -130.15 136.58 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.273 -0.269 . . . . 10.0 110.273 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.882 HD23 ' N ' ' A' ' 133' ' ' ILE . 4.7 tt -88.93 136.75 32.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.605 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.016 HG12 ' HB3' ' A' ' 22' ' ' ALA . 6.0 mt -154.01 143.48 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 10.0 110.789 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.909 ' HB ' HD13 ' A' ' 23' ' ' LEU . 2.0 mp -96.1 134.8 32.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 109.072 -0.714 . . . . 10.0 109.072 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.582 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 41.1 t80 -129.33 140.4 51.4 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.773 -0.771 . . . . 10.0 111.385 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.923 HD21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -159.97 151.2 19.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.36 0.6 . . . . 10.0 111.881 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 139' ' ' ASP . 1.4 m-20 -102.33 37.87 1.8 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.498 -0.774 . . . . 10.0 110.501 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.874 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 19.8 tt 39.63 20.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.58 -1.191 . . . . 10.0 113.653 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 137' ' ' ASP . 37.9 t70 -79.53 -57.45 3.68 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 122' ' ' SER . 31.2 mmmt -76.92 -32.5 57.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 10.0 110.356 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.874 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.78 -45.68 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.183 -0.917 . . . . 10.0 110.489 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.017 HD13 HG21 ' A' ' 91' ' ' VAL . 7.5 tp -64.13 -44.82 97.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 120.375 -0.53 . . . . 10.0 109.953 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 142' ' ' ILE . 44.7 tt0 -48.13 -43.16 30.92 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 68' ' ' ILE . 44.5 mt-10 -69.99 -32.89 71.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.236 -0.893 . . . . 10.0 110.58 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.698 ' CD1' HG11 ' A' ' 91' ' ' VAL . 34.1 mt -55.51 -40.38 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 120.953 0.406 . . . . 10.0 110.801 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.6 p -77.74 -50.63 12.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.873 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.6 p -77.89 5.06 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.088 0.403 . . . . 10.0 112.088 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.9 pttm . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.696 0.284 . . . . 10.0 111.638 -179.356 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 105' ' ' THR . 22.8 tptm . . . . . 0 CA--C 1.526 0.036 0 N-CA-C 111.835 0.309 . . . . 10.0 111.835 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.592 ' HG2' HG22 ' A' ' 105' ' ' THR . 34.2 mt-10 -121.69 164.28 17.63 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.738 0.78 . . . . 10.0 111.513 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.569 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 12.7 t80 -158.76 136.71 10.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.268 -1.333 . . . . 10.0 112.259 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.75 140.76 29.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.655 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.859 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -157.99 171.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 113.583 0.957 . . . . 10.0 113.583 -174.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.998 HD11 HD13 ' A' ' 82' ' ' ILE . 2.0 tm? -88.77 132.1 34.77 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.855 ' CB ' HD22 ' A' ' 102' ' ' LEU . 80.9 p -143.7 156.92 44.69 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.542 0.942 . . . . 10.0 113.542 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.767 ' CD1' HD11 ' A' ' 82' ' ' ILE . 4.1 p90 -153.11 158.35 41.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.902 -1.499 . . . . 10.0 109.81 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -88.58 125.4 34.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.351 0.596 . . . . 10.0 109.556 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.83 HG21 HD12 ' A' ' 71' ' ' ILE . 32.9 mm -115.09 81.03 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.51 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 58.8 m-20 52.29 60.26 3.94 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.957 -0.565 . . . . 10.0 112.12 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 8.2 mp0 80.96 -31.97 0.11 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.261 -0.881 . . . . 10.0 111.771 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -88.81 137.82 31.97 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.076 -0.712 . . . . 10.0 109.076 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.008 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.65 155.09 19.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.044 0.45 . . . . 10.0 111.21 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.882 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.8 tp -148.14 140.85 24.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.355 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.766 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -144.99 155.93 43.67 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.893 0.701 . . . . 10.0 112.893 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.863 ' CE2' HD22 ' A' ' 136' ' ' LEU . 3.3 m-85 -136.4 141.21 43.62 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.319 -0.855 . . . . 10.0 109.187 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.07 120.54 5.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.195 0.521 . . . . 10.0 110.692 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.859 HG13 ' HA ' ' A' ' 13' ' ' VAL . 34.2 m -60.36 -12.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.048 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -62.14 -46.86 87.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.006 0.431 . . . . 10.0 110.376 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.978 ' ND2' HG21 ' A' ' 138' ' ' ILE . 13.9 t30 -86.67 -45.33 11.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.924 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.718 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.4 mm -57.71 126.8 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.784 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.11 -65.78 0.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.533 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -169.13 168.77 9.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 10.0 111.683 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.404 ' HB ' HG11 ' A' ' 98' ' ' VAL . 35.2 m -88.86 148.4 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.366 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.43 HD12 ' HD2' ' A' ' 36' ' ' LYS . 17.6 pt -150.85 128.81 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -88.85 63.76 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.446 . . . . 10.0 111.234 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.948 ' HB2' HD12 ' A' ' 81' ' ' ILE . 68.6 mttm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.205 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.585 ' HA ' HG22 ' A' ' 63' ' ' VAL . 48.0 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.921 0.391 . . . . 10.0 111.57 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -61.02 -29.19 69.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.962 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.741 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -152.21 168.19 31.36 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.435 -0.888 . . . . 10.0 112.926 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 2.3 m -160.18 167.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.94 -0.393 . . . . 10.0 109.94 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.504 HG12 HD11 ' A' ' 60' ' ' ILE . 29.7 pt . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.226 0.536 . . . . 10.0 112.068 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.806 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.435 0.159 . . . . 10.0 111.202 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 50.6 Cg_endo -95.67 124.92 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.413 2.742 . . . . 10.0 113.431 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.741 HG22 ' C ' ' A' ' 51' ' ' GLY . 27.0 m -103.54 135.63 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.76 -0.459 . . . . 10.0 109.76 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 49' ' ' VAL . 91.3 t -142.27 156.34 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.49 0.662 . . . . 10.0 112.379 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.79 ' OD1' HD23 ' A' ' 94' ' ' LEU . 74.5 m-20 -72.69 74.98 1.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.151 -0.931 . . . . 10.0 109.364 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.872 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.8 tt -54.87 -35.89 64.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.286 0.565 . . . . 10.0 110.859 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.819 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -59.87 -20.9 59.82 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.447 -0.501 . . . . 10.0 109.687 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -83.15 -49.42 9.5 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.098 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.709 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.2 tt -58.32 -39.59 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.707 -1.22 . . . . 10.0 107.707 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.972 HD12 HD13 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -79.89 -36.05 37.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.267 -1.788 . . . . 10.0 109.573 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.612 ' O ' HD13 ' A' ' 69' ' ' LEU . . . 67.16 124.45 0.02 OUTLIER Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.676 -0.693 . . . . 10.0 112.89 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.972 HD13 HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -165.4 -168.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.727 0.411 . . . . 10.0 110.859 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 67.0 m -48.43 -35.02 11.96 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -31.3 135.82 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.251 -1.341 . . . . 10.0 113.53 176.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' A' ' 75' ' ' GLU . 64.2 t0 -129.33 -65.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.156 -0.929 . . . . 10.0 110.038 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER 157.58 -27.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.332 -0.394 . . . . 10.0 111.468 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.476 ' N ' ' OE1' ' A' ' 75' ' ' GLU . 24.9 pt20 -60.06 -48.32 82.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -77.87 -45.07 25.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.975 0.417 . . . . 10.0 111.592 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 96' ' ' ASP . 18.5 mmm -35.62 141.58 0.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.633 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -169.4 -28.95 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.829 ' O ' HD12 ' A' ' 94' ' ' LEU . 48.1 t -88.85 -175.96 5.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.628 0.252 . . . . 10.0 111.095 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.948 HD12 ' HB2' ' A' ' 36' ' ' LYS . 57.9 mt -156.61 140.48 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.954 0.407 . . . . 10.0 111.508 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.998 HD13 HD11 ' A' ' 14' ' ' LEU . 13.5 mt -113.27 150.12 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.607 . . . . 10.0 110.669 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.54 149.71 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.919 0.39 . . . . 10.0 110.852 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -151.3 -175.9 5.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.126 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.416 ' O ' ' CG2' ' A' ' 86' ' ' THR . 14.6 ptm180 -135.9 144.41 45.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.713 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.527 HG21 HG12 ' A' ' 138' ' ' ILE . 34.8 p -160.16 109.47 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 10.0 112.083 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.3 tppp? 47.19 47.16 16.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.691 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 53.0 m-20 74.18 33.54 0.91 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.144 -0.935 . . . . 10.0 111.279 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.878 HG12 HG22 ' A' ' 91' ' ' VAL . 60.4 t -130.47 110.14 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-N 115.215 -0.902 . . . . 10.0 109.485 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 46.1 mt-10 -88.35 100.62 13.16 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.515 -2.032 . . . . 10.0 105.515 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.983 HG21 HD13 ' A' ' 142' ' ' ILE . 5.0 t -88.62 153.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 113.343 -1.753 . . . . 10.0 113.482 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.491 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -123.1 155.1 17.24 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 114.231 -1.349 . . . . 10.0 112.707 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.579 ' HD1' ' N ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -144.43 126.66 15.69 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 120.963 0.411 . . . . 10.0 110.963 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.829 HD12 ' O ' ' A' ' 80' ' ' SER . 55.6 tp -88.64 130.27 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.111 0.482 . . . . 10.0 110.833 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.515 HG11 ' CD2' ' A' ' 16' ' ' PHE . 27.3 m -140.61 -175.27 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.961 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' MET . 19.8 t70 -93.92 -73.05 0.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.196 0.522 . . . . 10.0 111.161 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -131.27 115.42 16.28 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.341 -0.845 . . . . 10.0 108.923 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 8.7 p -98.02 111.7 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-O 122.354 1.074 . . . . 10.0 111.455 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -64.22 -27.15 68.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.062 -1.881 . . . . 10.0 111.131 -178.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.99 -121.42 5.51 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.949 -0.86 . . . . 10.0 110.949 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.4 t -52.86 129.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 117.145 0.472 . . . . 10.0 109.908 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.855 HD22 ' CB ' ' A' ' 15' ' ' SER . 60.8 tp -132.98 139.22 47.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.144 0.497 . . . . 10.0 111.226 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 15.9 ptp180 -88.89 71.27 8.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.564 -0.744 . . . . 10.0 109.641 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.828 HD12 HG11 ' A' ' 126' ' ' VAL . 6.4 mm -88.8 126.76 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.783 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.592 HG22 ' HG2' ' A' ' 10' ' ' GLU . 16.9 p -88.57 145.25 25.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.944 -1.873 . . . . 10.0 105.944 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.406 ' OE1' ' HG2' ' A' ' 108' ' ' GLN . 2.4 tp10 -147.33 89.51 1.79 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.845 -1.142 . . . . 10.0 112.846 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -86.43 7.56 25.31 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.552 -0.749 . . . . 10.0 109.5 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.406 ' HG2' ' OE1' ' A' ' 106' ' ' GLU . 55.8 mm-40 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-N 115.576 -0.738 . . . . 10.0 111.003 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.686 ' CE2' HD21 ' A' ' 69' ' ' LEU . 29.8 t80 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.092 0.472 . . . . 10.0 110.305 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 156.6 -53.25 0.41 Allowed Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.647 -0.706 . . . . 10.0 112.038 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 27.4 tptp 174.81 57.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 10.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -153.02 -42.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.41 -0.359 . . . . 10.0 111.888 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.767 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 93.6 p . . . . . 0 C--N 1.328 -0.362 0 C-N-CA 121.017 -0.273 . . . . 10.0 111.692 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.828 HG11 HD12 ' A' ' 104' ' ' ILE . 1.2 p . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 121.419 0.628 . . . . 10.0 112.366 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.512 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -165.6 135.15 3.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.08 -0.964 . . . . 10.0 109.744 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 4.3 m -159.51 152.58 22.01 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.031 0.443 . . . . 10.0 111.304 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.4 t70 55.81 47.07 21.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.773 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.72 33.55 49.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.513 -0.851 . . . . 10.0 111.663 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.6 ptp180 -138.78 134.0 32.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.348 . . . . 10.0 110.332 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' A' ' 127' ' ' LYS . 85.6 mt -88.88 148.52 23.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.172 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.008 HG12 ' HB3' ' A' ' 22' ' ' ALA . 2.9 mt -147.97 132.31 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.656 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.882 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.3 mp -88.78 141.2 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.593 ' C ' HD12 ' A' ' 136' ' ' LEU . 24.4 t80 -125.95 147.22 49.56 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.521 0.677 . . . . 10.0 111.595 -178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.863 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.7 mp -140.3 165.73 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.042 0.925 . . . . 10.0 112.86 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -135.21 26.16 3.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.849 -1.523 . . . . 10.0 107.833 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.978 HG21 ' ND2' ' A' ' 29' ' ' ASN . 12.4 tt 42.29 16.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.929 -1.487 . . . . 10.0 114.353 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.29 -60.29 2.33 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.671 0.619 . . . . 10.0 112.671 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.453 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.6 mptt -76.02 -29.76 58.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.437 0.637 . . . . 10.0 110.396 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.871 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.11 -46.96 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.137 -0.938 . . . . 10.0 110.715 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.983 HD13 HG21 ' A' ' 91' ' ' VAL . 7.6 tp -63.0 -43.95 99.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 120.012 -0.675 . . . . 10.0 109.624 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.695 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.4 tt0 -48.11 -46.61 34.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.635 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.65 ' HB2' HD11 ' A' ' 68' ' ' ILE . 56.0 mm-40 -73.52 -30.51 63.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.432 -0.804 . . . . 10.0 110.574 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.709 HD13 HG11 ' A' ' 91' ' ' VAL . 35.8 mt -54.69 -31.77 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 120.899 0.38 . . . . 10.0 110.788 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.3 p -96.47 -49.19 5.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.983 -0.553 . . . . 10.0 112.402 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 143' ' ' GLU . 10.3 p -85.49 13.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.875 0.694 . . . . 10.0 112.875 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 N-CA-C 111.789 0.292 . . . . 10.0 111.789 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.685 ' HG2' ' HG3' ' A' ' 10' ' ' GLU . 56.8 tttm . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.91 0.385 . . . . 10.0 110.747 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.685 ' HG3' ' HG2' ' A' ' 9' ' ' LYS . 88.3 mt-10 -149.04 164.24 35.2 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.356 0.598 . . . . 10.0 110.33 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.64 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.8 t80 -156.6 138.8 14.64 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.014 -0.993 . . . . 10.0 112.531 -174.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.417 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 12.3 pt-20 -88.81 138.85 31.04 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.915 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -155.94 166.62 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.62 0.724 . . . . 10.0 112.937 -177.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.648 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 3.0 tm? -88.88 133.5 34.26 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.843 ' CB ' HD22 ' A' ' 102' ' ' LEU . 37.2 t -153.29 151.39 29.96 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 1.041 ' CE2' HG11 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -138.49 174.98 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.288 -1.324 . . . . 10.0 110.773 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -88.58 139.77 30.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.348 -0.982 . . . . 10.0 108.348 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.008 HG21 HD12 ' A' ' 71' ' ' ILE . 21.0 mm -146.97 76.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.828 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.587 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 1.1 m-20 58.12 51.83 8.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.943 0.402 . . . . 10.0 111.281 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 38.4 mt-10 85.88 -25.64 0.11 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.224 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -88.82 130.64 35.34 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 110.237 -0.283 . . . . 10.0 110.237 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.004 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.66 114.32 25.15 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.651 ' HB2' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -88.85 136.6 32.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.096 -177.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -143.18 142.29 31.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.255 0.55 . . . . 10.0 112.344 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.844 ' CD2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -131.4 138.35 49.07 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.235 -1.024 . . . . 10.0 108.235 178.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' OD1' ' CB ' ' A' ' 28' ' ' ASP . 9.6 t0 -49.15 120.76 4.21 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.628 -0.429 . . . . 10.0 110.817 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.915 HG13 ' HA ' ' A' ' 13' ' ' VAL . 19.1 m -57.98 -14.94 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.235 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' CB ' ' OD1' ' A' ' 26' ' ' ASP . 7.2 t70 -63.02 -36.2 82.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.162 0.505 . . . . 10.0 109.898 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.803 HD21 HG22 ' A' ' 86' ' ' THR . 15.8 t-20 -95.19 -45.89 7.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.506 -0.77 . . . . 10.0 111.362 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.645 HG21 ' HG ' ' A' ' 14' ' ' LEU . 23.3 mm -61.35 132.31 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 120.823 0.344 . . . . 10.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' O ' ' CE ' ' A' ' 32' ' ' MET . 50.5 mt-10 -87.95 -64.46 1.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.962 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.424 ' HE2' ' HB2' ' A' ' 32' ' ' MET . 6.4 tpp -169.07 173.03 7.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.39 . . . . 10.0 110.855 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.728 HG11 HG11 ' A' ' 98' ' ' VAL . 34.0 m -100.31 126.76 53.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.781 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.68 HG13 ' HB ' ' A' ' 81' ' ' ILE . 11.9 pt -103.88 155.45 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.124 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -88.79 -175.78 5.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.991 -0.549 . . . . 10.0 111.171 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.416 ' CE ' ' HB3' ' A' ' 79' ' ' LYS . 19.3 ptpt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.025 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.926 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.7 t . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.846 0.355 . . . . 10.0 111.12 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.508 ' HG3' HG23 ' A' ' 62' ' ' VAL . 15.7 pt-20 -69.64 -40.73 76.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.611 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.584 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -165.91 -175.95 36.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.551 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 61' ' ' PRO . 2.0 m -155.31 168.88 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.248 -0.278 . . . . 10.0 110.248 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.827 HD11 HD11 ' A' ' 60' ' ' ILE . 26.2 pt . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 120.766 0.317 . . . . 10.0 111.463 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.016 HG22 ' HB2' ' A' ' 90' ' ' GLU . 29.1 pt . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.621 0.248 . . . . 10.0 111.345 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.803 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 85.0 Cg_endo -82.54 115.91 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.507 2.138 . . . . 10.0 112.808 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.584 HG22 ' C ' ' A' ' 51' ' ' GLY . 23.1 m -88.98 133.39 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.168 -0.679 . . . . 10.0 109.168 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.926 HG22 ' HA ' ' A' ' 49' ' ' VAL . 59.5 t -145.17 157.79 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.799 0.809 . . . . 10.0 113.153 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.527 ' N ' HG12 ' A' ' 63' ' ' VAL . 5.2 m120 -78.15 66.71 3.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.391 -1.277 . . . . 10.0 108.698 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.791 ' O ' HD23 ' A' ' 65' ' ' LEU . 6.4 tt -53.88 -29.35 41.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.837 -0.62 . . . . 10.0 111.531 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.635 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -64.89 -25.84 68.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.54 -0.541 . . . . 10.0 109.54 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 64' ' ' ASN . 24.1 ttpt -77.91 -52.13 9.32 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.236 -0.893 . . . . 10.0 111.0 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.691 HG22 ' HA ' ' A' ' 65' ' ' LEU . 10.3 tt -53.82 -40.17 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.884 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.1 tm? -75.72 -44.99 39.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.545 -1.661 . . . . 10.0 109.534 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.529 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 113.06 -95.65 0.78 Allowed Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.049 -0.523 . . . . 10.0 113.133 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.008 HD12 HG21 ' A' ' 18' ' ' ILE . 3.6 pt 48.66 164.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.097 0.777 . . . . 10.0 113.097 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.2 m -47.03 -36.81 8.39 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.158 -0.682 . . . . 10.0 109.158 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.885 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.0 t80 -26.09 140.09 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.791 -1.095 . . . . 10.0 112.808 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -160.31 34.66 0.17 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.248 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.521 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 50.4 mt-10 52.53 46.93 25.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.247 0.462 . . . . 10.0 112.247 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 77' ' ' LYS . 23.9 pt20 -97.87 -47.2 5.65 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.55 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 14.3 mmmm -108.96 -25.15 10.88 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.362 0.505 . . . . 10.0 112.362 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.64 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 3.2 mmm -35.94 144.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.724 0.409 . . . . 10.0 111.972 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 51.5 mtmt -160.7 -45.06 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.201 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.437 ' O ' HD12 ' A' ' 94' ' ' LEU . 74.5 m -88.86 142.86 27.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.994 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.68 ' HB ' HG13 ' A' ' 34' ' ' ILE . 73.6 mt -100.66 160.52 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.314 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.575 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 31.8 mt -123.63 158.74 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.591 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.512 ' N ' HG22 ' A' ' 82' ' ' ILE . 42.7 t -131.68 150.77 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.032 0.444 . . . . 10.0 111.222 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -156.15 171.78 19.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.896 -178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -128.24 129.05 45.82 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.803 HG22 HD21 ' A' ' 29' ' ' ASN . 67.1 p -145.51 108.27 4.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.879 0.325 . . . . 10.0 111.879 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 88' ' ' ASP . 14.9 tppt? 47.4 59.95 3.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.211 0.529 . . . . 10.0 110.269 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.492 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 2.4 p30 59.16 32.54 22.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.828 -1.078 . . . . 10.0 111.59 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.908 HG12 HG22 ' A' ' 91' ' ' VAL . 66.1 t -128.58 109.34 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 115.3 -0.864 . . . . 10.0 109.156 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 1.016 ' HB2' HG22 ' A' ' 60' ' ' ILE . 34.1 mt-10 -88.28 97.78 11.22 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.281 -1.748 . . . . 10.0 106.281 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.018 HG21 HD13 ' A' ' 142' ' ' ILE . 3.4 t -88.46 152.23 3.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 113.478 -1.692 . . . . 10.0 113.059 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.56 148.4 17.19 Favored Glycine 0 C--N 1.316 -0.547 0 CA-C-N 114.66 -1.155 . . . . 10.0 113.494 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.646 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -138.76 124.78 20.02 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.75 0.309 . . . . 10.0 110.45 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.566 HD13 HG12 ' A' ' 81' ' ' ILE . 54.7 tp -88.62 130.07 35.36 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.603 0.594 . . . . 10.0 112.603 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.041 HG11 ' CE2' ' A' ' 16' ' ' PHE . 34.2 m -143.55 -175.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 115.33 -0.85 . . . . 10.0 110.504 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 78' ' ' MET . 28.5 t70 -108.7 -62.96 1.39 Allowed 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 112.599 0.592 . . . . 10.0 112.599 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 16' ' ' PHE . 13.6 tpt180 -119.34 117.9 29.78 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.41 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.765 HG23 ' HD1' ' A' ' 16' ' ' PHE . 7.0 p -112.52 115.42 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 122.432 1.11 . . . . 10.0 111.502 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -65.84 -31.21 72.03 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 112.962 -1.926 . . . . 10.0 110.809 -178.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.55 -124.53 6.99 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.258 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.1 t -53.05 129.65 13.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.909 0.354 . . . . 10.0 110.129 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.843 HD22 ' CB ' ' A' ' 15' ' ' SER . 59.7 tp -132.68 138.9 47.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.994 0.426 . . . . 10.0 111.177 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.618 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -88.82 70.16 8.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.984 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.664 HG12 ' HG ' ' A' ' 102' ' ' LEU . 8.8 mm -88.94 130.87 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.656 HG22 ' HG2' ' A' ' 10' ' ' GLU . 32.0 p -88.75 -175.89 5.05 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.605 -1.257 . . . . 10.0 107.605 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -147.9 73.03 1.25 Allowed 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 118.929 -1.108 . . . . 10.0 112.79 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -102.57 20.79 16.45 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.701 -1.136 . . . . 10.0 109.1 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 115.474 -0.784 . . . . 10.0 111.382 -179.284 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.678 ' CE2' HD21 ' A' ' 69' ' ' LEU . 32.3 t80 . . . . . 0 N--CA 1.462 0.131 0 CA-C-O 121.011 0.434 . . . . 10.0 110.772 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.76 -137.73 7.15 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.564 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 120' ' ' LYS . 63.9 tttp -80.54 58.25 3.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.875 0.369 . . . . 10.0 110.934 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.597 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 16.2 tppt? -161.26 -40.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 10.0 110.804 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.408 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 88.0 p . . . . . 0 C--N 1.326 -0.424 0 N-CA-C 108.68 -0.859 . . . . 10.0 108.68 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.535 HG11 HD12 ' A' ' 104' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.934 0.397 . . . . 10.0 111.589 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.491 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 8.5 ptpp? -164.26 142.28 7.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.587 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 3.2 m -164.83 148.67 8.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.378 -0.374 . . . . 10.0 110.761 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' OD1' HG22 ' A' ' 128' ' ' THR . 1.0 OUTLIER 55.33 47.71 20.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.934 0.397 . . . . 10.0 111.019 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.81 33.56 43.03 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.997 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 128' ' ' THR . 6.5 ptt-85 -137.84 130.24 29.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.761 0.315 . . . . 10.0 110.251 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.1 mp -88.93 139.74 30.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.989 0.424 . . . . 10.0 111.183 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.004 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.7 mt -133.25 129.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.15 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.458 ' HB ' HD13 ' A' ' 23' ' ' LEU . 24.4 mm -88.92 120.74 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 108.606 -0.887 . . . . 10.0 108.606 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.527 ' CE1' HG21 ' A' ' 13' ' ' VAL . 52.9 t80 -121.38 148.51 44.28 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.239 -0.584 . . . . 10.0 110.363 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.846 HD23 HG21 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -161.01 148.12 15.25 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.505 0.669 . . . . 10.0 111.399 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.8 p-10 -95.87 32.43 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.4 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.865 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 19.7 tt 40.07 18.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.603 -1.18 . . . . 10.0 114.041 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 137' ' ' ASP . 38.4 t70 -79.73 -53.82 6.45 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.966 0.728 . . . . 10.0 112.966 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 121' ' ' LYS . 17.3 tppt? -77.77 -34.17 52.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.447 0.642 . . . . 10.0 110.438 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.865 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.52 -45.95 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.422 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.018 HD13 HG21 ' A' ' 91' ' ' VAL . 7.7 tp -64.48 -43.41 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.403 -0.519 . . . . 10.0 109.733 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.797 ' O ' HG12 ' A' ' 147' ' ' VAL . 44.4 tt0 -47.95 -41.16 24.24 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.117 -0.697 . . . . 10.0 109.117 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.458 ' HA ' HG12 ' A' ' 147' ' ' VAL . 50.7 mm-40 -70.73 -35.77 72.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.008 -0.996 . . . . 10.0 110.829 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.638 ' CD1' HG11 ' A' ' 91' ' ' VAL . 60.3 mt -55.18 -50.98 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.822 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.9 p -73.5 -53.34 10.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.975 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 143' ' ' GLU . 14.4 p -63.0 -17.81 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 10.0 111.791 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 120.779 0.323 . . . . 10.0 111.392 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 105' ' ' THR . 13.2 mmmm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.928 0.394 . . . . 10.0 111.213 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.595 ' HG2' HG22 ' A' ' 105' ' ' THR . 41.4 mt-10 -140.49 164.17 30.85 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.331 0.586 . . . . 10.0 110.531 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.577 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.0 t80 -156.52 139.36 15.24 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.894 -1.048 . . . . 10.0 112.453 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.42 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 16.7 pt-20 -88.76 138.77 31.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.567 -0.901 . . . . 10.0 108.567 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.947 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -154.97 170.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 113.317 0.858 . . . . 10.0 113.317 -176.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.95 HD11 HD13 ' A' ' 82' ' ' ILE . 3.1 tm? -88.62 132.79 34.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.988 -1.116 . . . . 10.0 107.988 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.831 ' HB3' HD22 ' A' ' 102' ' ' LEU . 83.5 p -143.16 152.55 41.92 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.376 0.88 . . . . 10.0 113.376 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.728 ' CE1' HD11 ' A' ' 18' ' ' ILE . 15.1 p90 -150.83 162.8 40.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.47 -1.241 . . . . 10.0 109.908 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.52 ' HG3' HD21 ' A' ' 99' ' ' LEU . 95.7 mt-10 -88.45 139.81 30.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.037 HG21 HD12 ' A' ' 71' ' ' ILE . 35.5 mm -134.47 90.03 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.421 -0.809 . . . . 10.0 111.697 -177.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 47.5 m-20 44.62 60.17 3.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.373 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.2 mt-10 87.36 -42.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.196 -0.911 . . . . 10.0 112.093 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.0 pt20 -88.96 146.18 25.05 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.603 -0.439 . . . . 10.0 109.879 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.969 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.61 166.97 13.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 10.0 110.882 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.9 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.3 tp -152.17 140.2 20.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.325 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.763 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -145.89 151.12 37.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 -177.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.917 ' CD2' HD21 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -133.12 141.3 48.09 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.15 -0.932 . . . . 10.0 108.714 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 137' ' ' ASP . 12.6 p-10 -49.73 122.76 6.83 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.551 -0.46 . . . . 10.0 111.046 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.947 HG13 ' HA ' ' A' ' 13' ' ' VAL . 24.8 m -61.27 -13.85 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.015 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -64.61 -40.48 95.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.406 0.622 . . . . 10.0 109.531 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.748 HD21 HG22 ' A' ' 86' ' ' THR . 16.5 t-20 -87.81 -46.09 9.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.972 -1.013 . . . . 10.0 110.54 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.762 HG21 ' HG ' ' A' ' 14' ' ' LEU . 22.5 mm -65.85 132.3 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.541 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.411 ' O ' ' CE ' ' A' ' 32' ' ' MET . 53.5 mm-40 -82.64 -64.03 1.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.656 -0.247 . . . . 10.0 111.368 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.411 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.03 172.54 7.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 10.0 111.026 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.474 ' CG1' HG11 ' A' ' 98' ' ' VAL . 34.9 m -89.0 147.09 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.749 -0.659 . . . . 10.0 111.613 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.528 HD13 ' CG2' ' A' ' 83' ' ' VAL . 29.0 pt -145.83 129.86 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.558 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 50.1 mt-10 -98.43 124.7 43.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.489 -0.323 . . . . 10.0 111.118 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.865 ' HB2' HD12 ' A' ' 81' ' ' ILE . 62.7 mttp . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.215 -0.448 . . . . 10.0 110.937 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.63 ' HA ' HG22 ' A' ' 63' ' ' VAL . 40.1 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.83 0.347 . . . . 10.0 111.917 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.41 ' OE1' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -93.46 -24.29 18.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.583 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.795 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -152.86 165.04 30.99 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.804 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.604 HG12 HG11 ' A' ' 49' ' ' VAL . 1.9 m -151.11 163.64 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.287 0.543 . . . . 10.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.092 HD11 HD11 ' A' ' 60' ' ' ILE . 27.6 pt . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.137 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.092 HD11 HD11 ' A' ' 53' ' ' ILE . 26.1 pt . . . . . 0 C--O 1.234 0.246 0 N-CA-C 111.432 0.16 . . . . 10.0 111.432 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 77.6 Cg_endo -95.46 114.76 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.352 2.701 . . . . 10.0 112.712 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.795 HG22 ' C ' ' A' ' 51' ' ' GLY . 33.7 m -88.98 141.04 14.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.648 -0.251 . . . . 10.0 110.512 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.63 HG22 ' HA ' ' A' ' 49' ' ' VAL . 84.1 t -142.93 156.29 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.258 0.551 . . . . 10.0 111.694 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.589 ' O ' ' HD3' ' A' ' 67' ' ' LYS . 4.0 m120 -77.26 61.39 2.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.951 0.882 . . . . 10.0 109.584 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.837 ' O ' HD23 ' A' ' 65' ' ' LEU . 7.5 tt -48.86 -26.34 2.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.776 . . . . 10.0 112.379 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.89 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -69.44 -26.34 64.55 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.993 -0.683 . . . . 10.0 111.301 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.658 ' HD3' ' H ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -87.42 -35.01 18.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.723 -0.391 . . . . 10.0 110.775 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.658 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 8.5 tt -57.84 -41.18 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.0 HD21 ' CE2' ' A' ' 118' ' ' PHE . 0.8 OUTLIER -79.36 -46.99 16.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.249 -1.796 . . . . 10.0 108.505 176.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 116.15 -85.17 0.39 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.173 -0.921 . . . . 10.0 112.656 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.037 HD12 HG21 ' A' ' 18' ' ' ILE . 3.0 pt 46.86 166.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 42.9 t -47.69 -34.72 8.56 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.857 ' HB3' HG13 ' A' ' 71' ' ' ILE . 14.6 t80 -31.37 143.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.877 -1.056 . . . . 10.0 112.932 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.95 41.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.722 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 57.37 38.05 28.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.108 -0.496 . . . . 10.0 111.228 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -90.28 -72.47 0.57 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.398 0.518 . . . . 10.0 112.398 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 78' ' ' MET . 0.1 OUTLIER -90.87 -20.73 21.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 10.0 112.204 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.452 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 20.9 mmt -21.13 138.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.087 0.773 . . . . 10.0 113.087 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -172.15 -38.96 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.492 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.718 ' O ' HD12 ' A' ' 94' ' ' LEU . 70.9 m -88.85 166.9 13.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.702 0.287 . . . . 10.0 110.997 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.865 HD12 ' HB2' ' A' ' 36' ' ' LYS . 85.5 mt -138.65 156.3 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.218 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.95 HD13 HD11 ' A' ' 14' ' ' LEU . 48.6 mt -132.78 158.23 43.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 121.081 0.467 . . . . 10.0 111.84 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.528 ' CG2' HD13 ' A' ' 34' ' ' ILE . 50.5 t -130.96 143.1 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.635 -0.712 . . . . 10.0 110.155 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.65 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -140.22 178.19 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.511 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.489 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 54.7 ttp180 -132.95 130.15 39.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.748 HG22 HD21 ' A' ' 29' ' ' ASN . 62.8 p -137.64 103.07 4.92 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.438 0.637 . . . . 10.0 111.832 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.6 tppp? 47.59 47.26 17.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.902 -1.045 . . . . 10.0 110.78 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 45.2 m-20 81.55 28.5 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.932 -1.031 . . . . 10.0 111.985 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.837 HG12 HG22 ' A' ' 91' ' ' VAL . 50.8 t -125.76 108.93 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.39 -0.823 . . . . 10.0 109.146 176.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.631 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 87.9 tt0 -88.24 99.49 12.26 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.869 HG21 HD13 ' A' ' 142' ' ' ILE . 2.7 t -88.66 157.71 3.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 113.338 -1.755 . . . . 10.0 112.653 -174.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -125.24 158.23 19.62 Favored Glycine 0 C--N 1.317 -0.487 0 CA-C-N 114.719 -1.128 . . . . 10.0 112.211 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.65 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.2 t80 -158.42 128.55 5.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.096 0.474 . . . . 10.0 112.082 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 80' ' ' SER . 63.2 tp -88.84 127.38 35.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.683 -0.69 . . . . 10.0 111.439 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.513 HG11 ' CZ ' ' A' ' 16' ' ' PHE . 32.5 m -135.34 -175.14 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.12 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.403 ' OD1' ' HG3' ' A' ' 77' ' ' LYS . 19.8 t70 -88.36 -79.64 0.3 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.167 0.508 . . . . 10.0 111.317 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -130.96 108.19 9.64 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.031 -0.729 . . . . 10.0 109.031 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.607 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.1 p -88.97 114.58 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.302 1.049 . . . . 10.0 111.58 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.71 -28.43 69.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.235 -1.802 . . . . 10.0 110.944 -178.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.1 -125.78 7.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.677 -0.773 . . . . 10.0 111.533 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -51.76 131.1 12.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.974 0.387 . . . . 10.0 110.499 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.831 HD22 ' HB3' ' A' ' 15' ' ' SER . 50.0 tp -134.92 138.51 44.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.952 0.406 . . . . 10.0 111.118 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.3 ptp85 -88.83 72.27 8.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.98 HD12 HG11 ' A' ' 126' ' ' VAL . 10.3 mm -88.95 130.17 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.598 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.595 HG22 ' HG2' ' A' ' 10' ' ' GLU . 16.3 p -88.64 149.66 23.42 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.454 -1.684 . . . . 10.0 106.454 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.424 ' OE1' ' CE2' ' A' ' 135' ' ' TYR . 8.3 tp10 -134.57 80.73 1.87 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 114.088 1.144 . . . . 10.0 114.088 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -88.66 -6.81 57.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 . . . . . 0 C--O 1.232 0.15 0 CA-C-N 114.784 -1.098 . . . . 10.0 111.025 -179.666 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 1.0 ' CE2' HD21 ' A' ' 69' ' ' LEU . 6.1 t80 . . . . . 0 CA--C 1.518 -0.286 0 CA-C-O 121.442 0.639 . . . . 10.0 109.441 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.23 28.29 1.18 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 114.949 -1.023 . . . . 10.0 113.592 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -70.63 -34.45 72.1 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 121' ' ' LYS . 16.6 tppt? -159.47 37.17 0.2 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.998 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.666 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 88.9 p . . . . . 0 CA--C 1.537 0.461 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.736 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.98 HG11 HD12 ' A' ' 104' ' ' ILE . 1.4 p . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 121.373 0.606 . . . . 10.0 111.842 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -158.91 132.62 7.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.43 -0.805 . . . . 10.0 110.724 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.734 ' O ' ' HB2' ' A' ' 131' ' ' ARG . 8.9 m -164.27 140.74 6.38 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.062 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 131' ' ' ARG . 25.3 m-20 62.42 45.74 6.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.03 0.443 . . . . 10.0 110.201 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 56.03 25.12 45.33 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.433 -0.889 . . . . 10.0 110.961 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.734 ' HB2' ' O ' ' A' ' 128' ' ' THR . 99.5 mtt180 -107.89 120.86 43.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.435 -0.383 . . . . 10.0 111.471 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 21' ' ' GLN . 86.1 mt -89.07 82.92 6.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.969 HG12 ' HB3' ' A' ' 22' ' ' ALA . 2.4 mt -88.77 131.37 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.9 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.98 148.35 4.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 107.917 -1.142 . . . . 10.0 107.917 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 35.7 t80 -141.16 151.89 44.23 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.028 -0.669 . . . . 10.0 111.457 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.917 HD21 ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -169.07 150.79 4.56 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 113.638 0.977 . . . . 10.0 113.638 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.404 ' HA ' ' OD1' ' A' ' 26' ' ' ASP . 55.0 p30 -99.33 32.92 2.59 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.604 -1.18 . . . . 10.0 109.716 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.904 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 16.2 tt 40.15 24.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.44 -1.255 . . . . 10.0 113.636 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -77.56 -60.41 2.38 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.017 0.747 . . . . 10.0 113.017 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -74.28 -29.19 61.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.162 0.506 . . . . 10.0 111.08 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.904 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.35 -46.78 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.737 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.869 HD13 HG21 ' A' ' 91' ' ' VAL . 7.2 tp -63.34 -47.11 93.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 120.29 -0.564 . . . . 10.0 110.482 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 147' ' ' VAL . 50.4 mt-10 -50.97 -39.47 55.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.558 ' HB2' HD11 ' A' ' 68' ' ' ILE . 5.7 mm-40 -77.86 -27.08 49.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.358 -0.837 . . . . 10.0 111.061 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.695 ' CD1' HG11 ' A' ' 91' ' ' VAL . 37.5 mt -53.85 -49.28 59.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 121.064 0.459 . . . . 10.0 110.211 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 77.9 p -82.65 -45.84 14.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.767 -0.652 . . . . 10.0 111.364 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 143' ' ' GLU . 51.5 t -58.15 -30.55 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.239 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.7 tptp . . . . . 0 C--N 1.328 -0.36 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -178.184 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.78 ' HE3' ' HA ' ' A' ' 9' ' ' LYS . 0.4 OUTLIER . . . . . 0 CA--C 1.526 0.044 0 CA-C-O 120.723 0.297 . . . . 10.0 110.585 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 33.5 mt-10 -139.4 164.14 30.64 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.337 -0.392 . . . . 10.0 109.988 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.56 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.5 t80 -164.78 139.67 5.37 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 113.265 0.839 . . . . 10.0 113.265 -174.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.423 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 3.0 mt-10 -88.67 135.03 33.71 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.294 -0.866 . . . . 10.0 109.16 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' A' ' 102' ' ' LEU . 1.2 p -152.36 169.35 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.823 0.675 . . . . 10.0 112.823 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.724 ' HG ' HG21 ' A' ' 30' ' ' ILE . 3.4 tm? -88.84 138.1 31.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.832 ' HB3' HD22 ' A' ' 102' ' ' LEU . 97.6 p -145.61 153.91 41.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 113.613 0.968 . . . . 10.0 113.613 -177.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -152.88 159.04 42.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.17 -1.377 . . . . 10.0 110.403 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.566 ' HG2' HD21 ' A' ' 99' ' ' LEU . 53.1 mm-40 -88.63 124.11 33.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.341 0.591 . . . . 10.0 109.968 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.109 HG21 HD12 ' A' ' 71' ' ' ILE . 22.9 mm -118.52 94.45 3.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.177 -0.92 . . . . 10.0 110.865 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 30.8 m-20 44.05 60.13 2.88 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.827 0.677 . . . . 10.0 112.827 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 48.2 mt-10 88.54 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.49 -0.777 . . . . 10.0 112.607 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.682 ' NE2' HD13 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -88.84 152.96 21.44 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.438 -0.505 . . . . 10.0 110.278 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.997 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -89.03 155.52 19.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.807 0.336 . . . . 10.0 110.875 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.831 HD12 ' N ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -141.35 133.96 28.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.469 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.831 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -140.18 153.29 46.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.91 0.707 . . . . 10.0 112.91 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.942 ' CE2' HD22 ' A' ' 136' ' ' LEU . 2.8 m-85 -138.08 144.89 41.13 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -43.53 100.49 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.425 0.631 . . . . 10.0 110.447 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.615 HG12 ' HA ' ' A' ' 13' ' ' VAL . 3.5 p -46.84 -19.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.021 -0.991 . . . . 10.0 111.137 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.62 -43.68 88.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.121 0.486 . . . . 10.0 109.75 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.678 ' CG ' HG21 ' A' ' 138' ' ' ILE . 18.0 t-20 -78.46 -43.27 27.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.485 -0.78 . . . . 10.0 110.607 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.724 HG21 ' HG ' ' A' ' 14' ' ' LEU . 13.0 mm -63.83 125.41 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.32 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.607 ' O ' ' HG3' ' A' ' 32' ' ' MET . 4.6 mm-40 -84.24 -76.6 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.764 0.283 . . . . 10.0 111.764 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.607 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 5.0 mtm -157.34 150.69 23.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.193 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.858 HG11 HG11 ' A' ' 98' ' ' VAL . 34.5 m -88.9 128.03 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.391 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.404 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 29.9 pt -100.38 179.48 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 10.0 111.29 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -88.91 150.87 22.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.119 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.4 tttm . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.16 -179.695 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.886 ' HA ' HG22 ' A' ' 63' ' ' VAL . 55.2 t . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.86 0.362 . . . . 10.0 111.14 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' A' ' 62' ' ' VAL . 17.0 pt-20 -71.86 -40.04 69.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.583 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 62' ' ' VAL . . . -169.06 -175.92 38.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.753 -0.737 . . . . 10.0 112.63 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 53' ' ' ILE . 3.5 m -158.93 172.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.691 0.282 . . . . 10.0 110.283 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 52' ' ' VAL . 30.7 pt . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.813 0.34 . . . . 10.0 111.344 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.782 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.2 pp . . . . . 0 C--O 1.235 0.339 0 CA-C-O 120.516 0.198 . . . . 10.0 110.788 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 60' ' ' ILE . 66.0 Cg_endo -98.15 117.72 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.203 2.602 . . . . 10.0 113.634 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 49' ' ' VAL . 18.5 m -97.12 133.64 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 109.084 -0.71 . . . . 10.0 109.084 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.886 HG22 ' HA ' ' A' ' 49' ' ' VAL . 68.0 t -141.3 159.9 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.783 0.801 . . . . 10.0 113.079 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.779 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.4 m120 -76.61 66.9 2.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.819 -1.082 . . . . 10.0 109.052 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.932 ' O ' HD23 ' A' ' 65' ' ' LEU . 6.3 tt -50.05 -26.46 4.4 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.705 -0.68 . . . . 10.0 111.404 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.656 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -64.91 -27.71 69.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.671 -0.412 . . . . 10.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.779 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -88.4 -36.92 16.27 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.015 -0.365 . . . . 10.0 110.015 178.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.741 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 8.5 tt -61.18 -37.7 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.942 HD11 HG23 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -77.88 -40.51 39.75 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 113.278 -1.783 . . . . 10.0 109.598 177.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.577 ' C ' HG12 ' A' ' 71' ' ' ILE . . . 112.3 -102.54 1.36 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 116.07 -0.514 . . . . 10.0 112.961 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.109 HD12 HG21 ' A' ' 18' ' ' ILE . 6.5 pt 45.98 -179.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 113.088 0.773 . . . . 10.0 113.088 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.653 ' O ' ' O ' ' A' ' 73' ' ' PHE . 72.1 m -57.52 -98.6 0.0 OUTLIER 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.62 -1.622 . . . . 10.0 106.62 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.663 ' HE2' ' N ' ' A' ' 67' ' ' LYS . 1.4 t80 50.65 138.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 119.22 -0.992 . . . . 10.0 113.357 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -159.55 27.39 0.19 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.71 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 66.89 -48.63 0.47 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.13 0.789 . . . . 10.0 113.13 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -38.89 -42.49 0.85 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -79.5 -39.7 31.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.947 0.404 . . . . 10.0 111.395 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.529 ' HG3' ' HA ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -47.33 135.21 10.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.902 0.705 . . . . 10.0 112.902 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 78' ' ' MET . 36.7 mtmm -164.43 32.57 0.07 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.91 -1.041 . . . . 10.0 109.624 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.584 ' O ' HD12 ' A' ' 94' ' ' LEU . 38.7 t -169.12 151.25 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.274 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.404 ' HB ' ' CG1' ' A' ' 34' ' ' ILE . 65.5 mt -120.16 143.08 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.998 0.427 . . . . 10.0 111.985 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.6 HD13 HD11 ' A' ' 14' ' ' LEU . 4.2 mt -111.67 123.48 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.971 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.9 t -92.86 148.13 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.973 0.416 . . . . 10.0 111.008 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -143.91 -175.87 4.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.69 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.803 ' O ' HG23 ' A' ' 86' ' ' THR . 15.3 tpp85 -133.3 160.84 36.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.381 -0.6 . . . . 10.0 109.381 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 85' ' ' ARG . 18.9 p -169.06 100.0 0.37 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.293 0.568 . . . . 10.0 112.018 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.482 ' HA ' ' CE ' ' A' ' 87' ' ' LYS . 2.2 tpmt? 43.99 46.41 6.92 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.002 -0.999 . . . . 10.0 110.55 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 11.6 m-20 82.8 31.96 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.69 -1.141 . . . . 10.0 111.713 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.88 HG12 HG22 ' A' ' 91' ' ' VAL . 44.4 t -130.03 112.12 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.26 -0.882 . . . . 10.0 109.261 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 12.2 mt-10 -88.36 99.91 12.61 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.176 -1.787 . . . . 10.0 106.176 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.976 HG21 HD13 ' A' ' 142' ' ' ILE . 2.6 t -88.77 159.54 2.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 113.91 -1.495 . . . . 10.0 112.106 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.47 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -127.89 154.22 19.67 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.546 -0.835 . . . . 10.0 113.415 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -144.62 128.64 17.54 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 120.722 0.296 . . . . 10.0 110.71 -179.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 80' ' ' SER . 65.1 tp -88.67 134.39 33.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.228 0.537 . . . . 10.0 111.698 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' A' ' 16' ' ' PHE . 35.6 m -147.93 -175.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.936 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -105.11 -65.2 1.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.317 0.488 . . . . 10.0 112.317 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -130.65 120.36 23.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.754 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.858 HG11 HG11 ' A' ' 33' ' ' VAL . 9.5 p -108.1 115.06 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-O 122.245 1.022 . . . . 10.0 111.621 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.566 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -64.95 -29.94 70.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.272 -1.786 . . . . 10.0 111.114 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 91.89 -124.43 7.65 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.646 -0.787 . . . . 10.0 111.321 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.43 134.1 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 117.01 0.405 . . . . 10.0 110.549 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.832 HD22 ' HB3' ' A' ' 15' ' ' SER . 59.8 tp -135.7 139.92 44.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.199 0.523 . . . . 10.0 111.178 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 27.1 ptt180 -88.91 71.63 8.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.67 -0.696 . . . . 10.0 110.407 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.004 HD12 HG21 ' A' ' 126' ' ' VAL . 17.8 mm -88.75 133.14 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 18.2 p -88.84 -175.94 5.04 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.395 -0.965 . . . . 10.0 108.395 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -147.31 77.4 1.44 Allowed 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.128 -1.029 . . . . 10.0 112.808 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -102.02 17.59 22.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.665 -1.152 . . . . 10.0 109.23 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 . . . . . 0 C--N 1.333 -0.113 0 CA-C-N 115.574 -0.739 . . . . 10.0 111.133 -179.525 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.669 ' CE1' HD21 ' A' ' 69' ' ' LEU . 39.7 t80 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.193 0.521 . . . . 10.0 110.315 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 143.92 45.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.821 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 62.31 52.34 3.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.055 0.455 . . . . 10.0 110.314 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.406 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 4.1 tppp? -141.56 -35.75 0.45 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 10.0 111.369 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.727 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 97.2 p . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 116.764 -0.198 . . . . 10.0 110.514 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 1.004 HG21 HD12 ' A' ' 104' ' ' ILE . 2.4 p . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 121.707 0.765 . . . . 10.0 112.111 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -141.41 135.53 30.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.638 ' O ' ' HB2' ' A' ' 131' ' ' ARG . 8.5 m -164.11 137.79 5.41 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.167 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 65.6 t0 60.78 41.99 14.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.89 0.376 . . . . 10.0 110.459 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.24 30.87 55.9 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.754 -0.938 . . . . 10.0 110.754 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.638 ' HB2' ' O ' ' A' ' 128' ' ' THR . 37.5 mmt180 -117.17 133.46 55.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.263 -0.469 . . . . 10.0 111.024 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 57.1 tp -88.91 79.55 7.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.11 -0.496 . . . . 10.0 110.143 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.997 HG12 ' HB3' ' A' ' 22' ' ' ALA . 4.0 mt -88.99 148.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 10.0 111.828 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.804 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -103.32 129.27 55.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 N-CA-C 108.69 -0.856 . . . . 10.0 108.69 177.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.663 ' C ' HD12 ' A' ' 136' ' ' LEU . 40.5 t80 -117.09 144.51 44.59 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.02 -0.672 . . . . 10.0 111.615 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.942 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.5 mp -137.61 169.06 18.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.18 -0.918 . . . . 10.0 111.852 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.453 ' O ' HG22 ' A' ' 138' ' ' ILE . 34.0 t70 -136.58 21.76 3.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.705 -1.134 . . . . 10.0 108.34 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.9 ' HA ' HG23 ' A' ' 141' ' ' ILE . 13.0 tt 43.76 17.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.173 -1.376 . . . . 10.0 113.824 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 142' ' ' ILE . 8.6 t0 -81.48 -59.11 2.74 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.627 0.603 . . . . 10.0 112.627 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.2 mptt -76.55 -34.18 58.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.613 0.721 . . . . 10.0 109.895 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.9 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.27 -46.0 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.835 -1.075 . . . . 10.0 110.63 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.976 HD13 HG21 ' A' ' 91' ' ' VAL . 7.5 tp -62.89 -43.2 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 120.254 -0.578 . . . . 10.0 109.725 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.642 ' O ' HG12 ' A' ' 147' ' ' VAL . 4.5 tp10 -47.11 -46.47 23.0 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.658 ' HB2' HD11 ' A' ' 68' ' ' ILE . 48.5 mt-10 -65.03 -36.89 85.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.25 -0.887 . . . . 10.0 110.298 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.659 ' CD1' HG11 ' A' ' 91' ' ' VAL . 23.3 mt -54.71 -41.12 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 120.896 0.379 . . . . 10.0 110.948 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.7 p -80.44 -50.3 10.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.636 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 143' ' ' GLU . 12.6 p -78.78 9.24 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.596 0.236 . . . . 10.0 111.613 -179.234 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.535 ' HD2' ' HG3' ' A' ' 10' ' ' GLU . 6.3 tmtm? . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.624 ' HG2' HG22 ' A' ' 105' ' ' THR . 45.5 mt-10 -140.71 164.25 30.69 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.004 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 9.9 t80 -160.11 139.49 11.0 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.567 -0.742 . . . . 10.0 112.789 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.526 ' OE2' HG12 ' A' ' 101' ' ' VAL . 23.5 tp10 -88.68 133.99 34.04 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.917 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.6 p -152.93 166.94 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 113.967 1.099 . . . . 10.0 113.967 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.636 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.2 tm? -88.94 134.54 33.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.158 -0.928 . . . . 10.0 108.657 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.784 ' CB ' HD22 ' A' ' 102' ' ' LEU . 40.5 t -148.56 158.04 43.86 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.772 0.796 . . . . 10.0 112.687 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.785 ' CE2' HG11 ' A' ' 95' ' ' VAL . 0.4 OUTLIER -148.35 165.61 30.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.182 -1.372 . . . . 10.0 110.411 -178.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.588 ' HG3' HD21 ' A' ' 99' ' ' LEU . 56.6 mt-10 -88.65 133.22 34.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.07 HG21 HD12 ' A' ' 71' ' ' ILE . 35.0 mm -132.06 95.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.437 -177.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 26.8 m-20 42.45 60.18 2.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.676 -0.693 . . . . 10.0 112.525 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.1 mt-10 85.72 -44.77 0.06 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.39 -0.823 . . . . 10.0 111.621 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -89.03 145.36 25.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.993 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.58 168.14 12.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.986 0.422 . . . . 10.0 111.089 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.751 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.9 OUTLIER -147.11 135.04 21.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.586 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.695 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -137.56 152.91 49.94 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.999 0.741 . . . . 10.0 112.999 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.61 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.2 m-85 -135.16 142.76 46.2 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.146 -0.934 . . . . 10.0 108.814 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' HZ ' ' A' ' 11' ' ' PHE . 12.7 p-10 -52.43 122.05 8.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.271 0.558 . . . . 10.0 111.328 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.917 HG13 ' HA ' ' A' ' 13' ' ' VAL . 27.2 m -61.27 -14.7 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.44 -0.8 . . . . 10.0 110.653 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.43 -44.51 94.35 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.184 0.516 . . . . 10.0 109.829 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.697 HD21 HG22 ' A' ' 86' ' ' THR . 21.7 t-20 -89.57 -42.52 11.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 10.0 110.566 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.636 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.8 mm -62.45 130.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.865 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 32' ' ' MET . 52.0 mm-40 -85.79 -68.97 0.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.33 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.6 mtm -169.21 156.02 6.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.148 0.499 . . . . 10.0 111.609 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.773 HG11 HG11 ' A' ' 98' ' ' VAL . 34.6 m -88.88 159.1 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.567 -0.742 . . . . 10.0 111.304 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.442 HG13 ' HB ' ' A' ' 81' ' ' ILE . 23.1 pt -151.55 162.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.963 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -88.83 146.58 24.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.174 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HA ' HD11 ' A' ' 81' ' ' ILE . 27.8 tptp . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.297 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.767 ' HA ' HG22 ' A' ' 63' ' ' VAL . 38.4 t . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.944 0.402 . . . . 10.0 111.19 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 9.8 pt-20 -75.77 -38.54 58.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.571 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.744 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -144.22 -177.04 18.78 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 120.183 -1.008 . . . . 10.0 113.095 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 61' ' ' PRO . 3.4 m -160.08 175.32 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.806 ' O ' HD12 ' A' ' 53' ' ' ILE . 2.2 pp . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 10.0 111.251 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.786 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.546 0.213 . . . . 10.0 110.839 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.583 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 89.0 Cg_endo -82.95 119.61 2.89 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.678 2.252 . . . . 10.0 113.483 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.744 HG22 ' C ' ' A' ' 51' ' ' GLY . 35.9 m -95.75 138.51 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.767 HG22 ' HA ' ' A' ' 49' ' ' VAL . 94.5 t -139.88 151.44 22.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.715 0.769 . . . . 10.0 112.581 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -78.57 67.44 4.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.688 -1.142 . . . . 10.0 109.668 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.824 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.3 tt -52.78 -38.56 61.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.305 -0.861 . . . . 10.0 111.2 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.76 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -53.34 -24.29 11.62 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.314 -0.554 . . . . 10.0 109.711 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.573 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -85.51 -48.37 9.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.784 -0.643 . . . . 10.0 110.307 178.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.781 HG22 ' HA ' ' A' ' 65' ' ' LEU . 8.2 tt -54.42 -38.85 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 107.867 -1.16 . . . . 10.0 107.867 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.904 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -79.65 -51.05 9.74 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 113.52 -1.673 . . . . 10.0 109.684 177.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 118.64 -86.38 0.4 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.879 -0.601 . . . . 10.0 112.508 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.07 HD12 HG21 ' A' ' 18' ' ' ILE . 3.5 pt 46.55 165.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 113.115 0.783 . . . . 10.0 113.115 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.5 m -47.8 -35.26 9.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.919 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.7 t80 -27.63 140.56 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.757 -1.11 . . . . 10.0 112.578 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 8.8 t70 -143.99 30.45 1.3 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.154 0.502 . . . . 10.0 110.815 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HA ' ' CE1' ' A' ' 73' ' ' PHE . 49.0 mt-10 66.69 -51.57 0.45 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.15 0.796 . . . . 10.0 113.15 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -44.84 -42.78 8.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.274 0.842 . . . . 10.0 113.274 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.536 ' NZ ' ' HB3' ' A' ' 77' ' ' LYS . 6.3 mtpm? -81.53 10.63 5.57 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.441 0.904 . . . . 10.0 113.441 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.438 ' CE ' ' CE1' ' A' ' 73' ' ' PHE . 33.8 mmt -68.11 145.4 54.43 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.205 -0.309 . . . . 10.0 111.005 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 54.9 mtpt -158.84 -50.43 0.06 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.654 0.264 . . . . 10.0 111.634 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.631 ' O ' HD12 ' A' ' 94' ' ' LEU . 47.5 t -88.88 -176.03 5.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 10.0 111.615 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.519 HG22 ' N ' ' A' ' 82' ' ' ILE . 47.0 mt -145.38 159.24 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.87 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 13.2 mt -136.62 141.33 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 84' ' ' ALA . 61.5 t -117.79 153.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.583 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -158.51 176.86 11.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.309 -0.405 . . . . 10.0 111.267 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -134.64 135.3 42.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.841 178.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.697 HG22 HD21 ' A' ' 29' ' ' ASN . 72.9 p -148.99 110.83 4.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 21.9 ttmm 47.31 48.52 16.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.346 0.593 . . . . 10.0 110.949 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 72.39 33.21 1.5 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.094 -0.957 . . . . 10.0 111.461 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.912 HG12 HG22 ' A' ' 91' ' ' VAL . 57.5 t -130.19 111.04 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.199 -0.91 . . . . 10.0 109.097 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.686 ' HB2' HG22 ' A' ' 60' ' ' ILE . 66.4 mt-10 -88.38 97.75 11.23 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 106.177 -1.786 . . . . 10.0 106.177 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.005 HG21 HD13 ' A' ' 142' ' ' ILE . 3.9 t -88.75 153.87 3.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 113.334 -1.757 . . . . 10.0 113.234 -174.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -128.74 143.5 14.51 Favored Glycine 0 C--N 1.316 -0.577 0 CA-C-N 114.586 -1.188 . . . . 10.0 113.044 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.6 OUTLIER -131.61 125.55 32.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.811 0.338 . . . . 10.0 110.24 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 80' ' ' SER . 40.1 tp -88.6 130.88 35.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.023 0.44 . . . . 10.0 110.835 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.785 HG11 ' CE2' ' A' ' 16' ' ' PHE . 28.1 m -137.01 -175.09 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.964 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 59.7 t0 -89.01 -76.6 0.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.29 0.567 . . . . 10.0 110.998 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -131.75 113.22 13.28 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.115 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.773 HG11 HG11 ' A' ' 33' ' ' VAL . 9.9 p -95.88 115.85 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 122.408 1.099 . . . . 10.0 111.772 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.588 HD21 ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -68.1 -28.24 67.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.044 -1.889 . . . . 10.0 111.043 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.92 -123.24 6.88 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.633 -0.794 . . . . 10.0 111.824 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.526 HG12 ' OE2' ' A' ' 12' ' ' GLU . 34.9 m -51.07 133.05 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.799 0.3 . . . . 10.0 111.03 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.784 HD22 ' CB ' ' A' ' 15' ' ' SER . 57.4 tp -137.77 139.79 40.24 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.08 0.467 . . . . 10.0 111.211 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 16.2 ptm180 -88.84 73.6 8.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.592 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.784 ' CG1' HG11 ' A' ' 13' ' ' VAL . 16.4 mm -88.79 165.28 2.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.624 HG22 ' HG2' ' A' ' 10' ' ' GLU . 25.4 p -124.61 -176.0 3.42 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.764 -1.199 . . . . 10.0 107.764 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.429 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 87.7 tt0 -137.04 67.05 1.45 Allowed 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.258 -0.977 . . . . 10.0 112.045 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -104.8 26.11 9.56 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.462 -1.245 . . . . 10.0 109.035 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.429 ' NE2' ' HA ' ' A' ' 106' ' ' GLU . 3.0 pm0 . . . . . 0 C--N 1.328 -0.334 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.665 ' CE2' HD21 ' A' ' 69' ' ' LEU . 51.6 t80 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 121.053 0.454 . . . . 10.0 110.159 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 120' ' ' LYS . . . 166.45 -49.36 0.26 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.604 -0.725 . . . . 10.0 112.012 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER 171.97 -33.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.044 0.45 . . . . 10.0 110.405 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -54.89 -46.45 74.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.754 -0.657 . . . . 10.0 111.257 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.523 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 80.9 p . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.864 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.661 HG11 HD12 ' A' ' 104' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.051 0.453 . . . . 10.0 111.667 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 22.2 pttp -163.65 133.92 4.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.546 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.591 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 14.0 m -167.09 156.43 10.55 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.369 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.4 ' N ' ' CG2' ' A' ' 128' ' ' THR . 62.7 m-20 59.94 45.76 11.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.967 0.413 . . . . 10.0 110.84 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.0 28.23 11.97 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.615 -0.802 . . . . 10.0 111.914 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 128' ' ' THR . 14.8 ptt180 -139.33 132.82 30.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 132' ' ' LEU . 3.9 mp -88.82 136.68 32.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.937 0.399 . . . . 10.0 111.546 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.993 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.6 mt -126.52 129.56 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.936 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.751 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.82 141.36 14.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 N-CA-C 108.934 -0.765 . . . . 10.0 108.934 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.423 ' HE1' HG21 ' A' ' 13' ' ' VAL . 42.3 t80 -124.8 146.2 49.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.28 0.562 . . . . 10.0 111.325 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.644 HD13 HG21 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -144.39 141.08 29.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.761 0.652 . . . . 10.0 112.761 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 139' ' ' ASP . 55.6 p30 -105.8 25.37 10.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.228 -0.896 . . . . 10.0 108.896 177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.919 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 15.3 tt 41.19 16.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 114.346 1.239 . . . . 10.0 114.346 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 38.2 t70 -79.69 -61.21 2.07 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.085 0.772 . . . . 10.0 113.085 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -74.91 -30.54 61.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.535 0.684 . . . . 10.0 110.567 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.919 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.25 -48.4 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.972 -1.013 . . . . 10.0 110.606 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.005 HD13 HG21 ' A' ' 91' ' ' VAL . 7.4 tp -62.19 -45.75 98.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 120.213 -0.595 . . . . 10.0 110.209 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.92 ' O ' HG12 ' A' ' 147' ' ' VAL . 63.1 mm-40 -47.74 -43.68 27.29 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 51.9 mm-40 -71.85 -39.27 69.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.045 -0.979 . . . . 10.0 110.429 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.674 ' CD1' HG11 ' A' ' 91' ' ' VAL . 46.8 mt -45.17 -38.48 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-O 120.803 0.335 . . . . 10.0 111.24 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.1 p -97.77 -53.79 3.31 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.21 0.818 . . . . 10.0 113.21 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 143' ' ' GLU . 8.6 p -84.2 13.16 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 113.466 0.913 . . . . 10.0 113.466 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 84.9 tttt . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 120.271 -0.572 . . . . 10.0 110.788 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.494 ' O ' HG22 ' A' ' 105' ' ' THR . 2.6 tmmm? . . . . . 0 C--O 1.23 0.075 0 N-CA-C 109.928 -0.397 . . . . 10.0 109.928 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 88.3 tt0 -138.96 161.14 38.06 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.272 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.602 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 11.0 t80 -165.85 139.48 4.39 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.45 -0.796 . . . . 10.0 112.917 -173.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 16.7 mt-10 -88.82 134.41 33.94 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.927 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -149.05 170.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 113.307 0.854 . . . . 10.0 113.307 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.88 HD11 HD13 ' A' ' 82' ' ' ILE . 3.1 tm? -88.91 132.88 34.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.815 ' HB3' HD22 ' A' ' 102' ' ' LEU . 86.6 p -143.09 153.64 43.12 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.687 0.756 . . . . 10.0 112.746 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.673 ' CD2' HG11 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -149.93 160.4 43.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.252 -1.34 . . . . 10.0 110.012 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -88.67 135.98 33.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.353 -0.61 . . . . 10.0 109.353 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.044 HG21 HD12 ' A' ' 71' ' ' ILE . 34.8 mm -130.79 81.99 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.361 -0.836 . . . . 10.0 111.34 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.723 ' OD2' ' HA ' ' A' ' 73' ' ' PHE . 19.9 m-20 50.82 60.23 4.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.462 0.542 . . . . 10.0 112.462 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 81.3 mt-10 81.98 -35.89 0.1 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.171 -0.922 . . . . 10.0 111.107 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.457 ' NE2' HD11 ' A' ' 134' ' ' ILE . 37.5 tt0 -88.87 136.71 32.86 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.252 -0.647 . . . . 10.0 109.252 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.019 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.72 162.12 16.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.054 0.454 . . . . 10.0 111.222 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.949 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.5 tp -148.63 139.33 22.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.165 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.756 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -143.55 153.56 42.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.927 0.714 . . . . 10.0 112.927 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.768 ' CE2' HD22 ' A' ' 136' ' ' LEU . 6.0 m-85 -135.37 140.56 45.1 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.222 -0.899 . . . . 10.0 109.169 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.452 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . 47.0 p-10 -49.17 123.3 7.09 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.106 0.479 . . . . 10.0 111.25 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.927 HG13 ' HA ' ' A' ' 13' ' ' VAL . 31.1 m -62.26 -13.25 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.573 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -61.16 -46.05 92.09 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.031 0.443 . . . . 10.0 110.047 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.715 ' CG ' HG21 ' A' ' 138' ' ' ILE . 16.0 t-20 -89.28 -45.04 9.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.562 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.69 HG21 ' HG ' ' A' ' 14' ' ' LEU . 17.5 mm -60.97 120.67 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.234 -0.439 . . . . 10.0 109.906 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 32' ' ' MET . 8.8 pt-20 -81.19 -58.85 2.88 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.198 0.444 . . . . 10.0 112.198 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.475 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -169.12 157.94 8.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.038 0.446 . . . . 10.0 111.725 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.623 ' CG1' HG11 ' A' ' 98' ' ' VAL . 30.4 m -88.94 152.16 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.697 -0.683 . . . . 10.0 111.508 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 pt -148.35 129.81 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -88.82 128.63 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 10.0 110.241 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.832 ' HB3' HD12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.883 0.373 . . . . 10.0 110.959 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.854 ' HA ' HG22 ' A' ' 63' ' ' VAL . 44.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.975 0.417 . . . . 10.0 111.632 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -90.31 -46.84 8.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.579 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.774 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -133.04 -179.08 15.98 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.764 -0.731 . . . . 10.0 112.774 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 53' ' ' ILE . 2.4 m -160.81 168.81 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 CA-C-O 120.848 0.356 . . . . 10.0 110.53 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.547 HG12 HD11 ' A' ' 60' ' ' ILE . 28.5 pt . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 116.319 -0.4 . . . . 10.0 110.719 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.76 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.232 0.153 0 N-CA-C 111.663 0.245 . . . . 10.0 111.663 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 70.2 Cg_endo -86.09 117.75 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.747 2.298 . . . . 10.0 112.958 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.774 HG22 ' C ' ' A' ' 51' ' ' GLY . 35.1 m -96.0 134.84 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.639 -0.504 . . . . 10.0 109.639 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.854 HG22 ' HA ' ' A' ' 49' ' ' VAL . 57.4 t -140.31 156.0 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.561 0.696 . . . . 10.0 112.406 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.493 ' N ' HG12 ' A' ' 63' ' ' VAL . 5.6 m120 -77.16 72.27 3.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.949 -1.023 . . . . 10.0 109.805 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.864 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.1 tt -53.86 -37.55 63.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.308 0.575 . . . . 10.0 110.587 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.793 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -56.75 -25.88 55.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.132 0.492 . . . . 10.0 109.69 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.526 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -82.01 -42.71 18.95 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.243 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 65' ' ' LEU . 7.9 tt -61.84 -37.61 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.883 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.1 tm? -78.35 -52.02 9.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 113.738 -1.574 . . . . 10.0 108.92 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 117.68 -82.87 0.33 Allowed Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.66 -0.7 . . . . 10.0 112.744 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.044 HD12 HG21 ' A' ' 18' ' ' ILE . 2.7 pt 45.36 173.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -50.16 -39.25 43.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.433 0.635 . . . . 10.0 109.32 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.792 ' HB3' HG13 ' A' ' 71' ' ' ILE . 4.3 t80 -28.21 145.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.672 -1.149 . . . . 10.0 113.904 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 65.4 t0 -137.63 -52.8 0.65 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.785 -1.098 . . . . 10.0 109.906 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' A' ' 74' ' ' ASP . 16.4 pt-20 163.57 -44.0 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.983 0.421 . . . . 10.0 111.624 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -51.31 -37.63 48.62 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 10.2 mmpt? -74.72 -29.68 61.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.11 0.411 . . . . 10.0 112.11 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.407 ' O ' ' CG ' ' A' ' 79' ' ' LYS . 29.3 mmt -43.84 130.55 5.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.888 0.375 . . . . 10.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 78' ' ' MET . 53.2 mtmt -162.1 -44.89 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.547 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.601 ' HB3' HG23 ' A' ' 95' ' ' VAL . 45.5 t -88.95 164.29 15.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.495 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.832 HD12 ' HB3' ' A' ' 36' ' ' LYS . 45.4 mt -140.98 125.97 18.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.694 0.283 . . . . 10.0 111.351 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.88 HD13 HD11 ' A' ' 14' ' ' LEU . 6.2 mt -100.42 155.27 4.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.459 -0.337 . . . . 10.0 111.203 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.75 145.66 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.645 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -143.46 -177.06 5.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.474 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.05 128.89 24.88 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.877 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.722 HG21 HG12 ' A' ' 138' ' ' ILE . 69.0 p -142.85 109.69 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.026 0.441 . . . . 10.0 111.914 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 47.8 49.99 16.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.388 0.614 . . . . 10.0 110.753 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 72.91 31.24 1.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.009 -0.996 . . . . 10.0 111.555 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.89 HG12 HG22 ' A' ' 91' ' ' VAL . 66.1 t -126.95 109.74 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.262 -0.881 . . . . 10.0 109.397 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 36.9 tt0 -88.36 99.12 12.01 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.799 -1.926 . . . . 10.0 105.799 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.023 HG21 HD13 ' A' ' 142' ' ' ILE . 5.3 t -88.67 152.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 113.181 -1.827 . . . . 10.0 113.196 -173.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -119.18 153.25 16.95 Favored Glycine 0 C--N 1.315 -0.606 0 CA-C-N 114.381 -1.281 . . . . 10.0 113.156 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -143.95 125.09 14.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.861 0.362 . . . . 10.0 110.559 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.534 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 42.3 tp -88.66 124.74 34.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.124 0.488 . . . . 10.0 110.516 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.673 HG11 ' CD2' ' A' ' 16' ' ' PHE . 17.1 m -132.87 -175.07 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.672 -0.694 . . . . 10.0 110.944 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 17.2 t70 -87.67 -71.79 0.55 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.536 0.684 . . . . 10.0 110.993 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -146.59 112.41 5.69 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.904 -1.044 . . . . 10.0 108.324 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.623 HG11 ' CG1' ' A' ' 33' ' ' VAL . 7.5 p -89.01 118.26 33.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 122.31 1.053 . . . . 10.0 112.939 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -66.12 -29.29 69.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.031 -1.895 . . . . 10.0 110.923 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.74 -123.43 7.31 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.556 -0.747 . . . . 10.0 111.498 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 m -52.89 136.85 13.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.977 0.389 . . . . 10.0 110.84 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' A' ' 15' ' ' SER . 45.5 tp -139.21 141.89 37.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.17 0.509 . . . . 10.0 111.237 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.433 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.3 ptp85 -88.9 71.8 8.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.753 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.834 HD12 HG11 ' A' ' 126' ' ' VAL . 15.7 mm -88.75 136.75 22.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 N-CA-C 109.554 -0.536 . . . . 10.0 109.554 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 14.7 p -88.82 -175.76 4.99 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -144.34 77.37 1.54 Allowed 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.721 -1.192 . . . . 10.0 113.262 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.41 22.17 16.3 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.414 -1.267 . . . . 10.0 108.173 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 . . . . . 0 C--N 1.333 -0.149 0 CA-C-N 114.81 -1.086 . . . . 10.0 111.921 -178.631 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.608 ' CE2' HD21 ' A' ' 69' ' ' LEU . 33.4 t80 . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 120.949 0.404 . . . . 10.0 110.808 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.67 -144.02 9.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.951 -0.643 . . . . 10.0 112.405 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -85.22 58.03 4.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.695 0.283 . . . . 10.0 110.639 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 17.3 tppt? -154.31 -40.05 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.919 0.341 . . . . 10.0 111.919 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.519 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 90.2 p . . . . . 0 C--N 1.329 -0.314 0 C-N-CA 121.187 -0.205 . . . . 10.0 110.824 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.949 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.6 p . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 121.416 0.627 . . . . 10.0 112.389 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.516 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 92.7 mttt -152.27 132.35 13.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.145 -0.934 . . . . 10.0 109.742 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 2.6 m -169.07 152.12 5.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.825 0.345 . . . . 10.0 111.164 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' OD1' HG22 ' A' ' 128' ' ' THR . 0.9 OUTLIER 56.83 47.95 16.98 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.916 0.389 . . . . 10.0 111.244 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 49.12 30.92 10.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.116 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 128' ' ' THR . 3.5 ptm180 -137.94 136.4 36.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.171 -0.307 . . . . 10.0 110.171 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.659 HD22 ' N ' ' A' ' 132' ' ' LEU . 2.0 mm? -88.88 135.59 33.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.907 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.019 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.9 mt -128.78 131.51 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.864 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.949 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.6 mp -88.87 140.12 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.238 -0.653 . . . . 10.0 109.238 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.719 ' C ' HD12 ' A' ' 136' ' ' LEU . 49.0 t80 -128.72 141.45 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.33 0.586 . . . . 10.0 111.282 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.768 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.6 mp -136.47 172.51 12.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.823 0.82 . . . . 10.0 112.666 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 137' ' ' ASP . 9.8 t70 -136.36 25.09 3.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.099 -1.41 . . . . 10.0 107.667 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.887 ' HA ' HG23 ' A' ' 141' ' ' ILE . 10.5 tt 42.6 17.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 114.164 -1.38 . . . . 10.0 114.086 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.408 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.5 t70 -82.33 -62.99 1.47 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.604 0.594 . . . . 10.0 112.604 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -73.93 -30.89 62.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.612 0.72 . . . . 10.0 109.981 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -69.29 -47.48 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.817 -1.083 . . . . 10.0 110.839 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.023 HD13 HG21 ' A' ' 91' ' ' VAL . 7.3 tp -60.74 -47.35 93.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 120.313 -0.555 . . . . 10.0 110.206 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.871 ' O ' HG12 ' A' ' 147' ' ' VAL . 5.5 mm-40 -49.14 -43.55 41.83 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.289 0.566 . . . . 10.0 109.62 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' A' ' 68' ' ' ILE . 5.7 mm-40 -72.6 -34.81 67.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.192 -0.913 . . . . 10.0 110.898 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.693 ' CD1' HG11 ' A' ' 91' ' ' VAL . 33.9 mt -47.93 -46.38 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-O 120.941 0.401 . . . . 10.0 111.093 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 80.6 p -86.25 -50.59 6.85 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.135 0.791 . . . . 10.0 113.135 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 143' ' ' GLU . 8.6 p -82.36 13.03 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.537 0.94 . . . . 10.0 113.537 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 62.4 tttm . . . . . 0 C--N 1.328 -0.35 0 C-N-CA 120.124 -0.63 . . . . 10.0 111.019 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.468 ' O ' HG22 ' A' ' 105' ' ' THR . 63.0 pttt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.007 0.432 . . . . 10.0 110.464 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.586 ' HG2' HG22 ' A' ' 105' ' ' THR . 41.8 mt-10 -145.48 164.25 32.16 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.449 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.5 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 16.1 t80 -153.38 141.9 20.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.863 -1.062 . . . . 10.0 112.606 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 27' ' ' VAL . 12.2 pt-20 -88.75 139.27 30.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.538 -0.756 . . . . 10.0 109.174 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.769 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -154.09 169.05 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.395 0.887 . . . . 10.0 113.395 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.879 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.9 tm? -88.79 132.26 34.71 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.819 ' HB3' HD22 ' A' ' 102' ' ' LEU . 94.7 p -140.8 150.35 43.21 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.8 ' CE1' HG11 ' A' ' 95' ' ' VAL . 4.6 p90 -150.71 162.57 40.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.523 -1.217 . . . . 10.0 110.308 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HG3' HD21 ' A' ' 99' ' ' LEU . 51.0 mt-10 -88.64 137.73 32.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.123 0.487 . . . . 10.0 109.802 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.975 HG21 HD12 ' A' ' 71' ' ' ILE . 17.8 mm -136.11 99.36 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.642 -0.708 . . . . 10.0 111.289 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.601 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 48.7 m-20 42.0 60.14 2.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.479 -0.782 . . . . 10.0 112.84 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.1 mt-10 86.6 -42.68 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.304 -0.862 . . . . 10.0 112.581 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.453 ' OE1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -89.03 155.7 19.31 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.393 -0.523 . . . . 10.0 110.261 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.799 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.64 165.84 14.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.846 0.355 . . . . 10.0 110.677 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -152.27 133.05 14.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.329 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.769 ' HB1' ' CG2' ' A' ' 13' ' ' VAL . . . -142.83 141.25 31.57 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.356 0.598 . . . . 10.0 112.372 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.092 ' CE2' HD13 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -118.0 141.08 48.84 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.248 -1.39 . . . . 10.0 107.248 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.456 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . 12.5 p-10 -45.29 105.85 0.07 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.365 0.602 . . . . 10.0 110.612 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.597 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 6.3 p -51.15 -18.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.212 -0.903 . . . . 10.0 110.685 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.69 -39.29 93.51 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.528 ' ND2' HD13 ' A' ' 138' ' ' ILE . 11.7 t30 -84.46 -45.78 12.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.091 -0.959 . . . . 10.0 110.506 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.879 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.0 mm -63.68 131.92 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.021 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -93.82 -61.19 1.59 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.028 0.381 . . . . 10.0 112.028 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -169.03 161.79 10.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 10.0 111.489 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.077 HG11 HG11 ' A' ' 98' ' ' VAL . 33.9 m -88.94 143.1 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.973 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.635 HG13 ' HB ' ' A' ' 81' ' ' ILE . 20.1 pt -126.47 157.36 37.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.572 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -88.82 139.93 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.945 0.402 . . . . 10.0 111.28 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.409 ' HB2' HD11 ' A' ' 81' ' ' ILE . 61.1 tttm . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.01 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.789 ' HA ' HG22 ' A' ' 63' ' ' VAL . 60.7 t . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.896 0.379 . . . . 10.0 111.368 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -73.88 -39.78 63.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.668 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.767 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -151.31 -175.8 23.5 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.253 -0.975 . . . . 10.0 113.009 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 m -156.01 171.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.847 0.356 . . . . 10.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.478 ' CD1' HD12 ' A' ' 34' ' ' ILE . 31.2 pt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.781 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.848 HG22 ' HB2' ' A' ' 90' ' ' GLU . 2.3 pp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.512 0.196 . . . . 10.0 111.296 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 95.3 Cg_endo -80.0 121.4 4.47 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.484 2.122 . . . . 10.0 112.815 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.767 HG22 ' C ' ' A' ' 51' ' ' GLY . 35.0 m -93.38 132.08 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.759 -0.655 . . . . 10.0 109.945 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 49' ' ' VAL . 86.5 t -141.31 162.34 21.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.278 0.561 . . . . 10.0 111.208 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.541 ' N ' HG12 ' A' ' 63' ' ' VAL . 4.6 m120 -102.78 85.42 2.56 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.693 -0.685 . . . . 10.0 110.593 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.092 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.2 tt -53.25 -41.34 65.35 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.542 -0.463 . . . . 10.0 110.521 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.025 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -55.6 -24.41 32.81 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.472 -0.491 . . . . 10.0 109.955 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.496 ' HD2' ' C ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -86.36 -38.54 17.33 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.01 178.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.835 HG22 ' O ' ' A' ' 65' ' ' LEU . 5.7 tt -64.83 -36.16 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 107.481 -1.303 . . . . 10.0 107.481 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.814 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -81.89 -53.74 5.91 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.292 -1.777 . . . . 10.0 108.643 178.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 116.07 -76.28 0.27 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.801 -1.09 . . . . 10.0 112.182 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.025 HD11 ' HB1' ' A' ' 66' ' ' ALA . 6.5 pt 43.05 -175.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 112.341 0.497 . . . . 10.0 112.341 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 52.5 m -60.33 -39.3 86.58 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.798 ' HB3' HG13 ' A' ' 71' ' ' ILE . 11.4 t80 -26.01 137.14 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.035 -0.984 . . . . 10.0 112.88 177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.435 ' O ' ' OE2' ' A' ' 75' ' ' GLU . 9.8 t70 -158.72 43.76 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.267 -0.879 . . . . 10.0 109.395 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.456 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 1.4 pp20? 37.53 38.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.176 -0.92 . . . . 10.0 112.091 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.408 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 16.1 pt20 -87.67 -49.47 7.12 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.786 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.462 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -106.87 -1.85 21.98 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.666 0.617 . . . . 10.0 112.666 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.51 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 12.1 mmt -42.07 139.28 1.38 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.71 0.291 . . . . 10.0 111.74 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -177.23 36.19 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.632 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.837 ' O ' HD12 ' A' ' 94' ' ' LEU . 69.9 m -169.02 143.73 3.12 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.499 -0.319 . . . . 10.0 110.624 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.635 ' HB ' HG13 ' A' ' 34' ' ' ILE . 67.1 mt -114.26 152.51 15.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 10.0 111.333 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.856 HD13 HD11 ' A' ' 14' ' ' LEU . 14.1 mt -123.98 133.45 69.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' A' ' 34' ' ' ILE . 83.7 t -103.33 150.45 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 10.0 110.83 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -158.08 174.0 15.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.242 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.497 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 6.8 ptm180 -129.28 147.58 51.12 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.206 -0.665 . . . . 10.0 109.206 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.488 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 67.5 p -161.82 109.02 1.38 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.011 0.434 . . . . 10.0 112.081 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? 46.8 48.86 14.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.416 0.627 . . . . 10.0 110.809 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 72.17 33.76 1.51 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 10.0 111.433 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.938 HG12 HG22 ' A' ' 91' ' ' VAL . 59.0 t -132.18 112.27 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 115.293 -0.867 . . . . 10.0 109.255 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.848 ' HB2' HG22 ' A' ' 60' ' ' ILE . 73.9 mt-10 -88.22 95.12 10.05 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.006 HG21 HD13 ' A' ' 142' ' ' ILE . 3.5 t -88.69 152.25 3.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 113.374 -1.739 . . . . 10.0 113.067 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -132.46 143.12 14.69 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.959 -1.019 . . . . 10.0 113.367 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.742 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.3 t80 -131.19 128.64 40.41 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.827 0.346 . . . . 10.0 111.061 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 80' ' ' SER . 58.2 tp -88.8 126.86 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.876 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.8 HG11 ' CE1' ' A' ' 16' ' ' PHE . 21.6 m -132.01 -175.22 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.693 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 44.1 t0 -87.98 -74.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.362 0.601 . . . . 10.0 111.273 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -130.7 117.42 19.43 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.166 -0.925 . . . . 10.0 108.521 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.077 HG11 HG11 ' A' ' 33' ' ' VAL . 7.5 p -101.05 116.6 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 122.484 1.135 . . . . 10.0 112.073 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -65.09 -29.27 70.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.002 -1.908 . . . . 10.0 110.801 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.3 -127.33 8.64 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.825 -0.702 . . . . 10.0 111.718 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.3 t -51.25 132.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 117.011 0.406 . . . . 10.0 110.472 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.819 HD22 ' HB3' ' A' ' 15' ' ' SER . 59.0 tp -137.09 138.86 40.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.027 0.441 . . . . 10.0 111.358 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.646 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.84 72.57 8.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.678 -0.692 . . . . 10.0 110.823 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.73 ' CG1' HG11 ' A' ' 13' ' ' VAL . 16.3 mm -88.78 133.3 31.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 N-CA-C 109.654 -0.498 . . . . 10.0 109.654 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.586 HG22 ' HG2' ' A' ' 10' ' ' GLU . 19.2 p -88.81 149.72 23.27 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -128.41 80.03 1.94 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 113.697 0.999 . . . . 10.0 113.697 -175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -97.69 2.75 50.06 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.59 -1.186 . . . . 10.0 107.896 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 . . . . . 0 C--N 1.339 0.151 0 CA-C-N 114.885 -1.052 . . . . 10.0 110.946 -179.546 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.552 ' CE2' ' CD2' ' A' ' 69' ' ' LEU . 26.0 t80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.167 0.508 . . . . 10.0 109.969 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 76.77 36.07 38.22 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.527 -0.761 . . . . 10.0 111.9 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 118' ' ' PHE . 87.7 tttt 178.86 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 10.5 tppt? -130.47 -68.43 0.69 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.441 -0.504 . . . . 10.0 112.066 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.611 ' HB3' HD12 ' A' ' 136' ' ' LEU . 38.1 t . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 120.88 0.372 . . . . 10.0 110.588 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 133' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.962 0.41 . . . . 10.0 110.81 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.482 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 1.0 OUTLIER -160.5 133.42 6.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.361 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.503 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 10.2 m -161.61 148.33 14.28 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.634 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.12 42.73 27.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.036 0.446 . . . . 10.0 110.761 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.16 36.16 51.49 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.736 -0.745 . . . . 10.0 112.059 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 128' ' ' THR . 5.0 ptp180 -132.86 139.71 47.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.639 0.257 . . . . 10.0 110.442 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.636 HD22 ' N ' ' A' ' 132' ' ' LEU . 2.3 mm? -88.78 139.33 30.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.875 0.369 . . . . 10.0 110.848 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.799 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.8 mt -150.85 143.44 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.413 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 23' ' ' LEU . 11.8 mt -111.82 122.62 66.49 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.745 0 N-CA-C 109.11 -0.7 . . . . 10.0 109.11 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 26' ' ' ASP . 16.4 t80 -100.99 172.53 6.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.875 ' CD1' HD11 ' A' ' 65' ' ' LEU . 4.1 tt -169.01 128.07 1.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.437 -0.505 . . . . 10.0 111.12 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 138' ' ' ILE . 12.3 p-10 -91.12 16.2 10.21 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.191 0.441 . . . . 10.0 112.191 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.931 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 20.5 tt 42.33 18.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 113.908 1.077 . . . . 10.0 113.908 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 137' ' ' ASP . 66.9 t0 -76.33 -56.19 4.86 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.94 0.719 . . . . 10.0 112.94 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 34.4 mmtp -80.1 -28.6 39.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.936 0.398 . . . . 10.0 110.997 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.931 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.5 -46.45 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.095 -0.502 . . . . 10.0 109.973 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.006 HD13 HG21 ' A' ' 91' ' ' VAL . 8.0 tp -65.04 -46.6 90.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 120.322 -0.551 . . . . 10.0 110.315 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.679 ' O ' HG12 ' A' ' 147' ' ' VAL . 3.3 tm-20 -48.56 -40.02 25.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 54.8 mm-40 -76.47 -34.86 58.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.838 -1.074 . . . . 10.0 110.729 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 141' ' ' ILE . 43.4 mt -48.97 -38.91 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 120.971 0.415 . . . . 10.0 110.824 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 79.5 p -88.66 -51.75 5.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.968 0.729 . . . . 10.0 112.968 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 143' ' ' GLU . 7.2 p -83.83 13.15 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.232 0.827 . . . . 10.0 113.232 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 28.0 tptp . . . . . 0 C--N 1.326 -0.437 0 C-N-CA 120.668 -0.413 . . . . 10.0 111.248 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 121.02 0.438 . . . . 10.0 110.19 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 95.1 mt-10 -140.8 164.28 30.64 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.509 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CE2' ' OH ' ' A' ' 135' ' ' TYR . 18.5 t80 -140.49 125.28 18.17 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 114.363 1.246 . . . . 10.0 114.363 -174.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -88.98 125.75 35.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.688 -1.967 . . . . 10.0 105.688 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.954 HG11 ' CG1' ' A' ' 104' ' ' ILE . 5.8 p -150.79 167.74 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 114.439 1.274 . . . . 10.0 114.439 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.688 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.3 tm? -88.77 133.58 34.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.051 -1.092 . . . . 10.0 108.051 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.754 ' HB3' HD22 ' A' ' 102' ' ' LEU . 57.1 p -144.89 158.11 43.91 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.749 0.785 . . . . 10.0 112.99 -177.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.61 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 2.1 p90 -152.97 156.8 39.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.147 -1.388 . . . . 10.0 109.996 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -88.67 106.39 18.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.363 0.602 . . . . 10.0 110.203 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.926 HG21 HD12 ' A' ' 71' ' ' ILE . 36.5 mm -88.89 102.51 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.173 -0.921 . . . . 10.0 110.973 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.748 ' OD1' HG22 ' A' ' 18' ' ' ILE . 12.2 p-10 32.92 60.33 0.41 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.094 1.146 . . . . 10.0 114.094 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.579 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 103.03 -51.3 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.07 0.948 . . . . 10.0 112.712 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.458 ' NE2' ' HB3' ' A' ' 72' ' ' SER . 1.6 pm0 -88.8 -175.73 4.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.695 -0.402 . . . . 10.0 110.363 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.017 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -112.83 159.83 18.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.104 0.478 . . . . 10.0 111.815 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.848 HD13 ' HB ' ' A' ' 134' ' ' ILE . 3.4 tp -150.4 136.72 18.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.951 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.673 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -138.77 152.5 47.98 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.335 0.865 . . . . 10.0 113.335 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.872 ' CZ ' HD22 ' A' ' 136' ' ' LEU . 4.7 m-85 -131.95 142.32 49.59 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.128 -0.942 . . . . 10.0 109.322 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.559 ' OD2' ' HB3' ' A' ' 28' ' ' ASP . 21.4 t0 -52.48 123.28 10.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.152 0.501 . . . . 10.0 110.415 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.932 HG13 ' HA ' ' A' ' 13' ' ' VAL . 33.2 m -63.69 -8.61 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 10.0 112.141 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.559 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 38.9 t70 -66.64 -47.4 72.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.533 -0.467 . . . . 10.0 109.833 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.721 ' CG ' HG21 ' A' ' 138' ' ' ILE . 19.2 t-20 -84.42 -44.43 13.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.637 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.688 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.3 mm -60.46 125.79 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.275 -0.421 . . . . 10.0 110.315 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HB3' ' CE ' ' A' ' 32' ' ' MET . 44.5 mt-10 -85.28 -62.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.58 -0.282 . . . . 10.0 111.435 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.424 ' CE ' ' HB3' ' A' ' 31' ' ' GLU . 1.2 pmm? -169.11 156.95 7.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.036 0.446 . . . . 10.0 111.322 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.592 HG11 HG11 ' A' ' 98' ' ' VAL . 35.6 m -88.93 161.66 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.761 -0.654 . . . . 10.0 111.547 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 33' ' ' VAL . 22.3 pt -158.06 133.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.502 -0.772 . . . . 10.0 110.742 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.8 63.82 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.326 0.584 . . . . 10.0 110.845 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 1.023 ' HB2' HD12 ' A' ' 81' ' ' ILE . 14.5 mmmm . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.341 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.732 ' HA ' HG22 ' A' ' 63' ' ' VAL . 41.0 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.947 0.403 . . . . 10.0 111.393 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.418 ' HG3' ' ND2' ' A' ' 64' ' ' ASN . 2.2 mm-40 -58.5 -38.19 77.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.715 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.678 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -148.49 165.57 29.1 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.382 -0.913 . . . . 10.0 113.324 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.507 ' CG1' ' CG1' ' A' ' 49' ' ' VAL . 2.9 m -161.91 169.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.426 ' CG1' HG13 ' A' ' 60' ' ' ILE . 30.3 pt . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 121.067 0.461 . . . . 10.0 111.73 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.963 HG22 ' HB2' ' A' ' 90' ' ' GLU . 2.2 pp . . . . . 0 C--O 1.236 0.391 0 CA-C-O 120.594 0.235 . . . . 10.0 111.504 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 98.0 Cg_endo -102.64 122.28 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.86 3.04 . . . . 10.0 112.589 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.678 HG22 ' C ' ' A' ' 51' ' ' GLY . 29.2 m -99.84 133.22 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.732 HG22 ' HA ' ' A' ' 49' ' ' VAL . 69.2 t -140.87 155.66 22.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.375 0.607 . . . . 10.0 111.75 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.771 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 4.2 m120 -70.27 66.59 0.3 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.39 -0.823 . . . . 10.0 109.777 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.882 HD22 ' CD2' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -52.08 -18.2 1.35 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.732 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.854 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -74.86 -27.68 60.35 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.465 -0.494 . . . . 10.0 110.169 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.771 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.94 -39.26 21.65 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.638 -0.504 . . . . 10.0 109.638 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.6 tt -57.78 -40.08 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 106.909 -1.515 . . . . 10.0 106.909 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.879 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.37 -45.13 23.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.399 -1.728 . . . . 10.0 107.939 176.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 113.08 -86.09 0.41 Allowed Glycine 0 C--N 1.335 0.488 0 CA-C-N 114.905 -1.043 . . . . 10.0 112.599 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.926 HD12 HG21 ' A' ' 18' ' ' ILE . 2.3 pt 46.89 167.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 113.41 0.893 . . . . 10.0 113.41 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.458 ' HB3' ' NE2' ' A' ' 21' ' ' GLN . 47.1 t -49.07 -37.93 22.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.364 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.786 ' HB3' HG13 ' A' ' 71' ' ' ILE . 3.1 t80 -22.5 141.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.274 1.213 . . . . 10.0 114.274 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' OD1' ' HG2' ' A' ' 75' ' ' GLU . 9.7 t70 -132.03 -58.64 0.95 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.803 -1.089 . . . . 10.0 109.306 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.479 ' HG2' ' OD1' ' A' ' 74' ' ' ASP . 11.7 pt-20 153.2 -42.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.027 0.531 . . . . 10.0 111.294 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -47.38 -40.95 18.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 10.0 112.239 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 10.7 mmpt? -77.09 -41.91 40.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.351 . . . . 10.0 111.054 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.642 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 21.4 mmt -45.39 144.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.422 0.527 . . . . 10.0 112.422 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.465 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -178.36 48.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.158 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.967 ' O ' HD12 ' A' ' 94' ' ' LEU . 79.1 p -169.05 -177.05 2.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.171 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.023 HD12 ' HB2' ' A' ' 36' ' ' LYS . 47.8 mt -154.41 140.27 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.074 0.398 . . . . 10.0 112.074 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 7.5 mt -108.84 162.45 6.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.171 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.486 ' N ' HG22 ' A' ' 82' ' ' ILE . 44.3 t -132.48 147.94 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.946 0.403 . . . . 10.0 110.958 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -155.15 175.33 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.838 -0.619 . . . . 10.0 111.172 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -131.69 131.27 42.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.72 HG21 HG12 ' A' ' 138' ' ' ILE . 59.1 p -145.75 109.38 4.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.954 0.407 . . . . 10.0 112.096 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 87' ' ' LYS . 37.4 ttmt 47.54 50.62 14.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.477 0.656 . . . . 10.0 110.765 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.01 32.21 2.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.1 -0.955 . . . . 10.0 111.524 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.91 HG12 HG22 ' A' ' 91' ' ' VAL . 66.0 t -129.62 109.85 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.207 177.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.963 ' HB2' HG22 ' A' ' 60' ' ' ILE . 32.2 mt-10 -88.38 97.79 11.25 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.078 -1.823 . . . . 10.0 106.078 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.012 HG21 HD13 ' A' ' 142' ' ' ILE . 4.2 t -88.59 153.94 3.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 113.285 -1.779 . . . . 10.0 113.56 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.71 158.73 22.33 Favored Glycine 0 C--N 1.318 -0.445 0 CA-C-N 114.509 -1.223 . . . . 10.0 112.802 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.882 ' CD2' HD22 ' A' ' 65' ' ' LEU . 1.4 t80 -144.45 134.5 24.04 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.851 0.358 . . . . 10.0 111.287 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 80' ' ' SER . 45.6 tp -88.56 123.02 32.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.935 0.398 . . . . 10.0 111.038 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.683 HG23 ' OG ' ' A' ' 80' ' ' SER . 5.2 m -132.91 -175.04 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.803 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 12.5 t70 -99.53 -56.02 2.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.356 0.598 . . . . 10.0 111.902 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.0 tpp85 -150.08 123.8 9.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.217 -0.902 . . . . 10.0 108.706 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.61 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.9 p -108.25 113.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 122.389 1.09 . . . . 10.0 112.325 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.33 -28.22 69.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 112.945 -1.934 . . . . 10.0 111.104 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.19 -118.94 5.09 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.825 -0.91 . . . . 10.0 110.825 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.9 130.1 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 117.066 0.433 . . . . 10.0 110.21 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.754 HD22 ' HB3' ' A' ' 15' ' ' SER . 15.3 tp -135.18 143.47 46.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.416 . . . . 10.0 110.755 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 2.4 ptp180 -88.86 78.11 7.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.772 -0.649 . . . . 10.0 111.742 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.954 ' CG1' HG11 ' A' ' 13' ' ' VAL . 14.5 mm -88.81 178.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 106.856 -1.535 . . . . 10.0 106.856 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 17.3 p -141.43 -175.91 4.53 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 88.2 tt0 -127.73 72.3 1.39 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.949 0.88 . . . . 10.0 112.738 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -108.82 19.49 19.57 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.197 -1.365 . . . . 10.0 107.767 176.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 . . . . . 0 C--N 1.335 -0.059 0 CA-C-N 115.068 -0.969 . . . . 10.0 111.363 -178.823 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.691 ' CE1' HD21 ' A' ' 69' ' ' LEU . 45.2 t80 . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 121.272 0.558 . . . . 10.0 109.864 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 144.61 -53.19 0.58 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.365 -0.834 . . . . 10.0 111.961 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 62.6 tttm 171.72 55.24 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 4.1 tppp? -154.41 -30.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.604 0.594 . . . . 10.0 112.604 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.784 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 87.8 p . . . . . 0 N--CA 1.455 -0.21 0 C-N-CA 120.694 -0.402 . . . . 10.0 111.833 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 133' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 121.405 0.621 . . . . 10.0 111.847 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.505 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -163.07 137.4 6.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.592 -0.731 . . . . 10.0 110.617 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.553 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 8.7 m -165.14 150.09 9.22 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.623 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 56.83 44.17 23.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.943 0.402 . . . . 10.0 110.801 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.21 33.91 39.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.696 -0.764 . . . . 10.0 112.04 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 128' ' ' THR . 14.2 ptt180 -133.49 136.19 44.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.1 mt -88.89 139.95 29.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.046 0.451 . . . . 10.0 111.585 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.017 HG12 ' HB3' ' A' ' 22' ' ' ALA . 4.1 mt -145.37 132.8 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.543 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.848 ' HB ' HD13 ' A' ' 23' ' ' LEU . 2.0 mp -88.89 149.56 3.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.617 -0.882 . . . . 10.0 108.617 177.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.489 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 38.6 t80 -135.38 145.11 47.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.036 -0.665 . . . . 10.0 111.707 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.872 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 6.2 mp -138.85 164.23 30.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.758 0.79 . . . . 10.0 112.416 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -134.53 26.71 3.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.439 -1.255 . . . . 10.0 108.402 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.926 ' HA ' HG23 ' A' ' 141' ' ' ILE . 8.4 tt 41.21 17.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 114.375 -1.284 . . . . 10.0 114.211 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.36 -62.42 1.66 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.691 0.626 . . . . 10.0 112.691 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -75.82 -31.85 59.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.611 0.719 . . . . 10.0 109.903 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.59 -45.82 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 114.759 -1.11 . . . . 10.0 110.785 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.012 HD13 HG21 ' A' ' 91' ' ' VAL . 7.9 tp -64.48 -43.18 96.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 C-N-CA 119.987 -0.685 . . . . 10.0 109.902 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.535 ' N ' HG23 ' A' ' 142' ' ' ILE . 35.1 tp10 -47.71 -46.47 29.63 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.293 0.568 . . . . 10.0 110.072 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.719 ' HB2' HD11 ' A' ' 68' ' ' ILE . 53.2 mm-40 -67.4 -36.45 81.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.409 -0.814 . . . . 10.0 110.597 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.639 ' CD1' HG11 ' A' ' 91' ' ' VAL . 54.1 mt -53.77 -38.72 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.92 0.391 . . . . 10.0 110.843 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.6 p -74.81 -48.8 23.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.368 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.8 p -79.23 6.26 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 111.952 0.353 . . . . 10.0 111.952 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.6 pttp . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.687 0.28 . . . . 10.0 111.462 -179.501 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.548 ' NZ ' HG21 ' A' ' 105' ' ' THR . 19.6 tptt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.746 0.307 . . . . 10.0 111.274 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 40.3 tt0 -117.02 163.9 15.53 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.435 0.636 . . . . 10.0 111.021 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.619 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.6 t80 -163.19 137.95 6.36 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.834 -1.075 . . . . 10.0 112.855 -174.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 68.1 mt-10 -88.8 138.93 30.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.632 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.859 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.1 p -155.58 174.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 -175.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.798 HD11 HD13 ' A' ' 82' ' ' ILE . 3.2 tm? -88.74 136.98 32.72 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.004 -1.109 . . . . 10.0 108.004 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.764 ' CB ' HD22 ' A' ' 102' ' ' LEU . 81.8 p -149.37 157.67 43.52 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 113.993 1.108 . . . . 10.0 113.993 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.739 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -149.98 158.08 43.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 113.948 -1.478 . . . . 10.0 109.837 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.719 ' HG2' HD21 ' A' ' 99' ' ' LEU . 5.1 mm-40 -88.59 88.95 7.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 10.0 111.048 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.053 HG21 HD12 ' A' ' 71' ' ' ILE . 16.8 mm -88.91 124.21 41.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.852 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.754 ' OD2' HG22 ' A' ' 18' ' ' ILE . 1.9 p30 36.62 60.07 0.95 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.601 -0.727 . . . . 10.0 112.571 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 76.97 -43.46 0.44 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.037 -0.983 . . . . 10.0 112.688 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 22' ' ' ALA . 3.0 pp0? -89.02 166.0 14.18 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 120.915 -0.314 . . . . 10.0 110.38 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.015 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.77 150.17 23.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 10.0 112.27 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.941 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -133.56 130.69 38.77 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 178.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.904 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -138.33 153.88 48.98 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.615 0.968 . . . . 10.0 113.615 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.86 ' CE2' HD22 ' A' ' 136' ' ' LEU . 2.3 m-85 -135.73 142.31 45.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.527 -1.215 . . . . 10.0 107.97 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -50.81 123.46 9.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 10.0 110.374 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.859 HG13 ' HA ' ' A' ' 13' ' ' VAL . 34.7 m -60.03 -12.29 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.508 -0.769 . . . . 10.0 111.863 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -63.42 -42.77 98.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.98 0.419 . . . . 10.0 110.127 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.692 ' CG ' HG21 ' A' ' 138' ' ' ILE . 12.1 t-20 -87.34 -45.68 10.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.561 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.784 HG21 ' HG ' ' A' ' 14' ' ' LEU . 11.8 mm -65.55 138.55 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.045 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 32' ' ' MET . 24.9 pt-20 -113.31 -50.07 2.88 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 3.5 mtm -163.95 -175.96 4.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.966 0.412 . . . . 10.0 111.552 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 98' ' ' VAL . 33.9 m -127.84 126.59 67.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.934 -0.576 . . . . 10.0 111.465 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.413 HG13 ' HB ' ' A' ' 81' ' ' ILE . 27.2 pt -96.15 171.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.038 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -88.83 147.63 24.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 10.0 110.947 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.66 ' HD2' HD11 ' A' ' 94' ' ' LEU . 63.4 tttp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.166 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.816 ' HA ' HG22 ' A' ' 63' ' ' VAL . 62.0 t . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.857 0.361 . . . . 10.0 111.146 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.769 ' HG3' HG23 ' A' ' 62' ' ' VAL . 22.7 pt-20 -75.82 -39.04 57.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.445 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -167.91 -175.91 38.05 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.54 -0.838 . . . . 10.0 113.085 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 53' ' ' ILE . 3.2 m -159.13 171.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.756 -0.461 . . . . 10.0 109.756 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 52' ' ' VAL . 31.5 pt . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 121.147 0.498 . . . . 10.0 112.332 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.799 HG22 ' HB3' ' A' ' 90' ' ' GLU . 2.2 pp . . . . . 0 C--O 1.235 0.301 0 CA-C-O 120.479 0.181 . . . . 10.0 110.735 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 92.1 Cg_endo -100.55 114.05 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.301 2.668 . . . . 10.0 113.19 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.769 HG23 ' HG3' ' A' ' 50' ' ' GLU . 19.7 m -89.14 133.12 32.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.956 -0.757 . . . . 10.0 108.956 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.816 HG22 ' HA ' ' A' ' 49' ' ' VAL . 63.1 t -143.31 156.21 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.657 0.741 . . . . 10.0 112.953 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.506 ' N ' HG12 ' A' ' 63' ' ' VAL . 74.6 m-20 -74.49 68.36 1.58 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.756 -1.111 . . . . 10.0 109.214 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.911 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.3 tt -53.41 -30.59 41.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.239 0.542 . . . . 10.0 110.814 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.638 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . . . -63.01 -26.5 68.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' HE2' ' A' ' 73' ' ' PHE . 0.8 OUTLIER -83.5 -42.0 17.36 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.966 179.19 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 65' ' ' LEU . 12.8 tt -58.79 -42.1 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 107.175 -1.416 . . . . 10.0 107.175 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.88 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -73.82 -45.28 52.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 113.76 -1.564 . . . . 10.0 108.435 176.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.498 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 113.52 -91.24 0.57 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.539 -0.755 . . . . 10.0 113.15 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.053 HD12 HG21 ' A' ' 18' ' ' ILE . 3.1 pt 48.28 164.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 112.812 0.671 . . . . 10.0 112.812 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.562 ' HB3' ' CG ' ' A' ' 19' ' ' ASP . 29.4 t -47.23 -32.99 4.98 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.328 -0.619 . . . . 10.0 109.328 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.856 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.2 t80 -33.18 141.55 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.191 -0.913 . . . . 10.0 112.533 176.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -171.87 43.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.49 -0.777 . . . . 10.0 110.196 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 78' ' ' MET . 50.0 mt-10 62.79 43.45 7.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.508 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 19.4 pt20 -74.54 -52.66 11.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HD2' ' C ' ' A' ' 76' ' ' GLN . 2.6 mptt -146.4 18.97 1.36 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 112.275 0.472 . . . . 10.0 112.275 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.628 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 9.4 mmm -47.45 145.85 2.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.582 0.229 . . . . 10.0 110.525 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -174.38 38.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 10.0 111.14 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.746 ' O ' HD12 ' A' ' 94' ' ' LEU . 71.1 m -169.14 162.47 10.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 10.0 109.875 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 70.3 mt -139.61 123.49 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.606 -0.438 . . . . 10.0 111.969 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.798 HD13 HD11 ' A' ' 14' ' ' LEU . 10.7 mt -89.01 130.96 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.494 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.32 146.64 9.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.071 0.462 . . . . 10.0 111.125 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -145.19 -178.72 6.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.566 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 41.8 mtm-85 -138.95 131.07 28.09 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.756 HG21 HG12 ' A' ' 138' ' ' ILE . 82.4 p -144.2 110.99 5.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.927 0.394 . . . . 10.0 112.035 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? 47.8 48.2 17.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.349 0.595 . . . . 10.0 110.735 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 73.51 32.35 1.21 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.085 -0.961 . . . . 10.0 111.564 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 91' ' ' VAL . 53.7 t -128.4 110.88 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.311 -0.859 . . . . 10.0 109.451 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.799 ' HB3' HG22 ' A' ' 60' ' ' ILE . 88.5 tt0 -88.27 98.34 11.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 106.14 -1.8 . . . . 10.0 106.14 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.01 HG21 HD13 ' A' ' 142' ' ' ILE . 3.6 t -88.62 153.93 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 112.983 -1.917 . . . . 10.0 113.353 -173.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -124.13 152.66 17.35 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-N 114.506 -1.225 . . . . 10.0 113.148 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.645 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -141.66 130.0 22.39 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.746 HD12 ' O ' ' A' ' 80' ' ' SER . 66.1 tp -88.56 133.68 34.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.205 0.526 . . . . 10.0 111.445 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.734 HG12 HD11 ' A' ' 18' ' ' ILE . 27.1 m -150.27 -175.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.357 -0.838 . . . . 10.0 110.776 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 78' ' ' MET . 60.3 t0 -111.51 -56.85 2.33 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.338 0.496 . . . . 10.0 112.338 -176.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -133.87 124.72 26.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.986 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 33' ' ' VAL . 5.9 p -115.94 113.12 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-O 122.336 1.065 . . . . 10.0 112.004 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.719 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -63.82 -30.19 71.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.292 -1.776 . . . . 10.0 111.343 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.58 -120.14 5.47 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.707 -0.957 . . . . 10.0 110.707 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.8 p -54.57 131.23 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 117.099 0.449 . . . . 10.0 110.064 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.764 HD22 ' CB ' ' A' ' 15' ' ' SER . 54.6 tp -135.02 139.42 44.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.142 0.496 . . . . 10.0 111.469 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.1 ptp85 -88.9 72.35 8.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.1 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.973 HD12 HG21 ' A' ' 126' ' ' VAL . 9.6 mm -88.73 132.79 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.188 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.8 p -88.51 148.28 24.21 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 106.989 -1.486 . . . . 10.0 106.989 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -140.25 90.08 2.34 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.506 -0.878 . . . . 10.0 111.849 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -91.15 16.43 9.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.741 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-N 115.524 -0.762 . . . . 10.0 110.685 -179.616 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.633 ' CE2' HD21 ' A' ' 69' ' ' LEU . 25.3 t80 . . . . . 0 N--CA 1.46 0.073 0 CA-C-O 121.031 0.443 . . . . 10.0 110.495 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.34 -146.58 18.24 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.712 -0.676 . . . . 10.0 112.341 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -88.23 54.05 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 10.0 110.678 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 68' ' ' ILE . 17.9 tppt? -139.55 -39.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.033 0.383 . . . . 10.0 112.033 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.583 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 99.6 p . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.664 0.269 . . . . 10.0 110.697 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.973 HG21 HD12 ' A' ' 104' ' ' ILE . 2.4 p . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 121.295 0.569 . . . . 10.0 111.686 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.42 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 96.5 mttt -147.02 140.65 25.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 131' ' ' ARG . 6.3 m -163.24 142.08 8.31 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.803 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 56.02 44.1 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.958 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.56 35.23 29.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.105 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.561 ' HD2' ' CG1' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -133.84 148.86 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.2 mp -88.75 139.33 30.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.399 0.619 . . . . 10.0 112.471 -177.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.015 HG12 ' HB3' ' A' ' 22' ' ' ALA . 6.2 mt -151.5 150.35 13.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.241 -0.891 . . . . 10.0 110.571 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.941 ' HB ' HD13 ' A' ' 23' ' ' LEU . 6.1 mm -103.6 130.9 53.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.552 ' C ' HD12 ' A' ' 136' ' ' LEU . 10.3 t80 -117.42 139.26 51.13 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 119.915 -0.714 . . . . 10.0 111.364 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.86 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.2 mp -135.67 165.98 24.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.497 -0.774 . . . . 10.0 112.145 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -135.45 24.28 3.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.657 -1.156 . . . . 10.0 108.293 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.901 ' HA ' HG23 ' A' ' 141' ' ' ILE . 11.1 tt 41.7 17.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.286 -1.325 . . . . 10.0 113.961 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.7 t70 -82.72 -60.19 2.26 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.729 0.64 . . . . 10.0 112.729 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 3.4 mptp? -75.3 -34.26 61.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.699 0.761 . . . . 10.0 109.631 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.901 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.45 -46.15 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.664 -1.153 . . . . 10.0 110.732 179.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.01 HD13 HG21 ' A' ' 91' ' ' VAL . 7.6 tp -62.73 -45.84 97.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 C-N-CA 120.193 -0.603 . . . . 10.0 110.436 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.738 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.3 tt0 -47.92 -44.61 30.01 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.351 0.596 . . . . 10.0 109.756 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.601 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.3 mt-10 -69.6 -30.94 68.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.246 -0.888 . . . . 10.0 110.898 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.653 ' CD1' HG11 ' A' ' 91' ' ' VAL . 48.4 mt -57.61 -54.01 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 120.843 0.354 . . . . 10.0 111.418 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.4 p -69.05 -52.28 30.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.868 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 143' ' ' GLU . 14.0 p -67.25 -12.46 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.811 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.842 0.354 . . . . 10.0 111.092 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.2 tttm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.005 0.431 . . . . 10.0 110.557 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.589 ' HG2' HG22 ' A' ' 105' ' ' THR . 35.1 mt-10 -124.95 164.23 20.56 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.53 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.617 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 12.1 t80 -153.6 137.51 16.27 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.718 -1.128 . . . . 10.0 113.037 -174.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 70.8 mt-10 -88.78 137.36 32.38 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.791 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -152.07 171.05 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.333 -0.849 . . . . 10.0 112.504 -175.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.681 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.9 tm? -88.85 134.94 33.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.795 ' HB3' HD22 ' A' ' 102' ' ' LEU . 80.6 p -148.16 153.03 38.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.096 0.776 . . . . 10.0 113.096 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.697 ' HZ ' ' CE1' ' A' ' 25' ' ' PHE . 1.8 p90 -149.79 168.1 24.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.269 -1.332 . . . . 10.0 110.143 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.55 129.67 35.42 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.829 HD11 HG12 ' A' ' 95' ' ' VAL . 4.5 mm -136.65 117.77 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.759 -0.655 . . . . 10.0 111.519 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.573 ' OD2' HG22 ' A' ' 18' ' ' ILE . 1.9 p30 38.44 60.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.17 -0.923 . . . . 10.0 112.621 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER 78.4 -43.06 0.35 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.916 -1.038 . . . . 10.0 112.742 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.534 ' NE2' ' HB ' ' A' ' 18' ' ' ILE . 3.5 pp0? -89.25 163.07 15.54 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.871 -0.332 . . . . 10.0 110.88 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.977 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.73 151.63 22.29 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.804 0.335 . . . . 10.0 110.84 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -133.58 134.75 43.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.077 -179.221 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.66 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -137.23 141.02 42.07 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.214 0.82 . . . . 10.0 113.214 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.04 ' CE2' HD13 ' A' ' 65' ' ' LEU . 1.4 m-85 -119.23 135.86 54.49 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.826 -1.175 . . . . 10.0 107.826 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -51.06 123.59 9.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.467 -0.493 . . . . 10.0 110.802 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.717 HG13 ' HA ' ' A' ' 13' ' ' VAL . 15.7 m -64.4 -8.68 5.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.608 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.6 -31.43 68.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.01 0.433 . . . . 10.0 110.524 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.958 ' ND2' HG21 ' A' ' 138' ' ' ILE . 14.5 t30 -106.88 -50.22 3.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.918 -0.583 . . . . 10.0 112.401 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.681 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.1 mm -49.61 135.88 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.779 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 32' ' ' MET . 16.3 pt-20 -111.45 -51.65 2.84 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.889 0.7 . . . . 10.0 112.889 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.4 mtm -169.07 157.93 8.16 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.058 0.456 . . . . 10.0 111.88 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.719 HG11 HG11 ' A' ' 98' ' ' VAL . 34.8 m -89.68 177.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.033 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.628 HG13 ' HB ' ' A' ' 81' ' ' ILE . 20.6 pt -160.66 157.47 2.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.383 -0.826 . . . . 10.0 110.192 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -88.75 136.62 32.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 10.0 111.398 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.546 ' HB2' HG13 ' A' ' 81' ' ' ILE . 1.2 tmtp? . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.009 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 63' ' ' VAL . 60.8 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.639 0.257 . . . . 10.0 110.776 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' OE2' HG23 ' A' ' 62' ' ' VAL . 1.7 pp20? -72.8 -35.91 67.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.445 -0.343 . . . . 10.0 111.725 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.539 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -158.66 -176.01 30.23 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 119.659 -1.258 . . . . 10.0 113.755 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 53' ' ' ILE . 2.0 m -156.95 169.76 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 52' ' ' VAL . 26.9 pt . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.946 0.403 . . . . 10.0 111.583 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.797 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.717 0.294 . . . . 10.0 111.326 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 95.2 Cg_endo -84.6 116.43 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.384 2.056 . . . . 10.0 112.593 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.539 HG22 ' C ' ' A' ' 51' ' ' GLY . 7.6 m -89.0 99.54 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.346 -0.612 . . . . 10.0 109.346 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 49' ' ' VAL . 3.1 t -99.52 -175.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.019 -0.991 . . . . 10.0 110.144 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.879 ' H ' HG12 ' A' ' 63' ' ' VAL . 38.1 m-20 -132.55 87.82 2.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.08 -0.509 . . . . 10.0 109.986 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.04 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.6 tt -51.14 -24.75 4.38 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.122 -0.631 . . . . 10.0 111.137 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.758 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -66.67 -29.51 69.54 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.827 -0.349 . . . . 10.0 111.058 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.828 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -86.08 -37.88 18.39 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.812 0.339 . . . . 10.0 110.15 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.728 HG22 ' HA ' ' A' ' 65' ' ' LEU . 10.3 tt -65.35 -38.24 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 107.508 -1.293 . . . . 10.0 107.508 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.827 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.5 tm? -78.29 -46.94 18.94 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.553 -1.658 . . . . 10.0 108.724 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.556 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 115.02 -89.64 0.51 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.305 -0.861 . . . . 10.0 112.633 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.842 HG13 ' HB3' ' A' ' 73' ' ' PHE . 4.4 pt 47.12 164.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 16.3 t -48.1 -33.05 7.62 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.842 ' HB3' HG13 ' A' ' 71' ' ' ILE . 16.5 t80 -30.6 145.42 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.219 -0.9 . . . . 10.0 112.634 176.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -166.44 33.62 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.31 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.495 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 56.2 mt-10 55.0 46.03 25.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.683 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.45 ' HB2' ' HE2' ' A' ' 77' ' ' LYS . 98.6 mm-40 -95.64 -53.48 3.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -102.09 -32.75 9.98 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.298 0.481 . . . . 10.0 112.298 -178.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.624 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 2.9 mmm -28.85 142.65 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.87 0.468 . . . . 10.0 112.248 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.76 39.33 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.079 -0.509 . . . . 10.0 111.283 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.4 t -169.06 127.69 1.02 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.736 -0.665 . . . . 10.0 109.644 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.628 ' HB ' HG13 ' A' ' 34' ' ' ILE . 47.8 mt -98.2 151.31 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.631 HD13 HD11 ' A' ' 14' ' ' LEU . 11.0 mt -115.65 123.8 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.879 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.526 ' CG2' HD13 ' A' ' 34' ' ' ILE . 65.3 t -91.31 147.6 5.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.503 0.668 . . . . 10.0 111.928 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -150.67 171.31 17.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.017 -0.992 . . . . 10.0 110.384 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.459 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 12.1 ptp180 -127.29 143.79 51.17 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.541 -0.54 . . . . 10.0 109.541 178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.5 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 34.5 p -159.0 108.56 1.94 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.269 0.47 . . . . 10.0 112.269 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.2 tppp? 46.79 48.49 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.355 0.598 . . . . 10.0 110.816 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 72.47 33.88 1.37 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.081 -0.963 . . . . 10.0 111.244 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.935 HG12 HG22 ' A' ' 91' ' ' VAL . 75.0 t -132.45 110.62 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-N 115.122 -0.945 . . . . 10.0 109.193 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.679 ' HB2' HG22 ' A' ' 60' ' ' ILE . 1.7 mp0 -88.36 96.25 10.51 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.043 HG21 HD13 ' A' ' 142' ' ' ILE . 3.4 t -88.64 153.26 3.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 113.273 -1.785 . . . . 10.0 112.792 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -131.84 153.87 20.69 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 114.997 -1.001 . . . . 10.0 113.701 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.726 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 t80 -139.86 128.54 23.12 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.453 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 51.1 tp -88.72 136.19 33.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.562 0.696 . . . . 10.0 112.209 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.829 HG12 HD11 ' A' ' 18' ' ' ILE . 23.8 m -148.86 -175.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.805 -1.089 . . . . 10.0 110.098 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.448 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 6.6 t70 -106.31 -57.96 1.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.496 HH12 HD11 ' A' ' 99' ' ' LEU . 55.4 ttp85 -133.96 116.34 15.45 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.369 0.604 . . . . 10.0 109.825 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.719 HG11 HG11 ' A' ' 33' ' ' VAL . 9.3 p -105.08 116.09 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 122.49 1.138 . . . . 10.0 111.852 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.641 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -65.73 -29.69 70.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.908 -1.951 . . . . 10.0 110.774 -178.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.8 -122.14 5.91 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.174 -0.77 . . . . 10.0 111.174 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -53.22 129.91 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 117.148 0.474 . . . . 10.0 110.292 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.804 ' HB3' HG13 ' A' ' 13' ' ' VAL . 60.7 tp -132.02 141.66 49.32 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.104 0.478 . . . . 10.0 111.236 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 103' ' ' ARG . 14.4 ptp180 -88.87 68.79 8.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.011 HD12 HG21 ' A' ' 126' ' ' VAL . 22.3 mm -88.75 132.04 34.63 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.589 HG22 ' HG2' ' A' ' 10' ' ' GLU . 30.3 p -88.73 -175.77 5.02 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.223 -1.028 . . . . 10.0 108.223 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -147.3 75.71 1.38 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.322 -0.951 . . . . 10.0 112.423 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -103.1 20.63 17.27 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.763 -1.108 . . . . 10.0 109.272 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.453 -179.396 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.716 ' CE1' HD21 ' A' ' 69' ' ' LEU . 19.8 t80 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.005 0.431 . . . . 10.0 110.949 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 146.57 53.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.901 -0.666 . . . . 10.0 112.16 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 68.62 55.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.087 0.47 . . . . 10.0 110.844 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.439 ' HD2' ' CE2' ' A' ' 118' ' ' PHE . 24.2 ttmm -148.08 -37.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.639 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 92.1 p . . . . . 0 C--N 1.328 -0.334 0 N-CA-C 109.746 -0.465 . . . . 10.0 109.746 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 1.011 HG21 HD12 ' A' ' 104' ' ' ILE . 2.2 p . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 121.096 0.474 . . . . 10.0 111.015 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -152.89 140.99 20.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.162 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.571 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 6.2 m -167.46 147.49 5.24 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.849 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 57.28 42.86 24.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.431 . . . . 10.0 110.809 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.0 34.44 30.94 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.108 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -132.99 148.44 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.693 0.282 . . . . 10.0 110.274 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.8 139.47 30.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 10.0 111.11 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.977 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.2 mt -152.28 156.56 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.954 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.646 ' HB ' HD13 ' A' ' 23' ' ' LEU . 63.4 mt -117.79 126.91 75.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.561 ' CE1' HG21 ' A' ' 13' ' ' VAL . 15.1 t80 -116.03 146.47 42.14 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.924 -0.31 . . . . 10.0 110.535 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.787 HD21 ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -161.29 154.05 20.68 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.752 0.787 . . . . 10.0 112.717 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 141' ' ' ILE . 2.9 p30 -105.59 133.99 49.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.754 -1.112 . . . . 10.0 108.52 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.958 HG21 ' ND2' ' A' ' 29' ' ' ASN . 15.2 tt -67.11 6.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -74.89 -47.79 28.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.902 0.382 . . . . 10.0 111.652 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.4 mptt -83.66 -34.76 24.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.163 0.506 . . . . 10.0 110.585 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -69.05 -35.83 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.593 179.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.043 HD13 HG21 ' A' ' 91' ' ' VAL . 7.8 tp -71.14 -44.15 74.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.527 ' N ' HG23 ' A' ' 142' ' ' ILE . 39.4 tt0 -47.3 -42.7 21.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.558 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.6 mt-10 -71.09 -35.34 71.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.471 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.71 HG13 ' O ' ' A' ' 141' ' ' ILE . 26.7 mt -53.43 -38.84 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-O 120.8 0.333 . . . . 10.0 111.096 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.6 p -80.65 -50.46 9.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.903 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.2 p -76.71 4.91 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 112.05 0.389 . . . . 10.0 112.05 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.0 pttp . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.527 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.511 ' O ' HG22 ' A' ' 105' ' ' THR . 31.3 mmmt . . . . . 0 N--CA 1.46 0.071 0 CA-C-O 120.747 0.308 . . . . 10.0 111.801 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.639 ' HG2' HG22 ' A' ' 105' ' ' THR . 77.2 mt-10 -129.84 164.26 24.51 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.364 0.602 . . . . 10.0 111.038 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.563 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 15.7 t80 -161.67 138.62 8.48 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.937 -1.029 . . . . 10.0 112.881 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.76 140.62 29.26 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.724 -0.671 . . . . 10.0 109.632 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.805 HG13 ' HB3' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -156.39 169.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 113.287 0.847 . . . . 10.0 113.287 -174.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.751 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.9 tm? -88.95 133.92 34.14 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.742 -1.207 . . . . 10.0 107.742 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.812 ' HB3' HD22 ' A' ' 102' ' ' LEU . 74.6 p -145.34 153.8 41.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 113.083 0.772 . . . . 10.0 113.083 -177.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.634 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 3.1 p90 -151.81 165.3 34.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.375 -1.284 . . . . 10.0 110.371 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -88.58 134.07 33.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.916 HG21 HD12 ' A' ' 71' ' ' ILE . 21.3 mm -131.56 93.49 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.479 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.0 OUTLIER 42.65 60.19 2.5 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 113.073 0.768 . . . . 10.0 113.073 178.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.586 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 88.71 -43.34 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.115 -0.948 . . . . 10.0 112.632 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.716 ' NE2' HD13 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -88.98 151.52 22.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.377 -0.529 . . . . 10.0 110.412 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.008 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.84 156.93 18.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.844 0.354 . . . . 10.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.791 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.2 tp -144.74 135.52 24.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.885 0.374 . . . . 10.0 110.858 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.749 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -142.27 151.69 42.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.943 -0.572 . . . . 10.0 112.364 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.859 ' CE2' HD22 ' A' ' 136' ' ' LEU . 2.8 m-85 -129.36 141.64 51.02 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -48.55 101.34 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.644 0.735 . . . . 10.0 109.369 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 13' ' ' VAL . 3.8 p -47.15 -13.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.523 -1.217 . . . . 10.0 112.862 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -62.9 -41.95 99.61 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.226 -0.589 . . . . 10.0 109.712 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.867 ' ND2' HG21 ' A' ' 138' ' ' ILE . 13.4 t30 -81.85 -48.4 11.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.126 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.751 HG21 ' HG ' ' A' ' 14' ' ' LEU . 18.0 mm -58.52 123.58 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.133 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.676 ' OE2' HG12 ' A' ' 83' ' ' VAL . 15.7 pt-20 -87.19 -54.81 4.11 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.477 0.547 . . . . 10.0 112.477 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.3 mtm -169.23 157.87 7.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.161 0.505 . . . . 10.0 112.352 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.844 HG11 HG11 ' A' ' 98' ' ' VAL . 34.3 m -88.88 148.05 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.057 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.516 HD13 HG21 ' A' ' 83' ' ' VAL . 32.0 pt -139.52 155.34 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -88.8 152.79 21.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.066 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.452 ' HD3' ' C ' ' A' ' 36' ' ' LYS . 12.3 tmtt? . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.721 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.624 ' HA ' HG22 ' A' ' 63' ' ' VAL . 58.6 t . . . . . 0 C--O 1.231 0.107 0 N-CA-C 111.912 0.338 . . . . 10.0 111.912 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -66.25 -30.94 71.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.972 0.415 . . . . 10.0 110.169 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.768 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -152.28 169.04 31.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.712 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 53' ' ' ILE . 3.6 m -158.62 171.96 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.661 0.267 . . . . 10.0 110.499 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.806 ' O ' HD12 ' A' ' 53' ' ' ILE . 2.2 pp . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.008 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.783 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.0 pp . . . . . 0 C--O 1.236 0.38 0 CA-C-O 120.303 0.097 . . . . 10.0 110.87 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 61.7 Cg_endo -97.31 123.97 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.365 2.71 . . . . 10.0 113.546 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.768 HG22 ' C ' ' A' ' 51' ' ' GLY . 34.4 m -102.62 135.5 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 49' ' ' VAL . 99.5 t -143.68 158.16 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.569 0.7 . . . . 10.0 112.543 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.821 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 4.1 m120 -70.38 67.69 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.945 -1.025 . . . . 10.0 109.702 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.927 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.9 tt -50.99 -31.07 16.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.336 0.589 . . . . 10.0 110.61 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.814 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -62.7 -22.96 66.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.81 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -88.4 -41.85 12.54 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 178.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 65' ' ' LEU . 7.6 tt -59.15 -40.38 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.844 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.88 -40.19 33.07 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.31 -1.768 . . . . 10.0 108.267 176.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 71' ' ' ILE . . . 71.32 121.62 0.05 OUTLIER Glycine 0 C--N 1.333 0.386 0 CA-C-N 114.791 -1.095 . . . . 10.0 113.05 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.916 HD12 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -162.86 -167.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.152 0.581 . . . . 10.0 109.972 -179.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 71.9 m -50.4 -32.34 17.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.616 0.722 . . . . 10.0 109.14 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.814 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 7.3 t80 -35.81 143.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.418 -1.265 . . . . 10.0 112.682 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -169.98 36.11 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.649 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 56.2 mt-10 55.54 37.7 29.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.439 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -82.85 -70.81 0.53 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.816 0.341 . . . . 10.0 111.718 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.62 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.4 mptt -94.93 -31.14 13.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.683 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.583 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 12.3 mmm -23.22 140.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.542 0.737 . . . . 10.0 112.221 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -164.11 -37.04 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.972 0.36 . . . . 10.0 111.972 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.851 ' O ' HD12 ' A' ' 94' ' ' LEU . 80.2 p -88.75 163.87 15.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.584 0.231 . . . . 10.0 111.002 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.451 HG21 HG11 ' A' ' 62' ' ' VAL . 67.7 mt -132.64 129.15 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.722 0.296 . . . . 10.0 111.643 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 14' ' ' LEU . 7.5 mt -93.5 150.79 3.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.741 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.676 HG12 ' OE2' ' A' ' 31' ' ' GLU . 46.6 t -121.45 142.04 39.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.458 . . . . 10.0 110.778 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -145.0 175.97 9.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.782 -0.644 . . . . 10.0 111.015 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.455 ' O ' ' CG2' ' A' ' 86' ' ' THR . 6.6 ptm180 -128.25 146.38 50.76 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.516 HG21 HG12 ' A' ' 138' ' ' ILE . 73.3 p -160.93 108.67 1.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.466 0.543 . . . . 10.0 112.466 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 47.08 48.41 15.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.371 0.605 . . . . 10.0 110.779 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 72.26 33.54 1.51 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.117 -0.947 . . . . 10.0 111.235 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.894 HG12 HG22 ' A' ' 91' ' ' VAL . 54.2 t -131.46 111.81 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-N 115.166 -0.924 . . . . 10.0 109.211 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.758 ' HB2' HG22 ' A' ' 60' ' ' ILE . 27.1 mt-10 -88.34 97.93 11.32 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.053 -1.832 . . . . 10.0 106.053 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.018 HG21 HD13 ' A' ' 142' ' ' ILE . 4.8 t -88.55 154.48 3.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.256 -1.793 . . . . 10.0 112.658 -174.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.1 156.3 21.91 Favored Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.702 -1.136 . . . . 10.0 113.065 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.59 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 t80 -146.3 131.94 18.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 10.0 110.935 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.851 HD12 ' O ' ' A' ' 80' ' ' SER . 58.8 tp -88.7 126.83 35.5 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.266 0.555 . . . . 10.0 112.066 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.583 ' HA ' ' HE3' ' A' ' 78' ' ' MET . 30.4 m -137.25 -175.08 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.261 -0.882 . . . . 10.0 109.89 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.78 -62.56 1.32 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.061 0.458 . . . . 10.0 112.191 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -133.93 117.86 17.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.756 -0.656 . . . . 10.0 109.66 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.844 HG11 HG11 ' A' ' 33' ' ' VAL . 9.3 p -104.95 116.07 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 122.451 1.12 . . . . 10.0 111.805 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -64.61 -30.33 71.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.02 -1.9 . . . . 10.0 110.747 -178.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.99 -124.4 6.98 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.487 -0.779 . . . . 10.0 111.259 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.3 p -52.17 128.15 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 117.035 0.418 . . . . 10.0 110.422 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 15' ' ' SER . 51.8 tp -132.06 139.06 48.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.039 0.447 . . . . 10.0 110.927 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.0 ptp85 -88.86 73.25 8.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.828 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.95 HD12 HG11 ' A' ' 126' ' ' VAL . 11.8 mm -88.78 126.21 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.737 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.639 HG22 ' HG2' ' A' ' 10' ' ' GLU . 17.7 p -88.74 146.21 25.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 176.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -131.31 70.7 1.46 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.069 -1.053 . . . . 10.0 113.398 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.99 -9.5 59.83 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.654 -1.157 . . . . 10.0 108.564 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-N 114.98 -1.009 . . . . 10.0 110.875 -179.93 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.634 ' CE1' HD21 ' A' ' 69' ' ' LEU . 23.7 t80 . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.188 0.518 . . . . 10.0 110.054 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' A' ' 120' ' ' LYS . . . 141.75 -58.75 0.56 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.478 -0.783 . . . . 10.0 112.052 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.441 ' CG ' ' O ' ' A' ' 119' ' ' GLY . 51.7 mtmt -163.78 56.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.55 0.214 . . . . 10.0 110.529 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.493 ' HG2' HD22 ' A' ' 69' ' ' LEU . 2.4 tpmt? -150.88 -40.54 0.12 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.509 ' CB ' ' HG ' ' A' ' 136' ' ' LEU . 91.8 p . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 121.0 -0.28 . . . . 10.0 111.386 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.985 HG13 ' HB ' ' A' ' 133' ' ' ILE . 2.3 p . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 121.603 0.716 . . . . 10.0 112.844 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.49 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 62.3 pttt -164.48 132.08 3.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.901 -1.045 . . . . 10.0 109.529 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 5.4 m -159.53 148.88 18.22 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.965 0.412 . . . . 10.0 111.476 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.461 ' HB3' ' NH2' ' A' ' 131' ' ' ARG . 38.6 t70 56.16 46.1 22.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.731 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.23 32.87 57.52 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.597 -0.811 . . . . 10.0 111.743 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.461 ' NH2' ' HB3' ' A' ' 129' ' ' ASP . 1.5 ptp85 -130.63 132.33 45.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.808 0.337 . . . . 10.0 110.221 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.5 tp -88.8 139.13 30.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.159 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.008 HG12 ' HB3' ' A' ' 22' ' ' ALA . 2.6 mt -141.57 126.69 17.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.039 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.791 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.2 mp -89.03 136.59 23.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.684 ' C ' HD12 ' A' ' 136' ' ' LEU . 46.5 t80 -128.8 140.96 51.47 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.537 0.684 . . . . 10.0 111.376 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.859 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.9 mp -130.89 178.26 6.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.486 -0.779 . . . . 10.0 112.078 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.8 p-10 -141.37 23.28 2.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.336 -1.302 . . . . 10.0 108.063 177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.871 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.3 tt 40.75 16.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 114.112 -1.404 . . . . 10.0 114.059 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 137' ' ' ASP . 66.7 t0 -80.0 -61.36 2.01 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.61 0.596 . . . . 10.0 112.61 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -78.34 -29.68 47.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.383 0.611 . . . . 10.0 110.412 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.871 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.21 -45.64 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 115.367 -0.833 . . . . 10.0 110.118 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.018 HD13 HG21 ' A' ' 91' ' ' VAL . 8.0 tp -64.42 -43.32 96.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 120.013 -0.675 . . . . 10.0 109.512 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.535 ' N ' HG23 ' A' ' 142' ' ' ILE . 39.5 tt0 -48.16 -42.59 30.01 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.814 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.635 ' HA ' HG12 ' A' ' 147' ' ' VAL . 55.1 mm-40 -70.26 -33.73 71.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.24 -0.891 . . . . 10.0 110.421 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.651 ' CD1' HG11 ' A' ' 91' ' ' VAL . 41.9 mt -57.22 -35.42 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.806 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.5 p -81.73 -50.45 9.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.655 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 144' ' ' GLU . 14.7 p -72.24 -5.21 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.948 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.42 ' CD ' ' O ' ' A' ' 145' ' ' ILE . 57.0 pttt . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.878 0.37 . . . . 10.0 111.469 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HE3' ' HB2' ' A' ' 10' ' ' GLU . 24.8 tptt . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 112.077 0.399 . . . . 10.0 112.077 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 42.4 tt0 -155.88 164.14 38.88 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.524 0.678 . . . . 10.0 111.477 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.676 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 11.4 t80 -159.49 140.41 12.53 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.616 -1.175 . . . . 10.0 112.483 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.66 130.64 35.25 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.168 -1.049 . . . . 10.0 108.168 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.892 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.6 p -149.0 166.23 3.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 -175.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 1.04 HD11 HD13 ' A' ' 82' ' ' ILE . 3.0 tm? -89.01 140.02 29.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.835 ' HB3' HD22 ' A' ' 102' ' ' LEU . 53.4 p -154.92 158.03 38.65 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 119.806 -0.757 . . . . 10.0 112.851 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.698 ' CZ ' ' HG ' ' A' ' 23' ' ' LEU . 17.4 p90 -150.42 166.16 30.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.589 -1.187 . . . . 10.0 110.109 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.622 ' HG2' HD21 ' A' ' 99' ' ' LEU . 53.2 mm-40 -88.54 142.38 27.75 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.699 -0.482 . . . . 10.0 109.699 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.031 HG21 HD12 ' A' ' 71' ' ' ILE . 33.4 mm -140.52 93.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.78 -0.645 . . . . 10.0 111.45 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.538 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 62.3 m-20 43.24 60.06 2.71 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.89 -0.595 . . . . 10.0 112.39 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.8 mt-10 85.53 -42.71 0.05 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.145 -0.934 . . . . 10.0 112.307 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.627 ' NE2' HG22 ' A' ' 71' ' ' ILE . 19.1 pt20 -88.96 147.08 24.51 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.612 -0.435 . . . . 10.0 109.988 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.009 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.92 166.53 13.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.127 0.489 . . . . 10.0 111.927 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.854 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.1 OUTLIER -140.39 143.57 35.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.549 -179.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.757 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -144.45 149.25 35.7 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.738 0.644 . . . . 10.0 112.738 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.798 ' CE2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -138.39 137.88 37.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.689 -0.856 . . . . 10.0 108.689 179.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -56.17 123.93 16.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.224 -0.591 . . . . 10.0 110.144 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.892 HG13 ' HA ' ' A' ' 13' ' ' VAL . 35.8 m -59.77 -10.54 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.381 -0.827 . . . . 10.0 112.098 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 1.4 p30 -60.03 -40.67 90.14 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.087 0.47 . . . . 10.0 110.089 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.745 HD21 HG22 ' A' ' 86' ' ' THR . 14.7 t-20 -93.3 -47.35 6.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 10.0 111.192 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.78 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.1 mm -57.93 121.91 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.507 ' O ' ' HG3' ' A' ' 32' ' ' MET . 12.4 pt-20 -84.34 -51.14 7.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.16 0.43 . . . . 10.0 112.16 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.9 mtm -169.1 154.69 6.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.248 0.547 . . . . 10.0 111.885 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.656 ' CG1' HD21 ' A' ' 14' ' ' LEU . 34.8 m -88.95 149.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.399 -0.819 . . . . 10.0 111.395 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.486 HG13 ' HB ' ' A' ' 81' ' ' ILE . 10.7 pt -143.57 -178.14 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.723 -0.672 . . . . 10.0 110.622 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -155.75 104.14 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.179 0.514 . . . . 10.0 110.701 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.788 -0.642 . . . . 10.0 111.083 -179.659 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.879 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.5 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.949 0.404 . . . . 10.0 111.476 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.85 -45.28 12.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.335 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.703 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -139.13 -176.38 14.65 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.578 -0.737 . . . . 10.0 112.498 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.525 ' O ' HG23 ' A' ' 53' ' ' ILE . 2.5 m -160.51 169.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 10.0 110.232 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.68 HD13 ' N ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 120.991 0.424 . . . . 10.0 111.211 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.902 HG22 ' HB2' ' A' ' 90' ' ' GLU . 20.3 pt . . . . . 0 C--O 1.234 0.287 0 N-CA-C 111.563 0.208 . . . . 10.0 111.563 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 94.2 Cg_endo -77.82 117.84 4.33 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.593 2.195 . . . . 10.0 112.201 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.703 HG22 ' C ' ' A' ' 51' ' ' GLY . 28.7 m -94.92 137.68 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.715 0.293 . . . . 10.0 110.423 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.879 HG22 ' HA ' ' A' ' 49' ' ' VAL . 88.3 t -140.47 154.91 22.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.479 0.657 . . . . 10.0 111.924 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.821 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.3 m120 -77.65 65.92 3.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.157 -0.929 . . . . 10.0 109.15 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.901 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.7 tt -49.64 -26.73 3.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.575 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.835 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -66.78 -29.15 69.02 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.347 -0.541 . . . . 10.0 110.596 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -87.92 -33.9 18.32 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 121.088 -0.245 . . . . 10.0 110.988 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.696 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.8 tt -57.37 -41.41 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 106.336 -1.727 . . . . 10.0 106.336 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.893 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -77.7 -49.74 13.86 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.231 -1.804 . . . . 10.0 108.392 176.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 115.48 -79.17 0.28 Allowed Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.229 -0.896 . . . . 10.0 112.746 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.031 HD12 HG21 ' A' ' 18' ' ' ILE . 2.3 pt 46.05 173.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.619 0.6 . . . . 10.0 112.619 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 19' ' ' ASP . 71.4 m -51.62 -36.21 44.97 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.849 ' HB3' HG13 ' A' ' 71' ' ' ILE . 3.7 t80 -30.14 145.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.996 -1.002 . . . . 10.0 113.536 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 35.9 t70 -134.62 -54.37 0.83 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.051 -0.977 . . . . 10.0 110.117 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.463 ' HA ' ' HE1' ' A' ' 73' ' ' PHE . 10.5 pt-20 164.52 -45.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.865 0.364 . . . . 10.0 111.644 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -55.52 -37.91 68.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HE3' ' N ' ' A' ' 77' ' ' LYS . 0.8 OUTLIER -68.27 -26.9 65.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.771 0.319 . . . . 10.0 111.331 -179.385 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.418 ' SD ' ' CE1' ' A' ' 73' ' ' PHE . 27.5 mmt -47.6 134.7 12.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.495 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 54.8 mtmt -160.75 -51.57 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.726 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.463 ' O ' HD12 ' A' ' 94' ' ' LEU . 52.3 m -90.14 -175.99 4.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.318 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 82' ' ' ILE . 75.5 mt -152.28 160.59 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.549 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.04 HD13 HD11 ' A' ' 14' ' ' LEU . 15.2 mt -142.23 140.69 29.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.903 0.382 . . . . 10.0 111.263 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 34' ' ' ILE . 44.8 t -110.62 149.74 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.139 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -147.9 175.6 10.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.8 -0.636 . . . . 10.0 110.573 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -133.21 129.99 38.48 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.745 HG22 HD21 ' A' ' 29' ' ' ASN . 44.8 p -144.42 108.78 4.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.319 0.489 . . . . 10.0 112.319 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.485 ' CE ' ' O ' ' A' ' 87' ' ' LYS . 8.1 ttpt 47.67 51.23 14.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.704 0.764 . . . . 10.0 110.806 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.0 31.1 2.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.964 -1.016 . . . . 10.0 111.611 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.873 HG12 HG22 ' A' ' 91' ' ' VAL . 55.7 t -128.33 108.37 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 115.178 -0.919 . . . . 10.0 109.028 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.902 ' HB2' HG22 ' A' ' 60' ' ' ILE . 1.4 mp0 -88.26 99.83 12.53 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.628 -1.99 . . . . 10.0 105.628 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.063 HG21 HD13 ' A' ' 142' ' ' ILE . 4.8 t -88.57 149.62 3.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 113.378 -1.737 . . . . 10.0 112.908 -173.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -119.07 157.78 15.16 Favored Glycine 0 C--N 1.31 -0.898 0 CA-C-N 113.862 -1.517 . . . . 10.0 112.423 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.683 ' CE2' HD22 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -149.75 123.66 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.292 0.568 . . . . 10.0 111.866 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.59 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 46.6 tp -88.78 120.18 29.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.954 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.474 HG11 ' CZ ' ' A' ' 16' ' ' PHE . 27.6 m -131.08 -175.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.48 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 5.2 t0 -84.61 -79.94 0.21 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.32 0.581 . . . . 10.0 110.704 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.81 110.59 8.71 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.675 -0.861 . . . . 10.0 108.675 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.607 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 10.5 p -88.93 114.52 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-O 122.319 1.057 . . . . 10.0 111.833 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.622 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -62.47 -28.65 69.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.23 -1.805 . . . . 10.0 110.827 -178.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.22 -121.07 5.93 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.006 -0.837 . . . . 10.0 111.006 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.68 127.33 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 117.076 0.438 . . . . 10.0 110.453 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.835 HD22 ' HB3' ' A' ' 15' ' ' SER . 46.9 tp -126.57 139.26 53.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.171 0.51 . . . . 10.0 110.743 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.0 ptp85 -88.87 76.95 7.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.381 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.795 ' CG1' HG11 ' A' ' 13' ' ' VAL . 10.1 mm -88.64 161.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 24.0 p -122.32 147.28 46.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 11.4 tt0 -104.96 66.81 0.77 Allowed 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.953 0.882 . . . . 10.0 112.256 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -96.31 17.74 15.28 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.456 -1.247 . . . . 10.0 108.677 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 C--O 1.231 0.128 0 CA-C-N 115.617 -0.72 . . . . 10.0 112.208 -179.486 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.637 ' CE2' HD21 ' A' ' 69' ' ' LEU . 45.8 t80 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 121.304 0.574 . . . . 10.0 109.791 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 175.04 -55.91 0.12 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.096 -0.956 . . . . 10.0 111.336 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 5.8 tmtt? 173.34 44.76 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 110.196 -0.298 . . . . 10.0 110.196 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 26.3 ttpp -163.89 48.78 0.13 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.408 0.522 . . . . 10.0 112.408 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.687 ' HB2' ' HB3' ' A' ' 136' ' ' LEU . 8.2 p . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 120.958 0.409 . . . . 10.0 112.056 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.892 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.7 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.543 0.687 . . . . 10.0 112.138 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 27.9 mtpp -154.62 134.02 12.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.944 -1.025 . . . . 10.0 109.839 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 16.3 m -163.04 149.9 12.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.895 0.379 . . . . 10.0 111.23 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.46 ' OD1' ' HB3' ' A' ' 131' ' ' ARG . 2.8 p30 46.15 48.49 12.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 10.0 111.5 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.66 43.24 68.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.82 -0.705 . . . . 10.0 112.212 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.46 ' HB3' ' OD1' ' A' ' 129' ' ' ASP . 3.5 ptm180 -138.97 134.17 32.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 10.0 110.625 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.93 137.37 32.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.939 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.009 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.9 mt -144.8 130.14 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.003 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.854 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.99 137.31 21.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 70.9 t80 -130.89 142.61 50.38 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.221 -0.592 . . . . 10.0 111.037 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.901 HD23 HG21 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -164.67 147.01 8.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.367 0.603 . . . . 10.0 112.35 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.409 ' OD1' ' CB ' ' A' ' 139' ' ' ASP . 3.0 p30 -96.46 35.02 1.53 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.806 0.812 . . . . 10.0 110.194 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.92 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 20.9 tt 39.95 20.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.328 -1.306 . . . . 10.0 114.14 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 66.5 t0 -79.3 -57.06 3.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.04 0.756 . . . . 10.0 113.04 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 121' ' ' LYS . 22.5 ttmm -77.96 -33.55 51.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 10.0 110.265 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.92 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -64.98 -45.26 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.946 178.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.063 HD13 HG21 ' A' ' 91' ' ' VAL . 5.8 tp -61.36 -44.57 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 C-N-CA 120.1 -0.64 . . . . 10.0 109.531 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 147' ' ' VAL . 43.6 mm-40 -47.16 -41.67 18.21 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.443 ' HG3' ' CD ' ' A' ' 121' ' ' LYS . 59.1 mm-40 -73.48 -31.39 63.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.36 -0.836 . . . . 10.0 111.177 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.66 ' CD1' HG11 ' A' ' 91' ' ' VAL . 44.5 mt -54.27 -48.16 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.973 0.416 . . . . 10.0 110.595 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.3 p -85.48 -45.98 11.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.978 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 143' ' ' GLU . 44.5 t -56.71 -31.49 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.585 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 48.4 tptt . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.066 0.46 . . . . 10.0 111.007 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.517 ' HE3' ' CB ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 121.148 0.499 . . . . 10.0 110.189 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 43.3 tt0 -148.52 163.96 35.65 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.661 -0.7 . . . . 10.0 110.648 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.667 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.4 t80 -158.79 139.14 12.38 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.052 -0.976 . . . . 10.0 112.54 -174.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -88.59 130.37 35.28 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.433 -0.951 . . . . 10.0 108.433 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.957 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.6 p -148.87 169.13 2.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 -175.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.818 ' HG ' HG21 ' A' ' 30' ' ' ILE . 3.3 tm? -88.8 139.18 30.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.857 ' HB3' HD22 ' A' ' 102' ' ' LEU . 83.3 p -149.15 154.17 38.79 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 119.806 -0.758 . . . . 10.0 112.881 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.77 ' CD2' HG11 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -149.24 167.18 26.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.409 -1.269 . . . . 10.0 110.775 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -88.63 123.81 33.46 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.03 -0.73 . . . . 10.0 109.03 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.908 HG21 HD12 ' A' ' 71' ' ' ILE . 9.7 mm -134.39 115.84 21.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.709 -0.678 . . . . 10.0 111.784 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.681 ' OD2' HG22 ' A' ' 18' ' ' ILE . 2.0 p30 39.08 60.12 1.53 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.717 . . . . 10.0 112.484 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 52.6 mt-10 78.08 -42.87 0.36 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.923 -1.035 . . . . 10.0 112.469 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.452 ' OE1' HG12 ' A' ' 134' ' ' ILE . 3.7 pp0? -91.83 158.74 16.16 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.295 -0.253 . . . . 10.0 110.717 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.874 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.74 148.37 24.0 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 121.078 0.466 . . . . 10.0 111.662 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.3 OUTLIER -124.35 133.19 53.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.409 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.889 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -134.06 152.15 51.72 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.443 0.905 . . . . 10.0 113.443 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.956 ' CZ ' HD12 ' A' ' 136' ' ' LEU . 5.6 m-85 -135.98 139.08 42.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.941 -1.027 . . . . 10.0 109.024 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -49.54 122.49 6.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.143 0.497 . . . . 10.0 111.175 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.957 HG13 ' HA ' ' A' ' 13' ' ' VAL . 19.9 m -61.06 -13.51 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.789 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -59.98 -41.81 92.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.13 0.49 . . . . 10.0 109.708 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.961 ' ND2' HG21 ' A' ' 138' ' ' ILE . 12.1 t30 -92.16 -48.52 6.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.641 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.818 HG21 ' HG ' ' A' ' 14' ' ' LEU . 22.3 mm -60.89 129.23 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.445 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 32' ' ' MET . 16.4 pt-20 -100.37 -53.01 3.22 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.7 mtm -169.22 156.11 6.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 10.0 111.732 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.945 HG12 HG23 ' A' ' 82' ' ' ILE . 33.1 m -100.1 129.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.76 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.417 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 27.5 pt -105.78 137.68 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 10.0 111.015 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -90.48 119.51 30.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.829 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.859 ' HB2' HD12 ' A' ' 81' ' ' ILE . 68.7 mttm . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.818 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.866 ' HA ' HG22 ' A' ' 63' ' ' VAL . 50.0 t . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.086 0.469 . . . . 10.0 111.669 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.431 ' HG3' ' ND2' ' A' ' 64' ' ' ASN . 35.7 mm-40 -63.71 -47.79 79.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.994 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.579 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -155.47 -176.01 27.15 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.415 -0.811 . . . . 10.0 112.576 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 m -148.16 169.97 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.878 0.37 . . . . 10.0 110.98 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 60' ' ' ILE . 29.6 pt . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 10.0 111.311 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 53' ' ' ILE . 22.3 pt . . . . . 0 C--O 1.234 0.275 0 CA-C-O 120.675 0.274 . . . . 10.0 111.669 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 83.0 Cg_endo -80.16 116.54 3.38 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.816 2.344 . . . . 10.0 113.362 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.579 HG22 ' C ' ' A' ' 51' ' ' GLY . 22.4 m -95.45 133.97 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.866 HG22 ' HA ' ' A' ' 49' ' ' VAL . 59.3 t -142.59 156.74 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.665 0.745 . . . . 10.0 112.832 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.874 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 80.1 m-20 -75.87 62.17 1.54 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.874 -1.057 . . . . 10.0 108.724 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.934 HD22 ' CD2' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -51.85 -20.48 2.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.74 -0.664 . . . . 10.0 111.621 -179.034 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.692 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -71.51 -30.66 66.21 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.287 -0.565 . . . . 10.0 110.133 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.874 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.58 -36.38 26.27 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.557 -0.164 . . . . 10.0 110.557 178.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 65' ' ' LEU . 9.1 tt -56.14 -40.86 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 106.402 -1.703 . . . . 10.0 106.402 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.009 HD11 HG23 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -76.81 -38.58 53.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 113.407 -1.724 . . . . 10.0 108.961 176.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.539 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 106.09 -92.12 0.78 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.607 -0.724 . . . . 10.0 113.598 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.009 HG23 HD11 ' A' ' 69' ' ' LEU . 3.4 pt 48.32 164.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 112.712 0.634 . . . . 10.0 112.712 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.543 ' HB2' ' CG ' ' A' ' 19' ' ' ASP . 29.2 m -49.16 -30.5 6.87 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.266 -0.642 . . . . 10.0 109.266 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.908 ' HB3' HG13 ' A' ' 71' ' ' ILE . 12.0 t80 -30.09 141.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.265 -0.88 . . . . 10.0 112.74 176.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -174.32 42.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.573 -0.739 . . . . 10.0 110.348 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 58.52 38.57 25.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -71.63 -42.77 67.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.846 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 96' ' ' ASP . 32.2 mmmt -146.11 23.92 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.85 0.315 . . . . 10.0 111.85 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.495 ' CE ' ' CE1' ' A' ' 73' ' ' PHE . 16.7 mmt -47.63 133.04 13.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.554 -0.294 . . . . 10.0 111.062 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -172.82 36.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.834 0.349 . . . . 10.0 111.137 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.62 ' OG ' HG23 ' A' ' 95' ' ' VAL . 92.3 p -169.11 154.07 5.83 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.637 -0.505 . . . . 10.0 109.637 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.859 HD12 ' HB2' ' A' ' 36' ' ' LYS . 51.8 mt -133.2 145.12 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.621 -0.432 . . . . 10.0 111.682 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.945 HG23 HG12 ' A' ' 33' ' ' VAL . 6.4 mt -110.21 144.6 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.483 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.99 140.09 46.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.147 0.499 . . . . 10.0 110.654 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -141.91 -175.97 4.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.992 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.48 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 6.4 ptm180 -135.55 143.1 45.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.513 ' OG1' ' HB ' ' A' ' 89' ' ' VAL . 41.6 p -158.83 109.39 2.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.876 0.37 . . . . 10.0 111.836 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 87' ' ' LYS . 36.4 ttmt 46.72 47.25 15.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.649 . . . . 10.0 110.687 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 52.8 m-20 74.49 34.07 0.8 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.939 -1.028 . . . . 10.0 111.342 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.895 HG12 HG22 ' A' ' 91' ' ' VAL . 60.1 t -130.36 110.76 19.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.419 -0.809 . . . . 10.0 109.858 177.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.692 ' HB3' HG22 ' A' ' 60' ' ' ILE . 35.6 tt0 -88.34 99.74 12.48 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 105.68 -1.97 . . . . 10.0 105.68 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.987 HG21 HD13 ' A' ' 142' ' ' ILE . 4.6 t -88.6 149.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 113.329 -1.76 . . . . 10.0 113.36 -173.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -121.56 149.56 17.22 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 113.912 -1.494 . . . . 10.0 113.071 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.934 ' CD2' HD22 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -141.83 128.49 20.33 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 120.783 0.325 . . . . 10.0 110.891 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.465 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 36.3 tp -88.64 131.38 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.108 0.48 . . . . 10.0 110.986 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.804 HG12 HD11 ' A' ' 18' ' ' ILE . 18.8 m -143.02 -175.02 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.386 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 7.9 t70 -90.94 -70.49 0.68 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.316 0.579 . . . . 10.0 111.902 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -142.14 112.91 7.34 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.175 -0.921 . . . . 10.0 108.678 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.668 ' CG1' HG21 ' A' ' 33' ' ' VAL . 7.5 p -91.35 114.42 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 122.463 1.125 . . . . 10.0 112.017 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.588 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -63.03 -29.13 70.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 112.817 -1.992 . . . . 10.0 110.969 -178.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.58 -123.59 6.99 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.595 -0.812 . . . . 10.0 111.279 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.69 133.36 16.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.061 0.431 . . . . 10.0 110.5 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.857 HD22 ' HB3' ' A' ' 15' ' ' SER . 53.6 tp -135.15 138.96 44.23 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.232 0.539 . . . . 10.0 111.234 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.699 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.1 OUTLIER -88.82 73.75 8.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.32 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.777 HD12 HG11 ' A' ' 126' ' ' VAL . 11.5 mm -88.8 133.06 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.691 -0.485 . . . . 10.0 109.691 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.6 p -88.57 146.54 25.07 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -129.26 75.2 1.63 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 114.164 1.172 . . . . 10.0 114.164 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -97.16 2.7 51.41 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.56 -1.274 . . . . 10.0 107.56 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 . . . . . 0 N--CA 1.452 -0.359 0 CA-C-N 114.621 -1.172 . . . . 10.0 110.7 -179.565 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.74 ' CE2' HD21 ' A' ' 69' ' ' LEU . 25.2 t80 . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 121.172 0.51 . . . . 10.0 110.035 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.7 -144.28 10.39 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.079 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -91.49 55.73 2.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.599 0.238 . . . . 10.0 110.667 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.516 ' NZ ' ' HB ' ' A' ' 141' ' ' ILE . 1.1 tmpt? -144.7 -44.79 0.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.915 -0.314 . . . . 10.0 111.314 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.825 ' CB ' HD22 ' A' ' 136' ' ' LEU . 47.4 t . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 119.643 -0.218 . . . . 10.0 110.428 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.91 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.7 p . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.211 0.529 . . . . 10.0 112.017 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 94.6 mttt -160.24 135.91 8.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.306 -0.861 . . . . 10.0 109.876 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 5.7 m -163.9 149.28 10.78 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.973 0.416 . . . . 10.0 111.254 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 55.24 46.64 23.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.838 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.52 34.53 49.5 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.581 -0.819 . . . . 10.0 111.797 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 128' ' ' THR . 2.5 ptp180 -136.21 135.42 39.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.824 0.345 . . . . 10.0 110.21 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.9 152.42 21.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.158 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.91 ' HB ' HG13 ' A' ' 126' ' ' VAL . 6.3 mt -151.22 129.86 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.05 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.921 ' HB ' HD13 ' A' ' 23' ' ' LEU . 6.7 mm -90.29 145.0 7.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.928 ' O ' HD23 ' A' ' 136' ' ' LEU . 38.1 t80 -133.5 136.32 45.0 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.197 0.522 . . . . 10.0 111.525 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.956 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 16.0 mt -138.17 147.5 43.92 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.66 0.743 . . . . 10.0 112.003 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.2 p-10 -105.51 26.43 9.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.703 -1.135 . . . . 10.0 108.86 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.961 HG21 ' ND2' ' A' ' 29' ' ' ASN . 12.6 tt 38.91 16.86 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 114.477 1.288 . . . . 10.0 114.477 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 137' ' ' ASP . 7.9 t0 -80.05 -62.35 1.71 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 144' ' ' GLU . 14.5 mmmm -73.7 -31.54 63.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.416 0.626 . . . . 10.0 110.451 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.902 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.96 -46.61 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.302 -0.863 . . . . 10.0 110.771 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.987 HD13 HG21 ' A' ' 91' ' ' VAL . 6.6 tp -60.92 -46.71 95.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 119.8 -0.76 . . . . 10.0 109.826 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.717 ' O ' HG12 ' A' ' 147' ' ' VAL . 96.7 mt-10 -48.87 -40.41 29.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.531 ' HA ' HG12 ' A' ' 147' ' ' VAL . 44.8 mt-10 -71.21 -39.03 72.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.182 -0.917 . . . . 10.0 110.528 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.657 ' CD1' HG11 ' A' ' 91' ' ' VAL . 34.4 mt -48.16 -43.79 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 120.797 0.332 . . . . 10.0 111.443 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.6 p -84.71 -53.47 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 143' ' ' GLU . 14.5 p -63.35 -21.45 28.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 111.718 0.266 . . . . 10.0 111.718 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HD2' ' CB ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.728 0.299 . . . . 10.0 110.832 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 37.8 tt0 -164.01 164.01 23.2 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.838 0.828 . . . . 10.0 111.295 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.611 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.3 t80 -150.85 138.62 19.83 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.964 -1.471 . . . . 10.0 112.862 -174.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 2.1 mt-10 -88.7 132.43 34.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.377 -0.828 . . . . 10.0 108.893 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.788 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.3 p -150.31 167.2 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 112.906 0.706 . . . . 10.0 112.906 -176.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 1.042 HD11 HD13 ' A' ' 82' ' ' ILE . 2.8 tm? -88.95 130.5 35.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.681 -0.859 . . . . 10.0 108.681 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.788 ' CB ' HD22 ' A' ' 102' ' ' LEU . 41.9 t -143.82 155.35 44.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.864 0.84 . . . . 10.0 112.565 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.663 ' CD2' HD11 ' A' ' 82' ' ' ILE . 2.2 p90 -150.09 163.74 37.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.181 -1.372 . . . . 10.0 110.241 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HG2' HD21 ' A' ' 99' ' ' LEU . 67.6 mm-40 -88.53 129.09 35.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.983 HG21 HD12 ' A' ' 71' ' ' ILE . 32.3 mm -122.85 87.89 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.319 -0.855 . . . . 10.0 111.259 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 41.5 m-20 51.48 60.04 4.15 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.838 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 61.7 mm-40 77.46 -32.48 0.18 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.45 -0.795 . . . . 10.0 111.708 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.495 ' NE2' HD11 ' A' ' 134' ' ' ILE . 38.6 tt0 -88.75 142.27 27.81 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.865 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.67 158.34 18.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.061 0.458 . . . . 10.0 112.086 -178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.76 HD12 ' H ' ' A' ' 24' ' ' ALA . 2.0 tp -152.28 139.62 19.47 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.123 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.76 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -141.99 144.68 33.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.426 0.528 . . . . 10.0 112.426 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.983 ' CE2' HD13 ' A' ' 65' ' ' LEU . 1.8 m-85 -119.54 138.84 52.93 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.969 -1.122 . . . . 10.0 107.969 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.66 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 26.4 t70 -51.57 123.52 10.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.01 0.433 . . . . 10.0 111.26 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.788 HG13 ' HA ' ' A' ' 13' ' ' VAL . 12.7 m -64.29 -10.53 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.705 -0.679 . . . . 10.0 112.106 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.66 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 53.6 m-20 -69.37 -38.94 78.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.007 -0.677 . . . . 10.0 109.454 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.901 HD21 HG22 ' A' ' 86' ' ' THR . 12.6 t-20 -89.86 -44.83 9.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.234 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.694 HG21 ' HG ' ' A' ' 14' ' ' LEU . 25.4 mm -65.41 129.24 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.091 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' OE2' HG12 ' A' ' 83' ' ' VAL . 14.8 pt-20 -95.55 -50.99 4.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.054 0.39 . . . . 10.0 112.054 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.7 mtm -168.99 155.07 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.185 0.516 . . . . 10.0 112.017 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.772 HG11 HG11 ' A' ' 98' ' ' VAL . 35.2 m -89.03 155.89 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.498 -0.774 . . . . 10.0 111.28 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 22.8 pt -150.44 138.58 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.046 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 22.7 pt-20 -104.65 110.96 23.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.693 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.182 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.464 HG11 ' CB ' ' A' ' 61' ' ' PRO . 57.4 t . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 121.007 0.432 . . . . 10.0 111.069 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -79.49 -34.94 40.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.857 -0.611 . . . . 10.0 111.31 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.669 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -151.6 -175.74 23.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.933 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.2 169.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.82 HD11 HD11 ' A' ' 60' ' ' ILE . 27.6 pt . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 10.0 111.052 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.883 HG22 ' HB2' ' A' ' 90' ' ' GLU . 18.7 pt . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.602 0.239 . . . . 10.0 111.494 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 80.7 Cg_endo -77.19 121.98 5.97 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.631 2.22 . . . . 10.0 112.601 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.669 HG22 ' C ' ' A' ' 51' ' ' GLY . 34.2 m -88.92 129.67 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.687 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.915 HG12 ' H ' ' A' ' 64' ' ' ASN . 3.2 t -113.5 -175.81 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.595 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.915 ' H ' HG12 ' A' ' 63' ' ' VAL . 11.7 p-10 -133.7 70.18 1.46 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.358 0.599 . . . . 10.0 110.709 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.983 HD13 ' CE2' ' A' ' 25' ' ' PHE . 5.6 tt -53.76 -37.59 63.56 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.821 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.824 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -50.57 -29.16 10.09 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.338 -0.545 . . . . 10.0 109.876 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.585 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -82.64 -43.59 16.77 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.617 -0.719 . . . . 10.0 110.631 178.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.0 tt -61.03 -37.58 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 122.096 0.951 . . . . 10.0 108.646 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.877 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -81.83 -53.95 5.76 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.713 -1.585 . . . . 10.0 109.219 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.488 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 119.09 -77.81 0.3 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.383 -0.826 . . . . 10.0 112.136 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.983 HD12 HG21 ' A' ' 18' ' ' ILE . 3.8 pt 44.69 177.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 113.122 0.786 . . . . 10.0 113.122 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.416 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 41.1 t -54.87 -38.37 67.42 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.806 ' HB3' HG13 ' A' ' 71' ' ' ILE . 5.9 t80 -24.6 140.66 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.635 -1.166 . . . . 10.0 113.571 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -172.71 37.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.321 -0.854 . . . . 10.0 110.095 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 54.33 35.11 22.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.884 -0.598 . . . . 10.0 111.304 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HB2' ' HZ3' ' A' ' 77' ' ' LYS . 98.3 mm-40 -81.03 -61.36 1.98 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.398 -0.364 . . . . 10.0 111.652 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 78' ' ' MET . 2.3 mppt? -103.14 -25.37 13.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.429 -0.35 . . . . 10.0 111.847 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 20.0 mmt -17.9 136.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -170.19 -34.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.771 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.81 ' O ' HD12 ' A' ' 94' ' ' LEU . 47.7 t -88.85 -176.02 5.07 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.832 0.349 . . . . 10.0 111.444 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 45.7 mt -152.37 158.34 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.897 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.042 HD13 HD11 ' A' ' 14' ' ' LEU . 12.3 mt -133.05 139.98 48.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.774 0.321 . . . . 10.0 111.052 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.465 HG12 ' OE2' ' A' ' 31' ' ' GLU . 44.4 t -109.17 152.68 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.066 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.47 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -155.37 169.71 23.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.364 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -128.04 132.72 49.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.901 HG22 HD21 ' A' ' 29' ' ' ASN . 57.6 p -148.3 109.19 4.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.817 0.303 . . . . 10.0 111.817 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 87' ' ' LYS . 22.3 ttmm 49.49 60.21 3.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.147 0.499 . . . . 10.0 110.282 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 87' ' ' LYS . 7.4 p-10 55.1 32.68 18.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.036 -0.984 . . . . 10.0 111.551 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 91' ' ' VAL . 70.7 t -125.62 109.34 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 115.16 -0.927 . . . . 10.0 108.732 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.883 ' HB2' HG22 ' A' ' 60' ' ' ILE . 28.5 mt-10 -88.46 94.59 9.91 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.871 -1.529 . . . . 10.0 106.871 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.03 HG21 HD13 ' A' ' 142' ' ' ILE . 3.1 t -88.57 155.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 113.035 -1.893 . . . . 10.0 112.856 -174.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.32 165.93 21.81 Favored Glycine 0 C--N 1.314 -0.693 0 CA-C-N 114.679 -1.146 . . . . 10.0 112.468 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.551 ' HE2' ' CZ ' ' A' ' 16' ' ' PHE . 2.6 t80 -151.62 133.61 15.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 10.0 110.839 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.81 HD12 ' O ' ' A' ' 80' ' ' SER . 67.3 tp -88.72 126.27 35.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.238 0.542 . . . . 10.0 111.898 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.529 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 15.4 m -135.61 -175.27 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.02 178.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -100.37 -60.04 1.6 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.203 0.525 . . . . 10.0 111.656 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.598 HH12 HD13 ' A' ' 99' ' ' LEU . 57.1 ttt-85 -144.46 117.08 8.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.382 -0.826 . . . . 10.0 108.891 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.772 HG11 HG11 ' A' ' 33' ' ' VAL . 7.5 p -101.08 118.22 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 122.336 1.065 . . . . 10.0 112.482 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.598 HD13 HH12 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -66.03 -29.22 69.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.219 -1.81 . . . . 10.0 110.674 -179.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.16 -125.05 7.61 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.485 -0.78 . . . . 10.0 111.425 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 m -52.33 131.13 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.944 0.372 . . . . 10.0 110.513 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.788 HD22 ' CB ' ' A' ' 15' ' ' SER . 56.6 tp -135.2 141.46 45.85 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.151 0.5 . . . . 10.0 111.258 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 103' ' ' ARG . 16.2 ptm180 -88.81 70.55 8.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.049 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.757 ' CG1' HG11 ' A' ' 13' ' ' VAL . 17.2 mm -88.65 136.76 22.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 107.922 -1.14 . . . . 10.0 107.922 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 37.9 p -88.65 -175.88 5.07 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.42 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 38.2 tt0 -149.6 77.06 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.06 -1.056 . . . . 10.0 113.393 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -111.69 22.17 15.28 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.255 -1.339 . . . . 10.0 107.519 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.42 ' NE2' ' HA ' ' A' ' 106' ' ' GLU . 3.3 pm0 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-N 114.902 -1.044 . . . . 10.0 111.628 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.594 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 26.6 t80 . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.833 0.349 . . . . 10.0 110.91 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.61 -36.64 0.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.56 -0.828 . . . . 10.0 112.941 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.47 ' NZ ' ' HB2' ' A' ' 120' ' ' LYS . 0.1 OUTLIER 176.33 124.98 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 2.7 tppp? 73.28 117.87 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.495 -0.775 . . . . 10.0 110.541 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.867 ' OG ' HD23 ' A' ' 69' ' ' LEU . 1.8 p . . . . . 0 CA--C 1.516 -0.345 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 133' ' ' ILE . 1.1 p . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 121.35 0.595 . . . . 10.0 111.593 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.505 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 87.0 tttt -164.77 135.81 4.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 10.0 110.284 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 8.5 m -161.76 150.52 15.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 120.976 0.417 . . . . 10.0 111.013 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 9.8 t70 55.18 48.02 20.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.442 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.3 35.03 34.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.664 -0.779 . . . . 10.0 111.977 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.618 HH12 ' HB2' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -137.33 133.14 34.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.703 0.287 . . . . 10.0 110.273 -179.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.654 HD12 ' N ' ' A' ' 132' ' ' LEU . 3.7 mp -88.93 139.08 30.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.892 0.377 . . . . 10.0 111.316 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.865 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.1 mt -145.36 136.7 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 10.0 110.621 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.717 ' CG2' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -95.87 132.92 38.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.597 ' CE1' HG21 ' A' ' 13' ' ' VAL . 12.7 t80 -120.43 144.69 47.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.229 0.538 . . . . 10.0 110.421 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.885 ' HG ' HD11 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -151.88 131.81 13.37 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.52 -0.764 . . . . 10.0 111.234 -177.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.708 ' N ' HD22 ' A' ' 136' ' ' LEU . 12.2 p-10 -95.05 34.74 1.34 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.218 0.532 . . . . 10.0 111.296 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.849 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.6 tt 38.4 19.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.375 1.25 . . . . 10.0 114.375 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 137' ' ' ASP . 64.3 t0 -77.29 -57.11 4.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.274 0.842 . . . . 10.0 113.274 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 121' ' ' LYS . 34.5 mmtp -76.08 -28.93 57.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.318 0.58 . . . . 10.0 111.248 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.849 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.76 -45.99 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.438 -0.801 . . . . 10.0 110.878 -179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.03 HD13 HG21 ' A' ' 91' ' ' VAL . 8.9 tp -67.34 -47.65 80.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 120.252 -0.579 . . . . 10.0 111.212 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.892 ' O ' HG12 ' A' ' 147' ' ' VAL . 48.5 mt-10 -50.33 -42.54 53.06 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.392 -0.595 . . . . 10.0 109.392 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' A' ' 68' ' ' ILE . 57.4 mm-40 -75.17 -27.24 59.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.123 -0.944 . . . . 10.0 111.04 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 142' ' ' ILE . 23.5 mt -55.41 -43.1 70.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.907 0.384 . . . . 10.0 110.72 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.4 p -86.33 -52.51 5.58 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.571 0.582 . . . . 10.0 112.571 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 143' ' ' GLU . 7.2 p -84.78 13.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.85 0.685 . . . . 10.0 112.85 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 120.712 0.292 . . . . 10.0 111.769 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.777 0.322 . . . . 10.0 111.075 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.41 ' HG2' HG22 ' A' ' 105' ' ' THR . 93.9 mt-10 -152.26 164.3 37.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.969 0.89 . . . . 10.0 111.842 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CE2' ' OH ' ' A' ' 135' ' ' TYR . 35.0 t80 -117.0 127.94 54.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.794 -1.548 . . . . 10.0 113.802 -175.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -89.02 126.2 35.32 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.649 -1.611 . . . . 10.0 106.649 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.973 HG11 ' CG1' ' A' ' 104' ' ' ILE . 4.2 p -151.83 167.74 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 114.476 1.287 . . . . 10.0 114.476 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.76 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.4 tm? -88.9 137.93 31.87 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 107.91 -1.144 . . . . 10.0 107.91 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.779 ' CB ' HD22 ' A' ' 102' ' ' LEU . 57.0 p -149.29 158.99 44.64 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.203 0.816 . . . . 10.0 113.203 -177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.696 ' CD2' HD11 ' A' ' 82' ' ' ILE . 6.9 p90 -152.3 165.92 33.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.217 -1.356 . . . . 10.0 110.42 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.6 137.25 32.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 10.0 109.715 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.975 HG21 HD12 ' A' ' 71' ' ' ILE . 28.4 mm -134.37 92.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.164 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.494 ' OD2' ' HA ' ' A' ' 73' ' ' PHE . 41.6 m-20 44.74 60.25 3.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.64 . . . . 10.0 112.701 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 45.9 mt-10 85.17 -42.59 0.06 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.282 -0.872 . . . . 10.0 111.879 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.1 pt20 -88.95 145.72 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.021 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.49 166.81 13.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.908 0.385 . . . . 10.0 110.785 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.8 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.5 tp -149.43 139.33 21.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.505 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.775 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -142.58 146.66 34.8 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.489 0.922 . . . . 10.0 113.489 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.874 ' CE2' HD21 ' A' ' 136' ' ' LEU . 1.6 m-85 -124.24 143.51 50.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.224 -0.898 . . . . 10.0 108.615 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -53.69 123.23 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.05 -0.352 . . . . 10.0 110.05 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.905 HG13 ' HA ' ' A' ' 13' ' ' VAL . 27.4 m -58.04 -14.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.567 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -62.64 -43.59 98.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.061 0.458 . . . . 10.0 110.204 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.842 ' ND2' HG21 ' A' ' 138' ' ' ILE . 14.9 t30 -84.7 -47.02 10.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.675 -0.693 . . . . 10.0 111.164 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.76 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.8 mm -61.03 132.28 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.217 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.442 ' HB3' ' CE ' ' A' ' 32' ' ' MET . 43.9 mt-10 -94.91 -60.4 1.7 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.376 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.442 ' CE ' ' HB3' ' A' ' 31' ' ' GLU . 1.2 pmm? -169.01 156.55 7.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.367 -0.379 . . . . 10.0 111.003 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.818 HG11 HG11 ' A' ' 98' ' ' VAL . 35.3 m -88.84 144.58 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 10.0 111.791 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.492 HG12 HG23 ' A' ' 83' ' ' VAL . 31.6 pt -137.89 136.81 45.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.593 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -88.95 120.82 30.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 10.0 110.68 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.979 ' HB2' HD12 ' A' ' 81' ' ' ILE . 62.0 mttp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.804 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.941 ' HA ' HG22 ' A' ' 63' ' ' VAL . 44.6 t . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.03 0.443 . . . . 10.0 111.58 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.43 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 24.2 mm-40 -88.34 -40.9 13.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.772 -0.649 . . . . 10.0 110.601 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 62' ' ' VAL . . . -135.22 160.9 24.54 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.345 -0.931 . . . . 10.0 113.747 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 61' ' ' PRO . 2.6 m -159.81 169.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.501 HG12 HD11 ' A' ' 60' ' ' ILE . 31.6 pt . . . . . 0 C--N 1.324 -0.534 0 CA-C-O 120.862 0.363 . . . . 10.0 111.073 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.813 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.1 pp . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.55 -0.167 . . . . 10.0 110.55 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 92.8 Cg_endo -99.57 121.82 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.068 2.512 . . . . 10.0 113.864 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 51' ' ' GLY . 19.5 m -103.52 127.57 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.844 -0.798 . . . . 10.0 108.844 177.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.941 HG22 ' HA ' ' A' ' 49' ' ' VAL . 47.3 t -139.59 160.36 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.851 0.834 . . . . 10.0 113.204 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.567 ' N ' HG12 ' A' ' 63' ' ' VAL . 4.3 m120 -75.96 73.39 2.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.591 -1.186 . . . . 10.0 108.667 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.911 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.3 tt -52.87 -38.53 61.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.293 0.568 . . . . 10.0 111.397 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.028 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -59.9 -18.5 45.29 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.193 -0.603 . . . . 10.0 110.03 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.534 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.1 tmmm? -85.41 -46.9 10.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.017 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.911 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.4 tt -53.86 -35.21 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 107.611 -1.255 . . . . 10.0 107.611 178.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.868 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -86.1 -56.08 3.63 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.08 -1.873 . . . . 10.0 109.82 178.263 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . 121.92 -81.47 0.34 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.307 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.028 HD11 ' CB ' ' A' ' 66' ' ' ALA . 2.9 pt 45.11 179.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.698 0.629 . . . . 10.0 112.698 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 45.7 t -54.75 -39.08 67.94 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.151 -0.685 . . . . 10.0 109.151 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.78 ' HB3' HG13 ' A' ' 71' ' ' ILE . 14.8 t80 -32.4 143.69 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.784 -1.098 . . . . 10.0 112.896 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -166.77 37.4 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.532 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 55.28 38.76 30.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.776 -0.647 . . . . 10.0 111.22 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.442 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 17.7 pt20 -94.01 -50.51 5.28 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.262 0.467 . . . . 10.0 112.262 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 12.4 mptt -111.16 -25.01 9.95 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.559 ' HE2' ' HD1' ' A' ' 73' ' ' PHE . 16.9 mmt -36.72 143.77 0.07 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.758 0.651 . . . . 10.0 112.758 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 53.6 mtmt -159.53 -41.38 0.05 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.91 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.963 ' O ' HD12 ' A' ' 94' ' ' LEU . 46.8 t -88.78 -175.99 5.08 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.913 0.387 . . . . 10.0 111.551 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.979 HD12 ' HB2' ' A' ' 36' ' ' LYS . 77.4 mt -146.55 154.22 12.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.328 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.696 HD11 ' CD2' ' A' ' 16' ' ' PHE . 10.8 mt -120.63 143.9 31.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.739 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 34' ' ' ILE . 72.1 t -111.41 149.85 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.974 0.416 . . . . 10.0 110.892 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -153.57 174.33 14.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 10.0 111.001 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 6.3 ptm180 -135.71 132.11 36.47 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.737 HG22 ' OD1' ' A' ' 29' ' ' ASN . 59.0 p -145.51 109.54 4.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.962 0.41 . . . . 10.0 111.922 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 14.7 tppt? 47.53 49.74 15.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.328 0.585 . . . . 10.0 110.851 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.05 31.57 1.45 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.066 -0.97 . . . . 10.0 111.519 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.93 HG12 HG22 ' A' ' 91' ' ' VAL . 67.6 t -128.33 108.56 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.23 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.7 ' HB2' HG22 ' A' ' 60' ' ' ILE . 6.4 mp0 -88.4 98.47 11.64 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.198 -1.779 . . . . 10.0 106.198 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.005 HG21 HD13 ' A' ' 142' ' ' ILE . 3.0 t -88.7 157.2 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 113.089 -1.869 . . . . 10.0 112.711 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -140.25 151.21 22.08 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 114.895 -1.048 . . . . 10.0 113.258 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.602 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.1 t80 -140.77 134.39 30.16 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.93 0.395 . . . . 10.0 111.003 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.963 HD12 ' O ' ' A' ' 80' ' ' SER . 31.7 tp -88.61 115.5 26.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 10.0 111.46 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.528 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 12.8 m -122.43 -175.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.933 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -100.15 -59.98 1.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.174 0.512 . . . . 10.0 111.825 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -141.26 113.37 7.94 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.547 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.818 HG11 HG11 ' A' ' 33' ' ' VAL . 9.5 p -99.79 111.28 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 122.461 1.124 . . . . 10.0 111.168 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -62.72 -28.51 70.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.909 -1.95 . . . . 10.0 111.161 -178.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.92 -122.73 6.52 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.964 -0.854 . . . . 10.0 110.964 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -53.94 131.82 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 117.06 0.43 . . . . 10.0 110.229 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.779 HD22 ' CB ' ' A' ' 15' ' ' SER . 19.4 tp -137.07 142.94 42.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 10.0 111.257 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.1 ptp85 -88.85 79.82 7.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.529 -0.76 . . . . 10.0 111.295 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.973 ' CG1' HG11 ' A' ' 13' ' ' VAL . 11.6 mm -88.76 178.78 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 104' ' ' ILE . 22.1 p -134.96 -175.85 4.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.774 -0.824 . . . . 10.0 108.774 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 35.5 tt0 -136.71 79.04 1.74 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.934 0.873 . . . . 10.0 112.516 -178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -119.89 22.29 11.58 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.23 -1.35 . . . . 10.0 107.522 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.466 0.36 0 CA-C-N 114.997 -1.001 . . . . 10.0 113.606 -178.258 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.855 ' CE1' HD21 ' A' ' 69' ' ' LEU . 20.2 t80 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.584 0.23 . . . . 10.0 111.494 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.0 -43.69 1.48 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.488 -0.863 . . . . 10.0 112.202 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -156.66 38.22 0.32 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.667 0.27 . . . . 10.0 111.013 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . 39.9 ttmt -157.06 -112.94 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.446 -0.343 . . . . 10.0 110.594 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 74.4 m . . . . . 0 CA--C 1.506 -0.714 0 N-CA-C 112.765 0.654 . . . . 10.0 112.765 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.652 HG21 HD12 ' A' ' 104' ' ' ILE . 1.1 p . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 131' ' ' ARG . 8.1 ptpp? -154.77 143.9 21.07 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.132 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 23.8 m -152.61 140.02 19.6 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.578 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 p30 45.28 48.39 10.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.045 0.45 . . . . 10.0 111.219 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.42 97.15 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.647 -0.787 . . . . 10.0 111.773 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.7 ptp180 -130.08 136.94 49.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.653 0.263 . . . . 10.0 110.581 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 132' ' ' LEU . 3.7 mp -88.9 138.56 31.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.661 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.021 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.5 mt -156.92 144.64 10.84 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-N 116.465 -0.334 . . . . 10.0 111.741 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.8 ' HB ' HD13 ' A' ' 23' ' ' LEU . 2.2 mp -99.69 146.82 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.542 ' CE1' HG21 ' A' ' 13' ' ' VAL . 56.5 t80 -141.36 151.22 43.36 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.494 -0.482 . . . . 10.0 110.98 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.874 HD21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -169.09 150.64 4.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.146 0.795 . . . . 10.0 113.146 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -95.26 32.74 1.67 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.885 -1.052 . . . . 10.0 110.127 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.842 HG21 ' ND2' ' A' ' 29' ' ' ASN . 10.1 tt 38.69 23.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 114.836 -1.075 . . . . 10.0 113.683 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -75.79 -58.28 3.38 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.545 0.943 . . . . 10.0 113.545 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 140' ' ' LYS . 7.2 mmpt? -78.23 -31.94 49.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.042 0.448 . . . . 10.0 110.698 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.832 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -65.17 -45.25 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.04 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.005 HD13 HG21 ' A' ' 91' ' ' VAL . 7.7 tp -65.49 -46.61 89.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.506 -0.478 . . . . 10.0 110.861 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 142' ' ' ILE . 47.3 mt-10 -48.46 -40.82 27.63 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.993 0.425 . . . . 10.0 110.159 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.572 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.1 mt-10 -68.67 -36.85 79.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.69 -0.686 . . . . 10.0 110.11 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.668 HD12 HD12 ' A' ' 142' ' ' ILE . 35.4 mt -53.62 -41.43 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.151 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.8 p -76.56 -49.93 15.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.785 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.7 p -75.33 1.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 112.082 0.401 . . . . 10.0 112.082 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.873 0.368 . . . . 10.0 111.274 -179.645 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.55 ' O ' HG22 ' A' ' 105' ' ' THR . 18.1 ttpt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.795 0.331 . . . . 10.0 111.419 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 42.6 tt0 -160.21 164.1 33.05 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.691 0.758 . . . . 10.0 111.464 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.569 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 14.6 t80 -158.55 138.91 12.47 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 114.26 -1.336 . . . . 10.0 112.527 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 29.2 mt-10 -88.62 139.47 30.44 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.938 -0.574 . . . . 10.0 109.527 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.921 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -155.47 167.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.752 1.019 . . . . 10.0 113.752 -175.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.592 HD13 ' C ' ' A' ' 14' ' ' LEU . 1.7 tm? -89.19 127.83 35.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.231 -0.895 . . . . 10.0 108.677 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.817 ' CB ' HD22 ' A' ' 102' ' ' LEU . 39.1 t -143.8 156.13 44.38 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.839 0.828 . . . . 10.0 113.131 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.696 ' HD2' HG23 ' A' ' 98' ' ' VAL . 1.3 p90 -146.53 160.05 42.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.851 -1.522 . . . . 10.0 109.917 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HG3' HD21 ' A' ' 99' ' ' LEU . 56.7 mt-10 -88.74 107.2 18.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.469 0.652 . . . . 10.0 110.066 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.75 HG21 HD12 ' A' ' 71' ' ' ILE . 30.6 mm -88.96 90.65 3.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.843 -1.071 . . . . 10.0 111.714 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 9.5 p-10 36.46 60.38 0.9 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.857 -1.065 . . . . 10.0 113.498 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 47.2 mt-10 100.07 -52.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.668 -1.151 . . . . 10.0 111.685 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.578 ' NE2' HD11 ' A' ' 134' ' ' ILE . 14.1 pt20 -89.04 150.17 22.9 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.024 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.76 170.44 10.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.016 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.2 tp -159.06 136.84 10.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.597 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.757 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -141.42 152.76 44.56 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.481 0.549 . . . . 10.0 112.481 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.951 ' CE2' HD22 ' A' ' 136' ' ' LEU . 4.9 m-85 -130.04 138.94 51.03 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.293 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -47.49 122.33 4.66 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.899 0.381 . . . . 10.0 110.982 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.921 HG13 ' HA ' ' A' ' 13' ' ' VAL . 27.4 m -61.91 -12.79 8.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.073 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.87 -42.51 97.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.96 0.41 . . . . 10.0 110.161 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.96 ' ND2' HG21 ' A' ' 138' ' ' ILE . 11.7 t30 -90.06 -47.24 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.895 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.582 HG21 ' HG ' ' A' ' 14' ' ' LEU . 19.7 mm -58.87 128.81 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.004 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' O ' ' CE ' ' A' ' 32' ' ' MET . 54.4 mt-10 -82.66 -65.4 1.02 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.077 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.414 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.7 tpp -169.08 173.71 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 10.0 111.322 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.573 ' CG1' HG11 ' A' ' 98' ' ' VAL . 35.3 m -89.01 150.99 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.488 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.574 HD13 ' CG2' ' A' ' 83' ' ' VAL . 12.7 pt -142.35 121.64 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.647 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.03 118.74 28.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 10.0 109.51 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.814 ' HB3' HD12 ' A' ' 81' ' ' ILE . 23.3 tptm . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.027 0.442 . . . . 10.0 111.026 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.9 ' HA ' HG22 ' A' ' 63' ' ' VAL . 46.8 t . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.016 0.436 . . . . 10.0 111.869 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 16.9 pt-20 -79.79 -37.39 35.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.418 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.616 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -161.02 -175.93 32.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.053 -0.594 . . . . 10.0 112.234 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 61' ' ' PRO . 3.5 m -158.46 175.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 110.163 -0.31 . . . . 10.0 110.163 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.027 HD11 HD11 ' A' ' 60' ' ' ILE . 24.3 pt . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.64 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.027 HD11 HD11 ' A' ' 53' ' ' ILE . 28.5 pt . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.507 0.194 . . . . 10.0 110.974 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 86.3 Cg_endo -81.89 119.65 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.402 2.068 . . . . 10.0 113.252 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.616 HG22 ' C ' ' A' ' 51' ' ' GLY . 27.7 m -98.49 137.25 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.312 -0.625 . . . . 10.0 109.312 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.9 HG22 ' HA ' ' A' ' 49' ' ' VAL . 96.6 t -143.0 156.09 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.717 0.77 . . . . 10.0 112.744 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.788 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 76.1 m-20 -73.74 66.09 1.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.704 -1.135 . . . . 10.0 108.33 177.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.94 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.6 tt -49.32 -28.33 4.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.921 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.694 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -61.89 -29.81 70.45 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.821 -0.351 . . . . 10.0 110.953 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.788 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -87.31 -36.94 17.58 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 110.423 -0.214 . . . . 10.0 110.423 178.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.758 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 8.1 tt -61.16 -41.04 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 106.623 -1.621 . . . . 10.0 106.623 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.843 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -76.05 -38.66 56.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 113.407 -1.724 . . . . 10.0 107.972 176.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 69' ' ' LEU . . . 70.06 120.82 0.04 OUTLIER Glycine 0 C--N 1.335 0.492 0 CA-C-N 114.827 -1.079 . . . . 10.0 113.154 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.791 HG23 ' CD1' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -160.57 -167.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.332 0.653 . . . . 10.0 109.546 -179.146 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.419 ' CB ' ' OD2' ' A' ' 19' ' ' ASP . 29.2 t -53.16 -34.41 56.71 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.694 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 6.0 t80 -28.57 138.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.608 -1.178 . . . . 10.0 112.95 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 9.2 t70 -160.58 35.66 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.581 -0.736 . . . . 10.0 109.986 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.95 40.01 3.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.502 -0.772 . . . . 10.0 112.194 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 21.0 mt-30 -95.98 -49.55 5.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.606 0.241 . . . . 10.0 111.29 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 76' ' ' GLN . 2.3 mppt? -98.09 -31.76 11.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.506 -0.316 . . . . 10.0 111.629 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.598 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 21.7 mmt -27.01 141.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt 178.62 50.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.79 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.923 ' O ' HD12 ' A' ' 94' ' ' LEU . 80.0 p -169.03 155.34 6.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.795 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.814 HD12 ' HB3' ' A' ' 36' ' ' LYS . 61.0 mt -126.88 142.22 43.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.781 -0.367 . . . . 10.0 111.595 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 4.5 mt -119.42 143.72 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.642 -0.253 . . . . 10.0 110.556 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.574 ' CG2' HD13 ' A' ' 34' ' ' ILE . 79.9 t -113.62 152.46 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.231 0.539 . . . . 10.0 111.328 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -155.93 173.73 16.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.449 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 6.7 ptm180 -130.4 146.7 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.566 -0.531 . . . . 10.0 109.566 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.486 HG21 HG12 ' A' ' 138' ' ' ILE . 41.1 p -160.47 108.55 1.62 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 87' ' ' LYS . 36.7 ttmt 46.27 48.76 13.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.386 0.613 . . . . 10.0 110.892 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 72.84 33.67 1.24 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.56 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.887 HG12 HG22 ' A' ' 91' ' ' VAL . 53.8 t -131.75 110.84 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 115.268 -0.878 . . . . 10.0 109.122 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.788 ' HB2' HG22 ' A' ' 60' ' ' ILE . 1.5 mp0 -88.38 97.81 11.26 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.341 -1.726 . . . . 10.0 106.341 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.014 HG21 HD13 ' A' ' 142' ' ' ILE . 3.4 t -88.55 153.18 3.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 113.367 -1.742 . . . . 10.0 112.474 -174.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -130.47 152.95 19.97 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 114.861 -1.063 . . . . 10.0 113.499 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.639 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -139.94 128.03 22.31 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.906 0.384 . . . . 10.0 110.898 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.923 HD12 ' O ' ' A' ' 80' ' ' SER . 50.8 tp -88.57 128.17 35.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.943 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.658 HG11 ' CE1' ' A' ' 16' ' ' PHE . 19.7 m -136.74 -175.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.971 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -96.88 -65.35 0.97 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.131 0.491 . . . . 10.0 112.188 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.1 tpt85 -135.81 119.25 16.87 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.529 -0.76 . . . . 10.0 109.144 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.696 HG23 ' HD2' ' A' ' 16' ' ' PHE . 8.6 p -106.29 112.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 122.5 1.143 . . . . 10.0 112.045 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -66.2 -27.93 68.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.825 -1.989 . . . . 10.0 111.305 -178.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.62 -122.15 6.13 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.526 -0.845 . . . . 10.0 111.327 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.0 t -52.49 134.4 14.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.868 0.334 . . . . 10.0 110.569 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.817 HD22 ' CB ' ' A' ' 15' ' ' SER . 57.7 tp -140.27 141.07 35.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.076 0.465 . . . . 10.0 111.219 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.7 ptp180 -88.92 73.08 8.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.521 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.099 HD12 HG11 ' A' ' 126' ' ' VAL . 17.6 mm -88.59 131.8 35.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 109.892 -0.41 . . . . 10.0 109.892 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 22.8 p -88.83 151.1 22.58 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 20.4 tt0 -124.49 73.89 1.29 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.123 0.964 . . . . 10.0 112.99 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.425 ' N ' ' OE1' ' A' ' 108' ' ' GLN . 5.7 m120 -113.65 15.67 18.8 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.844 -1.525 . . . . 10.0 107.403 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.45 ' OE1' ' N ' ' A' ' 108' ' ' GLN . 6.6 pm0 . . . . . 0 CA--C 1.519 -0.237 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.205 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.439 ' CE2' HD21 ' A' ' 69' ' ' LEU . 21.7 t80 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 121.072 0.463 . . . . 10.0 110.241 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 120' ' ' LYS . . . 148.91 -64.66 0.4 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.753 -0.658 . . . . 10.0 112.374 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 119' ' ' GLY . 67.7 mttm -163.61 53.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.673 0.273 . . . . 10.0 110.508 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -151.23 -43.34 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.879 0.326 . . . . 10.0 111.879 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.608 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 89.2 p . . . . . 0 CA--C 1.534 0.363 0 C-N-CA 121.245 -0.182 . . . . 10.0 111.312 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 1.099 HG11 HD12 ' A' ' 104' ' ' ILE . 1.5 p . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 121.389 0.614 . . . . 10.0 112.29 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 87.1 tttt -164.49 134.25 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.08 -0.964 . . . . 10.0 109.786 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 4.6 m -162.7 151.54 14.85 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 120.924 0.392 . . . . 10.0 111.12 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.42 45.8 21.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.979 0.419 . . . . 10.0 110.746 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.41 33.59 47.18 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.665 -0.778 . . . . 10.0 111.83 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 128' ' ' THR . 12.7 ptt180 -134.93 130.53 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.184 -0.302 . . . . 10.0 110.184 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 133' ' ' ILE . 2.8 tm? -88.87 135.23 33.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.852 0.358 . . . . 10.0 110.736 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.024 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.2 mt -130.8 130.75 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.345 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 1.016 ' HB ' HD13 ' A' ' 23' ' ' LEU . 5.1 mm -88.87 147.45 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.975 -1.12 . . . . 10.0 107.975 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.606 ' C ' HD12 ' A' ' 136' ' ' LEU . 32.9 t80 -137.02 141.39 42.5 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.71 -0.796 . . . . 10.0 111.671 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.951 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.7 mp -133.32 172.99 11.94 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.067 0.936 . . . . 10.0 112.679 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.37 24.94 2.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.935 -1.484 . . . . 10.0 108.336 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.96 HG21 ' ND2' ' A' ' 29' ' ' ASN . 10.3 tt 40.38 19.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.267 -1.333 . . . . 10.0 114.259 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 142' ' ' ILE . 9.1 t0 -82.64 -62.7 1.54 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -75.03 -29.81 60.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.447 0.642 . . . . 10.0 110.073 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.916 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.78 -46.36 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 115.097 -0.956 . . . . 10.0 110.723 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.014 HD13 HG21 ' A' ' 91' ' ' VAL . 7.6 tp -61.22 -44.56 98.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 119.911 -0.716 . . . . 10.0 109.595 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.87 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.4 tt0 -49.42 -47.52 47.98 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.829 -0.623 . . . . 10.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.593 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.5 mm-40 -66.13 -37.36 85.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.477 -0.783 . . . . 10.0 110.948 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.661 ' CD1' HG11 ' A' ' 91' ' ' VAL . 60.0 mt -51.4 -43.24 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 120.886 0.374 . . . . 10.0 111.208 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.9 p -87.61 -49.43 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.684 0.624 . . . . 10.0 112.684 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.87 HG12 ' O ' ' A' ' 143' ' ' GLU . 7.2 p -82.85 13.03 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.935 0.717 . . . . 10.0 112.935 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.575 ' HA ' ' HE3' ' A' ' 148' ' ' LYS . 2.0 tpmt? . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 120.708 -0.397 . . . . 10.0 111.131 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HD2' ' C ' ' A' ' 9' ' ' LYS . 3.4 tmmm? . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.028 0.442 . . . . 10.0 110.23 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 44.1 tt0 -141.37 163.46 32.89 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.392 0.615 . . . . 10.0 110.8 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.553 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.9 t80 -162.36 138.9 7.79 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.804 -1.089 . . . . 10.0 111.959 -174.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.422 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -88.68 141.22 28.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.891 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -157.43 171.32 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 113.817 1.043 . . . . 10.0 113.817 -176.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 1.08 HD11 HD13 ' A' ' 82' ' ' ILE . 3.1 tm? -88.72 136.03 33.21 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.942 ' HB3' HD22 ' A' ' 102' ' ' LEU . 55.5 p -151.42 156.49 40.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.8 0.81 . . . . 10.0 113.119 -177.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.729 ' CD2' HD11 ' A' ' 82' ' ' ILE . 7.7 p90 -149.67 166.54 29.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.198 -1.365 . . . . 10.0 110.06 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -88.59 140.33 29.56 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.215 -0.661 . . . . 10.0 109.215 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.015 HG21 HD12 ' A' ' 71' ' ' ILE . 35.8 mm -138.8 86.03 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.63 -0.714 . . . . 10.0 111.889 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 0.8 OUTLIER 51.48 60.03 4.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.808 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 48.4 mt-10 78.56 -35.15 0.18 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.465 -0.788 . . . . 10.0 111.09 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 134' ' ' ILE . 25.5 tt0 -88.82 139.31 30.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.078 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.75 163.87 15.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 10.0 111.118 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.894 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.0 OUTLIER -147.01 138.23 24.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.559 . . . . 10.0 111.133 -178.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -138.94 155.28 48.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.993 ' CE2' HD22 ' A' ' 136' ' ' LEU . 3.8 m-85 -138.44 138.67 38.38 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.995 -1.002 . . . . 10.0 108.926 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -51.35 121.57 6.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.948 0.404 . . . . 10.0 110.379 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.891 HG13 ' HA ' ' A' ' 13' ' ' VAL . 32.2 m -61.37 -11.9 5.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 10.0 111.175 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.99 -41.33 96.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 10.0 110.41 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.989 ' ND2' HG21 ' A' ' 138' ' ' ILE . 12.1 t30 -92.51 -46.68 7.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.35 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.838 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.7 mm -57.67 127.11 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.896 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' CE ' ' A' ' 32' ' ' MET . 54.2 mt-10 -82.93 -63.6 1.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.948 0.351 . . . . 10.0 111.948 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.418 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.8 tpp -169.08 173.91 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.979 0.418 . . . . 10.0 111.381 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.527 ' CG1' HG11 ' A' ' 98' ' ' VAL . 34.8 m -95.61 156.36 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.725 -0.67 . . . . 10.0 111.996 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 33' ' ' VAL . 17.3 pt -160.05 123.62 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.557 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 48.6 mp0 -89.13 116.92 27.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 10.0 111.214 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.487 ' HB2' ' NZ ' ' A' ' 36' ' ' LYS . 5.0 ttmp? . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.801 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.954 ' HA ' HG22 ' A' ' 63' ' ' VAL . 96.8 t . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 121.14 0.495 . . . . 10.0 111.261 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.79 -40.18 79.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.463 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.443 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -163.02 -175.79 34.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.331 -0.938 . . . . 10.0 113.219 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 53' ' ' ILE . 1.9 m -147.33 167.83 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.664 -0.495 . . . . 10.0 109.664 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.474 HG21 ' HD2' ' A' ' 36' ' ' LYS . 30.1 pt . . . . . 0 C--N 1.326 -0.437 0 CA-C-O 120.942 0.401 . . . . 10.0 111.551 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.827 HG22 ' HB2' ' A' ' 90' ' ' GLU . 2.4 pp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.666 0.269 . . . . 10.0 111.126 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 83.4 Cg_endo -81.04 115.38 2.99 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.469 2.113 . . . . 10.0 112.889 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 49' ' ' VAL . 26.9 m -89.02 135.63 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.954 HG22 ' HA ' ' A' ' 49' ' ' VAL . 82.6 t -137.36 154.38 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.791 0.805 . . . . 10.0 113.074 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.473 ' N ' HG12 ' A' ' 63' ' ' VAL . 74.6 m-20 -76.7 65.73 2.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.521 -1.218 . . . . 10.0 109.263 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.86 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.6 tt -53.48 -36.35 61.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.158 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.749 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -57.75 -23.47 52.29 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.207 -0.597 . . . . 10.0 109.426 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.633 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -82.86 -48.77 10.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.69 -0.686 . . . . 10.0 110.744 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 65' ' ' LEU . 11.0 tt -58.5 -39.87 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.863 -1.162 . . . . 10.0 107.863 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.879 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -76.42 -48.98 17.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 113.711 -1.586 . . . . 10.0 109.795 177.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.575 ' N ' HD13 ' A' ' 69' ' ' LEU . . . 118.56 -93.26 0.56 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.169 -0.539 . . . . 10.0 113.125 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.015 HD12 HG21 ' A' ' 18' ' ' ILE . 3.0 pt 48.57 163.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 113.112 0.782 . . . . 10.0 113.112 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 74.8 m -45.29 -36.54 4.12 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.884 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.7 t80 -27.03 141.52 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.546 -1.206 . . . . 10.0 113.005 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 9.0 t70 -161.81 32.15 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.242 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 94.4 mt-10 54.55 45.54 26.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.938 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -98.2 -36.12 10.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.492 0.553 . . . . 10.0 112.492 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.463 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 70.6 mmtt -136.88 17.9 3.04 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.357 0.873 . . . . 10.0 113.357 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.496 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 14.0 mmm -53.93 142.5 24.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -172.55 42.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.892 0.377 . . . . 10.0 111.267 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.9 ' O ' HD12 ' A' ' 94' ' ' LEU . 79.2 p -169.09 158.02 8.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 10.0 110.155 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.481 HD11 ' O ' ' A' ' 36' ' ' LYS . 45.1 mt -137.35 132.24 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.876 0.369 . . . . 10.0 111.404 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.08 HD13 HD11 ' A' ' 14' ' ' LEU . 26.5 mt -105.34 129.96 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.953 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.41 HG12 ' OE1' ' A' ' 31' ' ' GLU . 91.7 t -98.81 150.62 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.047 0.451 . . . . 10.0 110.93 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -153.73 174.84 14.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.962 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' CG2' ' A' ' 86' ' ' THR . 23.5 ptt180 -127.39 143.8 51.15 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.525 HG21 HG12 ' A' ' 138' ' ' ILE . 45.5 p -160.02 108.19 1.7 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.532 0.568 . . . . 10.0 112.532 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.4 tppp? 46.44 47.72 13.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.777 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.35 34.32 1.02 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.167 -0.924 . . . . 10.0 111.285 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.893 HG12 HG22 ' A' ' 91' ' ' VAL . 59.0 t -134.0 110.42 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 115.141 -0.936 . . . . 10.0 109.25 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.827 ' HB2' HG22 ' A' ' 60' ' ' ILE . 83.4 mt-10 -88.23 97.92 11.28 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.047 HG21 HD13 ' A' ' 142' ' ' ILE . 4.5 t -88.55 152.24 3.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.4 -1.727 . . . . 10.0 113.33 -173.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -124.5 157.26 18.79 Favored Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.443 -1.253 . . . . 10.0 113.164 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.618 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -143.84 123.83 13.58 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 120.964 0.412 . . . . 10.0 110.613 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 80' ' ' SER . 64.9 tp -88.74 126.75 35.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.146 0.498 . . . . 10.0 111.179 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.738 HG23 ' OG ' ' A' ' 80' ' ' SER . 26.8 m -136.88 -175.26 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.697 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 3.0 t0 -88.12 -77.94 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.501 . . . . 10.0 111.253 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 -128.63 107.97 10.13 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.611 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.0 p -88.99 113.79 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 122.434 1.111 . . . . 10.0 111.396 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -62.7 -28.67 70.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.036 -1.893 . . . . 10.0 111.106 -178.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.81 -121.2 5.51 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.777 -0.929 . . . . 10.0 110.777 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.99 126.77 9.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 117.203 0.501 . . . . 10.0 109.769 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 15' ' ' SER . 54.8 tp -128.05 136.16 50.85 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.028 0.442 . . . . 10.0 111.139 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.618 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -88.82 78.64 7.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.584 179.2 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.673 HG13 HG11 ' A' ' 13' ' ' VAL . 6.8 mm -88.57 157.39 3.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.832 -0.622 . . . . 10.0 109.454 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 24.0 p -116.65 148.47 40.97 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.056 -1.09 . . . . 10.0 108.056 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 37.1 tt0 -111.77 68.31 0.66 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.996 0.903 . . . . 10.0 112.016 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -99.55 8.31 44.58 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.02 -1.445 . . . . 10.0 108.014 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-N 114.691 -1.14 . . . . 10.0 110.398 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.697 ' CE2' HD21 ' A' ' 69' ' ' LEU . 55.9 t80 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.013 0.435 . . . . 10.0 110.309 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.88 -42.67 0.45 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.708 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.434 ' HE3' ' C ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER 179.85 40.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 122' ' ' SER . 2.9 tppp? -177.92 116.74 0.09 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.157 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.642 ' HB3' ' O ' ' A' ' 121' ' ' LYS . 13.2 t . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.903 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.871 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.8 p . . . . . 0 C--O 1.227 -0.13 0 CA-C-O 120.962 0.41 . . . . 10.0 111.593 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.495 ' N ' ' HD3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -165.91 132.24 2.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.203 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.498 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 15.6 m -163.91 157.47 18.68 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.354 -0.384 . . . . 10.0 110.662 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.42 ' N ' ' CG2' ' A' ' 128' ' ' THR . 63.1 m-20 58.16 44.57 18.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.958 0.409 . . . . 10.0 110.735 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.59 32.16 38.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.65 -0.786 . . . . 10.0 111.764 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 128' ' ' THR . 3.2 ptp180 -138.89 136.14 35.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 10.0 110.417 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.92 143.46 26.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.733 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.078 HG12 ' HB3' ' A' ' 22' ' ' ALA . 4.3 mt -137.43 129.19 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 10.0 111.567 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.894 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.97 134.54 28.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.41 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 31.1 t80 -118.31 136.09 53.91 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.514 0.673 . . . . 10.0 111.467 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.993 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.1 mp -126.81 172.39 10.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.127 0.965 . . . . 10.0 112.603 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 137' ' ' ASP . 9.8 t70 -144.2 26.59 1.48 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.635 -1.62 . . . . 10.0 107.211 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.989 HG21 ' ND2' ' A' ' 29' ' ' ASN . 11.9 tt 40.4 17.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 113.846 -1.525 . . . . 10.0 114.349 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 137' ' ' ASP . 7.8 t0 -79.53 -61.73 1.91 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.794 0.665 . . . . 10.0 112.794 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -77.05 -30.88 55.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.457 0.646 . . . . 10.0 110.341 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.863 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.89 -45.69 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 114.97 -1.014 . . . . 10.0 110.63 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.047 HD13 HG21 ' A' ' 91' ' ' VAL . 7.9 tp -65.91 -43.04 93.06 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 C-N-CA 119.898 -0.721 . . . . 10.0 110.034 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.54 ' N ' HG23 ' A' ' 142' ' ' ILE . 89.3 tt0 -46.47 -46.7 19.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.312 0.577 . . . . 10.0 109.788 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 148' ' ' LYS . 61.0 mm-40 -68.89 -39.58 79.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.205 -0.907 . . . . 10.0 110.761 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.638 ' CD1' HG11 ' A' ' 91' ' ' VAL . 56.4 mt -48.52 -44.02 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.83 0.347 . . . . 10.0 111.505 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.9 p -75.57 -51.35 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 10.0 112.152 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 144' ' ' GLU . 12.9 p -70.79 -6.22 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.461 0.541 . . . . 10.0 112.461 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.814 0.34 . . . . 10.0 110.754 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.843 0.354 . . . . 10.0 111.22 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.657 ' HG2' HG22 ' A' ' 105' ' ' THR . 83.4 mt-10 -138.77 164.3 29.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.522 0.677 . . . . 10.0 111.301 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.602 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.3 t80 -161.83 139.62 8.89 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.573 -1.194 . . . . 10.0 112.501 -174.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 24.5 pt-20 -88.68 140.01 29.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.52 -0.919 . . . . 10.0 108.52 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.911 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -155.47 171.28 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 N-CA-C 114.084 1.142 . . . . 10.0 114.084 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.713 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.8 tm? -88.81 134.73 33.84 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.779 ' HB3' HD22 ' A' ' 102' ' ' LEU . 82.6 p -146.17 152.12 38.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 113.242 0.831 . . . . 10.0 113.242 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.656 ' HD2' HG23 ' A' ' 98' ' ' VAL . 2.4 p90 -149.43 166.81 27.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.181 -1.372 . . . . 10.0 109.991 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.528 ' HG3' HD21 ' A' ' 99' ' ' LEU . 94.8 mt-10 -88.56 139.36 30.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.253 0.549 . . . . 10.0 109.745 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.016 HG21 HD12 ' A' ' 71' ' ' ILE . 28.5 mm -138.96 103.27 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.364 -0.834 . . . . 10.0 110.957 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.9 OUTLIER 42.69 60.15 2.53 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.533 0.568 . . . . 10.0 112.533 179.331 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 86.7 mt-10 80.82 -42.89 0.2 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.385 -0.825 . . . . 10.0 111.912 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.814 ' NE2' HD11 ' A' ' 134' ' ' ILE . 17.3 pt20 -88.97 154.41 20.24 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.034 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.91 168.52 12.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.906 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.0 OUTLIER -152.31 135.6 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.617 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.823 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -140.34 153.81 46.53 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.846 0.684 . . . . 10.0 112.846 -177.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CZ ' HD13 ' A' ' 136' ' ' LEU . 3.8 m-85 -135.54 143.07 45.52 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.071 -0.714 . . . . 10.0 109.071 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 36.6 t70 -49.39 124.24 8.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.18 0.514 . . . . 10.0 110.806 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.911 HG13 ' HA ' ' A' ' 13' ' ' VAL . 30.1 m -64.76 -9.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.37 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.57 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 1.3 m-20 -72.0 -43.26 65.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.922 ' ND2' HG21 ' A' ' 138' ' ' ILE . 10.1 t30 -80.78 -49.77 10.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.776 -1.102 . . . . 10.0 110.071 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.713 HG21 ' HG ' ' A' ' 14' ' ' LEU . 21.9 mm -62.32 134.2 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.013 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.409 ' O ' ' CE ' ' A' ' 32' ' ' MET . 4.5 mm-40 -94.09 -68.77 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.745 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.409 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.1 172.46 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.097 0.475 . . . . 10.0 111.087 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.025 HG11 HG11 ' A' ' 98' ' ' VAL . 33.9 m -97.54 145.8 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.571 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.458 HG13 ' HB ' ' A' ' 81' ' ' ILE . 11.1 pt -142.46 122.74 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.868 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 48.7 mt-10 -88.98 104.31 16.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.834 -0.432 . . . . 10.0 109.834 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 35' ' ' GLU . 67.9 mttm . . . . . 0 C--N 1.329 -0.305 0 N-CA-C 112.218 0.451 . . . . 10.0 112.218 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.87 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.6 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.978 0.418 . . . . 10.0 111.39 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.628 ' OE1' HD22 ' A' ' 94' ' ' LEU . 16.7 pt-20 -78.06 -39.12 42.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.983 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.634 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -158.06 179.36 33.82 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.314 -0.946 . . . . 10.0 113.275 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.462 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 3.2 m -162.54 171.72 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 31.7 pt . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 10.0 112.069 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.82 HG22 ' HB3' ' A' ' 90' ' ' GLU . 2.0 pp . . . . . 0 C--O 1.234 0.252 0 CA-C-O 120.626 0.251 . . . . 10.0 110.919 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 72.1 Cg_endo -99.7 114.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.178 2.585 . . . . 10.0 113.169 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' C ' ' A' ' 51' ' ' GLY . 29.1 m -89.0 134.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.87 HG22 ' HA ' ' A' ' 49' ' ' VAL . 92.0 t -143.21 154.2 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.736 0.779 . . . . 10.0 112.957 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.465 ' N ' HG12 ' A' ' 63' ' ' VAL . 74.5 m-20 -73.29 67.17 0.96 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.662 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.838 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.9 tt -53.58 -34.17 57.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.121 -178.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.801 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -61.27 -22.13 64.56 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.325 -0.55 . . . . 10.0 109.642 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.488 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.6 tmmm? -83.85 -50.14 8.37 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.835 -0.62 . . . . 10.0 109.945 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.0 tt -54.25 -40.12 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 107.602 -1.258 . . . . 10.0 107.602 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.897 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -77.67 -47.3 19.56 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.526 -1.67 . . . . 10.0 109.383 177.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.514 ' N ' HD13 ' A' ' 69' ' ' LEU . . . 116.63 -92.78 0.57 Allowed Glycine 0 C--N 1.337 0.63 0 CA-C-N 115.975 -0.557 . . . . 10.0 113.193 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.016 HD12 HG21 ' A' ' 18' ' ' ILE . 2.9 pt 48.25 164.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 45.2 t -45.83 -34.9 4.04 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.925 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.7 t80 -31.48 143.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.582 -1.19 . . . . 10.0 113.09 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -173.53 41.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.071 -0.968 . . . . 10.0 109.888 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HA ' ' HG2' ' A' ' 78' ' ' MET . 55.8 mt-10 62.92 41.6 8.4 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.782 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -72.44 -49.05 36.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.05 -0.523 . . . . 10.0 112.388 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.03 18.92 0.68 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.371 -0.532 . . . . 10.0 112.346 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.564 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 3.4 mmm -53.14 146.61 11.22 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.149 -0.315 . . . . 10.0 110.149 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HE2' ' OD1' ' A' ' 96' ' ' ASP . 48.2 mtmt -159.39 -45.85 0.05 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.779 0.323 . . . . 10.0 111.533 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.8 m -88.87 133.38 34.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.211 0.529 . . . . 10.0 111.332 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.458 ' HB ' HG13 ' A' ' 34' ' ' ILE . 25.9 mt -89.65 151.09 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.526 -0.761 . . . . 10.0 111.527 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.512 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 23.1 mt -115.04 156.6 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 10.0 110.291 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.511 ' N ' HG22 ' A' ' 82' ' ' ILE . 41.3 t -133.61 148.73 30.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.931 0.396 . . . . 10.0 110.995 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.713 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -152.89 175.86 12.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.798 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.663 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 52.6 ttm-85 -133.08 132.6 41.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.873 -0.417 . . . . 10.0 109.873 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.801 HG22 ' OD1' ' A' ' 29' ' ' ASN . 65.4 p -141.53 102.14 4.13 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.378 0.609 . . . . 10.0 111.602 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 15.1 tppt? 48.56 48.26 19.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.005 -0.998 . . . . 10.0 110.771 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 13.5 m-20 80.17 27.32 0.3 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.917 -1.038 . . . . 10.0 111.999 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.916 HG12 HG22 ' A' ' 91' ' ' VAL . 51.6 t -124.59 108.98 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.057 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.82 ' HB3' HG22 ' A' ' 60' ' ' ILE . 33.9 tt0 -88.37 97.88 11.3 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.373 -1.714 . . . . 10.0 106.373 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.992 HG21 HD13 ' A' ' 142' ' ' ILE . 3.2 t -88.57 158.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 113.123 -1.853 . . . . 10.0 112.14 -174.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.13 143.03 14.6 Favored Glycine 0 C--N 1.317 -0.486 0 C-N-CA 120.234 -0.984 . . . . 10.0 113.833 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.624 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -131.38 128.77 40.29 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.628 HD22 ' OE1' ' A' ' 50' ' ' GLU . 65.5 tp -88.52 133.52 34.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.437 0.636 . . . . 10.0 111.904 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.6 HG11 ' CE1' ' A' ' 16' ' ' PHE . 27.6 m -147.28 -175.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.014 -0.994 . . . . 10.0 110.209 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.465 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 16.0 t70 -109.94 -58.44 2.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.551 0.574 . . . . 10.0 112.551 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -127.83 122.72 33.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.383 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.025 HG11 HG11 ' A' ' 33' ' ' VAL . 7.3 p -116.35 117.78 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 122.3 1.048 . . . . 10.0 111.643 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.597 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -69.71 -29.33 66.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.183 -1.826 . . . . 10.0 110.852 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.33 -125.59 7.73 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.778 -0.725 . . . . 10.0 111.701 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.8 t -50.84 132.27 11.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 117.079 0.44 . . . . 10.0 110.367 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 15' ' ' SER . 51.8 tp -135.69 139.9 44.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.019 0.437 . . . . 10.0 111.519 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.3 ptp180 -88.85 76.26 7.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.453 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.82 ' CD1' HG11 ' A' ' 126' ' ' VAL . 14.3 mm -88.73 168.37 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.657 HG22 ' HG2' ' A' ' 10' ' ' GLU . 22.4 p -131.67 148.08 52.56 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.426 -0.953 . . . . 10.0 108.426 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 81.0 tt0 -106.4 72.07 0.9 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.894 0.854 . . . . 10.0 112.466 -177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -108.48 21.09 17.77 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-N 114.61 -1.177 . . . . 10.0 111.699 -178.747 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.73 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 2.9 t80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.927 0.394 . . . . 10.0 110.428 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.22 -145.26 10.53 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.529 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -87.43 -38.1 16.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.941 0.401 . . . . 10.0 110.93 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.47 ' NZ ' ' HB2' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -55.25 -33.23 62.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.696 -179.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.425 ' OG ' ' HG ' ' A' ' 136' ' ' LEU . 37.3 t . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 121.108 -0.237 . . . . 10.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 1.005 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.8 p . . . . . 0 C--O 1.226 -0.184 0 CA-C-O 120.979 0.419 . . . . 10.0 112.021 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 39.7 ttmt -163.66 132.76 3.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.663 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 129' ' ' ASP . 16.1 m -161.92 158.81 25.85 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 120.925 0.393 . . . . 10.0 111.435 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.451 ' N ' ' CG2' ' A' ' 128' ' ' THR . 9.4 p-10 44.6 52.89 7.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.69 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.6 37.13 41.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.541 -0.838 . . . . 10.0 111.98 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -146.06 126.46 14.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.61 ' C ' HD22 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -88.95 144.74 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.458 . . . . 10.0 110.607 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 1.034 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.9 mt -133.91 139.77 47.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.548 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.906 ' HB ' HD13 ' A' ' 23' ' ' LEU . 4.3 mm -88.81 143.71 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.413 -0.958 . . . . 10.0 108.413 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 24' ' ' ALA . 38.1 t80 -138.77 136.46 35.74 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.609 0.719 . . . . 10.0 111.824 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.645 HD13 ' CZ ' ' A' ' 25' ' ' PHE . 4.3 mp -129.43 149.8 51.06 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.719 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 137' ' ' ASP . 9.9 t70 -113.65 19.61 16.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.253 -1.339 . . . . 10.0 107.623 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.922 HG21 ' ND2' ' A' ' 29' ' ' ASN . 12.4 tt 39.19 20.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 114.283 -1.326 . . . . 10.0 113.67 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.7 t0 -81.89 -60.83 2.1 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.72 0.637 . . . . 10.0 112.72 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -75.48 -32.72 60.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.534 0.683 . . . . 10.0 109.915 -179.645 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.849 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.28 -45.25 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 114.911 -1.04 . . . . 10.0 110.558 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.992 HD13 HG21 ' A' ' 91' ' ' VAL . 8.0 tp -61.99 -46.02 97.41 Favored 'Isoleucine or valine' 0 C--N 1.337 0.054 0 C-N-CA 120.339 -0.545 . . . . 10.0 110.14 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.669 ' O ' HG12 ' A' ' 147' ' ' VAL . 51.9 mt-10 -49.24 -43.76 43.04 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.192 0.52 . . . . 10.0 109.72 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.617 ' HB2' HD11 ' A' ' 68' ' ' ILE . 54.9 mm-40 -66.25 -32.13 73.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.323 -0.853 . . . . 10.0 110.555 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.651 HD12 HD12 ' A' ' 142' ' ' ILE . 31.1 mt -58.98 -42.15 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 120.926 0.393 . . . . 10.0 110.85 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.3 p -79.8 -50.26 10.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.771 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 143' ' ' GLU . 12.9 p -75.78 0.96 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.437 ' HE2' ' CG2' ' A' ' 49' ' ' VAL . 23.0 pttp . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.837 0.351 . . . . 10.0 111.229 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.773 0.321 . . . . 10.0 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.518 ' O ' ' OG1' ' A' ' 3' ' ' THR . 18.5 ptpt -64.0 -43.47 95.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.828 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 34.4 p 65.73 -55.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.969 -0.56 . . . . 10.0 112.139 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.936 HD12 ' N ' ' A' ' 5' ' ' ALA . 4.1 pp -55.98 -36.71 68.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.705 0.288 . . . . 10.0 111.23 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.936 ' N ' HD12 ' A' ' 4' ' ' LEU . . . 62.39 134.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.083 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -178.6 140.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.708 ' O ' HD23 ' A' ' 8' ' ' LEU . . . 64.01 143.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.226 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.08 HD13 HD13 ' A' ' 109' ' ' LEU . 85.7 mt -147.5 44.75 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.828 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -81.83 -57.75 3.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.406 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.624 ' HG3' HG22 ' A' ' 105' ' ' THR . 29.3 mp0 -103.88 164.31 11.78 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.426 0.631 . . . . 10.0 110.975 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.641 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 17.5 t80 -161.4 140.11 9.77 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.936 -1.029 . . . . 10.0 112.963 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 27' ' ' VAL . 32.6 mt-10 -88.71 140.54 29.34 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.639 -0.709 . . . . 10.0 109.622 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.788 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -155.85 168.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 113.093 0.775 . . . . 10.0 113.093 -175.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.938 HD11 HD13 ' A' ' 82' ' ' ILE . 2.3 tm? -88.89 134.2 34.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.521 -1.289 . . . . 10.0 107.521 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.792 ' HB3' HD22 ' A' ' 102' ' ' LEU . 81.1 p -143.03 152.97 42.48 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.717 ' CE1' HG11 ' A' ' 95' ' ' VAL . 6.1 p90 -150.42 167.6 26.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.299 -1.319 . . . . 10.0 110.297 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -88.55 138.5 31.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.682 -0.488 . . . . 10.0 109.682 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.989 HG21 HD12 ' A' ' 71' ' ' ILE . 33.4 mm -136.56 93.23 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.335 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 50.1 m-20 45.59 60.08 3.28 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.593 -0.731 . . . . 10.0 112.513 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.6 mt-10 83.73 -39.99 0.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.29 -0.868 . . . . 10.0 112.081 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.3 pt20 -88.91 149.55 23.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.164 -0.31 . . . . 10.0 110.164 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.027 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.55 159.52 17.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.338 . . . . 10.0 110.893 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.857 HD13 ' HB ' ' A' ' 134' ' ' ILE . 2.1 tp -147.67 136.88 22.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.768 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.801 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -136.92 146.87 45.99 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.517 0.562 . . . . 10.0 112.517 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.003 ' CE2' HD13 ' A' ' 65' ' ' LEU . 2.0 m-30 -121.47 135.87 55.0 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.585 -0.894 . . . . 10.0 108.585 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.562 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 28.3 t70 -44.2 100.95 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.581 0.705 . . . . 10.0 110.499 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 6.2 p -50.37 -14.44 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.648 -1.16 . . . . 10.0 111.978 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.562 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 7.6 m-20 -64.51 -44.65 90.23 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.468 -0.493 . . . . 10.0 109.906 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.657 HD21 HG22 ' A' ' 86' ' ' THR . 22.6 t-20 -83.24 -41.51 18.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.725 -0.671 . . . . 10.0 110.733 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.758 HG21 ' HG ' ' A' ' 14' ' ' LEU . 32.9 mm -59.64 123.5 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.58 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 32' ' ' MET . 66.6 mm-40 -81.97 -61.89 1.78 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.01 0.374 . . . . 10.0 112.01 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.6 mtm -169.04 157.27 7.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 10.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.507 HG11 HG11 ' A' ' 98' ' ' VAL . 33.7 m -88.92 137.16 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.934 -0.576 . . . . 10.0 111.228 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.519 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 11.4 pt -123.96 135.53 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.345 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -88.99 118.74 28.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.518 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.834 ' HB3' HD12 ' A' ' 81' ' ' ILE . 39.5 ttmt -169.14 165.23 11.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 10.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.6 t -155.32 154.65 32.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 10.0 111.199 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.5 t70 54.15 46.29 25.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.466 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.647 HG22 ' H ' ' A' ' 52' ' ' VAL . 17.1 mt -70.15 137.4 24.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.827 -0.624 . . . . 10.0 111.515 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.82 HG23 ' HG2' ' A' ' 43' ' ' PRO . 4.8 m 38.49 78.83 0.34 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.108 -0.496 . . . . 10.0 112.076 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -86.17 -50.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.929 2.419 . . . . 10.0 113.997 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.67 HG22 ' HD3' ' A' ' 43' ' ' PRO . 19.1 m -73.45 -33.88 2.05 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.761 0.652 . . . . 10.0 112.761 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.82 ' HG2' HG23 ' A' ' 40' ' ' THR . 12.6 Cg_exo -70.74 10.55 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.381 2.054 . . . . 10.0 113.532 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -46.46 159.48 0.09 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 120.662 0.268 . . . . 10.0 110.522 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.8 p -174.75 -53.26 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.389 -0.524 . . . . 10.0 110.945 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -76.06 -118.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.187 -0.461 . . . . 10.0 110.625 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -169.33 -49.95 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.834 0.35 . . . . 10.0 110.583 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.522 ' CG ' ' HD2' ' A' ' 148' ' ' LYS . 3.1 m-85 -65.29 -52.54 53.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.913 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.759 ' HA ' HG22 ' A' ' 63' ' ' VAL . 49.0 t -62.94 107.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.917 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -68.86 -30.5 69.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.3 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.636 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -166.82 -175.91 37.39 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.536 -0.84 . . . . 10.0 112.959 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.647 ' H ' HG22 ' A' ' 39' ' ' ILE . 2.9 m -160.42 170.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.123 -0.695 . . . . 10.0 109.123 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 60' ' ' ILE . 30.1 pt -157.77 137.97 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.992 0.425 . . . . 10.0 111.884 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -88.84 136.4 33.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.693 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.0 tp -169.1 140.79 2.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.877 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 52.1 ttm-85 48.66 46.16 21.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.176 0.512 . . . . 10.0 110.859 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.27 41.79 80.45 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.986 -0.626 . . . . 10.0 113.034 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 58' ' ' ARG . 2.5 ptp180 -167.09 125.15 1.3 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 10.0 111.078 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.626 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -91.82 134.98 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.923 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.814 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.3 pp -109.22 135.88 20.19 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.518 -0.31 . . . . 10.0 110.983 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 85.0 Cg_endo -92.83 124.42 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.932 2.422 . . . . 10.0 112.735 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.636 HG22 ' C ' ' A' ' 51' ' ' GLY . 23.2 m -102.79 125.34 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 116.022 -0.536 . . . . 10.0 110.788 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.878 HG12 ' H ' ' A' ' 64' ' ' ASN . 14.0 t -130.66 -175.9 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.283 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.878 ' H ' HG12 ' A' ' 63' ' ' VAL . 5.2 m120 -120.24 96.85 5.32 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.71 -0.223 . . . . 10.0 110.526 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.003 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.1 tt -56.21 -32.13 64.11 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.273 0.559 . . . . 10.0 109.838 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.998 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -61.74 -24.52 66.86 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.23 -0.441 . . . . 10.0 109.884 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.464 ' HE3' ' CE2' ' A' ' 48' ' ' PHE . 1.4 tmmm? -82.28 -44.04 16.77 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.295 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.7 tt -64.58 -40.85 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 108.447 -0.946 . . . . 10.0 108.447 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.039 HD21 ' CE2' ' A' ' 118' ' ' PHE . 0.7 OUTLIER -77.88 -53.01 7.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 113.903 -1.499 . . . . 10.0 109.487 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 118.93 -80.48 0.32 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 115.454 -0.794 . . . . 10.0 112.702 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.998 HD11 ' CB ' ' A' ' 66' ' ' ALA . 3.3 pt 45.19 178.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.7 m -55.44 -37.53 67.82 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 109.054 -0.721 . . . . 10.0 109.054 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.841 ' HB3' HG13 ' A' ' 71' ' ' ILE . 16.1 t80 -31.07 143.92 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.772 -1.104 . . . . 10.0 112.995 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 9.4 t70 -169.84 39.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.351 -0.84 . . . . 10.0 109.702 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 78' ' ' MET . 94.9 mt-10 56.13 39.04 30.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.705 -0.679 . . . . 10.0 111.034 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -87.24 -63.76 1.26 Allowed 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 112.327 0.492 . . . . 10.0 112.327 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -108.35 16.24 23.3 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.538 0.57 . . . . 10.0 112.538 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.482 ' HE2' ' HD1' ' A' ' 73' ' ' PHE . 17.7 mmt -52.86 138.33 29.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.907 -0.133 . . . . 10.0 110.963 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -159.46 -48.63 0.05 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.524 0.565 . . . . 10.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.414 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 65.1 m -88.94 163.75 15.44 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.803 0.298 . . . . 10.0 111.803 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.834 HD12 ' HB3' ' A' ' 36' ' ' LYS . 72.6 mt -127.7 154.15 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.031 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.938 HD13 HD11 ' A' ' 14' ' ' LEU . 11.8 mt -128.15 146.12 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.421 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.14 149.93 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.438 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -156.86 130.61 8.23 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 116.497 -0.32 . . . . 10.0 111.776 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -88.8 133.17 34.34 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.715 -0.846 . . . . 10.0 108.715 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.657 HG22 HD21 ' A' ' 29' ' ' ASN . 43.8 p -147.63 108.61 4.22 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.669 0.618 . . . . 10.0 112.669 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 47.78 49.25 16.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.705 -0.68 . . . . 10.0 110.82 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 70.41 33.65 2.44 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.216 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.953 HG12 HG22 ' A' ' 91' ' ' VAL . 76.8 t -133.56 111.63 16.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.24 -0.891 . . . . 10.0 109.34 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.755 ' HB2' HG22 ' A' ' 60' ' ' ILE . 39.8 mt-10 -88.56 92.45 9.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.114 -1.439 . . . . 10.0 107.114 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.065 HG21 HD13 ' A' ' 142' ' ' ILE . 2.7 t -88.66 158.15 3.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 112.796 -2.002 . . . . 10.0 111.719 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -138.11 144.6 15.88 Favored Glycine 0 C--N 1.313 -0.697 0 C-N-CA 120.165 -1.016 . . . . 10.0 113.458 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 t80 -133.36 122.02 23.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.777 0.323 . . . . 10.0 110.618 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 95' ' ' VAL . 6.5 tt -88.85 132.56 34.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.141 0.496 . . . . 10.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.717 HG11 ' CE1' ' A' ' 16' ' ' PHE . 15.9 m -130.94 -175.33 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.431 -0.804 . . . . 10.0 111.373 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -81.27 -75.95 0.26 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.153 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -134.27 107.17 7.51 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.282 -0.872 . . . . 10.0 108.733 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.617 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 7.5 p -88.97 116.99 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 122.418 1.104 . . . . 10.0 111.967 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.607 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -68.75 -27.59 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.909 -1.95 . . . . 10.0 110.715 -178.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.74 -126.58 8.34 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.635 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -52.28 133.14 14.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.976 0.388 . . . . 10.0 110.754 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.792 HD22 ' HB3' ' A' ' 15' ' ' SER . 43.9 tp -137.7 138.33 39.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.059 0.457 . . . . 10.0 110.854 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.6 ptp180 -88.8 72.74 8.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.198 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.034 HD12 HG21 ' A' ' 126' ' ' VAL . 14.3 mm -88.98 131.62 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.771 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.624 HG22 ' HG3' ' A' ' 10' ' ' GLU . 20.6 p -88.76 147.24 24.56 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.356 -1.72 . . . . 10.0 106.356 175.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.411 ' HG2' ' HG ' ' A' ' 109' ' ' LEU . 84.3 tt0 -134.47 81.77 1.93 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.365 -0.934 . . . . 10.0 113.08 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -76.05 -5.28 45.7 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.296 -0.865 . . . . 10.0 109.343 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -64.8 -54.84 24.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.335 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 1.08 HD13 HD13 ' A' ' 8' ' ' LEU . 2.2 pp -81.28 145.19 31.04 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.668 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.424 ' HB3' HD12 ' A' ' 111' ' ' LEU . 38.4 t70 -172.9 -52.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.715 -0.675 . . . . 10.0 109.81 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 111' ' ' LEU . 3.7 mp -94.88 -40.54 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.633 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.2 t 176.52 44.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.292 -0.867 . . . . 10.0 110.339 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.827 ' O ' HG13 ' A' ' 114' ' ' VAL . 24.3 t-20 62.87 125.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.911 -0.586 . . . . 10.0 110.73 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -174.01 113.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.409 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.416 ' OG ' ' HG2' ' A' ' 117' ' ' LYS . 47.0 t -172.85 130.96 0.52 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.215 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -105.92 25.82 10.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.405 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.416 ' HG2' ' OG ' ' A' ' 115' ' ' SER . 30.2 mmmt -51.72 -35.32 42.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.539 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 1.039 ' CE2' HD21 ' A' ' 69' ' ' LEU . 4.3 t80 -165.19 38.94 0.07 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.534 0.683 . . . . 10.0 109.487 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 122' ' ' SER . . . -74.2 35.6 0.94 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.857 -1.065 . . . . 10.0 113.351 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -79.34 -32.63 43.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.346 0.593 . . . . 10.0 109.452 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 121' ' ' LYS . 17.1 tppt? -156.9 32.99 0.3 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.195 -0.911 . . . . 10.0 110.112 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.643 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 79.6 p 178.25 -160.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.211 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.558 ' HB2' ' HA ' ' A' ' 136' ' ' LEU . 42.2 mmtm -72.62 -52.36 15.73 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 111.422 0.156 . . . . 10.0 111.422 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 118' ' ' PHE . . . 157.24 172.54 24.56 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.285 -1.436 . . . . 10.0 115.05 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.931 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.6 tm? -72.29 144.4 48.37 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.818 -0.691 . . . . 10.0 110.762 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 1.034 HG21 HD12 ' A' ' 104' ' ' ILE . 2.3 p -121.08 153.27 24.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.34 0.59 . . . . 10.0 111.605 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.483 ' NZ ' ' HB3' ' A' ' 127' ' ' LYS . 7.2 ttpm? -152.14 140.31 20.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 18.7 m -159.67 144.63 15.32 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.887 0.375 . . . . 10.0 111.109 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 131' ' ' ARG . 2.9 p30 45.95 48.36 12.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.615 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.07 42.41 81.2 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.711 -0.757 . . . . 10.0 112.383 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.494 ' HD2' HD11 ' A' ' 133' ' ' ILE . 0.7 OUTLIER -136.25 139.93 43.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.823 0.344 . . . . 10.0 110.454 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.1 mp -88.87 137.28 32.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.98 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.027 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.0 mt -156.03 151.36 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.551 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.857 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.7 mp -101.41 144.69 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.467 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 35.6 t80 -139.75 142.64 36.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 119.839 -0.744 . . . . 10.0 111.973 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.855 HD22 ' O ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -158.1 144.17 17.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.644 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 137' ' ' ASP . 9.2 t70 -97.2 33.99 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.718 . . . . 10.0 110.004 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.855 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 18.5 tt 42.4 20.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.048 -0.978 . . . . 10.0 113.337 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 123' ' ' LYS . 38.6 t70 -77.14 -54.97 5.85 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -79.21 -30.66 43.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.151 0.5 . . . . 10.0 110.937 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.855 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.46 -45.33 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.657 -0.701 . . . . 10.0 110.199 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.065 HD13 HG21 ' A' ' 91' ' ' VAL . 8.3 tp -67.17 -45.5 86.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 120.622 -0.431 . . . . 10.0 110.538 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.662 ' O ' HG12 ' A' ' 147' ' ' VAL . 15.0 tp10 -48.05 -43.21 30.18 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.374 0.607 . . . . 10.0 109.64 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.663 ' HB2' HD11 ' A' ' 68' ' ' ILE . 55.5 mm-40 -72.44 -31.33 65.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.083 -0.962 . . . . 10.0 110.865 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.751 HG13 ' O ' ' A' ' 141' ' ' ILE . 38.6 mt -54.99 -41.59 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.942 0.401 . . . . 10.0 110.652 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.8 p -81.01 -52.26 7.62 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.926 -0.579 . . . . 10.0 112.162 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 143' ' ' GLU . 10.8 p -82.14 13.1 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.522 ' HD2' ' CG ' ' A' ' 48' ' ' PHE . 24.3 ttpp -44.79 -43.77 8.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.697 0.284 . . . . 10.0 111.739 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -56.84 127.13 30.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 10.0 111.023 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 168.91 -47.84 0.22 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.819 -0.705 . . . . 10.0 112.535 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.7 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.327 . . . . 10.0 111.054 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.437 ' HG2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.546 0.212 . . . . 10.0 111.488 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 1' ' ' MET . 13.1 mmmm 62.16 60.8 1.41 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.958 0.409 . . . . 10.0 111.246 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.1 t -50.66 -24.44 3.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 10.0 111.173 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.9 mt -56.84 -39.28 73.95 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.009 0.433 . . . . 10.0 110.2 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.65 132.32 53.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.587 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.476 ' OD2' ' HB3' ' A' ' 9' ' ' LYS . 35.7 t70 -178.8 163.32 1.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.979 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.32 139.01 3.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.94 0.4 . . . . 10.0 111.539 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.491 ' HB3' HD11 ' A' ' 109' ' ' LEU . 86.0 mt 66.19 44.05 2.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.448 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB3' ' OD2' ' A' ' 6' ' ' ASP . 21.0 ptmt -86.04 -48.28 8.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.964 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 105' ' ' THR . 39.8 mt-10 -117.7 164.26 15.25 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.319 0.58 . . . . 10.0 110.471 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.576 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 15.5 t80 -157.25 137.16 12.47 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.005 -0.998 . . . . 10.0 112.748 -174.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -88.73 139.86 30.04 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.476 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.98 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.1 p -156.06 171.76 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -174.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.948 HD11 HD13 ' A' ' 82' ' ' ILE . 3.3 tm? -88.92 137.18 32.55 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.871 ' HB3' HD22 ' A' ' 102' ' ' LEU . 76.7 p -149.19 153.62 37.92 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.685 0.995 . . . . 10.0 113.685 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.781 ' CE2' HG11 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -147.18 156.43 42.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.154 -1.384 . . . . 10.0 110.142 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -88.77 99.91 12.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.388 0.613 . . . . 10.0 109.868 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.992 HG21 HD12 ' A' ' 71' ' ' ILE . 27.6 mm -88.91 101.36 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.034 -0.985 . . . . 10.0 111.866 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.1 m-20 46.18 60.15 3.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.566 -0.743 . . . . 10.0 112.926 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.7 mt-10 86.6 -39.63 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.385 -0.825 . . . . 10.0 112.015 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.754 ' OE1' HD22 ' A' ' 132' ' ' LEU . 16.5 pt20 -88.83 -175.61 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.788 -0.449 . . . . 10.0 109.788 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.016 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -115.43 158.11 22.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.171 0.51 . . . . 10.0 111.472 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.909 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.3 OUTLIER -145.39 133.3 21.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.144 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.909 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -137.05 149.43 47.42 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.717 1.006 . . . . 10.0 113.717 -177.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.923 ' CE2' HD21 ' A' ' 136' ' ' LEU . 0.9 OUTLIER -132.18 138.11 47.87 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.634 -1.167 . . . . 10.0 108.329 178.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -49.0 122.69 6.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.066 0.46 . . . . 10.0 111.325 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.98 HG13 ' HA ' ' A' ' 13' ' ' VAL . 23.9 m -61.05 -14.24 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.63 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -61.14 -39.78 91.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.068 0.461 . . . . 10.0 110.22 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.753 HD21 HG22 ' A' ' 86' ' ' THR . 20.6 t-20 -95.49 -44.77 7.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.245 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.728 HG21 ' HG ' ' A' ' 14' ' ' LEU . 28.1 mm -57.32 129.53 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.59 -0.277 . . . . 10.0 110.471 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 32' ' ' MET . 50.4 mt-10 -88.32 -61.6 1.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.5 mtm -169.03 157.95 8.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.983 0.42 . . . . 10.0 111.563 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 98' ' ' VAL . 33.8 m -88.87 151.16 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.474 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.543 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 13.5 pt -154.13 134.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.01 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -101.93 111.81 24.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 10.0 110.608 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.446 ' O ' ' CG1' ' A' ' 39' ' ' ILE . 2.0 tmtp? -169.18 66.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.699 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.3 p -55.74 -168.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.37 . . . . 10.0 111.272 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 38.74 46.54 1.04 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.243 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.803 HD12 HG21 ' A' ' 62' ' ' VAL . 19.6 mt -77.56 138.38 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.665 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.626 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 4.0 m 34.57 91.57 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.963 -0.562 . . . . 10.0 112.499 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -89.24 -57.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.684 2.256 . . . . 10.0 113.506 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.58 HG12 ' HD3' ' A' ' 43' ' ' PRO . 14.2 p -81.54 -31.97 0.6 Allowed Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 113.198 0.814 . . . . 10.0 113.198 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HB2' HG23 ' A' ' 40' ' ' THR . 14.8 Cg_exo -67.97 5.16 1.18 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.124 1.882 . . . . 10.0 113.703 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.511 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -50.92 148.87 3.84 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.157 0.503 . . . . 10.0 112.04 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 41.7 t 174.92 60.28 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.604 -0.725 . . . . 10.0 110.92 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 20.8 tpp180 -170.46 -31.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.422 -0.353 . . . . 10.0 111.88 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 92.9 m-70 73.73 146.98 0.09 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.749 0.309 . . . . 10.0 110.676 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.489 ' HB3' ' HD2' ' A' ' 148' ' ' LYS . 1.8 t80 83.52 -46.74 0.12 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.737 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.948 ' HA ' HG22 ' A' ' 63' ' ' VAL . 48.7 t -72.65 128.56 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.902 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.545 ' HG3' HG23 ' A' ' 62' ' ' VAL . 12.3 pt-20 -74.9 -37.82 62.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.146 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 62' ' ' VAL . . . -168.02 -175.86 38.08 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.647 -0.787 . . . . 10.0 112.958 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.626 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.5 m -154.16 170.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.839 -0.43 . . . . 10.0 109.839 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.468 HG12 HD11 ' A' ' 60' ' ' ILE . 30.9 pt -157.47 145.21 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.867 0.365 . . . . 10.0 111.084 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.557 HD22 HD11 ' A' ' 59' ' ' ILE . 24.6 t-20 -88.71 142.11 27.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.061 -0.518 . . . . 10.0 111.167 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 tp -168.29 138.71 2.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.823 -0.626 . . . . 10.0 110.586 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.554 ' HG3' ' HG2' ' A' ' 58' ' ' ARG . 16.4 ptm180 44.79 45.75 8.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.38 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.49 40.89 99.31 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.85 -0.614 . . . . 10.0 113.704 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.554 ' HG2' ' HG3' ' A' ' 56' ' ' ARG . 16.0 ptp180 -169.15 130.06 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.877 0.338 . . . . 10.0 110.979 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -89.03 133.53 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.23 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.804 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.3 pp -104.86 135.74 19.26 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.935 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 79.5 Cg_endo -92.02 114.31 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.762 2.308 . . . . 10.0 113.383 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.803 HG21 HD12 ' A' ' 39' ' ' ILE . 23.0 m -91.05 136.03 25.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.948 HG22 ' HA ' ' A' ' 49' ' ' VAL . 62.7 t -139.09 159.01 29.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.719 0.771 . . . . 10.0 112.92 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.529 ' N ' HG12 ' A' ' 63' ' ' VAL . 5.7 m120 -74.14 63.0 0.95 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.745 -1.116 . . . . 10.0 109.062 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.863 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.9 tt -53.69 -32.21 50.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.763 -0.653 . . . . 10.0 111.22 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.853 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -62.85 -24.09 67.61 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.259 -0.576 . . . . 10.0 109.872 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -83.06 -45.41 14.05 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.137 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.813 HG22 ' O ' ' A' ' 65' ' ' LEU . 9.6 tt -57.73 -38.67 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 107.687 -1.227 . . . . 10.0 107.687 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.879 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.22 -47.15 18.61 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.801 -1.545 . . . . 10.0 108.473 177.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 117.67 -90.5 0.5 Allowed Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.456 -0.793 . . . . 10.0 112.714 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.992 HD12 HG21 ' A' ' 18' ' ' ILE . 3.2 pt 47.66 165.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.399 0.889 . . . . 10.0 113.399 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.6 m -47.05 -37.77 9.99 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.18 -0.674 . . . . 10.0 109.18 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.863 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.6 t80 -28.08 141.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.395 -1.275 . . . . 10.0 113.283 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -166.79 37.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.241 -0.891 . . . . 10.0 110.235 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 55.94 32.67 20.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.78 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.433 ' NE2' ' OD2' ' A' ' 19' ' ' ASP . 22.3 pt20 -95.42 -44.41 7.56 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -113.2 13.94 19.32 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.23 0.456 . . . . 10.0 112.23 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.42 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 29.5 mmt -59.8 140.62 56.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.904 0.383 . . . . 10.0 111.686 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 96' ' ' ASP . 14.4 ptmm? -179.64 39.2 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.013 -0.539 . . . . 10.0 110.817 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.895 ' O ' HD12 ' A' ' 94' ' ' LEU . 47.3 t -169.19 164.85 11.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.701 HD13 HD11 ' A' ' 39' ' ' ILE . 43.6 mt -139.84 152.25 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.961 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.948 HD13 HD11 ' A' ' 14' ' ' LEU . 9.8 mt -131.36 130.35 62.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.727 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 84' ' ' ALA . 74.6 t -98.24 156.83 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.051 0.453 . . . . 10.0 111.307 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.654 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -156.52 172.1 19.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.617 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -130.6 130.7 44.34 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.753 HG22 HD21 ' A' ' 29' ' ' ASN . 46.7 p -145.36 109.27 4.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.958 0.355 . . . . 10.0 111.958 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 87' ' ' LYS . 8.1 ttpt 48.02 49.89 16.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.614 0.721 . . . . 10.0 110.689 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 71.0 32.13 2.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.037 -0.983 . . . . 10.0 111.484 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.926 HG12 HG22 ' A' ' 91' ' ' VAL . 71.4 t -129.01 109.52 18.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.275 -0.875 . . . . 10.0 109.192 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.776 ' HB2' HG22 ' A' ' 60' ' ' ILE . 25.0 mp0 -88.35 97.36 11.0 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.278 -1.749 . . . . 10.0 106.278 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.017 HG21 HD13 ' A' ' 142' ' ' ILE . 3.6 t -88.55 153.55 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 113.291 -1.777 . . . . 10.0 113.016 -174.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -123.97 158.03 18.47 Favored Glycine 0 C--N 1.317 -0.485 0 CA-C-N 114.495 -1.229 . . . . 10.0 113.185 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.644 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -146.95 128.11 14.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.873 0.368 . . . . 10.0 110.915 -179.168 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.895 HD12 ' O ' ' A' ' 80' ' ' SER . 52.1 tp -88.66 128.14 35.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.999 0.428 . . . . 10.0 110.751 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.781 HG11 ' CE2' ' A' ' 16' ' ' PHE . 29.8 m -137.01 -175.11 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.428 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 45.8 t0 -92.96 -73.33 0.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.354 0.597 . . . . 10.0 111.17 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.494 ' NH1' HD22 ' A' ' 99' ' ' LEU . 57.9 ttt-85 -137.63 120.81 16.8 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.196 -0.911 . . . . 10.0 108.616 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.649 HG23 ' HD1' ' A' ' 16' ' ' PHE . 7.1 p -101.69 117.12 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 122.361 1.077 . . . . 10.0 112.898 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -65.42 -28.82 69.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.083 -1.871 . . . . 10.0 111.059 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.57 -122.63 6.57 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.552 -0.833 . . . . 10.0 111.171 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.97 133.59 16.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 117.045 0.422 . . . . 10.0 110.322 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.871 HD22 ' HB3' ' A' ' 15' ' ' SER . 57.2 tp -136.17 137.72 41.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.989 0.423 . . . . 10.0 111.048 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.9 ptp180 -88.85 71.73 8.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.315 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.04 HD12 HG21 ' A' ' 126' ' ' VAL . 14.2 mm -88.84 128.45 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.732 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.613 HG22 ' HG2' ' A' ' 10' ' ' GLU . 18.5 p -88.68 147.59 24.44 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.655 -1.609 . . . . 10.0 106.655 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.609 ' OE1' HD23 ' A' ' 109' ' ' LEU . 35.0 tt0 -137.07 79.08 1.73 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.443 -0.903 . . . . 10.0 112.663 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -72.98 -10.6 59.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.619 -0.719 . . . . 10.0 109.533 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -63.09 -48.39 78.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.443 -0.799 . . . . 10.0 110.932 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.609 HD23 ' OE1' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -61.57 165.47 4.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.953 -0.567 . . . . 10.0 111.921 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -175.74 -46.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.607 -0.724 . . . . 10.0 110.002 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.8 tp -124.65 -32.75 3.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.987 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.1 t 177.28 43.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.432 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 m120 61.65 120.54 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.884 -0.598 . . . . 10.0 110.999 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 115' ' ' SER . 10.9 t -156.79 97.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.142 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 46.1 t 175.34 133.83 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.797 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.445 ' O ' ' HA2' ' A' ' 124' ' ' GLY . 34.3 t70 -71.29 -70.1 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.761 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.611 ' HB2' ' CA ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER 66.57 -55.09 0.42 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 179.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.684 ' CE1' HD21 ' A' ' 69' ' ' LEU . 56.6 t80 -69.85 -58.04 4.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.11 0.481 . . . . 10.0 110.55 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 150.53 -54.5 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.568 -0.742 . . . . 10.0 112.091 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 54.9 tptt 173.85 60.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.978 0.418 . . . . 10.0 110.063 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.463 ' HB3' ' CE2' ' A' ' 118' ' ' PHE . 4.2 tppp? -154.47 -39.43 0.09 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.658 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.654 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 94.9 p -140.88 -163.64 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.561 -0.291 . . . . 10.0 110.724 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.58 ' HA ' ' HE2' ' A' ' 123' ' ' LYS . 5.4 mmpt? -70.6 -49.66 45.44 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.766 -0.374 . . . . 10.0 111.707 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.611 ' CA ' ' HB2' ' A' ' 117' ' ' LYS . . . 170.29 151.93 7.75 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 118.428 -1.844 . . . . 10.0 116.109 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.587 HD13 ' C ' ' A' ' 125' ' ' LEU . 2.8 tm? -73.61 124.41 25.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.563 -0.818 . . . . 10.0 109.653 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 1.04 HG21 HD12 ' A' ' 104' ' ' ILE . 2.4 p -97.63 154.19 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.452 0.644 . . . . 10.0 112.28 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -158.95 138.45 11.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.497 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 7.0 m -165.01 146.83 7.86 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.926 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 54.79 42.71 30.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.986 0.422 . . . . 10.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.4 37.68 60.67 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.836 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -130.15 136.58 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.273 -0.269 . . . . 10.0 110.273 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.882 HD23 ' N ' ' A' ' 133' ' ' ILE . 4.7 tt -88.93 136.75 32.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.605 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.016 HG12 ' HB3' ' A' ' 22' ' ' ALA . 6.0 mt -154.01 143.48 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 10.0 110.789 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.909 ' HB ' HD13 ' A' ' 23' ' ' LEU . 2.0 mp -96.1 134.8 32.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 N-CA-C 109.072 -0.714 . . . . 10.0 109.072 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.582 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 41.1 t80 -129.33 140.4 51.4 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.773 -0.771 . . . . 10.0 111.385 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.923 HD21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -159.97 151.2 19.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.36 0.6 . . . . 10.0 111.881 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 139' ' ' ASP . 1.4 m-20 -102.33 37.87 1.8 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.498 -0.774 . . . . 10.0 110.501 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.874 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 19.8 tt 39.63 20.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.58 -1.191 . . . . 10.0 113.653 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 137' ' ' ASP . 37.9 t70 -79.53 -57.45 3.68 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 122' ' ' SER . 31.2 mmmt -76.92 -32.5 57.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 10.0 110.356 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.874 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.78 -45.68 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.183 -0.917 . . . . 10.0 110.489 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.017 HD13 HG21 ' A' ' 91' ' ' VAL . 7.5 tp -64.13 -44.82 97.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 120.375 -0.53 . . . . 10.0 109.953 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 142' ' ' ILE . 44.7 tt0 -48.13 -43.16 30.92 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 68' ' ' ILE . 44.5 mt-10 -69.99 -32.89 71.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.236 -0.893 . . . . 10.0 110.58 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.698 ' CD1' HG11 ' A' ' 91' ' ' VAL . 34.1 mt -55.51 -40.38 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 120.953 0.406 . . . . 10.0 110.801 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.6 p -77.74 -50.63 12.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.954 -0.566 . . . . 10.0 111.873 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.6 p -77.89 5.06 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.088 0.403 . . . . 10.0 112.088 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.489 ' HD2' ' HB3' ' A' ' 48' ' ' PHE . 23.9 pttm -46.42 -41.44 13.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.696 0.284 . . . . 10.0 111.638 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.824 ' HG2' HG23 ' A' ' 151' ' ' VAL . 89.0 tt0 63.8 132.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.664 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -103.22 -47.13 1.36 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.71 -0.757 . . . . 10.0 112.424 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.824 HG23 ' HG2' ' A' ' 149' ' ' GLU . 65.5 t . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.817 0.342 . . . . 10.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.439 ' O ' ' HG2' ' A' ' 1' ' ' MET . 27.8 ttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.001 0.429 . . . . 10.0 110.818 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 3' ' ' THR . 75.0 mmtt -64.09 -42.83 96.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 51.0 m 72.65 -48.87 0.69 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.319 -0.401 . . . . 10.0 111.744 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.913 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.2 pp -56.14 -28.7 58.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.873 0.368 . . . . 10.0 110.945 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.913 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -54.0 131.89 41.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.222 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 62.16 123.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.986 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.31 135.95 55.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.426 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.829 HD13 ' CD2' ' A' ' 109' ' ' LEU . 84.3 mt -82.26 47.76 1.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.858 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.515 ' O ' HG22 ' A' ' 105' ' ' THR . 22.8 tptm -82.67 -53.41 5.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.477 -0.329 . . . . 10.0 111.835 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.592 ' HG2' HG22 ' A' ' 105' ' ' THR . 34.2 mt-10 -121.69 164.28 17.63 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.738 0.78 . . . . 10.0 111.513 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.569 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 12.7 t80 -158.76 136.71 10.48 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.268 -1.333 . . . . 10.0 112.259 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.75 140.76 29.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.655 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.859 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -157.99 171.24 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 113.583 0.957 . . . . 10.0 113.583 -174.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.998 HD11 HD13 ' A' ' 82' ' ' ILE . 2.0 tm? -88.77 132.1 34.77 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.855 ' CB ' HD22 ' A' ' 102' ' ' LEU . 80.9 p -143.7 156.92 44.69 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.542 0.942 . . . . 10.0 113.542 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.767 ' CD1' HD11 ' A' ' 82' ' ' ILE . 4.1 p90 -153.11 158.35 41.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.902 -1.499 . . . . 10.0 109.81 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -88.58 125.4 34.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.351 0.596 . . . . 10.0 109.556 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.83 HG21 HD12 ' A' ' 71' ' ' ILE . 32.9 mm -115.09 81.03 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.16 -0.927 . . . . 10.0 111.51 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 58.8 m-20 52.29 60.26 3.94 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.957 -0.565 . . . . 10.0 112.12 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 8.2 mp0 80.96 -31.97 0.11 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.261 -0.881 . . . . 10.0 111.771 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -88.81 137.82 31.97 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.076 -0.712 . . . . 10.0 109.076 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.008 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.65 155.09 19.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.044 0.45 . . . . 10.0 111.21 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.882 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.8 tp -148.14 140.85 24.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.355 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.766 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -144.99 155.93 43.67 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.893 0.701 . . . . 10.0 112.893 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.863 ' CE2' HD22 ' A' ' 136' ' ' LEU . 3.3 m-85 -136.4 141.21 43.62 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.319 -0.855 . . . . 10.0 109.187 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.07 120.54 5.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.195 0.521 . . . . 10.0 110.692 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.859 HG13 ' HA ' ' A' ' 13' ' ' VAL . 34.2 m -60.36 -12.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.048 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -62.14 -46.86 87.11 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.006 0.431 . . . . 10.0 110.376 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.978 ' ND2' HG21 ' A' ' 138' ' ' ILE . 13.9 t30 -86.67 -45.33 11.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.924 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.718 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.4 mm -57.71 126.8 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.784 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.11 -65.78 0.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.533 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -169.13 168.77 9.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.973 0.416 . . . . 10.0 111.683 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.404 ' HB ' HG11 ' A' ' 98' ' ' VAL . 35.2 m -88.86 148.4 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.366 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.43 HD12 ' HD2' ' A' ' 36' ' ' LYS . 17.6 pt -150.85 128.81 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.902 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -88.85 63.76 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.446 . . . . 10.0 111.234 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.948 ' HB2' HD12 ' A' ' 81' ' ' ILE . 68.6 mttm -89.06 154.23 20.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.205 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.1 p -152.61 144.39 23.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.364 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.5 t70 50.1 45.12 25.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.259 0.552 . . . . 10.0 110.787 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 45.4 mt -61.04 -69.77 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 10.0 112.12 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.588 HG23 ' HB2' ' A' ' 43' ' ' PRO . 96.7 m -149.71 66.7 8.33 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.231 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.42 -49.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.875 2.384 . . . . 10.0 113.205 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.505 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 45.6 t -72.46 -44.47 9.83 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.469 -0.332 . . . . 10.0 111.757 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.588 ' HB2' HG23 ' A' ' 40' ' ' THR . 12.1 Cg_exo -70.07 8.63 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.651 2.234 . . . . 10.0 113.538 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 45' ' ' SER . 17.6 ptmt -48.82 156.59 0.47 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.043 0.449 . . . . 10.0 111.829 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 44.2 t 177.76 48.72 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.589 -0.732 . . . . 10.0 111.438 178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.536 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 6.9 tpm_? -166.24 16.55 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.558 -0.292 . . . . 10.0 111.671 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.481 ' O ' ' O ' ' A' ' 46' ' ' ARG . 17.6 m80 56.49 137.01 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.766 0.317 . . . . 10.0 111.185 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' GLU . 3.2 m-85 68.8 -47.66 0.57 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.92 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.585 ' HA ' HG22 ' A' ' 63' ' ' VAL . 48.0 t -54.4 80.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.921 0.391 . . . . 10.0 111.57 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 48' ' ' PHE . 24.6 pt-20 -61.02 -29.19 69.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.546 . . . . 10.0 110.962 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.741 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -152.21 168.19 31.36 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.435 -0.888 . . . . 10.0 112.926 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.484 ' O ' ' CG2' ' A' ' 39' ' ' ILE . 2.3 m -160.18 167.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.94 -0.393 . . . . 10.0 109.94 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.504 HG12 HD11 ' A' ' 60' ' ' ILE . 29.7 pt -156.55 132.53 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.226 0.536 . . . . 10.0 112.068 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -88.91 140.94 28.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.44 -0.8 . . . . 10.0 110.812 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.2 tp -169.01 137.16 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.892 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 45.65 46.98 11.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.56 44.82 90.69 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.694 -0.765 . . . . 10.0 112.212 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.438 ' C ' HD12 ' A' ' 59' ' ' ILE . 4.5 tmm_? -161.14 125.04 3.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 10.0 111.034 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.6 mp -100.83 145.96 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.758 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.806 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.1 pp -126.86 137.13 29.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.61 -0.268 . . . . 10.0 111.202 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 50.6 Cg_endo -95.67 124.92 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.413 2.742 . . . . 10.0 113.431 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.741 HG22 ' C ' ' A' ' 51' ' ' GLY . 27.0 m -103.54 135.63 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.76 -0.459 . . . . 10.0 109.76 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 49' ' ' VAL . 91.3 t -142.27 156.34 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.49 0.662 . . . . 10.0 112.379 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.79 ' OD1' HD23 ' A' ' 94' ' ' LEU . 74.5 m-20 -72.69 74.98 1.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.151 -0.931 . . . . 10.0 109.364 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.872 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.8 tt -54.87 -35.89 64.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.286 0.565 . . . . 10.0 110.859 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.819 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -59.87 -20.9 59.82 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.447 -0.501 . . . . 10.0 109.687 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -83.15 -49.42 9.5 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.098 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.709 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.2 tt -58.32 -39.59 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.707 -1.22 . . . . 10.0 107.707 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.972 HD12 HD13 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -79.89 -36.05 37.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.267 -1.788 . . . . 10.0 109.573 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.612 ' O ' HD13 ' A' ' 69' ' ' LEU . . . 67.16 124.45 0.02 OUTLIER Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.676 -0.693 . . . . 10.0 112.89 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.972 HD13 HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -165.4 -168.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.727 0.411 . . . . 10.0 110.859 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 67.0 m -48.43 -35.02 11.96 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -31.3 135.82 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.251 -1.341 . . . . 10.0 113.53 176.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' A' ' 75' ' ' GLU . 64.2 t0 -129.33 -65.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.156 -0.929 . . . . 10.0 110.038 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER 157.58 -27.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.332 -0.394 . . . . 10.0 111.468 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.476 ' N ' ' OE1' ' A' ' 75' ' ' GLU . 24.9 pt20 -60.06 -48.32 82.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -77.87 -45.07 25.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.975 0.417 . . . . 10.0 111.592 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 96' ' ' ASP . 18.5 mmm -35.62 141.58 0.08 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.633 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -169.4 -28.95 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.829 ' O ' HD12 ' A' ' 94' ' ' LEU . 48.1 t -88.85 -175.96 5.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.628 0.252 . . . . 10.0 111.095 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.948 HD12 ' HB2' ' A' ' 36' ' ' LYS . 57.9 mt -156.61 140.48 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.954 0.407 . . . . 10.0 111.508 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.998 HD13 HD11 ' A' ' 14' ' ' LEU . 13.5 mt -113.27 150.12 15.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.866 -0.607 . . . . 10.0 110.669 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.54 149.71 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.919 0.39 . . . . 10.0 110.852 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -151.3 -175.9 5.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.126 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.416 ' O ' ' CG2' ' A' ' 86' ' ' THR . 14.6 ptm180 -135.9 144.41 45.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.713 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.527 HG21 HG12 ' A' ' 138' ' ' ILE . 34.8 p -160.16 109.47 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 10.0 112.083 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.3 tppp? 47.19 47.16 16.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.691 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 53.0 m-20 74.18 33.54 0.91 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.144 -0.935 . . . . 10.0 111.279 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.878 HG12 HG22 ' A' ' 91' ' ' VAL . 60.4 t -130.47 110.14 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-N 115.215 -0.902 . . . . 10.0 109.485 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 46.1 mt-10 -88.35 100.62 13.16 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 105.515 -2.032 . . . . 10.0 105.515 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.983 HG21 HD13 ' A' ' 142' ' ' ILE . 5.0 t -88.62 153.59 3.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 113.343 -1.753 . . . . 10.0 113.482 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.491 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -123.1 155.1 17.24 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 114.231 -1.349 . . . . 10.0 112.707 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.579 ' HD1' ' N ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -144.43 126.66 15.69 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 120.963 0.411 . . . . 10.0 110.963 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.829 HD12 ' O ' ' A' ' 80' ' ' SER . 55.6 tp -88.64 130.27 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.111 0.482 . . . . 10.0 110.833 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.515 HG11 ' CD2' ' A' ' 16' ' ' PHE . 27.3 m -140.61 -175.27 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.961 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' MET . 19.8 t70 -93.92 -73.05 0.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.196 0.522 . . . . 10.0 111.161 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -131.27 115.42 16.28 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.341 -0.845 . . . . 10.0 108.923 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 8.7 p -98.02 111.7 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-O 122.354 1.074 . . . . 10.0 111.455 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -64.22 -27.15 68.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.062 -1.881 . . . . 10.0 111.131 -178.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.99 -121.42 5.51 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.949 -0.86 . . . . 10.0 110.949 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.4 t -52.86 129.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 117.145 0.472 . . . . 10.0 109.908 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.855 HD22 ' CB ' ' A' ' 15' ' ' SER . 60.8 tp -132.98 139.22 47.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.144 0.497 . . . . 10.0 111.226 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 15.9 ptp180 -88.89 71.27 8.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.564 -0.744 . . . . 10.0 109.641 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.828 HD12 HG11 ' A' ' 126' ' ' VAL . 6.4 mm -88.8 126.76 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.783 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.592 HG22 ' HG2' ' A' ' 10' ' ' GLU . 16.9 p -88.57 145.25 25.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.944 -1.873 . . . . 10.0 105.944 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.496 ' CG ' ' CD1' ' A' ' 109' ' ' LEU . 2.4 tp10 -147.33 89.51 1.79 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.845 -1.142 . . . . 10.0 112.846 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -86.43 7.56 25.31 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.552 -0.749 . . . . 10.0 109.5 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.43 ' OE1' ' CB ' ' A' ' 115' ' ' SER . 55.8 mm-40 -69.11 -52.49 27.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.576 -0.738 . . . . 10.0 111.003 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.955 ' H ' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -76.6 45.1 0.39 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.17 -0.468 . . . . 10.0 112.209 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.556 ' HA ' HD12 ' A' ' 8' ' ' LEU . 37.7 t70 -74.66 -53.07 9.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.977 0.418 . . . . 10.0 110.311 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 111' ' ' LEU . 4.0 mp -102.75 -39.52 6.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.962 -0.563 . . . . 10.0 109.951 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t 176.04 39.63 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.437 -0.802 . . . . 10.0 110.742 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.497 ' H ' ' HA ' ' A' ' 109' ' ' LEU . 5.3 m120 60.6 111.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.909 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.458 ' O ' ' OG ' ' A' ' 115' ' ' SER . 6.6 t -159.49 100.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.13 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 114' ' ' VAL . 66.1 m -173.02 -175.76 1.28 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.967 0.413 . . . . 10.0 111.438 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -73.49 63.83 0.82 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.474 0.654 . . . . 10.0 110.989 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.532 ' HD2' ' HD2' ' A' ' 123' ' ' LYS . 47.3 mtmt -47.96 -41.87 26.11 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.055 -0.975 . . . . 10.0 111.545 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.686 ' CE2' HD21 ' A' ' 69' ' ' LEU . 29.8 t80 -178.4 -52.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.305 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 156.6 -53.25 0.41 Allowed Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.647 -0.706 . . . . 10.0 112.038 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 27.4 tptp 174.81 57.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 10.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -153.02 -42.91 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.41 -0.359 . . . . 10.0 111.888 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.767 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 93.6 p -116.79 -139.14 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.017 -0.273 . . . . 10.0 111.692 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HD2' ' HD2' ' A' ' 117' ' ' LYS . 23.2 tptm -159.96 16.79 0.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.629 0.603 . . . . 10.0 112.629 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -153.02 152.27 23.95 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 119.416 -1.373 . . . . 10.0 113.785 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.918 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.5 tm? -153.19 141.37 20.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.106 -0.701 . . . . 10.0 109.106 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.918 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.2 p -157.78 162.28 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.419 0.628 . . . . 10.0 112.366 -178.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.512 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -165.6 135.15 3.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.08 -0.964 . . . . 10.0 109.744 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 4.3 m -159.51 152.58 22.01 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.031 0.443 . . . . 10.0 111.304 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.4 t70 55.81 47.07 21.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.773 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.72 33.55 49.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.513 -0.851 . . . . 10.0 111.663 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.6 ptp180 -138.78 134.0 32.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.348 . . . . 10.0 110.332 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' A' ' 127' ' ' LYS . 85.6 mt -88.88 148.52 23.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.172 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.008 HG12 ' HB3' ' A' ' 22' ' ' ALA . 2.9 mt -147.97 132.31 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.656 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.882 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.3 mp -88.78 141.2 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.086 -0.709 . . . . 10.0 109.086 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.593 ' C ' HD12 ' A' ' 136' ' ' LEU . 24.4 t80 -125.95 147.22 49.56 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.521 0.677 . . . . 10.0 111.595 -178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.863 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.7 mp -140.3 165.73 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.042 0.925 . . . . 10.0 112.86 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -135.21 26.16 3.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.849 -1.523 . . . . 10.0 107.833 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.978 HG21 ' ND2' ' A' ' 29' ' ' ASN . 12.4 tt 42.29 16.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 113.929 -1.487 . . . . 10.0 114.353 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.29 -60.29 2.33 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.671 0.619 . . . . 10.0 112.671 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.453 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.6 mptt -76.02 -29.76 58.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.437 0.637 . . . . 10.0 110.396 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.871 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.11 -46.96 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.137 -0.938 . . . . 10.0 110.715 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.983 HD13 HG21 ' A' ' 91' ' ' VAL . 7.6 tp -63.0 -43.95 99.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 120.012 -0.675 . . . . 10.0 109.624 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.695 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.4 tt0 -48.11 -46.61 34.22 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.635 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.65 ' HB2' HD11 ' A' ' 68' ' ' ILE . 56.0 mm-40 -73.52 -30.51 63.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.432 -0.804 . . . . 10.0 110.574 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.709 HD13 HG11 ' A' ' 91' ' ' VAL . 35.8 mt -54.69 -31.77 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 120.899 0.38 . . . . 10.0 110.788 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.3 p -96.47 -49.19 5.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.983 -0.553 . . . . 10.0 112.402 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 143' ' ' GLU . 10.3 p -85.49 13.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.875 0.694 . . . . 10.0 112.875 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -47.04 -40.89 15.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.789 0.292 . . . . 10.0 111.789 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.81 130.38 45.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.92 0.39 . . . . 10.0 111.088 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 173.39 42.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.826 -0.702 . . . . 10.0 112.489 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 10.0 111.023 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.779 0.323 . . . . 10.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 39.5 ttmt -85.92 44.9 1.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.279 -0.418 . . . . 10.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.7 m 67.68 -60.35 0.39 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.364 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.925 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.9 pp -63.37 -33.17 74.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.077 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.925 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -57.8 135.17 56.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.391 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -159.62 133.64 7.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.724 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.08 130.03 42.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.315 -0.402 . . . . 10.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.696 HD11 ' CB ' ' A' ' 110' ' ' ASP . 68.6 mt -92.57 44.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 10.0 111.402 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.685 ' HG2' ' HG3' ' A' ' 10' ' ' GLU . 56.8 tttm -97.1 -60.69 1.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.747 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.685 ' HG3' ' HG2' ' A' ' 9' ' ' LYS . 88.3 mt-10 -149.04 164.24 35.2 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.356 0.598 . . . . 10.0 110.33 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.64 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.8 t80 -156.6 138.8 14.64 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.014 -0.993 . . . . 10.0 112.531 -174.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.417 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 12.3 pt-20 -88.81 138.85 31.04 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.915 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -155.94 166.62 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.62 0.724 . . . . 10.0 112.937 -177.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.648 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 3.0 tm? -88.88 133.5 34.26 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.958 -0.756 . . . . 10.0 108.958 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.843 ' CB ' HD22 ' A' ' 102' ' ' LEU . 37.2 t -153.29 151.39 29.96 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 1.041 ' CE2' HG11 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -138.49 174.98 9.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.288 -1.324 . . . . 10.0 110.773 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -88.58 139.77 30.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.348 -0.982 . . . . 10.0 108.348 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.008 HG21 HD12 ' A' ' 71' ' ' ILE . 21.0 mm -146.97 76.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.828 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.587 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 1.1 m-20 58.12 51.83 8.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.943 0.402 . . . . 10.0 111.281 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 38.4 mt-10 85.88 -25.64 0.11 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.224 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -88.82 130.64 35.34 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 110.237 -0.283 . . . . 10.0 110.237 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.004 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.66 114.32 25.15 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.651 ' HB2' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -88.85 136.6 32.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.096 -177.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -143.18 142.29 31.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.255 0.55 . . . . 10.0 112.344 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.844 ' CD2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -131.4 138.35 49.07 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.235 -1.024 . . . . 10.0 108.235 178.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' OD1' ' CB ' ' A' ' 28' ' ' ASP . 9.6 t0 -49.15 120.76 4.21 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.628 -0.429 . . . . 10.0 110.817 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.915 HG13 ' HA ' ' A' ' 13' ' ' VAL . 19.1 m -57.98 -14.94 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.235 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' CB ' ' OD1' ' A' ' 26' ' ' ASP . 7.2 t70 -63.02 -36.2 82.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.162 0.505 . . . . 10.0 109.898 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.803 HD21 HG22 ' A' ' 86' ' ' THR . 15.8 t-20 -95.19 -45.89 7.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.506 -0.77 . . . . 10.0 111.362 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.645 HG21 ' HG ' ' A' ' 14' ' ' LEU . 23.3 mm -61.35 132.31 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 120.823 0.344 . . . . 10.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' O ' ' CE ' ' A' ' 32' ' ' MET . 50.5 mt-10 -87.95 -64.46 1.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.962 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.424 ' HE2' ' HB2' ' A' ' 32' ' ' MET . 6.4 tpp -169.07 173.03 7.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.39 . . . . 10.0 110.855 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.728 HG11 HG11 ' A' ' 98' ' ' VAL . 34.0 m -100.31 126.76 53.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.781 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.68 HG13 ' HB ' ' A' ' 81' ' ' ILE . 11.9 pt -103.88 155.45 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.714 -0.675 . . . . 10.0 111.124 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -88.79 -175.78 5.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.991 -0.549 . . . . 10.0 111.171 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.416 ' CE ' ' HB3' ' A' ' 79' ' ' LYS . 19.3 ptpt -88.68 141.15 28.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 10.0 111.025 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.4 p -175.41 168.81 3.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 10.0 110.661 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -46.51 141.13 3.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.757 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 52' ' ' VAL . 6.5 mt -155.25 155.81 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.391 0.615 . . . . 10.0 112.303 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.877 HG23 ' HG2' ' A' ' 43' ' ' PRO . 15.2 m -45.61 98.52 0.19 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 114.774 -1.103 . . . . 10.0 111.523 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -96.51 -54.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.28 2.653 . . . . 10.0 114.524 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.605 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 47.3 t -63.6 -50.43 72.4 Favored Pre-proline 0 N--CA 1.463 0.178 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.877 ' HG2' HG23 ' A' ' 40' ' ' THR . 78.0 Cg_exo -49.45 -59.0 1.4 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.084 1.856 . . . . 10.0 112.54 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 45' ' ' SER . 4.0 tmmm? 57.92 -78.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.025 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 46' ' ' ARG . 30.2 t 55.34 154.67 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.861 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.596 ' HB2' ' O ' ' A' ' 45' ' ' SER . 1.3 mpp_? 82.12 -29.78 0.1 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.942 -0.572 . . . . 10.0 112.095 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 90.6 m-70 68.74 50.4 0.65 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.008 0.432 . . . . 10.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.496 ' CE2' ' HB ' ' A' ' 68' ' ' ILE . 8.5 t80 -172.36 -43.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 10.0 109.846 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.926 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.7 t -70.2 128.83 34.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.518 -0.765 . . . . 10.0 111.12 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.508 ' HG3' HG23 ' A' ' 62' ' ' VAL . 15.7 pt-20 -69.64 -40.73 76.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.611 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.584 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -165.91 -175.95 36.81 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.551 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 39' ' ' ILE . 2.0 m -155.31 168.88 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.248 -0.278 . . . . 10.0 110.248 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.827 HD11 HD11 ' A' ' 60' ' ' ILE . 26.2 pt -154.48 144.14 13.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.766 0.317 . . . . 10.0 111.463 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -88.78 137.68 32.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.044 -0.525 . . . . 10.0 111.295 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.445 ' HG ' ' HG2' ' A' ' 56' ' ' ARG . 54.4 tp -169.12 136.7 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.557 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' NE ' ' HA ' ' A' ' 56' ' ' ARG . 5.1 mmp_? 52.47 46.06 27.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.809 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.77 35.34 62.65 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.874 -0.603 . . . . 10.0 112.889 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -160.85 127.99 4.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 10.0 110.569 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.613 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.6 mp -89.05 124.37 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.109 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.016 HG22 ' HB2' ' A' ' 90' ' ' GLU . 29.1 pt -95.86 124.96 50.55 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.633 -0.258 . . . . 10.0 111.345 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.803 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 85.0 Cg_endo -82.54 115.91 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.507 2.138 . . . . 10.0 112.808 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.584 HG22 ' C ' ' A' ' 51' ' ' GLY . 23.1 m -88.98 133.39 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.168 -0.679 . . . . 10.0 109.168 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.926 HG22 ' HA ' ' A' ' 49' ' ' VAL . 59.5 t -145.17 157.79 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.799 0.809 . . . . 10.0 113.153 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.527 ' N ' HG12 ' A' ' 63' ' ' VAL . 5.2 m120 -78.15 66.71 3.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.391 -1.277 . . . . 10.0 108.698 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.791 ' O ' HD23 ' A' ' 65' ' ' LEU . 6.4 tt -53.88 -29.35 41.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.837 -0.62 . . . . 10.0 111.531 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.635 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -64.89 -25.84 68.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.54 -0.541 . . . . 10.0 109.54 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HE3' ' CE1' ' A' ' 48' ' ' PHE . 24.1 ttpt -77.91 -52.13 9.32 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.236 -0.893 . . . . 10.0 111.0 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.691 HG22 ' HA ' ' A' ' 65' ' ' LEU . 10.3 tt -53.82 -40.17 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.884 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.1 tm? -75.72 -44.99 39.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.545 -1.661 . . . . 10.0 109.534 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.529 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 113.06 -95.65 0.78 Allowed Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.049 -0.523 . . . . 10.0 113.133 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.008 HD12 HG21 ' A' ' 18' ' ' ILE . 3.6 pt 48.66 164.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.097 0.777 . . . . 10.0 113.097 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.2 m -47.03 -36.81 8.39 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.158 -0.682 . . . . 10.0 109.158 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.885 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.0 t80 -26.09 140.09 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.791 -1.095 . . . . 10.0 112.808 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -160.31 34.66 0.17 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.248 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.521 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 50.4 mt-10 52.53 46.93 25.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.247 0.462 . . . . 10.0 112.247 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 77' ' ' LYS . 23.9 pt20 -97.87 -47.2 5.65 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.746 0.647 . . . . 10.0 112.746 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.55 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 14.3 mmmm -108.96 -25.15 10.88 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.362 0.505 . . . . 10.0 112.362 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.64 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 3.2 mmm -35.94 144.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.724 0.409 . . . . 10.0 111.972 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 51.5 mtmt -160.7 -45.06 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.201 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.437 ' O ' HD12 ' A' ' 94' ' ' LEU . 74.5 m -88.86 142.86 27.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.994 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.68 ' HB ' HG13 ' A' ' 34' ' ' ILE . 73.6 mt -100.66 160.52 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.314 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.575 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 31.8 mt -123.63 158.74 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.591 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.512 ' N ' HG22 ' A' ' 82' ' ' ILE . 42.7 t -131.68 150.77 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.032 0.444 . . . . 10.0 111.222 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -156.15 171.78 19.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.896 -178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -128.24 129.05 45.82 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.803 HG22 HD21 ' A' ' 29' ' ' ASN . 67.1 p -145.51 108.27 4.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.879 0.325 . . . . 10.0 111.879 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 88' ' ' ASP . 14.9 tppt? 47.4 59.95 3.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.211 0.529 . . . . 10.0 110.269 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.492 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 2.4 p30 59.16 32.54 22.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.828 -1.078 . . . . 10.0 111.59 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.908 HG12 HG22 ' A' ' 91' ' ' VAL . 66.1 t -128.58 109.34 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 115.3 -0.864 . . . . 10.0 109.156 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 1.016 ' HB2' HG22 ' A' ' 60' ' ' ILE . 34.1 mt-10 -88.28 97.78 11.22 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.281 -1.748 . . . . 10.0 106.281 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.018 HG21 HD13 ' A' ' 142' ' ' ILE . 3.4 t -88.46 152.23 3.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 113.478 -1.692 . . . . 10.0 113.059 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.56 148.4 17.19 Favored Glycine 0 C--N 1.316 -0.547 0 CA-C-N 114.66 -1.155 . . . . 10.0 113.494 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.646 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -138.76 124.78 20.02 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.75 0.309 . . . . 10.0 110.45 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.566 HD13 HG12 ' A' ' 81' ' ' ILE . 54.7 tp -88.62 130.07 35.36 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.603 0.594 . . . . 10.0 112.603 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.041 HG11 ' CE2' ' A' ' 16' ' ' PHE . 34.2 m -143.55 -175.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 115.33 -0.85 . . . . 10.0 110.504 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 78' ' ' MET . 28.5 t70 -108.7 -62.96 1.39 Allowed 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 112.599 0.592 . . . . 10.0 112.599 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 16' ' ' PHE . 13.6 tpt180 -119.34 117.9 29.78 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.41 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.765 HG23 ' HD1' ' A' ' 16' ' ' PHE . 7.0 p -112.52 115.42 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 122.432 1.11 . . . . 10.0 111.502 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -65.84 -31.21 72.03 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 112.962 -1.926 . . . . 10.0 110.809 -178.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.55 -124.53 6.99 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.258 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.1 t -53.05 129.65 13.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.909 0.354 . . . . 10.0 110.129 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.843 HD22 ' CB ' ' A' ' 15' ' ' SER . 59.7 tp -132.68 138.9 47.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.994 0.426 . . . . 10.0 111.177 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.618 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -88.82 70.16 8.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.984 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.664 HG12 ' HG ' ' A' ' 102' ' ' LEU . 8.8 mm -88.94 130.87 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.656 HG22 ' HG2' ' A' ' 10' ' ' GLU . 32.0 p -88.75 -175.89 5.05 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.605 -1.257 . . . . 10.0 107.605 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.799 ' OE2' HD12 ' A' ' 109' ' ' LEU . 38.7 tt0 -147.9 73.03 1.25 Allowed 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 118.929 -1.108 . . . . 10.0 112.79 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -102.57 20.79 16.45 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.701 -1.136 . . . . 10.0 109.1 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.61 ' O ' HG23 ' A' ' 112' ' ' THR . 16.4 pt20 -125.05 -46.26 1.83 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.474 -0.784 . . . . 10.0 111.382 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.799 HD12 ' OE2' ' A' ' 106' ' ' GLU . 15.8 mt -69.66 -146.08 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.966 -0.383 . . . . 10.0 109.966 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.696 ' CB ' HD11 ' A' ' 8' ' ' LEU . 15.9 t70 70.9 -145.52 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.447 0.165 . . . . 10.0 111.447 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' H ' ' CG ' ' A' ' 110' ' ' ASP . 86.7 mt -68.77 -44.06 74.47 Favored 'General case' 0 CA--C 1.523 -0.078 0 N-CA-C 111.635 0.235 . . . . 10.0 111.635 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 108' ' ' GLN . 6.7 t -48.28 -32.22 7.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.069 0.461 . . . . 10.0 110.768 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 115' ' ' SER . 23.9 p30 44.75 54.85 6.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 10.0 112.167 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.522 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 40.8 t -68.89 63.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.264 0.554 . . . . 10.0 110.078 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.592 ' HA ' ' HB2' ' A' ' 123' ' ' LYS . 45.6 t -66.96 -12.38 59.53 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.621 -0.718 . . . . 10.0 111.739 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.97 17.94 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.062 0.764 . . . . 10.0 113.062 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.674 ' HD2' ' HB3' ' A' ' 125' ' ' LEU . 73.0 mmtt -64.24 -86.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.824 0.305 . . . . 10.0 111.824 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.678 ' CE2' HD21 ' A' ' 69' ' ' LEU . 32.3 t80 -70.61 -59.04 3.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.011 0.434 . . . . 10.0 110.772 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.76 -137.73 7.15 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.862 -0.685 . . . . 10.0 112.564 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 120' ' ' LYS . 63.9 tttp -80.54 58.25 3.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.875 0.369 . . . . 10.0 110.934 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.597 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 16.2 tppt? -161.26 -40.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.136 0.493 . . . . 10.0 110.804 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.408 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 88.0 p -163.52 -154.49 0.28 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.68 -0.859 . . . . 10.0 108.68 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -176.65 40.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.852 0.686 . . . . 10.0 112.852 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 135' ' ' TYR . . . -121.04 44.16 1.41 Allowed Glycine 0 C--O 1.223 -0.538 0 C-N-CA 119.899 -1.143 . . . . 10.0 112.571 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.781 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.1 tm? -62.98 130.17 43.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.781 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -144.1 163.14 14.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.589 -178.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.491 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 8.5 ptpp? -164.26 142.28 7.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.587 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 3.2 m -164.83 148.67 8.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.378 -0.374 . . . . 10.0 110.761 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' OD1' HG22 ' A' ' 128' ' ' THR . 1.0 OUTLIER 55.33 47.71 20.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.934 0.397 . . . . 10.0 111.019 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.81 33.56 43.03 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.997 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 128' ' ' THR . 6.5 ptt-85 -137.84 130.24 29.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.761 0.315 . . . . 10.0 110.251 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.1 mp -88.93 139.74 30.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.989 0.424 . . . . 10.0 111.183 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.004 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.7 mt -133.25 129.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.15 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.458 ' HB ' HD13 ' A' ' 23' ' ' LEU . 24.4 mm -88.92 120.74 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 108.606 -0.887 . . . . 10.0 108.606 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.9 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 52.9 t80 -121.38 148.51 44.28 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.239 -0.584 . . . . 10.0 110.363 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.846 HD23 HG21 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -161.01 148.12 15.25 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.505 0.669 . . . . 10.0 111.399 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.8 p-10 -95.87 32.43 1.88 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.4 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.865 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 19.7 tt 40.07 18.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.603 -1.18 . . . . 10.0 114.041 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 137' ' ' ASP . 38.4 t70 -79.73 -53.82 6.45 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.966 0.728 . . . . 10.0 112.966 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 121' ' ' LYS . 17.3 tppt? -77.77 -34.17 52.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.447 0.642 . . . . 10.0 110.438 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.865 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.52 -45.95 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.422 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.018 HD13 HG21 ' A' ' 91' ' ' VAL . 7.7 tp -64.48 -43.41 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.403 -0.519 . . . . 10.0 109.733 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.797 ' O ' HG12 ' A' ' 147' ' ' VAL . 44.4 tt0 -47.95 -41.16 24.24 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.117 -0.697 . . . . 10.0 109.117 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.458 ' HA ' HG12 ' A' ' 147' ' ' VAL . 50.7 mm-40 -70.73 -35.77 72.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.008 -0.996 . . . . 10.0 110.829 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.638 ' CD1' HG11 ' A' ' 91' ' ' VAL . 60.3 mt -55.18 -50.98 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.822 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.9 p -73.5 -53.34 10.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.975 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 143' ' ' GLU . 14.4 p -63.0 -17.81 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 10.0 111.791 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.1 OUTLIER -44.29 -48.73 9.56 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.779 0.323 . . . . 10.0 111.392 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -64.61 147.44 52.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.979 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -160.39 47.98 0.39 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 10.0 112.492 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.341 . . . . 10.0 110.961 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.776 0.322 . . . . 10.0 111.324 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -158.18 -114.17 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.367 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 69.6 p -157.37 -50.69 0.07 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.737 0.303 . . . . 10.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.944 HD12 ' N ' ' A' ' 5' ' ' ALA . 2.9 pp -59.13 -33.85 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.345 -0.389 . . . . 10.0 111.026 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.944 ' N ' HD12 ' A' ' 4' ' ' LEU . . . 54.38 62.65 2.47 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.247 0.462 . . . . 10.0 112.247 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 56.4 m-20 58.79 135.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.132 0.491 . . . . 10.0 111.667 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 6' ' ' ASP . . . 173.67 -69.56 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.965 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.7 mt 45.38 43.5 8.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.542 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 105' ' ' THR . 13.2 mmmm -82.21 -52.57 6.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.035 -0.53 . . . . 10.0 111.213 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.595 ' HG2' HG22 ' A' ' 105' ' ' THR . 41.4 mt-10 -140.49 164.17 30.85 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.331 0.586 . . . . 10.0 110.531 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.577 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.0 t80 -156.52 139.36 15.24 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.894 -1.048 . . . . 10.0 112.453 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 16.7 pt-20 -88.76 138.77 31.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.567 -0.901 . . . . 10.0 108.567 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.947 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -154.97 170.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 113.317 0.858 . . . . 10.0 113.317 -176.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.95 HD11 HD13 ' A' ' 82' ' ' ILE . 3.1 tm? -88.62 132.79 34.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.988 -1.116 . . . . 10.0 107.988 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.831 ' HB3' HD22 ' A' ' 102' ' ' LEU . 83.5 p -143.16 152.55 41.92 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 113.376 0.88 . . . . 10.0 113.376 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.728 ' CE1' HD11 ' A' ' 18' ' ' ILE . 15.1 p90 -150.83 162.8 40.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.47 -1.241 . . . . 10.0 109.908 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.52 ' HG3' HD21 ' A' ' 99' ' ' LEU . 95.7 mt-10 -88.45 139.81 30.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.037 HG21 HD12 ' A' ' 71' ' ' ILE . 35.5 mm -134.47 90.03 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.421 -0.809 . . . . 10.0 111.697 -177.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 47.5 m-20 44.62 60.17 3.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.373 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.2 mt-10 87.36 -42.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.196 -0.911 . . . . 10.0 112.093 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.0 pt20 -88.96 146.18 25.05 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.603 -0.439 . . . . 10.0 109.879 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.969 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.61 166.97 13.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 10.0 110.882 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.9 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.3 tp -152.17 140.2 20.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.326 -0.397 . . . . 10.0 111.325 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.763 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -145.89 151.12 37.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 -177.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.917 ' CD2' HD21 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -133.12 141.3 48.09 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.15 -0.932 . . . . 10.0 108.714 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 137' ' ' ASP . 12.6 p-10 -49.73 122.76 6.83 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.551 -0.46 . . . . 10.0 111.046 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.947 HG13 ' HA ' ' A' ' 13' ' ' VAL . 24.8 m -61.27 -13.85 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.015 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -64.61 -40.48 95.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.406 0.622 . . . . 10.0 109.531 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.748 HD21 HG22 ' A' ' 86' ' ' THR . 16.5 t-20 -87.81 -46.09 9.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.972 -1.013 . . . . 10.0 110.54 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.762 HG21 ' HG ' ' A' ' 14' ' ' LEU . 22.5 mm -65.85 132.3 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.541 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.411 ' O ' ' CE ' ' A' ' 32' ' ' MET . 53.5 mm-40 -82.64 -64.03 1.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.656 -0.247 . . . . 10.0 111.368 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.411 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.03 172.54 7.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 10.0 111.026 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.474 ' CG1' HG11 ' A' ' 98' ' ' VAL . 34.9 m -89.0 147.09 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.749 -0.659 . . . . 10.0 111.613 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.528 HD13 ' CG2' ' A' ' 83' ' ' VAL . 29.0 pt -145.83 129.86 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.558 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 50.1 mt-10 -98.43 124.7 43.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.489 -0.323 . . . . 10.0 111.118 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.865 ' HB2' HD12 ' A' ' 81' ' ' ILE . 62.7 mttp -160.42 -176.02 5.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.215 -0.448 . . . . 10.0 110.937 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.3 p -167.22 145.14 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.091 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 t70 48.82 45.01 22.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.304 0.573 . . . . 10.0 109.984 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.79 HD11 HD13 ' A' ' 81' ' ' ILE . 26.0 mt -49.81 -69.48 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.105 -0.952 . . . . 10.0 112.771 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.749 HG22 ' HG3' ' A' ' 43' ' ' PRO . 95.5 m -143.15 130.13 10.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.301 -0.409 . . . . 10.0 111.36 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -91.89 130.07 1.13 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.371 2.714 . . . . 10.0 113.366 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.807 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 40.1 t 58.53 43.19 0.87 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.346 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.807 ' HD3' ' N ' ' A' ' 42' ' ' VAL . 4.0 Cg_exo -79.83 3.28 7.71 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.648 2.232 . . . . 10.0 112.46 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 44' ' ' LYS . 2.7 mmmm -49.13 151.01 1.45 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.022 0.439 . . . . 10.0 112.06 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.3 t -174.2 68.25 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.853 -0.612 . . . . 10.0 111.773 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.5 ' O ' ' CG ' ' A' ' 47' ' ' HIS . 31.7 tpt85 66.97 46.53 1.57 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.049 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.5 ' CG ' ' O ' ' A' ' 46' ' ' ARG . 90.7 m-70 -163.07 -113.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.894 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.496 ' O ' ' CG ' ' A' ' 48' ' ' PHE . 16.2 t80 -173.8 36.79 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.157 0.503 . . . . 10.0 110.104 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.63 ' HA ' HG22 ' A' ' 63' ' ' VAL . 40.1 t -84.3 127.78 39.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.725 -0.67 . . . . 10.0 111.917 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.41 ' OE1' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -93.46 -24.29 18.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.583 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.795 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -152.86 165.04 30.99 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.804 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.604 HG12 HG11 ' A' ' 49' ' ' VAL . 1.9 m -151.11 163.64 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.287 0.543 . . . . 10.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.092 HD11 HD11 ' A' ' 60' ' ' ILE . 27.6 pt -160.22 146.26 5.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.137 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.446 HD22 HD11 ' A' ' 59' ' ' ILE . 23.4 t-20 -88.8 134.24 33.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.732 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.6 tp -169.05 143.05 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.662 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 78.0 ttt180 52.77 45.81 27.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.255 0.55 . . . . 10.0 110.493 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.4 38.09 61.68 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.755 -0.657 . . . . 10.0 112.746 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -169.06 139.06 2.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.824 0.345 . . . . 10.0 111.007 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.627 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.99 128.24 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.156 -0.474 . . . . 10.0 111.054 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.092 HD11 HD11 ' A' ' 53' ' ' ILE . 26.1 pt -98.69 139.92 21.43 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.217 -0.447 . . . . 10.0 111.432 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 77.6 Cg_endo -95.46 114.76 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.352 2.701 . . . . 10.0 112.712 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.795 HG22 ' C ' ' A' ' 51' ' ' GLY . 33.7 m -88.98 141.04 14.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.648 -0.251 . . . . 10.0 110.512 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.63 HG22 ' HA ' ' A' ' 49' ' ' VAL . 84.1 t -142.93 156.29 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.258 0.551 . . . . 10.0 111.694 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.589 ' O ' ' HD3' ' A' ' 67' ' ' LYS . 4.0 m120 -77.26 61.39 2.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.951 0.882 . . . . 10.0 109.584 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.837 ' O ' HD23 ' A' ' 65' ' ' LEU . 7.5 tt -48.86 -26.34 2.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.776 . . . . 10.0 112.379 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.89 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -69.44 -26.34 64.55 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 119.993 -0.683 . . . . 10.0 111.301 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.658 ' HD3' ' H ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -87.42 -35.01 18.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.723 -0.391 . . . . 10.0 110.775 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.658 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 8.5 tt -57.84 -41.18 79.27 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.0 HD21 ' CE2' ' A' ' 118' ' ' PHE . 0.8 OUTLIER -79.36 -46.99 16.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 113.249 -1.796 . . . . 10.0 108.505 176.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 116.15 -85.17 0.39 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.173 -0.921 . . . . 10.0 112.656 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.037 HD12 HG21 ' A' ' 18' ' ' ILE . 3.0 pt 46.86 166.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 42.9 t -47.69 -34.72 8.56 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.512 -0.551 . . . . 10.0 109.512 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.857 ' HB3' HG13 ' A' ' 71' ' ' ILE . 14.6 t80 -31.37 143.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.877 -1.056 . . . . 10.0 112.932 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.95 41.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.756 -0.656 . . . . 10.0 110.722 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 57.37 38.05 28.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.108 -0.496 . . . . 10.0 111.228 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -90.28 -72.47 0.57 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.398 0.518 . . . . 10.0 112.398 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 78' ' ' MET . 0.1 OUTLIER -90.87 -20.73 21.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 10.0 112.204 -178.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.452 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 20.9 mmt -21.13 138.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.087 0.773 . . . . 10.0 113.087 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -172.15 -38.96 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.492 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.718 ' O ' HD12 ' A' ' 94' ' ' LEU . 70.9 m -88.85 166.9 13.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.702 0.287 . . . . 10.0 110.997 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.865 HD12 ' HB2' ' A' ' 36' ' ' LYS . 85.5 mt -138.65 156.3 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.218 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.95 HD13 HD11 ' A' ' 14' ' ' LEU . 48.6 mt -132.78 158.23 43.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 121.081 0.467 . . . . 10.0 111.84 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.528 ' CG2' HD13 ' A' ' 34' ' ' ILE . 50.5 t -130.96 143.1 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.635 -0.712 . . . . 10.0 110.155 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.65 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -140.22 178.19 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.511 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.489 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 54.7 ttp180 -132.95 130.15 39.21 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.748 HG22 HD21 ' A' ' 29' ' ' ASN . 62.8 p -137.64 103.07 4.92 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.438 0.637 . . . . 10.0 111.832 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.6 tppp? 47.59 47.26 17.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.902 -1.045 . . . . 10.0 110.78 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 45.2 m-20 81.55 28.5 0.16 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.932 -1.031 . . . . 10.0 111.985 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.837 HG12 HG22 ' A' ' 91' ' ' VAL . 50.8 t -125.76 108.93 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.39 -0.823 . . . . 10.0 109.146 176.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.631 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 87.9 tt0 -88.24 99.49 12.26 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.869 HG21 HD13 ' A' ' 142' ' ' ILE . 2.7 t -88.66 157.71 3.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 113.338 -1.755 . . . . 10.0 112.653 -174.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -125.24 158.23 19.62 Favored Glycine 0 C--N 1.317 -0.487 0 CA-C-N 114.719 -1.128 . . . . 10.0 112.211 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.65 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.2 t80 -158.42 128.55 5.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.096 0.474 . . . . 10.0 112.082 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 80' ' ' SER . 63.2 tp -88.84 127.38 35.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.683 -0.69 . . . . 10.0 111.439 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.513 HG11 ' CZ ' ' A' ' 16' ' ' PHE . 32.5 m -135.34 -175.14 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.12 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.403 ' OD1' ' HG3' ' A' ' 77' ' ' LYS . 19.8 t70 -88.36 -79.64 0.3 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.167 0.508 . . . . 10.0 111.317 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -130.96 108.19 9.64 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.031 -0.729 . . . . 10.0 109.031 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.607 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.1 p -88.97 114.58 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.302 1.049 . . . . 10.0 111.58 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.71 -28.43 69.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.235 -1.802 . . . . 10.0 110.944 -178.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.1 -125.78 7.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.677 -0.773 . . . . 10.0 111.533 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -51.76 131.1 12.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.974 0.387 . . . . 10.0 110.499 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.831 HD22 ' HB3' ' A' ' 15' ' ' SER . 50.0 tp -134.92 138.51 44.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.952 0.406 . . . . 10.0 111.118 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.3 ptp85 -88.83 72.27 8.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.98 HD12 HG11 ' A' ' 126' ' ' VAL . 10.3 mm -88.95 130.17 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.598 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.595 HG22 ' HG2' ' A' ' 10' ' ' GLU . 16.3 p -88.64 149.66 23.42 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.454 -1.684 . . . . 10.0 106.454 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 109' ' ' LEU . 8.3 tp10 -134.57 80.73 1.87 Allowed 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 114.088 1.144 . . . . 10.0 114.088 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -88.66 -6.81 57.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -76.28 -53.2 8.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.784 -1.098 . . . . 10.0 111.025 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 54.4 mt -68.8 45.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.876 -0.602 . . . . 10.0 112.324 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.753 ' O ' HG13 ' A' ' 114' ' ' VAL . 64.5 t0 -76.63 113.11 13.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 110' ' ' ASP . 84.2 mt 69.28 -47.13 0.58 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.58 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 112' ' ' THR . 8.6 t -176.74 67.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.716 0.293 . . . . 10.0 111.393 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 p-10 44.89 71.25 0.27 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.26 -0.427 . . . . 10.0 111.462 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 110' ' ' ASP . 34.6 m -78.17 41.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 112.419 0.526 . . . . 10.0 112.419 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 42.1 t 172.56 129.57 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.757 0.313 . . . . 10.0 110.703 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 118' ' ' PHE . 29.6 m-20 -73.0 -54.07 9.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.746 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 125' ' ' LEU . 74.1 mmtt 66.74 -55.91 0.42 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.088 -0.505 . . . . 10.0 111.949 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 1.0 ' CE2' HD21 ' A' ' 69' ' ' LEU . 6.1 t80 -137.77 36.91 2.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.442 0.639 . . . . 10.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.23 28.29 1.18 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 114.949 -1.023 . . . . 10.0 113.592 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -70.63 -34.45 72.1 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 121' ' ' LYS . 16.6 tppt? -159.47 37.17 0.2 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.998 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.666 ' HB2' ' CB ' ' A' ' 136' ' ' LEU . 88.9 p -176.57 -144.12 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.767 -0.651 . . . . 10.0 110.736 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.513 ' HE3' ' HG2' ' A' ' 140' ' ' LYS . 95.5 mttt -160.94 26.2 0.14 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.023 0.749 . . . . 10.0 113.023 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -149.62 154.37 25.69 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 119.242 -1.456 . . . . 10.0 113.75 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.905 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.2 tm? -159.63 139.58 11.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.98 HG11 HD12 ' A' ' 104' ' ' ILE . 1.4 p -150.46 161.03 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.373 0.606 . . . . 10.0 111.842 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -158.91 132.62 7.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.43 -0.805 . . . . 10.0 110.724 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.734 ' O ' ' HB2' ' A' ' 131' ' ' ARG . 8.9 m -164.27 140.74 6.38 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.062 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 131' ' ' ARG . 25.3 m-20 62.42 45.74 6.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.03 0.443 . . . . 10.0 110.201 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 56.03 25.12 45.33 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.433 -0.889 . . . . 10.0 110.961 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.734 ' HB2' ' O ' ' A' ' 128' ' ' THR . 99.5 mtt180 -107.89 120.86 43.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.435 -0.383 . . . . 10.0 111.471 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 21' ' ' GLN . 86.1 mt -89.07 82.92 6.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.969 HG12 ' HB3' ' A' ' 22' ' ' ALA . 2.4 mt -88.77 131.37 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.9 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.98 148.35 4.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 107.917 -1.142 . . . . 10.0 107.917 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.527 ' O ' ' CA ' ' A' ' 124' ' ' GLY . 35.7 t80 -141.16 151.89 44.23 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.028 -0.669 . . . . 10.0 111.457 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.917 HD21 ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -169.07 150.79 4.56 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 113.638 0.977 . . . . 10.0 113.638 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.404 ' HA ' ' OD1' ' A' ' 26' ' ' ASP . 55.0 p30 -99.33 32.92 2.59 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.604 -1.18 . . . . 10.0 109.716 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.904 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 16.2 tt 40.15 24.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.44 -1.255 . . . . 10.0 113.636 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -77.56 -60.41 2.38 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.017 0.747 . . . . 10.0 113.017 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.513 ' HG2' ' HE3' ' A' ' 123' ' ' LYS . 42.9 mmtm -74.28 -29.19 61.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.162 0.506 . . . . 10.0 111.08 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.904 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.35 -46.78 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.737 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.869 HD13 HG21 ' A' ' 91' ' ' VAL . 7.2 tp -63.34 -47.11 93.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 120.29 -0.564 . . . . 10.0 110.482 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 147' ' ' VAL . 50.4 mt-10 -50.97 -39.47 55.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.558 ' HB2' HD11 ' A' ' 68' ' ' ILE . 5.7 mm-40 -77.86 -27.08 49.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.358 -0.837 . . . . 10.0 111.061 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.695 ' CD1' HG11 ' A' ' 91' ' ' VAL . 37.5 mt -53.85 -49.28 59.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 121.064 0.459 . . . . 10.0 110.211 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 77.9 p -82.65 -45.84 14.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.767 -0.652 . . . . 10.0 111.364 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 143' ' ' GLU . 51.5 t -58.15 -30.55 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.239 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.449 ' HG2' ' CG ' ' A' ' 48' ' ' PHE . 27.7 tptp -38.86 -48.84 1.6 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 61.38 151.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 10.0 110.89 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -161.45 -42.72 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.741 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.893 0.378 . . . . 10.0 111.049 179.929 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.731 0.301 . . . . 10.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HE2' ' HB3' ' A' ' 5' ' ' ALA . 36.9 mtmm -59.58 -45.36 92.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.998 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 54.8 m 71.69 -49.38 0.69 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.67 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 5' ' ' ALA . 4.3 pp -65.41 -40.81 93.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 10.0 110.555 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.882 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -94.77 130.1 41.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.224 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' O ' HD22 ' A' ' 8' ' ' LEU . 1.5 m-20 -68.4 133.4 48.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.454 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.23 132.6 54.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.786 0.327 . . . . 10.0 111.533 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.545 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.0 mm? -87.33 47.94 1.58 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.288 -0.414 . . . . 10.0 111.208 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.78 ' HE3' ' HA ' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -153.84 -54.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.723 0.297 . . . . 10.0 110.585 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 33.5 mt-10 -139.4 164.14 30.64 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.337 -0.392 . . . . 10.0 109.988 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.56 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.5 t80 -164.78 139.67 5.37 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 113.265 0.839 . . . . 10.0 113.265 -174.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.423 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 3.0 mt-10 -88.67 135.03 33.71 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.294 -0.866 . . . . 10.0 109.16 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' A' ' 102' ' ' LEU . 1.2 p -152.36 169.35 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.823 0.675 . . . . 10.0 112.823 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.724 ' HG ' HG21 ' A' ' 30' ' ' ILE . 3.4 tm? -88.84 138.1 31.72 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.832 ' HB3' HD22 ' A' ' 102' ' ' LEU . 97.6 p -145.61 153.91 41.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 113.613 0.968 . . . . 10.0 113.613 -177.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -152.88 159.04 42.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.17 -1.377 . . . . 10.0 110.403 -179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.566 ' HG2' HD21 ' A' ' 99' ' ' LEU . 53.1 mm-40 -88.63 124.11 33.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.341 0.591 . . . . 10.0 109.968 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.109 HG21 HD12 ' A' ' 71' ' ' ILE . 22.9 mm -118.52 94.45 3.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.177 -0.92 . . . . 10.0 110.865 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 30.8 m-20 44.05 60.13 2.88 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.827 0.677 . . . . 10.0 112.827 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 48.2 mt-10 88.54 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.49 -0.777 . . . . 10.0 112.607 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.682 ' NE2' HD13 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -88.84 152.96 21.44 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.438 -0.505 . . . . 10.0 110.278 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.997 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -89.03 155.52 19.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.807 0.336 . . . . 10.0 110.875 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.831 HD12 ' N ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -141.35 133.96 28.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.469 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.831 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -140.18 153.29 46.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.91 0.707 . . . . 10.0 112.91 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.942 ' CE2' HD22 ' A' ' 136' ' ' LEU . 2.8 m-85 -138.08 144.89 41.13 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -43.53 100.49 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.425 0.631 . . . . 10.0 110.447 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.615 HG12 ' HA ' ' A' ' 13' ' ' VAL . 3.5 p -46.84 -19.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.021 -0.991 . . . . 10.0 111.137 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.62 -43.68 88.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.121 0.486 . . . . 10.0 109.75 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.678 ' CG ' HG21 ' A' ' 138' ' ' ILE . 18.0 t-20 -78.46 -43.27 27.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.485 -0.78 . . . . 10.0 110.607 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.724 HG21 ' HG ' ' A' ' 14' ' ' LEU . 13.0 mm -63.83 125.41 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.32 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.607 ' O ' ' HG3' ' A' ' 32' ' ' MET . 4.6 mm-40 -84.24 -76.6 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.764 0.283 . . . . 10.0 111.764 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.607 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 5.0 mtm -157.34 150.69 23.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.193 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.858 HG11 HG11 ' A' ' 98' ' ' VAL . 34.5 m -88.9 128.03 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.391 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.404 ' CG1' ' HB ' ' A' ' 81' ' ' ILE . 29.9 pt -100.38 179.48 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 10.0 111.29 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -88.91 150.87 22.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.119 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -88.83 134.98 33.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.16 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t 178.29 -174.22 0.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.903 -0.589 . . . . 10.0 110.58 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.32 144.18 25.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 10.0 110.547 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.494 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 21.4 mt -155.61 -70.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.584 0.586 . . . . 10.0 112.584 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.858 HG23 ' HG2' ' A' ' 43' ' ' PRO . 99.2 m -145.86 66.43 11.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.474 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.75 -50.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.946 2.43 . . . . 10.0 112.985 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 60.0 t -78.29 -53.93 1.28 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.804 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.858 ' HG2' HG23 ' A' ' 40' ' ' THR . 19.1 Cg_endo -60.82 -12.48 22.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.176 1.918 . . . . 10.0 112.941 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -41.62 158.36 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.886 0.374 . . . . 10.0 110.951 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.6 t -178.98 66.53 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.809 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 39.3 mmt180 -152.24 -33.29 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.925 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 19.8 m80 69.45 46.47 0.74 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.274 0.559 . . . . 10.0 110.653 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.539 ' CE2' ' HE3' ' A' ' 67' ' ' LYS . 2.0 t80 -179.94 -41.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.389 -0.823 . . . . 10.0 108.915 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.886 ' HA ' HG22 ' A' ' 63' ' ' VAL . 55.2 t -73.78 129.26 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.14 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' A' ' 62' ' ' VAL . 17.0 pt-20 -71.86 -40.04 69.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.583 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 62' ' ' VAL . . . -169.06 -175.92 38.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.753 -0.737 . . . . 10.0 112.63 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 53' ' ' ILE . 3.5 m -158.93 172.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.691 0.282 . . . . 10.0 110.283 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 52' ' ' VAL . 30.7 pt -161.33 144.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.813 0.34 . . . . 10.0 111.344 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.572 ' ND2' HD11 ' A' ' 59' ' ' ILE . 25.6 t-20 -88.71 137.64 32.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.968 -0.56 . . . . 10.0 110.894 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.4 tp -169.07 140.09 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 49.07 46.92 22.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.264 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.37 40.32 76.14 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.912 -0.661 . . . . 10.0 112.729 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.8 tpt85 -168.92 128.06 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.686 0.279 . . . . 10.0 110.366 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.654 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -88.99 123.68 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.396 -0.365 . . . . 10.0 111.236 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.782 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.2 pp -89.18 134.34 33.31 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-N 116.563 -0.29 . . . . 10.0 110.788 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 60' ' ' ILE . 66.0 Cg_endo -98.15 117.72 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.203 2.602 . . . . 10.0 113.634 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 49' ' ' VAL . 18.5 m -97.12 133.64 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 109.084 -0.71 . . . . 10.0 109.084 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.886 HG22 ' HA ' ' A' ' 49' ' ' VAL . 68.0 t -141.3 159.9 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.783 0.801 . . . . 10.0 113.079 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.779 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.4 m120 -76.61 66.9 2.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.819 -1.082 . . . . 10.0 109.052 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.932 ' O ' HD23 ' A' ' 65' ' ' LEU . 6.3 tt -50.05 -26.46 4.4 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.705 -0.68 . . . . 10.0 111.404 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.656 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . . . -64.91 -27.71 69.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.671 -0.412 . . . . 10.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.779 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -88.4 -36.92 16.27 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.015 -0.365 . . . . 10.0 110.015 178.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.741 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 8.5 tt -61.18 -37.7 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.942 HD11 HG23 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -77.88 -40.51 39.75 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 113.278 -1.783 . . . . 10.0 109.598 177.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.577 ' C ' HG12 ' A' ' 71' ' ' ILE . . . 112.3 -102.54 1.36 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 116.07 -0.514 . . . . 10.0 112.961 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.109 HD12 HG21 ' A' ' 18' ' ' ILE . 6.5 pt 45.98 -179.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 113.088 0.773 . . . . 10.0 113.088 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.653 ' O ' ' O ' ' A' ' 73' ' ' PHE . 72.1 m -57.52 -98.6 0.0 OUTLIER 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.62 -1.622 . . . . 10.0 106.62 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.663 ' HE2' ' N ' ' A' ' 67' ' ' LYS . 1.4 t80 50.65 138.41 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 119.22 -0.992 . . . . 10.0 113.357 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -159.55 27.39 0.19 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.71 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 66.89 -48.63 0.47 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.13 0.789 . . . . 10.0 113.13 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -38.89 -42.49 0.85 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -79.5 -39.7 31.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.947 0.404 . . . . 10.0 111.395 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.529 ' HG3' ' HA ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -47.33 135.21 10.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.902 0.705 . . . . 10.0 112.902 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 78' ' ' MET . 36.7 mtmm -164.43 32.57 0.07 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.91 -1.041 . . . . 10.0 109.624 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.584 ' O ' HD12 ' A' ' 94' ' ' LEU . 38.7 t -169.12 151.25 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.274 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.404 ' HB ' ' CG1' ' A' ' 34' ' ' ILE . 65.5 mt -120.16 143.08 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.998 0.427 . . . . 10.0 111.985 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.6 HD13 HD11 ' A' ' 14' ' ' LEU . 4.2 mt -111.67 123.48 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.971 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.9 t -92.86 148.13 4.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.973 0.416 . . . . 10.0 111.008 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -143.91 -175.87 4.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.69 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.803 ' O ' HG23 ' A' ' 86' ' ' THR . 15.3 tpp85 -133.3 160.84 36.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.381 -0.6 . . . . 10.0 109.381 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 85' ' ' ARG . 18.9 p -169.06 100.0 0.37 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.293 0.568 . . . . 10.0 112.018 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.482 ' HA ' ' CE ' ' A' ' 87' ' ' LYS . 2.2 tpmt? 43.99 46.41 6.92 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.002 -0.999 . . . . 10.0 110.55 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 11.6 m-20 82.8 31.96 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.69 -1.141 . . . . 10.0 111.713 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.88 HG12 HG22 ' A' ' 91' ' ' VAL . 44.4 t -130.03 112.12 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.26 -0.882 . . . . 10.0 109.261 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 12.2 mt-10 -88.36 99.91 12.61 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.176 -1.787 . . . . 10.0 106.176 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.976 HG21 HD13 ' A' ' 142' ' ' ILE . 2.6 t -88.77 159.54 2.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 113.91 -1.495 . . . . 10.0 112.106 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.47 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -127.89 154.22 19.67 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.546 -0.835 . . . . 10.0 113.415 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -144.62 128.64 17.54 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 120.722 0.296 . . . . 10.0 110.71 -179.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 80' ' ' SER . 65.1 tp -88.67 134.39 33.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.228 0.537 . . . . 10.0 111.698 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' A' ' 16' ' ' PHE . 35.6 m -147.93 -175.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.936 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -105.11 -65.2 1.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.317 0.488 . . . . 10.0 112.317 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -130.65 120.36 23.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.754 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.858 HG11 HG11 ' A' ' 33' ' ' VAL . 9.5 p -108.1 115.06 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-O 122.245 1.022 . . . . 10.0 111.621 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.566 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -64.95 -29.94 70.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.272 -1.786 . . . . 10.0 111.114 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 91.89 -124.43 7.65 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.646 -0.787 . . . . 10.0 111.321 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.43 134.1 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 117.01 0.405 . . . . 10.0 110.549 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.832 HD22 ' HB3' ' A' ' 15' ' ' SER . 59.8 tp -135.7 139.92 44.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.199 0.523 . . . . 10.0 111.178 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 27.1 ptt180 -88.91 71.63 8.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.67 -0.696 . . . . 10.0 110.407 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.004 HD12 HG21 ' A' ' 126' ' ' VAL . 17.8 mm -88.75 133.14 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 18.2 p -88.84 -175.94 5.04 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.395 -0.965 . . . . 10.0 108.395 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.737 ' OE1' HD12 ' A' ' 109' ' ' LEU . 37.9 tt0 -147.31 77.4 1.44 Allowed 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.128 -1.029 . . . . 10.0 112.808 -177.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -102.02 17.59 22.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.665 -1.152 . . . . 10.0 109.23 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.458 ' O ' HG23 ' A' ' 114' ' ' VAL . 17.9 pt20 -118.48 -49.26 2.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.574 -0.739 . . . . 10.0 111.133 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.81 HD13 ' OD1' ' A' ' 113' ' ' ASN . 27.9 mt -63.16 141.12 58.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.616 -0.266 . . . . 10.0 110.335 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 65.0 t0 -165.52 134.21 3.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.625 -0.261 . . . . 10.0 110.658 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 110' ' ' ASP . 79.9 mt 70.63 -49.16 0.66 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.3 -0.409 . . . . 10.0 111.001 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.1 t -176.11 46.35 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.164 0.507 . . . . 10.0 110.126 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.81 ' OD1' HD13 ' A' ' 109' ' ' LEU . 65.9 m-20 66.4 124.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.633 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 115' ' ' SER . 46.5 t -72.75 -50.38 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.885 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 66.3 m 71.89 40.7 0.73 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.152 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 1.8 m-20 -146.59 92.88 2.21 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.721 -0.672 . . . . 10.0 111.395 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.578 ' HB2' ' CA ' ' A' ' 124' ' ' GLY . 32.8 mmtp -159.96 -46.12 0.05 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.687 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.669 ' CE1' HD21 ' A' ' 69' ' ' LEU . 39.7 t80 -67.22 -53.42 30.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.193 0.521 . . . . 10.0 110.315 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 143.92 45.44 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.821 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 62.31 52.34 3.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.055 0.455 . . . . 10.0 110.314 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.406 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 4.1 tppp? -141.56 -35.75 0.45 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 10.0 111.369 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.727 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 97.2 p -147.63 -159.95 1.1 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.764 -0.198 . . . . 10.0 110.514 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.568 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 2.0 tpmt? -64.64 -52.76 55.69 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.719 -0.392 . . . . 10.0 110.723 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.578 ' CA ' ' HB2' ' A' ' 117' ' ' LYS . . . 155.91 153.93 6.77 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 119.111 -1.519 . . . . 10.0 114.927 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.87 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.8 tm? -68.95 140.35 55.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.051 -0.575 . . . . 10.0 109.912 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 1.004 HG21 HD12 ' A' ' 104' ' ' ILE . 2.4 p -123.48 152.77 28.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.707 0.765 . . . . 10.0 112.111 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -141.41 135.53 30.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.919 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.638 ' O ' ' HB2' ' A' ' 131' ' ' ARG . 8.5 m -164.11 137.79 5.41 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.167 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 65.6 t0 60.78 41.99 14.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.89 0.376 . . . . 10.0 110.459 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.24 30.87 55.9 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.754 -0.938 . . . . 10.0 110.754 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.638 ' HB2' ' O ' ' A' ' 128' ' ' THR . 37.5 mmt180 -117.17 133.46 55.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.263 -0.469 . . . . 10.0 111.024 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.662 HD12 HD11 ' A' ' 125' ' ' LEU . 57.1 tp -88.91 79.55 7.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.11 -0.496 . . . . 10.0 110.143 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.997 HG12 ' HB3' ' A' ' 22' ' ' ALA . 4.0 mt -88.99 148.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 10.0 111.828 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.804 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -103.32 129.27 55.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 N-CA-C 108.69 -0.856 . . . . 10.0 108.69 177.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.663 ' C ' HD12 ' A' ' 136' ' ' LEU . 40.5 t80 -117.09 144.51 44.59 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.02 -0.672 . . . . 10.0 111.615 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.942 HD22 ' CE2' ' A' ' 25' ' ' PHE . 8.5 mp -137.61 169.06 18.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.18 -0.918 . . . . 10.0 111.852 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.565 ' HB2' ' HD2' ' A' ' 123' ' ' LYS . 34.0 t70 -136.58 21.76 3.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.705 -1.134 . . . . 10.0 108.34 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.9 ' HA ' HG23 ' A' ' 141' ' ' ILE . 13.0 tt 43.76 17.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.173 -1.376 . . . . 10.0 113.824 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 142' ' ' ILE . 8.6 t0 -81.48 -59.11 2.74 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.627 0.603 . . . . 10.0 112.627 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.2 mptt -76.55 -34.18 58.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.613 0.721 . . . . 10.0 109.895 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.9 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.27 -46.0 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.835 -1.075 . . . . 10.0 110.63 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.976 HD13 HG21 ' A' ' 91' ' ' VAL . 7.5 tp -62.89 -43.2 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 120.254 -0.578 . . . . 10.0 109.725 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.642 ' O ' HG12 ' A' ' 147' ' ' VAL . 4.5 tp10 -47.11 -46.47 23.0 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.658 ' HB2' HD11 ' A' ' 68' ' ' ILE . 48.5 mt-10 -65.03 -36.89 85.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.25 -0.887 . . . . 10.0 110.298 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.659 ' CD1' HG11 ' A' ' 91' ' ' VAL . 23.3 mt -54.71 -41.12 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 120.896 0.379 . . . . 10.0 110.948 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.7 p -80.44 -50.3 10.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 10.0 111.636 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 143' ' ' GLU . 12.6 p -78.78 9.24 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.458 ' HD2' ' CB ' ' A' ' 48' ' ' PHE . 22.8 ttpp -46.92 -47.6 21.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.596 0.236 . . . . 10.0 111.613 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 62.61 141.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.874 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -170.33 48.61 0.2 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.656 -0.783 . . . . 10.0 112.526 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.792 0.33 . . . . 10.0 111.042 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ttt . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 110.333 -0.247 . . . . 10.0 110.333 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 3' ' ' THR . 31.6 mmmt -68.38 -47.39 67.5 Favored 'General case' 0 C--N 1.334 -0.087 0 O-C-N 122.184 -0.322 . . . . 10.0 111.166 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.826 HG22 ' O ' ' A' ' 2' ' ' LYS . 14.3 t 60.83 -39.92 0.1 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.636 0.774 . . . . 10.0 113.014 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.5 pp -58.52 -32.1 68.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.38 . . . . 10.0 110.767 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.945 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -64.61 138.91 58.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.084 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 12.2 p-10 -169.78 128.66 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 10.0 111.03 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 6' ' ' ASP . . . 169.41 140.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.748 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.711 HD13 ' HB2' ' A' ' 111' ' ' LEU . 30.7 mt 62.79 54.48 2.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.102 0.477 . . . . 10.0 111.329 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.535 ' HD2' ' HG3' ' A' ' 10' ' ' GLU . 6.3 tmtm? -136.71 -47.02 0.6 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.508 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.624 ' HG2' HG22 ' A' ' 105' ' ' THR . 45.5 mt-10 -140.71 164.25 30.69 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.004 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 9.9 t80 -160.11 139.49 11.0 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.567 -0.742 . . . . 10.0 112.789 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.526 ' OE2' HG12 ' A' ' 101' ' ' VAL . 23.5 tp10 -88.68 133.99 34.04 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.917 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.6 p -152.93 166.94 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 113.967 1.099 . . . . 10.0 113.967 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.636 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.2 tm? -88.94 134.54 33.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.158 -0.928 . . . . 10.0 108.657 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.784 ' CB ' HD22 ' A' ' 102' ' ' LEU . 40.5 t -148.56 158.04 43.86 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.772 0.796 . . . . 10.0 112.687 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.785 ' CE2' HG11 ' A' ' 95' ' ' VAL . 0.4 OUTLIER -148.35 165.61 30.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.182 -1.372 . . . . 10.0 110.411 -178.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.588 ' HG3' HD21 ' A' ' 99' ' ' LEU . 56.6 mt-10 -88.65 133.22 34.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.07 HG21 HD12 ' A' ' 71' ' ' ILE . 35.0 mm -132.06 95.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.473 -0.785 . . . . 10.0 111.437 -177.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 26.8 m-20 42.45 60.18 2.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.676 -0.693 . . . . 10.0 112.525 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.1 mt-10 85.72 -44.77 0.06 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.39 -0.823 . . . . 10.0 111.621 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -89.03 145.36 25.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.993 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.58 168.14 12.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.986 0.422 . . . . 10.0 111.089 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.751 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.9 OUTLIER -147.11 135.04 21.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.586 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.695 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -137.56 152.91 49.94 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.999 0.741 . . . . 10.0 112.999 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.61 ' O ' HG23 ' A' ' 13' ' ' VAL . 4.2 m-85 -135.16 142.76 46.2 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.146 -0.934 . . . . 10.0 108.814 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' HZ ' ' A' ' 11' ' ' PHE . 12.7 p-10 -52.43 122.05 8.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.271 0.558 . . . . 10.0 111.328 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.917 HG13 ' HA ' ' A' ' 13' ' ' VAL . 27.2 m -61.27 -14.7 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.44 -0.8 . . . . 10.0 110.653 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.43 -44.51 94.35 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.184 0.516 . . . . 10.0 109.829 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.697 HD21 HG22 ' A' ' 86' ' ' THR . 21.7 t-20 -89.57 -42.52 11.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 10.0 110.566 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.636 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.8 mm -62.45 130.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.865 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 32' ' ' MET . 52.0 mm-40 -85.79 -68.97 0.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.33 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.6 mtm -169.21 156.02 6.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.148 0.499 . . . . 10.0 111.609 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.773 HG11 HG11 ' A' ' 98' ' ' VAL . 34.6 m -88.88 159.1 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.567 -0.742 . . . . 10.0 111.304 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.442 HG13 ' HB ' ' A' ' 81' ' ' ILE . 23.1 pt -151.55 162.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.963 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -88.83 146.58 24.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.174 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HA ' HD11 ' A' ' 81' ' ' ILE . 27.8 tptp -88.9 130.32 35.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.297 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.7 t 177.29 136.15 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.64 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t0 45.8 70.49 0.36 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 10.0 110.99 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.559 HD13 ' CG2' ' A' ' 53' ' ' ILE . 14.0 mt -141.51 158.1 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.475 0.655 . . . . 10.0 112.528 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.534 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 82.2 m -38.69 117.85 1.03 Allowed Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 114.624 -1.171 . . . . 10.0 111.55 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 40' ' ' THR . 16.0 Cg_exo -68.47 -65.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.625 2.217 . . . . 10.0 112.865 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.575 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 10.4 p -176.19 56.22 0.13 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.411 -0.359 . . . . 10.0 111.621 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 42' ' ' VAL . 8.6 Cg_exo -71.76 -34.07 9.41 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.93 2.42 . . . . 10.0 111.861 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 45' ' ' SER . 0.0 OUTLIER 62.3 -136.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.241 -0.652 . . . . 10.0 109.241 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 42.7 t 65.83 48.0 1.95 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.856 0.36 . . . . 10.0 110.969 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' ND1' ' A' ' 47' ' ' HIS . 16.1 tpp85 -170.93 -70.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.842 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.46 ' ND1' ' O ' ' A' ' 46' ' ' ARG . 41.7 m80 -155.95 -172.14 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 10.0 110.797 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 48' ' ' PHE . 45.8 t80 -68.83 60.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.751 -0.659 . . . . 10.0 111.065 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.767 ' HA ' HG22 ' A' ' 63' ' ' VAL . 38.4 t -128.43 128.56 68.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 10.0 111.19 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 9.8 pt-20 -75.77 -38.54 58.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.571 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.744 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -144.22 -177.04 18.78 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 120.183 -1.008 . . . . 10.0 113.095 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.534 ' H ' ' HB ' ' A' ' 40' ' ' THR . 3.4 m -160.08 175.32 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.806 ' O ' HD12 ' A' ' 53' ' ' ILE . 2.2 pp -155.94 137.72 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 10.0 111.251 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.459 ' ND2' HD11 ' A' ' 59' ' ' ILE . 25.7 t-20 -88.97 135.1 33.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.663 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 54' ' ' ASN . 83.1 mt -161.68 135.74 6.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.294 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 55' ' ' LEU . 16.3 ptm180 45.84 46.87 12.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.196 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.33 41.4 87.32 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.96 -0.638 . . . . 10.0 112.886 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -158.88 124.0 4.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.838 0.351 . . . . 10.0 110.552 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.631 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -93.94 132.91 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.148 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.786 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.4 pp -111.12 136.95 20.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.407 -0.361 . . . . 10.0 110.839 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.583 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 89.0 Cg_endo -82.95 119.61 2.89 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.678 2.252 . . . . 10.0 113.483 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.744 HG22 ' C ' ' A' ' 51' ' ' GLY . 35.9 m -95.75 138.51 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.767 HG22 ' HA ' ' A' ' 49' ' ' VAL . 94.5 t -139.88 151.44 22.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.715 0.769 . . . . 10.0 112.581 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -78.57 67.44 4.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.688 -1.142 . . . . 10.0 109.668 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.824 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.3 tt -52.78 -38.56 61.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.305 -0.861 . . . . 10.0 111.2 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.76 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -53.34 -24.29 11.62 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.314 -0.554 . . . . 10.0 109.711 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.573 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -85.51 -48.37 9.02 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.784 -0.643 . . . . 10.0 110.307 178.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.781 HG22 ' HA ' ' A' ' 65' ' ' LEU . 8.2 tt -54.42 -38.85 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 107.867 -1.16 . . . . 10.0 107.867 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.904 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -79.65 -51.05 9.74 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 113.52 -1.673 . . . . 10.0 109.684 177.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 118.64 -86.38 0.4 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.879 -0.601 . . . . 10.0 112.508 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.07 HD12 HG21 ' A' ' 18' ' ' ILE . 3.5 pt 46.55 165.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 113.115 0.783 . . . . 10.0 113.115 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 75.5 m -47.8 -35.26 9.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.919 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.7 t80 -27.63 140.56 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.757 -1.11 . . . . 10.0 112.578 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 8.8 t70 -143.99 30.45 1.3 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.154 0.502 . . . . 10.0 110.815 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HA ' ' CE1' ' A' ' 73' ' ' PHE . 49.0 mt-10 66.69 -51.57 0.45 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.15 0.796 . . . . 10.0 113.15 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -44.84 -42.78 8.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.274 0.842 . . . . 10.0 113.274 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.536 ' NZ ' ' HB3' ' A' ' 77' ' ' LYS . 6.3 mtpm? -81.53 10.63 5.57 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.441 0.904 . . . . 10.0 113.441 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.438 ' CE ' ' CE1' ' A' ' 73' ' ' PHE . 33.8 mmt -68.11 145.4 54.43 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.205 -0.309 . . . . 10.0 111.005 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 54.9 mtpt -158.84 -50.43 0.06 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.654 0.264 . . . . 10.0 111.634 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.631 ' O ' HD12 ' A' ' 94' ' ' LEU . 47.5 t -88.88 -176.03 5.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 10.0 111.615 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.519 HG22 ' N ' ' A' ' 82' ' ' ILE . 47.0 mt -145.38 159.24 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.87 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 13.2 mt -136.62 141.33 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 84' ' ' ALA . 61.5 t -117.79 153.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.583 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -158.51 176.86 11.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.309 -0.405 . . . . 10.0 111.267 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -134.64 135.3 42.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.841 178.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.697 HG22 HD21 ' A' ' 29' ' ' ASN . 72.9 p -148.99 110.83 4.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 21.9 ttmm 47.31 48.52 16.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.346 0.593 . . . . 10.0 110.949 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 72.39 33.21 1.5 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.094 -0.957 . . . . 10.0 111.461 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.912 HG12 HG22 ' A' ' 91' ' ' VAL . 57.5 t -130.19 111.04 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.199 -0.91 . . . . 10.0 109.097 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.686 ' HB2' HG22 ' A' ' 60' ' ' ILE . 66.4 mt-10 -88.38 97.75 11.23 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 106.177 -1.786 . . . . 10.0 106.177 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.005 HG21 HD13 ' A' ' 142' ' ' ILE . 3.9 t -88.75 153.87 3.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 113.334 -1.757 . . . . 10.0 113.234 -174.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -128.74 143.5 14.51 Favored Glycine 0 C--N 1.316 -0.577 0 CA-C-N 114.586 -1.188 . . . . 10.0 113.044 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.6 OUTLIER -131.61 125.55 32.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.811 0.338 . . . . 10.0 110.24 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 80' ' ' SER . 40.1 tp -88.6 130.88 35.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.023 0.44 . . . . 10.0 110.835 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.785 HG11 ' CE2' ' A' ' 16' ' ' PHE . 28.1 m -137.01 -175.09 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.964 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 59.7 t0 -89.01 -76.6 0.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.29 0.567 . . . . 10.0 110.998 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -131.75 113.22 13.28 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.115 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.773 HG11 HG11 ' A' ' 33' ' ' VAL . 9.9 p -95.88 115.85 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 122.408 1.099 . . . . 10.0 111.772 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.588 HD21 ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -68.1 -28.24 67.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.044 -1.889 . . . . 10.0 111.043 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.92 -123.24 6.88 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.633 -0.794 . . . . 10.0 111.824 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.526 HG12 ' OE2' ' A' ' 12' ' ' GLU . 34.9 m -51.07 133.05 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.799 0.3 . . . . 10.0 111.03 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.784 HD22 ' CB ' ' A' ' 15' ' ' SER . 57.4 tp -137.77 139.79 40.24 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.08 0.467 . . . . 10.0 111.211 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 16.2 ptm180 -88.84 73.6 8.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.592 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.784 ' CG1' HG11 ' A' ' 13' ' ' VAL . 16.4 mm -88.79 165.28 2.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.624 HG22 ' HG2' ' A' ' 10' ' ' GLU . 25.4 p -124.61 -176.0 3.42 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.764 -1.199 . . . . 10.0 107.764 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.538 ' HG3' ' HB2' ' A' ' 109' ' ' LEU . 87.7 tt0 -137.04 67.05 1.45 Allowed 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.258 -0.977 . . . . 10.0 112.045 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -104.8 26.11 9.56 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.462 -1.245 . . . . 10.0 109.035 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.429 ' NE2' ' HA ' ' A' ' 106' ' ' GLU . 3.0 pm0 -154.99 -30.82 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.593 HD21 ' HD2' ' A' ' 135' ' ' TYR . 43.7 mt -63.2 -47.49 82.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.003 0.372 . . . . 10.0 112.003 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 111' ' ' LEU . 23.0 t70 -158.48 -131.38 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.946 -0.301 . . . . 10.0 111.122 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.711 ' HB2' HD13 ' A' ' 8' ' ' LEU . 24.9 tp 70.41 -46.44 0.62 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.96 0.345 . . . . 10.0 111.609 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.544 HG22 ' HG ' ' A' ' 111' ' ' LEU . 8.2 t 178.99 -33.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.253 0.549 . . . . 10.0 110.327 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -57.06 -76.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.446 -0.797 . . . . 10.0 111.18 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.8 t 60.35 111.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.148 0.499 . . . . 10.0 110.777 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.7 t -176.61 140.1 0.34 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.059 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.446 ' HA ' ' HD2' ' A' ' 123' ' ' LYS . 11.0 p-10 -53.95 -39.33 65.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.97 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER 69.99 -59.29 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.217 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.665 ' CE2' HD21 ' A' ' 69' ' ' LEU . 51.6 t80 -71.8 -51.56 21.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.053 0.454 . . . . 10.0 110.159 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 120' ' ' LYS . . . 166.45 -49.36 0.26 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.604 -0.725 . . . . 10.0 112.012 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.481 ' NZ ' ' HB2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER 171.97 -33.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.044 0.45 . . . . 10.0 110.405 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -54.89 -46.45 74.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.754 -0.657 . . . . 10.0 111.257 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.523 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 80.9 p -116.13 -128.63 0.29 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.864 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.446 ' HD2' ' HA ' ' A' ' 116' ' ' ASP . 59.5 tptt -173.08 -35.72 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.728 0.64 . . . . 10.0 112.728 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -85.94 148.84 22.74 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.132 -1.033 . . . . 10.0 113.895 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.928 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.4 tm? -161.23 142.38 11.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.004 -0.739 . . . . 10.0 109.004 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.928 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -160.37 164.46 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.051 0.453 . . . . 10.0 111.667 -177.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 22.2 pttp -163.65 133.92 4.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.546 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.591 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 14.0 m -167.09 156.43 10.55 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.369 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.4 ' N ' ' CG2' ' A' ' 128' ' ' THR . 62.7 m-20 59.94 45.76 11.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.967 0.413 . . . . 10.0 110.84 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.0 28.23 11.97 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.615 -0.802 . . . . 10.0 111.914 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 128' ' ' THR . 14.8 ptt180 -139.33 132.82 30.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 132' ' ' LEU . 3.9 mp -88.82 136.68 32.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.937 0.399 . . . . 10.0 111.546 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.993 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.6 mt -126.52 129.56 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.936 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.751 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.82 141.36 14.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 N-CA-C 108.934 -0.765 . . . . 10.0 108.934 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.593 ' HD2' HD21 ' A' ' 109' ' ' LEU . 42.3 t80 -124.8 146.2 49.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.28 0.562 . . . . 10.0 111.325 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.644 HD13 HG21 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -144.39 141.08 29.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.761 0.652 . . . . 10.0 112.761 -178.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 139' ' ' ASP . 55.6 p30 -105.8 25.37 10.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.228 -0.896 . . . . 10.0 108.896 177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.919 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 15.3 tt 41.19 16.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 114.346 1.239 . . . . 10.0 114.346 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 38.2 t70 -79.69 -61.21 2.07 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.085 0.772 . . . . 10.0 113.085 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -74.91 -30.54 61.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.535 0.684 . . . . 10.0 110.567 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.919 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.25 -48.4 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.972 -1.013 . . . . 10.0 110.606 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.005 HD13 HG21 ' A' ' 91' ' ' VAL . 7.4 tp -62.19 -45.75 98.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 120.213 -0.595 . . . . 10.0 110.209 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.92 ' O ' HG12 ' A' ' 147' ' ' VAL . 63.1 mm-40 -47.74 -43.68 27.29 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 51.9 mm-40 -71.85 -39.27 69.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.045 -0.979 . . . . 10.0 110.429 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.674 ' CD1' HG11 ' A' ' 91' ' ' VAL . 46.8 mt -45.17 -38.48 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-O 120.803 0.335 . . . . 10.0 111.24 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.1 p -97.77 -53.79 3.31 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.21 0.818 . . . . 10.0 113.21 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 143' ' ' GLU . 8.6 p -84.2 13.16 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 113.466 0.913 . . . . 10.0 113.466 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 84.9 tttt -60.97 -42.12 97.71 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.271 -0.572 . . . . 10.0 110.788 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -170.27 135.51 1.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.908 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -178.93 -41.3 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.134 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 10.0 111.096 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.877 0.37 . . . . 10.0 111.209 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.624 ' HE2' ' HB3' ' A' ' 5' ' ' ALA . 37.0 mtmm -59.99 -44.57 94.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.054 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 51.3 m 71.5 -49.08 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.833 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.944 HD12 ' N ' ' A' ' 5' ' ' ALA . 4.0 pp -62.35 -37.12 84.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.917 0.389 . . . . 10.0 110.448 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.944 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -86.5 47.98 1.56 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.283 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 51.0 m-20 -134.39 145.24 48.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.87 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.655 ' O ' HD23 ' A' ' 8' ' ' LEU . . . 70.5 53.68 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 10.0 111.335 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 7' ' ' ALA . 88.5 mt -145.73 53.19 1.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.806 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.494 ' O ' HG22 ' A' ' 105' ' ' THR . 2.6 tmmm? -145.88 -51.81 0.24 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.993 -0.549 . . . . 10.0 109.928 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 88.3 tt0 -138.96 161.14 38.06 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.272 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 11.0 t80 -165.85 139.48 4.39 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.45 -0.796 . . . . 10.0 112.917 -173.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 16.7 mt-10 -88.82 134.41 33.94 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.927 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -149.05 170.0 2.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 113.307 0.854 . . . . 10.0 113.307 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.88 HD11 HD13 ' A' ' 82' ' ' ILE . 3.1 tm? -88.91 132.88 34.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.815 ' HB3' HD22 ' A' ' 102' ' ' LEU . 86.6 p -143.09 153.64 43.12 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.687 0.756 . . . . 10.0 112.746 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.673 ' CD2' HG11 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -149.93 160.4 43.63 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.252 -1.34 . . . . 10.0 110.012 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -88.67 135.98 33.23 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.353 -0.61 . . . . 10.0 109.353 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.044 HG21 HD12 ' A' ' 71' ' ' ILE . 34.8 mm -130.79 81.99 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.361 -0.836 . . . . 10.0 111.34 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.723 ' OD2' ' HA ' ' A' ' 73' ' ' PHE . 19.9 m-20 50.82 60.23 4.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.462 0.542 . . . . 10.0 112.462 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 81.3 mt-10 81.98 -35.89 0.1 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.171 -0.922 . . . . 10.0 111.107 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.457 ' NE2' HD11 ' A' ' 134' ' ' ILE . 37.5 tt0 -88.87 136.71 32.86 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.252 -0.647 . . . . 10.0 109.252 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.019 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.72 162.12 16.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.054 0.454 . . . . 10.0 111.222 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.949 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.5 tp -148.63 139.33 22.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.165 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.756 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -143.55 153.56 42.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.927 0.714 . . . . 10.0 112.927 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.768 ' CE2' HD22 ' A' ' 136' ' ' LEU . 6.0 m-85 -135.37 140.56 45.1 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.222 -0.899 . . . . 10.0 109.169 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.452 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . 47.0 p-10 -49.17 123.3 7.09 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.106 0.479 . . . . 10.0 111.25 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.927 HG13 ' HA ' ' A' ' 13' ' ' VAL . 31.1 m -62.26 -13.25 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.573 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -61.16 -46.05 92.09 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.031 0.443 . . . . 10.0 110.047 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.715 ' CG ' HG21 ' A' ' 138' ' ' ILE . 16.0 t-20 -89.28 -45.04 9.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.562 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.69 HG21 ' HG ' ' A' ' 14' ' ' LEU . 17.5 mm -60.97 120.67 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.234 -0.439 . . . . 10.0 109.906 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 32' ' ' MET . 8.8 pt-20 -81.19 -58.85 2.88 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.198 0.444 . . . . 10.0 112.198 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.475 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -169.12 157.94 8.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.038 0.446 . . . . 10.0 111.725 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.623 ' CG1' HG11 ' A' ' 98' ' ' VAL . 30.4 m -88.94 152.16 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.697 -0.683 . . . . 10.0 111.508 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 pt -148.35 129.81 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -88.82 128.63 35.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 10.0 110.241 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.832 ' HB3' HD12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -169.0 165.96 11.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.883 0.373 . . . . 10.0 110.959 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.4 t -154.27 148.61 26.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.176 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 9.8 t70 52.93 47.08 25.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.448 0.642 . . . . 10.0 110.021 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.534 HG21 HG23 ' A' ' 53' ' ' ILE . 19.9 mt -59.25 -69.43 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.221 -0.9 . . . . 10.0 112.513 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.784 HG23 ' HG2' ' A' ' 43' ' ' PRO . 75.4 m -153.84 67.07 5.81 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.99 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -83.51 -49.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.947 2.431 . . . . 10.0 113.942 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.672 HG22 ' HD3' ' A' ' 43' ' ' PRO . 18.9 m -74.99 -34.51 1.72 Allowed Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.984 0.735 . . . . 10.0 112.984 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.784 ' HG2' HG23 ' A' ' 40' ' ' THR . 12.9 Cg_exo -69.11 -79.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.98 1.786 . . . . 10.0 112.491 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.553 ' HG3' HG11 ' A' ' 52' ' ' VAL . 1.3 mmmm -70.83 130.54 41.95 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.879 -0.786 . . . . 10.0 108.879 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 29.1 t -175.87 118.09 0.15 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.237 -0.985 . . . . 10.0 111.571 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' HG3' ' CD2' ' A' ' 47' ' ' HIS . 16.5 ptm180 175.82 -47.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.793 -0.64 . . . . 10.0 110.695 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.424 ' CD2' ' HG3' ' A' ' 46' ' ' ARG . 84.3 m-70 -99.35 -152.97 0.42 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.431 . . . . 10.0 111.058 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.593 ' CE2' HG11 ' A' ' 63' ' ' VAL . 3.9 t80 -72.57 -35.02 67.87 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.854 ' HA ' HG22 ' A' ' 63' ' ' VAL . 44.9 t -54.45 127.93 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.975 0.417 . . . . 10.0 111.632 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -90.31 -46.84 8.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.579 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.774 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -133.04 -179.08 15.98 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.764 -0.731 . . . . 10.0 112.774 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.617 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.4 m -160.81 168.81 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 CA-C-O 120.848 0.356 . . . . 10.0 110.53 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.547 HG12 HD11 ' A' ' 60' ' ' ILE . 28.5 pt -157.8 147.37 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.319 -0.4 . . . . 10.0 110.719 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.457 HD22 HD11 ' A' ' 59' ' ' ILE . 23.7 t-20 -88.66 137.47 32.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.066 0.46 . . . . 10.0 111.305 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.893 HD13 ' N ' ' A' ' 56' ' ' ARG . 3.1 tm? -169.07 141.55 2.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.595 -0.73 . . . . 10.0 110.216 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.893 ' N ' HD13 ' A' ' 55' ' ' LEU . 51.8 ttm-85 51.36 45.75 27.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.174 0.511 . . . . 10.0 110.444 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.68 40.19 69.91 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.789 -0.642 . . . . 10.0 112.725 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -168.71 137.91 2.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 10.0 110.917 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.89 132.62 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.93 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.76 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.1 pp -103.38 139.28 19.97 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 10.0 111.663 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 70.2 Cg_endo -86.09 117.75 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.747 2.298 . . . . 10.0 112.958 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.774 HG22 ' C ' ' A' ' 51' ' ' GLY . 35.1 m -96.0 134.84 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.639 -0.504 . . . . 10.0 109.639 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.854 HG22 ' HA ' ' A' ' 49' ' ' VAL . 57.4 t -140.31 156.0 23.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.561 0.696 . . . . 10.0 112.406 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.493 ' N ' HG12 ' A' ' 63' ' ' VAL . 5.6 m120 -77.16 72.27 3.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.949 -1.023 . . . . 10.0 109.805 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.864 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.1 tt -53.86 -37.55 63.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.308 0.575 . . . . 10.0 110.587 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.793 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -56.75 -25.88 55.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.132 0.492 . . . . 10.0 109.69 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.526 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -82.01 -42.71 18.95 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.243 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 65' ' ' LEU . 7.9 tt -61.84 -37.61 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.883 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.1 tm? -78.35 -52.02 9.22 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 113.738 -1.574 . . . . 10.0 108.92 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 117.68 -82.87 0.33 Allowed Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.66 -0.7 . . . . 10.0 112.744 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.044 HD12 HG21 ' A' ' 18' ' ' ILE . 2.7 pt 45.36 173.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -50.16 -39.25 43.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.433 0.635 . . . . 10.0 109.32 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.792 ' HB3' HG13 ' A' ' 71' ' ' ILE . 4.3 t80 -28.21 145.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.672 -1.149 . . . . 10.0 113.904 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 65.4 t0 -137.63 -52.8 0.65 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.785 -1.098 . . . . 10.0 109.906 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' A' ' 74' ' ' ASP . 16.4 pt-20 163.57 -44.0 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.983 0.421 . . . . 10.0 111.624 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -51.31 -37.63 48.62 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 10.2 mmpt? -74.72 -29.68 61.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.11 0.411 . . . . 10.0 112.11 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.407 ' O ' ' CG ' ' A' ' 79' ' ' LYS . 29.3 mmt -43.84 130.55 5.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.888 0.375 . . . . 10.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 78' ' ' MET . 53.2 mtmt -162.1 -44.89 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.547 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.601 ' HB3' HG23 ' A' ' 95' ' ' VAL . 45.5 t -88.95 164.29 15.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.495 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.832 HD12 ' HB3' ' A' ' 36' ' ' LYS . 45.4 mt -140.98 125.97 18.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.694 0.283 . . . . 10.0 111.351 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.88 HD13 HD11 ' A' ' 14' ' ' LEU . 6.2 mt -100.42 155.27 4.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.459 -0.337 . . . . 10.0 111.203 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.75 145.66 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.645 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -143.46 -177.06 5.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 10.0 111.474 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.05 128.89 24.88 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.877 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.722 HG21 HG12 ' A' ' 138' ' ' ILE . 69.0 p -142.85 109.69 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.026 0.441 . . . . 10.0 111.914 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 47.8 49.99 16.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.388 0.614 . . . . 10.0 110.753 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 72.91 31.24 1.57 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.009 -0.996 . . . . 10.0 111.555 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.89 HG12 HG22 ' A' ' 91' ' ' VAL . 66.1 t -126.95 109.74 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.262 -0.881 . . . . 10.0 109.397 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 36.9 tt0 -88.36 99.12 12.01 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.799 -1.926 . . . . 10.0 105.799 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.023 HG21 HD13 ' A' ' 142' ' ' ILE . 5.3 t -88.67 152.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 113.181 -1.827 . . . . 10.0 113.196 -173.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -119.18 153.25 16.95 Favored Glycine 0 C--N 1.315 -0.606 0 CA-C-N 114.381 -1.281 . . . . 10.0 113.156 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -143.95 125.09 14.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.861 0.362 . . . . 10.0 110.559 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.534 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 42.3 tp -88.66 124.74 34.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.124 0.488 . . . . 10.0 110.516 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.673 HG11 ' CD2' ' A' ' 16' ' ' PHE . 17.1 m -132.87 -175.07 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.672 -0.694 . . . . 10.0 110.944 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 17.2 t70 -87.67 -71.79 0.55 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.536 0.684 . . . . 10.0 110.993 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -146.59 112.41 5.69 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.904 -1.044 . . . . 10.0 108.324 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.623 HG11 ' CG1' ' A' ' 33' ' ' VAL . 7.5 p -89.01 118.26 33.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 122.31 1.053 . . . . 10.0 112.939 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -66.12 -29.29 69.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.031 -1.895 . . . . 10.0 110.923 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.74 -123.43 7.31 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.556 -0.747 . . . . 10.0 111.498 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 m -52.89 136.85 13.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.977 0.389 . . . . 10.0 110.84 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' A' ' 15' ' ' SER . 45.5 tp -139.21 141.89 37.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.17 0.509 . . . . 10.0 111.237 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.433 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.3 ptp85 -88.9 71.8 8.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.753 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.834 HD12 HG11 ' A' ' 126' ' ' VAL . 15.7 mm -88.75 136.75 22.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 N-CA-C 109.554 -0.536 . . . . 10.0 109.554 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 14.7 p -88.82 -175.76 4.99 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 109' ' ' LEU . 87.0 tt0 -144.34 77.37 1.54 Allowed 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.721 -1.192 . . . . 10.0 113.262 -177.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.41 22.17 16.3 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.414 -1.267 . . . . 10.0 108.173 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.584 ' O ' HD23 ' A' ' 109' ' ' LEU . 14.0 pt20 -163.24 59.58 0.18 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.81 -1.086 . . . . 10.0 111.921 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.584 HD23 ' O ' ' A' ' 108' ' ' GLN . 89.1 mt -168.69 32.33 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.776 -1.102 . . . . 10.0 110.003 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.835 ' OD2' HG22 ' A' ' 112' ' ' THR . 38.4 t70 -55.78 155.35 6.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.495 -0.32 . . . . 10.0 110.633 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.1 tp -43.24 -49.06 6.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.921 0.391 . . . . 10.0 110.408 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.835 HG22 ' OD2' ' A' ' 110' ' ' ASP . 9.8 t -74.23 -31.63 62.68 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.516 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 61.09 122.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.694 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 115' ' ' SER . 11.5 t -155.46 90.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.781 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 114' ' ' VAL . 72.0 p 174.47 125.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.872 0.368 . . . . 10.0 111.297 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 119' ' ' GLY . 5.4 t70 -68.75 -52.15 33.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.509 . . . . 10.0 109.82 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.611 ' HE2' ' HA ' ' A' ' 117' ' ' LYS . 7.4 mmpt? 66.08 -59.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.354 -0.839 . . . . 10.0 112.275 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.608 ' CE2' HD21 ' A' ' 69' ' ' LEU . 33.4 t80 -103.09 -68.96 0.81 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.949 0.404 . . . . 10.0 110.808 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 162.67 -144.02 9.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.951 -0.643 . . . . 10.0 112.405 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -85.22 58.03 4.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.695 0.283 . . . . 10.0 110.639 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 17.3 tppt? -154.31 -40.05 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.919 0.341 . . . . 10.0 111.919 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.519 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 90.2 p -146.09 -142.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.187 -0.205 . . . . 10.0 110.824 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 32.9 mmmt -157.35 -33.48 0.08 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.415 0.524 . . . . 10.0 112.415 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -81.94 144.38 23.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.396 -0.907 . . . . 10.0 113.644 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.538 ' CB ' ' HB3' ' A' ' 117' ' ' LYS . 1.6 tm? -162.38 84.64 0.56 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.195 -0.668 . . . . 10.0 109.195 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.949 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.6 p -88.75 160.93 2.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.179 -0.919 . . . . 10.0 112.389 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.516 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 92.7 mttt -152.27 132.35 13.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.145 -0.934 . . . . 10.0 109.742 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 2.6 m -169.07 152.12 5.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.825 0.345 . . . . 10.0 111.164 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.465 ' OD1' HG22 ' A' ' 128' ' ' THR . 0.9 OUTLIER 56.83 47.95 16.98 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.916 0.389 . . . . 10.0 111.244 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 49.12 30.92 10.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.116 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 128' ' ' THR . 3.5 ptm180 -137.94 136.4 36.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.171 -0.307 . . . . 10.0 110.171 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.659 HD22 ' N ' ' A' ' 132' ' ' LEU . 2.0 mm? -88.88 135.59 33.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.907 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.019 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.9 mt -128.78 131.51 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.864 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.949 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.6 mp -88.87 140.12 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.238 -0.653 . . . . 10.0 109.238 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.719 ' C ' HD12 ' A' ' 136' ' ' LEU . 49.0 t80 -128.72 141.45 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.33 0.586 . . . . 10.0 111.282 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.768 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.6 mp -136.47 172.51 12.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.823 0.82 . . . . 10.0 112.666 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 137' ' ' ASP . 9.8 t70 -136.36 25.09 3.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.099 -1.41 . . . . 10.0 107.667 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.887 ' HA ' HG23 ' A' ' 141' ' ' ILE . 10.5 tt 42.6 17.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 114.164 -1.38 . . . . 10.0 114.086 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.408 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.5 t70 -82.33 -62.99 1.47 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.604 0.594 . . . . 10.0 112.604 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -73.93 -30.89 62.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.612 0.72 . . . . 10.0 109.981 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -69.29 -47.48 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.817 -1.083 . . . . 10.0 110.839 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.023 HD13 HG21 ' A' ' 91' ' ' VAL . 7.3 tp -60.74 -47.35 93.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 120.313 -0.555 . . . . 10.0 110.206 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.871 ' O ' HG12 ' A' ' 147' ' ' VAL . 5.5 mm-40 -49.14 -43.55 41.83 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.289 0.566 . . . . 10.0 109.62 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' A' ' 68' ' ' ILE . 5.7 mm-40 -72.6 -34.81 67.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.192 -0.913 . . . . 10.0 110.898 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.693 ' CD1' HG11 ' A' ' 91' ' ' VAL . 33.9 mt -47.93 -46.38 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-O 120.941 0.401 . . . . 10.0 111.093 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 80.6 p -86.25 -50.59 6.85 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.135 0.791 . . . . 10.0 113.135 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 143' ' ' GLU . 8.6 p -82.36 13.03 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.537 0.94 . . . . 10.0 113.537 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.514 ' HD3' ' CG ' ' A' ' 48' ' ' PHE . 62.4 tttm -58.87 -59.92 4.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.124 -0.63 . . . . 10.0 111.019 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -89.77 49.19 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 10.0 111.143 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -175.37 44.19 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.688 -0.768 . . . . 10.0 112.375 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 10.0 111.032 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.751 0.31 . . . . 10.0 111.19 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' O ' ' OG1' ' A' ' 3' ' ' THR . 97.1 mttt -60.38 -45.61 92.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.951 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 31.9 p 66.91 -50.87 0.47 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.089 -0.505 . . . . 10.0 112.307 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.966 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.6 pp -47.72 -36.65 11.68 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.678 0.275 . . . . 10.0 111.671 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.966 ' N ' HD12 ' A' ' 4' ' ' LEU . . . 48.65 -168.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.404 . . . . 10.0 111.754 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.23 135.42 50.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.939 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.54 137.56 58.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.659 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 110' ' ' ASP . 84.5 mt 58.68 47.58 12.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 10.0 111.489 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' O ' HG22 ' A' ' 105' ' ' THR . 63.0 pttt -64.02 -45.68 87.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.007 0.432 . . . . 10.0 110.464 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.586 ' HG2' HG22 ' A' ' 105' ' ' THR . 41.8 mt-10 -145.48 164.25 32.16 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.449 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.5 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 16.1 t80 -153.38 141.9 20.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.863 -1.062 . . . . 10.0 112.606 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 27' ' ' VAL . 12.2 pt-20 -88.75 139.27 30.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.538 -0.756 . . . . 10.0 109.174 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.769 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -154.09 169.05 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 113.395 0.887 . . . . 10.0 113.395 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.879 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.9 tm? -88.79 132.26 34.71 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.819 ' HB3' HD22 ' A' ' 102' ' ' LEU . 94.7 p -140.8 150.35 43.21 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.8 ' CE1' HG11 ' A' ' 95' ' ' VAL . 4.6 p90 -150.71 162.57 40.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.523 -1.217 . . . . 10.0 110.308 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HG3' HD21 ' A' ' 99' ' ' LEU . 51.0 mt-10 -88.64 137.73 32.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.123 0.487 . . . . 10.0 109.802 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.975 HG21 HD12 ' A' ' 71' ' ' ILE . 17.8 mm -136.11 99.36 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.642 -0.708 . . . . 10.0 111.289 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.601 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 48.7 m-20 42.0 60.14 2.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.479 -0.782 . . . . 10.0 112.84 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 46.1 mt-10 86.6 -42.68 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.304 -0.862 . . . . 10.0 112.581 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.453 ' OE1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -89.03 155.7 19.31 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.393 -0.523 . . . . 10.0 110.261 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.799 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.64 165.84 14.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.846 0.355 . . . . 10.0 110.677 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -152.27 133.05 14.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.329 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.769 ' HB1' ' CG2' ' A' ' 13' ' ' VAL . . . -142.83 141.25 31.57 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.356 0.598 . . . . 10.0 112.372 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.092 ' CE2' HD13 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -118.0 141.08 48.84 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.248 -1.39 . . . . 10.0 107.248 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.456 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . 12.5 p-10 -45.29 105.85 0.07 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.365 0.602 . . . . 10.0 110.612 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.597 ' CG1' ' HA ' ' A' ' 13' ' ' VAL . 6.3 p -51.15 -18.07 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.212 -0.903 . . . . 10.0 110.685 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.69 -39.29 93.51 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.528 ' ND2' HD13 ' A' ' 138' ' ' ILE . 11.7 t30 -84.46 -45.78 12.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.091 -0.959 . . . . 10.0 110.506 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.879 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.0 mm -63.68 131.92 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.021 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -93.82 -61.19 1.59 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.028 0.381 . . . . 10.0 112.028 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -169.03 161.79 10.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 10.0 111.489 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.077 HG11 HG11 ' A' ' 98' ' ' VAL . 33.9 m -88.94 143.1 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.973 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.635 HG13 ' HB ' ' A' ' 81' ' ' ILE . 20.1 pt -126.47 157.36 37.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.572 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -88.82 139.93 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.945 0.402 . . . . 10.0 111.28 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.409 ' HB2' HD11 ' A' ' 81' ' ' ILE . 61.1 tttm -88.77 134.54 33.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.01 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.443 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 68.6 m -168.91 127.99 1.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.472 . . . . 10.0 110.806 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 37' ' ' SER . 57.2 p30 24.73 47.13 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.687 0.617 . . . . 10.0 112.326 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.5 ' CG2' ' N ' ' A' ' 40' ' ' THR . 7.9 mt -64.53 156.72 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.353 0.597 . . . . 10.0 112.086 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.616 HG21 HG22 ' A' ' 52' ' ' VAL . 51.9 m -37.82 94.05 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 114.771 -1.104 . . . . 10.0 112.004 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -93.4 -62.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.032 2.488 . . . . 10.0 113.582 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.629 HG12 ' HD3' ' A' ' 43' ' ' PRO . 13.6 p -76.46 -33.36 1.19 Allowed Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.629 ' HD3' HG12 ' A' ' 42' ' ' VAL . 11.9 Cg_exo -71.06 11.05 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.265 1.977 . . . . 10.0 113.45 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -45.1 159.27 0.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.086 0.469 . . . . 10.0 111.655 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 47.8 t 179.15 -30.7 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.554 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.474 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 38.6 mmt180 -68.12 50.27 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 45.98 -129.78 1.24 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.484 0.549 . . . . 10.0 112.484 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.589 ' CE2' ' HE3' ' A' ' 67' ' ' LYS . 7.2 t80 -48.31 -34.99 11.44 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.789 ' HA ' HG22 ' A' ' 63' ' ' VAL . 60.7 t -45.68 128.22 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 10.0 111.368 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -73.88 -39.78 63.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.668 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.767 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -151.31 -175.8 23.5 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.253 -0.975 . . . . 10.0 113.009 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.616 HG22 HG21 ' A' ' 40' ' ' THR . 2.4 m -156.01 171.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.847 0.356 . . . . 10.0 110.605 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.478 ' CD1' HD12 ' A' ' 34' ' ' ILE . 31.2 pt -157.65 144.24 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.781 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' O ' HD23 ' A' ' 55' ' ' LEU . 45.1 t30 -88.78 132.87 34.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 10.0 111.403 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 54' ' ' ASN . 96.4 mt -160.78 140.65 10.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.297 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 49.76 45.89 24.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.962 0.41 . . . . 10.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.15 40.67 84.29 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.866 -0.683 . . . . 10.0 112.607 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -167.77 134.99 2.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 10.0 110.784 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.92 134.15 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.144 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.848 HG22 ' HB2' ' A' ' 90' ' ' GLU . 2.3 pp -109.23 132.98 20.93 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.296 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 95.3 Cg_endo -80.0 121.4 4.47 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.484 2.122 . . . . 10.0 112.815 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.767 HG22 ' C ' ' A' ' 51' ' ' GLY . 35.0 m -93.38 132.08 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.759 -0.655 . . . . 10.0 109.945 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 49' ' ' VAL . 86.5 t -141.31 162.34 21.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.278 0.561 . . . . 10.0 111.208 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.541 ' N ' HG12 ' A' ' 63' ' ' VAL . 4.6 m120 -102.78 85.42 2.56 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.693 -0.685 . . . . 10.0 110.593 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.092 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.2 tt -53.25 -41.34 65.35 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.542 -0.463 . . . . 10.0 110.521 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.025 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -55.6 -24.41 32.81 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.472 -0.491 . . . . 10.0 109.955 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HE3' ' CE2' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -86.36 -38.54 17.33 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.01 178.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.835 HG22 ' O ' ' A' ' 65' ' ' LEU . 5.7 tt -64.83 -36.16 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 107.481 -1.303 . . . . 10.0 107.481 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.814 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -81.89 -53.74 5.91 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.292 -1.777 . . . . 10.0 108.643 178.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 116.07 -76.28 0.27 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.801 -1.09 . . . . 10.0 112.182 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.025 HD11 ' HB1' ' A' ' 66' ' ' ALA . 6.5 pt 43.05 -175.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 112.341 0.497 . . . . 10.0 112.341 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 52.5 m -60.33 -39.3 86.58 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.798 ' HB3' HG13 ' A' ' 71' ' ' ILE . 11.4 t80 -26.01 137.14 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.035 -0.984 . . . . 10.0 112.88 177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.435 ' O ' ' OE2' ' A' ' 75' ' ' GLU . 9.8 t70 -158.72 43.76 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.267 -0.879 . . . . 10.0 109.395 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.456 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 1.4 pp20? 37.53 38.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.176 -0.92 . . . . 10.0 112.091 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.408 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 16.1 pt20 -87.67 -49.47 7.12 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.786 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.462 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -106.87 -1.85 21.98 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.666 0.617 . . . . 10.0 112.666 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.51 ' CE ' ' CD1' ' A' ' 73' ' ' PHE . 12.1 mmt -42.07 139.28 1.38 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.71 0.291 . . . . 10.0 111.74 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -177.23 36.19 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.632 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.837 ' O ' HD12 ' A' ' 94' ' ' LEU . 69.9 m -169.02 143.73 3.12 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.499 -0.319 . . . . 10.0 110.624 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.635 ' HB ' HG13 ' A' ' 34' ' ' ILE . 67.1 mt -114.26 152.51 15.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 10.0 111.333 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.856 HD13 HD11 ' A' ' 14' ' ' LEU . 14.1 mt -123.98 133.45 69.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.861 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.468 ' CG2' HD13 ' A' ' 34' ' ' ILE . 83.7 t -103.33 150.45 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 10.0 110.83 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -158.08 174.0 15.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.242 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.497 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 6.8 ptm180 -129.28 147.58 51.12 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.206 -0.665 . . . . 10.0 109.206 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.488 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 67.5 p -161.82 109.02 1.38 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.011 0.434 . . . . 10.0 112.081 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? 46.8 48.86 14.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.416 0.627 . . . . 10.0 110.809 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 72.17 33.76 1.51 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 10.0 111.433 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.938 HG12 HG22 ' A' ' 91' ' ' VAL . 59.0 t -132.18 112.27 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 115.293 -0.867 . . . . 10.0 109.255 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.848 ' HB2' HG22 ' A' ' 60' ' ' ILE . 73.9 mt-10 -88.22 95.12 10.05 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.006 HG21 HD13 ' A' ' 142' ' ' ILE . 3.5 t -88.69 152.25 3.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 113.374 -1.739 . . . . 10.0 113.067 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -132.46 143.12 14.69 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.959 -1.019 . . . . 10.0 113.367 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.742 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.3 t80 -131.19 128.64 40.41 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.827 0.346 . . . . 10.0 111.061 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 80' ' ' SER . 58.2 tp -88.8 126.86 35.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.876 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.8 HG11 ' CE1' ' A' ' 16' ' ' PHE . 21.6 m -132.01 -175.22 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.693 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 44.1 t0 -87.98 -74.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.362 0.601 . . . . 10.0 111.273 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -130.7 117.42 19.43 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.166 -0.925 . . . . 10.0 108.521 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.077 HG11 HG11 ' A' ' 33' ' ' VAL . 7.5 p -101.05 116.6 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 122.484 1.135 . . . . 10.0 112.073 -178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -65.09 -29.27 70.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.002 -1.908 . . . . 10.0 110.801 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.3 -127.33 8.64 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.825 -0.702 . . . . 10.0 111.718 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 50.3 t -51.25 132.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 117.011 0.406 . . . . 10.0 110.472 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.819 HD22 ' HB3' ' A' ' 15' ' ' SER . 59.0 tp -137.09 138.86 40.82 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.027 0.441 . . . . 10.0 111.358 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.646 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.84 72.57 8.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.678 -0.692 . . . . 10.0 110.823 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.73 ' CG1' HG11 ' A' ' 13' ' ' VAL . 16.3 mm -88.78 133.3 31.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 N-CA-C 109.654 -0.498 . . . . 10.0 109.654 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.586 HG22 ' HG2' ' A' ' 10' ' ' GLU . 19.2 p -88.81 149.72 23.27 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.616 ' OE2' HD12 ' A' ' 109' ' ' LEU . 37.1 tt0 -128.41 80.03 1.94 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 113.697 0.999 . . . . 10.0 113.697 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -97.69 2.75 50.06 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 114.59 -1.186 . . . . 10.0 107.896 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -84.23 -58.84 2.59 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 114.885 -1.052 . . . . 10.0 110.946 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.616 HD12 ' OE2' ' A' ' 106' ' ' GLU . 12.1 mt -57.73 -61.22 2.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.773 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.62 ' HA ' HD12 ' A' ' 8' ' ' LEU . 38.5 t70 45.13 101.42 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.25 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.528 ' O ' ' HB ' ' A' ' 112' ' ' THR . 3.1 mm? 68.64 -61.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.923 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.528 ' HB ' ' O ' ' A' ' 111' ' ' LEU . 8.4 t 167.59 43.05 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.43 -0.35 . . . . 10.0 111.76 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.431 ' ND2' ' HB3' ' A' ' 110' ' ' ASP . 80.2 m-20 -69.95 -52.14 26.92 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.881 -0.328 . . . . 10.0 111.192 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.7 t 67.56 113.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.152 0.501 . . . . 10.0 110.464 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.0 m -123.53 136.49 54.58 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.644 -0.707 . . . . 10.0 111.1 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 122' ' ' SER . 56.6 m-20 -60.23 -51.85 67.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.169 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.501 ' HA ' ' NZ ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER 60.84 33.5 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 10.0 111.135 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.552 ' CE2' ' CD2' ' A' ' 69' ' ' LEU . 26.0 t80 -175.6 -41.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.167 0.508 . . . . 10.0 109.969 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 76.77 36.07 38.22 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.527 -0.761 . . . . 10.0 111.9 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 118' ' ' PHE . 87.7 tttt 178.86 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.747 0.277 . . . . 10.0 111.747 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 140' ' ' LYS . 10.5 tppt? -130.47 -68.43 0.69 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.441 -0.504 . . . . 10.0 112.066 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.611 ' HB3' HD12 ' A' ' 136' ' ' LEU . 38.1 t 174.78 -79.41 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.88 0.372 . . . . 10.0 110.588 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.637 ' O ' ' N ' ' A' ' 125' ' ' LEU . 85.9 tttt 43.08 48.65 5.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 10.0 112.063 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 117' ' ' LYS . . . -56.77 72.72 0.01 OUTLIER Glycine 0 C--N 1.329 0.162 0 N-CA-C 111.021 -0.832 . . . . 10.0 111.021 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.904 HD13 ' N ' ' A' ' 126' ' ' VAL . 1.3 tm? -42.58 138.28 1.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.417 0.627 . . . . 10.0 111.776 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.904 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -146.65 160.22 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.954 -1.021 . . . . 10.0 110.81 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.482 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 1.0 OUTLIER -160.5 133.42 6.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.813 -0.631 . . . . 10.0 110.361 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.503 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 10.2 m -161.61 148.33 14.28 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.634 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.12 42.73 27.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.036 0.446 . . . . 10.0 110.761 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.16 36.16 51.49 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.736 -0.745 . . . . 10.0 112.059 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 128' ' ' THR . 5.0 ptp180 -132.86 139.71 47.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.639 0.257 . . . . 10.0 110.442 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.636 HD22 ' N ' ' A' ' 132' ' ' LEU . 2.3 mm? -88.78 139.33 30.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.875 0.369 . . . . 10.0 110.848 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.799 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.8 mt -150.85 143.44 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.413 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 23' ' ' LEU . 11.8 mt -111.82 122.62 66.49 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.745 0 N-CA-C 109.11 -0.7 . . . . 10.0 109.11 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 26' ' ' ASP . 16.4 t80 -100.99 172.53 6.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.875 ' CD1' HD11 ' A' ' 65' ' ' LEU . 4.1 tt -169.01 128.07 1.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.437 -0.505 . . . . 10.0 111.12 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 138' ' ' ILE . 12.3 p-10 -91.12 16.2 10.21 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.191 0.441 . . . . 10.0 112.191 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.931 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 20.5 tt 42.33 18.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 113.908 1.077 . . . . 10.0 113.908 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 137' ' ' ASP . 66.9 t0 -76.33 -56.19 4.86 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.94 0.719 . . . . 10.0 112.94 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 34.4 mmtp -80.1 -28.6 39.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.936 0.398 . . . . 10.0 110.997 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.931 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.5 -46.45 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.095 -0.502 . . . . 10.0 109.973 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.006 HD13 HG21 ' A' ' 91' ' ' VAL . 8.0 tp -65.04 -46.6 90.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 120.322 -0.551 . . . . 10.0 110.315 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.679 ' O ' HG12 ' A' ' 147' ' ' VAL . 3.3 tm-20 -48.56 -40.02 25.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 148' ' ' LYS . 54.8 mm-40 -76.47 -34.86 58.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.838 -1.074 . . . . 10.0 110.729 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 141' ' ' ILE . 43.4 mt -48.97 -38.91 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 120.971 0.415 . . . . 10.0 110.824 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 79.5 p -88.66 -51.75 5.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.968 0.729 . . . . 10.0 112.968 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 143' ' ' GLU . 7.2 p -83.83 13.15 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.232 0.827 . . . . 10.0 113.232 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.586 ' HG2' ' CD2' ' A' ' 48' ' ' PHE . 28.0 tptp -57.45 -41.96 81.55 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.668 -0.413 . . . . 10.0 111.248 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -166.2 139.62 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.319 -0.401 . . . . 10.0 111.014 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -176.39 41.94 0.11 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.78 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 10.0 110.943 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.82 0.343 . . . . 10.0 111.159 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.54 -47.9 81.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.087 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.4 m 68.18 -60.67 0.41 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.056 -0.52 . . . . 10.0 111.297 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.928 HD12 ' N ' ' A' ' 5' ' ' ALA . 4.2 pp -61.49 -42.14 98.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.553 -0.294 . . . . 10.0 111.076 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.928 ' N ' HD12 ' A' ' 4' ' ' LEU . . . 44.14 64.63 1.24 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.135 0.42 . . . . 10.0 112.135 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.868 ' OD2' HD13 ' A' ' 4' ' ' LEU . 59.9 m-20 -73.15 124.7 26.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.739 0.304 . . . . 10.0 110.851 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.66 -52.78 41.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.48 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.709 HD23 ' CD ' ' A' ' 106' ' ' GLU . 87.6 mt 51.34 44.2 29.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.162 0.506 . . . . 10.0 110.988 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -158.09 -47.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.624 -0.716 . . . . 10.0 110.19 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 95.1 mt-10 -140.8 164.28 30.64 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.509 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CE2' ' OH ' ' A' ' 135' ' ' TYR . 18.5 t80 -140.49 125.28 18.17 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 114.363 1.246 . . . . 10.0 114.363 -174.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -88.98 125.75 35.11 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.688 -1.967 . . . . 10.0 105.688 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.954 HG11 ' CG1' ' A' ' 104' ' ' ILE . 5.8 p -150.79 167.74 2.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 114.439 1.274 . . . . 10.0 114.439 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.688 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.3 tm? -88.77 133.58 34.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.051 -1.092 . . . . 10.0 108.051 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.754 ' HB3' HD22 ' A' ' 102' ' ' LEU . 57.1 p -144.89 158.11 43.91 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.749 0.785 . . . . 10.0 112.99 -177.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.61 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 2.1 p90 -152.97 156.8 39.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.147 -1.388 . . . . 10.0 109.996 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -88.67 106.39 18.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.363 0.602 . . . . 10.0 110.203 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.926 HG21 HD12 ' A' ' 71' ' ' ILE . 36.5 mm -88.89 102.51 13.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.173 -0.921 . . . . 10.0 110.973 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.748 ' OD1' HG22 ' A' ' 18' ' ' ILE . 12.2 p-10 32.92 60.33 0.41 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.094 1.146 . . . . 10.0 114.094 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.579 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 103.03 -51.3 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.07 0.948 . . . . 10.0 112.712 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.458 ' NE2' ' HB3' ' A' ' 72' ' ' SER . 1.6 pm0 -88.8 -175.73 4.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.695 -0.402 . . . . 10.0 110.363 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.017 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -112.83 159.83 18.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.104 0.478 . . . . 10.0 111.815 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.848 HD13 ' HB ' ' A' ' 134' ' ' ILE . 3.4 tp -150.4 136.72 18.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.951 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.673 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -138.77 152.5 47.98 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.335 0.865 . . . . 10.0 113.335 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.872 ' CZ ' HD22 ' A' ' 136' ' ' LEU . 4.7 m-85 -131.95 142.32 49.59 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.128 -0.942 . . . . 10.0 109.322 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.559 ' OD2' ' HB3' ' A' ' 28' ' ' ASP . 21.4 t0 -52.48 123.28 10.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.152 0.501 . . . . 10.0 110.415 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.932 HG13 ' HA ' ' A' ' 13' ' ' VAL . 33.2 m -63.69 -8.61 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 10.0 112.141 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.559 ' HB3' ' OD2' ' A' ' 26' ' ' ASP . 38.9 t70 -66.64 -47.4 72.69 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.533 -0.467 . . . . 10.0 109.833 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.721 ' CG ' HG21 ' A' ' 138' ' ' ILE . 19.2 t-20 -84.42 -44.43 13.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.637 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.688 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.3 mm -60.46 125.79 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 116.275 -0.421 . . . . 10.0 110.315 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HB3' ' CE ' ' A' ' 32' ' ' MET . 44.5 mt-10 -85.28 -62.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.58 -0.282 . . . . 10.0 111.435 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.424 ' CE ' ' HB3' ' A' ' 31' ' ' GLU . 1.2 pmm? -169.11 156.95 7.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.036 0.446 . . . . 10.0 111.322 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.592 HG11 HG11 ' A' ' 98' ' ' VAL . 35.6 m -88.93 161.66 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.761 -0.654 . . . . 10.0 111.547 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 33' ' ' VAL . 22.3 pt -158.06 133.36 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.502 -0.772 . . . . 10.0 110.742 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.8 63.82 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.326 0.584 . . . . 10.0 110.845 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 1.023 ' HB2' HD12 ' A' ' 81' ' ' ILE . 14.5 mmmm -88.98 153.13 21.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.341 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.9 m -156.73 150.25 24.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.422 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.1 t0 51.11 43.36 29.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.349 0.595 . . . . 10.0 110.542 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 36' ' ' LYS . 24.8 mt -71.89 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.167 -0.924 . . . . 10.0 112.376 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.643 HG23 ' HG2' ' A' ' 43' ' ' PRO . 58.5 m -146.04 78.69 11.33 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.747 -177.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -80.34 -56.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.348 2.699 . . . . 10.0 114.265 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.67 HG22 ' HD3' ' A' ' 43' ' ' PRO . 17.0 m -74.31 -35.9 2.44 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 112.821 0.675 . . . . 10.0 112.821 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.67 ' HD3' HG22 ' A' ' 42' ' ' VAL . 6.0 Cg_exo -76.66 13.75 1.36 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.328 2.019 . . . . 10.0 113.205 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.535 ' NZ ' ' HB3' ' A' ' 44' ' ' LYS . 5.6 ttpm? -45.78 -74.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.158 0.504 . . . . 10.0 111.659 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.9 t 44.4 42.42 5.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.482 -0.781 . . . . 10.0 111.532 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.564 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 38.7 mmt180 -158.32 -8.17 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.136 -0.484 . . . . 10.0 112.022 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 18.3 m80 69.52 -62.42 0.41 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.509 0.195 . . . . 10.0 111.29 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.483 ' HB2' ' HD2' ' A' ' 148' ' ' LYS . 3.7 m-85 -74.97 -47.98 26.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.719 0.295 . . . . 10.0 111.361 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.732 ' HA ' HG22 ' A' ' 63' ' ' VAL . 41.0 t -61.18 80.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 10.0 111.393 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.418 ' HG3' ' ND2' ' A' ' 64' ' ' ASN . 2.2 mm-40 -58.5 -38.19 77.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.715 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.678 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -148.49 165.57 29.1 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.382 -0.913 . . . . 10.0 113.324 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.57 HG22 HG21 ' A' ' 40' ' ' THR . 2.9 m -161.91 169.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.46 ' CG2' HG23 ' A' ' 39' ' ' ILE . 30.3 pt -156.12 137.74 5.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.067 0.461 . . . . 10.0 111.73 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.743 ' ND2' HD11 ' A' ' 59' ' ' ILE . 23.3 t-20 -125.95 119.8 28.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.239 -0.891 . . . . 10.0 110.108 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 54' ' ' ASN . 92.9 mt -161.36 141.07 10.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.945 0.402 . . . . 10.0 111.134 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 46.48 46.65 14.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.224 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.54 41.81 97.4 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.537 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.791 ' C ' HD12 ' A' ' 59' ' ' ILE . 76.0 mtt-85 -139.42 118.15 12.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 10.0 110.354 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.791 HD12 ' C ' ' A' ' 58' ' ' ARG . 1.5 mp -119.87 135.01 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.003 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.963 HG22 ' HB2' ' A' ' 90' ' ' GLU . 2.2 pp -143.74 135.86 13.19 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 121.0 -0.28 . . . . 10.0 111.504 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 98.0 Cg_endo -102.64 122.28 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.86 3.04 . . . . 10.0 112.589 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.678 HG22 ' C ' ' A' ' 51' ' ' GLY . 29.2 m -99.84 133.22 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.732 HG22 ' HA ' ' A' ' 49' ' ' VAL . 69.2 t -140.87 155.66 22.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.375 0.607 . . . . 10.0 111.75 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.771 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 4.2 m120 -70.27 66.59 0.3 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.39 -0.823 . . . . 10.0 109.777 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.882 HD22 ' CD2' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -52.08 -18.2 1.35 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.535 -0.302 . . . . 10.0 111.732 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.854 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -74.86 -27.68 60.35 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.465 -0.494 . . . . 10.0 110.169 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.771 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.94 -39.26 21.65 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.638 -0.504 . . . . 10.0 109.638 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.6 tt -57.78 -40.08 74.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 106.909 -1.515 . . . . 10.0 106.909 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.879 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.37 -45.13 23.23 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.399 -1.728 . . . . 10.0 107.939 176.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 113.08 -86.09 0.41 Allowed Glycine 0 C--N 1.335 0.488 0 CA-C-N 114.905 -1.043 . . . . 10.0 112.599 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.926 HD12 HG21 ' A' ' 18' ' ' ILE . 2.3 pt 46.89 167.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 113.41 0.893 . . . . 10.0 113.41 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.458 ' HB3' ' NE2' ' A' ' 21' ' ' GLN . 47.1 t -49.07 -37.93 22.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.364 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.786 ' HB3' HG13 ' A' ' 71' ' ' ILE . 3.1 t80 -22.5 141.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.274 1.213 . . . . 10.0 114.274 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' OD1' ' HG2' ' A' ' 75' ' ' GLU . 9.7 t70 -132.03 -58.64 0.95 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.803 -1.089 . . . . 10.0 109.306 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.479 ' HG2' ' OD1' ' A' ' 74' ' ' ASP . 11.7 pt-20 153.2 -42.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.027 0.531 . . . . 10.0 111.294 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -47.38 -40.95 18.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 10.0 112.239 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 10.7 mmpt? -77.09 -41.91 40.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.351 . . . . 10.0 111.054 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.642 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 21.4 mmt -45.39 144.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.422 0.527 . . . . 10.0 112.422 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.465 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -178.36 48.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.158 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.967 ' O ' HD12 ' A' ' 94' ' ' LEU . 79.1 p -169.05 -177.05 2.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.171 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.023 HD12 ' HB2' ' A' ' 36' ' ' LYS . 47.8 mt -154.41 140.27 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.074 0.398 . . . . 10.0 112.074 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 16' ' ' PHE . 7.5 mt -108.84 162.45 6.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.171 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.486 ' N ' HG22 ' A' ' 82' ' ' ILE . 44.3 t -132.48 147.94 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.946 0.403 . . . . 10.0 110.958 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -155.15 175.33 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.838 -0.619 . . . . 10.0 111.172 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -131.69 131.27 42.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.72 HG21 HG12 ' A' ' 138' ' ' ILE . 59.1 p -145.75 109.38 4.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.954 0.407 . . . . 10.0 112.096 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 87' ' ' LYS . 37.4 ttmt 47.54 50.62 14.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.477 0.656 . . . . 10.0 110.765 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.01 32.21 2.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.1 -0.955 . . . . 10.0 111.524 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.91 HG12 HG22 ' A' ' 91' ' ' VAL . 66.0 t -129.62 109.85 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.207 177.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.963 ' HB2' HG22 ' A' ' 60' ' ' ILE . 32.2 mt-10 -88.38 97.79 11.25 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.078 -1.823 . . . . 10.0 106.078 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.012 HG21 HD13 ' A' ' 142' ' ' ILE . 4.2 t -88.59 153.94 3.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 113.285 -1.779 . . . . 10.0 113.56 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.71 158.73 22.33 Favored Glycine 0 C--N 1.318 -0.445 0 CA-C-N 114.509 -1.223 . . . . 10.0 112.802 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.882 ' CD2' HD22 ' A' ' 65' ' ' LEU . 1.4 t80 -144.45 134.5 24.04 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.851 0.358 . . . . 10.0 111.287 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 80' ' ' SER . 45.6 tp -88.56 123.02 32.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.935 0.398 . . . . 10.0 111.038 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.683 HG23 ' OG ' ' A' ' 80' ' ' SER . 5.2 m -132.91 -175.04 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.803 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 12.5 t70 -99.53 -56.02 2.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.356 0.598 . . . . 10.0 111.902 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.0 tpp85 -150.08 123.8 9.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.217 -0.902 . . . . 10.0 108.706 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.61 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.9 p -108.25 113.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 122.389 1.09 . . . . 10.0 112.325 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.33 -28.22 69.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 112.945 -1.934 . . . . 10.0 111.104 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.19 -118.94 5.09 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.825 -0.91 . . . . 10.0 110.825 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.9 130.1 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 117.066 0.433 . . . . 10.0 110.21 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.754 HD22 ' HB3' ' A' ' 15' ' ' SER . 15.3 tp -135.18 143.47 46.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.416 . . . . 10.0 110.755 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 2.4 ptp180 -88.86 78.11 7.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.772 -0.649 . . . . 10.0 111.742 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.954 ' CG1' HG11 ' A' ' 13' ' ' VAL . 14.5 mm -88.81 178.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 106.856 -1.535 . . . . 10.0 106.856 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 17.3 p -141.43 -175.91 4.53 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.709 ' CD ' HD23 ' A' ' 8' ' ' LEU . 88.2 tt0 -127.73 72.3 1.39 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.949 0.88 . . . . 10.0 112.738 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -108.82 19.49 19.57 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.197 -1.365 . . . . 10.0 107.767 176.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 114' ' ' VAL . 75.0 mm-40 -125.64 -65.75 0.98 Allowed 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 115.068 -0.969 . . . . 10.0 111.363 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.825 HD23 ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -82.57 48.59 1.33 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.013 -0.54 . . . . 10.0 112.066 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.26 133.93 52.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 10.0 110.86 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.4 mt 68.94 -54.8 0.56 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.123 -0.49 . . . . 10.0 111.987 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 112' ' ' THR . 9.4 t -179.02 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.99 0.424 . . . . 10.0 111.229 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.613 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 24.6 t-20 67.31 114.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.972 -0.558 . . . . 10.0 111.007 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 108' ' ' GLN . 54.6 t -84.93 -42.66 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.342 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.4 m -168.4 153.05 6.2 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.092 -0.504 . . . . 10.0 111.01 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 26.8 m-20 -51.67 -34.44 38.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.501 . . . . 10.0 111.388 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 47.0 mmtm 69.24 -56.77 0.54 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.367 -0.378 . . . . 10.0 111.719 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.691 ' CE1' HD21 ' A' ' 69' ' ' LEU . 45.2 t80 -58.23 -46.37 86.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.272 0.558 . . . . 10.0 109.864 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 144.61 -53.19 0.58 Allowed Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.365 -0.834 . . . . 10.0 111.961 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 62.6 tttm 171.72 55.24 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 118' ' ' PHE . 4.1 tppp? -154.41 -30.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.604 0.594 . . . . 10.0 112.604 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.784 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 87.8 p -145.6 -163.9 1.83 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.694 -0.402 . . . . 10.0 111.833 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 23.6 tptm -72.11 -50.84 24.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.692 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 117' ' ' LYS . . . 170.02 -160.21 33.06 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 119.816 -1.183 . . . . 10.0 113.956 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.818 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.4 tm? -129.94 135.91 48.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.121 -0.54 . . . . 10.0 110.855 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.818 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.0 OUTLIER -117.47 159.98 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.405 0.621 . . . . 10.0 111.847 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.505 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -163.07 137.4 6.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.592 -0.731 . . . . 10.0 110.617 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.553 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 8.7 m -165.14 150.09 9.22 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.623 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 56.83 44.17 23.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.943 0.402 . . . . 10.0 110.801 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.21 33.91 39.2 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.696 -0.764 . . . . 10.0 112.04 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 128' ' ' THR . 14.2 ptt180 -133.49 136.19 44.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.201 -0.296 . . . . 10.0 110.201 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 86.1 mt -88.89 139.95 29.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.046 0.451 . . . . 10.0 111.585 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.017 HG12 ' HB3' ' A' ' 22' ' ' ALA . 4.1 mt -145.37 132.8 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.543 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.848 ' HB ' HD13 ' A' ' 23' ' ' LEU . 2.0 mp -88.89 149.56 3.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.617 -0.882 . . . . 10.0 108.617 177.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.489 ' OH ' ' CE2' ' A' ' 11' ' ' PHE . 38.6 t80 -135.38 145.11 47.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.036 -0.665 . . . . 10.0 111.707 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.872 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 6.2 mp -138.85 164.23 30.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.758 0.79 . . . . 10.0 112.416 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -134.53 26.71 3.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.439 -1.255 . . . . 10.0 108.402 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.926 ' HA ' HG23 ' A' ' 141' ' ' ILE . 8.4 tt 41.21 17.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 114.375 -1.284 . . . . 10.0 114.211 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -81.36 -62.42 1.66 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.691 0.626 . . . . 10.0 112.691 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -75.82 -31.85 59.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.611 0.719 . . . . 10.0 109.903 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.59 -45.82 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 114.759 -1.11 . . . . 10.0 110.785 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.012 HD13 HG21 ' A' ' 91' ' ' VAL . 7.9 tp -64.48 -43.18 96.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 C-N-CA 119.987 -0.685 . . . . 10.0 109.902 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.535 ' N ' HG23 ' A' ' 142' ' ' ILE . 35.1 tp10 -47.71 -46.47 29.63 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.293 0.568 . . . . 10.0 110.072 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.719 ' HB2' HD11 ' A' ' 68' ' ' ILE . 53.2 mm-40 -67.4 -36.45 81.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.409 -0.814 . . . . 10.0 110.597 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.639 ' CD1' HG11 ' A' ' 91' ' ' VAL . 54.1 mt -53.77 -38.72 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.92 0.391 . . . . 10.0 110.843 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.6 p -74.81 -48.8 23.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.368 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.8 p -79.23 6.26 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 111.952 0.353 . . . . 10.0 111.952 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.483 ' HD2' ' HB2' ' A' ' 48' ' ' PHE . 22.6 pttp -51.0 -34.09 27.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.687 0.28 . . . . 10.0 111.462 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 147' ' ' VAL . 52.8 mm-40 65.2 136.97 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.878 0.371 . . . . 10.0 111.038 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -176.54 45.35 0.11 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.898 -0.668 . . . . 10.0 112.33 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 43.8 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.352 . . . . 10.0 111.035 -179.884 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.845 0.355 . . . . 10.0 111.153 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' HG3' ' HG ' ' A' ' 4' ' ' LEU . 19.9 tptm -164.23 -43.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.266 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 38.6 m 76.29 -46.42 0.53 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.9 pp -53.32 -43.69 67.82 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.178 -0.209 . . . . 10.0 111.32 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.852 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -179.38 134.96 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 10.0 111.521 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -67.03 148.65 51.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.634 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 8' ' ' LEU . . . -171.25 140.44 1.47 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.214 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.885 HD13 HD12 ' A' ' 109' ' ' LEU . 80.4 mt 70.46 115.28 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.535 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.548 ' NZ ' HG21 ' A' ' 105' ' ' THR . 19.6 tptt -155.52 -57.85 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.526 -0.761 . . . . 10.0 111.274 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 40.3 tt0 -117.02 163.9 15.53 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 121.435 0.636 . . . . 10.0 111.021 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.619 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.6 t80 -163.19 137.95 6.36 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 114.834 -1.075 . . . . 10.0 112.855 -174.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 68.1 mt-10 -88.8 138.93 30.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.632 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.859 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.1 p -155.58 174.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 -175.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.798 HD11 HD13 ' A' ' 82' ' ' ILE . 3.2 tm? -88.74 136.98 32.72 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.004 -1.109 . . . . 10.0 108.004 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.764 ' CB ' HD22 ' A' ' 102' ' ' LEU . 81.8 p -149.37 157.67 43.52 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 113.993 1.108 . . . . 10.0 113.993 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.739 ' CE2' ' HG ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -149.98 158.08 43.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 113.948 -1.478 . . . . 10.0 109.837 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.719 ' HG2' HD21 ' A' ' 99' ' ' LEU . 5.1 mm-40 -88.59 88.95 7.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 10.0 111.048 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.053 HG21 HD12 ' A' ' 71' ' ' ILE . 16.8 mm -88.91 124.21 41.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.852 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.754 ' OD2' HG22 ' A' ' 18' ' ' ILE . 1.9 p30 36.62 60.07 0.95 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.601 -0.727 . . . . 10.0 112.571 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 76.97 -43.46 0.44 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.037 -0.983 . . . . 10.0 112.688 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 22' ' ' ALA . 3.0 pp0? -89.02 166.0 14.18 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 120.915 -0.314 . . . . 10.0 110.38 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.015 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.77 150.17 23.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 10.0 112.27 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.941 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -133.56 130.69 38.77 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 178.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.904 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -138.33 153.88 48.98 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.615 0.968 . . . . 10.0 113.615 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.86 ' CE2' HD22 ' A' ' 136' ' ' LEU . 2.3 m-85 -135.73 142.31 45.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.527 -1.215 . . . . 10.0 107.97 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -50.81 123.46 9.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 10.0 110.374 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.859 HG13 ' HA ' ' A' ' 13' ' ' VAL . 34.7 m -60.03 -12.29 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.508 -0.769 . . . . 10.0 111.863 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -63.42 -42.77 98.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.98 0.419 . . . . 10.0 110.127 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.692 ' CG ' HG21 ' A' ' 138' ' ' ILE . 12.1 t-20 -87.34 -45.68 10.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.561 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.784 HG21 ' HG ' ' A' ' 14' ' ' LEU . 11.8 mm -65.55 138.55 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.045 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 32' ' ' MET . 24.9 pt-20 -113.31 -50.07 2.88 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.379 0.511 . . . . 10.0 112.379 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 3.5 mtm -163.95 -175.96 4.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.966 0.412 . . . . 10.0 111.552 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 98' ' ' VAL . 33.9 m -127.84 126.59 67.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.934 -0.576 . . . . 10.0 111.465 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.413 HG13 ' HB ' ' A' ' 81' ' ' ILE . 27.2 pt -96.15 171.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.038 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -88.83 147.63 24.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 10.0 110.947 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.66 ' HD2' HD11 ' A' ' 94' ' ' LEU . 63.4 tttp -88.87 136.49 32.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.166 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 87.1 p 179.13 -167.67 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.81 -0.632 . . . . 10.0 110.353 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -52.31 140.0 22.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.543 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 40' ' ' THR . 24.7 mt -155.25 -83.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.405 0.52 . . . . 10.0 112.405 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.77 HG23 ' HG2' ' A' ' 43' ' ' PRO . 96.3 m -139.68 70.78 37.44 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.861 0.362 . . . . 10.0 111.253 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -86.14 -50.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.092 2.528 . . . . 10.0 113.448 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.643 HG12 ' HD3' ' A' ' 43' ' ' PRO . 13.2 p -74.43 -33.9 1.75 Allowed Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 112.682 0.623 . . . . 10.0 112.682 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.77 ' HG2' HG23 ' A' ' 40' ' ' THR . 10.5 Cg_exo -72.42 12.16 0.7 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.432 2.088 . . . . 10.0 113.141 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.536 ' HB2' ' NZ ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -45.56 160.03 0.06 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.174 0.511 . . . . 10.0 111.765 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.475 ' H ' ' HD2' ' A' ' 46' ' ' ARG . 47.3 t 176.92 45.52 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.225 -0.898 . . . . 10.0 110.773 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -177.75 -34.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.861 -0.609 . . . . 10.0 110.731 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.508 ' HB3' ' O ' ' A' ' 46' ' ' ARG . 77.4 t60 82.23 -45.97 0.17 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.131 -0.486 . . . . 10.0 111.727 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.509 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -57.2 -50.65 72.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 10.0 110.496 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.816 ' HA ' HG22 ' A' ' 63' ' ' VAL . 62.0 t -73.4 130.55 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.769 ' HG3' HG23 ' A' ' 62' ' ' VAL . 22.7 pt-20 -75.82 -39.04 57.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -167.91 -175.91 38.05 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.54 -0.838 . . . . 10.0 113.085 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 53' ' ' ILE . 3.2 m -159.13 171.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.756 -0.461 . . . . 10.0 109.756 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.487 ' CG2' HG23 ' A' ' 39' ' ' ILE . 31.5 pt -159.51 132.31 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.147 0.498 . . . . 10.0 112.332 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.853 ' ND2' HD11 ' A' ' 59' ' ' ILE . 20.7 t-20 -93.8 134.24 36.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.536 -0.757 . . . . 10.0 110.348 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.1 tp -169.09 138.77 2.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.988 0.423 . . . . 10.0 111.275 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 48.72 46.89 21.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.228 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 54.64 40.74 71.76 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.889 -0.672 . . . . 10.0 112.697 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.491 ' C ' HD12 ' A' ' 59' ' ' ILE . 64.0 mtt85 -158.19 121.64 3.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 10.0 110.737 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.853 HD11 ' ND2' ' A' ' 54' ' ' ASN . 1.4 mp -101.09 132.74 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.858 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.799 HG22 ' HB3' ' A' ' 90' ' ' GLU . 2.2 pp -114.01 134.24 22.19 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 116.638 -0.256 . . . . 10.0 110.735 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 92.1 Cg_endo -100.55 114.05 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.301 2.668 . . . . 10.0 113.19 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.769 HG23 ' HG3' ' A' ' 50' ' ' GLU . 19.7 m -89.14 133.12 32.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.956 -0.757 . . . . 10.0 108.956 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.816 HG22 ' HA ' ' A' ' 49' ' ' VAL . 63.1 t -143.31 156.21 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.657 0.741 . . . . 10.0 112.953 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.506 ' N ' HG12 ' A' ' 63' ' ' VAL . 74.6 m-20 -74.49 68.36 1.58 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.756 -1.111 . . . . 10.0 109.214 178.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.911 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.3 tt -53.41 -30.59 41.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.239 0.542 . . . . 10.0 110.814 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.638 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . . . -63.01 -26.5 68.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' N ' ' HE2' ' A' ' 73' ' ' PHE . 0.8 OUTLIER -83.5 -42.0 17.36 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.966 179.19 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 65' ' ' LEU . 12.8 tt -58.79 -42.1 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 107.175 -1.416 . . . . 10.0 107.175 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.88 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -73.82 -45.28 52.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 113.76 -1.564 . . . . 10.0 108.435 176.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.498 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 113.52 -91.24 0.57 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.539 -0.755 . . . . 10.0 113.15 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.053 HD12 HG21 ' A' ' 18' ' ' ILE . 3.1 pt 48.28 164.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 112.812 0.671 . . . . 10.0 112.812 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.562 ' HB3' ' CG ' ' A' ' 19' ' ' ASP . 29.4 t -47.23 -32.99 4.98 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.328 -0.619 . . . . 10.0 109.328 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.856 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.2 t80 -33.18 141.55 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.191 -0.913 . . . . 10.0 112.533 176.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -171.87 43.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.49 -0.777 . . . . 10.0 110.196 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 78' ' ' MET . 50.0 mt-10 62.79 43.45 7.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.942 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.508 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 19.4 pt20 -74.54 -52.66 11.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HD2' ' C ' ' A' ' 76' ' ' GLN . 2.6 mptt -146.4 18.97 1.36 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 112.275 0.472 . . . . 10.0 112.275 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.628 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 9.4 mmm -47.45 145.85 2.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.582 0.229 . . . . 10.0 110.525 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -174.38 38.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.888 0.375 . . . . 10.0 111.14 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.746 ' O ' HD12 ' A' ' 94' ' ' LEU . 71.1 m -169.14 162.47 10.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 10.0 109.875 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 70.3 mt -139.61 123.49 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.606 -0.438 . . . . 10.0 111.969 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.798 HD13 HD11 ' A' ' 14' ' ' LEU . 10.7 mt -89.01 130.96 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.494 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.32 146.64 9.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.071 0.462 . . . . 10.0 111.125 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -145.19 -178.72 6.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.566 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 41.8 mtm-85 -138.95 131.07 28.09 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.756 HG21 HG12 ' A' ' 138' ' ' ILE . 82.4 p -144.2 110.99 5.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.927 0.394 . . . . 10.0 112.035 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? 47.8 48.2 17.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.349 0.595 . . . . 10.0 110.735 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 73.51 32.35 1.21 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.085 -0.961 . . . . 10.0 111.564 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 91' ' ' VAL . 53.7 t -128.4 110.88 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.311 -0.859 . . . . 10.0 109.451 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.799 ' HB3' HG22 ' A' ' 60' ' ' ILE . 88.5 tt0 -88.27 98.34 11.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 106.14 -1.8 . . . . 10.0 106.14 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.01 HG21 HD13 ' A' ' 142' ' ' ILE . 3.6 t -88.62 153.93 3.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 112.983 -1.917 . . . . 10.0 113.353 -173.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -124.13 152.66 17.35 Favored Glycine 0 C--N 1.318 -0.455 0 CA-C-N 114.506 -1.225 . . . . 10.0 113.148 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.645 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -141.66 130.0 22.39 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.746 HD12 ' O ' ' A' ' 80' ' ' SER . 66.1 tp -88.56 133.68 34.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.205 0.526 . . . . 10.0 111.445 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.734 HG12 HD11 ' A' ' 18' ' ' ILE . 27.1 m -150.27 -175.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.357 -0.838 . . . . 10.0 110.776 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 78' ' ' MET . 60.3 t0 -111.51 -56.85 2.33 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 112.338 0.496 . . . . 10.0 112.338 -176.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -133.87 124.72 26.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.986 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.78 HG11 HG11 ' A' ' 33' ' ' VAL . 5.9 p -115.94 113.12 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-O 122.336 1.065 . . . . 10.0 112.004 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.719 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -63.82 -30.19 71.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.292 -1.776 . . . . 10.0 111.343 -178.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.58 -120.14 5.47 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.707 -0.957 . . . . 10.0 110.707 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.8 p -54.57 131.23 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 117.099 0.449 . . . . 10.0 110.064 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.764 HD22 ' CB ' ' A' ' 15' ' ' SER . 54.6 tp -135.02 139.42 44.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.142 0.496 . . . . 10.0 111.469 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.1 ptp85 -88.9 72.35 8.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.1 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.973 HD12 HG21 ' A' ' 126' ' ' VAL . 9.6 mm -88.73 132.79 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 116.421 -0.354 . . . . 10.0 110.188 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.8 p -88.51 148.28 24.21 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 106.989 -1.486 . . . . 10.0 106.989 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.479 ' HG2' ' CD2' ' A' ' 109' ' ' LEU . 18.6 tp10 -140.25 90.08 2.34 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.506 -0.878 . . . . 10.0 111.849 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -91.15 16.43 9.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.741 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.611 ' HA ' ' HB2' ' A' ' 113' ' ' ASN . 1.5 pt20 -118.97 -80.17 0.61 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.524 -0.762 . . . . 10.0 110.685 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.885 HD12 HD13 ' A' ' 8' ' ' LEU . 79.3 mt 63.5 -121.72 0.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.02 -0.537 . . . . 10.0 111.528 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.602 ' HA ' HG22 ' A' ' 114' ' ' VAL . 7.6 t70 -151.53 -45.49 0.11 Allowed 'General case' 0 C--O 1.23 0.047 0 CA-C-O 120.857 0.361 . . . . 10.0 110.79 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 111' ' ' LEU . 5.6 tt -63.94 -40.66 96.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.748 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.46 HG23 ' N ' ' A' ' 113' ' ' ASN . 9.4 t -95.01 -46.02 7.0 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.151 0.501 . . . . 10.0 111.288 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.611 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 75.5 m-80 -159.34 -158.31 0.66 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.309 -0.86 . . . . 10.0 109.904 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 110' ' ' ASP . 5.1 t -162.21 -58.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.841 0.353 . . . . 10.0 110.467 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 114' ' ' VAL . 99.4 p 58.55 117.92 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.22 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.438 ' O ' ' HA3' ' A' ' 124' ' ' GLY . 12.1 p-10 -60.24 -48.31 82.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.45 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.469 ' HB2' ' HA3' ' A' ' 124' ' ' GLY . 74.2 mmtt 64.82 -57.46 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.177 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.633 ' CE2' HD21 ' A' ' 69' ' ' LEU . 25.3 t80 -89.48 -56.39 3.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.031 0.443 . . . . 10.0 110.495 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.34 -146.58 18.24 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.712 -0.676 . . . . 10.0 112.341 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -88.23 54.05 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 10.0 110.678 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 68' ' ' ILE . 17.9 tppt? -139.55 -39.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.033 0.383 . . . . 10.0 112.033 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.583 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 99.6 p -152.98 -163.1 1.62 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.664 0.269 . . . . 10.0 110.697 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.565 ' HE2' ' CD2' ' A' ' 135' ' ' TYR . 0.1 OUTLIER -63.13 -55.21 27.21 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.875 -0.33 . . . . 10.0 110.351 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.536 ' N ' ' HE3' ' A' ' 123' ' ' LYS . . . 149.56 155.89 6.98 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.355 -1.403 . . . . 10.0 114.692 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.886 HD13 ' N ' ' A' ' 126' ' ' VAL . 3.1 tm? -60.25 144.7 49.66 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.87 -0.665 . . . . 10.0 110.632 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.973 HG21 HD12 ' A' ' 104' ' ' ILE . 2.4 p -127.38 156.51 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.295 0.569 . . . . 10.0 111.686 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.42 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 96.5 mttt -147.02 140.65 25.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 131' ' ' ARG . 6.3 m -163.24 142.08 8.31 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.803 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 56.02 44.1 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.958 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.56 35.23 29.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.105 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.561 ' HD2' ' CG1' ' A' ' 133' ' ' ILE . 0.0 OUTLIER -133.84 148.86 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.2 mp -88.75 139.33 30.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.399 0.619 . . . . 10.0 112.471 -177.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.015 HG12 ' HB3' ' A' ' 22' ' ' ALA . 6.2 mt -151.5 150.35 13.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.241 -0.891 . . . . 10.0 110.571 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.941 ' HB ' HD13 ' A' ' 23' ' ' LEU . 6.1 mm -103.6 130.9 53.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.565 ' CD2' ' HE2' ' A' ' 123' ' ' LYS . 10.3 t80 -117.42 139.26 51.13 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 119.915 -0.714 . . . . 10.0 111.364 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.86 HD22 ' CE2' ' A' ' 25' ' ' PHE . 7.2 mp -135.67 165.98 24.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.497 -0.774 . . . . 10.0 112.145 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 123' ' ' LYS . 10.6 p-10 -135.45 24.28 3.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.657 -1.156 . . . . 10.0 108.293 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.901 ' HA ' HG23 ' A' ' 141' ' ' ILE . 11.1 tt 41.7 17.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.286 -1.325 . . . . 10.0 113.961 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 142' ' ' ILE . 37.7 t70 -82.72 -60.19 2.26 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.729 0.64 . . . . 10.0 112.729 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 3.4 mptp? -75.3 -34.26 61.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.699 0.761 . . . . 10.0 109.631 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.901 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -66.45 -46.15 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.664 -1.153 . . . . 10.0 110.732 179.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.01 HD13 HG21 ' A' ' 91' ' ' VAL . 7.6 tp -62.73 -45.84 97.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 C-N-CA 120.193 -0.603 . . . . 10.0 110.436 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.738 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.3 tt0 -47.92 -44.61 30.01 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.351 0.596 . . . . 10.0 109.756 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.601 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.3 mt-10 -69.6 -30.94 68.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.246 -0.888 . . . . 10.0 110.898 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.653 ' CD1' HG11 ' A' ' 91' ' ' VAL . 48.4 mt -57.61 -54.01 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 120.843 0.354 . . . . 10.0 111.418 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.4 p -69.05 -52.28 30.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.868 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 143' ' ' GLU . 14.0 p -67.25 -12.46 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.811 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -46.53 -52.77 12.67 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.842 0.354 . . . . 10.0 111.092 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 38.3 tt0 -178.61 46.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.059 0.457 . . . . 10.0 110.829 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 80.26 42.61 10.38 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.897 -0.668 . . . . 10.0 112.21 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.724 HG11 ' CG2' ' A' ' 49' ' ' VAL . 47.4 t . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 120.909 0.385 . . . . 10.0 111.027 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.799 0.333 . . . . 10.0 110.973 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.935 ' HD2' ' HB2' ' A' ' 5' ' ' ALA . 4.9 ttmp? -63.2 -52.43 62.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.606 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.9 m 67.63 -54.64 0.49 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.495 0.554 . . . . 10.0 112.495 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.823 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.1 pp -55.14 -23.93 23.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.74 0.305 . . . . 10.0 111.386 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.935 ' HB2' ' HD2' ' A' ' 2' ' ' LYS . . . -51.51 130.09 26.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 10.0 111.431 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -67.93 142.09 56.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.779 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.54 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -53.46 -66.54 0.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.393 . . . . 10.0 111.57 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 7' ' ' ALA . 96.9 mt -159.96 44.01 0.22 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.855 0.36 . . . . 10.0 111.166 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -74.05 -51.99 14.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.557 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.589 ' HG2' HG22 ' A' ' 105' ' ' THR . 35.1 mt-10 -124.95 164.23 20.56 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.53 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.617 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 12.1 t80 -153.6 137.51 16.27 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.718 -1.128 . . . . 10.0 113.037 -174.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 70.8 mt-10 -88.78 137.36 32.38 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.791 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -152.07 171.05 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.333 -0.849 . . . . 10.0 112.504 -175.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.681 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.9 tm? -88.85 134.94 33.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.795 ' HB3' HD22 ' A' ' 102' ' ' LEU . 80.6 p -148.16 153.03 38.27 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.096 0.776 . . . . 10.0 113.096 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.697 ' HZ ' ' CE1' ' A' ' 25' ' ' PHE . 1.8 p90 -149.79 168.1 24.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.269 -1.332 . . . . 10.0 110.143 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.55 129.67 35.42 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.829 HD11 HG12 ' A' ' 95' ' ' VAL . 4.5 mm -136.65 117.77 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.759 -0.655 . . . . 10.0 111.519 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.573 ' OD2' HG22 ' A' ' 18' ' ' ILE . 1.9 p30 38.44 60.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.17 -0.923 . . . . 10.0 112.621 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 0.5 OUTLIER 78.4 -43.06 0.35 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.916 -1.038 . . . . 10.0 112.742 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.534 ' NE2' ' HB ' ' A' ' 18' ' ' ILE . 3.5 pp0? -89.25 163.07 15.54 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.871 -0.332 . . . . 10.0 110.88 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.977 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.73 151.63 22.29 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.804 0.335 . . . . 10.0 110.84 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -133.58 134.75 43.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.077 -179.221 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.66 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -137.23 141.02 42.07 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.214 0.82 . . . . 10.0 113.214 -177.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.04 ' CE2' HD13 ' A' ' 65' ' ' LEU . 1.4 m-85 -119.23 135.86 54.49 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.826 -1.175 . . . . 10.0 107.826 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -51.06 123.59 9.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.467 -0.493 . . . . 10.0 110.802 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.717 HG13 ' HA ' ' A' ' 13' ' ' VAL . 15.7 m -64.4 -8.68 5.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.608 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.6 -31.43 68.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.01 0.433 . . . . 10.0 110.524 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.958 ' ND2' HG21 ' A' ' 138' ' ' ILE . 14.5 t30 -106.88 -50.22 3.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.918 -0.583 . . . . 10.0 112.401 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.681 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.1 mm -49.61 135.88 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 116.69 -0.232 . . . . 10.0 110.779 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 32' ' ' MET . 16.3 pt-20 -111.45 -51.65 2.84 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.889 0.7 . . . . 10.0 112.889 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.4 mtm -169.07 157.93 8.16 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.058 0.456 . . . . 10.0 111.88 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.719 HG11 HG11 ' A' ' 98' ' ' VAL . 34.8 m -89.68 177.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.033 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.628 HG13 ' HB ' ' A' ' 81' ' ' ILE . 20.6 pt -160.66 157.47 2.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.383 -0.826 . . . . 10.0 110.192 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -88.75 136.62 32.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 10.0 111.398 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.546 ' HB2' HG13 ' A' ' 81' ' ' ILE . 1.2 tmtp? -88.91 130.03 35.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.009 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.527 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 80.1 p -175.73 129.69 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.974 0.416 . . . . 10.0 111.846 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.1 t0 40.19 44.53 1.57 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.68 -0.691 . . . . 10.0 111.954 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 40' ' ' THR . 7.9 mt -78.3 156.31 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.108 0.48 . . . . 10.0 111.565 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.885 HG23 ' HG2' ' A' ' 43' ' ' PRO . 22.3 m -36.64 93.57 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.048 -0.978 . . . . 10.0 112.09 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -95.18 -52.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.293 2.662 . . . . 10.0 114.204 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.515 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 45.3 t -67.69 -47.31 45.18 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 112.659 0.615 . . . . 10.0 112.659 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.885 ' HG2' HG23 ' A' ' 40' ' ' THR . 52.9 Cg_exo -53.79 -57.93 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.896 1.731 . . . . 10.0 112.22 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.446 ' HG2' ' H ' ' A' ' 47' ' ' HIS . 37.4 ttpt 58.33 -79.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.208 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' PRO . 68.3 m 42.23 44.64 3.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.65 -0.704 . . . . 10.0 112.164 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HD3' HG21 ' A' ' 49' ' ' VAL . 79.5 mtt-85 -160.92 -36.88 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.48 -0.327 . . . . 10.0 111.377 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 20.8 m80 73.04 -57.3 0.64 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.265 -0.425 . . . . 10.0 111.188 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 2.2 t80 -68.09 -53.22 27.02 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.846 -0.427 . . . . 10.0 109.846 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 63' ' ' VAL . 60.8 t -67.68 133.37 31.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.776 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' OE2' HG23 ' A' ' 62' ' ' VAL . 1.7 pp20? -72.8 -35.91 67.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.445 -0.343 . . . . 10.0 111.725 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.539 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -158.66 -176.01 30.23 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 119.659 -1.258 . . . . 10.0 113.755 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.603 HG22 HG21 ' A' ' 40' ' ' THR . 2.0 m -156.95 169.76 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.595 HG13 HD23 ' A' ' 55' ' ' LEU . 26.9 pt -158.78 138.15 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.946 0.403 . . . . 10.0 111.583 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.87 ' C ' HD22 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -88.91 116.88 27.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.607 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.87 HD22 ' C ' ' A' ' 54' ' ' ASN . 3.5 mm? -144.23 140.63 29.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.732 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 56' ' ' ARG . 10.4 mpt_? 53.39 45.84 27.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.061 0.458 . . . . 10.0 110.731 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.81 35.66 63.79 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.719 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.1 mtm-85 -160.24 131.22 5.67 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.765 0.317 . . . . 10.0 110.815 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.621 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.92 133.85 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.746 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.797 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.4 pp -115.69 132.72 23.02 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.422 -0.354 . . . . 10.0 111.326 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 95.2 Cg_endo -84.6 116.43 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.384 2.056 . . . . 10.0 112.593 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.539 HG22 ' C ' ' A' ' 51' ' ' GLY . 7.6 m -89.0 99.54 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.346 -0.612 . . . . 10.0 109.346 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 49' ' ' VAL . 3.1 t -99.52 -175.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.019 -0.991 . . . . 10.0 110.144 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.879 ' H ' HG12 ' A' ' 63' ' ' VAL . 38.1 m-20 -132.55 87.82 2.46 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.08 -0.509 . . . . 10.0 109.986 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.04 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.6 tt -51.14 -24.75 4.38 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.122 -0.631 . . . . 10.0 111.137 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.758 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -66.67 -29.51 69.54 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.827 -0.349 . . . . 10.0 111.058 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.828 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -86.08 -37.88 18.39 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.812 0.339 . . . . 10.0 110.15 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.728 HG22 ' HA ' ' A' ' 65' ' ' LEU . 10.3 tt -65.35 -38.24 82.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 107.508 -1.293 . . . . 10.0 107.508 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.827 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.5 tm? -78.29 -46.94 18.94 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.553 -1.658 . . . . 10.0 108.724 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.556 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 115.02 -89.64 0.51 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.305 -0.861 . . . . 10.0 112.633 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.842 HG13 ' HB3' ' A' ' 73' ' ' PHE . 4.4 pt 47.12 164.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.484 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 16.3 t -48.1 -33.05 7.62 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.325 -0.62 . . . . 10.0 109.325 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.842 ' HB3' HG13 ' A' ' 71' ' ' ILE . 16.5 t80 -30.6 145.42 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.219 -0.9 . . . . 10.0 112.634 176.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -166.44 33.62 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.31 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.495 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 56.2 mt-10 55.0 46.03 25.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.683 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.45 ' HB2' ' HE2' ' A' ' 77' ' ' LYS . 98.6 mm-40 -95.64 -53.48 3.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -102.09 -32.75 9.98 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.298 0.481 . . . . 10.0 112.298 -178.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.624 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 2.9 mmm -28.85 142.65 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.87 0.468 . . . . 10.0 112.248 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.76 39.33 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.079 -0.509 . . . . 10.0 111.283 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.4 t -169.06 127.69 1.02 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.736 -0.665 . . . . 10.0 109.644 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.628 ' HB ' HG13 ' A' ' 34' ' ' ILE . 47.8 mt -98.2 151.31 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.631 HD13 HD11 ' A' ' 14' ' ' LEU . 11.0 mt -115.65 123.8 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.879 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.526 ' CG2' HD13 ' A' ' 34' ' ' ILE . 65.3 t -91.31 147.6 5.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.503 0.668 . . . . 10.0 111.928 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -150.67 171.31 17.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.017 -0.992 . . . . 10.0 110.384 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.459 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 12.1 ptp180 -127.29 143.79 51.17 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.541 -0.54 . . . . 10.0 109.541 178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.5 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 34.5 p -159.0 108.56 1.94 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.269 0.47 . . . . 10.0 112.269 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.2 tppp? 46.79 48.49 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.355 0.598 . . . . 10.0 110.816 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 72.47 33.88 1.37 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.081 -0.963 . . . . 10.0 111.244 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.935 HG12 HG22 ' A' ' 91' ' ' VAL . 75.0 t -132.45 110.62 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-N 115.122 -0.945 . . . . 10.0 109.193 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.679 ' HB2' HG22 ' A' ' 60' ' ' ILE . 1.7 mp0 -88.36 96.25 10.51 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.043 HG21 HD13 ' A' ' 142' ' ' ILE . 3.4 t -88.64 153.26 3.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 113.273 -1.785 . . . . 10.0 112.792 -174.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -131.84 153.87 20.69 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 114.997 -1.001 . . . . 10.0 113.701 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.726 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 t80 -139.86 128.54 23.12 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.453 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 51.1 tp -88.72 136.19 33.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.562 0.696 . . . . 10.0 112.209 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.829 HG12 HD11 ' A' ' 18' ' ' ILE . 23.8 m -148.86 -175.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.805 -1.089 . . . . 10.0 110.098 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.448 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 6.6 t70 -106.31 -57.96 1.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.496 HH12 HD11 ' A' ' 99' ' ' LEU . 55.4 ttp85 -133.96 116.34 15.45 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.369 0.604 . . . . 10.0 109.825 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.719 HG11 HG11 ' A' ' 33' ' ' VAL . 9.3 p -105.08 116.09 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 122.49 1.138 . . . . 10.0 111.852 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.641 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -65.73 -29.69 70.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.908 -1.951 . . . . 10.0 110.774 -178.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.8 -122.14 5.91 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.174 -0.77 . . . . 10.0 111.174 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -53.22 129.91 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 117.148 0.474 . . . . 10.0 110.292 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.804 ' HB3' HG13 ' A' ' 13' ' ' VAL . 60.7 tp -132.02 141.66 49.32 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.104 0.478 . . . . 10.0 111.236 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 103' ' ' ARG . 14.4 ptp180 -88.87 68.79 8.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 10.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.011 HD12 HG21 ' A' ' 126' ' ' VAL . 22.3 mm -88.75 132.04 34.63 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.589 HG22 ' HG2' ' A' ' 10' ' ' GLU . 30.3 p -88.73 -175.77 5.02 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.223 -1.028 . . . . 10.0 108.223 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.768 ' OE2' HD12 ' A' ' 109' ' ' LEU . 37.1 tt0 -147.3 75.71 1.38 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.322 -0.951 . . . . 10.0 112.423 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -103.1 20.63 17.27 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.763 -1.108 . . . . 10.0 109.272 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -126.73 -49.45 1.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.453 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.768 HD12 ' OE2' ' A' ' 106' ' ' GLU . 17.5 mt -62.34 -31.12 71.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.841 0.353 . . . . 10.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 109' ' ' LEU . 66.7 t0 72.8 -57.7 0.62 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.928 -0.578 . . . . 10.0 111.036 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.968 HD12 ' N ' ' A' ' 112' ' ' THR . 3.6 pp 171.63 -35.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.566 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.968 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.7 t -90.59 2.84 55.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.366 -0.834 . . . . 10.0 111.764 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 58.25 76.01 0.36 Allowed 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.768 0.318 . . . . 10.0 110.393 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.726 HG23 HG23 ' A' ' 112' ' ' THR . 10.9 t -156.47 104.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.094 0.473 . . . . 10.0 110.721 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.9 t -174.4 -40.12 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.544 -0.753 . . . . 10.0 111.041 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 38.18 92.62 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.311 0.577 . . . . 10.0 112.005 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.616 ' HB2' ' HA3' ' A' ' 124' ' ' GLY . 73.0 mmtt -77.23 -20.47 55.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.367 -0.833 . . . . 10.0 112.124 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.735 ' HB2' ' HA2' ' A' ' 124' ' ' GLY . 19.8 t80 -73.82 -59.81 2.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.005 0.431 . . . . 10.0 110.949 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 146.57 53.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.901 -0.666 . . . . 10.0 112.16 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 68.62 55.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.087 0.47 . . . . 10.0 110.844 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.439 ' HD2' ' CE2' ' A' ' 118' ' ' PHE . 24.2 ttmm -148.08 -37.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.639 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 92.1 p -162.84 -161.36 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.746 -0.465 . . . . 10.0 109.746 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.739 ' HD2' HD21 ' A' ' 109' ' ' LEU . 73.6 mmtt -58.93 -44.26 91.31 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.775 0.321 . . . . 10.0 110.399 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.735 ' HA2' ' HB2' ' A' ' 118' ' ' PHE . . . 111.96 -168.5 12.76 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.523 -0.846 . . . . 10.0 114.26 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.931 HD13 ' N ' ' A' ' 126' ' ' VAL . 1.8 tm? -69.18 142.21 54.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.155 0.503 . . . . 10.0 111.244 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 1.011 HG21 HD12 ' A' ' 104' ' ' ILE . 2.2 p -131.54 157.09 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.643 -0.708 . . . . 10.0 111.015 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -152.89 140.99 20.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.162 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.571 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 6.2 m -167.46 147.49 5.24 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.849 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 57.28 42.86 24.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.431 . . . . 10.0 110.809 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.0 34.44 30.94 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.108 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -132.99 148.44 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.693 0.282 . . . . 10.0 110.274 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.8 139.47 30.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 10.0 111.11 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.977 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.2 mt -152.28 156.56 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.954 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.646 ' HB ' HD13 ' A' ' 23' ' ' LEU . 63.4 mt -117.79 126.91 75.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.595 -0.52 . . . . 10.0 109.595 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.561 ' CE1' HG21 ' A' ' 13' ' ' VAL . 15.1 t80 -116.03 146.47 42.14 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.924 -0.31 . . . . 10.0 110.535 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.787 HD21 ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -161.29 154.05 20.68 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.752 0.787 . . . . 10.0 112.717 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 141' ' ' ILE . 2.9 p30 -105.59 133.99 49.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.754 -1.112 . . . . 10.0 108.52 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.958 HG21 ' ND2' ' A' ' 29' ' ' ASN . 15.2 tt -67.11 6.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -74.89 -47.79 28.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.902 0.382 . . . . 10.0 111.652 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 12.4 mptt -83.66 -34.76 24.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.163 0.506 . . . . 10.0 110.585 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -69.05 -35.83 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.593 179.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.043 HD13 HG21 ' A' ' 91' ' ' VAL . 7.8 tp -71.14 -44.15 74.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.527 ' N ' HG23 ' A' ' 142' ' ' ILE . 39.4 tt0 -47.3 -42.7 21.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.558 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.6 mt-10 -71.09 -35.34 71.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.471 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.71 HG13 ' O ' ' A' ' 141' ' ' ILE . 26.7 mt -53.43 -38.84 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-O 120.8 0.333 . . . . 10.0 111.096 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.6 p -80.65 -50.46 9.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.903 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.2 p -76.71 4.91 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 112.05 0.389 . . . . 10.0 112.05 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.461 ' HD2' ' CB ' ' A' ' 48' ' ' PHE . 22.0 pttp -46.05 -33.22 3.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.44 134.52 22.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.855 0.36 . . . . 10.0 111.156 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.4 43.27 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.985 -0.626 . . . . 10.0 112.343 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.338 . . . . 10.0 110.946 -179.939 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 62.8 mtt . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.706 0.289 . . . . 10.0 111.111 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 1' ' ' MET . 67.1 mttm 69.63 -46.64 0.59 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.222 -0.445 . . . . 10.0 112.061 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.8 p 56.54 30.31 17.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.119 0.485 . . . . 10.0 110.502 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.9 mt -108.3 -51.74 2.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.649 -0.705 . . . . 10.0 110.33 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.18 134.43 38.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.784 -0.643 . . . . 10.0 111.184 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 43.34 -169.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.5 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 63.65 131.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.903 0.382 . . . . 10.0 111.136 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.962 HD13 HD12 ' A' ' 109' ' ' LEU . 53.2 mt -88.03 46.17 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.979 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.511 ' O ' HG22 ' A' ' 105' ' ' THR . 31.3 mmmt -84.93 -55.7 3.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 10.0 111.801 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.639 ' HG2' HG22 ' A' ' 105' ' ' THR . 77.2 mt-10 -129.84 164.26 24.51 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.364 0.602 . . . . 10.0 111.038 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.563 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 15.7 t80 -161.67 138.62 8.48 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.937 -1.029 . . . . 10.0 112.881 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -88.76 140.62 29.26 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.724 -0.671 . . . . 10.0 109.632 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.805 HG13 ' HB3' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -156.39 169.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 113.287 0.847 . . . . 10.0 113.287 -174.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.751 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.9 tm? -88.95 133.92 34.14 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.742 -1.207 . . . . 10.0 107.742 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.812 ' HB3' HD22 ' A' ' 102' ' ' LEU . 74.6 p -145.34 153.8 41.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 113.083 0.772 . . . . 10.0 113.083 -177.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.634 ' HB3' ' HA ' ' A' ' 98' ' ' VAL . 3.1 p90 -151.81 165.3 34.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.375 -1.284 . . . . 10.0 110.371 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -88.58 134.07 33.99 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.916 HG21 HD12 ' A' ' 71' ' ' ILE . 21.3 mm -131.56 93.49 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.479 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.0 OUTLIER 42.65 60.19 2.5 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 113.073 0.768 . . . . 10.0 113.073 178.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.586 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 5.7 mm-40 88.71 -43.34 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.115 -0.948 . . . . 10.0 112.632 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.716 ' NE2' HD13 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -88.98 151.52 22.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.377 -0.529 . . . . 10.0 110.412 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.008 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.84 156.93 18.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.844 0.354 . . . . 10.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.791 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.2 tp -144.74 135.52 24.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.885 0.374 . . . . 10.0 110.858 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.749 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -142.27 151.69 42.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.943 -0.572 . . . . 10.0 112.364 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.859 ' CE2' HD22 ' A' ' 136' ' ' LEU . 2.8 m-85 -129.36 141.64 51.02 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -48.55 101.34 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.644 0.735 . . . . 10.0 109.369 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 13' ' ' VAL . 3.8 p -47.15 -13.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.523 -1.217 . . . . 10.0 112.862 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -62.9 -41.95 99.61 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.226 -0.589 . . . . 10.0 109.712 179.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.867 ' ND2' HG21 ' A' ' 138' ' ' ILE . 13.4 t30 -81.85 -48.4 11.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.126 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.751 HG21 ' HG ' ' A' ' 14' ' ' LEU . 18.0 mm -58.52 123.58 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.133 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.676 ' OE2' HG12 ' A' ' 83' ' ' VAL . 15.7 pt-20 -87.19 -54.81 4.11 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.477 0.547 . . . . 10.0 112.477 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.3 mtm -169.23 157.87 7.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.161 0.505 . . . . 10.0 112.352 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.844 HG11 HG11 ' A' ' 98' ' ' VAL . 34.3 m -88.88 148.05 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.057 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.516 HD13 HG21 ' A' ' 83' ' ' VAL . 32.0 pt -139.52 155.34 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -88.8 152.79 21.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.066 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.479 ' HG2' HD12 ' A' ' 39' ' ' ILE . 12.3 tmtt? -88.79 125.78 35.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.721 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.447 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 48.4 t 178.38 137.36 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.841 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.2 t0 42.28 44.57 3.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.178 0.513 . . . . 10.0 111.14 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 52' ' ' VAL . 26.7 mt -93.61 -76.19 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.548 -0.751 . . . . 10.0 112.443 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.718 HG23 ' HG2' ' A' ' 43' ' ' PRO . 2.0 m -170.3 117.78 0.5 Allowed Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.42 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.38 -85.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.831 2.354 . . . . 10.0 113.513 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.631 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 35.1 m -149.08 47.24 0.48 Allowed Pre-proline 0 CA--C 1.531 0.231 0 N-CA-C 112.426 0.528 . . . . 10.0 112.426 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.718 ' HG2' HG23 ' A' ' 40' ' ' THR . 53.1 Cg_exo -55.35 -19.87 23.61 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.552 2.168 . . . . 10.0 111.672 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt 60.31 -131.36 0.88 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.805 -0.813 . . . . 10.0 108.805 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.457 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 10.7 m 55.52 25.22 7.63 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.838 0.352 . . . . 10.0 110.792 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 36.3 mmt180 -163.33 -37.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.653 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 83.6 m-70 80.35 -56.93 0.34 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.998 -0.547 . . . . 10.0 111.174 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' HB2' ' HD2' ' A' ' 148' ' ' LYS . 2.0 m-85 -77.64 -49.02 15.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 10.0 110.585 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.624 ' HA ' HG22 ' A' ' 63' ' ' VAL . 58.6 t -56.94 85.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.743 -0.662 . . . . 10.0 111.912 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -66.25 -30.94 71.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.972 0.415 . . . . 10.0 110.169 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.768 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -152.28 169.04 31.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.712 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.673 ' O ' HG23 ' A' ' 39' ' ' ILE . 3.6 m -158.62 171.96 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.661 0.267 . . . . 10.0 110.499 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.806 ' O ' HD12 ' A' ' 53' ' ' ILE . 2.2 pp -160.94 143.08 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.008 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.478 HD22 HD11 ' A' ' 59' ' ' ILE . 24.8 t-20 -88.84 142.28 27.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.479 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.8 HD13 ' N ' ' A' ' 56' ' ' ARG . 2.8 tm? -168.87 134.0 1.6 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.527 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.8 ' N ' HD13 ' A' ' 55' ' ' LEU . 15.1 ttp-105 48.71 47.2 21.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.777 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.1 39.15 79.47 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.959 -0.564 . . . . 10.0 113.02 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -159.59 124.8 4.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.764 0.316 . . . . 10.0 110.646 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.632 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -90.43 129.26 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.085 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.783 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.0 pp -99.09 139.65 21.14 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.87 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 61.7 Cg_endo -97.31 123.97 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.365 2.71 . . . . 10.0 113.546 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.768 HG22 ' C ' ' A' ' 51' ' ' GLY . 34.4 m -102.62 135.5 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 109.59 -0.522 . . . . 10.0 109.59 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 49' ' ' VAL . 99.5 t -143.68 158.16 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.569 0.7 . . . . 10.0 112.543 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.821 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 4.1 m120 -70.38 67.69 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.945 -1.025 . . . . 10.0 109.702 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.927 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.9 tt -50.99 -31.07 16.83 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.336 0.589 . . . . 10.0 110.61 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.814 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -62.7 -22.96 66.89 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.81 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -88.4 -41.85 12.54 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 178.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 65' ' ' LEU . 7.6 tt -59.15 -40.38 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.844 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -78.88 -40.19 33.07 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.31 -1.768 . . . . 10.0 108.267 176.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 71' ' ' ILE . . . 71.32 121.62 0.05 OUTLIER Glycine 0 C--N 1.333 0.386 0 CA-C-N 114.791 -1.095 . . . . 10.0 113.05 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.916 HD12 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -162.86 -167.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.152 0.581 . . . . 10.0 109.972 -179.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 71.9 m -50.4 -32.34 17.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.616 0.722 . . . . 10.0 109.14 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.814 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 7.3 t80 -35.81 143.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.418 -1.265 . . . . 10.0 112.682 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -169.98 36.11 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.649 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 56.2 mt-10 55.54 37.7 29.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.439 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -82.85 -70.81 0.53 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.816 0.341 . . . . 10.0 111.718 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.62 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.4 mptt -94.93 -31.14 13.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.683 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.583 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 12.3 mmm -23.22 140.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.542 0.737 . . . . 10.0 112.221 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -164.11 -37.04 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.972 0.36 . . . . 10.0 111.972 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.851 ' O ' HD12 ' A' ' 94' ' ' LEU . 80.2 p -88.75 163.87 15.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.584 0.231 . . . . 10.0 111.002 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' A' ' 39' ' ' ILE . 67.7 mt -132.64 129.15 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.722 0.296 . . . . 10.0 111.643 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 14' ' ' LEU . 7.5 mt -93.5 150.79 3.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.741 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.676 HG12 ' OE2' ' A' ' 31' ' ' GLU . 46.6 t -121.45 142.04 39.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.458 . . . . 10.0 110.778 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -145.0 175.97 9.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.782 -0.644 . . . . 10.0 111.015 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.455 ' O ' ' CG2' ' A' ' 86' ' ' THR . 6.6 ptm180 -128.25 146.38 50.76 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.287 -0.634 . . . . 10.0 109.287 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.516 HG21 HG12 ' A' ' 138' ' ' ILE . 73.3 p -160.93 108.67 1.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.466 0.543 . . . . 10.0 112.466 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 47.08 48.41 15.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.371 0.605 . . . . 10.0 110.779 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 72.26 33.54 1.51 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.117 -0.947 . . . . 10.0 111.235 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.894 HG12 HG22 ' A' ' 91' ' ' VAL . 54.2 t -131.46 111.81 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-N 115.166 -0.924 . . . . 10.0 109.211 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.758 ' HB2' HG22 ' A' ' 60' ' ' ILE . 27.1 mt-10 -88.34 97.93 11.32 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.053 -1.832 . . . . 10.0 106.053 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.018 HG21 HD13 ' A' ' 142' ' ' ILE . 4.8 t -88.55 154.48 3.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.256 -1.793 . . . . 10.0 112.658 -174.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.1 156.3 21.91 Favored Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.702 -1.136 . . . . 10.0 113.065 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.59 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 t80 -146.3 131.94 18.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 10.0 110.935 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.851 HD12 ' O ' ' A' ' 80' ' ' SER . 58.8 tp -88.7 126.83 35.5 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.266 0.555 . . . . 10.0 112.066 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.583 ' HA ' ' HE3' ' A' ' 78' ' ' MET . 30.4 m -137.25 -175.08 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.261 -0.882 . . . . 10.0 109.89 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.78 -62.56 1.32 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.061 0.458 . . . . 10.0 112.191 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -133.93 117.86 17.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.756 -0.656 . . . . 10.0 109.66 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.844 HG11 HG11 ' A' ' 33' ' ' VAL . 9.3 p -104.95 116.07 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 122.451 1.12 . . . . 10.0 111.805 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -64.61 -30.33 71.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.02 -1.9 . . . . 10.0 110.747 -178.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.99 -124.4 6.98 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.487 -0.779 . . . . 10.0 111.259 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.3 p -52.17 128.15 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 117.035 0.418 . . . . 10.0 110.422 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 15' ' ' SER . 51.8 tp -132.06 139.06 48.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.039 0.447 . . . . 10.0 110.927 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.0 ptp85 -88.86 73.25 8.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.874 -0.603 . . . . 10.0 109.828 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.95 HD12 HG11 ' A' ' 126' ' ' VAL . 11.8 mm -88.78 126.21 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.737 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.639 HG22 ' HG2' ' A' ' 10' ' ' GLU . 17.7 p -88.74 146.21 25.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 176.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' OE1' ' HG ' ' A' ' 109' ' ' LEU . 22.1 tt0 -131.31 70.7 1.46 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.069 -1.053 . . . . 10.0 113.398 -176.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.99 -9.5 59.83 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.654 -1.157 . . . . 10.0 108.564 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -93.14 -51.34 5.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.98 -1.009 . . . . 10.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.962 HD12 HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER 38.98 -144.88 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.424 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -130.64 41.28 3.4 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.098 0.475 . . . . 10.0 110.397 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.644 HD21 HD13 ' A' ' 109' ' ' LEU . 1.5 pt? -178.98 -39.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.85 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.598 ' HB ' HD12 ' A' ' 8' ' ' LEU . 6.0 t -57.47 -41.88 81.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.948 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 112' ' ' THR . 9.7 m120 -163.49 -38.8 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.522 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.518 HG13 ' CD ' ' A' ' 117' ' ' LYS . 59.8 t 73.66 -58.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.681 0.276 . . . . 10.0 111.083 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.6 m 69.62 -61.44 0.44 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.113 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 33.9 t70 -164.38 -46.08 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.049 -0.26 . . . . 10.0 111.437 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 10.1 mtmp? 72.21 -51.83 0.7 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.72 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.634 ' CE1' HD21 ' A' ' 69' ' ' LEU . 23.7 t80 179.49 -53.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.188 0.518 . . . . 10.0 110.054 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' A' ' 120' ' ' LYS . . . 141.75 -58.75 0.56 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.478 -0.783 . . . . 10.0 112.052 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.441 ' CG ' ' O ' ' A' ' 119' ' ' GLY . 51.7 mtmt -163.78 56.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.55 0.214 . . . . 10.0 110.529 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.493 ' HG2' HD22 ' A' ' 69' ' ' LEU . 2.4 tpmt? -150.88 -40.54 0.12 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.509 ' CB ' ' HG ' ' A' ' 136' ' ' LEU . 91.8 p -149.95 -135.06 0.07 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 121.0 -0.28 . . . . 10.0 111.386 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 117' ' ' LYS . 47.3 mmtm -152.84 25.26 0.57 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.566 0.58 . . . . 10.0 112.566 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 135' ' ' TYR . . . -146.6 139.93 8.37 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 119.297 -1.43 . . . . 10.0 114.116 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 2.3 tm? -155.44 78.93 1.02 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.538 -0.912 . . . . 10.0 108.538 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.985 HG13 ' HB ' ' A' ' 133' ' ' ILE . 2.3 p -88.81 159.57 2.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.351 -0.84 . . . . 10.0 112.844 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.49 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 62.3 pttt -164.48 132.08 3.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.901 -1.045 . . . . 10.0 109.529 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 5.4 m -159.53 148.88 18.22 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.965 0.412 . . . . 10.0 111.476 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' HB3' ' NH2' ' A' ' 131' ' ' ARG . 38.6 t70 56.16 46.1 22.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.731 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.23 32.87 57.52 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.597 -0.811 . . . . 10.0 111.743 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.461 ' NH2' ' HB3' ' A' ' 129' ' ' ASP . 1.5 ptp85 -130.63 132.33 45.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.808 0.337 . . . . 10.0 110.221 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.5 tp -88.8 139.13 30.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.272 -0.422 . . . . 10.0 111.159 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.008 HG12 ' HB3' ' A' ' 22' ' ' ALA . 2.6 mt -141.57 126.69 17.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.039 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.791 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.2 mp -89.03 136.59 23.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.684 ' C ' HD12 ' A' ' 136' ' ' LEU . 46.5 t80 -128.8 140.96 51.47 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.537 0.684 . . . . 10.0 111.376 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.859 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.9 mp -130.89 178.26 6.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.486 -0.779 . . . . 10.0 112.078 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.8 p-10 -141.37 23.28 2.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.336 -1.302 . . . . 10.0 108.063 177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.871 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.3 tt 40.75 16.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 114.112 -1.404 . . . . 10.0 114.059 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 137' ' ' ASP . 66.7 t0 -80.0 -61.36 2.01 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.61 0.596 . . . . 10.0 112.61 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -78.34 -29.68 47.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.383 0.611 . . . . 10.0 110.412 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.871 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.21 -45.64 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 115.367 -0.833 . . . . 10.0 110.118 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.018 HD13 HG21 ' A' ' 91' ' ' VAL . 8.0 tp -64.42 -43.32 96.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 120.013 -0.675 . . . . 10.0 109.512 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.535 ' N ' HG23 ' A' ' 142' ' ' ILE . 39.5 tt0 -48.16 -42.59 30.01 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.814 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.635 ' HA ' HG12 ' A' ' 147' ' ' VAL . 55.1 mm-40 -70.26 -33.73 71.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.24 -0.891 . . . . 10.0 110.421 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.651 ' CD1' HG11 ' A' ' 91' ' ' VAL . 41.9 mt -57.22 -35.42 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.806 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.5 p -81.73 -50.45 9.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.655 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 144' ' ' GLU . 14.7 p -72.24 -5.21 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.368 -0.378 . . . . 10.0 111.948 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.479 ' HD2' ' HB2' ' A' ' 48' ' ' PHE . 57.0 pttt -41.96 -44.12 3.35 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.878 0.37 . . . . 10.0 111.469 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -60.13 135.05 57.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.015 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -179.88 -45.47 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.414 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 10.0 110.979 -179.996 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.844 0.354 . . . . 10.0 111.119 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.63 ' HG2' HG22 ' A' ' 3' ' ' THR . 87.9 tttt -174.56 -63.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.729 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.63 HG22 ' HG2' ' A' ' 2' ' ' LYS . 5.3 t 171.43 -49.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.031 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.496 ' HG ' HG23 ' A' ' 3' ' ' THR . 79.6 mt -81.25 -54.28 5.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.974 0.416 . . . . 10.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.85 135.89 41.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.125 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 61.26 154.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 10.0 110.864 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.3 167.43 10.17 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.074 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.472 HD23 ' HG2' ' A' ' 106' ' ' GLU . 43.1 mt -68.78 58.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.097 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HE3' ' HB2' ' A' ' 10' ' ' GLU . 24.8 tptt -127.39 -60.6 1.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.077 0.399 . . . . 10.0 112.077 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 42.4 tt0 -155.88 164.14 38.88 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.524 0.678 . . . . 10.0 111.477 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.676 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 11.4 t80 -159.49 140.41 12.53 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.616 -1.175 . . . . 10.0 112.483 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.66 130.64 35.25 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.168 -1.049 . . . . 10.0 108.168 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.892 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.6 p -149.0 166.23 3.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 -175.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 1.04 HD11 HD13 ' A' ' 82' ' ' ILE . 3.0 tm? -89.01 140.02 29.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.835 ' HB3' HD22 ' A' ' 102' ' ' LEU . 53.4 p -154.92 158.03 38.65 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 119.806 -0.757 . . . . 10.0 112.851 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.698 ' CZ ' ' HG ' ' A' ' 23' ' ' LEU . 17.4 p90 -150.42 166.16 30.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.589 -1.187 . . . . 10.0 110.109 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.622 ' HG2' HD21 ' A' ' 99' ' ' LEU . 53.2 mm-40 -88.54 142.38 27.75 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.699 -0.482 . . . . 10.0 109.699 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.031 HG21 HD12 ' A' ' 71' ' ' ILE . 33.4 mm -140.52 93.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.78 -0.645 . . . . 10.0 111.45 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.538 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 62.3 m-20 43.24 60.06 2.71 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.89 -0.595 . . . . 10.0 112.39 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 40.8 mt-10 85.53 -42.71 0.05 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.145 -0.934 . . . . 10.0 112.307 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.627 ' NE2' HG22 ' A' ' 71' ' ' ILE . 19.1 pt20 -88.96 147.08 24.51 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.612 -0.435 . . . . 10.0 109.988 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.009 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.92 166.53 13.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.127 0.489 . . . . 10.0 111.927 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.854 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.1 OUTLIER -140.39 143.57 35.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.549 -179.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.757 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -144.45 149.25 35.7 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.738 0.644 . . . . 10.0 112.738 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.798 ' CE2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -138.39 137.88 37.71 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.689 -0.856 . . . . 10.0 108.689 179.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -56.17 123.93 16.16 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.224 -0.591 . . . . 10.0 110.144 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.892 HG13 ' HA ' ' A' ' 13' ' ' VAL . 35.8 m -59.77 -10.54 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.381 -0.827 . . . . 10.0 112.098 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 1.4 p30 -60.03 -40.67 90.14 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.087 0.47 . . . . 10.0 110.089 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.745 HD21 HG22 ' A' ' 86' ' ' THR . 14.7 t-20 -93.3 -47.35 6.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.741 -0.663 . . . . 10.0 111.192 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.78 HG21 ' HG ' ' A' ' 14' ' ' LEU . 26.1 mm -57.93 121.91 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.507 ' O ' ' HG3' ' A' ' 32' ' ' MET . 12.4 pt-20 -84.34 -51.14 7.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.16 0.43 . . . . 10.0 112.16 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.507 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.9 mtm -169.1 154.69 6.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.248 0.547 . . . . 10.0 111.885 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.656 ' CG1' HD21 ' A' ' 14' ' ' LEU . 34.8 m -88.95 149.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.399 -0.819 . . . . 10.0 111.395 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.486 HG13 ' HB ' ' A' ' 81' ' ' ILE . 10.7 pt -143.57 -178.14 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.723 -0.672 . . . . 10.0 110.622 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -155.75 104.14 2.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.179 0.514 . . . . 10.0 110.701 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -169.25 66.34 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.788 -0.642 . . . . 10.0 111.083 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -53.06 -170.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.989 0.423 . . . . 10.0 111.497 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p30 42.42 43.6 3.14 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.046 -0.525 . . . . 10.0 111.902 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.541 ' CG2' HG23 ' A' ' 53' ' ' ILE . 25.6 mt -73.65 144.29 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.846 -0.615 . . . . 10.0 111.802 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.871 HG23 ' HG2' ' A' ' 43' ' ' PRO . 20.1 m 25.97 71.32 0.39 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.722 -0.672 . . . . 10.0 112.337 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -86.35 -47.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.194 2.596 . . . . 10.0 113.127 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.498 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 47.1 t -67.61 -44.06 42.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.905 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.871 ' HG2' HG23 ' A' ' 40' ' ' THR . 35.6 Cg_exo -59.94 -55.55 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.127 1.885 . . . . 10.0 112.227 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD3' ' C ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER 39.53 -158.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.378 -0.374 . . . . 10.0 111.329 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 43.9 t 69.04 54.82 0.44 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.871 0.367 . . . . 10.0 111.451 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 11.5 tpt180 -140.15 40.19 1.94 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.133 0.492 . . . . 10.0 110.502 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.443 ' CD2' ' HA2' ' A' ' 150' ' ' GLY . 11.5 m80 54.98 -134.79 1.49 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.891 -0.595 . . . . 10.0 111.276 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.615 ' CD1' ' HG2' ' A' ' 148' ' ' LYS . 8.6 t80 -52.84 -36.79 59.32 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.796 0.331 . . . . 10.0 111.133 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.879 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.5 t -57.75 126.73 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 10.0 111.476 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.85 -45.28 12.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.335 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.703 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -139.13 -176.38 14.65 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.578 -0.737 . . . . 10.0 112.498 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.59 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.5 m -160.51 169.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 10.0 110.232 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.68 HD13 ' N ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -159.9 143.22 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.991 0.424 . . . . 10.0 111.211 178.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.498 ' O ' HD23 ' A' ' 55' ' ' LEU . 41.3 t30 -88.75 134.69 33.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.166 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 54' ' ' ASN . 96.8 mt -160.04 136.54 8.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.668 -0.696 . . . . 10.0 110.207 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.489 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . 0.1 OUTLIER 52.17 46.42 26.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.109 0.481 . . . . 10.0 110.413 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.34 37.42 65.51 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.801 -0.636 . . . . 10.0 112.822 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -159.36 130.5 6.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.773 0.32 . . . . 10.0 110.731 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.84 129.74 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.319 -0.4 . . . . 10.0 110.755 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.902 HG22 ' HB2' ' A' ' 90' ' ' GLU . 20.3 pt -107.6 129.81 23.7 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.305 -0.407 . . . . 10.0 111.563 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 94.2 Cg_endo -77.82 117.84 4.33 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.593 2.195 . . . . 10.0 112.201 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.703 HG22 ' C ' ' A' ' 51' ' ' GLY . 28.7 m -94.92 137.68 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.715 0.293 . . . . 10.0 110.423 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.879 HG22 ' HA ' ' A' ' 49' ' ' VAL . 88.3 t -140.47 154.91 22.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.479 0.657 . . . . 10.0 111.924 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.821 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 5.3 m120 -77.65 65.92 3.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.157 -0.929 . . . . 10.0 109.15 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.901 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.7 tt -49.64 -26.73 3.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.617 -0.72 . . . . 10.0 111.575 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.835 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -66.78 -29.15 69.02 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.347 -0.541 . . . . 10.0 110.596 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -87.92 -33.9 18.32 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 121.088 -0.245 . . . . 10.0 110.988 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.696 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.8 tt -57.37 -41.41 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 106.336 -1.727 . . . . 10.0 106.336 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.893 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -77.7 -49.74 13.86 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.231 -1.804 . . . . 10.0 108.392 176.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 71' ' ' ILE . . . 115.48 -79.17 0.28 Allowed Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.229 -0.896 . . . . 10.0 112.746 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.031 HD12 HG21 ' A' ' 18' ' ' ILE . 2.3 pt 46.05 173.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.619 0.6 . . . . 10.0 112.619 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 19' ' ' ASP . 71.4 m -51.62 -36.21 44.97 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.849 ' HB3' HG13 ' A' ' 71' ' ' ILE . 3.7 t80 -30.14 145.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.996 -1.002 . . . . 10.0 113.536 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 35.9 t70 -134.62 -54.37 0.83 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.051 -0.977 . . . . 10.0 110.117 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.463 ' HA ' ' HE1' ' A' ' 73' ' ' PHE . 10.5 pt-20 164.52 -45.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.865 0.364 . . . . 10.0 111.644 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -55.52 -37.91 68.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HE3' ' N ' ' A' ' 77' ' ' LYS . 0.8 OUTLIER -68.27 -26.9 65.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.771 0.319 . . . . 10.0 111.331 -179.385 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.418 ' SD ' ' CE1' ' A' ' 73' ' ' PHE . 27.5 mmt -47.6 134.7 12.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.495 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 54.8 mtmt -160.75 -51.57 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.22 -0.445 . . . . 10.0 110.726 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.463 ' O ' HD12 ' A' ' 94' ' ' LEU . 52.3 m -90.14 -175.99 4.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.318 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 39' ' ' ILE . 75.5 mt -152.28 160.59 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.549 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.04 HD13 HD11 ' A' ' 14' ' ' LEU . 15.2 mt -142.23 140.69 29.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.903 0.382 . . . . 10.0 111.263 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 34' ' ' ILE . 44.8 t -110.62 149.74 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.139 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -147.9 175.6 10.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.8 -0.636 . . . . 10.0 110.573 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -133.21 129.99 38.48 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.745 HG22 HD21 ' A' ' 29' ' ' ASN . 44.8 p -144.42 108.78 4.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.319 0.489 . . . . 10.0 112.319 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.485 ' CE ' ' O ' ' A' ' 87' ' ' LYS . 8.1 ttpt 47.67 51.23 14.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.704 0.764 . . . . 10.0 110.806 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.0 31.1 2.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.964 -1.016 . . . . 10.0 111.611 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.873 HG12 HG22 ' A' ' 91' ' ' VAL . 55.7 t -128.33 108.37 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 115.178 -0.919 . . . . 10.0 109.028 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.902 ' HB2' HG22 ' A' ' 60' ' ' ILE . 1.4 mp0 -88.26 99.83 12.53 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.628 -1.99 . . . . 10.0 105.628 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.063 HG21 HD13 ' A' ' 142' ' ' ILE . 4.8 t -88.57 149.62 3.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 113.378 -1.737 . . . . 10.0 112.908 -173.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 62' ' ' VAL . . . -119.07 157.78 15.16 Favored Glycine 0 C--N 1.31 -0.898 0 CA-C-N 113.862 -1.517 . . . . 10.0 112.423 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.683 ' CE2' HD22 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -149.75 123.66 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.292 0.568 . . . . 10.0 111.866 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.59 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 46.6 tp -88.78 120.18 29.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.954 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.474 HG11 ' CZ ' ' A' ' 16' ' ' PHE . 27.6 m -131.08 -175.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.48 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 5.2 t0 -84.61 -79.94 0.21 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.32 0.581 . . . . 10.0 110.704 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.81 110.59 8.71 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.675 -0.861 . . . . 10.0 108.675 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.607 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 10.5 p -88.93 114.52 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-O 122.319 1.057 . . . . 10.0 111.833 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.622 HD21 ' HG2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -62.47 -28.65 69.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.23 -1.805 . . . . 10.0 110.827 -178.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.22 -121.07 5.93 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.006 -0.837 . . . . 10.0 111.006 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.68 127.33 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 117.076 0.438 . . . . 10.0 110.453 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.835 HD22 ' HB3' ' A' ' 15' ' ' SER . 46.9 tp -126.57 139.26 53.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.171 0.51 . . . . 10.0 110.743 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.0 ptp85 -88.87 76.95 7.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.381 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.795 ' CG1' HG11 ' A' ' 13' ' ' VAL . 10.1 mm -88.64 161.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 24.0 p -122.32 147.28 46.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 109' ' ' LEU . 11.4 tt0 -104.96 66.81 0.77 Allowed 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.953 0.882 . . . . 10.0 112.256 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -96.31 17.74 15.28 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.456 -1.247 . . . . 10.0 108.677 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.632 ' HG2' HD12 ' A' ' 109' ' ' LEU . 2.2 pm0 -153.76 -46.42 0.09 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.617 -0.72 . . . . 10.0 112.208 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.914 HD21 ' CE2' ' A' ' 135' ' ' TYR . 7.6 mp -48.31 126.0 10.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.761 0.315 . . . . 10.0 111.603 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 109' ' ' LEU . 38.8 t70 82.48 -51.06 0.2 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.771 -0.649 . . . . 10.0 111.693 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.53 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . 49.3 tp -73.42 5.3 3.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.799 0.333 . . . . 10.0 111.01 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 111' ' ' LEU . 9.5 t 47.41 43.16 15.21 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 112.804 0.668 . . . . 10.0 112.804 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.621 ' HB2' ' HA ' ' A' ' 108' ' ' GLN . 4.1 m120 -80.79 -31.7 35.62 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.48 -0.488 . . . . 10.0 110.13 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.667 HG21 ' HG2' ' A' ' 117' ' ' LYS . 35.5 m -29.84 -45.71 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.822 -0.627 . . . . 10.0 112.373 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.516 ' N ' HG23 ' A' ' 114' ' ' VAL . 29.1 t 78.09 -43.72 0.38 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.378 -0.373 . . . . 10.0 111.229 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 36.4 t70 -134.41 -38.61 0.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.753 -0.203 . . . . 10.0 111.262 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.667 ' HG2' HG21 ' A' ' 114' ' ' VAL . 50.8 mttp 79.87 -45.97 0.32 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.355 -0.384 . . . . 10.0 111.516 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.637 ' CE2' HD21 ' A' ' 69' ' ' LEU . 45.8 t80 179.45 -45.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.304 0.574 . . . . 10.0 109.791 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 175.04 -55.91 0.12 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.096 -0.956 . . . . 10.0 111.336 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 5.8 tmtt? 173.34 44.76 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 110.196 -0.298 . . . . 10.0 110.196 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 26.3 ttpp -163.89 48.78 0.13 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.408 0.522 . . . . 10.0 112.408 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.687 ' HB2' ' HB3' ' A' ' 136' ' ' LEU . 8.2 p 172.45 171.69 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.958 0.409 . . . . 10.0 112.056 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 22.2 tptm -72.62 -52.69 14.36 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 117' ' ' LYS . . . -167.55 -164.02 22.47 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 119.23 -1.462 . . . . 10.0 114.837 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.786 HD22 ' HA ' ' A' ' 134' ' ' ILE . 1.7 tm? -139.02 125.42 20.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.155 -0.523 . . . . 10.0 109.901 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.892 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.7 p -103.71 154.53 5.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.543 0.687 . . . . 10.0 112.138 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 27.9 mtpp -154.62 134.02 12.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.944 -1.025 . . . . 10.0 109.839 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 16.3 m -163.04 149.9 12.73 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 120.895 0.379 . . . . 10.0 111.23 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.46 ' OD1' ' HB3' ' A' ' 131' ' ' ARG . 2.8 p30 46.15 48.49 12.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 10.0 111.5 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.66 43.24 68.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.82 -0.705 . . . . 10.0 112.212 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.46 ' HB3' ' OD1' ' A' ' 129' ' ' ASP . 3.5 ptm180 -138.97 134.17 32.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 10.0 110.625 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.93 137.37 32.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.939 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.009 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.9 mt -144.8 130.14 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 10.0 111.003 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.854 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.99 137.31 21.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.914 ' CE2' HD21 ' A' ' 109' ' ' LEU . 70.9 t80 -130.89 142.61 50.38 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.221 -0.592 . . . . 10.0 111.037 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.901 HD23 HG21 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -164.67 147.01 8.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.367 0.603 . . . . 10.0 112.35 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.409 ' OD1' ' CB ' ' A' ' 139' ' ' ASP . 3.0 p30 -96.46 35.02 1.53 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.806 0.812 . . . . 10.0 110.194 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.92 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 20.9 tt 39.95 20.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.328 -1.306 . . . . 10.0 114.14 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 66.5 t0 -79.3 -57.06 3.9 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.04 0.756 . . . . 10.0 113.04 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 121' ' ' LYS . 22.5 ttmm -77.96 -33.55 51.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 10.0 110.265 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.92 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -64.98 -45.26 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.395 -0.82 . . . . 10.0 109.946 178.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.063 HD13 HG21 ' A' ' 91' ' ' VAL . 5.8 tp -61.36 -44.57 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 C-N-CA 120.1 -0.64 . . . . 10.0 109.531 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 147' ' ' VAL . 43.6 mm-40 -47.16 -41.67 18.21 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.443 ' HG3' ' CD ' ' A' ' 121' ' ' LYS . 59.1 mm-40 -73.48 -31.39 63.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.36 -0.836 . . . . 10.0 111.177 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.66 ' CD1' HG11 ' A' ' 91' ' ' VAL . 44.5 mt -54.27 -48.16 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.973 0.416 . . . . 10.0 110.595 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.3 p -85.48 -45.98 11.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.978 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 143' ' ' GLU . 44.5 t -56.71 -31.49 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.585 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.615 ' HG2' ' CD1' ' A' ' 48' ' ' PHE . 48.4 tptt -42.38 -48.04 5.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.066 0.46 . . . . 10.0 111.007 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -179.31 126.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.431 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 47' ' ' HIS . . . 172.97 44.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.615 -0.802 . . . . 10.0 112.563 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 10.0 111.092 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttp . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.893 0.378 . . . . 10.0 111.171 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 3' ' ' THR . 97.6 mttt -64.59 -43.11 94.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.013 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 2' ' ' LYS . 54.8 m 72.43 -51.8 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.435 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.894 HD12 ' N ' ' A' ' 5' ' ' ALA . 4.2 pp -65.94 -39.07 90.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.872 0.368 . . . . 10.0 110.689 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.894 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -74.8 128.91 36.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.227 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -73.06 135.86 44.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.808 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.28 131.22 47.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.141 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.4 mt 62.52 109.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.66 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.517 ' HE3' ' CB ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -157.4 -50.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.189 -179.5 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 43.3 tt0 -148.52 163.96 35.65 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.661 -0.7 . . . . 10.0 110.648 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.667 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.4 t80 -158.79 139.14 12.38 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.052 -0.976 . . . . 10.0 112.54 -174.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -88.59 130.37 35.28 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.433 -0.951 . . . . 10.0 108.433 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.957 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.6 p -148.87 169.13 2.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 -175.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.818 ' HG ' HG21 ' A' ' 30' ' ' ILE . 3.3 tm? -88.8 139.18 30.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.857 ' HB3' HD22 ' A' ' 102' ' ' LEU . 83.3 p -149.15 154.17 38.79 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 119.806 -0.758 . . . . 10.0 112.881 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.77 ' CD2' HG11 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -149.24 167.18 26.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.409 -1.269 . . . . 10.0 110.775 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -88.63 123.81 33.46 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.03 -0.73 . . . . 10.0 109.03 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.908 HG21 HD12 ' A' ' 71' ' ' ILE . 9.7 mm -134.39 115.84 21.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.709 -0.678 . . . . 10.0 111.784 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.681 ' OD2' HG22 ' A' ' 18' ' ' ILE . 2.0 p30 39.08 60.12 1.53 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.717 . . . . 10.0 112.484 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 52.6 mt-10 78.08 -42.87 0.36 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.923 -1.035 . . . . 10.0 112.469 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.452 ' OE1' HG12 ' A' ' 134' ' ' ILE . 3.7 pp0? -91.83 158.74 16.16 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.295 -0.253 . . . . 10.0 110.717 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.874 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.74 148.37 24.0 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 121.078 0.466 . . . . 10.0 111.662 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' A' ' 134' ' ' ILE . 0.3 OUTLIER -124.35 133.19 53.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.389 -0.369 . . . . 10.0 110.409 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.889 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -134.06 152.15 51.72 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.443 0.905 . . . . 10.0 113.443 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.956 ' CZ ' HD12 ' A' ' 136' ' ' LEU . 5.6 m-85 -135.98 139.08 42.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.941 -1.027 . . . . 10.0 109.024 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -49.54 122.49 6.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.143 0.497 . . . . 10.0 111.175 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.957 HG13 ' HA ' ' A' ' 13' ' ' VAL . 19.9 m -61.06 -13.51 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.789 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -59.98 -41.81 92.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.13 0.49 . . . . 10.0 109.708 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.961 ' ND2' HG21 ' A' ' 138' ' ' ILE . 12.1 t30 -92.16 -48.52 6.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.641 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.818 HG21 ' HG ' ' A' ' 14' ' ' LEU . 22.3 mm -60.89 129.23 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.445 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 32' ' ' MET . 16.4 pt-20 -100.37 -53.01 3.22 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.7 mtm -169.22 156.11 6.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 10.0 111.732 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.945 HG12 HG23 ' A' ' 82' ' ' ILE . 33.1 m -100.1 129.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.76 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.417 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 27.5 pt -105.78 137.68 34.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.898 -0.592 . . . . 10.0 111.015 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -90.48 119.51 30.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.829 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.859 ' HB2' HD12 ' A' ' 81' ' ' ILE . 68.7 mttm -159.67 -178.65 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.818 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.6 t -168.12 148.94 5.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.87 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 t70 49.54 44.45 24.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.141 0.496 . . . . 10.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 41' ' ' PRO . 19.4 mt -63.42 155.83 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.499 -0.773 . . . . 10.0 111.917 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.869 HG23 ' HG2' ' A' ' 43' ' ' PRO . 16.0 m -20.48 81.77 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.958 -1.019 . . . . 10.0 112.826 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' N ' ' O ' ' A' ' 39' ' ' ILE . 88.8 Cg_endo -91.41 -50.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.966 2.444 . . . . 10.0 113.891 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.48 ' HB ' ' HD3' ' A' ' 43' ' ' PRO . 45.3 t -64.86 -45.1 74.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 112.288 0.477 . . . . 10.0 112.288 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.869 ' HG2' HG23 ' A' ' 40' ' ' THR . 50.6 Cg_exo -54.75 -49.67 15.93 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.293 1.995 . . . . 10.0 112.773 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' O ' ' OG ' ' A' ' 45' ' ' SER . 36.4 pttt 43.61 -129.02 0.83 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.61 -0.268 . . . . 10.0 111.198 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 44' ' ' LYS . 80.3 p 63.02 67.77 0.66 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 123.078 0.551 . . . . 10.0 111.681 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 2.8 tpm_? -161.26 -57.84 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.918 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.432 ' O ' ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER 169.77 -154.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.275 -0.42 . . . . 10.0 110.408 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.471 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 60.9 t80 -66.9 62.5 0.05 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.801 0.334 . . . . 10.0 110.298 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.866 ' HA ' HG22 ' A' ' 63' ' ' VAL . 50.0 t -132.0 133.52 60.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.086 0.469 . . . . 10.0 111.669 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.431 ' HG3' ' ND2' ' A' ' 64' ' ' ASN . 35.7 mm-40 -63.71 -47.79 79.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.994 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.579 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -155.47 -176.01 27.15 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.415 -0.811 . . . . 10.0 112.576 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.548 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.0 m -148.16 169.97 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.878 0.37 . . . . 10.0 110.98 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 60' ' ' ILE . 29.6 pt -153.26 139.89 12.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 10.0 111.311 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.51 HD22 HD11 ' A' ' 59' ' ' ILE . 24.5 t-20 -88.82 133.88 34.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.995 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 54' ' ' ASN . 97.1 mt -159.73 138.09 10.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.369 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.541 ' NE ' ' HA ' ' A' ' 56' ' ' ARG . 1.8 tpm_? 48.13 46.34 19.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.176 0.513 . . . . 10.0 110.559 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.36 42.66 89.39 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.954 -0.641 . . . . 10.0 112.661 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -165.37 129.17 2.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.39 . . . . 10.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -88.96 132.77 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.101 -0.499 . . . . 10.0 111.076 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 53' ' ' ILE . 22.3 pt -111.47 135.07 21.05 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.669 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 83.0 Cg_endo -80.16 116.54 3.38 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.816 2.344 . . . . 10.0 113.362 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.579 HG22 ' C ' ' A' ' 51' ' ' GLY . 22.4 m -95.45 133.97 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.866 HG22 ' HA ' ' A' ' 49' ' ' VAL . 59.3 t -142.59 156.74 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.665 0.745 . . . . 10.0 112.832 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.874 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 80.1 m-20 -75.87 62.17 1.54 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.874 -1.057 . . . . 10.0 108.724 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.934 HD22 ' CD2' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -51.85 -20.48 2.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.74 -0.664 . . . . 10.0 111.621 -179.034 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.692 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -71.51 -30.66 66.21 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.287 -0.565 . . . . 10.0 110.133 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.874 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -82.58 -36.38 26.27 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 110.557 -0.164 . . . . 10.0 110.557 178.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 65' ' ' LEU . 9.1 tt -56.14 -40.86 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 106.402 -1.703 . . . . 10.0 106.402 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.009 HD11 HG23 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -76.81 -38.58 53.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 113.407 -1.724 . . . . 10.0 108.961 176.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.539 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 106.09 -92.12 0.78 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.607 -0.724 . . . . 10.0 113.598 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.009 HG23 HD11 ' A' ' 69' ' ' LEU . 3.4 pt 48.32 164.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 112.712 0.634 . . . . 10.0 112.712 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.543 ' HB2' ' CG ' ' A' ' 19' ' ' ASP . 29.2 m -49.16 -30.5 6.87 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 109.266 -0.642 . . . . 10.0 109.266 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.908 ' HB3' HG13 ' A' ' 71' ' ' ILE . 12.0 t80 -30.09 141.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.265 -0.88 . . . . 10.0 112.74 176.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -174.32 42.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.573 -0.739 . . . . 10.0 110.348 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 58.52 38.57 25.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -71.63 -42.77 67.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.162 -0.472 . . . . 10.0 111.846 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 96' ' ' ASP . 32.2 mmmt -146.11 23.92 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.85 0.315 . . . . 10.0 111.85 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.495 ' CE ' ' CE1' ' A' ' 73' ' ' PHE . 16.7 mmt -47.63 133.04 13.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.554 -0.294 . . . . 10.0 111.062 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -172.82 36.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.834 0.349 . . . . 10.0 111.137 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.62 ' OG ' HG23 ' A' ' 95' ' ' VAL . 92.3 p -169.11 154.07 5.83 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.637 -0.505 . . . . 10.0 109.637 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.859 HD12 ' HB2' ' A' ' 36' ' ' LYS . 51.8 mt -133.2 145.12 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.621 -0.432 . . . . 10.0 111.682 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.945 HG23 HG12 ' A' ' 33' ' ' VAL . 6.4 mt -110.21 144.6 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.483 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.99 140.09 46.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.147 0.499 . . . . 10.0 110.654 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.649 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -141.91 -175.97 4.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.992 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.48 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 6.4 ptm180 -135.55 143.1 45.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.321 -0.622 . . . . 10.0 109.321 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.513 ' OG1' ' HB ' ' A' ' 89' ' ' VAL . 41.6 p -158.83 109.39 2.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.876 0.37 . . . . 10.0 111.836 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 87' ' ' LYS . 36.4 ttmt 46.72 47.25 15.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.649 . . . . 10.0 110.687 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 52.8 m-20 74.49 34.07 0.8 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.939 -1.028 . . . . 10.0 111.342 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.895 HG12 HG22 ' A' ' 91' ' ' VAL . 60.1 t -130.36 110.76 19.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.419 -0.809 . . . . 10.0 109.858 177.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.692 ' HB3' HG22 ' A' ' 60' ' ' ILE . 35.6 tt0 -88.34 99.74 12.48 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 105.68 -1.97 . . . . 10.0 105.68 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.987 HG21 HD13 ' A' ' 142' ' ' ILE . 4.6 t -88.6 149.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 113.329 -1.76 . . . . 10.0 113.36 -173.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -121.56 149.56 17.22 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 113.912 -1.494 . . . . 10.0 113.071 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.934 ' CD2' HD22 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -141.83 128.49 20.33 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 120.783 0.325 . . . . 10.0 110.891 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.465 ' N ' ' HD1' ' A' ' 93' ' ' PHE . 36.3 tp -88.64 131.38 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.108 0.48 . . . . 10.0 110.986 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.804 HG12 HD11 ' A' ' 18' ' ' ILE . 18.8 m -143.02 -175.02 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.386 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 77' ' ' LYS . 7.9 t70 -90.94 -70.49 0.68 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.316 0.579 . . . . 10.0 111.902 -177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -142.14 112.91 7.34 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.175 -0.921 . . . . 10.0 108.678 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.668 ' CG1' HG21 ' A' ' 33' ' ' VAL . 7.5 p -91.35 114.42 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 122.463 1.125 . . . . 10.0 112.017 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.588 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -63.03 -29.13 70.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 112.817 -1.992 . . . . 10.0 110.969 -178.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.58 -123.59 6.99 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.595 -0.812 . . . . 10.0 111.279 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.69 133.36 16.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.061 0.431 . . . . 10.0 110.5 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.857 HD22 ' HB3' ' A' ' 15' ' ' SER . 53.6 tp -135.15 138.96 44.23 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.232 0.539 . . . . 10.0 111.234 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.699 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.1 OUTLIER -88.82 73.75 8.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.32 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.777 HD12 HG11 ' A' ' 126' ' ' VAL . 11.5 mm -88.8 133.06 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 N-CA-C 109.691 -0.485 . . . . 10.0 109.691 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 20.6 p -88.57 146.54 25.07 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -129.26 75.2 1.63 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 114.164 1.172 . . . . 10.0 114.164 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -97.16 2.7 51.41 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.56 -1.274 . . . . 10.0 107.56 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.468 ' HB3' ' CE ' ' A' ' 117' ' ' LYS . 64.2 mm-40 -77.13 -61.71 1.89 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.621 -1.172 . . . . 10.0 110.7 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 16.0 mt -50.68 147.41 4.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.695 -0.684 . . . . 10.0 111.164 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 111' ' ' LEU . 66.5 t0 -153.05 67.9 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.258 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.737 ' CD1' HG22 ' A' ' 112' ' ' THR . 0.5 OUTLIER 97.45 -30.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.468 -0.787 . . . . 10.0 110.244 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.737 HG22 ' CD1' ' A' ' 111' ' ' LEU . 10.4 t -179.49 45.98 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.553 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER 62.69 124.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.584 -0.28 . . . . 10.0 110.297 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 110' ' ' ASP . 17.6 m -140.22 57.12 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 112.477 0.547 . . . . 10.0 112.477 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 117' ' ' LYS . 41.2 t 178.61 132.26 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 10.0 111.682 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 123' ' ' LYS . 1.5 m-20 -73.78 -51.46 16.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.519 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.529 ' HB3' ' CB ' ' A' ' 125' ' ' LEU . 48.5 mttm 70.66 -59.94 0.52 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.649 -0.705 . . . . 10.0 111.348 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.74 ' CE2' HD21 ' A' ' 69' ' ' LEU . 25.2 t80 -78.18 -52.68 8.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.172 0.51 . . . . 10.0 110.035 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.7 -144.28 10.39 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.079 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -91.49 55.73 2.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.599 0.238 . . . . 10.0 110.667 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.516 ' NZ ' ' HB ' ' A' ' 141' ' ' ILE . 1.1 tmpt? -144.7 -44.79 0.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.915 -0.314 . . . . 10.0 111.314 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.825 ' CB ' HD22 ' A' ' 136' ' ' LEU . 47.4 t -137.54 -137.88 0.14 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.643 -0.218 . . . . 10.0 110.428 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.54 ' HD3' ' HA ' ' A' ' 116' ' ' ASP . 48.5 mmtm -158.53 -29.66 0.07 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.685 0.994 . . . . 10.0 113.685 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.562 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -81.43 147.68 27.22 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.035 -1.079 . . . . 10.0 114.753 -177.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.868 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.8 tm? -162.36 138.54 7.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.91 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.7 p -149.79 159.57 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.211 0.529 . . . . 10.0 112.017 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.531 ' HE3' HD11 ' A' ' 125' ' ' LEU . 94.6 mttt -160.24 135.91 8.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.306 -0.861 . . . . 10.0 109.876 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 5.7 m -163.9 149.28 10.78 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.973 0.416 . . . . 10.0 111.254 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.5 t70 55.24 46.64 23.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.441 . . . . 10.0 110.838 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.52 34.53 49.5 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.581 -0.819 . . . . 10.0 111.797 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 128' ' ' THR . 2.5 ptp180 -136.21 135.42 39.08 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.824 0.345 . . . . 10.0 110.21 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.9 152.42 21.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.266 -0.425 . . . . 10.0 111.158 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.91 ' HB ' HG13 ' A' ' 126' ' ' VAL . 6.3 mt -151.22 129.86 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.034 -0.53 . . . . 10.0 111.05 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.921 ' HB ' HD13 ' A' ' 23' ' ' LEU . 6.7 mm -90.29 145.0 7.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.928 ' O ' HD23 ' A' ' 136' ' ' LEU . 38.1 t80 -133.5 136.32 45.0 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.197 0.522 . . . . 10.0 111.525 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.956 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 16.0 mt -138.17 147.5 43.92 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.66 0.743 . . . . 10.0 112.003 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 139' ' ' ASP . 12.2 p-10 -105.51 26.43 9.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.703 -1.135 . . . . 10.0 108.86 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.961 HG21 ' ND2' ' A' ' 29' ' ' ASN . 12.6 tt 38.91 16.86 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 114.477 1.288 . . . . 10.0 114.477 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 137' ' ' ASP . 7.9 t0 -80.05 -62.35 1.71 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 144' ' ' GLU . 14.5 mmmm -73.7 -31.54 63.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.416 0.626 . . . . 10.0 110.451 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.902 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.96 -46.61 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.302 -0.863 . . . . 10.0 110.771 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.987 HD13 HG21 ' A' ' 91' ' ' VAL . 6.6 tp -60.92 -46.71 95.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 119.8 -0.76 . . . . 10.0 109.826 177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.717 ' O ' HG12 ' A' ' 147' ' ' VAL . 96.7 mt-10 -48.87 -40.41 29.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.531 ' HA ' HG12 ' A' ' 147' ' ' VAL . 44.8 mt-10 -71.21 -39.03 72.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.182 -0.917 . . . . 10.0 110.528 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.657 ' CD1' HG11 ' A' ' 91' ' ' VAL . 34.4 mt -48.16 -43.79 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 120.797 0.332 . . . . 10.0 111.443 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.6 p -84.71 -53.47 5.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 143' ' ' GLU . 14.5 p -63.35 -21.45 28.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 0.5 OUTLIER -39.83 -41.68 1.17 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 111.718 0.266 . . . . 10.0 111.718 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -65.41 133.4 51.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.82 0.343 . . . . 10.0 110.796 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 175.43 41.51 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.779 -0.724 . . . . 10.0 111.982 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 10.0 110.982 -179.93 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtm . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.846 0.355 . . . . 10.0 111.232 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.57 ' HG2' HG22 ' A' ' 3' ' ' THR . 39.9 ttmt -60.57 -55.68 30.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.722 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.57 HG22 ' HG2' ' A' ' 2' ' ' LYS . 5.3 t 174.7 -50.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.615 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.879 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.9 pp -78.66 -37.41 42.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.546 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.879 ' N ' HD12 ' A' ' 4' ' ' LEU . . . 61.03 122.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.991 -0.55 . . . . 10.0 111.219 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 37.2 t70 60.45 136.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.089 -0.505 . . . . 10.0 111.177 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 6' ' ' ASP . . . 171.93 130.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.063 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.94 HD11 ' HB2' ' A' ' 111' ' ' LEU . 87.6 mt -92.02 42.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 10.0 111.088 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HD2' ' CB ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -98.61 -42.02 7.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.832 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 37.8 tt0 -164.01 164.01 23.2 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.838 0.828 . . . . 10.0 111.295 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.611 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.3 t80 -150.85 138.62 19.83 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 113.964 -1.471 . . . . 10.0 112.862 -174.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 2.1 mt-10 -88.7 132.43 34.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.377 -0.828 . . . . 10.0 108.893 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.788 ' HA ' HG13 ' A' ' 27' ' ' VAL . 1.3 p -150.31 167.2 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 112.906 0.706 . . . . 10.0 112.906 -176.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 1.042 HD11 HD13 ' A' ' 82' ' ' ILE . 2.8 tm? -88.95 130.5 35.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.681 -0.859 . . . . 10.0 108.681 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.788 ' CB ' HD22 ' A' ' 102' ' ' LEU . 41.9 t -143.82 155.35 44.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.864 0.84 . . . . 10.0 112.565 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.663 ' CD2' HD11 ' A' ' 82' ' ' ILE . 2.2 p90 -150.09 163.74 37.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.181 -1.372 . . . . 10.0 110.241 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.517 ' HG2' HD21 ' A' ' 99' ' ' LEU . 67.6 mm-40 -88.53 129.09 35.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.983 HG21 HD12 ' A' ' 71' ' ' ILE . 32.3 mm -122.85 87.89 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.319 -0.855 . . . . 10.0 111.259 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 41.5 m-20 51.48 60.04 4.15 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.876 -0.602 . . . . 10.0 111.838 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 61.7 mm-40 77.46 -32.48 0.18 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.45 -0.795 . . . . 10.0 111.708 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.495 ' NE2' HD11 ' A' ' 134' ' ' ILE . 38.6 tt0 -88.75 142.27 27.81 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.865 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.67 158.34 18.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.061 0.458 . . . . 10.0 112.086 -178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.76 HD12 ' H ' ' A' ' 24' ' ' ALA . 2.0 tp -152.28 139.62 19.47 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.123 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.76 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -141.99 144.68 33.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.426 0.528 . . . . 10.0 112.426 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.983 ' CE2' HD13 ' A' ' 65' ' ' LEU . 1.8 m-85 -119.54 138.84 52.93 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.969 -1.122 . . . . 10.0 107.969 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.66 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 26.4 t70 -51.57 123.52 10.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.01 0.433 . . . . 10.0 111.26 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.788 HG13 ' HA ' ' A' ' 13' ' ' VAL . 12.7 m -64.29 -10.53 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.705 -0.679 . . . . 10.0 112.106 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.66 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 53.6 m-20 -69.37 -38.94 78.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.007 -0.677 . . . . 10.0 109.454 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.901 HD21 HG22 ' A' ' 86' ' ' THR . 12.6 t-20 -89.86 -44.83 9.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.234 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.694 HG21 ' HG ' ' A' ' 14' ' ' LEU . 25.4 mm -65.41 129.24 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.091 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' OE2' HG12 ' A' ' 83' ' ' VAL . 14.8 pt-20 -95.55 -50.99 4.73 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.054 0.39 . . . . 10.0 112.054 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 31' ' ' GLU . 2.7 mtm -168.99 155.07 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.185 0.516 . . . . 10.0 112.017 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.772 HG11 HG11 ' A' ' 98' ' ' VAL . 35.2 m -89.03 155.89 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.498 -0.774 . . . . 10.0 111.28 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 22.8 pt -150.44 138.58 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.046 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 22.7 pt-20 -104.65 110.96 23.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.693 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' O ' HG13 ' A' ' 39' ' ' ILE . 24.5 ttmm -169.12 63.94 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 10.0 111.182 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.8 p -54.66 -173.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 10.0 111.16 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 t70 46.42 45.26 13.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 10.0 111.568 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.608 ' CD1' HD13 ' A' ' 81' ' ' ILE . 15.4 mt -77.72 156.27 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.737 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.916 HG23 ' HG2' ' A' ' 43' ' ' PRO . 27.8 m -17.17 80.55 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.047 -0.979 . . . . 10.0 112.895 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.477 ' N ' ' O ' ' A' ' 39' ' ' ILE . 84.3 Cg_endo -90.69 -50.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.032 2.488 . . . . 10.0 113.824 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.486 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 42.4 t -64.78 -45.62 75.28 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 112.058 0.392 . . . . 10.0 112.058 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.916 ' HG2' HG23 ' A' ' 40' ' ' THR . 44.2 Cg_exo -57.19 -54.3 3.76 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.212 1.942 . . . . 10.0 112.553 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? 43.66 -129.64 0.81 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.459 -0.337 . . . . 10.0 111.611 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t 67.24 54.48 0.72 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 122.794 0.438 . . . . 10.0 111.813 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 96.0 mtt180 -160.28 44.07 0.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.4 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 56.95 -133.39 1.35 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.197 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' CE1' ' HE2' ' A' ' 67' ' ' LYS . 4.1 t80 -55.44 -34.05 64.13 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.604 0.24 . . . . 10.0 111.624 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.464 HG11 ' CB ' ' A' ' 61' ' ' PRO . 57.4 t -47.76 116.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.007 0.432 . . . . 10.0 111.069 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -79.49 -34.94 40.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.857 -0.611 . . . . 10.0 111.31 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.669 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -151.6 -175.74 23.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.526 -0.845 . . . . 10.0 112.933 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.569 ' H ' ' HB ' ' A' ' 40' ' ' THR . 2.3 m -154.2 169.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.82 HD11 HD11 ' A' ' 60' ' ' ILE . 27.6 pt -157.88 141.07 6.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 10.0 111.052 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -88.81 138.94 30.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.02 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.848 HD13 ' N ' ' A' ' 56' ' ' ARG . 2.4 tm? -169.1 138.43 2.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.581 . . . . 10.0 110.459 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.848 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.7 OUTLIER 48.67 48.98 19.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.119 0.485 . . . . 10.0 110.373 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 53.34 41.67 62.94 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.886 -0.673 . . . . 10.0 112.808 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -165.94 128.23 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 10.0 110.859 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.649 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -88.99 132.74 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.865 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.883 HG22 ' HB2' ' A' ' 90' ' ' GLU . 18.7 pt -112.72 126.98 27.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.494 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 80.7 Cg_endo -77.19 121.98 5.97 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.631 2.22 . . . . 10.0 112.601 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.669 HG22 ' C ' ' A' ' 51' ' ' GLY . 34.2 m -88.92 129.67 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.687 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.915 HG12 ' H ' ' A' ' 64' ' ' ASN . 3.2 t -113.5 -175.81 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.595 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.915 ' H ' HG12 ' A' ' 63' ' ' VAL . 11.7 p-10 -133.7 70.18 1.46 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.358 0.599 . . . . 10.0 110.709 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.983 HD13 ' CE2' ' A' ' 25' ' ' PHE . 5.6 tt -53.76 -37.59 63.56 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.821 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.824 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -50.57 -29.16 10.09 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.338 -0.545 . . . . 10.0 109.876 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.585 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -82.64 -43.59 16.77 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.617 -0.719 . . . . 10.0 110.631 178.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.0 tt -61.03 -37.58 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 122.096 0.951 . . . . 10.0 108.646 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.877 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -81.83 -53.95 5.76 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.713 -1.585 . . . . 10.0 109.219 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.488 ' O ' HG13 ' A' ' 71' ' ' ILE . . . 119.09 -77.81 0.3 Allowed Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.383 -0.826 . . . . 10.0 112.136 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.983 HD12 HG21 ' A' ' 18' ' ' ILE . 3.8 pt 44.69 177.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 113.122 0.786 . . . . 10.0 113.122 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.416 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 41.1 t -54.87 -38.37 67.42 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.806 ' HB3' HG13 ' A' ' 71' ' ' ILE . 5.9 t80 -24.6 140.66 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.635 -1.166 . . . . 10.0 113.571 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -172.71 37.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.321 -0.854 . . . . 10.0 110.095 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 54.33 35.11 22.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.884 -0.598 . . . . 10.0 111.304 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HB2' ' HZ3' ' A' ' 77' ' ' LYS . 98.3 mm-40 -81.03 -61.36 1.98 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.398 -0.364 . . . . 10.0 111.652 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 78' ' ' MET . 2.3 mppt? -103.14 -25.37 13.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.429 -0.35 . . . . 10.0 111.847 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 20.0 mmt -17.9 136.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -170.19 -34.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.771 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.81 ' O ' HD12 ' A' ' 94' ' ' LEU . 47.7 t -88.85 -176.02 5.07 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.832 0.349 . . . . 10.0 111.444 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.608 HD13 ' CD1' ' A' ' 39' ' ' ILE . 45.7 mt -152.37 158.34 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.897 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.042 HD13 HD11 ' A' ' 14' ' ' LEU . 12.3 mt -133.05 139.98 48.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.774 0.321 . . . . 10.0 111.052 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.465 HG12 ' OE2' ' A' ' 31' ' ' GLU . 44.4 t -109.17 152.68 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.066 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.47 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -155.37 169.71 23.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.364 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -128.04 132.72 49.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.901 HG22 HD21 ' A' ' 29' ' ' ASN . 57.6 p -148.3 109.19 4.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.817 0.303 . . . . 10.0 111.817 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 87' ' ' LYS . 22.3 ttmm 49.49 60.21 3.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.147 0.499 . . . . 10.0 110.282 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 87' ' ' LYS . 7.4 p-10 55.1 32.68 18.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.036 -0.984 . . . . 10.0 111.551 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 91' ' ' VAL . 70.7 t -125.62 109.34 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 115.16 -0.927 . . . . 10.0 108.732 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.883 ' HB2' HG22 ' A' ' 60' ' ' ILE . 28.5 mt-10 -88.46 94.59 9.91 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.871 -1.529 . . . . 10.0 106.871 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.03 HG21 HD13 ' A' ' 142' ' ' ILE . 3.1 t -88.57 155.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 113.035 -1.893 . . . . 10.0 112.856 -174.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.32 165.93 21.81 Favored Glycine 0 C--N 1.314 -0.693 0 CA-C-N 114.679 -1.146 . . . . 10.0 112.468 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.551 ' HE2' ' CZ ' ' A' ' 16' ' ' PHE . 2.6 t80 -151.62 133.61 15.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 10.0 110.839 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.81 HD12 ' O ' ' A' ' 80' ' ' SER . 67.3 tp -88.72 126.27 35.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.238 0.542 . . . . 10.0 111.898 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.529 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 15.4 m -135.61 -175.27 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.02 178.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -100.37 -60.04 1.6 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.203 0.525 . . . . 10.0 111.656 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.598 HH12 HD13 ' A' ' 99' ' ' LEU . 57.1 ttt-85 -144.46 117.08 8.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.382 -0.826 . . . . 10.0 108.891 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.772 HG11 HG11 ' A' ' 33' ' ' VAL . 7.5 p -101.08 118.22 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 122.336 1.065 . . . . 10.0 112.482 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.598 HD13 HH12 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -66.03 -29.22 69.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.219 -1.81 . . . . 10.0 110.674 -179.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.16 -125.05 7.61 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.485 -0.78 . . . . 10.0 111.425 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 m -52.33 131.13 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.944 0.372 . . . . 10.0 110.513 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.788 HD22 ' CB ' ' A' ' 15' ' ' SER . 56.6 tp -135.2 141.46 45.85 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.151 0.5 . . . . 10.0 111.258 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 103' ' ' ARG . 16.2 ptm180 -88.81 70.55 8.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.049 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.757 ' CG1' HG11 ' A' ' 13' ' ' VAL . 17.2 mm -88.65 136.76 22.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 107.922 -1.14 . . . . 10.0 107.922 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 37.9 p -88.65 -175.88 5.07 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.615 ' HG3' HD12 ' A' ' 109' ' ' LEU . 38.2 tt0 -149.6 77.06 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.06 -1.056 . . . . 10.0 113.393 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -111.69 22.17 15.28 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.255 -1.339 . . . . 10.0 107.519 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.628 ' O ' HD23 ' A' ' 109' ' ' LEU . 3.3 pm0 -158.77 59.71 0.43 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.902 -1.044 . . . . 10.0 111.628 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.628 HD23 ' O ' ' A' ' 108' ' ' GLN . 76.5 mt -154.08 -43.12 0.09 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.914 -1.039 . . . . 10.0 111.409 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -168.69 157.34 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.069 0.461 . . . . 10.0 111.241 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.94 ' HB2' HD11 ' A' ' 8' ' ' LEU . 84.9 mt 65.72 97.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.184 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 111' ' ' LEU . 9.1 t 48.89 48.02 20.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.63 -0.713 . . . . 10.0 111.232 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.789 ' O ' HG13 ' A' ' 114' ' ' VAL . 78.5 m-20 -158.14 135.15 9.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.635 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -179.97 116.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.266 -179.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 t -168.12 147.69 4.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.065 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.623 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 1.5 m-20 -52.12 -48.4 64.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.239 -0.437 . . . . 10.0 111.172 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.53 ' HD3' ' CG ' ' A' ' 108' ' ' GLN . 35.0 mtmt 73.43 -59.62 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.676 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.605 ' CB ' ' HA ' ' A' ' 123' ' ' LYS . 26.6 t80 -96.81 -66.56 0.9 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.833 0.349 . . . . 10.0 110.91 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.61 -36.64 0.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.56 -0.828 . . . . 10.0 112.941 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.47 ' NZ ' ' HB2' ' A' ' 120' ' ' LYS . 0.1 OUTLIER 176.33 124.98 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 2.7 tppp? 73.28 117.87 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.495 -0.775 . . . . 10.0 110.541 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.867 ' OG ' HD23 ' A' ' 69' ' ' LEU . 1.8 p 53.81 47.05 24.49 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.623 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 22.5 pttp -75.79 47.76 0.44 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.532 -1.213 . . . . 10.0 113.883 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.766 ' O ' ' HB3' ' A' ' 135' ' ' TYR . . . -107.89 46.78 1.12 Allowed Glycine 0 C--O 1.221 -0.659 0 C-N-CA 119.713 -1.232 . . . . 10.0 112.455 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.907 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.5 tm? -52.72 140.82 22.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.193 -0.593 . . . . 10.0 111.006 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.907 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.1 p -148.15 160.69 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-O 121.35 0.595 . . . . 10.0 111.593 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.505 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 87.0 tttt -164.77 135.81 4.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 10.0 110.284 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 8.5 m -161.76 150.52 15.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 120.976 0.417 . . . . 10.0 111.013 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 9.8 t70 55.18 48.02 20.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.442 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.3 35.03 34.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.664 -0.779 . . . . 10.0 111.977 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.618 HH12 ' HB2' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -137.33 133.14 34.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.703 0.287 . . . . 10.0 110.273 -179.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.654 HD12 ' N ' ' A' ' 132' ' ' LEU . 3.7 mp -88.93 139.08 30.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.892 0.377 . . . . 10.0 111.316 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.865 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.1 mt -145.36 136.7 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 10.0 110.621 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.717 ' CG2' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -95.87 132.92 38.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.766 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 12.7 t80 -120.43 144.69 47.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.229 0.538 . . . . 10.0 110.421 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.885 ' HG ' HD11 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -151.88 131.81 13.37 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.52 -0.764 . . . . 10.0 111.234 -177.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.708 ' N ' HD22 ' A' ' 136' ' ' LEU . 12.2 p-10 -95.05 34.74 1.34 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.218 0.532 . . . . 10.0 111.296 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.849 ' HA ' ' CG2' ' A' ' 141' ' ' ILE . 12.6 tt 38.4 19.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.375 1.25 . . . . 10.0 114.375 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 137' ' ' ASP . 64.3 t0 -77.29 -57.11 4.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.274 0.842 . . . . 10.0 113.274 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 121' ' ' LYS . 34.5 mmtp -76.08 -28.93 57.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.318 0.58 . . . . 10.0 111.248 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.849 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.76 -45.99 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.438 -0.801 . . . . 10.0 110.878 -179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.03 HD13 HG21 ' A' ' 91' ' ' VAL . 8.9 tp -67.34 -47.65 80.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 120.252 -0.579 . . . . 10.0 111.212 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.892 ' O ' HG12 ' A' ' 147' ' ' VAL . 48.5 mt-10 -50.33 -42.54 53.06 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.392 -0.595 . . . . 10.0 109.392 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' A' ' 68' ' ' ILE . 57.4 mm-40 -75.17 -27.24 59.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.123 -0.944 . . . . 10.0 111.04 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 142' ' ' ILE . 23.5 mt -55.41 -43.1 70.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.907 0.384 . . . . 10.0 110.72 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.4 p -86.33 -52.51 5.58 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.571 0.582 . . . . 10.0 112.571 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 143' ' ' GLU . 7.2 p -84.78 13.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.85 0.685 . . . . 10.0 112.85 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.2 OUTLIER -40.02 -56.76 1.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.712 0.292 . . . . 10.0 111.769 -178.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 178.66 133.12 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.827 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.451 ' O ' HG12 ' A' ' 151' ' ' VAL . . . -67.97 -46.9 63.25 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.469 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 150' ' ' GLY . 12.3 p . . . . . 0 N--CA 1.464 0.237 0 CA-C-O 120.878 0.371 . . . . 10.0 111.539 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.812 0.339 . . . . 10.0 111.133 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -58.95 -44.66 91.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 10.0 111.092 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.1 m 69.65 -56.2 0.57 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.495 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 5' ' ' ALA . 3.5 pp -56.81 -30.26 63.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 10.0 110.936 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.915 ' N ' HD12 ' A' ' 4' ' ' LEU . . . 67.78 133.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 10.0 111.34 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.06 139.05 57.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.944 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.68 ' O ' HD23 ' A' ' 8' ' ' LEU . . . 178.87 140.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.165 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 7' ' ' ALA . 87.5 mt -147.88 42.81 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.656 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -88.95 -64.66 1.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 10.0 111.075 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.41 ' HG2' HG22 ' A' ' 105' ' ' THR . 93.9 mt-10 -152.26 164.3 37.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.969 0.89 . . . . 10.0 111.842 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CE2' ' OH ' ' A' ' 135' ' ' TYR . 35.0 t80 -117.0 127.94 54.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.794 -1.548 . . . . 10.0 113.802 -175.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -89.02 126.2 35.32 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.649 -1.611 . . . . 10.0 106.649 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.973 HG11 ' CG1' ' A' ' 104' ' ' ILE . 4.2 p -151.83 167.74 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 114.476 1.287 . . . . 10.0 114.476 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.76 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.4 tm? -88.9 137.93 31.87 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 107.91 -1.144 . . . . 10.0 107.91 178.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.779 ' CB ' HD22 ' A' ' 102' ' ' LEU . 57.0 p -149.29 158.99 44.64 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.203 0.816 . . . . 10.0 113.203 -177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.696 ' CD2' HD11 ' A' ' 82' ' ' ILE . 6.9 p90 -152.3 165.92 33.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.217 -1.356 . . . . 10.0 110.42 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.6 137.25 32.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 10.0 109.715 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.975 HG21 HD12 ' A' ' 71' ' ' ILE . 28.4 mm -134.37 92.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.164 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.494 ' OD2' ' HA ' ' A' ' 73' ' ' PHE . 41.6 m-20 44.74 60.25 3.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.64 . . . . 10.0 112.701 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 45.9 mt-10 85.17 -42.59 0.06 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.282 -0.872 . . . . 10.0 111.879 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 18' ' ' ILE . 3.1 pt20 -88.95 145.72 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.021 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.49 166.81 13.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.908 0.385 . . . . 10.0 110.785 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.8 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.5 tp -149.43 139.33 21.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.505 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.775 ' H ' HD12 ' A' ' 23' ' ' LEU . . . -142.58 146.66 34.8 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.489 0.922 . . . . 10.0 113.489 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.874 ' CE2' HD21 ' A' ' 136' ' ' LEU . 1.6 m-85 -124.24 143.51 50.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.224 -0.898 . . . . 10.0 108.615 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -53.69 123.23 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.05 -0.352 . . . . 10.0 110.05 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.905 HG13 ' HA ' ' A' ' 13' ' ' VAL . 27.4 m -58.04 -14.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.567 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -62.64 -43.59 98.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.061 0.458 . . . . 10.0 110.204 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.842 ' ND2' HG21 ' A' ' 138' ' ' ILE . 14.9 t30 -84.7 -47.02 10.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.675 -0.693 . . . . 10.0 111.164 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.76 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.8 mm -61.03 132.28 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.217 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.442 ' HB3' ' CE ' ' A' ' 32' ' ' MET . 43.9 mt-10 -94.91 -60.4 1.7 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.376 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.442 ' CE ' ' HB3' ' A' ' 31' ' ' GLU . 1.2 pmm? -169.01 156.55 7.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.367 -0.379 . . . . 10.0 111.003 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.818 HG11 HG11 ' A' ' 98' ' ' VAL . 35.3 m -88.84 144.58 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 10.0 111.791 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.492 HG12 HG23 ' A' ' 83' ' ' VAL . 31.6 pt -137.89 136.81 45.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.593 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -88.95 120.82 30.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 10.0 110.68 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.979 ' HB2' HD12 ' A' ' 81' ' ' ILE . 62.0 mttp -162.56 156.58 21.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.804 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.5 m -167.65 37.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.356 0.598 . . . . 10.0 111.059 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -167.86 44.03 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.151 -0.931 . . . . 10.0 110.567 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.809 HD11 ' CD ' ' A' ' 36' ' ' LYS . 15.9 mt -93.66 138.31 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.883 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.778 HG23 ' CG ' ' A' ' 43' ' ' PRO . 6.0 m 37.51 77.66 0.39 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.903 -0.59 . . . . 10.0 112.545 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -86.93 -47.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.801 2.334 . . . . 10.0 113.433 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.586 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 14.8 p -84.57 -31.2 0.46 Allowed Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 113.595 0.961 . . . . 10.0 113.595 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.778 ' CG ' HG23 ' A' ' 40' ' ' THR . 47.4 Cg_exo -55.57 -56.31 2.35 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 121.655 1.57 . . . . 10.0 112.913 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' NZ ' ' HB3' ' A' ' 44' ' ' LYS . 3.3 ttpm? 56.18 -131.85 1.66 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.603 -0.271 . . . . 10.0 110.3 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 23.3 t 78.64 -45.69 0.4 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.882 0.473 . . . . 10.0 112.188 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.451 ' CB ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -64.34 -31.4 72.6 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.895 0.331 . . . . 10.0 111.895 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 38.2 m80 69.87 -62.71 0.41 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.203 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.515 ' HB3' ' HD2' ' A' ' 148' ' ' LYS . 2.4 t80 -69.89 -43.49 71.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.133 0.492 . . . . 10.0 109.784 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.941 ' HA ' HG22 ' A' ' 63' ' ' VAL . 44.6 t -78.51 135.5 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.598 -0.728 . . . . 10.0 111.58 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.43 ' HG3' ' OD1' ' A' ' 64' ' ' ASN . 24.2 mm-40 -88.34 -40.9 13.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.772 -0.649 . . . . 10.0 110.601 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 62' ' ' VAL . . . -135.22 160.9 24.54 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.345 -0.931 . . . . 10.0 113.747 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.624 ' H ' HG22 ' A' ' 39' ' ' ILE . 2.6 m -159.81 169.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.501 HG12 HD11 ' A' ' 60' ' ' ILE . 31.6 pt -159.08 142.46 5.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.862 0.363 . . . . 10.0 111.073 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -88.75 141.38 28.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.989 -0.551 . . . . 10.0 111.064 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.667 HD13 ' N ' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -168.71 133.04 1.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.84 -0.618 . . . . 10.0 109.981 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.667 ' N ' HD13 ' A' ' 55' ' ' LEU . 35.3 mmt180 50.46 45.76 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 10.0 110.925 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.7 38.17 80.92 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.8 -0.636 . . . . 10.0 112.977 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -158.41 124.42 4.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.744 0.306 . . . . 10.0 110.596 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.613 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.6 mp -91.0 127.4 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.243 -0.435 . . . . 10.0 111.25 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.813 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.1 pp -94.92 134.94 24.09 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.55 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 92.8 Cg_endo -99.57 121.82 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.068 2.512 . . . . 10.0 113.864 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 51' ' ' GLY . 19.5 m -103.52 127.57 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 108.844 -0.798 . . . . 10.0 108.844 177.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.941 HG22 ' HA ' ' A' ' 49' ' ' VAL . 47.3 t -139.59 160.36 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.851 0.834 . . . . 10.0 113.204 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.567 ' N ' HG12 ' A' ' 63' ' ' VAL . 4.3 m120 -75.96 73.39 2.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.591 -1.186 . . . . 10.0 108.667 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.911 ' O ' HG22 ' A' ' 68' ' ' ILE . 5.3 tt -52.87 -38.53 61.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.293 0.568 . . . . 10.0 111.397 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.028 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -59.9 -18.5 45.29 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.193 -0.603 . . . . 10.0 110.03 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.534 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.1 tmmm? -85.41 -46.9 10.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.017 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.911 HG22 ' O ' ' A' ' 65' ' ' LEU . 8.4 tt -53.86 -35.21 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 107.611 -1.255 . . . . 10.0 107.611 178.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.868 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -86.1 -56.08 3.63 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.08 -1.873 . . . . 10.0 109.82 178.263 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . 121.92 -81.47 0.34 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.307 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.028 HD11 ' CB ' ' A' ' 66' ' ' ALA . 2.9 pt 45.11 179.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.698 0.629 . . . . 10.0 112.698 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 45.7 t -54.75 -39.08 67.94 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.151 -0.685 . . . . 10.0 109.151 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.78 ' HB3' HG13 ' A' ' 71' ' ' ILE . 14.8 t80 -32.4 143.69 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.784 -1.098 . . . . 10.0 112.896 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -166.77 37.4 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.659 -0.7 . . . . 10.0 110.532 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 55.28 38.76 30.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.776 -0.647 . . . . 10.0 111.22 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.442 ' C ' ' HD2' ' A' ' 77' ' ' LYS . 17.7 pt20 -94.01 -50.51 5.28 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 112.262 0.467 . . . . 10.0 112.262 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 12.4 mptt -111.16 -25.01 9.95 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.757 0.651 . . . . 10.0 112.757 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.559 ' HE2' ' HD1' ' A' ' 73' ' ' PHE . 16.9 mmt -36.72 143.77 0.07 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.758 0.651 . . . . 10.0 112.758 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 53.6 mtmt -159.53 -41.38 0.05 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.91 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.963 ' O ' HD12 ' A' ' 94' ' ' LEU . 46.8 t -88.78 -175.99 5.08 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.913 0.387 . . . . 10.0 111.551 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.979 HD12 ' HB2' ' A' ' 36' ' ' LYS . 77.4 mt -146.55 154.22 12.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.328 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.696 HD11 ' CD2' ' A' ' 16' ' ' PHE . 10.8 mt -120.63 143.9 31.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.739 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 34' ' ' ILE . 72.1 t -111.41 149.85 13.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.974 0.416 . . . . 10.0 110.892 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -153.57 174.33 14.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 10.0 111.001 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 6.3 ptm180 -135.71 132.11 36.47 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.696 -0.483 . . . . 10.0 109.696 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.737 HG22 ' OD1' ' A' ' 29' ' ' ASN . 59.0 p -145.51 109.54 4.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.962 0.41 . . . . 10.0 111.922 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 14.7 tppt? 47.53 49.74 15.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.328 0.585 . . . . 10.0 110.851 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.05 31.57 1.45 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.066 -0.97 . . . . 10.0 111.519 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.93 HG12 HG22 ' A' ' 91' ' ' VAL . 67.6 t -128.33 108.56 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.23 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.7 ' HB2' HG22 ' A' ' 60' ' ' ILE . 6.4 mp0 -88.4 98.47 11.64 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.198 -1.779 . . . . 10.0 106.198 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.005 HG21 HD13 ' A' ' 142' ' ' ILE . 3.0 t -88.7 157.2 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 113.089 -1.869 . . . . 10.0 112.711 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -140.25 151.21 22.08 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 114.895 -1.048 . . . . 10.0 113.258 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.602 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.1 t80 -140.77 134.39 30.16 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.93 0.395 . . . . 10.0 111.003 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.963 HD12 ' O ' ' A' ' 80' ' ' SER . 31.7 tp -88.61 115.5 26.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.062 -0.517 . . . . 10.0 111.46 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.528 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 12.8 m -122.43 -175.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.933 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -100.15 -59.98 1.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.174 0.512 . . . . 10.0 111.825 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -141.26 113.37 7.94 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.565 -0.743 . . . . 10.0 109.547 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.818 HG11 HG11 ' A' ' 33' ' ' VAL . 9.5 p -99.79 111.28 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 122.461 1.124 . . . . 10.0 111.168 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -62.72 -28.51 70.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.909 -1.95 . . . . 10.0 111.161 -178.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.92 -122.73 6.52 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.964 -0.854 . . . . 10.0 110.964 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 p -53.94 131.82 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 117.06 0.43 . . . . 10.0 110.229 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.779 HD22 ' CB ' ' A' ' 15' ' ' SER . 19.4 tp -137.07 142.94 42.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 10.0 111.257 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 5.1 ptp85 -88.85 79.82 7.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.529 -0.76 . . . . 10.0 111.295 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.973 ' CG1' HG11 ' A' ' 13' ' ' VAL . 11.6 mm -88.76 178.78 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 178.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 104' ' ' ILE . 22.1 p -134.96 -175.85 4.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.774 -0.824 . . . . 10.0 108.774 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.655 ' HG3' ' HB2' ' A' ' 109' ' ' LEU . 35.5 tt0 -136.71 79.04 1.74 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.934 0.873 . . . . 10.0 112.516 -178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.552 ' C ' HG21 ' A' ' 112' ' ' THR . 6.5 m120 -119.89 22.29 11.58 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.23 -1.35 . . . . 10.0 107.522 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.91 ' N ' HG21 ' A' ' 112' ' ' THR . 3.0 pt20 -150.11 -23.6 0.25 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.997 -1.001 . . . . 10.0 113.606 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.655 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 6.8 mp -57.43 -164.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.816 0.341 . . . . 10.0 111.341 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.99 -44.32 73.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.442 -0.344 . . . . 10.0 111.864 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.421 HD12 ' OE1' ' A' ' 106' ' ' GLU . 76.3 mt -54.06 -52.96 59.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.602 -0.272 . . . . 10.0 111.545 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.91 HG21 ' N ' ' A' ' 108' ' ' GLN . 9.0 t -60.66 -22.02 63.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 10.0 110.692 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 112' ' ' THR . 68.7 m-80 76.91 46.72 0.07 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.609 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 108' ' ' GLN . 10.6 t -152.01 45.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.055 0.455 . . . . 10.0 110.335 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 53.5 m -77.89 45.41 0.52 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.108 0.781 . . . . 10.0 113.108 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.69 -53.65 43.96 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 122' ' ' SER . 90.5 mttt 61.6 112.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.999 -1.0 . . . . 10.0 113.612 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.855 ' CE1' HD21 ' A' ' 69' ' ' LEU . 20.2 t80 58.33 19.99 6.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.639 -1.164 . . . . 10.0 111.494 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.0 -43.69 1.48 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.488 -0.863 . . . . 10.0 112.202 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -156.66 38.22 0.32 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.667 0.27 . . . . 10.0 111.013 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . 39.9 ttmt -157.06 -112.94 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.446 -0.343 . . . . 10.0 110.594 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.75 ' O ' ' N ' ' A' ' 124' ' ' GLY . 74.4 m -143.76 -45.35 0.27 Allowed 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 112.765 0.654 . . . . 10.0 112.765 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.723 ' NZ ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -53.85 55.92 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.487 -0.779 . . . . 10.0 112.132 -177.196 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.769 ' HA2' ' H ' ' A' ' 118' ' ' PHE . . . -51.63 130.19 34.58 Favored Glycine 0 CA--C 1.509 -0.341 0 CA-C-N 115.135 -0.939 . . . . 10.0 111.802 178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.697 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.3 tm? -70.74 127.41 32.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.549 0.69 . . . . 10.0 111.524 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.697 ' N ' HD13 ' A' ' 125' ' ' LEU . 1.1 p -123.02 155.77 28.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.783 -1.099 . . . . 10.0 109.944 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 131' ' ' ARG . 8.1 ptpp? -154.77 143.9 21.07 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.132 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 23.8 m -152.61 140.02 19.6 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.071 -0.513 . . . . 10.0 110.578 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 p30 45.28 48.39 10.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.045 0.45 . . . . 10.0 111.219 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.42 97.15 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.647 -0.787 . . . . 10.0 111.773 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 128' ' ' THR . 1.7 ptp180 -130.08 136.94 49.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.653 0.263 . . . . 10.0 110.581 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 132' ' ' LEU . 3.7 mp -88.9 138.56 31.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.661 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.021 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.5 mt -156.92 144.64 10.84 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-N 116.465 -0.334 . . . . 10.0 111.741 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.8 ' HB ' HD13 ' A' ' 23' ' ' LEU . 2.2 mp -99.69 146.82 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.542 ' CE1' HG21 ' A' ' 13' ' ' VAL . 56.5 t80 -141.36 151.22 43.36 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.494 -0.482 . . . . 10.0 110.98 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.874 HD21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -169.09 150.64 4.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.146 0.795 . . . . 10.0 113.146 -179.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -95.26 32.74 1.67 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.885 -1.052 . . . . 10.0 110.127 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.842 HG21 ' ND2' ' A' ' 29' ' ' ASN . 10.1 tt 38.69 23.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 114.836 -1.075 . . . . 10.0 113.683 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -75.79 -58.28 3.38 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.545 0.943 . . . . 10.0 113.545 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 140' ' ' LYS . 7.2 mmpt? -78.23 -31.94 49.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.042 0.448 . . . . 10.0 110.698 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.832 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -65.17 -45.25 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.04 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.005 HD13 HG21 ' A' ' 91' ' ' VAL . 7.7 tp -65.49 -46.61 89.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.506 -0.478 . . . . 10.0 110.861 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 142' ' ' ILE . 47.3 mt-10 -48.46 -40.82 27.63 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.993 0.425 . . . . 10.0 110.159 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.572 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.1 mt-10 -68.67 -36.85 79.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.69 -0.686 . . . . 10.0 110.11 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.668 HD12 HD12 ' A' ' 142' ' ' ILE . 35.4 mt -53.62 -41.43 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.151 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.8 p -76.56 -49.93 15.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.785 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 147' ' ' VAL . 14.7 p -75.33 1.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 112.082 0.401 . . . . 10.0 112.082 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.515 ' HD2' ' HB3' ' A' ' 48' ' ' PHE . 23.7 pttm -46.17 -44.63 16.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.873 0.368 . . . . 10.0 111.274 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -61.35 138.06 58.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.939 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.439 ' O ' HG12 ' A' ' 151' ' ' VAL . . . -176.74 -44.51 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.79 -0.719 . . . . 10.0 112.499 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 150' ' ' GLY . 11.8 p . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 120.832 0.349 . . . . 10.0 111.522 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.803 0.335 . . . . 10.0 111.203 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.609 ' HG2' HG22 ' A' ' 3' ' ' THR . 61.0 tttm -171.12 -63.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.609 HG22 ' HG2' ' A' ' 2' ' ' LYS . 7.7 t 171.44 -45.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.492 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.479 ' N ' HG23 ' A' ' 3' ' ' THR . 84.5 mt -69.5 -41.43 76.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.736 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.51 48.33 4.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.936 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -158.43 147.32 18.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.72 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -170.8 133.63 0.96 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.951 0.405 . . . . 10.0 111.442 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.835 HD11 HD13 ' A' ' 111' ' ' LEU . 93.0 mt -74.31 59.25 0.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.172 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.55 ' O ' HG22 ' A' ' 105' ' ' THR . 18.1 ttpt -138.48 -53.29 0.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.795 0.331 . . . . 10.0 111.419 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 42.6 tt0 -160.21 164.1 33.05 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.691 0.758 . . . . 10.0 111.464 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.569 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 14.6 t80 -158.55 138.91 12.47 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 114.26 -1.336 . . . . 10.0 112.527 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 29.2 mt-10 -88.62 139.47 30.44 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.938 -0.574 . . . . 10.0 109.527 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.921 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -155.47 167.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.752 1.019 . . . . 10.0 113.752 -175.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.592 HD13 ' C ' ' A' ' 14' ' ' LEU . 1.7 tm? -89.19 127.83 35.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.231 -0.895 . . . . 10.0 108.677 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.817 ' CB ' HD22 ' A' ' 102' ' ' LEU . 39.1 t -143.8 156.13 44.38 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.839 0.828 . . . . 10.0 113.131 -178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.696 ' HD2' HG23 ' A' ' 98' ' ' VAL . 1.3 p90 -146.53 160.05 42.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.851 -1.522 . . . . 10.0 109.917 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HG3' HD21 ' A' ' 99' ' ' LEU . 56.7 mt-10 -88.74 107.2 18.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.469 0.652 . . . . 10.0 110.066 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.75 HG21 HD12 ' A' ' 71' ' ' ILE . 30.6 mm -88.96 90.65 3.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.843 -1.071 . . . . 10.0 111.714 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 9.5 p-10 36.46 60.38 0.9 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.857 -1.065 . . . . 10.0 113.498 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 47.2 mt-10 100.07 -52.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.668 -1.151 . . . . 10.0 111.685 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.578 ' NE2' HD11 ' A' ' 134' ' ' ILE . 14.1 pt20 -89.04 150.17 22.9 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.024 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.76 170.44 10.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.016 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.2 tp -159.06 136.84 10.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.567 -0.742 . . . . 10.0 110.597 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.757 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -141.42 152.76 44.56 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.481 0.549 . . . . 10.0 112.481 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.951 ' CE2' HD22 ' A' ' 136' ' ' LEU . 4.9 m-85 -130.04 138.94 51.03 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.293 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -47.49 122.33 4.66 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.899 0.381 . . . . 10.0 110.982 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.921 HG13 ' HA ' ' A' ' 13' ' ' VAL . 27.4 m -61.91 -12.79 8.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.966 -0.561 . . . . 10.0 111.073 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.87 -42.51 97.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.96 0.41 . . . . 10.0 110.161 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.96 ' ND2' HG21 ' A' ' 138' ' ' ILE . 11.7 t30 -90.06 -47.24 7.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.895 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.582 HG21 ' HG ' ' A' ' 14' ' ' LEU . 19.7 mm -58.87 128.81 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.004 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' O ' ' CE ' ' A' ' 32' ' ' MET . 54.4 mt-10 -82.66 -65.4 1.02 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.077 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.414 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.7 tpp -169.08 173.71 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 10.0 111.322 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.573 ' CG1' HG11 ' A' ' 98' ' ' VAL . 35.3 m -89.01 150.99 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.488 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.574 HD13 ' CG2' ' A' ' 83' ' ' VAL . 12.7 pt -142.35 121.64 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.647 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.03 118.74 28.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 10.0 109.51 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.814 ' HB3' HD12 ' A' ' 81' ' ' ILE . 23.3 tptm -169.04 163.3 11.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.027 0.442 . . . . 10.0 111.026 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.8 t -152.08 -166.6 2.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.461 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 p30 40.94 37.46 0.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.291 0.567 . . . . 10.0 111.576 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 40' ' ' THR . 9.5 mt -80.31 158.26 4.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.337 -0.847 . . . . 10.0 110.959 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.519 ' HB ' ' H ' ' A' ' 52' ' ' VAL . 84.1 m -18.96 110.05 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.094 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 40' ' ' THR . 5.4 Cg_exo -78.26 44.97 1.71 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.176 2.584 . . . . 10.0 113.836 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 42' ' ' VAL . 39.6 t 51.85 51.41 9.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.843 0.354 . . . . 10.0 111.507 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD2' ' CG2' ' A' ' 40' ' ' THR . 85.4 Cg_endo -77.83 -100.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.612 2.208 . . . . 10.0 111.941 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -51.28 -41.13 60.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.602 0.715 . . . . 10.0 110.092 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.409 ' O ' ' CD2' ' A' ' 47' ' ' HIS . 43.7 t -48.0 -62.0 1.69 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.585 -1.189 . . . . 10.0 111.715 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 77.9 ttt180 49.79 27.09 2.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.586 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.422 ' HB3' ' H ' ' A' ' 48' ' ' PHE . 42.9 m170 -117.01 -157.94 0.68 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 10.0 111.45 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.514 ' CZ ' ' HE3' ' A' ' 67' ' ' LYS . 7.0 t80 -62.8 -39.15 93.36 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.816 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.9 ' HA ' HG22 ' A' ' 63' ' ' VAL . 46.8 t -57.04 129.76 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.869 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 63' ' ' VAL . 16.9 pt-20 -79.79 -37.39 35.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.418 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.616 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -161.02 -175.93 32.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.053 -0.594 . . . . 10.0 112.234 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.519 ' H ' ' HB ' ' A' ' 40' ' ' THR . 3.5 m -158.46 175.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 110.163 -0.31 . . . . 10.0 110.163 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.027 HD11 HD11 ' A' ' 60' ' ' ILE . 24.3 pt -157.41 144.27 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.64 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.505 ' O ' HD23 ' A' ' 55' ' ' LEU . 24.8 t-20 -88.74 133.87 34.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 10.0 111.567 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 54' ' ' ASN . 96.2 mt -161.04 138.33 9.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.47 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 20.8 tpp180 48.94 48.64 20.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 10.0 111.016 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 53.83 40.4 64.45 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.869 -0.681 . . . . 10.0 112.719 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.503 ' HD3' ' N ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -166.9 130.28 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.873 -0.418 . . . . 10.0 109.873 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.4 mp -88.83 124.79 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.383 -0.371 . . . . 10.0 111.378 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.027 HD11 HD11 ' A' ' 53' ' ' ILE . 28.5 pt -92.75 130.2 37.54 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.974 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 86.3 Cg_endo -81.89 119.65 3.28 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.402 2.068 . . . . 10.0 113.252 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.616 HG22 ' C ' ' A' ' 51' ' ' GLY . 27.7 m -98.49 137.25 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.312 -0.625 . . . . 10.0 109.312 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.9 HG22 ' HA ' ' A' ' 49' ' ' VAL . 96.6 t -143.0 156.09 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.717 0.77 . . . . 10.0 112.744 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.788 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 76.1 m-20 -73.74 66.09 1.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.704 -1.135 . . . . 10.0 108.33 177.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.94 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.6 tt -49.32 -28.33 4.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.921 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.694 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . . . -61.89 -29.81 70.45 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.821 -0.351 . . . . 10.0 110.953 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.788 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -87.31 -36.94 17.58 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 110.423 -0.214 . . . . 10.0 110.423 178.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.758 ' N ' ' HD2' ' A' ' 67' ' ' LYS . 8.1 tt -61.16 -41.04 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 106.623 -1.621 . . . . 10.0 106.623 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.843 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -76.05 -38.66 56.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 113.407 -1.724 . . . . 10.0 107.972 176.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 69' ' ' LEU . . . 70.06 120.82 0.04 OUTLIER Glycine 0 C--N 1.335 0.492 0 CA-C-N 114.827 -1.079 . . . . 10.0 113.154 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.791 HG23 ' CD1' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -160.57 -167.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.332 0.653 . . . . 10.0 109.546 -179.146 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.419 ' CB ' ' OD2' ' A' ' 19' ' ' ASP . 29.2 t -53.16 -34.41 56.71 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.694 ' CD2' ' HB3' ' A' ' 66' ' ' ALA . 6.0 t80 -28.57 138.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.608 -1.178 . . . . 10.0 112.95 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 9.2 t70 -160.58 35.66 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.581 -0.736 . . . . 10.0 109.986 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 43.95 40.01 3.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.502 -0.772 . . . . 10.0 112.194 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 77' ' ' LYS . 21.0 mt-30 -95.98 -49.55 5.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.606 0.241 . . . . 10.0 111.29 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 76' ' ' GLN . 2.3 mppt? -98.09 -31.76 11.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.506 -0.316 . . . . 10.0 111.629 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.598 ' SD ' ' HA ' ' A' ' 95' ' ' VAL . 21.7 mmt -27.01 141.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.764 0.653 . . . . 10.0 112.764 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt 178.62 50.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.79 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.923 ' O ' HD12 ' A' ' 94' ' ' LEU . 80.0 p -169.03 155.34 6.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.795 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.814 HD12 ' HB3' ' A' ' 36' ' ' LYS . 61.0 mt -126.88 142.22 43.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.781 -0.367 . . . . 10.0 111.595 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.584 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 4.5 mt -119.42 143.72 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.642 -0.253 . . . . 10.0 110.556 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.574 ' CG2' HD13 ' A' ' 34' ' ' ILE . 79.9 t -113.62 152.46 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.231 0.539 . . . . 10.0 111.328 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -155.93 173.73 16.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.447 -0.797 . . . . 10.0 110.449 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.437 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 6.7 ptm180 -130.4 146.7 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.566 -0.531 . . . . 10.0 109.566 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.486 HG21 HG12 ' A' ' 138' ' ' ILE . 41.1 p -160.47 108.55 1.62 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 87' ' ' LYS . 36.7 ttmt 46.27 48.76 13.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.386 0.613 . . . . 10.0 110.892 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 72.84 33.67 1.24 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.56 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.887 HG12 HG22 ' A' ' 91' ' ' VAL . 53.8 t -131.75 110.84 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 115.268 -0.878 . . . . 10.0 109.122 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.788 ' HB2' HG22 ' A' ' 60' ' ' ILE . 1.5 mp0 -88.38 97.81 11.26 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.341 -1.726 . . . . 10.0 106.341 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.014 HG21 HD13 ' A' ' 142' ' ' ILE . 3.4 t -88.55 153.18 3.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 113.367 -1.742 . . . . 10.0 112.474 -174.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -130.47 152.95 19.97 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 114.861 -1.063 . . . . 10.0 113.499 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.639 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -139.94 128.03 22.31 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.906 0.384 . . . . 10.0 110.898 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.923 HD12 ' O ' ' A' ' 80' ' ' SER . 50.8 tp -88.57 128.17 35.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.943 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.658 HG11 ' CE1' ' A' ' 16' ' ' PHE . 19.7 m -136.74 -175.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.971 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -96.88 -65.35 0.97 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.131 0.491 . . . . 10.0 112.188 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.1 tpt85 -135.81 119.25 16.87 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.529 -0.76 . . . . 10.0 109.144 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.696 HG23 ' HD2' ' A' ' 16' ' ' PHE . 8.6 p -106.29 112.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 122.5 1.143 . . . . 10.0 112.045 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -66.2 -27.93 68.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.825 -1.989 . . . . 10.0 111.305 -178.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.62 -122.15 6.13 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.526 -0.845 . . . . 10.0 111.327 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.0 t -52.49 134.4 14.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.868 0.334 . . . . 10.0 110.569 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.817 HD22 ' CB ' ' A' ' 15' ' ' SER . 57.7 tp -140.27 141.07 35.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.076 0.465 . . . . 10.0 111.219 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.7 ptp180 -88.92 73.08 8.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.521 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.099 HD12 HG11 ' A' ' 126' ' ' VAL . 17.6 mm -88.59 131.8 35.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 109.892 -0.41 . . . . 10.0 109.892 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 22.8 p -88.83 151.1 22.58 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.646 -1.242 . . . . 10.0 107.646 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.507 ' HG3' ' HG ' ' A' ' 109' ' ' LEU . 20.4 tt0 -124.49 73.89 1.29 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.123 0.964 . . . . 10.0 112.99 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 114' ' ' VAL . 5.7 m120 -113.65 15.67 18.8 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.844 -1.525 . . . . 10.0 107.403 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.656 ' HB3' HG23 ' A' ' 114' ' ' VAL . 6.6 pm0 -142.42 41.08 1.61 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.205 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.546 ' N ' HD23 ' A' ' 109' ' ' LEU . 1.6 pt? 173.55 51.14 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.68 -1.145 . . . . 10.0 110.661 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.55 ' OD1' HD21 ' A' ' 8' ' ' LEU . 7.3 t0 -172.72 -49.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.503 -0.771 . . . . 10.0 110.276 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.835 HD13 HD11 ' A' ' 8' ' ' LEU . 13.9 tp -94.29 -12.55 27.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.634 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 111' ' ' LEU . 15.1 t 56.42 42.31 27.73 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.327 0.651 . . . . 10.0 112.527 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.426 ' OD1' ' HG ' ' A' ' 111' ' ' LEU . 4.6 m120 -95.44 -29.86 14.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.101 0.476 . . . . 10.0 110.221 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.656 HG23 ' HB3' ' A' ' 108' ' ' GLN . 8.5 m -141.71 73.1 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.199 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.3 m -70.92 52.4 0.15 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.56 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.09 28.46 1.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.202 0.525 . . . . 10.0 110.561 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.42 ' HD3' ' HG3' ' A' ' 123' ' ' LYS . 91.9 mttt -46.56 -51.51 15.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.38 -0.827 . . . . 10.0 112.131 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.439 ' CE2' HD21 ' A' ' 69' ' ' LEU . 21.7 t80 -175.8 -53.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.072 0.463 . . . . 10.0 110.241 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 120' ' ' LYS . . . 148.91 -64.66 0.4 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.753 -0.658 . . . . 10.0 112.374 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 119' ' ' GLY . 67.7 mttm -163.61 53.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.673 0.273 . . . . 10.0 110.508 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -151.23 -43.34 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.879 0.326 . . . . 10.0 111.879 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.608 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . 89.2 p -126.77 -140.2 0.27 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 121.245 -0.182 . . . . 10.0 111.312 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 123' ' ' LYS . 56.9 tttm -164.88 28.04 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.935 -0.306 . . . . 10.0 111.82 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.502 ' C ' ' HB3' ' A' ' 135' ' ' TYR . . . -151.43 145.66 13.7 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.736 -1.221 . . . . 10.0 113.422 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.9 tm? -155.54 141.13 17.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 1.099 HG11 HD12 ' A' ' 104' ' ' ILE . 1.5 p -160.87 160.94 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.389 0.614 . . . . 10.0 112.29 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 87.1 tttt -164.49 134.25 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.08 -0.964 . . . . 10.0 109.786 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 4.6 m -162.7 151.54 14.85 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 120.924 0.392 . . . . 10.0 111.12 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.42 45.8 21.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.979 0.419 . . . . 10.0 110.746 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 53.41 33.59 47.18 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.665 -0.778 . . . . 10.0 111.83 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 128' ' ' THR . 12.7 ptt180 -134.93 130.53 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.184 -0.302 . . . . 10.0 110.184 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 133' ' ' ILE . 2.8 tm? -88.87 135.23 33.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.852 0.358 . . . . 10.0 110.736 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.024 HG12 ' HB3' ' A' ' 22' ' ' ALA . 3.2 mt -130.8 130.75 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.345 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 1.016 ' HB ' HD13 ' A' ' 23' ' ' LEU . 5.1 mm -88.87 147.45 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.975 -1.12 . . . . 10.0 107.975 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.606 ' C ' HD12 ' A' ' 136' ' ' LEU . 32.9 t80 -137.02 141.39 42.5 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.71 -0.796 . . . . 10.0 111.671 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.951 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.7 mp -133.32 172.99 11.94 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.067 0.936 . . . . 10.0 112.679 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -140.37 24.94 2.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.935 -1.484 . . . . 10.0 108.336 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.96 HG21 ' ND2' ' A' ' 29' ' ' ASN . 10.3 tt 40.38 19.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.267 -1.333 . . . . 10.0 114.259 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 142' ' ' ILE . 9.1 t0 -82.64 -62.7 1.54 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -75.03 -29.81 60.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.447 0.642 . . . . 10.0 110.073 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.916 HG23 ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -70.78 -46.36 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 115.097 -0.956 . . . . 10.0 110.723 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.014 HD13 HG21 ' A' ' 91' ' ' VAL . 7.6 tp -61.22 -44.56 98.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 119.911 -0.716 . . . . 10.0 109.595 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.87 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.4 tt0 -49.42 -47.52 47.98 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.829 -0.623 . . . . 10.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.593 ' HB2' HD11 ' A' ' 68' ' ' ILE . 49.5 mm-40 -66.13 -37.36 85.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.477 -0.783 . . . . 10.0 110.948 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.661 ' CD1' HG11 ' A' ' 91' ' ' VAL . 60.0 mt -51.4 -43.24 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 120.886 0.374 . . . . 10.0 111.208 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.9 p -87.61 -49.43 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.684 0.624 . . . . 10.0 112.684 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.87 HG12 ' O ' ' A' ' 143' ' ' GLU . 7.2 p -82.85 13.03 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.935 0.717 . . . . 10.0 112.935 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.575 ' HA ' ' HE3' ' A' ' 148' ' ' LYS . 2.0 tpmt? -53.99 -45.79 71.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.708 -0.397 . . . . 10.0 111.131 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -57.34 130.88 48.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.084 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 174.28 -46.65 0.14 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.843 -0.694 . . . . 10.0 112.377 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.6 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.828 0.347 . . . . 10.0 111.018 -179.968 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.803 0.335 . . . . 10.0 111.088 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.6 ' HG2' HG22 ' A' ' 3' ' ' THR . 61.5 tttm -66.47 -74.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.634 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.6 HG22 ' HG2' ' A' ' 2' ' ' LYS . 9.2 t 169.07 -46.9 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.018 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.495 ' N ' HG23 ' A' ' 3' ' ' THR . 85.8 mt -73.57 -42.31 61.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.259 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.97 57.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.824 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.36 135.98 55.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.743 0.306 . . . . 10.0 110.776 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 63.19 144.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.165 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.783 HD21 ' HA ' ' A' ' 110' ' ' ASP . 0.5 OUTLIER -155.27 55.56 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.918 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HD2' ' C ' ' A' ' 9' ' ' LYS . 3.4 tmmm? -156.52 -47.74 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.834 -0.621 . . . . 10.0 110.23 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 44.1 tt0 -141.37 163.46 32.89 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.392 0.615 . . . . 10.0 110.8 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.553 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 10.9 t80 -162.36 138.9 7.79 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.804 -1.089 . . . . 10.0 111.959 -174.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.422 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -88.68 141.22 28.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.891 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -157.43 171.32 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 113.817 1.043 . . . . 10.0 113.817 -176.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 1.08 HD11 HD13 ' A' ' 82' ' ' ILE . 3.1 tm? -88.72 136.03 33.21 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.942 ' HB3' HD22 ' A' ' 102' ' ' LEU . 55.5 p -151.42 156.49 40.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.8 0.81 . . . . 10.0 113.119 -177.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.729 ' CD2' HD11 ' A' ' 82' ' ' ILE . 7.7 p90 -149.67 166.54 29.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.198 -1.365 . . . . 10.0 110.06 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -88.59 140.33 29.56 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.215 -0.661 . . . . 10.0 109.215 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.015 HG21 HD12 ' A' ' 71' ' ' ILE . 35.8 mm -138.8 86.03 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.63 -0.714 . . . . 10.0 111.889 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 0.8 OUTLIER 51.48 60.03 4.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.885 -0.598 . . . . 10.0 111.808 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 48.4 mt-10 78.56 -35.15 0.18 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.465 -0.788 . . . . 10.0 111.09 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 134' ' ' ILE . 25.5 tt0 -88.82 139.31 30.59 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.422 -0.584 . . . . 10.0 109.422 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.078 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.75 163.87 15.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 10.0 111.118 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.894 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.0 OUTLIER -147.01 138.23 24.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.969 -0.559 . . . . 10.0 111.133 -178.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -138.94 155.28 48.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.993 ' CE2' HD22 ' A' ' 136' ' ' LEU . 3.8 m-85 -138.44 138.67 38.38 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.995 -1.002 . . . . 10.0 108.926 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -51.35 121.57 6.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.948 0.404 . . . . 10.0 110.379 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.891 HG13 ' HA ' ' A' ' 13' ' ' VAL . 32.2 m -61.37 -11.9 5.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.89 -0.596 . . . . 10.0 111.175 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.99 -41.33 96.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 10.0 110.41 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.989 ' ND2' HG21 ' A' ' 138' ' ' ILE . 12.1 t30 -92.51 -46.68 7.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.35 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.838 HG21 ' HG ' ' A' ' 14' ' ' LEU . 27.7 mm -57.67 127.11 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.896 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' CE ' ' A' ' 32' ' ' MET . 54.2 mt-10 -82.93 -63.6 1.33 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.948 0.351 . . . . 10.0 111.948 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.418 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.8 tpp -169.08 173.91 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.979 0.418 . . . . 10.0 111.381 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.527 ' CG1' HG11 ' A' ' 98' ' ' VAL . 34.8 m -95.61 156.36 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.725 -0.67 . . . . 10.0 111.996 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 33' ' ' VAL . 17.3 pt -160.05 123.62 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.557 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 48.6 mp0 -89.13 116.92 27.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.863 0.363 . . . . 10.0 111.214 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.487 ' HB2' ' NZ ' ' A' ' 36' ' ' LYS . 5.0 ttmp? -169.21 63.82 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.801 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 51.9 m -57.12 163.16 2.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.702 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.6 t70 55.96 50.65 13.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.704 -0.68 . . . . 10.0 112.158 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.746 HD12 HG21 ' A' ' 62' ' ' VAL . 17.5 mt -77.17 147.54 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.44 -0.345 . . . . 10.0 111.666 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.8 HG23 ' HG2' ' A' ' 43' ' ' PRO . 55.1 m 3.95 70.57 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.246 -0.888 . . . . 10.0 112.956 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -87.81 -52.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.76 2.307 . . . . 10.0 113.738 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 27.4 m -79.88 -30.38 0.61 Allowed Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 113.341 0.867 . . . . 10.0 113.341 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.8 ' HG2' HG23 ' A' ' 40' ' ' THR . 77.8 Cg_exo -51.51 -71.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.777 1.651 . . . . 10.0 112.95 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' NZ ' ' HB ' ' A' ' 49' ' ' VAL . 32.2 ttpt -67.91 -69.35 0.32 Allowed 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.664 0.745 . . . . 10.0 109.636 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.1 t 50.15 59.51 4.5 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.541 -1.209 . . . . 10.0 111.948 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.8 mmt-85 -148.1 -62.93 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.848 0.314 . . . . 10.0 111.848 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.431 ' HB2' ' HZ1' ' A' ' 44' ' ' LYS . 91.1 m-70 -76.42 -170.79 1.59 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 10.0 111.889 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' CG ' ' HD3' ' A' ' 148' ' ' LYS . 21.3 t80 -71.24 -43.69 66.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.331 -0.85 . . . . 10.0 111.094 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.954 ' HA ' HG22 ' A' ' 63' ' ' VAL . 96.8 t -49.23 127.33 4.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.14 0.495 . . . . 10.0 111.261 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.79 -40.18 79.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 10.0 111.463 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.443 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -163.02 -175.79 34.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.331 -0.938 . . . . 10.0 113.219 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.703 ' H ' ' HB ' ' A' ' 40' ' ' THR . 1.9 m -147.33 167.83 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.664 -0.495 . . . . 10.0 109.664 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.474 HG21 ' HD2' ' A' ' 36' ' ' LYS . 30.1 pt -158.87 145.48 7.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.942 0.401 . . . . 10.0 111.551 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' O ' HD23 ' A' ' 55' ' ' LEU . 41.3 t30 -88.79 135.57 33.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.001 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 54' ' ' ASN . 97.3 mt -159.32 138.89 11.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.376 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.2 mmt-85 48.38 45.69 20.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.449 . . . . 10.0 110.786 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.24 41.58 94.96 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.929 -0.653 . . . . 10.0 112.617 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -167.87 133.0 1.86 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.838 0.351 . . . . 10.0 110.97 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.614 HD12 ' N ' ' A' ' 59' ' ' ILE . 1.5 mp -88.94 141.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.099 -0.501 . . . . 10.0 111.123 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.827 HG22 ' HB2' ' A' ' 90' ' ' GLU . 2.4 pp -126.22 132.51 24.34 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.385 -0.371 . . . . 10.0 111.126 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 83.4 Cg_endo -81.04 115.38 2.99 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.469 2.113 . . . . 10.0 112.889 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.746 HG21 HD12 ' A' ' 39' ' ' ILE . 26.9 m -89.02 135.63 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.954 HG22 ' HA ' ' A' ' 49' ' ' VAL . 82.6 t -137.36 154.38 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.791 0.805 . . . . 10.0 113.074 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.473 ' N ' HG12 ' A' ' 63' ' ' VAL . 74.6 m-20 -76.7 65.73 2.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.521 -1.218 . . . . 10.0 109.263 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.86 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.6 tt -53.48 -36.35 61.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.158 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.749 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -57.75 -23.47 52.29 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.207 -0.597 . . . . 10.0 109.426 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.633 ' HE3' ' N ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -82.86 -48.77 10.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.69 -0.686 . . . . 10.0 110.744 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 65' ' ' LEU . 11.0 tt -58.5 -39.87 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 107.863 -1.162 . . . . 10.0 107.863 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.879 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -76.42 -48.98 17.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 113.711 -1.586 . . . . 10.0 109.795 177.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.575 ' N ' HD13 ' A' ' 69' ' ' LEU . . . 118.56 -93.26 0.56 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.169 -0.539 . . . . 10.0 113.125 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.015 HD12 HG21 ' A' ' 18' ' ' ILE . 3.0 pt 48.57 163.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 113.112 0.782 . . . . 10.0 113.112 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 74.8 m -45.29 -36.54 4.12 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.32 -0.622 . . . . 10.0 109.32 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.884 ' HB3' HG13 ' A' ' 71' ' ' ILE . 15.7 t80 -27.03 141.52 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.546 -1.206 . . . . 10.0 113.005 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 74' ' ' ASP . 9.0 t70 -161.81 32.15 0.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.242 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 78' ' ' MET . 94.4 mt-10 54.55 45.54 26.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.938 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -98.2 -36.12 10.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.492 0.553 . . . . 10.0 112.492 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.463 ' HB3' ' OD2' ' A' ' 96' ' ' ASP . 70.6 mmtt -136.88 17.9 3.04 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.357 0.873 . . . . 10.0 113.357 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.496 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 14.0 mmm -53.93 142.5 24.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.014 -0.365 . . . . 10.0 110.014 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -172.55 42.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.892 0.377 . . . . 10.0 111.267 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.9 ' O ' HD12 ' A' ' 94' ' ' LEU . 79.2 p -169.09 158.02 8.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 10.0 110.155 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.58 ' CD1' HD11 ' A' ' 39' ' ' ILE . 45.1 mt -137.35 132.24 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.876 0.369 . . . . 10.0 111.404 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.08 HD13 HD11 ' A' ' 14' ' ' LEU . 26.5 mt -105.34 129.96 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.953 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.41 HG12 ' OE1' ' A' ' 31' ' ' GLU . 91.7 t -98.81 150.62 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.047 0.451 . . . . 10.0 110.93 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -153.73 174.84 14.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.962 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' CG2' ' A' ' 86' ' ' THR . 23.5 ptt180 -127.39 143.8 51.15 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.525 HG21 HG12 ' A' ' 138' ' ' ILE . 45.5 p -160.02 108.19 1.7 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.532 0.568 . . . . 10.0 112.532 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 2.4 tppp? 46.44 47.72 13.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.777 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 1.5 m-20 73.35 34.32 1.02 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.167 -0.924 . . . . 10.0 111.285 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.893 HG12 HG22 ' A' ' 91' ' ' VAL . 59.0 t -134.0 110.42 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 115.141 -0.936 . . . . 10.0 109.25 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.827 ' HB2' HG22 ' A' ' 60' ' ' ILE . 83.4 mt-10 -88.23 97.92 11.28 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.047 HG21 HD13 ' A' ' 142' ' ' ILE . 4.5 t -88.55 152.24 3.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.4 -1.727 . . . . 10.0 113.33 -173.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 82' ' ' ILE . . . -124.5 157.26 18.79 Favored Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.443 -1.253 . . . . 10.0 113.164 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.618 ' CG ' ' HB3' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -143.84 123.83 13.58 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-O 120.964 0.412 . . . . 10.0 110.613 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 80' ' ' SER . 64.9 tp -88.74 126.75 35.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.146 0.498 . . . . 10.0 111.179 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.738 HG23 ' OG ' ' A' ' 80' ' ' SER . 26.8 m -136.88 -175.26 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.697 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 77' ' ' LYS . 3.0 t0 -88.12 -77.94 0.34 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.501 . . . . 10.0 111.253 -178.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.6 ttt85 -128.63 107.97 10.13 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.611 ' HA ' ' HB3' ' A' ' 16' ' ' PHE . 9.0 p -88.99 113.79 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 122.434 1.111 . . . . 10.0 111.396 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -62.7 -28.67 70.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.036 -1.893 . . . . 10.0 111.106 -178.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.81 -121.2 5.51 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.777 -0.929 . . . . 10.0 110.777 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.99 126.77 9.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 117.203 0.501 . . . . 10.0 109.769 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 15' ' ' SER . 54.8 tp -128.05 136.16 50.85 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.028 0.442 . . . . 10.0 111.139 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.618 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 0.2 OUTLIER -88.82 78.64 7.57 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.584 179.2 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.673 HG13 HG11 ' A' ' 13' ' ' VAL . 6.8 mm -88.57 157.39 3.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.832 -0.622 . . . . 10.0 109.454 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 24.0 p -116.65 148.47 40.97 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.056 -1.09 . . . . 10.0 108.056 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.503 ' OE2' HD22 ' A' ' 8' ' ' LEU . 37.1 tt0 -111.77 68.31 0.66 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.996 0.903 . . . . 10.0 112.016 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -99.55 8.31 44.58 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.02 -1.445 . . . . 10.0 108.014 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 113' ' ' ASN . 22.5 pt20 -106.68 -45.7 4.16 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.691 -1.14 . . . . 10.0 110.398 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 mt -85.38 33.79 0.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.115 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.783 ' HA ' HD21 ' A' ' 8' ' ' LEU . 6.7 t70 -75.04 120.85 21.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.634 0.254 . . . . 10.0 111.236 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.441 ' HG ' ' OD1' ' A' ' 110' ' ' ASP . 81.9 mt 65.76 -54.57 0.36 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.183 -0.462 . . . . 10.0 112.095 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 112' ' ' THR . 9.1 t -176.58 56.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.97 0.414 . . . . 10.0 110.557 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 108' ' ' GLN . 5.1 m120 69.47 131.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.693 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 114' ' ' VAL . 37.5 t -131.23 42.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.076 0.465 . . . . 10.0 111.146 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 114' ' ' VAL . 44.7 t 176.03 -151.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.731 -0.668 . . . . 10.0 109.83 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.476 ' O ' ' CG ' ' A' ' 117' ' ' LYS . 2.3 p30 -91.04 -125.74 0.08 Allowed 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.662 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 37.8 mttp -166.53 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.161 0.505 . . . . 10.0 110.086 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.697 ' CE2' HD21 ' A' ' 69' ' ' LEU . 55.9 t80 -176.34 -51.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.309 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.88 -42.67 0.45 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.708 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.434 ' HE3' ' C ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER 179.85 40.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.235 -0.654 . . . . 10.0 109.235 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 122' ' ' SER . 2.9 tppp? -177.92 116.74 0.09 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.618 -0.719 . . . . 10.0 110.157 -179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.642 ' HB3' ' O ' ' A' ' 121' ' ' LYS . 13.2 t 81.26 143.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 10.0 110.903 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.662 ' HA ' ' HB3' ' A' ' 117' ' ' LYS . 22.0 pttp -105.13 30.9 5.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.962 0.727 . . . . 10.0 112.962 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 135' ' ' TYR . . . -134.38 143.53 15.23 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 119.792 -1.194 . . . . 10.0 112.9 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.835 HD13 ' N ' ' A' ' 126' ' ' VAL . 2.2 tm? -153.5 134.31 13.82 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.812 -0.44 . . . . 10.0 109.812 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.871 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.8 p -149.58 162.31 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.962 0.41 . . . . 10.0 111.593 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.495 ' N ' ' HD3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -165.91 132.24 2.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.203 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.498 ' O ' ' HG2' ' A' ' 131' ' ' ARG . 15.6 m -163.91 157.47 18.68 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 116.354 -0.384 . . . . 10.0 110.662 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' N ' ' CG2' ' A' ' 128' ' ' THR . 63.1 m-20 58.16 44.57 18.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.958 0.409 . . . . 10.0 110.735 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 52.59 32.16 38.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.65 -0.786 . . . . 10.0 111.764 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 128' ' ' THR . 3.2 ptp180 -138.89 136.14 35.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 10.0 110.417 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 132' ' ' LEU . 4.0 mp -88.92 143.46 26.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.733 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.078 HG12 ' HB3' ' A' ' 22' ' ' ALA . 4.3 mt -137.43 129.19 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 10.0 111.567 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.894 ' HB ' HD13 ' A' ' 23' ' ' LEU . 1.4 mp -88.97 134.54 28.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.475 ' O ' ' CA ' ' A' ' 124' ' ' GLY . 31.1 t80 -118.31 136.09 53.91 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.514 0.673 . . . . 10.0 111.467 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.993 HD22 ' CE2' ' A' ' 25' ' ' PHE . 6.1 mp -126.81 172.39 10.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.127 0.965 . . . . 10.0 112.603 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 137' ' ' ASP . 9.8 t70 -144.2 26.59 1.48 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.635 -1.62 . . . . 10.0 107.211 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.989 HG21 ' ND2' ' A' ' 29' ' ' ASN . 11.9 tt 40.4 17.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 113.846 -1.525 . . . . 10.0 114.349 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 137' ' ' ASP . 7.8 t0 -79.53 -61.73 1.91 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.794 0.665 . . . . 10.0 112.794 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -77.05 -30.88 55.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.457 0.646 . . . . 10.0 110.341 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.863 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -67.89 -45.69 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 114.97 -1.014 . . . . 10.0 110.63 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.047 HD13 HG21 ' A' ' 91' ' ' VAL . 7.9 tp -65.91 -43.04 93.06 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 C-N-CA 119.898 -0.721 . . . . 10.0 110.034 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.54 ' N ' HG23 ' A' ' 142' ' ' ILE . 89.3 tt0 -46.47 -46.7 19.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.312 0.577 . . . . 10.0 109.788 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 148' ' ' LYS . 61.0 mm-40 -68.89 -39.58 79.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.205 -0.907 . . . . 10.0 110.761 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.638 ' CD1' HG11 ' A' ' 91' ' ' VAL . 56.4 mt -48.52 -44.02 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.83 0.347 . . . . 10.0 111.505 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.9 p -75.57 -51.35 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 10.0 112.152 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 144' ' ' GLU . 12.9 p -70.79 -6.22 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.461 0.541 . . . . 10.0 112.461 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -50.55 -44.23 56.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.814 0.34 . . . . 10.0 110.754 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 56.73 -168.22 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.497 . . . . 10.0 111.204 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.9 -40.62 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.048 -0.596 . . . . 10.0 112.08 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 151' ' ' VAL . 12.5 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 10.0 111.072 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.872 0.367 . . . . 10.0 111.092 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.804 ' HD2' ' HB3' ' A' ' 5' ' ' ALA . 5.8 ptpp? -94.29 -119.91 0.1 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.045 -0.525 . . . . 10.0 110.593 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 2' ' ' LYS . 72.5 p -160.67 -46.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 69.4 mt -67.63 -34.33 76.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.613 -0.721 . . . . 10.0 109.995 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.804 ' HB3' ' HD2' ' A' ' 2' ' ' LYS . . . -139.65 -160.37 1.06 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.012 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -151.27 129.95 12.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.109 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.694 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -58.4 142.61 47.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 10.0 111.445 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.801 HD22 ' CD ' ' A' ' 106' ' ' GLU . 85.7 mt -148.12 43.29 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.502 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -92.32 -49.98 5.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.22 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.657 ' HG2' HG22 ' A' ' 105' ' ' THR . 83.4 mt-10 -138.77 164.3 29.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.522 0.677 . . . . 10.0 111.301 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 13.3 t80 -161.83 139.62 8.89 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.573 -1.194 . . . . 10.0 112.501 -174.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' O ' ' CE1' ' A' ' 11' ' ' PHE . 24.5 pt-20 -88.68 140.01 29.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.52 -0.919 . . . . 10.0 108.52 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.911 ' HA ' HG13 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -155.47 171.28 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 N-CA-C 114.084 1.142 . . . . 10.0 114.084 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.713 ' HG ' HG21 ' A' ' 30' ' ' ILE . 2.8 tm? -88.81 134.73 33.84 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.779 ' HB3' HD22 ' A' ' 102' ' ' LEU . 82.6 p -146.17 152.12 38.73 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 113.242 0.831 . . . . 10.0 113.242 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.656 ' HD2' HG23 ' A' ' 98' ' ' VAL . 2.4 p90 -149.43 166.81 27.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.181 -1.372 . . . . 10.0 109.991 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.528 ' HG3' HD21 ' A' ' 99' ' ' LEU . 94.8 mt-10 -88.56 139.36 30.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.253 0.549 . . . . 10.0 109.745 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.016 HG21 HD12 ' A' ' 71' ' ' ILE . 28.5 mm -138.96 103.27 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.364 -0.834 . . . . 10.0 110.957 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 0.9 OUTLIER 42.69 60.15 2.53 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.533 0.568 . . . . 10.0 112.533 179.331 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 86.7 mt-10 80.82 -42.89 0.2 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.385 -0.825 . . . . 10.0 111.912 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.814 ' NE2' HD11 ' A' ' 134' ' ' ILE . 17.3 pt20 -88.97 154.41 20.24 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.034 ' HB3' HG12 ' A' ' 133' ' ' ILE . . . -88.91 168.52 12.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.906 HD13 ' HB ' ' A' ' 134' ' ' ILE . 1.0 OUTLIER -152.31 135.6 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.872 -0.604 . . . . 10.0 110.617 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.823 ' N ' HD12 ' A' ' 23' ' ' LEU . . . -140.34 153.81 46.53 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.846 0.684 . . . . 10.0 112.846 -177.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CZ ' HD13 ' A' ' 136' ' ' LEU . 3.8 m-85 -135.54 143.07 45.52 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.071 -0.714 . . . . 10.0 109.071 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 28' ' ' ASP . 36.6 t70 -49.39 124.24 8.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.18 0.514 . . . . 10.0 110.806 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.911 HG13 ' HA ' ' A' ' 13' ' ' VAL . 30.1 m -64.76 -9.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.553 -0.749 . . . . 10.0 112.37 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.57 ' HB2' ' OD2' ' A' ' 26' ' ' ASP . 1.3 m-20 -72.0 -43.26 65.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.922 ' ND2' HG21 ' A' ' 138' ' ' ILE . 10.1 t30 -80.78 -49.77 10.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.776 -1.102 . . . . 10.0 110.071 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.713 HG21 ' HG ' ' A' ' 14' ' ' LEU . 21.9 mm -62.32 134.2 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.013 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' O ' ' CE ' ' A' ' 32' ' ' MET . 4.5 mm-40 -94.09 -68.77 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.745 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.409 ' CE ' ' O ' ' A' ' 31' ' ' GLU . 6.4 tpp -169.1 172.46 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.097 0.475 . . . . 10.0 111.087 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.025 HG11 HG11 ' A' ' 98' ' ' VAL . 33.9 m -97.54 145.8 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.571 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.458 HG13 ' HB ' ' A' ' 81' ' ' ILE . 11.1 pt -142.46 122.74 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.868 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 48.7 mt-10 -88.98 104.31 16.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.834 -0.432 . . . . 10.0 109.834 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 35' ' ' GLU . 67.9 mttm -161.34 69.79 0.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.218 0.451 . . . . 10.0 112.218 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.4 t -63.63 -169.46 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.797 0.332 . . . . 10.0 110.51 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 9.5 t70 45.32 47.67 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.018 0.437 . . . . 10.0 111.556 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.663 HD11 ' CD1' ' A' ' 81' ' ' ILE . 28.4 mt -82.32 -100.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.11 -0.495 . . . . 10.0 111.319 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.571 ' CG2' ' CD ' ' A' ' 43' ' ' PRO . 20.0 m -102.83 122.78 44.6 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 122.905 0.482 . . . . 10.0 109.888 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.94 36.3 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.81 2.34 . . . . 10.0 114.66 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.748 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 41.1 t 57.78 48.26 2.73 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.859 0.361 . . . . 10.0 111.2 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.748 ' HD3' ' N ' ' A' ' 42' ' ' VAL . 6.1 Cg_exo -76.19 -74.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.808 2.338 . . . . 10.0 111.059 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.482 ' NZ ' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -77.95 -33.75 51.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.446 0.641 . . . . 10.0 110.111 178.17 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.44 ' OG ' ' HB ' ' A' ' 49' ' ' VAL . 26.6 t -40.41 150.58 0.06 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.665 -1.152 . . . . 10.0 112.92 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 27.0 mmm180 -84.57 40.93 0.82 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.418 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.417 ' HB3' ' O ' ' A' ' 46' ' ' ARG . 30.9 t-80 70.97 -49.6 0.68 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CE1' ' HE3' ' A' ' 67' ' ' LYS . 2.0 t80 -54.84 -52.25 63.34 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.604 0.24 . . . . 10.0 111.637 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.87 ' HA ' HG22 ' A' ' 63' ' ' VAL . 61.6 t -68.56 131.56 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 10.0 111.39 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.628 ' OE1' HD22 ' A' ' 94' ' ' LEU . 16.7 pt-20 -78.06 -39.12 42.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.983 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.634 ' C ' HG22 ' A' ' 62' ' ' VAL . . . -158.06 179.36 33.82 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.314 -0.946 . . . . 10.0 113.275 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.482 HG11 ' NZ ' ' A' ' 44' ' ' LYS . 3.2 m -162.54 171.72 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' A' ' 52' ' ' VAL . 31.7 pt -159.8 138.92 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.061 0.458 . . . . 10.0 112.069 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.887 ' C ' HD22 ' A' ' 55' ' ' LEU . 21.3 t-20 -114.18 118.87 35.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.078 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.887 HD22 ' C ' ' A' ' 54' ' ' ASN . 3.5 mm? -144.48 135.22 24.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.765 0.317 . . . . 10.0 111.487 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 42.66 51.09 5.01 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.669 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.24 42.56 97.32 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.711 -0.757 . . . . 10.0 112.454 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.657 ' C ' HD12 ' A' ' 59' ' ' ILE . 56.3 ttp180 -145.49 119.31 9.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 10.0 110.396 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.804 HD11 ' ND2' ' A' ' 54' ' ' ASN . 1.4 mp -110.05 140.86 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.988 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.82 HG22 ' HB3' ' A' ' 90' ' ' GLU . 2.0 pp -142.61 134.62 13.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.919 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 72.1 Cg_endo -99.7 114.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.178 2.585 . . . . 10.0 113.169 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' C ' ' A' ' 51' ' ' GLY . 29.1 m -89.0 134.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.87 HG22 ' HA ' ' A' ' 49' ' ' VAL . 92.0 t -143.21 154.2 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.736 0.779 . . . . 10.0 112.957 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.465 ' N ' HG12 ' A' ' 63' ' ' VAL . 74.5 m-20 -73.29 67.17 0.96 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.577 -1.192 . . . . 10.0 108.662 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.838 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.9 tt -53.58 -34.17 57.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.121 -178.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.801 ' CB ' HD11 ' A' ' 71' ' ' ILE . . . -61.27 -22.13 64.56 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.325 -0.55 . . . . 10.0 109.642 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.488 ' HE2' ' N ' ' A' ' 68' ' ' ILE . 1.6 tmmm? -83.85 -50.14 8.37 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.835 -0.62 . . . . 10.0 109.945 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 65' ' ' LEU . 10.0 tt -54.25 -40.12 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 107.602 -1.258 . . . . 10.0 107.602 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.897 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -77.67 -47.3 19.56 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.526 -1.67 . . . . 10.0 109.383 177.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.514 ' N ' HD13 ' A' ' 69' ' ' LEU . . . 116.63 -92.78 0.57 Allowed Glycine 0 C--N 1.337 0.63 0 CA-C-N 115.975 -0.557 . . . . 10.0 113.193 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.016 HD12 HG21 ' A' ' 18' ' ' ILE . 2.9 pt 48.25 164.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 45.2 t -45.83 -34.9 4.04 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.925 ' HB3' HG13 ' A' ' 71' ' ' ILE . 17.7 t80 -31.48 143.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.582 -1.19 . . . . 10.0 113.09 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -173.53 41.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.071 -0.968 . . . . 10.0 109.888 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HA ' ' HG2' ' A' ' 78' ' ' MET . 55.8 mt-10 62.92 41.6 8.4 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.782 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -72.44 -49.05 36.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.05 -0.523 . . . . 10.0 112.388 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.03 18.92 0.68 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.371 -0.532 . . . . 10.0 112.346 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.564 ' HE3' ' HA ' ' A' ' 95' ' ' VAL . 3.4 mmm -53.14 146.61 11.22 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.149 -0.315 . . . . 10.0 110.149 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HE2' ' OD1' ' A' ' 96' ' ' ASP . 48.2 mtmt -159.39 -45.85 0.05 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.779 0.323 . . . . 10.0 111.533 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.8 m -88.87 133.38 34.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.211 0.529 . . . . 10.0 111.332 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.663 ' CD1' HD11 ' A' ' 39' ' ' ILE . 25.9 mt -89.65 151.09 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.526 -0.761 . . . . 10.0 111.527 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.512 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 23.1 mt -115.04 156.6 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 10.0 110.291 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.511 ' N ' HG22 ' A' ' 82' ' ' ILE . 41.3 t -133.61 148.73 30.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.931 0.396 . . . . 10.0 110.995 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.713 ' O ' ' HA ' ' A' ' 90' ' ' GLU . . . -152.89 175.86 12.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.798 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.663 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 52.6 ttm-85 -133.08 132.6 41.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.873 -0.417 . . . . 10.0 109.873 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.801 HG22 ' OD1' ' A' ' 29' ' ' ASN . 65.4 p -141.53 102.14 4.13 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.378 0.609 . . . . 10.0 111.602 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 88' ' ' ASP . 15.1 tppt? 48.56 48.26 19.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.005 -0.998 . . . . 10.0 110.771 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 13.5 m-20 80.17 27.32 0.3 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.917 -1.038 . . . . 10.0 111.999 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.916 HG12 HG22 ' A' ' 91' ' ' VAL . 51.6 t -124.59 108.98 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.057 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.82 ' HB3' HG22 ' A' ' 60' ' ' ILE . 33.9 tt0 -88.37 97.88 11.3 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.373 -1.714 . . . . 10.0 106.373 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.992 HG21 HD13 ' A' ' 142' ' ' ILE . 3.2 t -88.57 158.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 113.123 -1.853 . . . . 10.0 112.14 -174.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.13 143.03 14.6 Favored Glycine 0 C--N 1.317 -0.486 0 C-N-CA 120.234 -0.984 . . . . 10.0 113.833 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.624 ' CD1' ' HB3' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -131.38 128.77 40.29 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.628 HD22 ' OE1' ' A' ' 50' ' ' GLU . 65.5 tp -88.52 133.52 34.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.437 0.636 . . . . 10.0 111.904 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.6 HG11 ' CE1' ' A' ' 16' ' ' PHE . 27.6 m -147.28 -175.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.014 -0.994 . . . . 10.0 110.209 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.465 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 16.0 t70 -109.94 -58.44 2.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.551 0.574 . . . . 10.0 112.551 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -127.83 122.72 33.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.383 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.025 HG11 HG11 ' A' ' 33' ' ' VAL . 7.3 p -116.35 117.78 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 122.3 1.048 . . . . 10.0 111.643 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.597 HD23 ' HA ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -69.71 -29.33 66.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.183 -1.826 . . . . 10.0 110.852 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.33 -125.59 7.73 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.778 -0.725 . . . . 10.0 111.701 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.8 t -50.84 132.27 11.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 117.079 0.44 . . . . 10.0 110.367 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 15' ' ' SER . 51.8 tp -135.69 139.9 44.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.019 0.437 . . . . 10.0 111.519 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 14.3 ptp180 -88.85 76.26 7.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.453 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.82 ' CD1' HG11 ' A' ' 126' ' ' VAL . 14.3 mm -88.73 168.37 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 N-CA-C 109.144 -0.687 . . . . 10.0 109.144 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.657 HG22 ' HG2' ' A' ' 10' ' ' GLU . 22.4 p -131.67 148.08 52.56 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.426 -0.953 . . . . 10.0 108.426 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.801 ' CD ' HD22 ' A' ' 8' ' ' LEU . 81.0 tt0 -106.4 72.07 0.9 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.894 0.854 . . . . 10.0 112.466 -177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -108.48 21.09 17.77 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.656 ' O ' HD23 ' A' ' 109' ' ' LEU . 19.6 pt20 -176.26 68.57 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.61 -1.177 . . . . 10.0 111.699 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 108' ' ' GLN . 78.4 mt -154.02 -42.02 0.09 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.098 -0.955 . . . . 10.0 111.485 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 111' ' ' LEU . 36.5 t70 -155.32 154.22 31.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 10.0 111.216 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 110' ' ' ASP . 56.4 tp 72.29 -57.46 0.62 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.179 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.631 ' OG1' HG23 ' A' ' 114' ' ' VAL . 9.7 t -62.1 -46.68 87.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.04 0.447 . . . . 10.0 110.892 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.5 ' N ' HG23 ' A' ' 112' ' ' THR . 5.3 m120 44.27 46.74 7.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.571 -0.741 . . . . 10.0 111.568 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.631 HG23 ' OG1' ' A' ' 112' ' ' THR . 68.3 t -62.95 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.528 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 46.8 t 179.63 167.47 1.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.838 0.351 . . . . 10.0 111.549 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 117' ' ' LYS . 1.5 m-20 -52.32 -33.62 43.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.947 -0.569 . . . . 10.0 111.23 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.525 ' HB3' ' CB ' ' A' ' 125' ' ' LEU . 46.2 mmtm 71.82 -56.61 0.64 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.12 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.73 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 2.9 t80 -108.59 -51.99 2.82 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.686 -0.406 . . . . 10.0 110.428 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.22 -145.26 10.53 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.529 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -87.43 -38.1 16.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.941 0.401 . . . . 10.0 110.93 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.47 ' NZ ' ' HB2' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -55.25 -33.23 62.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.857 -0.61 . . . . 10.0 111.696 -179.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.425 ' OG ' ' HG ' ' A' ' 136' ' ' LEU . 37.3 t -150.17 -149.94 0.32 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.108 -0.237 . . . . 10.0 111.18 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.478 ' NZ ' ' HB3' ' A' ' 123' ' ' LYS . 4.2 mmmp? -158.46 -25.41 0.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.632 0.605 . . . . 10.0 112.632 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 135' ' ' TYR . . . -74.35 137.81 23.32 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.182 -1.008 . . . . 10.0 113.914 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.525 ' CB ' ' HB3' ' A' ' 117' ' ' LYS . 1.7 tm? -158.1 79.92 0.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.705 -0.85 . . . . 10.0 108.705 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 1.005 HG13 ' HB ' ' A' ' 133' ' ' ILE . 1.8 p -88.82 163.6 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.177 -0.919 . . . . 10.0 112.021 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' N ' ' CG2' ' A' ' 126' ' ' VAL . 39.7 ttmt -163.66 132.76 3.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.663 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 129' ' ' ASP . 16.1 m -161.92 158.81 25.85 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 120.925 0.393 . . . . 10.0 111.435 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.451 ' N ' ' CG2' ' A' ' 128' ' ' THR . 9.4 p-10 44.6 52.89 7.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.69 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 51.6 37.13 41.05 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.541 -0.838 . . . . 10.0 111.98 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -146.06 126.46 14.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.088 -0.338 . . . . 10.0 110.088 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.61 ' C ' HD22 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -88.95 144.74 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.458 . . . . 10.0 110.607 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 1.034 HG12 ' HB3' ' A' ' 22' ' ' ALA . 5.9 mt -133.91 139.77 47.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.548 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.906 ' HB ' HD13 ' A' ' 23' ' ' LEU . 4.3 mm -88.81 143.71 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.413 -0.958 . . . . 10.0 108.413 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.527 ' HB3' ' HA3' ' A' ' 124' ' ' GLY . 38.1 t80 -138.77 136.46 35.74 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.609 0.719 . . . . 10.0 111.824 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.645 HD13 ' CZ ' ' A' ' 25' ' ' PHE . 4.3 mp -129.43 149.8 51.06 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.272 -0.876 . . . . 10.0 112.719 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 137' ' ' ASP . 9.9 t70 -113.65 19.61 16.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.253 -1.339 . . . . 10.0 107.623 177.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.922 HG21 ' ND2' ' A' ' 29' ' ' ASN . 12.4 tt 39.19 20.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 114.283 -1.326 . . . . 10.0 113.67 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 142' ' ' ILE . 66.7 t0 -81.89 -60.83 2.1 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.72 0.637 . . . . 10.0 112.72 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -75.48 -32.72 60.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.534 0.683 . . . . 10.0 109.915 -179.645 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.849 ' CG2' ' HA ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.28 -45.25 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 114.911 -1.04 . . . . 10.0 110.558 179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.992 HD13 HG21 ' A' ' 91' ' ' VAL . 8.0 tp -61.99 -46.02 97.41 Favored 'Isoleucine or valine' 0 C--N 1.337 0.054 0 C-N-CA 120.339 -0.545 . . . . 10.0 110.14 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.669 ' O ' HG12 ' A' ' 147' ' ' VAL . 51.9 mt-10 -49.24 -43.76 43.04 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.192 0.52 . . . . 10.0 109.72 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.617 ' HB2' HD11 ' A' ' 68' ' ' ILE . 54.9 mm-40 -66.25 -32.13 73.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.323 -0.853 . . . . 10.0 110.555 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.651 HD12 HD12 ' A' ' 142' ' ' ILE . 31.1 mt -58.98 -42.15 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 120.926 0.393 . . . . 10.0 110.85 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.3 p -79.8 -50.26 10.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.771 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 143' ' ' GLU . 12.9 p -75.78 0.96 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.437 ' HE2' ' CG2' ' A' ' 49' ' ' VAL . 23.0 pttp -45.22 -46.48 12.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.837 0.351 . . . . 10.0 111.229 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.96 134.24 49.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.841 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 178.31 43.71 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.636 -0.793 . . . . 10.0 112.513 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 10.0 111.009 179.961 . . . . . . . . 0 0 . 1 stop_ save_